From 1ec9e401964ce651be753fecc483e14a3ab32035 Mon Sep 17 00:00:00 2001 From: "vladimir.buzalka" Date: Fri, 5 Jun 2026 11:57:04 +0200 Subject: [PATCH] z230 --- ...42-33 77242113UCO3001 Clario MayoScore.csv | 47 + ...43-32 77242113UCO3001 Clario eCOA DCRs.csv | 182 ++ ...46-07 77242113UCO3001 Clario MayoDiary.csv | 1245 +++++++++ ...242113UCO3001_ANALYSIS Clario ECG DCRs.csv | 10 + ...sponsor-study-35472-samples-allSamples.csv | 1199 ++++++++ ...6940-activity-reports-documents-equery.csv | 79 + ...orts-documents-equery_unresponded_only.csv | 9 + ...36940-kit-inventory-on-hand-expiration.csv | 541 ++++ ...35472-kit-inventory-on-hand-expiration.csv | 284 ++ ...sponsor-study-36940-samples-allSamples.csv | 1514 ++++++++++ ...6940-activity-reports-documents-equery.csv | 75 + ...orts-documents-equery_unresponded_only.csv | 9 + ...6940-activity-reports-documents-equery.csv | 75 + ...orts-documents-equery_unresponded_only.csv | 9 + ...udy-36940-test-results-930525-standard.csv | 709 +++++ ...36940-test-results-930525-microbiology.csv | 6 + ...udy-36940-test-results-930556-standard.csv | 75 + ...36940-test-results-930556-microbiology.csv | 3 + ...udy-36940-test-results-930549-standard.csv | 242 ++ ...36940-test-results-930549-microbiology.csv | 3 + ...36940-test-results-930555-microbiology.csv | 6 + ...udy-36940-test-results-930555-standard.csv | 409 +++ ...udy-36940-test-results-930547-standard.csv | 500 ++++ ...36940-test-results-930547-microbiology.csv | 5 + ...36940-test-results-930539-microbiology.csv | 5 + ...udy-36940-test-results-930539-standard.csv | 178 ++ ...36940-test-results-930557-microbiology.csv | 6 + ...udy-36940-test-results-930557-standard.csv | 738 +++++ ...36940-test-results-930553-microbiology.csv | 4 + ...udy-36940-test-results-930553-standard.csv | 250 ++ ...36940-test-results-930536-microbiology.csv | 3 + ...udy-36940-test-results-930536-standard.csv | 127 + ...36940-test-results-930531-microbiology.csv | 3 + ...udy-35472-test-results-898745-standard.csv | 2448 +++++++++++++++++ ...udy-36940-test-results-930531-standard.csv | 243 ++ ...udy-35472-test-results-898739-standard.csv | 1899 +++++++++++++ ...udy-35472-test-results-898733-standard.csv | 2409 ++++++++++++++++ ...udy-35472-test-results-898744-standard.csv | 200 ++ ...udy-35472-test-results-898727-standard.csv | 994 +++++++ ...6940-activity-reports-documents-equery.csv | 76 + ...orts-documents-equery_unresponded_only.csv | 9 + ...udy-36940-test-results-930525-standard.csv | 709 +++++ ...udy-36940-test-results-930556-standard.csv | 75 + ...36940-test-results-930525-microbiology.csv | 6 + ...36940-test-results-930556-microbiology.csv | 3 + ...udy-36940-test-results-930549-standard.csv | 242 ++ ...36940-test-results-930549-microbiology.csv | 3 + ...udy-36940-test-results-930555-standard.csv | 422 +++ ...36940-test-results-930555-microbiology.csv | 6 + ...36940-test-results-930547-microbiology.csv | 5 + ...udy-36940-test-results-930547-standard.csv | 500 ++++ ...36940-test-results-930539-microbiology.csv | 5 + ...udy-36940-test-results-930539-standard.csv | 178 ++ ...36940-test-results-930557-microbiology.csv | 6 + ...udy-36940-test-results-930557-standard.csv | 738 +++++ ...36940-test-results-930553-microbiology.csv | 4 + ...36940-test-results-930536-microbiology.csv | 3 + ...udy-36940-test-results-930553-standard.csv | 250 ++ ...udy-36940-test-results-930536-standard.csv | 127 + ...36940-test-results-930531-microbiology.csv | 3 + ...udy-36940-test-results-930531-standard.csv | 243 ++ ...udy-35472-test-results-898745-standard.csv | 2448 +++++++++++++++++ ...udy-35472-test-results-898739-standard.csv | 1899 +++++++++++++ ...udy-35472-test-results-898733-standard.csv | 2409 ++++++++++++++++ ...udy-35472-test-results-898744-standard.csv | 200 ++ ...udy-35472-test-results-898727-standard.csv | 994 +++++++ .../BrowserMetrics-6A227387-63A0.pma | Bin 0 -> 4194304 bytes .../Default/Cache/Cache_Data/f_000010 | Bin 0 -> 184773 bytes .../Default/Code Cache/js/07924cabba2dbd71_0 | Bin 0 -> 29784 bytes .../Default/Code Cache/js/1884a2c7cf8bd0fc_0 | Bin 0 -> 18952 bytes .../Default/Code Cache/js/245e25c90b49f498_0 | Bin 0 -> 112688 bytes .../Default/Code Cache/js/2877672f9e30fe66_0 | Bin 0 -> 18180 bytes .../Default/Code Cache/js/318def2427171f8c_0 | Bin 0 -> 35088 bytes .../Default/Code Cache/js/5073d0b38ee6c87b_0 | Bin 0 -> 35308 bytes .../Default/Code Cache/js/6ac91d3e212f6092_0 | Bin 0 -> 30740 bytes .../Default/Code Cache/js/742766f146967483_0 | Bin 0 -> 37900 bytes .../Default/Code Cache/js/7e5a106893c414ad_0 | Bin 0 -> 18392 bytes .../Default/Code Cache/js/80b0948d2b7a7f7d_0 | Bin 0 -> 39728 bytes .../Default/Code Cache/js/87aed881955d029c_0 | Bin 0 -> 55300 bytes .../Default/Code Cache/js/9364a8e737f0d7be_0 | Bin 0 -> 19300 bytes .../Default/Code Cache/js/a413582fe2bfd4c4_0 | Bin 0 -> 31820 bytes .../Default/Code Cache/js/a88a45ac8c2956c3_0 | Bin 0 -> 18848 bytes .../Default/Code Cache/js/b3e8160d37fe8e2c_0 | Bin 0 -> 29784 bytes .../Default/Code Cache/js/be1066dbf7192317_0 | Bin 0 -> 54484 bytes .../Default/Code Cache/js/c3850e800f11cba5_0 | Bin 0 -> 22832 bytes .../Default/Code Cache/js/cbfe490d85252278_0 | Bin 0 -> 112808 bytes .../Default/Code Cache/js/d471eae342b04394_0 | Bin 0 -> 31396 bytes .../Default/Code Cache/js/dd1759a9cf2d60f1_0 | Bin 0 -> 19000 bytes .../Default/Code Cache/js/ef638d71743b45b4_0 | Bin 0 -> 33900 bytes .../Default/Code Cache/js/f655ca43d2607cea_0 | Bin 0 -> 18180 bytes .../Default/Code Cache/js/f9741c0887f69ce7_0 | Bin 0 -> 37300 bytes .../Default/Code Cache/js/fb2abdf29f069dcc_0 | Bin 0 -> 19084 bytes .../Default/Local Storage/leveldb/000185.ldb | Bin 0 -> 33152 bytes .../Default/Local Storage/leveldb/000188.ldb | Bin 0 -> 23545 bytes .../Default/Local Storage/leveldb/000189.log | Bin 0 -> 76349 bytes .../Default/Local Storage/leveldb/000190.ldb | Bin 0 -> 25884 bytes .../Default/Local Storage/leveldb/000191.log | Bin 0 -> 33990 bytes .../Default/Local Storage/leveldb/000192.ldb | Bin 0 -> 9979 bytes .../Sessions/Session_13425116005294563 | Bin 0 -> 35330 bytes .../Sessions/Session_13425116297819620 | Bin 0 -> 81884 bytes .../Default/Sessions/Tabs_13425116005578150 | Bin 0 -> 490794 bytes .../Default/Sessions/Tabs_13425116298054337 | Bin 0 -> 496945 bytes ...5 42847922MDD3003 CZ IWRS overview v1.xlsx | Bin 0 -> 150296 bytes ...5 77242113UCO3001 CZ IWRS overview v1.xlsx | Bin 0 -> 36163 bytes 104 files changed, 28306 insertions(+) create mode 100644 Clario/Downloads/Zpracovano/2026-06-05_08-42-33 77242113UCO3001 Clario MayoScore.csv create mode 100644 Clario/Downloads/Zpracovano/2026-06-05_08-43-32 77242113UCO3001 Clario eCOA DCRs.csv create mode 100644 Clario/Downloads/Zpracovano/2026-06-05_08-46-07 77242113UCO3001 Clario MayoDiary.csv create mode 100644 Clario/Downloads/Zpracovano/2026-06-05_08-49-04 77242113UCO3001_ANALYSIS Clario ECG DCRs.csv create mode 100644 Covance_MDD3003/Source/Zpracovano/2026-06-05_085844 sponsor-study-35472-samples-allSamples.csv create mode 100644 Covance_UCO3001/Source/2026-06-05_085228 sponsor-study-36940-activity-reports-documents-equery.csv create mode 100644 Covance_UCO3001/Source/2026-06-05_085228 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv create mode 100644 Covance_UCO3001/Source/Zpracovano/2026-06-05_085404 sponsor-study-36940-kit-inventory-on-hand-expiration.csv create mode 100644 Covance_UCO3001/Source/Zpracovano/2026-06-05_085423 sponsor-study-35472-kit-inventory-on-hand-expiration.csv create mode 100644 Covance_UCO3001/Source/Zpracovano/2026-06-05_085844 sponsor-study-36940-samples-allSamples.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-28_093416 sponsor-study-36940-activity-reports-documents-equery.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-28_093416 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140223 sponsor-study-36940-test-results-930525-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140224 sponsor-study-36940-test-results-930525-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140225 sponsor-study-36940-test-results-930556-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140241 sponsor-study-36940-test-results-930556-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140304 sponsor-study-36940-test-results-930549-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140310 sponsor-study-36940-test-results-930549-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140313 sponsor-study-36940-test-results-930555-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140319 sponsor-study-36940-test-results-930555-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140326 sponsor-study-36940-test-results-930547-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140330 sponsor-study-36940-test-results-930547-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140333 sponsor-study-36940-test-results-930539-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140341 sponsor-study-36940-test-results-930539-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140350 sponsor-study-36940-test-results-930557-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140350 sponsor-study-36940-test-results-930557-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140353 sponsor-study-36940-test-results-930553-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140402 sponsor-study-36940-test-results-930553-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140413 sponsor-study-36940-test-results-930536-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140415 sponsor-study-36940-test-results-930536-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140431 sponsor-study-36940-test-results-930531-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140435 sponsor-study-35472-test-results-898745-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140436 sponsor-study-36940-test-results-930531-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140506 sponsor-study-35472-test-results-898739-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140518 sponsor-study-35472-test-results-898733-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140526 sponsor-study-35472-test-results-898744-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-05-29_140545 sponsor-study-35472-test-results-898727-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122241 sponsor-study-36940-activity-reports-documents-equery.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122241 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122704 sponsor-study-36940-test-results-930525-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122705 sponsor-study-36940-test-results-930556-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122709 sponsor-study-36940-test-results-930525-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122710 sponsor-study-36940-test-results-930556-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122727 sponsor-study-36940-test-results-930549-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122729 sponsor-study-36940-test-results-930549-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122741 sponsor-study-36940-test-results-930555-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122743 sponsor-study-36940-test-results-930555-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122748 sponsor-study-36940-test-results-930547-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122750 sponsor-study-36940-test-results-930547-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122808 sponsor-study-36940-test-results-930539-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122808 sponsor-study-36940-test-results-930539-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122812 sponsor-study-36940-test-results-930557-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122821 sponsor-study-36940-test-results-930557-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122829 sponsor-study-36940-test-results-930553-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122832 sponsor-study-36940-test-results-930536-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122832 sponsor-study-36940-test-results-930553-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122844 sponsor-study-36940-test-results-930536-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122855 sponsor-study-36940-test-results-930531-microbiology.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122906 sponsor-study-36940-test-results-930531-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122909 sponsor-study-35472-test-results-898745-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122935 sponsor-study-35472-test-results-898739-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_122958 sponsor-study-35472-test-results-898733-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_123005 sponsor-study-35472-test-results-898744-standard.csv create mode 100644 Covance_UCO3001/Source/tmp/2026-06-01_123027 sponsor-study-35472-test-results-898727-standard.csv create mode 100644 Covance_UCO3001/browser_profile/BrowserMetrics/BrowserMetrics-6A227387-63A0.pma create mode 100644 Covance_UCO3001/browser_profile/Default/Cache/Cache_Data/f_000010 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/07924cabba2dbd71_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/1884a2c7cf8bd0fc_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/245e25c90b49f498_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/2877672f9e30fe66_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/318def2427171f8c_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/5073d0b38ee6c87b_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/6ac91d3e212f6092_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/742766f146967483_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/7e5a106893c414ad_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/80b0948d2b7a7f7d_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/87aed881955d029c_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/9364a8e737f0d7be_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/a413582fe2bfd4c4_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/a88a45ac8c2956c3_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/b3e8160d37fe8e2c_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/be1066dbf7192317_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/c3850e800f11cba5_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/cbfe490d85252278_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/d471eae342b04394_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/dd1759a9cf2d60f1_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/ef638d71743b45b4_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/f655ca43d2607cea_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/f9741c0887f69ce7_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/fb2abdf29f069dcc_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000185.ldb create mode 100644 Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000188.ldb create mode 100644 Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000189.log create mode 100644 Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000190.ldb create mode 100644 Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000191.log create mode 100644 Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000192.ldb create mode 100644 Covance_UCO3001/browser_profile/Default/Sessions/Session_13425116005294563 create mode 100644 Covance_UCO3001/browser_profile/Default/Sessions/Session_13425116297819620 create mode 100644 Covance_UCO3001/browser_profile/Default/Sessions/Tabs_13425116005578150 create mode 100644 Covance_UCO3001/browser_profile/Default/Sessions/Tabs_13425116298054337 create mode 100644 IWRS/Drugs/output/2026-06-05 42847922MDD3003 CZ IWRS overview v1.xlsx create mode 100644 IWRS/Drugs/output/2026-06-05 77242113UCO3001 CZ IWRS overview v1.xlsx diff --git a/Clario/Downloads/Zpracovano/2026-06-05_08-42-33 77242113UCO3001 Clario MayoScore.csv b/Clario/Downloads/Zpracovano/2026-06-05_08-42-33 77242113UCO3001 Clario MayoScore.csv new file mode 100644 index 0000000..76f0856 --- /dev/null +++ b/Clario/Downloads/Zpracovano/2026-06-05_08-42-33 77242113UCO3001 Clario MayoScore.csv @@ -0,0 +1,47 @@ +"Protocol","Study Population","Country","Site","Principal Investigator","Participant ID","Baseline Stool Frequency","Visit","Visit Date","Endoscopy Completed?","Endoscopy Date","Bowel Preparation Start Date 1","Bowel Preparation End Date 1","Bowel Preparation Start Date 2","Bowel Preparation End Date 2","Central Endoscopy Score","Local Endoscopy Score","PGA Score","Eligible Day (-1)","Day (-1) Excluded Reason(s)","Eligible Day (-2)","Day (-2) Excluded Reason(s)","Eligible Day (-3)","Day (-3) Excluded Reason(s)","Eligible Day (-4)","Day (-4) Excluded Reason(s)","Eligible Day (-5)","Day (-5) Excluded Reason(s)","Eligible Day (-6)","Day (-6) Excluded Reason(s)","Eligible Day (-7)","Day (-7) Excluded Reason(s)","Eligible Day (-8)","Day (-8) Excluded Reason(s)","Eligible Day (-9)","Day (-9) Excluded Reason(s)","Eligible Day (-10)","Day (-10) Excluded Reason(s)","Eligible Day (-1) Stool Count","Eligible Day (-2) Stool Count","Eligible Day (-3) Stool Count","Eligible Day (-4) Stool Count","Eligible Day (-5) Stool Count","Eligible Day (-6) Stool Count","Eligible Day (-7) Stool Count","Eligible Day (-8) Stool Count","Eligible Day (-9) Stool Count","Eligible Day (-10) Stool Count","Stool Frequency Sub-score","Eligible Day (-1) Rectal Bleeding Score","Eligible Day (-2) Rectal Bleeding Score","Eligible Day (-3) Rectal Bleeding Score","Eligible Day (-4) Rectal Bleeding Score","Eligible Day (-5) Rectal Bleeding Score","Eligible Day (-6) Rectal Bleeding Score","Eligible Day (-7) Rectal Bleeding Score","Eligible Day (-8) Rectal Bleeding Score","Eligible Day (-9) Rectal Bleeding Score","Eligible Day (-10) Rectal Bleeding Score","Rectal Bleeding Sub-score","Partial Mayo Score","Modified Mayo Score","Full Mayo Score","Site Action","Last Mayo Score Submission","Week I-12 Clinical Responder","Week I-12 Clinical Remission","Clinical Flare","Loss of Response","Partial Mayo Response Post Loss of Response","Partial Mayo Response for Clinical Non-Responders" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","1","I-0","19 Feb 2026","Yes","05 Feb 2026","04 Feb 2026","04 Feb 2026","-","-","2","-","3","18 Feb 2026","-","17 Feb 2026","-","16 Feb 2026","-","15 Feb 2026","-","14 Feb 2026","-","13 Feb 2026","-","12 Feb 2026","-","11 Feb 2026","Day Not Applicable for Calculation","10 Feb 2026","Day Not Applicable for Calculation","09 Feb 2026","Day Not Applicable for Calculation","10","8","7","5","7","8","8","-","-","-","3","1","1","1","0","1","1","1","-","-","-","1","7","6","9","-","08 Apr 2026 07:11:25","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","1","I-2","04 Mar 2026","-","-","-","-","-","-","-","-","3","03 Mar 2026","-","02 Mar 2026","-","01 Mar 2026","-","28 Feb 2026","-","27 Feb 2026","-","26 Feb 2026","-","25 Feb 2026","-","24 Feb 2026","Day Not Applicable for Calculation","23 Feb 2026","Day Not Applicable for Calculation","22 Feb 2026","Day Not Applicable for Calculation","5","4","5","4","5","6","6","-","-","-","2","1","0","1","0","1","0","1","-","-","-","1","6","","","-","28 May 2026 10:04:05","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","1","I-4","18 Mar 2026","-","-","-","-","-","-","-","-","2","17 Mar 2026","-","16 Mar 2026","-","15 Mar 2026","-","14 Mar 2026","-","13 Mar 2026","-","12 Mar 2026","-","11 Mar 2026","-","10 Mar 2026","Day Not Applicable for Calculation","09 Mar 2026","Day Not Applicable for Calculation","08 Mar 2026","Day Not Applicable for Calculation","5","5","5","4","5","4","5","-","-","-","2","1","0","0","1","1","1","0","-","-","-","1","5","","","-","08 Apr 2026 11:04:49","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","1","I-8","05 May 2026","-","-","-","-","-","-","-","-","1","04 May 2026","-","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","-","28 Apr 2026","-","27 Apr 2026","Day Not Applicable for Calculation","26 Apr 2026","Day Not Applicable for Calculation","25 Apr 2026","Day Not Applicable for Calculation","3","3","4","4","5","4","4","-","-","-","2","1","1","1","1","1","1","1","-","-","-","1","4","","","-","28 May 2026 14:42:53","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","1","I-12","13 May 2026","Yes","06 May 2026","05 May 2026","05 May 2026","-","-","1","-","1","12 May 2026","-","11 May 2026","-","10 May 2026","-","09 May 2026","-","08 May 2026","-","07 May 2026","-","06 May 2026","Endoscopy","05 May 2026","Bowel Preparation for Procedure;Day Not Applicable for Calculation","04 May 2026","-","03 May 2026","Day Not Applicable for Calculation","5","4","6","5","5","5","-","-","3","-","2","1","0","1","1","1","1","-","-","1","-","1","4","4","5","-","28 May 2026 14:43:11","Clinical Responder","No","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","1","I-0","08 Apr 2026","Yes","18 Mar 2026","17 Mar 2026","18 Mar 2026","-","-","2","-","2","07 Apr 2026","-","06 Apr 2026","-","05 Apr 2026","-","04 Apr 2026","Missing Diary","03 Apr 2026","-","02 Apr 2026","-","01 Apr 2026","-","31 Mar 2026","Day Not Applicable for Calculation","30 Mar 2026","Day Not Applicable for Calculation","29 Mar 2026","Day Not Applicable for Calculation","3","3","4","-","3","3","4","-","-","-","1","0","0","0","-","0","0","1","-","-","-","0","3","3","5","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","1","I-2","23 Apr 2026","-","-","-","-","-","-","-","-","2","22 Apr 2026","Missing Diary","21 Apr 2026","-","20 Apr 2026","-","19 Apr 2026","-","18 Apr 2026","-","17 Apr 2026","-","16 Apr 2026","-","15 Apr 2026","Day Not Applicable for Calculation","14 Apr 2026","Day Not Applicable for Calculation","13 Apr 2026","Day Not Applicable for Calculation","-","3","3","6","5","5","4","-","-","-","2","-","0","0","1","1","1","1","-","-","-","1","5","","","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","1","I-4","06 May 2026","-","-","-","-","-","-","-","-","1","05 May 2026","-","04 May 2026","-","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","-","28 Apr 2026","Day Not Applicable for Calculation","27 Apr 2026","Day Not Applicable for Calculation","26 Apr 2026","Day Not Applicable for Calculation","6","3","2","3","3","3","3","-","-","-","1","1","0","0","0","1","1","0","-","-","-","0","2","","","-","28 May 2026 14:43:38","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","1","I-8","04 Jun 2026","-","-","-","-","-","-","-","-","1","03 Jun 2026","-","02 Jun 2026","-","01 Jun 2026","-","31 May 2026","-","30 May 2026","-","29 May 2026","-","28 May 2026","-","27 May 2026","Day Not Applicable for Calculation","26 May 2026","Day Not Applicable for Calculation","25 May 2026","Day Not Applicable for Calculation","3","4","3","3","3","3","4","-","-","-","1","0","0","0","0","0","0","1","-","-","-","0","2","","","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","1","I-0","27 May 2026","Yes","13 May 2026","12 May 2026","12 May 2026","-","-","3","-","2","26 May 2026","-","25 May 2026","-","24 May 2026","-","23 May 2026","-","22 May 2026","-","21 May 2026","-","20 May 2026","-","19 May 2026","Day Not Applicable for Calculation","18 May 2026","Day Not Applicable for Calculation","17 May 2026","Day Not Applicable for Calculation","6","9","7","8","9","7","8","-","-","-","3","2","2","2","2","1","1","1","-","-","-","2","7","8","10","-","27 May 2026 07:24:39","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","1","I-0","20 Mar 2026","Yes","19 Feb 2026","-","-","-","-","3","-","3","19 Mar 2026","-","18 Mar 2026","-","17 Mar 2026","-","16 Mar 2026","-","15 Mar 2026","-","14 Mar 2026","-","13 Mar 2026","-","12 Mar 2026","Day Not Applicable for Calculation","11 Mar 2026","Day Not Applicable for Calculation","10 Mar 2026","Day Not Applicable for Calculation","7","7","8","8","7","8","5","-","-","-","3","2","1","1","1","1","1","0","-","-","-","1","7","7","10","-","20 Mar 2026 07:03:23","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","1","I-2","08 Apr 2026","-","-","-","-","-","-","-","-","2","07 Apr 2026","Medication For Diarrhea","06 Apr 2026","Medication For Diarrhea","05 Apr 2026","Medication For Diarrhea","04 Apr 2026","Medication For Diarrhea","03 Apr 2026","Medication For Diarrhea","02 Apr 2026","Medication For Diarrhea","01 Apr 2026","Medication For Diarrhea","31 Mar 2026","Medication For Diarrhea;Day Not Applicable for Calculation","30 Mar 2026","Medication For Diarrhea;Day Not Applicable for Calculation","29 Mar 2026","Day Not Applicable for Calculation","-","-","-","-","-","-","-","-","-","-","Non-Evaluable","-","-","-","-","-","-","-","-","-","-","Non-Evaluable","Non-Evaluable","Non-Evaluable","Non-Evaluable","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","1","I-4","15 Apr 2026","-","-","-","-","-","-","-","-","3","14 Apr 2026","-","13 Apr 2026","-","12 Apr 2026","-","11 Apr 2026","-","10 Apr 2026","-","09 Apr 2026","-","08 Apr 2026","-","07 Apr 2026","Medication For Diarrhea;Day Not Applicable for Calculation","06 Apr 2026","Medication For Diarrhea;Day Not Applicable for Calculation","05 Apr 2026","Medication For Diarrhea;Day Not Applicable for Calculation","9","22","20","19","17","18","18","-","-","-","3","1","3","2","2","2","2","2","-","-","-","2","8","","","-","04 Jun 2026 21:41:28","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","1","I-8","18 May 2026","-","-","-","-","-","-","-","-","2","17 May 2026","-","16 May 2026","-","15 May 2026","-","14 May 2026","-","13 May 2026","-","12 May 2026","-","11 May 2026","-","10 May 2026","Day Not Applicable for Calculation","09 May 2026","Day Not Applicable for Calculation","08 May 2026","Day Not Applicable for Calculation","7","5","9","7","7","8","8","-","-","-","3","1","1","1","1","1","1","1","-","-","-","1","6","","","-","04 Jun 2026 21:46:30","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","1","I-0","26 May 2026","Yes","14 May 2026","13 May 2026","13 May 2026","-","-","2","-","2","25 May 2026","-","24 May 2026","-","23 May 2026","-","22 May 2026","-","21 May 2026","-","20 May 2026","-","19 May 2026","-","18 May 2026","Day Not Applicable for Calculation","17 May 2026","Day Not Applicable for Calculation","16 May 2026","Day Not Applicable for Calculation","8","8","6","7","7","6","7","-","-","-","3","2","2","2","2","2","2","2","-","-","-","2","7","7","9","-","29 May 2026 15:45:00","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","1","I-0","05 May 2026","Yes","24 Apr 2026","23 Apr 2026","23 Apr 2026","-","-","2","-","2","04 May 2026","-","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","-","28 Apr 2026","-","27 Apr 2026","Day Not Applicable for Calculation","26 Apr 2026","Day Not Applicable for Calculation","25 Apr 2026","Day Not Applicable for Calculation","5","5","5","5","5","5","5","-","-","-","2","1","1","1","1","1","1","1","-","-","-","1","5","5","7","-","05 May 2026 11:19:40","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","1","I-2","19 May 2026","-","-","-","-","-","-","-","-","1","18 May 2026","-","17 May 2026","-","16 May 2026","-","15 May 2026","-","14 May 2026","-","13 May 2026","-","12 May 2026","-","11 May 2026","Day Not Applicable for Calculation","10 May 2026","Day Not Applicable for Calculation","09 May 2026","Day Not Applicable for Calculation","5","4","5","5","5","4","6","-","-","-","2","1","1","1","1","1","1","1","-","-","-","1","4","","","-","19 May 2026 10:38:25","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","1","I-4","04 Jun 2026","-","-","-","-","-","-","-","-","1","03 Jun 2026","-","02 Jun 2026","-","01 Jun 2026","-","31 May 2026","-","30 May 2026","-","29 May 2026","-","28 May 2026","-","27 May 2026","Day Not Applicable for Calculation","26 May 2026","Day Not Applicable for Calculation","25 May 2026","Day Not Applicable for Calculation","2","3","2","3","3","2","3","-","-","-","1","0","0","0","0","0","0","0","-","-","-","0","2","","","-","04 Jun 2026 09:24:54","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","5","I-0","07 Apr 2026","Yes","24 Mar 2026","22 Mar 2026","22 Mar 2026","-","-","2","-","2","06 Apr 2026","-","05 Apr 2026","-","04 Apr 2026","-","03 Apr 2026","-","02 Apr 2026","-","01 Apr 2026","-","31 Mar 2026","-","30 Mar 2026","Day Not Applicable for Calculation","29 Mar 2026","Day Not Applicable for Calculation","28 Mar 2026","Day Not Applicable for Calculation","8","11","5","9","11","10","13","-","-","-","3","1","2","2","2","2","2","2","-","-","-","2","7","7","9","-","04 May 2026 08:44:52","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","5","I-2","22 Apr 2026","-","-","-","-","-","-","-","-","2","21 Apr 2026","-","20 Apr 2026","-","19 Apr 2026","-","18 Apr 2026","-","17 Apr 2026","-","16 Apr 2026","-","15 Apr 2026","-","14 Apr 2026","Day Not Applicable for Calculation","13 Apr 2026","Day Not Applicable for Calculation","12 Apr 2026","Day Not Applicable for Calculation","7","5","6","6","7","8","2","-","-","-","1","1","0","1","1","1","2","0","-","-","-","1","4","","","-","04 May 2026 08:45:07","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","5","I-4","07 May 2026","-","-","-","-","-","-","-","-","1","06 May 2026","-","05 May 2026","-","04 May 2026","-","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","Day Not Applicable for Calculation","28 Apr 2026","Day Not Applicable for Calculation","27 Apr 2026","Day Not Applicable for Calculation","8","7","7","8","4","11","7","-","-","-","1","2","1","1","1","0","1","1","-","-","-","1","3","","","-","01 Jun 2026 00:57:35","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","5","I-8","03 Jun 2026","-","-","-","-","-","-","-","-","2","02 Jun 2026","-","01 Jun 2026","-","31 May 2026","-","30 May 2026","-","29 May 2026","-","28 May 2026","-","27 May 2026","-","26 May 2026","Day Not Applicable for Calculation","25 May 2026","Day Not Applicable for Calculation","24 May 2026","Day Not Applicable for Calculation","5","9","7","5","5","9","7","-","-","-","1","1","1","1","0","3","0","1","-","-","-","1","4","","","-","03 Jun 2026 17:47:25","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","1","I-0","24 Mar 2026","Yes","12 Mar 2026","11 Mar 2026","11 Mar 2026","-","-","2","-","2","23 Mar 2026","-","22 Mar 2026","-","21 Mar 2026","-","20 Mar 2026","-","19 Mar 2026","-","18 Mar 2026","-","17 Mar 2026","-","16 Mar 2026","Day Not Applicable for Calculation","15 Mar 2026","Day Not Applicable for Calculation","14 Mar 2026","Day Not Applicable for Calculation","8","6","5","7","6","7","6","-","-","-","3","1","1","1","0","1","1","1","-","-","-","1","6","6","8","-","05 Apr 2026 22:41:27","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","1","I-2","08 Apr 2026","-","-","-","-","-","-","-","-","2","07 Apr 2026","-","06 Apr 2026","-","05 Apr 2026","-","04 Apr 2026","-","03 Apr 2026","-","02 Apr 2026","-","01 Apr 2026","-","31 Mar 2026","Day Not Applicable for Calculation","30 Mar 2026","Day Not Applicable for Calculation","29 Mar 2026","Day Not Applicable for Calculation","5","2","3","6","5","5","5","-","-","-","2","0","0","0","0","1","1","0","-","-","-","0","4","","","-","28 May 2026 23:19:03","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","1","I-4","21 Apr 2026","-","-","-","-","-","-","-","-","0","20 Apr 2026","-","19 Apr 2026","-","18 Apr 2026","-","17 Apr 2026","-","16 Apr 2026","-","15 Apr 2026","-","14 Apr 2026","-","13 Apr 2026","Day Not Applicable for Calculation","12 Apr 2026","Day Not Applicable for Calculation","11 Apr 2026","Day Not Applicable for Calculation","4","3","4","3","3","4","4","-","-","-","2","0","0","0","0","0","0","0","-","-","-","0","2","","","-","27 May 2026 12:54:41","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","1","I-0","12 May 2026","Yes","21 Apr 2026","20 Apr 2026","21 Apr 2026","-","-","2","-","2","11 May 2026","-","10 May 2026","-","09 May 2026","-","08 May 2026","-","07 May 2026","-","06 May 2026","-","05 May 2026","Missing Diary","04 May 2026","Day Not Applicable for Calculation","03 May 2026","Day Not Applicable for Calculation","02 May 2026","Day Not Applicable for Calculation","2","1","1","1","1","2","-","-","-","-","0","0","0","0","0","0","0","-","-","-","-","0","2","2","4","-","28 May 2026 23:19:30","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","1","I-2","26 May 2026","-","-","-","-","-","-","-","-","1","25 May 2026","-","24 May 2026","Missing Diary","23 May 2026","-","22 May 2026","-","21 May 2026","-","20 May 2026","-","19 May 2026","-","18 May 2026","Missing Diary;Day Not Applicable for Calculation","17 May 2026","Day Not Applicable for Calculation","16 May 2026","Day Not Applicable for Calculation","1","-","1","2","1","2","2","-","-","-","1","0","-","0","0","0","0","0","-","-","-","0","2","","","-","28 May 2026 23:19:51","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10013","David Stepek","CZ100132003","0","I-0","02 Jun 2026","Yes","25 May 2026","24 May 2026","24 May 2026","-","-","2","-","2","01 Jun 2026","-","31 May 2026","-","30 May 2026","-","29 May 2026","-","28 May 2026","-","27 May 2026","-","26 May 2026","-","25 May 2026","Endoscopy;Missing Diary;Day Not Applicable for Calculation","24 May 2026","Bowel Preparation for Procedure;Missing Diary;Day Not Applicable for Calculation","23 May 2026","Missing Diary;Day Not Applicable for Calculation","8","8","11","10","10","11","6","-","-","-","3","2","2","1","2","1","2","2","-","-","-","2","7","7","9","-","02 Jun 2026 08:17:40","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","1","I-0","28 May 2026","Yes","19 May 2026","18 May 2026","19 May 2026","-","-","3","-","3","27 May 2026","-","26 May 2026","-","25 May 2026","-","24 May 2026","-","23 May 2026","-","22 May 2026","-","21 May 2026","-","20 May 2026","Day Not Applicable for Calculation","19 May 2026","Endoscopy;Bowel Preparation for Procedure;Day Not Applicable for Calculation","18 May 2026","Bowel Preparation for Procedure;Day Not Applicable for Calculation","14","15","15","15","15","15","15","-","-","-","3","2","3","3","2","2","3","3","-","-","-","3","9","9","12","-","28 May 2026 10:22:48","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adolescent","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","1","Unscheduled 1","04 May 2026","Yes","20 Apr 2026","12 Apr 2026","15 Apr 2026","-","-","2","-","3","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","-","28 Apr 2026","-","27 Apr 2026","-","26 Apr 2026","Day Not Applicable for Calculation","25 Apr 2026","Day Not Applicable for Calculation","24 Apr 2026","Day Not Applicable for Calculation","5","6","6","7","6","3","3","-","-","-","2","0","0","0","0","0","0","0","-","-","-","0","5","4","7","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adolescent","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","1","I-0","18 May 2026","Yes","01 May 2026","01 May 2026","01 May 2026","-","-","2","-","3","17 May 2026","-","16 May 2026","-","15 May 2026","-","14 May 2026","-","13 May 2026","-","12 May 2026","-","11 May 2026","-","10 May 2026","Day Not Applicable for Calculation","09 May 2026","Day Not Applicable for Calculation","08 May 2026","Day Not Applicable for Calculation","6","6","6","6","6","6","6","-","-","-","3","0","0","0","0","0","0","0","-","-","-","0","6","5","8","-","18 May 2026 08:38:55","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adolescent","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","1","I-2","01 Jun 2026","-","-","-","-","-","-","-","-","3","31 May 2026","-","30 May 2026","Missing Diary","29 May 2026","Missing Diary","28 May 2026","Missing Diary","27 May 2026","-","26 May 2026","-","25 May 2026","-","24 May 2026","Day Not Applicable for Calculation","23 May 2026","Day Not Applicable for Calculation","22 May 2026","Day Not Applicable for Calculation","6","-","-","-","6","6","6","-","-","-","3","0","-","-","-","0","0","0","-","-","-","0","6","","","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","1","I-0","07 Apr 2026","Yes","16 Mar 2026","15 Mar 2026","16 Mar 2026","-","-","3","-","3","06 Apr 2026","-","05 Apr 2026","-","04 Apr 2026","-","03 Apr 2026","-","02 Apr 2026","-","01 Apr 2026","-","31 Mar 2026","-","30 Mar 2026","Day Not Applicable for Calculation","29 Mar 2026","Day Not Applicable for Calculation","28 Mar 2026","Day Not Applicable for Calculation","11","11","10","11","11","10","9","-","-","-","3","2","2","2","2","2","2","2","-","-","-","2","8","8","11","-","20 Apr 2026 09:27:58","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","1","I-2","20 Apr 2026","-","-","-","-","-","-","-","-","3","19 Apr 2026","-","18 Apr 2026","-","17 Apr 2026","-","16 Apr 2026","-","15 Apr 2026","-","14 Apr 2026","-","13 Apr 2026","-","12 Apr 2026","Day Not Applicable for Calculation","11 Apr 2026","Day Not Applicable for Calculation","10 Apr 2026","Day Not Applicable for Calculation","8","7","9","8","8","7","8","-","-","-","3","2","2","1","1","1","2","1","-","-","-","1","7","","","-","20 Apr 2026 09:29:01","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","1","I-4","05 May 2026","-","-","-","-","-","-","-","-","1","04 May 2026","-","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","-","28 Apr 2026","-","27 Apr 2026","Day Not Applicable for Calculation","26 Apr 2026","Day Not Applicable for Calculation","25 Apr 2026","Day Not Applicable for Calculation","6","6","6","6","7","7","6","-","-","-","3","0","0","1","1","1","1","1","-","-","-","1","5","","","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","1","I-8","02 Jun 2026","-","-","-","-","-","-","-","-","1","01 Jun 2026","-","31 May 2026","-","30 May 2026","-","29 May 2026","-","28 May 2026","-","27 May 2026","-","26 May 2026","-","25 May 2026","Day Not Applicable for Calculation","24 May 2026","Day Not Applicable for Calculation","23 May 2026","Day Not Applicable for Calculation","3","4","4","4","5","5","5","-","-","-","2","0","0","0","0","0","1","1","-","-","-","0","3","","","-","02 Jun 2026 14:44:34","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","1","I-0","19 Feb 2026","Yes","11 Feb 2026","10 Feb 2026","11 Feb 2026","-","-","2","-","2","18 Feb 2026","-","17 Feb 2026","-","16 Feb 2026","-","15 Feb 2026","-","14 Feb 2026","-","13 Feb 2026","-","12 Feb 2026","-","11 Feb 2026","Endoscopy;Bowel Preparation for Procedure;Day Not Applicable for Calculation","10 Feb 2026","Bowel Preparation for Procedure;Day Not Applicable for Calculation","09 Feb 2026","Day Not Applicable for Calculation","3","2","2","3","4","3","2","-","-","-","1","1","1","0","0","0","2","2","-","-","-","1","4","4","6","-","19 Feb 2026 15:41:35","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","1","I-0","09 Mar 2026","Yes","11 Feb 2026","10 Feb 2026","11 Feb 2026","-","-","2","-","2","08 Mar 2026","-","07 Mar 2026","-","06 Mar 2026","-","05 Mar 2026","-","04 Mar 2026","-","03 Mar 2026","Missing Diary","02 Mar 2026","Missing Diary","01 Mar 2026","Missing Diary;Day Not Applicable for Calculation","28 Feb 2026","Missing Diary;Day Not Applicable for Calculation","27 Feb 2026","Missing Diary;Day Not Applicable for Calculation","7","7","6","6","7","-","-","-","-","-","3","2","2","2","2","2","-","-","-","-","-","2","7","7","9","-","22 Mar 2026 18:34:58","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","1","I-2","27 Mar 2026","-","-","-","-","-","-","-","-","2","26 Mar 2026","-","25 Mar 2026","-","24 Mar 2026","-","23 Mar 2026","-","22 Mar 2026","-","21 Mar 2026","-","20 Mar 2026","-","19 Mar 2026","Day Not Applicable for Calculation","18 Mar 2026","Day Not Applicable for Calculation","17 Mar 2026","Day Not Applicable for Calculation","7","3","3","3","5","5","5","-","-","-","2","0","0","1","1","1","1","2","-","-","-","1","5","","","-","27 Mar 2026 07:29:27","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","1","I-4","08 Apr 2026","-","-","-","-","-","-","-","-","2","07 Apr 2026","-","06 Apr 2026","-","05 Apr 2026","-","04 Apr 2026","-","03 Apr 2026","-","02 Apr 2026","-","01 Apr 2026","-","31 Mar 2026","Day Not Applicable for Calculation","30 Mar 2026","Day Not Applicable for Calculation","29 Mar 2026","Day Not Applicable for Calculation","3","3","4","4","5","4","3","-","-","-","2","1","0","0","2","1","1","2","-","-","-","1","5","","","-","08 Apr 2026 07:59:35","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","1","I-8","04 May 2026","-","-","-","-","-","-","-","-","2","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","-","28 Apr 2026","-","27 Apr 2026","-","26 Apr 2026","Day Not Applicable for Calculation","25 Apr 2026","Day Not Applicable for Calculation","24 Apr 2026","Missing Diary;Day Not Applicable for Calculation","3","5","3","3","3","2","3","-","-","-","1","0","0","0","0","0","0","0","-","-","-","0","3","","","-","04 May 2026 07:52:47","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","1","I-12","01 Jun 2026","Yes","20 May 2026","19 May 2026","20 May 2026","-","-","3","-","2","31 May 2026","-","30 May 2026","-","29 May 2026","-","28 May 2026","-","27 May 2026","-","26 May 2026","-","25 May 2026","-","24 May 2026","Day Not Applicable for Calculation","23 May 2026","Day Not Applicable for Calculation","22 May 2026","Day Not Applicable for Calculation","4","4","6","3","3","3","3","-","-","-","2","1","1","2","1","1","1","2","-","-","-","1","5","6","8","-","01 Jun 2026 14:25:57","Clinical Nonresponder","No","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","1","I-0","09 Apr 2026","Yes","08 Apr 2026","31 Mar 2026","01 Apr 2026","-","-","2","-","2","08 Apr 2026","Endoscopy","07 Apr 2026","-","06 Apr 2026","-","05 Apr 2026","-","04 Apr 2026","-","03 Apr 2026","-","02 Apr 2026","-","01 Apr 2026","Bowel Preparation for Procedure;Day Not Applicable for Calculation","31 Mar 2026","Bowel Preparation for Procedure;Day Not Applicable for Calculation","30 Mar 2026","-","-","3","3","4","3","4","3","-","-","3","1","-","2","2","2","2","2","2","-","-","2","2","5","5","7","-","29 May 2026 11:07:08","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","1","I-2","22 Apr 2026","-","-","-","-","-","-","-","-","2","21 Apr 2026","-","20 Apr 2026","-","19 Apr 2026","-","18 Apr 2026","-","17 Apr 2026","-","16 Apr 2026","-","15 Apr 2026","-","14 Apr 2026","Day Not Applicable for Calculation","13 Apr 2026","Day Not Applicable for Calculation","12 Apr 2026","Day Not Applicable for Calculation","3","3","5","3","2","3","2","-","-","-","1","1","2","2","1","1","1","2","-","-","-","1","4","","","-","05 May 2026 07:29:35","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","1","I-4","05 May 2026","-","-","-","-","-","-","-","-","2","04 May 2026","-","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","-","28 Apr 2026","-","27 Apr 2026","Day Not Applicable for Calculation","26 Apr 2026","Day Not Applicable for Calculation","25 Apr 2026","Day Not Applicable for Calculation","4","2","2","2","2","2","2","-","-","-","1","1","1","1","1","2","1","1","-","-","-","1","4","","","-","05 May 2026 07:30:02","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","1","I-8","02 Jun 2026","-","-","-","-","-","-","-","-","2","01 Jun 2026","-","31 May 2026","-","30 May 2026","-","29 May 2026","-","28 May 2026","-","27 May 2026","-","26 May 2026","-","25 May 2026","Day Not Applicable for Calculation","24 May 2026","Day Not Applicable for Calculation","23 May 2026","Day Not Applicable for Calculation","2","2","2","2","2","4","10","-","-","-","1","2","1","2","1","2","2","2","-","-","-","2","5","","","-","02 Jun 2026 08:18:08","N/A","N/A","N/A","N/A","N/A","N/A" diff --git a/Clario/Downloads/Zpracovano/2026-06-05_08-43-32 77242113UCO3001 Clario eCOA DCRs.csv b/Clario/Downloads/Zpracovano/2026-06-05_08-43-32 77242113UCO3001 Clario eCOA DCRs.csv new file mode 100644 index 0000000..f8a03d2 --- /dev/null +++ b/Clario/Downloads/Zpracovano/2026-06-05_08-43-32 77242113UCO3001 Clario eCOA DCRs.csv @@ -0,0 +1,182 @@ +"Protocol","Country","Site","PI Name","Subject ID","Age at Informed Consent","Baseline Stool Count","Confirm Baseline Stool Count","Data Correction ID","Creation Date UTC","Status","Description","Date of Last Action UTC","Total Open Period","Total Open Time (Days)","Current Status Time (Days)","Type","Next Action Required","Category","Query History","Reason for Change","Resolution" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","SW00703544","13-May-2026","Submitted","Please change answer to clinical remision from no to YES (week 12). Entry erros ","20-May-2026","15-21 Days","16","11","Query Active ","Site","New","(1) 20 May 2026 msullivan (Clario): Please confirm your request + +Dear Site. Thank you for submitting this Data Clarification Request. + +For us to process your request, please let us know the name of the form (with date) with question. + +Thank you. ERT/CLARIO Data Coordination Team + +","Entry Error","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","SW00696586","09-Apr-2026","ReadyForQC","Please correct date of endoscopy to date: 18 March 2026 (from 25 March 2026)","15-Apr-2026","Over 28 Days","38","34","Query Active ","Site","Site-Entered Data","","Entry Error","CLARIO RESOLUTION: + +Part 1: In Mayo Subscore (1) dated 08 Apr 2026 for I-0 visit, CLARIO to make the following changes: +- What was the date of endoscopy? (ENDODT1D): from 25 Mar 2026 to 18 Mar 2026 +- Data Flag (QSDFLG1B): from blank to check +" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","SW00704536","19-May-2026","ReadyForQC","Please change the endoscopy date to 19-FEB-2026. 06-MAR-2026 was entered in error. ","26-May-2026","8-14 Days","12","7","Query Active ","Site","Site-Entered Data","","Entry Error","CLARIO RESOLUTION: + +Part 1: In Mayo Subscore (1) dated 20 Mar 2026 for I-0 visit, CLARIO to make the following changes: +-What was the date of endoscopy? (ENDODT1D): from 06 Mar 2026 to 19 Feb 2026 +- Data Flag (QSDFLG1B): from blank to check +" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","SW00706684","01-Jun-2026","Submitted","The right endoscopy date is 23MAR2026, please change the date","01-Jun-2026","4-7 Days","4","4","","Clario DM","New","","Entry Error","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","SW00705646","26-May-2026","Submitted","Correct visit date I-O is 12-May-2026. All questionaries were filled on paper and entered in tablet later. +Log-in issue. ","01-Jun-2026","8-14 Days","8","3","","Clario DM","New","(1) 01 Jun 2026 msullivan (Clario): Please confirm your request + +Dear Site. Thank you for submitting this Data Clarification. + + Please provide the timestamps for each of the assessments if you used paper forms and transcribed into the device. + If unknown, ERT will use a dummy timestamp. + +Thank you. ERT/CLARIO Data Coordination Team. + +(2) 01 Jun 2026 dstepek@vnbrno.cz (Site User): time is unknown + +","Changed Information","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132003","49","0","","SW00706581","29-May-2026","ReadyForEntry","baseline stool count reported by subject is 0, please change to 1 as per CRA request (subject has 1 stool in 2-3 days if in remission)","04-Jun-2026","4-7 Days","4","1","","Clario DM","Demographic","","Changed Information","CLARIO RESOLUTION: + +Part 1: In System Variables form, CLARIO to make the following changes: +- Baseline Stool Count (PT.Custom4): from 0 to 1 +" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","SW00705916","27-May-2026","ReadyForQC","As per ATS investigation (ATS26040111), please remove the below form which was entered as a duplicate + +- MAYO Diary (5) 24 Apr 2026","05-Jun-2026","4-7 Days","7","","","Clario DM","Technical Revision","","Technical Revision - Other","CLARIO RESOLUTION: + +Part 1: CLARIO to delete MAYO Diary (5) dated 24 Apr 2026 +" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","SW00701729","06-May-2026","Completed","Dears, please delete data from visit I-0 (reported as 4th of May 2026) as this visit had to be postponed - see the previous DCR of this patient and change data request that was corrected. Patient has left the site before it was resolved and and new date of I-0 was planned. Patient continues to fill in his diary and patient is coming to I=0 visit within allowed window. We need the system and tablet to be ready to run new Mayo Score Report with updated and recent data (e.g. reflect new I-0 visit date, new eligible days -1 to -7.). +thank you, Jiri Skopek","19-May-2026","8-14 Days","8","","","","Visit Data","(1) 11 May 2026 msullivan (Clario): Please confirm your request + +Dear Site. Thank you for submitting this Data Clarification. + +Please note that the delete forms are allowed if the reason is one of the following. +If not, forms will move to unscheduled visit. + +Data collected by the wrong patient. +Data collected by someone other than the patient. +Data collected prior to informed consent, or after withdrawal from the study. +Duplicate data erroneously entered at an Unscheduled visit via paper transcription. +Data collected that is not expected per protocol. + +Also, I-0 visit is still ongoing. Please close the visit. +Once the visit was closed, we will process accoridngly. + +Thank you. ERT/CLARIO Data Coordination Team + +(2) 11 May 2026 jskopek (Site User): Dears, +I do not see any option that is adequate -from the list. Data are not needed to be deleted fully, they reflect the situation at May4th. Please mark it as unscheduled visit - as exactly that is the case. We need the system to be ready for I-0 visit planned for next week. +I will close the visit tomorrow - do you mean in tablet/ipad? +Thank you very much for your help! Jiri + +(3) 12 May 2026 venkata.ramana (Clario): Thank you for your response. +Please note that the visit I-0 was still ongoing but not closed yet. +So please close the visit. +Kind Regards, Clario Data Coordination Team. + +(4) 12 May 2026 jskopek (Site User): If I try to close the I-O visit in TABLET, it asks me if patient fulfils eligibility criteria to proceed to next visit based on these old data – if I answer NO, it asks me to DEACTIVATE patient. I do not want to DEACTIVATE patient – can you help WHERE and HOW to close this visit for you to change it to UNSCHEDULED and not to de-activate patient? +Thank you Jiri + + +","Other-delete visit I-0","CLARIO RESOLUTION: + +Part 1: In the following forms dated 04 May 2026, CLARIO to make the following changes: +-Event ID: from I-0 to Unscheduled Visit 1 +-Event At Entry: from I-0 to Unscheduled Visit 1 + ++Visit Start (49) ++ePRO Availability (1) ++Mayo Subscore (1) ++PGA (1) + +Part 2: CLARIO to delete the following forms dated 04 May 2026 for I-0 visit. + ++C-SSRS Since Last Visit (1) ++C-SSRS Since Last Visit Findings Report (1) + +Part 3: CLARIO to manually enter Visit End form for Unscheduled visit 1 with the following information: +-Protocol: 77242113UCO3001 +-Report Date: 04 May 2026 +-Report Start Date and Time: 04 May 2026 23:59:59 +-Event ID: Unscheduled Visit 1 +-Event End Date: 04 May 2026 23:59:59 +-Visit Status: Incomplete +-Phase At Entry: Screening +-Phase At Entry Timestamp: 13 Apr 2026 12:32:20 +-Event At Entry: Unscheduled visit 1 +-Event Start Date: 04 May 2026 23:59:59 +-Event Time Zone Offset in Milliseconds: 7200000 +-Session Repeat Number (SESREP1N): 0 +-Session Instance Id (SESINST1S): 3f1214f0-4788-11f1-a0cf-bb403212adce +" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","SW00701226","04-May-2026","Completed","Dears, we would like ask you to change the information I read on assignment form given by patient on April 13, 2026 (Visit 1), Baseline Stool Count (PT.Custom4) as 3 that should be reported as 1. +Patient has entered wrong number as he did not understood it should be number of stools when illness is in remission or absent. He is a child and did not reflected this question correctly. Therefore, please change Baseline Stool Count = 1. +Thank you, Jiri Skopek ","04-May-2026","1 Day","1","","","","Demographic","","Changed Information","(Clario instructions) + +1. Please make below changes in the assignment form: + +Baseline Stool Count (PT. Custom4): 03 to 01." +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","SW00699492","23-Apr-2026","ReadyForQC","Please correct the date of endoscopy done during screening visit of patient CZ100212001 to correct date 16-MAR-2026.","29-Apr-2026","Over 28 Days","29","25","Query Active ","Site","Site-Entered Data","","Changed Information","CLARIO RESOLUTION: + +Part 1: In the Mayo Subscore (1) dated 07 Apr 2026 for I-0 visit, CLARIO to make the following changes: +-What was the date of endoscopy? (ENDODT1D): from 24 Mar 2026 to 16 Mar 2026 +- Data Flag (QSDFLG1B): from blank to check +" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","SW00703322","12-May-2026","Completed","As per ATS investigation (ATS26040111), please remove the below form that's been entered as a duplicate + +- MAYO Diary (16) - 18 Mar 2026 +","20-May-2026","4-7 Days","6","","","","Technical Revision","","Technical Revision - Other","CLARIO RESOLUTION: + +Part 1: CLARIO to delete the MAYO Diary (16) dated 18 Mar 2026. +" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","SW00689748","09-Mar-2026","Completed","Dear all, + +Patient CZ 100222003 was randomized on 9 Mar 2026. Kindly correct the colonoscopy date to 11 Feb 2025. + +The date was initially entered as 21 Feb 2025 because the earlier date could not be entered in the system. The patient was rescreened.","02-Apr-2026","15-21 Days","17","","","","Site-Entered Data","(1) 13 Mar 2026 msullivan (Clario): Please confirm your request + +Dear Site. Thank you for submitting this Data Clarification. + +Could you please conform that if you are requesting following? + +Mayo Subscore (1) dated 09 Mar 2026 for I-0 visit +-What was the date of endoscopy? (ENDODT1D): from 23 Feb 2026 to 11 Feb 2025 + +Could you please confirm the year? This subject was assigned on 02 Mar 2026, you are providing that correct date is 11 Feb 2025 which a year ago. +If you are not requesting above, please provide us the name of the form with question. + +Thank you. ERT/CLARIO Data Coordination Team + + +(2) 13 Mar 2026 katerina.havlikova@clinoxus.com (Site User): confirm date of colonoscopy 11Feb2026 + +(3) 21 Mar 2026 msullivan (Clario): Dear Site, + +The requested changes to the Mayo data have been updated. Please navigate to the Mayo Score Report and resubmit the form for visit to log the updated Mayo Score form. Once done, please respond to this query confirming that the Mayo Score has been resubmitted. + +Thank you. ERT/CLARIO Data Coordination Team + +(4) 24 Mar 2026 jana.pomahacova@clinoxus.com (Site User): Thank you and sent + +","New Information","CLARIO RESOLUTION: + +Part 1: In the Mayo Subscore (1) dated 09 Mar 2026 for I-0 visit, CLARIO to make the following changes: +-What was the date of endoscopy? (ENDODT1D): from 23 Feb 2026 to 11 Feb 2025 +-Data Flag (QSDFLG1B): from blank to check" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","SW00705372","22-May-2026","Submitted","Dear all, please change Colonoscopz date from 8April2026 to date 01Apr2026 Thank you in advance","02-Jun-2026","8-14 Days","9","3","","Clario DM","New","(1) 29 May 2026 msullivan (Clario): Please confirm your request + +Dear Site. Thank you for submitting this Data Clarification. + +Please provide us the name of the form for this request. + +Thank you. ERT/CLARIO Data Coordination Team + +(2) 02 Jun 2026 katerina.havlikova@clinoxus.com (Site User): Dear all, please change Colonoscopy for Week I-12 date from 8April2026 to date 01Apr2026 Thank you in advance + +","Changed Information","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","SW00702538","08-May-2026","Completed","This TRR is to document the correction to the Mayo Subscore (1) form, where the following variables were populated with NULL values, due to a known core defect: +Event At Entry, Event Start Date, Event Time Zone Offset in Milliseconds.","12-May-2026","2-3 Days","2","","","","Technical Revision","","Technical Revision - Other","Please make the below changes in Mayo Subscore (1) dated 22 Apr 2026: + +-Event At Entry: I-0 +-Event Start Date: 09 Apr 2026 08:09:19 +-Event Time Zone Offset in Milliseconds: 7200000" diff --git a/Clario/Downloads/Zpracovano/2026-06-05_08-46-07 77242113UCO3001 Clario MayoDiary.csv b/Clario/Downloads/Zpracovano/2026-06-05_08-46-07 77242113UCO3001 Clario MayoDiary.csv new file mode 100644 index 0000000..18e5e78 --- /dev/null +++ b/Clario/Downloads/Zpracovano/2026-06-05_08-46-07 77242113UCO3001 Clario MayoDiary.csv @@ -0,0 +1,1245 @@ +"Protocol","Country","Site","PI Name","Subject ID","Age at Informed Consent","Baseline Stool Count","Confirm Baseline Stool Count","Report Date","Report Start Date/Time","Report End Date/Time","Duration","Form Number","Role","Original Source","Current Source","Constipation (Code)","Constipation","Diarrhea (Code)","Diarrhea","Irregularity (Code)","Irregularity","Not Applicable (Code)","Not Applicable","Stool Frequency","Stool Frequency Confirmation (Code)","Stool Frequency Confirmation","MAYO050 (Code)","MAYO050","Data Comment","Retro Data Entry Visit Flag (Code)","Retro Data Entry Visit Flag","Admin Language","Admin Device (Code)","Admin Device","Data Flag (Code)","Data Flag","User Name","Paper Source (Code)","Paper Source" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","22-Jan-2026 ","22-Jan-2026 18:01:10","22-Jan-2026 18:01:44","00:34","1","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","23-Jan-2026 ","23-Jan-2026 21:22:44","23-Jan-2026 21:23:25","00:41","2","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","24-Jan-2026 ","24-Jan-2026 18:04:18","24-Jan-2026 18:04:36","00:18","3","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","27-Jan-2026 ","28-Jan-2026 18:33:09","28-Jan-2026 18:33:24","00:15","4","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","28-Jan-2026 ","28-Jan-2026 18:34:00","28-Jan-2026 18:34:20","00:20","5","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","29-Jan-2026 ","29-Jan-2026 21:36:05","29-Jan-2026 21:36:22","00:17","6","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","30-Jan-2026 ","31-Jan-2026 00:05:37","31-Jan-2026 00:05:58","00:21","7","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","31-Jan-2026 ","31-Jan-2026 23:13:18","31-Jan-2026 23:13:35","00:17","8","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","01-Feb-2026 ","01-Feb-2026 19:26:08","01-Feb-2026 19:26:36","00:28","9","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","02-Feb-2026 ","02-Feb-2026 18:01:48","02-Feb-2026 18:02:06","00:18","10","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","03-Feb-2026 ","03-Feb-2026 18:02:54","03-Feb-2026 18:03:20","00:26","11","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","04-Feb-2026 ","04-Feb-2026 18:02:37","04-Feb-2026 18:03:09","00:32","12","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","05-Feb-2026 ","05-Feb-2026 22:23:29","05-Feb-2026 22:23:46","00:17","13","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","06-Feb-2026 ","06-Feb-2026 22:20:04","06-Feb-2026 22:20:19","00:15","14","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","07-Feb-2026 ","07-Feb-2026 18:02:19","07-Feb-2026 18:02:51","00:32","15","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","08-Feb-2026 ","08-Feb-2026 18:03:25","08-Feb-2026 18:03:46","00:21","16","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","09-Feb-2026 ","09-Feb-2026 19:06:44","09-Feb-2026 19:07:24","00:40","17","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","10-Feb-2026 ","10-Feb-2026 22:25:12","10-Feb-2026 22:25:32","00:20","18","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","11-Feb-2026 ","12-Feb-2026 18:34:50","12-Feb-2026 18:35:15","00:25","19","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","11","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","12-Feb-2026 ","12-Feb-2026 18:35:49","12-Feb-2026 18:36:01","00:12","20","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","13-Feb-2026 ","13-Feb-2026 18:14:41","13-Feb-2026 18:14:55","00:14","21","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","14-Feb-2026 ","14-Feb-2026 18:01:52","14-Feb-2026 18:02:30","00:38","22","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","15-Feb-2026 ","16-Feb-2026 19:00:39","16-Feb-2026 19:00:56","00:17","23","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","16-Feb-2026 ","16-Feb-2026 19:01:41","16-Feb-2026 19:01:54","00:13","24","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","17-Feb-2026 ","17-Feb-2026 18:35:12","17-Feb-2026 18:35:26","00:14","25","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","18-Feb-2026 ","18-Feb-2026 18:02:21","18-Feb-2026 18:02:37","00:16","26","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","19-Feb-2026 ","20-Feb-2026 20:40:28","20-Feb-2026 20:40:55","00:27","27","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","20-Feb-2026 ","20-Feb-2026 20:41:50","20-Feb-2026 20:42:13","00:23","28","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","21-Feb-2026 ","21-Feb-2026 22:17:51","21-Feb-2026 22:18:05","00:14","29","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","22-Feb-2026 ","23-Feb-2026 18:59:42","23-Feb-2026 18:59:59","00:17","30","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","23-Feb-2026 ","23-Feb-2026 19:00:43","23-Feb-2026 19:00:57","00:14","31","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","24-Feb-2026 ","24-Feb-2026 18:33:05","24-Feb-2026 18:33:18","00:13","32","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","25-Feb-2026 ","25-Feb-2026 20:00:09","25-Feb-2026 20:00:22","00:13","33","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","26-Feb-2026 ","26-Feb-2026 21:45:08","26-Feb-2026 21:45:42","00:34","34","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","27-Feb-2026 ","27-Feb-2026 21:43:17","27-Feb-2026 21:43:33","00:16","35","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","28-Feb-2026 ","28-Feb-2026 18:53:08","28-Feb-2026 18:53:54","00:46","36","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","01-Mar-2026 ","01-Mar-2026 19:53:01","01-Mar-2026 19:53:40","00:39","37","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","02-Mar-2026 ","02-Mar-2026 18:05:10","02-Mar-2026 18:05:26","00:16","38","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","03-Mar-2026 ","03-Mar-2026 19:44:37","03-Mar-2026 19:45:11","00:34","39","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","04-Mar-2026 ","04-Mar-2026 18:45:15","04-Mar-2026 18:45:35","00:20","40","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","05-Mar-2026 ","05-Mar-2026 18:58:16","05-Mar-2026 18:58:36","00:20","41","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","06-Mar-2026 ","06-Mar-2026 18:28:33","06-Mar-2026 18:28:49","00:16","42","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","07-Mar-2026 ","07-Mar-2026 19:46:29","07-Mar-2026 19:46:47","00:18","43","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","08-Mar-2026 ","08-Mar-2026 20:05:17","08-Mar-2026 20:05:48","00:31","44","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","09-Mar-2026 ","09-Mar-2026 19:06:21","09-Mar-2026 19:06:43","00:22","45","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","10-Mar-2026 ","10-Mar-2026 18:19:08","10-Mar-2026 18:19:29","00:21","46","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","11-Mar-2026 ","11-Mar-2026 21:03:53","11-Mar-2026 21:04:07","00:14","47","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","12-Mar-2026 ","12-Mar-2026 18:17:30","12-Mar-2026 18:17:50","00:20","48","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","13-Mar-2026 ","13-Mar-2026 18:05:59","13-Mar-2026 18:07:01","01:02","49","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","14-Mar-2026 ","14-Mar-2026 20:44:54","14-Mar-2026 20:45:13","00:19","50","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","15-Mar-2026 ","15-Mar-2026 18:36:33","15-Mar-2026 18:36:52","00:19","51","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","16-Mar-2026 ","16-Mar-2026 22:48:59","16-Mar-2026 22:49:17","00:18","52","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","17-Mar-2026 ","17-Mar-2026 18:02:01","17-Mar-2026 18:02:18","00:17","53","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","18-Mar-2026 ","18-Mar-2026 21:00:45","18-Mar-2026 21:01:25","00:40","54","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","19-Mar-2026 ","19-Mar-2026 21:31:31","19-Mar-2026 21:32:18","00:47","55","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","20-Mar-2026 ","21-Mar-2026 14:10:40","21-Mar-2026 14:10:56","00:16","56","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","21-Mar-2026 ","21-Mar-2026 23:09:00","21-Mar-2026 23:09:18","00:18","57","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","22-Mar-2026 ","22-Mar-2026 19:08:29","22-Mar-2026 19:08:50","00:21","58","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","23-Mar-2026 ","23-Mar-2026 18:16:57","23-Mar-2026 18:17:14","00:17","59","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","24-Mar-2026 ","24-Mar-2026 21:05:21","24-Mar-2026 21:05:35","00:14","60","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","25-Mar-2026 ","25-Mar-2026 21:08:43","25-Mar-2026 21:09:39","00:56","61","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","26-Mar-2026 ","26-Mar-2026 20:46:45","26-Mar-2026 20:47:05","00:20","62","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","27-Mar-2026 ","27-Mar-2026 20:55:30","27-Mar-2026 20:55:57","00:27","63","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","28-Mar-2026 ","28-Mar-2026 20:00:16","28-Mar-2026 20:00:32","00:16","64","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","29-Mar-2026 ","29-Mar-2026 22:09:04","29-Mar-2026 22:09:18","00:14","65","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","30-Mar-2026 ","31-Mar-2026 11:57:59","31-Mar-2026 11:58:17","00:18","66","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","31-Mar-2026 ","01-Apr-2026 18:21:26","01-Apr-2026 18:22:46","01:20","67","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","01-Apr-2026 ","01-Apr-2026 18:23:44","01-Apr-2026 18:23:58","00:14","68","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","02-Apr-2026 ","02-Apr-2026 20:54:02","02-Apr-2026 20:54:22","00:20","69","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","03-Apr-2026 ","03-Apr-2026 19:54:40","03-Apr-2026 19:55:08","00:28","70","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","04-Apr-2026 ","04-Apr-2026 18:11:01","04-Apr-2026 18:11:24","00:23","71","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","05-Apr-2026 ","05-Apr-2026 23:04:39","05-Apr-2026 23:05:04","00:25","72","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","06-Apr-2026 ","06-Apr-2026 21:42:50","06-Apr-2026 21:43:12","00:22","73","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","07-Apr-2026 ","07-Apr-2026 21:43:47","07-Apr-2026 21:44:05","00:18","74","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","08-Apr-2026 ","09-Apr-2026 21:36:29","09-Apr-2026 21:36:45","00:16","75","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","09-Apr-2026 ","09-Apr-2026 21:39:42","09-Apr-2026 21:40:10","00:28","76","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","10-Apr-2026 ","10-Apr-2026 18:05:18","10-Apr-2026 18:05:37","00:19","77","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","11-Apr-2026 ","11-Apr-2026 23:16:18","11-Apr-2026 23:16:50","00:32","78","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","12-Apr-2026 ","12-Apr-2026 20:31:50","12-Apr-2026 20:32:07","00:17","79","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","13-Apr-2026 ","13-Apr-2026 22:52:20","13-Apr-2026 22:52:40","00:20","80","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","14-Apr-2026 ","14-Apr-2026 21:00:55","14-Apr-2026 21:01:12","00:17","81","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","15-Apr-2026 ","15-Apr-2026 21:26:28","15-Apr-2026 21:26:45","00:17","82","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","16-Apr-2026 ","16-Apr-2026 20:36:59","16-Apr-2026 20:37:29","00:30","83","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","17-Apr-2026 ","17-Apr-2026 18:35:45","17-Apr-2026 18:36:18","00:33","84","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","18-Apr-2026 ","19-Apr-2026 19:09:05","19-Apr-2026 19:09:27","00:22","85","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","19-Apr-2026 ","19-Apr-2026 19:10:48","19-Apr-2026 19:11:05","00:17","86","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","20-Apr-2026 ","20-Apr-2026 21:41:27","20-Apr-2026 21:42:05","00:38","87","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","21-Apr-2026 ","21-Apr-2026 18:16:50","21-Apr-2026 18:17:13","00:23","88","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","24-Apr-2026 ","25-Apr-2026 21:27:18","25-Apr-2026 21:27:37","00:19","89","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","25-Apr-2026 ","25-Apr-2026 21:28:48","25-Apr-2026 21:29:07","00:19","90","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","26-Apr-2026 ","26-Apr-2026 21:20:40","26-Apr-2026 21:21:09","00:29","91","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","27-Apr-2026 ","27-Apr-2026 19:23:32","27-Apr-2026 19:23:57","00:25","92","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","28-Apr-2026 ","28-Apr-2026 20:20:00","28-Apr-2026 20:20:16","00:16","93","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","29-Apr-2026 ","29-Apr-2026 18:40:54","29-Apr-2026 18:41:13","00:19","94","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","30-Apr-2026 ","01-May-2026 19:13:21","01-May-2026 19:13:42","00:21","95","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","01-May-2026 ","01-May-2026 19:15:10","01-May-2026 19:15:41","00:31","96","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","02-May-2026 ","02-May-2026 20:04:07","02-May-2026 20:04:25","00:18","97","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","03-May-2026 ","03-May-2026 20:30:45","03-May-2026 20:31:11","00:26","98","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","04-May-2026 ","04-May-2026 22:14:16","04-May-2026 22:14:39","00:23","99","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","05-May-2026 ","05-May-2026 18:03:33","05-May-2026 18:03:59","00:26","100","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","06-May-2026 ","06-May-2026 19:09:27","06-May-2026 19:10:10","00:43","101","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","07-May-2026 ","07-May-2026 22:20:20","07-May-2026 22:20:44","00:24","102","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","08-May-2026 ","08-May-2026 22:31:15","08-May-2026 22:31:30","00:15","103","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","09-May-2026 ","09-May-2026 22:14:16","09-May-2026 22:14:41","00:25","104","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","10-May-2026 ","10-May-2026 22:59:00","10-May-2026 22:59:24","00:24","105","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","11-May-2026 ","11-May-2026 21:17:29","11-May-2026 21:18:07","00:38","106","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","12-May-2026 ","12-May-2026 20:23:13","12-May-2026 20:24:06","00:53","107","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","13-May-2026 ","13-May-2026 18:08:45","13-May-2026 18:09:03","00:18","108","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","15-May-2026 ","15-May-2026 23:21:17","15-May-2026 23:21:35","00:18","109","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","16-May-2026 ","17-May-2026 18:26:06","17-May-2026 18:26:24","00:18","110","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","17-May-2026 ","17-May-2026 18:27:28","17-May-2026 18:27:43","00:15","111","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","18-May-2026 ","18-May-2026 20:31:21","18-May-2026 20:31:43","00:22","112","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","19-May-2026 ","19-May-2026 18:40:11","19-May-2026 18:40:28","00:17","113","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","20-May-2026 ","20-May-2026 22:17:46","20-May-2026 22:18:01","00:15","114","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","21-May-2026 ","21-May-2026 20:03:10","21-May-2026 20:03:28","00:18","115","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","22-May-2026 ","22-May-2026 18:35:01","22-May-2026 18:35:16","00:15","116","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","23-May-2026 ","23-May-2026 22:25:17","23-May-2026 22:26:05","00:48","117","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","24-May-2026 ","25-May-2026 18:08:43","25-May-2026 18:09:27","00:44","118","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","25-May-2026 ","25-May-2026 18:10:27","25-May-2026 18:11:02","00:35","119","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","26-May-2026 ","26-May-2026 20:54:59","26-May-2026 20:55:19","00:20","120","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","27-May-2026 ","27-May-2026 22:05:34","27-May-2026 22:06:07","00:33","121","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","28-May-2026 ","28-May-2026 18:48:45","28-May-2026 18:48:59","00:14","122","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","29-May-2026 ","29-May-2026 21:11:23","29-May-2026 21:11:52","00:29","123","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","30-May-2026 ","30-May-2026 18:29:24","30-May-2026 18:29:40","00:16","124","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","31-May-2026 ","31-May-2026 19:18:22","31-May-2026 19:18:40","00:18","125","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","01-Jun-2026 ","01-Jun-2026 21:22:48","01-Jun-2026 21:23:09","00:21","126","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","02-Jun-2026 ","02-Jun-2026 21:15:00","02-Jun-2026 21:15:21","00:21","127","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","03-Jun-2026 ","03-Jun-2026 21:18:20","03-Jun-2026 21:18:38","00:18","128","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","04-Jun-2026 ","04-Jun-2026 22:51:45","04-Jun-2026 22:52:11","00:26","129","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","02-Mar-2026 ","02-Mar-2026 18:03:24","02-Mar-2026 18:03:45","00:21","1","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","03-Mar-2026 ","03-Mar-2026 19:43:48","03-Mar-2026 19:45:18","01:30","2","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","04-Mar-2026 ","04-Mar-2026 19:03:27","04-Mar-2026 19:03:48","00:21","3","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","05-Mar-2026 ","05-Mar-2026 19:15:46","05-Mar-2026 19:16:04","00:18","4","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","06-Mar-2026 ","06-Mar-2026 18:23:46","06-Mar-2026 18:25:08","01:22","5","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","07-Mar-2026 ","07-Mar-2026 19:05:22","07-Mar-2026 19:05:45","00:23","6","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","08-Mar-2026 ","08-Mar-2026 19:09:52","08-Mar-2026 19:10:47","00:55","7","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","09-Mar-2026 ","09-Mar-2026 19:08:05","09-Mar-2026 19:08:19","00:14","8","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","10-Mar-2026 ","10-Mar-2026 18:15:08","10-Mar-2026 18:15:19","00:11","9","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","11-Mar-2026 ","11-Mar-2026 20:13:00","11-Mar-2026 20:13:15","00:15","10","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","12-Mar-2026 ","12-Mar-2026 19:05:47","12-Mar-2026 19:06:03","00:16","11","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","13-Mar-2026 ","13-Mar-2026 18:59:16","13-Mar-2026 18:59:52","00:36","12","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","14-Mar-2026 ","14-Mar-2026 20:12:42","14-Mar-2026 20:13:14","00:32","13","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","15-Mar-2026 ","15-Mar-2026 22:50:36","15-Mar-2026 22:50:57","00:21","14","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","16-Mar-2026 ","16-Mar-2026 18:15:35","16-Mar-2026 18:15:52","00:17","15","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","17-Mar-2026 ","17-Mar-2026 21:15:59","17-Mar-2026 21:16:11","00:12","16","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","18-Mar-2026 ","18-Mar-2026 18:32:31","18-Mar-2026 18:33:05","00:34","17","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","19-Mar-2026 ","19-Mar-2026 22:19:19","19-Mar-2026 22:19:35","00:16","18","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","20-Mar-2026 ","21-Mar-2026 21:58:25","21-Mar-2026 21:58:52","00:27","19","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","21-Mar-2026 ","21-Mar-2026 21:59:25","21-Mar-2026 21:59:50","00:25","20","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","22-Mar-2026 ","22-Mar-2026 18:16:36","22-Mar-2026 18:17:03","00:27","21","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","23-Mar-2026 ","23-Mar-2026 18:15:48","23-Mar-2026 18:16:13","00:25","22","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","24-Mar-2026 ","24-Mar-2026 19:56:01","24-Mar-2026 19:56:15","00:14","23","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","25-Mar-2026 ","25-Mar-2026 20:46:53","25-Mar-2026 20:47:12","00:19","24","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","26-Mar-2026 ","26-Mar-2026 20:54:13","26-Mar-2026 20:54:28","00:15","25","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","27-Mar-2026 ","27-Mar-2026 23:09:08","27-Mar-2026 23:09:26","00:18","26","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","28-Mar-2026 ","28-Mar-2026 20:02:00","28-Mar-2026 20:02:18","00:18","27","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","29-Mar-2026 ","29-Mar-2026 21:11:54","29-Mar-2026 21:12:13","00:19","28","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","30-Mar-2026 ","31-Mar-2026 11:57:02","31-Mar-2026 11:57:16","00:14","29","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","31-Mar-2026 ","01-Apr-2026 18:10:49","01-Apr-2026 18:11:06","00:17","30","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","01-Apr-2026 ","01-Apr-2026 18:11:44","01-Apr-2026 18:12:00","00:16","31","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","02-Apr-2026 ","02-Apr-2026 18:12:37","02-Apr-2026 18:12:55","00:18","32","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","03-Apr-2026 ","03-Apr-2026 21:58:59","03-Apr-2026 21:59:15","00:16","33","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","05-Apr-2026 ","05-Apr-2026 23:02:10","05-Apr-2026 23:02:29","00:19","34","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","06-Apr-2026 ","06-Apr-2026 22:14:46","06-Apr-2026 22:15:03","00:17","35","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","07-Apr-2026 ","07-Apr-2026 21:02:39","07-Apr-2026 21:02:52","00:13","36","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","08-Apr-2026 ","09-Apr-2026 21:40:54","09-Apr-2026 21:41:13","00:19","37","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","09-Apr-2026 ","09-Apr-2026 21:41:51","09-Apr-2026 21:42:08","00:17","38","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","10-Apr-2026 ","10-Apr-2026 20:05:38","10-Apr-2026 20:05:53","00:15","39","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","11-Apr-2026 ","11-Apr-2026 23:17:33","11-Apr-2026 23:17:46","00:13","40","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","12-Apr-2026 ","12-Apr-2026 18:21:45","12-Apr-2026 18:22:02","00:17","41","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","13-Apr-2026 ","13-Apr-2026 22:47:41","13-Apr-2026 22:48:01","00:20","42","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","14-Apr-2026 ","14-Apr-2026 22:06:10","14-Apr-2026 22:06:29","00:19","43","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","15-Apr-2026 ","15-Apr-2026 19:38:20","15-Apr-2026 19:38:45","00:25","44","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","16-Apr-2026 ","17-Apr-2026 18:32:51","17-Apr-2026 18:33:06","00:15","45","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","17-Apr-2026 ","17-Apr-2026 18:34:57","17-Apr-2026 18:35:14","00:17","46","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","18-Apr-2026 ","19-Apr-2026 18:11:33","19-Apr-2026 18:11:51","00:18","47","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","19-Apr-2026 ","19-Apr-2026 18:12:51","19-Apr-2026 18:13:09","00:18","48","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","20-Apr-2026 ","20-Apr-2026 21:40:01","20-Apr-2026 21:40:36","00:35","49","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","21-Apr-2026 ","21-Apr-2026 19:09:36","21-Apr-2026 19:09:49","00:13","50","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","24-Apr-2026 ","25-Apr-2026 19:44:57","25-Apr-2026 19:45:15","00:18","51","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","25-Apr-2026 ","25-Apr-2026 19:46:37","25-Apr-2026 19:47:02","00:25","52","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","26-Apr-2026 ","26-Apr-2026 21:19:11","26-Apr-2026 21:19:40","00:29","53","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","27-Apr-2026 ","28-Apr-2026 18:23:35","28-Apr-2026 18:23:51","00:16","54","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","28-Apr-2026 ","28-Apr-2026 18:25:15","28-Apr-2026 18:25:30","00:15","55","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","29-Apr-2026 ","29-Apr-2026 20:13:53","29-Apr-2026 20:14:08","00:15","56","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","30-Apr-2026 ","01-May-2026 19:10:14","01-May-2026 19:10:37","00:23","57","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","01-May-2026 ","01-May-2026 19:11:24","01-May-2026 19:11:41","00:17","58","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","02-May-2026 ","02-May-2026 18:48:16","02-May-2026 18:48:47","00:31","59","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","03-May-2026 ","03-May-2026 20:28:17","03-May-2026 20:28:34","00:17","60","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","04-May-2026 ","04-May-2026 21:19:12","04-May-2026 21:19:32","00:20","61","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","05-May-2026 ","05-May-2026 18:01:14","05-May-2026 18:01:32","00:18","62","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","06-May-2026 ","06-May-2026 19:34:21","06-May-2026 19:35:29","01:08","63","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","07-May-2026 ","07-May-2026 22:31:00","07-May-2026 22:31:21","00:21","64","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","08-May-2026 ","08-May-2026 22:36:30","08-May-2026 22:36:51","00:21","65","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","09-May-2026 ","09-May-2026 22:10:53","09-May-2026 22:11:08","00:15","66","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","10-May-2026 ","10-May-2026 20:03:46","10-May-2026 20:04:16","00:30","67","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","11-May-2026 ","11-May-2026 19:05:57","11-May-2026 19:06:14","00:17","68","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","12-May-2026 ","12-May-2026 20:13:55","12-May-2026 20:14:35","00:40","69","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","13-May-2026 ","13-May-2026 20:47:02","13-May-2026 20:47:37","00:35","70","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","14-May-2026 ","14-May-2026 20:49:31","14-May-2026 20:49:46","00:15","71","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","15-May-2026 ","15-May-2026 23:18:53","15-May-2026 23:19:24","00:31","72","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","16-May-2026 ","17-May-2026 18:08:11","17-May-2026 18:08:34","00:23","73","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","17-May-2026 ","17-May-2026 18:09:32","17-May-2026 18:10:09","00:37","74","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","18-May-2026 ","18-May-2026 21:06:45","18-May-2026 21:07:04","00:19","75","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","19-May-2026 ","19-May-2026 18:37:55","19-May-2026 18:38:08","00:13","76","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","20-May-2026 ","20-May-2026 22:15:44","20-May-2026 22:16:06","00:22","77","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","21-May-2026 ","21-May-2026 21:44:30","21-May-2026 21:44:46","00:16","78","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","22-May-2026 ","22-May-2026 18:49:41","22-May-2026 18:49:54","00:13","79","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","23-May-2026 ","23-May-2026 22:23:52","23-May-2026 22:24:37","00:45","80","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","24-May-2026 ","25-May-2026 18:07:16","25-May-2026 18:07:52","00:36","81","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","25-May-2026 ","25-May-2026 18:08:56","25-May-2026 18:09:26","00:30","82","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","26-May-2026 ","26-May-2026 21:43:50","26-May-2026 21:44:07","00:17","83","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","27-May-2026 ","27-May-2026 22:01:50","27-May-2026 22:02:46","00:56","84","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","28-May-2026 ","28-May-2026 19:31:12","28-May-2026 19:31:27","00:15","85","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","29-May-2026 ","29-May-2026 19:52:20","29-May-2026 19:52:38","00:18","86","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","30-May-2026 ","30-May-2026 18:53:09","30-May-2026 18:53:41","00:32","87","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","31-May-2026 ","31-May-2026 19:16:40","31-May-2026 19:16:55","00:15","88","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","01-Jun-2026 ","02-Jun-2026 19:05:37","02-Jun-2026 19:05:53","00:16","89","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","02-Jun-2026 ","02-Jun-2026 19:06:33","02-Jun-2026 19:06:51","00:18","90","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","03-Jun-2026 ","03-Jun-2026 22:04:49","03-Jun-2026 22:05:04","00:15","91","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","04-Jun-2026 ","04-Jun-2026 20:05:37","04-Jun-2026 20:06:01","00:24","92","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","05-May-2026 ","05-May-2026 18:01:55","05-May-2026 18:02:09","00:14","1","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","06-May-2026 ","06-May-2026 20:29:15","06-May-2026 20:29:29","00:14","2","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","07-May-2026 ","07-May-2026 22:18:42","07-May-2026 22:19:01","00:19","3","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","08-May-2026 ","08-May-2026 22:31:03","08-May-2026 22:31:18","00:15","4","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","09-May-2026 ","09-May-2026 22:22:24","09-May-2026 22:22:43","00:19","5","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","10-May-2026 ","10-May-2026 23:12:50","10-May-2026 23:13:05","00:15","6","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","11-May-2026 ","11-May-2026 21:16:13","11-May-2026 21:16:37","00:24","7","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","12-May-2026 ","12-May-2026 22:36:19","12-May-2026 22:36:35","00:16","8","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","13-May-2026 ","13-May-2026 20:07:41","13-May-2026 20:08:02","00:21","9","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","15-May-2026 ","15-May-2026 23:23:21","15-May-2026 23:23:32","00:11","10","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","16-May-2026 ","17-May-2026 21:56:34","17-May-2026 21:56:46","00:12","11","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","17-May-2026 ","17-May-2026 21:57:29","17-May-2026 21:57:49","00:20","12","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","18-May-2026 ","18-May-2026 22:48:11","18-May-2026 22:48:25","00:14","13","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","19-May-2026 ","19-May-2026 18:38:52","19-May-2026 18:39:17","00:25","14","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","20-May-2026 ","20-May-2026 22:15:48","20-May-2026 22:16:02","00:14","15","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","21-May-2026 ","21-May-2026 19:42:51","21-May-2026 19:43:04","00:13","16","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","22-May-2026 ","22-May-2026 18:04:07","22-May-2026 18:04:26","00:19","17","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","23-May-2026 ","23-May-2026 22:26:18","23-May-2026 22:26:29","00:11","18","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","24-May-2026 ","25-May-2026 18:08:46","25-May-2026 18:09:14","00:28","19","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","25-May-2026 ","25-May-2026 18:10:28","25-May-2026 18:10:50","00:22","20","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","26-May-2026 ","26-May-2026 21:13:16","26-May-2026 21:13:33","00:17","21","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","27-May-2026 ","27-May-2026 22:03:15","27-May-2026 22:04:03","00:48","22","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","28-May-2026 ","28-May-2026 18:35:28","28-May-2026 18:35:57","00:29","23","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","29-May-2026 ","29-May-2026 23:05:33","29-May-2026 23:05:50","00:17","24","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","30-May-2026 ","30-May-2026 18:21:49","30-May-2026 18:22:05","00:16","25","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","31-May-2026 ","31-May-2026 18:08:43","31-May-2026 18:08:58","00:15","26","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","01-Jun-2026 ","01-Jun-2026 20:49:23","01-Jun-2026 20:49:46","00:23","27","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","02-Jun-2026 ","02-Jun-2026 21:14:37","02-Jun-2026 21:14:57","00:20","28","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","03-Jun-2026 ","03-Jun-2026 21:18:46","03-Jun-2026 21:19:06","00:20","29","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","04-Jun-2026 ","04-Jun-2026 20:03:56","04-Jun-2026 20:04:14","00:18","30","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012004","47","1","","03-Jun-2026 ","03-Jun-2026 18:09:12","03-Jun-2026 18:10:34","01:22","1","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012004","47","1","","04-Jun-2026 ","04-Jun-2026 18:01:20","04-Jun-2026 18:01:58","00:38","2","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","13-May-2026 ","13-May-2026 21:40:48","13-May-2026 21:41:52","01:04","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","14-May-2026 ","14-May-2026 21:39:37","14-May-2026 21:40:25","00:48","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","15-May-2026 ","15-May-2026 23:28:11","15-May-2026 23:28:26","00:15","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","16-May-2026 ","16-May-2026 22:36:22","16-May-2026 22:36:56","00:34","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","17-May-2026 ","17-May-2026 21:24:12","17-May-2026 21:24:34","00:22","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","18-May-2026 ","18-May-2026 22:07:40","18-May-2026 22:07:59","00:19","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","19-May-2026 ","19-May-2026 22:03:42","19-May-2026 22:03:55","00:13","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","20-May-2026 ","20-May-2026 23:04:59","20-May-2026 23:05:17","00:18","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","21-May-2026 ","21-May-2026 23:14:46","21-May-2026 23:15:04","00:18","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","22-May-2026 ","22-May-2026 23:02:18","22-May-2026 23:02:43","00:25","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","23-May-2026 ","23-May-2026 21:45:15","23-May-2026 21:45:28","00:13","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","24-May-2026 ","24-May-2026 22:28:16","24-May-2026 22:29:20","01:04","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","25-May-2026 ","25-May-2026 22:41:05","25-May-2026 22:48:09","07:04","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","26-May-2026 ","26-May-2026 23:09:08","26-May-2026 23:10:22","01:14","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","27-May-2026 ","27-May-2026 22:44:40","27-May-2026 22:45:03","00:23","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","28-May-2026 ","28-May-2026 23:20:33","28-May-2026 23:20:51","00:18","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","30-May-2026 ","30-May-2026 23:14:18","30-May-2026 23:14:30","00:12","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","31-May-2026 ","31-May-2026 22:46:18","31-May-2026 22:47:09","00:51","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","01-Jun-2026 ","01-Jun-2026 22:41:39","01-Jun-2026 22:42:31","00:52","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","02-Jun-2026 ","02-Jun-2026 22:46:47","02-Jun-2026 22:47:09","00:22","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","03-Jun-2026 ","03-Jun-2026 22:33:25","03-Jun-2026 22:33:46","00:21","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","04-Jun-2026 ","04-Jun-2026 23:21:32","04-Jun-2026 23:21:43","00:11","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","14-Feb-2026 ","14-Feb-2026 18:03:39","14-Feb-2026 18:04:26","00:47","1","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","15-Feb-2026 ","15-Feb-2026 18:01:50","15-Feb-2026 18:02:24","00:34","2","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","16-Feb-2026 ","16-Feb-2026 18:01:30","16-Feb-2026 18:01:56","00:26","3","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","17-Feb-2026 ","17-Feb-2026 18:01:04","17-Feb-2026 18:01:14","00:10","4","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","18-Feb-2026 ","18-Feb-2026 18:02:17","18-Feb-2026 18:02:32","00:15","5","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","19-Feb-2026 ","19-Feb-2026 18:09:20","19-Feb-2026 18:09:50","00:30","6","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","20-Feb-2026 ","20-Feb-2026 18:14:47","20-Feb-2026 18:15:20","00:33","7","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","21-Feb-2026 ","21-Feb-2026 18:03:34","21-Feb-2026 18:03:56","00:22","8","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","22-Feb-2026 ","22-Feb-2026 20:08:20","22-Feb-2026 20:08:34","00:14","9","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","23-Feb-2026 ","23-Feb-2026 18:01:20","23-Feb-2026 18:01:41","00:21","10","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","24-Feb-2026 ","24-Feb-2026 18:01:33","24-Feb-2026 18:01:44","00:11","11","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","25-Feb-2026 ","25-Feb-2026 19:01:41","25-Feb-2026 19:01:55","00:14","12","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","26-Feb-2026 ","26-Feb-2026 18:03:34","26-Feb-2026 18:03:52","00:18","13","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","27-Feb-2026 ","27-Feb-2026 20:42:12","27-Feb-2026 20:42:21","00:09","14","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","28-Feb-2026 ","28-Feb-2026 18:01:04","28-Feb-2026 18:01:15","00:11","15","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","01-Mar-2026 ","01-Mar-2026 18:01:16","01-Mar-2026 18:01:32","00:16","16","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","02-Mar-2026 ","03-Mar-2026 05:26:34","03-Mar-2026 05:26:46","00:12","17","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","03-Mar-2026 ","03-Mar-2026 18:04:19","03-Mar-2026 18:04:31","00:12","18","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","04-Mar-2026 ","04-Mar-2026 18:01:30","04-Mar-2026 18:01:49","00:19","19","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","05-Mar-2026 ","05-Mar-2026 18:45:17","05-Mar-2026 18:45:33","00:16","20","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","06-Mar-2026 ","06-Mar-2026 18:01:03","06-Mar-2026 18:01:14","00:11","21","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","07-Mar-2026 ","07-Mar-2026 18:02:17","07-Mar-2026 18:02:32","00:15","22","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","08-Mar-2026 ","08-Mar-2026 19:22:45","08-Mar-2026 19:23:09","00:24","23","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","09-Mar-2026 ","09-Mar-2026 18:31:35","09-Mar-2026 18:31:47","00:12","24","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","10-Mar-2026 ","11-Mar-2026 04:23:18","11-Mar-2026 04:23:33","00:15","25","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","11-Mar-2026 ","11-Mar-2026 19:37:36","11-Mar-2026 19:37:46","00:10","26","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","12-Mar-2026 ","12-Mar-2026 18:38:17","12-Mar-2026 18:38:48","00:31","27","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","13-Mar-2026 ","13-Mar-2026 18:11:32","13-Mar-2026 18:12:40","01:08","28","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","14-Mar-2026 ","15-Mar-2026 18:01:21","15-Mar-2026 18:01:42","00:21","29","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","15-Mar-2026 ","15-Mar-2026 18:02:03","15-Mar-2026 18:02:15","00:12","30","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","16-Mar-2026 ","16-Mar-2026 18:01:07","16-Mar-2026 18:01:18","00:11","31","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","17-Mar-2026 ","17-Mar-2026 18:01:24","17-Mar-2026 18:01:45","00:21","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","18-Mar-2026 ","18-Mar-2026 18:01:37","18-Mar-2026 18:01:49","00:12","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","19-Mar-2026 ","19-Mar-2026 22:33:50","19-Mar-2026 22:34:02","00:12","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","20-Mar-2026 ","20-Mar-2026 18:15:17","20-Mar-2026 18:15:44","00:27","35","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","22-Mar-2026 ","23-Mar-2026 14:36:21","23-Mar-2026 14:36:42","00:21","36","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","15","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","23-Mar-2026 ","23-Mar-2026 18:01:19","23-Mar-2026 18:01:30","00:11","37","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","17","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","24-Mar-2026 ","24-Mar-2026 18:01:21","24-Mar-2026 18:01:30","00:09","38","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","25-Mar-2026 ","25-Mar-2026 18:25:02","25-Mar-2026 18:25:32","00:30","39","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","26-Mar-2026 ","26-Mar-2026 21:16:14","26-Mar-2026 21:16:57","00:43","40","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","27-Mar-2026 ","27-Mar-2026 18:01:41","27-Mar-2026 18:02:23","00:42","41","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","28-Mar-2026 ","28-Mar-2026 18:02:57","28-Mar-2026 18:03:21","00:24","42","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","29-Mar-2026 ","29-Mar-2026 19:21:39","29-Mar-2026 19:21:51","00:12","43","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","30-Mar-2026 ","30-Mar-2026 18:44:16","30-Mar-2026 18:44:28","00:12","44","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","31-Mar-2026 ","31-Mar-2026 21:37:52","31-Mar-2026 21:38:05","00:13","45","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","14","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","01-Apr-2026 ","01-Apr-2026 21:10:45","01-Apr-2026 21:11:02","00:17","46","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","12","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","02-Apr-2026 ","03-Apr-2026 18:42:35","03-Apr-2026 18:42:48","00:13","47","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","03-Apr-2026 ","03-Apr-2026 18:43:12","03-Apr-2026 18:43:21","00:09","48","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","11","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","04-Apr-2026 ","04-Apr-2026 22:55:47","04-Apr-2026 22:55:57","00:10","49","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","13","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","05-Apr-2026 ","06-Apr-2026 18:01:34","06-Apr-2026 18:01:49","00:15","50","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","06-Apr-2026 ","06-Apr-2026 18:02:13","06-Apr-2026 18:02:23","00:10","51","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","16","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","07-Apr-2026 ","07-Apr-2026 20:36:00","07-Apr-2026 20:36:10","00:10","52","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","17","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","08-Apr-2026 ","09-Apr-2026 18:12:35","09-Apr-2026 18:12:49","00:14","53","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","18","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","09-Apr-2026 ","09-Apr-2026 18:13:13","09-Apr-2026 18:13:27","00:14","54","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","18","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","10-Apr-2026 ","11-Apr-2026 18:01:29","11-Apr-2026 18:01:43","00:14","55","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","17","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","11-Apr-2026 ","11-Apr-2026 18:02:09","11-Apr-2026 18:02:19","00:10","56","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","19","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","12-Apr-2026 ","12-Apr-2026 18:01:35","12-Apr-2026 18:01:55","00:20","57","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","20","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","13-Apr-2026 ","13-Apr-2026 18:01:30","13-Apr-2026 18:01:51","00:21","58","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","22","1","Yes, I confirm this is the correct stool count","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","14-Apr-2026 ","14-Apr-2026 19:02:00","14-Apr-2026 19:02:23","00:23","59","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","15-Apr-2026 ","15-Apr-2026 18:26:38","15-Apr-2026 18:26:49","00:11","60","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","12","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","18-Apr-2026 ","19-Apr-2026 14:44:39","19-Apr-2026 14:44:50","00:11","61","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","19-Apr-2026 ","19-Apr-2026 18:01:18","19-Apr-2026 18:01:27","00:09","62","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","20-Apr-2026 ","20-Apr-2026 20:33:26","20-Apr-2026 20:33:37","00:11","63","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","21-Apr-2026 ","22-Apr-2026 21:55:40","22-Apr-2026 21:55:51","00:11","64","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","22-Apr-2026 ","22-Apr-2026 21:56:21","22-Apr-2026 21:56:30","00:09","65","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","23-Apr-2026 ","23-Apr-2026 18:46:35","23-Apr-2026 18:46:49","00:14","66","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","24-Apr-2026 ","25-Apr-2026 18:23:56","25-Apr-2026 18:24:09","00:13","67","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","25-Apr-2026 ","25-Apr-2026 18:24:36","25-Apr-2026 18:24:46","00:10","68","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","26-Apr-2026 ","26-Apr-2026 21:00:47","26-Apr-2026 21:00:56","00:09","69","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","27-Apr-2026 ","27-Apr-2026 18:22:29","27-Apr-2026 18:22:37","00:08","70","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","28-Apr-2026 ","28-Apr-2026 22:44:39","28-Apr-2026 22:44:49","00:10","71","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","29-Apr-2026 ","29-Apr-2026 22:49:50","29-Apr-2026 22:49:59","00:09","72","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","30-Apr-2026 ","30-Apr-2026 20:47:29","30-Apr-2026 20:47:37","00:08","73","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","01-May-2026 ","01-May-2026 21:43:23","01-May-2026 21:43:33","00:10","74","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","02-May-2026 ","02-May-2026 21:07:46","02-May-2026 21:07:56","00:10","75","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","03-May-2026 ","03-May-2026 21:43:35","03-May-2026 21:43:47","00:12","76","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","05-May-2026 ","06-May-2026 18:20:31","06-May-2026 18:20:43","00:12","77","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","06-May-2026 ","06-May-2026 18:21:12","06-May-2026 18:21:22","00:10","78","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","07-May-2026 ","07-May-2026 20:37:45","07-May-2026 20:38:13","00:28","79","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","08-May-2026 ","08-May-2026 18:31:28","08-May-2026 18:31:38","00:10","80","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","09-May-2026 ","09-May-2026 21:38:50","09-May-2026 21:38:58","00:08","81","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","10-May-2026 ","10-May-2026 22:01:51","10-May-2026 22:02:04","00:13","82","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","11-May-2026 ","11-May-2026 22:42:31","11-May-2026 22:42:39","00:08","83","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","12-May-2026 ","12-May-2026 19:03:36","12-May-2026 19:03:48","00:12","84","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","13-May-2026 ","13-May-2026 20:59:19","13-May-2026 20:59:30","00:11","85","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","14-May-2026 ","14-May-2026 20:18:42","14-May-2026 20:18:54","00:12","86","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","15-May-2026 ","15-May-2026 20:48:11","15-May-2026 20:48:21","00:10","87","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","16-May-2026 ","17-May-2026 19:32:54","17-May-2026 19:33:03","00:09","88","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","17-May-2026 ","17-May-2026 19:33:35","17-May-2026 19:33:43","00:08","89","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","18-May-2026 ","18-May-2026 20:55:22","18-May-2026 20:55:31","00:09","90","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","19-May-2026 ","19-May-2026 22:00:42","19-May-2026 22:00:50","00:08","91","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","20-May-2026 ","20-May-2026 19:56:20","20-May-2026 19:56:35","00:15","92","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","21-May-2026 ","21-May-2026 20:02:23","21-May-2026 20:02:32","00:09","93","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","22-May-2026 ","22-May-2026 22:00:12","22-May-2026 22:00:25","00:13","94","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","23-May-2026 ","23-May-2026 22:09:23","23-May-2026 22:09:31","00:08","95","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","24-May-2026 ","25-May-2026 19:37:07","25-May-2026 19:37:19","00:12","96","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","25-May-2026 ","25-May-2026 19:37:51","25-May-2026 19:38:01","00:10","97","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","26-May-2026 ","26-May-2026 19:50:53","26-May-2026 19:51:00","00:07","98","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","27-May-2026 ","27-May-2026 21:24:04","27-May-2026 21:24:12","00:08","99","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","28-May-2026 ","29-May-2026 20:53:24","29-May-2026 20:53:44","00:20","100","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","29-May-2026 ","29-May-2026 20:54:07","29-May-2026 20:54:17","00:10","101","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","30-May-2026 ","30-May-2026 22:07:38","30-May-2026 22:07:46","00:08","102","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","31-May-2026 ","31-May-2026 20:02:26","31-May-2026 20:02:34","00:08","103","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","02-Jun-2026 ","03-Jun-2026 10:53:02","03-Jun-2026 10:53:13","00:11","104","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","03-Jun-2026 ","03-Jun-2026 18:50:49","03-Jun-2026 18:50:56","00:07","105","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","04-Jun-2026 ","04-Jun-2026 19:07:13","04-Jun-2026 19:07:21","00:08","106","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","20-Apr-2026 ","20-Apr-2026 21:15:38","20-Apr-2026 21:16:41","01:03","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","21-Apr-2026 ","21-Apr-2026 18:03:25","21-Apr-2026 18:04:56","01:31","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","22-Apr-2026 ","22-Apr-2026 19:12:37","22-Apr-2026 19:13:09","00:32","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","23-Apr-2026 ","23-Apr-2026 20:30:34","23-Apr-2026 20:31:02","00:28","4","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","24-Apr-2026 ","24-Apr-2026 20:09:04","24-Apr-2026 20:09:46","00:42","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","25-Apr-2026 ","25-Apr-2026 20:06:32","25-Apr-2026 20:07:07","00:35","6","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","26-Apr-2026 ","26-Apr-2026 21:59:32","26-Apr-2026 22:00:01","00:29","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","27-Apr-2026 ","27-Apr-2026 19:38:17","27-Apr-2026 19:38:44","00:27","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","28-Apr-2026 ","28-Apr-2026 23:29:55","28-Apr-2026 23:30:19","00:24","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","29-Apr-2026 ","29-Apr-2026 19:44:25","29-Apr-2026 19:44:49","00:24","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","30-Apr-2026 ","30-Apr-2026 18:03:54","30-Apr-2026 18:04:24","00:30","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","01-May-2026 ","01-May-2026 21:14:03","01-May-2026 21:14:43","00:40","12","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","02-May-2026 ","02-May-2026 18:01:20","02-May-2026 18:01:55","00:35","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","03-May-2026 ","03-May-2026 23:02:06","03-May-2026 23:02:39","00:33","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","04-May-2026 ","04-May-2026 22:02:36","04-May-2026 22:03:10","00:34","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","05-May-2026 ","05-May-2026 20:28:15","05-May-2026 20:29:13","00:58","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","06-May-2026 ","06-May-2026 18:07:07","06-May-2026 18:08:40","01:33","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","07-May-2026 ","07-May-2026 21:39:42","07-May-2026 21:40:09","00:27","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","08-May-2026 ","08-May-2026 19:18:31","08-May-2026 19:19:10","00:39","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","09-May-2026 ","09-May-2026 22:03:28","09-May-2026 22:04:07","00:39","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","10-May-2026 ","10-May-2026 21:59:21","10-May-2026 22:00:01","00:40","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","11-May-2026 ","11-May-2026 20:50:01","11-May-2026 20:50:22","00:21","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","12-May-2026 ","12-May-2026 22:35:56","12-May-2026 22:36:50","00:54","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","13-May-2026 ","13-May-2026 21:41:50","13-May-2026 21:42:19","00:29","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","14-May-2026 ","14-May-2026 21:16:25","14-May-2026 21:17:02","00:37","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","15-May-2026 ","15-May-2026 21:52:56","15-May-2026 21:53:22","00:26","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","16-May-2026 ","16-May-2026 18:31:25","16-May-2026 18:31:51","00:26","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","17-May-2026 ","17-May-2026 20:47:42","17-May-2026 20:48:00","00:18","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","18-May-2026 ","19-May-2026 06:20:57","19-May-2026 06:21:20","00:23","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","19-May-2026 ","19-May-2026 20:42:32","19-May-2026 20:42:58","00:26","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","20-May-2026 ","21-May-2026 06:15:07","21-May-2026 06:15:24","00:17","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","21-May-2026 ","21-May-2026 21:38:28","21-May-2026 21:39:00","00:32","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","22-May-2026 ","22-May-2026 22:14:30","22-May-2026 22:14:59","00:29","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","23-May-2026 ","23-May-2026 22:46:03","23-May-2026 22:46:25","00:22","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","24-May-2026 ","25-May-2026 07:10:54","25-May-2026 07:11:24","00:30","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","25-May-2026 ","25-May-2026 19:21:24","25-May-2026 19:21:48","00:24","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","26-May-2026 ","26-May-2026 20:04:29","26-May-2026 20:05:07","00:38","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","28-May-2026 ","29-May-2026 12:32:12","29-May-2026 12:32:32","00:20","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","29-May-2026 ","29-May-2026 20:10:11","29-May-2026 20:10:30","00:19","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","30-May-2026 ","31-May-2026 00:20:30","31-May-2026 00:20:55","00:25","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","31-May-2026 ","01-Jun-2026 06:36:31","01-Jun-2026 06:36:58","00:27","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","01-Jun-2026 ","02-Jun-2026 01:57:42","02-Jun-2026 01:58:05","00:23","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","02-Jun-2026 ","02-Jun-2026 18:01:25","02-Jun-2026 18:01:58","00:33","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","03-Jun-2026 ","03-Jun-2026 20:16:54","03-Jun-2026 20:17:14","00:20","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","04-Jun-2026 ","05-Jun-2026 04:51:56","05-Jun-2026 04:52:23","00:27","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","31-Mar-2026 ","31-Mar-2026 18:29:57","31-Mar-2026 18:47:37","17:40","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","01-Apr-2026 ","01-Apr-2026 18:31:44","01-Apr-2026 18:33:40","01:56","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","02-Apr-2026 ","02-Apr-2026 18:36:48","02-Apr-2026 18:37:55","01:07","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","03-Apr-2026 ","03-Apr-2026 18:33:32","03-Apr-2026 18:34:22","00:50","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","04-Apr-2026 ","04-Apr-2026 18:34:52","04-Apr-2026 18:35:36","00:44","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","05-Apr-2026 ","05-Apr-2026 19:08:11","05-Apr-2026 19:08:38","00:27","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","06-Apr-2026 ","06-Apr-2026 18:33:36","06-Apr-2026 18:34:13","00:37","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","07-Apr-2026 ","07-Apr-2026 18:47:34","07-Apr-2026 18:48:10","00:36","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","08-Apr-2026 ","09-Apr-2026 18:23:22","09-Apr-2026 18:24:09","00:47","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","09-Apr-2026 ","09-Apr-2026 18:24:36","09-Apr-2026 18:25:06","00:30","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","10-Apr-2026 ","10-Apr-2026 18:01:29","10-Apr-2026 18:02:12","00:43","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","11-Apr-2026 ","11-Apr-2026 18:17:12","11-Apr-2026 18:18:02","00:50","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","12-Apr-2026 ","12-Apr-2026 18:04:08","12-Apr-2026 18:05:08","01:00","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","13-Apr-2026 ","13-Apr-2026 18:29:53","13-Apr-2026 18:30:18","00:25","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","14-Apr-2026 ","14-Apr-2026 18:16:55","14-Apr-2026 18:17:17","00:22","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","15-Apr-2026 ","15-Apr-2026 18:11:38","15-Apr-2026 18:12:08","00:30","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","16-Apr-2026 ","16-Apr-2026 18:09:46","16-Apr-2026 18:10:31","00:45","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","17-Apr-2026 ","17-Apr-2026 18:42:09","17-Apr-2026 18:43:13","01:04","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","18-Apr-2026 ","18-Apr-2026 18:15:17","18-Apr-2026 18:16:21","01:04","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","19-Apr-2026 ","19-Apr-2026 19:05:45","19-Apr-2026 19:06:13","00:28","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","20-Apr-2026 ","20-Apr-2026 18:27:20","20-Apr-2026 18:28:23","01:03","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","21-Apr-2026 ","21-Apr-2026 18:19:48","21-Apr-2026 18:20:25","00:37","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","22-Apr-2026 ","22-Apr-2026 18:12:05","22-Apr-2026 18:12:42","00:37","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","23-Apr-2026 ","23-Apr-2026 18:05:12","23-Apr-2026 18:05:40","00:28","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","24-Apr-2026 ","24-Apr-2026 18:15:58","24-Apr-2026 18:16:23","00:25","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","25-Apr-2026 ","25-Apr-2026 18:27:21","25-Apr-2026 18:27:43","00:22","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","26-Apr-2026 ","26-Apr-2026 19:37:21","26-Apr-2026 19:37:44","00:23","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","27-Apr-2026 ","27-Apr-2026 18:32:55","27-Apr-2026 18:33:18","00:23","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","28-Apr-2026 ","28-Apr-2026 18:12:37","28-Apr-2026 18:13:06","00:29","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","29-Apr-2026 ","29-Apr-2026 18:22:57","29-Apr-2026 18:23:18","00:21","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","30-Apr-2026 ","30-Apr-2026 18:05:56","30-Apr-2026 18:06:38","00:42","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","01-May-2026 ","01-May-2026 18:06:30","01-May-2026 18:06:53","00:23","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","02-May-2026 ","02-May-2026 18:06:44","02-May-2026 18:07:10","00:26","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","03-May-2026 ","03-May-2026 18:20:14","03-May-2026 18:20:40","00:26","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","04-May-2026 ","04-May-2026 18:10:14","04-May-2026 18:10:39","00:25","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","05-May-2026 ","05-May-2026 18:13:52","05-May-2026 18:14:14","00:22","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","06-May-2026 ","06-May-2026 18:27:25","06-May-2026 18:27:43","00:18","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","07-May-2026 ","07-May-2026 18:16:09","07-May-2026 18:16:34","00:25","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","08-May-2026 ","08-May-2026 18:05:30","08-May-2026 18:05:50","00:20","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","09-May-2026 ","09-May-2026 18:03:43","09-May-2026 18:04:01","00:18","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","10-May-2026 ","10-May-2026 18:13:20","10-May-2026 18:13:42","00:22","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","11-May-2026 ","11-May-2026 18:02:26","11-May-2026 18:02:54","00:28","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","12-May-2026 ","12-May-2026 18:16:11","12-May-2026 18:16:34","00:23","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","13-May-2026 ","13-May-2026 18:13:23","13-May-2026 18:13:42","00:19","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","14-May-2026 ","14-May-2026 18:18:23","14-May-2026 18:18:56","00:33","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","15-May-2026 ","15-May-2026 18:05:23","15-May-2026 18:05:47","00:24","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","16-May-2026 ","16-May-2026 19:15:24","16-May-2026 19:15:50","00:26","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","17-May-2026 ","17-May-2026 18:42:31","17-May-2026 18:42:46","00:15","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","18-May-2026 ","18-May-2026 18:07:10","18-May-2026 18:07:31","00:21","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","19-May-2026 ","19-May-2026 18:08:00","19-May-2026 18:08:22","00:22","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","20-May-2026 ","20-May-2026 18:46:47","20-May-2026 18:47:10","00:23","51","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","21-May-2026 ","21-May-2026 18:25:08","21-May-2026 18:25:33","00:25","52","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","22-May-2026 ","22-May-2026 18:10:28","22-May-2026 18:10:57","00:29","53","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","23-May-2026 ","23-May-2026 18:49:12","23-May-2026 18:49:37","00:25","54","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","24-May-2026 ","24-May-2026 18:24:57","24-May-2026 18:25:19","00:22","55","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","25-May-2026 ","25-May-2026 18:59:42","25-May-2026 19:00:03","00:21","56","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","26-May-2026 ","26-May-2026 19:02:50","26-May-2026 19:03:13","00:23","57","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","27-May-2026 ","27-May-2026 18:16:05","27-May-2026 18:16:24","00:19","58","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","28-May-2026 ","28-May-2026 18:12:59","28-May-2026 18:13:22","00:23","59","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","29-May-2026 ","29-May-2026 18:14:55","29-May-2026 18:15:12","00:17","60","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","30-May-2026 ","30-May-2026 18:15:22","30-May-2026 18:15:41","00:19","61","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","31-May-2026 ","31-May-2026 18:10:53","31-May-2026 18:11:09","00:16","62","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","01-Jun-2026 ","01-Jun-2026 18:10:37","01-Jun-2026 18:11:05","00:28","63","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","02-Jun-2026 ","02-Jun-2026 21:17:02","02-Jun-2026 21:17:20","00:18","64","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","03-Jun-2026 ","03-Jun-2026 18:03:12","03-Jun-2026 18:03:28","00:16","65","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","04-Jun-2026 ","04-Jun-2026 18:03:16","04-Jun-2026 18:03:40","00:24","66","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","16-Apr-2026 ","16-Apr-2026 18:04:28","16-Apr-2026 18:06:48","02:20","1","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","17-Apr-2026 ","17-Apr-2026 21:22:55","17-Apr-2026 21:25:27","02:32","2","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","18-Apr-2026 ","19-Apr-2026 20:05:25","19-Apr-2026 20:07:39","02:14","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","19-Apr-2026 ","19-Apr-2026 20:08:07","19-Apr-2026 20:12:24","04:17","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","20-Apr-2026 ","21-Apr-2026 21:33:43","21-Apr-2026 21:36:30","02:47","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","21-Apr-2026 ","21-Apr-2026 21:37:06","21-Apr-2026 21:38:37","01:31","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","22-Apr-2026 ","23-Apr-2026 22:28:26","23-Apr-2026 22:30:27","02:01","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","23-Apr-2026 ","23-Apr-2026 22:31:08","23-Apr-2026 22:32:58","01:50","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","24-Apr-2026 ","25-Apr-2026 19:10:46","25-Apr-2026 19:13:10","02:24","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","25-Apr-2026 ","25-Apr-2026 19:13:39","25-Apr-2026 19:14:21","00:42","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","26-Apr-2026 ","26-Apr-2026 20:00:34","26-Apr-2026 20:01:48","01:14","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","27-Apr-2026 ","27-Apr-2026 20:59:09","27-Apr-2026 21:03:03","03:54","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","28-Apr-2026 ","29-Apr-2026 12:06:59","29-Apr-2026 12:09:04","02:05","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","29-Apr-2026 ","30-Apr-2026 20:47:12","30-Apr-2026 20:48:25","01:13","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","30-Apr-2026 ","30-Apr-2026 20:48:54","30-Apr-2026 20:49:27","00:33","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","01-May-2026 ","01-May-2026 23:05:43","01-May-2026 23:08:41","02:58","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","02-May-2026 ","02-May-2026 21:59:39","02-May-2026 22:00:07","00:28","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","03-May-2026 ","03-May-2026 20:48:50","03-May-2026 20:49:39","00:49","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","04-May-2026 ","04-May-2026 23:06:12","04-May-2026 23:07:05","00:53","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","05-May-2026 ","05-May-2026 22:34:33","05-May-2026 22:36:46","02:13","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","06-May-2026 ","07-May-2026 20:20:36","07-May-2026 20:21:23","00:47","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","07-May-2026 ","07-May-2026 20:21:51","07-May-2026 20:22:22","00:31","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","09-May-2026 ","10-May-2026 09:56:26","10-May-2026 09:57:46","01:20","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","12-May-2026 ","12-May-2026 23:17:00","12-May-2026 23:17:43","00:43","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","13-May-2026 ","13-May-2026 19:25:14","13-May-2026 19:26:42","01:28","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","14-May-2026 ","14-May-2026 18:38:36","14-May-2026 18:39:02","00:26","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","15-May-2026 ","15-May-2026 22:58:22","15-May-2026 22:59:14","00:52","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","16-May-2026 ","16-May-2026 23:23:13","16-May-2026 23:23:30","00:17","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","17-May-2026 ","18-May-2026 12:46:24","18-May-2026 12:47:00","00:36","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","18-May-2026 ","18-May-2026 23:24:01","18-May-2026 23:26:28","02:27","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","18-Mar-2026 ","18-Mar-2026 18:17:26","18-Mar-2026 18:18:51","01:25","1","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","19-Mar-2026 ","19-Mar-2026 18:01:22","19-Mar-2026 18:02:22","01:00","2","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","20-Mar-2026 ","20-Mar-2026 18:01:14","20-Mar-2026 18:02:17","01:03","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","21-Mar-2026 ","21-Mar-2026 18:28:25","21-Mar-2026 18:28:40","00:15","4","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","22-Mar-2026 ","22-Mar-2026 18:01:58","22-Mar-2026 18:02:15","00:17","5","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","23-Mar-2026 ","24-Mar-2026 00:33:23","24-Mar-2026 00:33:51","00:28","6","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","24-Mar-2026 ","24-Mar-2026 18:01:20","24-Mar-2026 18:01:42","00:22","7","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","25-Mar-2026 ","25-Mar-2026 18:05:59","25-Mar-2026 18:06:09","00:10","8","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","26-Mar-2026 ","26-Mar-2026 18:57:42","26-Mar-2026 18:58:00","00:18","9","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","27-Mar-2026 ","27-Mar-2026 18:05:26","27-Mar-2026 18:05:44","00:18","10","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","28-Mar-2026 ","28-Mar-2026 18:34:55","28-Mar-2026 18:35:13","00:18","11","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","29-Mar-2026 ","29-Mar-2026 18:01:26","29-Mar-2026 18:01:40","00:14","12","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","30-Mar-2026 ","30-Mar-2026 18:15:14","30-Mar-2026 18:15:34","00:20","13","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","31-Mar-2026 ","31-Mar-2026 18:03:24","31-Mar-2026 18:03:43","00:19","14","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","01-Apr-2026 ","01-Apr-2026 18:19:46","01-Apr-2026 18:20:00","00:14","15","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","02-Apr-2026 ","02-Apr-2026 19:54:55","02-Apr-2026 19:55:05","00:10","16","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","03-Apr-2026 ","03-Apr-2026 22:16:32","03-Apr-2026 22:16:45","00:13","17","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","04-Apr-2026 ","04-Apr-2026 18:04:41","04-Apr-2026 18:05:01","00:20","18","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","05-Apr-2026 ","05-Apr-2026 22:47:52","05-Apr-2026 22:48:02","00:10","19","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","06-Apr-2026 ","07-Apr-2026 06:06:47","07-Apr-2026 06:07:10","00:23","20","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","07-Apr-2026 ","07-Apr-2026 18:10:33","07-Apr-2026 18:11:05","00:32","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","08-Apr-2026 ","09-Apr-2026 21:11:31","09-Apr-2026 21:12:00","00:29","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","09-Apr-2026 ","09-Apr-2026 21:12:19","09-Apr-2026 21:12:49","00:30","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","10-Apr-2026 ","10-Apr-2026 18:04:26","10-Apr-2026 18:04:42","00:16","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","11-Apr-2026 ","11-Apr-2026 19:27:38","11-Apr-2026 19:27:54","00:16","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","12-Apr-2026 ","12-Apr-2026 18:01:17","12-Apr-2026 18:01:29","00:12","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","13-Apr-2026 ","14-Apr-2026 05:43:24","14-Apr-2026 05:43:41","00:17","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","14-Apr-2026 ","14-Apr-2026 18:23:04","14-Apr-2026 18:23:16","00:12","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","15-Apr-2026 ","15-Apr-2026 18:01:41","15-Apr-2026 18:01:50","00:09","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","16-Apr-2026 ","16-Apr-2026 18:20:20","16-Apr-2026 18:20:33","00:13","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","17-Apr-2026 ","17-Apr-2026 18:30:28","17-Apr-2026 18:30:46","00:18","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","18-Apr-2026 ","18-Apr-2026 22:43:21","18-Apr-2026 22:43:31","00:10","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","19-Apr-2026 ","19-Apr-2026 18:20:54","19-Apr-2026 18:21:17","00:23","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","20-Apr-2026 ","21-Apr-2026 06:17:37","21-Apr-2026 06:18:03","00:26","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","21-Apr-2026 ","21-Apr-2026 18:01:02","21-Apr-2026 18:01:33","00:31","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","22-Apr-2026 ","22-Apr-2026 19:26:08","22-Apr-2026 19:26:32","00:24","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","23-Apr-2026 ","23-Apr-2026 18:11:27","23-Apr-2026 18:11:39","00:12","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","24-Apr-2026 ","24-Apr-2026 21:33:17","24-Apr-2026 21:33:38","00:21","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","25-Apr-2026 ","25-Apr-2026 21:50:02","25-Apr-2026 21:50:24","00:22","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","26-Apr-2026 ","26-Apr-2026 19:05:52","26-Apr-2026 19:06:03","00:11","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","27-Apr-2026 ","27-Apr-2026 18:39:18","27-Apr-2026 18:39:30","00:12","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","28-Apr-2026 ","28-Apr-2026 18:31:50","28-Apr-2026 18:32:10","00:20","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","29-Apr-2026 ","29-Apr-2026 18:46:29","29-Apr-2026 18:46:58","00:29","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","30-Apr-2026 ","30-Apr-2026 18:14:43","30-Apr-2026 18:15:07","00:24","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","01-May-2026 ","01-May-2026 22:22:43","01-May-2026 22:22:57","00:14","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","02-May-2026 ","02-May-2026 18:04:04","02-May-2026 18:04:16","00:12","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","03-May-2026 ","03-May-2026 18:02:06","03-May-2026 18:03:05","00:59","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","04-May-2026 ","04-May-2026 18:33:13","04-May-2026 18:33:26","00:13","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","05-May-2026 ","05-May-2026 19:02:55","05-May-2026 19:03:06","00:11","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","06-May-2026 ","06-May-2026 18:03:45","06-May-2026 18:04:11","00:26","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","07-May-2026 ","07-May-2026 21:26:53","07-May-2026 21:27:10","00:17","51","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","08-May-2026 ","08-May-2026 18:36:10","08-May-2026 18:36:31","00:21","52","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","09-May-2026 ","10-May-2026 19:42:33","10-May-2026 19:42:51","00:18","53","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","10-May-2026 ","10-May-2026 19:43:17","10-May-2026 19:43:27","00:10","54","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","11-May-2026 ","12-May-2026 06:36:35","12-May-2026 06:36:58","00:23","55","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","12-May-2026 ","13-May-2026 05:13:59","13-May-2026 05:14:14","00:15","56","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","13-May-2026 ","13-May-2026 18:05:45","13-May-2026 18:05:57","00:12","57","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","14-May-2026 ","14-May-2026 18:41:45","14-May-2026 18:41:59","00:14","58","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","15-May-2026 ","15-May-2026 19:46:08","15-May-2026 19:46:37","00:29","59","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","16-May-2026 ","16-May-2026 19:28:50","16-May-2026 19:29:04","00:14","60","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","17-May-2026 ","17-May-2026 19:42:34","17-May-2026 19:42:45","00:11","61","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","18-May-2026 ","18-May-2026 18:05:59","18-May-2026 18:06:14","00:15","62","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","19-May-2026 ","19-May-2026 19:20:23","19-May-2026 19:20:39","00:16","63","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","20-May-2026 ","20-May-2026 18:44:46","20-May-2026 18:44:58","00:12","64","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","21-May-2026 ","21-May-2026 18:26:11","21-May-2026 18:26:22","00:11","65","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","22-May-2026 ","22-May-2026 18:00:39","22-May-2026 18:01:09","00:30","66","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","23-May-2026 ","23-May-2026 19:15:06","23-May-2026 19:15:15","00:09","67","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","24-May-2026 ","24-May-2026 18:08:48","24-May-2026 18:09:01","00:13","68","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","25-May-2026 ","25-May-2026 21:52:52","25-May-2026 21:53:04","00:12","69","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","26-May-2026 ","26-May-2026 19:41:29","26-May-2026 19:41:42","00:13","70","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","27-May-2026 ","27-May-2026 19:08:12","27-May-2026 19:08:25","00:13","71","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","28-May-2026 ","28-May-2026 19:53:30","28-May-2026 19:53:47","00:17","72","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","29-May-2026 ","29-May-2026 19:03:08","29-May-2026 19:03:25","00:17","73","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","30-May-2026 ","30-May-2026 18:28:54","30-May-2026 18:29:12","00:18","74","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","31-May-2026 ","31-May-2026 20:52:43","31-May-2026 20:52:56","00:13","75","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","01-Jun-2026 ","01-Jun-2026 18:01:44","01-Jun-2026 18:01:55","00:11","76","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","02-Jun-2026 ","02-Jun-2026 19:23:05","02-Jun-2026 19:23:18","00:13","77","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","03-Jun-2026 ","03-Jun-2026 20:16:32","03-Jun-2026 20:16:45","00:13","78","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","04-Jun-2026 ","04-Jun-2026 19:01:12","04-Jun-2026 19:01:34","00:22","79","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","27-Feb-2026 ","27-Feb-2026 23:03:44","27-Feb-2026 23:05:27","01:43","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","28-Feb-2026 ","28-Feb-2026 22:00:47","28-Feb-2026 22:01:40","00:53","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","01-Mar-2026 ","01-Mar-2026 23:09:45","01-Mar-2026 23:10:07","00:22","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","02-Mar-2026 ","03-Mar-2026 21:17:31","03-Mar-2026 21:18:07","00:36","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","03-Mar-2026 ","03-Mar-2026 21:18:25","03-Mar-2026 21:18:51","00:26","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","04-Mar-2026 ","04-Mar-2026 21:07:08","04-Mar-2026 21:07:32","00:24","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","05-Mar-2026 ","05-Mar-2026 21:46:49","05-Mar-2026 21:47:07","00:18","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","06-Mar-2026 ","06-Mar-2026 20:40:38","06-Mar-2026 20:40:58","00:20","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","07-Mar-2026 ","07-Mar-2026 21:42:08","07-Mar-2026 21:42:22","00:14","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","08-Mar-2026 ","08-Mar-2026 21:03:19","08-Mar-2026 21:04:22","01:03","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","09-Mar-2026 ","09-Mar-2026 19:46:43","09-Mar-2026 19:47:09","00:26","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","10-Mar-2026 ","10-Mar-2026 20:21:28","10-Mar-2026 20:21:44","00:16","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","11-Mar-2026 ","11-Mar-2026 19:06:20","11-Mar-2026 19:06:34","00:14","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","12-Mar-2026 ","12-Mar-2026 21:14:54","12-Mar-2026 21:15:33","00:39","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","13-Mar-2026 ","13-Mar-2026 20:57:55","13-Mar-2026 20:58:17","00:22","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","14-Mar-2026 ","15-Mar-2026 07:17:23","15-Mar-2026 07:18:13","00:50","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","15-Mar-2026 ","15-Mar-2026 20:10:10","15-Mar-2026 20:10:42","00:32","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","16-Mar-2026 ","16-Mar-2026 22:25:52","16-Mar-2026 22:26:14","00:22","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","17-Mar-2026 ","17-Mar-2026 22:09:11","17-Mar-2026 22:09:28","00:17","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","18-Mar-2026 ","18-Mar-2026 20:38:45","18-Mar-2026 20:39:02","00:17","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","19-Mar-2026 ","19-Mar-2026 20:16:41","19-Mar-2026 20:16:54","00:13","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","20-Mar-2026 ","20-Mar-2026 22:41:13","20-Mar-2026 22:41:30","00:17","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","21-Mar-2026 ","21-Mar-2026 21:18:07","21-Mar-2026 21:19:04","00:57","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","22-Mar-2026 ","22-Mar-2026 22:15:27","22-Mar-2026 22:15:47","00:20","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","23-Mar-2026 ","23-Mar-2026 20:42:59","23-Mar-2026 20:43:09","00:10","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","24-Mar-2026 ","24-Mar-2026 20:00:24","24-Mar-2026 20:01:00","00:36","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","25-Mar-2026 ","25-Mar-2026 20:21:59","25-Mar-2026 20:22:17","00:18","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","26-Mar-2026 ","26-Mar-2026 21:44:02","26-Mar-2026 21:44:15","00:13","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","27-Mar-2026 ","28-Mar-2026 01:49:30","28-Mar-2026 01:49:52","00:22","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","28-Mar-2026 ","28-Mar-2026 20:43:13","28-Mar-2026 20:43:29","00:16","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","29-Mar-2026 ","29-Mar-2026 22:28:00","29-Mar-2026 22:28:35","00:35","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","30-Mar-2026 ","30-Mar-2026 21:46:17","30-Mar-2026 21:46:29","00:12","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","31-Mar-2026 ","31-Mar-2026 20:40:46","31-Mar-2026 20:40:58","00:12","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","01-Apr-2026 ","01-Apr-2026 21:24:04","01-Apr-2026 21:24:19","00:15","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","02-Apr-2026 ","02-Apr-2026 21:40:44","02-Apr-2026 21:40:59","00:15","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","03-Apr-2026 ","03-Apr-2026 22:39:57","03-Apr-2026 22:40:09","00:12","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","04-Apr-2026 ","04-Apr-2026 22:20:46","04-Apr-2026 22:21:00","00:14","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","05-Apr-2026 ","05-Apr-2026 22:23:58","05-Apr-2026 22:24:11","00:13","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","06-Apr-2026 ","06-Apr-2026 22:45:16","06-Apr-2026 22:45:36","00:20","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","07-Apr-2026 ","07-Apr-2026 23:22:12","07-Apr-2026 23:22:24","00:12","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","08-Apr-2026 ","09-Apr-2026 18:14:46","09-Apr-2026 18:14:59","00:13","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","09-Apr-2026 ","09-Apr-2026 18:15:24","09-Apr-2026 18:15:34","00:10","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","10-Apr-2026 ","10-Apr-2026 22:19:01","10-Apr-2026 22:19:17","00:16","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","11-Apr-2026 ","11-Apr-2026 22:52:56","11-Apr-2026 22:53:14","00:18","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","12-Apr-2026 ","12-Apr-2026 21:27:59","12-Apr-2026 21:28:08","00:09","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","13-Apr-2026 ","14-Apr-2026 00:16:06","14-Apr-2026 00:16:21","00:15","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","14-Apr-2026 ","14-Apr-2026 21:23:53","14-Apr-2026 21:24:03","00:10","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","15-Apr-2026 ","15-Apr-2026 18:45:29","15-Apr-2026 18:45:37","00:08","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","16-Apr-2026 ","16-Apr-2026 21:46:45","16-Apr-2026 21:46:56","00:11","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","17-Apr-2026 ","17-Apr-2026 21:47:44","17-Apr-2026 21:47:55","00:11","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","18-Apr-2026 ","18-Apr-2026 21:08:02","18-Apr-2026 21:08:16","00:14","51","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","19-Apr-2026 ","19-Apr-2026 21:06:45","19-Apr-2026 21:06:58","00:13","52","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","20-Apr-2026 ","20-Apr-2026 21:23:26","20-Apr-2026 21:23:36","00:10","53","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","21-Apr-2026 ","21-Apr-2026 21:56:38","21-Apr-2026 21:56:58","00:20","54","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","22-Apr-2026 ","22-Apr-2026 21:18:10","22-Apr-2026 21:18:20","00:10","55","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","23-Apr-2026 ","23-Apr-2026 21:46:41","23-Apr-2026 21:46:54","00:13","56","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","24-Apr-2026 ","24-Apr-2026 21:59:32","24-Apr-2026 21:59:56","00:24","57","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","25-Apr-2026 ","25-Apr-2026 22:34:04","25-Apr-2026 22:34:16","00:12","58","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","26-Apr-2026 ","26-Apr-2026 18:32:29","26-Apr-2026 18:32:39","00:10","59","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","27-Apr-2026 ","27-Apr-2026 20:48:50","27-Apr-2026 20:49:05","00:15","60","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","28-Apr-2026 ","28-Apr-2026 21:33:40","28-Apr-2026 21:33:56","00:16","61","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","29-Apr-2026 ","29-Apr-2026 22:24:17","29-Apr-2026 22:24:31","00:14","62","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","30-Apr-2026 ","30-Apr-2026 20:44:59","30-Apr-2026 20:45:10","00:11","63","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","01-May-2026 ","01-May-2026 22:08:20","01-May-2026 22:08:36","00:16","64","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","02-May-2026 ","02-May-2026 22:47:23","02-May-2026 22:47:36","00:13","65","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","03-May-2026 ","03-May-2026 22:04:34","03-May-2026 22:04:46","00:12","66","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","04-May-2026 ","04-May-2026 22:18:22","04-May-2026 22:18:37","00:15","67","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","05-May-2026 ","05-May-2026 20:52:05","05-May-2026 20:52:21","00:16","68","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","06-May-2026 ","06-May-2026 21:53:26","06-May-2026 21:53:40","00:14","69","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","07-May-2026 ","07-May-2026 22:03:10","07-May-2026 22:03:25","00:15","70","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","08-May-2026 ","09-May-2026 08:05:31","09-May-2026 08:06:06","00:35","71","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","09-May-2026 ","09-May-2026 22:35:37","09-May-2026 22:36:16","00:39","72","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","10-May-2026 ","10-May-2026 22:57:33","10-May-2026 22:57:43","00:10","73","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","11-May-2026 ","11-May-2026 22:05:17","11-May-2026 22:05:27","00:10","74","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","12-May-2026 ","12-May-2026 22:11:54","12-May-2026 22:12:06","00:12","75","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","13-May-2026 ","13-May-2026 19:03:38","13-May-2026 19:03:48","00:10","76","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","14-May-2026 ","14-May-2026 21:45:03","14-May-2026 21:45:12","00:09","77","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","15-May-2026 ","15-May-2026 21:23:03","15-May-2026 21:23:15","00:12","78","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","16-May-2026 ","16-May-2026 22:50:45","16-May-2026 22:50:54","00:09","79","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","17-May-2026 ","17-May-2026 23:21:33","17-May-2026 23:21:47","00:14","80","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","18-May-2026 ","18-May-2026 20:53:38","18-May-2026 20:53:47","00:09","81","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","19-May-2026 ","19-May-2026 22:30:38","19-May-2026 22:30:47","00:09","82","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","20-May-2026 ","20-May-2026 22:46:06","20-May-2026 22:46:26","00:20","83","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","21-May-2026 ","21-May-2026 21:37:09","21-May-2026 21:37:24","00:15","84","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","22-May-2026 ","22-May-2026 22:05:40","22-May-2026 22:05:59","00:19","85","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","23-May-2026 ","24-May-2026 10:05:24","24-May-2026 10:05:44","00:20","86","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","24-May-2026 ","24-May-2026 22:03:18","24-May-2026 22:03:28","00:10","87","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","25-May-2026 ","26-May-2026 07:34:48","26-May-2026 07:35:03","00:15","88","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","26-May-2026 ","26-May-2026 21:00:23","26-May-2026 21:00:32","00:09","89","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","27-May-2026 ","27-May-2026 23:02:15","27-May-2026 23:02:28","00:13","90","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","28-May-2026 ","28-May-2026 21:49:06","28-May-2026 21:49:34","00:28","91","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","29-May-2026 ","29-May-2026 22:58:10","29-May-2026 22:58:24","00:14","92","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","30-May-2026 ","30-May-2026 23:07:43","30-May-2026 23:08:00","00:17","93","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","31-May-2026 ","31-May-2026 21:26:36","31-May-2026 21:26:46","00:10","94","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","01-Jun-2026 ","01-Jun-2026 22:06:48","01-Jun-2026 22:06:58","00:10","95","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","02-Jun-2026 ","02-Jun-2026 22:38:41","02-Jun-2026 22:38:55","00:14","96","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","03-Jun-2026 ","03-Jun-2026 20:06:21","03-Jun-2026 20:06:46","00:25","97","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","04-Jun-2026 ","04-Jun-2026 21:44:46","04-Jun-2026 21:45:12","00:26","98","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","01-Apr-2026 ","01-Apr-2026 20:42:48","01-Apr-2026 20:44:08","01:20","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","02-Apr-2026 ","02-Apr-2026 22:34:46","02-Apr-2026 22:35:23","00:37","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","03-Apr-2026 ","03-Apr-2026 19:40:50","03-Apr-2026 19:41:26","00:36","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","04-Apr-2026 ","04-Apr-2026 21:34:52","04-Apr-2026 21:35:20","00:28","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","05-Apr-2026 ","05-Apr-2026 20:47:56","05-Apr-2026 20:48:17","00:21","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","06-Apr-2026 ","06-Apr-2026 23:05:55","06-Apr-2026 23:06:13","00:18","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","07-Apr-2026 ","07-Apr-2026 21:39:21","07-Apr-2026 21:39:43","00:22","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","08-Apr-2026 ","09-Apr-2026 18:02:39","09-Apr-2026 18:03:05","00:26","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","09-Apr-2026 ","09-Apr-2026 18:03:29","09-Apr-2026 18:03:43","00:14","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","10-Apr-2026 ","10-Apr-2026 18:17:13","10-Apr-2026 18:17:32","00:19","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","11-Apr-2026 ","11-Apr-2026 18:02:06","11-Apr-2026 18:02:31","00:25","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","12-Apr-2026 ","12-Apr-2026 20:40:55","12-Apr-2026 20:41:15","00:20","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","13-Apr-2026 ","13-Apr-2026 19:31:34","13-Apr-2026 19:31:48","00:14","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","14-Apr-2026 ","14-Apr-2026 20:27:48","14-Apr-2026 20:28:12","00:24","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","15-Apr-2026 ","16-Apr-2026 07:42:13","16-Apr-2026 07:42:32","00:19","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","16-Apr-2026 ","16-Apr-2026 19:55:45","16-Apr-2026 19:56:05","00:20","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","17-Apr-2026 ","17-Apr-2026 21:11:08","17-Apr-2026 21:11:44","00:36","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","18-Apr-2026 ","18-Apr-2026 18:24:43","18-Apr-2026 18:24:57","00:14","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","19-Apr-2026 ","20-Apr-2026 09:13:58","20-Apr-2026 09:14:22","00:24","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","20-Apr-2026 ","20-Apr-2026 18:50:09","20-Apr-2026 18:50:29","00:20","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","21-Apr-2026 ","21-Apr-2026 18:02:37","21-Apr-2026 18:05:29","02:52","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","18","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","22-Apr-2026 ","22-Apr-2026 22:35:07","22-Apr-2026 22:35:25","00:18","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","23-Apr-2026 ","24-Apr-2026 08:04:27","24-Apr-2026 08:04:41","00:14","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","24-Apr-2026 ","25-Apr-2026 09:53:31","25-Apr-2026 09:53:51","00:20","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","25-Apr-2026 ","25-Apr-2026 21:15:46","25-Apr-2026 21:15:58","00:12","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","26-Apr-2026 ","26-Apr-2026 22:16:21","26-Apr-2026 22:16:32","00:11","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","27-Apr-2026 ","27-Apr-2026 21:04:26","27-Apr-2026 21:04:39","00:13","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","28-Apr-2026 ","29-Apr-2026 17:52:10","29-Apr-2026 17:53:02","00:52","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","29-Apr-2026 ","30-Apr-2026 22:35:16","30-Apr-2026 22:36:01","00:45","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","30-Apr-2026 ","30-Apr-2026 22:36:45","30-Apr-2026 22:37:21","00:36","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","01-May-2026 ","01-May-2026 21:49:37","01-May-2026 21:49:54","00:17","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","02-May-2026 ","02-May-2026 22:03:41","02-May-2026 22:03:53","00:12","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","03-May-2026 ","03-May-2026 20:30:41","03-May-2026 20:30:52","00:11","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","04-May-2026 ","04-May-2026 23:27:30","04-May-2026 23:27:43","00:13","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","06-May-2026 ","07-May-2026 18:06:55","07-May-2026 18:07:08","00:13","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","07-May-2026 ","07-May-2026 18:07:33","07-May-2026 18:07:44","00:11","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","08-May-2026 ","08-May-2026 22:42:00","08-May-2026 22:42:16","00:16","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","09-May-2026 ","10-May-2026 21:18:31","10-May-2026 21:18:44","00:13","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","10-May-2026 ","10-May-2026 21:20:11","10-May-2026 21:20:22","00:11","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","11-May-2026 ","12-May-2026 10:48:02","12-May-2026 10:48:16","00:14","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","12-May-2026 ","12-May-2026 22:37:05","12-May-2026 22:37:24","00:19","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","15-May-2026 ","16-May-2026 21:29:32","16-May-2026 21:29:53","00:21","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","16-May-2026 ","16-May-2026 21:30:21","16-May-2026 21:31:03","00:42","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","17-May-2026 ","17-May-2026 20:09:06","17-May-2026 20:09:20","00:14","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","19-May-2026 ","20-May-2026 22:54:46","20-May-2026 22:55:16","00:30","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","20-May-2026 ","20-May-2026 22:56:47","20-May-2026 22:57:06","00:19","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","21-May-2026 ","22-May-2026 18:02:38","22-May-2026 18:02:50","00:12","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","22-May-2026 ","22-May-2026 18:03:46","22-May-2026 18:04:09","00:23","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","23-May-2026 ","23-May-2026 21:39:50","23-May-2026 21:40:02","00:12","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","25-May-2026 ","26-May-2026 18:01:24","26-May-2026 18:01:41","00:17","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","26-May-2026 ","26-May-2026 18:02:05","26-May-2026 18:02:19","00:14","51","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","28-May-2026 ","29-May-2026 21:55:32","29-May-2026 21:55:59","00:27","52","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","29-May-2026 ","29-May-2026 21:56:21","29-May-2026 21:56:43","00:22","53","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","30-May-2026 ","30-May-2026 18:42:12","30-May-2026 18:42:36","00:24","54","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","31-May-2026 ","31-May-2026 22:45:51","31-May-2026 22:46:12","00:21","55","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","01-Jun-2026 ","01-Jun-2026 21:39:27","01-Jun-2026 21:39:44","00:17","56","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","03-Jun-2026 ","04-Jun-2026 18:31:00","04-Jun-2026 18:31:18","00:18","57","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","04-Jun-2026 ","04-Jun-2026 18:31:41","04-Jun-2026 18:32:03","00:22","58","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132003","49","0","","26-May-2026 ","26-May-2026 20:55:38","26-May-2026 20:56:02","00:24","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132003","49","0","","27-May-2026 ","27-May-2026 19:26:19","27-May-2026 19:26:34","00:15","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132003","49","0","","28-May-2026 ","29-May-2026 18:54:58","29-May-2026 18:55:16","00:18","3","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132003","49","0","","29-May-2026 ","29-May-2026 18:55:33","29-May-2026 18:55:55","00:22","4","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132003","49","0","","30-May-2026 ","30-May-2026 18:08:30","30-May-2026 18:08:48","00:18","5","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","11","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132003","49","0","","31-May-2026 ","31-May-2026 19:32:37","31-May-2026 19:32:51","00:14","6","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132003","49","0","","01-Jun-2026 ","01-Jun-2026 18:39:58","01-Jun-2026 18:40:16","00:18","7","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132003","49","0","","02-Jun-2026 ","03-Jun-2026 20:11:30","03-Jun-2026 20:11:47","00:17","8","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132003","49","0","","03-Jun-2026 ","03-Jun-2026 20:12:04","03-Jun-2026 20:12:17","00:13","9","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132003","49","0","","04-Jun-2026 ","04-Jun-2026 20:46:30","04-Jun-2026 20:46:40","00:10","10","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","21-Apr-2026 ","21-Apr-2026 19:20:32","21-Apr-2026 19:22:54","02:22","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","14","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","22-Apr-2026 ","22-Apr-2026 19:08:50","22-Apr-2026 19:10:28","01:38","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","12","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","23-Apr-2026 ","23-Apr-2026 18:47:18","23-Apr-2026 18:47:46","00:28","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","24-Apr-2026 ","24-Apr-2026 20:09:26","24-Apr-2026 20:10:25","00:59","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","25-Apr-2026 ","25-Apr-2026 19:59:57","25-Apr-2026 20:00:25","00:28","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","26-Apr-2026 ","26-Apr-2026 18:17:01","26-Apr-2026 18:17:45","00:44","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","27-Apr-2026 ","27-Apr-2026 19:51:27","27-Apr-2026 19:52:00","00:33","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","28-Apr-2026 ","28-Apr-2026 20:01:23","28-Apr-2026 20:01:47","00:24","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","12","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","29-Apr-2026 ","29-Apr-2026 18:53:09","29-Apr-2026 18:53:39","00:30","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","30-Apr-2026 ","30-Apr-2026 19:59:27","30-Apr-2026 19:59:51","00:24","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","01-May-2026 ","01-May-2026 19:30:00","01-May-2026 19:30:47","00:47","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","02-May-2026 ","02-May-2026 23:09:28","02-May-2026 23:09:52","00:24","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","03-May-2026 ","03-May-2026 21:23:26","03-May-2026 21:23:59","00:33","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","04-May-2026 ","04-May-2026 19:29:17","04-May-2026 19:29:50","00:33","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","05-May-2026 ","05-May-2026 22:29:06","05-May-2026 22:29:41","00:35","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","14","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","06-May-2026 ","06-May-2026 20:10:08","06-May-2026 20:10:42","00:34","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","17","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","07-May-2026 ","07-May-2026 19:28:33","07-May-2026 19:28:49","00:16","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","12","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","08-May-2026 ","08-May-2026 19:32:48","08-May-2026 19:33:22","00:34","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","15","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","09-May-2026 ","09-May-2026 19:58:49","09-May-2026 20:00:29","01:40","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","23","1","Yes, I confirm this is the correct stool count","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","10-May-2026 ","10-May-2026 20:11:37","10-May-2026 20:12:05","00:28","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","21","1","Yes, I confirm this is the correct stool count","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","11-May-2026 ","11-May-2026 21:26:07","11-May-2026 21:26:32","00:25","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","21","1","Yes, I confirm this is the correct stool count","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","12-May-2026 ","12-May-2026 20:55:03","12-May-2026 20:55:28","00:25","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","18","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","13-May-2026 ","13-May-2026 20:35:38","13-May-2026 20:35:54","00:16","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","19","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","14-May-2026 ","14-May-2026 20:01:12","14-May-2026 20:01:34","00:22","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","17","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","15-May-2026 ","15-May-2026 20:30:56","15-May-2026 20:31:10","00:14","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","20","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","16-May-2026 ","16-May-2026 19:36:34","16-May-2026 19:36:54","00:20","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","18","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","17-May-2026 ","17-May-2026 19:57:53","17-May-2026 19:58:15","00:22","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","20","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","18-May-2026 ","18-May-2026 19:28:19","18-May-2026 19:28:52","00:33","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","18","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","19-May-2026 ","19-May-2026 20:01:15","19-May-2026 20:01:41","00:26","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","17","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","20-May-2026 ","20-May-2026 19:30:02","20-May-2026 19:30:24","00:22","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","21-May-2026 ","21-May-2026 19:34:46","21-May-2026 19:35:04","00:18","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","15","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","22-May-2026 ","22-May-2026 20:01:59","22-May-2026 20:02:19","00:20","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","15","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","23-May-2026 ","23-May-2026 22:20:42","23-May-2026 22:20:58","00:16","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","15","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","24-May-2026 ","24-May-2026 21:51:20","24-May-2026 21:51:41","00:21","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","15","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","25-May-2026 ","25-May-2026 20:47:57","25-May-2026 20:48:23","00:26","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","15","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","26-May-2026 ","26-May-2026 19:54:28","26-May-2026 19:54:46","00:18","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","15","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","27-May-2026 ","27-May-2026 19:35:37","27-May-2026 19:35:58","00:21","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","14","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","28-May-2026 ","28-May-2026 20:08:12","28-May-2026 20:08:36","00:24","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","29-May-2026 ","29-May-2026 19:30:44","29-May-2026 19:31:19","00:35","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","30-May-2026 ","30-May-2026 19:27:08","30-May-2026 19:27:36","00:28","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","31-May-2026 ","31-May-2026 19:11:49","31-May-2026 19:12:10","00:21","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","01-Jun-2026 ","01-Jun-2026 19:24:44","01-Jun-2026 19:25:12","00:28","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","02-Jun-2026 ","02-Jun-2026 20:39:30","02-Jun-2026 20:39:47","00:17","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","03-Jun-2026 ","03-Jun-2026 19:42:20","03-Jun-2026 19:43:04","00:44","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","04-Jun-2026 ","04-Jun-2026 20:01:23","04-Jun-2026 20:01:40","00:17","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162002","42","1","","27-May-2026 ","27-May-2026 22:05:52","27-May-2026 22:06:46","00:54","1","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162002","42","1","","28-May-2026 ","28-May-2026 20:33:03","28-May-2026 20:33:32","00:29","2","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162002","42","1","","29-May-2026 ","29-May-2026 19:58:09","29-May-2026 19:58:29","00:20","3","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162002","42","1","","30-May-2026 ","30-May-2026 22:00:15","30-May-2026 22:00:26","00:11","4","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162002","42","1","","31-May-2026 ","31-May-2026 22:29:28","31-May-2026 22:29:42","00:14","5","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162002","42","1","","01-Jun-2026 ","01-Jun-2026 19:08:59","01-Jun-2026 19:09:09","00:10","6","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162002","42","1","","02-Jun-2026 ","02-Jun-2026 18:49:31","02-Jun-2026 18:49:45","00:14","7","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162002","42","1","","03-Jun-2026 ","03-Jun-2026 18:26:02","03-Jun-2026 18:26:26","00:24","8","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162002","42","1","","04-Jun-2026 ","04-Jun-2026 22:23:10","04-Jun-2026 22:23:25","00:15","9","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","13-Apr-2026 ","13-Apr-2026 18:02:00","13-Apr-2026 18:03:08","01:08","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","14-Apr-2026 ","14-Apr-2026 18:01:42","14-Apr-2026 18:02:26","00:44","2","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","15-Apr-2026 ","15-Apr-2026 18:01:38","15-Apr-2026 18:02:04","00:26","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","16-Apr-2026 ","16-Apr-2026 18:32:28","16-Apr-2026 18:32:52","00:24","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","17-Apr-2026 ","17-Apr-2026 18:01:23","17-Apr-2026 18:01:40","00:17","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","18-Apr-2026 ","18-Apr-2026 18:01:26","18-Apr-2026 18:01:37","00:11","6","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","19-Apr-2026 ","19-Apr-2026 18:01:23","19-Apr-2026 18:01:40","00:17","7","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","20-Apr-2026 ","20-Apr-2026 20:46:30","20-Apr-2026 20:46:51","00:21","8","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","21-Apr-2026 ","21-Apr-2026 18:13:48","21-Apr-2026 18:13:57","00:09","9","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","22-Apr-2026 ","22-Apr-2026 18:06:03","22-Apr-2026 18:06:18","00:15","10","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","23-Apr-2026 ","23-Apr-2026 18:09:32","23-Apr-2026 18:09:44","00:12","11","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","24-Apr-2026 ","24-Apr-2026 18:01:08","24-Apr-2026 18:01:22","00:14","12","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","25-Apr-2026 ","25-Apr-2026 18:36:43","25-Apr-2026 18:36:56","00:13","13","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","26-Apr-2026 ","26-Apr-2026 18:01:56","26-Apr-2026 18:02:12","00:16","14","Patient","BYODHandheld","BYODHandheld","1","Yes","0","","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","27-Apr-2026 ","27-Apr-2026 18:01:05","27-Apr-2026 18:01:19","00:14","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","28-Apr-2026 ","28-Apr-2026 21:12:00","28-Apr-2026 21:12:13","00:13","16","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","29-Apr-2026 ","29-Apr-2026 18:01:04","29-Apr-2026 18:01:15","00:11","17","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","30-Apr-2026 ","30-Apr-2026 18:56:10","30-Apr-2026 18:56:21","00:11","18","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","01-May-2026 ","01-May-2026 18:01:23","01-May-2026 18:01:39","00:16","19","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","02-May-2026 ","02-May-2026 18:01:21","02-May-2026 18:01:39","00:18","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","03-May-2026 ","03-May-2026 18:01:14","03-May-2026 18:01:26","00:12","21","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","04-May-2026 ","04-May-2026 18:01:29","04-May-2026 18:02:07","00:38","22","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","05-May-2026 ","05-May-2026 18:18:48","05-May-2026 18:19:11","00:23","23","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","06-May-2026 ","06-May-2026 18:01:52","06-May-2026 18:02:05","00:13","24","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","07-May-2026 ","07-May-2026 18:01:54","07-May-2026 18:02:38","00:44","25","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","08-May-2026 ","08-May-2026 18:01:35","08-May-2026 18:01:45","00:10","26","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","09-May-2026 ","09-May-2026 18:01:07","09-May-2026 18:01:23","00:16","27","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","10-May-2026 ","10-May-2026 18:01:29","10-May-2026 18:02:07","00:38","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","11-May-2026 ","11-May-2026 20:05:03","11-May-2026 20:05:14","00:11","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","12-May-2026 ","12-May-2026 19:46:23","12-May-2026 19:46:39","00:16","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","13-May-2026 ","13-May-2026 21:37:54","13-May-2026 21:38:14","00:20","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","14-May-2026 ","14-May-2026 19:47:34","14-May-2026 19:48:33","00:59","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","15-May-2026 ","15-May-2026 18:04:38","15-May-2026 18:04:49","00:11","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","16-May-2026 ","16-May-2026 18:01:42","16-May-2026 18:02:35","00:53","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","17-May-2026 ","17-May-2026 19:30:43","17-May-2026 19:31:40","00:57","35","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","18-May-2026 ","18-May-2026 19:46:33","18-May-2026 19:46:59","00:26","36","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","19-May-2026 ","19-May-2026 18:02:50","19-May-2026 18:03:08","00:18","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","20-May-2026 ","20-May-2026 18:02:27","20-May-2026 18:02:40","00:13","38","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","21-May-2026 ","21-May-2026 20:51:11","21-May-2026 20:51:22","00:11","39","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","22-May-2026 ","22-May-2026 21:27:22","22-May-2026 21:27:31","00:09","40","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","23-May-2026 ","23-May-2026 22:20:05","23-May-2026 22:20:21","00:16","41","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","24-May-2026 ","24-May-2026 20:24:10","24-May-2026 20:24:27","00:17","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","25-May-2026 ","25-May-2026 21:49:27","25-May-2026 21:49:36","00:09","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","26-May-2026 ","26-May-2026 22:32:04","26-May-2026 22:32:17","00:13","44","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","27-May-2026 ","27-May-2026 22:44:49","27-May-2026 22:45:01","00:12","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","31-May-2026 ","01-Jun-2026 07:59:37","01-Jun-2026 08:00:22","00:45","46","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","01-Jun-2026 ","01-Jun-2026 18:01:51","01-Jun-2026 18:02:13","00:22","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","02-Jun-2026 ","02-Jun-2026 23:16:09","02-Jun-2026 23:16:22","00:13","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","03-Jun-2026 ","03-Jun-2026 23:03:37","03-Jun-2026 23:03:52","00:15","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","04-Jun-2026 ","04-Jun-2026 22:05:17","04-Jun-2026 22:05:30","00:13","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","01-Mar-2026 ","02-Mar-2026 18:40:39","02-Mar-2026 18:42:35","01:56","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","02-Mar-2026 ","02-Mar-2026 18:42:58","02-Mar-2026 18:44:02","01:04","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","03-Mar-2026 ","03-Mar-2026 18:16:16","03-Mar-2026 18:17:20","01:04","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","04-Mar-2026 ","04-Mar-2026 19:00:11","04-Mar-2026 19:00:54","00:43","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","05-Mar-2026 ","05-Mar-2026 18:08:45","05-Mar-2026 18:09:18","00:33","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","06-Mar-2026 ","06-Mar-2026 18:18:34","06-Mar-2026 18:19:08","00:34","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","07-Mar-2026 ","07-Mar-2026 18:01:32","07-Mar-2026 18:02:01","00:29","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","08-Mar-2026 ","08-Mar-2026 18:09:54","08-Mar-2026 18:10:19","00:25","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","09-Mar-2026 ","09-Mar-2026 18:50:13","09-Mar-2026 18:50:41","00:28","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","10-Mar-2026 ","10-Mar-2026 18:24:14","10-Mar-2026 18:24:43","00:29","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","11-Mar-2026 ","11-Mar-2026 19:06:52","11-Mar-2026 19:07:11","00:19","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","12-Mar-2026 ","12-Mar-2026 18:07:54","12-Mar-2026 18:08:18","00:24","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","13-Mar-2026 ","13-Mar-2026 18:12:06","13-Mar-2026 18:12:30","00:24","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","14-Mar-2026 ","15-Mar-2026 18:30:45","15-Mar-2026 18:31:18","00:33","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","15-Mar-2026 ","15-Mar-2026 18:32:00","15-Mar-2026 18:32:31","00:31","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","16-Mar-2026 ","16-Mar-2026 19:00:29","16-Mar-2026 19:01:41","01:12","16","Patient","BYODHandheld","BYODHandheld","1","Yes","0","","0","","0","","24","1","Yes, I confirm this is the correct stool count","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","17-Mar-2026 ","17-Mar-2026 18:03:41","17-Mar-2026 18:04:05","00:24","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","18-Mar-2026 ","18-Mar-2026 19:07:09","18-Mar-2026 19:07:36","00:27","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","19-Mar-2026 ","19-Mar-2026 19:24:39","19-Mar-2026 19:25:08","00:29","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","20-Mar-2026 ","20-Mar-2026 18:39:21","20-Mar-2026 18:39:53","00:32","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","21-Mar-2026 ","21-Mar-2026 18:49:04","21-Mar-2026 18:49:27","00:23","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","12","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","22-Mar-2026 ","22-Mar-2026 18:12:30","22-Mar-2026 18:12:57","00:27","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","23-Mar-2026 ","23-Mar-2026 18:07:23","23-Mar-2026 18:07:47","00:24","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","24-Mar-2026 ","24-Mar-2026 19:10:30","24-Mar-2026 19:11:07","00:37","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","25-Mar-2026 ","25-Mar-2026 19:10:29","25-Mar-2026 19:10:52","00:23","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","26-Mar-2026 ","26-Mar-2026 19:14:57","26-Mar-2026 19:15:22","00:25","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","27-Mar-2026 ","27-Mar-2026 18:12:05","27-Mar-2026 18:12:28","00:23","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","28-Mar-2026 ","28-Mar-2026 18:02:25","28-Mar-2026 18:02:48","00:23","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","12","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","29-Mar-2026 ","29-Mar-2026 18:09:12","29-Mar-2026 18:09:37","00:25","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","30-Mar-2026 ","30-Mar-2026 18:09:29","30-Mar-2026 18:09:52","00:23","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","31-Mar-2026 ","31-Mar-2026 18:18:41","31-Mar-2026 18:19:11","00:30","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","01-Apr-2026 ","01-Apr-2026 19:27:09","01-Apr-2026 19:27:31","00:22","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","02-Apr-2026 ","02-Apr-2026 18:11:54","02-Apr-2026 18:12:24","00:30","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","03-Apr-2026 ","03-Apr-2026 18:38:38","03-Apr-2026 18:38:58","00:20","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","04-Apr-2026 ","04-Apr-2026 18:03:04","04-Apr-2026 18:03:28","00:24","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","05-Apr-2026 ","05-Apr-2026 18:13:29","05-Apr-2026 18:13:50","00:21","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","06-Apr-2026 ","06-Apr-2026 20:42:37","06-Apr-2026 20:42:57","00:20","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","07-Apr-2026 ","07-Apr-2026 18:58:01","07-Apr-2026 18:58:20","00:19","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","08-Apr-2026 ","09-Apr-2026 18:05:31","09-Apr-2026 18:05:59","00:28","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","09-Apr-2026 ","09-Apr-2026 18:06:30","09-Apr-2026 18:07:07","00:37","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","10-Apr-2026 ","10-Apr-2026 18:13:58","10-Apr-2026 18:14:20","00:22","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","11-Apr-2026 ","11-Apr-2026 18:02:38","11-Apr-2026 18:03:02","00:24","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","12-Apr-2026 ","12-Apr-2026 18:08:16","12-Apr-2026 18:08:44","00:28","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","13-Apr-2026 ","13-Apr-2026 19:20:43","13-Apr-2026 19:21:05","00:22","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","14-Apr-2026 ","14-Apr-2026 18:18:45","14-Apr-2026 18:19:12","00:27","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","15-Apr-2026 ","15-Apr-2026 18:01:54","15-Apr-2026 18:02:17","00:23","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","16-Apr-2026 ","16-Apr-2026 18:04:15","16-Apr-2026 18:04:39","00:24","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","17-Apr-2026 ","17-Apr-2026 18:05:38","17-Apr-2026 18:06:11","00:33","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","18-Apr-2026 ","18-Apr-2026 18:02:10","18-Apr-2026 18:02:38","00:28","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","19-Apr-2026 ","19-Apr-2026 19:24:43","19-Apr-2026 19:25:10","00:27","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","20-Apr-2026 ","20-Apr-2026 18:36:26","20-Apr-2026 18:36:54","00:28","51","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","21-Apr-2026 ","21-Apr-2026 18:10:57","21-Apr-2026 18:11:17","00:20","52","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","22-Apr-2026 ","22-Apr-2026 18:47:22","22-Apr-2026 18:47:44","00:22","53","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","23-Apr-2026 ","23-Apr-2026 18:04:27","23-Apr-2026 18:04:52","00:25","54","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","24-Apr-2026 ","24-Apr-2026 18:03:12","24-Apr-2026 18:03:36","00:24","55","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","25-Apr-2026 ","25-Apr-2026 20:48:03","25-Apr-2026 20:48:23","00:20","56","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","26-Apr-2026 ","26-Apr-2026 19:10:03","26-Apr-2026 19:10:28","00:25","57","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","27-Apr-2026 ","27-Apr-2026 18:10:02","27-Apr-2026 18:10:25","00:23","58","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","28-Apr-2026 ","28-Apr-2026 18:03:12","28-Apr-2026 18:03:35","00:23","59","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","29-Apr-2026 ","29-Apr-2026 18:09:26","29-Apr-2026 18:10:02","00:36","60","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","30-Apr-2026 ","01-May-2026 18:26:24","01-May-2026 18:27:02","00:38","61","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","01-May-2026 ","01-May-2026 18:27:45","01-May-2026 18:28:20","00:35","62","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","02-May-2026 ","02-May-2026 19:54:00","02-May-2026 19:54:30","00:30","63","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","03-May-2026 ","03-May-2026 18:24:50","03-May-2026 18:25:14","00:24","64","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","04-May-2026 ","05-May-2026 19:36:17","05-May-2026 19:36:48","00:31","65","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","05-May-2026 ","05-May-2026 19:37:23","05-May-2026 19:37:43","00:20","66","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","06-May-2026 ","06-May-2026 18:18:59","06-May-2026 18:19:20","00:21","67","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","07-May-2026 ","07-May-2026 18:04:36","07-May-2026 18:05:00","00:24","68","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","08-May-2026 ","08-May-2026 18:22:35","08-May-2026 18:22:53","00:18","69","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","09-May-2026 ","09-May-2026 18:39:28","09-May-2026 18:39:51","00:23","70","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","10-May-2026 ","10-May-2026 18:30:41","10-May-2026 18:31:24","00:43","71","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","11-May-2026 ","11-May-2026 18:23:54","11-May-2026 18:24:14","00:20","72","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","12-May-2026 ","12-May-2026 18:23:43","12-May-2026 18:24:00","00:17","73","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","13-May-2026 ","13-May-2026 18:27:48","13-May-2026 18:28:14","00:26","74","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","14-May-2026 ","14-May-2026 18:11:36","14-May-2026 18:11:53","00:17","75","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","15-May-2026 ","15-May-2026 19:19:15","15-May-2026 19:19:34","00:19","76","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","16-May-2026 ","16-May-2026 18:44:47","16-May-2026 18:45:07","00:20","77","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","17-May-2026 ","17-May-2026 19:48:23","17-May-2026 19:48:53","00:30","78","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","18-May-2026 ","18-May-2026 18:08:29","18-May-2026 18:08:53","00:24","79","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","19-May-2026 ","19-May-2026 18:09:31","19-May-2026 18:10:01","00:30","80","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","20-May-2026 ","20-May-2026 18:18:41","20-May-2026 18:19:07","00:26","81","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","21-May-2026 ","21-May-2026 18:23:15","21-May-2026 18:24:11","00:56","82","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","22-May-2026 ","22-May-2026 18:06:32","22-May-2026 18:07:05","00:33","83","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","23-May-2026 ","23-May-2026 18:20:11","23-May-2026 18:20:38","00:27","84","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","24-May-2026 ","24-May-2026 18:08:45","24-May-2026 18:09:06","00:21","85","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","25-May-2026 ","25-May-2026 18:11:49","25-May-2026 18:12:14","00:25","86","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","26-May-2026 ","26-May-2026 18:15:47","26-May-2026 18:16:11","00:24","87","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","27-May-2026 ","27-May-2026 18:14:45","27-May-2026 18:15:04","00:19","88","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","28-May-2026 ","29-May-2026 18:26:37","29-May-2026 18:27:06","00:29","89","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","29-May-2026 ","29-May-2026 18:27:39","29-May-2026 18:27:57","00:18","90","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","30-May-2026 ","30-May-2026 18:08:14","30-May-2026 18:08:43","00:29","91","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","31-May-2026 ","31-May-2026 18:33:56","31-May-2026 18:34:17","00:21","92","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","01-Jun-2026 ","01-Jun-2026 19:16:03","01-Jun-2026 19:16:21","00:18","93","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","02-Jun-2026 ","02-Jun-2026 20:03:09","02-Jun-2026 20:03:35","00:26","94","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","03-Jun-2026 ","03-Jun-2026 18:23:04","03-Jun-2026 18:23:25","00:21","95","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","04-Jun-2026 ","04-Jun-2026 18:52:32","04-Jun-2026 18:52:53","00:21","96","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","15-Jan-2026 ","15-Jan-2026 22:48:04","15-Jan-2026 22:48:28","00:24","1","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","16-Jan-2026 ","16-Jan-2026 18:55:34","16-Jan-2026 18:56:14","00:40","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","17-Jan-2026 ","17-Jan-2026 18:01:51","17-Jan-2026 18:02:19","00:28","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","18-Jan-2026 ","18-Jan-2026 18:25:55","18-Jan-2026 18:26:19","00:24","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","19-Jan-2026 ","19-Jan-2026 18:10:54","19-Jan-2026 18:11:19","00:25","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","20-Jan-2026 ","20-Jan-2026 18:04:44","20-Jan-2026 18:05:02","00:18","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","21-Jan-2026 ","21-Jan-2026 18:06:08","21-Jan-2026 18:06:32","00:24","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","22-Jan-2026 ","22-Jan-2026 18:49:45","22-Jan-2026 18:50:08","00:23","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","23-Jan-2026 ","23-Jan-2026 20:50:48","23-Jan-2026 20:51:10","00:22","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","24-Jan-2026 ","24-Jan-2026 23:07:44","24-Jan-2026 23:08:20","00:36","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","25-Jan-2026 ","25-Jan-2026 20:58:21","25-Jan-2026 20:58:46","00:25","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","26-Jan-2026 ","26-Jan-2026 20:36:58","26-Jan-2026 20:37:09","00:11","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","27-Jan-2026 ","27-Jan-2026 20:54:52","27-Jan-2026 20:55:08","00:16","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","28-Jan-2026 ","28-Jan-2026 18:14:23","28-Jan-2026 18:14:40","00:17","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","29-Jan-2026 ","29-Jan-2026 18:50:46","29-Jan-2026 18:51:05","00:19","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","30-Jan-2026 ","30-Jan-2026 18:26:27","30-Jan-2026 18:26:45","00:18","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","31-Jan-2026 ","31-Jan-2026 19:52:40","31-Jan-2026 19:52:54","00:14","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","01-Feb-2026 ","01-Feb-2026 18:40:02","01-Feb-2026 18:40:16","00:14","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","02-Feb-2026 ","02-Feb-2026 19:32:39","02-Feb-2026 19:32:58","00:19","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","03-Feb-2026 ","03-Feb-2026 18:01:25","03-Feb-2026 18:01:39","00:14","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","04-Feb-2026 ","04-Feb-2026 18:59:17","04-Feb-2026 18:59:46","00:29","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","05-Feb-2026 ","05-Feb-2026 18:13:09","05-Feb-2026 18:13:33","00:24","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","06-Feb-2026 ","06-Feb-2026 18:17:15","06-Feb-2026 18:17:32","00:17","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","07-Feb-2026 ","07-Feb-2026 18:55:47","07-Feb-2026 18:56:19","00:32","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","08-Feb-2026 ","08-Feb-2026 18:01:33","08-Feb-2026 18:01:46","00:13","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","09-Feb-2026 ","09-Feb-2026 18:31:24","09-Feb-2026 18:31:36","00:12","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","10-Feb-2026 ","11-Feb-2026 18:49:47","11-Feb-2026 18:50:04","00:17","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","11-Feb-2026 ","11-Feb-2026 18:50:24","11-Feb-2026 18:50:38","00:14","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","12-Feb-2026 ","12-Feb-2026 18:36:48","12-Feb-2026 18:37:03","00:15","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","13-Feb-2026 ","13-Feb-2026 18:44:19","13-Feb-2026 18:44:46","00:27","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","14-Feb-2026 ","15-Feb-2026 19:02:43","15-Feb-2026 19:03:08","00:25","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","15-Feb-2026 ","15-Feb-2026 19:03:35","15-Feb-2026 19:03:54","00:19","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","16-Feb-2026 ","16-Feb-2026 18:24:47","16-Feb-2026 18:24:59","00:12","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","17-Feb-2026 ","17-Feb-2026 18:19:20","17-Feb-2026 18:19:33","00:13","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","18-Feb-2026 ","19-Feb-2026 21:30:15","19-Feb-2026 21:30:32","00:17","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","19-Feb-2026 ","19-Feb-2026 21:30:55","19-Feb-2026 21:31:06","00:11","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","20-Feb-2026 ","20-Feb-2026 18:07:24","20-Feb-2026 18:07:39","00:15","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","21-Feb-2026 ","21-Feb-2026 18:04:27","21-Feb-2026 18:04:45","00:18","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","22-Feb-2026 ","22-Feb-2026 18:27:54","22-Feb-2026 18:28:07","00:13","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","23-Feb-2026 ","23-Feb-2026 20:13:02","23-Feb-2026 20:13:16","00:14","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","24-Feb-2026 ","24-Feb-2026 18:10:58","24-Feb-2026 18:11:27","00:29","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","25-Feb-2026 ","25-Feb-2026 19:28:29","25-Feb-2026 19:28:55","00:26","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","26-Feb-2026 ","26-Feb-2026 18:36:10","26-Feb-2026 18:36:28","00:18","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","27-Feb-2026 ","28-Feb-2026 22:20:16","28-Feb-2026 22:20:35","00:19","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","28-Feb-2026 ","28-Feb-2026 22:20:57","28-Feb-2026 22:21:08","00:11","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","01-Mar-2026 ","01-Mar-2026 18:29:02","01-Mar-2026 18:29:21","00:19","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","23-Jan-2026 ","23-Jan-2026 18:44:00","23-Jan-2026 18:44:48","00:48","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","24-Jan-2026 ","24-Jan-2026 20:04:49","24-Jan-2026 20:05:45","00:56","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","25-Jan-2026 ","26-Jan-2026 18:05:41","26-Jan-2026 18:06:13","00:32","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","26-Jan-2026 ","26-Jan-2026 18:06:31","26-Jan-2026 18:06:49","00:18","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","27-Jan-2026 ","27-Jan-2026 22:05:35","27-Jan-2026 22:05:59","00:24","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","28-Jan-2026 ","28-Jan-2026 19:49:36","28-Jan-2026 19:49:50","00:14","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","29-Jan-2026 ","29-Jan-2026 19:33:56","29-Jan-2026 19:34:09","00:13","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","30-Jan-2026 ","30-Jan-2026 18:48:41","30-Jan-2026 18:48:57","00:16","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","31-Jan-2026 ","31-Jan-2026 20:02:38","31-Jan-2026 20:02:51","00:13","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","01-Feb-2026 ","01-Feb-2026 20:59:03","01-Feb-2026 20:59:19","00:16","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","02-Feb-2026 ","02-Feb-2026 18:01:41","02-Feb-2026 18:01:59","00:18","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","03-Feb-2026 ","03-Feb-2026 18:22:38","03-Feb-2026 18:23:07","00:29","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","04-Feb-2026 ","04-Feb-2026 18:59:50","04-Feb-2026 19:00:03","00:13","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","05-Feb-2026 ","05-Feb-2026 19:40:08","05-Feb-2026 19:40:20","00:12","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","06-Feb-2026 ","06-Feb-2026 18:11:13","06-Feb-2026 18:11:32","00:19","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","07-Feb-2026 ","08-Feb-2026 14:02:35","08-Feb-2026 14:03:10","00:35","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","08-Feb-2026 ","08-Feb-2026 18:25:38","08-Feb-2026 18:26:04","00:26","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","09-Feb-2026 ","09-Feb-2026 20:19:15","09-Feb-2026 20:19:25","00:10","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","10-Feb-2026 ","10-Feb-2026 21:54:07","10-Feb-2026 21:54:42","00:35","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","11-Feb-2026 ","11-Feb-2026 18:34:20","11-Feb-2026 18:34:44","00:24","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","12-Feb-2026 ","12-Feb-2026 19:11:56","12-Feb-2026 19:12:14","00:18","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","13-Feb-2026 ","13-Feb-2026 19:51:22","13-Feb-2026 19:51:34","00:12","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","14-Feb-2026 ","14-Feb-2026 18:02:05","14-Feb-2026 18:03:12","01:07","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","15-Feb-2026 ","15-Feb-2026 18:45:30","15-Feb-2026 18:45:56","00:26","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","16-Feb-2026 ","16-Feb-2026 19:01:35","16-Feb-2026 19:02:07","00:32","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","17-Feb-2026 ","17-Feb-2026 19:58:00","17-Feb-2026 19:58:26","00:26","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","18-Feb-2026 ","18-Feb-2026 19:35:30","18-Feb-2026 19:36:48","01:18","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","04-Mar-2026 ","04-Mar-2026 18:45:26","04-Mar-2026 18:45:57","00:31","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","05-Mar-2026 ","05-Mar-2026 20:32:08","05-Mar-2026 20:33:10","01:02","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","06-Mar-2026 ","06-Mar-2026 19:51:49","06-Mar-2026 19:52:07","00:18","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","07-Mar-2026 ","07-Mar-2026 20:14:59","07-Mar-2026 20:15:18","00:19","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","08-Mar-2026 ","08-Mar-2026 21:42:48","08-Mar-2026 21:42:58","00:10","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","09-Mar-2026 ","09-Mar-2026 21:47:51","09-Mar-2026 21:48:12","00:21","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","10-Mar-2026 ","10-Mar-2026 21:33:00","10-Mar-2026 21:34:34","01:34","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","11-Mar-2026 ","11-Mar-2026 21:05:27","11-Mar-2026 21:05:46","00:19","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","12-Mar-2026 ","12-Mar-2026 21:40:59","12-Mar-2026 21:41:44","00:45","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","13-Mar-2026 ","13-Mar-2026 19:50:45","13-Mar-2026 19:51:55","01:10","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","14-Mar-2026 ","14-Mar-2026 18:04:37","14-Mar-2026 18:04:50","00:13","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","15-Mar-2026 ","15-Mar-2026 19:58:48","15-Mar-2026 19:59:01","00:13","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","16-Mar-2026 ","16-Mar-2026 20:52:43","16-Mar-2026 20:53:00","00:17","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","17-Mar-2026 ","17-Mar-2026 20:33:05","17-Mar-2026 20:33:21","00:16","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","18-Mar-2026 ","18-Mar-2026 22:02:13","18-Mar-2026 22:02:45","00:32","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","19-Mar-2026 ","19-Mar-2026 21:20:17","19-Mar-2026 21:20:33","00:16","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","20-Mar-2026 ","20-Mar-2026 19:07:44","20-Mar-2026 19:07:56","00:12","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","21-Mar-2026 ","21-Mar-2026 18:42:15","21-Mar-2026 18:42:28","00:13","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","22-Mar-2026 ","22-Mar-2026 19:24:00","22-Mar-2026 19:25:07","01:07","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","23-Mar-2026 ","23-Mar-2026 18:24:50","23-Mar-2026 18:25:19","00:29","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","24-Mar-2026 ","24-Mar-2026 20:58:13","24-Mar-2026 20:58:34","00:21","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","25-Mar-2026 ","25-Mar-2026 18:01:28","25-Mar-2026 18:01:40","00:12","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","26-Mar-2026 ","26-Mar-2026 19:59:46","26-Mar-2026 19:59:59","00:13","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","27-Mar-2026 ","27-Mar-2026 19:05:42","27-Mar-2026 19:06:36","00:54","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","28-Mar-2026 ","28-Mar-2026 21:40:08","28-Mar-2026 21:40:33","00:25","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","29-Mar-2026 ","30-Mar-2026 02:54:17","30-Mar-2026 02:55:12","00:55","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","30-Mar-2026 ","30-Mar-2026 19:29:58","30-Mar-2026 19:30:29","00:31","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","31-Mar-2026 ","31-Mar-2026 19:54:16","31-Mar-2026 19:54:28","00:12","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","01-Apr-2026 ","01-Apr-2026 19:00:10","01-Apr-2026 19:01:09","00:59","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","02-Apr-2026 ","03-Apr-2026 05:28:24","03-Apr-2026 05:28:44","00:20","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","03-Apr-2026 ","03-Apr-2026 20:36:14","03-Apr-2026 20:36:50","00:36","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","04-Apr-2026 ","04-Apr-2026 18:40:00","04-Apr-2026 18:41:36","01:36","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","05-Apr-2026 ","05-Apr-2026 18:53:00","05-Apr-2026 18:53:58","00:58","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","06-Apr-2026 ","06-Apr-2026 18:09:33","06-Apr-2026 18:10:09","00:36","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","07-Apr-2026 ","07-Apr-2026 19:18:44","07-Apr-2026 19:19:47","01:03","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","08-Apr-2026 ","09-Apr-2026 12:37:30","09-Apr-2026 12:37:48","00:18","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","09-Apr-2026 ","09-Apr-2026 20:55:59","09-Apr-2026 20:56:29","00:30","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","10-Apr-2026 ","10-Apr-2026 22:53:17","10-Apr-2026 22:53:40","00:23","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","11-Apr-2026 ","11-Apr-2026 20:04:52","11-Apr-2026 20:05:06","00:14","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","12-Apr-2026 ","12-Apr-2026 21:58:52","12-Apr-2026 21:59:11","00:19","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","13-Apr-2026 ","13-Apr-2026 21:45:51","13-Apr-2026 21:46:02","00:11","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","14-Apr-2026 ","14-Apr-2026 20:39:25","14-Apr-2026 20:39:58","00:33","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","15-Apr-2026 ","15-Apr-2026 20:14:56","15-Apr-2026 20:16:04","01:08","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","16-Apr-2026 ","16-Apr-2026 20:20:38","16-Apr-2026 20:21:56","01:18","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","17-Apr-2026 ","18-Apr-2026 04:36:28","18-Apr-2026 04:36:51","00:23","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","18-Apr-2026 ","18-Apr-2026 18:45:45","18-Apr-2026 18:46:34","00:49","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","19-Apr-2026 ","19-Apr-2026 21:11:57","19-Apr-2026 21:12:23","00:26","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","20-Apr-2026 ","20-Apr-2026 18:30:44","20-Apr-2026 18:31:27","00:43","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","21-Apr-2026 ","21-Apr-2026 19:33:38","21-Apr-2026 19:34:05","00:27","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","22-Apr-2026 ","23-Apr-2026 05:04:23","23-Apr-2026 05:04:33","00:10","51","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","23-Apr-2026 ","23-Apr-2026 21:46:23","23-Apr-2026 21:47:03","00:40","52","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","25-Apr-2026 ","26-Apr-2026 06:44:01","26-Apr-2026 06:44:16","00:15","53","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","26-Apr-2026 ","26-Apr-2026 19:53:35","26-Apr-2026 19:54:20","00:45","54","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","27-Apr-2026 ","27-Apr-2026 18:16:59","27-Apr-2026 18:17:38","00:39","55","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","28-Apr-2026 ","28-Apr-2026 18:27:59","28-Apr-2026 18:28:13","00:14","56","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","29-Apr-2026 ","29-Apr-2026 20:30:50","29-Apr-2026 20:31:01","00:11","57","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","30-Apr-2026 ","30-Apr-2026 21:43:01","30-Apr-2026 21:43:29","00:28","58","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","01-May-2026 ","01-May-2026 21:30:29","01-May-2026 21:30:42","00:13","59","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","02-May-2026 ","02-May-2026 22:01:00","02-May-2026 22:01:10","00:10","60","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","03-May-2026 ","03-May-2026 20:11:42","03-May-2026 20:12:16","00:34","61","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","04-May-2026 ","04-May-2026 18:41:10","04-May-2026 18:41:25","00:15","62","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","05-May-2026 ","05-May-2026 19:24:22","05-May-2026 19:24:54","00:32","63","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","06-May-2026 ","06-May-2026 21:53:22","06-May-2026 21:54:12","00:50","64","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","07-May-2026 ","07-May-2026 21:12:19","07-May-2026 21:12:29","00:10","65","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","08-May-2026 ","08-May-2026 18:11:04","08-May-2026 18:11:14","00:10","66","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","09-May-2026 ","09-May-2026 19:52:08","09-May-2026 19:52:17","00:09","67","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","10-May-2026 ","10-May-2026 19:39:21","10-May-2026 19:40:22","01:01","68","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","11-May-2026 ","11-May-2026 18:56:35","11-May-2026 18:56:46","00:11","69","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","12-May-2026 ","12-May-2026 18:17:34","12-May-2026 18:18:06","00:32","70","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","13-May-2026 ","13-May-2026 21:41:52","13-May-2026 21:42:04","00:12","71","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","14-May-2026 ","14-May-2026 20:29:40","14-May-2026 20:30:52","01:12","72","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","15-May-2026 ","15-May-2026 18:44:45","15-May-2026 18:44:59","00:14","73","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","16-May-2026 ","16-May-2026 18:11:24","16-May-2026 18:11:52","00:28","74","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","17-May-2026 ","18-May-2026 18:42:40","18-May-2026 18:43:20","00:40","75","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","18-May-2026 ","18-May-2026 18:43:51","18-May-2026 18:44:00","00:09","76","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","19-May-2026 ","19-May-2026 21:58:19","19-May-2026 21:58:29","00:10","77","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","20-May-2026 ","20-May-2026 18:41:02","20-May-2026 18:41:24","00:22","78","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","21-May-2026 ","21-May-2026 21:05:33","21-May-2026 21:05:54","00:21","79","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","22-May-2026 ","22-May-2026 21:17:24","22-May-2026 21:17:38","00:14","80","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","23-May-2026 ","23-May-2026 18:42:12","23-May-2026 18:42:28","00:16","81","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","24-May-2026 ","24-May-2026 21:24:54","24-May-2026 21:25:21","00:27","82","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","25-May-2026 ","25-May-2026 19:37:39","25-May-2026 19:38:41","01:02","83","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","26-May-2026 ","26-May-2026 20:52:27","26-May-2026 20:53:19","00:52","84","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","27-May-2026 ","27-May-2026 18:37:02","27-May-2026 18:37:22","00:20","85","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","28-May-2026 ","28-May-2026 19:26:08","28-May-2026 19:26:48","00:40","86","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","29-May-2026 ","29-May-2026 18:44:54","29-May-2026 18:45:07","00:13","87","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","30-May-2026 ","30-May-2026 19:51:02","30-May-2026 19:53:12","02:10","88","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","31-May-2026 ","31-May-2026 18:13:14","31-May-2026 18:13:29","00:15","89","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","01-Jun-2026 ","01-Jun-2026 20:24:43","01-Jun-2026 20:25:02","00:19","90","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","02-Jun-2026 ","02-Jun-2026 19:16:07","02-Jun-2026 19:16:33","00:26","91","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","03-Jun-2026 ","03-Jun-2026 20:34:33","03-Jun-2026 20:35:00","00:27","92","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","04-Jun-2026 ","05-Jun-2026 05:56:13","05-Jun-2026 05:56:29","00:16","93","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","03-Mar-2026 ","04-Mar-2026 11:19:17","04-Mar-2026 11:53:02","33:45","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","04-Mar-2026 ","04-Mar-2026 18:04:55","04-Mar-2026 18:05:39","00:44","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","05-Mar-2026 ","05-Mar-2026 18:01:34","05-Mar-2026 18:02:10","00:36","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","06-Mar-2026 ","06-Mar-2026 18:01:58","06-Mar-2026 18:02:42","00:44","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","07-Mar-2026 ","07-Mar-2026 18:52:44","07-Mar-2026 18:53:15","00:31","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","08-Mar-2026 ","08-Mar-2026 19:16:55","08-Mar-2026 19:17:25","00:30","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","09-Mar-2026 ","09-Mar-2026 18:03:55","09-Mar-2026 18:04:22","00:27","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","10-Mar-2026 ","10-Mar-2026 22:05:01","10-Mar-2026 22:05:54","00:53","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","11-Mar-2026 ","11-Mar-2026 19:47:14","11-Mar-2026 19:47:34","00:20","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","12-Mar-2026 ","12-Mar-2026 18:09:02","12-Mar-2026 18:09:41","00:39","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","13-Mar-2026 ","14-Mar-2026 18:47:40","14-Mar-2026 18:48:18","00:38","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","14-Mar-2026 ","14-Mar-2026 18:48:43","14-Mar-2026 18:49:08","00:25","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","16-Mar-2026 ","17-Mar-2026 02:08:04","17-Mar-2026 02:08:39","00:35","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","17-Mar-2026 ","17-Mar-2026 18:27:58","17-Mar-2026 18:28:17","00:19","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","18-Mar-2026 ","18-Mar-2026 18:16:46","18-Mar-2026 18:17:14","00:28","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","19-Mar-2026 ","20-Mar-2026 18:47:51","20-Mar-2026 18:48:14","00:23","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","20-Mar-2026 ","20-Mar-2026 18:48:37","20-Mar-2026 18:48:54","00:17","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","21-Mar-2026 ","21-Mar-2026 18:03:32","21-Mar-2026 18:04:08","00:36","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","23-Mar-2026 ","24-Mar-2026 01:29:03","24-Mar-2026 01:29:24","00:21","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","04-Mar-2026 ","04-Mar-2026 20:05:13","04-Mar-2026 20:06:22","01:09","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","05-Mar-2026 ","05-Mar-2026 20:56:18","05-Mar-2026 20:56:52","00:34","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","06-Mar-2026 ","06-Mar-2026 20:35:33","06-Mar-2026 20:36:03","00:30","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","07-Mar-2026 ","07-Mar-2026 21:51:03","07-Mar-2026 21:51:41","00:38","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","08-Mar-2026 ","08-Mar-2026 21:58:24","08-Mar-2026 21:58:44","00:20","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","09-Mar-2026 ","09-Mar-2026 20:43:38","09-Mar-2026 20:43:55","00:17","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","10-Mar-2026 ","10-Mar-2026 21:52:06","10-Mar-2026 21:52:26","00:20","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","11-Mar-2026 ","11-Mar-2026 21:26:55","11-Mar-2026 21:27:18","00:23","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","12-Mar-2026 ","13-Mar-2026 06:06:13","13-Mar-2026 06:06:39","00:26","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","13-Mar-2026 ","13-Mar-2026 20:35:28","13-Mar-2026 20:35:47","00:19","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","14-Mar-2026 ","14-Mar-2026 21:12:23","14-Mar-2026 21:12:39","00:16","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","15-Mar-2026 ","16-Mar-2026 02:24:42","16-Mar-2026 02:25:07","00:25","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","16-Mar-2026 ","16-Mar-2026 19:52:46","16-Mar-2026 19:53:05","00:19","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","17-Mar-2026 ","17-Mar-2026 20:44:50","17-Mar-2026 20:45:06","00:16","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","18-Mar-2026 ","18-Mar-2026 18:02:48","18-Mar-2026 18:03:12","00:24","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","19-Mar-2026 ","19-Mar-2026 18:24:13","19-Mar-2026 18:24:27","00:14","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","20-Mar-2026 ","20-Mar-2026 20:53:18","20-Mar-2026 20:53:34","00:16","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","21-Mar-2026 ","21-Mar-2026 19:58:33","21-Mar-2026 19:58:52","00:19","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","22-Mar-2026 ","22-Mar-2026 20:57:32","22-Mar-2026 20:57:48","00:16","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","23-Mar-2026 ","23-Mar-2026 20:25:57","23-Mar-2026 20:26:19","00:22","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","24-Mar-2026 ","24-Mar-2026 20:00:09","24-Mar-2026 20:00:26","00:17","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","25-Mar-2026 ","25-Mar-2026 19:46:02","25-Mar-2026 19:46:19","00:17","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","26-Mar-2026 ","26-Mar-2026 20:34:57","26-Mar-2026 20:35:36","00:39","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","27-Mar-2026 ","27-Mar-2026 20:26:42","27-Mar-2026 20:27:00","00:18","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","28-Mar-2026 ","28-Mar-2026 19:58:42","28-Mar-2026 19:58:55","00:13","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","29-Mar-2026 ","29-Mar-2026 20:46:26","29-Mar-2026 20:46:38","00:12","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","30-Mar-2026 ","30-Mar-2026 22:11:21","30-Mar-2026 22:11:35","00:14","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","31-Mar-2026 ","31-Mar-2026 22:46:39","31-Mar-2026 22:47:25","00:46","28","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","01-Apr-2026 ","01-Apr-2026 21:38:53","01-Apr-2026 21:39:31","00:38","29","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","02-Apr-2026 ","02-Apr-2026 21:22:31","02-Apr-2026 21:22:58","00:27","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","03-Apr-2026 ","03-Apr-2026 21:13:09","03-Apr-2026 21:13:24","00:15","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","04-Apr-2026 ","04-Apr-2026 21:48:32","04-Apr-2026 21:48:47","00:15","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","05-Apr-2026 ","05-Apr-2026 22:11:06","05-Apr-2026 22:11:18","00:12","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","06-Apr-2026 ","06-Apr-2026 22:24:02","06-Apr-2026 22:24:13","00:11","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","07-Apr-2026 ","07-Apr-2026 21:17:38","07-Apr-2026 21:17:49","00:11","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","08-Apr-2026 ","09-Apr-2026 19:34:11","09-Apr-2026 19:35:01","00:50","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","09-Apr-2026 ","09-Apr-2026 19:35:23","09-Apr-2026 19:35:44","00:21","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","10-Apr-2026 ","10-Apr-2026 20:45:38","10-Apr-2026 20:45:51","00:13","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","11-Apr-2026 ","11-Apr-2026 21:18:17","11-Apr-2026 21:18:37","00:20","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","12-Apr-2026 ","12-Apr-2026 21:52:59","12-Apr-2026 21:53:16","00:17","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","13-Apr-2026 ","13-Apr-2026 20:06:14","13-Apr-2026 20:06:28","00:14","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","14-Apr-2026 ","14-Apr-2026 20:32:26","14-Apr-2026 20:33:15","00:49","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","15-Apr-2026 ","15-Apr-2026 22:47:23","15-Apr-2026 22:47:48","00:25","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","16-Apr-2026 ","16-Apr-2026 22:09:53","16-Apr-2026 22:26:28","16:35","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","17-Apr-2026 ","17-Apr-2026 21:45:10","17-Apr-2026 21:45:34","00:24","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","18-Apr-2026 ","18-Apr-2026 20:13:56","18-Apr-2026 20:14:28","00:32","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","19-Apr-2026 ","19-Apr-2026 21:05:25","19-Apr-2026 21:05:47","00:22","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","20-Apr-2026 ","20-Apr-2026 19:50:05","20-Apr-2026 19:50:31","00:26","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","21-Apr-2026 ","21-Apr-2026 21:06:17","21-Apr-2026 21:06:38","00:21","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","22-Apr-2026 ","22-Apr-2026 21:58:23","22-Apr-2026 21:58:37","00:14","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","23-Apr-2026 ","23-Apr-2026 20:20:07","23-Apr-2026 20:20:30","00:23","51","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","24-Apr-2026 ","24-Apr-2026 21:02:15","24-Apr-2026 21:02:44","00:29","52","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","25-Apr-2026 ","25-Apr-2026 21:46:33","25-Apr-2026 21:46:44","00:11","53","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","26-Apr-2026 ","26-Apr-2026 21:47:59","26-Apr-2026 21:48:16","00:17","54","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","27-Apr-2026 ","27-Apr-2026 22:14:24","27-Apr-2026 22:14:48","00:24","55","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","28-Apr-2026 ","28-Apr-2026 22:15:05","28-Apr-2026 22:15:20","00:15","56","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","29-Apr-2026 ","29-Apr-2026 21:40:35","29-Apr-2026 21:40:53","00:18","57","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","30-Apr-2026 ","30-Apr-2026 22:25:00","30-Apr-2026 22:25:11","00:11","58","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","01-May-2026 ","01-May-2026 22:29:53","01-May-2026 22:30:10","00:17","59","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","02-May-2026 ","02-May-2026 20:46:50","02-May-2026 20:47:02","00:12","60","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","03-May-2026 ","03-May-2026 22:35:34","03-May-2026 22:35:49","00:15","61","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","04-May-2026 ","05-May-2026 05:52:09","05-May-2026 05:52:35","00:26","62","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","05-May-2026 ","05-May-2026 21:58:12","05-May-2026 21:58:35","00:23","63","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","06-May-2026 ","07-May-2026 08:49:07","07-May-2026 08:49:20","00:13","64","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","07-May-2026 ","07-May-2026 21:53:49","07-May-2026 21:54:04","00:15","65","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","08-May-2026 ","08-May-2026 21:54:15","08-May-2026 21:54:26","00:11","66","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","09-May-2026 ","09-May-2026 21:16:14","09-May-2026 21:16:33","00:19","67","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","10-May-2026 ","10-May-2026 22:31:35","10-May-2026 22:31:45","00:10","68","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","11-May-2026 ","11-May-2026 22:06:26","11-May-2026 22:06:52","00:26","69","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","12-May-2026 ","12-May-2026 21:01:56","12-May-2026 21:02:12","00:16","70","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","13-May-2026 ","13-May-2026 22:30:52","13-May-2026 22:31:05","00:13","71","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","14-May-2026 ","14-May-2026 21:57:20","14-May-2026 21:57:33","00:13","72","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","15-May-2026 ","15-May-2026 22:18:39","15-May-2026 22:18:59","00:20","73","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","16-May-2026 ","16-May-2026 22:35:15","16-May-2026 22:35:26","00:11","74","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","17-May-2026 ","17-May-2026 19:49:55","17-May-2026 19:51:44","01:49","75","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","18-May-2026 ","18-May-2026 20:08:02","18-May-2026 20:08:15","00:13","76","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","19-May-2026 ","19-May-2026 23:07:57","19-May-2026 23:08:13","00:16","77","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","20-May-2026 ","20-May-2026 21:05:24","20-May-2026 21:05:35","00:11","78","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","21-May-2026 ","21-May-2026 22:39:47","21-May-2026 22:40:29","00:42","79","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","22-May-2026 ","22-May-2026 22:47:30","22-May-2026 22:47:42","00:12","80","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","23-May-2026 ","23-May-2026 21:43:46","23-May-2026 21:43:56","00:10","81","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","24-May-2026 ","24-May-2026 22:10:38","24-May-2026 22:10:48","00:10","82","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","25-May-2026 ","25-May-2026 21:58:41","25-May-2026 21:58:55","00:14","83","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","26-May-2026 ","26-May-2026 21:30:28","26-May-2026 21:30:46","00:18","84","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","27-May-2026 ","27-May-2026 22:00:22","27-May-2026 22:00:36","00:14","85","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","28-May-2026 ","29-May-2026 19:50:01","29-May-2026 19:50:17","00:16","86","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","29-May-2026 ","29-May-2026 19:50:40","29-May-2026 19:50:53","00:13","87","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","30-May-2026 ","30-May-2026 22:31:10","30-May-2026 22:31:21","00:11","88","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","31-May-2026 ","31-May-2026 21:51:51","31-May-2026 21:52:13","00:22","89","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","01-Jun-2026 ","01-Jun-2026 21:12:38","01-Jun-2026 21:12:51","00:13","90","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","02-Jun-2026 ","02-Jun-2026 22:43:49","02-Jun-2026 22:43:59","00:10","91","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","03-Jun-2026 ","03-Jun-2026 21:19:57","03-Jun-2026 21:20:07","00:10","92","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","04-Jun-2026 ","04-Jun-2026 22:08:15","04-Jun-2026 22:08:26","00:11","93","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" diff --git a/Clario/Downloads/Zpracovano/2026-06-05_08-49-04 77242113UCO3001_ANALYSIS Clario ECG DCRs.csv b/Clario/Downloads/Zpracovano/2026-06-05_08-49-04 77242113UCO3001_ANALYSIS Clario ECG DCRs.csv new file mode 100644 index 0000000..96a467a --- /dev/null +++ b/Clario/Downloads/Zpracovano/2026-06-05_08-49-04 77242113UCO3001_ANALYSIS Clario ECG DCRs.csv @@ -0,0 +1,10 @@ +"Protocol","Country","Site ID","PI_NAME","Subject Number","Age","Data Correction ID","Creation Date UTC","Status","Date of Last Action UTC","Total Open Period","Total Open Time (Days)","Current Status Time (Days)","Type","Next Action Required","Category","Query History","Reason for Change" +"77242113UCO3001_ANALYSIS","Czech Republic The","CZ10001","Falc, Matej","CZ100012001","48 Years","16923867","14-May-2026","Escalated","04-Jun-2026","15-21 Days","15","1","QUERY","Site","Patient","(5) 04 Jun 2026 Clario: We have still only received one of the expected three timepoints for WEEK I-12. You can upload scans of your paper ECGs using the Site Upload Tool. ---- Instructions can be found in the ""Reference Materials"" tab of the study portal. Please contact Customer Care for assistance if needed!","Data Checks" +"77242113UCO3001_ANALYSIS","Czech Republic The","CZ10001","Falc, Matej","CZ100012001","48 Years","16567067","22-Jan-2026","Resolved","28-Jan-2026","4-7 Days","4","","QUERY","","Patient","MD Falc","Data Checks" +"77242113UCO3001_ANALYSIS","Czech Republic The","CZ10009","Pumprla, Jiri","CZ100092001","49 Years","16776685","31-Mar-2026","Resolved","13-May-2026","Over 28 Days","29","","QUERY","","Patient","(2) 13 May 2026 Clario: I confirm, that only ONE ECG was collected by mistake.","Data Checks" +"77242113UCO3001_ANALYSIS","Czech Republic The","CZ10013","Stepek, David","CZ100130003","49 Years","16988974","04-Jun-2026","Unresolved","04-Jun-2026","1 Day","1","1","DCR","Clario DM","Transmittal","Affected Event: 'SCREENING'","" +"77242113UCO3001_ANALYSIS","Czech Republic The","CZ10013","Stepek, David","CZ100130003","49 Years","16985006","03-Jun-2026","Resolved","04-Jun-2026","1 Day","1","","QUERY","","Patient","(2) 04 Jun 2026 Clario: by mistake only one strip was taken","Data Checks" +"77242113UCO3001_ANALYSIS","Czech Republic The","CZ10013","Stepek, David","CZ100132001","29 Years","16981256","02-Jun-2026","Resolved","04-Jun-2026","2-3 Days","2","","QUERY","","Transmittal","Visit: SCREENING/","Data Checks" +"77242113UCO3001_ANALYSIS","Czech Republic The","CZ10013","Stepek, David","CZ100132002","29 Years","16985014","03-Jun-2026","Resolved","04-Jun-2026","1 Day","1","","QUERY","","Patient","(2) 04 Jun 2026 Clario: by mistake only one strip was expected","Data Checks" +"77242113UCO3001_ANALYSIS","Czech Republic The","CZ10021","Bortlik, Martin","CZ100212001","61 Years","16717619","11-Mar-2026","Resolved","28-Apr-2026","Over 28 Days","32","","QUERY","","Patient","(2) 28 Apr 2026 Clario: I confirmed that due to technical problems, the ECG was done only twice","Data Checks" +"77242113UCO3001_ANALYSIS","Czech Republic The","CZ10022","Hrabak, Petr","CZ100222003","39 Years","16945114","21-May-2026","Resolved","04-Jun-2026","8-14 Days","10","","DCR","","Patient","(7) 04 Jun 2026 Portal, EXPeRT: It was mistake NO ECG for this date 20May2026 was done","" diff --git a/Covance_MDD3003/Source/Zpracovano/2026-06-05_085844 sponsor-study-35472-samples-allSamples.csv b/Covance_MDD3003/Source/Zpracovano/2026-06-05_085844 sponsor-study-35472-samples-allSamples.csv new file mode 100644 index 0000000..866ff43 --- /dev/null +++ b/Covance_MDD3003/Source/Zpracovano/2026-06-05_085844 sponsor-study-35472-samples-allSamples.csv @@ -0,0 +1,1199 @@ +Protocol Code,Investigator No.,Investigator Name,Patient No.,Collection Date,Protocol Visit Code,Kit Receipt Date,Container Receipt Date,Accession,Container No.,Container Barcode No.,Specimen Type,Sample Status,Expected Receipt Condition,Actual Receipt Condition,Container Label Line 1,Container Label Line 2,SM Sample Status,SMART Specimen Class Description,Aliquot Created Date,Aliquoted Date,Collection Time,Container Receipt Time,Country,Courier,Kit Receipt Time,Parent Barcode Number,Parent Sample Type,Project,Region,Screening No.,Shipped To Organization Name,Site Waybill No.,Site - Scheduled Shipment Date,Site - Shipment Created Date,Site - Shipment Details Entered Date,SMART Specimen Class,Visit Description,Parent Barcode,Children Barcode +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,1,622535097101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,2,622535097102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,3,622535097103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,4,622535097104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,5,622535097105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,6,622535097106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,7,622535097107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,12-Aug-2025,6225350971,8,622535097108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:30,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,9,622535097109,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,10,622535097110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,1,622535097201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,3,622535097203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,4,622535097204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,2,622535097202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,5,622535097205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,6,622535097206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,7,622535097207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,24-Sep-2025,6225350972,8,622535097208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,9,622535097209,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,10,622535097210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,1,622535097501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,2,622535097502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,3,622535097503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,5,622535097505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,6,622535097506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,4,622535097504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,7,622535097507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,12-Nov-2025,6225350975,8,622535097508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:10,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,9,622535097509,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,10,622535097510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,1,622535097701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,2,622535097702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,3,622535097703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,4,622535097704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,5,622535097705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,6,622535097706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,7,622535097707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,15-Oct-2025,6225350977,8,622535097708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,9,622535097709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,10,622535097710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,1,622535098101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,,6225350981,2,622535098102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,09-Sep-2025,6225350981,3,622535098103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,,6225350981,4,622535098104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,5,622535098105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,6,622535098106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,,6225350982,2,622535098202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,12-Nov-2025,6225350982,3,622535098203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,1,622535098201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,7,622535098107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,,6225350982,4,622535098204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,5,622535098205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,6,622535098206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,7,622535098207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,1,622535098401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,,6225350984,2,622535098402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,22-Oct-2025,6225350984,3,622535098403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,,6225350984,4,622535098404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,5,622535098405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,6,622535098406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,7,622535098407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,5,622535098805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,6,622535098806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,7,622535098807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,8,622535098808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,1,622535098801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,9,622535098809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,2,622535098802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,22-Oct-2025,6225350988,3,622535098803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,4,622535098804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,1,622535100201,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,2,622535100202,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,3,622535100203,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,4,622535100204,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,5,622535100205,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,21-Aug-2025,6225351002,6,622535100206,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,7,622535100207,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,8,622535100208,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,9,622535100209,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,10,622535100210,"Serum, SST",Not Received,Ambient,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,1,622535100401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,2,622535100402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,3,622535100403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,4,622535100404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,5,622535100405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,6,622535100406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,7,622535100407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,8,622535100408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,9,622535100409,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,10,622535100410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,2,622535100602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,1,622535100601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,3,622535100603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,4,622535100604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,5,622535100605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,6,622535100606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,7,622535100607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,8,622535100608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,9,622535100609,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,10,622535100610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351036,1,622535103601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,3,622535103603,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,4,622535103604,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,2,622535103602,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,5,622535103605,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,7,622535103607,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,8,622535103608,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,6,622535103606,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,2,622535103702,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,9,622535103609,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,3,622535103703,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351036,10,622535103610,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,12-Nov-2025,6225351037,1,622535103701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,6,622535103706,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,9,622535103709,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,8,622535103708,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,12-Nov-2025,6225351037,10,622535103710,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,7,622535103707,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,4,622535103704,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,5,622535103705,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,2,622535104002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,1,622535104001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,5,622535104005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,4,622535104004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,6,622535104006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,8,622535104008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,9,622535104009,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,3,622535104003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,7,622535104007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,3,622535104103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,5,622535104105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,6,622535104106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,4,622535104104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,7,622535104107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,8,622535104108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,1,622535104101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,10,622535104010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,2,622535104102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,9,622535104109,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,10,622535104110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,1,622535104201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,4,622535104204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,3,622535104203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,5,622535104205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,6,622535104206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,2,622535104202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,10,622535104210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,28-Aug-2025,6225351042,8,622535104208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,9,622535104209,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,7,622535104207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,1,622535104401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,2,622535104402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,3,622535104403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,4,622535104404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,5,622535104405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,6,622535104406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,7,622535104407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,9,622535104409,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,10,622535104410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,1,622535104501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,2,622535104502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,3,622535104503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,8,622535104408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,4,622535104504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,5,622535104505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,7,622535104507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,8,622535104508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,6,622535104506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,9,622535104509,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,10,622535104510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,1,622535104601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,3,622535104603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,4,622535104604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,5,622535104605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,6,622535104606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,8,622535104608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,2,622535104602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,9,622535104609,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,10,622535104610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,7,622535104607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,2,622535104702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,3,622535104703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,4,622535104704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,5,622535104705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,6,622535104706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,8,622535104708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,1,622535104701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,7,622535104707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,9,622535104709,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,10,622535104710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,1,622535104901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,,6225351049,2,622535104902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:55,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,3,622535104903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,,6225351049,4,622535104904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:55,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,5,622535104905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,6,622535104906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,7,622535104907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,1,622535105001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,,6225351050,2,622535105002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:19,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,,6225351050,4,622535105004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:19,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,5,622535105005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,6,622535105006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,3,622535105003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,1,622535105101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,,6225351051,2,622535105102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:47,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,28-Aug-2025,6225351051,3,622535105103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,7,622535105007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,,6225351051,4,622535105104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:47,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,6,622535105106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,5,622535105105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,7,622535105107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,3,622535105203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,5,622535105205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,6,622535105206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,,6225351052,2,622535105202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,,6225351052,4,622535105204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,1,622535105201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,7,622535105207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,1,622535105601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,2,622535105602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,3,622535105603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,4,622535105604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,5,622535105605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,6,622535105606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,7,622535105607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,8,622535105608,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,9,622535105609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,1,622535105701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,2,622535105702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,3,622535105703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,4,622535105704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,5,622535105705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,6,622535105706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,7,622535105707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,8,622535105708,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,9,622535105709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,1,622535106601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,3,622535106603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,4,622535106604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,7,622535106607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,8,622535106608,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,9,622535106609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,6,622535106606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,5,622535106605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,2,622535106602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,3,622535107003,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,09-Sep-2025,6225351070,4,622535107004,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,2,622535107002,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,5,622535107005,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,6,622535107006,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,1,622535107001,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,9,622535107009,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,8,622535107008,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,7,622535107007,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,10,622535107010,"Serum, SST",Not Received,Ambient,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,2,622535107202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,3,622535107203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,4,622535107204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,5,622535107205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,6,622535107206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,7,622535107207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,1,622535107201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,10,622535107210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,9,622535107209,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,8,622535107208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,2,622535107402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,3,622535107403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,4,622535107404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,1,622535107401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,7,622535107407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,10,622535107410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,9,622535107409,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,6,622535107406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,5,622535107405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,2,622535107602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,1,622535107601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,8,622535107408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,3,622535107603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,5,622535107605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,6,622535107606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,4,622535107604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,7,622535107607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,9,622535107609,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,10,622535107610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,07-Aug-2025,6225351076,8,622535107608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,3,622535107703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,1,622535107701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,4,622535107704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,5,622535107705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,6,622535107706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,7,622535107707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,8,622535107708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,9,622535107709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,10,622535107710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,2,622535107702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,5,622535107805,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,6,622535107806,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,7,622535107807,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,8,622535107808,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,9,622535107809,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,4,622535107804,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,3,622535107803,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,2,622535107802,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,1,622535107801,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,10,622535107810,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,1,622535108001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,2,622535108002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,7,622535108007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,06-Nov-2025,6225351080,8,622535108008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,9,622535108009,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,3,622535108003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,10,622535108010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,1,622535108101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,3,622535108103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,4,622535108004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,4,622535108104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,2,622535108102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,5,622535108105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,5,622535108005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,6,622535108006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,8,622535108108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,10,622535108110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,9,622535108109,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351082,2,622535108202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,7,622535108107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,3,622535108203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351082,4,622535108204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,6,622535108106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,5,622535108205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,6,622535108206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,1,622535108301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351083,2,622535108302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:07,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,3,622535108303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351083,4,622535108304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:07,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,5,622535108305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,1,622535108201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,6,622535108306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,7,622535108207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,7,622535108307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,1,622535108401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351084,4,622535108404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,3,622535108403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,5,622535108405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351084,2,622535108402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,7,622535108407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,6,622535108406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,2,622535109302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,1,622535109301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,3,622535109303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,5,622535109305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,4,622535109304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,6,622535109306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,7,622535109307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,8,622535109308,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,9,622535109309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,1,622535109401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,3,622535109403,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,2,622535109402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,4,622535109404,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,5,622535109405,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,6,622535109406,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,7,622535109407,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,8,622535109408,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,1,622535109501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,2,622535109502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,3,622535109503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,5,622535109505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,7,622535109507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,8,622535109508,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,4,622535109504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,6,622535109506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,9,622535109409,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,9,622535109509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,1,622535110601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,2,622535110602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,4,622535110604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,5,622535110605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,3,622535110603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,6,622535110606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,7,622535110607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,08-Aug-2025,6225351106,8,622535110608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,9,622535110609,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,10,622535110610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,1,622535110901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,4,622535110904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,5,622535110905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,6,622535110906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,7,622535110907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,05-Sep-2025,6225351109,8,622535110908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,2,622535110902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,9,622535110909,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,10,622535110910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,1,622535111001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,2,622535111002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,3,622535111003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,4,622535111004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,5,622535111005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,6,622535111006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,7,622535111007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,3,622535110903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,9,622535111009,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,03-Oct-2025,6225351110,8,622535111008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,10,622535111010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,1,622535111101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,2,622535111102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,3,622535111103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,4,622535111104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,5,622535111105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,6,622535111106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,03-Oct-2025,6225351111,8,622535111108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,9,622535111109,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,7,622535111107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,10,622535111110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,1,622535112001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351120,2,622535112002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,24-Oct-2025,6225351120,3,622535112003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351120,4,622535112004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,5,622535112005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,6,622535112006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,7,622535112007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,2,622535112602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,1,622535112601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,3,622535112603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,4,622535112604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,10-Dec-2025,6225351126,5,622535112605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,6,622535112606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,8,622535112608,"Red Cells, Clot",Not Received,,,TSH,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,7,622535112607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,9,622535112609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,2,622631362502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,1,622631362501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,3,622631362503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,5,622631362505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,4,622631362504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,6,622631362506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,7,622631362507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,,6226550646,2,622655064602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,1,622655064601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,7,622655064607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,5,622655064605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,,6226550646,4,622655064604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,6,622655064606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,3,622655064603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,,6226551697,4,622655169704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,5,622655169705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,1,622655169701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,6,622655169706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,7,622655169707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,1,622655169801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,3,622655169703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,,6226551698,4,622655169804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,,6226551697,2,622655169702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,,6226551698,2,622655169802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,6,622655169806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,3,622655169803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,5,622655169805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,7,622655169807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,4,622656088704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,20-May-2026,6226560887,3,622656088703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,16:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,2,622656088702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,1,622656088701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,5,622656088705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,6,622656088706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,1,622656088801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,7,622656088707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,3,622656088803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,7,622656088807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,9,622656088809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,20-May-2026,6226560888,5,622656088805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,4,622656088804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,8,622656088808,"Red Cells, Clot",Not Received,,,TSH,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,2,622656088802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,6,622656088806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,2,622656089102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,3,622656089103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,1,622656089101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,4,622656089104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,6,622656089106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,8,622656089108,"Red Cells, Clot",Not Received,,,TSH,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,20-May-2026,6226560891,5,622656089105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,14:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,7,622656089107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,9,622656089109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,17-Feb-2026,6226561517,3,622656151703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,,6226561517,4,622656151704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,5,622656151705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,,6226561517,2,622656151702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,1,622656151701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,6,622656151706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,7,622656151707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,29-May-2026,P2DBW13,30-May-2026,30-May-2026,6226649754,1,622664975401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,29-May-2026,P2DBW13,30-May-2026,,6226649754,2,622664975402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,29-May-2026,P2DBW13,30-May-2026,,6226649754,4,622664975404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,29-May-2026,P2DBW13,30-May-2026,03-Jun-2026,6226649754,3,622664975403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,29-May-2026,P2DBW13,30-May-2026,30-May-2026,6226649754,5,622664975405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,29-May-2026,P2DBW13,30-May-2026,30-May-2026,6226649754,6,622664975406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,29-May-2026,P2DBW13,30-May-2026,30-May-2026,6226649754,7,622664975407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,1,622668695201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,,6226686952,2,622668695202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,3,622668695203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,,6226686952,4,622668695204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,5,622668695205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,6,622668695206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,7,622668695207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,1,622668695301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,2,622668695302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,3,622668695303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,4,622668695304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,5,622668695305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,6,622668695306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,7,622668695407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,8,622668695308,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,9,622668695309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,7,622668695307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,1,622668695401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,3,622668695403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,4,622668695404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,5,622668695405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,6,622668695406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,2,622668695402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,6,622675255406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,2,622675255502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,5,622675255405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,3,622675255503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,4,622675255404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,7,622675255407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,4,622675255504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,20-May-2026,6226752555,5,622675255505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,2,622675255402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,3,622675255403,"Plasma, EDTA",Received,Frozen,Default Return Ambient,INSULIN,FROZEN,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,1,622675255401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,1,622675255501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,7,622675255507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,8,622675255508,"Red Cells, Clot",Not Received,,,TSH,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,9,622675255509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,6,622675255506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,1,622678085301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,5,622678085305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,2,622678085302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,3,622678085303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,4,622678085304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,8,622678085308,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,9,622678085309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,6,622678085306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,7,622678085307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,1,622678085501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,2,622678085502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,4,622678085504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,5,622678085505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,6,622678085506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,7,622678085507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,8,622678085508,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,9,622678085509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,3,622678085503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,1,622678085601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,2,622678085602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,3,622678085603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,4,622678085604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,6,622678085606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,7,622678085607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,8,622678085608,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,9,622678085609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,3,622678085703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,6,622678085706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,5,622678085705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,7,622678085707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,8,622678085708,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,9,622678085709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,1,622678085701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,4,622678085704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,2,622678085702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,5,622678085605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,3,622678573903,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,2,622678573902,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,4,622678573904,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,7,622678573907,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,9,622678573909,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,5,622678573905,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,6,622678573906,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,8,622678573908,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,1,622678573901,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,19-Feb-2026,6226785739,10,622678573910,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,1,622678574001,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,7,622678574007,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,5,622678574005,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,16-Dec-2025,6226785740,8,622678574008,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:53,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,2,622678574002,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,6,622678574006,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,3,622678574003,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,4,622678574004,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,9,622678574009,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,16-Dec-2025,6226785740,10,622678574010,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:53,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,,6226804961,2,622680496102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,,6226804961,4,622680496104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,3,622680496103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,5,622680496205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,7,622680496207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,9,622680496209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,6,622680496106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,5,622680496105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,3,622680496203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,1,622680496101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,4,622680496204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,8,622680496208,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,7,622680496107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,6,622680496206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,2,622680496202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,1,622680496201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,2,622693560602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,4,622693560604,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,3,622693560603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,5,622693560605,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,1,622693560601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,7,622693560607,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,16-Dec-2025,6226935606,6,622693560606,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,05:55,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,8,622693560608,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,9,622693560609,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,1,622697694301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,,6226976943,2,622697694302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,31-Jan-2026,6226976943,3,622697694303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:00,07:20,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,,6226976943,4,622697694304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,6,622697694306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,7,622697694307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,5,622697694305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,,6226991311,4,622699131104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:14,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,5,622699131105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,6,622699131106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,7,622699131107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,3,622699131103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,1,622699131101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,,6226991311,2,622699131102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:14,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,1,622704330201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,,6227043302,4,622704330204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,5,622704330205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,19-Nov-2025,6227043302,3,622704330203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,,6227043302,2,622704330202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,6,622704330206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,7,622704330207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,1,622707241901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,,6227072419,2,622707241902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:17,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,,6227072419,4,622707241904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:17,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,6,622707241906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,3,622707241903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,7,622707241907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,5,622707241905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,2,622710690502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,1,622710690501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,03-Dec-2025,6227106905,3,622710690503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,4,622710690504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,6,622710690506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,5,622710690505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,7,622710690507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,8,622710690508,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,9,622710690509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,1,622710690601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,2,622710690602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,23-Dec-2025,6227106906,3,622710690603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:25,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,4,622710690604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,5,622710690605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,6,622710690606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,9,622710690609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,7,622710690607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,8,622710690608,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,6,622714456006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,7,622714456007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,1,622714456001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,,6227144561,2,622714456102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,5,622714456005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,1,622714456101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,,6227144561,4,622714456104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,3,622714456103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,5,622714456105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,3,622714456003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,6,622714456106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,,6227144560,4,622714456004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,,6227144560,2,622714456002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,1,622714456201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,5,622714456205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,7,622714456107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,7,622714456207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,,6227144562,4,622714456204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:13,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,,6227144562,2,622714456202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:13,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,16-Dec-2025,6227144562,3,622714456203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:13,05:55,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,6,622714456206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,7,622717890807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,9,622717890809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,3,622717890903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,6,622717890806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,4,622717890904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,2,622717890802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,1,622717890901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,8,622717890808,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,1,622717890801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,2,622717890902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,04-Feb-2026,6227178909,5,622717890905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,4,622717890804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,3,622717890803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,6,622717890906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,8,622717890908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,9,622717890909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,7,622717890907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,1,622717891001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,3,622717891003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,4,622717891004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,2,622717891002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,20-May-2026,6227178910,5,622717891005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,14-Jan-2026,6227178908,5,622717890805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:20,07:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,8,622717891008,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,9,622717891009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,2,622717891102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,7,622717891007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,1,622717891101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,4,622717891104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,11-Mar-2026,6227178911,5,622717891105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:50,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,6,622717891106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,7,622717891107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,9,622717891109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,6,622717891006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,3,622717891103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,1,622717891201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,8,622717891108,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,2,622717891202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,3,622717891203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,14-Jan-2026,6227178912,5,622717891205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:00,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,4,622717891204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,7,622717891207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,8,622717891208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,6,622717891206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,9,622717891209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,1,622726123001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,,6227261230,2,622726123002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,,6227261230,4,622726123004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,5,622726123005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,10-Dec-2025,6227261230,3,622726123003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,6,622726123006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,7,622726123007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,1,622726183501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,2,622726183502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,21-May-2026,6227261835,3,622726183503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,4,622726183504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,5,622726183505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,6,622726183506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,7,622726183507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,1,622726183601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,2,622726183602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,3,622726183603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,4,622726183604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,5,622726183605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,6,622726183606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,7,622726183607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,8,622726183608,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,9,622726183609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,3,622749837903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,1,622749837901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,2,622749837902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,8,622749838008,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,7,622749838007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,7,622749837907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,9,622749838009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,9,622749837909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,1,622749838001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,6,622749838006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,3,622749838003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,5,622749837905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,2,622749838002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,5,622749838005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,4,622749837904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,4,622749838004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,8,622749837908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,6,622749837906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,9,622752024209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,3,622752024203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,7,622752024307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,5,622752024305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,4,622752024204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,1,622752024201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,3,622752024303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,6,622752024306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,1,622752024301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,4,622752024304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,8,622752024308,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,2,622752024202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,6,622752024206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,5,622752024205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,2,622752024302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,8,622752024208,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,7,622752024207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,9,622752024309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,2,622752024502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,3,622752024503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,8,622752024508,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,1,622752024501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,9,622752024509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,4,622752024504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,5,622752024505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,6,622752024506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,7,622752024507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,1,622754124901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,2,622754124902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,3,622754124903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,6,622754124906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,4,622754124904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,7,622754124907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,5,622754124905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,1,622754125101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,,6227541251,2,622754125102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,06:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,10,622754124910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,30-Jan-2026,6227541249,8,622754124908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,9,622754124909,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,6,622754125206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,1,622754125201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,7,622754125107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,25-Feb-2026,6227541252,3,622754125203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,,6227541251,4,622754125104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,06:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,,6227541252,2,622754125202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,,6227541252,4,622754125204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,6,622754125106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,5,622754125205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,7,622754125207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,5,622754125105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,1,622754125601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,5,622754125605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,2,622754125602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,4,622754125604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,7,622754125607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,20-May-2026,6227541256,3,622754125603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,3,622754125103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,6,622754125606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,9,622754125609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,21-Jan-2026,6227541257,3,622754125703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,8,622754125608,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,8,622754125708,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,1,622754125701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,5,622754125705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,6,622754125706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,4,622754125704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,7,622754125707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,9,622754125709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,2,622754125802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,,6227541259,4,622754125904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,2,622754125702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,18-Feb-2026,6227541259,3,622754125903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,9,622754125809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,6,622754125906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,7,622754125907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,1,622754125801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,4,622754125804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,6,622754125806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,1,622754125901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,5,622754125805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,7,622754125807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,3,622754125803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,5,622754125905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,1,622754126001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,5,622754126005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,,6227541260,2,622754126002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:40,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,21-Jan-2026,6227541260,3,622754126003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:40,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,8,622754125808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,,6227541259,2,622754125902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,1,622754126101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,,6227541260,4,622754126004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:40,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,6,622754126006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,2,622754126102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,4,622754126104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,7,622754126007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,5,622754126105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,6,622754126106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,20-May-2026,6227541261,3,622754126103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,7,622754126107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,2,622754126402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,1,622754126401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,4,622754126404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,3,622754126403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,6,622754126406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,5,622754126405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,7,622754126407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,6,622754216006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,7,622754216007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,5,622754216005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,9,622754216009,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,2,622754216002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,10,622754216010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,1,622754216101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,8,622754216008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,1,622754216001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,4,622754216104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,2,622754216102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,8,622754216108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,3,622754216103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,6,622754216106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,10,622754216110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,4,622754216004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,3,622754216003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,9,622754216109,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,7,622754216107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,5,622754216105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,5,622754217005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,1,622754217001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,7,622754217007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,3,622754217003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,8,622754217008,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,2,622754217002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,6,622754217006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,1,622754217101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,9,622754217009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,3,622754217103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,4,622754217004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,5,622754217105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,2,622754217102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,6,622754217106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,8,622754217108,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,7,622754217107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,9,622754217109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,2,622754217202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,4,622754217104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,3,622754217203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,1,622754217201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,5,622754217205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,6,622754217206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,9,622754217209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,7,622754217207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,4,622754217204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,8,622754217208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,1,622754217301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,5,622754217305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,6,622754217306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,7,622754217307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,8,622754217308,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,2,622754217302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,9,622754217309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,3,622754217303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,4,622754217304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,2,622754218202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,3,622754218203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,4,622754218204,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,5,622754218205,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,8,622754218208,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,1,622754218201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,7,622754218207,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,9,622754218209,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,6,622754218206,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,10,622754218210,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,10,622693560610,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,11,622693560611,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,2,622754732902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,3,622754732903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,4,622754732904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,6,622754732906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,7,622754732907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,5,622754732905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,04-Mar-2026,6227547329,8,622754732908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,10,622754732910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,9,622754732909,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,2,622754733002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,1,622754733001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,3,622754733003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,4,622754733004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,5,622754733005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,6,622754733006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,7,622754733007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,04-Feb-2026,6227547330,8,622754733008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:40,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,9,622754733009,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,10,622754733010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,2,622754733102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,1,622754732901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,3,622754733103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,4,622754733104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,5,622754733105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,6,622754733106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,7,622754733107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,11-Mar-2026,6227547331,8,622754733108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,1,622754733201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,,6227547332,2,622754733202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,04-Mar-2026,6227547332,3,622754733203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,,6227547332,4,622754733204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,5,622754733205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,6,622754733206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,7,622754733207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,1,622754733101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,1,622754733301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,,6227547333,2,622754733302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,3,622754733303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,,6227547333,4,622754733304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,6,622754733306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,5,622754733305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,7,622754733307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,9,622754733109,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,10,622754733110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,1,622754733601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,2,622754733602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,3,622754733603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,4,622754733604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,5,622754733605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,6,622754733606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,7,622754733607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,15-Apr-2026,6227547336,8,622754733608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:15,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,9,622754733609,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,2,622754733702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,15-Apr-2026,6227547337,3,622754733703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:15,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,4,622754733704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,6,622754733706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,5,622754733705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,9,622754733709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,2,622754733802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,20-May-2026,6227547338,3,622754733803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,1,622754733801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,4,622754733804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,7,622754733807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,5,622754733805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,6,622754733806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,8,622754733708,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,7,622754733707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,8,622754733808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,9,622754733809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,1,622754733701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,10,622754733610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,3,622776726703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,4,622776726704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,1,622776726701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,2,622776726702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,7,622776726707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,5,622776726705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,6,622776726706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,9,622776726709,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,04-Feb-2026,6227767267,8,622776726708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,10,622776726710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,2,622776845802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,4,622776845804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,1,622776845801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,3,622776845803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,20-May-2026,6227768458,5,622776845805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,6,622776845806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,8,622776845808,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,7,622776845807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,1,622776845901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,3,622776845903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,4,622776845904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,9,622776845809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,4,622776846004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,6,622776845906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,08-Apr-2026,6227768460,5,622776846005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:00,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,2,622776846002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,7,622776845907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,3,622776846003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,8,622776845908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,18-Mar-2026,6227768459,5,622776845905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,9,622776845909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,7,622776846007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,8,622776846008,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,1,622776846001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,9,622776846009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,2,622776845902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,6,622776846006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,1,622777550501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,5,622777550505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,4,622777550504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,6,622777550506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,7,622777550507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,2,622777550502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,3,622777550503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,9,622777550509,"Red Cells, Clot",Not Received,,,TSH,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775508,2,622777550802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,1,622777550701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,5,622777550805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,18-Feb-2026,6227775507,3,622777550703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:30,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775507,4,622777550704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,18-Feb-2026,6227775508,3,622777550803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:10,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,6,622777550706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,7,622777550707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,5,622777550705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,7,622777550807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,6,622777550806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,1,622777550801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775507,2,622777550702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,10,622777550510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775508,4,622777550804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,31-Jan-2026,6227775505,8,622777550508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,16:50,07:20,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,3,622779740603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,6,622779740606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,5,622779740605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,4,622779740604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,8,622779740608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,9,622779740609,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,7,622779740607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,2,622779740602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,1,622779740601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,1,622779740701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,3,622779740703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,4,622779740704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,10,622779740610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,5,622779740705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,6,622779740706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,7,622779740707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,9,622779740709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,5,622779740805,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,6,622779740806,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,4,622779740804,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,10,622779740710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,2,622779740702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,8,622779740708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,1,622779740801,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,8,622779740808,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,2,622779740802,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,3,622779740803,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,7,622779740807,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,9,622779740809,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,10,622779740810,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,3,622784472503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,6,622784472506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,5,622784472505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,,6227844725,4,622784472504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,7,622784472507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,1,622784472501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,,6227844725,2,622784472502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,11,622777550511,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,1,622811446001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,4,622811446004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,5,622811446005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,6,622811446006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,2,622811446002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,3,622811446003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,7,622811446007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,10,622680496210,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,8,622811446008,"Urine, no preservative",Not Received,Ambient,,,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,02-Apr-2026,6228232037,5,622823203705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,6,622823203706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,8,622823203708,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,9,622823203709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,7,622823203707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,1,622823203701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,3,622823203703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,4,622823203704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,2,622823203702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,1,622823429701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,2,622823429702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,3,622823429703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,7,622823429707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,8,622823429708,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,1,622823429801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,06-May-2026,6228234297,5,622823429705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,6,622823429706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,9,622823429709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,6,622823429806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,5,622823429805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,2,622823429802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,9,622823429809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,4,622823429804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,4,622823429704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,8,622823429808,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,3,622823429803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,5,622823430005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,7,622823429807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,2,622823430002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,1,622823430001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,3,622823430003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,6,622823430006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,9,622823430009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,8,622823430008,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,4,622823430004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,7,622823430007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,10,622656088810,"Urine, no preservative",Not Received,Ambient,,,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,10,622675255510,"Urine, no preservative",Not Received,Ambient,,,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,8,622631362508,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,10,622668695410,"Serum, SST",Canceled,Ambient,,TSH,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,9,622668695409,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,8,622668695408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,10,622754126410,"Serum, SST",Canceled,Ambient,,TSH,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,8,622754126408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,9,622754126409,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,10,622754125810,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,11,622754218211,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,10,622754733710,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,8,622675255408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,8,622656088708,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,8,622754126108,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,10,622754125610,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,10,622754733810,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,2,622860565202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,4,622860565204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,27-May-2026,6228605653,5,622860565305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,1,622860565201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,9,622860565209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,1,622860565301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,3,622860565203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,8,622860565308,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,9,622860565309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,8,622860565208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,6,622860565206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,6,622860565306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,7,622860565307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,2,622860565302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,7,622860565207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,4,622860565304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,27-May-2026,6228605652,5,622860565205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,3,622860565303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,8,622726183508,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,29-May-2026,P2DBW13,30-May-2026,,6226649754,10,622664975410,"Serum, SST",Canceled,Ambient,,TSH,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,29-May-2026,P2DBW13,30-May-2026,,6226649754,8,622664975408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,29-May-2026,P2DBW13,30-May-2026,,6226649754,9,622664975409,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, diff --git a/Covance_UCO3001/Source/2026-06-05_085228 sponsor-study-36940-activity-reports-documents-equery.csv b/Covance_UCO3001/Source/2026-06-05_085228 sponsor-study-36940-activity-reports-documents-equery.csv new file mode 100644 index 0000000..3bdae31 --- /dev/null +++ b/Covance_UCO3001/Source/2026-06-05_085228 sponsor-study-36940-activity-reports-documents-equery.csv @@ -0,0 +1,79 @@ +Site,Country,Visit,Visit Collection Date,Accession,Subject,eQueryId,Create Date,Response Date Time,Issue Type,Status,Time Before Response,User Name,Email,Study Role +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Unscheduled,"Mar 13, 2026 8:40 AM",6227323295,CZ100222004,2047932,"Mar 17, 2026 3:49 PM","Mar 17, 2026 9:07 PM",VST,Closed,5h 17m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Unscheduled,"Mar 13, 2026 7:45 AM",6227323297,CZ100222005,2047949,"Mar 17, 2026 3:56 PM","Mar 17, 2026 9:09 PM",VST,Closed,5h 12m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 0,"Mar 9, 2026 8:50 AM",6227323270,CZ100222003,2038559,"Mar 11, 2026 4:39 PM","Mar 11, 2026 8:32 PM","AGE, ADT201, AMT58660, AMT3542",Closed,3h 53m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 2,"Mar 27, 2026 7:10 AM",6227323272,CZ100222003,2073305,"Apr 1, 2026 7:54 PM","Apr 2, 2026 7:37 AM",AMT58660,Closed,11h 43m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 4,"Apr 8, 2026 8:05 AM",6227323274,CZ100222003,2086982,"Apr 10, 2026 1:00 PM","Apr 10, 2026 1:06 PM",AMT58660,Closed,5m,Katerina Havlikova,katerina.havlikova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 2, 2026 11:00 AM",6227810899,CZ100222003,2029805,"Mar 5, 2026 6:36 PM","Mar 6, 2026 9:01 AM","AMT58660, AMT3542",Closed,14h 24m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 4, 2026 9:20 AM",6227810900,CZ100222005,2031896,"Mar 6, 2026 6:45 PM","Mar 6, 2026 7:25 PM","AMT58660, AMT3542",Closed,40m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 3, 2026 12:10 PM",6227810901,CZ100222004,2029774,"Mar 5, 2026 6:23 PM","Mar 6, 2026 7:24 PM","AMT58660, AMT3542",Closed,1d,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 0,"Apr 9, 2026 10:35 AM",6228173397,CZ100222005,2089669,"Apr 13, 2026 2:06 PM","Apr 23, 2026 12:53 PM",PCFCOM,Closed,9d,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 0,"Apr 7, 2026 10:37 AM",6227635207,CZ100212001,2085089,"Apr 9, 2026 2:54 PM","Apr 15, 2026 7:20 AM","AMT58660, AMT15602",Closed,5d,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Screening,"Feb 25, 2026 12:15 PM",6227635204,CZ100212001,2019716,"Feb 27, 2026 12:09 PM","Mar 3, 2026 11:11 AM","AMT58660, AMT3542",Closed,3d,Zdenka Dvorakova,dvorakova.zdenka@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 2,"Apr 20, 2026 8:43 AM",6227635208,CZ100212001,2106304,"Apr 22, 2026 7:04 PM","Apr 23, 2026 9:21 AM",AMT58660,Closed,14h 16m,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 4,"May 5, 2026 10:00 AM",6227635211,CZ100212001,2133221,"May 9, 2026 6:24 PM","May 11, 2026 2:34 PM",AMT58660,Closed,1d,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Biopsy,"May 25, 2026 12:00 AM",6228501732,CZ100132003,2165892,"May 29, 2026 3:13 PM","May 31, 2026 9:26 PM",ADT8471,Closed,2d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10020 - Dr.Lucie Gonsorcikova,CZECH REPUBLIC,Screening,"Apr 13, 2026 12:20 PM",6227993962,CZ100201001,2094721,"Apr 15, 2026 6:02 PM","Apr 21, 2026 12:47 PM","AMT58660, AMT3542",Closed,5d,Zuzana Zahradnikova,zuzana.zahradnikova@ftn.cz,Investigator +CZ10020 - Dr.Lucie Gonsorcikova,CZECH REPUBLIC,Induction Week 0,"May 18, 2026 9:28 AM",6227993966,CZ100201001,2156061,"May 22, 2026 9:37 PM","May 25, 2026 6:43 AM","ADT201, AMT58660, AMT3542",Closed,2d,Zuzana Zahradnikova,zuzana.zahradnikova@ftn.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 0,"Mar 24, 2026 9:40 AM",6227635142,CZ100132001,2064220,"Mar 26, 2026 9:37 PM",,"AMT58660, AMT3542",Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 0,"Mar 24, 2026 9:40 AM",6227635142,CZ100132001,2066330,"Mar 27, 2026 6:43 PM","Mar 30, 2026 10:41 PM",AMT58660,Closed,3d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 2,"Apr 7, 2026 8:50 AM",6227635144,CZ100132001,2087084,"Apr 10, 2026 1:27 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 2,"Apr 7, 2026 8:50 AM",6227635144,CZ100132001,2100086,"Apr 18, 2026 11:15 AM","Apr 22, 2026 7:51 PM",AMT58660,Closed,4d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 4,"Apr 21, 2026 8:45 AM",6227635146,CZ100132001,2108501,"Apr 23, 2026 6:55 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 4,"Apr 21, 2026 8:45 AM",6227635146,CZ100132001,2123492,"May 4, 2026 7:24 PM","May 5, 2026 3:30 PM",AMT58660,Closed,20h 6m,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2101883,"Apr 20, 2026 6:49 PM","Apr 22, 2026 7:51 PM",AMT58660,Closed,2d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2090916,"Apr 13, 2026 9:15 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2079289,"Apr 6, 2026 3:21 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Feb 26, 2026 1:20 PM",6227635140,CZ100132001,2033901,"Mar 9, 2026 3:53 PM","Mar 16, 2026 10:08 PM","SCD, AMT58660, AMT3542",Closed,7d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Feb 26, 2026 1:20 PM",6227635140,CZ100132001,2023257,"Mar 2, 2026 6:47 PM",,"SCD, AGE, AMT58660, AMT3542",Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"May 6, 2026 10:45 AM",6227635141,CZ100132003,2137874,"May 12, 2026 8:03 PM","May 19, 2026 7:48 AM",AMT58660,Closed,6d,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Biopsy,"Apr 21, 2026 12:00 AM",6227635159,CZ100132002,2109534,"Apr 24, 2026 12:45 PM",,ADT8471,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Biopsy,"Apr 21, 2026 12:00 AM",6227635159,CZ100132002,2123486,"May 4, 2026 7:23 PM","May 5, 2026 3:30 PM",ADT8471,Closed,20h 7m,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10016 - Dr.Robert Mudr,CZECH REPUBLIC,Screening,"Apr 21, 2026 10:45 AM",6227635171,CZ100162001,2109874,"Apr 24, 2026 2:00 PM",,AMT58660,Closed,,,, +CZ10016 - Dr.Robert Mudr,CZECH REPUBLIC,Screening,"Apr 21, 2026 10:45 AM",6227635171,CZ100162001,2123465,"May 4, 2026 7:16 PM","May 5, 2026 10:04 AM",AMT58660,Closed,14h 48m,Petr Pekny,petr.pekny@nmskb.cz,Investigator +CZ10016 - Dr.Robert Mudr,CZECH REPUBLIC,Screening,"May 27, 2026 12:35 PM",6227635173,CZ100162002,2168473,"Jun 1, 2026 3:20 PM","Jun 1, 2026 3:50 PM",AMT58660,Closed,29m,Petr Pekny,petr.pekny@nmskb.cz,Investigator +CZ10016 - Dr.Robert Mudr,CZECH REPUBLIC,Induction Week 0,"May 28, 2026 10:45 AM",6227635174,CZ100162001,2173754,"Jun 3, 2026 7:23 PM","Jun 3, 2026 11:14 PM",AMT58660,Closed,3h 50m,Petr Pekny,petr.pekny@nmskb.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Screening,"Mar 2, 2026 7:00 AM",6227323204,CZ100012002,2032628,"Mar 9, 2026 10:33 AM","Mar 9, 2026 11:58 AM",AMT58660,Closed,1h 24m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Screening,"Mar 2, 2026 7:00 AM",6227323204,CZ100012002,2026645,"Mar 4, 2026 12:58 PM","Mar 6, 2026 6:01 PM","AMT58660, AMT3542",Closed,2d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 0,,6227323206,,2112374,"Apr 27, 2026 2:17 PM","May 5, 2026 11:24 AM","PCFCOM, ADT201, AMT58660, AMT3542",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 2,"Apr 23, 2026 7:40 AM",6227323207,CZ100012002,2113312,"Apr 27, 2026 6:35 PM","Apr 28, 2026 9:06 PM",AMT58660,Closed,1d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 2,"Mar 4, 2026 7:00 AM",6227323208,CZ100012001,2030545,"Mar 6, 2026 11:02 AM","Mar 6, 2026 11:42 AM","AMT58660, AMT688",Closed,39m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 4,"Mar 18, 2026 7:05 AM",6227323210,CZ100012001,2053955,"Mar 20, 2026 2:50 PM","Mar 25, 2026 3:29 PM","SCD, AMT58660",Closed,5d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Stool Pathogens,"Jan 28, 2026 6:00 AM",6227323211,CZ100012001,1976585,"Jan 30, 2026 1:21 PM","Feb 6, 2026 2:37 PM","VST, AGE",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Stool Pathogens,"Jan 28, 2026 6:00 AM",6227323211,CZ100012001,1991148,"Feb 9, 2026 7:43 PM","Feb 13, 2026 8:04 AM",AGE,Closed,3d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Biopsy,"Feb 5, 2026 12:00 AM",6227323223,CZ100012001,1989998,"Feb 9, 2026 1:42 PM","Feb 10, 2026 6:46 PM",VST,Closed,1d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2141856,"May 14, 2026 4:23 PM","May 19, 2026 12:54 PM","SCD, AGE",Closed,4d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2152157,"May 21, 2026 11:32 AM","May 26, 2026 8:15 AM",AGE,Closed,4d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2112413,"Apr 27, 2026 2:24 PM","May 5, 2026 11:25 AM","PSX, SCT, VST, AGE, ADT201",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2126904,"May 6, 2026 12:02 PM","May 12, 2026 4:58 PM","SCT, VST, AGE",Closed,6d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,,6227323231,,2053405,"Mar 20, 2026 12:14 PM","Mar 30, 2026 12:54 AM",PCFCOM,Closed,9d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,,6227323233,,2053482,"Mar 20, 2026 12:40 PM","Mar 27, 2026 9:58 AM",PCFCOM,Closed,6d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 0,"Apr 8, 2026 7:10 AM",6228036554,CZ100012002,2089973,"Apr 13, 2026 3:26 PM","Apr 21, 2026 1:32 PM",AMT15602,Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Biopsy,"May 13, 2026 12:00 AM",6228252073,CZ100012003,2147778,"May 19, 2026 10:13 AM","May 21, 2026 4:38 PM",VST,Closed,2d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 4,"May 6, 2026 8:05 AM",6227933142,CZ100012002,2134478,"May 11, 2026 2:54 PM","May 11, 2026 3:11 PM","AMT58660, AMT3542",Closed,16m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 12,"May 13, 2026 8:05 AM",6227933143,CZ100012001,2147202,"May 18, 2026 7:51 PM","May 19, 2026 8:38 AM",AMT58660,Closed,12h 47m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Unscheduled,,6227697745,,2140058,"May 13, 2026 7:02 PM","May 26, 2026 9:46 AM",PCFCOM,Response Received,12d,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Screening,"Mar 18, 2026 9:18 AM",6227697718,CZ100122001,2053959,"Mar 20, 2026 2:52 PM","Mar 23, 2026 12:00 PM","SCT, AMT58660",Closed,2d,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 0,"Apr 7, 2026 11:45 AM",6227697719,CZ100122001,2085069,"Apr 9, 2026 2:48 PM","Apr 9, 2026 6:28 PM",AMT58660,Closed,3h 39m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 2,"Apr 22, 2026 9:25 AM",6227697722,CZ100122001,2113315,"Apr 27, 2026 6:35 PM","Apr 27, 2026 8:50 PM",AMT58660,Closed,2h 14m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 4,"May 7, 2026 12:40 PM",6227697723,CZ100122001,2142322,"May 14, 2026 7:10 PM","May 14, 2026 7:42 PM",AMT58660,Closed,31m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Biopsy,"Mar 23, 2026 12:00 AM",6227697736,CZ100122001,2060524,"Mar 25, 2026 12:53 PM","Mar 25, 2026 2:09 PM",AMT23260,Closed,1h 15m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Mar 31, 2026 8:30 AM",6227323330,CZ100092001,2075611,"Apr 2, 2026 5:37 PM",,AMT58660,Closed,,,, +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Mar 31, 2026 8:30 AM",6227323330,CZ100092001,2085558,"Apr 9, 2026 5:08 PM","Apr 10, 2026 2:06 PM",AMT58660,Closed,20h 58m,Jiri Pumprla,research@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Apr 16, 2026 12:00 PM",6227323332,CZ100092002,2101792,"Apr 20, 2026 6:19 PM","Apr 23, 2026 1:22 PM",AMT58660,Closed,2d,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Induction Week 0,"May 5, 2026 11:30 AM",6227323334,CZ100092001,2133224,"May 9, 2026 6:30 PM","May 13, 2026 10:10 AM","AMT58660, ADT809",Closed,3d,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Induction Week 2,"May 19, 2026 10:50 AM",6227323335,CZ100092001,2158952,"May 26, 2026 12:21 PM","May 27, 2026 9:03 AM",AMT58660,Closed,20h 42m,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Unscheduled,"Mar 17, 2026 8:00 AM",6227323265,CZ100062001,2052144,"Mar 19, 2026 4:08 PM","Mar 24, 2026 9:29 AM","PSX, SCT, AGE",Closed,4d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Screening,"Apr 20, 2026 7:45 AM",6227323234,CZ100062002,2106334,"Apr 22, 2026 7:18 PM","Apr 22, 2026 7:36 PM",AMT58660,Closed,18m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 0,"Mar 20, 2026 8:00 AM",6227323237,CZ100062001,2064023,"Mar 26, 2026 7:00 PM","Mar 27, 2026 9:04 AM",PCFCOM,Closed,14h 3m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 0,"Mar 20, 2026 8:00 AM",6227323237,CZ100062001,2061456,"Mar 25, 2026 6:16 PM","Mar 26, 2026 8:38 AM",AMT58660,Closed,14h 22m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 0,"May 26, 2026 9:20 AM",6227323238,CZ100062002,2168534,"Jun 1, 2026 3:33 PM",,"ADT201, AMT58660",Open,,,, +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 2,"Apr 8, 2026 7:10 AM",6227323240,CZ100062001,2086807,"Apr 10, 2026 12:21 PM","Apr 18, 2026 10:40 PM","AMT58660, ADT809",Closed,8d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 4,"Apr 15, 2026 8:45 AM",6227323242,CZ100062001,2102704,"Apr 21, 2026 11:22 AM","Apr 22, 2026 7:36 PM",AMT58660,Closed,1d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Biopsy,"Feb 19, 2026 12:00 AM",6227323254,CZ100062001,2014333,"Feb 24, 2026 4:13 PM","Feb 24, 2026 8:20 PM",VST,Closed,4h 6m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10003 - Dr. Leksa Vaclav,CZECH REPUBLIC,Screening,"May 13, 2026 8:15 AM",6227323299,CZ100032001,2154732,"May 22, 2026 12:36 PM","May 25, 2026 8:57 AM",AMT58660,Closed,2d,Leksa Vaclav,vaclav.leksa@seznam.cz,Investigator +title,value,,,,,,,,,,,,, +Search,,,,,,,,,,,,,, +Site,"930551, 930556, 930525, 930549, 930543, 930547, 930555, 930557, 930539, 930536, 930553, 930531",,,,,,,,,,,,, +Unresponded Only?,FALSE,,,,,,,,,,,,, +Posted,From - To - ,,,,,,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-06-05_085228 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv b/Covance_UCO3001/Source/2026-06-05_085228 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv new file mode 100644 index 0000000..145db9b --- /dev/null +++ b/Covance_UCO3001/Source/2026-06-05_085228 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv @@ -0,0 +1,9 @@ +Site,Country,Visit,Visit Collection Date,Accession,Subject,eQueryId,Create Date,Response Date Time,Issue Type,Status,Time Before Response,User Name,Email,Study Role +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 0,"May 26, 2026 9:20 AM",6227323238,CZ100062002,2168534,"Jun 1, 2026 3:33 PM",,"ADT201, AMT58660",Open,,,, +,,,,,,,,,,,,,, +,,,,,,,,,,,,,, +title,value,,,,,,,,,,,,, +Search,,,,,,,,,,,,,, +Site,"930551, 930556, 930525, 930549, 930543, 930547, 930555, 930557, 930539, 930536, 930553, 930531",,,,,,,,,,,,, +Unresponded Only?,TRUE,,,,,,,,,,,,, +Posted,From - To - ,,,,,,,,,,,,, diff --git a/Covance_UCO3001/Source/Zpracovano/2026-06-05_085404 sponsor-study-36940-kit-inventory-on-hand-expiration.csv b/Covance_UCO3001/Source/Zpracovano/2026-06-05_085404 sponsor-study-36940-kit-inventory-on-hand-expiration.csv new file mode 100644 index 0000000..e61eb84 --- /dev/null +++ b/Covance_UCO3001/Source/Zpracovano/2026-06-05_085404 sponsor-study-36940-kit-inventory-on-hand-expiration.csv @@ -0,0 +1,541 @@ +Project No.,Region,Country,Site,Kit Type,Description,Accession,Shipped Date,Expiration Date,Days to Expiration +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,1,Screening,6227323202,"Nov 21, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,1,Screening,6228114609,"Mar 10, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,2,Induction Week 0,6228036552,"Feb 27, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,2,Induction Week 0,6228462182,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,2,Induction Week 0,6228462184,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,2,Induction Week 0,6228462183,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,3,Induction Week 2,6227933141,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,3,Induction Week 2,6228462185,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,3,Induction Week 2,6228462186,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,3,Induction Week 2,6228462187,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,4,Induction Week 4,6227323209,"Nov 21, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,4,Induction Week 4,6228462189,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,4,Induction Week 4,6228462188,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,5,Induction Week 12,6227810906,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,5,Induction Week 12,6227933144,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,5,Induction Week 12,6228462190,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,5,Induction Week 12,6228462191,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,6,Maintenance Week 4,6227933145,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,6,Maintenance Week 4,6227933146,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,7,Maintenance Week 12,6227933147,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,7,Maintenance Week 12,6227933148,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228137358,"Mar 12, 2026","Jan 29, 2027",237 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462192,"Apr 28, 2026","May 25, 2027",353 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462193,"Apr 28, 2026","May 25, 2027",353 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462194,"Apr 28, 2026","May 25, 2027",353 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462196,"Apr 28, 2026","May 25, 2027",353 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462197,"Apr 28, 2026","May 25, 2027",353 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462195,"Apr 28, 2026","May 25, 2027",353 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-2,TB Testing,6227323220,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-2,TB Testing,6227323221,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-3,Biopsy,6227323222,"Nov 21, 2025","Sep 12, 2026",98 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-3,Biopsy,6228252071,"Mar 26, 2026","Jul 20, 2027",409 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-4,Induction ED,6227323225,"Nov 21, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-4,Induction ED,6227323226,"Nov 21, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-5,Biologic Drug Level,6227323227,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-5,Biologic Drug Level,6227323228,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-6,Maintenance ED,6227810907,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-6,Maintenance ED,6227810909,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-6,Maintenance ED,6227810908,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-8,Liver Function Tests,6227323229,"Nov 21, 2025","Jul 1, 2026",25 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-8,Liver Function Tests,6227323230,"Nov 21, 2025","Jul 1, 2026",25 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-9,LTE Maintenance ED,6227810910,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-9,LTE Maintenance ED,6227810911,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-9,LTE Maintenance ED,6227810912,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-10,Safety FU,6227323214,"Nov 21, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-10,Safety FU,6227323215,"Nov 21, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-11,DILI,6227323216,"Nov 21, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-12,DNA,6227323218,"Nov 21, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-12,DNA,6228252069,"Mar 26, 2026","Mar 31, 2027",298 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-12,DNA,6228252070,"Mar 26, 2026","Mar 31, 2027",298 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-12,DNA,6228252068,"Mar 26, 2026","Mar 31, 2027",298 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462198,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462199,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462200,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462202,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462201,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462203,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462206,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462205,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462204,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462207,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489756,"May 1, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489757,"May 1, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489758,"May 1, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489761,"May 1, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489760,"May 1, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489759,"May 1, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489763,"May 1, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489762,"May 1, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,1,Screening,6227323298,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,1,Screening,6227323300,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,2,Induction Week 0,6227323301,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,2,Induction Week 0,6227323302,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,3,Induction Week 2,6227323303,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,3,Induction Week 2,6227323304,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,4,Induction Week 4,6227323306,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,4,Induction Week 4,6227323305,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,5,Induction Week 12,6228676757,"May 15, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-1,Stool Pathogens,6227323307,"Nov 21, 2025","Dec 26, 2026",203 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-1,Stool Pathogens,6227323308,"Nov 21, 2025","Dec 26, 2026",203 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-2,TB Testing,6227323316,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-2,TB Testing,6227323317,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-3,Biopsy,6227323319,"Nov 21, 2025","Sep 12, 2026",98 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-3,Biopsy,6227323318,"Nov 21, 2025","Sep 12, 2026",98 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-4,Induction ED,6227323321,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-4,Induction ED,6227323322,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-5,Biologic Drug Level,6227323323,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-5,Biologic Drug Level,6227323324,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-6,Maintenance ED,6228676759,"May 15, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-6,Maintenance ED,6228676760,"May 15, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-6,Maintenance ED,6228676758,"May 15, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-8,Liver Function Tests,6227323326,"Nov 21, 2025","Jul 1, 2026",25 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-8,Liver Function Tests,6227323325,"Nov 21, 2025","Jul 1, 2026",25 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-9,LTE Maintenance ED,6228676762,"May 15, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-9,LTE Maintenance ED,6228676763,"May 15, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-9,LTE Maintenance ED,6228676761,"May 15, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-10,Safety FU,6227323310,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-10,Safety FU,6227323311,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-11,DILI,6227323312,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-12,DNA,6227323313,"Nov 21, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-12,DNA,6227323314,"Nov 21, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-12,DNA,6227323315,"Nov 21, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,U,Unscheduled,6227323328,"Nov 21, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,U,Unscheduled,6227323327,"Nov 21, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,U,Unscheduled,6227323329,"Nov 21, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,1,Screening,6227323235,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,1,Screening,6228492883,"Apr 23, 2026","Nov 30, 2026",177 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,1,Screening,6228492884,"Apr 23, 2026","Nov 30, 2026",177 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,1,Screening,6228492885,"Apr 23, 2026","Nov 30, 2026",177 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,2,Induction Week 0,6228265099,"Mar 27, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,2,Induction Week 0,6228265098,"Mar 27, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,2,Induction Week 0,6228265100,"Mar 27, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,3,Induction Week 2,6227323239,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,3,Induction Week 2,6228407563,"Apr 15, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,3,Induction Week 2,6228407564,"Apr 15, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,3,Induction Week 2,6228407565,"Apr 15, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,4,Induction Week 4,6227323241,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,4,Induction Week 4,6228461735,"Apr 21, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,4,Induction Week 4,6228461736,"Apr 21, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,4,Induction Week 4,6228461734,"Apr 21, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,5,Induction Week 12,6228013269,"Feb 25, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,5,Induction Week 12,6228492886,"Apr 23, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,6,Maintenance Week 4,6228194338,"Mar 23, 2026","Sep 30, 2026",116 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,6,Maintenance Week 4,6228690541,"May 19, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-1,Stool Pathogens,6228194340,"Mar 23, 2026","Mar 5, 2027",272 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-1,Stool Pathogens,6228194339,"Mar 23, 2026","Mar 5, 2027",272 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-3,Biopsy,6228690542,"May 19, 2026","Aug 7, 2027",427 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-3,Biopsy,6228690544,"May 19, 2026","Aug 7, 2027",427 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-3,Biopsy,6228690543,"May 19, 2026","Aug 7, 2027",427 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-4,Induction ED,6227323257,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-4,Induction ED,6227323258,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-5,Biologic Drug Level,6227323260,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-5,Biologic Drug Level,6227323259,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-6,Maintenance ED,6228013270,"Feb 25, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-6,Maintenance ED,6228013271,"Feb 25, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-6,Maintenance ED,6228013272,"Feb 25, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-8,Liver Function Tests,6227323261,"Nov 21, 2025","Jul 1, 2026",25 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-8,Liver Function Tests,6227323262,"Nov 21, 2025","Jul 1, 2026",25 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-9,LTE Maintenance ED,6228013275,"Feb 25, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-9,LTE Maintenance ED,6228013273,"Feb 25, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-9,LTE Maintenance ED,6228013274,"Feb 25, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-10,Safety FU,6227323246,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-10,Safety FU,6227323247,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-11,DILI,6227323248,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-12,DNA,6227323250,"Nov 21, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-12,DNA,6227323249,"Nov 21, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,U,Unscheduled,6227323263,"Nov 21, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,1,Screening,6227323331,"Nov 23, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,1,Screening,6227765941,"Jan 29, 2026","Sep 30, 2026",116 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,1,Screening,6227765942,"Jan 29, 2026","Sep 30, 2026",116 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,1,Screening,6227765943,"Jan 29, 2026","Sep 30, 2026",116 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,2,Induction Week 0,6227323333,"Nov 23, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,2,Induction Week 0,6227765944,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,2,Induction Week 0,6227765945,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,2,Induction Week 0,6227765946,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,3,Induction Week 2,6227323336,"Nov 23, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,3,Induction Week 2,6227765948,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,3,Induction Week 2,6227765947,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,3,Induction Week 2,6227765949,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227323337,"Nov 23, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227323338,"Nov 23, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227765950,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227765951,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227765952,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,5,Induction Week 12,6227765953,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,5,Induction Week 12,6227765954,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,5,Induction Week 12,6227765955,"Jan 29, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227323339,"Nov 23, 2025","Dec 26, 2026",203 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227765956,"Jan 29, 2026","Jan 15, 2027",223 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227765957,"Jan 29, 2026","Jan 15, 2027",223 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227765958,"Jan 29, 2026","Jan 15, 2027",223 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227765959,"Jan 29, 2026","Jan 15, 2027",223 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227323349,"Nov 23, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227765963,"Jan 29, 2026","Sep 30, 2026",116 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227765964,"Jan 29, 2026","Sep 30, 2026",116 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227765965,"Jan 29, 2026","Sep 30, 2026",116 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227765966,"Jan 29, 2026","Sep 30, 2026",116 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227323350,"Nov 23, 2025","Sep 12, 2026",98 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227323352,"Nov 23, 2025","Sep 12, 2026",98 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227765967,"Jan 29, 2026","Nov 28, 2026",175 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227765968,"Jan 29, 2026","Nov 28, 2026",175 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227765970,"Jan 29, 2026","Nov 28, 2026",175 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227765969,"Jan 29, 2026","Nov 28, 2026",175 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-4,Induction ED,6227323353,"Nov 23, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-4,Induction ED,6227323354,"Nov 23, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227323356,"Nov 23, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227765973,"Jan 29, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227765972,"Jan 29, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227765974,"Jan 29, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227765971,"Jan 29, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-6,Maintenance ED,6228357528,"Apr 7, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-6,Maintenance ED,6228357529,"Apr 7, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-6,Maintenance ED,6228357530,"Apr 7, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-8,Liver Function Tests,6227323357,"Nov 23, 2025","Jul 1, 2026",25 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-8,Liver Function Tests,6227323358,"Nov 23, 2025","Jul 1, 2026",25 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-9,LTE Maintenance ED,6228357532,"Apr 7, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-9,LTE Maintenance ED,6228357533,"Apr 7, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-9,LTE Maintenance ED,6228357531,"Apr 7, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-10,Safety FU,6227323342,"Nov 23, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-10,Safety FU,6227323343,"Nov 23, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-11,DILI,6227323344,"Nov 23, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227323347,"Nov 23, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227323345,"Nov 23, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227765961,"Jan 29, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227765962,"Jan 29, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227765960,"Jan 29, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227323359,"Nov 23, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227323361,"Nov 23, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227323360,"Nov 23, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227765975,"Jan 29, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227765976,"Jan 29, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227765977,"Jan 29, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,1,Screening,6227993930,"Feb 17, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,1,Screening,6227993931,"Feb 17, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,1,Screening,6227993932,"Feb 17, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,2,Induction Week 0,6227993933,"Feb 17, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,2,Induction Week 0,6227993934,"Feb 17, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,3,Induction Week 2,6227993935,"Feb 17, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,3,Induction Week 2,6227993936,"Feb 17, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,4,Induction Week 4,6227993937,"Feb 17, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,4,Induction Week 4,6227993938,"Feb 17, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-1,Stool Pathogens,6227993941,"Feb 17, 2026","Jan 15, 2027",223 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-1,Stool Pathogens,6227993940,"Feb 17, 2026","Jan 15, 2027",223 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-1,Stool Pathogens,6227993939,"Feb 17, 2026","Jan 15, 2027",223 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-2,TB Testing,6227993949,"Feb 17, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-2,TB Testing,6227993948,"Feb 17, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-3,Biopsy,6227993952,"Feb 17, 2026","Nov 28, 2026",175 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-3,Biopsy,6227993951,"Feb 17, 2026","Nov 28, 2026",175 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-3,Biopsy,6227993950,"Feb 17, 2026","Nov 28, 2026",175 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-4,Induction ED,6227993954,"Feb 17, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-4,Induction ED,6227993953,"Feb 17, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-5,Biologic Drug Level,6227993955,"Feb 17, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-5,Biologic Drug Level,6227993956,"Feb 17, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-8,Liver Function Tests,6227993957,"Feb 17, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-8,Liver Function Tests,6227993958,"Feb 17, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-10,Safety FU,6227993943,"Feb 17, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-10,Safety FU,6227993942,"Feb 17, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-11,DILI,6227993944,"Feb 17, 2026","Sep 30, 2026",116 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-12,DNA,6227993945,"Feb 17, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-12,DNA,6227993946,"Feb 17, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-12,DNA,6227993947,"Feb 17, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,U,Unscheduled,6227993959,"Feb 17, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,U,Unscheduled,6227993960,"Feb 17, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,U,Unscheduled,6227993961,"Feb 17, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,1,Screening,6227697716,"Jan 12, 2026","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,1,Screening,6227697717,"Jan 12, 2026","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,2,Induction Week 0,6227697720,"Jan 12, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,2,Induction Week 0,6228398468,"Apr 14, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,2,Induction Week 0,6228398470,"Apr 14, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,2,Induction Week 0,6228398469,"Apr 14, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,3,Induction Week 2,6227697721,"Jan 12, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,3,Induction Week 2,6228512528,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,3,Induction Week 2,6228512526,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,3,Induction Week 2,6228512527,"Apr 28, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,4,Induction Week 4,6227697724,"Jan 12, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,4,Induction Week 4,6228628517,"May 11, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,4,Induction Week 4,6228628515,"May 11, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,4,Induction Week 4,6228628516,"May 11, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,5,Induction Week 12,6228251912,"Mar 26, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,6,Maintenance Week 4,6228628518,"May 11, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-1,Stool Pathogens,6227697726,"Jan 12, 2026","Jan 14, 2027",222 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-1,Stool Pathogens,6227697727,"Jan 12, 2026","Jan 14, 2027",222 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-2,TB Testing,6227697735,"Jan 12, 2026","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-2,TB Testing,6227697734,"Jan 12, 2026","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-3,Biopsy,6227697737,"Jan 12, 2026","May 11, 2027",339 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-3,Biopsy,6227697738,"Jan 12, 2026","May 11, 2027",339 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-4,Induction ED,6227697740,"Jan 12, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-4,Induction ED,6227697739,"Jan 12, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-5,Biologic Drug Level,6227697741,"Jan 12, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-5,Biologic Drug Level,6227697742,"Jan 12, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-6,Maintenance ED,6228251914,"Mar 26, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-6,Maintenance ED,6228251913,"Mar 26, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-6,Maintenance ED,6228251915,"Mar 26, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-8,Liver Function Tests,6227697743,"Jan 12, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-8,Liver Function Tests,6227697744,"Jan 12, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-9,LTE Maintenance ED,6228251918,"Mar 26, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-9,LTE Maintenance ED,6228251916,"Mar 26, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-9,LTE Maintenance ED,6228251917,"Mar 26, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-10,Safety FU,6227697728,"Jan 12, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-10,Safety FU,6227697729,"Jan 12, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-11,DILI,6227697730,"Jan 12, 2026","Jul 31, 2026",55 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-12,DNA,6227697733,"Jan 12, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-12,DNA,6227697732,"Jan 12, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,U,Unscheduled,6227697747,"Jan 12, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,U,Unscheduled,6227697746,"Jan 12, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,1,Screening,6228367755,"Apr 8, 2026","Nov 30, 2026",177 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,1,Screening,6228367756,"Apr 8, 2026","Nov 30, 2026",177 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,1,Screening,6228367757,"Apr 8, 2026","Nov 30, 2026",177 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,2,Induction Week 0,6227635143,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,2,Induction Week 0,6228308226,"Apr 1, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,3,Induction Week 2,6227635145,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,3,Induction Week 2,6228398114,"Apr 14, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,3,Induction Week 2,6228398116,"Apr 14, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,4,Induction Week 4,6227635147,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,4,Induction Week 4,6228501725,"Apr 26, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,4,Induction Week 4,6228501727,"Apr 26, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,4,Induction Week 4,6228501726,"Apr 26, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,5,Induction Week 12,6228308227,"Apr 1, 2026","Jan 31, 2027",239 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,5,Induction Week 12,6228367758,"Apr 8, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,5,Induction Week 12,6228762734,"Jun 4, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,6,Maintenance Week 4,6228501728,"Apr 26, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,6,Maintenance Week 4,6228501729,"Apr 26, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-1,Stool Pathogens,6228367759,"Apr 8, 2026","Mar 5, 2027",272 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-1,Stool Pathogens,6228367760,"Apr 8, 2026","Mar 5, 2027",272 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-1,Stool Pathogens,6228367761,"Apr 8, 2026","Mar 5, 2027",272 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-2,TB Testing,6227635158,"Jan 5, 2026","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-2,TB Testing,6227635157,"Jan 5, 2026","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-3,Biopsy,6227635160,"Jan 5, 2026","Oct 15, 2026",131 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-3,Biopsy,6228501731,"Apr 26, 2026","Aug 7, 2027",427 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-3,Biopsy,6228501730,"Apr 26, 2026","Aug 7, 2027",427 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-4,Induction ED,6227635163,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-4,Induction ED,6227635162,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-5,Biologic Drug Level,6227635164,"Jan 5, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-5,Biologic Drug Level,6227635165,"Jan 5, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-6,Maintenance ED,6228095872,"Mar 5, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-6,Maintenance ED,6228095870,"Mar 5, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-6,Maintenance ED,6228095871,"Mar 5, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-8,Liver Function Tests,6227635167,"Jan 5, 2026","Sep 12, 2026",98 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-8,Liver Function Tests,6227635166,"Jan 5, 2026","Sep 12, 2026",98 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-9,LTE Maintenance ED,6228095874,"Mar 5, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-9,LTE Maintenance ED,6228095873,"Mar 5, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-9,LTE Maintenance ED,6228095875,"Mar 5, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-10,Safety FU,6227635151,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-10,Safety FU,6227635152,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-11,DILI,6227635153,"Jan 5, 2026","Jul 31, 2026",55 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-12,DNA,6228762735,"Jun 4, 2026","Mar 31, 2027",298 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-12,DNA,6228762736,"Jun 4, 2026","Mar 31, 2027",298 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-12,DNA,6228762737,"Jun 4, 2026","Mar 31, 2027",298 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,U,Unscheduled,6227635168,"Jan 5, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,U,Unscheduled,6227635169,"Jan 5, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,U,Unscheduled,6227635170,"Jan 5, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6227259263,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6227259264,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6227259265,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6228510217,"Apr 30, 2026","Nov 30, 2026",177 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6228510218,"Apr 30, 2026","Nov 30, 2026",177 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,2,Induction Week 0,6227259267,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,2,Induction Week 0,6227259266,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,2,Induction Week 0,6228510219,"Apr 30, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,2,Induction Week 0,6228510220,"Apr 30, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,3,Induction Week 2,6227259268,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,3,Induction Week 2,6227259269,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,3,Induction Week 2,6228510221,"Apr 30, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,3,Induction Week 2,6228510222,"Apr 30, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,4,Induction Week 4,6227259270,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,4,Induction Week 4,6227259271,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-1,Stool Pathogens,6227259274,"Nov 13, 2025","Dec 26, 2026",203 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-1,Stool Pathogens,6227259273,"Nov 13, 2025","Dec 26, 2026",203 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-1,Stool Pathogens,6227259272,"Nov 13, 2025","Dec 26, 2026",203 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-2,TB Testing,6227259281,"Nov 13, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-2,TB Testing,6227259282,"Nov 13, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-3,Biopsy,6227259283,"Nov 13, 2025","Sep 12, 2026",98 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-3,Biopsy,6227259284,"Nov 13, 2025","Sep 12, 2026",98 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-3,Biopsy,6227259285,"Nov 13, 2025","Sep 12, 2026",98 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-4,Induction ED,6227259286,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-4,Induction ED,6227259287,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-5,Biologic Drug Level,6227259289,"Nov 13, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-5,Biologic Drug Level,6227259288,"Nov 13, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-8,Liver Function Tests,6227259290,"Nov 13, 2025","Jul 1, 2026",25 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-8,Liver Function Tests,6227259291,"Nov 13, 2025","Jul 1, 2026",25 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-10,Safety FU,6227259276,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-10,Safety FU,6227259275,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-11,DILI,6227259277,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-12,DNA,6227259280,"Nov 13, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-12,DNA,6227259278,"Nov 13, 2025","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,U,Unscheduled,6227259294,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,U,Unscheduled,6227259293,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,U,Unscheduled,6227259292,"Nov 13, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,1,Screening,6227635172,"Jan 5, 2026","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,2,Induction Week 0,6227635175,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,3,Induction Week 2,6227635176,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,3,Induction Week 2,6227635177,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,4,Induction Week 4,6227635178,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,4,Induction Week 4,6227635179,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,5,Induction Week 12,6228501793,"Apr 26, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-1,Stool Pathogens,6227635181,"Jan 5, 2026","Jan 14, 2027",222 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-2,TB Testing,6227635189,"Jan 5, 2026","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-2,TB Testing,6227635190,"Jan 5, 2026","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-3,Biopsy,6227635191,"Jan 5, 2026","Oct 15, 2026",131 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-3,Biopsy,6227635192,"Jan 5, 2026","Oct 15, 2026",131 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-4,Induction ED,6227635195,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-4,Induction ED,6227635194,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-5,Biologic Drug Level,6227635197,"Jan 5, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-5,Biologic Drug Level,6227635196,"Jan 5, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-6,Maintenance ED,6228501795,"Apr 26, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-6,Maintenance ED,6228501794,"Apr 26, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-6,Maintenance ED,6228501796,"Apr 26, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-8,Liver Function Tests,6227635198,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-8,Liver Function Tests,6227635199,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-9,LTE Maintenance ED,6228501797,"Apr 26, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-9,LTE Maintenance ED,6228501798,"Apr 26, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-9,LTE Maintenance ED,6228501799,"Apr 26, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-10,Safety FU,6227635183,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-10,Safety FU,6227635184,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-11,DILI,6227635185,"Jan 5, 2026","Jul 31, 2026",55 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-12,DNA,6227635188,"Jan 5, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-12,DNA,6227635187,"Jan 5, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,U,Unscheduled,6227635200,"Jan 5, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,U,Unscheduled,6227635202,"Jan 5, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,U,Unscheduled,6227635201,"Jan 5, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,1,Screening,6227993964,"Feb 18, 2026","Sep 30, 2026",116 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,1,Screening,6227993963,"Feb 18, 2026","Sep 30, 2026",116 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6227993965,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6228707090,"May 22, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6228707091,"May 22, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6228707092,"May 22, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6228711855,"May 29, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,3,Induction Week 2,6227993967,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,4,Induction Week 4,6227993969,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,4,Induction Week 4,6227993970,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,5,Induction Week 12,6228436352,"Apr 19, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-1,Stool Pathogens,6227993973,"Feb 18, 2026","Jan 15, 2027",223 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-1,Stool Pathogens,6227993972,"Feb 18, 2026","Jan 15, 2027",223 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-2,TB Testing,6227993980,"Feb 18, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-2,TB Testing,6227993981,"Feb 18, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-3,Biopsy,6227993983,"Feb 18, 2026","May 11, 2027",339 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-3,Biopsy,6227993982,"Feb 18, 2026","May 11, 2027",339 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-4,Induction ED,6227993985,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-4,Induction ED,6227993986,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-5,Biologic Drug Level,6227993988,"Feb 18, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-5,Biologic Drug Level,6228711856,"May 29, 2026","May 31, 2027",359 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-6,Maintenance ED,6228436354,"Apr 19, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-6,Maintenance ED,6228436353,"Apr 19, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-6,Maintenance ED,6228436355,"Apr 19, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-8,Liver Function Tests,6227993989,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-8,Liver Function Tests,6227993990,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-9,LTE Maintenance ED,6228436356,"Apr 19, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-9,LTE Maintenance ED,6228436357,"Apr 19, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-9,LTE Maintenance ED,6228436358,"Apr 19, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-10,Safety FU,6227993974,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-10,Safety FU,6227993975,"Feb 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-11,DILI,6227993976,"Feb 18, 2026","Sep 30, 2026",116 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-12,DNA,6227993978,"Feb 18, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-12,DNA,6227993979,"Feb 18, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,U,Unscheduled,6227993991,"Feb 18, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,U,Unscheduled,6227993992,"Feb 18, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,U,Unscheduled,6227993993,"Feb 18, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,1,Screening,6227635205,"Jan 5, 2026","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,1,Screening,6227635203,"Jan 5, 2026","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,2,Induction Week 0,6227635206,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,2,Induction Week 0,6228398426,"Apr 14, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,2,Induction Week 0,6228398427,"Apr 14, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,2,Induction Week 0,6228398428,"Apr 14, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,3,Induction Week 2,6227635209,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,3,Induction Week 2,6228492827,"Apr 23, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,3,Induction Week 2,6228492828,"Apr 23, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,3,Induction Week 2,6228492826,"Apr 23, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,4,Induction Week 4,6227635210,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,4,Induction Week 4,6228605821,"May 7, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,4,Induction Week 4,6228605823,"May 7, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,4,Induction Week 4,6228605822,"May 7, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,5,Induction Week 12,6228084840,"Mar 4, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,6,Maintenance Week 4,6228605824,"May 7, 2026","Feb 28, 2027",267 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-1,Stool Pathogens,6227635214,"Jan 5, 2026","Jan 14, 2027",222 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-1,Stool Pathogens,6227635212,"Jan 5, 2026","Jan 14, 2027",222 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-2,TB Testing,6227635221,"Jan 5, 2026","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-2,TB Testing,6227635222,"Jan 5, 2026","Aug 31, 2026",86 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-3,Biopsy,6227635224,"Jan 5, 2026","Nov 25, 2026",172 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-3,Biopsy,6227635225,"Jan 5, 2026","Nov 25, 2026",172 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-4,Induction ED,6227635226,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-4,Induction ED,6227635227,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-5,Biologic Drug Level,6227635228,"Jan 5, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-5,Biologic Drug Level,6227635229,"Jan 5, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-6,Maintenance ED,6228084843,"Mar 4, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-6,Maintenance ED,6228084842,"Mar 4, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-6,Maintenance ED,6228084841,"Mar 4, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-8,Liver Function Tests,6227635230,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-8,Liver Function Tests,6227635231,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-9,LTE Maintenance ED,6228084845,"Mar 4, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-9,LTE Maintenance ED,6228084844,"Mar 4, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-9,LTE Maintenance ED,6228084846,"Mar 4, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-10,Safety FU,6227635215,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-10,Safety FU,6227635216,"Jan 5, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-11,DILI,6227635217,"Jan 5, 2026","Jul 31, 2026",55 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-12,DNA,6227635219,"Jan 5, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-12,DNA,6227635220,"Jan 5, 2026","Dec 31, 2026",208 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,U,Unscheduled,6227635234,"Jan 5, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,U,Unscheduled,6227635233,"Jan 5, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,U,Unscheduled,6227635232,"Jan 5, 2026","Oct 31, 2026",147 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6227323267,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228137352,"Mar 11, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228137353,"Mar 11, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228137354,"Mar 11, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228179928,"Mar 23, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228179930,"Mar 23, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228179929,"Mar 23, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,2,Induction Week 0,6227323269,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,2,Induction Week 0,6228173395,"Mar 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,2,Induction Week 0,6228173396,"Mar 18, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,3,Induction Week 2,6227323271,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,3,Induction Week 2,6228179931,"Mar 23, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,3,Induction Week 2,6228179933,"Mar 23, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,4,Induction Week 4,6227323273,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,4,Induction Week 4,6228179934,"Mar 23, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,4,Induction Week 4,6228179935,"Mar 23, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,5,Induction Week 12,6227752380,"Jan 20, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,5,Induction Week 12,6227810902,"Jan 28, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,5,Induction Week 12,6228137356,"Mar 11, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,6,Maintenance Week 4,6228023948,"Feb 25, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,6,Maintenance Week 4,6228023949,"Feb 25, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,12,LTE Maintenance Wk56,6228179938,"Mar 23, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,12,LTE Maintenance Wk56,6228179937,"Mar 23, 2026","Oct 11, 2026",127 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-1,Stool Pathogens,6227323275,"Nov 21, 2025","Dec 26, 2026",203 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-1,Stool Pathogens,6227810903,"Jan 28, 2026","Jan 15, 2027",223 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-1,Stool Pathogens,6228179939,"Mar 23, 2026","Jan 29, 2027",237 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-1,Stool Pathogens,6228179940,"Mar 23, 2026","Jan 29, 2027",237 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-2,TB Testing,6227323284,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-2,TB Testing,6227323285,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6227323288,"Nov 21, 2025","Sep 12, 2026",98 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6228023950,"Feb 25, 2026","Nov 28, 2026",175 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6228023952,"Feb 25, 2026","May 11, 2027",339 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6228179946,"Mar 23, 2026","Jul 20, 2027",409 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6228179944,"Mar 23, 2026","Jul 20, 2027",409 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-4,Induction ED,6227323289,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-4,Induction ED,6227323290,"Nov 21, 2025","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-5,Biologic Drug Level,6227323291,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-5,Biologic Drug Level,6227323292,"Nov 21, 2025","Jun 30, 2026",24 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-6,Maintenance ED,6227752381,"Jan 20, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-6,Maintenance ED,6227752383,"Jan 20, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-6,Maintenance ED,6227752382,"Jan 20, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-8,Liver Function Tests,6227323293,"Nov 21, 2025","Jul 1, 2026",25 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-8,Liver Function Tests,6227323294,"Nov 21, 2025","Jul 1, 2026",25 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-9,LTE Maintenance ED,6227752385,"Jan 20, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-9,LTE Maintenance ED,6227752386,"Jan 20, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-9,LTE Maintenance ED,6227752384,"Jan 20, 2026","Oct 7, 2026",123 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-10,Safety FU,6227323279,"Nov 21, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-10,Safety FU,6227323278,"Nov 21, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-11,DILI,6227323280,"Nov 21, 2025","May 31, 2026",-5 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-12,DNA,6227323281,"Nov 21, 2025","Jul 31, 2026",55 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-12,DNA,6227323282,"Nov 21, 2025","Jul 31, 2026",55 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-12,DNA,6228179941,"Mar 23, 2026","Mar 31, 2027",298 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-12,DNA,6228179943,"Mar 23, 2026","Mar 31, 2027",298 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,U,Unscheduled,6227323296,"Nov 21, 2025","Aug 31, 2026",86 +title,value,,,,,,,, +Search,,,,,,,,, +Site,"CZ10012 Dr.Stefan Konecny, CZ10021 Dr.Martin Bortlik, CZ10016 Dr.Robert Mudr, CZ10003 Dr. Leksa Vaclav, CZ10009 Dr. Jiri Pumprla, CZ10015 Dr.Jan Matous, CZ10013 Dr.David Stepek, CZ10006 Dr. Michal Konecny, CZ10001 Dr. Matej Falc, CZ10010 Dr.Nabil El Lababidi, CZ10022 Dr. Petr Hrabak, CZ10020 Dr.Lucie Gonsorcikova",,,,,,,, +Expiration Date Range,From - To - ,,,,,,,, +Shipped Date Range,From - To - ,,,,,,,, +Kit Type,,,,,,,,, +Ignore Record Limit,TRUE,,,,,,,, diff --git a/Covance_UCO3001/Source/Zpracovano/2026-06-05_085423 sponsor-study-35472-kit-inventory-on-hand-expiration.csv b/Covance_UCO3001/Source/Zpracovano/2026-06-05_085423 sponsor-study-35472-kit-inventory-on-hand-expiration.csv new file mode 100644 index 0000000..e68ccdc --- /dev/null +++ b/Covance_UCO3001/Source/Zpracovano/2026-06-05_085423 sponsor-study-35472-kit-inventory-on-hand-expiration.csv @@ -0,0 +1,284 @@ +Project No.,Region,Country,Site,Kit Type,Description,Accession,Shipped Date,Expiration Date,Days to Expiration +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350973,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350970,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350974,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350976,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350978,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350979,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6227541248,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6227541247,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6228149461,"Mar 13, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6228149462,"Mar 13, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6228149463,"Mar 13, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6225350980,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6225350983,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6227261232,"Nov 18, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6227261231,"Nov 18, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6227541250,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6227541253,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6225350985,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6225350986,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6225350987,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6227547334,"Dec 31, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6227547335,"Dec 31, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,4,Part 2 OL Induction Baseline,6225350989,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,4,Part 2 OL Induction Baseline,6227541255,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,4,Part 2 OL Induction Baseline,6227541254,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,4,Part 2 OL Induction Baseline,6227547339,"Dec 31, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6226573502,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6226889397,"Oct 7, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6227261233,"Nov 18, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6227541263,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6227541262,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6226573503,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6226889398,"Oct 7, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6227043303,"Oct 23, 2025","Jul 31, 2026",55 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6227261234,"Nov 18, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6228149464,"Mar 13, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6228149465,"Mar 13, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6226889399,"Oct 7, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6227541265,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6227541267,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6227541268,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6227541266,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573504,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573505,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573507,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573506,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573508,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6227541269,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6227541270,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6227541272,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6227541271,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350990,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350991,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350992,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350993,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350994,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6227768461,"Jan 27, 2026","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6228605654,"May 7, 2026","Feb 28, 2027",267 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6228605655,"May 7, 2026","Feb 28, 2027",267 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350996,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350995,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350997,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350998,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350999,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6227768462,"Jan 27, 2026","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6227768463,"Jan 27, 2026","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6227768464,"Jan 27, 2026","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6227768465,"Jan 27, 2026","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-4,Liver Monitoring,6225351000,"Feb 24, 2025","Sep 1, 2025",-277 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-4,Liver Monitoring,6227547340,"Dec 31, 2025","Sep 12, 2026",98 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-4,Liver Monitoring,6227768466,"Jan 27, 2026","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-5,Suspected Liver Event FU,6225351001,"Feb 24, 2025","Jul 31, 2025",-309 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-5,Suspected Liver Event FU,6227547341,"Dec 31, 2025","Jul 31, 2026",55 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-5,Suspected Liver Event FU,6227768467,"Jan 27, 2026","Jul 31, 2026",55 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6225351003,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6226649755,"Aug 29, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6226649756,"Aug 29, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178914,"Nov 14, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178913,"Nov 14, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178915,"Nov 14, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178916,"Nov 14, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178917,"Nov 14, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178919,"Nov 14, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178918,"Nov 14, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6225351038,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6225351039,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6225351043,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6227520226,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6227520225,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6227520227,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6225351048,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226551696,"Aug 22, 2025","Apr 17, 2026",-49 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226551699,"Aug 22, 2025","Apr 17, 2026",-49 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226551700,"Aug 22, 2025","Apr 17, 2026",-49 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655163,"Sep 5, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655166,"Sep 5, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655165,"Sep 5, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655162,"Sep 5, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655164,"Sep 5, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6225351053,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6225351054,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6225351055,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6227520230,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6227520228,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6227520229,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780849,"Sep 24, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780851,"Sep 24, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780848,"Sep 24, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780852,"Sep 24, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780850,"Sep 24, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6227520231,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6227520233,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6227520232,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6226550654,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6226561520,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6227072416,"Oct 20, 2025","Jul 31, 2026",55 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6227072415,"Oct 20, 2025","Jul 31, 2026",55 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6227072418,"Oct 20, 2025","Jul 31, 2026",55 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6227072417,"Oct 20, 2025","Jul 31, 2026",55 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6226313626,"Jul 14, 2025","Apr 17, 2026",-49 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6226550655,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6226561521,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6227520234,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6227520235,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6227520236,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,7,Part 2 DB Week 13,6226313627,"Jul 14, 2025","Apr 17, 2026",-49 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,7,Part 2 DB Week 13,6226550656,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,7,Part 2 DB Week 13,6226561522,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,7,Part 2 DB Week 13,6226804963,"Sep 25, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313628,"Jul 14, 2025","Apr 17, 2026",-49 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313629,"Jul 14, 2025","Apr 17, 2026",-49 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313630,"Jul 14, 2025","Apr 17, 2026",-49 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313631,"Jul 14, 2025","Apr 17, 2026",-49 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313632,"Jul 14, 2025","Apr 17, 2026",-49 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520237,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520239,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520240,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520241,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520238,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351058,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351059,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351061,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351062,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351060,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6226780854,"Sep 24, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6227520244,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6227520246,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6225351065,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6225351067,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6225351064,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6225351063,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520248,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520250,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520247,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520249,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520251,"Dec 26, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-4,Liver Monitoring,6225351068,"Feb 24, 2025","Sep 1, 2025",-277 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-5,Suspected Liver Event FU,6225351069,"Feb 24, 2025","Jul 31, 2025",-309 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,U,Retest,6225351071,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,U,Retest,6228023802,"Feb 25, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,U,Retest,6228023803,"Feb 25, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6225351073,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6225351075,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6225351079,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6227542163,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6227542162,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6228149810,"Mar 13, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6228149812,"Mar 13, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6228149811,"Mar 13, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6225351085,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6225351086,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6227542165,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6227542164,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6227844727,"Feb 1, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6227844726,"Feb 1, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6225351087,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6225351088,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6225351089,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6227542167,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6227542168,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6227542169,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6227542166,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,4,Part 2 OL Induction Baseline,6225351091,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,4,Part 2 OL Induction Baseline,6225351090,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,5,Part 2 OL Induction Day 29,6226935605,"Oct 14, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,5,Part 2 OL Induction Day 29,6228013045,"Feb 26, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6226550647,"Aug 18, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6226561518,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6226991312,"Oct 26, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6228013046,"Feb 26, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6228114461,"Mar 11, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6228398393,"Apr 15, 2026","Feb 28, 2027",267 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6226550648,"Aug 18, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6226561519,"Aug 21, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6226991313,"Oct 26, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6227261837,"Nov 20, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6227261838,"Nov 20, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6228114462,"Mar 11, 2026","Oct 11, 2026",127 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550649,"Aug 18, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550650,"Aug 18, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550652,"Aug 18, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550651,"Aug 18, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550653,"Aug 18, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6225351092,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6225351096,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6227498378,"Dec 22, 2025","Aug 31, 2026",86 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6228232036,"Mar 25, 2026","Jan 3, 2027",211 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6228232038,"Mar 25, 2026","Jan 3, 2027",211 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6228234299,"Mar 30, 2026","Jan 3, 2027",211 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351097,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351099,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351101,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351100,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351098,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6227542174,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6227542176,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6227542175,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6227542177,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-4,Liver Monitoring,6225351102,"Feb 24, 2025","Sep 1, 2025",-277 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-4,Liver Monitoring,6227542179,"Dec 25, 2025","Sep 12, 2026",98 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-4,Liver Monitoring,6227542178,"Dec 25, 2025","Sep 12, 2026",98 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-5,Suspected Liver Event FU,6225351103,"Feb 24, 2025","Jul 31, 2025",-309 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-5,Suspected Liver Event FU,6227542180,"Dec 25, 2025","Jun 30, 2026",24 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-5,Suspected Liver Event FU,6227542181,"Dec 25, 2025","Jun 30, 2026",24 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6225351104,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6225351105,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6227542183,"Dec 25, 2025","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6228417882,"Apr 15, 2026","Feb 28, 2027",267 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6228417883,"Apr 15, 2026","Feb 28, 2027",267 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351107,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351108,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351112,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351113,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351114,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351115,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6227767268,"Jan 27, 2026","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6227775503,"Jan 23, 2026","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6227775504,"Jan 23, 2026","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6225351117,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6225351116,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6225351118,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6225351119,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6227767269,"Jan 27, 2026","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6227767270,"Jan 27, 2026","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6227775506,"Jan 23, 2026","Oct 7, 2026",123 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6225351123,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6225351122,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6225351121,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6228742569,"May 25, 2026","Feb 28, 2027",267 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6228742568,"May 25, 2026","Feb 28, 2027",267 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,4,Part 2 OL Induction Baseline,6225351124,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,4,Part 2 OL Induction Baseline,6225351125,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,6,Part 2 DB Baseline,6226976944,"Oct 26, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,6,Part 2 DB Baseline,6228521304,"Apr 30, 2026","Feb 28, 2027",267 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,7,Part 2 DB Week 13,6226560889,"Aug 20, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,7,Part 2 DB Week 13,6226752556,"Sep 17, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,7,Part 2 DB Week 13,6226976945,"Oct 26, 2025","May 31, 2026",-5 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6226560890,"Aug 20, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6226560892,"Aug 20, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6226560894,"Aug 20, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6226560893,"Aug 20, 2025","Jul 1, 2026",25 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6228389162,"Apr 15, 2026","Feb 28, 2027",267 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6228389161,"Apr 15, 2026","Feb 28, 2027",267 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-2,End of Phase/Treatment,6225351129,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-2,End of Phase/Treatment,6225351128,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-2,End of Phase/Treatment,6225351130,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-2,End of Phase/Treatment,6225351127,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351131,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351132,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351133,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351134,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351135,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-4,Liver Monitoring,6225351136,"Feb 24, 2025","Sep 1, 2025",-277 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-5,Suspected Liver Event FU,6225351137,"Feb 24, 2025","Jul 31, 2025",-309 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,U,Retest,6225351139,"Feb 24, 2025","Dec 1, 2025",-186 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,U,Retest,6225351138,"Feb 24, 2025","Dec 1, 2025",-186 +title,value,,,,,,,, +Search,,,,,,,,, +Site,"CZ10004 Dr. Erik Herman, CZ10012 Dr.Ales Urban, CZ10011 Dr. Marta Lendlova, CZ10008 Dr.Zdenek Solle",,,,,,,, +Expiration Date Range,From - To - ,,,,,,,, +Shipped Date Range,From - To - ,,,,,,,, +Kit Type,,,,,,,,, +Ignore Record Limit,TRUE,,,,,,,, diff --git a/Covance_UCO3001/Source/Zpracovano/2026-06-05_085844 sponsor-study-36940-samples-allSamples.csv b/Covance_UCO3001/Source/Zpracovano/2026-06-05_085844 sponsor-study-36940-samples-allSamples.csv new file mode 100644 index 0000000..d6e741f --- /dev/null +++ b/Covance_UCO3001/Source/Zpracovano/2026-06-05_085844 sponsor-study-36940-samples-allSamples.csv @@ -0,0 +1,1514 @@ +Protocol Code,Investigator No.,Investigator Name,Patient No.,Collection Date,Protocol Visit Code,Kit Receipt Date,Container Receipt Date,Accession,Container No.,Container Barcode No.,Specimen Type,Sample Status,Expected Receipt Condition,Actual Receipt Condition,Container Label Line 1,Container Label Line 2,SM Sample Status,SMART Specimen Class Description,Aliquot Created Date,Aliquoted Date,Collection Time,Container Receipt Time,Country,Courier,Kit Receipt Time,Parent Barcode Number,Parent Sample Type,Project,Region,Screening No.,Shipped To Organization Name,Site Waybill No.,Site - Scheduled Shipment Date,Site - Shipment Created Date,Site - Shipment Details Entered Date,SMART Specimen Class,Visit Description,Parent Barcode,Children Barcode +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,1,622732320301,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,2,622732320302,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,3,622732320303,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,7,622732320307,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,8,622732320308,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,5,622732320305,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,6,622732320306,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,11,622732320311,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,4,622732320304,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,14,622732320314,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,12,622732320312,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,15,622732320315,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,1,622732320401,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,9,622732320309,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,3,622732320403,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,4,622732320404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,2,622732320402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,6,622732320406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,7,622732320407,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,5,622732320405,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,,6227323203,10,622732320310,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,08:00,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,13,622732320313,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM PANEL, BETA",HCG & FSH,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,9,622732320409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,10,622732320410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,11,622732320411,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,13,622732320413,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM PANEL, BETA",HCG & FSH,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,14,622732320414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,15,622732320415,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,8,622732320408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,1,622732320501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,12,622732320412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,2,622732320502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,4,622732320504,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,7,622732320507,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,3,622732320503,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,6,622732320506,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,10,622732320510,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,9,622732320509,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,8,622732320508,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,5,622732320505,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,11,622732320511,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,13,622732320513,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,14,622732320514,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,15,622732320515,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,16,622732320516,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,18,622732320518,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,1,622732320601,"Whole Blood, EDTA, Dry",Canceled,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,17,622732320517,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,12,622732320512,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,4,622732320604,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,7,622732320607,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,8,622732320608,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,9,622732320609,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,10,622732320610,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,11,622732320611,Whole Blood PAXgene RNA,Not Received,Frozen,Specimen not submitted,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,12,622732320612,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,2,622732320602,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,6,622732320606,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,3,622732320603,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,5,622732320605,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,23-Apr-2026,6227323206,17,622732320617,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,14,622732320614,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,23-Apr-2026,6227323206,18,622732320618,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,2,622732320702,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,16,622732320616,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,3,622732320703,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,1,622732320701,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,15,622732320615,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,13,622732320613,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,4,622732320704,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,5,622732320705,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,6,622732320706,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,7,622732320707,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,8,622732320708,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,9,622732320709,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,10,622732320710,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,11,622732320711,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,12,622732320712,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,13,622732320713,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,14,622732320714,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,16,622732320716,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,17,622732320717,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,1,622732320801,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,2,622732320802,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,3,622732320803,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,5,622732320805,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,4,622732320804,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,7,622732320807,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,8,622732320808,"Stool, unpreserved",Canceled,Frozen,,STOOL I-2,77242113UCO3001-1,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,10,622732320810,"Stool, unpreserved",Canceled,Frozen,,STOOL I-2,77242113UCO3001-3,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,15,622732320715,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,11,622732320811,"Stool, unpreserved",Canceled,Frozen,,STOOL I-2,77242113UCO3001-4,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,9,622732320809,"Stool, unpreserved",Canceled,Frozen,,STOOL I-2,77242113UCO3001-2,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,12,622732320812,"Stool, unpreserved",Canceled,Frozen,,STOOL I-2,77242113UCO3001-5,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,13,622732320813,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,14,622732320814,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,15,622732320815,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,16,622732320816,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,17,622732320817,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,6,622732320806,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,2,622732321002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,4,622732321004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,1,622732321001,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,3,622732321003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,6,622732321006,"Stool, unpreserved",Canceled,Frozen,,STOOL I-4,77242113UCO3001-1,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,5,622732321005,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,7,622732321007,"Stool, unpreserved",Canceled,Frozen,,STOOL I-4,77242113UCO3001-2,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,8,622732321008,"Stool, unpreserved",Canceled,Frozen,,STOOL I-4,77242113UCO3001-3,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,9,622732321009,"Stool, unpreserved",Canceled,Frozen,,STOOL I-4,77242113UCO3001-4,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,10,622732321010,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,12,622732321012,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,14,622732321014,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,11,622732321011,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,13,622732321013,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,15,622732321015,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,16,622732321016,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,17,622732321017,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,18,622732321018,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,19,622732321019,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,21,622732321021,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,20,622732321020,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,22,622732321022,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,1,622732321101,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,2,622732321102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,3,622732321103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,4,622732321104,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,1,622732321201,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,3,622732321203,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,4,622732321204,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,2,622732321202,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,,6227323213,1,622732321301,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,30-Apr-2026,6227323213,2,622732321302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,30-Apr-2026,6227323213,3,622732321303,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,,6227323213,4,622732321304,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,DNA,20-Feb-2026,20-Feb-2026,6227323217,1,622732321701,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,DNA,19-Mar-2026,19-Mar-2026,6227323219,1,622732321901,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,06-Feb-2026,6227323223,1,622732322301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,07-Feb-2026,6227323223,2,622732322302,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,07-Feb-2026,6227323223,3,622732322303,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:20,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,,6227323223,4,622732322304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,20-Mar-2026,6227323224,2,622732322402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,19-Mar-2026,6227323224,1,622732322401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,20-Mar-2026,6227323224,3,622732322403,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,,6227323224,4,622732322404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,2,622732323102,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,3,622732323103,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,4,622732323104,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323231,5,622732323105,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,6,622732323106,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,23-Apr-2026,6227323231,8,622732323108,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,7,622732323107,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,1,622732323101,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,9,622732323109,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,10,622732323110,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,12,622732323112,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,14,622732323114,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,13,622732323113,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,17,622732323117,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,18,622732323118,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,15,622732323115,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,16,622732323116,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,11,622732323111,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,19,622732323119,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,20,622732323120,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,22,622732323122,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,21,622732323121,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,25,622732323125,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,26,622732323126,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,24,622732323124,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,23,622732323123,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,27,622732323127,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,28,622732323128,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,29,622732323129,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,30,622732323130,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,3,622732323203,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,4,622732323204,"Serum, SST",Canceled,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,5,622732323205,"Serum, SST",Not Received,Ambient,,FSH,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,6,622732323206,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,7,622732323207,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,8,622732323208,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,1,622732323201,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,2,622732323202,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,10,622732323210,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,12,622732323212,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,14,622732323214,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,13,622732323213,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,11,622732323211,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,15,622732323215,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,9,622732323209,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,16,622732323216,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,17,622732323217,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,21,622732323221,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,23,622732323223,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,26,622732323226,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,20,622732323220,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,24,622732323224,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,22,622732323222,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,27,622732323227,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,25,622732323225,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,19,622732323219,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,28,622732323228,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,18,622732323218,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,29,622732323229,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,2,622732323302,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,4,622732323304,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,30,622732323230,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,3,622732323303,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,6,622732323306,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,7,622732323307,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,1,622732323301,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,5,622732323305,"Serum, SST",Not Received,Ambient,,FSH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,8,622732323308,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,9,622732323309,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,10,622732323310,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,13,622732323313,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,12,622732323312,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,16,622732323316,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,14,622732323314,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,15,622732323315,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,11,622732323311,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,17,622732323317,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,19,622732323319,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,24,622732323324,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,20,622732323320,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,23,622732323323,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,26,622732323326,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,25,622732323325,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,22,622732323322,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,27,622732323327,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,21,622732323321,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,18,622732323318,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,29,622732323329,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,30,622732323330,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,28,622732323328,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,2,622732323402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,3,622732323403,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,4,622732323404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,5,622732323405,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,1,622732323401,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,6,622732323406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,10,622732323410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,8,622732323408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,11,622732323411,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,7,622732323407,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,9,622732323409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,15,622732323415,"Serum, SST",Canceled,Ambient,,FSH,FROZEN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,14,622732323414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,13,622732323413,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,12,622732323412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,2,622732323602,"Plasma, QuantiFERON Nil",Canceled,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,1,622732323601,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,3,622732323603,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,4,622732323604,"Plasma, QuantiFERON TB1",Canceled,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,8,622732323608,"Plasma, QuantiFERON Mitoge",Canceled,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,5,622732323605,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,9,622732323609,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,7,622732323607,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,6,622732323606,"Plasma, QuantiFERON TB2",Canceled,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,11,622732323611,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,12,622732323612,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,10,622732323610,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,13,622732323613,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,14,622732323614,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,15,622732323615,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,2,622732323702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,4,622732323704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,1,622732323701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,3,622732323703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,7,622732323707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,8,622732323708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,5,622732323705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,6,622732323706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,11,622732323711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,12,622732323712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,9,622732323709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,13,622732323713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,10,622732323710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,15,622732323715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,14,622732323714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,17,622732323717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,18,622732323718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,16,622732323716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,1,622732323801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,2,622732323802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,4,622732323804,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,5,622732323805,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,7,622732323807,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,8,622732323808,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,6,622732323806,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,10,622732323810,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,11,622732323811,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,13,622732323813,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,12,622732323812,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,9,622732323809,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,16,622732323816,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,15,622732323815,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,14,622732323814,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,18,622732323818,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,17,622732323817,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,2,622732324002,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,1,622732324001,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,15,622732324015,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,13,622732324013,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,16,622732324016,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,14,622732324014,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,5,622732324005,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,4,622732324004,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,8,622732324008,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-1,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,9,622732324009,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,6,622732324006,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,3,622732324003,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,10,622732324010,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,7,622732324007,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,17,622732324017,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,12,622732324012,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,11,622732324011,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,3,622732323803,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,1,622732324201,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,2,622732324202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,3,622732324203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,4,622732324204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,5,622732324205,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,9,622732324209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,10,622732324210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,7,622732324207,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,8,622732324208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,11,622732324211,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,6,622732324206,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,13,622732324213,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,12,622732324212,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,15,622732324215,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,16,622732324216,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,17,622732324217,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,19,622732324219,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,14,622732324214,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,21,622732324221,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,18,622732324218,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,20,622732324220,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,22,622732324222,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,1,622732324301,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,3,622732324303,"Culture, Stool",Canceled,Ambient,,STOOL CULTURE,,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,,6227323244,1,622732324401,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:20,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,4,622732324304,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,2,622732324402,"Stool, unpreserved",Canceled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,07:20,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,18-Mar-2026,6227323243,2,622732324302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,3,622732324403,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:20,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,,6227323244,4,622732324404,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,07:20,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,12-Mar-2026,6227323245,3,622732324503,"Culture, Stool",Received,Ambient,Default Return Frozen,STOOL CULTURE,,,,,,09:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,4,622732324504,"Stool, ova & parasites(PVA)",Canceled,Ambient,,OVA & PARASITES 2,PVA,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,1,622732324501,"Stool, ova & parasites(form)",Canceled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,2,622732324502,"Stool, unpreserved",Canceled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,DNA,21-Mar-2026,21-Mar-2026,6227323251,1,622732325101,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,1,622732325201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,2,622732325202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,3,622732325203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,4,622732325204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,5,622732325205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,6,622732325206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,7,622732325207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,8,622732325208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,2,622732325302,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,1,622732325301,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,6,622732325306,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,5,622732325305,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,3,622732325303,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,8,622732325308,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,7,622732325307,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,2,622732325402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,1,622732325401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,,6227323254,4,622732325404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,4,622732325304,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,29-May-2026,BX12,30-May-2026,02-Jun-2026,6227323255,2,622732325502,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,29-May-2026,BX12,30-May-2026,30-May-2026,6227323255,1,622732325501,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,29-May-2026,BX12,30-May-2026,02-Jun-2026,6227323255,3,622732325503,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,3,622732325403,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,05:55,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,29-May-2026,BX12,30-May-2026,02-Jun-2026,6227323255,4,622732325504,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,BIOPSY PK,77242113UCO3001,,,,,00:00,07:00,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,1,622732325601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,2,622732325602,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,3,622732325603,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,,6227323256,4,622732325604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,7,622732326407,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,6,622732326406,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,12-Mar-2026,6227323264,1,622732326401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,12-Mar-2026,6227323264,2,622732326402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,9,622732326409,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,10,622732326410,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,3,622732326403,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,8,622732326408,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,11,622732326411,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,4,622732326404,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,13,622732326413,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,12,622732326412,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,15,622732326415,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,14,622732326414,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,17,622732326417,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,16,622732326416,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,18,622732326418,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,20,622732326420,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,5,622732326405,"Serum, SST",Not Received,Ambient,,FSH,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,22,622732326422,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,21,622732326421,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,23,622732326423,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,24,622732326424,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,25,622732326425,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,19,622732326419,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,26,622732326426,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,27,622732326427,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,28,622732326428,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,29,622732326429,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,30,622732326430,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,18-Mar-2026,6227323265,1,622732326501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,3,622732326503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,4,622732326504,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,18-Mar-2026,6227323265,2,622732326502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,5,622732326505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,8,622732326508,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,6,622732326506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,7,622732326507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,9,622732326509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,10,622732326510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,11,622732326511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,12,622732326512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,13,622732326513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,14,622732326514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,15,622732326515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,21,622732326521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,18,622732326518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,17,622732326517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,25,622732326525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,22,622732326522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,20,622732326520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,29,622732326529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,27,622732326527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,24,622732326524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,16,622732326516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,19,622732326519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,28,622732326528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,26,622732326526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,30,622732326530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,23,622732326523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,1,622732326601,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,3,622732326603,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,2,622732326602,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,5,622732326605,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,7,622732326607,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,6,622732326606,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,9,622732326609,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,10,622732326610,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,8,622732326608,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,4,622732326604,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,12,622732326612,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,13,622732326613,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,11,622732326611,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,14,622732326614,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,15,622732326615,"Serum, SST",Canceled,Ambient,,FSH,,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,1,622732326801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,2,622732326802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,3,622732326803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,4,622732326804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,5,622732326805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,6,622732326806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,7,622732326807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,12,622732326812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,13,622732326813,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,14,622732326814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,15,622732326815,"Serum, SST",Canceled,Ambient,,FSH,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,8,622732326808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,10,622732326810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,9,622732326809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,11,622732326811,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,3,622732327003,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,2,622732327002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,4,622732327004,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,5,622732327005,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,6,622732327006,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,1,622732327001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,8,622732327008,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,7,622732327007,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,10,622732327010,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,9,622732327009,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,11,622732327011,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,12,622732327012,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,13,622732327013,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,14,622732327014,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,15,622732327015,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,18,622732327018,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,17,622732327017,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,16,622732327016,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,1,622732327201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,2,622732327202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,12,622732327212,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,13,622732327213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,3,622732327203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,11,622732327211,"Stool, unpreserved",Canceled,Frozen,,STOOL I-2,77242113UCO3001-4,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,14,622732327214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,15,622732327215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,17,622732327217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,10,622732327210,"Stool, unpreserved",Canceled,Frozen,,STOOL I-2,77242113UCO3001-3,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,16,622732327216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,5,622732327205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,6,622732327206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,4,622732327204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,7,622732327207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,8,622732327208,"Stool, unpreserved",Canceled,Frozen,,STOOL I-2,77242113UCO3001-1,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,9,622732327209,"Stool, unpreserved",Canceled,Frozen,,STOOL I-2,77242113UCO3001-2,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,1,622732327401,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,2,622732327402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,3,622732327403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,5,622732327405,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,4,622732327404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,6,622732327406,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-1,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,7,622732327407,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,8,622732327408,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,9,622732327409,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,11,622732327411,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,10,622732327410,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,12,622732327412,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,20,622732327420,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,21,622732327421,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,13,622732327413,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,22,622732327422,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,15,622732327415,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,19,622732327419,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,16,622732327416,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,14,622732327414,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,17,622732327417,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,18,622732327418,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,,6227323276,1,622732327601,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,16:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,16-Jan-2026,6227323276,2,622732327602,"Stool, unpreserved",Canceled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,16:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,,6227323276,4,622732327604,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,16:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,16-Jan-2026,6227323276,3,622732327603,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,16:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,,6227323277,1,622732327701,"Stool, ova & parasites(form)",Canceled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,10:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,24-Jan-2026,6227323277,3,622732327703,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,10:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,24-Jan-2026,6227323277,2,622732327702,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,10:10,12:40,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,,6227323277,4,622732327704,"Stool, ova & parasites(PVA)",Canceled,Ambient,,OVA & PARASITES 2,PVA,,,,,10:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,DNA,10-Mar-2026,10-Mar-2026,6227323283,1,622732328301,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,19-Feb-2026,6227323286,1,622732328601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,10:20,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,21-Feb-2026,6227323286,3,622732328603,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,05:55,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,21-Feb-2026,6227323286,2,622732328602,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,05:55,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,,6227323286,4,622732328604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,12-Feb-2026,6227323287,1,622732328701,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,14-Feb-2026,6227323287,3,622732328703,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:45,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,,6227323287,4,622732328704,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,14-Feb-2026,6227323287,2,622732328702,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,05:55,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,2,622732329502,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,3,622732329503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,1,622732329501,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,6,622732329506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,5,622732329505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,7,622732329507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,8,622732329508,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,11,622732329511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,9,622732329509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,10,622732329510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,14-Mar-2026,6227323295,4,622732329504,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,08:40,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,12,622732329512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,13,622732329513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,14,622732329514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,16,622732329516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,15,622732329515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,17,622732329517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,19,622732329519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,18,622732329518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,20,622732329520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,23,622732329523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,22,622732329522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,21,622732329521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,25,622732329525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,26,622732329526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,27,622732329527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,24,622732329524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,29,622732329529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,30,622732329530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,28,622732329528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,2,622732329702,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,14-Mar-2026,6227323297,4,622732329704,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,07:45,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,6,622732329706,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,5,622732329705,"Serum, SST",Not Received,Ambient,,FSH,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,1,622732329701,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,3,622732329703,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,7,622732329707,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,8,622732329708,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,10,622732329710,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,9,622732329709,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,11,622732329711,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,12,622732329712,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,14,622732329714,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,13,622732329713,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,18,622732329718,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,16,622732329716,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,15,622732329715,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,20,622732329720,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,19,622732329719,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,17,622732329717,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,21,622732329721,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,23,622732329723,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,25,622732329725,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,27,622732329727,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,26,622732329726,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,28,622732329728,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,29,622732329729,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,30,622732329730,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,22,622732329722,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,24,622732329724,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,1,622732329901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,3,622732329903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,4,622732329904,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,5,622732329905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,2,622732329902,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,7,622732329907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,8,622732329908,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,9,622732329909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,6,622732329906,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,11,622732329911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,12,622732329912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,10,622732329910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,13,622732329913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,15,622732329915,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,14,622732329914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,1,622732330901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,2,622732330902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,4,622732330904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,3,622732330903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,28-May-2026,6227323320,1,622732332001,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,29-May-2026,6227323320,2,622732332002,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,29-May-2026,6227323320,3,622732332003,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,,6227323320,4,622732332004,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,1,622732333001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,2,622732333002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,3,622732333003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,5,622732333005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,4,622732333004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,7,622732333007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,8,622732333008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,9,622732333009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,6,622732333006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,10,622732333010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,11,622732333011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,13,622732333013,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,12,622732333012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,15,622732333015,"Serum, SST",Canceled,Ambient,,FSH,FROZEN,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,14,622732333014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,1,622732333201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,2,622732333202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,3,622732333203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,6,622732333206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,4,622732333204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,8,622732333208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,9,622732333209,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,5,622732333205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,10,622732333210,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,7,622732333207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,11,622732333211,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,12,622732333212,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,14,622732333214,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,13,622732333213,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,15,622732333215,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,1,622732333401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,4,622732333404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,2,622732333402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,5,622732333405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,3,622732333403,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,6,622732333406,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,7,622732333407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,8,622732333408,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,9,622732333409,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,10,622732333410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,11,622732333411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,12,622732333412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,13,622732333413,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,14,622732333414,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,15,622732333415,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,16,622732333416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,17,622732333417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,18,622732333418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,2,622732333502,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,3,622732333503,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,5,622732333505,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,1,622732333501,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,7,622732333507,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,6,622732333506,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,4,622732333504,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,8,622732333508,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,9,622732333509,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-2,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,11,622732333511,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-4,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,10,622732333510,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-3,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,13,622732333513,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,15,622732333515,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,16,622732333516,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,17,622732333517,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,14,622732333514,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,12,622732333512,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,2,622732334002,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,4,622732334004,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,3,622732334003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,1,622732334001,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,1,622732334101,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,2,622732334102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,3,622732334103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,4,622732334104,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,DNA,06-May-2026,06-May-2026,6227323346,1,622732334601,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,1,622732334801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,2,622732334802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,3,622732334803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,4,622732334804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,5,622732334805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,7,622732334807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,6,622732334806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,8,622732334808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,,6227323351,4,622732335104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,3,622732335103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,2,622732335102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,1,622732335101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,BDL,06-May-2026,,6227323355,1,622732335501,"Red Cells, Clot",Not Received,,,DRUG LEVEL TESTING,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,BDL,06-May-2026,06-May-2026,6227323355,2,622732335502,"Serum, SST",Shipped,Frozen,Default Return Frozen,"ADA, GOL, INF",UST OR VED FROZEN,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,1,622763513901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,3,622763513903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,8,622763513908,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,4,622763513904,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,2,622763513902,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,5,622763514005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,8,622763514008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,13,622763513913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,6,622763513906,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,6,622763514006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,7,622763514007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,9,622763514009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,10,622763513910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,15,622763513915,"Serum, SST",Canceled,Ambient,,FSH,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,12,622763513912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,9,622763513909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,7,622763513907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,4,622763514004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,11,622763513911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,2,622763514002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,3,622763514003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,1,622763514001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,5,622763513905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,14,622763513914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,12,622763514012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,14,622763514014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,1,622763514101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,15,622763514015,"Serum, SST",Canceled,Ambient,,FSH,FROZEN,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,2,622763514102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,11,622763514011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,10,622763514010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,3,622763514103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,13,622763514013,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,8,622763514108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,9,622763514109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,11,622763514111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,12,622763514112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,10,622763514110,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,13,622763514113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,7,622763514107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,6,622763514106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,3,622763514203,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,4,622763514204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,13,622763514213,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,5,622763514205,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,5,622763514105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,4,622763514104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,6,622763514206,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,14,622763514214,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,2,622763514202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,10,622763514210,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,1,622763514201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,15,622763514215,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,7,622763514207,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,9,622763514209,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,16,622763514216,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,17,622763514217,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,14,622763514114,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,15,622763514115,"Serum, SST",Canceled,Ambient,,FSH,FROZEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,12,622763514212,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,11,622763514211,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,8,622763514208,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,18,622763514218,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,7,622763514407,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,6,622763514406,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,3,622763514403,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,2,622763514402,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,1,622763514401,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,15,622763514415,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,16,622763514416,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,8,622763514408,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,10,622763514410,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-3,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,4,622763514404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,17,622763514417,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,12,622763514412,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,11,622763514411,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-4,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,14,622763514414,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,13,622763514413,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,5,622763514405,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,9,622763514409,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,2,622763514602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,3,622763514603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,8,622763514608,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,9,622763514609,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-4,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,10,622763514610,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,16,622763514616,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,14,622763514614,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,21,622763514621,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,4,622763514604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,5,622763514605,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,15,622763514615,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,18,622763514618,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,11,622763514611,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,13,622763514613,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,6,622763514606,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,22,622763514622,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,7,622763514607,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,19,622763514619,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,1,622763514601,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,17,622763514617,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,12,622763514612,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,20,622763514620,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,3,622763514803,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,4,622763514804,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,1,622763514801,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,2,622763515002,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,3,622763515003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,2,622763514902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,4,622763515004,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,2,622763514802,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,1,622763514901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,4,622763514904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,3,622763514903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,1,622763515001,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,DNA,26-Mar-2026,26-Mar-2026,6227635156,1,622763515601,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,DNA,03-Jun-2026,03-Jun-2026,6227635154,1,622763515401,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,DNA,27-May-2026,27-May-2026,6227635155,1,622763515501,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,,6227635159,4,622763515904,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,22-Apr-2026,6227635159,1,622763515901,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,23-Apr-2026,6227635159,2,622763515902,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,23-Apr-2026,6227635159,3,622763515903,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,14-Mar-2026,6227635161,3,622763516103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:20,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,,6227635161,4,622763516104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,13-Mar-2026,6227635161,1,622763516101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,14-Mar-2026,6227635161,2,622763516102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,1,622763517101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,2,622763517102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,5,622763517105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,7,622763517107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,3,622763517103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,6,622763517106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,4,622763517104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,10,622763517110,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,14,622763517114,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,15,622763517115,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,11,622763517111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,8,622763517108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,9,622763517109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,13,622763517113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,12,622763517112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,30-May-2026,6227635173,2,622763517302,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:35,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,30-May-2026,6227635173,6,622763517306,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:35,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,7,622763517307,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,30-May-2026,6227635173,8,622763517308,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:35,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,5,622763517305,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,10,622763517310,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,30-May-2026,6227635173,4,622763517304,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:35,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,9,622763517309,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,1,622763517301,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,3,622763517303,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,14,622763517314,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,13,622763517313,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,29-May-2026,6227635174,1,622763517401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,15,622763517315,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,30-May-2026,6227635174,3,622763517403,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,10:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,11,622763517311,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,29-May-2026,6227635174,2,622763517402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,12,622763517312,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,30-May-2026,6227635174,9,622763517409,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,,6227635174,5,622763517405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,30-May-2026,6227635174,11,622763517411,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,30-May-2026,6227635174,6,622763517406,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,,6227635174,12,622763517412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,30-May-2026,6227635174,4,622763517404,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,,6227635174,7,622763517407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,30-May-2026,6227635174,8,622763517408,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,30-May-2026,6227635174,13,622763517413,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,30-May-2026,6227635174,10,622763517410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,30-May-2026,6227635174,14,622763517414,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,29-May-2026,6227635174,18,622763517418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,,6227635174,17,622763517417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,30-May-2026,6227635174,15,622763517415,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,I-0,29-May-2026,30-May-2026,6227635174,16,622763517416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,,6227635180,1,622763518001,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,13:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,28-May-2026,6227635180,3,622763518003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,13:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,,6227635180,4,622763518004,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,13:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,30-May-2026,6227635180,2,622763518002,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,13:15,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,4,622763518204,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,25-Apr-2026,6227635182,3,622763518203,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,08:45,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,1,622763518201,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,2,622763518202,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,C-DIFF TOXIN,& PCR FROZEN,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,28-May-2026,DNA,30-May-2026,30-May-2026,6227635186,1,622763518601,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,10:45,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,21-May-2026,6227635193,2,622763519302,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,20-May-2026,6227635193,1,622763519301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,21-May-2026,6227635193,3,622763519303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,,6227635193,4,622763519304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,1,622763520401,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,2,622763520402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,3,622763520403,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,15,622763520415,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,9,622763520409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,10,622763520410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,11,622763520411,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,12,622763520412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,13,622763520413,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,5,622763520405,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,4,622763520404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,14,622763520414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,7,622763520407,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,6,622763520406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,8,622763520408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,2,622763520702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,8,622763520708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,5,622763520705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,4,622763520704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,9,622763520709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,1,622763520701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,11,622763520711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,3,622763520703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,6,622763520706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,17,622763520717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,18,622763520718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,2,622763520802,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,3,622763520803,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,13,622763520713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,1,622763520801,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,7,622763520707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,10,622763520710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,12,622763520712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,16,622763520716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,7,622763520807,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,9,622763520809,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,10,622763520810,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,11,622763520811,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,14,622763520714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,15,622763520715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,12,622763520812,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,4,622763520804,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,6,622763520806,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,8,622763520808,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,17,622763520817,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,14,622763520814,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,5,622763520805,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,13,622763520813,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,16,622763520816,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,15,622763520815,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,2,622763521102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,3,622763521103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,4,622763521104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,1,622763521101,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,8,622763521108,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,10,622763521110,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,6,622763521106,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,5,622763521105,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,11,622763521111,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,13,622763521113,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,14,622763521114,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,7,622763521107,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,19,622763521119,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,16,622763521116,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,20,622763521120,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,9,622763521109,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,21,622763521121,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,22,622763521122,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,17,622763521117,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,18,622763521118,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,12,622763521112,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,2,622763521302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,3,622763521303,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,4,622763521304,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,15,622763521115,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,1,622763521301,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,DNA,09-Apr-2026,09-Apr-2026,6227635218,1,622763521801,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,2,622763522302,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,1,622763522301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,3,622763522303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,,6227635223,4,622763522304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,2,622769771802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,3,622769771803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,5,622769771805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,1,622769771801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,6,622769771806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,4,622769771804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,7,622769771807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,11,622769771811,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,13,622769771813,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,10,622769771810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,14,622769771814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,15,622769771815,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,8,622769771808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,1,622769771901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,2,622769771902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,4,622769771904,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,5,622769771905,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,3,622769771903,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,8,622769771908,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,7,622769771907,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,6,622769771906,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,10,622769771910,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,9,622769771809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,11,622769771911,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,12,622769771812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,9,622769771909,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,12,622769771912,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,13,622769771913,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,14,622769771914,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,17,622769771917,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,15,622769771915,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,16,622769771916,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,18,622769771918,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,6,622769772206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,7,622769772207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,13,622769772213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,10,622769772210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,12,622769772212,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,11,622769772211,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,14,622769772214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,8,622769772208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-1,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,15,622769772215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,9,622769772209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,2,622769772202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,5,622769772205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,3,622769772203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,4,622769772204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,1,622769772201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,1,622769772301,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,4,622769772304,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,2,622769772302,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,3,622769772303,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,5,622769772305,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,7,622769772307,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,16,622769772216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,17,622769772217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,21,622769772321,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,6,622769772306,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-1,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,12,622769772312,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,13,622769772313,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,14,622769772314,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,9,622769772309,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,18,622769772318,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,16,622769772316,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,17,622769772317,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,8,622769772308,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,15,622769772315,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,19,622769772319,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,10,622769772310,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,20,622769772320,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,22,622769772322,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,11,622769772311,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,,6227697725,1,622769772501,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,17:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,19-Mar-2026,6227697725,3,622769772503,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,17:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,,6227697725,4,622769772504,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,17:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,19-Mar-2026,6227697725,2,622769772502,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,17:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,26-Mar-2026,6227697736,2,622769773602,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,DNA,08-Apr-2026,08-Apr-2026,6227697731,1,622769773101,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,24-Mar-2026,6227697736,1,622769773601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,,6227697736,4,622769773604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,26-Mar-2026,6227697736,3,622769773603,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,5,622769774505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,1,622769774501,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,6,622769774506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,4,622769774504,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,08-May-2026,6227697745,8,622769774508,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,3,622769774503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,2,622769774502,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,7,622769774507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,9,622769774509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,14,622769774514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,16,622769774516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,18,622769774518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,17,622769774517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,13,622769774513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,12,622769774512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,11,622769774511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,15,622769774515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,19,622769774519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,10,622769774510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,30,622769774530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,20,622769774520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,22,622769774522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,25,622769774525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,23,622769774523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,26,622769774526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,21,622769774521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,29,622769774529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,27,622769774527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,24,622769774524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,28,622769774528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,1,622781089901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,3,622781089903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,2,622781089902,"Plasma, QuantiFERON Nil",Canceled,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,4,622781089904,"Plasma, QuantiFERON TB1",Canceled,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,5,622781089905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,6,622781089906,"Plasma, QuantiFERON TB2",Canceled,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,10,622781089910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,11,622781089911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,12,622781089912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,13,622781089913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,14,622781089914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,15,622781089915,"Serum, SST",Canceled,Ambient,,FSH,,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,8,622781089908,"Plasma, QuantiFERON Mitoge",Canceled,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,9,622781089909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,2,622781090002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,4,622781090004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,6,622781090006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,7,622781090007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,8,622781090008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,9,622781090009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,10,622781090010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,3,622781090003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,5,622781090005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,12,622781090012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,14,622781090014,"Serum, SST",Canceled,Ambient,,CHEM PANEL &,BETA HCG,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,13,622781090013,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,15,622781090015,"Serum, SST",Canceled,Ambient,,FSH,FROZEN,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,1,622781090101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,2,622781090102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,3,622781090103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,4,622781090104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,1,622781090001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,6,622781090106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,7,622781090107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,8,622781090108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,04-Mar-2026,6227810901,9,622781090109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,10,622781090110,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,11,622781090111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,04-Mar-2026,6227810901,12,622781090112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,14,622781090114,"Serum, SST",Canceled,Ambient,,CHEM PANEL &,BETA HCG,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,13,622781090113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,7,622781089907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,11,622781090011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,5,622781090105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,15,622781090115,"Serum, SST",Canceled,Ambient,,FSH,,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227810904,2,622781090402,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227810904,3,622781090403,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,,6227810904,4,622781090404,"Stool, ova & parasites(PVA)",Canceled,Ambient,,OVA & PARASITES 2,PVA,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,,6227810905,1,622781090501,"Stool, ova & parasites(form)",Canceled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,04-Mar-2026,6227810905,2,622781090502,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,04-Mar-2026,6227810905,3,622781090503,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,,6227810905,4,622781090504,"Stool, ova & parasites(PVA)",Canceled,Ambient,,OVA & PARASITES 2,PVA,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,,6227810904,1,622781090401,"Stool, ova & parasites(form)",Canceled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,06-Feb-2026,6227323223,5,622732322305,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,13:01,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,3,622793314203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,5,622793314205,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,2,622793314202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,4,622793314204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,6,622793314206,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,1,622793314201,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,7,622793314207,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,10,622793314210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,12,622793314212,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,9,622793314209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,11,622793314211,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,8,622793314208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,14,622793314214,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,17,622793314217,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,13,622793314213,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,18,622793314218,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,1,622793314301,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,15,622793314215,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,19,622793314219,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,2,622793314302,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,21,622793314221,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,22,622793314222,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,20,622793314220,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,16,622793314216,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,4,622793314304,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,8,622793314308,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,7,622793314307,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,3,622793314303,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,20,622793314320,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,6,622793314306,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,9,622793314309,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-5,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,11,622793314311,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-12TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,19,622793314319,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,17,622793314317,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,22,622793314322,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,EXPEDITED FRZN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,10,622793314310,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,16,622793314316,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-12 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,23,622793314323,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,18,622793314318,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,12,622793314312,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,15,622793314315,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-12 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,14,622793314314,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,13,622793314313,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMAPK I-12 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,5,622793314305,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-12,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,21,622793314321,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,12-Feb-2026,6227323287,5,622732328705,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,12:52,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,2,622799396202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,15,622799396215,"Serum, SST",Canceled,Ambient,,FSH,FROZEN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,4,622799396204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,1,622799396201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,10,622799396210,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,14,622799396214,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,3,622799396203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,8,622799396208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,12,622799396212,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,11,622799396211,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,7,622799396207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,9,622799396209,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,5,622799396205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,6,622799396206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,13,622799396213,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,14,622799396614,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,17,622799396617,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,2,622799396602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,3,622799396603,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,12,622799396612,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,1,622799396601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,13,622799396613,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,7,622799396607,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,15,622799396615,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,8,622799396608,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,4,622799396604,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,10,622799396610,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,11,622799396611,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,6,622799396606,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,5,622799396605,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,16,622799396616,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,18,622799396618,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,9,622799396609,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,02-Jun-2026,6227993968,8,622799396808,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,08:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,,6227993968,1,622799396801,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,02-Jun-2026,6227993968,13,622799396813,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,02-Jun-2026,6227993968,2,622799396802,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,08:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,,6227993968,10,622799396810,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,08:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,02-Jun-2026,6227993968,4,622799396804,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,08:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,02-Jun-2026,6227993968,14,622799396814,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,,6227993968,12,622799396812,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,08:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,,6227993968,5,622799396805,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,02-Jun-2026,6227993968,7,622799396807,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,08:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,,6227993968,11,622799396811,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,08:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,,6227993968,3,622799396803,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,,6227993968,9,622799396809,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,08:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,02-Jun-2026,6227993968,17,622799396817,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,,6227993968,16,622799396816,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,02-Jun-2026,6227993968,6,622799396806,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,08:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,01-Jun-2026,I-2,02-Jun-2026,02-Jun-2026,6227993968,15,622799396815,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,,6227993971,4,622799397104,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,06:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,14-Apr-2026,6227993971,3,622799397103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,,6227993971,1,622799397101,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,06:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,14-Apr-2026,6227993971,2,622799397102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,DNA,20-May-2026,20-May-2026,6227993977,1,622799397701,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,16-Apr-2026,6227993984,1,622799398401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,17-Apr-2026,6227993984,3,622799398403,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,,6227993984,4,622799398404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,17-Apr-2026,6227993984,2,622799398402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,BDL,20-May-2026,20-May-2026,6227993987,2,622799398702,"Serum, SST",Shipped,Frozen,Default Return Frozen,"ADA, GOL, INF",UST OR VED FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,BDL,20-May-2026,,6227993987,1,622799398701,"Red Cells, Clot",Not Received,,,DRUG LEVEL TESTING,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,5,622732324405,,Canceled,,,,,,,,,07:20,12:28,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,6,622732324406,,Canceled,,,,,,,,,07:20,12:28,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,19-Feb-2026,6227323286,5,622732328605,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,15:49,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,04-Apr-2026,6228023951,2,622802395102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,02-Apr-2026,6228023951,1,622802395101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,04-Apr-2026,6228023951,3,622802395103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,,6228023951,4,622802395104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,5,622732325405,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,14:49,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,3,622803655303,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,5,622803655305,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,7,622803655307,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,8,622803655308,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,4,622803655304,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,1,622803655301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,6,622803655306,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,2,622803655302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,12,622803655312,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,13,622803655313,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,15,622803655315,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,11,622803655311,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,17,622803655317,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,18,622803655318,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,14,622803655314,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,9,622803655309,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,16,622803655316,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,4,622803655404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,5,622803655405,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,1,622803655401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,6,622803655406,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,7,622803655407,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,9,622803655409,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,10,622803655410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,8,622803655408,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,10,622803655310,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,3,622803655403,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,11,622803655411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,2,622803655402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,12,622803655412,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,13,622803655413,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,14,622803655414,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,15,622803655415,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,16,622803655416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,17,622803655417,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,18,622803655418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,30-May-2026,6228114608,1,622811460801,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,07:30,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,30-May-2026,6228114608,7,622811460807,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:30,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,30-May-2026,6228114608,3,622811460803,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,07:30,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,30-May-2026,6228114608,6,622811460806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:30,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,30-May-2026,6228114608,8,622811460808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:30,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,29-May-2026,6228114608,9,622811460809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,30-May-2026,6228114608,4,622811460804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:30,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,30-May-2026,6228114608,5,622811460805,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:30,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,29-May-2026,6228114608,11,622811460811,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,29-May-2026,6228114608,10,622811460810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,30-May-2026,6228114608,2,622811460802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:30,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,29-May-2026,6228114608,12,622811460812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,29-May-2026,6228114608,14,622811460814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,,6228114608,15,622811460815,"Serum, SST",Canceled,Ambient,,FSH,FROZEN,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,28-May-2026,SCRN,29-May-2026,29-May-2026,6228114608,13,622811460813,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,BETA HCG,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,1,622811461001,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,2,622811461002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,5,622811461005,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,3,622811461003,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,6,622811461006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,4,622811461004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,10,622811461010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,11,622811461011,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,9,622811461009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,7,622811461007,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,12,622811461012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,13,622811461013,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,BETA HCG,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,14,622811461014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,8,622811461008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,,6228114610,15,622811461015,"Serum, SST",Canceled,Ambient,,FSH,FROZEN,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,02-Jun-2026,6228137355,11,622813735511,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-12TROUGH,77242113UCO3001,,,,,14:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,,6228137355,12,622813735512,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,14:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,02-Jun-2026,6228137355,16,622813735516,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-12 PRE,77242113UCO3001-2,,,,,14:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,,6228137355,8,622813735508,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-4,,,,,14:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,,6228137355,9,622813735509,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-5,,,,,14:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,,6228137355,14,622813735514,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,14:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,,6228137355,7,622813735507,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-3,,,,,14:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,,6228137355,10,622813735510,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,14:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,02-Jun-2026,6228137355,15,622813735515,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-12 PRE,77242113UCO3001-1,,,,,14:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,,6228137355,17,622813735517,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,14:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,02-Jun-2026,6228137355,13,622813735513,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMAPK I-12 PEAK,77242113UCO3001,,,,,14:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,,6228137355,6,622813735506,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-2,,,,,14:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,02-Jun-2026,6228137355,21,622813735521,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,14:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,02-Jun-2026,6228137355,20,622813735520,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,14:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,02-Jun-2026,6228137355,22,622813735522,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,EXPEDITED FRZN,,,,,14:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,02-Jun-2026,6228137355,18,622813735518,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,14:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,02-Jun-2026,6228137355,23,622813735523,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,14:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,02-Jun-2026,6228137355,19,622813735519,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,14:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,02-Jun-2026,SCRNSTOOL,04-Jun-2026,,6228137357,1,622813735701,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,18:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,02-Jun-2026,SCRNSTOOL,04-Jun-2026,,6228137357,4,622813735704,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,18:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,02-Jun-2026,SCRNSTOOL,04-Jun-2026,04-Jun-2026,6228137357,3,622813735703,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,18:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,02-Jun-2026,6228137355,2,622813735502,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,14:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,02-Jun-2026,6228137355,3,622813735503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,14:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,02-Jun-2026,6228137355,5,622813735505,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,STOOL I-12,77242113UCO3001,,,,,14:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,02-Jun-2026,6228137355,4,622813735504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,14:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,3,622813735903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012004,02-Jun-2026,SCRNSTOOL,04-Jun-2026,04-Jun-2026,6228137357,2,622813735702,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,18:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,1,622813735901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,4,622813735904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,01-Jun-2026,I-12,02-Jun-2026,,6228137355,1,622813735501,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,14:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,2,622813735902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,1,622817339701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,4,622817339704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,3,622817339703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,2,622817339702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,6,622817339706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,8,622817339708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,5,622817339705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,7,622817339707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,12,622817339712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,16,622817339716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,18,622817339718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,17,622817339717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,9,622817339709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,14,622817339714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,11,622817339711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,10,622817339710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,15,622817339715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,13,622817339713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,14,622817993214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,9,622817993209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,15,622817993215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,16,622817993216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,12,622817993212,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,13,622817993213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,17,622817993217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,10,622817993210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,11,622817993211,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,1,622817993201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,3,622817993203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,4,622817993204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,7,622817993207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,2,622817993202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,8,622817993208,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,1,622817993601,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,2,622817993602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,6,622817993606,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,4,622817993604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,10,622817993610,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,5,622817993605,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,14,622817993614,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,11,622817993611,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,12,622817993612,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,13,622817993613,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,16,622817993616,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,15,622817993615,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,9,622817993609,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,19,622817993619,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,18,622817993618,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,3,622817993603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,17,622817993617,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,6,622817993206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,5,622817993205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,20,622817993620,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,21,622817993621,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,8,622817993608,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,7,622817993607,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,22,622817993622,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,DNA,10-Apr-2026,10-Apr-2026,6228179942,1,622817994201,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,3,622817994503,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,4,622817994504,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,BIOPSY PK,77242113UCO3001,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,21-May-2026,6228179945,1,622817994501,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,2,622817994502,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,,6228194341,1,622819434101,"Stool, ova & parasites(form)",Canceled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,,6228194341,4,622819434104,"Stool, ova & parasites(PVA)",Canceled,Ambient,,OVA & PARASITES 2,PVA,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6228194341,3,622819434103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6228194341,2,622819434102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,13-Mar-2026,6227635161,5,622763516105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:58,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,5,622763522305,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,13:49,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,31,622732323331,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,19-Mar-2026,6227323224,5,622732322405,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:46,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,3,622825207203,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,07-May-2026,6228252072,1,622825207201,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,08:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,,6228252073,4,622825207304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,15-May-2026,6228252073,2,622825207302,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,4,622825207204,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,BIOPSY PK,77242113UCO3001,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,2,622825207202,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,15-May-2026,6228252073,3,622825207303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,14-May-2026,6228252073,1,622825207301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,24-Mar-2026,6227697736,5,622769773605,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:15,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,1,622830822401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,2,622830822402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,5,622830822405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,6,622830822406,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,7,622830822407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,9,622830822409,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,10,622830822410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,8,622830822408,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,11,622830822411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,13,622830822413,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,3,622830822403,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,4,622830822404,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,14,622830822414,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,16,622830822416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,15,622830822415,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,12,622830822412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,17,622830822417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,03-Jun-2026,6228308225,1,622830822501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,03-Jun-2026,6228308225,2,622830822502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,03-Jun-2026,6228308225,6,622830822506,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,,6228308225,3,622830822503,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,18,622830822418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,03-Jun-2026,6228308225,8,622830822508,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,,6228308225,5,622830822505,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,03-Jun-2026,6228308225,11,622830822511,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,03-Jun-2026,6228308225,9,622830822509,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,03-Jun-2026,6228308225,10,622830822510,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,,6228308225,7,622830822507,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,03-Jun-2026,6228308225,15,622830822515,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,03-Jun-2026,6228308225,16,622830822516,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,03-Jun-2026,6228308225,13,622830822513,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,,6228308225,12,622830822512,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,03-Jun-2026,6228308225,4,622830822504,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,,6228308225,17,622830822517,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,03-Jun-2026,6228308225,14,622830822514,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,02-Jun-2026,I-0,03-Jun-2026,03-Jun-2026,6228308225,18,622830822518,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,02-Apr-2026,6228023951,5,622802395105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:31,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,3,622839811503,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,2,622839811502,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,4,622839811504,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,6,622839811506,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,5,622839811505,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,7,622839811507,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,8,622839811508,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,10,622839811510,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,9,622839811509,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,11,622839811511,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,12,622839811512,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,13,622839811513,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,14,622839811514,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,1,622839811501,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,17,622839811517,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,15,622839811515,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,16,622839811516,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,19,622817339719,,Canceled,,,,,,,,,10:35,13:56,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,16-Apr-2026,6227993984,5,622799398405,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:04,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,22-Apr-2026,6227635159,5,622763515905,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:18,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,26-May-2026,6228501732,1,622850173201,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,28-May-2026,6228501732,2,622850173202,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,,6228501732,4,622850173204,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,28-May-2026,6228501732,3,622850173203,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,5,622732335105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,14:22,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,1,622861056401,"Stool, ova & parasites(form)",Not Received,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,3,622861056403,"Culture, Stool",Canceled,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,4,622861056404,"Stool, ova & parasites(PVA)",Not Received,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,07-May-2026,6228610564,2,622861056402,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,07-May-2026,6228252072,5,622825207205,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:52,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,08-May-2026,6227697745,31,622769774531,,In Inventory,,Default Return Frozen,,,,,,,,16:05,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,14-May-2026,6228252073,5,622825207305,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,12:51,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,5,622732325605,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,13:06,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,20-May-2026,6227635193,5,622763519305,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:34,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,21-May-2026,6228179945,5,622817994505,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,14:59,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,26-May-2026,6228501732,5,622850173205,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,13:03,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,28-May-2026,6227323320,5,622732332005,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,14:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,29-May-2026,BX12,30-May-2026,30-May-2026,6227323255,5,622732325505,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,15:53,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Biopsy,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-28_093416 sponsor-study-36940-activity-reports-documents-equery.csv b/Covance_UCO3001/Source/tmp/2026-05-28_093416 sponsor-study-36940-activity-reports-documents-equery.csv new file mode 100644 index 0000000..2c896c5 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-28_093416 sponsor-study-36940-activity-reports-documents-equery.csv @@ -0,0 +1,75 @@ +Site,Country,Visit,Visit Collection Date,Accession,Subject,eQueryId,Create Date,Response Date Time,Issue Type,Status,Time Before Response,User Name,Email,Study Role +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Unscheduled,"Mar 13, 2026 8:40 AM",6227323295,CZ100222004,2047932,"Mar 17, 2026 3:49 PM","Mar 17, 2026 9:07 PM",VST,Closed,5h 17m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Unscheduled,"Mar 13, 2026 7:45 AM",6227323297,CZ100222005,2047949,"Mar 17, 2026 3:56 PM","Mar 17, 2026 9:09 PM",VST,Closed,5h 12m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 0,"Mar 9, 2026 8:50 AM",6227323270,CZ100222003,2038559,"Mar 11, 2026 4:39 PM","Mar 11, 2026 8:32 PM","AGE, ADT201, AMT58660, AMT3542",Closed,3h 53m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 2,"Mar 27, 2026 7:10 AM",6227323272,CZ100222003,2073305,"Apr 1, 2026 7:54 PM","Apr 2, 2026 7:37 AM",AMT58660,Closed,11h 43m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 4,"Apr 8, 2026 8:05 AM",6227323274,CZ100222003,2086982,"Apr 10, 2026 1:00 PM","Apr 10, 2026 1:06 PM",AMT58660,Closed,5m,Katerina Havlikova,katerina.havlikova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 4, 2026 9:20 AM",6227810900,CZ100222005,2031896,"Mar 6, 2026 6:45 PM","Mar 6, 2026 7:25 PM","AMT58660, AMT3542",Closed,40m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 2, 2026 11:00 AM",6227810899,CZ100222003,2029805,"Mar 5, 2026 6:36 PM","Mar 6, 2026 9:01 AM","AMT58660, AMT3542",Closed,14h 24m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 3, 2026 12:10 PM",6227810901,CZ100222004,2029774,"Mar 5, 2026 6:23 PM","Mar 6, 2026 7:24 PM","AMT58660, AMT3542",Closed,1d,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 0,"Apr 9, 2026 10:35 AM",6228173397,CZ100222005,2089669,"Apr 13, 2026 2:06 PM","Apr 23, 2026 12:53 PM",PCFCOM,Closed,9d,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 0,"Apr 7, 2026 10:37 AM",6227635207,CZ100212001,2085089,"Apr 9, 2026 2:54 PM","Apr 15, 2026 7:20 AM","AMT58660, AMT15602",Closed,5d,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Screening,"Feb 25, 2026 12:15 PM",6227635204,CZ100212001,2019716,"Feb 27, 2026 12:09 PM","Mar 3, 2026 11:11 AM","AMT58660, AMT3542",Closed,3d,Zdenka Dvorakova,dvorakova.zdenka@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 2,"Apr 20, 2026 8:43 AM",6227635208,CZ100212001,2106304,"Apr 22, 2026 7:04 PM","Apr 23, 2026 9:21 AM",AMT58660,Closed,14h 16m,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 4,"May 5, 2026 10:00 AM",6227635211,CZ100212001,2133221,"May 9, 2026 6:24 PM","May 11, 2026 2:34 PM",AMT58660,Closed,1d,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10020 - Dr.Lucie Gonsorcikova,CZECH REPUBLIC,Screening,"Apr 13, 2026 12:20 PM",6227993962,CZ100201001,2094721,"Apr 15, 2026 6:02 PM","Apr 21, 2026 12:47 PM","AMT58660, AMT3542",Closed,5d,Zuzana Zahradnikova,zuzana.zahradnikova@ftn.cz,Investigator +CZ10020 - Dr.Lucie Gonsorcikova,CZECH REPUBLIC,Induction Week 0,"May 18, 2026 9:28 AM",6227993966,CZ100201001,2156061,"May 22, 2026 9:37 PM","May 25, 2026 6:43 AM","ADT201, AMT58660, AMT3542",Closed,2d,Zuzana Zahradnikova,zuzana.zahradnikova@ftn.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Mar 31, 2026 8:30 AM",6227323330,CZ100092001,2075611,"Apr 2, 2026 5:37 PM",,AMT58660,Closed,,,, +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Mar 31, 2026 8:30 AM",6227323330,CZ100092001,2085558,"Apr 9, 2026 5:08 PM","Apr 10, 2026 2:06 PM",AMT58660,Closed,20h 58m,Jiri Pumprla,research@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Apr 16, 2026 12:00 PM",6227323332,CZ100092002,2101792,"Apr 20, 2026 6:19 PM","Apr 23, 2026 1:22 PM",AMT58660,Closed,2d,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Induction Week 0,"May 5, 2026 11:30 AM",6227323334,CZ100092001,2133224,"May 9, 2026 6:30 PM","May 13, 2026 10:10 AM","AMT58660, ADT809",Closed,3d,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Induction Week 2,"May 19, 2026 10:50 AM",6227323335,CZ100092001,2158952,"May 26, 2026 12:21 PM","May 27, 2026 9:03 AM",AMT58660,Closed,20h 42m,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10016 - Dr.Robert Mudr,CZECH REPUBLIC,Screening,"Apr 21, 2026 10:45 AM",6227635171,CZ100162001,2109874,"Apr 24, 2026 2:00 PM",,AMT58660,Closed,,,, +CZ10016 - Dr.Robert Mudr,CZECH REPUBLIC,Screening,"Apr 21, 2026 10:45 AM",6227635171,CZ100162001,2123465,"May 4, 2026 7:16 PM","May 5, 2026 10:04 AM",AMT58660,Closed,14h 48m,Petr Pekny,petr.pekny@nmskb.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 0,"Mar 24, 2026 9:40 AM",6227635142,CZ100132001,2064220,"Mar 26, 2026 9:37 PM",,"AMT58660, AMT3542",Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 0,"Mar 24, 2026 9:40 AM",6227635142,CZ100132001,2066330,"Mar 27, 2026 6:43 PM","Mar 30, 2026 10:41 PM",AMT58660,Closed,3d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 2,"Apr 7, 2026 8:50 AM",6227635144,CZ100132001,2087084,"Apr 10, 2026 1:27 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 2,"Apr 7, 2026 8:50 AM",6227635144,CZ100132001,2100086,"Apr 18, 2026 11:15 AM","Apr 22, 2026 7:51 PM",AMT58660,Closed,4d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 4,"Apr 21, 2026 8:45 AM",6227635146,CZ100132001,2108501,"Apr 23, 2026 6:55 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 4,"Apr 21, 2026 8:45 AM",6227635146,CZ100132001,2123492,"May 4, 2026 7:24 PM","May 5, 2026 3:30 PM",AMT58660,Closed,20h 6m,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2101883,"Apr 20, 2026 6:49 PM","Apr 22, 2026 7:51 PM",AMT58660,Closed,2d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2090916,"Apr 13, 2026 9:15 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2079289,"Apr 6, 2026 3:21 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Feb 26, 2026 1:20 PM",6227635140,CZ100132001,2033901,"Mar 9, 2026 3:53 PM","Mar 16, 2026 10:08 PM","SCD, AMT58660, AMT3542",Closed,7d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Feb 26, 2026 1:20 PM",6227635140,CZ100132001,2023257,"Mar 2, 2026 6:47 PM",,"SCD, AGE, AMT58660, AMT3542",Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"May 6, 2026 10:45 AM",6227635141,CZ100132003,2137874,"May 12, 2026 8:03 PM","May 19, 2026 7:48 AM",AMT58660,Closed,6d,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Biopsy,"Apr 21, 2026 12:00 AM",6227635159,CZ100132002,2109534,"Apr 24, 2026 12:45 PM",,ADT8471,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Biopsy,"Apr 21, 2026 12:00 AM",6227635159,CZ100132002,2123486,"May 4, 2026 7:23 PM","May 5, 2026 3:30 PM",ADT8471,Closed,20h 7m,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Unscheduled,,6227697745,,2140058,"May 13, 2026 7:02 PM","May 26, 2026 9:46 AM",PCFCOM,Response Received,12d,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Screening,"Mar 18, 2026 9:18 AM",6227697718,CZ100122001,2053959,"Mar 20, 2026 2:52 PM","Mar 23, 2026 12:00 PM","SCT, AMT58660",Closed,2d,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 0,"Apr 7, 2026 11:45 AM",6227697719,CZ100122001,2085069,"Apr 9, 2026 2:48 PM","Apr 9, 2026 6:28 PM",AMT58660,Closed,3h 39m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 2,"Apr 22, 2026 9:25 AM",6227697722,CZ100122001,2113315,"Apr 27, 2026 6:35 PM","Apr 27, 2026 8:50 PM",AMT58660,Closed,2h 14m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 4,"May 7, 2026 12:40 PM",6227697723,CZ100122001,2142322,"May 14, 2026 7:10 PM","May 14, 2026 7:42 PM",AMT58660,Closed,31m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Biopsy,"Mar 23, 2026 12:00 AM",6227697736,CZ100122001,2060524,"Mar 25, 2026 12:53 PM","Mar 25, 2026 2:09 PM",AMT23260,Closed,1h 15m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Unscheduled,"Mar 17, 2026 8:00 AM",6227323265,CZ100062001,2052144,"Mar 19, 2026 4:08 PM","Mar 24, 2026 9:29 AM","PSX, SCT, AGE",Closed,4d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Screening,"Apr 20, 2026 7:45 AM",6227323234,CZ100062002,2106334,"Apr 22, 2026 7:18 PM","Apr 22, 2026 7:36 PM",AMT58660,Closed,18m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 0,"Mar 20, 2026 8:00 AM",6227323237,CZ100062001,2064023,"Mar 26, 2026 7:00 PM","Mar 27, 2026 9:04 AM",PCFCOM,Closed,14h 3m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 0,"Mar 20, 2026 8:00 AM",6227323237,CZ100062001,2061456,"Mar 25, 2026 6:16 PM","Mar 26, 2026 8:38 AM",AMT58660,Closed,14h 22m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 2,"Apr 8, 2026 7:10 AM",6227323240,CZ100062001,2086807,"Apr 10, 2026 12:21 PM","Apr 18, 2026 10:40 PM","AMT58660, ADT809",Closed,8d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 4,"Apr 15, 2026 8:45 AM",6227323242,CZ100062001,2102704,"Apr 21, 2026 11:22 AM","Apr 22, 2026 7:36 PM",AMT58660,Closed,1d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Biopsy,"Feb 19, 2026 12:00 AM",6227323254,CZ100062001,2014333,"Feb 24, 2026 4:13 PM","Feb 24, 2026 8:20 PM",VST,Closed,4h 6m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Screening,"Mar 2, 2026 7:00 AM",6227323204,CZ100012002,2032628,"Mar 9, 2026 10:33 AM","Mar 9, 2026 11:58 AM",AMT58660,Closed,1h 24m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Screening,"Mar 2, 2026 7:00 AM",6227323204,CZ100012002,2026645,"Mar 4, 2026 12:58 PM","Mar 6, 2026 6:01 PM","AMT58660, AMT3542",Closed,2d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 0,,6227323206,,2112374,"Apr 27, 2026 2:17 PM","May 5, 2026 11:24 AM","PCFCOM, ADT201, AMT58660, AMT3542",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 2,"Apr 23, 2026 7:40 AM",6227323207,CZ100012002,2113312,"Apr 27, 2026 6:35 PM","Apr 28, 2026 9:06 PM",AMT58660,Closed,1d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 2,"Mar 4, 2026 7:00 AM",6227323208,CZ100012001,2030545,"Mar 6, 2026 11:02 AM","Mar 6, 2026 11:42 AM","AMT58660, AMT688",Closed,39m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 4,"Mar 18, 2026 7:05 AM",6227323210,CZ100012001,2053955,"Mar 20, 2026 2:50 PM","Mar 25, 2026 3:29 PM","SCD, AMT58660",Closed,5d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Stool Pathogens,"Jan 28, 2026 6:00 AM",6227323211,CZ100012001,1976585,"Jan 30, 2026 1:21 PM","Feb 6, 2026 2:37 PM","VST, AGE",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Stool Pathogens,"Jan 28, 2026 6:00 AM",6227323211,CZ100012001,1991148,"Feb 9, 2026 7:43 PM","Feb 13, 2026 8:04 AM",AGE,Closed,3d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Biopsy,"Feb 5, 2026 12:00 AM",6227323223,CZ100012001,1989998,"Feb 9, 2026 1:42 PM","Feb 10, 2026 6:46 PM",VST,Closed,1d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,,6227323231,,2053405,"Mar 20, 2026 12:14 PM","Mar 30, 2026 12:54 AM",PCFCOM,Closed,9d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2141856,"May 14, 2026 4:23 PM","May 19, 2026 12:54 PM","SCD, AGE",Closed,4d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2152157,"May 21, 2026 11:32 AM","May 26, 2026 8:15 AM",AGE,Closed,4d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2112413,"Apr 27, 2026 2:24 PM","May 5, 2026 11:25 AM","PSX, SCT, VST, AGE, ADT201",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2126904,"May 6, 2026 12:02 PM","May 12, 2026 4:58 PM","SCT, VST, AGE",Closed,6d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,,6227323233,,2053482,"Mar 20, 2026 12:40 PM","Mar 27, 2026 9:58 AM",PCFCOM,Closed,6d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 0,"Apr 8, 2026 7:10 AM",6228036554,CZ100012002,2089973,"Apr 13, 2026 3:26 PM","Apr 21, 2026 1:32 PM",AMT15602,Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Biopsy,"May 13, 2026 12:00 AM",6228252073,CZ100012003,2147778,"May 19, 2026 10:13 AM","May 21, 2026 4:38 PM",VST,Closed,2d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 4,"May 6, 2026 8:05 AM",6227933142,CZ100012002,2134478,"May 11, 2026 2:54 PM","May 11, 2026 3:11 PM","AMT58660, AMT3542",Closed,16m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 12,"May 13, 2026 8:05 AM",6227933143,CZ100012001,2147202,"May 18, 2026 7:51 PM","May 19, 2026 8:38 AM",AMT58660,Closed,12h 47m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10003 - Dr. Leksa Vaclav,CZECH REPUBLIC,Screening,"May 13, 2026 8:15 AM",6227323299,CZ100032001,2154732,"May 22, 2026 12:36 PM","May 25, 2026 8:57 AM",AMT58660,Closed,2d,Leksa Vaclav,vaclav.leksa@seznam.cz,Investigator +title,value,,,,,,,,,,,,, +Search,,,,,,,,,,,,,, +Site,"930551, 930556, 930525, 930549, 930543, 930547, 930555, 930557, 930539, 930536, 930553, 930531",,,,,,,,,,,,, +Unresponded Only?,FALSE,,,,,,,,,,,,, +Posted,From - To - ,,,,,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-28_093416 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv b/Covance_UCO3001/Source/tmp/2026-05-28_093416 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv new file mode 100644 index 0000000..652a478 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-28_093416 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv @@ -0,0 +1,9 @@ +Site,Country,Visit,Visit Collection Date,Accession,Subject,eQueryId,Create Date,Response Date Time,Issue Type,Status,Time Before Response,User Name,Email,Study Role +,,,,,,,,,,,,,, +,,,,,,,,,,,,,, +,,,,,,,,,,,,,, +title,value,,,,,,,,,,,,, +Search,,,,,,,,,,,,,, +Site,"930551, 930556, 930525, 930549, 930543, 930547, 930555, 930557, 930539, 930536, 930553, 930531",,,,,,,,,,,,, +Unresponded Only?,TRUE,,,,,,,,,,,,, +Posted,From - To - ,,,,,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery.csv b/Covance_UCO3001/Source/tmp/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery.csv new file mode 100644 index 0000000..687aab1 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery.csv @@ -0,0 +1,75 @@ +Site,Country,Visit,Visit Collection Date,Accession,Subject,eQueryId,Create Date,Response Date Time,Issue Type,Status,Time Before Response,User Name,Email,Study Role +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Unscheduled,"Mar 13, 2026 8:40 AM",6227323295,CZ100222004,2047932,"Mar 17, 2026 3:49 PM","Mar 17, 2026 9:07 PM",VST,Closed,5h 17m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Unscheduled,"Mar 13, 2026 7:45 AM",6227323297,CZ100222005,2047949,"Mar 17, 2026 3:56 PM","Mar 17, 2026 9:09 PM",VST,Closed,5h 12m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 0,"Mar 9, 2026 8:50 AM",6227323270,CZ100222003,2038559,"Mar 11, 2026 4:39 PM","Mar 11, 2026 8:32 PM","AGE, ADT201, AMT58660, AMT3542",Closed,3h 53m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 2,"Mar 27, 2026 7:10 AM",6227323272,CZ100222003,2073305,"Apr 1, 2026 7:54 PM","Apr 2, 2026 7:37 AM",AMT58660,Closed,11h 43m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 4,"Apr 8, 2026 8:05 AM",6227323274,CZ100222003,2086982,"Apr 10, 2026 1:00 PM","Apr 10, 2026 1:06 PM",AMT58660,Closed,5m,Katerina Havlikova,katerina.havlikova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 2, 2026 11:00 AM",6227810899,CZ100222003,2029805,"Mar 5, 2026 6:36 PM","Mar 6, 2026 9:01 AM","AMT58660, AMT3542",Closed,14h 24m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 4, 2026 9:20 AM",6227810900,CZ100222005,2031896,"Mar 6, 2026 6:45 PM","Mar 6, 2026 7:25 PM","AMT58660, AMT3542",Closed,40m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 3, 2026 12:10 PM",6227810901,CZ100222004,2029774,"Mar 5, 2026 6:23 PM","Mar 6, 2026 7:24 PM","AMT58660, AMT3542",Closed,1d,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 0,"Apr 9, 2026 10:35 AM",6228173397,CZ100222005,2089669,"Apr 13, 2026 2:06 PM","Apr 23, 2026 12:53 PM",PCFCOM,Closed,9d,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Screening,"Feb 25, 2026 12:15 PM",6227635204,CZ100212001,2019716,"Feb 27, 2026 12:09 PM","Mar 3, 2026 11:11 AM","AMT58660, AMT3542",Closed,3d,Zdenka Dvorakova,dvorakova.zdenka@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 0,"Apr 7, 2026 10:37 AM",6227635207,CZ100212001,2085089,"Apr 9, 2026 2:54 PM","Apr 15, 2026 7:20 AM","AMT58660, AMT15602",Closed,5d,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 2,"Apr 20, 2026 8:43 AM",6227635208,CZ100212001,2106304,"Apr 22, 2026 7:04 PM","Apr 23, 2026 9:21 AM",AMT58660,Closed,14h 16m,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 4,"May 5, 2026 10:00 AM",6227635211,CZ100212001,2133221,"May 9, 2026 6:24 PM","May 11, 2026 2:34 PM",AMT58660,Closed,1d,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10020 - Dr.Lucie Gonsorcikova,CZECH REPUBLIC,Screening,"Apr 13, 2026 12:20 PM",6227993962,CZ100201001,2094721,"Apr 15, 2026 6:02 PM","Apr 21, 2026 12:47 PM","AMT58660, AMT3542",Closed,5d,Zuzana Zahradnikova,zuzana.zahradnikova@ftn.cz,Investigator +CZ10020 - Dr.Lucie Gonsorcikova,CZECH REPUBLIC,Induction Week 0,"May 18, 2026 9:28 AM",6227993966,CZ100201001,2156061,"May 22, 2026 9:37 PM","May 25, 2026 6:43 AM","ADT201, AMT58660, AMT3542",Closed,2d,Zuzana Zahradnikova,zuzana.zahradnikova@ftn.cz,Investigator +CZ10016 - Dr.Robert Mudr,CZECH REPUBLIC,Screening,"Apr 21, 2026 10:45 AM",6227635171,CZ100162001,2109874,"Apr 24, 2026 2:00 PM",,AMT58660,Closed,,,, +CZ10016 - Dr.Robert Mudr,CZECH REPUBLIC,Screening,"Apr 21, 2026 10:45 AM",6227635171,CZ100162001,2123465,"May 4, 2026 7:16 PM","May 5, 2026 10:04 AM",AMT58660,Closed,14h 48m,Petr Pekny,petr.pekny@nmskb.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 0,"Mar 24, 2026 9:40 AM",6227635142,CZ100132001,2064220,"Mar 26, 2026 9:37 PM",,"AMT58660, AMT3542",Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 0,"Mar 24, 2026 9:40 AM",6227635142,CZ100132001,2066330,"Mar 27, 2026 6:43 PM","Mar 30, 2026 10:41 PM",AMT58660,Closed,3d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 2,"Apr 7, 2026 8:50 AM",6227635144,CZ100132001,2087084,"Apr 10, 2026 1:27 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 2,"Apr 7, 2026 8:50 AM",6227635144,CZ100132001,2100086,"Apr 18, 2026 11:15 AM","Apr 22, 2026 7:51 PM",AMT58660,Closed,4d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 4,"Apr 21, 2026 8:45 AM",6227635146,CZ100132001,2108501,"Apr 23, 2026 6:55 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 4,"Apr 21, 2026 8:45 AM",6227635146,CZ100132001,2123492,"May 4, 2026 7:24 PM","May 5, 2026 3:30 PM",AMT58660,Closed,20h 6m,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2101883,"Apr 20, 2026 6:49 PM","Apr 22, 2026 7:51 PM",AMT58660,Closed,2d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2090916,"Apr 13, 2026 9:15 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2079289,"Apr 6, 2026 3:21 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Feb 26, 2026 1:20 PM",6227635140,CZ100132001,2033901,"Mar 9, 2026 3:53 PM","Mar 16, 2026 10:08 PM","SCD, AMT58660, AMT3542",Closed,7d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Feb 26, 2026 1:20 PM",6227635140,CZ100132001,2023257,"Mar 2, 2026 6:47 PM",,"SCD, AGE, AMT58660, AMT3542",Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"May 6, 2026 10:45 AM",6227635141,CZ100132003,2137874,"May 12, 2026 8:03 PM","May 19, 2026 7:48 AM",AMT58660,Closed,6d,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Biopsy,"Apr 21, 2026 12:00 AM",6227635159,CZ100132002,2109534,"Apr 24, 2026 12:45 PM",,ADT8471,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Biopsy,"Apr 21, 2026 12:00 AM",6227635159,CZ100132002,2123486,"May 4, 2026 7:23 PM","May 5, 2026 3:30 PM",ADT8471,Closed,20h 7m,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Unscheduled,,6227697745,,2140058,"May 13, 2026 7:02 PM","May 26, 2026 9:46 AM",PCFCOM,Response Received,12d,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Screening,"Mar 18, 2026 9:18 AM",6227697718,CZ100122001,2053959,"Mar 20, 2026 2:52 PM","Mar 23, 2026 12:00 PM","SCT, AMT58660",Closed,2d,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 0,"Apr 7, 2026 11:45 AM",6227697719,CZ100122001,2085069,"Apr 9, 2026 2:48 PM","Apr 9, 2026 6:28 PM",AMT58660,Closed,3h 39m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 2,"Apr 22, 2026 9:25 AM",6227697722,CZ100122001,2113315,"Apr 27, 2026 6:35 PM","Apr 27, 2026 8:50 PM",AMT58660,Closed,2h 14m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 4,"May 7, 2026 12:40 PM",6227697723,CZ100122001,2142322,"May 14, 2026 7:10 PM","May 14, 2026 7:42 PM",AMT58660,Closed,31m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Biopsy,"Mar 23, 2026 12:00 AM",6227697736,CZ100122001,2060524,"Mar 25, 2026 12:53 PM","Mar 25, 2026 2:09 PM",AMT23260,Closed,1h 15m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Mar 31, 2026 8:30 AM",6227323330,CZ100092001,2075611,"Apr 2, 2026 5:37 PM",,AMT58660,Closed,,,, +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Mar 31, 2026 8:30 AM",6227323330,CZ100092001,2085558,"Apr 9, 2026 5:08 PM","Apr 10, 2026 2:06 PM",AMT58660,Closed,20h 58m,Jiri Pumprla,research@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Apr 16, 2026 12:00 PM",6227323332,CZ100092002,2101792,"Apr 20, 2026 6:19 PM","Apr 23, 2026 1:22 PM",AMT58660,Closed,2d,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Induction Week 0,"May 5, 2026 11:30 AM",6227323334,CZ100092001,2133224,"May 9, 2026 6:30 PM","May 13, 2026 10:10 AM","AMT58660, ADT809",Closed,3d,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Induction Week 2,"May 19, 2026 10:50 AM",6227323335,CZ100092001,2158952,"May 26, 2026 12:21 PM","May 27, 2026 9:03 AM",AMT58660,Closed,20h 42m,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Unscheduled,"Mar 17, 2026 8:00 AM",6227323265,CZ100062001,2052144,"Mar 19, 2026 4:08 PM","Mar 24, 2026 9:29 AM","PSX, SCT, AGE",Closed,4d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Screening,"Apr 20, 2026 7:45 AM",6227323234,CZ100062002,2106334,"Apr 22, 2026 7:18 PM","Apr 22, 2026 7:36 PM",AMT58660,Closed,18m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 0,"Mar 20, 2026 8:00 AM",6227323237,CZ100062001,2064023,"Mar 26, 2026 7:00 PM","Mar 27, 2026 9:04 AM",PCFCOM,Closed,14h 3m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 0,"Mar 20, 2026 8:00 AM",6227323237,CZ100062001,2061456,"Mar 25, 2026 6:16 PM","Mar 26, 2026 8:38 AM",AMT58660,Closed,14h 22m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 2,"Apr 8, 2026 7:10 AM",6227323240,CZ100062001,2086807,"Apr 10, 2026 12:21 PM","Apr 18, 2026 10:40 PM","AMT58660, ADT809",Closed,8d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 4,"Apr 15, 2026 8:45 AM",6227323242,CZ100062001,2102704,"Apr 21, 2026 11:22 AM","Apr 22, 2026 7:36 PM",AMT58660,Closed,1d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Biopsy,"Feb 19, 2026 12:00 AM",6227323254,CZ100062001,2014333,"Feb 24, 2026 4:13 PM","Feb 24, 2026 8:20 PM",VST,Closed,4h 6m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10003 - Dr. Leksa Vaclav,CZECH REPUBLIC,Screening,"May 13, 2026 8:15 AM",6227323299,CZ100032001,2154732,"May 22, 2026 12:36 PM","May 25, 2026 8:57 AM",AMT58660,Closed,2d,Leksa Vaclav,vaclav.leksa@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Screening,"Mar 2, 2026 7:00 AM",6227323204,CZ100012002,2032628,"Mar 9, 2026 10:33 AM","Mar 9, 2026 11:58 AM",AMT58660,Closed,1h 24m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Screening,"Mar 2, 2026 7:00 AM",6227323204,CZ100012002,2026645,"Mar 4, 2026 12:58 PM","Mar 6, 2026 6:01 PM","AMT58660, AMT3542",Closed,2d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 0,,6227323206,,2112374,"Apr 27, 2026 2:17 PM","May 5, 2026 11:24 AM","PCFCOM, ADT201, AMT58660, AMT3542",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 2,"Apr 23, 2026 7:40 AM",6227323207,CZ100012002,2113312,"Apr 27, 2026 6:35 PM","Apr 28, 2026 9:06 PM",AMT58660,Closed,1d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 2,"Mar 4, 2026 7:00 AM",6227323208,CZ100012001,2030545,"Mar 6, 2026 11:02 AM","Mar 6, 2026 11:42 AM","AMT58660, AMT688",Closed,39m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 4,"Mar 18, 2026 7:05 AM",6227323210,CZ100012001,2053955,"Mar 20, 2026 2:50 PM","Mar 25, 2026 3:29 PM","SCD, AMT58660",Closed,5d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Stool Pathogens,"Jan 28, 2026 6:00 AM",6227323211,CZ100012001,1976585,"Jan 30, 2026 1:21 PM","Feb 6, 2026 2:37 PM","VST, AGE",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Stool Pathogens,"Jan 28, 2026 6:00 AM",6227323211,CZ100012001,1991148,"Feb 9, 2026 7:43 PM","Feb 13, 2026 8:04 AM",AGE,Closed,3d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Biopsy,"Feb 5, 2026 12:00 AM",6227323223,CZ100012001,1989998,"Feb 9, 2026 1:42 PM","Feb 10, 2026 6:46 PM",VST,Closed,1d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,,6227323231,,2053405,"Mar 20, 2026 12:14 PM","Mar 30, 2026 12:54 AM",PCFCOM,Closed,9d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2141856,"May 14, 2026 4:23 PM","May 19, 2026 12:54 PM","SCD, AGE",Closed,4d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2152157,"May 21, 2026 11:32 AM","May 26, 2026 8:15 AM",AGE,Closed,4d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2112413,"Apr 27, 2026 2:24 PM","May 5, 2026 11:25 AM","PSX, SCT, VST, AGE, ADT201",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2126904,"May 6, 2026 12:02 PM","May 12, 2026 4:58 PM","SCT, VST, AGE",Closed,6d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,,6227323233,,2053482,"Mar 20, 2026 12:40 PM","Mar 27, 2026 9:58 AM",PCFCOM,Closed,6d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 0,"Apr 8, 2026 7:10 AM",6228036554,CZ100012002,2089973,"Apr 13, 2026 3:26 PM","Apr 21, 2026 1:32 PM",AMT15602,Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Biopsy,"May 13, 2026 12:00 AM",6228252073,CZ100012003,2147778,"May 19, 2026 10:13 AM","May 21, 2026 4:38 PM",VST,Closed,2d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 4,"May 6, 2026 8:05 AM",6227933142,CZ100012002,2134478,"May 11, 2026 2:54 PM","May 11, 2026 3:11 PM","AMT58660, AMT3542",Closed,16m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 12,"May 13, 2026 8:05 AM",6227933143,CZ100012001,2147202,"May 18, 2026 7:51 PM","May 19, 2026 8:38 AM",AMT58660,Closed,12h 47m,Matej Falc,matesfalc@seznam.cz,Investigator +title,value,,,,,,,,,,,,, +Search,,,,,,,,,,,,,, +Site,"930551, 930556, 930525, 930549, 930543, 930547, 930555, 930557, 930539, 930536, 930553, 930531",,,,,,,,,,,,, +Unresponded Only?,FALSE,,,,,,,,,,,,, +Posted,From - To - ,,,,,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv b/Covance_UCO3001/Source/tmp/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv new file mode 100644 index 0000000..652a478 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv @@ -0,0 +1,9 @@ +Site,Country,Visit,Visit Collection Date,Accession,Subject,eQueryId,Create Date,Response Date Time,Issue Type,Status,Time Before Response,User Name,Email,Study Role +,,,,,,,,,,,,,, +,,,,,,,,,,,,,, +,,,,,,,,,,,,,, +title,value,,,,,,,,,,,,, +Search,,,,,,,,,,,,,, +Site,"930551, 930556, 930525, 930549, 930543, 930547, 930555, 930557, 930539, 930536, 930553, 930531",,,,,,,,,,,,, +Unresponded Only?,TRUE,,,,,,,,,,,,, +Posted,From - To - ,,,,,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140223 sponsor-study-36940-test-results-930525-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140223 sponsor-study-36940-test-results-930525-standard.csv new file mode 100644 index 0000000..65d2d3f --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140223 sponsor-study-36940-test-results-930525-standard.csv @@ -0,0 +1,709 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,20-May-2026,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,11:44,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,22-May-2026,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Alkaline Phosphatase,,68,,,,,40 - 129,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,ALT (SGPT),,10,,,,,5 - 48,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,GGT,,10,,,,,10 - 61,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,LDH,,164,,,,,53 - 234,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,101,,,,,40 - 110,umol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Uric Acid,,255,,,,,125 - 488,umol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Phosphorus,,1.10,,,,,0.71 - 1.65,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Creatine Kinase,,131,,,,,39 - 308,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Bicarbonate,,25.4,,,,,19.3 - 29.3,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Magnesium,,0.82,,,,,0.66 - 1.07,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,87,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,FECAL COLLECTION D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,FECAL COLLECTION D/T,Stool Collection Time,Y,06:40,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,127 - 181,g/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.72,,,,,3.8 - 10.7,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.17,,,,,1.96 - 7.23,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.71,,,,,0.91 - 4.28,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.36,,,,,0.12 - 0.92,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.44,,,,,0 - 0.57,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.4,,,,,40.5 - 75,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.0,,,,,15.4 - 48.5,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.3,,,,,2.6 - 10.1,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,7.7,,H,,,0 - 6.8,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,294,,,,,140 - 400,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:40,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:50,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:40,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:40,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Alkaline Phosphatase,,65,,,,,40 - 129,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,ALT (SGPT),,7,,,,,5 - 48,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,GGT,,7,,L,,,10 - 61,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,LDH,,147,,,,,53 - 234,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,88,,,,,40 - 110,umol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Glucose,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Uric Acid,,261,,,,,125 - 488,umol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Creatine Kinase,,112,,,,,39 - 308,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Bicarbonate,,23.2,,,,,19.3 - 29.3,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Magnesium,,0.76,,,,,0.66 - 1.07,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,102,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,FECAL COLLECTION D/T,Stool Collection Date,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,FECAL COLLECTION D/T,Stool Collection Time,Y,05:40,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,127 - 181,g/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.39 - 0.54, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.68,,,,,3.8 - 10.7,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.92,,,,,1.96 - 7.23,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.94,,,,,0.91 - 4.28,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.40,,,,,0 - 0.57,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.7,,,,,40.5 - 75,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.0,,,,,15.4 - 48.5,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.9,,,,,2.6 - 10.1,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,5.9,,,,,0 - 6.8,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,308,,,,,140 - 400,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,14:15,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,15:25,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,14:15,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,05:40,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.2,,,,,0 - 6.2,umol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Alkaline Phosphatase,,71,,,,,40 - 129,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,ALT (SGPT),,7,,,,,5 - 48,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,GGT,,7,,L,,,10 - 61,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,LDH,,153,,,,,53 - 234,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Urea Nitrogen,,4.9,,,,,1.4 - 8.6,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,86,,,,,40 - 110,umol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Glucose,,4.2,,,,,3.9 - 5.6,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Uric Acid,,299,,,,,125 - 488,umol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Creatine Kinase,,116,,,,,39 - 308,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Bicarbonate,,23.9,,,,,19.3 - 29.3,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Magnesium,,0.80,,,,,0.66 - 1.07,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,106,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,FECAL COLLECTION D/T,Stool Collection Date,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,FECAL COLLECTION D/T,Stool Collection Time,Y,05:55,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,146,,,,,127 - 181,g/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.07,,,,,3.8 - 10.7,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.83,,,,,1.96 - 7.23,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.67,,,,,0.91 - 4.28,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.32,,,,,0.12 - 0.92,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.19,,,,,0 - 0.57,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.1,,,,,40.5 - 75,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.6,,,,,15.4 - 48.5,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.2,,,,,2.6 - 10.1,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.2,,,,,0 - 6.8,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,314,,,,,140 - 400,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,LIPID PANEL,Direct HDL-C 4th Generation,,1.90,,H,,,1.03 - 1.53,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,LIPID PANEL,Triglycerides (GPO),,0.43,,L,,,0.56 - 3.62,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,LIPID PANEL,Cholesterol (High Performance),,3.22,,L,,,3.88 - 6.83,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,LIPID PANEL,LDL Chol Friedewald 4th,,1.12,,,,,0 - 3.34,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:35,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,11:45,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:35,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,05:55,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Alkaline Phosphatase,,64,,,,,40 - 129,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,ALT (SGPT),,42,,,,,5 - 48,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,AST (SGOT),,31,,,,,8 - 40,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,GGT,,24,,,,,10 - 61,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,LDH,,225,,,,,53 - 234,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Urea Nitrogen,,10.1,,H,,,1.4 - 8.6,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,110,,,,,40 - 110,umol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Uric Acid,,455,,,,,125 - 488,umol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Creatine Kinase,,367,,H,,,39 - 308,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Bicarbonate,,24.7,,,,,19.3 - 29.3,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Magnesium,,0.77,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,76,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,FECAL COLLECTION D/T,Stool Collection Date,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,FECAL COLLECTION D/T,Stool Collection Time,Y,05:15,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,135,,,,,127 - 181,g/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,85,,,,,79 - 96,fL +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.70,,,,,3.8 - 10.7,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.33,,,,,1.96 - 7.23,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.26,,,,,0.91 - 4.28,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.67,R,H,,,0 - 0.57,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,40.8,,,,,40.5 - 75,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,39.6,,,,,15.4 - 48.5,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.0,,,,,2.6 - 10.1,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,11.7,R,H,,,0 - 6.8,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,282,,,,,140 - 400,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:15,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,05:15,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,01-Apr-2026,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:46,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,03-Apr-2026,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Alkaline Phosphatase,,58,,,,,40 - 129,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,ALT (SGPT),,26,,,,,5 - 48,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,LDH,,170,,,,,53 - 234,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Urea Nitrogen,,9.4,R,H,,,1.4 - 8.6,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,104,,,,,40 - 110,umol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Glucose,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Uric Acid,,353,,,,,125 - 488,umol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Phosphorus,,1.32,,,,,0.71 - 1.65,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Creatine Kinase,,167,,,,,39 - 308,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Bicarbonate,,23.9,,,,,19.3 - 29.3,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Magnesium,,0.73,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,80,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,FECAL COLLECTION D/T,Stool Collection Date,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,FECAL COLLECTION D/T,Stool Collection Time,Y,05:40,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,133,,,,,127 - 181,g/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.5 - 6.4,TI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.92,,,,,3.8 - 10.7,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.29,,,,,1.96 - 7.23,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.57,,,,,0.91 - 4.28,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.41,,,,,0.12 - 0.92,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.61,R,H,,,0 - 0.57,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,38.7,R,L,,,40.5 - 75,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,43.4,,,,,15.4 - 48.5,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,10.3,R,H,,,0 - 6.8,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,252,,,,,140 - 400,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:20,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,05:40,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Total Bilirubin,,3,,,,Result verified by repeat analysis,3 - 21,umol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,Result verified by repeat analysis,0 - 6.2,umol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,40 - 129,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,5 - 48,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,GGT,,19,,,,,10 - 50,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Urea Nitrogen,,5.5,,,,,1.4 - 8.6,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,108,,,,,40 - 119,umol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Uric Acid,,429,,,,,149 - 494,umol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Calcium (EDTA),,2.07,,,,,2.07 - 2.64,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Phosphorus,,1.02,,,,,0.71 - 1.65,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Total Protein,,55,,L,,,60 - 80,g/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Albumin-BCG,,35,,,,,33 - 49,g/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Creatine Kinase,,49,,,,,39 - 308,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Sodium,,148,,H,,,135 - 145,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Bicarbonate,,24.4,,,,,19.3 - 29.3,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Chloride,,110,,,,,94 - 112,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Magnesium,,0.82,,,,,0.66 - 0.98,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Alkaline Phosphatase,,73,,,,,40 - 129,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,ALT (SGPT),,5,,,,,5 - 48,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,GGT,,6,R,L,,,10 - 61,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,LDH,,149,,,,,53 - 234,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Urea Nitrogen,,3.8,,,,,1.4 - 8.6,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 110,umol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Uric Acid,,277,,,,,125 - 488,umol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Phosphorus,,1.23,,,,,0.71 - 1.65,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Creatine Kinase,,119,,,,,39 - 308,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Bicarbonate,,27.4,,,,,19.3 - 29.3,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Alkaline Phosphatase,,91,,,,,40 - 129,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,ALT (SGPT),,79,R,H,,,5 - 48,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,AST (SGOT),,51,R,H,,,8 - 40,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,GGT,,45,,,,,10 - 61,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,LDH,,228,,,,,53 - 234,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Urea Nitrogen,,8.3,,,,,1.4 - 8.6,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,106,,,,,40 - 110,umol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Uric Acid,,418,,,,,125 - 488,umol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Phosphorus,,1.10,,,,,0.71 - 1.65,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Creatine Kinase,,250,,,,,39 - 308,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Bicarbonate,,25.4,,,,,19.3 - 29.3,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Magnesium,,0.73,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,79,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,FECAL COLLECTION D/T,Stool Collection Date,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,FECAL COLLECTION D/T,Stool Collection Time,Y,08:55,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,127 - 181,g/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.5 - 6.4,TI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.70,,,,,3.8 - 10.7,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.17,,,,,1.96 - 7.23,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.01,,,,,0.91 - 4.28,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,1.08,R,H,,,0 - 0.57,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.4,,,,,40.5 - 75,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.9,,,,,15.4 - 48.5,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,16.1,R,H,,,0 - 6.8,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,262,,,,,140 - 400,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,LIPID PANEL,Direct HDL-C 4th Generation,,1.13,,,,,1.03 - 1.53,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,LIPID PANEL,Triglycerides (GPO),,0.84,,,,,0.56 - 3.62,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,LIPID PANEL,Cholesterol (High Performance),,5.14,,,,,3.88 - 6.83,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,LIPID PANEL,LDL Chol Friedewald 4th,,3.63,,H,,,0 - 3.34,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:50,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:05,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:50,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,08:55,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SUBJECT HEIGHT (CM),Height (cm),Y,190,,,,,cm, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Total Bilirubin,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,ALT (SGPT),,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,AST (SGOT),,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,GGT,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,LDH,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Urea Nitrogen,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Glucose,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Uric Acid,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Calcium (EDTA),,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Phosphorus,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Total Protein,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Albumin-BCG,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Creatine Kinase,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Sodium,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Potassium,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Bicarbonate,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Chloride,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Magnesium,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,148,,,,,127 - 181,g/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.67,,,,,3.8 - 10.7,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.96,,,,,1.96 - 7.23,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.68,,,,,0.91 - 4.28,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.51,,,,,0.12 - 0.92,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.42,,,,,0 - 0.57,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.3,,,,,40.5 - 75,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,25.2,,,,,15.4 - 48.5,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.7,,,,,2.6 - 10.1,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,6.3,,,,,0 - 6.8,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.5,,,,,0 - 2,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,341,,,,,140 - 400,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,SUBJECT HEIGHT (CM),Height (cm),Y,188,,,,,cm, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Total Bilirubin,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,ALT (SGPT),,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,AST (SGOT),,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,GGT,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,LDH,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Urea Nitrogen,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Glucose,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Uric Acid,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Calcium (EDTA),,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Phosphorus,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Total Protein,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Albumin-BCG,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Creatine Kinase,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Sodium,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Potassium,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Bicarbonate,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Chloride,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Magnesium,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,91,,L,,,125 - 170,g/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.31,,L,,,0.37 - 0.51, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.7,,L,,,4 - 5.8,TI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,25,,L,,,26 - 34,pg +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,80 - 100,fL +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,11.98,,H,,,3.8 - 10.7,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,9.38,,H,,,1.96 - 7.23,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.49,,,,,0.8 - 3,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.88,,,,,0.12 - 0.92,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.18,,,,,0 - 0.57,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,78.4,,H,,,40.5 - 75,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,12.4,,L,,,15.4 - 48.5,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.3,,,,,2.6 - 10.1,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.5,,,,,0 - 6.8,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,465,,H,,,130 - 394,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,SUBJECT HEIGHT (CM),Height (cm),Y,158,,,,,cm, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.9,,,,,0 - 6.2,umol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Alkaline Phosphatase,,78,,,,,40 - 129,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,ALT (SGPT),,69,,H,,,5 - 48,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,AST (SGOT),,33,,,,,8 - 40,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,GGT,,38,,,,,10 - 61,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,LDH,,213,,,,,53 - 234,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Urea Nitrogen,,8.9,,H,,,1.4 - 8.6,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,105,,,,,40 - 110,umol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Uric Acid,,414,,,,,125 - 488,umol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Phosphorus,,1.17,,,,,0.71 - 1.65,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Creatine Kinase,,157,,,,,39 - 308,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Bicarbonate,,25.4,,,,,19.3 - 29.3,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Magnesium,,0.74,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,80,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,138,,,,,127 - 181,g/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.39 - 0.54, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.5 - 6.4,TI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.87,,,,,3.8 - 10.7,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.24,,,,,1.96 - 7.23,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.46,,,,,0.91 - 4.28,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.79,R,H,,,0 - 0.57,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,38.2,R,L,,,40.5 - 75,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,41.9,,,,,15.4 - 48.5,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.7,,,,,2.6 - 10.1,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,13.5,R,H,,,0 - 6.8,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,302,,,,,140 - 400,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,,,,Test group cancelled: No specimen received,,, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,18-Feb-2026,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,07:39,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,INFLAMED AREA,Inflamed area?,,No,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,20-Feb-2026,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,11-Feb-2026,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,14:38,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,13-Feb-2026,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.9,,,,,0 - 6.2,umol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Alkaline Phosphatase,,55,,,,,40 - 129,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,5 - 48,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,GGT,,12,,,,,10 - 61,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,LDH,,190,,,,,53 - 234,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Urea Nitrogen,,8.5,,,,,1.4 - 8.6,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,115,,H,,,40 - 110,umol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Uric Acid,,337,,,,,125 - 488,umol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Phosphorus,,0.86,,,,,0.71 - 1.65,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Creatine Kinase,,144,,,,,39 - 308,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Bicarbonate,,27.5,,,,,19.3 - 29.3,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Magnesium,,0.75,,,,,0.66 - 1.07,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CKD-EPI 2021,CKD-EPI 2021 Without Race,,72,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,127 - 181,g/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.82,,,,,3.8 - 10.7,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.49,,,,,1.96 - 7.23,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.54,,,,,0.91 - 4.28,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.41,,,,,0.12 - 0.92,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.34,,,,,0 - 0.57,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,42.7,,,,,40.5 - 75,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,43.7,,,,,15.4 - 48.5,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.0,,,,,2.6 - 10.1,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,5.9,,,,,0 - 6.8,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,224,,,,,140 - 400,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEPATITIS B SURFACE AB NON-US,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100222001,,,,,Male,Stool Pathogens,R,"Jan 15, 2026 4:55 PM",6227323276,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,Test group cancelled: Specimen received beyond stability,,, +CZ100222001,,,,,Male,Stool Pathogens,R,"Jan 15, 2026 4:55 PM",6227323276,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,Test group cancelled: Specimen received beyond stability,,, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.4,,,,,0 - 6.2,umol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Alkaline Phosphatase,,140,,H,,,40 - 129,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,5 - 48,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,AST (SGOT),,28,,,,,8 - 40,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,GGT,,136,,H,,,10 - 61,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,LDH,,186,,,,,53 - 234,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,78,,,,,40 - 110,umol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Uric Acid,,408,,,,,125 - 488,umol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Creatine Kinase,,131,,,,,39 - 308,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Magnesium,,0.82,,,,,0.66 - 1.07,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CKD-EPI 2021,CKD-EPI 2021 Without Race,,111,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,85,,L,,,127 - 181,g/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.30,,L,,,0.39 - 0.54, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,L,,,4.5 - 6.4,TI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,21,,L,,,26 - 34,pg +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Microcytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Anisocytosis,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,74,,L,,,79 - 96,fL +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,15.03,,H,,,3.8 - 10.7,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,11.38,,H,,,1.96 - 7.23,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.59,,,,,0.91 - 4.28,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.82,,,,,0.12 - 0.92,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.11,,,,,0 - 0.2,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,75.7,,H,,,40.5 - 75,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,17.3,,,,,15.4 - 48.5,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,529,,H,,,140 - 400,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEPATITIS B SURFACE AB NON-US,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140224 sponsor-study-36940-test-results-930525-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140224 sponsor-study-36940-test-results-930525-microbiology.csv new file mode 100644 index 0000000..a4242f9 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140224 sponsor-study-36940-test-results-930525-microbiology.csv @@ -0,0 +1,6 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100222001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Jan 15, 2026 4:55 PM",6227323276,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,R, +CZ100222002 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Jan 23, 2026 10:10 AM",6227323277,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100222004 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Mar 3, 2026 12:20 PM",6227810905,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100222005 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Mar 4, 2026 9:10 AM",6227810904,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140225 sponsor-study-36940-test-results-930556-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140225 sponsor-study-36940-test-results-930556-standard.csv new file mode 100644 index 0000000..3271150 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140225 sponsor-study-36940-test-results-930556-standard.csv @@ -0,0 +1,75 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,27-May-2026,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:10,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: Specimen received in expired coll. container; unable to perform test.,,, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,35 - 104,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,AST (SGOT),,11,,,,,8 - 40,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,GGT,,9,,,,,4 - 49,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,LDH,,128,,,,,53 - 234,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Glucose,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Uric Acid,,192,,,,,125 - 428,umol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Calcium (EDTA),,2.24,,,,,2.07 - 2.64,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Phosphorus,,1.00,,,,,0.71 - 1.65,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Creatine Kinase,,85,,,,,26 - 192,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Magnesium,,0.79,,,,,0.66 - 1.07,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,94,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,114,,L,,,116 - 164,g/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4.1 - 5.6,TI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,,26 - 34,pg +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 98,fL +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.80,,,,,3.8 - 10.7,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.53,,,,,1.96 - 7.23,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.32,,,,,0.91 - 4.28,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.47,,,,,0.12 - 0.92,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.44,,,,,0 - 0.57,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.2,,,,,40.5 - 75,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,15.0,,L,,,15.4 - 48.5,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,5.0,,,,,0 - 6.8,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,513,,H,,,140 - 400,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140241 sponsor-study-36940-test-results-930556-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140241 sponsor-study-36940-test-results-930556-microbiology.csv new file mode 100644 index 0000000..fba7493 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140241 sponsor-study-36940-test-results-930556-microbiology.csv @@ -0,0 +1,3 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100032001 - null,,,,Female,SCRNSTOOL Stool Pathogens,"May 13, 2026 9:30 AM",6227323309,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140304 sponsor-study-36940-test-results-930549-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140304 sponsor-study-36940-test-results-930549-standard.csv new file mode 100644 index 0000000..533a201 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140304 sponsor-study-36940-test-results-930549-standard.csv @@ -0,0 +1,242 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Alkaline Phosphatase,,82,,,,,35 - 104,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,GGT,,11,,,,,4 - 49,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Urea Nitrogen,,2.1,,,,,1.4 - 8.6,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,55,,,,,31 - 101,umol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Glucose,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Uric Acid,,277,,,,,125 - 428,umol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Calcium (EDTA),,2.54,,,,,2.07 - 2.64,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Phosphorus,,0.81,,,,,0.71 - 1.65,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Total Protein,,84,,,,,61 - 84,g/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Albumin-BCG,,51,,H,,,33 - 49,g/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Creatine Kinase,,55,,,,,26 - 192,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Bicarbonate,,23.5,,,,,19.3 - 29.3,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Magnesium,,0.89,,,,,0.66 - 1.07,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,129,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,FECAL COLLECTION D/T,Stool Collection Date,Y,,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,FECAL COLLECTION D/T,Stool Collection Time,Y,,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,Result verified by repeat analysis,116 - 164,g/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,Result verified by repeat analysis,4.1 - 5.6,TI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,27,,,,Result verified by repeat analysis,26 - 34,pg +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Anisocytosis,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,83,,,,Result verified by repeat analysis,79 - 98,fL +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.41,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.73,,,,,1.96 - 7.23,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.41,,,,,0.91 - 4.28,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.22,,,,,0.12 - 0.92,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,,0 - 0.57,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.00,,,,,0 - 0.2,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.0,,,,,40.5 - 75,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.0,,,,,15.4 - 48.5,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.0,,,,,0 - 2,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,340,,,,Result verified by repeat analysis,140 - 400,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,07-May-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,12:40,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,07-May-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,14:20,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,07-May-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,12:40,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Alkaline Phosphatase,,71,,,,,35 - 104,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,4 - 43,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,GGT,,12,,,,,4 - 49,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,LDH,,138,,,,,53 - 234,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Urea Nitrogen,,3.5,,,,,1.4 - 8.6,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Glucose,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Uric Acid,,296,,,,,125 - 428,umol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Calcium (EDTA),,2.55,,,,,2.07 - 2.64,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Phosphorus,,0.77,,,,,0.71 - 1.65,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Creatine Kinase,,49,,,,,26 - 192,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Bicarbonate,,25.3,,,,,19.3 - 29.3,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Magnesium,,0.83,,,,,0.66 - 1.07,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,129,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,FECAL COLLECTION D/T,Stool Collection Date,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,FECAL COLLECTION D/T,Stool Collection Time,Y,05:30,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,128,,,,Result verified by repeat analysis,116 - 164,g/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,Result verified by repeat analysis,0.34 - 0.48, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,Result verified by repeat analysis,4.1 - 5.6,TI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,26,,,,Result verified by repeat analysis,26 - 34,pg +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,81,,,,Result verified by repeat analysis,79 - 98,fL +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.60,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.39,,,,,1.96 - 7.23,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.54,,,,,0.91 - 4.28,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.47,,,,Result verified by repeat analysis,0.12 - 0.92,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,Result verified by repeat analysis,0 - 0.57,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,Result verified by repeat analysis,0 - 0.2,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,66.6,,,,Result verified by repeat analysis,40.5 - 75,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,23.5,,,,Result verified by repeat analysis,15.4 - 48.5,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,Result verified by repeat analysis,2.6 - 10.1,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.8,,,,Result verified by repeat analysis,0 - 6.8,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,Result verified by repeat analysis,0 - 2,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,300,,,,Result verified by repeat analysis,140 - 400,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,09:25,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:45,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,09:25,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,05:30,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Alkaline Phosphatase,,66,,,,,35 - 104,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,4 - 43,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,GGT,,12,,,,,4 - 49,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,LDH,,157,,,,,53 - 234,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Urea Nitrogen,,3.0,,,,,1.4 - 8.6,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,51,,,,,31 - 101,umol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Uric Acid,,258,,,,,125 - 428,umol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Phosphorus,,0.84,,,,,0.71 - 1.65,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Creatine Kinase,,51,,,,,26 - 192,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Bicarbonate,,23.0,,,,,19.3 - 29.3,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Magnesium,,0.82,,,,,0.66 - 1.07,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,131,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,FECAL COLLECTION D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,FECAL COLLECTION D/T,Stool Collection Time,Y,06:00,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,115,R,L,,,116 - 164,g/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,25,R,L,,,26 - 34,pg +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,80,,,,,79 - 98,fL +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.11,,,,,3.8 - 10.7,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.31,,,,,1.96 - 7.23,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.15,,,,,0.91 - 4.28,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.54,,,,,0.12 - 0.92,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,69.3,,,,,40.5 - 75,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,23.6,,,,,15.4 - 48.5,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.9,,,,,2.6 - 10.1,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.5,,,,,0 - 6.8,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,386,,,,,140 - 400,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,LIPID PANEL,Direct HDL-C 4th Generation,,1.35,,,,,1.03 - 1.53,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,LIPID PANEL,Triglycerides (GPO),,1.11,,,,,0.41 - 1.63,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,LIPID PANEL,Cholesterol (High Performance),,4.41,,,,,3.31 - 5.64,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,LIPID PANEL,LDL Chol Friedewald 4th,,2.55,,,,,0 - 3.34,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,11:45,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,13:35,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,11:45,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,06:00,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,ANATOMICAL SITE,Anatomical Site,Y,15 cm,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,23-Mar-2026,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:42,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,25-Mar-2026,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Total Bilirubin,,<3,R,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,Result verified by repeat analysis,0 - 6.2,umol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Alkaline Phosphatase,,74,,,,,35 - 104,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,4 - 43,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,GGT,,9,,,,,4 - 49,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Urea Nitrogen,,2.5,,,,,1.4 - 8.6,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,55,,,,,31 - 101,umol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Glucose,,5.5,,,,,3.9 - 5.6,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Uric Acid,,226,,,,,125 - 428,umol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Phosphorus,,0.90,,,,,0.71 - 1.65,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Creatine Kinase,,84,,,,,26 - 192,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Potassium,,5.1,,,,,3.5 - 5.2,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Bicarbonate,,19.2,,L,,,19.3 - 29.3,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Magnesium,,0.83,,,,,0.66 - 1.07,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,129,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,111,R,L,,,116 - 164,g/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,24,R,L,,,26 - 34,pg +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,78,R,L,,,79 - 98,fL +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.66,,,,,3.8 - 10.7,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.37,,,,,1.96 - 7.23,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.63,,,,,0.91 - 4.28,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.55,,,,,0.12 - 0.92,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,70.2,,,,,40.5 - 75,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,21.2,,,,,15.4 - 48.5,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,,2.6 - 10.1,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,412,R,H,,,140 - 400,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100122001,,,,,Female,Stool Pathogens,,"Mar 17, 2026 5:30 PM",6227697725,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100122001,,,,,Female,Stool Pathogens,,"Mar 17, 2026 5:30 PM",6227697725,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140310 sponsor-study-36940-test-results-930549-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140310 sponsor-study-36940-test-results-930549-microbiology.csv new file mode 100644 index 0000000..a05daf8 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140310 sponsor-study-36940-test-results-930549-microbiology.csv @@ -0,0 +1,3 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100122001 - null,,,,Female,SCRNSTOOL Stool Pathogens,"Mar 17, 2026 5:30 PM",6227697725,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140313 sponsor-study-36940-test-results-930555-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140313 sponsor-study-36940-test-results-930555-microbiology.csv new file mode 100644 index 0000000..90a8458 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140313 sponsor-study-36940-test-results-930555-microbiology.csv @@ -0,0 +1,6 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100062001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Feb 16, 2026 7:20 AM",6227323244,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100062001 - null,,,,Male,UNSCSTOOL Stool Pathogens,"Mar 11, 2026 9:15 AM",6227323245,STOOL CULTURE,,,,Test group cancelled: Specimen received beyond stability,,,,,,,,,,, +CZ100062001 - null,,,,Male,UNSCSTOOL Stool Pathogens,"Mar 17, 2026 9:00 AM",6227323243,STOOL CULTURE,,,,Test group cancelled: No specimen received,,,,,,,,,,, +CZ100062002 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 20, 2026 7:45 AM",6228194341,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140319 sponsor-study-36940-test-results-930555-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140319 sponsor-study-36940-test-results-930555-standard.csv new file mode 100644 index 0000000..71d4c30 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140319 sponsor-study-36940-test-results-930555-standard.csv @@ -0,0 +1,409 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Total Bilirubin,,18,,,,,3 - 21,umol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.8,,,,,0 - 6.2,umol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Alkaline Phosphatase,,63,,,,,40 - 129,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,ALT (SGPT),,12,,,,,5 - 48,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,GGT,,17,,,,,10 - 61,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,LDH,,124,,,,,53 - 234,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Urea Nitrogen,,3.2,,,,,1.4 - 8.6,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,40 - 110,umol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Glucose,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Uric Acid,,298,,,,,125 - 488,umol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Phosphorus,,1.21,,,,,0.71 - 1.65,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Creatine Kinase,,106,,,,,39 - 308,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,FECAL COLLECTION D/T,Stool Collection Date,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,FECAL COLLECTION D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,129,,,,,127 - 181,g/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.39 - 0.54, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,L,,,4.5 - 6.4,TI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 96,fL +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.10,,,,,3.8 - 10.7,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.34,,,,,1.96 - 7.23,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.09,,,,,0.91 - 4.28,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.48,,,,,0.12 - 0.92,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.5,,,,,40.5 - 75,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,21.4,,,,,15.4 - 48.5,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.5,,,,,2.6 - 10.1,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.2,,,,,0 - 6.8,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,270,,,,,140 - 400,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,IS SUBJECT FASTING?,Is Subject Fasting?,Y,,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,LIPID PANEL,Direct HDL-C 4th Generation,,0.90,,L,,,1.03 - 1.53,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,LIPID PANEL,Triglycerides (GPO),,0.88,,,,,0.62 - 3.69,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,LIPID PANEL,Cholesterol (High Performance),,2.48,,L,,Result verified by repeat analysis,4.19 - 7.24,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,LIPID PANEL,LDL Chol Friedewald 4th,,1.18,,,,,0 - 3.34,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,PA1 EEA-2?,Approved to use EEA-2?,,,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:15,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:05,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:15,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SUBJECT HEIGHT (CM),Height (cm),Y,,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,ANATOMICAL SITE,Anatomical Site,Y,15-20,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,14-May-2026,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:15,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,16-May-2026,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Alkaline Phosphatase,,65,,,,,40 - 129,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,ALT (SGPT),,13,,,,,5 - 48,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,GGT,,17,,,,,10 - 61,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,71,,,,,40 - 110,umol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Uric Acid,,338,,,,,125 - 488,umol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Phosphorus,,1.19,,,,,0.71 - 1.65,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Creatine Kinase,,281,,,,,39 - 308,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Bicarbonate,,26.0,,,,,19.3 - 29.3,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,108,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,127 - 181,g/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.39 - 0.54, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Anisocytosis,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.17,,,,,3.8 - 10.7,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.25,,,,,1.96 - 7.23,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.20,,,,,0.91 - 4.28,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.38,,,,,0.12 - 0.92,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.22,,,,,0 - 0.57,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.11,,,,,0 - 0.2,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.0,,,,,40.5 - 75,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.9,,,,,15.4 - 48.5,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.1,,,,,2.6 - 10.1,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,5.3,,,,,0 - 6.8,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.7,,H,,,0 - 2,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,306,,,,,140 - 400,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Alkaline Phosphatase,,91,,,,,40 - 129,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,5 - 48,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,LDH,,118,,,,,53 - 234,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Urea Nitrogen,,1.6,,,,,1.4 - 8.6,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,92,,,,,40 - 110,umol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Glucose,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Uric Acid,,424,,,,,125 - 488,umol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Calcium (EDTA),,2.51,,,,,2.07 - 2.64,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Phosphorus,,1.29,,,,,0.71 - 1.65,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Total Protein,,78,,,,,61 - 84,g/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Creatine Kinase,,41,,,,,39 - 308,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Bicarbonate,,24.0,,,,,19.3 - 29.3,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Chloride,,96,,,,,94 - 112,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Magnesium,,0.93,,H,,,0.7 - 0.9,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,106,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,FECAL COLLECTION D/T,Stool Collection Date,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,FECAL COLLECTION D/T,Stool Collection Time,Y,20:30,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,122,R,L,,,127 - 181,g/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,24,R,L,,,26 - 34,pg +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,83,,,,,79 - 96,fL +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,14.93,R,H,,,3.8 - 10.7,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,10.00,R,H,,,1.96 - 7.23,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.54,,,,,0.91 - 4.28,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,1.79,R,H,,,0.12 - 0.92,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.60,R,H,,,0 - 0.57,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.00,,,,,0 - 0.2,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,67.0,,,,,40.5 - 75,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,17.0,,,,,15.4 - 48.5,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,12.0,R,H,,,2.6 - 10.1,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.0,,,,,0 - 6.8,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.0,,,,,0 - 2,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,647,R,H,,,140 - 400,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:15,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:40,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:15,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,20:30,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,40 - 129,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,5 - 48,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,LDH,,113,,,,,53 - 234,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Urea Nitrogen,,2.0,,,,,1.4 - 8.6,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,86,,,,,40 - 110,umol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Glucose,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Uric Acid,,410,,,,,125 - 488,umol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Phosphorus,,1.28,,,,,0.71 - 1.65,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Creatine Kinase,,64,,,,,39 - 308,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Bicarbonate,,23.2,,,,,19.3 - 29.3,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Magnesium,,0.93,R,H,,,0.7 - 0.9,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,115,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,FECAL COLLECTION D/T,Stool Collection Date,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,FECAL COLLECTION D/T,Stool Collection Time,Y,07:10,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:20,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,07:10,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,40 - 129,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,5 - 48,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,GGT,,18,,,,,10 - 61,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,LDH,,141,,,,,53 - 234,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Urea Nitrogen,,2.5,,,,,1.4 - 8.6,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,40 - 110,umol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Glucose,,4.0,,,,,3.9 - 5.6,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Uric Acid,,415,,,,,125 - 488,umol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Phosphorus,,1.26,,,,,0.71 - 1.65,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Creatine Kinase,,119,,,,,39 - 308,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Bicarbonate,,23.3,,,,,19.3 - 29.3,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Magnesium,,0.90,,,,,0.7 - 0.9,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,128,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,FECAL COLLECTION D/T,Stool Collection Date,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,FECAL COLLECTION D/T,Stool Collection Time,Y,08:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,121,,L,,,127 - 181,g/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,25,,L,,,26 - 34,pg +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,81,,,,,79 - 96,fL +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,13.09,,H,,,3.8 - 10.7,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,9.29,,H,,,1.96 - 7.23,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.23,,,,,0.91 - 4.28,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,1.31,,H,,,0.12 - 0.92,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.13,,,,,0 - 0.2,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.0,,,,,40.5 - 75,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,17.0,,,,,15.4 - 48.5,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.0,,,,,2.6 - 10.1,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,445,,H,,,140 - 400,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,IS SUBJECT FASTING?,Is Subject Fasting?,Y,No,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,LIPID PANEL,Direct HDL-C 4th Generation,,1.53,,,,,1.03 - 1.53,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,LIPID PANEL,Triglycerides (GPO),,0.81,,,,,0.42 - 1.67,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,LIPID PANEL,Cholesterol (High Performance),,4.16,,,,,2.95 - 5.12,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,LIPID PANEL,LDL Chol Friedewald 4th,,2.26,,,,,0 - 3.34,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,08:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 17, 2026 9:00 AM",6227323243,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 17, 2026 9:00 AM",6227323243,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,TB Testing,,"Mar 11, 2026 9:10 AM",6227323253,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,ANATOMICAL SITE,Anatomical Site,Y,18,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,BIOPSY COLLECTION METHOD,Collection Method,Y,sigmoidoscopy,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,19-Feb-2026,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,07:20,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,23-Feb-2026,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Feb 16, 2026 7:20 AM",6227323244,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,Test group cancelled: Specimen received beyond stability,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Feb 16, 2026 7:20 AM",6227323244,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,Test group cancelled: Specimen received beyond stability,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Alkaline Phosphatase,,93,,,,,55 - 149,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,5 - 48,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,GGT,,64,,H,,,10 - 61,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,LDH,,105,,,,,53 - 234,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Urea Nitrogen,,1.5,,,,,1.4 - 8.6,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,40 - 110,umol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Glucose,,4.2,,,,,3.9 - 5.6,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Uric Acid,,288,,,,,125 - 488,umol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Phosphorus,,0.85,,,,,0.71 - 1.65,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Albumin-BCG,,39,,,,,33 - 49,g/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Creatine Kinase,,34,,L,,,39 - 308,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Bicarbonate,,25.5,,,,,19.3 - 29.3,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Magnesium,,0.95,,H,,,0.7 - 0.9,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CKD-EPI 2021,CKD-EPI 2021 Without Race,,133,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEPATITIS B SURFACE AB NON-US,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,TB Testing,,"Feb 16, 2026 7:03 AM",6227323252,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Indeterminate,,,,,Normal=Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140326 sponsor-study-36940-test-results-930547-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140326 sponsor-study-36940-test-results-930547-standard.csv new file mode 100644 index 0000000..d606dbc --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140326 sponsor-study-36940-test-results-930547-standard.csv @@ -0,0 +1,500 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Alkaline Phosphatase,,73,,,,,40 - 129,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,5 - 48,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,AST (SGOT),,22,,,,,8 - 40,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,GGT,,18,,,,,10 - 61,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,LDH,,164,,,,,53 - 234,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Glucose,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Uric Acid,,346,,,,,125 - 488,umol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Calcium (EDTA),,2.46,,,,,2.07 - 2.64,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Phosphorus,,1.01,,,,,0.71 - 1.65,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Creatine Kinase,,206,,,,,39 - 308,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Bicarbonate,,20.1,,,,,19.3 - 29.3,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Magnesium,,0.85,,,,,0.66 - 1.07,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,103,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,FECAL COLLECTION D/T,Stool Collection Date,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,FECAL COLLECTION D/T,Stool Collection Time,Y,07:00,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,127 - 181,g/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,33,,,,,26 - 34,pg +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,H,,,79 - 96,fL +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.61,,,,,3.8 - 10.7,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.81,,,,,1.96 - 7.23,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.03,,,,,0.91 - 4.28,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.50,,,,,0.12 - 0.92,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.23,,,,,0 - 0.57,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,50.0,,,,,40.5 - 75,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.1,,,,,15.4 - 48.5,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.9,,,,,2.6 - 10.1,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.0,,,,,0 - 6.8,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,283,,,,,140 - 400,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,09:05,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:10,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,09:05,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,07:00,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SUBJECT HEIGHT (CM),Height (cm),Y,196,,,,,cm, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,25-May-2026,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:05,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,INFLAMED AREA,Inflamed area?,,,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,12:00,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,27-May-2026,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.9,,,,,0 - 6.2,umol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Alkaline Phosphatase,,77,,,,,40 - 129,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,5 - 48,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,GGT,,16,,,,,10 - 61,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,LDH,,159,,,,,53 - 234,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 8.6,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,96,,,,,40 - 110,umol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Glucose,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Uric Acid,,342,,,,,125 - 488,umol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Calcium (EDTA),,2.48,,,,,2.07 - 2.64,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Creatine Kinase,,204,,,,,39 - 308,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Bicarbonate,,21.8,,,,,19.3 - 29.3,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Magnesium,,0.85,,,,,0.66 - 1.07,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,94,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,FECAL COLLECTION D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,FECAL COLLECTION D/T,Stool Collection Time,Y,08:50,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,33,,,,,26 - 34,pg +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 96,fL +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.64,,,,,3.8 - 10.7,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.04,,,,,1.96 - 7.23,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.81,,,,,0.91 - 4.28,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.59,,,,,0.12 - 0.92,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.9,,,,,40.5 - 75,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.0,,,,,15.4 - 48.5,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.4,,H,,,2.6 - 10.1,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.8,,,,,0 - 6.8,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,275,,,,,140 - 400,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,LIPID PANEL,Direct HDL-C 4th Generation,,1.26,,,,,1.03 - 1.53,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,LIPID PANEL,Triglycerides (GPO),,1.63,,,,,0.5 - 2.81,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,LIPID PANEL,Cholesterol (High Performance),,4.71,,,,,3.31 - 6.1,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,LIPID PANEL,LDL Chol Friedewald 4th,,2.70,,,,,0 - 3.34,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,PA1 EEA-2?,Approved to use EEA-2?,,No,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:25,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,11:30,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:25,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,08:50,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SUBJECT HEIGHT (CM),Height (cm),Y,196,,,,,cm, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Alkaline Phosphatase,,95,,,,,35 - 104,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,AST (SGOT),,22,,,,,8 - 40,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,GGT,,34,,,,,4 - 49,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Urea Nitrogen,,2.8,,,,,1.4 - 8.6,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 101,umol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Glucose,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Uric Acid,,357,,,,,125 - 428,umol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Creatine Kinase,,51,,,,,26 - 192,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,95,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,133,,,,,116 - 164,g/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,,26 - 34,pg +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,84,,,,,79 - 98,fL +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.91,,,,,3.8 - 10.7,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.94,,,,,1.96 - 7.23,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.35,,,,,0.91 - 4.28,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.5,,,,,40.5 - 75,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.5,,,,,15.4 - 48.5,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.3,,,,,0 - 2,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,271,,,,,140 - 400,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Alkaline Phosphatase,,88,,,,,40 - 129,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,ALT (SGPT),,36,,,,,5 - 48,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,AST (SGOT),,30,,,,,8 - 40,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,GGT,,21,,,,,10 - 61,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,LDH,,172,,,,,53 - 234,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Urea Nitrogen,,6.2,,,,,1.4 - 8.6,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,71,,,,,40 - 110,umol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Uric Acid,,297,,,,,125 - 488,umol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Phosphorus,,1.22,,,,,0.71 - 1.65,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Creatine Kinase,,177,,,,,39 - 308,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Bicarbonate,,26.7,,,,,19.3 - 29.3,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Magnesium,,0.83,,,,,0.66 - 1.07,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,123,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,FECAL COLLECTION D/T,Stool Collection Date,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,FECAL COLLECTION D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,152,,,,,127 - 181,g/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.31,,,,,3.8 - 10.7,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.98,,,,,1.96 - 7.23,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.64,,,,,0.91 - 4.28,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.30,,,,,0.12 - 0.92,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.30,,,,,0 - 0.57,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,46.0,,,,,40.5 - 75,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.0,,,,,15.4 - 48.5,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.0,,,,,2.6 - 10.1,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,7.0,,H,,,0 - 6.8,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.0,,,,,0 - 2,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,226,,,,,140 - 400,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:45,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:50,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:45,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,21-Apr-2026,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:45,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,12:00,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,23-Apr-2026,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Alkaline Phosphatase,,87,,,,,40 - 129,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,ALT (SGPT),,27,,,,,5 - 48,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,LDH,,174,,,,,53 - 234,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Urea Nitrogen,,5.5,,,,,1.4 - 8.6,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,87,,,,,40 - 110,umol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Uric Acid,,299,,,,,125 - 488,umol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Phosphorus,,1.17,,,,,0.71 - 1.65,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Creatine Kinase,,177,,,,,39 - 308,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Bicarbonate,,26.5,,,,,19.3 - 29.3,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Magnesium,,0.79,,,,,0.66 - 1.07,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,107,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,FECAL COLLECTION D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,FECAL COLLECTION D/T,Stool Collection Time,Y,06:30,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,150,,,,,127 - 181,g/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 96,fL +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.89,,,,,3.8 - 10.7,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.33,,,,,1.96 - 7.23,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.84,,,,,0.91 - 4.28,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.25,,,,,0.12 - 0.92,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.37,,,,,0 - 0.57,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.7,,,,,40.5 - 75,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,37.7,,,,,15.4 - 48.5,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.2,,,,,2.6 - 10.1,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,7.7,R,H,,,0 - 6.8,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.8,,,,,0 - 2,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,217,,,,,140 - 400,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:50,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:00,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:50,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:30,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Alkaline Phosphatase,,69,,,,,40 - 129,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,5 - 48,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,GGT,,15,,,,,10 - 61,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,LDH,,130,,,,,53 - 234,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 8.6,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,82,,,,,40 - 110,umol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Glucose,,7.1,,H,,,3.9 - 5.6,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Uric Acid,,301,,,,,125 - 488,umol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Phosphorus,,1.42,,,,,0.71 - 1.65,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Creatine Kinase,,91,,,,,39 - 308,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Bicarbonate,,22.2,,,,,19.3 - 29.3,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Magnesium,,0.75,,,,,0.66 - 1.07,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,114,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,147,,,,,127 - 181,g/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.39 - 0.54, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,R,L,,,4.5 - 6.4,TI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,34,,,,,26 - 34,pg +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 96,fL +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.60,,,,,3.8 - 10.7,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.44,,,,,1.96 - 7.23,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.11,,,,,0.91 - 4.28,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.65,,,,,0.12 - 0.92,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.28,,,,,0 - 0.57,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.12,,,,,0 - 0.2,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.4,,,,,40.5 - 75,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.8,,,,,15.4 - 48.5,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.6,,,,,2.6 - 10.1,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.7,,,,,0 - 6.8,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.5,,,,,0 - 2,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,256,,,,,140 - 400,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Alkaline Phosphatase,,80,,,,,40 - 129,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,5 - 48,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,LDH,,166,,,,,53 - 234,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Urea Nitrogen,,7.7,,,,,1.4 - 8.6,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Glucose,,4.3,,,,,3.9 - 5.6,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Uric Acid,,336,,,,,125 - 488,umol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Phosphorus,,1.04,,,,,0.71 - 1.65,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Creatine Kinase,,135,,,,,39 - 308,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Bicarbonate,,22.2,,,,,19.3 - 29.3,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Magnesium,,0.78,,,,,0.66 - 1.07,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,103,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,FECAL COLLECTION D/T,Stool Collection Date,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,FECAL COLLECTION D/T,Stool Collection Time,Y,07:30,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,156,,,,,127 - 181,g/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.39 - 0.54, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 96,fL +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.53,,,,,3.8 - 10.7,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.00,,,,,1.96 - 7.23,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.61,,,,,0.91 - 4.28,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.25,,,,,0.12 - 0.92,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.57,,,,,0 - 0.57,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.3,,,,,40.5 - 75,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.0,,,,,15.4 - 48.5,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.6,,,,,2.6 - 10.1,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,10.4,R,H,,,0 - 6.8,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.8,,,,,0 - 2,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,235,,,,,140 - 400,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,LIPID PANEL,Direct HDL-C 4th Generation,,1.91,,H,,,1.03 - 1.53,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,LIPID PANEL,Triglycerides (GPO),,0.67,,,,,0.5 - 2.81,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,LIPID PANEL,Cholesterol (High Performance),,4.26,,,,,3.31 - 6.1,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,LIPID PANEL,LDL Chol Friedewald 4th,,2.04,,,,,0 - 3.34,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,09:40,R,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:45,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,09:40,R,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,07:30,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,12-Mar-2026,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,07:52,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,14-Mar-2026,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.7,,,,,0 - 6.2,umol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Alkaline Phosphatase,,95,,,,,40 - 129,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,5 - 48,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,GGT,,16,,,,,10 - 61,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,LDH,,149,,,,,53 - 234,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Urea Nitrogen,,7.1,,,,,1.4 - 8.6,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Glucose,,6.6,,H,,,3.9 - 5.6,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Uric Acid,,358,,,,,125 - 488,umol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,39 - 308,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Potassium,,3.8,,,,,3.5 - 5.2,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Magnesium,,0.75,,,,,0.66 - 1.07,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,103,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 96,fL +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.82,,,,,3.8 - 10.7,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.88,,,,,1.96 - 7.23,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.03,,,,,0.91 - 4.28,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.26,,,,,0.12 - 0.92,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.57,,,,,0 - 0.57,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,49.4,,,,,40.5 - 75,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.9,,,,,15.4 - 48.5,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.4,,,,,2.6 - 10.1,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,9.9,,H,,,0 - 6.8,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,222,,,,,140 - 400,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,SUBJECT HEIGHT (CM),Height (cm),Y,163,,,,,cm, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140330 sponsor-study-36940-test-results-930547-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140330 sponsor-study-36940-test-results-930547-microbiology.csv new file mode 100644 index 0000000..b9b31df --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140330 sponsor-study-36940-test-results-930547-microbiology.csv @@ -0,0 +1,5 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100132001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Feb 26, 2026 10:35 AM",6227635149,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100132002 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 1, 2026 8:30 AM",6227635148,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100132003 - null,,,,Female,SCRNSTOOL Stool Pathogens,"May 7, 2026 5:45 AM",6227635150,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140333 sponsor-study-36940-test-results-930539-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140333 sponsor-study-36940-test-results-930539-microbiology.csv new file mode 100644 index 0000000..035d1ae --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140333 sponsor-study-36940-test-results-930539-microbiology.csv @@ -0,0 +1,5 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100162001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 24, 2026 8:45 AM",6227635182,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100162001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"May 6, 2026 9:30 AM",6228610564,STOOL CULTURE,,,,Test group cancelled: No specimen received,,,,,,,,,,, +CZ100162002 - null,,,,Male,SCRNSTOOL Stool Pathogens,"May 27, 2026 1:15 PM",6227635180,STOOL CULTURE,,,,,,,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140341 sponsor-study-36940-test-results-930539-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140341 sponsor-study-36940-test-results-930539-standard.csv new file mode 100644 index 0000000..54c2205 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140341 sponsor-study-36940-test-results-930539-standard.csv @@ -0,0 +1,178 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Alkaline Phosphatase,,50,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,AST (SGOT),,10,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,GGT,,15,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,LDH,,167,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Urea Nitrogen,,4.9,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Glucose,,5.7,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Uric Acid,,239,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Calcium (EDTA),,2.22,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Phosphorus,,0.91,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Total Protein,,60,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Albumin-BCG,,35,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Creatine Kinase,,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Sodium,,140,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Potassium,,3.8,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Bicarbonate,,26.1,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Chloride,,102,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Magnesium,,0.88,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,FECAL COLLECTION D/T,Stool Collection Date,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,FECAL COLLECTION D/T,Stool Collection Time,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,118,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,12.78,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,9.55,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.58,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.46,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.8,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,20.3,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,3.6,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,371,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,IS SUBJECT FASTING?,Is Subject Fasting?,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,LIPID PANEL,Direct HDL-C 4th Generation,,1.18,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,LIPID PANEL,Triglycerides (GPO),,1.61,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,LIPID PANEL,Cholesterol (High Performance),,4.55,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,LIPID PANEL,LDL Chol Friedewald 4th,,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,PA1 EEA-2?,Approved to use EEA-2?,,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SUBJECT HEIGHT (CM),Height (cm),Y,,,,,,, +CZ100162002,,,,,Male,Stool Pathogens,,"May 27, 2026 1:15 PM",6227635180,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,,,, +CZ100162002,,,,,Male,Stool Pathogens,,"May 27, 2026 1:15 PM",6227635180,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,,,, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Alkaline Phosphatase,,105,,,,,40 - 129,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,5 - 48,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,LDH,,194,,,,,53 - 234,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,69,,,,,40 - 110,umol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Glucose,,5.9,,H,,,3.9 - 5.6,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Uric Acid,,242,,,,,125 - 488,umol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Phosphorus,,0.82,,,,,0.71 - 1.65,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Creatine Kinase,,67,,,,,39 - 308,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Bicarbonate,,23.9,,,,,19.3 - 29.3,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Magnesium,,0.89,,,,,0.66 - 1.07,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,127 - 181,g/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.92,,,,,3.8 - 10.7,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.54,,,,,1.96 - 7.23,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.14,,,,,0.91 - 4.28,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.20,,,,,0.12 - 0.92,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.03,,,,,0 - 0.57,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,80.1,,H,,,40.5 - 75,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,16.5,,,,,15.4 - 48.5,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,2.8,,,,,2.6 - 10.1,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.4,,,,,0 - 6.8,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.2,,,,,0 - 2,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,363,,,,,140 - 400,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,PA1 EEA-2?,Approved to use EEA-2?,,,,,,,, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,,,,,,, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,SUBJECT HEIGHT (CM),Height (cm),Y,,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,19-May-2026,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:40,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,12:00,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,21-May-2026,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100162001,,,,,Male,Stool Pathogens,,"May 6, 2026 9:30 AM",6228610564,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100162001,,,,,Male,Stool Pathogens,,"May 6, 2026 9:30 AM",6228610564,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100162001,,,,,Male,Stool Pathogens,,"Apr 24, 2026 8:45 AM",6227635182,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,,,, +CZ100162001,,,,,Male,Stool Pathogens,,"Apr 24, 2026 8:45 AM",6227635182,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,,,, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,40 - 129,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,5 - 48,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,GGT,,18,,,,,10 - 61,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,LDH,,186,,,,,53 - 234,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Urea Nitrogen,,6.8,,,,,1.4 - 8.6,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,96,,,,,40 - 110,umol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Glucose,,5.9,,H,,,3.9 - 5.6,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Uric Acid,,233,,,,,125 - 488,umol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Phosphorus,,0.76,,,,,0.71 - 1.65,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Creatine Kinase,,36,R,L,,,39 - 308,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Bicarbonate,,26.8,,,,,19.3 - 29.3,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Magnesium,,0.85,,,,,0.66 - 1.07,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,84,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 96,fL +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,13.56,,H,,,3.8 - 10.7,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,11.03,,H,,,1.96 - 7.23,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.38,,,,,0.91 - 4.28,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.65,,,,,0.12 - 0.92,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.36,,,,,0 - 0.57,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.14,,,,,0 - 0.2,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,81.3,,H,,,40.5 - 75,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,10.2,,L,,,15.4 - 48.5,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.8,,,,,2.6 - 10.1,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.7,,,,,0 - 6.8,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,233,,,,,140 - 400,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140350 sponsor-study-36940-test-results-930557-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140350 sponsor-study-36940-test-results-930557-microbiology.csv new file mode 100644 index 0000000..e9d3b93 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140350 sponsor-study-36940-test-results-930557-microbiology.csv @@ -0,0 +1,6 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100012001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Jan 28, 2026 6:00 AM",6227323211,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,R, +CZ100012001 - null,,,,Male,UNSCSTOOL Stool Pathogens,"Apr 22, 2026 7:00 AM",6228137359,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100012002 - null,,,,Female,SCRNSTOOL Stool Pathogens,"Mar 3, 2026 1:00 PM",6227323212,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100012003 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 29, 2026 7:55 AM",6227323213,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140350 sponsor-study-36940-test-results-930557-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140350 sponsor-study-36940-test-results-930557-standard.csv new file mode 100644 index 0000000..969a6a7 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140350 sponsor-study-36940-test-results-930557-standard.csv @@ -0,0 +1,738 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Alkaline Phosphatase,,90,,,,,40 - 129,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,ALT (SGPT),,27,,,,,5 - 48,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,AST (SGOT),,35,,,,,8 - 40,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,GGT,,63,R,H,,,10 - 61,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,LDH,,167,,,,,53 - 234,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Urea Nitrogen,,7.1,,,,,1.4 - 8.6,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,95,,,,,40 - 110,umol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Glucose,,5.3,,,,,3.9 - 5.6,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Uric Acid,,342,,,,,125 - 488,umol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Calcium (EDTA),,2.56,,,,,2.07 - 2.64,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Phosphorus,,0.97,,,,,0.71 - 1.65,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Total Protein,,84,,,,,61 - 84,g/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Creatine Kinase,,217,,,,,39 - 308,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Potassium,,5.2,,,,,3.5 - 5.2,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Bicarbonate,,20.1,,,,,19.3 - 29.3,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Magnesium,,0.85,,,,,0.66 - 1.07,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,86,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,127 - 181,g/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.49,,,,,0.39 - 0.54, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.4,,,,,4.5 - 6.4,TI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,,26 - 34,pg +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.70,,,,,3.8 - 10.7,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.42,,,,,1.96 - 7.23,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.25,,,,,0.91 - 4.28,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.75,,,,,0.12 - 0.92,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.19,,,,,0 - 0.57,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.0,,,,,40.5 - 75,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.4,,,,,15.4 - 48.5,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.0,,,,,2.6 - 10.1,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.7,,,,,0 - 6.8,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,483,R,H,,,140 - 400,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,SUBJECT HEIGHT (CM),Height (cm),Y,178,,,,,cm, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.0,,,,,0 - 6.2,umol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Alkaline Phosphatase,,104,,,,,40 - 129,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,GGT,,16,,,,,10 - 61,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,LDH,,165,,,,,53 - 234,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Urea Nitrogen,,6.4,,,,,1.4 - 8.6,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 119,umol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Glucose,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Uric Acid,,324,,,,,149 - 494,umol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Phosphorus,,0.82,,,,,0.71 - 1.65,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Creatine Kinase,,82,,,,,39 - 308,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Bicarbonate,,20.6,,,,,19.3 - 29.3,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Magnesium,,0.84,,,,,0.66 - 1.07,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,87,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,FECAL COLLECTION D/T,Stool Collection Date,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,FECAL COLLECTION D/T,Stool Collection Time,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,159,,,,,127 - 181,g/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.50,,,,,0.39 - 0.54, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.4,,,,,4.5 - 6.4,TI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 96,fL +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.01,,,,,3.8 - 10.7,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,7.04,,,,,1.96 - 7.23,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.38,,,,,0.91 - 4.28,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.44,,,,,0.12 - 0.92,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,78.1,,H,,,40.5 - 75,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,15.3,,L,,,15.4 - 48.5,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.9,,,,,2.6 - 10.1,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.2,,,,,0 - 6.8,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,265,,,,,140 - 400,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,LIPID PANEL,Direct HDL-C 4th Generation,,1.34,,,,,1.03 - 1.53,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,LIPID PANEL,Triglycerides (GPO),,0.65,,,,,0.65 - 3.61,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,LIPID PANEL,Cholesterol (High Performance),,4.32,,L,,,4.4 - 7.53,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,LIPID PANEL,LDL Chol Friedewald 4th,,2.68,,,,,0 - 3.34,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SUBJECT HEIGHT (CM),Height (cm),Y,175,,,,,cm, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Alkaline Phosphatase,,62,,,,,40 - 129,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,ALT (SGPT),,46,,,,,5 - 48,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,GGT,,30,,,,,10 - 61,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,LDH,,238,,H,,,53 - 234,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Urea Nitrogen,,4.4,,,,,1.4 - 8.6,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,84,,,,,40 - 110,umol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Uric Acid,,328,,,,,125 - 488,umol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Phosphorus,,1.26,,,,,0.71 - 1.65,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Creatine Kinase,,96,,,,,39 - 308,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Bicarbonate,,25.1,,,,,19.3 - 29.3,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Magnesium,,0.87,,,,,0.66 - 1.07,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,99,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,FECAL COLLECTION D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,142,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.67,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.93,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.10,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,68.4,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,24.3,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.7,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,343,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,LIPID PANEL,Direct HDL-C 4th Generation,,2.02,,H,,,1.03 - 1.53,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,LIPID PANEL,Triglycerides (GPO),,1.21,,,,,0.62 - 3.69,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,LIPID PANEL,Cholesterol (High Performance),,5.32,,,,,4.19 - 7.24,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,LIPID PANEL,LDL Chol Friedewald 4th,,2.75,,,,,0 - 3.34,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,13-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,13-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:30,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,13-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,ANATOMICAL SITE,Anatomical Site,Y,30,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,13-May-2026,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:00,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,15-May-2026,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Alkaline Phosphatase,,99,,,,,35 - 104,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,AST (SGOT),,29,,,,,8 - 40,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,GGT,,23,,,,,5 - 50,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,LDH,,181,,,,,53 - 234,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Urea Nitrogen,,5.3,,,,,1.4 - 10.4,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,54,,,,,31 - 110,umol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Glucose,,6.0,,H,,,3.9 - 5.6,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Uric Acid,,293,,,,,149 - 446,umol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Calcium (EDTA),,2.53,,,,,2.07 - 2.64,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Phosphorus,,1.19,,,,,0.71 - 1.65,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Total Protein,,79,,,,,60 - 80,g/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 46,g/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Creatine Kinase,,143,,,,,26 - 192,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Sodium,,141,,,,,135 - 145,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Bicarbonate,,22.3,,,,,19.3 - 29.3,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Magnesium,,0.91,,,,,0.66 - 0.98,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,91,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,FECAL COLLECTION D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,115 - 158,g/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,3.9 - 5.5,TI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,80 - 100,fL +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.54,,,,,3.8 - 10.7,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.11,,,,,1.96 - 7.23,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.15,,,,,0.8 - 3,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.23,,,,,0.12 - 0.92,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.02,,,,,0 - 0.57,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,46.5,,,,,40.5 - 75,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,47.4,,,,,15.4 - 48.5,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.1,,,,,2.6 - 10.1,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.5,,,,,0 - 6.8,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,117,R,L,,,130 - 394,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,06-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,06-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:05,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,06-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,06-May-2026,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,07:20,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,08-May-2026,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100012003,,,,,Male,Stool Pathogens,,"Apr 29, 2026 7:55 AM",6227323213,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012003,,,,,Male,Stool Pathogens,,"Apr 29, 2026 7:55 AM",6227323213,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Alkaline Phosphatase,,115,,,,,40 - 129,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,ALT (SGPT),,22,,,,,5 - 48,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,GGT,,15,,,,,10 - 61,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,88,,,,,40 - 119,umol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Glucose,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Uric Acid,,306,,,,,149 - 494,umol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Phosphorus,,0.90,,,,,0.71 - 1.65,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,39 - 308,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Bicarbonate,,21.5,,,,,19.3 - 29.3,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Magnesium,,0.90,,,,,0.66 - 1.07,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,91,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,161,,,,,127 - 181,g/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.49,,,,,0.39 - 0.54, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.5,,,,,4.5 - 6.4,TI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.61,,,,,3.8 - 10.7,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.63,,,,,1.96 - 7.23,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.42,,,,,0.91 - 4.28,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.38,,,,,0.12 - 0.92,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.0,,,,,40.5 - 75,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,18.7,,,,,15.4 - 48.5,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.7,,,,,0 - 6.8,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,242,,,,,140 - 400,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,SUBJECT HEIGHT (CM),Height (cm),Y,175,,,,,cm, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.5,,,,,0 - 6.2,umol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Alkaline Phosphatase,,102,,,,,35 - 104,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,GGT,,23,,,,,5 - 50,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,LDH,,154,,,,,53 - 234,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 10.4,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,53,,,,,31 - 110,umol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Glucose,,6.3,,H,,,3.9 - 5.6,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Uric Acid,,252,,,,,149 - 446,umol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Calcium (EDTA),,2.50,,,,,2.07 - 2.64,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Phosphorus,,1.16,,,,,0.71 - 1.65,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Total Protein,,76,,,,,60 - 80,g/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 46,g/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Creatine Kinase,,83,,,,,26 - 192,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Magnesium,,0.94,,,,,0.66 - 0.98,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,91,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,FECAL COLLECTION D/T,Stool Collection Date,Y,23-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,FECAL COLLECTION D/T,Stool Collection Time,Y,07:40,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,144,,,,Result verified by repeat analysis,115 - 158,g/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,Result verified by repeat analysis,3.9 - 5.5,TI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,Result verified by repeat analysis,26 - 34,pg +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,80 - 100,fL +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.47,,L,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.78,,L,,Result verified by repeat analysis,1.96 - 7.23,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.46,,,,,0.8 - 3,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.16,,,,Result verified by repeat analysis,0.12 - 0.92,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,Result verified by repeat analysis,0 - 0.57,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,Result verified by repeat analysis,0 - 0.2,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.4,,,,Result verified by repeat analysis,40.5 - 75,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,42.2,,,,Result verified by repeat analysis,15.4 - 48.5,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.5,,,,Result verified by repeat analysis,2.6 - 10.1,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,Result verified by repeat analysis,0 - 6.8,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,Result verified by repeat analysis,0 - 2,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,118,,L,,Result verified by repeat analysis,130 - 394,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,23-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:40,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,23-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:40,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,23-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,07:40,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.7,,,,,0 - 6.2,umol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Alkaline Phosphatase,,96,,,,,35 - 104,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,AST (SGOT),,28,,,,,8 - 40,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,GGT,,19,,,,,5 - 50,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Urea Nitrogen,,5.3,,,,,1.4 - 10.4,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 110,umol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Glucose,,6.2,R,H,,,3.9 - 5.6,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Uric Acid,,284,,,,,149 - 446,umol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Calcium (EDTA),,2.50,,,,,2.07 - 2.64,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Total Protein,,78,,,,,60 - 80,g/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 46,g/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Creatine Kinase,,113,,,,,26 - 192,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Bicarbonate,,24.0,,,,,19.3 - 29.3,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Magnesium,,0.97,,,,,0.66 - 0.98,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,90,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,FECAL COLLECTION D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,115 - 158,g/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,3.9 - 5.5,TI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,,26 - 34,pg +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,80 - 100,fL +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.59,R,L,,,3.8 - 10.7,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.64,R,L,,,1.96 - 7.23,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.72,,,,,0.8 - 3,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.19,,,,,0.12 - 0.92,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.03,,,,,0 - 0.57,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,45.6,,,,,40.5 - 75,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,47.9,,,,,15.4 - 48.5,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.2,,,,,2.6 - 10.1,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.7,,,,,0 - 6.8,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,126,R,L,,,130 - 394,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,LIPID PANEL,Direct HDL-C 4th Generation,,2.07,R,H,,,1.03 - 1.53,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,LIPID PANEL,Triglycerides (GPO),,1.04,,,,,0.63 - 2.71,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,LIPID PANEL,Cholesterol (High Performance),,4.56,R,L,,,5.35 - 9.1,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,LIPID PANEL,LDL Chol Friedewald 4th,,2.01,,,,,0 - 3.34,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,08-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:15,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SUBJECT HEIGHT (CM),Height (cm),Y,170,,,,,cm, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,AST>/=3XULN,AST >/= 3 X ULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Alkaline Phosphatase,,66,,,,,40 - 129,U/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,ALT (SGPT),,50,,H,,,5 - 48,U/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,AST (SGOT),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,GGT,,25,,,,,10 - 61,U/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Urea Nitrogen,,6.7,,,,,1.4 - 8.6,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Glucose,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Uric Acid,,302,,,,,125 - 488,umol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Calcium (EDTA),,2.50,,,,,2.07 - 2.64,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Phosphorus,,1.95,R,H,,,0.71 - 1.65,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Creatine Kinase,,66,,,,,39 - 308,U/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Bicarbonate,,24.8,,,,,19.3 - 29.3,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Magnesium,,0.95,,,,,0.66 - 1.07,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,92,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,FECAL COLLECTION D/T,Stool Collection Date,Y,17-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.77,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.03,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.25,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.07,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.3,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,18.6,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,327,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,18-Mar-2026,R,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,18-Mar-2026,R,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,18-Mar-2026,R,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,17-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,ANATOMICAL SITE,Anatomical Site,Y,25 DISTANCE IN CM FROM ANAL VERGE,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,18-Mar-2026,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:30,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,20-Mar-2026,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,ALP<2XULN,ALP<2XULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,ALT>/=3XULN,ALT >/= 3 X ULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,AST>/=3XULN,AST >/= 3 X ULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Total Bilirubin,,18,,,,,3 - 21,umol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,ALT (SGPT),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,AST (SGOT),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,GGT,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,80,,,,,40 - 110,umol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Glucose,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Uric Acid,,276,,,,,125 - 488,umol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Calcium (EDTA),,2.24,,,,,2.07 - 2.64,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Phosphorus,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Creatine Kinase,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Potassium,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Bicarbonate,,20.3,,,,,19.3 - 29.3,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Magnesium,,0.88,,,,,0.66 - 1.07,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,105,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,FECAL COLLECTION D/T,Stool Collection Date,Y,03-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,R,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,155,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.48,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 96,fL +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.57,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.08,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.16,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.26,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,73.3,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,20.7,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.7,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,343,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,04-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:00,R,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,04-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:00,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,04-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:00,R,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,03-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,18:00,R,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Alkaline Phosphatase,,100,,,,,35 - 104,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,GGT,,27,,,,,5 - 50,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,LDH,,120,,,,,53 - 234,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Urea Nitrogen,,4.9,,,,,1.4 - 10.4,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,49,,,,,31 - 110,umol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Glucose,,7.0,,H,,,3.9 - 5.6,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Uric Acid,,233,,,,,149 - 446,umol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Total Protein,,75,,,,,60 - 80,g/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 46,g/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Creatine Kinase,,101,,,,,26 - 192,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Potassium,,3.9,,,,,3.5 - 5.2,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Bicarbonate,,22.1,,,,,19.3 - 29.3,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Magnesium,,0.89,,,,,0.66 - 0.98,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,93,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,115 - 158,g/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,3.9 - 5.5,TI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,85,,,,,80 - 100,fL +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.95,,,,,3.8 - 10.7,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.86,,L,,,1.96 - 7.23,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.81,,,,,0.8 - 3,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.25,,,,,0.12 - 0.92,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.02,,,,,0 - 0.57,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.1,,,,,40.5 - 75,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,45.7,,,,,15.4 - 48.5,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.3,,,,,2.6 - 10.1,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.4,,,,,0 - 6.8,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,150,,,,,130 - 394,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,SUBJECT HEIGHT (CM),Height (cm),Y,170,,,,,cm, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Total Bilirubin,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,ALT (SGPT),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,AST (SGOT),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,GGT,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Urea Nitrogen,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Glucose,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Uric Acid,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Calcium (EDTA),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Phosphorus,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Total Protein,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Albumin-BCG,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Creatine Kinase,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Sodium,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Potassium,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Bicarbonate,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Chloride,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Magnesium,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CKD-EPI 2021,CKD-EPI 2021 Without Race,,Required testing unavailable,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,FECAL COLLECTION D/T,Stool Collection Date,Y,18-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.88,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.46,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.78,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.47,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.4,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,31.2,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.3,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,330,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,LIPID PANEL,Direct HDL-C 4th Generation,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,LIPID PANEL,Triglycerides (GPO),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,LIPID PANEL,Cholesterol (High Performance),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,LIPID PANEL,LDL Chol Friedewald 4th,,Required testing unavailable,,,,,0 - 3.34,mmol/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,19-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:20,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,19-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:50,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,19-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:20,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,18-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,ANATOMICAL SITE,Anatomical Site,Y,30,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,05-Feb-2026,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:30,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,07-Feb-2026,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Alkaline Phosphatase,,61,,,,,40 - 129,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,5 - 48,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,GGT,,24,,,,,10 - 61,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,LDH,,146,,,,,53 - 234,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,79,,,,,40 - 110,umol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Glucose,,5.5,,,,,3.9 - 5.6,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Uric Acid,,338,,,,,125 - 488,umol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Phosphorus,,0.48,,LT,,Result verified by repeat analysis,0.71 - 1.65,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Creatine Kinase,,60,,,,,39 - 308,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Bicarbonate,,25.1,,,,,19.3 - 29.3,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Magnesium,,0.92,,,,,0.66 - 1.07,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CKD-EPI 2021,CKD-EPI 2021 Without Race,,106,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.92,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.40,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.00,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.27,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,69.1,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,20.2,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.1,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.0,,,,,0 - 2,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,309,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEPATITIS B SURFACE AB NON-US,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140353 sponsor-study-36940-test-results-930553-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140353 sponsor-study-36940-test-results-930553-microbiology.csv new file mode 100644 index 0000000..95b16c0 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140353 sponsor-study-36940-test-results-930553-microbiology.csv @@ -0,0 +1,4 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100092001 - null,,,,Female,SCRNSTOOL Stool Pathogens,"Apr 2, 2026 6:15 AM",6227323340,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100092002 - null,,,,Female,SCRNSTOOL Stool Pathogens,"Apr 20, 2026 6:10 AM",6227323341,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140402 sponsor-study-36940-test-results-930553-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140402 sponsor-study-36940-test-results-930553-standard.csv new file mode 100644 index 0000000..2a84d67 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140402 sponsor-study-36940-test-results-930553-standard.csv @@ -0,0 +1,250 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Total Bilirubin,,17,,,,,3 - 21,umol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.0,,,,,0 - 6.2,umol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,35 - 104,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,GGT,,15,,,,,4 - 49,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,LDH,,154,,,,,53 - 234,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Urea Nitrogen,,3.4,,,,,1.4 - 8.6,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,73,,,,,31 - 101,umol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Uric Acid,,196,,,,,149 - 446,umol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Calcium (EDTA),,2.47,,,,,2.07 - 2.64,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Phosphorus,,1.10,,,,,0.71 - 1.65,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,26 - 192,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Sodium,,136,,,,,132 - 147,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,86,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,FECAL COLLECTION D/T,Stool Collection Date,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,FECAL COLLECTION D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,116 - 164,g/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,32,,,,,26 - 34,pg +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.57,,,,,3.8 - 10.7,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.33,,,,,1.96 - 7.23,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.77,,,,,0.91 - 4.28,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.9,,,,,40.5 - 75,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.9,,,,,15.4 - 48.5,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.4,,,,,2.6 - 10.1,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.8,,,,,0 - 6.8,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,258,,,,,140 - 400,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:50,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,11:55,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:50,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.5,,,,,0 - 6.2,umol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Alkaline Phosphatase,,55,,,,,35 - 104,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,4 - 43,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,GGT,,13,,,,,4 - 49,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,LDH,,152,,,,,53 - 234,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,62,,,,,31 - 101,umol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Glucose,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Uric Acid,,178,,,,,149 - 446,umol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Creatine Kinase,,87,,,,,26 - 192,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Bicarbonate,,21.5,,,,,19.3 - 29.3,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Magnesium,,0.94,,,,,0.66 - 1.07,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,105,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,FECAL COLLECTION D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,FECAL COLLECTION D/T,Stool Collection Time,Y,06:30,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,116 - 164,g/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 98,fL +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.60,,,,,3.8 - 10.7,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.94,,,,,1.96 - 7.23,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.22,,,,,0.91 - 4.28,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.32,,,,,0.12 - 0.92,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.9,,,,,40.5 - 75,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.5,,,,,15.4 - 48.5,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,207,,,,,140 - 400,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,LIPID PANEL,Direct HDL-C 4th Generation,,1.70,,H,,,1.03 - 1.53,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,LIPID PANEL,Triglycerides (GPO),,0.59,,,,,0.59 - 2.96,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,LIPID PANEL,Cholesterol (High Performance),,4.49,,,,,4.42 - 7.53,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,LIPID PANEL,LDL Chol Friedewald 4th,,2.52,,,,,0 - 3.34,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,PA1 EEA-2?,Approved to use EEA-2?,,No,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,11:30,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,12:45,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,11:30,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,06:30,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100092002,,,,,Female,TB Testing,,"May 5, 2026 9:00 AM",6227323348,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,24-Apr-2026,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,11:09,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,12:00,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,29-Apr-2026,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Alkaline Phosphatase,,56,,,,,35 - 104,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,4 - 43,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,GGT,,10,,,,,4 - 49,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,LDH,,159,,,,,53 - 234,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Urea Nitrogen,,6.1,,,,,1.4 - 8.6,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,90,,,,,31 - 101,umol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Uric Acid,,268,,,,,149 - 446,umol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Phosphorus,,1.14,,,,,0.71 - 1.65,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Creatine Kinase,,176,,,,,26 - 192,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Bicarbonate,,27.2,,,,,19.3 - 29.3,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Magnesium,,0.93,,,,,0.66 - 1.07,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,65,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,138,,,,,116 - 164,g/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,32,,,,,26 - 34,pg +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.05,,,,,3.8 - 10.7,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.87,,L,,,1.96 - 7.23,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.72,,,,,0.91 - 4.28,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,46.1,,,,,40.5 - 75,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,42.6,,,,,15.4 - 48.5,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,,2.6 - 10.1,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.4,,,,,0 - 6.8,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,216,,,,,140 - 400,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Positive,,RX,,Result verified by repeat analysis,Normal=Negative, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,SERUM BETA HCG,"B-hCG, Quantitative",,0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Alkaline Phosphatase,,56,,,,,35 - 104,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,4 - 43,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,GGT,,12,,,,,4 - 49,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,LDH,,137,,,,,53 - 234,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Urea Nitrogen,,2.7,,,,,1.4 - 8.6,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Glucose,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Uric Acid,,207,,,,,125 - 428,umol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Phosphorus,,1.15,,,,,0.71 - 1.65,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Creatine Kinase,,81,,,,,26 - 192,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Bicarbonate,,23.7,,,,,19.3 - 29.3,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Magnesium,,0.91,,,,,0.66 - 1.07,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,107,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,147,,,,,116 - 164,g/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.74,,,,,3.8 - 10.7,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.76,,,,,1.96 - 7.23,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.18,,,,,0.91 - 4.28,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.46,,,,,0.12 - 0.92,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.26,,,,,0 - 0.57,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.5,,,,,40.5 - 75,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,20.6,,,,,15.4 - 48.5,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.9,,,,,2.6 - 10.1,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.5,,,,,0 - 6.8,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.5,,,,,0 - 2,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,263,,,,,140 - 400,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,PA1 EEA-2?,Approved to use EEA-2?,,No,,,,,, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140413 sponsor-study-36940-test-results-930536-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140413 sponsor-study-36940-test-results-930536-microbiology.csv new file mode 100644 index 0000000..4dfdeb2 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140413 sponsor-study-36940-test-results-930536-microbiology.csv @@ -0,0 +1,3 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100201001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 13, 2026 6:00 AM",6227993971,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140415 sponsor-study-36940-test-results-930536-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140415 sponsor-study-36940-test-results-930536-standard.csv new file mode 100644 index 0000000..0f4a823 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140415 sponsor-study-36940-test-results-930536-standard.csv @@ -0,0 +1,127 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,2003 SCHWARTZ EGFR,2003 Schwartz eGFR,,191,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.0,,,,,0 - 6.2,umol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Alkaline Phosphatase,,282,,,,,82 - 331,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,6 - 43,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,AST (SGOT),,26,,,,,10 - 40,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,GGT,,15,,,,,0 - 51,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,LDH,,214,,,,,105 - 235,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,51,,,,,23 - 83,umol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Glucose,,4.3,,,,,3.9 - 5.6,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Uric Acid,,336,,,,,184 - 416,umol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Calcium (EDTA),,2.47,,,,,2.1 - 2.57,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Phosphorus,,1.58,,,,,0.71 - 1.65,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Total Protein,,85,,H,,,61 - 84,g/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,29 - 47,g/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Creatine Kinase,,65,,,,,18 - 363,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Sodium,,136,,,,,132 - 147,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.7 - 0.9,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CRP COPY,C Reactive Protein COPY,,1.9,,,,,0.4 - 2,mg/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,FECAL CALPROTECTIN COPY,Fecal Calprotectin COPY,,3749.9,,H,,,Normal: <80ug/g$Borderline: 80-160$ug/g. Elevated:>160$ug/g, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,FECAL COLLECTION D/T,Stool Collection Date,Y,17-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,114,,L,,,127 - 181,g/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,L,,,0.39 - 0.54, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,L,,,4.5 - 6.4,TI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,27,,,,,26 - 34,pg +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.73,,,,,4.35 - 13.15,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.06,,,,,1.65 - 8.15,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.42,,,,,0.95 - 5.25,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.83,,,,,0.4 - 1.3,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.34,,H,,,0 - 0.3,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,52.0,,,,,40.5 - 75,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.1,,,,,15.4 - 48.5,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.5,,H,,,4 - 8,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.5,,H,,,0 - 2.8,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 1,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,607,,H,,,140 - 400,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,LIPID PANEL,Direct HDL-C 4th Generation,,1.27,,,,,1.03 - 1.53,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,LIPID PANEL,Triglycerides (GPO),,1.17,,,,,0.42 - 1.67,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,LIPID PANEL,Cholesterol (High Performance),,3.50,,,,,2.95 - 5.12,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,LIPID PANEL,LDL Chol Friedewald 4th,,1.69,,,,,0 - 3.34,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,18-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,09:28,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,18-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:52,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,18-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,09:28,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,17-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SUBJECT HEIGHT (CM),Height (cm),Y,157,,,,,cm, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,ANATOMICAL SITE,Anatomical Site,Y,20-25,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,15-Apr-2026,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,13:00,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,17-Apr-2026,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,2003 SCHWARTZ EGFR,2003 Schwartz eGFR,,211,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.2,,,,,0 - 6.2,umol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Alkaline Phosphatase,,322,,,,,82 - 331,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,6 - 43,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,AST (SGOT),,29,,,,,10 - 40,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,GGT,,17,,,,,0 - 51,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,LDH,,221,,,,,105 - 235,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,46,,,,,23 - 83,umol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Glucose,,4.1,,,,,3.9 - 5.6,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Uric Acid,,326,,,,,184 - 416,umol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Calcium (EDTA),,2.57,,,,,2.1 - 2.57,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Phosphorus,,1.72,,H,,,0.71 - 1.65,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Total Protein,,87,,H,,,61 - 84,g/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,29 - 47,g/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Creatine Kinase,,94,,,,,18 - 363,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Sodium,,136,,,,,132 - 147,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Bicarbonate,,20.7,,,,,19.3 - 29.3,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Magnesium,,0.77,,,,,0.7 - 0.9,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,118,,L,,Result verified by repeat analysis,127 - 181,g/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,L,,,0.39 - 0.54, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,L,,Result verified by repeat analysis,4.5 - 6.4,TI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,Result verified by repeat analysis,26 - 34,pg +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.04,,,,Result verified by repeat analysis,4.35 - 13.15,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.19,,,,Result verified by repeat analysis,1.65 - 8.15,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.73,,,,,0.95 - 5.25,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.77,,,,Result verified by repeat analysis,0.4 - 1.3,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.29,,,,Result verified by repeat analysis,0 - 0.3,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,Result verified by repeat analysis,0 - 0.2,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.7,,,,Result verified by repeat analysis,40.5 - 75,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,37.2,,,,Result verified by repeat analysis,15.4 - 48.5,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.6,,,,Result verified by repeat analysis,4 - 8,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,H,,Result verified by repeat analysis,0 - 2.8,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,Result verified by repeat analysis,0 - 1,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,490,,H,,Result verified by repeat analysis,140 - 400,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,SUBJECT HEIGHT (CM),Height (cm),Y,157,,,,,cm, +CZ100201001,,,,,Male,Stool Pathogens,,"Apr 13, 2026 6:00 AM",6227993971,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100201001,,,,,Male,Stool Pathogens,,"Apr 13, 2026 6:00 AM",6227993971,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140431 sponsor-study-36940-test-results-930531-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140431 sponsor-study-36940-test-results-930531-microbiology.csv new file mode 100644 index 0000000..9f10aa5 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140431 sponsor-study-36940-test-results-930531-microbiology.csv @@ -0,0 +1,3 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100212001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Mar 1, 2026 2:00 PM",6227635213,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140435 sponsor-study-35472-test-results-898745-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140435 sponsor-study-35472-test-results-898745-standard.csv new file mode 100644 index 0000000..d9b79db --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140435 sponsor-study-35472-test-results-898745-standard.csv @@ -0,0 +1,2448 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 12,/HPF +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Alkaline Phosphatase,,87,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,GGT,,30,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,LDH,,154,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,49,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Uric Acid,,314,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Calcium (EDTA),,2.51,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Phosphorus,,1.25,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Creatine Kinase,,202,,H,,,26 - 192,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Bicarbonate,,21.2,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,144,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.81,,,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.47,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.67,,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.43,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,50.7,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,41.7,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.8,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,504,,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.6,,H,,,<6.5 %, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,23.94,,H,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,LIPID PANEL,Direct HDL-C 4th Generation,,1.34,,,,,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,LIPID PANEL,Triglycerides (GPO),,2.54,,H,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,LIPID PANEL,Cholesterol (High Performance),,6.04,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,LIPID PANEL,LDL Chol Friedewald 4th,,3.54,,H,,,0 - 3.34,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,TSH,TSH 3rd IS-QT,,3.138,,,,,0.45 - 5.33,mIU/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Specific Gravity,,1.020,,,,,1 - 1.04, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,C-REACTIVE PROTEIN,C Reactive Protein HS,,10.2,,H,,,0 - 5,mg/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Alkaline Phosphatase,,90,,,,,35 - 104,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,GGT,,22,,,,,5 - 50,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,LDH,,185,,,,,53 - 234,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 10.4,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,64,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Glucose Fasting,,6.3,R,H,,,3.9 - 5.6,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Uric Acid,,316,,,,,149 - 446,umol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Phosphorus,,1.07,,,,,0.71 - 1.65,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Total Protein,,80,,,,,60 - 80,g/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Albumin-BCG,,47,R,H,,,33 - 46,g/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Creatine Kinase,,88,,,,,26 - 192,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Sodium,,136,,,,,135 - 145,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Bicarbonate,,18.7,R,L,,,19.3 - 29.3,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,163,R,H,,,115 - 158,g/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.50,R,H,,,0.34 - 0.48, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,3.9 - 5.5,TI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,80 - 100,fL +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,11.22,R,H,,,3.8 - 10.7,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.82,,,,,1.96 - 7.23,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.47,R,H,,,0.8 - 3,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.75,,,,,0.12 - 0.92,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.8,,,,,40.5 - 75,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.9,,,,,15.4 - 48.5,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,285,,,,,130 - 394,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.9,,,,,<6.5 %, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,15.61,,,,,1.9 - 23,uIU/mL +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,LIPID PANEL,Direct HDL-C 4th Generation,,1.36,,,,,1.03 - 1.53,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,LIPID PANEL,Triglycerides (GPO),,2.89,R,H,,,0.63 - 2.71,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,LIPID PANEL,Cholesterol (High Performance),,7.08,,,,,5.35 - 9.1,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,LIPID PANEL,LDL Chol Friedewald 4th,,4.40,,H,,,0 - 3.34,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,TSH,TSH 3rd IS-QT,,0.546,,,,,0.45 - 5.33,mIU/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Specific Gravity,,1.016,,,,,1.01 - 1.03, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Blood,,Trace,,,,,Ref Rng:$Negative-Trace, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.3,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CELLULAR ELEMENTS,Ur WBC/HPF,,8,,,,,0 - 12,/HPF +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.2,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Alkaline Phosphatase,,83,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,ALT (SGPT),,22,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,GGT,,32,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,LDH,,169,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,51,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Uric Acid,,383,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Calcium (EDTA),,2.52,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Creatine Kinase,,201,,H,,,26 - 192,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Bicarbonate,,21.6,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,95,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.33,,,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.06,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.53,,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.53,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.6,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.1,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.1,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,525,R,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,16.12,,,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,LIPID PANEL,Direct HDL-C 4th Generation,,1.37,,,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,LIPID PANEL,Triglycerides (GPO),,2.79,,H,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,LIPID PANEL,Cholesterol (High Performance),,6.50,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,LIPID PANEL,LDL Chol Friedewald 4th,,3.85,,H,,,0 - 3.34,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,RETICULOCYTES,Reticulocyte Count %,,1.5,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Specific Gravity,,1.029,,,,,1 - 1.04, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Alkaline Phosphatase,,66,,,,,35 - 104,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,GGT,,36,,,,,4 - 49,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,LDH,,192,,,,,53 - 234,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Glucose Fasting,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Uric Acid,,277,,,,,149 - 446,umol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Calcium (EDTA),,2.08,,,,,2.07 - 2.64,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Phosphorus,,0.90,,,,,0.71 - 1.65,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Total Protein,,62,,,,,61 - 84,g/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Creatine Kinase,,84,,,,,26 - 192,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Sodium,,144,,,,,132 - 147,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Potassium,,3.5,,,,,3.5 - 5.2,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Bicarbonate,,22.5,,,,,19.3 - 29.3,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Chloride,,109,,,,,94 - 112,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,132,,,,,116 - 164,g/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.40,,,,,3.8 - 10.7,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.63,,,,,1.96 - 7.23,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.90,,,,,0.91 - 4.28,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.78,,,,,0.12 - 0.92,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,48.8,,,,,40.5 - 75,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.1,,,,,15.4 - 48.5,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,14.4,R,H,,,2.6 - 10.1,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,248,,,,,140 - 400,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.25,,,,,1.9 - 23,uIU/mL +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,LIPID PANEL,Direct HDL-C 4th Generation,,1.92,,H,,,1.03 - 1.53,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,LIPID PANEL,Triglycerides (GPO),,1.20,,,,,0.59 - 2.96,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,LIPID PANEL,Cholesterol (High Performance),,3.66,,L,,,4.42 - 7.53,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,LIPID PANEL,LDL Chol Friedewald 4th,,1.19,,,,,0 - 3.34,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,TSH,TSH 3rd IS-QT,,3.352,,,,,0.45 - 5.33,mIU/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Alkaline Phosphatase,,137,,H,,,35 - 104,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,4 - 43,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,GGT,,14,,,,,5 - 50,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,LDH,,170,,,,,53 - 234,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Urea Nitrogen,,5.3,,,,,1.4 - 8.6,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,61,,,,,31 - 101,umol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Glucose Fasting,,5.6,,,,,3.9 - 5.6,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Uric Acid,,204,,,,,149 - 446,umol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Phosphorus,,0.96,,,,,0.71 - 1.65,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Total Protein,,73,,,,,60 - 80,g/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Creatine Kinase,,78,,,,,26 - 192,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Sodium,,145,,,,,135 - 145,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Bicarbonate,,21.6,,,,,19.3 - 29.3,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Chloride,,109,,,,,94 - 112,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,150,,,,,115 - 158,g/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.34 - 0.48, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,3.9 - 5.5,TI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,80 - 100,fL +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.17,,,,,3.8 - 10.7,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.80,,,,,1.96 - 7.23,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.79,,,,,0.8 - 3,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.41,,,,,0.12 - 0.92,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.0,,,,,40.5 - 75,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.9,,,,,15.4 - 48.5,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.3,,,,,0 - 2,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,239,,,,,130 - 394,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.88,,,,,1.9 - 23,uIU/mL +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,LIPID PANEL,Direct HDL-C 4th Generation,,1.85,,H,,,1.03 - 1.53,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,LIPID PANEL,Triglycerides (GPO),,0.61,,L,,,0.63 - 2.71,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,LIPID PANEL,Cholesterol (High Performance),,5.06,,,,,4.86 - 8.28,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,LIPID PANEL,LDL Chol Friedewald 4th,,2.93,,,,,0 - 3.34,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,TSH,TSH 3rd IS-QT,,0.955,,,,,0.45 - 5.33,mIU/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1.01 - 1.03, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.2,,,,,0 - 5,mg/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.0,,,,,0 - 6.2,umol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Alkaline Phosphatase,,62,,,,,35 - 104,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,4 - 43,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,GGT,,16,,,,,5 - 50,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,64,,,,,31 - 101,umol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Glucose Fasting,,5.8,,H,,,3.9 - 5.6,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Uric Acid,,216,,,,,149 - 446,umol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Total Protein,,63,,,,,60 - 80,g/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Creatine Kinase,,151,,,,,26 - 192,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Sodium,,142,,,,,135 - 145,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Bicarbonate,,21.4,,,,,19.3 - 29.3,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Chloride,,108,,,,,94 - 112,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,152,,,,,115 - 158,g/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.34 - 0.48, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,3.9 - 5.5,TI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,100,,,,,80 - 100,fL +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.94,,,,,3.8 - 10.7,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.03,,,,,1.96 - 7.23,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.45,,,,,0.8 - 3,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.32,,,,,0.12 - 0.92,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,75.9,R,H,,,40.5 - 75,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,18.3,,,,,15.4 - 48.5,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.0,,,,,2.6 - 10.1,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,244,,,,,130 - 394,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.00,,,,,1.9 - 23,uIU/mL +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,LIPID PANEL,Direct HDL-C 4th Generation,,1.24,,,,,1.03 - 1.53,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,LIPID PANEL,Triglycerides (GPO),,0.74,,,,,0.63 - 2.71,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,LIPID PANEL,Cholesterol (High Performance),,4.25,,L,,,4.86 - 8.28,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,LIPID PANEL,LDL Chol Friedewald 4th,,2.67,,,,,0 - 3.34,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,TSH,TSH 3rd IS-QT,,1.798,,,,,0.45 - 5.33,mIU/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Specific Gravity,,1.016,,,,,1.01 - 1.03, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Alkaline Phosphatase,,81,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,GGT,,19,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,LDH,,193,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Urea Nitrogen,,4.7,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Uric Acid,,206,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Phosphorus,,1.36,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Creatine Kinase,,82,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Sodium,,145,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Bicarbonate,,25.9,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,139,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.84,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.66,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.78,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.27,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.0,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.8,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.7,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.7,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,274,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.31,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,LIPID PANEL,Direct HDL-C 4th Generation,,1.64,,H,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,LIPID PANEL,Triglycerides (GPO),,0.68,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,LIPID PANEL,Cholesterol (High Performance),,5.02,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,LIPID PANEL,LDL Chol Friedewald 4th,,3.07,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,TSH,TSH 3rd IS-QT,,1.896,,,,,0.45 - 5.33,mIU/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Specific Gravity,,1.022,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.6,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Alkaline Phosphatase,,88,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,GGT,,32,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,LDH,,156,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,39,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Uric Acid,,335,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Calcium (EDTA),,2.12,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Phosphorus,,1.07,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Albumin-BCG,,39,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Creatine Kinase,,135,,,,,26 - 192,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Bicarbonate,,20.2,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Chloride,,109,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,DIRECT LDL,Direct LDL-C 3rd Gen,,3.40,,H,,,<3.36 mmol/L, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,11.75,,H,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.71,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,4.08,,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.60,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.24,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.11,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.1,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.7,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.1,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,550,,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.7,R,H,,,<6.5 %, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,73.67,R,H,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,LIPID PANEL,Direct HDL-C 4th Generation,,1.00,,L,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,LIPID PANEL,Triglycerides (GPO),,5.91,,H SF,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,LIPID PANEL,Cholesterol (High Performance),,5.54,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,LIPID PANEL,LDL Chol Friedewald 4th,,,,,Test cancelled: Invalid/High Triglycerides,,, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,RETICULOCYTES,Reticulocyte Count %,,1.7,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,TSH,TSH 3rd IS-QT,,2.578,,,,,0.45 - 5.33,mIU/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1 - 1.04, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Alkaline Phosphatase,,69,,,,,35 - 104,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,4 - 43,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,AST (SGOT),,36,,,,,8 - 40,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,GGT,,43,,,,,4 - 49,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,LDH,,193,,,,,53 - 234,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Uric Acid,,321,,,,,149 - 446,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Calcium (EDTA),,2.13,,,,,2.07 - 2.64,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Phosphorus,,0.91,,,,,0.71 - 1.65,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Creatine Kinase,,93,,,,,26 - 192,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Potassium,,3.7,,,,,3.5 - 5.2,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Bicarbonate,,25.6,,,,,19.3 - 29.3,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Chloride,,107,,,,,94 - 112,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.65,,,,,1.25 - 1.92,mL/sec +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,75.1,,,,,kg, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,GFR,EGFR by MDRD,,81,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,116 - 164,g/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.08,,,,,3.8 - 10.7,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.60,,,,,1.96 - 7.23,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.79,,,,,0.91 - 4.28,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.52,,,,,0.12 - 0.92,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.1,,,,,40.5 - 75,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.3,,,,,15.4 - 48.5,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.2,R,H,,,2.6 - 10.1,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.4,,,,,0 - 6.8,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,267,,,,,140 - 400,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.13,,,,,1.9 - 23,uIU/mL +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,LIPID PANEL,Direct HDL-C 4th Generation,,2.21,,H,,,1.03 - 1.53,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,LIPID PANEL,Triglycerides (GPO),,0.81,,,,,0.59 - 2.96,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,LIPID PANEL,Cholesterol (High Performance),,3.95,,L,,,4.42 - 7.53,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,LIPID PANEL,LDL Chol Friedewald 4th,,1.37,,,,,0 - 3.34,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,TSH,TSH 3rd IS-QT,,3.004,,,,,0.45 - 5.33,mIU/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Specific Gravity,,1.020,,,,,1 - 1.04, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.0,,,,,0 - 5,mg/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,35 - 104,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,GGT,,17,,,,,5 - 50,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,LDH,,163,,,,,53 - 234,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 10.4,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Uric Acid,,265,,,,,149 - 446,umol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Phosphorus,,1.45,,,,,0.71 - 1.65,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Total Protein,,78,,,,,60 - 80,g/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Albumin-BCG,,47,R,H,,,33 - 46,g/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Creatine Kinase,,80,,,,,26 - 192,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Bicarbonate,,21.7,,,,,19.3 - 29.3,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,159,R,H,,,115 - 158,g/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.34 - 0.48, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,3.9 - 5.5,TI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,80 - 100,fL +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.76,,,,,3.8 - 10.7,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.09,,,,,1.96 - 7.23,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.77,R,H,,,0.8 - 3,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.73,,,,,0.12 - 0.92,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,52.1,,,,,40.5 - 75,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.6,,,,,15.4 - 48.5,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.5,,,,,2.6 - 10.1,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.2,,,,,0 - 6.8,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,307,,,,,130 - 394,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.8,,,,,<6.5 %, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,LIPID PANEL,Direct HDL-C 4th Generation,,1.36,,,,,1.03 - 1.53,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,LIPID PANEL,Triglycerides (GPO),,3.03,,H,,,0.63 - 2.71,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,LIPID PANEL,Cholesterol (High Performance),,7.15,,,,,5.35 - 9.1,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,LIPID PANEL,LDL Chol Friedewald 4th,,4.40,,H,,,0 - 3.34,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,TSH,TSH 3rd IS-QT,,1.854,,,,,0.45 - 5.33,mIU/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Specific Gravity,,1.012,,,,,1.01 - 1.03, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Alkaline Phosphatase,,100,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,ALT (SGPT),,30,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,GGT,,18,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,LDH,,235,,H,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Uric Acid,,308,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Creatine Kinase,,119,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Bicarbonate,,24.5,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.03,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.95,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.62,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.32,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.6,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.2,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.3,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.5,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Platelet clumps present,,, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,8.28,,,,,1.9 - 23,uIU/mL +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,LIPID PANEL,Direct HDL-C 4th Generation,,1.34,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,LIPID PANEL,Triglycerides (GPO),,1.17,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,LIPID PANEL,Cholesterol (High Performance),,6.97,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,LIPID PANEL,LDL Chol Friedewald 4th,,5.09,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,RETICULOCYTES,Reticulocyte Count %,,1.7,,,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,TSH,TSH 3rd IS-QT,,,,,Test group cancelled: No specimen received,,, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Specific Gravity,,1.022,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.8,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CELLULAR ELEMENTS,Ur WBC/HPF,,7,,,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.1,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Alkaline Phosphatase,,86,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,ALT (SGPT),,61,R,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,AST (SGOT),,37,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,GGT,,25,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,LDH,,181,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Glucose Fasting,,6.1,R,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Uric Acid,,287,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Phosphorus,,1.16,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Total Protein,,64,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Creatine Kinase,,52,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Bicarbonate,,25.7,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.52,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.64,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.27,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.38,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.7,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.2,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,310,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.4,,,,,<6.5 %, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,18.47,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,LIPID PANEL,Direct HDL-C 4th Generation,,0.95,R,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,LIPID PANEL,Triglycerides (GPO),,1.13,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,LIPID PANEL,Cholesterol (High Performance),,2.38,,L,,Result verified by repeat analysis,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,LIPID PANEL,LDL Chol Friedewald 4th,,0.91,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,RETICULOCYTES,Reticulocyte Count %,,2.0,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,TSH,TSH 3rd IS-QT,,0.827,,,,,0.45 - 5.33,mIU/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Leukocyte Esterase,,+2,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Total Bilirubin,,19,,,,,3 - 21,umol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.6,,,,,0 - 6.2,umol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Alkaline Phosphatase,,122,,H,,,35 - 104,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,GGT,,12,,,,,5 - 50,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,LDH,,154,,,,,53 - 234,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 8.6,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Glucose Fasting,,6.3,,H,,,3.9 - 5.6,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Uric Acid,,223,,,,,149 - 446,umol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Phosphorus,,0.91,,,,,0.71 - 1.65,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Total Protein,,68,,,,,60 - 80,g/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Creatine Kinase,,85,,,,,26 - 192,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,147,,,,,115 - 158,g/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.34 - 0.48, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,3.9 - 5.5,TI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,94,,,,,80 - 100,fL +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.41,,,,,3.8 - 10.7,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.51,,,,,1.96 - 7.23,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.33,,,,,0.8 - 3,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.35,,,,,0.12 - 0.92,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.7,,,,,40.5 - 75,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.2,,,,,15.4 - 48.5,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.5,,,,,2.6 - 10.1,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,232,,,,,130 - 394,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.38,,,,,1.9 - 23,uIU/mL +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,LIPID PANEL,Direct HDL-C 4th Generation,,1.74,R,H,,,1.03 - 1.53,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,LIPID PANEL,Triglycerides (GPO),,0.57,R,L,,,0.63 - 2.71,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,LIPID PANEL,Cholesterol (High Performance),,4.75,R,L,,,4.86 - 8.28,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,LIPID PANEL,LDL Chol Friedewald 4th,,2.75,,,,,0 - 3.34,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1.01 - 1.03, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,C-REACTIVE PROTEIN,C Reactive Protein HS,,8.5,R,H,,,0 - 5,mg/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Alkaline Phosphatase,,61,,,,,35 - 104,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,4 - 43,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,GGT,,14,,,,,5 - 50,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,LDH,,150,,,,,53 - 234,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Urea Nitrogen,,4.4,,,,,1.4 - 8.6,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Uric Acid,,207,,,,,149 - 446,umol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Phosphorus,,0.89,,,,,0.71 - 1.65,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Total Protein,,63,,,,,60 - 80,g/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Creatine Kinase,,78,,,,,26 - 192,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Sodium,,142,,,,,135 - 145,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Chloride,,107,,,,,94 - 112,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,149,,,,,115 - 158,g/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,3.9 - 5.5,TI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,80 - 100,fL +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.75,,,,,3.8 - 10.7,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.15,,,,,1.96 - 7.23,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.07,,,,,0.8 - 3,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.38,,,,,0.12 - 0.92,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,72.1,,,,,40.5 - 75,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,18.6,,,,,15.4 - 48.5,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,234,,,,,130 - 394,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.19,,,,,1.9 - 23,uIU/mL +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,LIPID PANEL,Direct HDL-C 4th Generation,,1.30,,,,,1.03 - 1.53,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,LIPID PANEL,Triglycerides (GPO),,0.41,,L,,,0.63 - 2.71,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,LIPID PANEL,Cholesterol (High Performance),,4.53,,L,,,4.86 - 8.28,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,LIPID PANEL,LDL Chol Friedewald 4th,,3.04,,,,,0 - 3.34,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1.01 - 1.03, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Alkaline Phosphatase,,78,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,ALT (SGPT),,29,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,GGT,,23,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,LDH,,214,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,80,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Uric Acid,,248,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Phosphorus,,0.93,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Total Protein,,64,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Creatine Kinase,,128,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Bicarbonate,,25.8,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,138,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,94,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.44,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.15,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.79,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.9,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.9,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.7,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,290,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.23,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,LIPID PANEL,Direct HDL-C 4th Generation,,1.67,,H,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,LIPID PANEL,Triglycerides (GPO),,0.88,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,LIPID PANEL,Cholesterol (High Performance),,5.28,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,LIPID PANEL,LDL Chol Friedewald 4th,,3.21,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,TSH,TSH 3rd IS-QT,,1.525,,,,,0.45 - 5.33,mIU/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur pH,,7.0,,,,,5 - 8, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.4,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.8,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Alkaline Phosphatase,,81,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,GGT,,52,,H,,,4 - 49,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,LDH,,153,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Urea Nitrogen,,3.3,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,66,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Uric Acid,,273,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Phosphorus,,1.02,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Creatine Kinase,,118,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Bicarbonate,,23.2,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,131,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.38,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.04,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.60,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.23,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.6,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,40.7,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.6,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.6,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,315,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.2,,,,,<6.5 %, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.83,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,LIPID PANEL,Direct HDL-C 4th Generation,,1.70,,H,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,LIPID PANEL,Triglycerides (GPO),,2.24,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,LIPID PANEL,Cholesterol (High Performance),,5.71,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,LIPID PANEL,LDL Chol Friedewald 4th,,2.98,,,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,RETICULOCYTES,Reticulocyte Count %,,1.9,,,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,TSH,TSH 3rd IS-QT,,4.319,,,,,0.45 - 5.33,mIU/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Specific Gravity,,1.021,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.0,,,,,0 - 5,mg/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Alkaline Phosphatase,,130,,H,,,35 - 104,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,ALT (SGPT),,10,,,,,4 - 43,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,GGT,,13,,,,,5 - 50,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Urea Nitrogen,,5.6,,,,,1.4 - 8.6,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Uric Acid,,232,,,,,149 - 446,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Calcium (EDTA),,2.49,,,,,2.07 - 2.64,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Phosphorus,,0.93,,,,,0.71 - 1.65,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Total Protein,,73,,,,,60 - 80,g/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Creatine Kinase,,59,,,,,26 - 192,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Sodium,,141,,,,,135 - 145,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Bicarbonate,,25.2,,,,,19.3 - 29.3,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.61,,,,,1.25 - 1.92,mL/sec +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,75.5,,,,,kg, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,FSH,Follicle Stimulating Hormone,,57.83,,,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,GFR,EGFR by MDRD,,83,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,159,R,H,,,115 - 158,g/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.49,R,H,,,0.34 - 0.48, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,3.9 - 5.5,TI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,80 - 100,fL +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.19,,,,,3.8 - 10.7,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.31,,,,,1.96 - 7.23,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.30,,,,,0.8 - 3,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.18,,,,,0 - 0.57,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.5,,,,,40.5 - 75,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,37.2,,,,,15.4 - 48.5,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.5,,,,,2.6 - 10.1,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,,,,0 - 6.8,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,255,,,,,130 - 394,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.27,,,,,1.9 - 23,uIU/mL +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,LIPID PANEL,Direct HDL-C 4th Generation,,1.70,,H,,,1.03 - 1.53,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,LIPID PANEL,Triglycerides (GPO),,0.84,,,,,0.63 - 2.71,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,LIPID PANEL,Cholesterol (High Performance),,5.60,,,,,4.86 - 8.28,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,LIPID PANEL,LDL Chol Friedewald 4th,,3.52,,H,,,0 - 3.34,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,TSH,TSH 3rd IS-QT,,0.932,,,,,0.45 - 5.33,mIU/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1.01 - 1.03, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CELLULAR ELEMENTS,Ur WBC/HPF,,48,R,H,,,0 - 12,/HPF +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,GGT,,28,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,LDH,,141,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,52,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Glucose Fasting,,6.7,R,H,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Uric Acid,,325,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Calcium (EDTA),,2.52,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Phosphorus,,1.23,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Creatine Kinase,,205,R,H,,,26 - 192,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Bicarbonate,,24.4,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,138,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.95,,,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.30,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.84,R,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.62,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.3,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.6,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.2,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.4,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,486,R,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,118.97,R,H,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,LIPID PANEL,Direct HDL-C 4th Generation,,1.32,,,,,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,LIPID PANEL,Triglycerides (GPO),,2.60,R,H,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,LIPID PANEL,Cholesterol (High Performance),,5.47,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,LIPID PANEL,LDL Chol Friedewald 4th,,2.96,,,,,0 - 3.34,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Specific Gravity,,1.033,R,,,,1 - 1.04, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Protein,,+2,R,H SF,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Ketones,,Trace,R,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,R,H SF,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,C-REACTIVE PROTEIN,C Reactive Protein HS,,9.0,R,H,,,0 - 5,mg/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CELLULAR ELEMENTS,Ur WBC/HPF,,6,,,,,0 - 12,/HPF +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CELLULAR ELEMENTS,Ur Squamous Epithelial Cells,,38,,,,,0 - 3,/HPF +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Alkaline Phosphatase,,65,,,,,35 - 104,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,GGT,,16,,,,,5 - 50,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,LDH,,183,,,,,53 - 234,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Uric Acid,,133,R,L,,,149 - 446,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Phosphorus,,0.91,,,,,0.71 - 1.65,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Total Protein,,63,,,,,60 - 80,g/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Creatine Kinase,,87,,,,,26 - 192,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Bicarbonate,,22.0,,,,,19.3 - 29.3,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.29,,,,,1.25 - 1.92,mL/sec +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,58.2,,,,,kg, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,GFR,EGFR by MDRD,,90,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,148,,,,,115 - 158,g/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.34 - 0.48, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,3.9 - 5.5,TI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,99,,,,,80 - 100,fL +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.46,,,,,3.8 - 10.7,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.63,,,,,1.96 - 7.23,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.19,,,,,0.8 - 3,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,66.4,,,,,40.5 - 75,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,21.7,,,,,15.4 - 48.5,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.0,,,,,2.6 - 10.1,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,247,,,,,130 - 394,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.23,,,,,1.9 - 23,uIU/mL +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,LIPID PANEL,Direct HDL-C 4th Generation,,1.28,,,,,1.03 - 1.53,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,LIPID PANEL,Triglycerides (GPO),,0.70,,,,,0.63 - 2.71,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,LIPID PANEL,Cholesterol (High Performance),,4.86,,,,,4.86 - 8.28,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,LIPID PANEL,LDL Chol Friedewald 4th,,3.26,,,,,0 - 3.34,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,TSH,TSH 3rd IS-QT,,1.723,,,,,0.45 - 5.33,mIU/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1.01 - 1.03, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Protein,,Trace,R,H,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Glucose,,Trace,R,H,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.1,,,,,0 - 5,mg/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,35 - 104,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,4 - 43,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,GGT,,17,,,,,5 - 50,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Urea Nitrogen,,6.7,,,,,1.4 - 10.4,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,70,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Glucose Fasting,,5.7,R,H,,,3.9 - 5.6,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Uric Acid,,312,,,,,149 - 446,umol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Phosphorus,,1.48,,,,,0.71 - 1.65,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 46,g/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Creatine Kinase,,66,,,,,26 - 192,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Bicarbonate,,21.8,,,,,19.3 - 29.3,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,161,R,H,,,115 - 158,g/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.48,,,,,0.34 - 0.48, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.3,,,,,3.9 - 5.5,TI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,80 - 100,fL +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.57,,,,,3.8 - 10.7,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.16,,,,,1.96 - 7.23,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.42,R,H,,,0.8 - 3,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.76,,,,,0.12 - 0.92,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.0,,,,,40.5 - 75,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.8,,,,,15.4 - 48.5,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.0,,,,,2.6 - 10.1,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,300,,,,,130 - 394,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.83,,,,,1.9 - 23,uIU/mL +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,LIPID PANEL,Direct HDL-C 4th Generation,,1.33,,,,,1.03 - 1.53,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,LIPID PANEL,Triglycerides (GPO),,2.03,,,,,0.63 - 2.71,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,LIPID PANEL,Cholesterol (High Performance),,6.94,,,,,5.35 - 9.1,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,LIPID PANEL,LDL Chol Friedewald 4th,,4.68,,H,,,0 - 3.34,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1.01 - 1.03, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CELLULAR ELEMENTS,Ur WBC/HPF,,5,,,,,0 - 12,/HPF +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CELLULAR ELEMENTS,Ur Transitional Epi Cells,,1,,,,,0 /HPF, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Alkaline Phosphatase,,79,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,ALT (SGPT),,21,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,GGT,,17,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,LDH,,205,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,73,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Uric Acid,,239,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Phosphorus,,1.25,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Bicarbonate,,25.3,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.66,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.75,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.38,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.9,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.6,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.4,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.6,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,312,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.82,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,LIPID PANEL,Direct HDL-C 4th Generation,,1.68,,H,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,LIPID PANEL,Triglycerides (GPO),,0.71,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,LIPID PANEL,Cholesterol (High Performance),,5.23,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,LIPID PANEL,LDL Chol Friedewald 4th,,3.22,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.4,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CELLULAR ELEMENTS,Ur WBC/HPF,,>150,,HT,,,0 - 12,/HPF +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Alkaline Phosphatase,,76,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,GGT,,25,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,LDH,,130,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,53,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Uric Acid,,357,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Phosphorus,,1.26,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Creatine Kinase,,154,,,,,26 - 192,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Bicarbonate,,23.0,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.63,,H,,,1.25 - 1.92,mL/sec +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,53,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,87.2,,,,,kg, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,GFR,EGFR by MDRD,,107,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,142,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,11.22,R,H,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.93,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.51,,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.50,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.22,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.8,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,31.3,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.4,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,509,R,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.4,,,,,<6.5 %, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,39.05,,H,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,LIPID PANEL,Direct HDL-C 4th Generation,,1.21,,,,,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,LIPID PANEL,Triglycerides (GPO),,3.23,,H,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,LIPID PANEL,Cholesterol (High Performance),,5.80,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,LIPID PANEL,LDL Chol Friedewald 4th,,3.11,,,,,0 - 3.34,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,RETICULOCYTES,Reticulocyte Count %,,1.9,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,TSH,TSH 3rd IS-QT,,2.280,,,,,0.45 - 5.33,mIU/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,C-REACTIVE PROTEIN,C Reactive Protein HS,,7.3,,H,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CELLULAR ELEMENTS,Ur WBC/HPF,,32,,H,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.9,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,ALT (SGPT),,55,,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,AST (SGOT),,30,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,GGT,,27,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,LDH,,175,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Glucose Fasting,,7.2,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Uric Acid,,263,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Phosphorus,,0.95,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Creatine Kinase,,38,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Bicarbonate,,25.0,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,159,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.29,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.53,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.07,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.45,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.2,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.5,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.2,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.1,,,,,0 - 2,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,296,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.4,,,,,<6.5 %, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,33.25,,H,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,LIPID PANEL,Direct HDL-C 4th Generation,,1.02,,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,LIPID PANEL,Triglycerides (GPO),,1.15,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,LIPID PANEL,Cholesterol (High Performance),,2.80,,L,,,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,LIPID PANEL,LDL Chol Friedewald 4th,,1.25,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,TSH,TSH 3rd IS-QT,,0.595,,,,,0.45 - 5.33,mIU/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Specific Gravity,,1.015,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.8,,,,,0 - 5,mg/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CELLULAR ELEMENTS,Ur RBC/HPF,,1,,,,,0 - 8,/HPF +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 12,/HPF +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Alkaline Phosphatase,,87,,,,,35 - 104,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,4 - 43,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,GGT,,15,,,,,5 - 50,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,LDH,,150,,,,,53 - 234,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 10.4,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Glucose Fasting,,7.0,,H,,,3.9 - 5.6,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Uric Acid,,320,,,,,149 - 446,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Phosphorus,,1.31,,,,,0.71 - 1.65,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Total Protein,,78,,,,,60 - 80,g/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 46,g/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Creatine Kinase,,87,,,,,26 - 192,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.29,,,,,1.25 - 1.92,mL/sec +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,68.5,,,,,kg, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,FSH,Follicle Stimulating Hormone,,78.10,,,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,GFR,EGFR by MDRD,,81,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,165,,H,,,115 - 158,g/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.48,,,,,0.34 - 0.48, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.3,,,,,3.9 - 5.5,TI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,80 - 100,fL +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.07,,,,,3.8 - 10.7,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.15,,,,,1.96 - 7.23,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.08,,H,,,0.8 - 3,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.65,,,,,0.12 - 0.92,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.0,,,,,40.5 - 75,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.6,,,,,15.4 - 48.5,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.4,,,,,0 - 6.8,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,269,,,,,130 - 394,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.9,,,,,<6.5 %, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,47.53,,H,,,1.9 - 23,uIU/mL +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,LIPID PANEL,Direct HDL-C 4th Generation,,1.28,,,,,1.03 - 1.53,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,LIPID PANEL,Triglycerides (GPO),,1.84,,,,,0.63 - 2.71,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,LIPID PANEL,Cholesterol (High Performance),,6.82,,,,,5.35 - 9.1,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,LIPID PANEL,LDL Chol Friedewald 4th,,4.70,,H,,,0 - 3.34,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,TSH,TSH 3rd IS-QT,,1.806,,,,,0.45 - 5.33,mIU/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1.01 - 1.03, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Blood,,Trace,,,,,Ref Rng:$Negative-Trace, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.0,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CELLULAR ELEMENTS,Ur WBC/HPF,,27,,H,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.7,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Alkaline Phosphatase,,84,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,ALT (SGPT),,53,,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,GGT,,26,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,LDH,,172,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Glucose Fasting,,6.8,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Uric Acid,,279,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Phosphorus,,1.21,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Creatine Kinase,,45,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Bicarbonate,,25.1,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.45,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.94,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.68,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.51,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.24,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.4,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,31.7,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,302,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,13.07,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,LIPID PANEL,Direct HDL-C 4th Generation,,0.98,,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,LIPID PANEL,Triglycerides (GPO),,0.95,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,LIPID PANEL,Cholesterol (High Performance),,2.57,,L,,Result verified by repeat analysis,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,LIPID PANEL,LDL Chol Friedewald 4th,,1.15,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CELLULAR ELEMENTS,Ur WBC/HPF,,5,,,,,0 - 12,/HPF +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CELLULAR ELEMENTS,Ur Transitional Epi Cells,,1,,,,,0 /HPF, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Alkaline Phosphatase,,71,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,GGT,,18,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,LDH,,203,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Urea Nitrogen,,3.2,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,70,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Uric Acid,,221,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Phosphorus,,1.12,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Total Protein,,64,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Creatine Kinase,,96,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Bicarbonate,,27.1,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.16,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.30,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.50,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.23,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.2,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.0,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.5,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.0,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,272,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.3,,,,,<6.5 %, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.94,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,LIPID PANEL,Direct HDL-C 4th Generation,,1.49,,,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,LIPID PANEL,Triglycerides (GPO),,0.80,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,LIPID PANEL,Cholesterol (High Performance),,4.76,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,LIPID PANEL,LDL Chol Friedewald 4th,,2.90,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,TSH,TSH 3rd IS-QT,,1.175,,,,,0.45 - 5.33,mIU/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Specific Gravity,,1.016,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur pH,,7.0,,,,,5 - 8, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.8,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Total Bilirubin,,4,,,,Result verified by repeat analysis,3 - 21,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Alkaline Phosphatase,,78,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,ALT (SGPT),,40,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,AST (SGOT),,33,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,GGT,,49,,,,,4 - 49,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Uric Acid,,300,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Phosphorus,,1.35,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Creatine Kinase,,102,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Bicarbonate,,25.0,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,126,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.9,,L,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.94,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.95,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.05,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.61,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.29,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,42.5,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,43.9,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.7,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.2,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,341,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.3,,,,,<6.5 %, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.23,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,LIPID PANEL,Direct HDL-C 4th Generation,,1.37,,,,,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,LIPID PANEL,Triglycerides (GPO),,1.49,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,LIPID PANEL,Cholesterol (High Performance),,4.70,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,LIPID PANEL,LDL Chol Friedewald 4th,,2.65,,,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,RETICULOCYTES,Reticulocyte Count %,,2.7,,H,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,TSH,TSH 3rd IS-QT,,3.282,,,,,0.45 - 5.33,mIU/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.5,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.2,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Alkaline Phosphatase,,99,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,ALT (SGPT),,30,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,AST (SGOT),,30,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,GGT,,18,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,LDH,,205,,,,,53 - 234,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Uric Acid,,323,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Calcium (EDTA),,2.27,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Creatine Kinase,,161,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Potassium,,3.7,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Bicarbonate,,24.3,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,144,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.41,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.46,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.53,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.25,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.7,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.8,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.3,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Platelet clumps present,,, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.7,,,,,<6.5 %, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,8.57,,,,,1.9 - 23,uIU/mL +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,LIPID PANEL,Direct HDL-C 4th Generation,,1.14,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,LIPID PANEL,Triglycerides (GPO),,1.23,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,LIPID PANEL,Cholesterol (High Performance),,6.67,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,LIPID PANEL,LDL Chol Friedewald 4th,,4.97,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,RETICULOCYTES,Reticulocyte Count %,,1.5,,,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,TSH,TSH 3rd IS-QT,,2.238,,,,,0.45 - 5.33,mIU/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.3,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CELLULAR ELEMENTS,Ur WBC/HPF,,9,,,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.8,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,ALT (SGPT),,50,,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,GGT,,24,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,LDH,,167,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Glucose Fasting,,6.3,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Uric Acid,,274,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Phosphorus,,1.21,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Creatine Kinase,,45,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Potassium,,5.0,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Bicarbonate,,25.7,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.24,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.24,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.33,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.45,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.6,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.3,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,330,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.1,,,,,<6.5 %, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,14.65,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,LIPID PANEL,Direct HDL-C 4th Generation,,1.03,,,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,LIPID PANEL,Triglycerides (GPO),,1.18,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,LIPID PANEL,Cholesterol (High Performance),,2.69,,L,,,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,LIPID PANEL,LDL Chol Friedewald 4th,,1.12,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,TSH,TSH 3rd IS-QT,,1.264,,,,,0.45 - 5.33,mIU/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Specific Gravity,,1.021,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.8,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 12,/HPF +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,GGT,,22,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,LDH,,199,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,69,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Uric Acid,,242,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Phosphorus,,1.18,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Creatine Kinase,,113,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Bicarbonate,,29.7,,H,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.80,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.73,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.58,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.36,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,56.9,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.9,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.6,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,308,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,1.74,,L,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,LIPID PANEL,Direct HDL-C 4th Generation,,1.50,,,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,LIPID PANEL,Triglycerides (GPO),,0.88,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,LIPID PANEL,Cholesterol (High Performance),,5.66,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,LIPID PANEL,LDL Chol Friedewald 4th,,3.76,,H,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Specific Gravity,,1.016,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur pH,,7.5,,,,,5 - 8, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.0,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Alkaline Phosphatase,,72,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,GGT,,45,,,,,4 - 49,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,LDH,,135,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,59,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Uric Acid,,277,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Creatine Kinase,,94,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Bicarbonate,,23.2,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,125,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,R,L,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.92,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.08,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.93,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.56,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.31,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,44.5,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,42.3,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.1,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.4,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,304,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.03,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,LIPID PANEL,Direct HDL-C 4th Generation,,1.36,,,,,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,LIPID PANEL,Triglycerides (GPO),,2.05,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,LIPID PANEL,Cholesterol (High Performance),,5.46,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,LIPID PANEL,LDL Chol Friedewald 4th,,3.16,,,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,TSH,TSH 3rd IS-QT,,1.135,,,,,0.45 - 5.33,mIU/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.8,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Alkaline Phosphatase,,100,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,ALT (SGPT),,29,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,AST (SGOT),,33,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,GGT,,17,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,LDH,,257,,H,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Uric Acid,,318,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Creatine Kinase,,276,,H,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Bicarbonate,,24.3,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.48,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.40,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.48,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.5,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.1,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.9,R,H,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.2,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,143,,,,,140 - 400,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.90,,,,,1.9 - 23,uIU/mL +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,LIPID PANEL,Direct HDL-C 4th Generation,,1.12,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,LIPID PANEL,Triglycerides (GPO),,1.26,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,LIPID PANEL,Cholesterol (High Performance),,5.71,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,LIPID PANEL,LDL Chol Friedewald 4th,,4.01,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Specific Gravity,,1.020,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CELLULAR ELEMENTS,Ur WBC/HPF,,10,,,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.2,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Alkaline Phosphatase,,91,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,ALT (SGPT),,49,,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,AST (SGOT),,31,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,GGT,,22,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,LDH,,176,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Glucose Fasting,,6.8,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Uric Acid,,282,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Calcium (EDTA),,2.46,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Phosphorus,,1.34,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Creatine Kinase,,51,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Potassium,,5.1,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Bicarbonate,,22.7,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,147,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.87,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.64,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.53,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.42,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.20,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.9,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.3,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.5,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,294,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,12.54,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,LIPID PANEL,Direct HDL-C 4th Generation,,0.96,,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,LIPID PANEL,Triglycerides (GPO),,0.90,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,LIPID PANEL,Cholesterol (High Performance),,2.39,,L,,Result verified by repeat analysis,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,LIPID PANEL,LDL Chol Friedewald 4th,,1.02,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Leukocyte Esterase,,+2,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CELLULAR ELEMENTS,Ur RBC/HPF,,1,,,,,0 - 8,/HPF +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CELLULAR ELEMENTS,Ur WBC/HPF,,7,,,,,0 - 12,/HPF +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Alkaline Phosphatase,,84,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,GGT,,21,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,LDH,,206,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,78,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Glucose Fasting,,5.5,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Uric Acid,,260,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Phosphorus,,1.17,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Creatine Kinase,,107,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Bicarbonate,,22.4,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.58,,,,,1.25 - 1.92,mL/sec +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,78,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,81.6,,,,,kg, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,GFR,EGFR by MDRD,,67,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.09,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.99,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.48,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.12,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.8,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.2,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.0,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.3,,H,,,0 - 2,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,313,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.1,,,,,<6.5%, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.19,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,LIPID PANEL,Direct HDL-C 4th Generation,,1.52,,,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,LIPID PANEL,Triglycerides (GPO),,1.01,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,LIPID PANEL,Cholesterol (High Performance),,5.29,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,LIPID PANEL,LDL Chol Friedewald 4th,,3.31,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,TSH,TSH 3rd IS-QT,,1.461,,,,,0.45 - 5.33,mIU/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Protein,,Trace,R,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.5,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.7,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Alkaline Phosphatase,,77,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,ALT (SGPT),,27,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,GGT,,45,,,,,4 - 49,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Urea Nitrogen,,3.5,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Uric Acid,,261,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Phosphorus,,1.12,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Creatine Kinase,,99,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Bicarbonate,,21.9,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,126,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.55,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.59,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.09,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.63,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.20,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.9,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.7,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.3,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.6,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,324,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.08,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,LIPID PANEL,Direct HDL-C 4th Generation,,1.54,,H,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,LIPID PANEL,Triglycerides (GPO),,2.08,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,LIPID PANEL,Cholesterol (High Performance),,5.37,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,LIPID PANEL,LDL Chol Friedewald 4th,,2.88,,,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.5,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CELLULAR ELEMENTS,Ur WBC/HPF,,5,,,,,0 - 12,/HPF +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.0,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Alkaline Phosphatase,,99,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,ALT (SGPT),,32,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,AST (SGOT),,32,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,GGT,,18,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,LDH,,232,,,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Urea Nitrogen,,4.7,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Glucose Fasting,,5.3,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Uric Acid,,392,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Creatine Kinase,,160,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.39,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.58,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.36,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.31,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.8,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.9,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.1,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Platelet clumps present,,, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.8,,,,,<6.5%, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,LIPID PANEL,Direct HDL-C 4th Generation,,1.11,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,LIPID PANEL,Triglycerides (GPO),,1.60,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,LIPID PANEL,Cholesterol (High Performance),,6.83,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,LIPID PANEL,LDL Chol Friedewald 4th,,4.99,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,RETICULOCYTES,Reticulocyte Count %,,1.7,,,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,TSH,TSH 3rd IS-QT,,2.025,,,,,0.45 - 5.33,mIU/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Specific Gravity,,1.018,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur pH,,7.0,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,R,H,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.9,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CELLULAR ELEMENTS,Ur WBC/HPF,,42,,H,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.7,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Alkaline Phosphatase,,83,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,ALT (SGPT),,69,,H RX,,,4 - 43,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,AST (SGOT),,40,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,GGT,,27,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,LDH,,190,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Urea Nitrogen,,3.8,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Glucose Fasting,,7.5,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Uric Acid,,309,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Phosphorus,,1.28,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Creatine Kinase,,48,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Bicarbonate,,24.7,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.65,,,,,1.25 - 1.92,mL/sec +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,79.2,,,,,kg, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,GFR,EGFR by MDRD,,74,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.69,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.48,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.44,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.48,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.23,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,66.8,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,25.1,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.9,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,324,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,6.6,,H,,,<6.5%, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,13.86,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,LIPID PANEL,Direct HDL-C 4th Generation,,0.89,,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,LIPID PANEL,Triglycerides (GPO),,1.13,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,LIPID PANEL,Cholesterol (High Performance),,2.44,,L,,Result verified by repeat analysis,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,LIPID PANEL,LDL Chol Friedewald 4th,,1.03,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,RETICULOCYTES,Reticulocyte Count %,,2.0,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,TSH,TSH 3rd IS-QT,,1.524,,,,,0.45 - 5.33,mIU/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.1,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Alkaline Phosphatase,,82,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,GGT,,47,,,,,4 - 49,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,LDH,,153,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,69,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Uric Acid,,322,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Calcium (EDTA),,2.47,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Total Protein,,79,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Creatine Kinase,,104,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Bicarbonate,,22.9,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.88,,,,,1.25 - 1.92,mL/sec +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,69,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,78.6,,,,,kg, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,Result verified by repeat analysis,Neg;$Cutoff = 50 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,GFR,EGFR by MDRD,,80,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,106,,H,,,79 - 98,fL +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.54,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.33,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.64,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.36,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,42.0,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,47.6,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.7,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,301,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.3,,,,,<6.5%, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.36,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,LIPID PANEL,Direct HDL-C 4th Generation,,1.94,,H,,,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,LIPID PANEL,Triglycerides (GPO),,1.55,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,LIPID PANEL,Cholesterol (High Performance),,6.28,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,LIPID PANEL,LDL Chol Friedewald 4th,,3.63,,H,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,TSH,TSH 3rd IS-QT,,1.391,,,,,0.45 - 5.33,mIU/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Specific Gravity,,1.018,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.1,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Alkaline Phosphatase,,104,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,ALT (SGPT),,30,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,GGT,,20,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,LDH,,224,,,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Uric Acid,,358,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Phosphorus,,1.33,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Creatine Kinase,,159,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Bicarbonate,,23.6,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,135,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.75,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.17,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.12,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,45.7,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,44.7,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.1,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,157,,,,,140 - 400,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,11.38,,,,,1.9 - 23,uIU/mL +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,LIPID PANEL,Direct HDL-C 4th Generation,,1.10,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,LIPID PANEL,Triglycerides (GPO),,1.77,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,LIPID PANEL,Cholesterol (High Performance),,6.54,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,LIPID PANEL,LDL Chol Friedewald 4th,,4.63,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,RETICULOCYTES,Reticulocyte Count %,,3.5,,H,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Specific Gravity,,1.015,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Retest,,"Aug 19, 2025 10:00 AM",6225351002,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040001,,,56,years,Female,Retest,,"Aug 19, 2025 10:00 AM",6225351002,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CELLULAR ELEMENTS,Ur WBC/HPF,,10,,,,,0 - 12,/HPF +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Alkaline Phosphatase,,106,,H,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,ALT (SGPT),,28,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,GGT,,19,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,LDH,,241,,H,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,87,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Glucose Fasting,,6.5,,H,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Uric Acid,,349,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Phosphorus,,0.95,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Creatine Kinase,,140,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Bicarbonate,,23.9,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.23,,L,,,1.25 - 1.92,mL/sec +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,87,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,72.5,,,,,kg, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,FSH,Follicle Stimulating Hormone,,50.25,,,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,GFR,EGFR by MDRD,,59,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,139,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.75,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.40,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.88,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,50.5,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,39.4,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.3,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,163,,,,,140 - 400,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,4.7,,,,,<6.5%, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,LIPID PANEL,Direct HDL-C 4th Generation,,0.97,,L,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,LIPID PANEL,Triglycerides (GPO),,3.99,,H,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,LIPID PANEL,Cholesterol (High Performance),,6.69,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,LIPID PANEL,LDL Chol Friedewald 4th,,3.89,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,RETICULOCYTES,Reticulocyte Count %,,2.9,,H,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,TSH,TSH 3rd IS-QT,,2.272,,,,,0.45 - 5.33,mIU/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Protein,,Trace,R,H,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,R,H,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140436 sponsor-study-36940-test-results-930531-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140436 sponsor-study-36940-test-results-930531-standard.csv new file mode 100644 index 0000000..4d4b87b --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140436 sponsor-study-36940-test-results-930531-standard.csv @@ -0,0 +1,243 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Total Bilirubin,,4,,,,Result verified by repeat analysis,3 - 21,umol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Alkaline Phosphatase,,113,,,,,40 - 129,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,ALT (SGPT),,12,,,,,5 - 48,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,GGT,,23,,,,,10 - 50,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,LDH,,195,,,,,53 - 234,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Urea Nitrogen,,2.7,,,,,1.4 - 8.6,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,73,,,,,40 - 119,umol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Glucose,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Uric Acid,,409,,,,,149 - 494,umol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Phosphorus,,1.01,,,,,0.71 - 1.65,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Total Protein,,73,,,,,60 - 80,g/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Creatine Kinase,,159,,,,,39 - 308,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Potassium,,5.1,,,,,3.5 - 5.2,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Magnesium,,0.90,,,,,0.66 - 0.98,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,100,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,FECAL COLLECTION D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,FECAL COLLECTION D/T,Stool Collection Time,Y,06:50,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,98,,L,,,125 - 170,g/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.34,,L,,,0.37 - 0.51, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4 - 5.8,TI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,22,,L,,Result verified by repeat analysis,26 - 34,pg +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Microcytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,76,,L,,,80 - 100,fL +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.13,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.41,,,,,1.96 - 7.23,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.42,,,,,0.8 - 3,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.93,,H,,,0.12 - 0.92,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.29,,,,,0 - 0.57,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,70.2,,,,,40.5 - 75,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,15.6,,,,,15.4 - 48.5,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.1,,,,,2.6 - 10.1,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.1,,,,,0 - 6.8,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,812,,HT,,,130 - 394,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:00,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,13:00,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:00,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:50,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Unable to calc due to LOQ,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Unable to calc due to LOQ,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,Result verified by repeat analysis,0 - 6.2,umol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Alkaline Phosphatase,,112,,,,,40 - 129,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,5 - 48,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,GGT,,27,,,,,10 - 50,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,LDH,,150,,,,,53 - 234,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Urea Nitrogen,,2.4,,,,,1.4 - 8.6,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,74,,,,,40 - 119,umol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Glucose,,6.1,,H,,,3.9 - 5.6,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Uric Acid,,378,,,,,149 - 494,umol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Phosphorus,,1.02,,,,,0.71 - 1.65,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Total Protein,,70,,,,,60 - 80,g/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Albumin-BCG,,40,,,,,33 - 49,g/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Creatine Kinase,,77,,,,,39 - 308,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Potassium,,5.2,,,,,3.5 - 5.2,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Bicarbonate,,22.9,,,,,19.3 - 29.3,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Magnesium,,0.87,,,,,0.66 - 0.98,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,99,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,FECAL COLLECTION D/T,Stool Collection Date,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,FECAL COLLECTION D/T,Stool Collection Time,Y,06:00,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,106,,L,,,125 - 170,g/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,L,,,0.37 - 0.51, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4 - 5.8,TI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,23,,L,,,26 - 34,pg +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,77,,L,,,80 - 100,fL +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.30,,,,,3.8 - 10.7,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.31,,,,,1.96 - 7.23,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.61,,,,,0.8 - 3,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.94,,H,,,0.12 - 0.92,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.35,,,,,0 - 0.57,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,67.8,,,,,40.5 - 75,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,17.3,,,,,15.4 - 48.5,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.2,,H,,,2.6 - 10.1,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.8,,,,,0 - 6.8,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,796,,HT,,,130 - 394,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:45,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:24,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:45,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:00,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Alkaline Phosphatase,,121,,,,,40 - 129,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,ALT (SGPT),,13,,,,,5 - 48,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,GGT,,39,,,,,10 - 50,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,LDH,,158,,,,,53 - 234,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Urea Nitrogen,,3.0,,,,,1.4 - 8.6,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,80,,,,,40 - 119,umol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Uric Acid,,446,,,,,149 - 494,umol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Total Protein,,74,,,,,60 - 80,g/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Creatine Kinase,,64,,,,,39 - 308,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Sodium,,141,,,,,135 - 145,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Potassium,,5.2,,,,,3.5 - 5.2,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Bicarbonate,,21.0,,,,,19.3 - 29.3,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Magnesium,,0.88,,,,,0.66 - 0.98,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,97,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,FECAL COLLECTION D/T,Stool Collection Date,Y,06-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,FECAL COLLECTION D/T,Stool Collection Time,Y,16:00,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,113,,L,,,125 - 170,g/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.37 - 0.51, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4 - 5.8,TI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,23,,L,,,26 - 34,pg +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Anisocytosis,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,79,,L,,,80 - 100,fL +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,12.49,,H,,,3.8 - 10.7,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,8.91,,H,,,1.96 - 7.23,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.02,,,,,0.8 - 3,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,1.14,,H,,,0.12 - 0.92,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.33,,,,,0 - 0.57,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.3,,,,,40.5 - 75,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,16.2,,,,,15.4 - 48.5,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.1,,,,,2.6 - 10.1,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.6,,,,,0 - 6.8,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,584,,H,,,130 - 394,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,LIPID PANEL,Direct HDL-C 4th Generation,,1.01,R,L,,,1.03 - 1.53,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,LIPID PANEL,Triglycerides (GPO),,1.57,,,,,0.65 - 2.94,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,LIPID PANEL,Cholesterol (High Performance),,5.40,,,,,4.53 - 7.71,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,LIPID PANEL,LDL Chol Friedewald 4th,,3.67,,H,,,0 - 3.34,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:37,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,07-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,11:55,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:37,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,06-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,16:00,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,ANATOMICAL SITE,Anatomical Site,Y,20,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,16-Mar-2026,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,13:00,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,19-Mar-2026,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,Result verified by repeat analysis,0 - 6.2,umol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Alkaline Phosphatase,,120,,,,,40 - 129,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,GGT,,39,,,,,10 - 50,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,LDH,,174,,,,,53 - 234,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Urea Nitrogen,,3.0,,,,,1.4 - 8.6,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,40 - 119,umol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Glucose,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Uric Acid,,357,,,,,149 - 494,umol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Total Protein,,70,,,,,60 - 80,g/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Creatine Kinase,,149,,,,,39 - 308,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Sodium,,141,,,,,135 - 145,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Bicarbonate,,18.4,,L,,,19.3 - 29.3,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Magnesium,,0.79,,,,,0.66 - 0.98,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,99,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,120,,L,,,125 - 170,g/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.37 - 0.51, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4 - 5.8,TI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,24,,L,,,26 - 34,pg +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,79,,L,,,80 - 100,fL +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.50,,,,,3.8 - 10.7,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.09,,,,,1.96 - 7.23,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.97,,,,,0.8 - 3,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,1.07,,H,,,0.12 - 0.92,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.27,,,,,0 - 0.57,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.9,,,,,40.5 - 75,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,23.3,,,,,15.4 - 48.5,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,12.6,,H,,,2.6 - 10.1,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.1,,,,,0 - 6.8,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,567,,H,,,130 - 394,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,SUBJECT HEIGHT (CM),Height (cm),Y,178,,,,,cm, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140506 sponsor-study-35472-test-results-898739-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140506 sponsor-study-35472-test-results-898739-standard.csv new file mode 100644 index 0000000..777a3b4 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140506 sponsor-study-35472-test-results-898739-standard.csv @@ -0,0 +1,1899 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 5,/HPF +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.7,,,,,0 - 6.2,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Alkaline Phosphatase,,55,,,,,40 - 129,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,ALT (SGPT),,27,,,,,5 - 48,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,GGT,,43,,,,,10 - 61,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,LDH,,168,,,,,53 - 234,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Urea Nitrogen,,3.5,,,,,1.4 - 8.6,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Glucose Fasting,,5.3,,,,,3.9 - 5.6,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Serum Uric Acid,,351,,,,,125 - 488,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Phosphorus,,0.86,,,,,0.71 - 1.65,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Albumin-BCG,,50,,H,,,33 - 49,g/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,39 - 308,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Serum Bicarbonate,,26.0,,,,,19.3 - 29.3,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,149,,,,,127 - 181,g/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,84,,,,,79 - 96,fL +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.24,,,,,3.8 - 10.7,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.54,,,,,1.96 - 7.23,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.12,,,,,0.91 - 4.28,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.53,,,,,0.12 - 0.92,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,,0 - 0.57,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,67.2,,,,,40.5 - 75,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,25.7,,,,,15.4 - 48.5,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.4,,,,,2.6 - 10.1,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.5,,,,,0 - 6.8,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,193,,,,,140 - 400,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,10.23,,,,,1.9 - 23,uIU/mL +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,LIPID PANEL,Direct HDL-C 4th Generation,,0.92,,L,,,1.03 - 1.53,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,LIPID PANEL,Triglycerides (GPO),,3.09,,,,,0.62 - 3.69,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,LIPID PANEL,Cholesterol (High Performance),,5.48,,,,,4.19 - 7.24,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,LIPID PANEL,LDL Chol Friedewald 4th,,3.14,,,,,0 - 3.34,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,TSH,TSH 3rd IS-QT,,1.690,,,,,0.45 - 5.33,mIU/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Specific Gravity,,1.026,,,,,1 - 1.04, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.7,,,,,0 - 5,mg/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Alkaline Phosphatase,,65,,,,,35 - 104,U/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,ALT (SGPT),,53,,H,,,4 - 43,U/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,AST (SGOT),,47,,H,,,8 - 40,U/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,GGT,,101,,H,,,5 - 50,U/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,LDH,,186,,,,,53 - 234,U/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Urea Nitrogen,,1.4,,,,,1.4 - 8.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,52,,,,,31 - 101,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Glucose Fasting,,5.8,,H,,,3.9 - 5.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Serum Uric Acid,,426,,,,,149 - 446,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Calcium (EDTA),,2.60,,,,,2.07 - 2.64,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Phosphorus,,1.17,,,,,0.71 - 1.65,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Creatine Kinase,,164,,,,,26 - 192,U/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Serum Sodium,,135,,,,,135 - 145,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Serum Potassium,,3.9,,,,,3.5 - 5.2,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Serum Bicarbonate,,21.2,,,,,19.3 - 29.3,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Serum Chloride,,94,,,,,94 - 112,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,148,,,,,115 - 158,g/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,3.9 - 5.5,TI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,100,,,,,80 - 100,fL +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.45,,,,,3.8 - 10.7,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.74,,,,,1.96 - 7.23,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.85,,,,,0.8 - 3,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.33,,,,,0 - 0.57,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,56.1,,,,,40.5 - 75,% +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.8,,,,,15.4 - 48.5,% +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.9,,,,,0 - 6.8,% +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,261,,,,,130 - 394,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.3,,,,,<6.5 %, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.91,,,,,1.9 - 23,uIU/mL +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,IS SUBJECT FASTING?,Is Subject Fasting?,Y,No,,,,,, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,LIPID PANEL,Direct HDL-C 4th Generation,,1.71,,H,,,1.03 - 1.53,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,LIPID PANEL,Triglycerides (GPO),,1.73,,,,,0.63 - 2.71,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,LIPID PANEL,Cholesterol (High Performance),,3.78,,L,,,4.86 - 8.28,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,LIPID PANEL,LDL Chol Friedewald 4th,,1.28,,,,,0 - 3.34,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,TSH,TSH 3rd IS-QT,,,,,Test group cancelled: No specimen received,,, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1.01 - 1.03, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Ketones,,Trace,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.3,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Alkaline Phosphatase,,54,,,,,40 - 129,U/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,5 - 48,U/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,GGT,,41,,,,,10 - 61,U/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,LDH,,149,,,,,53 - 234,U/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,80,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Serum Uric Acid,,379,,,,,125 - 488,umol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Calcium (EDTA),,2.53,,,,,2.07 - 2.64,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Phosphorus,,0.89,,,,,0.71 - 1.65,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Total Protein,,81,,,,,61 - 84,g/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Albumin-BCG,,50,,H,,,33 - 49,g/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Creatine Kinase,,88,,,,,39 - 308,U/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Serum Bicarbonate,,24.1,,,,,19.3 - 29.3,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,152,,,,,127 - 181,g/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.3,,,,,4.5 - 6.4,TI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,84,,,,,79 - 96,fL +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.35,,,,,3.8 - 10.7,GI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.03,,,,,1.96 - 7.23,GI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.94,,,,,0.91 - 4.28,GI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.30,,,,,0.12 - 0.92,GI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,56.6,,,,,40.5 - 75,% +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.4,,,,,15.4 - 48.5,% +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,% +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,202,,,,,140 - 400,GI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.79,,,,,1.9 - 23,uIU/mL +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,LIPID PANEL,Direct HDL-C 4th Generation,,0.94,,L,,,1.03 - 1.53,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,LIPID PANEL,Triglycerides (GPO),,2.61,,,,,0.62 - 3.69,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,LIPID PANEL,Cholesterol (High Performance),,5.47,,,,,4.19 - 7.24,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,LIPID PANEL,LDL Chol Friedewald 4th,,3.33,,,,,0 - 3.34,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 5,/HPF +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Alkaline Phosphatase,,61,,,,,40 - 129,U/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,5 - 48,U/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,GGT,,34,,,,,10 - 61,U/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,LDH,,164,,,,,53 - 234,U/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,74,,,,,40 - 119,umol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Serum Uric Acid,,266,,,,,149 - 494,umol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Creatine Kinase,,77,,,,,39 - 308,U/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Serum Bicarbonate,,19.7,,,,,19.3 - 29.3,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,161,,,,,127 - 181,g/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 96,fL +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.90,,,,,3.8 - 10.7,GI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.20,,,,,1.96 - 7.23,GI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.94,,,,,0.91 - 4.28,GI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.58,,,,,0.12 - 0.92,GI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.7,,,,,40.5 - 75,% +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.8,,,,,15.4 - 48.5,% +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.9,,,,,2.6 - 10.1,% +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,% +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,259,,,,,140 - 400,GI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,14.04,,,,,1.9 - 23,uIU/mL +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,LIPID PANEL,Direct HDL-C 4th Generation,,1.20,,,,,1.03 - 1.53,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,LIPID PANEL,Triglycerides (GPO),,2.38,,,,,0.65 - 3.61,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,LIPID PANEL,Cholesterol (High Performance),,6.59,,,,,4.4 - 7.53,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,LIPID PANEL,LDL Chol Friedewald 4th,,4.30,,H,,,0 - 3.34,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,TSH,TSH 3rd IS-QT,,1.196,,,,,0.45 - 5.33,mIU/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,R,H,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,C-REACTIVE PROTEIN,C Reactive Protein HS,,5.2,,H,,,0 - 5,mg/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Alkaline Phosphatase,,54,,,,,40 - 129,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,ALT (SGPT),,30,,,,,5 - 48,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,GGT,,42,,,,,10 - 61,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,LDH,,169,,,,,53 - 234,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Urea Nitrogen,,2.9,,,,,1.4 - 8.6,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Serum Uric Acid,,370,,,,,125 - 488,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Calcium (EDTA),,2.49,,,,,2.07 - 2.64,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Phosphorus,,0.84,,,,,0.71 - 1.65,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Albumin-BCG,,50,,H,,,33 - 49,g/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Creatine Kinase,,127,,,,,39 - 308,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Serum Bicarbonate,,26.2,,,,,19.3 - 29.3,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,127 - 181,g/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,85,,,,,79 - 96,fL +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.86,,,,,3.8 - 10.7,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.33,,,,,1.96 - 7.23,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.05,,,,,0.91 - 4.28,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,48.0,,,,,40.5 - 75,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,42.2,,,,,15.4 - 48.5,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.2,,,,,2.6 - 10.1,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.2,,,,,0 - 6.8,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,189,,,,,140 - 400,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,8.45,,,,,1.9 - 23,uIU/mL +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,LIPID PANEL,Direct HDL-C 4th Generation,,0.78,,L,,,1.03 - 1.53,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,LIPID PANEL,Triglycerides (GPO),,3.51,,,,,0.62 - 3.69,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,LIPID PANEL,Cholesterol (High Performance),,4.45,,,,,4.19 - 7.24,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,LIPID PANEL,LDL Chol Friedewald 4th,,2.06,,,,,0 - 3.34,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,TSH,TSH 3rd IS-QT,,1.040,,,,,0.45 - 5.33,mIU/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Specific Gravity,,1.033,,,,,1 - 1.04, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur pH,,7.0,,,,,5 - 8, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Urobilinogen,,+2,,H,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.8,,,,,0 - 6.2,umol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Alkaline Phosphatase,,52,,,,,40 - 129,U/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,ALT (SGPT),,26,,,,,5 - 48,U/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,AST (SGOT),,22,,,,,8 - 40,U/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,GGT,,49,,,,,10 - 61,U/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,LDH,,143,,,,,53 - 234,U/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Serum Uric Acid,,359,,,,,125 - 488,umol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Calcium (EDTA),,2.57,,,,,2.07 - 2.64,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Phosphorus,,0.64,,LT,,Result verified by repeat analysis,0.71 - 1.65,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Total Protein,,78,,,,,61 - 84,g/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Albumin-BCG,,51,,H,,,33 - 49,g/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Creatine Kinase,,102,,,,,39 - 308,U/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Serum Sodium,,143,,,,,132 - 147,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Serum Bicarbonate,,25.8,,,,,19.3 - 29.3,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.27,,H,,,1.42 - 2.08,mL/sec +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,77,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,85.4,,,,,kg, +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Alkaline Phosphatase,,54,,,,,40 - 129,U/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,ALT (SGPT),,35,,,,,5 - 48,U/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,GGT,,54,,,,,10 - 61,U/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,LDH,,155,,,,,53 - 234,U/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Urea Nitrogen,,2.6,,,,,1.4 - 8.6,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,81,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Serum Uric Acid,,385,,,,,125 - 488,umol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Calcium (EDTA),,2.59,,,,,2.07 - 2.64,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Phosphorus,,0.57,,LT,,Result verified by repeat analysis,0.71 - 1.65,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Total Protein,,79,,,,,61 - 84,g/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Albumin-BCG,,51,,H,,,33 - 49,g/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Creatine Kinase,,110,,,,,39 - 308,U/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Serum Bicarbonate,,26.8,,,,,19.3 - 29.3,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,160,,,,,127 - 181,g/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.5,,,,,4.5 - 6.4,TI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.67,,,,,3.8 - 10.7,GI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.99,,,,,1.96 - 7.23,GI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.20,,,,,0.91 - 4.28,GI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.45,,,,,0.12 - 0.92,GI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.03,,,,,0 - 0.57,GI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.8,,,,,40.5 - 75,% +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.9,,,,,15.4 - 48.5,% +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.4,,,,,0 - 6.8,% +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.2,,,,,0 - 2,% +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,185,,,,,140 - 400,GI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,9.79,,,,,1.9 - 23,uIU/mL +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,LIPID PANEL,Direct HDL-C 4th Generation,,0.84,,L,,,1.03 - 1.53,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,LIPID PANEL,Triglycerides (GPO),,3.38,,,,,0.62 - 3.69,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,LIPID PANEL,Cholesterol (High Performance),,4.73,,,,,4.19 - 7.24,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,LIPID PANEL,LDL Chol Friedewald 4th,,2.34,,,,,0 - 3.34,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Specific Gravity,,1.029,,,,,1 - 1.04, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.0,,,,,0 - 5,mg/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.1,,,,,0 - 6.2,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Alkaline Phosphatase,,67,,,,,35 - 104,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,4 - 43,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,GGT,,40,,,,,4 - 49,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,LDH,,180,,,,,53 - 234,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Urea Nitrogen,,2.4,,,,,1.4 - 8.6,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Glucose Fasting,,5.3,,,,,3.9 - 5.6,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Serum Uric Acid,,222,,,,,149 - 446,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Calcium (EDTA),,2.26,,,,,2.07 - 2.64,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Phosphorus,,0.82,,,,,0.71 - 1.65,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Creatine Kinase,,83,,,,,26 - 192,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Serum Bicarbonate,,24.5,,,,,19.3 - 29.3,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,132,,,,,116 - 164,g/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4.1 - 5.6,TI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,99,R,H,,,79 - 98,fL +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.87,,,,,3.8 - 10.7,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.00,,,,,1.96 - 7.23,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.51,,,,,0.91 - 4.28,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.22,,,,,0.12 - 0.92,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.6,,,,,40.5 - 75,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.9,,,,,15.4 - 48.5,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.6,,,,,2.6 - 10.1,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.4,,,,,0 - 6.8,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,281,,,,,140 - 400,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.73,,,,,1.9 - 23,uIU/mL +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,LIPID PANEL,Direct HDL-C 4th Generation,,2.34,R,H,,,1.03 - 1.53,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,LIPID PANEL,Triglycerides (GPO),,1.13,,,,,0.59 - 2.96,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,LIPID PANEL,Cholesterol (High Performance),,5.38,,,,,4.42 - 7.53,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,LIPID PANEL,LDL Chol Friedewald 4th,,2.52,,,,,0 - 3.34,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,RETICULOCYTES,Reticulocyte Count %,,2.0,,,,,0.6 - 2.5,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,TSH,TSH 3rd IS-QT,,1.897,,,,,0.45 - 5.33,mIU/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Specific Gravity,,1.026,,,,,1 - 1.04, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.9,,,,,0 - 6.2,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Alkaline Phosphatase,,68,,,,,35 - 104,U/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,ALT (SGPT),,70,,H RX,,,4 - 43,U/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,AST (SGOT),,56,,H,,,8 - 40,U/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,GGT,,98,,H,,,5 - 50,U/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,LDH,,188,,,,,53 - 234,U/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Urea Nitrogen,,2.1,,,,,1.4 - 8.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,52,,,,,31 - 101,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Glucose Fasting,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Serum Uric Acid,,419,,,,,149 - 446,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Calcium (EDTA),,2.56,,,,,2.07 - 2.64,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Creatine Kinase,,109,,,,,26 - 192,U/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Serum Sodium,,138,,,,,135 - 145,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Serum Bicarbonate,,26.5,,,,,19.3 - 29.3,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Serum Chloride,,96,,,,,94 - 112,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,115 - 158,g/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,3.9 - 5.5,TI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,104,,H,,,80 - 100,fL +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.88,,,,,3.8 - 10.7,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.64,,,,,1.96 - 7.23,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.55,,,,,0.8 - 3,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.51,,,,,0.12 - 0.92,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.0,,,,,40.5 - 75,% +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,37.2,,,,,15.4 - 48.5,% +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.4,,,,,2.6 - 10.1,% +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,288,,,,,130 - 394,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.19,,,,,1.9 - 23,uIU/mL +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,LIPID PANEL,Direct HDL-C 4th Generation,,1.60,,H,,,1.03 - 1.53,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,LIPID PANEL,Triglycerides (GPO),,1.16,,,,,0.63 - 2.71,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,LIPID PANEL,Cholesterol (High Performance),,3.65,,L,,,4.86 - 8.28,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,LIPID PANEL,LDL Chol Friedewald 4th,,1.52,,,,,0 - 3.34,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,TSH,TSH 3rd IS-QT,,0.906,,,,,0.45 - 5.33,mIU/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Specific Gravity,,1.012,,,,,1.01 - 1.03, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Ketones,,Trace,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.0,,,,,0 - 5,mg/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 5,/HPF +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Alkaline Phosphatase,,67,,,,,40 - 129,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,GGT,,30,,,,,10 - 61,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,83,,,,,40 - 119,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Glucose Fasting,,6.8,,H,,,3.9 - 5.6,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Serum Uric Acid,,297,,,,,149 - 494,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Creatine Kinase,,63,,,,,39 - 308,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Serum Bicarbonate,,21.1,,,,,19.3 - 29.3,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,157,,,,,127 - 181,g/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.48,,,,,0.39 - 0.54, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,100,,H,,,79 - 96,fL +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.88,,,,,3.8 - 10.7,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.58,,,,,1.96 - 7.23,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.46,,,,,0.91 - 4.28,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.59,,,,,0.12 - 0.92,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.19,,,,,0 - 0.57,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.8,,,,,40.5 - 75,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.7,,,,,15.4 - 48.5,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,243,,,,,140 - 400,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,35.89,,H,,,1.9 - 23,uIU/mL +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,LIPID PANEL,Direct HDL-C 4th Generation,,1.18,,,,,1.03 - 1.53,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,LIPID PANEL,Triglycerides (GPO),,2.11,,,,,0.65 - 3.61,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,LIPID PANEL,Cholesterol (High Performance),,5.10,,,,,4.4 - 7.53,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,LIPID PANEL,LDL Chol Friedewald 4th,,2.95,,,,,0 - 3.34,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,TSH,TSH 3rd IS-QT,,0.729,,,,,0.45 - 5.33,mIU/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Specific Gravity,,1.030,,,,,1 - 1.04, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.5,,,,,0 - 5,mg/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.0,,,,,0 - 6.2,umol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Alkaline Phosphatase,,72,,,,,35 - 104,U/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,GGT,,40,,,,,4 - 49,U/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,LDH,,177,,,,,53 - 234,U/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 101,umol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Serum Uric Acid,,398,,,,,149 - 446,umol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Calcium (EDTA),,2.49,,,,,2.07 - 2.64,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Phosphorus,,0.96,,,,,0.71 - 1.65,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Creatine Kinase,,73,,,,,26 - 192,U/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Serum Bicarbonate,,22.1,,,,,19.3 - 29.3,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Serum Chloride,,98,,,,,94 - 112,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,149,,,,,116 - 164,g/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.34 - 0.48, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,79 - 98,fL +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.74,,,,,3.8 - 10.7,GI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.11,,,,,1.96 - 7.23,GI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.22,,,,,0.91 - 4.28,GI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.27,,,,,0.12 - 0.92,GI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.0,,,,,40.5 - 75,% +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.1,,,,,15.4 - 48.5,% +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.0,,,,,2.6 - 10.1,% +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.2,,,,,0 - 6.8,% +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,564,,H,,,140 - 400,GI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.03,,,,,1.9 - 23,uIU/mL +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,LIPID PANEL,Direct HDL-C 4th Generation,,2.53,,H,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,LIPID PANEL,Triglycerides (GPO),,2.65,,,,,0.59 - 2.96,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,LIPID PANEL,Cholesterol (High Performance),,5.29,,,,,4.42 - 7.53,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,LIPID PANEL,LDL Chol Friedewald 4th,,1.55,,,,,0 - 3.34,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Specific Gravity,,1.020,,,,,1 - 1.04, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Alkaline Phosphatase,,57,,,,,40 - 129,U/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,ALT (SGPT),,26,,,,,5 - 48,U/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,GGT,,44,,,,,10 - 61,U/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,LDH,,173,,,,,53 - 234,U/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,78,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Serum Uric Acid,,379,,,,,125 - 488,umol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Calcium (EDTA),,2.62,,,,,2.07 - 2.64,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Phosphorus,,0.80,,,,,0.71 - 1.65,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Total Protein,,84,,,,,61 - 84,g/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Albumin-BCG,,53,,H,,,33 - 49,g/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Creatine Kinase,,108,,,,,39 - 308,U/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Serum Sodium,,145,,,,,132 - 147,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.31,,H,,,1.42 - 2.08,mL/sec +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,78,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,87.0,,,,,kg, +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,LIPID PANEL,Direct HDL-C 4th Generation,,0.94,,L,,,1.03 - 1.53,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,LIPID PANEL,Triglycerides (GPO),,2.31,,,,,0.56 - 3.62,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,LIPID PANEL,Cholesterol (High Performance),,5.76,,,,,3.88 - 6.83,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,LIPID PANEL,LDL Chol Friedewald 4th,,3.76,,H,,,0 - 3.34,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,TSH,TSH 3rd IS-QT,,1.044,,,,,0.45 - 5.33,mIU/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,C-REACTIVE PROTEIN,C Reactive Protein HS,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Total Bilirubin,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,ALT (SGPT),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,AST (SGOT),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,GGT,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,LDH,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Urea Nitrogen,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Glucose Fasting,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Serum Uric Acid,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Calcium (EDTA),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Phosphorus,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Total Protein,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Albumin-BCG,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Creatine Kinase,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Serum Sodium,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Serum Potassium,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Serum Bicarbonate,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Serum Chloride,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,Required testing unavailable,,,,,1.42 - 2.08,mL/sec +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,87.0,,,,,kg, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,GFR,EGFR by MDRD,,Required testing unavailable,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,127 - 181,g/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.79,,,,,3.8 - 10.7,GI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.23,,,,,1.96 - 7.23,GI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.09,,,,,0.91 - 4.28,GI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.41,,,,,0.12 - 0.92,GI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.03,,,,,0 - 0.57,GI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.4,,,,,40.5 - 75,% +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.8,,,,,15.4 - 48.5,% +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.5,,,,,0 - 6.8,% +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,207,,,,,140 - 400,GI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,15.62,,,,,1.9 - 23,uIU/mL +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,LIPID PANEL,Direct HDL-C 4th Generation,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,LIPID PANEL,Triglycerides (GPO),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,LIPID PANEL,Cholesterol (High Performance),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,LIPID PANEL,LDL Chol Friedewald 4th,,Required testing unavailable,,,,,0 - 3.34,mmol/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,TSH,TSH 3rd IS-QT,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Specific Gravity,,1.032,,,,,1 - 1.04, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur pH,,7.0,,,,,5 - 8, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,C-REACTIVE PROTEIN,C Reactive Protein HS,,7.3,,H,,,0 - 5,mg/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CELLULAR ELEMENTS,Ur RBC/HPF,,2,,,,,0 - 3,/HPF +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CELLULAR ELEMENTS,Ur WBC/HPF,,7,,H,,,0 - 5,/HPF +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Alkaline Phosphatase,,58,,,,,40 - 129,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,GGT,,26,,,,,10 - 61,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,LDH,,171,,,,,53 - 234,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,86,,,,,40 - 119,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Glucose Fasting,,6.0,,H,,,3.9 - 5.6,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Serum Uric Acid,,317,,,,,149 - 494,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Calcium (EDTA),,2.26,,,,,2.07 - 2.64,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Phosphorus,,0.98,,,,,0.71 - 1.65,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Creatine Kinase,,76,,,,,39 - 308,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Serum Bicarbonate,,25.0,,,,,19.3 - 29.3,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.5 - 6.4,TI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,99,,H,,,79 - 96,fL +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.00,,,,,3.8 - 10.7,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.16,,,,,1.96 - 7.23,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.99,,,,,0.91 - 4.28,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.71,,,,,0.12 - 0.92,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,68.4,,,,,40.5 - 75,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,22.2,,,,,15.4 - 48.5,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.9,,,,,2.6 - 10.1,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.2,,,,,0 - 2,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,256,,,,,140 - 400,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,11.88,,,,,1.9 - 23,uIU/mL +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,LIPID PANEL,Direct HDL-C 4th Generation,,1.07,,,,,1.03 - 1.53,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,LIPID PANEL,Triglycerides (GPO),,1.52,,,,,0.65 - 3.61,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,LIPID PANEL,Cholesterol (High Performance),,4.74,,,,,4.4 - 7.53,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,LIPID PANEL,LDL Chol Friedewald 4th,,2.97,,,,,0 - 3.34,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,MISCELLANEOUS ELEMENTS,Ur Sperm,,Present,,,,,Ref Rng:Not present, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,TSH,TSH 3rd IS-QT,,0.706,,,,,0.45 - 5.33,mIU/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Specific Gravity,,1.032,,,,,1 - 1.04, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.6,,,,,0 - 5,mg/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Alkaline Phosphatase,,63,,,,,35 - 104,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,GGT,,31,,,,,4 - 49,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,LDH,,166,,,,,53 - 234,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Urea Nitrogen,,2.9,,,,,1.4 - 8.6,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Serum Uric Acid,,189,,,,,149 - 446,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Phosphorus,,0.99,,,,,0.71 - 1.65,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Creatine Kinase,,77,,,,,26 - 192,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,116 - 164,g/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,79 - 98,fL +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.79,,,,,3.8 - 10.7,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.69,,,,,1.96 - 7.23,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.52,,,,,0.91 - 4.28,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.7,,,,,40.5 - 75,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.3,,,,,15.4 - 48.5,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.5,,,,,0 - 6.8,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,402,,H,,,140 - 400,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.90,,,,,1.9 - 23,uIU/mL +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,LIPID PANEL,Direct HDL-C 4th Generation,,1.98,,H,,,1.03 - 1.53,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,LIPID PANEL,Triglycerides (GPO),,1.65,,,,,0.59 - 2.96,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,LIPID PANEL,Cholesterol (High Performance),,5.40,,,,,4.42 - 7.53,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,LIPID PANEL,LDL Chol Friedewald 4th,,2.66,,,,,0 - 3.34,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,RETICULOCYTES,Reticulocyte Count %,,2.3,,,,,0.6 - 2.5,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,TSH,TSH 3rd IS-QT,,1.816,,,,,0.45 - 5.33,mIU/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1 - 1.04, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.6,,,,,0 - 5,mg/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CELLULAR ELEMENTS,Ur RBC/HPF,,1,,,,,0 - 8,/HPF +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 12,/HPF +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Alkaline Phosphatase,,36,,,,,35 - 104,U/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,4 - 43,U/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,GGT,,6,,,,,4 - 49,U/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,LDH,,153,,,,,53 - 234,U/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Serum Uric Acid,,259,,,,,125 - 428,umol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Phosphorus,,0.98,,,,,0.71 - 1.65,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Creatine Kinase,,105,,,,,26 - 192,U/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Serum Bicarbonate,,22.1,,,,,19.3 - 29.3,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,131,,,,,116 - 164,g/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,82,,,,,79 - 98,fL +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.46,,,,,3.8 - 10.7,GI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.81,,,,,1.96 - 7.23,GI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.34,,,,,0.91 - 4.28,GI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.24,,,,,0.12 - 0.92,GI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,69.7,,,,,40.5 - 75,% +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,24.6,,,,,15.4 - 48.5,% +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.4,,,,,2.6 - 10.1,% +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,267,,,,,140 - 400,GI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.3,,,,,<6.5%, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.64,,,,,1.9 - 23,uIU/mL +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,LIPID PANEL,Direct HDL-C 4th Generation,,1.66,R,H,,,1.03 - 1.53,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,LIPID PANEL,Triglycerides (GPO),,1.43,,,,,0.41 - 1.63,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,LIPID PANEL,Cholesterol (High Performance),,4.82,,,,,3.31 - 5.64,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,LIPID PANEL,LDL Chol Friedewald 4th,,2.51,,,,,0 - 3.34,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,MICROORGANISMS,Ur Yeast-Budding,,Present,,,,,Ref Rng:Not present, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,MICROORGANISMS,Ur Yeast-Hyphae,,Present,,,,,Ref Rng:Not present, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,RETICULOCYTES,Reticulocyte Count %,,0.6,,,,,0.6 - 2.5,% +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,TSH,TSH 3rd IS-QT,,1.379,,,,,0.45 - 5.33,mIU/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Leukocyte Esterase,,+2,,H SF,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CASTS,Ur Hyaline Casts/LPF,,27,,,,,0 /LPF, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Alkaline Phosphatase,,61,,,,,35 - 104,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,ALT (SGPT),,64,,H,,,4 - 43,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,AST (SGOT),,63,,H RX,,,8 - 40,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,GGT,,85,,H,,,5 - 50,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,LDH,,207,,,,,53 - 234,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Urea Nitrogen,,2.8,,,,,1.4 - 8.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Serum Uric Acid,,423,,,,,149 - 446,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Phosphorus,,1.23,,,,,0.71 - 1.65,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Total Protein,,78,,,,,60 - 80,g/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Creatine Kinase,,141,,,,,26 - 192,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Serum Bicarbonate,,22.7,,,,,19.3 - 29.3,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Serum Chloride,,99,,,,,94 - 112,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,138,,,,,115 - 158,g/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,3.9 - 5.5,TI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,102,,H,,,80 - 100,fL +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.70,,,,,3.8 - 10.7,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.73,,,,,1.96 - 7.23,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.43,,,,,0.8 - 3,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.35,,,,,0.12 - 0.92,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.7,,,,,40.5 - 75,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.2,,,,,15.4 - 48.5,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.2,,,,,2.6 - 10.1,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,274,,,,,130 - 394,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.35,,,,,1.9 - 23,uIU/mL +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,LIPID PANEL,Direct HDL-C 4th Generation,,1.68,,H,,,1.03 - 1.53,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,LIPID PANEL,Triglycerides (GPO),,1.03,,,,,0.63 - 2.71,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,LIPID PANEL,Cholesterol (High Performance),,5.23,,,,,4.86 - 8.28,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,LIPID PANEL,LDL Chol Friedewald 4th,,3.08,,,,,0 - 3.34,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1.01 - 1.03, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Protein,,+1,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Ketones,,Trace,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,C-REACTIVE PROTEIN,C Reactive Protein HS,,8.3,,H,,,0 - 5,mg/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Alkaline Phosphatase,,64,,,,,40 - 129,U/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,5 - 48,U/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,GGT,,28,,,,,10 - 61,U/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,LDH,,163,,,,,53 - 234,U/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 8.6,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,83,,,,,40 - 119,umol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Serum Uric Acid,,311,,,,,149 - 494,umol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Calcium (EDTA),,2.30,,,,,2.07 - 2.64,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Creatine Kinase,,73,,,,,39 - 308,U/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Serum Bicarbonate,,21.0,,,,,19.3 - 29.3,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,158,,,,,127 - 181,g/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.48,,,,,0.39 - 0.54, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,99,R,H,,,79 - 96,fL +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.66,,,,,3.8 - 10.7,GI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,7.67,R,H,,,1.96 - 7.23,GI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.03,,,,,0.91 - 4.28,GI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.77,,,,,0.12 - 0.92,GI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.9,,,,,40.5 - 75,% +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.1,,,,,15.4 - 48.5,% +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.3,,,,,2.6 - 10.1,% +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.4,,,,,0 - 6.8,% +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,251,,,,,140 - 400,GI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.56,,,,,1.9 - 23,uIU/mL +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,LIPID PANEL,Direct HDL-C 4th Generation,,1.04,,,,,1.03 - 1.53,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,LIPID PANEL,Triglycerides (GPO),,1.84,,,,,0.65 - 3.61,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,LIPID PANEL,Cholesterol (High Performance),,5.15,,,,,4.4 - 7.53,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,LIPID PANEL,LDL Chol Friedewald 4th,,3.27,,,,,0 - 3.34,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Specific Gravity,,1.012,,,,,1 - 1.04, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,C-REACTIVE PROTEIN,C Reactive Protein HS,,6.1,,H,,,0 - 5,mg/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Alkaline Phosphatase,,106,,,,,40 - 129,U/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,ALT (SGPT),,32,,,,,5 - 48,U/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,AST (SGOT),,28,,,,,8 - 40,U/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,GGT,,105,,H,,,10 - 61,U/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,LDH,,140,,,,,53 - 234,U/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Urea Nitrogen,,3.2,,,,,1.4 - 8.6,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,98,,,,,40 - 119,umol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Glucose Fasting,,5.3,,,,,3.9 - 5.6,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Serum Uric Acid,,378,,,,,149 - 494,umol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Phosphorus,,0.96,,,,,0.71 - 1.65,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Creatine Kinase,,55,,,,,39 - 308,U/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Serum Bicarbonate,,26.4,,,,,19.3 - 29.3,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,127 - 181,g/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.39 - 0.54, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,94,,,,,79 - 96,fL +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.05,,,,,3.8 - 10.7,GI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.34,,,,,1.96 - 7.23,GI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.31,,,,,0.91 - 4.28,GI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.30,,,,,0.12 - 0.92,GI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.8,,,,,40.5 - 75,% +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.3,,,,,15.4 - 48.5,% +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.4,,,,,2.6 - 10.1,% +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,219,,,,,140 - 400,GI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.3,,,,,<6.5%, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.63,,,,,1.9 - 23,uIU/mL +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,LIPID PANEL,Direct HDL-C 4th Generation,,1.31,,,,,1.03 - 1.53,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,LIPID PANEL,Triglycerides (GPO),,1.15,,,,,0.65 - 3.61,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,LIPID PANEL,Cholesterol (High Performance),,6.10,,,,,4.4 - 7.53,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,LIPID PANEL,LDL Chol Friedewald 4th,,4.26,,H,,,0 - 3.34,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,% +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,TSH,TSH 3rd IS-QT,,0.733,,,,,0.45 - 5.33,mIU/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Specific Gravity,,1.015,,,,,1 - 1.04, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.7,,,,,0 - 5,mg/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.0,,,,,0 - 6.2,umol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Alkaline Phosphatase,,77,,,,,35 - 104,U/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,ALT (SGPT),,22,,,,,4 - 43,U/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,GGT,,28,,,,,4 - 49,U/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,LDH,,184,,,,,53 - 234,U/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Urea Nitrogen,,3.5,,,,,1.4 - 8.6,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,62,,,,,31 - 101,umol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Serum Uric Acid,,259,,,,,149 - 446,umol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Calcium (EDTA),,2.46,,,,,2.07 - 2.64,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Phosphorus,,1.16,,,,,0.71 - 1.65,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Creatine Kinase,,82,,,,,26 - 192,U/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,116 - 164,g/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,79 - 98,fL +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.32,,,,,3.8 - 10.7,GI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.74,,,,,1.96 - 7.23,GI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.91,,,,,0.91 - 4.28,GI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.45,,,,,0.12 - 0.92,GI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.2,,,,,40.5 - 75,% +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.3,,,,,15.4 - 48.5,% +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,,2.6 - 10.1,% +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.7,,,,,0 - 6.8,% +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,356,,,,,140 - 400,GI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.42,,,,,1.9 - 23,uIU/mL +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,LIPID PANEL,Direct HDL-C 4th Generation,,1.90,,H,,,1.03 - 1.53,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,LIPID PANEL,Triglycerides (GPO),,1.05,,,,,0.59 - 2.96,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,LIPID PANEL,Cholesterol (High Performance),,5.04,,,,,4.42 - 7.53,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,LIPID PANEL,LDL Chol Friedewald 4th,,2.66,,,,,0 - 3.34,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,RETICULOCYTES,Reticulocyte Count %,,2.3,,,,,0.6 - 2.5,% +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1 - 1.04, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.5,,,,,0 - 5,mg/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Alkaline Phosphatase,,42,,,,,35 - 104,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,GGT,,6,,,,,4 - 49,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,LDH,,169,,,,,53 - 234,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,67,,,,,31 - 101,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Serum Uric Acid,,273,,,,,125 - 428,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Phosphorus,,0.98,,,,,0.71 - 1.65,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Creatine Kinase,,113,,,,,26 - 192,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Serum Bicarbonate,,20.6,,,,,19.3 - 29.3,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,135,,,,,116 - 164,g/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.1 - 5.6,TI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,82,,,,,79 - 98,fL +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.49,,,,,3.8 - 10.7,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.33,,,,,1.96 - 7.23,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.72,,,,,0.91 - 4.28,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.35,,,,,0.12 - 0.92,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,66.8,,,,,40.5 - 75,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.5,,,,,15.4 - 48.5,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,327,,,,,140 - 400,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.98,,,,,1.9 - 23,uIU/mL +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,LIPID PANEL,Direct HDL-C 4th Generation,,1.69,R,H,,,1.03 - 1.53,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,LIPID PANEL,Triglycerides (GPO),,1.86,R,H,,,0.41 - 1.63,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,LIPID PANEL,Cholesterol (High Performance),,5.31,,,,,3.31 - 5.64,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,LIPID PANEL,LDL Chol Friedewald 4th,,2.77,,,,,0 - 3.34,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,RETICULOCYTES,Reticulocyte Count %,,0.8,,,,,0.6 - 2.5,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Specific Gravity,,1.022,,,,,1 - 1.04, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Blood,,+3,R,H SF,,,Ref Rng:$Negative-Trace, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.4,,,,,0 - 5,mg/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CASTS,Ur Hyaline Casts/LPF,,4,,,,,0 /LPF, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Alkaline Phosphatase,,62,,,,,35 - 104,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,ALT (SGPT),,35,,,,,4 - 43,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,AST (SGOT),,29,,,,,8 - 40,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,GGT,,51,,H,,,5 - 50,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,LDH,,178,,,,,53 - 234,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Urea Nitrogen,,3.3,,,,,1.4 - 8.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,55,,,,,31 - 101,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Glucose Fasting,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Serum Uric Acid,,451,,H,,,149 - 446,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Calcium (EDTA),,2.53,,,,,2.07 - 2.64,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Phosphorus,,1.03,,,,,0.71 - 1.65,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Total Protein,,74,,,,,60 - 80,g/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Creatine Kinase,,153,,,,,26 - 192,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Serum Sodium,,138,,,,,135 - 145,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Serum Potassium,,3.9,,,,,3.5 - 5.2,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Serum Bicarbonate,,23.9,,,,,19.3 - 29.3,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Serum Chloride,,97,,,,,94 - 112,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,133,,,,,115 - 158,g/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,3.9 - 5.5,TI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,101,R,H,,,80 - 100,fL +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.90,,,,,3.8 - 10.7,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.97,,,,,1.96 - 7.23,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.30,,,,,0.8 - 3,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.20,,,,,0 - 0.57,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,50.3,,,,,40.5 - 75,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.9,,,,,15.4 - 48.5,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.8,,,,,2.6 - 10.1,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.3,,,,,0 - 6.8,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,244,,,,,130 - 394,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.6,,,,,<6.5%, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.01,,,,,1.9 - 23,uIU/mL +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,LIPID PANEL,Direct HDL-C 4th Generation,,1.47,,,,,1.03 - 1.53,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,LIPID PANEL,Triglycerides (GPO),,1.30,,,,,0.63 - 2.71,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,LIPID PANEL,Cholesterol (High Performance),,3.27,,L,,,4.86 - 8.28,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,LIPID PANEL,LDL Chol Friedewald 4th,,1.20,,,,,0 - 3.34,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,TSH,TSH 3rd IS-QT,,1.174,,,,,0.45 - 5.33,mIU/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1.01 - 1.03, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Ketones,,Trace,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.6,,,,,0 - 6.2,umol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Alkaline Phosphatase,,80,,,,,40 - 129,U/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,ALT (SGPT),,31,,,,,5 - 48,U/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,AST (SGOT),,30,,,,,8 - 40,U/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,GGT,,68,R,H,,,10 - 61,U/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,LDH,,163,,,,,53 - 234,U/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Urea Nitrogen,,3.8,,,,,1.4 - 8.6,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,93,,,,,40 - 119,umol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Serum Uric Acid,,448,,,,,149 - 494,umol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Phosphorus,,0.78,,,,,0.71 - 1.65,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Creatine Kinase,,143,,,,,39 - 308,U/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Serum Potassium,,3.8,,,,,3.5 - 5.2,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Serum Bicarbonate,,24.3,,,,,19.3 - 29.3,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Serum Chloride,,98,,,,,94 - 112,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,127 - 181,g/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.39 - 0.54, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,94,,,,,79 - 96,fL +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.18,,,,,3.8 - 10.7,GI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.32,,,,,1.96 - 7.23,GI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.51,,,,,0.91 - 4.28,GI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.23,,,,,0.12 - 0.92,GI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.09,,,,,0 - 0.57,GI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.7,,,,,40.5 - 75,% +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.1,,,,,15.4 - 48.5,% +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,203,,,,,140 - 400,GI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,8.51,,,,,1.9 - 23,uIU/mL +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,LIPID PANEL,Direct HDL-C 4th Generation,,1.29,,,,,1.03 - 1.53,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,LIPID PANEL,Triglycerides (GPO),,1.22,,,,,0.65 - 3.61,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,LIPID PANEL,Cholesterol (High Performance),,5.80,,,,,4.4 - 7.53,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,LIPID PANEL,LDL Chol Friedewald 4th,,3.95,,H,,,0 - 3.34,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,RETICULOCYTES,Reticulocyte Count %,,0.6,,,,,0.6 - 2.5,% +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Specific Gravity,,1.014,,,,,1 - 1.04, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.5,,,,,0 - 5,mg/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,40 - 129,U/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,GGT,,29,,,,,10 - 61,U/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,LDH,,173,,,,,53 - 234,U/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,73,,,,,40 - 119,umol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Serum Uric Acid,,268,,,,,149 - 494,umol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Calcium (EDTA),,2.26,,,,,2.07 - 2.64,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Phosphorus,,1.02,,,,,0.71 - 1.65,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Creatine Kinase,,93,,,,,39 - 308,U/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Serum Bicarbonate,,20.0,,,,,19.3 - 29.3,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.12,,H,,,1.42 - 2.08,mL/sec +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,73,,,,,40 - 119,umol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,85.0,,,,,kg, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,GFR,EGFR by MDRD,,98,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,127 - 181,g/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,101,,H,,,79 - 96,fL +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.62,,,,,3.8 - 10.7,GI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.14,,,,,1.96 - 7.23,GI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.83,,,,,0.91 - 4.28,GI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.48,,,,,0.12 - 0.92,GI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.2,,,,,40.5 - 75,% +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,21.2,,,,,15.4 - 48.5,% +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,218,,,,,140 - 400,GI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.5,,,,,<6.5%, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.69,,,,,1.9 - 23,uIU/mL +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,LIPID PANEL,Direct HDL-C 4th Generation,,1.08,,,,,1.03 - 1.53,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,LIPID PANEL,Triglycerides (GPO),,2.26,,,,,0.65 - 3.61,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,LIPID PANEL,Cholesterol (High Performance),,4.47,,,,,4.4 - 7.53,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,LIPID PANEL,LDL Chol Friedewald 4th,,2.35,,,,,0 - 3.34,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,TSH,TSH 3rd IS-QT,,0.878,,,,,0.45 - 5.33,mIU/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Specific Gravity,,1.013,,,,,1 - 1.04, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.5,,,,,0 - 5,mg/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Alkaline Phosphatase,,63,,,,,35 - 104,U/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,4 - 43,U/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,GGT,,22,,,,,4 - 49,U/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,LDH,,182,,,,,53 - 234,U/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Urea Nitrogen,,3.0,,,,,1.4 - 8.6,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Serum Uric Acid,,224,,,,,149 - 446,umol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Creatine Kinase,,71,,,,,26 - 192,U/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Serum Bicarbonate,,22.7,,,,,19.3 - 29.3,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.81,,,,,1.25 - 1.92,mL/sec +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,69.0,,,,,kg, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,FSH,Follicle Stimulating Hormone,,6.17,,RX,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,GFR,EGFR by MDRD,,97,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,116 - 164,g/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,98,,,,,79 - 98,fL +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.11,,,,,3.8 - 10.7,GI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.39,,,,,1.96 - 7.23,GI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.04,,,,,0.91 - 4.28,GI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.8,,,,,40.5 - 75,% +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.7,,,,,15.4 - 48.5,% +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,% +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,431,,H,,,140 - 400,GI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.2,,,,,<6.5%, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.05,,,,,1.9 - 23,uIU/mL +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,LIPID PANEL,Direct HDL-C 4th Generation,,1.95,,H,,,1.03 - 1.53,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,LIPID PANEL,Triglycerides (GPO),,1.54,,,,,0.59 - 2.96,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,LIPID PANEL,Cholesterol (High Performance),,5.27,,,,,4.42 - 7.53,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,LIPID PANEL,LDL Chol Friedewald 4th,,2.61,,,,,0 - 3.34,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,RETICULOCYTES,Reticulocyte Count %,,2.9,,H,,,0.6 - 2.5,% +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,TSH,TSH 3rd IS-QT,,1.573,,,,,0.45 - 5.33,mIU/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Specific Gravity,,1.010,,,,,1 - 1.04, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Alkaline Phosphatase,,38,,,,,35 - 104,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,GGT,,6,,,,,4 - 49,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,LDH,,162,,,,,53 - 234,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Urea Nitrogen,,3.5,,,,,1.4 - 8.6,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,59,,,,,31 - 101,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Serum Uric Acid,,260,,,,,125 - 428,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Calcium (EDTA),,2.26,,,,,2.07 - 2.64,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Phosphorus,,0.56,,LT,,Result verified by repeat analysis,0.71 - 1.65,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Creatine Kinase,,358,R,H,,,26 - 192,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Serum Bicarbonate,,21.1,,,,,19.3 - 29.3,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,132,,,,,116 - 164,g/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.1 - 5.6,TI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,82,,,,,79 - 98,fL +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.52,,,,,3.8 - 10.7,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.93,,,,,1.96 - 7.23,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.25,,,,,0.91 - 4.28,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.27,,,,,0.12 - 0.92,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,64.8,,,,,40.5 - 75,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.6,,,,,15.4 - 48.5,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.4,,,,,0 - 6.8,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.2,,,,,0 - 2,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,262,,,,,140 - 400,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.2,,,,,<6.5%, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.63,,,,,1.9 - 23,uIU/mL +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,IS SUBJECT FASTING?,Is Subject Fasting?,Y,No,,,,,, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,LIPID PANEL,Direct HDL-C 4th Generation,,1.42,,,,,1.03 - 1.53,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,LIPID PANEL,Triglycerides (GPO),,1.42,,,,,0.41 - 1.63,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,LIPID PANEL,Cholesterol (High Performance),,4.13,,,,,3.31 - 5.64,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,LIPID PANEL,LDL Chol Friedewald 4th,,2.06,,,,,0 - 3.34,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,TSH,TSH 3rd IS-QT,,1.160,,,,,0.45 - 5.33,mIU/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Specific Gravity,,1.020,,,,,1 - 1.04, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,IS SUBJECT FASTING?,Is Subject Fasting?,Y,No,,,,,, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.1,,,,,0 - 6.2,umol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Alkaline Phosphatase,,70,,,,,35 - 104,U/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,ALT (SGPT),,40,,,,,4 - 43,U/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,AST (SGOT),,35,,,,,8 - 40,U/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,GGT,,54,,H,,,5 - 50,U/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,LDH,,184,,,,,53 - 234,U/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Urea Nitrogen,,2.1,,,,,1.4 - 8.6,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Glucose Fasting,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Serum Uric Acid,,413,,,,,149 - 446,umol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Calcium (EDTA),,2.58,,,,,2.07 - 2.64,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Phosphorus,,1.19,,,,,0.71 - 1.65,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Creatine Kinase,,155,,,,,26 - 192,U/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Serum Bicarbonate,,22.5,,,,,19.3 - 29.3,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Serum Chloride,,96,,,,,94 - 112,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,115 - 158,g/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,3.9 - 5.5,TI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,101,R,H,,,80 - 100,fL +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.55,,,,,3.8 - 10.7,GI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.20,,,,,1.96 - 7.23,GI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.66,,,,,0.8 - 3,GI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.44,,,,,0.12 - 0.92,GI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.21,,,,,0 - 0.57,GI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.5,,,,,40.5 - 75,% +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.1,,,,,15.4 - 48.5,% +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.9,,,,,2.6 - 10.1,% +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.8,,,,,0 - 6.8,% +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,275,,,,,130 - 394,GI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.10,,,,,1.9 - 23,uIU/mL +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,LIPID PANEL,Direct HDL-C 4th Generation,,1.39,,,,,1.03 - 1.53,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,LIPID PANEL,Triglycerides (GPO),,1.36,,,,,0.63 - 2.71,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,LIPID PANEL,Cholesterol (High Performance),,3.50,,L,,,4.86 - 8.28,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,LIPID PANEL,LDL Chol Friedewald 4th,,1.49,,,,,0 - 3.34,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Specific Gravity,,1.010,,,,,1.01 - 1.03, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Ketones,,+1,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.5,,,,,0 - 5,mg/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.9,,,,,0 - 6.2,umol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Alkaline Phosphatase,,76,,,,,40 - 129,U/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,5 - 48,U/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,GGT,,61,,,,,10 - 61,U/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,LDH,,160,,,,,53 - 234,U/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Urea Nitrogen,,4.8,,,,,1.4 - 8.6,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,87,,,,,40 - 119,umol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Serum Uric Acid,,353,,,,,149 - 494,umol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Phosphorus,,0.79,,,,,0.71 - 1.65,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Creatine Kinase,,153,,,,,39 - 308,U/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Serum Bicarbonate,,21.7,,,,,19.3 - 29.3,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.83,,,,,1.42 - 2.08,mL/sec +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,87,,,,,40 - 119,umol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,89.2,,,,,kg, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,DRUG SCREEN URINE,Opiates,,Detected (unconfirmed),,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,GFR,EGFR by MDRD,,80,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,152,,,,,127 - 181,g/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.39 - 0.54, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 96,fL +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.94,,,,,3.8 - 10.7,GI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.25,,,,,1.96 - 7.23,GI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.33,,,,,0.91 - 4.28,GI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.22,,,,,0.12 - 0.92,GI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.9,,,,,40.5 - 75,% +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.0,,,,,15.4 - 48.5,% +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.5,,,,,2.6 - 10.1,% +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,222,,,,,140 - 400,GI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.5,,,,,<6.5%, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.22,,,,,1.9 - 23,uIU/mL +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,LIPID PANEL,Direct HDL-C 4th Generation,,1.15,,,,,1.03 - 1.53,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,LIPID PANEL,Triglycerides (GPO),,0.89,,,,,0.65 - 3.61,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,LIPID PANEL,Cholesterol (High Performance),,5.43,,,,,4.4 - 7.53,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,LIPID PANEL,LDL Chol Friedewald 4th,,3.87,,H,,,0 - 3.34,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,OPIATE CONFIRMATION URINE,Opiates Confirmed-LCMSMS-LDT,,Codeine (Confirmed),,RX,,,No Ref Rng, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,OPIATE CONFIRMATION URINE,Opiates Confirmed-LCMSMS-LDT,,Morphine (Confirmed),,RX,,,No Ref Rng, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,OPIATE CONFIRMATION URINE,Opiates Confirmed-LCMSMS-LDT,,6-MAM not present,,,,,No Ref Rng, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,TSH,TSH 3rd IS-QT,,0.914,,,,,0.45 - 5.33,mIU/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1 - 1.04, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Ketones,,+1,,H,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.3,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CELLULAR ELEMENTS,Ur WBC/HPF,,4,,,,,0 - 12,/HPF +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,35 - 104,U/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,4 - 43,U/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,GGT,,43,,,,,5 - 50,U/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,LDH,,183,,,,,53 - 234,U/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Urea Nitrogen,,3.2,,,,,1.4 - 8.6,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,47,,,,,31 - 101,umol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Glucose Fasting,,6.0,,H,,,3.9 - 5.6,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Serum Uric Acid,,253,,,,,149 - 446,umol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Phosphorus,,1.22,,,,,0.71 - 1.65,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Total Protein,,68,,,,,60 - 80,g/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Creatine Kinase,,89,,,,,26 - 192,U/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Serum Sodium,,143,,,,,135 - 145,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Serum Bicarbonate,,24.4,,,,,19.3 - 29.3,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.47,,H,,,1.25 - 1.92,mL/sec +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,47,,,,,31 - 101,umol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,89.0,,,,,kg, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,FSH,Follicle Stimulating Hormone,,29.08,,RX,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,GFR,EGFR by MDRD,,116,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,129,,,,,115 - 158,g/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,3.9 - 5.5,TI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,80 - 100,fL +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.29,,,,,3.8 - 10.7,GI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.65,,,,,1.96 - 7.23,GI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.23,,,,,0.8 - 3,GI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.31,,,,,0.12 - 0.92,GI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.7,,,,,40.5 - 75,% +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.6,,,,,15.4 - 48.5,% +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.2,,,,,2.6 - 10.1,% +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,% +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,250,,,,,130 - 394,GI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,6.4,,,,,<6.5%, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,15.80,,,,,1.9 - 23,uIU/mL +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,LIPID PANEL,Direct HDL-C 4th Generation,,1.50,,,,,1.03 - 1.53,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,LIPID PANEL,Triglycerides (GPO),,1.69,,,,,0.63 - 2.71,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,LIPID PANEL,Cholesterol (High Performance),,4.20,,L,,,4.86 - 8.28,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,LIPID PANEL,LDL Chol Friedewald 4th,,1.93,,,,,0 - 3.34,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,RETICULOCYTES,Reticulocyte Count %,,1.5,,,,,0.6 - 2.5,% +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,TSH,TSH 3rd IS-QT,,1.074,,,,,0.45 - 5.33,mIU/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1.01 - 1.03, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,R,H SF,,,Ref Rng:Negative, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Alkaline Phosphatase,,73,,,,,35 - 104,U/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,ALT (SGPT),,40,,,,,4 - 43,U/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,GGT,,56,R,H,,,5 - 50,U/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,LDH,,169,,,,,53 - 234,U/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Urea Nitrogen,,2.9,,,,,1.4 - 8.6,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,51,,,,,31 - 101,umol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Serum Uric Acid,,479,R,H,,,149 - 446,umol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Calcium (EDTA),,2.56,,,,,2.07 - 2.64,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Phosphorus,,1.22,,,,,0.71 - 1.65,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Total Protein,,74,,,,,60 - 80,g/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Creatine Kinase,,135,,,,,26 - 192,U/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Serum Chloride,,96,,,,,94 - 112,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.51,,H,,,1.25 - 1.92,mL/sec +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,51,,,,,31 - 101,umol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,93.1,,,,,kg, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,FSH,Follicle Stimulating Hormone,,30.27,,RX,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,GFR,EGFR by MDRD,,106,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,115 - 158,g/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.9,,,,,3.9 - 5.5,TI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,102,R,H,,,80 - 100,fL +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.37,,,,,3.8 - 10.7,GI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.86,,,,,1.96 - 7.23,GI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.96,,,,,0.8 - 3,GI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.3,,,,,40.5 - 75,% +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.6,,,,,15.4 - 48.5,% +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.3,,,,,2.6 - 10.1,% +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,232,,,,,130 - 394,GI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,6.2,,,,,<6.5%, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.31,,,,,1.9 - 23,uIU/mL +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,LIPID PANEL,Direct HDL-C 4th Generation,,1.30,,,,,1.03 - 1.53,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,LIPID PANEL,Triglycerides (GPO),,1.55,,,,,0.63 - 2.71,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,LIPID PANEL,Cholesterol (High Performance),,3.52,R,L,,,4.86 - 8.28,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,LIPID PANEL,LDL Chol Friedewald 4th,,1.51,,,,,0 - 3.34,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,TSH,TSH 3rd IS-QT,,1.889,,,,,0.45 - 5.33,mIU/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Specific Gravity,,1.015,,,,,1.01 - 1.03, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.0,,,,,0 - 5,mg/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CELLULAR ELEMENTS,Ur WBC/HPF,,3,,,,,0 - 12,/HPF +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Alkaline Phosphatase,,44,,,,,35 - 104,U/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,ALT (SGPT),,12,,,,,4 - 43,U/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,GGT,,6,,,,,4 - 49,U/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,LDH,,157,,,,,53 - 234,U/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,71,,,,,31 - 101,umol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Serum Uric Acid,,263,,,,,125 - 428,umol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Phosphorus,,0.71,,,,,0.71 - 1.65,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Creatine Kinase,,260,,H,,,26 - 192,U/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,,116 - 164,g/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.1 - 5.6,TI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,82,,,,,79 - 98,fL +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.54,,,,,3.8 - 10.7,GI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.08,,,,,1.96 - 7.23,GI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.06,,,,,0.91 - 4.28,GI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,,0 - 0.57,GI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,73.7,,,,,40.5 - 75,% +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.3,,,,,15.4 - 48.5,% +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.8,,,,,0 - 6.8,% +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,260,,,,,140 - 400,GI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,16.54,,,,,1.9 - 23,uIU/mL +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,IS SUBJECT FASTING?,Is Subject Fasting?,Y,No,,,,,, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,LIPID PANEL,Direct HDL-C 4th Generation,,1.52,,,,,1.03 - 1.53,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,LIPID PANEL,Triglycerides (GPO),,1.60,,,,,0.41 - 1.63,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,LIPID PANEL,Cholesterol (High Performance),,4.24,,,,,3.31 - 5.64,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,LIPID PANEL,LDL Chol Friedewald 4th,,1.99,,,,,0 - 3.34,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,MISCELLANEOUS ELEMENTS,Ur Fat,,Present,,H,,,Ref Rng:Not present, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,RETICULOCYTES,Reticulocyte Count %,,0.6,,,,,0.6 - 2.5,% +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Specific Gravity,,1.031,,,,,1 - 1.04, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Ketones,,Trace,,H,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.3,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.2,,,,,0 - 6.2,umol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Alkaline Phosphatase,,59,,,,,35 - 104,U/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,ALT (SGPT),,12,,,,,4 - 43,U/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,GGT,,8,,,,,4 - 49,U/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,LDH,,144,,,,,53 - 234,U/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Serum Uric Acid,,235,,,,,125 - 428,umol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Creatine Kinase,,87,,,,,26 - 192,U/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Serum Bicarbonate,,22.5,,,,,19.3 - 29.3,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.06,,H,,,1.25 - 1.92,mL/sec +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,65.0,,,,,kg, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,GFR,EGFR by MDRD,,100,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,,116 - 164,g/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.1 - 5.6,TI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,82,,,,,79 - 98,fL +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.86,,,,,3.8 - 10.7,GI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.93,,,,,1.96 - 7.23,GI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.59,,,,,0.91 - 4.28,GI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.27,,,,,0.12 - 0.92,GI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,,0 - 0.57,GI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.3,,,,,40.5 - 75,% +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.7,,,,,15.4 - 48.5,% +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,261,,,,,140 - 400,GI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.4,,,,,<6.5%, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.26,,,,,1.9 - 23,uIU/mL +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,LIPID PANEL,Direct HDL-C 4th Generation,,1.54,,H,,,1.03 - 1.53,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,LIPID PANEL,Triglycerides (GPO),,0.87,,,,,0.41 - 1.63,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,LIPID PANEL,Cholesterol (High Performance),,4.29,,,,,3.31 - 5.64,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,LIPID PANEL,LDL Chol Friedewald 4th,,2.35,,,,,0 - 3.34,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,RETICULOCYTES,Reticulocyte Count %,,0.6,,,,,0.6 - 2.5,% +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,TSH,TSH 3rd IS-QT,,0.904,,,,,0.45 - 5.33,mIU/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1 - 1.04, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140518 sponsor-study-35472-test-results-898733-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140518 sponsor-study-35472-test-results-898733-standard.csv new file mode 100644 index 0000000..c1822ff --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140518 sponsor-study-35472-test-results-898733-standard.csv @@ -0,0 +1,2409 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.2,,,,,0 - 5,mg/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Alkaline Phosphatase,,59,,,,,35 - 104,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,4 - 43,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,GGT,,27,,,,,4 - 49,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,LDH,,176,,,,,53 - 234,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,74,,,,,31 - 101,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Uric Acid,,289,,,,,149 - 446,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Phosphorus,,1.12,,,,,0.71 - 1.65,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Creatine Kinase,,263,,H,,,26 - 192,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Bicarbonate,,23.3,,,,,19.3 - 29.3,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,139,,,,Result verified by repeat analysis,116 - 164,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,Result verified by repeat analysis,0.34 - 0.48, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,Result verified by repeat analysis,4.1 - 5.6,TI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,Result verified by repeat analysis,79 - 98,fL +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.14,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.07,,,,,1.96 - 7.23,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.57,,,,,0.91 - 4.28,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.0,,,,,40.5 - 75,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.0,,,,,15.4 - 48.5,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.0,,,,,2.6 - 10.1,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,309,,,,Result verified by repeat analysis,140 - 400,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.37,,,,,1.9 - 23,uIU/mL +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,LIPID PANEL,Direct HDL-C 4th Generation,,1.79,,H,,,1.03 - 1.53,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,LIPID PANEL,Triglycerides (GPO),,1.51,,,,,0.59 - 2.96,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,LIPID PANEL,Cholesterol (High Performance),,5.75,,,,,4.42 - 7.53,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,LIPID PANEL,LDL Chol Friedewald 4th,,3.27,,,,,0 - 3.34,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,TSH,TSH 3rd IS-QT,,4.824,,,,,0.45 - 5.33,mIU/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Specific Gravity,,1.029,,,,,1 - 1.04, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,C-REACTIVE PROTEIN,C Reactive Protein HS,,7.3,,H,,,0 - 5,mg/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.9,,,,,0 - 6.2,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Alkaline Phosphatase,,80,,,,,40 - 129,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,ALT (SGPT),,163,,H RX,,,5 - 48,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,AST (SGOT),,127,,H RX,,,8 - 40,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,GGT,,350,,HT,,Result verified by repeat analysis,10 - 50,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,LDH,,224,,,,,53 - 234,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Urea Nitrogen,,4.1,,,,,1.4 - 8.6,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,106,,,,,40 - 119,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Glucose Fasting,,6.1,,H,,,3.9 - 5.6,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Uric Acid,,512,,H,,,149 - 494,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Phosphorus,,0.81,,,,,0.71 - 1.65,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Creatine Kinase,,348,,H,,,39 - 308,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,125 - 170,g/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.37 - 0.51, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4 - 5.8,TI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,100,,,,,80 - 100,fL +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.89,,,,,3.8 - 10.7,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.35,,,,,1.96 - 7.23,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.13,,,,,0.8 - 3,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.03,,,,,0 - 0.57,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.5,,,,,40.5 - 75,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.0,,,,,15.4 - 48.5,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.7,,,,,2.6 - 10.1,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,137,R,L,,,140 - 400,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.3,,,,,<6.5 %, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,30.61,,H,,,1.9 - 23,uIU/mL +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,LIPID PANEL,Direct HDL-C 4th Generation,,1.03,,,,,1.03 - 1.53,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,LIPID PANEL,Triglycerides (GPO),,2.89,,,,,0.65 - 3.61,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,LIPID PANEL,Cholesterol (High Performance),,4.82,,,,,4.4 - 7.53,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,LIPID PANEL,LDL Chol Friedewald 4th,,2.47,,,,,0 - 3.34,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,RETICULOCYTES,Reticulocyte Count %,,1.5,,,,,0.6 - 2.5,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,TSH,TSH 3rd IS-QT,,1.982,,,,,0.45 - 5.33,mIU/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Specific Gravity,,1.010,,,,,1.01 - 1.03, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Alkaline Phosphatase,,92,,,,,40 - 129,U/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,5 - 48,U/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,LDH,,144,,,,,53 - 234,U/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,92,,,,,40 - 110,umol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Uric Acid,,249,,,,,125 - 488,umol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Calcium (EDTA),,2.51,,,,,2.07 - 2.64,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Phosphorus,,0.97,,,,,0.71 - 1.65,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Albumin-BCG,,50,R,H,,,33 - 49,g/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Creatine Kinase,,224,,,,,39 - 308,U/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Bicarbonate,,27.9,,,,,19.3 - 29.3,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Chloride,,98,,,,,94 - 112,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,127 - 181,g/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 96,fL +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.75,,,,,3.8 - 10.7,GI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.09,,,,,1.96 - 7.23,GI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.22,,,,,0.91 - 4.28,GI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.35,,,,,0.12 - 0.92,GI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.0,,,,,40.5 - 75,% +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,25.8,,,,,15.4 - 48.5,% +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.3,,,,,2.6 - 10.1,% +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.4,,,,,0 - 6.8,% +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,216,,,,,140 - 400,GI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.3,,,,,<6.5 %, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.44,,,,,1.9 - 23,uIU/mL +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,LIPID PANEL,Direct HDL-C 4th Generation,,1.34,,,,,1.03 - 1.53,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,LIPID PANEL,Triglycerides (GPO),,0.59,,,,,0.5 - 2.81,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,LIPID PANEL,Cholesterol (High Performance),,3.92,,,,,3.31 - 6.1,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,LIPID PANEL,LDL Chol Friedewald 4th,,2.31,,,,,0 - 3.34,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,TSH,TSH 3rd IS-QT,,1.256,,,,,0.45 - 5.33,mIU/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Specific Gravity,,1.012,,,,,1 - 1.04, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.8,,,,,0 - 6.2,umol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Alkaline Phosphatase,,104,,,,,40 - 129,U/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,5 - 48,U/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Urea Nitrogen,,6.2,,,,,1.4 - 8.6,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,95,,,,,40 - 110,umol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Uric Acid,,216,,,,,125 - 488,umol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Phosphorus,,1.25,,,,,0.71 - 1.65,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Albumin-BCG,,52,,H,,,33 - 49,g/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Creatine Kinase,,196,,,,,39 - 308,U/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.59,,,,,1.42 - 2.08,mL/sec +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,95,,,,,40 - 110,umol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,64.0,,,,,kg, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,FSH,Follicle Stimulating Hormone,,6.14,,RX,,,1.3 - 19.3,IU/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,146,,,,,127 - 181,g/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.24,,,,,3.8 - 10.7,GI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.97,,,,,1.96 - 7.23,GI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.72,,,,,0.91 - 4.28,GI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.6,,,,,40.5 - 75,% +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.6,,,,,15.4 - 48.5,% +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,% +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,223,,,,,140 - 400,GI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.3,,,,,<6.5 %, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.85,,,,,1.9 - 23,uIU/mL +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,LIPID PANEL,Direct HDL-C 4th Generation,,1.40,,,,,1.03 - 1.53,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,LIPID PANEL,Triglycerides (GPO),,0.81,,,,,0.5 - 2.81,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,LIPID PANEL,Cholesterol (High Performance),,4.33,,,,,3.31 - 6.1,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,LIPID PANEL,LDL Chol Friedewald 4th,,2.56,,,,,0 - 3.34,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,TSH,TSH 3rd IS-QT,,1.789,,,,,0.45 - 5.33,mIU/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Specific Gravity,,1.028,,,,,1 - 1.04, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.1,,,,,0 - 5,mg/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.6,,,,,0 - 6.2,umol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Alkaline Phosphatase,,58,,,,,40 - 129,U/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,ALT (SGPT),,86,,H RX,,,5 - 48,U/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,AST (SGOT),,74,,H RX,,,8 - 40,U/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,GGT,,83,,H,,,10 - 50,U/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,LDH,,187,,,,,53 - 234,U/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,107,,,,,40 - 119,umol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Glucose Fasting,,8.0,,H,,,3.9 - 5.6,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Uric Acid,,500,,H,,,149 - 494,umol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Phosphorus,,0.92,,,,,0.71 - 1.65,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Creatine Kinase,,238,,,,,39 - 308,U/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Potassium,,3.8,,,,,3.5 - 5.2,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Chloride,,99,,,,,94 - 112,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,125 - 170,g/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.37 - 0.51, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4 - 5.8,TI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,80 - 100,fL +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.57,,,,,3.8 - 10.7,GI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.18,,,,,1.96 - 7.23,GI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.84,,,,,0.8 - 3,GI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.44,,,,,0.12 - 0.92,GI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.1,,,,,40.5 - 75,% +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.0,,,,,15.4 - 48.5,% +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.9,,,,,2.6 - 10.1,% +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,169,,,,,140 - 400,GI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,33.13,,H,,,1.9 - 23,uIU/mL +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,LIPID PANEL,Direct HDL-C 4th Generation,,0.70,,L,,,1.03 - 1.53,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,LIPID PANEL,Triglycerides (GPO),,2.48,,,,,0.65 - 3.61,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,LIPID PANEL,Cholesterol (High Performance),,4.55,,,,,4.4 - 7.53,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,LIPID PANEL,LDL Chol Friedewald 4th,,2.71,,,,,0 - 3.34,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,% +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Specific Gravity,,1.018,,,,,1.01 - 1.03, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.7,,,,,0 - 5,mg/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Total Bilirubin,,15,,,,,3 - 21,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.6,,,,,0 - 6.2,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Alkaline Phosphatase,,101,,,,,35 - 104,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,4 - 43,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,GGT,,13,,,,,4 - 49,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,LDH,,175,,,,,53 - 234,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,54,,,,,31 - 101,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Uric Acid,,232,,,,,125 - 428,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Total Protein,,80,,,,,61 - 84,g/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Creatine Kinase,,52,,,,,26 - 192,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Bicarbonate,,22.0,,,,,19.3 - 29.3,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CRYSTALS,Ur Uric Acid Crystals,,Present,,,,,Ref Rng:Not present, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,FREE T4,Free Thyroxine-QT,,18,,H,,,8 - 14,pmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,128,,,,,116 - 164,g/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.85,,,,,3.8 - 10.7,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.16,,,,,1.96 - 7.23,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.28,,,,,0.91 - 4.28,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.31,,,,,0.12 - 0.92,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.0,,,,,40.5 - 75,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.9,,,,,15.4 - 48.5,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.3,,,,,2.6 - 10.1,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,312,,,,,140 - 400,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,4.7,,,,,<6.5 %, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.75,,,,,1.9 - 23,uIU/mL +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,LIPID PANEL,Direct HDL-C 4th Generation,,1.07,,,,,1.03 - 1.53,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,LIPID PANEL,Triglycerides (GPO),,0.77,,,,,0.44 - 1.99,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,LIPID PANEL,Cholesterol (High Performance),,3.77,,,,,3.65 - 6.21,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,LIPID PANEL,LDL Chol Friedewald 4th,,2.35,,,,,0 - 3.34,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,RETICULOCYTES,Reticulocyte Count %,,1.5,,,,,0.6 - 2.5,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,TSH,TSH 3rd IS-QT,,0.119,,L SF,,,0.45 - 5.33,mIU/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1 - 1.04, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.7,,,,,0 - 5,mg/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Alkaline Phosphatase,,53,,,,,35 - 104,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,AST (SGOT),,11,,,,,8 - 40,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,GGT,,12,,,,,4 - 49,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,LDH,,134,,,,,53 - 234,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 8.6,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Uric Acid,,216,,,,,125 - 428,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Phosphorus,,0.83,,,,,0.71 - 1.65,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Creatine Kinase,,83,,,,,26 - 192,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Bicarbonate,,23.3,,,,,19.3 - 29.3,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,121,,,,,116 - 164,g/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,L,,,4.1 - 5.6,TI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.63,,,,,3.8 - 10.7,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.66,,,,,1.96 - 7.23,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.64,,,,,0.91 - 4.28,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.20,,,,,0.12 - 0.92,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.5,,,,,40.5 - 75,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.3,,,,,15.4 - 48.5,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.3,,,,,2.6 - 10.1,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.4,,,,,0 - 6.8,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,273,,,,,140 - 400,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.32,,,,,1.9 - 23,uIU/mL +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,LIPID PANEL,Direct HDL-C 4th Generation,,1.68,,H,,,1.03 - 1.53,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,LIPID PANEL,Triglycerides (GPO),,0.69,,,,,0.44 - 1.99,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,LIPID PANEL,Cholesterol (High Performance),,4.75,,,,,3.65 - 6.21,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,LIPID PANEL,LDL Chol Friedewald 4th,,2.75,,,,,0 - 3.34,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,TSH,TSH 3rd IS-QT,,1.607,,,,,0.45 - 5.33,mIU/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Specific Gravity,,1.027,,,,,1 - 1.04, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.2,,,,,0 - 5,mg/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Alkaline Phosphatase,,64,,,,,35 - 104,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,ALT (SGPT),,21,,,,,4 - 43,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,GGT,,30,,,,,4 - 49,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,LDH,,164,,,,,53 - 234,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Urea Nitrogen,,4.5,,,,,1.4 - 8.6,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Uric Acid,,315,,,,,149 - 446,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Phosphorus,,1.08,,,,,0.71 - 1.65,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Creatine Kinase,,151,,,,,26 - 192,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Bicarbonate,,24.8,,,,,19.3 - 29.3,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,135,,,,,116 - 164,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.44,,,,,3.8 - 10.7,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.89,,,,,1.96 - 7.23,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.02,,,,,0.91 - 4.28,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,52.3,,,,,40.5 - 75,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,40.6,,,,,15.4 - 48.5,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.5,,,,,2.6 - 10.1,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,307,,,,,140 - 400,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.60,,,,,1.9 - 23,uIU/mL +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,LIPID PANEL,Direct HDL-C 4th Generation,,1.98,,H,,,1.03 - 1.53,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,LIPID PANEL,Triglycerides (GPO),,1.32,,,,,0.59 - 2.96,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,LIPID PANEL,Cholesterol (High Performance),,5.66,,,,,4.42 - 7.53,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,LIPID PANEL,LDL Chol Friedewald 4th,,3.08,,,,,0 - 3.34,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,TSH,TSH 3rd IS-QT,,3.912,,,,,0.45 - 5.33,mIU/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1 - 1.04, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.7,,,,,0 - 5,mg/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 5,/HPF +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.2,,,,,0 - 6.2,umol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Alkaline Phosphatase,,91,,,,,40 - 129,U/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,ALT (SGPT),,29,,,,,5 - 48,U/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,AST (SGOT),,39,,,,,8 - 40,U/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,LDH,,206,,,,,53 - 234,U/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Urea Nitrogen,,5.5,,,,,1.4 - 8.6,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,104,,,,,40 - 110,umol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Glucose Fasting,,5.6,,,,,3.9 - 5.6,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Uric Acid,,223,,,,,125 - 488,umol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Calcium (EDTA),,2.58,,,,,2.07 - 2.64,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Albumin-BCG,,51,R,H,,,33 - 49,g/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Creatine Kinase,,1857,R,H SF,,Diluted for quantitation,39 - 308,U/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,157,,,,,127 - 181,g/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.41,,,,,3.8 - 10.7,GI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.57,,,,,1.96 - 7.23,GI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.23,,,,,0.91 - 4.28,GI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.48,,,,,0.12 - 0.92,GI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.3,,,,,40.5 - 75,% +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.1,,,,,15.4 - 48.5,% +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.5,,,,,2.6 - 10.1,% +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,% +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,242,,,,,140 - 400,GI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.71,,,,,1.9 - 23,uIU/mL +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,LIPID PANEL,Direct HDL-C 4th Generation,,1.23,,,,,1.03 - 1.53,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,LIPID PANEL,Triglycerides (GPO),,1.12,,,,,0.5 - 2.81,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,LIPID PANEL,Cholesterol (High Performance),,3.95,,,,,3.31 - 6.1,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,LIPID PANEL,LDL Chol Friedewald 4th,,2.21,,,,,0 - 3.34,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,RETICULOCYTES,Reticulocyte Count %,,0.6,,,,,0.6 - 2.5,% +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Specific Gravity,,1.036,R,H,,,1 - 1.04, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Protein,,Trace,R,H,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.7,,,,,0 - 5,mg/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.1,,,,,0 - 6.2,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Alkaline Phosphatase,,53,,,,,40 - 129,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,ALT (SGPT),,79,,H RX,,,5 - 48,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,AST (SGOT),,46,,H,,,8 - 40,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,GGT,,68,,H,,,10 - 50,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Urea Nitrogen,,4.8,,,,,1.4 - 8.6,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,95,,,,,40 - 119,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Glucose Fasting,,7.0,,H,,,3.9 - 5.6,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Uric Acid,,393,,,,,149 - 494,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Calcium (EDTA),,2.28,,,,,2.07 - 2.64,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Phosphorus,,0.81,,,,,0.71 - 1.65,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Total Protein,,72,,,,,60 - 80,g/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Creatine Kinase,,212,,,,,39 - 308,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Bicarbonate,,22.5,,,,,19.3 - 29.3,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,132,,,,,125 - 170,g/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.37 - 0.51, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.9,,L,,,4 - 5.8,TI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,98,,,,,80 - 100,fL +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.42,,,,,3.8 - 10.7,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.42,,,,,1.96 - 7.23,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.61,,,,,0.8 - 3,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.28,,,,,0.12 - 0.92,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.8,,,,,40.5 - 75,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.4,,,,,15.4 - 48.5,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.4,,,,,2.6 - 10.1,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,149,,,,,140 - 400,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.2,,,,,<6.5 %, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,33.25,R,H,,,1.9 - 23,uIU/mL +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,LIPID PANEL,Direct HDL-C 4th Generation,,0.79,,L,,,1.03 - 1.53,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,LIPID PANEL,Triglycerides (GPO),,2.48,,,,,0.65 - 3.61,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,LIPID PANEL,Cholesterol (High Performance),,4.67,,,,,4.4 - 7.53,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,LIPID PANEL,LDL Chol Friedewald 4th,,2.74,,,,,0 - 3.34,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,TSH,TSH 3rd IS-QT,,1.053,,,,,0.45 - 5.33,mIU/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1.01 - 1.03, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.7,,,,,0 - 5,mg/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,40 - 129,U/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,ALT (SGPT),,22,,,,,5 - 48,U/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,GGT,,26,,,,,10 - 61,U/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,86,,,,,40 - 110,umol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Uric Acid,,261,,,,,125 - 488,umol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Calcium (EDTA),,2.52,,,,,2.07 - 2.64,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Albumin-BCG,,53,,H,,,33 - 49,g/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Creatine Kinase,,70,,,,,39 - 308,U/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Bicarbonate,,25.3,,,,,19.3 - 29.3,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.99,,,,,1.42 - 2.08,mL/sec +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,86,,,,,40 - 110,umol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,81.1,,,,,kg, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,GFR,EGFR by MDRD,,87,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.2,,,,,<6.5 %, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.94,,,,,1.9 - 23,uIU/mL +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,LIPID PANEL,Direct HDL-C 4th Generation,,0.90,,L,,,1.03 - 1.53,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,LIPID PANEL,Triglycerides (GPO),,1.55,,,,,0.56 - 3.62,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,LIPID PANEL,Cholesterol (High Performance),,4.40,,,,,3.88 - 6.83,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,LIPID PANEL,LDL Chol Friedewald 4th,,2.79,,,,,0 - 3.34,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,RETICULOCYTES,Reticulocyte Count %,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,TSH,TSH 3rd IS-QT,,0.855,,,,,0.45 - 5.33,mIU/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,C-REACTIVE PROTEIN,C Reactive Protein HS,,12.0,,H,,,0 - 5,mg/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.7,,,,,0 - 6.2,umol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Alkaline Phosphatase,,120,,,,,40 - 129,U/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,GGT,,15,,,,,10 - 50,U/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,LDH,,165,,,,,53 - 234,U/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Urea Nitrogen,,6.1,,,,,1.4 - 8.6,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,108,,,,,40 - 119,umol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Uric Acid,,237,,,,,149 - 494,umol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Phosphorus,,0.98,,,,,0.71 - 1.65,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Total Protein,,84,,H,,,60 - 80,g/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Creatine Kinase,,116,,,,,39 - 308,U/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Sodium,,138,,,,,135 - 145,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Bicarbonate,,17.8,,L,,,19.3 - 29.3,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.23,,L,,,1.42 - 2.08,mL/sec +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,108,,,,,40 - 119,umol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,82.0,,,,,kg, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,GFR,EGFR by MDRD,,60,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,125 - 170,g/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.37 - 0.51, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4 - 5.8,TI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,83,,,,,80 - 100,fL +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.37,,,,,3.8 - 10.7,GI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.83,,,,,1.96 - 7.23,GI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.79,,,,,0.8 - 3,GI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.61,,,,,0.12 - 0.92,GI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,72.9,,,,,40.5 - 75,% +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.1,,,,,15.4 - 48.5,% +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,% +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,% +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,509,R,H,,,130 - 394,GI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.5,,H,,,<6.5 %, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.10,,,,,1.9 - 23,uIU/mL +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,LIPID PANEL,Direct HDL-C 4th Generation,,1.24,,,,,1.03 - 1.53,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,LIPID PANEL,Triglycerides (GPO),,1.36,,,,,0.65 - 2.94,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,LIPID PANEL,Cholesterol (High Performance),,3.73,,L,,,4.53 - 7.71,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,LIPID PANEL,LDL Chol Friedewald 4th,,1.87,,,,,0 - 3.34,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,% +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,TSH,TSH 3rd IS-QT,,1.311,,,,,0.45 - 5.33,mIU/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1.01 - 1.03, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.5,,,,,0 - 5,mg/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Total Bilirubin,,15,,,,,3 - 21,umol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.7,,,,,0 - 6.2,umol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,40 - 129,U/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,5 - 48,U/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,LDH,,157,,,,,53 - 234,U/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Urea Nitrogen,,4.9,,,,,1.4 - 8.6,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,90,,,,,40 - 110,umol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Uric Acid,,287,,,,,125 - 488,umol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Calcium (EDTA),,2.55,,,,,2.07 - 2.64,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Albumin-BCG,,51,,H,,,33 - 49,g/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Creatine Kinase,,332,,H,,,39 - 308,U/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Potassium,,3.9,,,,,3.5 - 5.2,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.60,,,,,1.42 - 2.08,mL/sec +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,90,,,,,40 - 110,umol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,61.0,,,,,kg, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,GFR,EGFR by MDRD,,89,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,149,,,,,127 - 181,g/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.69,,,,,3.8 - 10.7,GI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.98,,,,,1.96 - 7.23,GI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.11,,,,,0.91 - 4.28,GI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.45,,,,,0.12 - 0.92,GI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.5,,,,,40.5 - 75,% +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,16.5,,,,,15.4 - 48.5,% +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.8,,,,,2.6 - 10.1,% +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,% +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,262,,,,,140 - 400,GI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.81,,,,,1.9 - 23,uIU/mL +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,LIPID PANEL,Direct HDL-C 4th Generation,,1.32,,,,,1.03 - 1.53,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,LIPID PANEL,Triglycerides (GPO),,0.69,,,,,0.5 - 2.81,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,LIPID PANEL,Cholesterol (High Performance),,4.31,,,,,3.31 - 6.1,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,LIPID PANEL,LDL Chol Friedewald 4th,,2.67,,,,,0 - 3.34,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,TSH,TSH 3rd IS-QT,,0.928,,,,,0.45 - 5.33,mIU/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1 - 1.04, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.4,,,,,0 - 5,mg/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Alkaline Phosphatase,,67,,,,,35 - 104,U/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,ALT (SGPT),,28,,,,,4 - 43,U/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,AST (SGOT),,30,,,,,8 - 40,U/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,GGT,,27,,,,,4 - 49,U/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,LDH,,166,,,,,53 - 234,U/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Urea Nitrogen,,4.7,,,,,1.4 - 8.6,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Uric Acid,,337,,,,,149 - 446,umol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Calcium (EDTA),,2.51,,,,,2.07 - 2.64,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Phosphorus,,1.16,,,,,0.71 - 1.65,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Creatine Kinase,,148,,,,,26 - 192,U/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Bicarbonate,,21.7,,,,,19.3 - 29.3,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,116 - 164,g/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.09,,,,,3.8 - 10.7,GI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.49,,,,,1.96 - 7.23,GI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.02,,,,,0.91 - 4.28,GI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.6,,,,,40.5 - 75,% +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,37.4,,,,,15.4 - 48.5,% +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.0,,,,,2.6 - 10.1,% +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,316,,,,,140 - 400,GI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.12,,,,,1.9 - 23,uIU/mL +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,LIPID PANEL,Direct HDL-C 4th Generation,,1.96,,H,,,1.03 - 1.53,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,LIPID PANEL,Triglycerides (GPO),,1.32,,,,,0.59 - 2.96,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,LIPID PANEL,Cholesterol (High Performance),,5.64,,,,,4.42 - 7.53,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,LIPID PANEL,LDL Chol Friedewald 4th,,3.08,,,,,0 - 3.34,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,RETICULOCYTES,Reticulocyte Count %,,0.6,,,,,0.6 - 2.5,% +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Specific Gravity,,1.021,,,,,1 - 1.04, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.0,,,,,0 - 5,mg/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CELLULAR ELEMENTS,Ur WBC/HPF,,3,,,,,0 - 12,/HPF +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Alkaline Phosphatase,,90,,,,,35 - 104,U/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,GGT,,8,,,,,4 - 49,U/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,LDH,,150,,,,,53 - 234,U/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Urea Nitrogen,,4.1,,,,,1.4 - 8.6,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,61,,,,,31 - 101,umol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Uric Acid,,250,,,,,125 - 428,umol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Calcium (EDTA),,2.30,,,,,2.07 - 2.64,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Phosphorus,,1.08,,,,,0.71 - 1.65,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Creatine Kinase,,69,,,,,26 - 192,U/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.73,,,,,3.8 - 10.7,GI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.57,,,,,1.96 - 7.23,GI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.54,,,,,0.91 - 4.28,GI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.42,,,,,0.12 - 0.92,GI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.1,,,,,40.5 - 75,% +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.9,,,,,15.4 - 48.5,% +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,348,,,,,140 - 400,GI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.60,,,,,1.9 - 23,uIU/mL +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,LIPID PANEL,Direct HDL-C 4th Generation,,1.10,,,,,1.03 - 1.53,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,LIPID PANEL,Triglycerides (GPO),,1.17,,,,,0.44 - 1.99,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,LIPID PANEL,Cholesterol (High Performance),,4.41,,,,,3.65 - 6.21,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,LIPID PANEL,LDL Chol Friedewald 4th,,2.77,,,,,0 - 3.34,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,RETICULOCYTES,Reticulocyte Count %,,1.9,,,,,0.6 - 2.5,% +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Specific Gravity,,1.026,,,,,1 - 1.04, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.2,,,,,0 - 5,mg/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CELLULAR ELEMENTS,Ur WBC/HPF,,4,,,,,0 - 12,/HPF +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,35 - 104,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,4 - 43,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,AST (SGOT),,13,,,,,8 - 40,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,GGT,,16,,,,,4 - 49,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,LDH,,128,,,,,53 - 234,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Urea Nitrogen,,7.9,,,,,1.4 - 8.6,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,84,,,,,31 - 101,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Uric Acid,,250,,,,,125 - 428,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Phosphorus,,0.97,,,,,0.71 - 1.65,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Creatine Kinase,,79,,,,,26 - 192,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Bicarbonate,,22.0,,,,,19.3 - 29.3,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,123,,,,,116 - 164,g/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.34 - 0.48, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4.1 - 5.6,TI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.99,,,,,3.8 - 10.7,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.90,,L,,,1.96 - 7.23,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.74,,,,,0.91 - 4.28,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.18,,,,,0.12 - 0.92,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.6,,,,,40.5 - 75,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,43.6,,,,,15.4 - 48.5,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.5,,,,,2.6 - 10.1,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.8,,,,,0 - 6.8,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,301,,,,,140 - 400,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.63,,,,,1.9 - 23,uIU/mL +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,LIPID PANEL,Direct HDL-C 4th Generation,,1.75,,H,,,1.03 - 1.53,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,LIPID PANEL,Triglycerides (GPO),,0.50,,,,,0.44 - 1.99,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,LIPID PANEL,Cholesterol (High Performance),,4.64,,,,,3.65 - 6.21,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,LIPID PANEL,LDL Chol Friedewald 4th,,2.66,,,,,0 - 3.34,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,TSH,TSH 3rd IS-QT,,1.963,,,,,0.45 - 5.33,mIU/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Blood,,+1,,H,,,Ref Rng:$Negative-Trace, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.5,,,,,0 - 5,mg/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Alkaline Phosphatase,,52,,,,,40 - 129,U/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,ALT (SGPT),,77,,H RX,,,5 - 48,U/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,AST (SGOT),,49,,H,,,8 - 40,U/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,GGT,,53,,H,,,10 - 50,U/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,LDH,,139,,,,,53 - 234,U/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 119,umol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Glucose Fasting,,6.3,,H,,,3.9 - 5.6,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Uric Acid,,507,,H,,,149 - 494,umol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Phosphorus,,0.92,,,,,0.71 - 1.65,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Total Protein,,74,,,,,60 - 80,g/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Creatine Kinase,,201,,,,,39 - 308,U/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Bicarbonate,,27.8,,,,,19.3 - 29.3,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,128,,,,,125 - 170,g/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.37 - 0.51, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.9,,L,,,4 - 5.8,TI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,80 - 100,fL +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.20,,,,,3.8 - 10.7,GI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.39,,,,,1.96 - 7.23,GI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.38,,,,,0.8 - 3,GI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,,0 - 0.57,GI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.0,,,,,40.5 - 75,% +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.9,,,,,15.4 - 48.5,% +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.8,,,,,2.6 - 10.1,% +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,% +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,% +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,144,,,,,140 - 400,GI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,22.36,,,,,1.9 - 23,uIU/mL +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,LIPID PANEL,Direct HDL-C 4th Generation,,0.75,,L,,,1.03 - 1.53,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,LIPID PANEL,Triglycerides (GPO),,3.00,,,,,0.65 - 3.61,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,LIPID PANEL,Cholesterol (High Performance),,4.63,,,,,4.4 - 7.53,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,LIPID PANEL,LDL Chol Friedewald 4th,,2.51,,,,,0 - 3.34,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Specific Gravity,,1.010,,,,,1.01 - 1.03, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Alkaline Phosphatase,,39,,,,,35 - 104,U/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,ALT (SGPT),,7,,,,,4 - 43,U/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,AST (SGOT),,13,,,,,8 - 40,U/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,GGT,,10,,,,,4 - 49,U/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,LDH,,144,,,,,53 - 234,U/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Urea Nitrogen,,2.9,,,,,1.4 - 8.6,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Uric Acid,,162,,,,,125 - 428,umol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Phosphorus,,0.94,,,,,0.71 - 1.65,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Creatine Kinase,,56,,,,,26 - 192,U/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Bicarbonate,,26.3,,,,,19.3 - 29.3,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.79,,,,,1.25 - 1.92,mL/sec +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,70.3,,,,,kg, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,GFR,EGFR by MDRD,,88,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,Result verified by repeat analysis,116 - 164,g/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,Result verified by repeat analysis,4.1 - 5.6,TI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.80,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.45,,,,Result verified by repeat analysis,1.96 - 7.23,GI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.67,,,,,0.91 - 4.28,GI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.43,,,,Result verified by repeat analysis,0.12 - 0.92,GI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.21,,,,Result verified by repeat analysis,0 - 0.57,GI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,Result verified by repeat analysis,0 - 0.2,GI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.1,,,,Result verified by repeat analysis,40.5 - 75,% +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.7,,,,Result verified by repeat analysis,15.4 - 48.5,% +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.0,,,,Result verified by repeat analysis,2.6 - 10.1,% +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.4,,,,Result verified by repeat analysis,0 - 6.8,% +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,Result verified by repeat analysis,0 - 2,% +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,254,,,,Result verified by repeat analysis,140 - 400,GI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.02,,,,,1.9 - 23,uIU/mL +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,LIPID PANEL,Direct HDL-C 4th Generation,,1.67,,H,,,1.03 - 1.53,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,LIPID PANEL,Triglycerides (GPO),,0.69,,,,,0.51 - 2.42,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,LIPID PANEL,Cholesterol (High Performance),,5.79,,,,,4.01 - 6.85,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,LIPID PANEL,LDL Chol Friedewald 4th,,3.80,,H,,,0 - 3.34,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,TSH,TSH 3rd IS-QT,,1.837,,,,,0.45 - 5.33,mIU/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Specific Gravity,,1.005,,,,,1 - 1.04, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CELLULAR ELEMENTS,Ur RBC/HPF,,3,,,,,0 - 8,/HPF +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,35 - 104,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,4 - 43,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,GGT,,21,,,,,4 - 49,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,LDH,,167,,,,,53 - 234,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Uric Acid,,286,,,,,149 - 446,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Phosphorus,,1.01,,,,,0.71 - 1.65,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Creatine Kinase,,147,,,,,26 - 192,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Bicarbonate,,22.4,,,,,19.3 - 29.3,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,FREE T4,Free Thyroxine-QT,,9,,,,,8 - 14,pmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,116 - 164,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 98,fL +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.42,,,,,3.8 - 10.7,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.84,,,,,1.96 - 7.23,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.08,,,,,0.91 - 4.28,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.8,,,,,40.5 - 75,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,41.6,,,,,15.4 - 48.5,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,3.9,,,,,2.6 - 10.1,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.8,,,,,0 - 6.8,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,332,,,,,140 - 400,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.2,,,,,<6.5 %, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.98,,,,,1.9 - 23,uIU/mL +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,LIPID PANEL,Direct HDL-C 4th Generation,,2.01,,H,,,1.03 - 1.53,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,LIPID PANEL,Triglycerides (GPO),,1.43,,,,,0.59 - 2.96,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,LIPID PANEL,Cholesterol (High Performance),,5.46,,,,,4.42 - 7.53,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,LIPID PANEL,LDL Chol Friedewald 4th,,2.80,,,,,0 - 3.34,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,TSH,TSH 3rd IS-QT,,6.224,,H SF,,,0.45 - 5.33,mIU/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Specific Gravity,,1.033,,,,,1 - 1.04, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.2,,,,,0 - 5,mg/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Alkaline Phosphatase,,73,,,,,35 - 104,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,AST (SGOT),,13,,,,,8 - 40,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,GGT,,7,,,,,4 - 49,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,LDH,,145,,,,,53 - 234,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Glucose Fasting,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Uric Acid,,236,,,,,125 - 428,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Phosphorus,,1.19,,,,,0.71 - 1.65,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Creatine Kinase,,72,,,,,26 - 192,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,,116 - 164,g/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.59,,,,,3.8 - 10.7,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.25,,,,,1.96 - 7.23,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.64,,,,,0.91 - 4.28,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.37,,,,,0.12 - 0.92,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.19,,,,,0 - 0.2,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,64.5,,,,,40.5 - 75,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,24.9,,,,,15.4 - 48.5,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.9,,H,,,0 - 2,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,300,,,,,140 - 400,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,4.9,,,,,<6.5 %, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.92,,,,,1.9 - 23,uIU/mL +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,LIPID PANEL,Direct HDL-C 4th Generation,,1.01,,L,,,1.03 - 1.53,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,LIPID PANEL,Triglycerides (GPO),,1.05,,,,,0.44 - 1.99,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,LIPID PANEL,Cholesterol (High Performance),,3.68,,,,,3.65 - 6.21,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,LIPID PANEL,LDL Chol Friedewald 4th,,2.19,,,,,0 - 3.34,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,TSH,TSH 3rd IS-QT,,1.385,,,,,0.45 - 5.33,mIU/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,C-REACTIVE PROTEIN,C Reactive Protein HS,,8.1,,H,,,0 - 5,mg/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Alkaline Phosphatase,,51,,,,,40 - 129,U/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,ALT (SGPT),,79,,H RX,,,5 - 48,U/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,AST (SGOT),,51,,H,,,8 - 40,U/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,GGT,,52,,H,,,10 - 50,U/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,LDH,,160,,,,,53 - 234,U/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Urea Nitrogen,,4.5,,,,,1.4 - 8.6,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,92,,,,,40 - 119,umol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Glucose Fasting,,6.1,,H,,,3.9 - 5.6,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Uric Acid,,521,,H,,,149 - 494,umol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Phosphorus,,1.00,,,,,0.71 - 1.65,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Total Protein,,75,,,,,60 - 80,g/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Creatine Kinase,,206,,,,,39 - 308,U/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Bicarbonate,,25.6,,,,,19.3 - 29.3,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.95,,,,,1.42 - 2.08,mL/sec +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,92,,,,,40 - 119,umol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,108.0,,,,,kg, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,GFR,EGFR by MDRD,,73,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,132,,,,,125 - 170,g/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.37 - 0.51, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,4 - 5.8,TI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,80 - 100,fL +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.10,,,,,3.8 - 10.7,GI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.77,,,,,1.96 - 7.23,GI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.71,,,,,0.8 - 3,GI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.52,,,,,0.12 - 0.92,GI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.7,,,,,40.5 - 75,% +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.1,,,,,15.4 - 48.5,% +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.5,,,,,2.6 - 10.1,% +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,178,,,,,140 - 400,GI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.2,,,,,<6.5 %, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,15.17,,,,,1.9 - 23,uIU/mL +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,LIPID PANEL,Direct HDL-C 4th Generation,,0.74,,L,,,1.03 - 1.53,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,LIPID PANEL,Triglycerides (GPO),,2.04,,,,,0.65 - 3.61,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,LIPID PANEL,Cholesterol (High Performance),,4.38,,L,,,4.4 - 7.53,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,LIPID PANEL,LDL Chol Friedewald 4th,,2.71,,,,,0 - 3.34,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,RETICULOCYTES,Reticulocyte Count %,,1.9,,,,,0.6 - 2.5,% +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,TSH,TSH 3rd IS-QT,,1.243,,,,,0.45 - 5.33,mIU/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Specific Gravity,,1.013,,,,,1.01 - 1.03, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Alkaline Phosphatase,,93,,,,,40 - 129,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,ALT (SGPT),,128,,H RX,,,5 - 48,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,AST (SGOT),,54,,H,,,8 - 40,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,GGT,,247,,H,,Result verified by repeat analysis,10 - 61,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 8.6,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Uric Acid,,430,,,,,125 - 488,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Calcium (EDTA),,2.56,,,,,2.07 - 2.64,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Phosphorus,,1.25,,,,,0.71 - 1.65,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Creatine Kinase,,127,,,,,39 - 308,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Bicarbonate,,24.5,,,,,19.3 - 29.3,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,162,,,,,127 - 181,g/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.4,,,,,4.5 - 6.4,TI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.78,,,,,3.8 - 10.7,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.00,,,,,1.96 - 7.23,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.31,,,,,0.91 - 4.28,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.26,,,,,0.12 - 0.92,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.8,,,,,40.5 - 75,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.5,,,,,15.4 - 48.5,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.4,,,,,0 - 6.8,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,271,,,,,140 - 400,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,8.27,,,,,1.9 - 23,uIU/mL +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,LIPID PANEL,Direct HDL-C 4th Generation,,1.32,,,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,LIPID PANEL,Triglycerides (GPO),,2.24,,,,,0.5 - 2.81,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,LIPID PANEL,Cholesterol (High Performance),,5.39,,,,,3.31 - 6.1,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,LIPID PANEL,LDL Chol Friedewald 4th,,3.04,,,,,0 - 3.34,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,TSH,TSH 3rd IS-QT,,1.417,,,,,0.45 - 5.33,mIU/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.0,,,,,0 - 5,mg/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Alkaline Phosphatase,,63,,,,,35 - 104,U/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,GGT,,15,,,,,4 - 49,U/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,LDH,,142,,,,,53 - 234,U/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,81,,,,,31 - 101,umol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Uric Acid,,291,,,,,125 - 428,umol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Phosphorus,,1.15,,,,,0.71 - 1.65,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Creatine Kinase,,109,,,,,26 - 192,U/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Bicarbonate,,21.7,,,,,19.3 - 29.3,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.55,,,,,1.25 - 1.92,mL/sec +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,81,,,,,31 - 101,umol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,68.0,,,,,kg, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,FSH,Follicle Stimulating Hormone,,1.95,,RX,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,124,,,,,116 - 164,g/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.34 - 0.48, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.35,,,,,3.8 - 10.7,GI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.19,,,,,1.96 - 7.23,GI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.57,,,,,0.91 - 4.28,GI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.6,,,,,40.5 - 75,% +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.4,,,,,15.4 - 48.5,% +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.3,,,,,2.6 - 10.1,% +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.6,,,,,0 - 2,% +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,340,,,,,140 - 400,GI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.7,,,,,<6.5 %, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.35,,,,,1.9 - 23,uIU/mL +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,LIPID PANEL,Direct HDL-C 4th Generation,,1.82,,H,,,1.03 - 1.53,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,LIPID PANEL,Triglycerides (GPO),,0.63,,,,,0.44 - 1.99,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,LIPID PANEL,Cholesterol (High Performance),,5.11,,,,,3.65 - 6.21,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,LIPID PANEL,LDL Chol Friedewald 4th,,3.00,,,,,0 - 3.34,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,% +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,TSH,TSH 3rd IS-QT,,2.024,,,,,0.45 - 5.33,mIU/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.7,,,,,0 - 5,mg/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Alkaline Phosphatase,,62,,,,,35 - 104,U/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,ALT (SGPT),,21,,,,,4 - 43,U/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,GGT,,33,,,,,4 - 49,U/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,LDH,,158,,,,,53 - 234,U/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Urea Nitrogen,,4.1,,,,,1.4 - 8.6,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,73,,,,,31 - 101,umol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Glucose Fasting,,4.2,,,,,3.9 - 5.6,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Uric Acid,,307,,,,,149 - 446,umol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Phosphorus,,1.07,,,,,0.71 - 1.65,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Creatine Kinase,,203,,H,,,26 - 192,U/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Bicarbonate,,22.0,,,,,19.3 - 29.3,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.49,,,,,3.8 - 10.7,GI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.93,,,,,1.96 - 7.23,GI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.72,,,,,0.91 - 4.28,GI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.32,,,,,0 - 0.57,GI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.17,,,,,0 - 0.2,GI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,45.2,,,,,40.5 - 75,% +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,41.9,,,,,15.4 - 48.5,% +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.3,,,,,2.6 - 10.1,% +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.9,,,,,0 - 6.8,% +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.7,R,H,,,0 - 2,% +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,332,,,,,140 - 400,GI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.15,,,,,1.9 - 23,uIU/mL +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,LIPID PANEL,Direct HDL-C 4th Generation,,1.91,,H,,,1.03 - 1.53,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,LIPID PANEL,Triglycerides (GPO),,1.28,,,,,0.59 - 2.96,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,LIPID PANEL,Cholesterol (High Performance),,5.21,,,,,4.42 - 7.53,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,LIPID PANEL,LDL Chol Friedewald 4th,,2.71,,,,,0 - 3.34,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,C-REACTIVE PROTEIN,C Reactive Protein HS,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Total Bilirubin,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,ALT (SGPT),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,AST (SGOT),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,GGT,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,LDH,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Urea Nitrogen,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Glucose Fasting,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Uric Acid,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Calcium (EDTA),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Phosphorus,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Total Protein,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Albumin-BCG,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Creatine Kinase,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Sodium,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Potassium,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Bicarbonate,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Chloride,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,126,,,,,116 - 164,g/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.49,,,,,3.8 - 10.7,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.37,,,,,1.96 - 7.23,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.74,,,,,0.91 - 4.28,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.07,,,,,0 - 0.57,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,52.8,,,,,40.5 - 75,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.7,,,,,15.4 - 48.5,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,299,,,,,140 - 400,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.65,,,,,1.9 - 23,uIU/mL +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,LIPID PANEL,Direct HDL-C 4th Generation,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,LIPID PANEL,Triglycerides (GPO),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,LIPID PANEL,Cholesterol (High Performance),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,LIPID PANEL,LDL Chol Friedewald 4th,,Required testing unavailable,,,,,0 - 3.34,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,TSH,TSH 3rd IS-QT,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Specific Gravity,,1.011,,,,,1 - 1.04, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.1,,,,,0 - 5,mg/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CELLULAR ELEMENTS,Ur WBC/HPF,,5,,,,,0 - 12,/HPF +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CELLULAR ELEMENTS,Ur Squamous Epithelial Cells,,80,,,,,0 - 3,/HPF +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Alkaline Phosphatase,,98,,,,,35 - 104,U/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,4 - 43,U/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,AST (SGOT),,10,,,,,8 - 40,U/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,GGT,,8,,,,,4 - 49,U/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,LDH,,142,,,,,53 - 234,U/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Urea Nitrogen,,4.8,,,,,1.4 - 8.6,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,62,,,,,31 - 101,umol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Uric Acid,,261,,,,,125 - 428,umol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Phosphorus,,1.10,,,,,0.71 - 1.65,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Total Protein,,78,,,,,61 - 84,g/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Creatine Kinase,,42,,,,,26 - 192,U/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Bicarbonate,,21.8,,,,,19.3 - 29.3,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.82,,,,,3.8 - 10.7,GI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.12,,,,,1.96 - 7.23,GI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.07,,,,,0.91 - 4.28,GI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.4,,,,,40.5 - 75,% +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.4,,,,,15.4 - 48.5,% +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,% +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,322,,,,,140 - 400,GI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.28,,,,,1.9 - 23,uIU/mL +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,LIPID PANEL,Direct HDL-C 4th Generation,,1.25,,,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,LIPID PANEL,Triglycerides (GPO),,0.86,,,,,0.44 - 1.99,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,LIPID PANEL,Cholesterol (High Performance),,4.48,,,,,3.65 - 6.21,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,LIPID PANEL,LDL Chol Friedewald 4th,,2.84,,,,,0 - 3.34,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,% +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Specific Gravity,,1.037,,H,,,1 - 1.04, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.4,,,,,0 - 5,mg/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.6,,,,,0 - 6.2,umol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Alkaline Phosphatase,,100,,,,,35 - 104,U/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,4 - 43,U/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,GGT,,63,,H,,,4 - 49,U/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,LDH,,174,,,,,53 - 234,U/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Uric Acid,,291,,,,,149 - 446,umol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Phosphorus,,1.02,,,,,0.71 - 1.65,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Total Protein,,78,,,,,61 - 84,g/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Creatine Kinase,,141,,,,,26 - 192,U/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.17,,L,,,1.25 - 1.92,mL/sec +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,59.2,,,,,kg, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,FREE T4,Free Thyroxine-QT,,9,,,,,8 - 14,pmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,GFR,EGFR by MDRD,,69,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,116 - 164,g/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 98,fL +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.44,,,,,3.8 - 10.7,GI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.83,,,,,1.96 - 7.23,GI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,4.07,,,,,0.91 - 4.28,GI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.21,,,,,0 - 0.57,GI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,38.0,R,L,,,40.5 - 75,% +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,54.7,R,H,,,15.4 - 48.5,% +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,3.8,,,,,2.6 - 10.1,% +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.8,,,,,0 - 6.8,% +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,295,,,,,140 - 400,GI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.3,,,,,<6.5%, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.96,,,,,1.9 - 23,uIU/mL +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,LIPID PANEL,Direct HDL-C 4th Generation,,1.84,,H,,,1.03 - 1.53,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,LIPID PANEL,Triglycerides (GPO),,1.42,,,,,0.59 - 2.96,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,LIPID PANEL,Cholesterol (High Performance),,5.78,,,,,4.42 - 7.53,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,LIPID PANEL,LDL Chol Friedewald 4th,,3.29,,,,,0 - 3.34,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,TSH,TSH 3rd IS-QT,,5.438,R,H SF,,,0.45 - 5.33,mIU/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.4,,,,,0 - 5,mg/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Alkaline Phosphatase,,84,,,,,40 - 129,U/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,ALT (SGPT),,64,,H,,,5 - 48,U/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,GGT,,123,,H,,,10 - 61,U/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,LDH,,159,,,,,53 - 234,U/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Urea Nitrogen,,6.3,,,,,1.4 - 8.6,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 110,umol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Uric Acid,,419,,,,,125 - 488,umol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Calcium (EDTA),,2.53,,,,,2.07 - 2.64,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Phosphorus,,1.27,,,,,0.71 - 1.65,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Creatine Kinase,,141,,,,,39 - 308,U/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Bicarbonate,,21.9,,,,,19.3 - 29.3,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,157,,,,,127 - 181,g/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.88,,,,,3.8 - 10.7,GI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.07,,,,,1.96 - 7.23,GI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.32,,,,,0.91 - 4.28,GI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.9,,,,,40.5 - 75,% +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.1,,,,,15.4 - 48.5,% +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.9,,,,,2.6 - 10.1,% +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.0,,,,,0 - 6.8,% +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,266,,,,,140 - 400,GI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.45,,,,,1.9 - 23,uIU/mL +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,LIPID PANEL,Direct HDL-C 4th Generation,,0.92,,L,,,1.03 - 1.53,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,LIPID PANEL,Triglycerides (GPO),,1.73,,,,,0.5 - 2.81,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,LIPID PANEL,Cholesterol (High Performance),,4.62,,,,,3.31 - 6.1,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,LIPID PANEL,LDL Chol Friedewald 4th,,2.91,,,,,0 - 3.34,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,C-REACTIVE PROTEIN,C Reactive Protein HS,,5.3,,H,,,0 - 5,mg/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CELLULAR ELEMENTS,Ur WBC/HPF,,3,,,,,0 - 12,/HPF +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Alkaline Phosphatase,,101,,,,,35 - 104,U/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,AST (SGOT),,12,,,,,8 - 40,U/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,GGT,,6,,,,,4 - 49,U/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,LDH,,157,,,,,53 - 234,U/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Uric Acid,,232,,,,,125 - 428,umol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Calcium (EDTA),,2.27,,,,,2.07 - 2.64,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Phosphorus,,1.14,,,,,0.71 - 1.65,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Creatine Kinase,,59,,,,,26 - 192,U/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Sodium,,136,,,,,132 - 147,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Bicarbonate,,21.4,,,,,19.3 - 29.3,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.50,,H,,,1.25 - 1.92,mL/sec +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,75.2,,,,,kg, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,GFR,EGFR by MDRD,,108,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,,116 - 164,g/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.26,,,,,3.8 - 10.7,GI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.66,,,,,1.96 - 7.23,GI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.98,,,,,0.91 - 4.28,GI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,64.1,,,,,40.5 - 75,% +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.4,,,,,15.4 - 48.5,% +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,% +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,335,,,,,140 - 400,GI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,4.8,,,,,<6.5%, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.40,,,,,1.9 - 23,uIU/mL +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,LIPID PANEL,Direct HDL-C 4th Generation,,0.99,,L,,,1.03 - 1.53,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,LIPID PANEL,Triglycerides (GPO),,0.76,,,,,0.44 - 1.99,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,LIPID PANEL,Cholesterol (High Performance),,4.01,,,,,3.65 - 6.21,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,LIPID PANEL,LDL Chol Friedewald 4th,,2.67,,,,,0 - 3.34,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,RETICULOCYTES,Reticulocyte Count %,,2.4,,,,,0.6 - 2.5,% +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,TSH,TSH 3rd IS-QT,,1.593,,,,,0.45 - 5.33,mIU/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Specific Gravity,,1.029,,,,,1 - 1.04, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,BENZODIAZEPINE CONFIRM. UR,BenzodiazepineConf-LCMSMS-LDT,,Oxazepam (Confirmed),R,RX,,,No Ref Rng, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.2,,,,,0 - 5,mg/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,40 - 129,U/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,ALT (SGPT),,27,,,,,5 - 48,U/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,GGT,,17,,,,,10 - 61,U/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Urea Nitrogen,,6.1,,,,,1.4 - 8.6,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,83,,,,,40 - 110,umol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Uric Acid,,344,,,,,125 - 488,umol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Calcium (EDTA),,2.46,,,,,2.07 - 2.64,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Phosphorus,,1.03,,,,,0.71 - 1.65,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Total Protein,,78,,,,,61 - 84,g/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Creatine Kinase,,232,,,,,39 - 308,U/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.37,,H,,,1.42 - 2.08,mL/sec +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,83,,,,,40 - 110,umol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,89.1,,,,,kg, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Detected (unconfirmed),,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,GFR,EGFR by MDRD,,93,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,141,,,,,127 - 181,g/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.39 - 0.54, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.5 - 6.4,TI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.63,,,,,3.8 - 10.7,GI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.10,,,,,1.96 - 7.23,GI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.01,,,,,0.91 - 4.28,GI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.37,,,,,0.12 - 0.92,GI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,46.8,,,,,40.5 - 75,% +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,45.4,,,,,15.4 - 48.5,% +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,306,,,,,140 - 400,GI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.3,,,,,<6.5%, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,16.63,,,,,1.9 - 23,uIU/mL +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,LIPID PANEL,Direct HDL-C 4th Generation,,0.95,R,L,,,1.03 - 1.53,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,LIPID PANEL,Triglycerides (GPO),,2.07,,,,,0.56 - 3.62,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,LIPID PANEL,Cholesterol (High Performance),,5.65,,,,,3.88 - 6.83,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,LIPID PANEL,LDL Chol Friedewald 4th,,3.75,,H,,,0 - 3.34,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,TSH,TSH 3rd IS-QT,,2.249,,,,,0.45 - 5.33,mIU/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1 - 1.04, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.4,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,35 - 104,U/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,AST (SGOT),,11,,,,,8 - 40,U/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,GGT,,13,,,,,4 - 49,U/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,LDH,,126,,,,,53 - 234,U/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,31 - 101,umol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Uric Acid,,217,,,,,125 - 428,umol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Phosphorus,,1.01,,,,,0.71 - 1.65,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Creatine Kinase,,66,,,,,26 - 192,U/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Bicarbonate,,24.5,,,,,19.3 - 29.3,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,121,,,,,116 - 164,g/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.05,,,,,3.8 - 10.7,GI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.88,,,,,1.96 - 7.23,GI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.73,,,,,0.91 - 4.28,GI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.1,,,,,40.5 - 75,% +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.3,,,,,15.4 - 48.5,% +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.7,,,,,2.6 - 10.1,% +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.6,,,,,0 - 6.8,% +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,286,,,,,140 - 400,GI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.08,,,,,1.9 - 23,uIU/mL +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,LIPID PANEL,Direct HDL-C 4th Generation,,1.85,R,H,,,1.03 - 1.53,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,LIPID PANEL,Triglycerides (GPO),,0.57,,,,,0.44 - 1.99,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,LIPID PANEL,Cholesterol (High Performance),,4.35,,,,,3.65 - 6.21,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,LIPID PANEL,LDL Chol Friedewald 4th,,2.24,,,,,0 - 3.34,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,RETICULOCYTES,Reticulocyte Count %,,0.8,,,,,0.6 - 2.5,% +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Specific Gravity,,1.015,,,,,1 - 1.04, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.8,,,,,0 - 6.2,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Alkaline Phosphatase,,88,,,,,40 - 129,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,ALT (SGPT),,46,,,,,5 - 48,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,GGT,,129,,H,,,10 - 61,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,LDH,,156,,,,,53 - 234,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 110,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Uric Acid,,429,,,,,125 - 488,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Calcium (EDTA),,2.56,,,,,2.07 - 2.64,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Creatine Kinase,,131,,,,,39 - 308,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Bicarbonate,,21.4,,,,,19.3 - 29.3,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,157,,,,,127 - 181,g/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.39 - 0.54, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.79,,,,,3.8 - 10.7,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.75,,,,,1.96 - 7.23,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.48,,,,,0.91 - 4.28,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.5,,,,,40.5 - 75,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.9,,,,,15.4 - 48.5,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,,2.6 - 10.1,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,,,,0 - 6.8,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.5,,,,,0 - 2,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,280,,,,,140 - 400,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,4.8,,,,,<6.5%, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,10.32,,,,,1.9 - 23,uIU/mL +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,LIPID PANEL,Direct HDL-C 4th Generation,,0.92,,L,,,1.03 - 1.53,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,LIPID PANEL,Triglycerides (GPO),,1.99,,,,,0.5 - 2.81,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,LIPID PANEL,Cholesterol (High Performance),,4.77,,,,,3.31 - 6.1,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,LIPID PANEL,LDL Chol Friedewald 4th,,2.94,,,,,0 - 3.34,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,TSH,TSH 3rd IS-QT,,1.125,,,,,0.45 - 5.33,mIU/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.4,,,,,0 - 5,mg/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,35 - 104,U/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,GGT,,16,,,,,4 - 49,U/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,LDH,,124,,,,,53 - 234,U/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Urea Nitrogen,,4.5,,,,,1.4 - 8.6,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 101,umol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Glucose Fasting,,4.3,,,,,3.9 - 5.6,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Uric Acid,,303,,,,,125 - 428,umol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Phosphorus,,1.03,,,,,0.71 - 1.65,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Creatine Kinase,,79,,,,,26 - 192,U/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Bicarbonate,,23.6,,,,,19.3 - 29.3,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,,116 - 164,g/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,83,,,,,79 - 98,fL +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.69,,,,,3.8 - 10.7,GI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.05,,,,,1.96 - 7.23,GI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.72,,,,,0.91 - 4.28,GI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.34,,,,,0 - 0.57,GI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.5,,,,,40.5 - 75,% +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.1,,,,,15.4 - 48.5,% +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.6,,,,,2.6 - 10.1,% +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,6.1,,,,,0 - 6.8,% +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.6,,,,,0 - 2,% +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,274,,,,,140 - 400,GI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.2,,,,,<6.5%, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.14,,,,,1.9 - 23,uIU/mL +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,LIPID PANEL,Direct HDL-C 4th Generation,,1.48,,,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,LIPID PANEL,Triglycerides (GPO),,0.82,,,,,0.44 - 1.99,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,LIPID PANEL,Cholesterol (High Performance),,3.76,,,,,3.65 - 6.21,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,LIPID PANEL,LDL Chol Friedewald 4th,,1.90,,,,,0 - 3.34,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,TSH,TSH 3rd IS-QT,,1.582,,,,,0.45 - 5.33,mIU/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Specific Gravity,,1.011,,,,,1 - 1.04, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.4,,,,,0 - 5,mg/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Alkaline Phosphatase,,80,,,,,35 - 104,U/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,ALT (SGPT),,32,,,,,4 - 43,U/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,AST (SGOT),,34,,,,,8 - 40,U/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,GGT,,25,,,,,5 - 50,U/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,LDH,,167,,,,,53 - 234,U/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Uric Acid,,265,,,,,149 - 446,umol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Phosphorus,,1.18,,,,,0.71 - 1.65,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Total Protein,,63,,,,,60 - 80,g/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Creatine Kinase,,46,,,,,26 - 192,U/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Sodium,,143,,,,,135 - 145,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Bicarbonate,,24.9,,,,,19.3 - 29.3,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.74,,,,,1.25 - 1.92,mL/sec +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,75.3,,,,,kg, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,GFR,EGFR by MDRD,,90,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,146,,,,,115 - 158,g/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,3.9 - 5.5,TI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,95,,,,,80 - 100,fL +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.39,R,L,,,3.8 - 10.7,GI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.95,R,L,,,1.96 - 7.23,GI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.01,,,,,0.8 - 3,GI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.24,,,,,0.12 - 0.92,GI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.5,,,,,40.5 - 75,% +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.8,,,,,15.4 - 48.5,% +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.1,,,,,2.6 - 10.1,% +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.8,,,,,0 - 6.8,% +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,169,,,,,130 - 394,GI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.6,,,,,<6.5%, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.01,,,,,1.9 - 23,uIU/mL +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,LIPID PANEL,Direct HDL-C 4th Generation,,1.49,,,,,1.03 - 1.53,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,LIPID PANEL,Triglycerides (GPO),,0.88,,,,,0.63 - 2.71,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,LIPID PANEL,Cholesterol (High Performance),,4.46,R,L,,,4.86 - 8.28,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,LIPID PANEL,LDL Chol Friedewald 4th,,2.57,,,,,0 - 3.34,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,TSH,TSH 3rd IS-QT,,2.205,,,,,0.45 - 5.33,mIU/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1.01 - 1.03, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.0,,,,,0 - 5,mg/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Alkaline Phosphatase,,61,,,,,35 - 104,U/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,ALT (SGPT),,13,,,,,4 - 43,U/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,GGT,,14,,,,,4 - 49,U/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,LDH,,137,,,,,53 - 234,U/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Glucose Fasting,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Uric Acid,,273,,,,,125 - 428,umol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Phosphorus,,1.07,,,,,0.71 - 1.65,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Creatine Kinase,,123,,,,,26 - 192,U/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.59,,,,,1.25 - 1.92,mL/sec +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,68.1,,,,,kg, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,GFR,EGFR by MDRD,,73,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,125,,,,,116 - 164,g/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.30,,,,,3.8 - 10.7,GI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.33,,,,,1.96 - 7.23,GI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.57,,,,,0.91 - 4.28,GI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.1,,,,,40.5 - 75,% +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.6,,,,,15.4 - 48.5,% +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,% +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,250,,,,,140 - 400,GI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.5,,,,,<6.5%, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.11,,,,,1.9 - 23,uIU/mL +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,LIPID PANEL,Direct HDL-C 4th Generation,,1.65,,H,,,1.03 - 1.53,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,LIPID PANEL,Triglycerides (GPO),,0.93,,,,,0.44 - 1.99,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,LIPID PANEL,Cholesterol (High Performance),,4.65,,,,,3.65 - 6.21,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,LIPID PANEL,LDL Chol Friedewald 4th,,2.57,,,,,0 - 3.34,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,TSH,TSH 3rd IS-QT,,3.025,,,,,0.45 - 5.33,mIU/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Specific Gravity,,1.014,,,,,1 - 1.04, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.3,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,40 - 129,U/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,ALT (SGPT),,46,,,,,5 - 48,U/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,GGT,,93,,H,,,10 - 61,U/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,LDH,,165,,,,,53 - 234,U/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Urea Nitrogen,,5.7,,,,,1.4 - 8.6,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,94,,,,,40 - 110,umol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Uric Acid,,427,,,,,125 - 488,umol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Calcium (EDTA),,2.57,,,,,2.07 - 2.64,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Phosphorus,,1.18,,,,,0.71 - 1.65,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Creatine Kinase,,89,,,,,39 - 308,U/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Bicarbonate,,21.0,,,,,19.3 - 29.3,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,165,,,,,127 - 181,g/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.70,,,,,3.8 - 10.7,GI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.28,,,,,1.96 - 7.23,GI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.74,,,,,0.91 - 4.28,GI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,1.34,R,H,,,0 - 0.57,GI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.00,,,,,0 - 0.2,GI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,49.0,,,,,40.5 - 75,% +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.0,,,,,15.4 - 48.5,% +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,% +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,20.0,R,H,,,0 - 6.8,% +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.0,,,,,0 - 2,% +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,250,,,,,140 - 400,GI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,LIPID PANEL,Direct HDL-C 4th Generation,,0.77,,L,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,LIPID PANEL,Triglycerides (GPO),,1.72,,,,,0.5 - 2.81,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,LIPID PANEL,Cholesterol (High Performance),,4.31,,,,,3.31 - 6.1,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,LIPID PANEL,LDL Chol Friedewald 4th,,2.75,,,,,0 - 3.34,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Specific Gravity,,1.018,,,,,1 - 1.04, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.1,,,,,0 - 5,mg/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CELLULAR ELEMENTS,Ur WBC/HPF,,3,,,,,0 - 12,/HPF +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.8,,,,,0 - 6.2,umol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Alkaline Phosphatase,,83,,,,,35 - 104,U/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,ALT (SGPT),,10,,,,,4 - 43,U/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,AST (SGOT),,11,,,,,8 - 40,U/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,GGT,,14,,,,,4 - 49,U/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,LDH,,133,,,,,53 - 234,U/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Urea Nitrogen,,4.4,,,,,1.4 - 8.6,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 101,umol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Uric Acid,,303,,,,,125 - 428,umol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Creatine Kinase,,79,,,,,26 - 192,U/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Bicarbonate,,22.2,,,,,19.3 - 29.3,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,129,,,,,116 - 164,g/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,85,,,,,79 - 98,fL +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.56,,,,,3.8 - 10.7,GI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.30,,,,,1.96 - 7.23,GI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.54,,,,,0.91 - 4.28,GI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.20,,,,,0 - 0.57,GI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.11,,,,,0 - 0.2,GI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.4,,,,,40.5 - 75,% +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.9,,,,,15.4 - 48.5,% +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.1,,,,,2.6 - 10.1,% +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.6,,,,,0 - 6.8,% +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.0,,,,,0 - 2,% +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,255,,,,,140 - 400,GI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.14,,,,,1.9 - 23,uIU/mL +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,LIPID PANEL,Direct HDL-C 4th Generation,,1.22,,,,,1.03 - 1.53,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,LIPID PANEL,Triglycerides (GPO),,0.56,,,,,0.44 - 1.99,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,LIPID PANEL,Cholesterol (High Performance),,3.42,,L,,,3.65 - 6.21,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,LIPID PANEL,LDL Chol Friedewald 4th,,1.94,,,,,0 - 3.34,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,RETICULOCYTES,Reticulocyte Count %,,0.8,,,,,0.6 - 2.5,% +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Specific Gravity,,1.029,,,,,1 - 1.04, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Blood,,Trace,,,,,Ref Rng:$Negative-Trace, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.7,,,,,0 - 6.2,umol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,40 - 129,U/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,ALT (SGPT),,73,,H RX,,,5 - 48,U/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,AST (SGOT),,31,,,,,8 - 40,U/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,GGT,,149,,H,,,10 - 61,U/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,LDH,,171,,,,,53 - 234,U/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 8.6,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,104,,,,,40 - 110,umol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Uric Acid,,469,,,,,125 - 488,umol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Calcium (EDTA),,2.57,,,,,2.07 - 2.64,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Phosphorus,,1.15,,,,,0.71 - 1.65,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Total Protein,,80,,,,,61 - 84,g/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Albumin-BCG,,50,,H,,,33 - 49,g/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Creatine Kinase,,138,,,,,39 - 308,U/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Bicarbonate,,21.5,,,,,19.3 - 29.3,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.14,,H,,,1.42 - 2.08,mL/sec +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,104,,,,,40 - 110,umol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,93.8,,,,,kg, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,GFR,EGFR by MDRD,,76,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,169,,,,,127 - 181,g/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.49,,,,,0.39 - 0.54, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.4,,,,,4.5 - 6.4,TI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.17,,,,,3.8 - 10.7,GI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.44,,,,,1.96 - 7.23,GI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.28,,,,,0.91 - 4.28,GI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.4,,,,,40.5 - 75,% +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.7,,,,,15.4 - 48.5,% +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,% +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.5,,,,,0 - 6.8,% +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,% +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,259,,,,,140 - 400,GI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,4.8,,,,,<6.5%, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.13,,,,,1.9 - 23,uIU/mL +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,LIPID PANEL,Direct HDL-C 4th Generation,,0.96,,L,,,1.03 - 1.53,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,LIPID PANEL,Triglycerides (GPO),,2.37,,,,,0.5 - 2.81,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,LIPID PANEL,Cholesterol (High Performance),,5.50,,,,,3.31 - 6.1,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,LIPID PANEL,LDL Chol Friedewald 4th,,3.45,,H,,,0 - 3.34,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,% +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,TSH,TSH 3rd IS-QT,,2.030,,,,,0.45 - 5.33,mIU/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.4,,,,,0 - 5,mg/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Alkaline Phosphatase,,77,,,,,35 - 104,U/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,ALT (SGPT),,10,,,,,4 - 43,U/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,AST (SGOT),,12,,,,,8 - 40,U/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,GGT,,14,,,,,4 - 49,U/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,LDH,,127,,,,,53 - 234,U/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Urea Nitrogen,,6.1,,,,,1.4 - 8.6,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Uric Acid,,273,,,,,125 - 428,umol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Phosphorus,,1.14,,,,,0.71 - 1.65,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Creatine Kinase,,88,,,,,26 - 192,U/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Bicarbonate,,21.2,,,,,19.3 - 29.3,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.33,,H,,,1.25 - 1.92,mL/sec +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,79.2,,,,,kg, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,FSH,Follicle Stimulating Hormone,,3.55,,RX,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,GFR,EGFR by MDRD,,92,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,128,,,,,116 - 164,g/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Beyond stability,,, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Beyond stability,,, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.62,,,,,3.8 - 10.7,GI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.19,,,,,1.96 - 7.23,GI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.85,,,,,0.91 - 4.28,GI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.19,,,,,0 - 0.57,GI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,56.7,,,,,40.5 - 75,% +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.0,,,,,15.4 - 48.5,% +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.4,,,,,0 - 6.8,% +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,253,,,,,140 - 400,GI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.1,,,,,<6.5%, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.61,,,,,1.9 - 23,uIU/mL +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,LIPID PANEL,Direct HDL-C 4th Generation,,1.23,,,,,1.03 - 1.53,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,LIPID PANEL,Triglycerides (GPO),,0.46,,,,,0.44 - 1.99,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,LIPID PANEL,Cholesterol (High Performance),,3.59,R,L,,,3.65 - 6.21,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,LIPID PANEL,LDL Chol Friedewald 4th,,2.15,,,,,0 - 3.34,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,% +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,TSH,TSH 3rd IS-QT,,1.803,,,,,0.45 - 5.33,mIU/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140526 sponsor-study-35472-test-results-898744-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140526 sponsor-study-35472-test-results-898744-standard.csv new file mode 100644 index 0000000..1cacad6 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140526 sponsor-study-35472-test-results-898744-standard.csv @@ -0,0 +1,200 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.6,,,,,0 - 6.2,umol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,40 - 129,U/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,ALT (SGPT),,37,,,,,5 - 48,U/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,AST (SGOT),,63,R,H RX,,,8 - 40,U/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,GGT,,143,R,H,,,10 - 50,U/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,LDH,,148,,,,,53 - 234,U/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Urea Nitrogen,,8.4,,,,,1.4 - 8.6,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,93,,,,,40 - 119,umol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Glucose Fasting,,8.5,R,H RX,,,3.9 - 5.6,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Serum Uric Acid,,397,,,,,149 - 494,umol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Calcium (EDTA),,2.51,,,,,2.07 - 2.64,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Phosphorus,,1.21,,,,,0.71 - 1.65,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Total Protein,,81,R,H,,,60 - 80,g/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Creatine Kinase,,54,,,,,39 - 308,U/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Serum Bicarbonate,,23.3,,,,,19.3 - 29.3,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Serum Chloride,,96,,,,,94 - 112,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.85,,,,,1.42 - 2.08,mL/sec +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,93,,,,,40 - 119,umol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,106.6,,,,,kg, +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,8.7,R,H RX,,,<6.5%, +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,C-REACTIVE PROTEIN,C Reactive Protein HS,,11.9,,H,,,0 - 5,mg/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CASTS,Ur Hyaline Casts/LPF,,96,,,,,0 /LPF, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CELLULAR ELEMENTS,Ur RBC/HPF,,5,,H,,,0 - 3,/HPF +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 5,/HPF +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.9,,,,,0 - 6.2,umol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Alkaline Phosphatase,,70,,,,,40 - 129,U/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,ALT (SGPT),,36,,,,,5 - 48,U/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,AST (SGOT),,72,,H RX,,,8 - 40,U/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,GGT,,264,,HT,,Result verified by repeat analysis,10 - 50,U/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,LDH,,171,,,,,53 - 234,U/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Urea Nitrogen,,7.3,,,,,1.4 - 8.6,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,109,,,,,40 - 119,umol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Glucose Fasting,,8.3,,H,,,3.9 - 5.6,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Serum Uric Acid,,497,,H,,,149 - 494,umol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Calcium (EDTA),,2.55,,,,,2.07 - 2.64,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Phosphorus,,1.17,,,,,0.71 - 1.65,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Total Protein,,84,,H,,,60 - 80,g/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Creatine Kinase,,37,,L,,,39 - 308,U/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Serum Potassium,,3.9,,,,,3.5 - 5.2,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Serum Bicarbonate,,23.7,,,,,19.3 - 29.3,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Serum Chloride,,94,,,,,94 - 112,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.60,,,,,1.42 - 2.08,mL/sec +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,109,,,,,40 - 119,umol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,108.0,,,,,kg, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DIRECT LDL,Direct LDL-C 3rd Gen,,3.83,R,H,,,<3.36 mmol/L, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,GFR,EGFR by MDRD,,60,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,160,,,,,125 - 170,g/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.37 - 0.51, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4 - 5.8,TI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,80 - 100,fL +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.32,,,,,3.8 - 10.7,GI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.59,,,,,1.96 - 7.23,GI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.36,,,,,0.8 - 3,GI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,1.06,,H,,,0.12 - 0.92,GI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.12,,,,,0 - 0.2,GI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.9,,,,,40.5 - 75,% +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,22.9,,,,,15.4 - 48.5,% +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.3,,H,,,2.6 - 10.1,% +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.7,,,,,0 - 6.8,% +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,% +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,311,,,,,130 - 394,GI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,8.9,,H RX,,,<6.5%, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,12.96,,,,,1.9 - 23,uIU/mL +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,LIPID PANEL,Direct HDL-C 4th Generation,,0.81,,L,,,1.03 - 1.53,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,LIPID PANEL,Triglycerides (GPO),,5.76,,H SF,,,0.65 - 2.94,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,LIPID PANEL,Cholesterol (High Performance),,6.27,,,,,4.53 - 7.71,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,LIPID PANEL,LDL Chol Friedewald 4th,,,,,Test cancelled: Invalid/High Triglycerides,,, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,RETICULOCYTES,Reticulocyte Count %,,4.6,,H,,,0.6 - 2.5,% +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,TSH,TSH 3rd IS-QT,,3.611,,,,,0.45 - 5.33,mIU/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Specific Gravity,,1.034,,H,,,1.01 - 1.03, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Protein,,+1,,H,,,Ref Rng:Negative, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Glucose,,+1,,H,,,Ref Rng:Normal, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Ketones,,Trace,,H,,,Ref Rng:Negative, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Urobilinogen,,+1,,H,,,Ref Rng:Normal, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.2,,,,,0 - 6.2,umol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,35 - 104,U/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,4 - 43,U/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,GGT,,32,,,,,5 - 50,U/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,LDH,,176,,,,,53 - 234,U/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Urea Nitrogen,,3.5,,,,,1.4 - 8.6,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Glucose Fasting,,9.7,,H RX,,,3.9 - 5.6,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Serum Uric Acid,,289,,,,,149 - 446,umol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Total Protein,,66,,,,,60 - 80,g/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Creatine Kinase,,135,,,,,26 - 192,U/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Serum Sodium,,143,,,,,135 - 145,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Serum Bicarbonate,,22.7,,,,,19.3 - 29.3,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.05,,L,,,1.25 - 1.92,mL/sec +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,63.0,,,,,kg, +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,7.8,,H,,,<6.5%, +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.9,,,,,0 - 5,mg/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CELLULAR ELEMENTS,Ur WBC/HPF,,3,,,,,0 - 12,/HPF +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,35 - 104,U/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,GGT,,31,,,,,5 - 50,U/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,LDH,,192,,,,,53 - 234,U/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Glucose Fasting,,9.2,,H RX,,,3.9 - 5.6,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Serum Uric Acid,,325,,,,,149 - 446,umol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Calcium (EDTA),,2.54,,,,,2.07 - 2.64,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Total Protein,,67,,,,,60 - 80,g/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Creatine Kinase,,143,,,,,26 - 192,U/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Serum Sodium,,141,,,,,135 - 145,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Serum Bicarbonate,,20.8,,,,,19.3 - 29.3,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.05,,L,,,1.25 - 1.92,mL/sec +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,63.0,,,,,kg, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,GFR,EGFR by MDRD,,64,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,142,,,,,115 - 158,g/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,3.9 - 5.5,TI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,80 - 100,fL +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.78,,H,,,3.8 - 10.7,GI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.25,,,,,1.96 - 7.23,GI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.50,,H,,,0.8 - 3,GI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.52,,,,,0.12 - 0.92,GI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.37,,,,,0 - 0.57,GI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.13,,,,,0 - 0.2,GI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.0,,,,,40.5 - 75,% +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.5,,,,,15.4 - 48.5,% +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.8,,,,,2.6 - 10.1,% +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.4,,,,,0 - 6.8,% +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,% +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,284,,,,,130 - 394,GI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,7.7,,H,,,<6.5%, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,14.50,,,,,1.9 - 23,uIU/mL +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,LIPID PANEL,Direct HDL-C 4th Generation,,1.94,,H,,,1.03 - 1.53,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,LIPID PANEL,Triglycerides (GPO),,1.32,,,,,0.63 - 2.71,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,LIPID PANEL,Cholesterol (High Performance),,4.53,,L,,,4.86 - 8.28,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,LIPID PANEL,LDL Chol Friedewald 4th,,1.99,,,,,0 - 3.34,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,TSH,TSH 3rd IS-QT,,1.354,,,,,0.45 - 5.33,mIU/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Specific Gravity,,1.011,,,,,1.01 - 1.03, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Leukocyte Esterase,,+2,,H SF,,,Ref Rng:Negative, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE diff --git a/Covance_UCO3001/Source/tmp/2026-05-29_140545 sponsor-study-35472-test-results-898727-standard.csv b/Covance_UCO3001/Source/tmp/2026-05-29_140545 sponsor-study-35472-test-results-898727-standard.csv new file mode 100644 index 0000000..e17118e --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-05-29_140545 sponsor-study-35472-test-results-898727-standard.csv @@ -0,0 +1,994 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CELLULAR ELEMENTS,Ur RBC/HPF,,5,,,,,0 - 8,/HPF +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Alkaline Phosphatase,,56,,,,,35 - 104,U/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,ALT (SGPT),,13,,,,,4 - 43,U/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,GGT,,22,,,,,5 - 50,U/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,LDH,,162,,,,,53 - 234,U/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,71,,,,,31 - 101,umol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Glucose Fasting,,4.0,,,,,3.9 - 5.6,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Serum Uric Acid,,242,,,,,149 - 446,umol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Phosphorus,,1.08,,,,,0.71 - 1.65,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Total Protein,,64,,,,,60 - 80,g/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Creatine Kinase,,52,,,,,26 - 192,U/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Serum Bicarbonate,,22.9,,,,,19.3 - 29.3,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,119,,,,Result verified by repeat analysis,115 - 158,g/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.8,,L,,Result verified by repeat analysis,3.9 - 5.5,TI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,80 - 100,fL +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.80,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.34,,,,Result verified by repeat analysis,1.96 - 7.23,GI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.86,,,,,0.8 - 3,GI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.44,,,,Result verified by repeat analysis,0.12 - 0.92,GI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,Result verified by repeat analysis,0 - 0.57,GI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,Result verified by repeat analysis,0 - 0.2,GI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.8,,,,Result verified by repeat analysis,40.5 - 75,% +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.3,,,,Result verified by repeat analysis,15.4 - 48.5,% +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,Result verified by repeat analysis,2.6 - 10.1,% +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.8,,,,Result verified by repeat analysis,0 - 6.8,% +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,Result verified by repeat analysis,0 - 2,% +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,459,,H,,Result verified by repeat analysis,130 - 394,GI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,25.80,,H,,,1.9 - 23,uIU/mL +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,LIPID PANEL,Direct HDL-C 4th Generation,,0.97,,L,,,1.03 - 1.53,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,LIPID PANEL,Triglycerides (GPO),,1.49,,,,,0.63 - 2.71,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,LIPID PANEL,Cholesterol (High Performance),,4.00,,L,,,4.86 - 8.28,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,LIPID PANEL,LDL Chol Friedewald 4th,,2.35,,,,,0 - 3.34,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Specific Gravity,,1.013,,,,,1.01 - 1.03, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,C-REACTIVE PROTEIN,C Reactive Protein HS,,<0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,40 - 129,U/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,ALT (SGPT),,35,,,,,5 - 48,U/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,AST (SGOT),,28,,,,,8 - 40,U/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,LDH,,149,,,,,53 - 234,U/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,40 - 110,umol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Serum Uric Acid,,285,,,,,125 - 488,umol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Phosphorus,,1.11,,,,,0.71 - 1.65,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Creatine Kinase,,157,,,,,39 - 308,U/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Serum Potassium,,3.9,,,,,3.5 - 5.2,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Serum Bicarbonate,,24.5,,,,,19.3 - 29.3,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.52,,,,,3.8 - 10.7,GI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.31,,,,,1.96 - 7.23,GI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.76,,,,,0.91 - 4.28,GI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.32,,,,,0.12 - 0.92,GI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.8,,,,,40.5 - 75,% +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,31.9,,,,,15.4 - 48.5,% +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,174,,,,,140 - 400,GI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.95,,,,,1.9 - 23,uIU/mL +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,LIPID PANEL,Direct HDL-C 4th Generation,,1.39,,,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,LIPID PANEL,Triglycerides (GPO),,0.75,,,,,0.5 - 2.81,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,LIPID PANEL,Cholesterol (High Performance),,3.90,,,,,3.31 - 6.1,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,LIPID PANEL,LDL Chol Friedewald 4th,,2.17,,,,,0 - 3.34,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Specific Gravity,,1.012,,,,,1 - 1.04, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.5,,,,,0 - 5,mg/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Alkaline Phosphatase,,54,,,,,35 - 104,U/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,4 - 43,U/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,GGT,,23,,,,,5 - 50,U/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,LDH,,143,,,,,53 - 234,U/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Urea Nitrogen,,3.8,,,,,1.4 - 8.6,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Glucose Fasting,,5.3,,,,,3.9 - 5.6,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Serum Uric Acid,,259,,,,,149 - 446,umol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Calcium (EDTA),,2.47,,,,,2.07 - 2.64,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Total Protein,,69,,,,,60 - 80,g/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Creatine Kinase,,41,,,,,26 - 192,U/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Serum Sodium,,143,,,,,135 - 145,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Serum Bicarbonate,,25.2,,,,,19.3 - 29.3,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,122,,,,,115 - 158,g/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.34 - 0.48, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,3.9 - 5.5,TI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,94,,,,,80 - 100,fL +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.11,,,,,3.8 - 10.7,GI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.82,,,,,1.96 - 7.23,GI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.76,,,,,0.8 - 3,GI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.43,,,,,0.12 - 0.92,GI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.07,,,,,0 - 0.57,GI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,67.8,,,,,40.5 - 75,% +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,24.8,,,,,15.4 - 48.5,% +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.1,,,,,2.6 - 10.1,% +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.2,,,,,0 - 2,% +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,466,R,H,,,130 - 394,GI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,9.83,,,,,1.9 - 23,uIU/mL +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,LIPID PANEL,Direct HDL-C 4th Generation,,1.06,,,,,1.03 - 1.53,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,LIPID PANEL,Triglycerides (GPO),,1.56,,,,,0.63 - 2.71,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,LIPID PANEL,Cholesterol (High Performance),,4.33,,L,,,4.86 - 8.28,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,LIPID PANEL,LDL Chol Friedewald 4th,,2.56,,,,,0 - 3.34,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,TSH,TSH 3rd IS-QT,,0.806,,,,,0.45 - 5.33,mIU/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Specific Gravity,,1.010,,,,,1.01 - 1.03, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Alkaline Phosphatase,,62,,,,,40 - 129,U/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,ALT (SGPT),,39,,,,,5 - 48,U/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,AST (SGOT),,29,,,,,8 - 40,U/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,LDH,,156,,,,,53 - 234,U/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 8.6,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,74,,,,,40 - 110,umol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Glucose Fasting,,5.5,,,,,3.9 - 5.6,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Serum Uric Acid,,330,,,,,125 - 488,umol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Calcium (EDTA),,2.29,,,,,2.07 - 2.64,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Phosphorus,,1.11,,,,,0.71 - 1.65,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Creatine Kinase,,149,,,,,39 - 308,U/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Serum Bicarbonate,,23.2,,,,,19.3 - 29.3,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,159,,,,,127 - 181,g/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.94,,,,,3.8 - 10.7,GI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.55,,,,,1.96 - 7.23,GI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.81,,,,,0.91 - 4.28,GI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.8,,,,,40.5 - 75,% +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.5,,,,,15.4 - 48.5,% +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.5,,,,,0 - 6.8,% +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,189,,,,,140 - 400,GI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,19.10,,,,,1.9 - 23,uIU/mL +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,LIPID PANEL,Direct HDL-C 4th Generation,,1.09,,,,,1.03 - 1.53,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,LIPID PANEL,Triglycerides (GPO),,1.96,,,,,0.5 - 2.81,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,LIPID PANEL,Cholesterol (High Performance),,3.72,,,,,3.31 - 6.1,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,LIPID PANEL,LDL Chol Friedewald 4th,,1.73,,,,,0 - 3.34,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,TSH,TSH 3rd IS-QT,,1.089,,,,,0.45 - 5.33,mIU/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,C-REACTIVE PROTEIN,C Reactive Protein HS,,9.2,,H,,,0 - 5,mg/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Total Bilirubin,,16,,,,,3 - 21,umol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.6,,,,,0 - 6.2,umol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Alkaline Phosphatase,,77,,,,,40 - 129,U/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,ALT (SGPT),,37,,,,,5 - 48,U/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,AST (SGOT),,29,,,,,8 - 40,U/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,GGT,,79,R,H,,,10 - 61,U/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,LDH,,103,,,,,53 - 234,U/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Urea Nitrogen,,2.3,,,,,1.4 - 8.6,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,74,,,,,40 - 110,umol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Serum Uric Acid,,427,,,,,125 - 488,umol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Phosphorus,,0.97,,,,,0.71 - 1.65,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Creatine Kinase,,102,,,,,39 - 308,U/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Serum Potassium,,3.8,,,,,3.5 - 5.2,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Serum Bicarbonate,,25.2,,,,,19.3 - 29.3,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Serum Chloride,,97,,,,,94 - 112,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,160,,,,,127 - 181,g/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.04,,,,,3.8 - 10.7,GI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.60,,,,,1.96 - 7.23,GI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.86,,,,,0.91 - 4.28,GI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.41,,,,,0.12 - 0.92,GI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.3,,,,,40.5 - 75,% +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.4,,,,,15.4 - 48.5,% +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.7,,,,,0 - 6.8,% +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,366,,,,,140 - 400,GI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.7,,,,,<6.5 %, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,R,"Mar 6, 2026 2:00 PM",6226560891,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,16.55,,,,,1.9 - 23,uIU/mL +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,LIPID PANEL,Direct HDL-C 4th Generation,,1.23,,,,,1.03 - 1.53,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,LIPID PANEL,Triglycerides (GPO),,1.94,,,,,0.56 - 3.62,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,LIPID PANEL,Cholesterol (High Performance),,4.72,,,,,3.88 - 6.83,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,LIPID PANEL,LDL Chol Friedewald 4th,,2.60,,,,,0 - 3.34,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,TSH,TSH 3rd IS-QT,,0.976,,,,,0.45 - 5.33,mIU/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Specific Gravity,,1.016,,,,,1 - 1.04, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Alkaline Phosphatase,,55,,,,,35 - 104,U/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,4 - 43,U/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,GGT,,21,,,,,5 - 50,U/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,LDH,,136,,,,,53 - 234,U/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Urea Nitrogen,,4.1,,,,,1.4 - 8.6,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,80,,,,,31 - 101,umol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Serum Uric Acid,,273,,,,,149 - 446,umol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Calcium (EDTA),,2.49,,,,,2.07 - 2.64,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Total Protein,,69,,,,,60 - 80,g/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Creatine Kinase,,42,,,,,26 - 192,U/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Serum Sodium,,142,,,,,135 - 145,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Serum Bicarbonate,,24.2,,,,,19.3 - 29.3,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,122,,,,,115 - 158,g/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.34 - 0.48, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,3.9 - 5.5,TI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,80 - 100,fL +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.67,,,,,3.8 - 10.7,GI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.77,,,,,1.96 - 7.23,GI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.32,,,,,0.8 - 3,GI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.19,,,,,0 - 0.57,GI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.2,,,,,40.5 - 75,% +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.3,,,,,15.4 - 48.5,% +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.0,,,,,2.6 - 10.1,% +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.0,,,,,0 - 6.8,% +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.5,,,,,0 - 2,% +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,453,,H,,,130 - 394,GI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,14.65,,,,,1.9 - 23,uIU/mL +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,LIPID PANEL,Direct HDL-C 4th Generation,,1.00,,L,,,1.03 - 1.53,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,LIPID PANEL,Triglycerides (GPO),,1.31,,,,,0.63 - 2.71,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,LIPID PANEL,Cholesterol (High Performance),,4.11,,L,,,4.86 - 8.28,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,LIPID PANEL,LDL Chol Friedewald 4th,,2.51,,,,,0 - 3.34,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1.01 - 1.03, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,C-REACTIVE PROTEIN,C Reactive Protein HS,,<0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Alkaline Phosphatase,,55,,,,,40 - 129,U/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,5 - 48,U/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,GGT,,12,,,,,10 - 61,U/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,LDH,,133,,,,,53 - 234,U/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,40 - 110,umol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Serum Uric Acid,,244,,,,,125 - 488,umol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Total Protein,,63,,,,,61 - 84,g/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Creatine Kinase,,139,,,,,39 - 308,U/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Serum Bicarbonate,,22.9,,,,,19.3 - 29.3,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,156,,,,,127 - 181,g/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.41,,L,,,3.8 - 10.7,GI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.63,,L,,,1.96 - 7.23,GI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.42,,,,,0.91 - 4.28,GI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.22,,,,,0.12 - 0.92,GI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.9,,,,,40.5 - 75,% +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,41.7,,,,,15.4 - 48.5,% +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.6,,,,,2.6 - 10.1,% +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,% +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.6,,,,,0 - 2,% +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,160,,,,,140 - 400,GI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.99,,,,,1.9 - 23,uIU/mL +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,LIPID PANEL,Direct HDL-C 4th Generation,,1.32,,,,,1.03 - 1.53,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,LIPID PANEL,Triglycerides (GPO),,0.52,,,,,0.5 - 2.81,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,LIPID PANEL,Cholesterol (High Performance),,3.73,,,,,3.31 - 6.1,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,LIPID PANEL,LDL Chol Friedewald 4th,,2.17,,,,,0 - 3.34,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,% +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1 - 1.04, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,C-REACTIVE PROTEIN,C Reactive Protein HS,,<0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.9,,,,,0 - 6.2,umol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Alkaline Phosphatase,,57,,,,,40 - 129,U/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,ALT (SGPT),,22,,,,,5 - 48,U/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,GGT,,11,,,,,10 - 61,U/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,LDH,,131,,,,,53 - 234,U/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Urea Nitrogen,,5.8,,,,,1.4 - 8.6,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,40 - 110,umol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Glucose Fasting,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Serum Uric Acid,,300,,,,,125 - 488,umol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Total Protein,,62,,,,,61 - 84,g/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Creatine Kinase,,120,,,,,39 - 308,U/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Serum Bicarbonate,,25.3,,,,,19.3 - 29.3,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.28,,H,,,1.42 - 2.08,mL/sec +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,76,,,,,40 - 110,umol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,75.0,,,,,kg, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,GFR,EGFR by MDRD,,107,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,152,,,,,127 - 181,g/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 96,fL +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.30,,,,,3.8 - 10.7,GI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.90,,,,,1.96 - 7.23,GI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.77,,,,,0.91 - 4.28,GI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.35,,,,,0.12 - 0.92,GI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.14,,,,,0 - 0.2,GI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.7,,,,,40.5 - 75,% +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.3,,,,,15.4 - 48.5,% +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.6,,,,,2.6 - 10.1,% +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.7,,,,,0 - 6.8,% +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.6,,H,,,0 - 2,% +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,189,,,,,140 - 400,GI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,4.9,,,,,<6.5 %, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.16,,,,,1.9 - 23,uIU/mL +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,LIPID PANEL,Direct HDL-C 4th Generation,,1.43,,,,,1.03 - 1.53,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,LIPID PANEL,Triglycerides (GPO),,0.61,,,,,0.5 - 2.81,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,LIPID PANEL,Cholesterol (High Performance),,3.71,,,,,3.31 - 6.1,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,LIPID PANEL,LDL Chol Friedewald 4th,,2.00,,,,,0 - 3.34,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,TSH,TSH 3rd IS-QT,,1.462,,,,,0.45 - 5.33,mIU/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1 - 1.04, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,BENZODIAZEPINE CONFIRM. UR,BenzodiazepineConf-LCMSMS-LDT,,Temazepam (Confirmed),,RX,,,No Ref Rng, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,BENZODIAZEPINE CONFIRM. UR,BenzodiazepineConf-LCMSMS-LDT,,Oxazepam (Confirmed),,RX,,,No Ref Rng, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Alkaline Phosphatase,,55,,,,,35 - 104,U/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,4 - 43,U/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,GGT,,21,,,,,5 - 50,U/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,LDH,,136,,,,,53 - 234,U/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,31 - 101,umol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Serum Uric Acid,,247,,,,,149 - 446,umol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Total Protein,,68,,,,,60 - 80,g/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Creatine Kinase,,44,,,,,26 - 192,U/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Serum Sodium,,142,,,,,135 - 145,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Serum Bicarbonate,,23.5,,,,,19.3 - 29.3,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.25,,,,,1.25 - 1.92,mL/sec +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,77,,,,,31 - 101,umol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,74.0,,,,,kg, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Detected (unconfirmed),,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,FSH,Follicle Stimulating Hormone,,55.96,,,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,GFR,EGFR by MDRD,,65,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,119,,,,,115 - 158,g/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.9,,,,,3.9 - 5.5,TI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,80 - 100,fL +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.94,,,,,3.8 - 10.7,GI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.50,,,,,1.96 - 7.23,GI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.91,,,,,0.8 - 3,GI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,64.8,,,,,40.5 - 75,% +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.5,,,,,15.4 - 48.5,% +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.5,,,,,0 - 6.8,% +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,448,R,H,,,130 - 394,GI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.62,,,,,1.9 - 23,uIU/mL +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,LIPID PANEL,Direct HDL-C 4th Generation,,1.02,R,L,,,1.03 - 1.53,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,LIPID PANEL,Triglycerides (GPO),,1.44,,,,,0.63 - 2.71,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,LIPID PANEL,Cholesterol (High Performance),,4.25,R,L,,,4.86 - 8.28,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,LIPID PANEL,LDL Chol Friedewald 4th,,2.57,,,,,0 - 3.34,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,% +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,TSH,TSH 3rd IS-QT,,0.834,,,,,0.45 - 5.33,mIU/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Specific Gravity,,1.007,,,,,1.01 - 1.03, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.8,,,,,0 - 5,mg/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Alkaline Phosphatase,,70,,,,,40 - 129,U/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,ALT (SGPT),,41,,,,,5 - 48,U/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,GGT,,81,,H,,,10 - 61,U/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,LDH,,92,,,,,53 - 234,U/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Urea Nitrogen,,3.3,,,,,1.4 - 8.6,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,74,,,,,40 - 110,umol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Glucose Fasting,,6.1,,H,,,3.9 - 5.6,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Serum Uric Acid,,412,,,,,125 - 488,umol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Phosphorus,,0.94,,,,,0.71 - 1.65,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Creatine Kinase,,148,,,,,39 - 308,U/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Serum Bicarbonate,,25.4,,,,,19.3 - 29.3,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,127 - 181,g/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.61,,,,,3.8 - 10.7,GI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.00,,,,,1.96 - 7.23,GI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.02,,,,,0.91 - 4.28,GI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.5,,,,,40.5 - 75,% +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.5,,,,,15.4 - 48.5,% +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,322,,,,,140 - 400,GI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,63.81,,H,,,1.9 - 23,uIU/mL +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,LIPID PANEL,Direct HDL-C 4th Generation,,1.13,,,,,1.03 - 1.53,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,LIPID PANEL,Triglycerides (GPO),,2.66,,,,,0.56 - 3.62,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,LIPID PANEL,Cholesterol (High Performance),,4.84,,,,,3.88 - 6.83,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,LIPID PANEL,LDL Chol Friedewald 4th,,2.49,,,,,0 - 3.34,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Specific Gravity,,1.022,,,,,1 - 1.04, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.0,,,,,0 - 5,mg/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Alkaline Phosphatase,,74,,,,,40 - 129,U/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,ALT (SGPT),,42,,,,,5 - 48,U/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,GGT,,70,,H,,,10 - 61,U/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,LDH,,89,,,,,53 - 234,U/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Urea Nitrogen,,3.1,,,,,1.4 - 8.6,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,40 - 110,umol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Glucose Fasting,,6.6,R,H,,,3.9 - 5.6,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Serum Uric Acid,,418,,,,,125 - 488,umol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Phosphorus,,0.91,,,,,0.71 - 1.65,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,39 - 308,U/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Serum Bicarbonate,,26.3,,,,,19.3 - 29.3,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,127 - 181,g/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,84,,,,,79 - 96,fL +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.86,,,,,3.8 - 10.7,GI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.10,,,,,1.96 - 7.23,GI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.01,,,,,0.91 - 4.28,GI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.30,,,,,0 - 0.57,GI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.8,,,,,40.5 - 75,% +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.2,,,,,15.4 - 48.5,% +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.7,,,,,2.6 - 10.1,% +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.3,,,,,0 - 6.8,% +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,374,,,,,140 - 400,GI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.7,,,,,<6.5 %, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,196.11,,H,,,1.9 - 23,uIU/mL +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,LIPID PANEL,Direct HDL-C 4th Generation,,0.97,,L,,,1.03 - 1.53,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,LIPID PANEL,Triglycerides (GPO),,2.92,,,,,0.56 - 3.62,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,LIPID PANEL,Cholesterol (High Performance),,4.31,,,,,3.88 - 6.83,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,LIPID PANEL,LDL Chol Friedewald 4th,,2.00,,,,,0 - 3.34,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,TSH,TSH 3rd IS-QT,,0.889,,,,,0.45 - 5.33,mIU/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Specific Gravity,,1.011,,,,,1 - 1.04, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.6,,,,,0 - 5,mg/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Alkaline Phosphatase,,67,,,,,40 - 129,U/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,ALT (SGPT),,34,,,,,5 - 48,U/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,GGT,,69,,H,,,10 - 61,U/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,LDH,,98,,,,,53 - 234,U/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Urea Nitrogen,,2.2,,,,,1.4 - 8.6,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,40 - 110,umol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Glucose Fasting,,5.6,,,,,3.9 - 5.6,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Serum Uric Acid,,520,R,H,,,125 - 488,umol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Phosphorus,,1.19,,,,,0.71 - 1.65,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Creatine Kinase,,126,,,,,39 - 308,U/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Serum Bicarbonate,,21.4,,,,,19.3 - 29.3,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,146,,,,,127 - 181,g/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.43,,,,,3.8 - 10.7,GI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.49,,,,,1.96 - 7.23,GI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.20,,,,,0.91 - 4.28,GI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.44,,,,,0.12 - 0.92,GI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.24,,,,,0 - 0.57,GI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.4,,,,,40.5 - 75,% +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.2,,,,,15.4 - 48.5,% +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,% +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.8,,,,,0 - 6.8,% +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,288,,,,,140 - 400,GI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,15.24,,,,,1.9 - 23,uIU/mL +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,LIPID PANEL,Direct HDL-C 4th Generation,,1.15,,,,,1.03 - 1.53,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,LIPID PANEL,Triglycerides (GPO),,1.64,,,,,0.56 - 3.62,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,LIPID PANEL,Cholesterol (High Performance),,4.19,,,,,3.88 - 6.83,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,LIPID PANEL,LDL Chol Friedewald 4th,,2.29,,,,,0 - 3.34,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Specific Gravity,,1.011,,,,,1 - 1.04, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.6,,,,,0 - 5,mg/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Alkaline Phosphatase,,65,,,,,40 - 129,U/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,ALT (SGPT),,36,,,,,5 - 48,U/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,GGT,,62,,H,,,10 - 61,U/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,LDH,,105,,,,,53 - 234,U/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Urea Nitrogen,,2.2,,,,,1.4 - 8.6,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,40 - 110,umol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Glucose Fasting,,5.8,,H,,,3.9 - 5.6,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Serum Uric Acid,,472,,,,,125 - 488,umol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Phosphorus,,1.14,,,,,0.71 - 1.65,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Creatine Kinase,,132,,,,,39 - 308,U/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Serum Bicarbonate,,21.0,,,,,19.3 - 29.3,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,3.53,,H,,,1.42 - 2.08,mL/sec +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,77,,,,,40 - 110,umol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,130.2,,,,,kg, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,GFR,EGFR by MDRD,,98,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,148,,,,,127 - 181,g/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,85,,,,,79 - 96,fL +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.89,,,,,3.8 - 10.7,GI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.47,,,,,1.96 - 7.23,GI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.93,,,,,0.91 - 4.28,GI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.30,,,,,0.12 - 0.92,GI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.8,,,,,40.5 - 75,% +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.7,,,,,15.4 - 48.5,% +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.1,,,,,2.6 - 10.1,% +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,,,,0 - 6.8,% +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,369,,,,,140 - 400,GI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.5,,,,,<6.5%, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,16.15,,,,,1.9 - 23,uIU/mL +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,LIPID PANEL,Direct HDL-C 4th Generation,,1.24,,,,,1.03 - 1.53,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,LIPID PANEL,Triglycerides (GPO),,1.40,,,,,0.56 - 3.62,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,LIPID PANEL,Cholesterol (High Performance),,4.07,,,,,3.88 - 6.83,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,LIPID PANEL,LDL Chol Friedewald 4th,,2.19,,,,,0 - 3.34,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,% +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,TSH,TSH 3rd IS-QT,,1.099,,,,,0.45 - 5.33,mIU/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.4,,,,,0 - 5,mg/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Alkaline Phosphatase,,84,,,,,35 - 104,U/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,ALT (SGPT),,36,,,,,4 - 43,U/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,GGT,,44,,,,,4 - 49,U/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,LDH,,220,,,,,53 - 234,U/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Urea Nitrogen,,3.4,,,,,1.4 - 8.6,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Serum Uric Acid,,295,,,,,125 - 428,umol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Phosphorus,,0.89,,,,,0.71 - 1.65,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Creatine Kinase,,92,,,,,26 - 192,U/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Serum Bicarbonate,,23.7,,,,,19.3 - 29.3,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,3.78,,H,,,1.25 - 1.92,mL/sec +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,105.0,,,,,kg, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,GFR,EGFR by MDRD,,114,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,116 - 164,g/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 98,fL +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.91,,,,,3.8 - 10.7,GI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.15,,,,,1.96 - 7.23,GI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.38,,,,,0.91 - 4.28,GI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,,0 - 0.57,GI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,70.3,,,,,40.5 - 75,% +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,23.3,,,,,15.4 - 48.5,% +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.7,,,,,0 - 6.8,% +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.1,,,,,0 - 2,% +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,241,,,,,140 - 400,GI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,4.9,,,,,<6.5%, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,15.68,,,,,1.9 - 23,uIU/mL +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,LIPID PANEL,Direct HDL-C 4th Generation,,1.23,,,,,1.03 - 1.53,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,LIPID PANEL,Triglycerides (GPO),,1.78,R,H,,,0.41 - 1.63,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,LIPID PANEL,Cholesterol (High Performance),,5.53,,,,,3.31 - 5.64,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,LIPID PANEL,LDL Chol Friedewald 4th,,3.48,,H,,,0 - 3.34,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,RETICULOCYTES,Reticulocyte Count %,,2.0,,,,,0.6 - 2.5,% +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,TSH,TSH 3rd IS-QT,,2.503,,,,,0.45 - 5.33,mIU/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Specific Gravity,,1.014,,,,,1 - 1.04, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.4,,,,,0 - 5,mg/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Alkaline Phosphatase,,69,,,,,35 - 104,U/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,ALT (SGPT),,5,,,,,4 - 43,U/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,AST (SGOT),,13,,,,,8 - 40,U/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,GGT,,<4,,L,,Result verified by repeat analysis,4 - 49,U/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,LDH,,143,,,,,53 - 234,U/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Urea Nitrogen,,4.8,,,,,1.4 - 8.6,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Glucose Fasting,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Serum Uric Acid,,193,,,,,125 - 428,umol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Calcium (EDTA),,2.29,,,,,2.07 - 2.64,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Creatine Kinase,,75,,,,,26 - 192,U/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Serum Bicarbonate,,21.2,,,,,19.3 - 29.3,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.06,,H,,,1.25 - 1.92,mL/sec +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,65.8,,,,,kg, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,GFR,EGFR by MDRD,,105,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,131,,,,,116 - 164,g/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 98,fL +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.06,,,,,3.8 - 10.7,GI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.38,,,,,1.96 - 7.23,GI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.11,,,,,0.91 - 4.28,GI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.35,,,,,0.12 - 0.92,GI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.20,,,,,0 - 0.57,GI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,66.7,,,,,40.5 - 75,% +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,21.9,,,,,15.4 - 48.5,% +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.8,,,,,2.6 - 10.1,% +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.9,,,,,0 - 6.8,% +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,182,,,,,140 - 400,GI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.0,,,,,<6.5%, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,LIPID PANEL,Direct HDL-C 4th Generation,,1.77,R,H,,,1.03 - 1.53,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,LIPID PANEL,Triglycerides (GPO),,0.71,,,,,0.44 - 1.99,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,LIPID PANEL,Cholesterol (High Performance),,5.82,,,,,3.65 - 6.21,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,LIPID PANEL,LDL Chol Friedewald 4th,,3.72,,H,,,0 - 3.34,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,RETICULOCYTES,Reticulocyte Count %,,1.7,,,,,0.6 - 2.5,% +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,TSH,TSH 3rd IS-QT,,1.847,,,,,0.45 - 5.33,mIU/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1 - 1.04, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.6,,,,,0 - 5,mg/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Alkaline Phosphatase,,71,,,,,35 - 104,U/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,4 - 43,U/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,AST (SGOT),,31,,,,,8 - 40,U/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,GGT,,79,R,H,,,4 - 49,U/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,LDH,,144,,,,,53 - 234,U/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,93,,,,,31 - 101,umol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Serum Uric Acid,,405,,,,,149 - 446,umol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Phosphorus,,0.92,,,,,0.71 - 1.65,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Creatine Kinase,,157,,,,,26 - 192,U/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.33,,,,,1.25 - 1.92,mL/sec +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,93,,,,,31 - 101,umol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,83.8,,,,,kg, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,FSH,Follicle Stimulating Hormone,,32.96,,RX,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,GFR,EGFR by MDRD,,54,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,117,,,,,116 - 164,g/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.35,,,,,0.34 - 0.48, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,81,,,,,79 - 98,fL +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.93,,,,,3.8 - 10.7,GI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.05,,,,,1.96 - 7.23,GI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.14,,,,,0.91 - 4.28,GI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.46,,,,,0.12 - 0.92,GI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.25,,,,,0 - 0.57,GI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,68.3,,,,,40.5 - 75,% +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.2,,,,,15.4 - 48.5,% +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.8,,,,,2.6 - 10.1,% +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.2,,,,,0 - 6.8,% +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,157,,,,,140 - 400,GI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,6.5,,H,,,<6.5%, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,27.42,,H,,,1.9 - 23,uIU/mL +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,LIPID PANEL,Direct HDL-C 4th Generation,,0.82,R,L,,,1.03 - 1.53,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,LIPID PANEL,Triglycerides (GPO),,2.78,,,,,0.59 - 2.96,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,LIPID PANEL,Cholesterol (High Performance),,5.73,,,,,4.42 - 7.53,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,LIPID PANEL,LDL Chol Friedewald 4th,,3.64,,H,,,0 - 3.34,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,TSH,TSH 3rd IS-QT,,1.091,,,,,0.45 - 5.33,mIU/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122241 sponsor-study-36940-activity-reports-documents-equery.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122241 sponsor-study-36940-activity-reports-documents-equery.csv new file mode 100644 index 0000000..70a741b --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122241 sponsor-study-36940-activity-reports-documents-equery.csv @@ -0,0 +1,76 @@ +Site,Country,Visit,Visit Collection Date,Accession,Subject,eQueryId,Create Date,Response Date Time,Issue Type,Status,Time Before Response,User Name,Email,Study Role +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Unscheduled,"Mar 13, 2026 8:40 AM",6227323295,CZ100222004,2047932,"Mar 17, 2026 3:49 PM","Mar 17, 2026 9:07 PM",VST,Closed,5h 17m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Unscheduled,"Mar 13, 2026 7:45 AM",6227323297,CZ100222005,2047949,"Mar 17, 2026 3:56 PM","Mar 17, 2026 9:09 PM",VST,Closed,5h 12m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 0,"Mar 9, 2026 8:50 AM",6227323270,CZ100222003,2038559,"Mar 11, 2026 4:39 PM","Mar 11, 2026 8:32 PM","AGE, ADT201, AMT58660, AMT3542",Closed,3h 53m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 2,"Mar 27, 2026 7:10 AM",6227323272,CZ100222003,2073305,"Apr 1, 2026 7:54 PM","Apr 2, 2026 7:37 AM",AMT58660,Closed,11h 43m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 4,"Apr 8, 2026 8:05 AM",6227323274,CZ100222003,2086982,"Apr 10, 2026 1:00 PM","Apr 10, 2026 1:06 PM",AMT58660,Closed,5m,Katerina Havlikova,katerina.havlikova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 2, 2026 11:00 AM",6227810899,CZ100222003,2029805,"Mar 5, 2026 6:36 PM","Mar 6, 2026 9:01 AM","AMT58660, AMT3542",Closed,14h 24m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 4, 2026 9:20 AM",6227810900,CZ100222005,2031896,"Mar 6, 2026 6:45 PM","Mar 6, 2026 7:25 PM","AMT58660, AMT3542",Closed,40m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 3, 2026 12:10 PM",6227810901,CZ100222004,2029774,"Mar 5, 2026 6:23 PM","Mar 6, 2026 7:24 PM","AMT58660, AMT3542",Closed,1d,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 0,"Apr 9, 2026 10:35 AM",6228173397,CZ100222005,2089669,"Apr 13, 2026 2:06 PM","Apr 23, 2026 12:53 PM",PCFCOM,Closed,9d,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Screening,"Feb 25, 2026 12:15 PM",6227635204,CZ100212001,2019716,"Feb 27, 2026 12:09 PM","Mar 3, 2026 11:11 AM","AMT58660, AMT3542",Closed,3d,Zdenka Dvorakova,dvorakova.zdenka@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 0,"Apr 7, 2026 10:37 AM",6227635207,CZ100212001,2085089,"Apr 9, 2026 2:54 PM","Apr 15, 2026 7:20 AM","AMT58660, AMT15602",Closed,5d,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 2,"Apr 20, 2026 8:43 AM",6227635208,CZ100212001,2106304,"Apr 22, 2026 7:04 PM","Apr 23, 2026 9:21 AM",AMT58660,Closed,14h 16m,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 4,"May 5, 2026 10:00 AM",6227635211,CZ100212001,2133221,"May 9, 2026 6:24 PM","May 11, 2026 2:34 PM",AMT58660,Closed,1d,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10020 - Dr.Lucie Gonsorcikova,CZECH REPUBLIC,Screening,"Apr 13, 2026 12:20 PM",6227993962,CZ100201001,2094721,"Apr 15, 2026 6:02 PM","Apr 21, 2026 12:47 PM","AMT58660, AMT3542",Closed,5d,Zuzana Zahradnikova,zuzana.zahradnikova@ftn.cz,Investigator +CZ10020 - Dr.Lucie Gonsorcikova,CZECH REPUBLIC,Induction Week 0,"May 18, 2026 9:28 AM",6227993966,CZ100201001,2156061,"May 22, 2026 9:37 PM","May 25, 2026 6:43 AM","ADT201, AMT58660, AMT3542",Closed,2d,Zuzana Zahradnikova,zuzana.zahradnikova@ftn.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Biopsy,"May 25, 2026 12:00 AM",6228501732,CZ100132003,2165892,"May 29, 2026 3:13 PM","May 31, 2026 9:26 PM",ADT8471,Response Received,2d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Screening,"Mar 2, 2026 7:00 AM",6227323204,CZ100012002,2032628,"Mar 9, 2026 10:33 AM","Mar 9, 2026 11:58 AM",AMT58660,Closed,1h 24m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Screening,"Mar 2, 2026 7:00 AM",6227323204,CZ100012002,2026645,"Mar 4, 2026 12:58 PM","Mar 6, 2026 6:01 PM","AMT58660, AMT3542",Closed,2d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 0,,6227323206,,2112374,"Apr 27, 2026 2:17 PM","May 5, 2026 11:24 AM","PCFCOM, ADT201, AMT58660, AMT3542",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 2,"Apr 23, 2026 7:40 AM",6227323207,CZ100012002,2113312,"Apr 27, 2026 6:35 PM","Apr 28, 2026 9:06 PM",AMT58660,Closed,1d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 2,"Mar 4, 2026 7:00 AM",6227323208,CZ100012001,2030545,"Mar 6, 2026 11:02 AM","Mar 6, 2026 11:42 AM","AMT58660, AMT688",Closed,39m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 4,"Mar 18, 2026 7:05 AM",6227323210,CZ100012001,2053955,"Mar 20, 2026 2:50 PM","Mar 25, 2026 3:29 PM","SCD, AMT58660",Closed,5d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Stool Pathogens,"Jan 28, 2026 6:00 AM",6227323211,CZ100012001,1976585,"Jan 30, 2026 1:21 PM","Feb 6, 2026 2:37 PM","VST, AGE",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Stool Pathogens,"Jan 28, 2026 6:00 AM",6227323211,CZ100012001,1991148,"Feb 9, 2026 7:43 PM","Feb 13, 2026 8:04 AM",AGE,Closed,3d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Biopsy,"Feb 5, 2026 12:00 AM",6227323223,CZ100012001,1989998,"Feb 9, 2026 1:42 PM","Feb 10, 2026 6:46 PM",VST,Closed,1d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,,6227323231,,2053405,"Mar 20, 2026 12:14 PM","Mar 30, 2026 12:54 AM",PCFCOM,Closed,9d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2141856,"May 14, 2026 4:23 PM","May 19, 2026 12:54 PM","SCD, AGE",Closed,4d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2152157,"May 21, 2026 11:32 AM","May 26, 2026 8:15 AM",AGE,Closed,4d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2112413,"Apr 27, 2026 2:24 PM","May 5, 2026 11:25 AM","PSX, SCT, VST, AGE, ADT201",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2126904,"May 6, 2026 12:02 PM","May 12, 2026 4:58 PM","SCT, VST, AGE",Closed,6d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,,6227323233,,2053482,"Mar 20, 2026 12:40 PM","Mar 27, 2026 9:58 AM",PCFCOM,Closed,6d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 0,"Apr 8, 2026 7:10 AM",6228036554,CZ100012002,2089973,"Apr 13, 2026 3:26 PM","Apr 21, 2026 1:32 PM",AMT15602,Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Biopsy,"May 13, 2026 12:00 AM",6228252073,CZ100012003,2147778,"May 19, 2026 10:13 AM","May 21, 2026 4:38 PM",VST,Closed,2d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 4,"May 6, 2026 8:05 AM",6227933142,CZ100012002,2134478,"May 11, 2026 2:54 PM","May 11, 2026 3:11 PM","AMT58660, AMT3542",Closed,16m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 12,"May 13, 2026 8:05 AM",6227933143,CZ100012001,2147202,"May 18, 2026 7:51 PM","May 19, 2026 8:38 AM",AMT58660,Closed,12h 47m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10016 - Dr.Robert Mudr,CZECH REPUBLIC,Screening,"Apr 21, 2026 10:45 AM",6227635171,CZ100162001,2109874,"Apr 24, 2026 2:00 PM",,AMT58660,Closed,,,, +CZ10016 - Dr.Robert Mudr,CZECH REPUBLIC,Screening,"Apr 21, 2026 10:45 AM",6227635171,CZ100162001,2123465,"May 4, 2026 7:16 PM","May 5, 2026 10:04 AM",AMT58660,Closed,14h 48m,Petr Pekny,petr.pekny@nmskb.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 0,"Mar 24, 2026 9:40 AM",6227635142,CZ100132001,2064220,"Mar 26, 2026 9:37 PM",,"AMT58660, AMT3542",Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 0,"Mar 24, 2026 9:40 AM",6227635142,CZ100132001,2066330,"Mar 27, 2026 6:43 PM","Mar 30, 2026 10:41 PM",AMT58660,Closed,3d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 2,"Apr 7, 2026 8:50 AM",6227635144,CZ100132001,2087084,"Apr 10, 2026 1:27 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 2,"Apr 7, 2026 8:50 AM",6227635144,CZ100132001,2100086,"Apr 18, 2026 11:15 AM","Apr 22, 2026 7:51 PM",AMT58660,Closed,4d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 4,"Apr 21, 2026 8:45 AM",6227635146,CZ100132001,2108501,"Apr 23, 2026 6:55 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 4,"Apr 21, 2026 8:45 AM",6227635146,CZ100132001,2123492,"May 4, 2026 7:24 PM","May 5, 2026 3:30 PM",AMT58660,Closed,20h 6m,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2101883,"Apr 20, 2026 6:49 PM","Apr 22, 2026 7:51 PM",AMT58660,Closed,2d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2090916,"Apr 13, 2026 9:15 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2079289,"Apr 6, 2026 3:21 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Feb 26, 2026 1:20 PM",6227635140,CZ100132001,2033901,"Mar 9, 2026 3:53 PM","Mar 16, 2026 10:08 PM","SCD, AMT58660, AMT3542",Closed,7d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Feb 26, 2026 1:20 PM",6227635140,CZ100132001,2023257,"Mar 2, 2026 6:47 PM",,"SCD, AGE, AMT58660, AMT3542",Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"May 6, 2026 10:45 AM",6227635141,CZ100132003,2137874,"May 12, 2026 8:03 PM","May 19, 2026 7:48 AM",AMT58660,Closed,6d,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Biopsy,"Apr 21, 2026 12:00 AM",6227635159,CZ100132002,2109534,"Apr 24, 2026 12:45 PM",,ADT8471,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Biopsy,"Apr 21, 2026 12:00 AM",6227635159,CZ100132002,2123486,"May 4, 2026 7:23 PM","May 5, 2026 3:30 PM",ADT8471,Closed,20h 7m,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Unscheduled,,6227697745,,2140058,"May 13, 2026 7:02 PM","May 26, 2026 9:46 AM",PCFCOM,Response Received,12d,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Screening,"Mar 18, 2026 9:18 AM",6227697718,CZ100122001,2053959,"Mar 20, 2026 2:52 PM","Mar 23, 2026 12:00 PM","SCT, AMT58660",Closed,2d,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 0,"Apr 7, 2026 11:45 AM",6227697719,CZ100122001,2085069,"Apr 9, 2026 2:48 PM","Apr 9, 2026 6:28 PM",AMT58660,Closed,3h 39m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 2,"Apr 22, 2026 9:25 AM",6227697722,CZ100122001,2113315,"Apr 27, 2026 6:35 PM","Apr 27, 2026 8:50 PM",AMT58660,Closed,2h 14m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 4,"May 7, 2026 12:40 PM",6227697723,CZ100122001,2142322,"May 14, 2026 7:10 PM","May 14, 2026 7:42 PM",AMT58660,Closed,31m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Biopsy,"Mar 23, 2026 12:00 AM",6227697736,CZ100122001,2060524,"Mar 25, 2026 12:53 PM","Mar 25, 2026 2:09 PM",AMT23260,Closed,1h 15m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Mar 31, 2026 8:30 AM",6227323330,CZ100092001,2075611,"Apr 2, 2026 5:37 PM",,AMT58660,Closed,,,, +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Mar 31, 2026 8:30 AM",6227323330,CZ100092001,2085558,"Apr 9, 2026 5:08 PM","Apr 10, 2026 2:06 PM",AMT58660,Closed,20h 58m,Jiri Pumprla,research@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Apr 16, 2026 12:00 PM",6227323332,CZ100092002,2101792,"Apr 20, 2026 6:19 PM","Apr 23, 2026 1:22 PM",AMT58660,Closed,2d,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Induction Week 0,"May 5, 2026 11:30 AM",6227323334,CZ100092001,2133224,"May 9, 2026 6:30 PM","May 13, 2026 10:10 AM","AMT58660, ADT809",Closed,3d,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Induction Week 2,"May 19, 2026 10:50 AM",6227323335,CZ100092001,2158952,"May 26, 2026 12:21 PM","May 27, 2026 9:03 AM",AMT58660,Closed,20h 42m,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Unscheduled,"Mar 17, 2026 8:00 AM",6227323265,CZ100062001,2052144,"Mar 19, 2026 4:08 PM","Mar 24, 2026 9:29 AM","PSX, SCT, AGE",Closed,4d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Screening,"Apr 20, 2026 7:45 AM",6227323234,CZ100062002,2106334,"Apr 22, 2026 7:18 PM","Apr 22, 2026 7:36 PM",AMT58660,Closed,18m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 0,"Mar 20, 2026 8:00 AM",6227323237,CZ100062001,2064023,"Mar 26, 2026 7:00 PM","Mar 27, 2026 9:04 AM",PCFCOM,Closed,14h 3m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 0,"Mar 20, 2026 8:00 AM",6227323237,CZ100062001,2061456,"Mar 25, 2026 6:16 PM","Mar 26, 2026 8:38 AM",AMT58660,Closed,14h 22m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 2,"Apr 8, 2026 7:10 AM",6227323240,CZ100062001,2086807,"Apr 10, 2026 12:21 PM","Apr 18, 2026 10:40 PM","AMT58660, ADT809",Closed,8d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 4,"Apr 15, 2026 8:45 AM",6227323242,CZ100062001,2102704,"Apr 21, 2026 11:22 AM","Apr 22, 2026 7:36 PM",AMT58660,Closed,1d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Biopsy,"Feb 19, 2026 12:00 AM",6227323254,CZ100062001,2014333,"Feb 24, 2026 4:13 PM","Feb 24, 2026 8:20 PM",VST,Closed,4h 6m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10003 - Dr. Leksa Vaclav,CZECH REPUBLIC,Screening,"May 13, 2026 8:15 AM",6227323299,CZ100032001,2154732,"May 22, 2026 12:36 PM","May 25, 2026 8:57 AM",AMT58660,Closed,2d,Leksa Vaclav,vaclav.leksa@seznam.cz,Investigator +title,value,,,,,,,,,,,,, +Search,,,,,,,,,,,,,, +Site,"930551, 930556, 930525, 930549, 930543, 930547, 930555, 930557, 930539, 930536, 930553, 930531",,,,,,,,,,,,, +Unresponded Only?,FALSE,,,,,,,,,,,,, +Posted,From - To - ,,,,,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122241 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122241 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv new file mode 100644 index 0000000..652a478 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122241 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv @@ -0,0 +1,9 @@ +Site,Country,Visit,Visit Collection Date,Accession,Subject,eQueryId,Create Date,Response Date Time,Issue Type,Status,Time Before Response,User Name,Email,Study Role +,,,,,,,,,,,,,, +,,,,,,,,,,,,,, +,,,,,,,,,,,,,, +title,value,,,,,,,,,,,,, +Search,,,,,,,,,,,,,, +Site,"930551, 930556, 930525, 930549, 930543, 930547, 930555, 930557, 930539, 930536, 930553, 930531",,,,,,,,,,,,, +Unresponded Only?,TRUE,,,,,,,,,,,,, +Posted,From - To - ,,,,,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122704 sponsor-study-36940-test-results-930525-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122704 sponsor-study-36940-test-results-930525-standard.csv new file mode 100644 index 0000000..65d2d3f --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122704 sponsor-study-36940-test-results-930525-standard.csv @@ -0,0 +1,709 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,20-May-2026,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,11:44,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,22-May-2026,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Alkaline Phosphatase,,68,,,,,40 - 129,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,ALT (SGPT),,10,,,,,5 - 48,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,GGT,,10,,,,,10 - 61,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,LDH,,164,,,,,53 - 234,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,101,,,,,40 - 110,umol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Uric Acid,,255,,,,,125 - 488,umol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Phosphorus,,1.10,,,,,0.71 - 1.65,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Creatine Kinase,,131,,,,,39 - 308,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Bicarbonate,,25.4,,,,,19.3 - 29.3,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Magnesium,,0.82,,,,,0.66 - 1.07,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,87,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,FECAL COLLECTION D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,FECAL COLLECTION D/T,Stool Collection Time,Y,06:40,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,127 - 181,g/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.72,,,,,3.8 - 10.7,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.17,,,,,1.96 - 7.23,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.71,,,,,0.91 - 4.28,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.36,,,,,0.12 - 0.92,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.44,,,,,0 - 0.57,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.4,,,,,40.5 - 75,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.0,,,,,15.4 - 48.5,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.3,,,,,2.6 - 10.1,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,7.7,,H,,,0 - 6.8,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,294,,,,,140 - 400,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:40,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:50,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:40,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:40,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Alkaline Phosphatase,,65,,,,,40 - 129,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,ALT (SGPT),,7,,,,,5 - 48,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,GGT,,7,,L,,,10 - 61,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,LDH,,147,,,,,53 - 234,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,88,,,,,40 - 110,umol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Glucose,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Uric Acid,,261,,,,,125 - 488,umol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Creatine Kinase,,112,,,,,39 - 308,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Bicarbonate,,23.2,,,,,19.3 - 29.3,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Magnesium,,0.76,,,,,0.66 - 1.07,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,102,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,FECAL COLLECTION D/T,Stool Collection Date,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,FECAL COLLECTION D/T,Stool Collection Time,Y,05:40,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,127 - 181,g/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.39 - 0.54, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.68,,,,,3.8 - 10.7,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.92,,,,,1.96 - 7.23,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.94,,,,,0.91 - 4.28,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.40,,,,,0 - 0.57,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.7,,,,,40.5 - 75,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.0,,,,,15.4 - 48.5,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.9,,,,,2.6 - 10.1,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,5.9,,,,,0 - 6.8,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,308,,,,,140 - 400,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,14:15,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,15:25,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,14:15,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,05:40,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.2,,,,,0 - 6.2,umol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Alkaline Phosphatase,,71,,,,,40 - 129,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,ALT (SGPT),,7,,,,,5 - 48,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,GGT,,7,,L,,,10 - 61,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,LDH,,153,,,,,53 - 234,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Urea Nitrogen,,4.9,,,,,1.4 - 8.6,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,86,,,,,40 - 110,umol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Glucose,,4.2,,,,,3.9 - 5.6,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Uric Acid,,299,,,,,125 - 488,umol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Creatine Kinase,,116,,,,,39 - 308,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Bicarbonate,,23.9,,,,,19.3 - 29.3,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Magnesium,,0.80,,,,,0.66 - 1.07,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,106,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,FECAL COLLECTION D/T,Stool Collection Date,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,FECAL COLLECTION D/T,Stool Collection Time,Y,05:55,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,146,,,,,127 - 181,g/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.07,,,,,3.8 - 10.7,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.83,,,,,1.96 - 7.23,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.67,,,,,0.91 - 4.28,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.32,,,,,0.12 - 0.92,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.19,,,,,0 - 0.57,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.1,,,,,40.5 - 75,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.6,,,,,15.4 - 48.5,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.2,,,,,2.6 - 10.1,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.2,,,,,0 - 6.8,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,314,,,,,140 - 400,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,LIPID PANEL,Direct HDL-C 4th Generation,,1.90,,H,,,1.03 - 1.53,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,LIPID PANEL,Triglycerides (GPO),,0.43,,L,,,0.56 - 3.62,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,LIPID PANEL,Cholesterol (High Performance),,3.22,,L,,,3.88 - 6.83,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,LIPID PANEL,LDL Chol Friedewald 4th,,1.12,,,,,0 - 3.34,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:35,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,11:45,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:35,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,05:55,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Alkaline Phosphatase,,64,,,,,40 - 129,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,ALT (SGPT),,42,,,,,5 - 48,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,AST (SGOT),,31,,,,,8 - 40,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,GGT,,24,,,,,10 - 61,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,LDH,,225,,,,,53 - 234,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Urea Nitrogen,,10.1,,H,,,1.4 - 8.6,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,110,,,,,40 - 110,umol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Uric Acid,,455,,,,,125 - 488,umol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Creatine Kinase,,367,,H,,,39 - 308,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Bicarbonate,,24.7,,,,,19.3 - 29.3,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Magnesium,,0.77,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,76,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,FECAL COLLECTION D/T,Stool Collection Date,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,FECAL COLLECTION D/T,Stool Collection Time,Y,05:15,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,135,,,,,127 - 181,g/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,85,,,,,79 - 96,fL +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.70,,,,,3.8 - 10.7,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.33,,,,,1.96 - 7.23,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.26,,,,,0.91 - 4.28,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.67,R,H,,,0 - 0.57,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,40.8,,,,,40.5 - 75,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,39.6,,,,,15.4 - 48.5,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.0,,,,,2.6 - 10.1,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,11.7,R,H,,,0 - 6.8,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,282,,,,,140 - 400,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:15,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,05:15,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,01-Apr-2026,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:46,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,03-Apr-2026,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Alkaline Phosphatase,,58,,,,,40 - 129,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,ALT (SGPT),,26,,,,,5 - 48,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,LDH,,170,,,,,53 - 234,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Urea Nitrogen,,9.4,R,H,,,1.4 - 8.6,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,104,,,,,40 - 110,umol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Glucose,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Uric Acid,,353,,,,,125 - 488,umol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Phosphorus,,1.32,,,,,0.71 - 1.65,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Creatine Kinase,,167,,,,,39 - 308,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Bicarbonate,,23.9,,,,,19.3 - 29.3,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Magnesium,,0.73,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,80,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,FECAL COLLECTION D/T,Stool Collection Date,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,FECAL COLLECTION D/T,Stool Collection Time,Y,05:40,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,133,,,,,127 - 181,g/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.5 - 6.4,TI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.92,,,,,3.8 - 10.7,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.29,,,,,1.96 - 7.23,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.57,,,,,0.91 - 4.28,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.41,,,,,0.12 - 0.92,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.61,R,H,,,0 - 0.57,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,38.7,R,L,,,40.5 - 75,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,43.4,,,,,15.4 - 48.5,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,10.3,R,H,,,0 - 6.8,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,252,,,,,140 - 400,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:20,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,05:40,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Total Bilirubin,,3,,,,Result verified by repeat analysis,3 - 21,umol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,Result verified by repeat analysis,0 - 6.2,umol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,40 - 129,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,5 - 48,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,GGT,,19,,,,,10 - 50,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Urea Nitrogen,,5.5,,,,,1.4 - 8.6,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,108,,,,,40 - 119,umol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Uric Acid,,429,,,,,149 - 494,umol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Calcium (EDTA),,2.07,,,,,2.07 - 2.64,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Phosphorus,,1.02,,,,,0.71 - 1.65,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Total Protein,,55,,L,,,60 - 80,g/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Albumin-BCG,,35,,,,,33 - 49,g/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Creatine Kinase,,49,,,,,39 - 308,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Sodium,,148,,H,,,135 - 145,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Bicarbonate,,24.4,,,,,19.3 - 29.3,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Chloride,,110,,,,,94 - 112,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Magnesium,,0.82,,,,,0.66 - 0.98,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Alkaline Phosphatase,,73,,,,,40 - 129,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,ALT (SGPT),,5,,,,,5 - 48,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,GGT,,6,R,L,,,10 - 61,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,LDH,,149,,,,,53 - 234,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Urea Nitrogen,,3.8,,,,,1.4 - 8.6,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 110,umol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Uric Acid,,277,,,,,125 - 488,umol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Phosphorus,,1.23,,,,,0.71 - 1.65,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Creatine Kinase,,119,,,,,39 - 308,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Bicarbonate,,27.4,,,,,19.3 - 29.3,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Alkaline Phosphatase,,91,,,,,40 - 129,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,ALT (SGPT),,79,R,H,,,5 - 48,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,AST (SGOT),,51,R,H,,,8 - 40,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,GGT,,45,,,,,10 - 61,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,LDH,,228,,,,,53 - 234,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Urea Nitrogen,,8.3,,,,,1.4 - 8.6,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,106,,,,,40 - 110,umol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Uric Acid,,418,,,,,125 - 488,umol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Phosphorus,,1.10,,,,,0.71 - 1.65,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Creatine Kinase,,250,,,,,39 - 308,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Bicarbonate,,25.4,,,,,19.3 - 29.3,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Magnesium,,0.73,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,79,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,FECAL COLLECTION D/T,Stool Collection Date,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,FECAL COLLECTION D/T,Stool Collection Time,Y,08:55,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,127 - 181,g/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.5 - 6.4,TI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.70,,,,,3.8 - 10.7,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.17,,,,,1.96 - 7.23,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.01,,,,,0.91 - 4.28,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,1.08,R,H,,,0 - 0.57,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.4,,,,,40.5 - 75,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.9,,,,,15.4 - 48.5,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,16.1,R,H,,,0 - 6.8,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,262,,,,,140 - 400,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,LIPID PANEL,Direct HDL-C 4th Generation,,1.13,,,,,1.03 - 1.53,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,LIPID PANEL,Triglycerides (GPO),,0.84,,,,,0.56 - 3.62,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,LIPID PANEL,Cholesterol (High Performance),,5.14,,,,,3.88 - 6.83,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,LIPID PANEL,LDL Chol Friedewald 4th,,3.63,,H,,,0 - 3.34,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:50,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:05,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:50,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,08:55,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SUBJECT HEIGHT (CM),Height (cm),Y,190,,,,,cm, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Total Bilirubin,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,ALT (SGPT),,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,AST (SGOT),,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,GGT,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,LDH,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Urea Nitrogen,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Glucose,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Uric Acid,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Calcium (EDTA),,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Phosphorus,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Total Protein,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Albumin-BCG,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Creatine Kinase,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Sodium,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Potassium,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Bicarbonate,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Chloride,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Magnesium,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,148,,,,,127 - 181,g/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.67,,,,,3.8 - 10.7,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.96,,,,,1.96 - 7.23,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.68,,,,,0.91 - 4.28,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.51,,,,,0.12 - 0.92,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.42,,,,,0 - 0.57,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.3,,,,,40.5 - 75,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,25.2,,,,,15.4 - 48.5,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.7,,,,,2.6 - 10.1,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,6.3,,,,,0 - 6.8,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.5,,,,,0 - 2,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,341,,,,,140 - 400,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,SUBJECT HEIGHT (CM),Height (cm),Y,188,,,,,cm, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Total Bilirubin,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,ALT (SGPT),,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,AST (SGOT),,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,GGT,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,LDH,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Urea Nitrogen,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Glucose,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Uric Acid,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Calcium (EDTA),,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Phosphorus,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Total Protein,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Albumin-BCG,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Creatine Kinase,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Sodium,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Potassium,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Bicarbonate,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Chloride,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Magnesium,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,91,,L,,,125 - 170,g/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.31,,L,,,0.37 - 0.51, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.7,,L,,,4 - 5.8,TI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,25,,L,,,26 - 34,pg +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,80 - 100,fL +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,11.98,,H,,,3.8 - 10.7,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,9.38,,H,,,1.96 - 7.23,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.49,,,,,0.8 - 3,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.88,,,,,0.12 - 0.92,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.18,,,,,0 - 0.57,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,78.4,,H,,,40.5 - 75,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,12.4,,L,,,15.4 - 48.5,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.3,,,,,2.6 - 10.1,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.5,,,,,0 - 6.8,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,465,,H,,,130 - 394,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,SUBJECT HEIGHT (CM),Height (cm),Y,158,,,,,cm, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.9,,,,,0 - 6.2,umol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Alkaline Phosphatase,,78,,,,,40 - 129,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,ALT (SGPT),,69,,H,,,5 - 48,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,AST (SGOT),,33,,,,,8 - 40,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,GGT,,38,,,,,10 - 61,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,LDH,,213,,,,,53 - 234,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Urea Nitrogen,,8.9,,H,,,1.4 - 8.6,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,105,,,,,40 - 110,umol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Uric Acid,,414,,,,,125 - 488,umol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Phosphorus,,1.17,,,,,0.71 - 1.65,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Creatine Kinase,,157,,,,,39 - 308,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Bicarbonate,,25.4,,,,,19.3 - 29.3,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Magnesium,,0.74,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,80,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,138,,,,,127 - 181,g/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.39 - 0.54, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.5 - 6.4,TI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.87,,,,,3.8 - 10.7,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.24,,,,,1.96 - 7.23,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.46,,,,,0.91 - 4.28,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.79,R,H,,,0 - 0.57,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,38.2,R,L,,,40.5 - 75,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,41.9,,,,,15.4 - 48.5,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.7,,,,,2.6 - 10.1,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,13.5,R,H,,,0 - 6.8,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,302,,,,,140 - 400,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,,,,Test group cancelled: No specimen received,,, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,18-Feb-2026,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,07:39,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,INFLAMED AREA,Inflamed area?,,No,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,20-Feb-2026,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,11-Feb-2026,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,14:38,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,13-Feb-2026,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.9,,,,,0 - 6.2,umol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Alkaline Phosphatase,,55,,,,,40 - 129,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,5 - 48,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,GGT,,12,,,,,10 - 61,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,LDH,,190,,,,,53 - 234,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Urea Nitrogen,,8.5,,,,,1.4 - 8.6,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,115,,H,,,40 - 110,umol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Uric Acid,,337,,,,,125 - 488,umol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Phosphorus,,0.86,,,,,0.71 - 1.65,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Creatine Kinase,,144,,,,,39 - 308,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Bicarbonate,,27.5,,,,,19.3 - 29.3,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Magnesium,,0.75,,,,,0.66 - 1.07,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CKD-EPI 2021,CKD-EPI 2021 Without Race,,72,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,127 - 181,g/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.82,,,,,3.8 - 10.7,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.49,,,,,1.96 - 7.23,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.54,,,,,0.91 - 4.28,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.41,,,,,0.12 - 0.92,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.34,,,,,0 - 0.57,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,42.7,,,,,40.5 - 75,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,43.7,,,,,15.4 - 48.5,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.0,,,,,2.6 - 10.1,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,5.9,,,,,0 - 6.8,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,224,,,,,140 - 400,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEPATITIS B SURFACE AB NON-US,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100222001,,,,,Male,Stool Pathogens,R,"Jan 15, 2026 4:55 PM",6227323276,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,Test group cancelled: Specimen received beyond stability,,, +CZ100222001,,,,,Male,Stool Pathogens,R,"Jan 15, 2026 4:55 PM",6227323276,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,Test group cancelled: Specimen received beyond stability,,, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.4,,,,,0 - 6.2,umol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Alkaline Phosphatase,,140,,H,,,40 - 129,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,5 - 48,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,AST (SGOT),,28,,,,,8 - 40,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,GGT,,136,,H,,,10 - 61,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,LDH,,186,,,,,53 - 234,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,78,,,,,40 - 110,umol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Uric Acid,,408,,,,,125 - 488,umol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Creatine Kinase,,131,,,,,39 - 308,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Magnesium,,0.82,,,,,0.66 - 1.07,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CKD-EPI 2021,CKD-EPI 2021 Without Race,,111,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,85,,L,,,127 - 181,g/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.30,,L,,,0.39 - 0.54, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,L,,,4.5 - 6.4,TI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,21,,L,,,26 - 34,pg +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Microcytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Anisocytosis,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,74,,L,,,79 - 96,fL +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,15.03,,H,,,3.8 - 10.7,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,11.38,,H,,,1.96 - 7.23,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.59,,,,,0.91 - 4.28,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.82,,,,,0.12 - 0.92,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.11,,,,,0 - 0.2,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,75.7,,H,,,40.5 - 75,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,17.3,,,,,15.4 - 48.5,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,529,,H,,,140 - 400,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEPATITIS B SURFACE AB NON-US,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122705 sponsor-study-36940-test-results-930556-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122705 sponsor-study-36940-test-results-930556-standard.csv new file mode 100644 index 0000000..d10a076 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122705 sponsor-study-36940-test-results-930556-standard.csv @@ -0,0 +1,75 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,27-May-2026,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:10,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,29-May-2026,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: Specimen received in expired coll. container; unable to perform test.,,, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,35 - 104,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,AST (SGOT),,11,,,,,8 - 40,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,GGT,,9,,,,,4 - 49,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,LDH,,128,,,,,53 - 234,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Glucose,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Uric Acid,,192,,,,,125 - 428,umol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Calcium (EDTA),,2.24,,,,,2.07 - 2.64,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Phosphorus,,1.00,,,,,0.71 - 1.65,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Creatine Kinase,,85,,,,,26 - 192,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Magnesium,,0.79,,,,,0.66 - 1.07,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,94,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,114,,L,,,116 - 164,g/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4.1 - 5.6,TI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,,26 - 34,pg +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 98,fL +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.80,,,,,3.8 - 10.7,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.53,,,,,1.96 - 7.23,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.32,,,,,0.91 - 4.28,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.47,,,,,0.12 - 0.92,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.44,,,,,0 - 0.57,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.2,,,,,40.5 - 75,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,15.0,,L,,,15.4 - 48.5,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,5.0,,,,,0 - 6.8,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,513,,H,,,140 - 400,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122709 sponsor-study-36940-test-results-930525-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122709 sponsor-study-36940-test-results-930525-microbiology.csv new file mode 100644 index 0000000..a4242f9 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122709 sponsor-study-36940-test-results-930525-microbiology.csv @@ -0,0 +1,6 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100222001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Jan 15, 2026 4:55 PM",6227323276,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,R, +CZ100222002 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Jan 23, 2026 10:10 AM",6227323277,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100222004 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Mar 3, 2026 12:20 PM",6227810905,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100222005 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Mar 4, 2026 9:10 AM",6227810904,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122710 sponsor-study-36940-test-results-930556-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122710 sponsor-study-36940-test-results-930556-microbiology.csv new file mode 100644 index 0000000..fba7493 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122710 sponsor-study-36940-test-results-930556-microbiology.csv @@ -0,0 +1,3 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100032001 - null,,,,Female,SCRNSTOOL Stool Pathogens,"May 13, 2026 9:30 AM",6227323309,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122727 sponsor-study-36940-test-results-930549-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122727 sponsor-study-36940-test-results-930549-standard.csv new file mode 100644 index 0000000..533a201 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122727 sponsor-study-36940-test-results-930549-standard.csv @@ -0,0 +1,242 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Alkaline Phosphatase,,82,,,,,35 - 104,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,GGT,,11,,,,,4 - 49,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Urea Nitrogen,,2.1,,,,,1.4 - 8.6,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,55,,,,,31 - 101,umol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Glucose,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Uric Acid,,277,,,,,125 - 428,umol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Calcium (EDTA),,2.54,,,,,2.07 - 2.64,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Phosphorus,,0.81,,,,,0.71 - 1.65,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Total Protein,,84,,,,,61 - 84,g/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Albumin-BCG,,51,,H,,,33 - 49,g/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Creatine Kinase,,55,,,,,26 - 192,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Bicarbonate,,23.5,,,,,19.3 - 29.3,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Magnesium,,0.89,,,,,0.66 - 1.07,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,129,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,FECAL COLLECTION D/T,Stool Collection Date,Y,,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,FECAL COLLECTION D/T,Stool Collection Time,Y,,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,Result verified by repeat analysis,116 - 164,g/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,Result verified by repeat analysis,4.1 - 5.6,TI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,27,,,,Result verified by repeat analysis,26 - 34,pg +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Anisocytosis,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,83,,,,Result verified by repeat analysis,79 - 98,fL +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.41,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.73,,,,,1.96 - 7.23,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.41,,,,,0.91 - 4.28,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.22,,,,,0.12 - 0.92,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,,0 - 0.57,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.00,,,,,0 - 0.2,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.0,,,,,40.5 - 75,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.0,,,,,15.4 - 48.5,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.0,,,,,0 - 2,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,340,,,,Result verified by repeat analysis,140 - 400,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,07-May-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,12:40,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,07-May-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,14:20,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,07-May-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,12:40,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Alkaline Phosphatase,,71,,,,,35 - 104,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,4 - 43,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,GGT,,12,,,,,4 - 49,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,LDH,,138,,,,,53 - 234,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Urea Nitrogen,,3.5,,,,,1.4 - 8.6,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Glucose,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Uric Acid,,296,,,,,125 - 428,umol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Calcium (EDTA),,2.55,,,,,2.07 - 2.64,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Phosphorus,,0.77,,,,,0.71 - 1.65,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Creatine Kinase,,49,,,,,26 - 192,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Bicarbonate,,25.3,,,,,19.3 - 29.3,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Magnesium,,0.83,,,,,0.66 - 1.07,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,129,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,FECAL COLLECTION D/T,Stool Collection Date,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,FECAL COLLECTION D/T,Stool Collection Time,Y,05:30,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,128,,,,Result verified by repeat analysis,116 - 164,g/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,Result verified by repeat analysis,0.34 - 0.48, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,Result verified by repeat analysis,4.1 - 5.6,TI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,26,,,,Result verified by repeat analysis,26 - 34,pg +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,81,,,,Result verified by repeat analysis,79 - 98,fL +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.60,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.39,,,,,1.96 - 7.23,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.54,,,,,0.91 - 4.28,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.47,,,,Result verified by repeat analysis,0.12 - 0.92,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,Result verified by repeat analysis,0 - 0.57,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,Result verified by repeat analysis,0 - 0.2,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,66.6,,,,Result verified by repeat analysis,40.5 - 75,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,23.5,,,,Result verified by repeat analysis,15.4 - 48.5,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,Result verified by repeat analysis,2.6 - 10.1,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.8,,,,Result verified by repeat analysis,0 - 6.8,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,Result verified by repeat analysis,0 - 2,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,300,,,,Result verified by repeat analysis,140 - 400,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,09:25,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:45,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,09:25,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,05:30,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Alkaline Phosphatase,,66,,,,,35 - 104,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,4 - 43,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,GGT,,12,,,,,4 - 49,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,LDH,,157,,,,,53 - 234,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Urea Nitrogen,,3.0,,,,,1.4 - 8.6,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,51,,,,,31 - 101,umol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Uric Acid,,258,,,,,125 - 428,umol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Phosphorus,,0.84,,,,,0.71 - 1.65,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Creatine Kinase,,51,,,,,26 - 192,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Bicarbonate,,23.0,,,,,19.3 - 29.3,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Magnesium,,0.82,,,,,0.66 - 1.07,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,131,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,FECAL COLLECTION D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,FECAL COLLECTION D/T,Stool Collection Time,Y,06:00,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,115,R,L,,,116 - 164,g/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,25,R,L,,,26 - 34,pg +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,80,,,,,79 - 98,fL +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.11,,,,,3.8 - 10.7,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.31,,,,,1.96 - 7.23,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.15,,,,,0.91 - 4.28,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.54,,,,,0.12 - 0.92,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,69.3,,,,,40.5 - 75,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,23.6,,,,,15.4 - 48.5,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.9,,,,,2.6 - 10.1,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.5,,,,,0 - 6.8,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,386,,,,,140 - 400,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,LIPID PANEL,Direct HDL-C 4th Generation,,1.35,,,,,1.03 - 1.53,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,LIPID PANEL,Triglycerides (GPO),,1.11,,,,,0.41 - 1.63,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,LIPID PANEL,Cholesterol (High Performance),,4.41,,,,,3.31 - 5.64,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,LIPID PANEL,LDL Chol Friedewald 4th,,2.55,,,,,0 - 3.34,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,11:45,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,13:35,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,11:45,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,06:00,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,ANATOMICAL SITE,Anatomical Site,Y,15 cm,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,23-Mar-2026,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:42,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,25-Mar-2026,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Total Bilirubin,,<3,R,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,Result verified by repeat analysis,0 - 6.2,umol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Alkaline Phosphatase,,74,,,,,35 - 104,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,4 - 43,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,GGT,,9,,,,,4 - 49,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Urea Nitrogen,,2.5,,,,,1.4 - 8.6,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,55,,,,,31 - 101,umol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Glucose,,5.5,,,,,3.9 - 5.6,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Uric Acid,,226,,,,,125 - 428,umol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Phosphorus,,0.90,,,,,0.71 - 1.65,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Creatine Kinase,,84,,,,,26 - 192,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Potassium,,5.1,,,,,3.5 - 5.2,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Bicarbonate,,19.2,,L,,,19.3 - 29.3,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Magnesium,,0.83,,,,,0.66 - 1.07,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,129,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,111,R,L,,,116 - 164,g/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,24,R,L,,,26 - 34,pg +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,78,R,L,,,79 - 98,fL +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.66,,,,,3.8 - 10.7,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.37,,,,,1.96 - 7.23,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.63,,,,,0.91 - 4.28,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.55,,,,,0.12 - 0.92,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,70.2,,,,,40.5 - 75,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,21.2,,,,,15.4 - 48.5,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,,2.6 - 10.1,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,412,R,H,,,140 - 400,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100122001,,,,,Female,Stool Pathogens,,"Mar 17, 2026 5:30 PM",6227697725,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100122001,,,,,Female,Stool Pathogens,,"Mar 17, 2026 5:30 PM",6227697725,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122729 sponsor-study-36940-test-results-930549-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122729 sponsor-study-36940-test-results-930549-microbiology.csv new file mode 100644 index 0000000..a05daf8 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122729 sponsor-study-36940-test-results-930549-microbiology.csv @@ -0,0 +1,3 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100122001 - null,,,,Female,SCRNSTOOL Stool Pathogens,"Mar 17, 2026 5:30 PM",6227697725,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122741 sponsor-study-36940-test-results-930555-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122741 sponsor-study-36940-test-results-930555-standard.csv new file mode 100644 index 0000000..20b1475 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122741 sponsor-study-36940-test-results-930555-standard.csv @@ -0,0 +1,422 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100062001,,,,,Male,Biopsy,,"May 29, 2026 12:00 AM",6227323255,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100062001,,,,,Male,Biopsy,,"May 29, 2026 12:00 AM",6227323255,BIOPSY COLLECTION METHOD,Collection Method,Y,sigmoidoscopy,,,,,, +CZ100062001,,,,,Male,Biopsy,,"May 29, 2026 12:00 AM",6227323255,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100062001,,,,,Male,Biopsy,,"May 29, 2026 12:00 AM",6227323255,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,28-May-2026,,,,,, +CZ100062001,,,,,Male,Biopsy,,"May 29, 2026 12:00 AM",6227323255,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:15,,,,,, +CZ100062001,,,,,Male,Biopsy,,"May 29, 2026 12:00 AM",6227323255,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100062001,,,,,Male,Biopsy,,"May 29, 2026 12:00 AM",6227323255,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100062001,,,,,Male,Biopsy,,"May 29, 2026 12:00 AM",6227323255,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100062001,,,,,Male,Biopsy,,"May 29, 2026 12:00 AM",6227323255,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,,,,,,, +CZ100062001,,,,,Male,Biopsy,,"May 29, 2026 12:00 AM",6227323255,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,,,,,,, +CZ100062001,,,,,Male,Biopsy,,"May 29, 2026 12:00 AM",6227323255,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,,,,,,, +CZ100062001,,,,,Male,Biopsy,,"May 29, 2026 12:00 AM",6227323255,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,,,,,,, +CZ100062001,,,,,Male,Biopsy,,"May 29, 2026 12:00 AM",6227323255,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Total Bilirubin,,18,,,,,3 - 21,umol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.8,,,,,0 - 6.2,umol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Alkaline Phosphatase,,63,,,,,40 - 129,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,ALT (SGPT),,12,,,,,5 - 48,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,GGT,,17,,,,,10 - 61,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,LDH,,124,,,,,53 - 234,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Urea Nitrogen,,3.2,,,,,1.4 - 8.6,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,40 - 110,umol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Glucose,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Uric Acid,,298,,,,,125 - 488,umol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Phosphorus,,1.21,,,,,0.71 - 1.65,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Creatine Kinase,,106,,,,,39 - 308,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,FECAL COLLECTION D/T,Stool Collection Date,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,FECAL COLLECTION D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,129,,,,,127 - 181,g/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.39 - 0.54, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,L,,,4.5 - 6.4,TI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 96,fL +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.10,,,,,3.8 - 10.7,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.34,,,,,1.96 - 7.23,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.09,,,,,0.91 - 4.28,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.48,,,,,0.12 - 0.92,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.5,,,,,40.5 - 75,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,21.4,,,,,15.4 - 48.5,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.5,,,,,2.6 - 10.1,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.2,,,,,0 - 6.8,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,270,,,,,140 - 400,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,IS SUBJECT FASTING?,Is Subject Fasting?,Y,,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,LIPID PANEL,Direct HDL-C 4th Generation,,0.90,,L,,,1.03 - 1.53,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,LIPID PANEL,Triglycerides (GPO),,0.88,,,,,0.62 - 3.69,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,LIPID PANEL,Cholesterol (High Performance),,2.48,,L,,Result verified by repeat analysis,4.19 - 7.24,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,LIPID PANEL,LDL Chol Friedewald 4th,,1.18,,,,,0 - 3.34,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,PA1 EEA-2?,Approved to use EEA-2?,,,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:15,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:05,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:15,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SUBJECT HEIGHT (CM),Height (cm),Y,,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,ANATOMICAL SITE,Anatomical Site,Y,15-20,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,14-May-2026,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:15,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,16-May-2026,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Alkaline Phosphatase,,65,,,,,40 - 129,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,ALT (SGPT),,13,,,,,5 - 48,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,GGT,,17,,,,,10 - 61,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,71,,,,,40 - 110,umol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Uric Acid,,338,,,,,125 - 488,umol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Phosphorus,,1.19,,,,,0.71 - 1.65,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Creatine Kinase,,281,,,,,39 - 308,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Bicarbonate,,26.0,,,,,19.3 - 29.3,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,108,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,127 - 181,g/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.39 - 0.54, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Anisocytosis,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.17,,,,,3.8 - 10.7,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.25,,,,,1.96 - 7.23,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.20,,,,,0.91 - 4.28,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.38,,,,,0.12 - 0.92,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.22,,,,,0 - 0.57,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.11,,,,,0 - 0.2,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.0,,,,,40.5 - 75,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.9,,,,,15.4 - 48.5,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.1,,,,,2.6 - 10.1,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,5.3,,,,,0 - 6.8,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.7,,H,,,0 - 2,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,306,,,,,140 - 400,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Alkaline Phosphatase,,91,,,,,40 - 129,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,5 - 48,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,LDH,,118,,,,,53 - 234,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Urea Nitrogen,,1.6,,,,,1.4 - 8.6,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,92,,,,,40 - 110,umol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Glucose,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Uric Acid,,424,,,,,125 - 488,umol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Calcium (EDTA),,2.51,,,,,2.07 - 2.64,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Phosphorus,,1.29,,,,,0.71 - 1.65,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Total Protein,,78,,,,,61 - 84,g/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Creatine Kinase,,41,,,,,39 - 308,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Bicarbonate,,24.0,,,,,19.3 - 29.3,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Chloride,,96,,,,,94 - 112,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Magnesium,,0.93,,H,,,0.7 - 0.9,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,106,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,FECAL COLLECTION D/T,Stool Collection Date,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,FECAL COLLECTION D/T,Stool Collection Time,Y,20:30,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,122,R,L,,,127 - 181,g/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,24,R,L,,,26 - 34,pg +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,83,,,,,79 - 96,fL +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,14.93,R,H,,,3.8 - 10.7,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,10.00,R,H,,,1.96 - 7.23,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.54,,,,,0.91 - 4.28,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,1.79,R,H,,,0.12 - 0.92,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.60,R,H,,,0 - 0.57,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.00,,,,,0 - 0.2,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,67.0,,,,,40.5 - 75,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,17.0,,,,,15.4 - 48.5,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,12.0,R,H,,,2.6 - 10.1,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.0,,,,,0 - 6.8,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.0,,,,,0 - 2,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,647,R,H,,,140 - 400,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:15,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:40,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:15,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,20:30,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,40 - 129,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,5 - 48,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,LDH,,113,,,,,53 - 234,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Urea Nitrogen,,2.0,,,,,1.4 - 8.6,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,86,,,,,40 - 110,umol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Glucose,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Uric Acid,,410,,,,,125 - 488,umol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Phosphorus,,1.28,,,,,0.71 - 1.65,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Creatine Kinase,,64,,,,,39 - 308,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Bicarbonate,,23.2,,,,,19.3 - 29.3,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Magnesium,,0.93,R,H,,,0.7 - 0.9,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,115,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,FECAL COLLECTION D/T,Stool Collection Date,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,FECAL COLLECTION D/T,Stool Collection Time,Y,07:10,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:20,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,07:10,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,40 - 129,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,5 - 48,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,GGT,,18,,,,,10 - 61,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,LDH,,141,,,,,53 - 234,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Urea Nitrogen,,2.5,,,,,1.4 - 8.6,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,40 - 110,umol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Glucose,,4.0,,,,,3.9 - 5.6,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Uric Acid,,415,,,,,125 - 488,umol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Phosphorus,,1.26,,,,,0.71 - 1.65,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Creatine Kinase,,119,,,,,39 - 308,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Bicarbonate,,23.3,,,,,19.3 - 29.3,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Magnesium,,0.90,,,,,0.7 - 0.9,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,128,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,FECAL COLLECTION D/T,Stool Collection Date,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,FECAL COLLECTION D/T,Stool Collection Time,Y,08:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,121,,L,,,127 - 181,g/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,25,,L,,,26 - 34,pg +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,81,,,,,79 - 96,fL +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,13.09,,H,,,3.8 - 10.7,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,9.29,,H,,,1.96 - 7.23,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.23,,,,,0.91 - 4.28,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,1.31,,H,,,0.12 - 0.92,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.13,,,,,0 - 0.2,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.0,,,,,40.5 - 75,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,17.0,,,,,15.4 - 48.5,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.0,,,,,2.6 - 10.1,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,445,,H,,,140 - 400,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,IS SUBJECT FASTING?,Is Subject Fasting?,Y,No,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,LIPID PANEL,Direct HDL-C 4th Generation,,1.53,,,,,1.03 - 1.53,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,LIPID PANEL,Triglycerides (GPO),,0.81,,,,,0.42 - 1.67,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,LIPID PANEL,Cholesterol (High Performance),,4.16,,,,,2.95 - 5.12,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,LIPID PANEL,LDL Chol Friedewald 4th,,2.26,,,,,0 - 3.34,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,08:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 17, 2026 9:00 AM",6227323243,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 17, 2026 9:00 AM",6227323243,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,TB Testing,,"Mar 11, 2026 9:10 AM",6227323253,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,ANATOMICAL SITE,Anatomical Site,Y,18,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,BIOPSY COLLECTION METHOD,Collection Method,Y,sigmoidoscopy,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,19-Feb-2026,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,07:20,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,23-Feb-2026,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Feb 16, 2026 7:20 AM",6227323244,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,Test group cancelled: Specimen received beyond stability,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Feb 16, 2026 7:20 AM",6227323244,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,Test group cancelled: Specimen received beyond stability,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Alkaline Phosphatase,,93,,,,,55 - 149,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,5 - 48,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,GGT,,64,,H,,,10 - 61,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,LDH,,105,,,,,53 - 234,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Urea Nitrogen,,1.5,,,,,1.4 - 8.6,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,40 - 110,umol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Glucose,,4.2,,,,,3.9 - 5.6,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Uric Acid,,288,,,,,125 - 488,umol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Phosphorus,,0.85,,,,,0.71 - 1.65,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Albumin-BCG,,39,,,,,33 - 49,g/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Creatine Kinase,,34,,L,,,39 - 308,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Bicarbonate,,25.5,,,,,19.3 - 29.3,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Magnesium,,0.95,,H,,,0.7 - 0.9,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CKD-EPI 2021,CKD-EPI 2021 Without Race,,133,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEPATITIS B SURFACE AB NON-US,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,TB Testing,,"Feb 16, 2026 7:03 AM",6227323252,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Indeterminate,,,,,Normal=Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122743 sponsor-study-36940-test-results-930555-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122743 sponsor-study-36940-test-results-930555-microbiology.csv new file mode 100644 index 0000000..90a8458 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122743 sponsor-study-36940-test-results-930555-microbiology.csv @@ -0,0 +1,6 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100062001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Feb 16, 2026 7:20 AM",6227323244,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100062001 - null,,,,Male,UNSCSTOOL Stool Pathogens,"Mar 11, 2026 9:15 AM",6227323245,STOOL CULTURE,,,,Test group cancelled: Specimen received beyond stability,,,,,,,,,,, +CZ100062001 - null,,,,Male,UNSCSTOOL Stool Pathogens,"Mar 17, 2026 9:00 AM",6227323243,STOOL CULTURE,,,,Test group cancelled: No specimen received,,,,,,,,,,, +CZ100062002 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 20, 2026 7:45 AM",6228194341,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122748 sponsor-study-36940-test-results-930547-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122748 sponsor-study-36940-test-results-930547-microbiology.csv new file mode 100644 index 0000000..b9b31df --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122748 sponsor-study-36940-test-results-930547-microbiology.csv @@ -0,0 +1,5 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100132001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Feb 26, 2026 10:35 AM",6227635149,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100132002 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 1, 2026 8:30 AM",6227635148,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100132003 - null,,,,Female,SCRNSTOOL Stool Pathogens,"May 7, 2026 5:45 AM",6227635150,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122750 sponsor-study-36940-test-results-930547-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122750 sponsor-study-36940-test-results-930547-standard.csv new file mode 100644 index 0000000..d606dbc --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122750 sponsor-study-36940-test-results-930547-standard.csv @@ -0,0 +1,500 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Alkaline Phosphatase,,73,,,,,40 - 129,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,5 - 48,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,AST (SGOT),,22,,,,,8 - 40,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,GGT,,18,,,,,10 - 61,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,LDH,,164,,,,,53 - 234,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Glucose,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Uric Acid,,346,,,,,125 - 488,umol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Calcium (EDTA),,2.46,,,,,2.07 - 2.64,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Phosphorus,,1.01,,,,,0.71 - 1.65,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Creatine Kinase,,206,,,,,39 - 308,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Bicarbonate,,20.1,,,,,19.3 - 29.3,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Magnesium,,0.85,,,,,0.66 - 1.07,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,103,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,FECAL COLLECTION D/T,Stool Collection Date,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,FECAL COLLECTION D/T,Stool Collection Time,Y,07:00,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,127 - 181,g/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,33,,,,,26 - 34,pg +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,H,,,79 - 96,fL +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.61,,,,,3.8 - 10.7,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.81,,,,,1.96 - 7.23,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.03,,,,,0.91 - 4.28,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.50,,,,,0.12 - 0.92,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.23,,,,,0 - 0.57,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,50.0,,,,,40.5 - 75,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.1,,,,,15.4 - 48.5,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.9,,,,,2.6 - 10.1,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.0,,,,,0 - 6.8,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,283,,,,,140 - 400,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,09:05,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:10,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,09:05,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,07:00,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SUBJECT HEIGHT (CM),Height (cm),Y,196,,,,,cm, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,25-May-2026,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:05,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,INFLAMED AREA,Inflamed area?,,,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,12:00,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,27-May-2026,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.9,,,,,0 - 6.2,umol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Alkaline Phosphatase,,77,,,,,40 - 129,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,5 - 48,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,GGT,,16,,,,,10 - 61,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,LDH,,159,,,,,53 - 234,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 8.6,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,96,,,,,40 - 110,umol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Glucose,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Uric Acid,,342,,,,,125 - 488,umol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Calcium (EDTA),,2.48,,,,,2.07 - 2.64,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Creatine Kinase,,204,,,,,39 - 308,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Bicarbonate,,21.8,,,,,19.3 - 29.3,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Magnesium,,0.85,,,,,0.66 - 1.07,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,94,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,FECAL COLLECTION D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,FECAL COLLECTION D/T,Stool Collection Time,Y,08:50,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,33,,,,,26 - 34,pg +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 96,fL +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.64,,,,,3.8 - 10.7,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.04,,,,,1.96 - 7.23,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.81,,,,,0.91 - 4.28,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.59,,,,,0.12 - 0.92,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.9,,,,,40.5 - 75,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.0,,,,,15.4 - 48.5,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.4,,H,,,2.6 - 10.1,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.8,,,,,0 - 6.8,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,275,,,,,140 - 400,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,LIPID PANEL,Direct HDL-C 4th Generation,,1.26,,,,,1.03 - 1.53,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,LIPID PANEL,Triglycerides (GPO),,1.63,,,,,0.5 - 2.81,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,LIPID PANEL,Cholesterol (High Performance),,4.71,,,,,3.31 - 6.1,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,LIPID PANEL,LDL Chol Friedewald 4th,,2.70,,,,,0 - 3.34,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,PA1 EEA-2?,Approved to use EEA-2?,,No,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:25,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,11:30,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:25,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,08:50,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SUBJECT HEIGHT (CM),Height (cm),Y,196,,,,,cm, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Alkaline Phosphatase,,95,,,,,35 - 104,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,AST (SGOT),,22,,,,,8 - 40,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,GGT,,34,,,,,4 - 49,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Urea Nitrogen,,2.8,,,,,1.4 - 8.6,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 101,umol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Glucose,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Uric Acid,,357,,,,,125 - 428,umol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Creatine Kinase,,51,,,,,26 - 192,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,95,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,133,,,,,116 - 164,g/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,,26 - 34,pg +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,84,,,,,79 - 98,fL +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.91,,,,,3.8 - 10.7,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.94,,,,,1.96 - 7.23,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.35,,,,,0.91 - 4.28,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.5,,,,,40.5 - 75,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.5,,,,,15.4 - 48.5,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.3,,,,,0 - 2,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,271,,,,,140 - 400,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Alkaline Phosphatase,,88,,,,,40 - 129,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,ALT (SGPT),,36,,,,,5 - 48,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,AST (SGOT),,30,,,,,8 - 40,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,GGT,,21,,,,,10 - 61,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,LDH,,172,,,,,53 - 234,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Urea Nitrogen,,6.2,,,,,1.4 - 8.6,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,71,,,,,40 - 110,umol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Uric Acid,,297,,,,,125 - 488,umol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Phosphorus,,1.22,,,,,0.71 - 1.65,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Creatine Kinase,,177,,,,,39 - 308,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Bicarbonate,,26.7,,,,,19.3 - 29.3,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Magnesium,,0.83,,,,,0.66 - 1.07,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,123,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,FECAL COLLECTION D/T,Stool Collection Date,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,FECAL COLLECTION D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,152,,,,,127 - 181,g/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.31,,,,,3.8 - 10.7,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.98,,,,,1.96 - 7.23,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.64,,,,,0.91 - 4.28,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.30,,,,,0.12 - 0.92,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.30,,,,,0 - 0.57,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,46.0,,,,,40.5 - 75,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.0,,,,,15.4 - 48.5,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.0,,,,,2.6 - 10.1,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,7.0,,H,,,0 - 6.8,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.0,,,,,0 - 2,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,226,,,,,140 - 400,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:45,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:50,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:45,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,21-Apr-2026,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:45,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,12:00,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,23-Apr-2026,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Alkaline Phosphatase,,87,,,,,40 - 129,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,ALT (SGPT),,27,,,,,5 - 48,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,LDH,,174,,,,,53 - 234,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Urea Nitrogen,,5.5,,,,,1.4 - 8.6,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,87,,,,,40 - 110,umol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Uric Acid,,299,,,,,125 - 488,umol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Phosphorus,,1.17,,,,,0.71 - 1.65,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Creatine Kinase,,177,,,,,39 - 308,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Bicarbonate,,26.5,,,,,19.3 - 29.3,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Magnesium,,0.79,,,,,0.66 - 1.07,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,107,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,FECAL COLLECTION D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,FECAL COLLECTION D/T,Stool Collection Time,Y,06:30,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,150,,,,,127 - 181,g/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 96,fL +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.89,,,,,3.8 - 10.7,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.33,,,,,1.96 - 7.23,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.84,,,,,0.91 - 4.28,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.25,,,,,0.12 - 0.92,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.37,,,,,0 - 0.57,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.7,,,,,40.5 - 75,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,37.7,,,,,15.4 - 48.5,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.2,,,,,2.6 - 10.1,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,7.7,R,H,,,0 - 6.8,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.8,,,,,0 - 2,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,217,,,,,140 - 400,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:50,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:00,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:50,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:30,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Alkaline Phosphatase,,69,,,,,40 - 129,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,5 - 48,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,GGT,,15,,,,,10 - 61,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,LDH,,130,,,,,53 - 234,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 8.6,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,82,,,,,40 - 110,umol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Glucose,,7.1,,H,,,3.9 - 5.6,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Uric Acid,,301,,,,,125 - 488,umol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Phosphorus,,1.42,,,,,0.71 - 1.65,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Creatine Kinase,,91,,,,,39 - 308,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Bicarbonate,,22.2,,,,,19.3 - 29.3,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Magnesium,,0.75,,,,,0.66 - 1.07,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,114,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,147,,,,,127 - 181,g/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.39 - 0.54, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,R,L,,,4.5 - 6.4,TI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,34,,,,,26 - 34,pg +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 96,fL +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.60,,,,,3.8 - 10.7,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.44,,,,,1.96 - 7.23,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.11,,,,,0.91 - 4.28,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.65,,,,,0.12 - 0.92,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.28,,,,,0 - 0.57,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.12,,,,,0 - 0.2,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.4,,,,,40.5 - 75,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.8,,,,,15.4 - 48.5,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.6,,,,,2.6 - 10.1,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.7,,,,,0 - 6.8,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.5,,,,,0 - 2,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,256,,,,,140 - 400,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Alkaline Phosphatase,,80,,,,,40 - 129,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,5 - 48,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,LDH,,166,,,,,53 - 234,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Urea Nitrogen,,7.7,,,,,1.4 - 8.6,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Glucose,,4.3,,,,,3.9 - 5.6,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Uric Acid,,336,,,,,125 - 488,umol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Phosphorus,,1.04,,,,,0.71 - 1.65,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Creatine Kinase,,135,,,,,39 - 308,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Bicarbonate,,22.2,,,,,19.3 - 29.3,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Magnesium,,0.78,,,,,0.66 - 1.07,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,103,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,FECAL COLLECTION D/T,Stool Collection Date,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,FECAL COLLECTION D/T,Stool Collection Time,Y,07:30,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,156,,,,,127 - 181,g/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.39 - 0.54, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 96,fL +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.53,,,,,3.8 - 10.7,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.00,,,,,1.96 - 7.23,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.61,,,,,0.91 - 4.28,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.25,,,,,0.12 - 0.92,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.57,,,,,0 - 0.57,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.3,,,,,40.5 - 75,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.0,,,,,15.4 - 48.5,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.6,,,,,2.6 - 10.1,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,10.4,R,H,,,0 - 6.8,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.8,,,,,0 - 2,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,235,,,,,140 - 400,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,LIPID PANEL,Direct HDL-C 4th Generation,,1.91,,H,,,1.03 - 1.53,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,LIPID PANEL,Triglycerides (GPO),,0.67,,,,,0.5 - 2.81,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,LIPID PANEL,Cholesterol (High Performance),,4.26,,,,,3.31 - 6.1,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,LIPID PANEL,LDL Chol Friedewald 4th,,2.04,,,,,0 - 3.34,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,09:40,R,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:45,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,09:40,R,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,07:30,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,12-Mar-2026,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,07:52,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,14-Mar-2026,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.7,,,,,0 - 6.2,umol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Alkaline Phosphatase,,95,,,,,40 - 129,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,5 - 48,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,GGT,,16,,,,,10 - 61,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,LDH,,149,,,,,53 - 234,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Urea Nitrogen,,7.1,,,,,1.4 - 8.6,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Glucose,,6.6,,H,,,3.9 - 5.6,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Uric Acid,,358,,,,,125 - 488,umol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,39 - 308,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Potassium,,3.8,,,,,3.5 - 5.2,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Magnesium,,0.75,,,,,0.66 - 1.07,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,103,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 96,fL +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.82,,,,,3.8 - 10.7,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.88,,,,,1.96 - 7.23,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.03,,,,,0.91 - 4.28,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.26,,,,,0.12 - 0.92,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.57,,,,,0 - 0.57,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,49.4,,,,,40.5 - 75,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.9,,,,,15.4 - 48.5,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.4,,,,,2.6 - 10.1,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,9.9,,H,,,0 - 6.8,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,222,,,,,140 - 400,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,SUBJECT HEIGHT (CM),Height (cm),Y,163,,,,,cm, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122808 sponsor-study-36940-test-results-930539-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122808 sponsor-study-36940-test-results-930539-microbiology.csv new file mode 100644 index 0000000..035d1ae --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122808 sponsor-study-36940-test-results-930539-microbiology.csv @@ -0,0 +1,5 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100162001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 24, 2026 8:45 AM",6227635182,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100162001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"May 6, 2026 9:30 AM",6228610564,STOOL CULTURE,,,,Test group cancelled: No specimen received,,,,,,,,,,, +CZ100162002 - null,,,,Male,SCRNSTOOL Stool Pathogens,"May 27, 2026 1:15 PM",6227635180,STOOL CULTURE,,,,,,,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122808 sponsor-study-36940-test-results-930539-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122808 sponsor-study-36940-test-results-930539-standard.csv new file mode 100644 index 0000000..32bb9c9 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122808 sponsor-study-36940-test-results-930539-standard.csv @@ -0,0 +1,178 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.8,,,,,0 - 6.2,umol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Alkaline Phosphatase,,50,,,,,40 - 129,U/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,5 - 48,U/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,AST (SGOT),,10,,,,,8 - 40,U/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,GGT,,15,,,,,10 - 61,U/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,LDH,,167,,,,,53 - 234,U/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Urea Nitrogen,,4.9,,,,,1.4 - 8.6,mmol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 110,umol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Glucose,,5.7,R,H,,,3.9 - 5.6,mmol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Uric Acid,,239,,,,,125 - 488,umol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Calcium (EDTA),,2.22,,,,,2.07 - 2.64,mmol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Phosphorus,,0.91,,,,,0.71 - 1.65,mmol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Total Protein,,60,R,L,,,61 - 84,g/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Albumin-BCG,,35,,,,,33 - 49,g/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Creatine Kinase,,<18,R,L,,Result verified by repeat analysis,39 - 308,U/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Potassium,,3.8,,,,,3.5 - 5.2,mmol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Bicarbonate,,26.1,,,,,19.3 - 29.3,mmol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Magnesium,,0.88,,,,,0.66 - 1.07,mmol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,FECAL COLLECTION D/T,Stool Collection Date,Y,28-May-2026,,,,,, +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,FECAL COLLECTION D/T,Stool Collection Time,Y,06:00,,,,,, +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,118,R,L,,,127 - 181,g/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,R,L,,,0.39 - 0.54, +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,R,L,,,4.5 - 6.4,TI/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 96,fL +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,12.78,R,H,,,3.8 - 10.7,GI/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,9.55,R,H,,,1.96 - 7.23,GI/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.58,,,,,0.91 - 4.28,GI/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.46,,,,,0.12 - 0.92,GI/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.8,,,,,40.5 - 75,% +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,20.3,,,,,15.4 - 48.5,% +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,3.6,,,,,2.6 - 10.1,% +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,371,,,,,140 - 400,GI/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,LIPID PANEL,Direct HDL-C 4th Generation,,1.18,,,,,1.03 - 1.53,mmol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,LIPID PANEL,Triglycerides (GPO),,1.61,,,,,0.62 - 3.69,mmol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,LIPID PANEL,Cholesterol (High Performance),,4.55,,,,,4.19 - 7.24,mmol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,LIPID PANEL,LDL Chol Friedewald 4th,,2.63,,,,,0 - 3.34,mmol/L +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,PA1 EEA-2?,Approved to use EEA-2?,,,,,,,, +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,28-May-2026,,,,,, +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:45,,,,,, +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,28-May-2026,,,,,, +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,11:53,,,,,, +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,28-May-2026,,,,,, +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:45,,,,,, +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,28-May-2026,,,,,, +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,06:00,,,,,, +CZ100162001,,,,,Male,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SUBJECT HEIGHT (CM),Height (cm),Y,,,,,,, +CZ100162002,,,,,Male,Stool Pathogens,,"May 27, 2026 1:15 PM",6227635180,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,,,, +CZ100162002,,,,,Male,Stool Pathogens,,"May 27, 2026 1:15 PM",6227635180,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,,,, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Alkaline Phosphatase,,105,,,,,40 - 129,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,5 - 48,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,LDH,,194,,,,,53 - 234,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,69,,,,,40 - 110,umol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Glucose,,5.9,,H,,,3.9 - 5.6,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Uric Acid,,242,,,,,125 - 488,umol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Phosphorus,,0.82,,,,,0.71 - 1.65,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Creatine Kinase,,67,,,,,39 - 308,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Bicarbonate,,23.9,,,,,19.3 - 29.3,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Magnesium,,0.89,,,,,0.66 - 1.07,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,127 - 181,g/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.92,,,,,3.8 - 10.7,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.54,,,,,1.96 - 7.23,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.14,,,,,0.91 - 4.28,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.20,,,,,0.12 - 0.92,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.03,,,,,0 - 0.57,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,80.1,,H,,,40.5 - 75,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,16.5,,,,,15.4 - 48.5,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,2.8,,,,,2.6 - 10.1,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.4,,,,,0 - 6.8,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.2,,,,,0 - 2,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,363,,,,,140 - 400,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,PA1 EEA-2?,Approved to use EEA-2?,,,,,,,, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,,,,,,, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,SUBJECT HEIGHT (CM),Height (cm),Y,,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,19-May-2026,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:40,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,12:00,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,21-May-2026,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100162001,,,,,Male,Stool Pathogens,,"May 6, 2026 9:30 AM",6228610564,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100162001,,,,,Male,Stool Pathogens,,"May 6, 2026 9:30 AM",6228610564,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100162001,,,,,Male,Stool Pathogens,,"Apr 24, 2026 8:45 AM",6227635182,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,,,, +CZ100162001,,,,,Male,Stool Pathogens,,"Apr 24, 2026 8:45 AM",6227635182,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,,,, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,40 - 129,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,5 - 48,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,GGT,,18,,,,,10 - 61,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,LDH,,186,,,,,53 - 234,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Urea Nitrogen,,6.8,,,,,1.4 - 8.6,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,96,,,,,40 - 110,umol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Glucose,,5.9,,H,,,3.9 - 5.6,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Uric Acid,,233,,,,,125 - 488,umol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Phosphorus,,0.76,,,,,0.71 - 1.65,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Creatine Kinase,,36,R,L,,,39 - 308,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Bicarbonate,,26.8,,,,,19.3 - 29.3,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Magnesium,,0.85,,,,,0.66 - 1.07,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,84,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 96,fL +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,13.56,,H,,,3.8 - 10.7,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,11.03,,H,,,1.96 - 7.23,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.38,,,,,0.91 - 4.28,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.65,,,,,0.12 - 0.92,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.36,,,,,0 - 0.57,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.14,,,,,0 - 0.2,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,81.3,,H,,,40.5 - 75,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,10.2,,L,,,15.4 - 48.5,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.8,,,,,2.6 - 10.1,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.7,,,,,0 - 6.8,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,233,,,,,140 - 400,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122812 sponsor-study-36940-test-results-930557-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122812 sponsor-study-36940-test-results-930557-microbiology.csv new file mode 100644 index 0000000..e9d3b93 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122812 sponsor-study-36940-test-results-930557-microbiology.csv @@ -0,0 +1,6 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100012001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Jan 28, 2026 6:00 AM",6227323211,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,R, +CZ100012001 - null,,,,Male,UNSCSTOOL Stool Pathogens,"Apr 22, 2026 7:00 AM",6228137359,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100012002 - null,,,,Female,SCRNSTOOL Stool Pathogens,"Mar 3, 2026 1:00 PM",6227323212,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100012003 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 29, 2026 7:55 AM",6227323213,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122821 sponsor-study-36940-test-results-930557-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122821 sponsor-study-36940-test-results-930557-standard.csv new file mode 100644 index 0000000..dc8ee7c --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122821 sponsor-study-36940-test-results-930557-standard.csv @@ -0,0 +1,738 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.0,,,,,0 - 6.2,umol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Alkaline Phosphatase,,90,,,,,40 - 129,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,ALT (SGPT),,27,,,,,5 - 48,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,AST (SGOT),,35,,,,,8 - 40,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,GGT,,63,R,H,,,10 - 61,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,LDH,,167,,,,,53 - 234,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Urea Nitrogen,,7.1,,,,,1.4 - 8.6,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,95,,,,,40 - 110,umol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Glucose,,5.3,,,,,3.9 - 5.6,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Uric Acid,,342,,,,,125 - 488,umol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Calcium (EDTA),,2.56,,,,,2.07 - 2.64,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Phosphorus,,0.97,,,,,0.71 - 1.65,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Total Protein,,84,,,,,61 - 84,g/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Creatine Kinase,,217,,,,,39 - 308,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Potassium,,5.2,,,,,3.5 - 5.2,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Bicarbonate,,20.1,,,,,19.3 - 29.3,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Magnesium,,0.85,,,,,0.66 - 1.07,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,86,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,127 - 181,g/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.49,,,,,0.39 - 0.54, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.4,,,,,4.5 - 6.4,TI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,,26 - 34,pg +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.70,,,,,3.8 - 10.7,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.42,,,,,1.96 - 7.23,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.25,,,,,0.91 - 4.28,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.75,,,,,0.12 - 0.92,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.19,,,,,0 - 0.57,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.0,,,,,40.5 - 75,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.4,,,,,15.4 - 48.5,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.0,,,,,2.6 - 10.1,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.7,,,,,0 - 6.8,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,483,R,H,,,140 - 400,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,SUBJECT HEIGHT (CM),Height (cm),Y,178,,,,,cm, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.0,,,,,0 - 6.2,umol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Alkaline Phosphatase,,104,,,,,40 - 129,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,GGT,,16,,,,,10 - 61,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,LDH,,165,,,,,53 - 234,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Urea Nitrogen,,6.4,,,,,1.4 - 8.6,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 119,umol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Glucose,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Uric Acid,,324,,,,,149 - 494,umol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Phosphorus,,0.82,,,,,0.71 - 1.65,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Creatine Kinase,,82,,,,,39 - 308,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Bicarbonate,,20.6,,,,,19.3 - 29.3,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Magnesium,,0.84,,,,,0.66 - 1.07,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,87,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,FECAL COLLECTION D/T,Stool Collection Date,Y,26-May-2026,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,159,,,,,127 - 181,g/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.50,,,,,0.39 - 0.54, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.4,,,,,4.5 - 6.4,TI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 96,fL +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.01,,,,,3.8 - 10.7,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,7.04,,,,,1.96 - 7.23,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.38,,,,,0.91 - 4.28,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.44,,,,,0.12 - 0.92,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,78.1,,H,,,40.5 - 75,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,15.3,,L,,,15.4 - 48.5,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.9,,,,,2.6 - 10.1,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.2,,,,,0 - 6.8,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,265,,,,,140 - 400,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,LIPID PANEL,Direct HDL-C 4th Generation,,1.34,,,,,1.03 - 1.53,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,LIPID PANEL,Triglycerides (GPO),,0.65,,,,,0.65 - 3.61,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,LIPID PANEL,Cholesterol (High Performance),,4.32,,L,,,4.4 - 7.53,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,LIPID PANEL,LDL Chol Friedewald 4th,,2.68,,,,,0 - 3.34,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,27-May-2026,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:25,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,27-May-2026,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:30,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,27-May-2026,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:25,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,26-May-2026,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SUBJECT HEIGHT (CM),Height (cm),Y,175,,,,,cm, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Alkaline Phosphatase,,62,,,,,40 - 129,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,ALT (SGPT),,46,,,,,5 - 48,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,GGT,,30,,,,,10 - 61,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,LDH,,238,,H,,,53 - 234,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Urea Nitrogen,,4.4,,,,,1.4 - 8.6,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,84,,,,,40 - 110,umol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Uric Acid,,328,,,,,125 - 488,umol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Phosphorus,,1.26,,,,,0.71 - 1.65,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Creatine Kinase,,96,,,,,39 - 308,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Bicarbonate,,25.1,,,,,19.3 - 29.3,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Magnesium,,0.87,,,,,0.66 - 1.07,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,99,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,FECAL COLLECTION D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,142,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.67,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.93,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.10,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,68.4,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,24.3,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.7,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,343,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,LIPID PANEL,Direct HDL-C 4th Generation,,2.02,,H,,,1.03 - 1.53,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,LIPID PANEL,Triglycerides (GPO),,1.21,,,,,0.62 - 3.69,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,LIPID PANEL,Cholesterol (High Performance),,5.32,,,,,4.19 - 7.24,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,LIPID PANEL,LDL Chol Friedewald 4th,,2.75,,,,,0 - 3.34,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,13-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,13-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:30,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,13-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,ANATOMICAL SITE,Anatomical Site,Y,30,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,13-May-2026,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:00,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,15-May-2026,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Alkaline Phosphatase,,99,,,,,35 - 104,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,AST (SGOT),,29,,,,,8 - 40,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,GGT,,23,,,,,5 - 50,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,LDH,,181,,,,,53 - 234,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Urea Nitrogen,,5.3,,,,,1.4 - 10.4,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,54,,,,,31 - 110,umol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Glucose,,6.0,,H,,,3.9 - 5.6,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Uric Acid,,293,,,,,149 - 446,umol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Calcium (EDTA),,2.53,,,,,2.07 - 2.64,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Phosphorus,,1.19,,,,,0.71 - 1.65,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Total Protein,,79,,,,,60 - 80,g/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 46,g/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Creatine Kinase,,143,,,,,26 - 192,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Sodium,,141,,,,,135 - 145,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Bicarbonate,,22.3,,,,,19.3 - 29.3,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Magnesium,,0.91,,,,,0.66 - 0.98,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,91,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,FECAL COLLECTION D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,115 - 158,g/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,3.9 - 5.5,TI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,80 - 100,fL +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.54,,,,,3.8 - 10.7,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.11,,,,,1.96 - 7.23,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.15,,,,,0.8 - 3,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.23,,,,,0.12 - 0.92,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.02,,,,,0 - 0.57,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,46.5,,,,,40.5 - 75,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,47.4,,,,,15.4 - 48.5,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.1,,,,,2.6 - 10.1,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.5,,,,,0 - 6.8,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,117,R,L,,,130 - 394,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,06-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,06-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:05,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,06-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,06-May-2026,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,07:20,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,08-May-2026,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100012003,,,,,Male,Stool Pathogens,,"Apr 29, 2026 7:55 AM",6227323213,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012003,,,,,Male,Stool Pathogens,,"Apr 29, 2026 7:55 AM",6227323213,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Alkaline Phosphatase,,115,,,,,40 - 129,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,ALT (SGPT),,22,,,,,5 - 48,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,GGT,,15,,,,,10 - 61,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,88,,,,,40 - 119,umol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Glucose,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Uric Acid,,306,,,,,149 - 494,umol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Phosphorus,,0.90,,,,,0.71 - 1.65,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,39 - 308,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Bicarbonate,,21.5,,,,,19.3 - 29.3,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Magnesium,,0.90,,,,,0.66 - 1.07,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,91,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,161,,,,,127 - 181,g/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.49,,,,,0.39 - 0.54, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.5,,,,,4.5 - 6.4,TI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.61,,,,,3.8 - 10.7,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.63,,,,,1.96 - 7.23,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.42,,,,,0.91 - 4.28,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.38,,,,,0.12 - 0.92,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.0,,,,,40.5 - 75,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,18.7,,,,,15.4 - 48.5,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.7,,,,,0 - 6.8,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,242,,,,,140 - 400,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,SUBJECT HEIGHT (CM),Height (cm),Y,175,,,,,cm, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.5,,,,,0 - 6.2,umol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Alkaline Phosphatase,,102,,,,,35 - 104,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,GGT,,23,,,,,5 - 50,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,LDH,,154,,,,,53 - 234,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 10.4,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,53,,,,,31 - 110,umol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Glucose,,6.3,,H,,,3.9 - 5.6,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Uric Acid,,252,,,,,149 - 446,umol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Calcium (EDTA),,2.50,,,,,2.07 - 2.64,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Phosphorus,,1.16,,,,,0.71 - 1.65,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Total Protein,,76,,,,,60 - 80,g/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 46,g/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Creatine Kinase,,83,,,,,26 - 192,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Magnesium,,0.94,,,,,0.66 - 0.98,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,91,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,FECAL COLLECTION D/T,Stool Collection Date,Y,23-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,FECAL COLLECTION D/T,Stool Collection Time,Y,07:40,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,144,,,,Result verified by repeat analysis,115 - 158,g/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,Result verified by repeat analysis,3.9 - 5.5,TI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,Result verified by repeat analysis,26 - 34,pg +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,80 - 100,fL +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.47,,L,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.78,,L,,Result verified by repeat analysis,1.96 - 7.23,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.46,,,,,0.8 - 3,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.16,,,,Result verified by repeat analysis,0.12 - 0.92,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,Result verified by repeat analysis,0 - 0.57,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,Result verified by repeat analysis,0 - 0.2,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.4,,,,Result verified by repeat analysis,40.5 - 75,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,42.2,,,,Result verified by repeat analysis,15.4 - 48.5,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.5,,,,Result verified by repeat analysis,2.6 - 10.1,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,Result verified by repeat analysis,0 - 6.8,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,Result verified by repeat analysis,0 - 2,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,118,,L,,Result verified by repeat analysis,130 - 394,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,23-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:40,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,23-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:40,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,23-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,07:40,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.7,,,,,0 - 6.2,umol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Alkaline Phosphatase,,96,,,,,35 - 104,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,AST (SGOT),,28,,,,,8 - 40,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,GGT,,19,,,,,5 - 50,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Urea Nitrogen,,5.3,,,,,1.4 - 10.4,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 110,umol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Glucose,,6.2,R,H,,,3.9 - 5.6,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Uric Acid,,284,,,,,149 - 446,umol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Calcium (EDTA),,2.50,,,,,2.07 - 2.64,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Total Protein,,78,,,,,60 - 80,g/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 46,g/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Creatine Kinase,,113,,,,,26 - 192,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Bicarbonate,,24.0,,,,,19.3 - 29.3,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Magnesium,,0.97,,,,,0.66 - 0.98,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,90,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,FECAL COLLECTION D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,115 - 158,g/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,3.9 - 5.5,TI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,,26 - 34,pg +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,80 - 100,fL +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.59,R,L,,,3.8 - 10.7,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.64,R,L,,,1.96 - 7.23,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.72,,,,,0.8 - 3,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.19,,,,,0.12 - 0.92,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.03,,,,,0 - 0.57,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,45.6,,,,,40.5 - 75,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,47.9,,,,,15.4 - 48.5,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.2,,,,,2.6 - 10.1,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.7,,,,,0 - 6.8,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,126,R,L,,,130 - 394,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,LIPID PANEL,Direct HDL-C 4th Generation,,2.07,R,H,,,1.03 - 1.53,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,LIPID PANEL,Triglycerides (GPO),,1.04,,,,,0.63 - 2.71,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,LIPID PANEL,Cholesterol (High Performance),,4.56,R,L,,,5.35 - 9.1,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,LIPID PANEL,LDL Chol Friedewald 4th,,2.01,,,,,0 - 3.34,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,08-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:15,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SUBJECT HEIGHT (CM),Height (cm),Y,170,,,,,cm, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,AST>/=3XULN,AST >/= 3 X ULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Alkaline Phosphatase,,66,,,,,40 - 129,U/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,ALT (SGPT),,50,,H,,,5 - 48,U/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,AST (SGOT),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,GGT,,25,,,,,10 - 61,U/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Urea Nitrogen,,6.7,,,,,1.4 - 8.6,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Glucose,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Uric Acid,,302,,,,,125 - 488,umol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Calcium (EDTA),,2.50,,,,,2.07 - 2.64,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Phosphorus,,1.95,R,H,,,0.71 - 1.65,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Creatine Kinase,,66,,,,,39 - 308,U/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Bicarbonate,,24.8,,,,,19.3 - 29.3,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Magnesium,,0.95,,,,,0.66 - 1.07,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,92,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,FECAL COLLECTION D/T,Stool Collection Date,Y,17-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.77,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.03,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.25,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.07,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.3,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,18.6,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,327,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,18-Mar-2026,R,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,18-Mar-2026,R,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,18-Mar-2026,R,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,17-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,ANATOMICAL SITE,Anatomical Site,Y,25 DISTANCE IN CM FROM ANAL VERGE,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,18-Mar-2026,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:30,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,20-Mar-2026,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,ALP<2XULN,ALP<2XULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,ALT>/=3XULN,ALT >/= 3 X ULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,AST>/=3XULN,AST >/= 3 X ULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Total Bilirubin,,18,,,,,3 - 21,umol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,ALT (SGPT),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,AST (SGOT),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,GGT,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,80,,,,,40 - 110,umol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Glucose,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Uric Acid,,276,,,,,125 - 488,umol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Calcium (EDTA),,2.24,,,,,2.07 - 2.64,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Phosphorus,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Creatine Kinase,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Potassium,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Bicarbonate,,20.3,,,,,19.3 - 29.3,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Magnesium,,0.88,,,,,0.66 - 1.07,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,105,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,FECAL COLLECTION D/T,Stool Collection Date,Y,03-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,R,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,155,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.48,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 96,fL +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.57,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.08,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.16,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.26,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,73.3,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,20.7,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.7,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,343,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,04-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:00,R,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,04-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:00,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,04-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:00,R,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,03-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,18:00,R,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Alkaline Phosphatase,,100,,,,,35 - 104,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,GGT,,27,,,,,5 - 50,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,LDH,,120,,,,,53 - 234,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Urea Nitrogen,,4.9,,,,,1.4 - 10.4,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,49,,,,,31 - 110,umol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Glucose,,7.0,,H,,,3.9 - 5.6,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Uric Acid,,233,,,,,149 - 446,umol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Total Protein,,75,,,,,60 - 80,g/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 46,g/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Creatine Kinase,,101,,,,,26 - 192,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Potassium,,3.9,,,,,3.5 - 5.2,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Bicarbonate,,22.1,,,,,19.3 - 29.3,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Magnesium,,0.89,,,,,0.66 - 0.98,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,93,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,115 - 158,g/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,3.9 - 5.5,TI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,85,,,,,80 - 100,fL +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.95,,,,,3.8 - 10.7,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.86,,L,,,1.96 - 7.23,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.81,,,,,0.8 - 3,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.25,,,,,0.12 - 0.92,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.02,,,,,0 - 0.57,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.1,,,,,40.5 - 75,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,45.7,,,,,15.4 - 48.5,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.3,,,,,2.6 - 10.1,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.4,,,,,0 - 6.8,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,150,,,,,130 - 394,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,SUBJECT HEIGHT (CM),Height (cm),Y,170,,,,,cm, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Total Bilirubin,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,ALT (SGPT),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,AST (SGOT),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,GGT,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Urea Nitrogen,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Glucose,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Uric Acid,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Calcium (EDTA),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Phosphorus,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Total Protein,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Albumin-BCG,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Creatine Kinase,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Sodium,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Potassium,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Bicarbonate,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Chloride,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Magnesium,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CKD-EPI 2021,CKD-EPI 2021 Without Race,,Required testing unavailable,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,FECAL COLLECTION D/T,Stool Collection Date,Y,18-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.88,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.46,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.78,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.47,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.4,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,31.2,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.3,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,330,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,LIPID PANEL,Direct HDL-C 4th Generation,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,LIPID PANEL,Triglycerides (GPO),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,LIPID PANEL,Cholesterol (High Performance),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,LIPID PANEL,LDL Chol Friedewald 4th,,Required testing unavailable,,,,,0 - 3.34,mmol/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,19-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:20,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,19-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:50,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,19-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:20,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,18-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,ANATOMICAL SITE,Anatomical Site,Y,30,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,05-Feb-2026,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:30,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,07-Feb-2026,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Alkaline Phosphatase,,61,,,,,40 - 129,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,5 - 48,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,GGT,,24,,,,,10 - 61,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,LDH,,146,,,,,53 - 234,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,79,,,,,40 - 110,umol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Glucose,,5.5,,,,,3.9 - 5.6,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Uric Acid,,338,,,,,125 - 488,umol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Phosphorus,,0.48,,LT,,Result verified by repeat analysis,0.71 - 1.65,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Creatine Kinase,,60,,,,,39 - 308,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Bicarbonate,,25.1,,,,,19.3 - 29.3,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Magnesium,,0.92,,,,,0.66 - 1.07,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CKD-EPI 2021,CKD-EPI 2021 Without Race,,106,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.92,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.40,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.00,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.27,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,69.1,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,20.2,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.1,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.0,,,,,0 - 2,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,309,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEPATITIS B SURFACE AB NON-US,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122829 sponsor-study-36940-test-results-930553-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122829 sponsor-study-36940-test-results-930553-microbiology.csv new file mode 100644 index 0000000..95b16c0 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122829 sponsor-study-36940-test-results-930553-microbiology.csv @@ -0,0 +1,4 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100092001 - null,,,,Female,SCRNSTOOL Stool Pathogens,"Apr 2, 2026 6:15 AM",6227323340,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100092002 - null,,,,Female,SCRNSTOOL Stool Pathogens,"Apr 20, 2026 6:10 AM",6227323341,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122832 sponsor-study-36940-test-results-930536-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122832 sponsor-study-36940-test-results-930536-microbiology.csv new file mode 100644 index 0000000..4dfdeb2 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122832 sponsor-study-36940-test-results-930536-microbiology.csv @@ -0,0 +1,3 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100201001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 13, 2026 6:00 AM",6227993971,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122832 sponsor-study-36940-test-results-930553-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122832 sponsor-study-36940-test-results-930553-standard.csv new file mode 100644 index 0000000..2a84d67 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122832 sponsor-study-36940-test-results-930553-standard.csv @@ -0,0 +1,250 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Total Bilirubin,,17,,,,,3 - 21,umol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.0,,,,,0 - 6.2,umol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,35 - 104,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,GGT,,15,,,,,4 - 49,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,LDH,,154,,,,,53 - 234,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Urea Nitrogen,,3.4,,,,,1.4 - 8.6,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,73,,,,,31 - 101,umol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Uric Acid,,196,,,,,149 - 446,umol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Calcium (EDTA),,2.47,,,,,2.07 - 2.64,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Phosphorus,,1.10,,,,,0.71 - 1.65,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,26 - 192,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Sodium,,136,,,,,132 - 147,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,86,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,FECAL COLLECTION D/T,Stool Collection Date,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,FECAL COLLECTION D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,116 - 164,g/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,32,,,,,26 - 34,pg +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.57,,,,,3.8 - 10.7,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.33,,,,,1.96 - 7.23,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.77,,,,,0.91 - 4.28,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.9,,,,,40.5 - 75,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.9,,,,,15.4 - 48.5,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.4,,,,,2.6 - 10.1,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.8,,,,,0 - 6.8,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,258,,,,,140 - 400,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:50,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,11:55,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:50,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.5,,,,,0 - 6.2,umol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Alkaline Phosphatase,,55,,,,,35 - 104,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,4 - 43,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,GGT,,13,,,,,4 - 49,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,LDH,,152,,,,,53 - 234,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,62,,,,,31 - 101,umol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Glucose,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Uric Acid,,178,,,,,149 - 446,umol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Creatine Kinase,,87,,,,,26 - 192,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Bicarbonate,,21.5,,,,,19.3 - 29.3,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Magnesium,,0.94,,,,,0.66 - 1.07,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,105,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,FECAL COLLECTION D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,FECAL COLLECTION D/T,Stool Collection Time,Y,06:30,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,116 - 164,g/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 98,fL +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.60,,,,,3.8 - 10.7,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.94,,,,,1.96 - 7.23,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.22,,,,,0.91 - 4.28,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.32,,,,,0.12 - 0.92,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.9,,,,,40.5 - 75,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.5,,,,,15.4 - 48.5,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,207,,,,,140 - 400,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,LIPID PANEL,Direct HDL-C 4th Generation,,1.70,,H,,,1.03 - 1.53,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,LIPID PANEL,Triglycerides (GPO),,0.59,,,,,0.59 - 2.96,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,LIPID PANEL,Cholesterol (High Performance),,4.49,,,,,4.42 - 7.53,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,LIPID PANEL,LDL Chol Friedewald 4th,,2.52,,,,,0 - 3.34,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,PA1 EEA-2?,Approved to use EEA-2?,,No,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,11:30,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,12:45,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,11:30,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,06:30,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100092002,,,,,Female,TB Testing,,"May 5, 2026 9:00 AM",6227323348,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,24-Apr-2026,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,11:09,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,12:00,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,29-Apr-2026,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Alkaline Phosphatase,,56,,,,,35 - 104,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,4 - 43,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,GGT,,10,,,,,4 - 49,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,LDH,,159,,,,,53 - 234,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Urea Nitrogen,,6.1,,,,,1.4 - 8.6,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,90,,,,,31 - 101,umol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Uric Acid,,268,,,,,149 - 446,umol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Phosphorus,,1.14,,,,,0.71 - 1.65,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Creatine Kinase,,176,,,,,26 - 192,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Bicarbonate,,27.2,,,,,19.3 - 29.3,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Magnesium,,0.93,,,,,0.66 - 1.07,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,65,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,138,,,,,116 - 164,g/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,32,,,,,26 - 34,pg +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.05,,,,,3.8 - 10.7,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.87,,L,,,1.96 - 7.23,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.72,,,,,0.91 - 4.28,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,46.1,,,,,40.5 - 75,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,42.6,,,,,15.4 - 48.5,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,,2.6 - 10.1,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.4,,,,,0 - 6.8,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,216,,,,,140 - 400,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Positive,,RX,,Result verified by repeat analysis,Normal=Negative, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,SERUM BETA HCG,"B-hCG, Quantitative",,0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Alkaline Phosphatase,,56,,,,,35 - 104,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,4 - 43,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,GGT,,12,,,,,4 - 49,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,LDH,,137,,,,,53 - 234,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Urea Nitrogen,,2.7,,,,,1.4 - 8.6,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Glucose,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Uric Acid,,207,,,,,125 - 428,umol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Phosphorus,,1.15,,,,,0.71 - 1.65,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Creatine Kinase,,81,,,,,26 - 192,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Bicarbonate,,23.7,,,,,19.3 - 29.3,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Magnesium,,0.91,,,,,0.66 - 1.07,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,107,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,147,,,,,116 - 164,g/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.74,,,,,3.8 - 10.7,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.76,,,,,1.96 - 7.23,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.18,,,,,0.91 - 4.28,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.46,,,,,0.12 - 0.92,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.26,,,,,0 - 0.57,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.5,,,,,40.5 - 75,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,20.6,,,,,15.4 - 48.5,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.9,,,,,2.6 - 10.1,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.5,,,,,0 - 6.8,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.5,,,,,0 - 2,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,263,,,,,140 - 400,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,PA1 EEA-2?,Approved to use EEA-2?,,No,,,,,, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122844 sponsor-study-36940-test-results-930536-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122844 sponsor-study-36940-test-results-930536-standard.csv new file mode 100644 index 0000000..0f4a823 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122844 sponsor-study-36940-test-results-930536-standard.csv @@ -0,0 +1,127 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,2003 SCHWARTZ EGFR,2003 Schwartz eGFR,,191,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.0,,,,,0 - 6.2,umol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Alkaline Phosphatase,,282,,,,,82 - 331,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,6 - 43,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,AST (SGOT),,26,,,,,10 - 40,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,GGT,,15,,,,,0 - 51,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,LDH,,214,,,,,105 - 235,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,51,,,,,23 - 83,umol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Glucose,,4.3,,,,,3.9 - 5.6,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Uric Acid,,336,,,,,184 - 416,umol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Calcium (EDTA),,2.47,,,,,2.1 - 2.57,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Phosphorus,,1.58,,,,,0.71 - 1.65,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Total Protein,,85,,H,,,61 - 84,g/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,29 - 47,g/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Creatine Kinase,,65,,,,,18 - 363,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Sodium,,136,,,,,132 - 147,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.7 - 0.9,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CRP COPY,C Reactive Protein COPY,,1.9,,,,,0.4 - 2,mg/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,FECAL CALPROTECTIN COPY,Fecal Calprotectin COPY,,3749.9,,H,,,Normal: <80ug/g$Borderline: 80-160$ug/g. Elevated:>160$ug/g, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,FECAL COLLECTION D/T,Stool Collection Date,Y,17-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,114,,L,,,127 - 181,g/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,L,,,0.39 - 0.54, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,L,,,4.5 - 6.4,TI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,27,,,,,26 - 34,pg +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.73,,,,,4.35 - 13.15,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.06,,,,,1.65 - 8.15,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.42,,,,,0.95 - 5.25,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.83,,,,,0.4 - 1.3,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.34,,H,,,0 - 0.3,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,52.0,,,,,40.5 - 75,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.1,,,,,15.4 - 48.5,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.5,,H,,,4 - 8,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.5,,H,,,0 - 2.8,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 1,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,607,,H,,,140 - 400,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,LIPID PANEL,Direct HDL-C 4th Generation,,1.27,,,,,1.03 - 1.53,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,LIPID PANEL,Triglycerides (GPO),,1.17,,,,,0.42 - 1.67,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,LIPID PANEL,Cholesterol (High Performance),,3.50,,,,,2.95 - 5.12,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,LIPID PANEL,LDL Chol Friedewald 4th,,1.69,,,,,0 - 3.34,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,18-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,09:28,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,18-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:52,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,18-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,09:28,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,17-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SUBJECT HEIGHT (CM),Height (cm),Y,157,,,,,cm, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,ANATOMICAL SITE,Anatomical Site,Y,20-25,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,15-Apr-2026,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,13:00,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,17-Apr-2026,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,2003 SCHWARTZ EGFR,2003 Schwartz eGFR,,211,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.2,,,,,0 - 6.2,umol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Alkaline Phosphatase,,322,,,,,82 - 331,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,6 - 43,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,AST (SGOT),,29,,,,,10 - 40,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,GGT,,17,,,,,0 - 51,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,LDH,,221,,,,,105 - 235,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,46,,,,,23 - 83,umol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Glucose,,4.1,,,,,3.9 - 5.6,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Uric Acid,,326,,,,,184 - 416,umol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Calcium (EDTA),,2.57,,,,,2.1 - 2.57,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Phosphorus,,1.72,,H,,,0.71 - 1.65,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Total Protein,,87,,H,,,61 - 84,g/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,29 - 47,g/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Creatine Kinase,,94,,,,,18 - 363,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Sodium,,136,,,,,132 - 147,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Bicarbonate,,20.7,,,,,19.3 - 29.3,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Magnesium,,0.77,,,,,0.7 - 0.9,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,118,,L,,Result verified by repeat analysis,127 - 181,g/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,L,,,0.39 - 0.54, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,L,,Result verified by repeat analysis,4.5 - 6.4,TI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,Result verified by repeat analysis,26 - 34,pg +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.04,,,,Result verified by repeat analysis,4.35 - 13.15,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.19,,,,Result verified by repeat analysis,1.65 - 8.15,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.73,,,,,0.95 - 5.25,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.77,,,,Result verified by repeat analysis,0.4 - 1.3,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.29,,,,Result verified by repeat analysis,0 - 0.3,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,Result verified by repeat analysis,0 - 0.2,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.7,,,,Result verified by repeat analysis,40.5 - 75,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,37.2,,,,Result verified by repeat analysis,15.4 - 48.5,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.6,,,,Result verified by repeat analysis,4 - 8,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,H,,Result verified by repeat analysis,0 - 2.8,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,Result verified by repeat analysis,0 - 1,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,490,,H,,Result verified by repeat analysis,140 - 400,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,SUBJECT HEIGHT (CM),Height (cm),Y,157,,,,,cm, +CZ100201001,,,,,Male,Stool Pathogens,,"Apr 13, 2026 6:00 AM",6227993971,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100201001,,,,,Male,Stool Pathogens,,"Apr 13, 2026 6:00 AM",6227993971,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122855 sponsor-study-36940-test-results-930531-microbiology.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122855 sponsor-study-36940-test-results-930531-microbiology.csv new file mode 100644 index 0000000..9f10aa5 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122855 sponsor-study-36940-test-results-930531-microbiology.csv @@ -0,0 +1,3 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100212001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Mar 1, 2026 2:00 PM",6227635213,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122906 sponsor-study-36940-test-results-930531-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122906 sponsor-study-36940-test-results-930531-standard.csv new file mode 100644 index 0000000..4d4b87b --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122906 sponsor-study-36940-test-results-930531-standard.csv @@ -0,0 +1,243 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Total Bilirubin,,4,,,,Result verified by repeat analysis,3 - 21,umol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Alkaline Phosphatase,,113,,,,,40 - 129,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,ALT (SGPT),,12,,,,,5 - 48,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,GGT,,23,,,,,10 - 50,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,LDH,,195,,,,,53 - 234,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Urea Nitrogen,,2.7,,,,,1.4 - 8.6,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,73,,,,,40 - 119,umol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Glucose,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Uric Acid,,409,,,,,149 - 494,umol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Phosphorus,,1.01,,,,,0.71 - 1.65,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Total Protein,,73,,,,,60 - 80,g/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Creatine Kinase,,159,,,,,39 - 308,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Potassium,,5.1,,,,,3.5 - 5.2,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Magnesium,,0.90,,,,,0.66 - 0.98,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,100,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,FECAL COLLECTION D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,FECAL COLLECTION D/T,Stool Collection Time,Y,06:50,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,98,,L,,,125 - 170,g/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.34,,L,,,0.37 - 0.51, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4 - 5.8,TI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,22,,L,,Result verified by repeat analysis,26 - 34,pg +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Microcytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,76,,L,,,80 - 100,fL +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.13,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.41,,,,,1.96 - 7.23,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.42,,,,,0.8 - 3,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.93,,H,,,0.12 - 0.92,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.29,,,,,0 - 0.57,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,70.2,,,,,40.5 - 75,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,15.6,,,,,15.4 - 48.5,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.1,,,,,2.6 - 10.1,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.1,,,,,0 - 6.8,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,812,,HT,,,130 - 394,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:00,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,13:00,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:00,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:50,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Unable to calc due to LOQ,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Unable to calc due to LOQ,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,Result verified by repeat analysis,0 - 6.2,umol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Alkaline Phosphatase,,112,,,,,40 - 129,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,5 - 48,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,GGT,,27,,,,,10 - 50,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,LDH,,150,,,,,53 - 234,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Urea Nitrogen,,2.4,,,,,1.4 - 8.6,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,74,,,,,40 - 119,umol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Glucose,,6.1,,H,,,3.9 - 5.6,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Uric Acid,,378,,,,,149 - 494,umol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Phosphorus,,1.02,,,,,0.71 - 1.65,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Total Protein,,70,,,,,60 - 80,g/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Albumin-BCG,,40,,,,,33 - 49,g/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Creatine Kinase,,77,,,,,39 - 308,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Potassium,,5.2,,,,,3.5 - 5.2,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Bicarbonate,,22.9,,,,,19.3 - 29.3,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Magnesium,,0.87,,,,,0.66 - 0.98,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,99,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,FECAL COLLECTION D/T,Stool Collection Date,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,FECAL COLLECTION D/T,Stool Collection Time,Y,06:00,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,106,,L,,,125 - 170,g/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,L,,,0.37 - 0.51, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4 - 5.8,TI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,23,,L,,,26 - 34,pg +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,77,,L,,,80 - 100,fL +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.30,,,,,3.8 - 10.7,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.31,,,,,1.96 - 7.23,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.61,,,,,0.8 - 3,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.94,,H,,,0.12 - 0.92,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.35,,,,,0 - 0.57,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,67.8,,,,,40.5 - 75,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,17.3,,,,,15.4 - 48.5,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.2,,H,,,2.6 - 10.1,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.8,,,,,0 - 6.8,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,796,,HT,,,130 - 394,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:45,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:24,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:45,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:00,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Alkaline Phosphatase,,121,,,,,40 - 129,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,ALT (SGPT),,13,,,,,5 - 48,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,GGT,,39,,,,,10 - 50,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,LDH,,158,,,,,53 - 234,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Urea Nitrogen,,3.0,,,,,1.4 - 8.6,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,80,,,,,40 - 119,umol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Uric Acid,,446,,,,,149 - 494,umol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Total Protein,,74,,,,,60 - 80,g/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Creatine Kinase,,64,,,,,39 - 308,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Sodium,,141,,,,,135 - 145,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Potassium,,5.2,,,,,3.5 - 5.2,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Bicarbonate,,21.0,,,,,19.3 - 29.3,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Magnesium,,0.88,,,,,0.66 - 0.98,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,97,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,FECAL COLLECTION D/T,Stool Collection Date,Y,06-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,FECAL COLLECTION D/T,Stool Collection Time,Y,16:00,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,113,,L,,,125 - 170,g/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.37 - 0.51, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4 - 5.8,TI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,23,,L,,,26 - 34,pg +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Anisocytosis,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,79,,L,,,80 - 100,fL +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,12.49,,H,,,3.8 - 10.7,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,8.91,,H,,,1.96 - 7.23,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.02,,,,,0.8 - 3,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,1.14,,H,,,0.12 - 0.92,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.33,,,,,0 - 0.57,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.3,,,,,40.5 - 75,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,16.2,,,,,15.4 - 48.5,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.1,,,,,2.6 - 10.1,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.6,,,,,0 - 6.8,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,584,,H,,,130 - 394,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,LIPID PANEL,Direct HDL-C 4th Generation,,1.01,R,L,,,1.03 - 1.53,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,LIPID PANEL,Triglycerides (GPO),,1.57,,,,,0.65 - 2.94,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,LIPID PANEL,Cholesterol (High Performance),,5.40,,,,,4.53 - 7.71,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,LIPID PANEL,LDL Chol Friedewald 4th,,3.67,,H,,,0 - 3.34,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:37,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,07-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,11:55,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:37,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,06-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,16:00,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,ANATOMICAL SITE,Anatomical Site,Y,20,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,16-Mar-2026,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,13:00,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,19-Mar-2026,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,Result verified by repeat analysis,0 - 6.2,umol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Alkaline Phosphatase,,120,,,,,40 - 129,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,GGT,,39,,,,,10 - 50,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,LDH,,174,,,,,53 - 234,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Urea Nitrogen,,3.0,,,,,1.4 - 8.6,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,40 - 119,umol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Glucose,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Uric Acid,,357,,,,,149 - 494,umol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Total Protein,,70,,,,,60 - 80,g/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Creatine Kinase,,149,,,,,39 - 308,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Sodium,,141,,,,,135 - 145,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Bicarbonate,,18.4,,L,,,19.3 - 29.3,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Magnesium,,0.79,,,,,0.66 - 0.98,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,99,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,120,,L,,,125 - 170,g/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.37 - 0.51, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4 - 5.8,TI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,24,,L,,,26 - 34,pg +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,79,,L,,,80 - 100,fL +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.50,,,,,3.8 - 10.7,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.09,,,,,1.96 - 7.23,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.97,,,,,0.8 - 3,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,1.07,,H,,,0.12 - 0.92,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.27,,,,,0 - 0.57,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.9,,,,,40.5 - 75,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,23.3,,,,,15.4 - 48.5,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,12.6,,H,,,2.6 - 10.1,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.1,,,,,0 - 6.8,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,567,,H,,,130 - 394,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,SUBJECT HEIGHT (CM),Height (cm),Y,178,,,,,cm, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122909 sponsor-study-35472-test-results-898745-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122909 sponsor-study-35472-test-results-898745-standard.csv new file mode 100644 index 0000000..d9b79db --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122909 sponsor-study-35472-test-results-898745-standard.csv @@ -0,0 +1,2448 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 12,/HPF +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Alkaline Phosphatase,,87,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,GGT,,30,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,LDH,,154,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,49,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Uric Acid,,314,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Calcium (EDTA),,2.51,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Phosphorus,,1.25,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Creatine Kinase,,202,,H,,,26 - 192,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Bicarbonate,,21.2,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,144,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.81,,,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.47,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.67,,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.43,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,50.7,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,41.7,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.8,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,504,,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.6,,H,,,<6.5 %, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,23.94,,H,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,LIPID PANEL,Direct HDL-C 4th Generation,,1.34,,,,,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,LIPID PANEL,Triglycerides (GPO),,2.54,,H,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,LIPID PANEL,Cholesterol (High Performance),,6.04,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,LIPID PANEL,LDL Chol Friedewald 4th,,3.54,,H,,,0 - 3.34,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,TSH,TSH 3rd IS-QT,,3.138,,,,,0.45 - 5.33,mIU/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Specific Gravity,,1.020,,,,,1 - 1.04, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,C-REACTIVE PROTEIN,C Reactive Protein HS,,10.2,,H,,,0 - 5,mg/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Alkaline Phosphatase,,90,,,,,35 - 104,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,GGT,,22,,,,,5 - 50,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,LDH,,185,,,,,53 - 234,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 10.4,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,64,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Glucose Fasting,,6.3,R,H,,,3.9 - 5.6,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Uric Acid,,316,,,,,149 - 446,umol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Phosphorus,,1.07,,,,,0.71 - 1.65,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Total Protein,,80,,,,,60 - 80,g/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Albumin-BCG,,47,R,H,,,33 - 46,g/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Creatine Kinase,,88,,,,,26 - 192,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Sodium,,136,,,,,135 - 145,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Bicarbonate,,18.7,R,L,,,19.3 - 29.3,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,163,R,H,,,115 - 158,g/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.50,R,H,,,0.34 - 0.48, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,3.9 - 5.5,TI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,80 - 100,fL +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,11.22,R,H,,,3.8 - 10.7,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.82,,,,,1.96 - 7.23,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.47,R,H,,,0.8 - 3,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.75,,,,,0.12 - 0.92,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.8,,,,,40.5 - 75,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.9,,,,,15.4 - 48.5,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,285,,,,,130 - 394,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.9,,,,,<6.5 %, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,15.61,,,,,1.9 - 23,uIU/mL +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,LIPID PANEL,Direct HDL-C 4th Generation,,1.36,,,,,1.03 - 1.53,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,LIPID PANEL,Triglycerides (GPO),,2.89,R,H,,,0.63 - 2.71,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,LIPID PANEL,Cholesterol (High Performance),,7.08,,,,,5.35 - 9.1,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,LIPID PANEL,LDL Chol Friedewald 4th,,4.40,,H,,,0 - 3.34,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,TSH,TSH 3rd IS-QT,,0.546,,,,,0.45 - 5.33,mIU/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Specific Gravity,,1.016,,,,,1.01 - 1.03, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Blood,,Trace,,,,,Ref Rng:$Negative-Trace, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.3,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CELLULAR ELEMENTS,Ur WBC/HPF,,8,,,,,0 - 12,/HPF +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.2,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Alkaline Phosphatase,,83,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,ALT (SGPT),,22,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,GGT,,32,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,LDH,,169,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,51,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Uric Acid,,383,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Calcium (EDTA),,2.52,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Creatine Kinase,,201,,H,,,26 - 192,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Bicarbonate,,21.6,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,95,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.33,,,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.06,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.53,,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.53,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.6,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.1,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.1,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,525,R,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,16.12,,,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,LIPID PANEL,Direct HDL-C 4th Generation,,1.37,,,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,LIPID PANEL,Triglycerides (GPO),,2.79,,H,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,LIPID PANEL,Cholesterol (High Performance),,6.50,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,LIPID PANEL,LDL Chol Friedewald 4th,,3.85,,H,,,0 - 3.34,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,RETICULOCYTES,Reticulocyte Count %,,1.5,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Specific Gravity,,1.029,,,,,1 - 1.04, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Alkaline Phosphatase,,66,,,,,35 - 104,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,GGT,,36,,,,,4 - 49,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,LDH,,192,,,,,53 - 234,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Glucose Fasting,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Uric Acid,,277,,,,,149 - 446,umol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Calcium (EDTA),,2.08,,,,,2.07 - 2.64,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Phosphorus,,0.90,,,,,0.71 - 1.65,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Total Protein,,62,,,,,61 - 84,g/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Creatine Kinase,,84,,,,,26 - 192,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Sodium,,144,,,,,132 - 147,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Potassium,,3.5,,,,,3.5 - 5.2,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Bicarbonate,,22.5,,,,,19.3 - 29.3,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Chloride,,109,,,,,94 - 112,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,132,,,,,116 - 164,g/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.40,,,,,3.8 - 10.7,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.63,,,,,1.96 - 7.23,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.90,,,,,0.91 - 4.28,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.78,,,,,0.12 - 0.92,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,48.8,,,,,40.5 - 75,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.1,,,,,15.4 - 48.5,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,14.4,R,H,,,2.6 - 10.1,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,248,,,,,140 - 400,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.25,,,,,1.9 - 23,uIU/mL +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,LIPID PANEL,Direct HDL-C 4th Generation,,1.92,,H,,,1.03 - 1.53,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,LIPID PANEL,Triglycerides (GPO),,1.20,,,,,0.59 - 2.96,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,LIPID PANEL,Cholesterol (High Performance),,3.66,,L,,,4.42 - 7.53,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,LIPID PANEL,LDL Chol Friedewald 4th,,1.19,,,,,0 - 3.34,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,TSH,TSH 3rd IS-QT,,3.352,,,,,0.45 - 5.33,mIU/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Alkaline Phosphatase,,137,,H,,,35 - 104,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,4 - 43,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,GGT,,14,,,,,5 - 50,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,LDH,,170,,,,,53 - 234,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Urea Nitrogen,,5.3,,,,,1.4 - 8.6,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,61,,,,,31 - 101,umol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Glucose Fasting,,5.6,,,,,3.9 - 5.6,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Uric Acid,,204,,,,,149 - 446,umol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Phosphorus,,0.96,,,,,0.71 - 1.65,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Total Protein,,73,,,,,60 - 80,g/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Creatine Kinase,,78,,,,,26 - 192,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Sodium,,145,,,,,135 - 145,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Bicarbonate,,21.6,,,,,19.3 - 29.3,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Chloride,,109,,,,,94 - 112,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,150,,,,,115 - 158,g/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.34 - 0.48, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,3.9 - 5.5,TI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,80 - 100,fL +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.17,,,,,3.8 - 10.7,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.80,,,,,1.96 - 7.23,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.79,,,,,0.8 - 3,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.41,,,,,0.12 - 0.92,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.0,,,,,40.5 - 75,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.9,,,,,15.4 - 48.5,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.3,,,,,0 - 2,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,239,,,,,130 - 394,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.88,,,,,1.9 - 23,uIU/mL +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,LIPID PANEL,Direct HDL-C 4th Generation,,1.85,,H,,,1.03 - 1.53,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,LIPID PANEL,Triglycerides (GPO),,0.61,,L,,,0.63 - 2.71,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,LIPID PANEL,Cholesterol (High Performance),,5.06,,,,,4.86 - 8.28,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,LIPID PANEL,LDL Chol Friedewald 4th,,2.93,,,,,0 - 3.34,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,TSH,TSH 3rd IS-QT,,0.955,,,,,0.45 - 5.33,mIU/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1.01 - 1.03, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.2,,,,,0 - 5,mg/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.0,,,,,0 - 6.2,umol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Alkaline Phosphatase,,62,,,,,35 - 104,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,4 - 43,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,GGT,,16,,,,,5 - 50,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,64,,,,,31 - 101,umol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Glucose Fasting,,5.8,,H,,,3.9 - 5.6,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Uric Acid,,216,,,,,149 - 446,umol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Total Protein,,63,,,,,60 - 80,g/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Creatine Kinase,,151,,,,,26 - 192,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Sodium,,142,,,,,135 - 145,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Bicarbonate,,21.4,,,,,19.3 - 29.3,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Chloride,,108,,,,,94 - 112,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,152,,,,,115 - 158,g/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.34 - 0.48, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,3.9 - 5.5,TI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,100,,,,,80 - 100,fL +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.94,,,,,3.8 - 10.7,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.03,,,,,1.96 - 7.23,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.45,,,,,0.8 - 3,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.32,,,,,0.12 - 0.92,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,75.9,R,H,,,40.5 - 75,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,18.3,,,,,15.4 - 48.5,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.0,,,,,2.6 - 10.1,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,244,,,,,130 - 394,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.00,,,,,1.9 - 23,uIU/mL +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,LIPID PANEL,Direct HDL-C 4th Generation,,1.24,,,,,1.03 - 1.53,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,LIPID PANEL,Triglycerides (GPO),,0.74,,,,,0.63 - 2.71,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,LIPID PANEL,Cholesterol (High Performance),,4.25,,L,,,4.86 - 8.28,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,LIPID PANEL,LDL Chol Friedewald 4th,,2.67,,,,,0 - 3.34,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,TSH,TSH 3rd IS-QT,,1.798,,,,,0.45 - 5.33,mIU/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Specific Gravity,,1.016,,,,,1.01 - 1.03, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Alkaline Phosphatase,,81,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,GGT,,19,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,LDH,,193,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Urea Nitrogen,,4.7,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Uric Acid,,206,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Phosphorus,,1.36,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Creatine Kinase,,82,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Sodium,,145,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Bicarbonate,,25.9,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,139,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.84,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.66,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.78,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.27,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.0,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.8,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.7,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.7,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,274,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.31,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,LIPID PANEL,Direct HDL-C 4th Generation,,1.64,,H,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,LIPID PANEL,Triglycerides (GPO),,0.68,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,LIPID PANEL,Cholesterol (High Performance),,5.02,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,LIPID PANEL,LDL Chol Friedewald 4th,,3.07,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,TSH,TSH 3rd IS-QT,,1.896,,,,,0.45 - 5.33,mIU/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Specific Gravity,,1.022,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.6,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Alkaline Phosphatase,,88,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,GGT,,32,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,LDH,,156,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,39,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Uric Acid,,335,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Calcium (EDTA),,2.12,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Phosphorus,,1.07,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Albumin-BCG,,39,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Creatine Kinase,,135,,,,,26 - 192,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Bicarbonate,,20.2,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Chloride,,109,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,DIRECT LDL,Direct LDL-C 3rd Gen,,3.40,,H,,,<3.36 mmol/L, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,11.75,,H,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.71,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,4.08,,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.60,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.24,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.11,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.1,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.7,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.1,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,550,,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.7,R,H,,,<6.5 %, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,73.67,R,H,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,LIPID PANEL,Direct HDL-C 4th Generation,,1.00,,L,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,LIPID PANEL,Triglycerides (GPO),,5.91,,H SF,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,LIPID PANEL,Cholesterol (High Performance),,5.54,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,LIPID PANEL,LDL Chol Friedewald 4th,,,,,Test cancelled: Invalid/High Triglycerides,,, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,RETICULOCYTES,Reticulocyte Count %,,1.7,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,TSH,TSH 3rd IS-QT,,2.578,,,,,0.45 - 5.33,mIU/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1 - 1.04, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Alkaline Phosphatase,,69,,,,,35 - 104,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,4 - 43,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,AST (SGOT),,36,,,,,8 - 40,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,GGT,,43,,,,,4 - 49,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,LDH,,193,,,,,53 - 234,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Uric Acid,,321,,,,,149 - 446,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Calcium (EDTA),,2.13,,,,,2.07 - 2.64,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Phosphorus,,0.91,,,,,0.71 - 1.65,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Creatine Kinase,,93,,,,,26 - 192,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Potassium,,3.7,,,,,3.5 - 5.2,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Bicarbonate,,25.6,,,,,19.3 - 29.3,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Chloride,,107,,,,,94 - 112,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.65,,,,,1.25 - 1.92,mL/sec +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,75.1,,,,,kg, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,GFR,EGFR by MDRD,,81,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,116 - 164,g/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.08,,,,,3.8 - 10.7,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.60,,,,,1.96 - 7.23,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.79,,,,,0.91 - 4.28,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.52,,,,,0.12 - 0.92,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.1,,,,,40.5 - 75,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.3,,,,,15.4 - 48.5,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.2,R,H,,,2.6 - 10.1,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.4,,,,,0 - 6.8,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,267,,,,,140 - 400,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.13,,,,,1.9 - 23,uIU/mL +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,LIPID PANEL,Direct HDL-C 4th Generation,,2.21,,H,,,1.03 - 1.53,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,LIPID PANEL,Triglycerides (GPO),,0.81,,,,,0.59 - 2.96,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,LIPID PANEL,Cholesterol (High Performance),,3.95,,L,,,4.42 - 7.53,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,LIPID PANEL,LDL Chol Friedewald 4th,,1.37,,,,,0 - 3.34,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,TSH,TSH 3rd IS-QT,,3.004,,,,,0.45 - 5.33,mIU/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Specific Gravity,,1.020,,,,,1 - 1.04, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.0,,,,,0 - 5,mg/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,35 - 104,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,GGT,,17,,,,,5 - 50,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,LDH,,163,,,,,53 - 234,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 10.4,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Uric Acid,,265,,,,,149 - 446,umol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Phosphorus,,1.45,,,,,0.71 - 1.65,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Total Protein,,78,,,,,60 - 80,g/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Albumin-BCG,,47,R,H,,,33 - 46,g/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Creatine Kinase,,80,,,,,26 - 192,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Bicarbonate,,21.7,,,,,19.3 - 29.3,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,159,R,H,,,115 - 158,g/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.34 - 0.48, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,3.9 - 5.5,TI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,80 - 100,fL +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.76,,,,,3.8 - 10.7,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.09,,,,,1.96 - 7.23,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.77,R,H,,,0.8 - 3,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.73,,,,,0.12 - 0.92,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,52.1,,,,,40.5 - 75,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.6,,,,,15.4 - 48.5,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.5,,,,,2.6 - 10.1,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.2,,,,,0 - 6.8,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,307,,,,,130 - 394,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.8,,,,,<6.5 %, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,LIPID PANEL,Direct HDL-C 4th Generation,,1.36,,,,,1.03 - 1.53,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,LIPID PANEL,Triglycerides (GPO),,3.03,,H,,,0.63 - 2.71,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,LIPID PANEL,Cholesterol (High Performance),,7.15,,,,,5.35 - 9.1,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,LIPID PANEL,LDL Chol Friedewald 4th,,4.40,,H,,,0 - 3.34,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,TSH,TSH 3rd IS-QT,,1.854,,,,,0.45 - 5.33,mIU/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Specific Gravity,,1.012,,,,,1.01 - 1.03, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Alkaline Phosphatase,,100,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,ALT (SGPT),,30,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,GGT,,18,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,LDH,,235,,H,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Uric Acid,,308,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Creatine Kinase,,119,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Bicarbonate,,24.5,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.03,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.95,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.62,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.32,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.6,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.2,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.3,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.5,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Platelet clumps present,,, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,8.28,,,,,1.9 - 23,uIU/mL +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,LIPID PANEL,Direct HDL-C 4th Generation,,1.34,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,LIPID PANEL,Triglycerides (GPO),,1.17,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,LIPID PANEL,Cholesterol (High Performance),,6.97,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,LIPID PANEL,LDL Chol Friedewald 4th,,5.09,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,RETICULOCYTES,Reticulocyte Count %,,1.7,,,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,TSH,TSH 3rd IS-QT,,,,,Test group cancelled: No specimen received,,, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Specific Gravity,,1.022,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.8,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CELLULAR ELEMENTS,Ur WBC/HPF,,7,,,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.1,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Alkaline Phosphatase,,86,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,ALT (SGPT),,61,R,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,AST (SGOT),,37,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,GGT,,25,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,LDH,,181,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Glucose Fasting,,6.1,R,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Uric Acid,,287,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Phosphorus,,1.16,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Total Protein,,64,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Creatine Kinase,,52,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Bicarbonate,,25.7,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.52,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.64,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.27,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.38,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.7,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.2,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,310,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.4,,,,,<6.5 %, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,18.47,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,LIPID PANEL,Direct HDL-C 4th Generation,,0.95,R,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,LIPID PANEL,Triglycerides (GPO),,1.13,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,LIPID PANEL,Cholesterol (High Performance),,2.38,,L,,Result verified by repeat analysis,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,LIPID PANEL,LDL Chol Friedewald 4th,,0.91,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,RETICULOCYTES,Reticulocyte Count %,,2.0,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,TSH,TSH 3rd IS-QT,,0.827,,,,,0.45 - 5.33,mIU/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Leukocyte Esterase,,+2,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Total Bilirubin,,19,,,,,3 - 21,umol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.6,,,,,0 - 6.2,umol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Alkaline Phosphatase,,122,,H,,,35 - 104,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,GGT,,12,,,,,5 - 50,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,LDH,,154,,,,,53 - 234,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 8.6,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Glucose Fasting,,6.3,,H,,,3.9 - 5.6,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Uric Acid,,223,,,,,149 - 446,umol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Phosphorus,,0.91,,,,,0.71 - 1.65,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Total Protein,,68,,,,,60 - 80,g/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Creatine Kinase,,85,,,,,26 - 192,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,147,,,,,115 - 158,g/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.34 - 0.48, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,3.9 - 5.5,TI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,94,,,,,80 - 100,fL +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.41,,,,,3.8 - 10.7,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.51,,,,,1.96 - 7.23,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.33,,,,,0.8 - 3,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.35,,,,,0.12 - 0.92,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.7,,,,,40.5 - 75,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.2,,,,,15.4 - 48.5,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.5,,,,,2.6 - 10.1,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,232,,,,,130 - 394,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.38,,,,,1.9 - 23,uIU/mL +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,LIPID PANEL,Direct HDL-C 4th Generation,,1.74,R,H,,,1.03 - 1.53,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,LIPID PANEL,Triglycerides (GPO),,0.57,R,L,,,0.63 - 2.71,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,LIPID PANEL,Cholesterol (High Performance),,4.75,R,L,,,4.86 - 8.28,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,LIPID PANEL,LDL Chol Friedewald 4th,,2.75,,,,,0 - 3.34,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1.01 - 1.03, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,C-REACTIVE PROTEIN,C Reactive Protein HS,,8.5,R,H,,,0 - 5,mg/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Alkaline Phosphatase,,61,,,,,35 - 104,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,4 - 43,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,GGT,,14,,,,,5 - 50,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,LDH,,150,,,,,53 - 234,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Urea Nitrogen,,4.4,,,,,1.4 - 8.6,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Uric Acid,,207,,,,,149 - 446,umol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Phosphorus,,0.89,,,,,0.71 - 1.65,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Total Protein,,63,,,,,60 - 80,g/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Creatine Kinase,,78,,,,,26 - 192,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Sodium,,142,,,,,135 - 145,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Chloride,,107,,,,,94 - 112,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,149,,,,,115 - 158,g/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,3.9 - 5.5,TI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,80 - 100,fL +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.75,,,,,3.8 - 10.7,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.15,,,,,1.96 - 7.23,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.07,,,,,0.8 - 3,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.38,,,,,0.12 - 0.92,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,72.1,,,,,40.5 - 75,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,18.6,,,,,15.4 - 48.5,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,234,,,,,130 - 394,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.19,,,,,1.9 - 23,uIU/mL +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,LIPID PANEL,Direct HDL-C 4th Generation,,1.30,,,,,1.03 - 1.53,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,LIPID PANEL,Triglycerides (GPO),,0.41,,L,,,0.63 - 2.71,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,LIPID PANEL,Cholesterol (High Performance),,4.53,,L,,,4.86 - 8.28,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,LIPID PANEL,LDL Chol Friedewald 4th,,3.04,,,,,0 - 3.34,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1.01 - 1.03, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Alkaline Phosphatase,,78,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,ALT (SGPT),,29,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,GGT,,23,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,LDH,,214,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,80,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Uric Acid,,248,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Phosphorus,,0.93,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Total Protein,,64,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Creatine Kinase,,128,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Bicarbonate,,25.8,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,138,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,94,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.44,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.15,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.79,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.9,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.9,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.7,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,290,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.23,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,LIPID PANEL,Direct HDL-C 4th Generation,,1.67,,H,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,LIPID PANEL,Triglycerides (GPO),,0.88,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,LIPID PANEL,Cholesterol (High Performance),,5.28,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,LIPID PANEL,LDL Chol Friedewald 4th,,3.21,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,TSH,TSH 3rd IS-QT,,1.525,,,,,0.45 - 5.33,mIU/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur pH,,7.0,,,,,5 - 8, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.4,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.8,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Alkaline Phosphatase,,81,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,GGT,,52,,H,,,4 - 49,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,LDH,,153,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Urea Nitrogen,,3.3,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,66,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Uric Acid,,273,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Phosphorus,,1.02,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Creatine Kinase,,118,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Bicarbonate,,23.2,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,131,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.38,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.04,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.60,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.23,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.6,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,40.7,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.6,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.6,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,315,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.2,,,,,<6.5 %, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.83,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,LIPID PANEL,Direct HDL-C 4th Generation,,1.70,,H,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,LIPID PANEL,Triglycerides (GPO),,2.24,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,LIPID PANEL,Cholesterol (High Performance),,5.71,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,LIPID PANEL,LDL Chol Friedewald 4th,,2.98,,,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,RETICULOCYTES,Reticulocyte Count %,,1.9,,,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,TSH,TSH 3rd IS-QT,,4.319,,,,,0.45 - 5.33,mIU/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Specific Gravity,,1.021,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.0,,,,,0 - 5,mg/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Alkaline Phosphatase,,130,,H,,,35 - 104,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,ALT (SGPT),,10,,,,,4 - 43,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,GGT,,13,,,,,5 - 50,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Urea Nitrogen,,5.6,,,,,1.4 - 8.6,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Uric Acid,,232,,,,,149 - 446,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Calcium (EDTA),,2.49,,,,,2.07 - 2.64,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Phosphorus,,0.93,,,,,0.71 - 1.65,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Total Protein,,73,,,,,60 - 80,g/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Creatine Kinase,,59,,,,,26 - 192,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Sodium,,141,,,,,135 - 145,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Bicarbonate,,25.2,,,,,19.3 - 29.3,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.61,,,,,1.25 - 1.92,mL/sec +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,75.5,,,,,kg, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,FSH,Follicle Stimulating Hormone,,57.83,,,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,GFR,EGFR by MDRD,,83,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,159,R,H,,,115 - 158,g/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.49,R,H,,,0.34 - 0.48, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,3.9 - 5.5,TI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,80 - 100,fL +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.19,,,,,3.8 - 10.7,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.31,,,,,1.96 - 7.23,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.30,,,,,0.8 - 3,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.18,,,,,0 - 0.57,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.5,,,,,40.5 - 75,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,37.2,,,,,15.4 - 48.5,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.5,,,,,2.6 - 10.1,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,,,,0 - 6.8,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,255,,,,,130 - 394,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.27,,,,,1.9 - 23,uIU/mL +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,LIPID PANEL,Direct HDL-C 4th Generation,,1.70,,H,,,1.03 - 1.53,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,LIPID PANEL,Triglycerides (GPO),,0.84,,,,,0.63 - 2.71,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,LIPID PANEL,Cholesterol (High Performance),,5.60,,,,,4.86 - 8.28,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,LIPID PANEL,LDL Chol Friedewald 4th,,3.52,,H,,,0 - 3.34,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,TSH,TSH 3rd IS-QT,,0.932,,,,,0.45 - 5.33,mIU/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1.01 - 1.03, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CELLULAR ELEMENTS,Ur WBC/HPF,,48,R,H,,,0 - 12,/HPF +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,GGT,,28,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,LDH,,141,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,52,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Glucose Fasting,,6.7,R,H,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Uric Acid,,325,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Calcium (EDTA),,2.52,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Phosphorus,,1.23,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Creatine Kinase,,205,R,H,,,26 - 192,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Bicarbonate,,24.4,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,138,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.95,,,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.30,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.84,R,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.62,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.3,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.6,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.2,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.4,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,486,R,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,118.97,R,H,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,LIPID PANEL,Direct HDL-C 4th Generation,,1.32,,,,,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,LIPID PANEL,Triglycerides (GPO),,2.60,R,H,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,LIPID PANEL,Cholesterol (High Performance),,5.47,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,LIPID PANEL,LDL Chol Friedewald 4th,,2.96,,,,,0 - 3.34,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Specific Gravity,,1.033,R,,,,1 - 1.04, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Protein,,+2,R,H SF,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Ketones,,Trace,R,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,R,H SF,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,C-REACTIVE PROTEIN,C Reactive Protein HS,,9.0,R,H,,,0 - 5,mg/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CELLULAR ELEMENTS,Ur WBC/HPF,,6,,,,,0 - 12,/HPF +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CELLULAR ELEMENTS,Ur Squamous Epithelial Cells,,38,,,,,0 - 3,/HPF +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Alkaline Phosphatase,,65,,,,,35 - 104,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,GGT,,16,,,,,5 - 50,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,LDH,,183,,,,,53 - 234,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Uric Acid,,133,R,L,,,149 - 446,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Phosphorus,,0.91,,,,,0.71 - 1.65,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Total Protein,,63,,,,,60 - 80,g/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Creatine Kinase,,87,,,,,26 - 192,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Bicarbonate,,22.0,,,,,19.3 - 29.3,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.29,,,,,1.25 - 1.92,mL/sec +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,58.2,,,,,kg, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,GFR,EGFR by MDRD,,90,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,148,,,,,115 - 158,g/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.34 - 0.48, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,3.9 - 5.5,TI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,99,,,,,80 - 100,fL +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.46,,,,,3.8 - 10.7,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.63,,,,,1.96 - 7.23,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.19,,,,,0.8 - 3,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,66.4,,,,,40.5 - 75,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,21.7,,,,,15.4 - 48.5,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.0,,,,,2.6 - 10.1,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,247,,,,,130 - 394,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.23,,,,,1.9 - 23,uIU/mL +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,LIPID PANEL,Direct HDL-C 4th Generation,,1.28,,,,,1.03 - 1.53,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,LIPID PANEL,Triglycerides (GPO),,0.70,,,,,0.63 - 2.71,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,LIPID PANEL,Cholesterol (High Performance),,4.86,,,,,4.86 - 8.28,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,LIPID PANEL,LDL Chol Friedewald 4th,,3.26,,,,,0 - 3.34,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,TSH,TSH 3rd IS-QT,,1.723,,,,,0.45 - 5.33,mIU/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1.01 - 1.03, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Protein,,Trace,R,H,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Glucose,,Trace,R,H,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.1,,,,,0 - 5,mg/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,35 - 104,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,4 - 43,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,GGT,,17,,,,,5 - 50,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Urea Nitrogen,,6.7,,,,,1.4 - 10.4,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,70,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Glucose Fasting,,5.7,R,H,,,3.9 - 5.6,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Uric Acid,,312,,,,,149 - 446,umol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Phosphorus,,1.48,,,,,0.71 - 1.65,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 46,g/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Creatine Kinase,,66,,,,,26 - 192,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Bicarbonate,,21.8,,,,,19.3 - 29.3,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,161,R,H,,,115 - 158,g/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.48,,,,,0.34 - 0.48, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.3,,,,,3.9 - 5.5,TI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,80 - 100,fL +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.57,,,,,3.8 - 10.7,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.16,,,,,1.96 - 7.23,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.42,R,H,,,0.8 - 3,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.76,,,,,0.12 - 0.92,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.0,,,,,40.5 - 75,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.8,,,,,15.4 - 48.5,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.0,,,,,2.6 - 10.1,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,300,,,,,130 - 394,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.83,,,,,1.9 - 23,uIU/mL +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,LIPID PANEL,Direct HDL-C 4th Generation,,1.33,,,,,1.03 - 1.53,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,LIPID PANEL,Triglycerides (GPO),,2.03,,,,,0.63 - 2.71,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,LIPID PANEL,Cholesterol (High Performance),,6.94,,,,,5.35 - 9.1,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,LIPID PANEL,LDL Chol Friedewald 4th,,4.68,,H,,,0 - 3.34,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1.01 - 1.03, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CELLULAR ELEMENTS,Ur WBC/HPF,,5,,,,,0 - 12,/HPF +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CELLULAR ELEMENTS,Ur Transitional Epi Cells,,1,,,,,0 /HPF, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Alkaline Phosphatase,,79,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,ALT (SGPT),,21,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,GGT,,17,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,LDH,,205,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,73,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Uric Acid,,239,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Phosphorus,,1.25,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Bicarbonate,,25.3,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.66,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.75,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.38,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.9,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.6,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.4,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.6,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,312,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.82,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,LIPID PANEL,Direct HDL-C 4th Generation,,1.68,,H,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,LIPID PANEL,Triglycerides (GPO),,0.71,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,LIPID PANEL,Cholesterol (High Performance),,5.23,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,LIPID PANEL,LDL Chol Friedewald 4th,,3.22,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.4,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CELLULAR ELEMENTS,Ur WBC/HPF,,>150,,HT,,,0 - 12,/HPF +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Alkaline Phosphatase,,76,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,GGT,,25,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,LDH,,130,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,53,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Uric Acid,,357,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Phosphorus,,1.26,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Creatine Kinase,,154,,,,,26 - 192,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Bicarbonate,,23.0,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.63,,H,,,1.25 - 1.92,mL/sec +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,53,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,87.2,,,,,kg, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,GFR,EGFR by MDRD,,107,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,142,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,11.22,R,H,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.93,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.51,,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.50,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.22,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.8,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,31.3,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.4,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,509,R,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.4,,,,,<6.5 %, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,39.05,,H,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,LIPID PANEL,Direct HDL-C 4th Generation,,1.21,,,,,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,LIPID PANEL,Triglycerides (GPO),,3.23,,H,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,LIPID PANEL,Cholesterol (High Performance),,5.80,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,LIPID PANEL,LDL Chol Friedewald 4th,,3.11,,,,,0 - 3.34,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,RETICULOCYTES,Reticulocyte Count %,,1.9,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,TSH,TSH 3rd IS-QT,,2.280,,,,,0.45 - 5.33,mIU/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,C-REACTIVE PROTEIN,C Reactive Protein HS,,7.3,,H,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CELLULAR ELEMENTS,Ur WBC/HPF,,32,,H,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.9,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,ALT (SGPT),,55,,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,AST (SGOT),,30,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,GGT,,27,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,LDH,,175,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Glucose Fasting,,7.2,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Uric Acid,,263,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Phosphorus,,0.95,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Creatine Kinase,,38,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Bicarbonate,,25.0,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,159,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.29,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.53,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.07,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.45,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.2,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.5,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.2,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.1,,,,,0 - 2,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,296,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.4,,,,,<6.5 %, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,33.25,,H,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,LIPID PANEL,Direct HDL-C 4th Generation,,1.02,,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,LIPID PANEL,Triglycerides (GPO),,1.15,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,LIPID PANEL,Cholesterol (High Performance),,2.80,,L,,,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,LIPID PANEL,LDL Chol Friedewald 4th,,1.25,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,TSH,TSH 3rd IS-QT,,0.595,,,,,0.45 - 5.33,mIU/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Specific Gravity,,1.015,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.8,,,,,0 - 5,mg/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CELLULAR ELEMENTS,Ur RBC/HPF,,1,,,,,0 - 8,/HPF +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 12,/HPF +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Alkaline Phosphatase,,87,,,,,35 - 104,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,4 - 43,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,GGT,,15,,,,,5 - 50,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,LDH,,150,,,,,53 - 234,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 10.4,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Glucose Fasting,,7.0,,H,,,3.9 - 5.6,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Uric Acid,,320,,,,,149 - 446,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Phosphorus,,1.31,,,,,0.71 - 1.65,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Total Protein,,78,,,,,60 - 80,g/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 46,g/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Creatine Kinase,,87,,,,,26 - 192,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.29,,,,,1.25 - 1.92,mL/sec +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,68.5,,,,,kg, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,FSH,Follicle Stimulating Hormone,,78.10,,,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,GFR,EGFR by MDRD,,81,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,165,,H,,,115 - 158,g/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.48,,,,,0.34 - 0.48, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.3,,,,,3.9 - 5.5,TI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,80 - 100,fL +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.07,,,,,3.8 - 10.7,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.15,,,,,1.96 - 7.23,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.08,,H,,,0.8 - 3,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.65,,,,,0.12 - 0.92,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.0,,,,,40.5 - 75,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.6,,,,,15.4 - 48.5,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.4,,,,,0 - 6.8,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,269,,,,,130 - 394,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.9,,,,,<6.5 %, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,47.53,,H,,,1.9 - 23,uIU/mL +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,LIPID PANEL,Direct HDL-C 4th Generation,,1.28,,,,,1.03 - 1.53,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,LIPID PANEL,Triglycerides (GPO),,1.84,,,,,0.63 - 2.71,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,LIPID PANEL,Cholesterol (High Performance),,6.82,,,,,5.35 - 9.1,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,LIPID PANEL,LDL Chol Friedewald 4th,,4.70,,H,,,0 - 3.34,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,TSH,TSH 3rd IS-QT,,1.806,,,,,0.45 - 5.33,mIU/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1.01 - 1.03, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Blood,,Trace,,,,,Ref Rng:$Negative-Trace, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.0,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CELLULAR ELEMENTS,Ur WBC/HPF,,27,,H,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.7,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Alkaline Phosphatase,,84,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,ALT (SGPT),,53,,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,GGT,,26,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,LDH,,172,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Glucose Fasting,,6.8,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Uric Acid,,279,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Phosphorus,,1.21,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Creatine Kinase,,45,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Bicarbonate,,25.1,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.45,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.94,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.68,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.51,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.24,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.4,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,31.7,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,302,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,13.07,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,LIPID PANEL,Direct HDL-C 4th Generation,,0.98,,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,LIPID PANEL,Triglycerides (GPO),,0.95,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,LIPID PANEL,Cholesterol (High Performance),,2.57,,L,,Result verified by repeat analysis,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,LIPID PANEL,LDL Chol Friedewald 4th,,1.15,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CELLULAR ELEMENTS,Ur WBC/HPF,,5,,,,,0 - 12,/HPF +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CELLULAR ELEMENTS,Ur Transitional Epi Cells,,1,,,,,0 /HPF, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Alkaline Phosphatase,,71,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,GGT,,18,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,LDH,,203,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Urea Nitrogen,,3.2,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,70,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Uric Acid,,221,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Phosphorus,,1.12,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Total Protein,,64,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Creatine Kinase,,96,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Bicarbonate,,27.1,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.16,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.30,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.50,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.23,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.2,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.0,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.5,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.0,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,272,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.3,,,,,<6.5 %, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.94,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,LIPID PANEL,Direct HDL-C 4th Generation,,1.49,,,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,LIPID PANEL,Triglycerides (GPO),,0.80,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,LIPID PANEL,Cholesterol (High Performance),,4.76,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,LIPID PANEL,LDL Chol Friedewald 4th,,2.90,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,TSH,TSH 3rd IS-QT,,1.175,,,,,0.45 - 5.33,mIU/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Specific Gravity,,1.016,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur pH,,7.0,,,,,5 - 8, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.8,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Total Bilirubin,,4,,,,Result verified by repeat analysis,3 - 21,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Alkaline Phosphatase,,78,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,ALT (SGPT),,40,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,AST (SGOT),,33,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,GGT,,49,,,,,4 - 49,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Uric Acid,,300,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Phosphorus,,1.35,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Creatine Kinase,,102,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Bicarbonate,,25.0,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,126,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.9,,L,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.94,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.95,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.05,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.61,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.29,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,42.5,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,43.9,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.7,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.2,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,341,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.3,,,,,<6.5 %, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.23,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,LIPID PANEL,Direct HDL-C 4th Generation,,1.37,,,,,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,LIPID PANEL,Triglycerides (GPO),,1.49,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,LIPID PANEL,Cholesterol (High Performance),,4.70,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,LIPID PANEL,LDL Chol Friedewald 4th,,2.65,,,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,RETICULOCYTES,Reticulocyte Count %,,2.7,,H,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,TSH,TSH 3rd IS-QT,,3.282,,,,,0.45 - 5.33,mIU/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.5,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.2,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Alkaline Phosphatase,,99,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,ALT (SGPT),,30,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,AST (SGOT),,30,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,GGT,,18,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,LDH,,205,,,,,53 - 234,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Uric Acid,,323,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Calcium (EDTA),,2.27,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Creatine Kinase,,161,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Potassium,,3.7,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Bicarbonate,,24.3,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,144,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.41,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.46,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.53,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.25,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.7,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.8,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.3,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Platelet clumps present,,, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.7,,,,,<6.5 %, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,8.57,,,,,1.9 - 23,uIU/mL +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,LIPID PANEL,Direct HDL-C 4th Generation,,1.14,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,LIPID PANEL,Triglycerides (GPO),,1.23,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,LIPID PANEL,Cholesterol (High Performance),,6.67,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,LIPID PANEL,LDL Chol Friedewald 4th,,4.97,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,RETICULOCYTES,Reticulocyte Count %,,1.5,,,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,TSH,TSH 3rd IS-QT,,2.238,,,,,0.45 - 5.33,mIU/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.3,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CELLULAR ELEMENTS,Ur WBC/HPF,,9,,,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.8,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,ALT (SGPT),,50,,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,GGT,,24,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,LDH,,167,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Glucose Fasting,,6.3,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Uric Acid,,274,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Phosphorus,,1.21,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Creatine Kinase,,45,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Potassium,,5.0,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Bicarbonate,,25.7,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.24,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.24,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.33,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.45,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.6,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.3,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,330,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.1,,,,,<6.5 %, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,14.65,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,LIPID PANEL,Direct HDL-C 4th Generation,,1.03,,,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,LIPID PANEL,Triglycerides (GPO),,1.18,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,LIPID PANEL,Cholesterol (High Performance),,2.69,,L,,,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,LIPID PANEL,LDL Chol Friedewald 4th,,1.12,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,TSH,TSH 3rd IS-QT,,1.264,,,,,0.45 - 5.33,mIU/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Specific Gravity,,1.021,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.8,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 12,/HPF +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,GGT,,22,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,LDH,,199,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,69,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Uric Acid,,242,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Phosphorus,,1.18,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Creatine Kinase,,113,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Bicarbonate,,29.7,,H,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.80,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.73,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.58,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.36,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,56.9,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.9,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.6,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,308,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,1.74,,L,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,LIPID PANEL,Direct HDL-C 4th Generation,,1.50,,,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,LIPID PANEL,Triglycerides (GPO),,0.88,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,LIPID PANEL,Cholesterol (High Performance),,5.66,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,LIPID PANEL,LDL Chol Friedewald 4th,,3.76,,H,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Specific Gravity,,1.016,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur pH,,7.5,,,,,5 - 8, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.0,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Alkaline Phosphatase,,72,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,GGT,,45,,,,,4 - 49,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,LDH,,135,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,59,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Uric Acid,,277,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Creatine Kinase,,94,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Bicarbonate,,23.2,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,125,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,R,L,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.92,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.08,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.93,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.56,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.31,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,44.5,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,42.3,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.1,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.4,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,304,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.03,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,LIPID PANEL,Direct HDL-C 4th Generation,,1.36,,,,,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,LIPID PANEL,Triglycerides (GPO),,2.05,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,LIPID PANEL,Cholesterol (High Performance),,5.46,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,LIPID PANEL,LDL Chol Friedewald 4th,,3.16,,,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,TSH,TSH 3rd IS-QT,,1.135,,,,,0.45 - 5.33,mIU/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.8,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Alkaline Phosphatase,,100,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,ALT (SGPT),,29,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,AST (SGOT),,33,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,GGT,,17,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,LDH,,257,,H,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Uric Acid,,318,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Creatine Kinase,,276,,H,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Bicarbonate,,24.3,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.48,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.40,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.48,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.5,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.1,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.9,R,H,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.2,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,143,,,,,140 - 400,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.90,,,,,1.9 - 23,uIU/mL +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,LIPID PANEL,Direct HDL-C 4th Generation,,1.12,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,LIPID PANEL,Triglycerides (GPO),,1.26,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,LIPID PANEL,Cholesterol (High Performance),,5.71,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,LIPID PANEL,LDL Chol Friedewald 4th,,4.01,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Specific Gravity,,1.020,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CELLULAR ELEMENTS,Ur WBC/HPF,,10,,,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.2,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Alkaline Phosphatase,,91,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,ALT (SGPT),,49,,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,AST (SGOT),,31,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,GGT,,22,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,LDH,,176,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Glucose Fasting,,6.8,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Uric Acid,,282,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Calcium (EDTA),,2.46,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Phosphorus,,1.34,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Creatine Kinase,,51,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Potassium,,5.1,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Bicarbonate,,22.7,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,147,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.87,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.64,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.53,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.42,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.20,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.9,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.3,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.5,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,294,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,12.54,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,LIPID PANEL,Direct HDL-C 4th Generation,,0.96,,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,LIPID PANEL,Triglycerides (GPO),,0.90,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,LIPID PANEL,Cholesterol (High Performance),,2.39,,L,,Result verified by repeat analysis,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,LIPID PANEL,LDL Chol Friedewald 4th,,1.02,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Leukocyte Esterase,,+2,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CELLULAR ELEMENTS,Ur RBC/HPF,,1,,,,,0 - 8,/HPF +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CELLULAR ELEMENTS,Ur WBC/HPF,,7,,,,,0 - 12,/HPF +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Alkaline Phosphatase,,84,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,GGT,,21,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,LDH,,206,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,78,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Glucose Fasting,,5.5,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Uric Acid,,260,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Phosphorus,,1.17,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Creatine Kinase,,107,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Bicarbonate,,22.4,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.58,,,,,1.25 - 1.92,mL/sec +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,78,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,81.6,,,,,kg, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,GFR,EGFR by MDRD,,67,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.09,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.99,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.48,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.12,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.8,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.2,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.0,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.3,,H,,,0 - 2,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,313,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.1,,,,,<6.5%, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.19,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,LIPID PANEL,Direct HDL-C 4th Generation,,1.52,,,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,LIPID PANEL,Triglycerides (GPO),,1.01,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,LIPID PANEL,Cholesterol (High Performance),,5.29,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,LIPID PANEL,LDL Chol Friedewald 4th,,3.31,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,TSH,TSH 3rd IS-QT,,1.461,,,,,0.45 - 5.33,mIU/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Protein,,Trace,R,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.5,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.7,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Alkaline Phosphatase,,77,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,ALT (SGPT),,27,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,GGT,,45,,,,,4 - 49,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Urea Nitrogen,,3.5,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Uric Acid,,261,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Phosphorus,,1.12,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Creatine Kinase,,99,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Bicarbonate,,21.9,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,126,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.55,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.59,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.09,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.63,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.20,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.9,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.7,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.3,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.6,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,324,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.08,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,LIPID PANEL,Direct HDL-C 4th Generation,,1.54,,H,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,LIPID PANEL,Triglycerides (GPO),,2.08,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,LIPID PANEL,Cholesterol (High Performance),,5.37,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,LIPID PANEL,LDL Chol Friedewald 4th,,2.88,,,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.5,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CELLULAR ELEMENTS,Ur WBC/HPF,,5,,,,,0 - 12,/HPF +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.0,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Alkaline Phosphatase,,99,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,ALT (SGPT),,32,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,AST (SGOT),,32,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,GGT,,18,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,LDH,,232,,,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Urea Nitrogen,,4.7,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Glucose Fasting,,5.3,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Uric Acid,,392,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Creatine Kinase,,160,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.39,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.58,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.36,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.31,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.8,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.9,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.1,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Platelet clumps present,,, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.8,,,,,<6.5%, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,LIPID PANEL,Direct HDL-C 4th Generation,,1.11,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,LIPID PANEL,Triglycerides (GPO),,1.60,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,LIPID PANEL,Cholesterol (High Performance),,6.83,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,LIPID PANEL,LDL Chol Friedewald 4th,,4.99,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,RETICULOCYTES,Reticulocyte Count %,,1.7,,,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,TSH,TSH 3rd IS-QT,,2.025,,,,,0.45 - 5.33,mIU/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Specific Gravity,,1.018,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur pH,,7.0,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,R,H,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.9,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CELLULAR ELEMENTS,Ur WBC/HPF,,42,,H,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.7,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Alkaline Phosphatase,,83,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,ALT (SGPT),,69,,H RX,,,4 - 43,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,AST (SGOT),,40,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,GGT,,27,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,LDH,,190,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Urea Nitrogen,,3.8,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Glucose Fasting,,7.5,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Uric Acid,,309,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Phosphorus,,1.28,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Creatine Kinase,,48,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Bicarbonate,,24.7,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.65,,,,,1.25 - 1.92,mL/sec +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,79.2,,,,,kg, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,GFR,EGFR by MDRD,,74,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.69,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.48,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.44,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.48,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.23,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,66.8,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,25.1,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.9,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,324,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,6.6,,H,,,<6.5%, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,13.86,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,LIPID PANEL,Direct HDL-C 4th Generation,,0.89,,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,LIPID PANEL,Triglycerides (GPO),,1.13,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,LIPID PANEL,Cholesterol (High Performance),,2.44,,L,,Result verified by repeat analysis,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,LIPID PANEL,LDL Chol Friedewald 4th,,1.03,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,RETICULOCYTES,Reticulocyte Count %,,2.0,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,TSH,TSH 3rd IS-QT,,1.524,,,,,0.45 - 5.33,mIU/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.1,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Alkaline Phosphatase,,82,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,GGT,,47,,,,,4 - 49,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,LDH,,153,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,69,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Uric Acid,,322,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Calcium (EDTA),,2.47,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Total Protein,,79,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Creatine Kinase,,104,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Bicarbonate,,22.9,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.88,,,,,1.25 - 1.92,mL/sec +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,69,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,78.6,,,,,kg, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,Result verified by repeat analysis,Neg;$Cutoff = 50 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,GFR,EGFR by MDRD,,80,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,106,,H,,,79 - 98,fL +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.54,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.33,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.64,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.36,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,42.0,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,47.6,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.7,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,301,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.3,,,,,<6.5%, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.36,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,LIPID PANEL,Direct HDL-C 4th Generation,,1.94,,H,,,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,LIPID PANEL,Triglycerides (GPO),,1.55,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,LIPID PANEL,Cholesterol (High Performance),,6.28,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,LIPID PANEL,LDL Chol Friedewald 4th,,3.63,,H,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,TSH,TSH 3rd IS-QT,,1.391,,,,,0.45 - 5.33,mIU/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Specific Gravity,,1.018,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.1,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Alkaline Phosphatase,,104,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,ALT (SGPT),,30,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,GGT,,20,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,LDH,,224,,,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Uric Acid,,358,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Phosphorus,,1.33,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Creatine Kinase,,159,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Bicarbonate,,23.6,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,135,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.75,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.17,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.12,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,45.7,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,44.7,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.1,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,157,,,,,140 - 400,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,11.38,,,,,1.9 - 23,uIU/mL +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,LIPID PANEL,Direct HDL-C 4th Generation,,1.10,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,LIPID PANEL,Triglycerides (GPO),,1.77,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,LIPID PANEL,Cholesterol (High Performance),,6.54,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,LIPID PANEL,LDL Chol Friedewald 4th,,4.63,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,RETICULOCYTES,Reticulocyte Count %,,3.5,,H,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Specific Gravity,,1.015,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Retest,,"Aug 19, 2025 10:00 AM",6225351002,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040001,,,56,years,Female,Retest,,"Aug 19, 2025 10:00 AM",6225351002,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CELLULAR ELEMENTS,Ur WBC/HPF,,10,,,,,0 - 12,/HPF +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Alkaline Phosphatase,,106,,H,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,ALT (SGPT),,28,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,GGT,,19,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,LDH,,241,,H,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,87,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Glucose Fasting,,6.5,,H,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Uric Acid,,349,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Phosphorus,,0.95,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Creatine Kinase,,140,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Bicarbonate,,23.9,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.23,,L,,,1.25 - 1.92,mL/sec +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,87,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,72.5,,,,,kg, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,FSH,Follicle Stimulating Hormone,,50.25,,,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,GFR,EGFR by MDRD,,59,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,139,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.75,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.40,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.88,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,50.5,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,39.4,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.3,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,163,,,,,140 - 400,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,4.7,,,,,<6.5%, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,LIPID PANEL,Direct HDL-C 4th Generation,,0.97,,L,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,LIPID PANEL,Triglycerides (GPO),,3.99,,H,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,LIPID PANEL,Cholesterol (High Performance),,6.69,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,LIPID PANEL,LDL Chol Friedewald 4th,,3.89,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,RETICULOCYTES,Reticulocyte Count %,,2.9,,H,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,TSH,TSH 3rd IS-QT,,2.272,,,,,0.45 - 5.33,mIU/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Protein,,Trace,R,H,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,R,H,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122935 sponsor-study-35472-test-results-898739-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122935 sponsor-study-35472-test-results-898739-standard.csv new file mode 100644 index 0000000..777a3b4 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122935 sponsor-study-35472-test-results-898739-standard.csv @@ -0,0 +1,1899 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 5,/HPF +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.7,,,,,0 - 6.2,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Alkaline Phosphatase,,55,,,,,40 - 129,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,ALT (SGPT),,27,,,,,5 - 48,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,GGT,,43,,,,,10 - 61,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,LDH,,168,,,,,53 - 234,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Urea Nitrogen,,3.5,,,,,1.4 - 8.6,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Glucose Fasting,,5.3,,,,,3.9 - 5.6,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Serum Uric Acid,,351,,,,,125 - 488,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Phosphorus,,0.86,,,,,0.71 - 1.65,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Albumin-BCG,,50,,H,,,33 - 49,g/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,39 - 308,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Serum Bicarbonate,,26.0,,,,,19.3 - 29.3,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,149,,,,,127 - 181,g/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,84,,,,,79 - 96,fL +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.24,,,,,3.8 - 10.7,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.54,,,,,1.96 - 7.23,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.12,,,,,0.91 - 4.28,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.53,,,,,0.12 - 0.92,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,,0 - 0.57,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,67.2,,,,,40.5 - 75,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,25.7,,,,,15.4 - 48.5,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.4,,,,,2.6 - 10.1,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.5,,,,,0 - 6.8,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,193,,,,,140 - 400,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,10.23,,,,,1.9 - 23,uIU/mL +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,LIPID PANEL,Direct HDL-C 4th Generation,,0.92,,L,,,1.03 - 1.53,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,LIPID PANEL,Triglycerides (GPO),,3.09,,,,,0.62 - 3.69,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,LIPID PANEL,Cholesterol (High Performance),,5.48,,,,,4.19 - 7.24,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,LIPID PANEL,LDL Chol Friedewald 4th,,3.14,,,,,0 - 3.34,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,TSH,TSH 3rd IS-QT,,1.690,,,,,0.45 - 5.33,mIU/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Specific Gravity,,1.026,,,,,1 - 1.04, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Apr 29, 2026 11:20 AM",6227520243,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.7,,,,,0 - 5,mg/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Alkaline Phosphatase,,65,,,,,35 - 104,U/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,ALT (SGPT),,53,,H,,,4 - 43,U/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,AST (SGOT),,47,,H,,,8 - 40,U/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,GGT,,101,,H,,,5 - 50,U/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,LDH,,186,,,,,53 - 234,U/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Urea Nitrogen,,1.4,,,,,1.4 - 8.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,52,,,,,31 - 101,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Glucose Fasting,,5.8,,H,,,3.9 - 5.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Serum Uric Acid,,426,,,,,149 - 446,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Calcium (EDTA),,2.60,,,,,2.07 - 2.64,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Phosphorus,,1.17,,,,,0.71 - 1.65,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Creatine Kinase,,164,,,,,26 - 192,U/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Serum Sodium,,135,,,,,135 - 145,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Serum Potassium,,3.9,,,,,3.5 - 5.2,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Serum Bicarbonate,,21.2,,,,,19.3 - 29.3,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,CHEMISTRY PANEL,Serum Chloride,,94,,,,,94 - 112,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,148,,,,,115 - 158,g/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,3.9 - 5.5,TI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,100,,,,,80 - 100,fL +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.45,,,,,3.8 - 10.7,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.74,,,,,1.96 - 7.23,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.85,,,,,0.8 - 3,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.33,,,,,0 - 0.57,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,56.1,,,,,40.5 - 75,% +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.8,,,,,15.4 - 48.5,% +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.9,,,,,0 - 6.8,% +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,261,,,,,130 - 394,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.3,,,,,<6.5 %, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.91,,,,,1.9 - 23,uIU/mL +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,IS SUBJECT FASTING?,Is Subject Fasting?,Y,No,,,,,, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,LIPID PANEL,Direct HDL-C 4th Generation,,1.71,,H,,,1.03 - 1.53,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,LIPID PANEL,Triglycerides (GPO),,1.73,,,,,0.63 - 2.71,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,LIPID PANEL,Cholesterol (High Performance),,3.78,,L,,,4.86 - 8.28,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,LIPID PANEL,LDL Chol Friedewald 4th,,1.28,,,,,0 - 3.34,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,TSH,TSH 3rd IS-QT,,,,,Test group cancelled: No specimen received,,, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1.01 - 1.03, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Ketones,,Trace,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 12:01 PM",6226686954,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.3,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Alkaline Phosphatase,,54,,,,,40 - 129,U/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,5 - 48,U/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,GGT,,41,,,,,10 - 61,U/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,LDH,,149,,,,,53 - 234,U/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,80,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Serum Uric Acid,,379,,,,,125 - 488,umol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Calcium (EDTA),,2.53,,,,,2.07 - 2.64,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Phosphorus,,0.89,,,,,0.71 - 1.65,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Total Protein,,81,,,,,61 - 84,g/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Albumin-BCG,,50,,H,,,33 - 49,g/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Creatine Kinase,,88,,,,,39 - 308,U/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Serum Bicarbonate,,24.1,,,,,19.3 - 29.3,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,152,,,,,127 - 181,g/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.3,,,,,4.5 - 6.4,TI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,84,,,,,79 - 96,fL +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.35,,,,,3.8 - 10.7,GI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.03,,,,,1.96 - 7.23,GI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.94,,,,,0.91 - 4.28,GI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.30,,,,,0.12 - 0.92,GI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,56.6,,,,,40.5 - 75,% +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.4,,,,,15.4 - 48.5,% +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,% +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,202,,,,,140 - 400,GI/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.79,,,,,1.9 - 23,uIU/mL +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,LIPID PANEL,Direct HDL-C 4th Generation,,0.94,,L,,,1.03 - 1.53,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,LIPID PANEL,Triglycerides (GPO),,2.61,,,,,0.62 - 3.69,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,LIPID PANEL,Cholesterol (High Performance),,5.47,,,,,4.19 - 7.24,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,LIPID PANEL,LDL Chol Friedewald 4th,,3.33,,,,,0 - 3.34,mmol/L +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 2 OL Induction Day 29,,"Apr 1, 2026 11:10 AM",6226313625,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 5,/HPF +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Alkaline Phosphatase,,61,,,,,40 - 129,U/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,5 - 48,U/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,GGT,,34,,,,,10 - 61,U/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,LDH,,164,,,,,53 - 234,U/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,74,,,,,40 - 119,umol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Serum Uric Acid,,266,,,,,149 - 494,umol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Creatine Kinase,,77,,,,,39 - 308,U/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Serum Bicarbonate,,19.7,,,,,19.3 - 29.3,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,161,,,,,127 - 181,g/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 96,fL +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.90,,,,,3.8 - 10.7,GI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.20,,,,,1.96 - 7.23,GI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.94,,,,,0.91 - 4.28,GI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.58,,,,,0.12 - 0.92,GI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.7,,,,,40.5 - 75,% +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.8,,,,,15.4 - 48.5,% +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.9,,,,,2.6 - 10.1,% +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,% +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,259,,,,,140 - 400,GI/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,14.04,,,,,1.9 - 23,uIU/mL +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,LIPID PANEL,Direct HDL-C 4th Generation,,1.20,,,,,1.03 - 1.53,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,LIPID PANEL,Triglycerides (GPO),,2.38,,,,,0.65 - 3.61,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,LIPID PANEL,Cholesterol (High Performance),,6.59,,,,,4.4 - 7.53,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,LIPID PANEL,LDL Chol Friedewald 4th,,4.30,,H,,,0 - 3.34,mmol/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,TSH,TSH 3rd IS-QT,,1.196,,,,,0.45 - 5.33,mIU/L +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,R,H,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 2 DB Baseline,,"Mar 10, 2026 11:10 AM",6226804962,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,C-REACTIVE PROTEIN,C Reactive Protein HS,,5.2,,H,,,0 - 5,mg/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Alkaline Phosphatase,,54,,,,,40 - 129,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,ALT (SGPT),,30,,,,,5 - 48,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,GGT,,42,,,,,10 - 61,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,LDH,,169,,,,,53 - 234,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Urea Nitrogen,,2.9,,,,,1.4 - 8.6,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Serum Uric Acid,,370,,,,,125 - 488,umol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Calcium (EDTA),,2.49,,,,,2.07 - 2.64,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Phosphorus,,0.84,,,,,0.71 - 1.65,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Albumin-BCG,,50,,H,,,33 - 49,g/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Creatine Kinase,,127,,,,,39 - 308,U/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Serum Bicarbonate,,26.2,,,,,19.3 - 29.3,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,127 - 181,g/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,85,,,,,79 - 96,fL +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.86,,,,,3.8 - 10.7,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.33,,,,,1.96 - 7.23,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.05,,,,,0.91 - 4.28,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,48.0,,,,,40.5 - 75,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,42.2,,,,,15.4 - 48.5,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.2,,,,,2.6 - 10.1,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.2,,,,,0 - 6.8,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,189,,,,,140 - 400,GI/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,8.45,,,,,1.9 - 23,uIU/mL +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,LIPID PANEL,Direct HDL-C 4th Generation,,0.78,,L,,,1.03 - 1.53,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,LIPID PANEL,Triglycerides (GPO),,3.51,,,,,0.62 - 3.69,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,LIPID PANEL,Cholesterol (High Performance),,4.45,,,,,4.19 - 7.24,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,LIPID PANEL,LDL Chol Friedewald 4th,,2.06,,,,,0 - 3.34,mmol/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,TSH,TSH 3rd IS-QT,,1.040,,,,,0.45 - 5.33,mIU/L +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Specific Gravity,,1.033,,,,,1 - 1.04, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur pH,,7.0,,,,,5 - 8, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Urobilinogen,,+2,,H,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,End of Phase/Treatment,,"Mar 4, 2026 12:50 PM",6227520245,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.8,,,,,0 - 6.2,umol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Alkaline Phosphatase,,52,,,,,40 - 129,U/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,ALT (SGPT),,26,,,,,5 - 48,U/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,AST (SGOT),,22,,,,,8 - 40,U/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,GGT,,49,,,,,10 - 61,U/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,LDH,,143,,,,,53 - 234,U/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Serum Uric Acid,,359,,,,,125 - 488,umol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Calcium (EDTA),,2.57,,,,,2.07 - 2.64,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Phosphorus,,0.64,,LT,,Result verified by repeat analysis,0.71 - 1.65,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Total Protein,,78,,,,,61 - 84,g/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Albumin-BCG,,51,,H,,,33 - 49,g/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Creatine Kinase,,102,,,,,39 - 308,U/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Serum Sodium,,143,,,,,132 - 147,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Serum Bicarbonate,,25.8,,,,,19.3 - 29.3,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.27,,H,,,1.42 - 2.08,mL/sec +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,77,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,85.4,,,,,kg, +CZ100080007,,,40,years,Male,Retest,,"Feb 18, 2026 10:35 AM",6226785739,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Alkaline Phosphatase,,54,,,,,40 - 129,U/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,ALT (SGPT),,35,,,,,5 - 48,U/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,GGT,,54,,,,,10 - 61,U/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,LDH,,155,,,,,53 - 234,U/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Urea Nitrogen,,2.6,,,,,1.4 - 8.6,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,81,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Serum Uric Acid,,385,,,,,125 - 488,umol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Calcium (EDTA),,2.59,,,,,2.07 - 2.64,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Phosphorus,,0.57,,LT,,Result verified by repeat analysis,0.71 - 1.65,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Total Protein,,79,,,,,61 - 84,g/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Albumin-BCG,,51,,H,,,33 - 49,g/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Creatine Kinase,,110,,,,,39 - 308,U/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Serum Bicarbonate,,26.8,,,,,19.3 - 29.3,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,160,,,,,127 - 181,g/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.5,,,,,4.5 - 6.4,TI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.67,,,,,3.8 - 10.7,GI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.99,,,,,1.96 - 7.23,GI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.20,,,,,0.91 - 4.28,GI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.45,,,,,0.12 - 0.92,GI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.03,,,,,0 - 0.57,GI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.8,,,,,40.5 - 75,% +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.9,,,,,15.4 - 48.5,% +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.4,,,,,0 - 6.8,% +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.2,,,,,0 - 2,% +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,185,,,,,140 - 400,GI/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,9.79,,,,,1.9 - 23,uIU/mL +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,LIPID PANEL,Direct HDL-C 4th Generation,,0.84,,L,,,1.03 - 1.53,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,LIPID PANEL,Triglycerides (GPO),,3.38,,,,,0.62 - 3.69,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,LIPID PANEL,Cholesterol (High Performance),,4.73,,,,,4.19 - 7.24,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,LIPID PANEL,LDL Chol Friedewald 4th,,2.34,,,,,0 - 3.34,mmol/L +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Specific Gravity,,1.029,,,,,1 - 1.04, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 DB Baseline,,"Jan 21, 2026 11:23 AM",6226551697,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.0,,,,,0 - 5,mg/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.1,,,,,0 - 6.2,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Alkaline Phosphatase,,67,,,,,35 - 104,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,4 - 43,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,GGT,,40,,,,,4 - 49,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,LDH,,180,,,,,53 - 234,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Urea Nitrogen,,2.4,,,,,1.4 - 8.6,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Glucose Fasting,,5.3,,,,,3.9 - 5.6,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Serum Uric Acid,,222,,,,,149 - 446,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Calcium (EDTA),,2.26,,,,,2.07 - 2.64,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Phosphorus,,0.82,,,,,0.71 - 1.65,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Creatine Kinase,,83,,,,,26 - 192,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Serum Bicarbonate,,24.5,,,,,19.3 - 29.3,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,132,,,,,116 - 164,g/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4.1 - 5.6,TI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,99,R,H,,,79 - 98,fL +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.87,,,,,3.8 - 10.7,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.00,,,,,1.96 - 7.23,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.51,,,,,0.91 - 4.28,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.22,,,,,0.12 - 0.92,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.6,,,,,40.5 - 75,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.9,,,,,15.4 - 48.5,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.6,,,,,2.6 - 10.1,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.4,,,,,0 - 6.8,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,281,,,,,140 - 400,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.73,,,,,1.9 - 23,uIU/mL +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,LIPID PANEL,Direct HDL-C 4th Generation,,2.34,R,H,,,1.03 - 1.53,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,LIPID PANEL,Triglycerides (GPO),,1.13,,,,,0.59 - 2.96,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,LIPID PANEL,Cholesterol (High Performance),,5.38,,,,,4.42 - 7.53,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,LIPID PANEL,LDL Chol Friedewald 4th,,2.52,,,,,0 - 3.34,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,RETICULOCYTES,Reticulocyte Count %,,2.0,,,,,0.6 - 2.5,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,TSH,TSH 3rd IS-QT,,1.897,,,,,0.45 - 5.33,mIU/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Specific Gravity,,1.026,,,,,1 - 1.04, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Jan 14, 2026 11:18 AM",6226780857,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.9,,,,,0 - 6.2,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Alkaline Phosphatase,,68,,,,,35 - 104,U/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,ALT (SGPT),,70,,H RX,,,4 - 43,U/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,AST (SGOT),,56,,H,,,8 - 40,U/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,GGT,,98,,H,,,5 - 50,U/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,LDH,,188,,,,,53 - 234,U/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Urea Nitrogen,,2.1,,,,,1.4 - 8.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,52,,,,,31 - 101,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Glucose Fasting,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Serum Uric Acid,,419,,,,,149 - 446,umol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Calcium (EDTA),,2.56,,,,,2.07 - 2.64,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Creatine Kinase,,109,,,,,26 - 192,U/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Serum Sodium,,138,,,,,135 - 145,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Serum Bicarbonate,,26.5,,,,,19.3 - 29.3,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,CHEMISTRY PANEL,Serum Chloride,,96,,,,,94 - 112,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,115 - 158,g/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,3.9 - 5.5,TI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,104,,H,,,80 - 100,fL +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.88,,,,,3.8 - 10.7,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.64,,,,,1.96 - 7.23,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.55,,,,,0.8 - 3,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.51,,,,,0.12 - 0.92,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.0,,,,,40.5 - 75,% +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,37.2,,,,,15.4 - 48.5,% +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.4,,,,,2.6 - 10.1,% +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,288,,,,,130 - 394,GI/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.19,,,,,1.9 - 23,uIU/mL +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,LIPID PANEL,Direct HDL-C 4th Generation,,1.60,,H,,,1.03 - 1.53,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,LIPID PANEL,Triglycerides (GPO),,1.16,,,,,0.63 - 2.71,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,LIPID PANEL,Cholesterol (High Performance),,3.65,,L,,,4.86 - 8.28,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,LIPID PANEL,LDL Chol Friedewald 4th,,1.52,,,,,0 - 3.34,mmol/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,TSH,TSH 3rd IS-QT,,0.906,,,,,0.45 - 5.33,mIU/L +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Specific Gravity,,1.012,,,,,1.01 - 1.03, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Ketones,,Trace,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 DB Baseline,,"Jan 13, 2026 1:15 PM",6226686953,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.0,,,,,0 - 5,mg/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 5,/HPF +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Alkaline Phosphatase,,67,,,,,40 - 129,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,GGT,,30,,,,,10 - 61,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,83,,,,,40 - 119,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Glucose Fasting,,6.8,,H,,,3.9 - 5.6,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Serum Uric Acid,,297,,,,,149 - 494,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Creatine Kinase,,63,,,,,39 - 308,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Serum Bicarbonate,,21.1,,,,,19.3 - 29.3,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,157,,,,,127 - 181,g/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.48,,,,,0.39 - 0.54, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,100,,H,,,79 - 96,fL +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.88,,,,,3.8 - 10.7,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.58,,,,,1.96 - 7.23,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.46,,,,,0.91 - 4.28,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.59,,,,,0.12 - 0.92,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.19,,,,,0 - 0.57,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.8,,,,,40.5 - 75,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.7,,,,,15.4 - 48.5,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,243,,,,,140 - 400,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,35.89,,H,,,1.9 - 23,uIU/mL +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,LIPID PANEL,Direct HDL-C 4th Generation,,1.18,,,,,1.03 - 1.53,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,LIPID PANEL,Triglycerides (GPO),,2.11,,,,,0.65 - 3.61,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,LIPID PANEL,Cholesterol (High Performance),,5.10,,,,,4.4 - 7.53,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,LIPID PANEL,LDL Chol Friedewald 4th,,2.95,,,,,0 - 3.34,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,TSH,TSH 3rd IS-QT,,0.729,,,,,0.45 - 5.33,mIU/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Specific Gravity,,1.030,,,,,1 - 1.04, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Jan 13, 2026 10:45 AM",6227520242,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.5,,,,,0 - 5,mg/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.0,,,,,0 - 6.2,umol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Alkaline Phosphatase,,72,,,,,35 - 104,U/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,GGT,,40,,,,,4 - 49,U/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,LDH,,177,,,,,53 - 234,U/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 101,umol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Serum Uric Acid,,398,,,,,149 - 446,umol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Calcium (EDTA),,2.49,,,,,2.07 - 2.64,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Phosphorus,,0.96,,,,,0.71 - 1.65,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Creatine Kinase,,73,,,,,26 - 192,U/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Serum Bicarbonate,,22.1,,,,,19.3 - 29.3,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,CHEMISTRY PANEL,Serum Chloride,,98,,,,,94 - 112,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,149,,,,,116 - 164,g/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.34 - 0.48, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,79 - 98,fL +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.74,,,,,3.8 - 10.7,GI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.11,,,,,1.96 - 7.23,GI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.22,,,,,0.91 - 4.28,GI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.27,,,,,0.12 - 0.92,GI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.0,,,,,40.5 - 75,% +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.1,,,,,15.4 - 48.5,% +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.0,,,,,2.6 - 10.1,% +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.2,,,,,0 - 6.8,% +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,564,,H,,,140 - 400,GI/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.03,,,,,1.9 - 23,uIU/mL +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,LIPID PANEL,Direct HDL-C 4th Generation,,2.53,,H,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,LIPID PANEL,Triglycerides (GPO),,2.65,,,,,0.59 - 2.96,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,LIPID PANEL,Cholesterol (High Performance),,5.29,,,,,4.42 - 7.53,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,LIPID PANEL,LDL Chol Friedewald 4th,,1.55,,,,,0 - 3.34,mmol/L +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Specific Gravity,,1.020,,,,,1 - 1.04, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 2 OL Induction Day 29,,"Dec 17, 2025 11:17 AM",6227072419,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Alkaline Phosphatase,,57,,,,,40 - 129,U/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,ALT (SGPT),,26,,,,,5 - 48,U/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,GGT,,44,,,,,10 - 61,U/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,LDH,,173,,,,,53 - 234,U/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,78,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Serum Uric Acid,,379,,,,,125 - 488,umol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Calcium (EDTA),,2.62,,,,,2.07 - 2.64,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Phosphorus,,0.80,,,,,0.71 - 1.65,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Total Protein,,84,,,,,61 - 84,g/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Albumin-BCG,,53,,H,,,33 - 49,g/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Creatine Kinase,,108,,,,,39 - 308,U/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Serum Sodium,,145,,,,,132 - 147,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.31,,H,,,1.42 - 2.08,mL/sec +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,78,,,,,40 - 110,umol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,87.0,,,,,kg, +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,LIPID PANEL,Direct HDL-C 4th Generation,,0.94,,L,,,1.03 - 1.53,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,LIPID PANEL,Triglycerides (GPO),,2.31,,,,,0.56 - 3.62,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,LIPID PANEL,Cholesterol (High Performance),,5.76,,,,,3.88 - 6.83,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,LIPID PANEL,LDL Chol Friedewald 4th,,3.76,,H,,,0 - 3.34,mmol/L +CZ100080007,,,40,years,Male,Retest,,"Dec 15, 2025 10:53 AM",6226785740,TSH,TSH 3rd IS-QT,,1.044,,,,,0.45 - 5.33,mIU/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,C-REACTIVE PROTEIN,C Reactive Protein HS,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Total Bilirubin,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,ALT (SGPT),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,AST (SGOT),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,GGT,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,LDH,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Urea Nitrogen,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Glucose Fasting,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Serum Uric Acid,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Calcium (EDTA),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Phosphorus,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Total Protein,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Albumin-BCG,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Creatine Kinase,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Serum Sodium,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Serum Potassium,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Serum Bicarbonate,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CHEMISTRY PANEL,Serum Chloride,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,Required testing unavailable,,,,,1.42 - 2.08,mL/sec +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,87.0,,,,,kg, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,GFR,EGFR by MDRD,,Required testing unavailable,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,127 - 181,g/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.79,,,,,3.8 - 10.7,GI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.23,,,,,1.96 - 7.23,GI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.09,,,,,0.91 - 4.28,GI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.41,,,,,0.12 - 0.92,GI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.03,,,,,0 - 0.57,GI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.4,,,,,40.5 - 75,% +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.8,,,,,15.4 - 48.5,% +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.5,,,,,0 - 6.8,% +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,207,,,,,140 - 400,GI/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,15.62,,,,,1.9 - 23,uIU/mL +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,LIPID PANEL,Direct HDL-C 4th Generation,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,LIPID PANEL,Triglycerides (GPO),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,LIPID PANEL,Cholesterol (High Performance),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,LIPID PANEL,LDL Chol Friedewald 4th,,Required testing unavailable,,,,,0 - 3.34,mmol/L +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,TSH,TSH 3rd IS-QT,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Specific Gravity,,1.032,,,,,1 - 1.04, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur pH,,7.0,,,,,5 - 8, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080007,,,40,years,Male,Part 1 Screening,,"Dec 10, 2025 10:20 AM",6225351044,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,C-REACTIVE PROTEIN,C Reactive Protein HS,,7.3,,H,,,0 - 5,mg/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CELLULAR ELEMENTS,Ur RBC/HPF,,2,,,,,0 - 3,/HPF +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CELLULAR ELEMENTS,Ur WBC/HPF,,7,,H,,,0 - 5,/HPF +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Alkaline Phosphatase,,58,,,,,40 - 129,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,GGT,,26,,,,,10 - 61,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,LDH,,171,,,,,53 - 234,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,86,,,,,40 - 119,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Glucose Fasting,,6.0,,H,,,3.9 - 5.6,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Serum Uric Acid,,317,,,,,149 - 494,umol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Calcium (EDTA),,2.26,,,,,2.07 - 2.64,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Phosphorus,,0.98,,,,,0.71 - 1.65,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Creatine Kinase,,76,,,,,39 - 308,U/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Serum Bicarbonate,,25.0,,,,,19.3 - 29.3,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.5 - 6.4,TI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,99,,H,,,79 - 96,fL +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.00,,,,,3.8 - 10.7,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.16,,,,,1.96 - 7.23,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.99,,,,,0.91 - 4.28,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.71,,,,,0.12 - 0.92,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,68.4,,,,,40.5 - 75,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,22.2,,,,,15.4 - 48.5,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.9,,,,,2.6 - 10.1,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.2,,,,,0 - 2,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,256,,,,,140 - 400,GI/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,11.88,,,,,1.9 - 23,uIU/mL +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,LIPID PANEL,Direct HDL-C 4th Generation,,1.07,,,,,1.03 - 1.53,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,LIPID PANEL,Triglycerides (GPO),,1.52,,,,,0.65 - 3.61,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,LIPID PANEL,Cholesterol (High Performance),,4.74,,,,,4.4 - 7.53,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,LIPID PANEL,LDL Chol Friedewald 4th,,2.97,,,,,0 - 3.34,mmol/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,MISCELLANEOUS ELEMENTS,Ur Sperm,,Present,,,,,Ref Rng:Not present, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,TSH,TSH 3rd IS-QT,,0.706,,,,,0.45 - 5.33,mIU/L +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Specific Gravity,,1.032,,,,,1 - 1.04, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,End of Phase/Treatment,,"Dec 9, 2025 11:35 AM",6226780855,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.6,,,,,0 - 5,mg/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Alkaline Phosphatase,,63,,,,,35 - 104,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,GGT,,31,,,,,4 - 49,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,LDH,,166,,,,,53 - 234,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Urea Nitrogen,,2.9,,,,,1.4 - 8.6,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Serum Uric Acid,,189,,,,,149 - 446,umol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Phosphorus,,0.99,,,,,0.71 - 1.65,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Creatine Kinase,,77,,,,,26 - 192,U/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,116 - 164,g/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,79 - 98,fL +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.79,,,,,3.8 - 10.7,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.69,,,,,1.96 - 7.23,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.52,,,,,0.91 - 4.28,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.7,,,,,40.5 - 75,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.3,,,,,15.4 - 48.5,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.5,,,,,0 - 6.8,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,402,,H,,,140 - 400,GI/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.90,,,,,1.9 - 23,uIU/mL +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,LIPID PANEL,Direct HDL-C 4th Generation,,1.98,,H,,,1.03 - 1.53,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,LIPID PANEL,Triglycerides (GPO),,1.65,,,,,0.59 - 2.96,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,LIPID PANEL,Cholesterol (High Performance),,5.40,,,,,4.42 - 7.53,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,LIPID PANEL,LDL Chol Friedewald 4th,,2.66,,,,,0 - 3.34,mmol/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,RETICULOCYTES,Reticulocyte Count %,,2.3,,,,,0.6 - 2.5,% +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,TSH,TSH 3rd IS-QT,,1.816,,,,,0.45 - 5.33,mIU/L +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1 - 1.04, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,End of Phase/Treatment,,"Nov 18, 2025 11:06 AM",6226780856,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.6,,,,,0 - 5,mg/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CELLULAR ELEMENTS,Ur RBC/HPF,,1,,,,,0 - 8,/HPF +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 12,/HPF +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Alkaline Phosphatase,,36,,,,,35 - 104,U/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,4 - 43,U/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,GGT,,6,,,,,4 - 49,U/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,LDH,,153,,,,,53 - 234,U/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Serum Uric Acid,,259,,,,,125 - 428,umol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Phosphorus,,0.98,,,,,0.71 - 1.65,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Creatine Kinase,,105,,,,,26 - 192,U/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Serum Bicarbonate,,22.1,,,,,19.3 - 29.3,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,131,,,,,116 - 164,g/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,82,,,,,79 - 98,fL +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.46,,,,,3.8 - 10.7,GI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.81,,,,,1.96 - 7.23,GI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.34,,,,,0.91 - 4.28,GI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.24,,,,,0.12 - 0.92,GI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,69.7,,,,,40.5 - 75,% +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,24.6,,,,,15.4 - 48.5,% +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.4,,,,,2.6 - 10.1,% +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,267,,,,,140 - 400,GI/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.3,,,,,<6.5%, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.64,,,,,1.9 - 23,uIU/mL +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,LIPID PANEL,Direct HDL-C 4th Generation,,1.66,R,H,,,1.03 - 1.53,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,LIPID PANEL,Triglycerides (GPO),,1.43,,,,,0.41 - 1.63,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,LIPID PANEL,Cholesterol (High Performance),,4.82,,,,,3.31 - 5.64,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,LIPID PANEL,LDL Chol Friedewald 4th,,2.51,,,,,0 - 3.34,mmol/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,MICROORGANISMS,Ur Yeast-Budding,,Present,,,,,Ref Rng:Not present, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,MICROORGANISMS,Ur Yeast-Hyphae,,Present,,,,,Ref Rng:Not present, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,RETICULOCYTES,Reticulocyte Count %,,0.6,,,,,0.6 - 2.5,% +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,TSH,TSH 3rd IS-QT,,1.379,,,,,0.45 - 5.33,mIU/L +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MACRO PANEL,Ur Leukocyte Esterase,,+2,,H SF,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,End of Phase/Treatment,,"Nov 5, 2025 12:50 PM",6226780853,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CASTS,Ur Hyaline Casts/LPF,,27,,,,,0 /LPF, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Alkaline Phosphatase,,61,,,,,35 - 104,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,ALT (SGPT),,64,,H,,,4 - 43,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,AST (SGOT),,63,,H RX,,,8 - 40,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,GGT,,85,,H,,,5 - 50,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,LDH,,207,,,,,53 - 234,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Urea Nitrogen,,2.8,,,,,1.4 - 8.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Serum Uric Acid,,423,,,,,149 - 446,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Phosphorus,,1.23,,,,,0.71 - 1.65,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Total Protein,,78,,,,,60 - 80,g/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Creatine Kinase,,141,,,,,26 - 192,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Serum Bicarbonate,,22.7,,,,,19.3 - 29.3,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,CHEMISTRY PANEL,Serum Chloride,,99,,,,,94 - 112,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,138,,,,,115 - 158,g/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,3.9 - 5.5,TI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,102,,H,,,80 - 100,fL +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.70,,,,,3.8 - 10.7,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.73,,,,,1.96 - 7.23,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.43,,,,,0.8 - 3,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.35,,,,,0.12 - 0.92,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.7,,,,,40.5 - 75,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.2,,,,,15.4 - 48.5,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.2,,,,,2.6 - 10.1,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,274,,,,,130 - 394,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.35,,,,,1.9 - 23,uIU/mL +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,LIPID PANEL,Direct HDL-C 4th Generation,,1.68,,H,,,1.03 - 1.53,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,LIPID PANEL,Triglycerides (GPO),,1.03,,,,,0.63 - 2.71,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,LIPID PANEL,Cholesterol (High Performance),,5.23,,,,,4.86 - 8.28,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,LIPID PANEL,LDL Chol Friedewald 4th,,3.08,,,,,0 - 3.34,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1.01 - 1.03, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Protein,,+1,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Ketones,,Trace,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Day 29,,"Nov 4, 2025 12:05 PM",6226804961,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,C-REACTIVE PROTEIN,C Reactive Protein HS,,8.3,,H,,,0 - 5,mg/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Alkaline Phosphatase,,64,,,,,40 - 129,U/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,5 - 48,U/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,GGT,,28,,,,,10 - 61,U/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,LDH,,163,,,,,53 - 234,U/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 8.6,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,83,,,,,40 - 119,umol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Serum Uric Acid,,311,,,,,149 - 494,umol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Calcium (EDTA),,2.30,,,,,2.07 - 2.64,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Creatine Kinase,,73,,,,,39 - 308,U/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Serum Bicarbonate,,21.0,,,,,19.3 - 29.3,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,158,,,,,127 - 181,g/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.48,,,,,0.39 - 0.54, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,99,R,H,,,79 - 96,fL +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.66,,,,,3.8 - 10.7,GI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,7.67,R,H,,,1.96 - 7.23,GI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.03,,,,,0.91 - 4.28,GI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.77,,,,,0.12 - 0.92,GI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.9,,,,,40.5 - 75,% +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.1,,,,,15.4 - 48.5,% +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.3,,,,,2.6 - 10.1,% +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.4,,,,,0 - 6.8,% +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,251,,,,,140 - 400,GI/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.56,,,,,1.9 - 23,uIU/mL +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,LIPID PANEL,Direct HDL-C 4th Generation,,1.04,,,,,1.03 - 1.53,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,LIPID PANEL,Triglycerides (GPO),,1.84,,,,,0.65 - 3.61,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,LIPID PANEL,Cholesterol (High Performance),,5.15,,,,,4.4 - 7.53,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,LIPID PANEL,LDL Chol Friedewald 4th,,3.27,,,,,0 - 3.34,mmol/L +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Specific Gravity,,1.012,,,,,1 - 1.04, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 DB Baseline,,"Oct 29, 2025 10:10 AM",6226551698,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,C-REACTIVE PROTEIN,C Reactive Protein HS,,6.1,,H,,,0 - 5,mg/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Alkaline Phosphatase,,106,,,,,40 - 129,U/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,ALT (SGPT),,32,,,,,5 - 48,U/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,AST (SGOT),,28,,,,,8 - 40,U/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,GGT,,105,,H,,,10 - 61,U/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,LDH,,140,,,,,53 - 234,U/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Urea Nitrogen,,3.2,,,,,1.4 - 8.6,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,98,,,,,40 - 119,umol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Glucose Fasting,,5.3,,,,,3.9 - 5.6,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Serum Uric Acid,,378,,,,,149 - 494,umol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Phosphorus,,0.96,,,,,0.71 - 1.65,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Creatine Kinase,,55,,,,,39 - 308,U/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Serum Bicarbonate,,26.4,,,,,19.3 - 29.3,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,127 - 181,g/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.39 - 0.54, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,94,,,,,79 - 96,fL +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.05,,,,,3.8 - 10.7,GI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.34,,,,,1.96 - 7.23,GI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.31,,,,,0.91 - 4.28,GI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.30,,,,,0.12 - 0.92,GI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.8,,,,,40.5 - 75,% +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.3,,,,,15.4 - 48.5,% +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.4,,,,,2.6 - 10.1,% +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,219,,,,,140 - 400,GI/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.3,,,,,<6.5%, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.63,,,,,1.9 - 23,uIU/mL +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,LIPID PANEL,Direct HDL-C 4th Generation,,1.31,,,,,1.03 - 1.53,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,LIPID PANEL,Triglycerides (GPO),,1.15,,,,,0.65 - 3.61,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,LIPID PANEL,Cholesterol (High Performance),,6.10,,,,,4.4 - 7.53,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,LIPID PANEL,LDL Chol Friedewald 4th,,4.26,,H,,,0 - 3.34,mmol/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,% +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,TSH,TSH 3rd IS-QT,,0.733,,,,,0.45 - 5.33,mIU/L +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Specific Gravity,,1.015,,,,,1 - 1.04, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Early Withdrawal,,"Oct 14, 2025 12:30 PM",6225351066,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.7,,,,,0 - 5,mg/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.0,,,,,0 - 6.2,umol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Alkaline Phosphatase,,77,,,,,35 - 104,U/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,ALT (SGPT),,22,,,,,4 - 43,U/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,GGT,,28,,,,,4 - 49,U/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,LDH,,184,,,,,53 - 234,U/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Urea Nitrogen,,3.5,,,,,1.4 - 8.6,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,62,,,,,31 - 101,umol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Serum Uric Acid,,259,,,,,149 - 446,umol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Calcium (EDTA),,2.46,,,,,2.07 - 2.64,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Phosphorus,,1.16,,,,,0.71 - 1.65,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Creatine Kinase,,82,,,,,26 - 192,U/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,116 - 164,g/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,79 - 98,fL +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.32,,,,,3.8 - 10.7,GI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.74,,,,,1.96 - 7.23,GI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.91,,,,,0.91 - 4.28,GI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.45,,,,,0.12 - 0.92,GI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.2,,,,,40.5 - 75,% +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.3,,,,,15.4 - 48.5,% +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,,2.6 - 10.1,% +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.7,,,,,0 - 6.8,% +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,356,,,,,140 - 400,GI/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.42,,,,,1.9 - 23,uIU/mL +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,LIPID PANEL,Direct HDL-C 4th Generation,,1.90,,H,,,1.03 - 1.53,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,LIPID PANEL,Triglycerides (GPO),,1.05,,,,,0.59 - 2.96,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,LIPID PANEL,Cholesterol (High Performance),,5.04,,,,,4.42 - 7.53,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,LIPID PANEL,LDL Chol Friedewald 4th,,2.66,,,,,0 - 3.34,mmol/L +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,RETICULOCYTES,Reticulocyte Count %,,2.3,,,,,0.6 - 2.5,% +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1 - 1.04, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 DB Baseline,,"Oct 8, 2025 11:19 AM",6225351050,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.5,,,,,0 - 5,mg/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Alkaline Phosphatase,,42,,,,,35 - 104,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,GGT,,6,,,,,4 - 49,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,LDH,,169,,,,,53 - 234,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,67,,,,,31 - 101,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Serum Uric Acid,,273,,,,,125 - 428,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Phosphorus,,0.98,,,,,0.71 - 1.65,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Creatine Kinase,,113,,,,,26 - 192,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Serum Bicarbonate,,20.6,,,,,19.3 - 29.3,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,135,,,,,116 - 164,g/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.1 - 5.6,TI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,82,,,,,79 - 98,fL +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.49,,,,,3.8 - 10.7,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.33,,,,,1.96 - 7.23,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.72,,,,,0.91 - 4.28,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.35,,,,,0.12 - 0.92,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,66.8,,,,,40.5 - 75,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.5,,,,,15.4 - 48.5,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,327,,,,,140 - 400,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.98,,,,,1.9 - 23,uIU/mL +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,LIPID PANEL,Direct HDL-C 4th Generation,,1.69,R,H,,,1.03 - 1.53,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,LIPID PANEL,Triglycerides (GPO),,1.86,R,H,,,0.41 - 1.63,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,LIPID PANEL,Cholesterol (High Performance),,5.31,,,,,3.31 - 5.64,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,LIPID PANEL,LDL Chol Friedewald 4th,,2.77,,,,,0 - 3.34,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,RETICULOCYTES,Reticulocyte Count %,,0.8,,,,,0.6 - 2.5,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Specific Gravity,,1.022,,,,,1 - 1.04, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Blood,,+3,R,H SF,,,Ref Rng:$Negative-Trace, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Day 29,,"Oct 8, 2025 9:20 AM",6226686952,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.4,,,,,0 - 5,mg/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CASTS,Ur Hyaline Casts/LPF,,4,,,,,0 /LPF, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Alkaline Phosphatase,,62,,,,,35 - 104,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,ALT (SGPT),,35,,,,,4 - 43,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,AST (SGOT),,29,,,,,8 - 40,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,GGT,,51,,H,,,5 - 50,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,LDH,,178,,,,,53 - 234,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Urea Nitrogen,,3.3,,,,,1.4 - 8.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,55,,,,,31 - 101,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Glucose Fasting,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Serum Uric Acid,,451,,H,,,149 - 446,umol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Calcium (EDTA),,2.53,,,,,2.07 - 2.64,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Phosphorus,,1.03,,,,,0.71 - 1.65,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Total Protein,,74,,,,,60 - 80,g/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Creatine Kinase,,153,,,,,26 - 192,U/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Serum Sodium,,138,,,,,135 - 145,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Serum Potassium,,3.9,,,,,3.5 - 5.2,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Serum Bicarbonate,,23.9,,,,,19.3 - 29.3,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,CHEMISTRY PANEL,Serum Chloride,,97,,,,,94 - 112,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,133,,,,,115 - 158,g/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,3.9 - 5.5,TI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,101,R,H,,,80 - 100,fL +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.90,,,,,3.8 - 10.7,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.97,,,,,1.96 - 7.23,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.30,,,,,0.8 - 3,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.20,,,,,0 - 0.57,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,50.3,,,,,40.5 - 75,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.9,,,,,15.4 - 48.5,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.8,,,,,2.6 - 10.1,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.3,,,,,0 - 6.8,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,244,,,,,130 - 394,GI/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.6,,,,,<6.5%, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.01,,,,,1.9 - 23,uIU/mL +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,LIPID PANEL,Direct HDL-C 4th Generation,,1.47,,,,,1.03 - 1.53,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,LIPID PANEL,Triglycerides (GPO),,1.30,,,,,0.63 - 2.71,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,LIPID PANEL,Cholesterol (High Performance),,3.27,,L,,,4.86 - 8.28,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,LIPID PANEL,LDL Chol Friedewald 4th,,1.20,,,,,0 - 3.34,mmol/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,TSH,TSH 3rd IS-QT,,1.174,,,,,0.45 - 5.33,mIU/L +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1.01 - 1.03, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Ketones,,Trace,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 2 OL Induction Baseline,,"Oct 7, 2025 12:02 PM",6225351057,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.6,,,,,0 - 6.2,umol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Alkaline Phosphatase,,80,,,,,40 - 129,U/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,ALT (SGPT),,31,,,,,5 - 48,U/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,AST (SGOT),,30,,,,,8 - 40,U/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,GGT,,68,R,H,,,10 - 61,U/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,LDH,,163,,,,,53 - 234,U/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Urea Nitrogen,,3.8,,,,,1.4 - 8.6,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,93,,,,,40 - 119,umol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Serum Uric Acid,,448,,,,,149 - 494,umol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Phosphorus,,0.78,,,,,0.71 - 1.65,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Creatine Kinase,,143,,,,,39 - 308,U/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Serum Potassium,,3.8,,,,,3.5 - 5.2,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Serum Bicarbonate,,24.3,,,,,19.3 - 29.3,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,CHEMISTRY PANEL,Serum Chloride,,98,,,,,94 - 112,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,127 - 181,g/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.39 - 0.54, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,94,,,,,79 - 96,fL +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.18,,,,,3.8 - 10.7,GI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.32,,,,,1.96 - 7.23,GI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.51,,,,,0.91 - 4.28,GI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.23,,,,,0.12 - 0.92,GI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.09,,,,,0 - 0.57,GI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.7,,,,,40.5 - 75,% +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.1,,,,,15.4 - 48.5,% +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,203,,,,,140 - 400,GI/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,8.51,,,,,1.9 - 23,uIU/mL +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,LIPID PANEL,Direct HDL-C 4th Generation,,1.29,,,,,1.03 - 1.53,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,LIPID PANEL,Triglycerides (GPO),,1.22,,,,,0.65 - 3.61,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,LIPID PANEL,Cholesterol (High Performance),,5.80,,,,,4.4 - 7.53,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,LIPID PANEL,LDL Chol Friedewald 4th,,3.95,,H,,,0 - 3.34,mmol/L +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,RETICULOCYTES,Reticulocyte Count %,,0.6,,,,,0.6 - 2.5,% +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Specific Gravity,,1.014,,,,,1 - 1.04, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 DB Baseline,,"Sep 16, 2025 12:35 PM",6225351052,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.5,,,,,0 - 5,mg/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,40 - 129,U/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,GGT,,29,,,,,10 - 61,U/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,LDH,,173,,,,,53 - 234,U/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,73,,,,,40 - 119,umol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Serum Uric Acid,,268,,,,,149 - 494,umol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Calcium (EDTA),,2.26,,,,,2.07 - 2.64,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Phosphorus,,1.02,,,,,0.71 - 1.65,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Creatine Kinase,,93,,,,,39 - 308,U/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Serum Bicarbonate,,20.0,,,,,19.3 - 29.3,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.12,,H,,,1.42 - 2.08,mL/sec +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,73,,,,,40 - 119,umol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,85.0,,,,,kg, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,GFR,EGFR by MDRD,,98,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,127 - 181,g/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,101,,H,,,79 - 96,fL +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.62,,,,,3.8 - 10.7,GI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.14,,,,,1.96 - 7.23,GI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.83,,,,,0.91 - 4.28,GI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.48,,,,,0.12 - 0.92,GI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.2,,,,,40.5 - 75,% +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,21.2,,,,,15.4 - 48.5,% +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,218,,,,,140 - 400,GI/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.5,,,,,<6.5%, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.69,,,,,1.9 - 23,uIU/mL +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,LIPID PANEL,Direct HDL-C 4th Generation,,1.08,,,,,1.03 - 1.53,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,LIPID PANEL,Triglycerides (GPO),,2.26,,,,,0.65 - 3.61,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,LIPID PANEL,Cholesterol (High Performance),,4.47,,,,,4.4 - 7.53,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,LIPID PANEL,LDL Chol Friedewald 4th,,2.35,,,,,0 - 3.34,mmol/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,TSH,TSH 3rd IS-QT,,0.878,,,,,0.45 - 5.33,mIU/L +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Specific Gravity,,1.013,,,,,1 - 1.04, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080006,,,52,years,Male,Part 1 Screening,,"Sep 16, 2025 9:45 AM",6225351040,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.5,,,,,0 - 5,mg/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Alkaline Phosphatase,,63,,,,,35 - 104,U/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,4 - 43,U/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,GGT,,22,,,,,4 - 49,U/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,LDH,,182,,,,,53 - 234,U/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Urea Nitrogen,,3.0,,,,,1.4 - 8.6,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Serum Uric Acid,,224,,,,,149 - 446,umol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Creatine Kinase,,71,,,,,26 - 192,U/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Serum Bicarbonate,,22.7,,,,,19.3 - 29.3,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.81,,,,,1.25 - 1.92,mL/sec +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,69.0,,,,,kg, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,FSH,Follicle Stimulating Hormone,,6.17,,RX,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,GFR,EGFR by MDRD,,97,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,116 - 164,g/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,98,,,,,79 - 98,fL +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.11,,,,,3.8 - 10.7,GI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.39,,,,,1.96 - 7.23,GI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.04,,,,,0.91 - 4.28,GI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.8,,,,,40.5 - 75,% +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.7,,,,,15.4 - 48.5,% +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,% +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,431,,H,,,140 - 400,GI/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.2,,,,,<6.5%, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.05,,,,,1.9 - 23,uIU/mL +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,LIPID PANEL,Direct HDL-C 4th Generation,,1.95,,H,,,1.03 - 1.53,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,LIPID PANEL,Triglycerides (GPO),,1.54,,,,,0.59 - 2.96,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,LIPID PANEL,Cholesterol (High Performance),,5.27,,,,,4.42 - 7.53,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,LIPID PANEL,LDL Chol Friedewald 4th,,2.61,,,,,0 - 3.34,mmol/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,RETICULOCYTES,Reticulocyte Count %,,2.9,,H,,,0.6 - 2.5,% +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,TSH,TSH 3rd IS-QT,,1.573,,,,,0.45 - 5.33,mIU/L +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Specific Gravity,,1.010,,,,,1 - 1.04, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080005,,,55,years,Female,Part 1 Screening,,"Sep 10, 2025 1:31 PM",6225351046,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Alkaline Phosphatase,,38,,,,,35 - 104,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,GGT,,6,,,,,4 - 49,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,LDH,,162,,,,,53 - 234,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Urea Nitrogen,,3.5,,,,,1.4 - 8.6,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,59,,,,,31 - 101,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Serum Uric Acid,,260,,,,,125 - 428,umol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Calcium (EDTA),,2.26,,,,,2.07 - 2.64,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Phosphorus,,0.56,,LT,,Result verified by repeat analysis,0.71 - 1.65,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Creatine Kinase,,358,R,H,,,26 - 192,U/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Serum Bicarbonate,,21.1,,,,,19.3 - 29.3,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,132,,,,,116 - 164,g/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.1 - 5.6,TI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,82,,,,,79 - 98,fL +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.52,,,,,3.8 - 10.7,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.93,,,,,1.96 - 7.23,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.25,,,,,0.91 - 4.28,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.27,,,,,0.12 - 0.92,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,64.8,,,,,40.5 - 75,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.6,,,,,15.4 - 48.5,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.4,,,,,0 - 6.8,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.2,,,,,0 - 2,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,262,,,,,140 - 400,GI/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.2,,,,,<6.5%, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.63,,,,,1.9 - 23,uIU/mL +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,IS SUBJECT FASTING?,Is Subject Fasting?,Y,No,,,,,, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,LIPID PANEL,Direct HDL-C 4th Generation,,1.42,,,,,1.03 - 1.53,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,LIPID PANEL,Triglycerides (GPO),,1.42,,,,,0.41 - 1.63,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,LIPID PANEL,Cholesterol (High Performance),,4.13,,,,,3.31 - 5.64,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,LIPID PANEL,LDL Chol Friedewald 4th,,2.06,,,,,0 - 3.34,mmol/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,TSH,TSH 3rd IS-QT,,1.160,,,,,0.45 - 5.33,mIU/L +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Specific Gravity,,1.020,,,,,1 - 1.04, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 2 OL Induction Baseline,R,"Sep 10, 2025 11:35 AM",6225351056,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080004,,,54,years,Male,Retest,,"Sep 8, 2025 10:00 AM",6225351070,IS SUBJECT FASTING?,Is Subject Fasting?,Y,No,,,,,, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.1,,,,,0 - 6.2,umol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Alkaline Phosphatase,,70,,,,,35 - 104,U/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,ALT (SGPT),,40,,,,,4 - 43,U/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,AST (SGOT),,35,,,,,8 - 40,U/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,GGT,,54,,H,,,5 - 50,U/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,LDH,,184,,,,,53 - 234,U/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Urea Nitrogen,,2.1,,,,,1.4 - 8.6,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Glucose Fasting,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Serum Uric Acid,,413,,,,,149 - 446,umol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Calcium (EDTA),,2.58,,,,,2.07 - 2.64,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Phosphorus,,1.19,,,,,0.71 - 1.65,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Creatine Kinase,,155,,,,,26 - 192,U/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Serum Bicarbonate,,22.5,,,,,19.3 - 29.3,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,CHEMISTRY PANEL,Serum Chloride,,96,,,,,94 - 112,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,115 - 158,g/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,3.9 - 5.5,TI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,101,R,H,,,80 - 100,fL +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.55,,,,,3.8 - 10.7,GI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.20,,,,,1.96 - 7.23,GI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.66,,,,,0.8 - 3,GI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.44,,,,,0.12 - 0.92,GI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.21,,,,,0 - 0.57,GI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.5,,,,,40.5 - 75,% +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.1,,,,,15.4 - 48.5,% +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.9,,,,,2.6 - 10.1,% +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.8,,,,,0 - 6.8,% +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,275,,,,,130 - 394,GI/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.10,,,,,1.9 - 23,uIU/mL +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,LIPID PANEL,Direct HDL-C 4th Generation,,1.39,,,,,1.03 - 1.53,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,LIPID PANEL,Triglycerides (GPO),,1.36,,,,,0.63 - 2.71,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,LIPID PANEL,Cholesterol (High Performance),,3.50,,L,,,4.86 - 8.28,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,LIPID PANEL,LDL Chol Friedewald 4th,,1.49,,,,,0 - 3.34,mmol/L +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Specific Gravity,,1.010,,,,,1.01 - 1.03, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Ketones,,+1,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 DB Baseline,,"Aug 26, 2025 12:47 PM",6225351051,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.5,,,,,0 - 5,mg/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.9,,,,,0 - 6.2,umol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Alkaline Phosphatase,,76,,,,,40 - 129,U/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,5 - 48,U/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,GGT,,61,,,,,10 - 61,U/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,LDH,,160,,,,,53 - 234,U/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Urea Nitrogen,,4.8,,,,,1.4 - 8.6,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,87,,,,,40 - 119,umol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Serum Uric Acid,,353,,,,,149 - 494,umol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Phosphorus,,0.79,,,,,0.71 - 1.65,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Creatine Kinase,,153,,,,,39 - 308,U/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Serum Bicarbonate,,21.7,,,,,19.3 - 29.3,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.83,,,,,1.42 - 2.08,mL/sec +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,87,,,,,40 - 119,umol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,89.2,,,,,kg, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,DRUG SCREEN URINE,Opiates,,Detected (unconfirmed),,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,GFR,EGFR by MDRD,,80,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,152,,,,,127 - 181,g/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.39 - 0.54, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 96,fL +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.94,,,,,3.8 - 10.7,GI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.25,,,,,1.96 - 7.23,GI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.33,,,,,0.91 - 4.28,GI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.22,,,,,0.12 - 0.92,GI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.9,,,,,40.5 - 75,% +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.0,,,,,15.4 - 48.5,% +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.5,,,,,2.6 - 10.1,% +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,222,,,,,140 - 400,GI/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.5,,,,,<6.5%, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.22,,,,,1.9 - 23,uIU/mL +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,LIPID PANEL,Direct HDL-C 4th Generation,,1.15,,,,,1.03 - 1.53,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,LIPID PANEL,Triglycerides (GPO),,0.89,,,,,0.65 - 3.61,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,LIPID PANEL,Cholesterol (High Performance),,5.43,,,,,4.4 - 7.53,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,LIPID PANEL,LDL Chol Friedewald 4th,,3.87,,H,,,0 - 3.34,mmol/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,OPIATE CONFIRMATION URINE,Opiates Confirmed-LCMSMS-LDT,,Codeine (Confirmed),,RX,,,No Ref Rng, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,OPIATE CONFIRMATION URINE,Opiates Confirmed-LCMSMS-LDT,,Morphine (Confirmed),,RX,,,No Ref Rng, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,OPIATE CONFIRMATION URINE,Opiates Confirmed-LCMSMS-LDT,,6-MAM not present,,,,,No Ref Rng, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,TSH,TSH 3rd IS-QT,,0.914,,,,,0.45 - 5.33,mIU/L +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1 - 1.04, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Ketones,,+1,,H,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080004,,,54,years,Male,Part 1 Screening,,"Aug 26, 2025 11:08 AM",6225351042,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.3,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CELLULAR ELEMENTS,Ur WBC/HPF,,4,,,,,0 - 12,/HPF +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,35 - 104,U/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,4 - 43,U/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,GGT,,43,,,,,5 - 50,U/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,LDH,,183,,,,,53 - 234,U/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Urea Nitrogen,,3.2,,,,,1.4 - 8.6,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,47,,,,,31 - 101,umol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Glucose Fasting,,6.0,,H,,,3.9 - 5.6,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Serum Uric Acid,,253,,,,,149 - 446,umol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Phosphorus,,1.22,,,,,0.71 - 1.65,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Total Protein,,68,,,,,60 - 80,g/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Creatine Kinase,,89,,,,,26 - 192,U/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Serum Sodium,,143,,,,,135 - 145,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Serum Bicarbonate,,24.4,,,,,19.3 - 29.3,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.47,,H,,,1.25 - 1.92,mL/sec +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,47,,,,,31 - 101,umol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,89.0,,,,,kg, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,FSH,Follicle Stimulating Hormone,,29.08,,RX,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,GFR,EGFR by MDRD,,116,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,129,,,,,115 - 158,g/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,3.9 - 5.5,TI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,80 - 100,fL +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.29,,,,,3.8 - 10.7,GI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.65,,,,,1.96 - 7.23,GI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.23,,,,,0.8 - 3,GI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.31,,,,,0.12 - 0.92,GI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.7,,,,,40.5 - 75,% +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.6,,,,,15.4 - 48.5,% +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.2,,,,,2.6 - 10.1,% +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,% +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,250,,,,,130 - 394,GI/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,6.4,,,,,<6.5%, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,15.80,,,,,1.9 - 23,uIU/mL +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,LIPID PANEL,Direct HDL-C 4th Generation,,1.50,,,,,1.03 - 1.53,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,LIPID PANEL,Triglycerides (GPO),,1.69,,,,,0.63 - 2.71,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,LIPID PANEL,Cholesterol (High Performance),,4.20,,L,,,4.86 - 8.28,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,LIPID PANEL,LDL Chol Friedewald 4th,,1.93,,,,,0 - 3.34,mmol/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,RETICULOCYTES,Reticulocyte Count %,,1.5,,,,,0.6 - 2.5,% +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,TSH,TSH 3rd IS-QT,,1.074,,,,,0.45 - 5.33,mIU/L +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1.01 - 1.03, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,R,H SF,,,Ref Rng:Negative, +CZ100080003,,,66,years,Female,Part 1 Screening,,"Aug 6, 2025 11:43 AM",6225351041,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Alkaline Phosphatase,,73,,,,,35 - 104,U/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,ALT (SGPT),,40,,,,,4 - 43,U/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,GGT,,56,R,H,,,5 - 50,U/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,LDH,,169,,,,,53 - 234,U/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Urea Nitrogen,,2.9,,,,,1.4 - 8.6,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,51,,,,,31 - 101,umol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Serum Uric Acid,,479,R,H,,,149 - 446,umol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Calcium (EDTA),,2.56,,,,,2.07 - 2.64,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Phosphorus,,1.22,,,,,0.71 - 1.65,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Total Protein,,74,,,,,60 - 80,g/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Creatine Kinase,,135,,,,,26 - 192,U/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CHEMISTRY PANEL,Serum Chloride,,96,,,,,94 - 112,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.51,,H,,,1.25 - 1.92,mL/sec +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,51,,,,,31 - 101,umol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,93.1,,,,,kg, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,FSH,Follicle Stimulating Hormone,,30.27,,RX,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,GFR,EGFR by MDRD,,106,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,115 - 158,g/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.9,,,,,3.9 - 5.5,TI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,102,R,H,,,80 - 100,fL +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.37,,,,,3.8 - 10.7,GI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.86,,,,,1.96 - 7.23,GI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.96,,,,,0.8 - 3,GI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.3,,,,,40.5 - 75,% +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.6,,,,,15.4 - 48.5,% +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.3,,,,,2.6 - 10.1,% +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,232,,,,,130 - 394,GI/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,6.2,,,,,<6.5%, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.31,,,,,1.9 - 23,uIU/mL +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,LIPID PANEL,Direct HDL-C 4th Generation,,1.30,,,,,1.03 - 1.53,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,LIPID PANEL,Triglycerides (GPO),,1.55,,,,,0.63 - 2.71,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,LIPID PANEL,Cholesterol (High Performance),,3.52,R,L,,,4.86 - 8.28,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,LIPID PANEL,LDL Chol Friedewald 4th,,1.51,,,,,0 - 3.34,mmol/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,TSH,TSH 3rd IS-QT,,1.889,,,,,0.45 - 5.33,mIU/L +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Specific Gravity,,1.015,,,,,1.01 - 1.03, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080002,,,62,years,Female,Part 1 Screening,R,"Aug 5, 2025 11:58 AM",6225351045,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.0,,,,,0 - 5,mg/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CELLULAR ELEMENTS,Ur WBC/HPF,,3,,,,,0 - 12,/HPF +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Alkaline Phosphatase,,44,,,,,35 - 104,U/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,ALT (SGPT),,12,,,,,4 - 43,U/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,GGT,,6,,,,,4 - 49,U/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,LDH,,157,,,,,53 - 234,U/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,71,,,,,31 - 101,umol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Serum Uric Acid,,263,,,,,125 - 428,umol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Phosphorus,,0.71,,,,,0.71 - 1.65,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Creatine Kinase,,260,,H,,,26 - 192,U/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,,116 - 164,g/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.1 - 5.6,TI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,82,,,,,79 - 98,fL +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.54,,,,,3.8 - 10.7,GI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.08,,,,,1.96 - 7.23,GI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.06,,,,,0.91 - 4.28,GI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,,0 - 0.57,GI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,73.7,,,,,40.5 - 75,% +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.3,,,,,15.4 - 48.5,% +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.8,,,,,0 - 6.8,% +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,260,,,,,140 - 400,GI/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,16.54,,,,,1.9 - 23,uIU/mL +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,IS SUBJECT FASTING?,Is Subject Fasting?,Y,No,,,,,, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,LIPID PANEL,Direct HDL-C 4th Generation,,1.52,,,,,1.03 - 1.53,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,LIPID PANEL,Triglycerides (GPO),,1.60,,,,,0.41 - 1.63,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,LIPID PANEL,Cholesterol (High Performance),,4.24,,,,,3.31 - 5.64,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,LIPID PANEL,LDL Chol Friedewald 4th,,1.99,,,,,0 - 3.34,mmol/L +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,MISCELLANEOUS ELEMENTS,Ur Fat,,Present,,H,,,Ref Rng:Not present, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,RETICULOCYTES,Reticulocyte Count %,,0.6,,,,,0.6 - 2.5,% +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Specific Gravity,,1.031,,,,,1 - 1.04, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Ketones,,Trace,,H,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 DB Baseline,,"Jul 30, 2025 11:55 AM",6225351049,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.3,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.2,,,,,0 - 6.2,umol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Alkaline Phosphatase,,59,,,,,35 - 104,U/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,ALT (SGPT),,12,,,,,4 - 43,U/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,GGT,,8,,,,,4 - 49,U/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,LDH,,144,,,,,53 - 234,U/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Serum Uric Acid,,235,,,,,125 - 428,umol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Creatine Kinase,,87,,,,,26 - 192,U/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Serum Bicarbonate,,22.5,,,,,19.3 - 29.3,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.06,,H,,,1.25 - 1.92,mL/sec +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,65.0,,,,,kg, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,GFR,EGFR by MDRD,,100,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,,116 - 164,g/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.1 - 5.6,TI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,82,,,,,79 - 98,fL +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.86,,,,,3.8 - 10.7,GI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.93,,,,,1.96 - 7.23,GI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.59,,,,,0.91 - 4.28,GI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.27,,,,,0.12 - 0.92,GI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,,0 - 0.57,GI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.3,,,,,40.5 - 75,% +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.7,,,,,15.4 - 48.5,% +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,261,,,,,140 - 400,GI/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.4,,,,,<6.5%, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.26,,,,,1.9 - 23,uIU/mL +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,LIPID PANEL,Direct HDL-C 4th Generation,,1.54,,H,,,1.03 - 1.53,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,LIPID PANEL,Triglycerides (GPO),,0.87,,,,,0.41 - 1.63,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,LIPID PANEL,Cholesterol (High Performance),,4.29,,,,,3.31 - 5.64,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,LIPID PANEL,LDL Chol Friedewald 4th,,2.35,,,,,0 - 3.34,mmol/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,RETICULOCYTES,Reticulocyte Count %,,0.6,,,,,0.6 - 2.5,% +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,TSH,TSH 3rd IS-QT,,0.904,,,,,0.45 - 5.33,mIU/L +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1 - 1.04, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100080001,,,26,years,Female,Part 1 Screening,,"Jul 2, 2025 11:12 AM",6225351047,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_122958 sponsor-study-35472-test-results-898733-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_122958 sponsor-study-35472-test-results-898733-standard.csv new file mode 100644 index 0000000..c1822ff --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_122958 sponsor-study-35472-test-results-898733-standard.csv @@ -0,0 +1,2409 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.2,,,,,0 - 5,mg/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Alkaline Phosphatase,,59,,,,,35 - 104,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,4 - 43,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,GGT,,27,,,,,4 - 49,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,LDH,,176,,,,,53 - 234,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,74,,,,,31 - 101,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Uric Acid,,289,,,,,149 - 446,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Phosphorus,,1.12,,,,,0.71 - 1.65,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Creatine Kinase,,263,,H,,,26 - 192,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Bicarbonate,,23.3,,,,,19.3 - 29.3,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,139,,,,Result verified by repeat analysis,116 - 164,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,Result verified by repeat analysis,0.34 - 0.48, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,Result verified by repeat analysis,4.1 - 5.6,TI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,Result verified by repeat analysis,79 - 98,fL +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.14,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.07,,,,,1.96 - 7.23,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.57,,,,,0.91 - 4.28,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.0,,,,,40.5 - 75,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.0,,,,,15.4 - 48.5,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.0,,,,,2.6 - 10.1,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,309,,,,Result verified by repeat analysis,140 - 400,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.37,,,,,1.9 - 23,uIU/mL +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,LIPID PANEL,Direct HDL-C 4th Generation,,1.79,,H,,,1.03 - 1.53,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,LIPID PANEL,Triglycerides (GPO),,1.51,,,,,0.59 - 2.96,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,LIPID PANEL,Cholesterol (High Performance),,5.75,,,,,4.42 - 7.53,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,LIPID PANEL,LDL Chol Friedewald 4th,,3.27,,,,,0 - 3.34,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,TSH,TSH 3rd IS-QT,,4.824,,,,,0.45 - 5.33,mIU/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Specific Gravity,,1.029,,,,,1 - 1.04, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,C-REACTIVE PROTEIN,C Reactive Protein HS,,7.3,,H,,,0 - 5,mg/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.9,,,,,0 - 6.2,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Alkaline Phosphatase,,80,,,,,40 - 129,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,ALT (SGPT),,163,,H RX,,,5 - 48,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,AST (SGOT),,127,,H RX,,,8 - 40,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,GGT,,350,,HT,,Result verified by repeat analysis,10 - 50,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,LDH,,224,,,,,53 - 234,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Urea Nitrogen,,4.1,,,,,1.4 - 8.6,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,106,,,,,40 - 119,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Glucose Fasting,,6.1,,H,,,3.9 - 5.6,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Uric Acid,,512,,H,,,149 - 494,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Phosphorus,,0.81,,,,,0.71 - 1.65,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Creatine Kinase,,348,,H,,,39 - 308,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,125 - 170,g/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.37 - 0.51, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4 - 5.8,TI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,100,,,,,80 - 100,fL +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.89,,,,,3.8 - 10.7,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.35,,,,,1.96 - 7.23,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.13,,,,,0.8 - 3,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.03,,,,,0 - 0.57,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.5,,,,,40.5 - 75,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.0,,,,,15.4 - 48.5,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.7,,,,,2.6 - 10.1,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,137,R,L,,,140 - 400,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.3,,,,,<6.5 %, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,30.61,,H,,,1.9 - 23,uIU/mL +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,LIPID PANEL,Direct HDL-C 4th Generation,,1.03,,,,,1.03 - 1.53,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,LIPID PANEL,Triglycerides (GPO),,2.89,,,,,0.65 - 3.61,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,LIPID PANEL,Cholesterol (High Performance),,4.82,,,,,4.4 - 7.53,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,LIPID PANEL,LDL Chol Friedewald 4th,,2.47,,,,,0 - 3.34,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,RETICULOCYTES,Reticulocyte Count %,,1.5,,,,,0.6 - 2.5,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,TSH,TSH 3rd IS-QT,,1.982,,,,,0.45 - 5.33,mIU/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Specific Gravity,,1.010,,,,,1.01 - 1.03, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Alkaline Phosphatase,,92,,,,,40 - 129,U/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,5 - 48,U/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,LDH,,144,,,,,53 - 234,U/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,92,,,,,40 - 110,umol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Uric Acid,,249,,,,,125 - 488,umol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Calcium (EDTA),,2.51,,,,,2.07 - 2.64,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Phosphorus,,0.97,,,,,0.71 - 1.65,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Albumin-BCG,,50,R,H,,,33 - 49,g/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Creatine Kinase,,224,,,,,39 - 308,U/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Bicarbonate,,27.9,,,,,19.3 - 29.3,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Chloride,,98,,,,,94 - 112,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,127 - 181,g/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 96,fL +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.75,,,,,3.8 - 10.7,GI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.09,,,,,1.96 - 7.23,GI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.22,,,,,0.91 - 4.28,GI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.35,,,,,0.12 - 0.92,GI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.0,,,,,40.5 - 75,% +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,25.8,,,,,15.4 - 48.5,% +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.3,,,,,2.6 - 10.1,% +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.4,,,,,0 - 6.8,% +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,216,,,,,140 - 400,GI/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.3,,,,,<6.5 %, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.44,,,,,1.9 - 23,uIU/mL +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,LIPID PANEL,Direct HDL-C 4th Generation,,1.34,,,,,1.03 - 1.53,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,LIPID PANEL,Triglycerides (GPO),,0.59,,,,,0.5 - 2.81,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,LIPID PANEL,Cholesterol (High Performance),,3.92,,,,,3.31 - 6.1,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,LIPID PANEL,LDL Chol Friedewald 4th,,2.31,,,,,0 - 3.34,mmol/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,TSH,TSH 3rd IS-QT,,1.256,,,,,0.45 - 5.33,mIU/L +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Specific Gravity,,1.012,,,,,1 - 1.04, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.8,,,,,0 - 6.2,umol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Alkaline Phosphatase,,104,,,,,40 - 129,U/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,5 - 48,U/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Urea Nitrogen,,6.2,,,,,1.4 - 8.6,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,95,,,,,40 - 110,umol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Uric Acid,,216,,,,,125 - 488,umol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Phosphorus,,1.25,,,,,0.71 - 1.65,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Albumin-BCG,,52,,H,,,33 - 49,g/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Creatine Kinase,,196,,,,,39 - 308,U/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.59,,,,,1.42 - 2.08,mL/sec +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,95,,,,,40 - 110,umol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,64.0,,,,,kg, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,FSH,Follicle Stimulating Hormone,,6.14,,RX,,,1.3 - 19.3,IU/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,146,,,,,127 - 181,g/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.24,,,,,3.8 - 10.7,GI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.97,,,,,1.96 - 7.23,GI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.72,,,,,0.91 - 4.28,GI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.6,,,,,40.5 - 75,% +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.6,,,,,15.4 - 48.5,% +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,% +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,223,,,,,140 - 400,GI/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.3,,,,,<6.5 %, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.85,,,,,1.9 - 23,uIU/mL +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,LIPID PANEL,Direct HDL-C 4th Generation,,1.40,,,,,1.03 - 1.53,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,LIPID PANEL,Triglycerides (GPO),,0.81,,,,,0.5 - 2.81,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,LIPID PANEL,Cholesterol (High Performance),,4.33,,,,,3.31 - 6.1,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,LIPID PANEL,LDL Chol Friedewald 4th,,2.56,,,,,0 - 3.34,mmol/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,TSH,TSH 3rd IS-QT,,1.789,,,,,0.45 - 5.33,mIU/L +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Specific Gravity,,1.028,,,,,1 - 1.04, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.1,,,,,0 - 5,mg/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.6,,,,,0 - 6.2,umol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Alkaline Phosphatase,,58,,,,,40 - 129,U/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,ALT (SGPT),,86,,H RX,,,5 - 48,U/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,AST (SGOT),,74,,H RX,,,8 - 40,U/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,GGT,,83,,H,,,10 - 50,U/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,LDH,,187,,,,,53 - 234,U/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,107,,,,,40 - 119,umol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Glucose Fasting,,8.0,,H,,,3.9 - 5.6,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Uric Acid,,500,,H,,,149 - 494,umol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Phosphorus,,0.92,,,,,0.71 - 1.65,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Creatine Kinase,,238,,,,,39 - 308,U/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Potassium,,3.8,,,,,3.5 - 5.2,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Chloride,,99,,,,,94 - 112,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,125 - 170,g/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.37 - 0.51, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4 - 5.8,TI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,80 - 100,fL +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.57,,,,,3.8 - 10.7,GI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.18,,,,,1.96 - 7.23,GI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.84,,,,,0.8 - 3,GI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.44,,,,,0.12 - 0.92,GI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.1,,,,,40.5 - 75,% +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.0,,,,,15.4 - 48.5,% +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.9,,,,,2.6 - 10.1,% +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,169,,,,,140 - 400,GI/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,33.13,,H,,,1.9 - 23,uIU/mL +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,LIPID PANEL,Direct HDL-C 4th Generation,,0.70,,L,,,1.03 - 1.53,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,LIPID PANEL,Triglycerides (GPO),,2.48,,,,,0.65 - 3.61,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,LIPID PANEL,Cholesterol (High Performance),,4.55,,,,,4.4 - 7.53,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,LIPID PANEL,LDL Chol Friedewald 4th,,2.71,,,,,0 - 3.34,mmol/L +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,% +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Specific Gravity,,1.018,,,,,1.01 - 1.03, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.7,,,,,0 - 5,mg/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Total Bilirubin,,15,,,,,3 - 21,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.6,,,,,0 - 6.2,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Alkaline Phosphatase,,101,,,,,35 - 104,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,4 - 43,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,GGT,,13,,,,,4 - 49,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,LDH,,175,,,,,53 - 234,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,54,,,,,31 - 101,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Uric Acid,,232,,,,,125 - 428,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Total Protein,,80,,,,,61 - 84,g/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Creatine Kinase,,52,,,,,26 - 192,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Bicarbonate,,22.0,,,,,19.3 - 29.3,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CRYSTALS,Ur Uric Acid Crystals,,Present,,,,,Ref Rng:Not present, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,FREE T4,Free Thyroxine-QT,,18,,H,,,8 - 14,pmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,128,,,,,116 - 164,g/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.85,,,,,3.8 - 10.7,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.16,,,,,1.96 - 7.23,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.28,,,,,0.91 - 4.28,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.31,,,,,0.12 - 0.92,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.0,,,,,40.5 - 75,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.9,,,,,15.4 - 48.5,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.3,,,,,2.6 - 10.1,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,312,,,,,140 - 400,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,4.7,,,,,<6.5 %, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.75,,,,,1.9 - 23,uIU/mL +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,LIPID PANEL,Direct HDL-C 4th Generation,,1.07,,,,,1.03 - 1.53,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,LIPID PANEL,Triglycerides (GPO),,0.77,,,,,0.44 - 1.99,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,LIPID PANEL,Cholesterol (High Performance),,3.77,,,,,3.65 - 6.21,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,LIPID PANEL,LDL Chol Friedewald 4th,,2.35,,,,,0 - 3.34,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,RETICULOCYTES,Reticulocyte Count %,,1.5,,,,,0.6 - 2.5,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,TSH,TSH 3rd IS-QT,,0.119,,L SF,,,0.45 - 5.33,mIU/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1 - 1.04, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.7,,,,,0 - 5,mg/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Alkaline Phosphatase,,53,,,,,35 - 104,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,AST (SGOT),,11,,,,,8 - 40,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,GGT,,12,,,,,4 - 49,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,LDH,,134,,,,,53 - 234,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 8.6,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Uric Acid,,216,,,,,125 - 428,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Phosphorus,,0.83,,,,,0.71 - 1.65,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Creatine Kinase,,83,,,,,26 - 192,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Bicarbonate,,23.3,,,,,19.3 - 29.3,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,121,,,,,116 - 164,g/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,L,,,4.1 - 5.6,TI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.63,,,,,3.8 - 10.7,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.66,,,,,1.96 - 7.23,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.64,,,,,0.91 - 4.28,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.20,,,,,0.12 - 0.92,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.5,,,,,40.5 - 75,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.3,,,,,15.4 - 48.5,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.3,,,,,2.6 - 10.1,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.4,,,,,0 - 6.8,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,273,,,,,140 - 400,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.32,,,,,1.9 - 23,uIU/mL +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,LIPID PANEL,Direct HDL-C 4th Generation,,1.68,,H,,,1.03 - 1.53,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,LIPID PANEL,Triglycerides (GPO),,0.69,,,,,0.44 - 1.99,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,LIPID PANEL,Cholesterol (High Performance),,4.75,,,,,3.65 - 6.21,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,LIPID PANEL,LDL Chol Friedewald 4th,,2.75,,,,,0 - 3.34,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,TSH,TSH 3rd IS-QT,,1.607,,,,,0.45 - 5.33,mIU/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Specific Gravity,,1.027,,,,,1 - 1.04, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.2,,,,,0 - 5,mg/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Alkaline Phosphatase,,64,,,,,35 - 104,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,ALT (SGPT),,21,,,,,4 - 43,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,GGT,,30,,,,,4 - 49,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,LDH,,164,,,,,53 - 234,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Urea Nitrogen,,4.5,,,,,1.4 - 8.6,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Uric Acid,,315,,,,,149 - 446,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Phosphorus,,1.08,,,,,0.71 - 1.65,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Creatine Kinase,,151,,,,,26 - 192,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Bicarbonate,,24.8,,,,,19.3 - 29.3,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,135,,,,,116 - 164,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.44,,,,,3.8 - 10.7,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.89,,,,,1.96 - 7.23,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.02,,,,,0.91 - 4.28,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,52.3,,,,,40.5 - 75,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,40.6,,,,,15.4 - 48.5,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.5,,,,,2.6 - 10.1,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,307,,,,,140 - 400,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.60,,,,,1.9 - 23,uIU/mL +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,LIPID PANEL,Direct HDL-C 4th Generation,,1.98,,H,,,1.03 - 1.53,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,LIPID PANEL,Triglycerides (GPO),,1.32,,,,,0.59 - 2.96,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,LIPID PANEL,Cholesterol (High Performance),,5.66,,,,,4.42 - 7.53,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,LIPID PANEL,LDL Chol Friedewald 4th,,3.08,,,,,0 - 3.34,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,TSH,TSH 3rd IS-QT,,3.912,,,,,0.45 - 5.33,mIU/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1 - 1.04, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.7,,,,,0 - 5,mg/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 5,/HPF +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.2,,,,,0 - 6.2,umol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Alkaline Phosphatase,,91,,,,,40 - 129,U/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,ALT (SGPT),,29,,,,,5 - 48,U/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,AST (SGOT),,39,,,,,8 - 40,U/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,LDH,,206,,,,,53 - 234,U/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Urea Nitrogen,,5.5,,,,,1.4 - 8.6,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,104,,,,,40 - 110,umol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Glucose Fasting,,5.6,,,,,3.9 - 5.6,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Uric Acid,,223,,,,,125 - 488,umol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Calcium (EDTA),,2.58,,,,,2.07 - 2.64,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Albumin-BCG,,51,R,H,,,33 - 49,g/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Creatine Kinase,,1857,R,H SF,,Diluted for quantitation,39 - 308,U/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,157,,,,,127 - 181,g/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.41,,,,,3.8 - 10.7,GI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.57,,,,,1.96 - 7.23,GI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.23,,,,,0.91 - 4.28,GI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.48,,,,,0.12 - 0.92,GI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.3,,,,,40.5 - 75,% +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.1,,,,,15.4 - 48.5,% +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.5,,,,,2.6 - 10.1,% +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,% +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,242,,,,,140 - 400,GI/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.71,,,,,1.9 - 23,uIU/mL +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,LIPID PANEL,Direct HDL-C 4th Generation,,1.23,,,,,1.03 - 1.53,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,LIPID PANEL,Triglycerides (GPO),,1.12,,,,,0.5 - 2.81,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,LIPID PANEL,Cholesterol (High Performance),,3.95,,,,,3.31 - 6.1,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,LIPID PANEL,LDL Chol Friedewald 4th,,2.21,,,,,0 - 3.34,mmol/L +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,RETICULOCYTES,Reticulocyte Count %,,0.6,,,,,0.6 - 2.5,% +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Specific Gravity,,1.036,R,H,,,1 - 1.04, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Protein,,Trace,R,H,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.7,,,,,0 - 5,mg/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.1,,,,,0 - 6.2,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Alkaline Phosphatase,,53,,,,,40 - 129,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,ALT (SGPT),,79,,H RX,,,5 - 48,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,AST (SGOT),,46,,H,,,8 - 40,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,GGT,,68,,H,,,10 - 50,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Urea Nitrogen,,4.8,,,,,1.4 - 8.6,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,95,,,,,40 - 119,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Glucose Fasting,,7.0,,H,,,3.9 - 5.6,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Uric Acid,,393,,,,,149 - 494,umol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Calcium (EDTA),,2.28,,,,,2.07 - 2.64,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Phosphorus,,0.81,,,,,0.71 - 1.65,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Total Protein,,72,,,,,60 - 80,g/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Creatine Kinase,,212,,,,,39 - 308,U/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Bicarbonate,,22.5,,,,,19.3 - 29.3,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,132,,,,,125 - 170,g/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.37 - 0.51, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.9,,L,,,4 - 5.8,TI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,98,,,,,80 - 100,fL +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.42,,,,,3.8 - 10.7,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.42,,,,,1.96 - 7.23,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.61,,,,,0.8 - 3,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.28,,,,,0.12 - 0.92,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.8,,,,,40.5 - 75,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.4,,,,,15.4 - 48.5,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.4,,,,,2.6 - 10.1,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,149,,,,,140 - 400,GI/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.2,,,,,<6.5 %, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,33.25,R,H,,,1.9 - 23,uIU/mL +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,LIPID PANEL,Direct HDL-C 4th Generation,,0.79,,L,,,1.03 - 1.53,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,LIPID PANEL,Triglycerides (GPO),,2.48,,,,,0.65 - 3.61,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,LIPID PANEL,Cholesterol (High Performance),,4.67,,,,,4.4 - 7.53,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,LIPID PANEL,LDL Chol Friedewald 4th,,2.74,,,,,0 - 3.34,mmol/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,TSH,TSH 3rd IS-QT,,1.053,,,,,0.45 - 5.33,mIU/L +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1.01 - 1.03, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.7,,,,,0 - 5,mg/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,40 - 129,U/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,ALT (SGPT),,22,,,,,5 - 48,U/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,GGT,,26,,,,,10 - 61,U/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,86,,,,,40 - 110,umol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Uric Acid,,261,,,,,125 - 488,umol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Calcium (EDTA),,2.52,,,,,2.07 - 2.64,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Albumin-BCG,,53,,H,,,33 - 49,g/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Creatine Kinase,,70,,,,,39 - 308,U/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Bicarbonate,,25.3,,,,,19.3 - 29.3,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.99,,,,,1.42 - 2.08,mL/sec +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,86,,,,,40 - 110,umol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,81.1,,,,,kg, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,GFR,EGFR by MDRD,,87,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.2,,,,,<6.5 %, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.94,,,,,1.9 - 23,uIU/mL +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,LIPID PANEL,Direct HDL-C 4th Generation,,0.90,,L,,,1.03 - 1.53,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,LIPID PANEL,Triglycerides (GPO),,1.55,,,,,0.56 - 3.62,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,LIPID PANEL,Cholesterol (High Performance),,4.40,,,,,3.88 - 6.83,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,LIPID PANEL,LDL Chol Friedewald 4th,,2.79,,,,,0 - 3.34,mmol/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,RETICULOCYTES,Reticulocyte Count %,,,,,Test cancelled: Clotted Blood Received,,, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,TSH,TSH 3rd IS-QT,,0.855,,,,,0.45 - 5.33,mIU/L +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,C-REACTIVE PROTEIN,C Reactive Protein HS,,12.0,,H,,,0 - 5,mg/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.7,,,,,0 - 6.2,umol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Alkaline Phosphatase,,120,,,,,40 - 129,U/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,GGT,,15,,,,,10 - 50,U/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,LDH,,165,,,,,53 - 234,U/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Urea Nitrogen,,6.1,,,,,1.4 - 8.6,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,108,,,,,40 - 119,umol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Uric Acid,,237,,,,,149 - 494,umol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Phosphorus,,0.98,,,,,0.71 - 1.65,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Total Protein,,84,,H,,,60 - 80,g/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Creatine Kinase,,116,,,,,39 - 308,U/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Sodium,,138,,,,,135 - 145,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Bicarbonate,,17.8,,L,,,19.3 - 29.3,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.23,,L,,,1.42 - 2.08,mL/sec +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,108,,,,,40 - 119,umol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,82.0,,,,,kg, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,GFR,EGFR by MDRD,,60,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,125 - 170,g/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.37 - 0.51, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4 - 5.8,TI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,83,,,,,80 - 100,fL +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.37,,,,,3.8 - 10.7,GI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.83,,,,,1.96 - 7.23,GI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.79,,,,,0.8 - 3,GI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.61,,,,,0.12 - 0.92,GI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,72.9,,,,,40.5 - 75,% +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.1,,,,,15.4 - 48.5,% +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,% +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,% +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,509,R,H,,,130 - 394,GI/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.5,,H,,,<6.5 %, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.10,,,,,1.9 - 23,uIU/mL +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,LIPID PANEL,Direct HDL-C 4th Generation,,1.24,,,,,1.03 - 1.53,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,LIPID PANEL,Triglycerides (GPO),,1.36,,,,,0.65 - 2.94,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,LIPID PANEL,Cholesterol (High Performance),,3.73,,L,,,4.53 - 7.71,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,LIPID PANEL,LDL Chol Friedewald 4th,,1.87,,,,,0 - 3.34,mmol/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,% +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,TSH,TSH 3rd IS-QT,,1.311,,,,,0.45 - 5.33,mIU/L +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1.01 - 1.03, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.5,,,,,0 - 5,mg/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Total Bilirubin,,15,,,,,3 - 21,umol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.7,,,,,0 - 6.2,umol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,40 - 129,U/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,5 - 48,U/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,LDH,,157,,,,,53 - 234,U/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Urea Nitrogen,,4.9,,,,,1.4 - 8.6,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,90,,,,,40 - 110,umol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Uric Acid,,287,,,,,125 - 488,umol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Calcium (EDTA),,2.55,,,,,2.07 - 2.64,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Albumin-BCG,,51,,H,,,33 - 49,g/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Creatine Kinase,,332,,H,,,39 - 308,U/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Potassium,,3.9,,,,,3.5 - 5.2,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.60,,,,,1.42 - 2.08,mL/sec +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,90,,,,,40 - 110,umol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,61.0,,,,,kg, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,GFR,EGFR by MDRD,,89,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,149,,,,,127 - 181,g/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.69,,,,,3.8 - 10.7,GI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.98,,,,,1.96 - 7.23,GI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.11,,,,,0.91 - 4.28,GI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.45,,,,,0.12 - 0.92,GI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.5,,,,,40.5 - 75,% +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,16.5,,,,,15.4 - 48.5,% +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.8,,,,,2.6 - 10.1,% +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,% +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,262,,,,,140 - 400,GI/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.81,,,,,1.9 - 23,uIU/mL +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,LIPID PANEL,Direct HDL-C 4th Generation,,1.32,,,,,1.03 - 1.53,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,LIPID PANEL,Triglycerides (GPO),,0.69,,,,,0.5 - 2.81,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,LIPID PANEL,Cholesterol (High Performance),,4.31,,,,,3.31 - 6.1,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,LIPID PANEL,LDL Chol Friedewald 4th,,2.67,,,,,0 - 3.34,mmol/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,TSH,TSH 3rd IS-QT,,0.928,,,,,0.45 - 5.33,mIU/L +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1 - 1.04, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.4,,,,,0 - 5,mg/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Alkaline Phosphatase,,67,,,,,35 - 104,U/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,ALT (SGPT),,28,,,,,4 - 43,U/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,AST (SGOT),,30,,,,,8 - 40,U/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,GGT,,27,,,,,4 - 49,U/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,LDH,,166,,,,,53 - 234,U/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Urea Nitrogen,,4.7,,,,,1.4 - 8.6,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Uric Acid,,337,,,,,149 - 446,umol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Calcium (EDTA),,2.51,,,,,2.07 - 2.64,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Phosphorus,,1.16,,,,,0.71 - 1.65,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Creatine Kinase,,148,,,,,26 - 192,U/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Bicarbonate,,21.7,,,,,19.3 - 29.3,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,116 - 164,g/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.09,,,,,3.8 - 10.7,GI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.49,,,,,1.96 - 7.23,GI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.02,,,,,0.91 - 4.28,GI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.6,,,,,40.5 - 75,% +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,37.4,,,,,15.4 - 48.5,% +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.0,,,,,2.6 - 10.1,% +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,316,,,,,140 - 400,GI/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.12,,,,,1.9 - 23,uIU/mL +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,LIPID PANEL,Direct HDL-C 4th Generation,,1.96,,H,,,1.03 - 1.53,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,LIPID PANEL,Triglycerides (GPO),,1.32,,,,,0.59 - 2.96,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,LIPID PANEL,Cholesterol (High Performance),,5.64,,,,,4.42 - 7.53,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,LIPID PANEL,LDL Chol Friedewald 4th,,3.08,,,,,0 - 3.34,mmol/L +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,RETICULOCYTES,Reticulocyte Count %,,0.6,,,,,0.6 - 2.5,% +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Specific Gravity,,1.021,,,,,1 - 1.04, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.0,,,,,0 - 5,mg/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CELLULAR ELEMENTS,Ur WBC/HPF,,3,,,,,0 - 12,/HPF +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Alkaline Phosphatase,,90,,,,,35 - 104,U/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,GGT,,8,,,,,4 - 49,U/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,LDH,,150,,,,,53 - 234,U/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Urea Nitrogen,,4.1,,,,,1.4 - 8.6,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,61,,,,,31 - 101,umol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Uric Acid,,250,,,,,125 - 428,umol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Calcium (EDTA),,2.30,,,,,2.07 - 2.64,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Phosphorus,,1.08,,,,,0.71 - 1.65,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Creatine Kinase,,69,,,,,26 - 192,U/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.73,,,,,3.8 - 10.7,GI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.57,,,,,1.96 - 7.23,GI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.54,,,,,0.91 - 4.28,GI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.42,,,,,0.12 - 0.92,GI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.1,,,,,40.5 - 75,% +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.9,,,,,15.4 - 48.5,% +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,348,,,,,140 - 400,GI/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.60,,,,,1.9 - 23,uIU/mL +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,LIPID PANEL,Direct HDL-C 4th Generation,,1.10,,,,,1.03 - 1.53,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,LIPID PANEL,Triglycerides (GPO),,1.17,,,,,0.44 - 1.99,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,LIPID PANEL,Cholesterol (High Performance),,4.41,,,,,3.65 - 6.21,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,LIPID PANEL,LDL Chol Friedewald 4th,,2.77,,,,,0 - 3.34,mmol/L +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,RETICULOCYTES,Reticulocyte Count %,,1.9,,,,,0.6 - 2.5,% +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Specific Gravity,,1.026,,,,,1 - 1.04, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.2,,,,,0 - 5,mg/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CELLULAR ELEMENTS,Ur WBC/HPF,,4,,,,,0 - 12,/HPF +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,35 - 104,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,4 - 43,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,AST (SGOT),,13,,,,,8 - 40,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,GGT,,16,,,,,4 - 49,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,LDH,,128,,,,,53 - 234,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Urea Nitrogen,,7.9,,,,,1.4 - 8.6,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,84,,,,,31 - 101,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Uric Acid,,250,,,,,125 - 428,umol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Phosphorus,,0.97,,,,,0.71 - 1.65,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Creatine Kinase,,79,,,,,26 - 192,U/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Bicarbonate,,22.0,,,,,19.3 - 29.3,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,123,,,,,116 - 164,g/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.34 - 0.48, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4.1 - 5.6,TI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.99,,,,,3.8 - 10.7,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.90,,L,,,1.96 - 7.23,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.74,,,,,0.91 - 4.28,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.18,,,,,0.12 - 0.92,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.6,,,,,40.5 - 75,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,43.6,,,,,15.4 - 48.5,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.5,,,,,2.6 - 10.1,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.8,,,,,0 - 6.8,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,301,,,,,140 - 400,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.63,,,,,1.9 - 23,uIU/mL +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,LIPID PANEL,Direct HDL-C 4th Generation,,1.75,,H,,,1.03 - 1.53,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,LIPID PANEL,Triglycerides (GPO),,0.50,,,,,0.44 - 1.99,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,LIPID PANEL,Cholesterol (High Performance),,4.64,,,,,3.65 - 6.21,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,LIPID PANEL,LDL Chol Friedewald 4th,,2.66,,,,,0 - 3.34,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,TSH,TSH 3rd IS-QT,,1.963,,,,,0.45 - 5.33,mIU/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Blood,,+1,,H,,,Ref Rng:$Negative-Trace, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.5,,,,,0 - 5,mg/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Alkaline Phosphatase,,52,,,,,40 - 129,U/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,ALT (SGPT),,77,,H RX,,,5 - 48,U/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,AST (SGOT),,49,,H,,,8 - 40,U/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,GGT,,53,,H,,,10 - 50,U/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,LDH,,139,,,,,53 - 234,U/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 119,umol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Glucose Fasting,,6.3,,H,,,3.9 - 5.6,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Uric Acid,,507,,H,,,149 - 494,umol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Phosphorus,,0.92,,,,,0.71 - 1.65,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Total Protein,,74,,,,,60 - 80,g/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Creatine Kinase,,201,,,,,39 - 308,U/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Bicarbonate,,27.8,,,,,19.3 - 29.3,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,128,,,,,125 - 170,g/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.37 - 0.51, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.9,,L,,,4 - 5.8,TI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,80 - 100,fL +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.20,,,,,3.8 - 10.7,GI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.39,,,,,1.96 - 7.23,GI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.38,,,,,0.8 - 3,GI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,,0 - 0.57,GI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.0,,,,,40.5 - 75,% +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.9,,,,,15.4 - 48.5,% +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.8,,,,,2.6 - 10.1,% +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,% +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,% +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,144,,,,,140 - 400,GI/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,22.36,,,,,1.9 - 23,uIU/mL +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,LIPID PANEL,Direct HDL-C 4th Generation,,0.75,,L,,,1.03 - 1.53,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,LIPID PANEL,Triglycerides (GPO),,3.00,,,,,0.65 - 3.61,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,LIPID PANEL,Cholesterol (High Performance),,4.63,,,,,4.4 - 7.53,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,LIPID PANEL,LDL Chol Friedewald 4th,,2.51,,,,,0 - 3.34,mmol/L +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Specific Gravity,,1.010,,,,,1.01 - 1.03, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Alkaline Phosphatase,,39,,,,,35 - 104,U/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,ALT (SGPT),,7,,,,,4 - 43,U/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,AST (SGOT),,13,,,,,8 - 40,U/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,GGT,,10,,,,,4 - 49,U/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,LDH,,144,,,,,53 - 234,U/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Urea Nitrogen,,2.9,,,,,1.4 - 8.6,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Uric Acid,,162,,,,,125 - 428,umol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Phosphorus,,0.94,,,,,0.71 - 1.65,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Creatine Kinase,,56,,,,,26 - 192,U/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Bicarbonate,,26.3,,,,,19.3 - 29.3,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.79,,,,,1.25 - 1.92,mL/sec +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,70.3,,,,,kg, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,GFR,EGFR by MDRD,,88,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,Result verified by repeat analysis,116 - 164,g/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,Result verified by repeat analysis,4.1 - 5.6,TI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.80,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.45,,,,Result verified by repeat analysis,1.96 - 7.23,GI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.67,,,,,0.91 - 4.28,GI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.43,,,,Result verified by repeat analysis,0.12 - 0.92,GI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.21,,,,Result verified by repeat analysis,0 - 0.57,GI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,Result verified by repeat analysis,0 - 0.2,GI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.1,,,,Result verified by repeat analysis,40.5 - 75,% +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.7,,,,Result verified by repeat analysis,15.4 - 48.5,% +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.0,,,,Result verified by repeat analysis,2.6 - 10.1,% +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.4,,,,Result verified by repeat analysis,0 - 6.8,% +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,Result verified by repeat analysis,0 - 2,% +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,254,,,,Result verified by repeat analysis,140 - 400,GI/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.02,,,,,1.9 - 23,uIU/mL +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,LIPID PANEL,Direct HDL-C 4th Generation,,1.67,,H,,,1.03 - 1.53,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,LIPID PANEL,Triglycerides (GPO),,0.69,,,,,0.51 - 2.42,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,LIPID PANEL,Cholesterol (High Performance),,5.79,,,,,4.01 - 6.85,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,LIPID PANEL,LDL Chol Friedewald 4th,,3.80,,H,,,0 - 3.34,mmol/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,TSH,TSH 3rd IS-QT,,1.837,,,,,0.45 - 5.33,mIU/L +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Specific Gravity,,1.005,,,,,1 - 1.04, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CELLULAR ELEMENTS,Ur RBC/HPF,,3,,,,,0 - 8,/HPF +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,35 - 104,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,4 - 43,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,GGT,,21,,,,,4 - 49,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,LDH,,167,,,,,53 - 234,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Uric Acid,,286,,,,,149 - 446,umol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Phosphorus,,1.01,,,,,0.71 - 1.65,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Creatine Kinase,,147,,,,,26 - 192,U/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Bicarbonate,,22.4,,,,,19.3 - 29.3,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,FREE T4,Free Thyroxine-QT,,9,,,,,8 - 14,pmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,116 - 164,g/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 98,fL +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.42,,,,,3.8 - 10.7,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.84,,,,,1.96 - 7.23,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.08,,,,,0.91 - 4.28,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.8,,,,,40.5 - 75,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,41.6,,,,,15.4 - 48.5,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,3.9,,,,,2.6 - 10.1,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.8,,,,,0 - 6.8,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,332,,,,,140 - 400,GI/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.2,,,,,<6.5 %, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.98,,,,,1.9 - 23,uIU/mL +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,LIPID PANEL,Direct HDL-C 4th Generation,,2.01,,H,,,1.03 - 1.53,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,LIPID PANEL,Triglycerides (GPO),,1.43,,,,,0.59 - 2.96,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,LIPID PANEL,Cholesterol (High Performance),,5.46,,,,,4.42 - 7.53,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,LIPID PANEL,LDL Chol Friedewald 4th,,2.80,,,,,0 - 3.34,mmol/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,TSH,TSH 3rd IS-QT,,6.224,,H SF,,,0.45 - 5.33,mIU/L +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Specific Gravity,,1.033,,,,,1 - 1.04, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.2,,,,,0 - 5,mg/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Alkaline Phosphatase,,73,,,,,35 - 104,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,AST (SGOT),,13,,,,,8 - 40,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,GGT,,7,,,,,4 - 49,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,LDH,,145,,,,,53 - 234,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Glucose Fasting,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Uric Acid,,236,,,,,125 - 428,umol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Phosphorus,,1.19,,,,,0.71 - 1.65,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Creatine Kinase,,72,,,,,26 - 192,U/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,,116 - 164,g/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.59,,,,,3.8 - 10.7,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.25,,,,,1.96 - 7.23,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.64,,,,,0.91 - 4.28,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.37,,,,,0.12 - 0.92,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.19,,,,,0 - 0.2,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,64.5,,,,,40.5 - 75,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,24.9,,,,,15.4 - 48.5,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.9,,H,,,0 - 2,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,300,,,,,140 - 400,GI/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,4.9,,,,,<6.5 %, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.92,,,,,1.9 - 23,uIU/mL +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,LIPID PANEL,Direct HDL-C 4th Generation,,1.01,,L,,,1.03 - 1.53,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,LIPID PANEL,Triglycerides (GPO),,1.05,,,,,0.44 - 1.99,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,LIPID PANEL,Cholesterol (High Performance),,3.68,,,,,3.65 - 6.21,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,LIPID PANEL,LDL Chol Friedewald 4th,,2.19,,,,,0 - 3.34,mmol/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,TSH,TSH 3rd IS-QT,,1.385,,,,,0.45 - 5.33,mIU/L +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,C-REACTIVE PROTEIN,C Reactive Protein HS,,8.1,,H,,,0 - 5,mg/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Alkaline Phosphatase,,51,,,,,40 - 129,U/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,ALT (SGPT),,79,,H RX,,,5 - 48,U/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,AST (SGOT),,51,,H,,,8 - 40,U/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,GGT,,52,,H,,,10 - 50,U/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,LDH,,160,,,,,53 - 234,U/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Urea Nitrogen,,4.5,,,,,1.4 - 8.6,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,92,,,,,40 - 119,umol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Glucose Fasting,,6.1,,H,,,3.9 - 5.6,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Uric Acid,,521,,H,,,149 - 494,umol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Phosphorus,,1.00,,,,,0.71 - 1.65,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Total Protein,,75,,,,,60 - 80,g/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Creatine Kinase,,206,,,,,39 - 308,U/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Bicarbonate,,25.6,,,,,19.3 - 29.3,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.95,,,,,1.42 - 2.08,mL/sec +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,92,,,,,40 - 119,umol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,108.0,,,,,kg, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,GFR,EGFR by MDRD,,73,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,132,,,,,125 - 170,g/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.37 - 0.51, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,4 - 5.8,TI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,80 - 100,fL +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.10,,,,,3.8 - 10.7,GI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.77,,,,,1.96 - 7.23,GI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.71,,,,,0.8 - 3,GI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.52,,,,,0.12 - 0.92,GI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.7,,,,,40.5 - 75,% +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.1,,,,,15.4 - 48.5,% +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.5,,,,,2.6 - 10.1,% +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,178,,,,,140 - 400,GI/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.2,,,,,<6.5 %, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,15.17,,,,,1.9 - 23,uIU/mL +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,LIPID PANEL,Direct HDL-C 4th Generation,,0.74,,L,,,1.03 - 1.53,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,LIPID PANEL,Triglycerides (GPO),,2.04,,,,,0.65 - 3.61,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,LIPID PANEL,Cholesterol (High Performance),,4.38,,L,,,4.4 - 7.53,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,LIPID PANEL,LDL Chol Friedewald 4th,,2.71,,,,,0 - 3.34,mmol/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,RETICULOCYTES,Reticulocyte Count %,,1.9,,,,,0.6 - 2.5,% +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,TSH,TSH 3rd IS-QT,,1.243,,,,,0.45 - 5.33,mIU/L +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Specific Gravity,,1.013,,,,,1.01 - 1.03, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Alkaline Phosphatase,,93,,,,,40 - 129,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,ALT (SGPT),,128,,H RX,,,5 - 48,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,AST (SGOT),,54,,H,,,8 - 40,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,GGT,,247,,H,,Result verified by repeat analysis,10 - 61,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 8.6,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Uric Acid,,430,,,,,125 - 488,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Calcium (EDTA),,2.56,,,,,2.07 - 2.64,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Phosphorus,,1.25,,,,,0.71 - 1.65,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Creatine Kinase,,127,,,,,39 - 308,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Bicarbonate,,24.5,,,,,19.3 - 29.3,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,162,,,,,127 - 181,g/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.4,,,,,4.5 - 6.4,TI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.78,,,,,3.8 - 10.7,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.00,,,,,1.96 - 7.23,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.31,,,,,0.91 - 4.28,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.26,,,,,0.12 - 0.92,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.8,,,,,40.5 - 75,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.5,,,,,15.4 - 48.5,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.4,,,,,0 - 6.8,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,271,,,,,140 - 400,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,8.27,,,,,1.9 - 23,uIU/mL +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,LIPID PANEL,Direct HDL-C 4th Generation,,1.32,,,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,LIPID PANEL,Triglycerides (GPO),,2.24,,,,,0.5 - 2.81,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,LIPID PANEL,Cholesterol (High Performance),,5.39,,,,,3.31 - 6.1,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,LIPID PANEL,LDL Chol Friedewald 4th,,3.04,,,,,0 - 3.34,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,TSH,TSH 3rd IS-QT,,1.417,,,,,0.45 - 5.33,mIU/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.0,,,,,0 - 5,mg/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Alkaline Phosphatase,,63,,,,,35 - 104,U/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,GGT,,15,,,,,4 - 49,U/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,LDH,,142,,,,,53 - 234,U/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,81,,,,,31 - 101,umol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Uric Acid,,291,,,,,125 - 428,umol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Phosphorus,,1.15,,,,,0.71 - 1.65,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Creatine Kinase,,109,,,,,26 - 192,U/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Bicarbonate,,21.7,,,,,19.3 - 29.3,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.55,,,,,1.25 - 1.92,mL/sec +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,81,,,,,31 - 101,umol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,68.0,,,,,kg, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,FSH,Follicle Stimulating Hormone,,1.95,,RX,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,124,,,,,116 - 164,g/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.34 - 0.48, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.35,,,,,3.8 - 10.7,GI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.19,,,,,1.96 - 7.23,GI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.57,,,,,0.91 - 4.28,GI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.6,,,,,40.5 - 75,% +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.4,,,,,15.4 - 48.5,% +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.3,,,,,2.6 - 10.1,% +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.6,,,,,0 - 2,% +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,340,,,,,140 - 400,GI/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.7,,,,,<6.5 %, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.35,,,,,1.9 - 23,uIU/mL +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,LIPID PANEL,Direct HDL-C 4th Generation,,1.82,,H,,,1.03 - 1.53,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,LIPID PANEL,Triglycerides (GPO),,0.63,,,,,0.44 - 1.99,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,LIPID PANEL,Cholesterol (High Performance),,5.11,,,,,3.65 - 6.21,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,LIPID PANEL,LDL Chol Friedewald 4th,,3.00,,,,,0 - 3.34,mmol/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,% +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,TSH,TSH 3rd IS-QT,,2.024,,,,,0.45 - 5.33,mIU/L +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.7,,,,,0 - 5,mg/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Alkaline Phosphatase,,62,,,,,35 - 104,U/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,ALT (SGPT),,21,,,,,4 - 43,U/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,GGT,,33,,,,,4 - 49,U/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,LDH,,158,,,,,53 - 234,U/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Urea Nitrogen,,4.1,,,,,1.4 - 8.6,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,73,,,,,31 - 101,umol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Glucose Fasting,,4.2,,,,,3.9 - 5.6,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Uric Acid,,307,,,,,149 - 446,umol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Phosphorus,,1.07,,,,,0.71 - 1.65,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Creatine Kinase,,203,,H,,,26 - 192,U/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Bicarbonate,,22.0,,,,,19.3 - 29.3,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.49,,,,,3.8 - 10.7,GI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.93,,,,,1.96 - 7.23,GI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.72,,,,,0.91 - 4.28,GI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.32,,,,,0 - 0.57,GI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.17,,,,,0 - 0.2,GI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,45.2,,,,,40.5 - 75,% +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,41.9,,,,,15.4 - 48.5,% +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.3,,,,,2.6 - 10.1,% +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.9,,,,,0 - 6.8,% +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.7,R,H,,,0 - 2,% +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,332,,,,,140 - 400,GI/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.15,,,,,1.9 - 23,uIU/mL +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,LIPID PANEL,Direct HDL-C 4th Generation,,1.91,,H,,,1.03 - 1.53,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,LIPID PANEL,Triglycerides (GPO),,1.28,,,,,0.59 - 2.96,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,LIPID PANEL,Cholesterol (High Performance),,5.21,,,,,4.42 - 7.53,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,LIPID PANEL,LDL Chol Friedewald 4th,,2.71,,,,,0 - 3.34,mmol/L +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,C-REACTIVE PROTEIN,C Reactive Protein HS,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Total Bilirubin,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,ALT (SGPT),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,AST (SGOT),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,GGT,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,LDH,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Urea Nitrogen,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Glucose Fasting,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Uric Acid,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Calcium (EDTA),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Phosphorus,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Total Protein,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Albumin-BCG,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Creatine Kinase,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Sodium,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Potassium,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Bicarbonate,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Chloride,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,126,,,,,116 - 164,g/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.49,,,,,3.8 - 10.7,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.37,,,,,1.96 - 7.23,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.74,,,,,0.91 - 4.28,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.07,,,,,0 - 0.57,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,52.8,,,,,40.5 - 75,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.7,,,,,15.4 - 48.5,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,299,,,,,140 - 400,GI/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.65,,,,,1.9 - 23,uIU/mL +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,LIPID PANEL,Direct HDL-C 4th Generation,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,LIPID PANEL,Triglycerides (GPO),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,LIPID PANEL,Cholesterol (High Performance),,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,LIPID PANEL,LDL Chol Friedewald 4th,,Required testing unavailable,,,,,0 - 3.34,mmol/L +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,% +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,TSH,TSH 3rd IS-QT,,,,,"Test cancelled: Expired contain, test cancel",,, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Specific Gravity,,1.011,,,,,1 - 1.04, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.1,,,,,0 - 5,mg/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CELLULAR ELEMENTS,Ur WBC/HPF,,5,,,,,0 - 12,/HPF +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CELLULAR ELEMENTS,Ur Squamous Epithelial Cells,,80,,,,,0 - 3,/HPF +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Alkaline Phosphatase,,98,,,,,35 - 104,U/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,4 - 43,U/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,AST (SGOT),,10,,,,,8 - 40,U/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,GGT,,8,,,,,4 - 49,U/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,LDH,,142,,,,,53 - 234,U/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Urea Nitrogen,,4.8,,,,,1.4 - 8.6,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,62,,,,,31 - 101,umol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Uric Acid,,261,,,,,125 - 428,umol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Phosphorus,,1.10,,,,,0.71 - 1.65,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Total Protein,,78,,,,,61 - 84,g/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Creatine Kinase,,42,,,,,26 - 192,U/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Bicarbonate,,21.8,,,,,19.3 - 29.3,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.82,,,,,3.8 - 10.7,GI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.12,,,,,1.96 - 7.23,GI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.07,,,,,0.91 - 4.28,GI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.4,,,,,40.5 - 75,% +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.4,,,,,15.4 - 48.5,% +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,% +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,322,,,,,140 - 400,GI/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.28,,,,,1.9 - 23,uIU/mL +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,LIPID PANEL,Direct HDL-C 4th Generation,,1.25,,,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,LIPID PANEL,Triglycerides (GPO),,0.86,,,,,0.44 - 1.99,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,LIPID PANEL,Cholesterol (High Performance),,4.48,,,,,3.65 - 6.21,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,LIPID PANEL,LDL Chol Friedewald 4th,,2.84,,,,,0 - 3.34,mmol/L +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,% +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Specific Gravity,,1.037,,H,,,1 - 1.04, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.4,,,,,0 - 5,mg/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.6,,,,,0 - 6.2,umol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Alkaline Phosphatase,,100,,,,,35 - 104,U/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,4 - 43,U/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,GGT,,63,,H,,,4 - 49,U/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,LDH,,174,,,,,53 - 234,U/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Uric Acid,,291,,,,,149 - 446,umol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Phosphorus,,1.02,,,,,0.71 - 1.65,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Total Protein,,78,,,,,61 - 84,g/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Creatine Kinase,,141,,,,,26 - 192,U/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.17,,L,,,1.25 - 1.92,mL/sec +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,59.2,,,,,kg, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,FREE T4,Free Thyroxine-QT,,9,,,,,8 - 14,pmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,GFR,EGFR by MDRD,,69,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,116 - 164,g/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 98,fL +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.44,,,,,3.8 - 10.7,GI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.83,,,,,1.96 - 7.23,GI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,4.07,,,,,0.91 - 4.28,GI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.21,,,,,0 - 0.57,GI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,38.0,R,L,,,40.5 - 75,% +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,54.7,R,H,,,15.4 - 48.5,% +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,3.8,,,,,2.6 - 10.1,% +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.8,,,,,0 - 6.8,% +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,295,,,,,140 - 400,GI/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.3,,,,,<6.5%, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.96,,,,,1.9 - 23,uIU/mL +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,LIPID PANEL,Direct HDL-C 4th Generation,,1.84,,H,,,1.03 - 1.53,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,LIPID PANEL,Triglycerides (GPO),,1.42,,,,,0.59 - 2.96,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,LIPID PANEL,Cholesterol (High Performance),,5.78,,,,,4.42 - 7.53,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,LIPID PANEL,LDL Chol Friedewald 4th,,3.29,,,,,0 - 3.34,mmol/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,TSH,TSH 3rd IS-QT,,5.438,R,H SF,,,0.45 - 5.33,mIU/L +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.4,,,,,0 - 5,mg/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Alkaline Phosphatase,,84,,,,,40 - 129,U/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,ALT (SGPT),,64,,H,,,5 - 48,U/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,GGT,,123,,H,,,10 - 61,U/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,LDH,,159,,,,,53 - 234,U/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Urea Nitrogen,,6.3,,,,,1.4 - 8.6,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 110,umol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Uric Acid,,419,,,,,125 - 488,umol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Calcium (EDTA),,2.53,,,,,2.07 - 2.64,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Phosphorus,,1.27,,,,,0.71 - 1.65,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Creatine Kinase,,141,,,,,39 - 308,U/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Bicarbonate,,21.9,,,,,19.3 - 29.3,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,157,,,,,127 - 181,g/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.88,,,,,3.8 - 10.7,GI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.07,,,,,1.96 - 7.23,GI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.32,,,,,0.91 - 4.28,GI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.9,,,,,40.5 - 75,% +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.1,,,,,15.4 - 48.5,% +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.9,,,,,2.6 - 10.1,% +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.0,,,,,0 - 6.8,% +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,266,,,,,140 - 400,GI/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.45,,,,,1.9 - 23,uIU/mL +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,LIPID PANEL,Direct HDL-C 4th Generation,,0.92,,L,,,1.03 - 1.53,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,LIPID PANEL,Triglycerides (GPO),,1.73,,,,,0.5 - 2.81,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,LIPID PANEL,Cholesterol (High Performance),,4.62,,,,,3.31 - 6.1,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,LIPID PANEL,LDL Chol Friedewald 4th,,2.91,,,,,0 - 3.34,mmol/L +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,C-REACTIVE PROTEIN,C Reactive Protein HS,,5.3,,H,,,0 - 5,mg/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CELLULAR ELEMENTS,Ur WBC/HPF,,3,,,,,0 - 12,/HPF +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Alkaline Phosphatase,,101,,,,,35 - 104,U/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,AST (SGOT),,12,,,,,8 - 40,U/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,GGT,,6,,,,,4 - 49,U/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,LDH,,157,,,,,53 - 234,U/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Uric Acid,,232,,,,,125 - 428,umol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Calcium (EDTA),,2.27,,,,,2.07 - 2.64,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Phosphorus,,1.14,,,,,0.71 - 1.65,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Creatine Kinase,,59,,,,,26 - 192,U/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Sodium,,136,,,,,132 - 147,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Bicarbonate,,21.4,,,,,19.3 - 29.3,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.50,,H,,,1.25 - 1.92,mL/sec +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,75.2,,,,,kg, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,GFR,EGFR by MDRD,,108,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,,116 - 164,g/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.26,,,,,3.8 - 10.7,GI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.66,,,,,1.96 - 7.23,GI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.98,,,,,0.91 - 4.28,GI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,64.1,,,,,40.5 - 75,% +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.4,,,,,15.4 - 48.5,% +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,% +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,335,,,,,140 - 400,GI/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,4.8,,,,,<6.5%, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.40,,,,,1.9 - 23,uIU/mL +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,LIPID PANEL,Direct HDL-C 4th Generation,,0.99,,L,,,1.03 - 1.53,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,LIPID PANEL,Triglycerides (GPO),,0.76,,,,,0.44 - 1.99,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,LIPID PANEL,Cholesterol (High Performance),,4.01,,,,,3.65 - 6.21,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,LIPID PANEL,LDL Chol Friedewald 4th,,2.67,,,,,0 - 3.34,mmol/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,RETICULOCYTES,Reticulocyte Count %,,2.4,,,,,0.6 - 2.5,% +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,TSH,TSH 3rd IS-QT,,1.593,,,,,0.45 - 5.33,mIU/L +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Specific Gravity,,1.029,,,,,1 - 1.04, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative, +CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,BENZODIAZEPINE CONFIRM. UR,BenzodiazepineConf-LCMSMS-LDT,,Oxazepam (Confirmed),R,RX,,,No Ref Rng, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.2,,,,,0 - 5,mg/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,40 - 129,U/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,ALT (SGPT),,27,,,,,5 - 48,U/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,GGT,,17,,,,,10 - 61,U/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Urea Nitrogen,,6.1,,,,,1.4 - 8.6,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,83,,,,,40 - 110,umol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Uric Acid,,344,,,,,125 - 488,umol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Calcium (EDTA),,2.46,,,,,2.07 - 2.64,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Phosphorus,,1.03,,,,,0.71 - 1.65,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Total Protein,,78,,,,,61 - 84,g/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Creatine Kinase,,232,,,,,39 - 308,U/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.37,,H,,,1.42 - 2.08,mL/sec +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,83,,,,,40 - 110,umol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,89.1,,,,,kg, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Detected (unconfirmed),,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,GFR,EGFR by MDRD,,93,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,141,,,,,127 - 181,g/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.39 - 0.54, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.5 - 6.4,TI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.63,,,,,3.8 - 10.7,GI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.10,,,,,1.96 - 7.23,GI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.01,,,,,0.91 - 4.28,GI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.37,,,,,0.12 - 0.92,GI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,46.8,,,,,40.5 - 75,% +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,45.4,,,,,15.4 - 48.5,% +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,306,,,,,140 - 400,GI/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.3,,,,,<6.5%, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,16.63,,,,,1.9 - 23,uIU/mL +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,LIPID PANEL,Direct HDL-C 4th Generation,,0.95,R,L,,,1.03 - 1.53,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,LIPID PANEL,Triglycerides (GPO),,2.07,,,,,0.56 - 3.62,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,LIPID PANEL,Cholesterol (High Performance),,5.65,,,,,3.88 - 6.83,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,LIPID PANEL,LDL Chol Friedewald 4th,,3.75,,H,,,0 - 3.34,mmol/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,TSH,TSH 3rd IS-QT,,2.249,,,,,0.45 - 5.33,mIU/L +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1 - 1.04, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.4,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,35 - 104,U/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,AST (SGOT),,11,,,,,8 - 40,U/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,GGT,,13,,,,,4 - 49,U/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,LDH,,126,,,,,53 - 234,U/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,31 - 101,umol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Uric Acid,,217,,,,,125 - 428,umol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Phosphorus,,1.01,,,,,0.71 - 1.65,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Creatine Kinase,,66,,,,,26 - 192,U/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Bicarbonate,,24.5,,,,,19.3 - 29.3,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,121,,,,,116 - 164,g/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.05,,,,,3.8 - 10.7,GI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.88,,,,,1.96 - 7.23,GI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.73,,,,,0.91 - 4.28,GI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.1,,,,,40.5 - 75,% +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.3,,,,,15.4 - 48.5,% +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.7,,,,,2.6 - 10.1,% +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.6,,,,,0 - 6.8,% +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,286,,,,,140 - 400,GI/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.08,,,,,1.9 - 23,uIU/mL +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,LIPID PANEL,Direct HDL-C 4th Generation,,1.85,R,H,,,1.03 - 1.53,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,LIPID PANEL,Triglycerides (GPO),,0.57,,,,,0.44 - 1.99,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,LIPID PANEL,Cholesterol (High Performance),,4.35,,,,,3.65 - 6.21,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,LIPID PANEL,LDL Chol Friedewald 4th,,2.24,,,,,0 - 3.34,mmol/L +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,RETICULOCYTES,Reticulocyte Count %,,0.8,,,,,0.6 - 2.5,% +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Specific Gravity,,1.015,,,,,1 - 1.04, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.8,,,,,0 - 6.2,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Alkaline Phosphatase,,88,,,,,40 - 129,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,ALT (SGPT),,46,,,,,5 - 48,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,GGT,,129,,H,,,10 - 61,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,LDH,,156,,,,,53 - 234,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 110,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Uric Acid,,429,,,,,125 - 488,umol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Calcium (EDTA),,2.56,,,,,2.07 - 2.64,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Creatine Kinase,,131,,,,,39 - 308,U/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Bicarbonate,,21.4,,,,,19.3 - 29.3,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,157,,,,,127 - 181,g/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.39 - 0.54, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.79,,,,,3.8 - 10.7,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.75,,,,,1.96 - 7.23,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.48,,,,,0.91 - 4.28,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.5,,,,,40.5 - 75,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.9,,,,,15.4 - 48.5,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,,2.6 - 10.1,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,,,,0 - 6.8,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.5,,,,,0 - 2,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,280,,,,,140 - 400,GI/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,4.8,,,,,<6.5%, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,10.32,,,,,1.9 - 23,uIU/mL +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,LIPID PANEL,Direct HDL-C 4th Generation,,0.92,,L,,,1.03 - 1.53,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,LIPID PANEL,Triglycerides (GPO),,1.99,,,,,0.5 - 2.81,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,LIPID PANEL,Cholesterol (High Performance),,4.77,,,,,3.31 - 6.1,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,LIPID PANEL,LDL Chol Friedewald 4th,,2.94,,,,,0 - 3.34,mmol/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,TSH,TSH 3rd IS-QT,,1.125,,,,,0.45 - 5.33,mIU/L +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.4,,,,,0 - 5,mg/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,35 - 104,U/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,GGT,,16,,,,,4 - 49,U/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,LDH,,124,,,,,53 - 234,U/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Urea Nitrogen,,4.5,,,,,1.4 - 8.6,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 101,umol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Glucose Fasting,,4.3,,,,,3.9 - 5.6,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Uric Acid,,303,,,,,125 - 428,umol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Phosphorus,,1.03,,,,,0.71 - 1.65,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Creatine Kinase,,79,,,,,26 - 192,U/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Bicarbonate,,23.6,,,,,19.3 - 29.3,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,,116 - 164,g/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,83,,,,,79 - 98,fL +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.69,,,,,3.8 - 10.7,GI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.05,,,,,1.96 - 7.23,GI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.72,,,,,0.91 - 4.28,GI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.34,,,,,0 - 0.57,GI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.5,,,,,40.5 - 75,% +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.1,,,,,15.4 - 48.5,% +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.6,,,,,2.6 - 10.1,% +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,6.1,,,,,0 - 6.8,% +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.6,,,,,0 - 2,% +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,274,,,,,140 - 400,GI/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.2,,,,,<6.5%, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.14,,,,,1.9 - 23,uIU/mL +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,LIPID PANEL,Direct HDL-C 4th Generation,,1.48,,,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,LIPID PANEL,Triglycerides (GPO),,0.82,,,,,0.44 - 1.99,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,LIPID PANEL,Cholesterol (High Performance),,3.76,,,,,3.65 - 6.21,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,LIPID PANEL,LDL Chol Friedewald 4th,,1.90,,,,,0 - 3.34,mmol/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,TSH,TSH 3rd IS-QT,,1.582,,,,,0.45 - 5.33,mIU/L +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Specific Gravity,,1.011,,,,,1 - 1.04, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.4,,,,,0 - 5,mg/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Alkaline Phosphatase,,80,,,,,35 - 104,U/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,ALT (SGPT),,32,,,,,4 - 43,U/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,AST (SGOT),,34,,,,,8 - 40,U/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,GGT,,25,,,,,5 - 50,U/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,LDH,,167,,,,,53 - 234,U/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Uric Acid,,265,,,,,149 - 446,umol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Phosphorus,,1.18,,,,,0.71 - 1.65,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Total Protein,,63,,,,,60 - 80,g/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Creatine Kinase,,46,,,,,26 - 192,U/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Sodium,,143,,,,,135 - 145,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Bicarbonate,,24.9,,,,,19.3 - 29.3,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.74,,,,,1.25 - 1.92,mL/sec +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,75.3,,,,,kg, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,GFR,EGFR by MDRD,,90,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,146,,,,,115 - 158,g/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,3.9 - 5.5,TI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,95,,,,,80 - 100,fL +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.39,R,L,,,3.8 - 10.7,GI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.95,R,L,,,1.96 - 7.23,GI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.01,,,,,0.8 - 3,GI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.24,,,,,0.12 - 0.92,GI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.5,,,,,40.5 - 75,% +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.8,,,,,15.4 - 48.5,% +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.1,,,,,2.6 - 10.1,% +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.8,,,,,0 - 6.8,% +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,169,,,,,130 - 394,GI/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.6,,,,,<6.5%, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.01,,,,,1.9 - 23,uIU/mL +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,LIPID PANEL,Direct HDL-C 4th Generation,,1.49,,,,,1.03 - 1.53,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,LIPID PANEL,Triglycerides (GPO),,0.88,,,,,0.63 - 2.71,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,LIPID PANEL,Cholesterol (High Performance),,4.46,R,L,,,4.86 - 8.28,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,LIPID PANEL,LDL Chol Friedewald 4th,,2.57,,,,,0 - 3.34,mmol/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,TSH,TSH 3rd IS-QT,,2.205,,,,,0.45 - 5.33,mIU/L +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1.01 - 1.03, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.0,,,,,0 - 5,mg/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Alkaline Phosphatase,,61,,,,,35 - 104,U/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,ALT (SGPT),,13,,,,,4 - 43,U/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,GGT,,14,,,,,4 - 49,U/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,LDH,,137,,,,,53 - 234,U/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Glucose Fasting,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Uric Acid,,273,,,,,125 - 428,umol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Phosphorus,,1.07,,,,,0.71 - 1.65,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Creatine Kinase,,123,,,,,26 - 192,U/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.59,,,,,1.25 - 1.92,mL/sec +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,68.1,,,,,kg, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,GFR,EGFR by MDRD,,73,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,125,,,,,116 - 164,g/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.30,,,,,3.8 - 10.7,GI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.33,,,,,1.96 - 7.23,GI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.57,,,,,0.91 - 4.28,GI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.1,,,,,40.5 - 75,% +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.6,,,,,15.4 - 48.5,% +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,% +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,250,,,,,140 - 400,GI/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.5,,,,,<6.5%, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.11,,,,,1.9 - 23,uIU/mL +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,LIPID PANEL,Direct HDL-C 4th Generation,,1.65,,H,,,1.03 - 1.53,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,LIPID PANEL,Triglycerides (GPO),,0.93,,,,,0.44 - 1.99,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,LIPID PANEL,Cholesterol (High Performance),,4.65,,,,,3.65 - 6.21,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,LIPID PANEL,LDL Chol Friedewald 4th,,2.57,,,,,0 - 3.34,mmol/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,TSH,TSH 3rd IS-QT,,3.025,,,,,0.45 - 5.33,mIU/L +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Specific Gravity,,1.014,,,,,1 - 1.04, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.3,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,40 - 129,U/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,ALT (SGPT),,46,,,,,5 - 48,U/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,GGT,,93,,H,,,10 - 61,U/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,LDH,,165,,,,,53 - 234,U/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Urea Nitrogen,,5.7,,,,,1.4 - 8.6,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,94,,,,,40 - 110,umol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Uric Acid,,427,,,,,125 - 488,umol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Calcium (EDTA),,2.57,,,,,2.07 - 2.64,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Phosphorus,,1.18,,,,,0.71 - 1.65,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Creatine Kinase,,89,,,,,39 - 308,U/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Bicarbonate,,21.0,,,,,19.3 - 29.3,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,165,,,,,127 - 181,g/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.70,,,,,3.8 - 10.7,GI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.28,,,,,1.96 - 7.23,GI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.74,,,,,0.91 - 4.28,GI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,1.34,R,H,,,0 - 0.57,GI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.00,,,,,0 - 0.2,GI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,49.0,,,,,40.5 - 75,% +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.0,,,,,15.4 - 48.5,% +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,% +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,20.0,R,H,,,0 - 6.8,% +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.0,,,,,0 - 2,% +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,250,,,,,140 - 400,GI/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,LIPID PANEL,Direct HDL-C 4th Generation,,0.77,,L,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,LIPID PANEL,Triglycerides (GPO),,1.72,,,,,0.5 - 2.81,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,LIPID PANEL,Cholesterol (High Performance),,4.31,,,,,3.31 - 6.1,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,LIPID PANEL,LDL Chol Friedewald 4th,,2.75,,,,,0 - 3.34,mmol/L +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Specific Gravity,,1.018,,,,,1 - 1.04, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.1,,,,,0 - 5,mg/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CELLULAR ELEMENTS,Ur WBC/HPF,,3,,,,,0 - 12,/HPF +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.8,,,,,0 - 6.2,umol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Alkaline Phosphatase,,83,,,,,35 - 104,U/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,ALT (SGPT),,10,,,,,4 - 43,U/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,AST (SGOT),,11,,,,,8 - 40,U/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,GGT,,14,,,,,4 - 49,U/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,LDH,,133,,,,,53 - 234,U/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Urea Nitrogen,,4.4,,,,,1.4 - 8.6,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 101,umol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Uric Acid,,303,,,,,125 - 428,umol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Creatine Kinase,,79,,,,,26 - 192,U/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Bicarbonate,,22.2,,,,,19.3 - 29.3,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,129,,,,,116 - 164,g/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,85,,,,,79 - 98,fL +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.56,,,,,3.8 - 10.7,GI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.30,,,,,1.96 - 7.23,GI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.54,,,,,0.91 - 4.28,GI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.20,,,,,0 - 0.57,GI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.11,,,,,0 - 0.2,GI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.4,,,,,40.5 - 75,% +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.9,,,,,15.4 - 48.5,% +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.1,,,,,2.6 - 10.1,% +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.6,,,,,0 - 6.8,% +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.0,,,,,0 - 2,% +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,255,,,,,140 - 400,GI/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.14,,,,,1.9 - 23,uIU/mL +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,LIPID PANEL,Direct HDL-C 4th Generation,,1.22,,,,,1.03 - 1.53,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,LIPID PANEL,Triglycerides (GPO),,0.56,,,,,0.44 - 1.99,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,LIPID PANEL,Cholesterol (High Performance),,3.42,,L,,,3.65 - 6.21,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,LIPID PANEL,LDL Chol Friedewald 4th,,1.94,,,,,0 - 3.34,mmol/L +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,RETICULOCYTES,Reticulocyte Count %,,0.8,,,,,0.6 - 2.5,% +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Specific Gravity,,1.029,,,,,1 - 1.04, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Blood,,Trace,,,,,Ref Rng:$Negative-Trace, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.7,,,,,0 - 6.2,umol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,40 - 129,U/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,ALT (SGPT),,73,,H RX,,,5 - 48,U/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,AST (SGOT),,31,,,,,8 - 40,U/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,GGT,,149,,H,,,10 - 61,U/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,LDH,,171,,,,,53 - 234,U/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 8.6,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,104,,,,,40 - 110,umol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Uric Acid,,469,,,,,125 - 488,umol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Calcium (EDTA),,2.57,,,,,2.07 - 2.64,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Phosphorus,,1.15,,,,,0.71 - 1.65,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Total Protein,,80,,,,,61 - 84,g/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Albumin-BCG,,50,,H,,,33 - 49,g/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Creatine Kinase,,138,,,,,39 - 308,U/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Bicarbonate,,21.5,,,,,19.3 - 29.3,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.14,,H,,,1.42 - 2.08,mL/sec +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,104,,,,,40 - 110,umol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,93.8,,,,,kg, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,GFR,EGFR by MDRD,,76,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,169,,,,,127 - 181,g/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.49,,,,,0.39 - 0.54, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.4,,,,,4.5 - 6.4,TI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.17,,,,,3.8 - 10.7,GI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.44,,,,,1.96 - 7.23,GI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.28,,,,,0.91 - 4.28,GI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.4,,,,,40.5 - 75,% +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.7,,,,,15.4 - 48.5,% +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,% +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.5,,,,,0 - 6.8,% +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,% +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,259,,,,,140 - 400,GI/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,4.8,,,,,<6.5%, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.13,,,,,1.9 - 23,uIU/mL +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,LIPID PANEL,Direct HDL-C 4th Generation,,0.96,,L,,,1.03 - 1.53,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,LIPID PANEL,Triglycerides (GPO),,2.37,,,,,0.5 - 2.81,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,LIPID PANEL,Cholesterol (High Performance),,5.50,,,,,3.31 - 6.1,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,LIPID PANEL,LDL Chol Friedewald 4th,,3.45,,H,,,0 - 3.34,mmol/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,% +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,TSH,TSH 3rd IS-QT,,2.030,,,,,0.45 - 5.33,mIU/L +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.4,,,,,0 - 5,mg/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Alkaline Phosphatase,,77,,,,,35 - 104,U/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,ALT (SGPT),,10,,,,,4 - 43,U/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,AST (SGOT),,12,,,,,8 - 40,U/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,GGT,,14,,,,,4 - 49,U/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,LDH,,127,,,,,53 - 234,U/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Urea Nitrogen,,6.1,,,,,1.4 - 8.6,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Uric Acid,,273,,,,,125 - 428,umol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Phosphorus,,1.14,,,,,0.71 - 1.65,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Creatine Kinase,,88,,,,,26 - 192,U/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Bicarbonate,,21.2,,,,,19.3 - 29.3,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.33,,H,,,1.25 - 1.92,mL/sec +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,79.2,,,,,kg, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,FSH,Follicle Stimulating Hormone,,3.55,,RX,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,GFR,EGFR by MDRD,,92,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,128,,,,,116 - 164,g/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Beyond stability,,, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Beyond stability,,, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.62,,,,,3.8 - 10.7,GI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.19,,,,,1.96 - 7.23,GI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.85,,,,,0.91 - 4.28,GI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.19,,,,,0 - 0.57,GI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,56.7,,,,,40.5 - 75,% +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.0,,,,,15.4 - 48.5,% +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.4,,,,,0 - 6.8,% +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,253,,,,,140 - 400,GI/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.1,,,,,<6.5%, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.61,,,,,1.9 - 23,uIU/mL +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,LIPID PANEL,Direct HDL-C 4th Generation,,1.23,,,,,1.03 - 1.53,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,LIPID PANEL,Triglycerides (GPO),,0.46,,,,,0.44 - 1.99,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,LIPID PANEL,Cholesterol (High Performance),,3.59,R,L,,,3.65 - 6.21,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,LIPID PANEL,LDL Chol Friedewald 4th,,2.15,,,,,0 - 3.34,mmol/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,% +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,TSH,TSH 3rd IS-QT,,1.803,,,,,0.45 - 5.33,mIU/L +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_123005 sponsor-study-35472-test-results-898744-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_123005 sponsor-study-35472-test-results-898744-standard.csv new file mode 100644 index 0000000..1cacad6 --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_123005 sponsor-study-35472-test-results-898744-standard.csv @@ -0,0 +1,200 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.6,,,,,0 - 6.2,umol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,40 - 129,U/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,ALT (SGPT),,37,,,,,5 - 48,U/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,AST (SGOT),,63,R,H RX,,,8 - 40,U/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,GGT,,143,R,H,,,10 - 50,U/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,LDH,,148,,,,,53 - 234,U/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Urea Nitrogen,,8.4,,,,,1.4 - 8.6,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,93,,,,,40 - 119,umol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Glucose Fasting,,8.5,R,H RX,,,3.9 - 5.6,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Serum Uric Acid,,397,,,,,149 - 494,umol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Calcium (EDTA),,2.51,,,,,2.07 - 2.64,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Phosphorus,,1.21,,,,,0.71 - 1.65,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Total Protein,,81,R,H,,,60 - 80,g/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Creatine Kinase,,54,,,,,39 - 308,U/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Serum Bicarbonate,,23.3,,,,,19.3 - 29.3,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CHEMISTRY PANEL,Serum Chloride,,96,,,,,94 - 112,mmol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.85,,,,,1.42 - 2.08,mL/sec +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,93,,,,,40 - 119,umol/L +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,106.6,,,,,kg, +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,8.7,R,H RX,,,<6.5%, +CZ100050002,,,62,years,Male,Retest,,"Nov 11, 2025 10:04 AM",6225351037,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,C-REACTIVE PROTEIN,C Reactive Protein HS,,11.9,,H,,,0 - 5,mg/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CASTS,Ur Hyaline Casts/LPF,,96,,,,,0 /LPF, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CELLULAR ELEMENTS,Ur RBC/HPF,,5,,H,,,0 - 3,/HPF +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 5,/HPF +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.9,,,,,0 - 6.2,umol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Alkaline Phosphatase,,70,,,,,40 - 129,U/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,ALT (SGPT),,36,,,,,5 - 48,U/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,AST (SGOT),,72,,H RX,,,8 - 40,U/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,GGT,,264,,HT,,Result verified by repeat analysis,10 - 50,U/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,LDH,,171,,,,,53 - 234,U/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Urea Nitrogen,,7.3,,,,,1.4 - 8.6,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,109,,,,,40 - 119,umol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Glucose Fasting,,8.3,,H,,,3.9 - 5.6,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Serum Uric Acid,,497,,H,,,149 - 494,umol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Calcium (EDTA),,2.55,,,,,2.07 - 2.64,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Phosphorus,,1.17,,,,,0.71 - 1.65,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Total Protein,,84,,H,,,60 - 80,g/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Creatine Kinase,,37,,L,,,39 - 308,U/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Serum Potassium,,3.9,,,,,3.5 - 5.2,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Serum Bicarbonate,,23.7,,,,,19.3 - 29.3,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CHEMISTRY PANEL,Serum Chloride,,94,,,,,94 - 112,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.60,,,,,1.42 - 2.08,mL/sec +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,109,,,,,40 - 119,umol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,108.0,,,,,kg, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DIRECT LDL,Direct LDL-C 3rd Gen,,3.83,R,H,,,<3.36 mmol/L, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,GFR,EGFR by MDRD,,60,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,160,,,,,125 - 170,g/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.37 - 0.51, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4 - 5.8,TI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,80 - 100,fL +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.32,,,,,3.8 - 10.7,GI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.59,,,,,1.96 - 7.23,GI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.36,,,,,0.8 - 3,GI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,1.06,,H,,,0.12 - 0.92,GI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.12,,,,,0 - 0.2,GI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.9,,,,,40.5 - 75,% +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,22.9,,,,,15.4 - 48.5,% +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.3,,H,,,2.6 - 10.1,% +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.7,,,,,0 - 6.8,% +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,% +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,311,,,,,130 - 394,GI/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,8.9,,H RX,,,<6.5%, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,12.96,,,,,1.9 - 23,uIU/mL +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,LIPID PANEL,Direct HDL-C 4th Generation,,0.81,,L,,,1.03 - 1.53,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,LIPID PANEL,Triglycerides (GPO),,5.76,,H SF,,,0.65 - 2.94,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,LIPID PANEL,Cholesterol (High Performance),,6.27,,,,,4.53 - 7.71,mmol/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,LIPID PANEL,LDL Chol Friedewald 4th,,,,,Test cancelled: Invalid/High Triglycerides,,, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,RETICULOCYTES,Reticulocyte Count %,,4.6,,H,,,0.6 - 2.5,% +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,TSH,TSH 3rd IS-QT,,3.611,,,,,0.45 - 5.33,mIU/L +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Specific Gravity,,1.034,,H,,,1.01 - 1.03, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Protein,,+1,,H,,,Ref Rng:Negative, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Glucose,,+1,,H,,,Ref Rng:Normal, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Ketones,,Trace,,H,,,Ref Rng:Negative, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Urobilinogen,,+1,,H,,,Ref Rng:Normal, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100050002,,,62,years,Male,Part 1 Screening,,"Nov 3, 2025 12:08 PM",6225351004,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.2,,,,,0 - 6.2,umol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,35 - 104,U/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,4 - 43,U/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,GGT,,32,,,,,5 - 50,U/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,LDH,,176,,,,,53 - 234,U/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Urea Nitrogen,,3.5,,,,,1.4 - 8.6,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Glucose Fasting,,9.7,,H RX,,,3.9 - 5.6,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Serum Uric Acid,,289,,,,,149 - 446,umol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Total Protein,,66,,,,,60 - 80,g/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Creatine Kinase,,135,,,,,26 - 192,U/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Serum Sodium,,143,,,,,135 - 145,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Serum Bicarbonate,,22.7,,,,,19.3 - 29.3,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.05,,L,,,1.25 - 1.92,mL/sec +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,63.0,,,,,kg, +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,7.8,,H,,,<6.5%, +CZ100050001,,,65,years,Female,Retest,R,"Sep 16, 2025 10:00 AM",6225351036,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.9,,,,,0 - 5,mg/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CELLULAR ELEMENTS,Ur WBC/HPF,,3,,,,,0 - 12,/HPF +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,35 - 104,U/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,GGT,,31,,,,,5 - 50,U/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,LDH,,192,,,,,53 - 234,U/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Glucose Fasting,,9.2,,H RX,,,3.9 - 5.6,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Serum Uric Acid,,325,,,,,149 - 446,umol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Calcium (EDTA),,2.54,,,,,2.07 - 2.64,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Total Protein,,67,,,,,60 - 80,g/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Creatine Kinase,,143,,,,,26 - 192,U/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Serum Sodium,,141,,,,,135 - 145,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Serum Bicarbonate,,20.8,,,,,19.3 - 29.3,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.05,,L,,,1.25 - 1.92,mL/sec +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,63.0,,,,,kg, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,GFR,EGFR by MDRD,,64,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,142,,,,,115 - 158,g/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,3.9 - 5.5,TI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,80 - 100,fL +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.78,,H,,,3.8 - 10.7,GI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.25,,,,,1.96 - 7.23,GI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.50,,H,,,0.8 - 3,GI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.52,,,,,0.12 - 0.92,GI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.37,,,,,0 - 0.57,GI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.13,,,,,0 - 0.2,GI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.0,,,,,40.5 - 75,% +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.5,,,,,15.4 - 48.5,% +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.8,,,,,2.6 - 10.1,% +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.4,,,,,0 - 6.8,% +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,% +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,284,,,,,130 - 394,GI/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,7.7,,H,,,<6.5%, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,14.50,,,,,1.9 - 23,uIU/mL +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,LIPID PANEL,Direct HDL-C 4th Generation,,1.94,,H,,,1.03 - 1.53,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,LIPID PANEL,Triglycerides (GPO),,1.32,,,,,0.63 - 2.71,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,LIPID PANEL,Cholesterol (High Performance),,4.53,,L,,,4.86 - 8.28,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,LIPID PANEL,LDL Chol Friedewald 4th,,1.99,,,,,0 - 3.34,mmol/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,TSH,TSH 3rd IS-QT,,1.354,,,,,0.45 - 5.33,mIU/L +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Specific Gravity,,1.011,,,,,1.01 - 1.03, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MACRO PANEL,Ur Leukocyte Esterase,,+2,,H SF,,,Ref Rng:Negative, +CZ100050001,,,65,years,Female,Part 1 Screening,,"Sep 9, 2025 11:10 AM",6225351006,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE diff --git a/Covance_UCO3001/Source/tmp/2026-06-01_123027 sponsor-study-35472-test-results-898727-standard.csv b/Covance_UCO3001/Source/tmp/2026-06-01_123027 sponsor-study-35472-test-results-898727-standard.csv new file mode 100644 index 0000000..e17118e --- /dev/null +++ b/Covance_UCO3001/Source/tmp/2026-06-01_123027 sponsor-study-35472-test-results-898727-standard.csv @@ -0,0 +1,994 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CELLULAR ELEMENTS,Ur RBC/HPF,,5,,,,,0 - 8,/HPF +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Alkaline Phosphatase,,56,,,,,35 - 104,U/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,ALT (SGPT),,13,,,,,4 - 43,U/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,GGT,,22,,,,,5 - 50,U/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,LDH,,162,,,,,53 - 234,U/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,71,,,,,31 - 101,umol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Glucose Fasting,,4.0,,,,,3.9 - 5.6,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Serum Uric Acid,,242,,,,,149 - 446,umol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Phosphorus,,1.08,,,,,0.71 - 1.65,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Total Protein,,64,,,,,60 - 80,g/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Creatine Kinase,,52,,,,,26 - 192,U/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Serum Bicarbonate,,22.9,,,,,19.3 - 29.3,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,119,,,,Result verified by repeat analysis,115 - 158,g/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.8,,L,,Result verified by repeat analysis,3.9 - 5.5,TI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,80 - 100,fL +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.80,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.34,,,,Result verified by repeat analysis,1.96 - 7.23,GI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.86,,,,,0.8 - 3,GI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.44,,,,Result verified by repeat analysis,0.12 - 0.92,GI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,Result verified by repeat analysis,0 - 0.57,GI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,Result verified by repeat analysis,0 - 0.2,GI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.8,,,,Result verified by repeat analysis,40.5 - 75,% +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.3,,,,Result verified by repeat analysis,15.4 - 48.5,% +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,Result verified by repeat analysis,2.6 - 10.1,% +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.8,,,,Result verified by repeat analysis,0 - 6.8,% +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,Result verified by repeat analysis,0 - 2,% +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,459,,H,,Result verified by repeat analysis,130 - 394,GI/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,25.80,,H,,,1.9 - 23,uIU/mL +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,LIPID PANEL,Direct HDL-C 4th Generation,,0.97,,L,,,1.03 - 1.53,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,LIPID PANEL,Triglycerides (GPO),,1.49,,,,,0.63 - 2.71,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,LIPID PANEL,Cholesterol (High Performance),,4.00,,L,,,4.86 - 8.28,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,LIPID PANEL,LDL Chol Friedewald 4th,,2.35,,,,,0 - 3.34,mmol/L +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Specific Gravity,,1.013,,,,,1.01 - 1.03, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 2 OL Induction Day 29,,"Apr 23, 2026 4:00 PM",6226560887,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,C-REACTIVE PROTEIN,C Reactive Protein HS,,<0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,40 - 129,U/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,ALT (SGPT),,35,,,,,5 - 48,U/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,AST (SGOT),,28,,,,,8 - 40,U/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,LDH,,149,,,,,53 - 234,U/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,40 - 110,umol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Serum Uric Acid,,285,,,,,125 - 488,umol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Phosphorus,,1.11,,,,,0.71 - 1.65,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Creatine Kinase,,157,,,,,39 - 308,U/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Serum Potassium,,3.9,,,,,3.5 - 5.2,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Serum Bicarbonate,,24.5,,,,,19.3 - 29.3,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.52,,,,,3.8 - 10.7,GI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.31,,,,,1.96 - 7.23,GI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.76,,,,,0.91 - 4.28,GI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.32,,,,,0.12 - 0.92,GI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.8,,,,,40.5 - 75,% +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,31.9,,,,,15.4 - 48.5,% +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,174,,,,,140 - 400,GI/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.95,,,,,1.9 - 23,uIU/mL +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,LIPID PANEL,Direct HDL-C 4th Generation,,1.39,,,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,LIPID PANEL,Triglycerides (GPO),,0.75,,,,,0.5 - 2.81,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,LIPID PANEL,Cholesterol (High Performance),,3.90,,,,,3.31 - 6.1,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,LIPID PANEL,LDL Chol Friedewald 4th,,2.17,,,,,0 - 3.34,mmol/L +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Specific Gravity,,1.012,,,,,1 - 1.04, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 2 OL Induction Day 29,,"Apr 22, 2026 3:30 PM",6226752554,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.5,,,,,0 - 5,mg/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Alkaline Phosphatase,,54,,,,,35 - 104,U/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,4 - 43,U/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,GGT,,23,,,,,5 - 50,U/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,LDH,,143,,,,,53 - 234,U/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Urea Nitrogen,,3.8,,,,,1.4 - 8.6,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Glucose Fasting,,5.3,,,,,3.9 - 5.6,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Serum Uric Acid,,259,,,,,149 - 446,umol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Calcium (EDTA),,2.47,,,,,2.07 - 2.64,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Total Protein,,69,,,,,60 - 80,g/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Creatine Kinase,,41,,,,,26 - 192,U/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Serum Sodium,,143,,,,,135 - 145,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Serum Bicarbonate,,25.2,,,,,19.3 - 29.3,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,122,,,,,115 - 158,g/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.34 - 0.48, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,3.9 - 5.5,TI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,94,,,,,80 - 100,fL +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.11,,,,,3.8 - 10.7,GI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.82,,,,,1.96 - 7.23,GI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.76,,,,,0.8 - 3,GI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.43,,,,,0.12 - 0.92,GI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.07,,,,,0 - 0.57,GI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,67.8,,,,,40.5 - 75,% +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,24.8,,,,,15.4 - 48.5,% +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.1,,,,,2.6 - 10.1,% +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.2,,,,,0 - 2,% +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,466,R,H,,,130 - 394,GI/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,9.83,,,,,1.9 - 23,uIU/mL +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,LIPID PANEL,Direct HDL-C 4th Generation,,1.06,,,,,1.03 - 1.53,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,LIPID PANEL,Triglycerides (GPO),,1.56,,,,,0.63 - 2.71,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,LIPID PANEL,Cholesterol (High Performance),,4.33,,L,,,4.86 - 8.28,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,LIPID PANEL,LDL Chol Friedewald 4th,,2.56,,,,,0 - 3.34,mmol/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,TSH,TSH 3rd IS-QT,,0.806,,,,,0.45 - 5.33,mIU/L +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Specific Gravity,,1.010,,,,,1.01 - 1.03, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,End of Phase/Treatment,R,"Mar 25, 2026 5:00 PM",6226560888,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Alkaline Phosphatase,,62,,,,,40 - 129,U/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,ALT (SGPT),,39,,,,,5 - 48,U/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,AST (SGOT),,29,,,,,8 - 40,U/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,LDH,,156,,,,,53 - 234,U/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 8.6,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,74,,,,,40 - 110,umol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Glucose Fasting,,5.5,,,,,3.9 - 5.6,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Serum Uric Acid,,330,,,,,125 - 488,umol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Calcium (EDTA),,2.29,,,,,2.07 - 2.64,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Phosphorus,,1.11,,,,,0.71 - 1.65,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Creatine Kinase,,149,,,,,39 - 308,U/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Serum Bicarbonate,,23.2,,,,,19.3 - 29.3,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,159,,,,,127 - 181,g/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.94,,,,,3.8 - 10.7,GI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.55,,,,,1.96 - 7.23,GI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.81,,,,,0.91 - 4.28,GI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.8,,,,,40.5 - 75,% +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.5,,,,,15.4 - 48.5,% +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.5,,,,,0 - 6.8,% +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,189,,,,,140 - 400,GI/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,19.10,,,,,1.9 - 23,uIU/mL +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,LIPID PANEL,Direct HDL-C 4th Generation,,1.09,,,,,1.03 - 1.53,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,LIPID PANEL,Triglycerides (GPO),,1.96,,,,,0.5 - 2.81,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,LIPID PANEL,Cholesterol (High Performance),,3.72,,,,,3.31 - 6.1,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,LIPID PANEL,LDL Chol Friedewald 4th,,1.73,,,,,0 - 3.34,mmol/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,TSH,TSH 3rd IS-QT,,1.089,,,,,0.45 - 5.33,mIU/L +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,End of Phase/Treatment,R,"Mar 25, 2026 3:00 PM",6226752555,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,C-REACTIVE PROTEIN,C Reactive Protein HS,,9.2,,H,,,0 - 5,mg/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Total Bilirubin,,16,,,,,3 - 21,umol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.6,,,,,0 - 6.2,umol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Alkaline Phosphatase,,77,,,,,40 - 129,U/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,ALT (SGPT),,37,,,,,5 - 48,U/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,AST (SGOT),,29,,,,,8 - 40,U/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,GGT,,79,R,H,,,10 - 61,U/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,LDH,,103,,,,,53 - 234,U/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Urea Nitrogen,,2.3,,,,,1.4 - 8.6,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,74,,,,,40 - 110,umol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Serum Uric Acid,,427,,,,,125 - 488,umol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Phosphorus,,0.97,,,,,0.71 - 1.65,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Creatine Kinase,,102,,,,,39 - 308,U/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Serum Potassium,,3.8,,,,,3.5 - 5.2,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Serum Bicarbonate,,25.2,,,,,19.3 - 29.3,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,CHEMISTRY PANEL,Serum Chloride,,97,,,,,94 - 112,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,160,,,,,127 - 181,g/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.04,,,,,3.8 - 10.7,GI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.60,,,,,1.96 - 7.23,GI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.86,,,,,0.91 - 4.28,GI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.41,,,,,0.12 - 0.92,GI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.3,,,,,40.5 - 75,% +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.4,,,,,15.4 - 48.5,% +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.7,,,,,0 - 6.8,% +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,366,,,,,140 - 400,GI/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.7,,,,,<6.5 %, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,R,"Mar 6, 2026 2:00 PM",6226560891,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,16.55,,,,,1.9 - 23,uIU/mL +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,LIPID PANEL,Direct HDL-C 4th Generation,,1.23,,,,,1.03 - 1.53,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,LIPID PANEL,Triglycerides (GPO),,1.94,,,,,0.56 - 3.62,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,LIPID PANEL,Cholesterol (High Performance),,4.72,,,,,3.88 - 6.83,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,LIPID PANEL,LDL Chol Friedewald 4th,,2.60,,,,,0 - 3.34,mmol/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,TSH,TSH 3rd IS-QT,,0.976,,,,,0.45 - 5.33,mIU/L +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Specific Gravity,,1.016,,,,,1 - 1.04, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 DB Every 12 Weeks,,"Mar 6, 2026 2:00 PM",6226560891,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Alkaline Phosphatase,,55,,,,,35 - 104,U/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,4 - 43,U/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,GGT,,21,,,,,5 - 50,U/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,LDH,,136,,,,,53 - 234,U/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Urea Nitrogen,,4.1,,,,,1.4 - 8.6,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,80,,,,,31 - 101,umol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Serum Uric Acid,,273,,,,,149 - 446,umol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Calcium (EDTA),,2.49,,,,,2.07 - 2.64,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Total Protein,,69,,,,,60 - 80,g/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Creatine Kinase,,42,,,,,26 - 192,U/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Serum Sodium,,142,,,,,135 - 145,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Serum Bicarbonate,,24.2,,,,,19.3 - 29.3,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,122,,,,,115 - 158,g/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.34 - 0.48, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,3.9 - 5.5,TI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,80 - 100,fL +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.67,,,,,3.8 - 10.7,GI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.77,,,,,1.96 - 7.23,GI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.32,,,,,0.8 - 3,GI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.19,,,,,0 - 0.57,GI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.2,,,,,40.5 - 75,% +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.3,,,,,15.4 - 48.5,% +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.0,,,,,2.6 - 10.1,% +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.0,,,,,0 - 6.8,% +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.5,,,,,0 - 2,% +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,453,,H,,,130 - 394,GI/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,14.65,,,,,1.9 - 23,uIU/mL +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,LIPID PANEL,Direct HDL-C 4th Generation,,1.00,,L,,,1.03 - 1.53,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,LIPID PANEL,Triglycerides (GPO),,1.31,,,,,0.63 - 2.71,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,LIPID PANEL,Cholesterol (High Performance),,4.11,,L,,,4.86 - 8.28,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,LIPID PANEL,LDL Chol Friedewald 4th,,2.51,,,,,0 - 3.34,mmol/L +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1.01 - 1.03, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 DB Baseline,,"Feb 15, 2026 3:10 PM",6227775508,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,C-REACTIVE PROTEIN,C Reactive Protein HS,,<0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Alkaline Phosphatase,,55,,,,,40 - 129,U/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,5 - 48,U/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,GGT,,12,,,,,10 - 61,U/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,LDH,,133,,,,,53 - 234,U/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,40 - 110,umol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Serum Uric Acid,,244,,,,,125 - 488,umol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Total Protein,,63,,,,,61 - 84,g/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Creatine Kinase,,139,,,,,39 - 308,U/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Serum Bicarbonate,,22.9,,,,,19.3 - 29.3,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,156,,,,,127 - 181,g/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.41,,L,,,3.8 - 10.7,GI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.63,,L,,,1.96 - 7.23,GI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.42,,,,,0.91 - 4.28,GI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.22,,,,,0.12 - 0.92,GI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.9,,,,,40.5 - 75,% +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,41.7,,,,,15.4 - 48.5,% +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.6,,,,,2.6 - 10.1,% +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,% +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.6,,,,,0 - 2,% +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,160,,,,,140 - 400,GI/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.99,,,,,1.9 - 23,uIU/mL +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,LIPID PANEL,Direct HDL-C 4th Generation,,1.32,,,,,1.03 - 1.53,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,LIPID PANEL,Triglycerides (GPO),,0.52,,,,,0.5 - 2.81,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,LIPID PANEL,Cholesterol (High Performance),,3.73,,,,,3.31 - 6.1,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,LIPID PANEL,LDL Chol Friedewald 4th,,2.17,,,,,0 - 3.34,mmol/L +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,% +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1 - 1.04, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 DB Baseline,,"Feb 15, 2026 1:30 PM",6227775507,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,C-REACTIVE PROTEIN,C Reactive Protein HS,,<0.2,,,,Result verified by repeat analysis,0 - 5,mg/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.9,,,,,0 - 6.2,umol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Alkaline Phosphatase,,57,,,,,40 - 129,U/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,ALT (SGPT),,22,,,,,5 - 48,U/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,GGT,,11,,,,,10 - 61,U/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,LDH,,131,,,,,53 - 234,U/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Urea Nitrogen,,5.8,,,,,1.4 - 8.6,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,40 - 110,umol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Glucose Fasting,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Serum Uric Acid,,300,,,,,125 - 488,umol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Total Protein,,62,,,,,61 - 84,g/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Creatine Kinase,,120,,,,,39 - 308,U/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Serum Bicarbonate,,25.3,,,,,19.3 - 29.3,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.28,,H,,,1.42 - 2.08,mL/sec +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,76,,,,,40 - 110,umol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,75.0,,,,,kg, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,GFR,EGFR by MDRD,,107,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,152,,,,,127 - 181,g/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 96,fL +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.30,,,,,3.8 - 10.7,GI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.90,,,,,1.96 - 7.23,GI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.77,,,,,0.91 - 4.28,GI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.35,,,,,0.12 - 0.92,GI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.14,,,,,0 - 0.2,GI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.7,,,,,40.5 - 75,% +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.3,,,,,15.4 - 48.5,% +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.6,,,,,2.6 - 10.1,% +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.7,,,,,0 - 6.8,% +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.6,,H,,,0 - 2,% +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,189,,,,,140 - 400,GI/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,4.9,,,,,<6.5 %, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.16,,,,,1.9 - 23,uIU/mL +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,LIPID PANEL,Direct HDL-C 4th Generation,,1.43,,,,,1.03 - 1.53,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,LIPID PANEL,Triglycerides (GPO),,0.61,,,,,0.5 - 2.81,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,LIPID PANEL,Cholesterol (High Performance),,3.71,,,,,3.31 - 6.1,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,LIPID PANEL,LDL Chol Friedewald 4th,,2.00,,,,,0 - 3.34,mmol/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,TSH,TSH 3rd IS-QT,,1.462,,,,,0.45 - 5.33,mIU/L +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1 - 1.04, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120006,,,27,years,Male,Part 1 Screening,,"Feb 1, 2026 12:25 PM",6227767267,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,BENZODIAZEPINE CONFIRM. UR,BenzodiazepineConf-LCMSMS-LDT,,Temazepam (Confirmed),,RX,,,No Ref Rng, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,BENZODIAZEPINE CONFIRM. UR,BenzodiazepineConf-LCMSMS-LDT,,Oxazepam (Confirmed),,RX,,,No Ref Rng, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Alkaline Phosphatase,,55,,,,,35 - 104,U/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,4 - 43,U/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,GGT,,21,,,,,5 - 50,U/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,LDH,,136,,,,,53 - 234,U/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,31 - 101,umol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Serum Uric Acid,,247,,,,,149 - 446,umol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Total Protein,,68,,,,,60 - 80,g/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Creatine Kinase,,44,,,,,26 - 192,U/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Serum Sodium,,142,,,,,135 - 145,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Serum Bicarbonate,,23.5,,,,,19.3 - 29.3,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.25,,,,,1.25 - 1.92,mL/sec +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,77,,,,,31 - 101,umol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,74.0,,,,,kg, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Detected (unconfirmed),,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,FSH,Follicle Stimulating Hormone,,55.96,,,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,GFR,EGFR by MDRD,,65,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,119,,,,,115 - 158,g/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.9,,,,,3.9 - 5.5,TI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,80 - 100,fL +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.94,,,,,3.8 - 10.7,GI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.50,,,,,1.96 - 7.23,GI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.91,,,,,0.8 - 3,GI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,64.8,,,,,40.5 - 75,% +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.5,,,,,15.4 - 48.5,% +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.5,,,,,0 - 6.8,% +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,448,R,H,,,130 - 394,GI/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.62,,,,,1.9 - 23,uIU/mL +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,LIPID PANEL,Direct HDL-C 4th Generation,,1.02,R,L,,,1.03 - 1.53,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,LIPID PANEL,Triglycerides (GPO),,1.44,,,,,0.63 - 2.71,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,LIPID PANEL,Cholesterol (High Performance),,4.25,R,L,,,4.86 - 8.28,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,LIPID PANEL,LDL Chol Friedewald 4th,,2.57,,,,,0 - 3.34,mmol/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,% +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,TSH,TSH 3rd IS-QT,,0.834,,,,,0.45 - 5.33,mIU/L +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Specific Gravity,,1.007,,,,,1.01 - 1.03, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120005,,,65,years,Female,Part 1 Screening,,"Jan 28, 2026 4:50 PM",6227775505,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.8,,,,,0 - 5,mg/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Alkaline Phosphatase,,70,,,,,40 - 129,U/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,ALT (SGPT),,41,,,,,5 - 48,U/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,GGT,,81,,H,,,10 - 61,U/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,LDH,,92,,,,,53 - 234,U/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Urea Nitrogen,,3.3,,,,,1.4 - 8.6,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,74,,,,,40 - 110,umol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Glucose Fasting,,6.1,,H,,,3.9 - 5.6,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Serum Uric Acid,,412,,,,,125 - 488,umol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Phosphorus,,0.94,,,,,0.71 - 1.65,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Creatine Kinase,,148,,,,,39 - 308,U/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Serum Bicarbonate,,25.4,,,,,19.3 - 29.3,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,127 - 181,g/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.61,,,,,3.8 - 10.7,GI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.00,,,,,1.96 - 7.23,GI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.02,,,,,0.91 - 4.28,GI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.5,,,,,40.5 - 75,% +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.5,,,,,15.4 - 48.5,% +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,322,,,,,140 - 400,GI/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,63.81,,H,,,1.9 - 23,uIU/mL +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,LIPID PANEL,Direct HDL-C 4th Generation,,1.13,,,,,1.03 - 1.53,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,LIPID PANEL,Triglycerides (GPO),,2.66,,,,,0.56 - 3.62,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,LIPID PANEL,Cholesterol (High Performance),,4.84,,,,,3.88 - 6.83,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,LIPID PANEL,LDL Chol Friedewald 4th,,2.49,,,,,0 - 3.34,mmol/L +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Specific Gravity,,1.022,,,,,1 - 1.04, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 2 OL Induction Day 29,,"Jan 2, 2026 12:00 PM",6226976943,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.0,,,,,0 - 5,mg/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Alkaline Phosphatase,,74,,,,,40 - 129,U/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,ALT (SGPT),,42,,,,,5 - 48,U/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,GGT,,70,,H,,,10 - 61,U/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,LDH,,89,,,,,53 - 234,U/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Urea Nitrogen,,3.1,,,,,1.4 - 8.6,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,40 - 110,umol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Glucose Fasting,,6.6,R,H,,,3.9 - 5.6,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Serum Uric Acid,,418,,,,,125 - 488,umol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Phosphorus,,0.91,,,,,0.71 - 1.65,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,39 - 308,U/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Serum Bicarbonate,,26.3,,,,,19.3 - 29.3,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,127 - 181,g/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,84,,,,,79 - 96,fL +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.86,,,,,3.8 - 10.7,GI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.10,,,,,1.96 - 7.23,GI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.01,,,,,0.91 - 4.28,GI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.30,,,,,0 - 0.57,GI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.8,,,,,40.5 - 75,% +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.2,,,,,15.4 - 48.5,% +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.7,,,,,2.6 - 10.1,% +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.3,,,,,0 - 6.8,% +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,374,,,,,140 - 400,GI/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.7,,,,,<6.5 %, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,196.11,,H,,,1.9 - 23,uIU/mL +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,LIPID PANEL,Direct HDL-C 4th Generation,,0.97,,L,,,1.03 - 1.53,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,LIPID PANEL,Triglycerides (GPO),,2.92,,,,,0.56 - 3.62,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,LIPID PANEL,Cholesterol (High Performance),,4.31,,,,,3.88 - 6.83,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,LIPID PANEL,LDL Chol Friedewald 4th,,2.00,,,,,0 - 3.34,mmol/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,TSH,TSH 3rd IS-QT,,0.889,,,,,0.45 - 5.33,mIU/L +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Specific Gravity,,1.011,,,,,1 - 1.04, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,End of Phase/Treatment,,"Dec 5, 2025 3:00 PM",6225351126,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.6,,,,,0 - 5,mg/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Alkaline Phosphatase,,67,,,,,40 - 129,U/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,ALT (SGPT),,34,,,,,5 - 48,U/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,GGT,,69,,H,,,10 - 61,U/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,LDH,,98,,,,,53 - 234,U/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Urea Nitrogen,,2.2,,,,,1.4 - 8.6,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,40 - 110,umol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Glucose Fasting,,5.6,,,,,3.9 - 5.6,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Serum Uric Acid,,520,R,H,,,125 - 488,umol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Phosphorus,,1.19,,,,,0.71 - 1.65,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Creatine Kinase,,126,,,,,39 - 308,U/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Serum Bicarbonate,,21.4,,,,,19.3 - 29.3,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,146,,,,,127 - 181,g/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.43,,,,,3.8 - 10.7,GI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.49,,,,,1.96 - 7.23,GI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.20,,,,,0.91 - 4.28,GI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.44,,,,,0.12 - 0.92,GI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.24,,,,,0 - 0.57,GI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.4,,,,,40.5 - 75,% +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.2,,,,,15.4 - 48.5,% +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,% +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.8,,,,,0 - 6.8,% +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,288,,,,,140 - 400,GI/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,15.24,,,,,1.9 - 23,uIU/mL +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,LIPID PANEL,Direct HDL-C 4th Generation,,1.15,,,,,1.03 - 1.53,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,LIPID PANEL,Triglycerides (GPO),,1.64,,,,,0.56 - 3.62,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,LIPID PANEL,Cholesterol (High Performance),,4.19,,,,,3.88 - 6.83,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,LIPID PANEL,LDL Chol Friedewald 4th,,2.29,,,,,0 - 3.34,mmol/L +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Specific Gravity,,1.011,,,,,1 - 1.04, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 DB Baseline,,"Oct 22, 2025 12:15 PM",6225351120,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.6,,,,,0 - 5,mg/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Alkaline Phosphatase,,65,,,,,40 - 129,U/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,ALT (SGPT),,36,,,,,5 - 48,U/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,GGT,,62,,H,,,10 - 61,U/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,LDH,,105,,,,,53 - 234,U/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Urea Nitrogen,,2.2,,,,,1.4 - 8.6,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,40 - 110,umol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Glucose Fasting,,5.8,,H,,,3.9 - 5.6,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Serum Uric Acid,,472,,,,,125 - 488,umol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Phosphorus,,1.14,,,,,0.71 - 1.65,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Creatine Kinase,,132,,,,,39 - 308,U/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Serum Bicarbonate,,21.0,,,,,19.3 - 29.3,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,3.53,,H,,,1.42 - 2.08,mL/sec +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,77,,,,,40 - 110,umol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,130.2,,,,,kg, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,GFR,EGFR by MDRD,,98,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,148,,,,,127 - 181,g/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,85,,,,,79 - 96,fL +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.89,,,,,3.8 - 10.7,GI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.47,,,,,1.96 - 7.23,GI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.93,,,,,0.91 - 4.28,GI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.30,,,,,0.12 - 0.92,GI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.8,,,,,40.5 - 75,% +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.7,,,,,15.4 - 48.5,% +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.1,,,,,2.6 - 10.1,% +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,,,,0 - 6.8,% +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,369,,,,,140 - 400,GI/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.5,,,,,<6.5%, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,16.15,,,,,1.9 - 23,uIU/mL +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,LIPID PANEL,Direct HDL-C 4th Generation,,1.24,,,,,1.03 - 1.53,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,LIPID PANEL,Triglycerides (GPO),,1.40,,,,,0.56 - 3.62,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,LIPID PANEL,Cholesterol (High Performance),,4.07,,,,,3.88 - 6.83,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,LIPID PANEL,LDL Chol Friedewald 4th,,2.19,,,,,0 - 3.34,mmol/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,% +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,TSH,TSH 3rd IS-QT,,1.099,,,,,0.45 - 5.33,mIU/L +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120004,,,39,years,Male,Part 1 Screening,,"Oct 1, 2025 1:00 PM",6225351111,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.4,,,,,0 - 5,mg/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Alkaline Phosphatase,,84,,,,,35 - 104,U/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,ALT (SGPT),,36,,,,,4 - 43,U/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,GGT,,44,,,,,4 - 49,U/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,LDH,,220,,,,,53 - 234,U/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Urea Nitrogen,,3.4,,,,,1.4 - 8.6,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Serum Uric Acid,,295,,,,,125 - 428,umol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Phosphorus,,0.89,,,,,0.71 - 1.65,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Creatine Kinase,,92,,,,,26 - 192,U/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Serum Bicarbonate,,23.7,,,,,19.3 - 29.3,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,3.78,,H,,,1.25 - 1.92,mL/sec +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,105.0,,,,,kg, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,GFR,EGFR by MDRD,,114,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,116 - 164,g/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 98,fL +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.91,,,,,3.8 - 10.7,GI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.15,,,,,1.96 - 7.23,GI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.38,,,,,0.91 - 4.28,GI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,,0 - 0.57,GI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,70.3,,,,,40.5 - 75,% +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,23.3,,,,,15.4 - 48.5,% +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.7,,,,,0 - 6.8,% +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.1,,,,,0 - 2,% +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,241,,,,,140 - 400,GI/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,4.9,,,,,<6.5%, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,15.68,,,,,1.9 - 23,uIU/mL +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,LIPID PANEL,Direct HDL-C 4th Generation,,1.23,,,,,1.03 - 1.53,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,LIPID PANEL,Triglycerides (GPO),,1.78,R,H,,,0.41 - 1.63,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,LIPID PANEL,Cholesterol (High Performance),,5.53,,,,,3.31 - 5.64,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,LIPID PANEL,LDL Chol Friedewald 4th,,3.48,,H,,,0 - 3.34,mmol/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,RETICULOCYTES,Reticulocyte Count %,,2.0,,,,,0.6 - 2.5,% +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,TSH,TSH 3rd IS-QT,,2.503,,,,,0.45 - 5.33,mIU/L +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Specific Gravity,,1.014,,,,,1 - 1.04, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120003,,,21,years,Female,Part 1 Screening,,"Oct 1, 2025 11:00 AM",6225351110,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.4,,,,,0 - 5,mg/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Alkaline Phosphatase,,69,,,,,35 - 104,U/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,ALT (SGPT),,5,,,,,4 - 43,U/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,AST (SGOT),,13,,,,,8 - 40,U/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,GGT,,<4,,L,,Result verified by repeat analysis,4 - 49,U/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,LDH,,143,,,,,53 - 234,U/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Urea Nitrogen,,4.8,,,,,1.4 - 8.6,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Glucose Fasting,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Serum Uric Acid,,193,,,,,125 - 428,umol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Calcium (EDTA),,2.29,,,,,2.07 - 2.64,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Creatine Kinase,,75,,,,,26 - 192,U/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Serum Bicarbonate,,21.2,,,,,19.3 - 29.3,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.06,,H,,,1.25 - 1.92,mL/sec +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,65.8,,,,,kg, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,GFR,EGFR by MDRD,,105,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,131,,,,,116 - 164,g/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 98,fL +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.06,,,,,3.8 - 10.7,GI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.38,,,,,1.96 - 7.23,GI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.11,,,,,0.91 - 4.28,GI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.35,,,,,0.12 - 0.92,GI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.20,,,,,0 - 0.57,GI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,66.7,,,,,40.5 - 75,% +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,21.9,,,,,15.4 - 48.5,% +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.8,,,,,2.6 - 10.1,% +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.9,,,,,0 - 6.8,% +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,182,,,,,140 - 400,GI/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.0,,,,,<6.5%, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,LIPID PANEL,Direct HDL-C 4th Generation,,1.77,R,H,,,1.03 - 1.53,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,LIPID PANEL,Triglycerides (GPO),,0.71,,,,,0.44 - 1.99,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,LIPID PANEL,Cholesterol (High Performance),,5.82,,,,,3.65 - 6.21,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,LIPID PANEL,LDL Chol Friedewald 4th,,3.72,,H,,,0 - 3.34,mmol/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,RETICULOCYTES,Reticulocyte Count %,,1.7,,,,,0.6 - 2.5,% +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,TSH,TSH 3rd IS-QT,,1.847,,,,,0.45 - 5.33,mIU/L +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1 - 1.04, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120002,,,40,years,Female,Part 1 Screening,,"Sep 3, 2025 1:00 PM",6225351109,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.6,,,,,0 - 5,mg/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Alkaline Phosphatase,,71,,,,,35 - 104,U/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,4 - 43,U/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,AST (SGOT),,31,,,,,8 - 40,U/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,GGT,,79,R,H,,,4 - 49,U/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,LDH,,144,,,,,53 - 234,U/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,93,,,,,31 - 101,umol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Serum Uric Acid,,405,,,,,149 - 446,umol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Phosphorus,,0.92,,,,,0.71 - 1.65,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Creatine Kinase,,157,,,,,26 - 192,U/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.33,,,,,1.25 - 1.92,mL/sec +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,93,,,,,31 - 101,umol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,83.8,,,,,kg, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,FSH,Follicle Stimulating Hormone,,32.96,,RX,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,GFR,EGFR by MDRD,,54,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,117,,,,,116 - 164,g/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.35,,,,,0.34 - 0.48, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,81,,,,,79 - 98,fL +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.93,,,,,3.8 - 10.7,GI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.05,,,,,1.96 - 7.23,GI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.14,,,,,0.91 - 4.28,GI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.46,,,,,0.12 - 0.92,GI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.25,,,,,0 - 0.57,GI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,68.3,,,,,40.5 - 75,% +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.2,,,,,15.4 - 48.5,% +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.8,,,,,2.6 - 10.1,% +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.2,,,,,0 - 6.8,% +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,157,,,,,140 - 400,GI/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,6.5,,H,,,<6.5%, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,27.42,,H,,,1.9 - 23,uIU/mL +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,LIPID PANEL,Direct HDL-C 4th Generation,,0.82,R,L,,,1.03 - 1.53,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,LIPID PANEL,Triglycerides (GPO),,2.78,,,,,0.59 - 2.96,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,LIPID PANEL,Cholesterol (High Performance),,5.73,,,,,4.42 - 7.53,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,LIPID PANEL,LDL Chol Friedewald 4th,,3.64,,H,,,0 - 3.34,mmol/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,TSH,TSH 3rd IS-QT,,1.091,,,,,0.45 - 5.33,mIU/L +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100120001,,,56,years,Female,Part 1 Screening,,"Aug 6, 2025 1:35 PM",6225351106,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, diff --git a/Covance_UCO3001/browser_profile/BrowserMetrics/BrowserMetrics-6A227387-63A0.pma b/Covance_UCO3001/browser_profile/BrowserMetrics/BrowserMetrics-6A227387-63A0.pma new file mode 100644 index 0000000000000000000000000000000000000000..3d54d50ad8dadee4f87f6dbff28974b09b3e3943 GIT binary patch literal 4194304 zcmeEv349bq_J2*dBB(?Z1rZ5{63~oXLI95p2}h7XBng6NCdnijNM^>F$pwlLudIsT zwSc-hUWh1)H{KBy@x~JrapR3Ac4J12@CWLEYsR)SuEtGr=uSLxDHrw>t1jp%lJM-193cvDPX>9fs@;g2bQ6O9 z>X0Xx?Fk3HMIj-UgG>Gg&ME$Wi}|7pJbEk!jR5Teowa!WQryJk+AGHFdui9cW>6W< zfh+SVjOy~UUCta&Fysw|J-)E3yxd>p4*P@7iSA%|?G$kRr9pQ^$f@IML?ndkv;ki| z!SPX=2_X8-9YLKyok3kdiJ*NzT|wPI`-1iZ?GNe>BDov@>H#_sbP%W~=wQ$xpkAQf zphH22fer^Hg9d;GfsO>FfQEunLBl{JL8C!qLC1m8L7AW_plP5SP(J8X&{-go=bk-# z&cjXAgIMm%@uTRsxj=O1-%|j7Ro7u_z!Lehjy&mwyXGASmUI*@0il_1vZFVv+!aA* z`Mlwoo=|0ZScXl*wJmaH{7Dcfy_a)#*O99r)Px@#BJqh&uYb97kDkLv9qSzC95Z_4 z2nlcCOrD_IJZ~VeJ6W-m0q7G%NO>PCq27( z-(HEyjuf%TAue@@)ebYswGPMBuKQIC9Cv2VO&5PW2hUeMa>@fe|9;5S6Y<<>|D8Ye ztXq8UOF3e0A|;lF9Itc8-?iK!b~)+?)+InbhI7;>h^rC?jT-45RXk#BVQO)SdqnD} zlC;9qvF=f$Q%gJ}Mjku7#8Z6iu#u}0R_=Fy!YW7c;bY&t@#UQ3$9%kI;q&!k=)#R_ z%eP)X^3HBco;+qtL+X9IPka56N#RlBzMGqR-q3|dKi_-bt@})SFz>*uKl<&->$mua zwAI@?yyRKfr>Oeyb8Amp?LBx+i}GU&cimEdjQ>5C`5@0!-OzPqpPxH@KepSpTLx!dkd^vGx9f|(uGp4)(^Id{soEZz z(D=#M7hbk*&$J)+JLCHV*SjA~{B-I)KcF6>;8Pi*I+E)ttw1H0*>YA!SMmJ?>yp8NDp)`gFg~(-D>KXoRDB zY7JZF4+OlvQW@IN3p2uHcr%8N>a^vZjG#Xh%Jfuui#+ri>4oWj3loU(zL{o|_o)t5 zc&2#VRkid!>7rVZXbSFkT8?Xr~AWa#qkmyk*W9@qMsg5raSB|bcZ~y zfH$MuiyRF#{T*hR=&!$PlnF{YRv-|j$!{>z?%U*je?`C_^5mdo`AG`#-nA)vYAf*D zb8CG?R18H&6fDy3B$GUM;pCvdGH{mR%l}HfobU5j`|w8m@MZ3xr#NnSMBDD#CD1N` zb_ujgpj`s(5@?q|y9C-L@LwZ=rT8U0o)N(S3yn{>Ky*hpN{+Rpf#3P)-gn|((eeCM z^AGW^7(>shYmRRn&xnm9S;vi>=vx%$6k%wi43Wkg*P!tt8XKaqAR7CjJ{t8?Xnf}= z5W0JEOlLgq>7a?AlR!Bj9?L1fGyNuX^v_eraS~}j366d@^=XoyPLShgDF>mC-0;?q z6Mb=Swy&&B+;kL~luLY`_dZrHPy=Zipp1E=ib| zo8f3&wGM(;@j`5J+%gCJH`l*TLyaPL`NzEu9J}fndM3wsb-v*%#4LBvD+gLa&WSY` zS}pbz=ekQg+5TdWbArcR&M5b|eG_ZEVFP%E-)9UL z7uAlGbA5S4#M&>bqv4Wn+(%k+kdf}VieS5#}ffg&HpGrJe`ApR#j&AHR3cl~MKi;@VU zbOs(F&d~Vm9}kZK#VKKVLPp4B+(<5wm7g!E0S+}CN<)=fA_m-A!@1&uN!P!2@kOs0 zv2*zq;yR7b{w?5~|uD zP!i>#r~-fw4S)xIVCKl-O_7WU2v@v$7Q$X<`jcF#v23jz4E&*R*>~S=eSO3I+3WCg zL?wvaAd_$W7rW*JJtZOM)Lg$W7t=x>XRaqa%UxdSImuHi1100i`JRmQIsO5^-xegf zspWJn{9BW2@cqhVyDpf}k;0Lqy8~C|OQv#B%4rLF_LQL4XofBGX-f|?@{RKu&7*9O zr-1+9_c9!VHKsB;jctNRoX0icM7Pv zeCGPW?UJfTNxu_rF2`y;OT++eYvrNa<|VFgZYaGI?@MQtW5~heBWjCNejkk!XOy{p zK2N!bmQ&JKDM(k1m*T7gas65af8x17bm!lv*8itp89jZ*mLr(*W)Rs zypI_r2saz_XY!Zq#Qi`#Uy96E! zWT+)ey>7%LgeuP@#6b3YJ@`{P?w?E%Ixg$s>oq!9M9<`M%&X3qY+RIdr+F*9;gB=R zf$GWi&i6PoJtc0QCjFPomwp4uSk+&FCcKi-?W%AM>pkwqke5+yXNJ zx;sRHV7|$Y-tx*|wif63{pHSlXkO}cx`VZ+xaWB)11tn5>=P`1DDRG)FZH>sgP9`bO9vogeiVrL0GrDb3l$ zgTGyUr`NMBz(e}U1)}unneeFgSJ~#5cYIp-vfC&(MmW;X%tvsG({W~njEUCb8JO$j zpJ2@Y%J=GU<@Rd!pw{uEEdJn_-?|LFLdU~=3mE(pOVp5CRw&b7;r9Bb`mqY4*xFuh zv5|hY=j10NH+|PpPoMd%rtdS-=WwdtD?7sAx^ScT0k28FtiIzL)zgN2v~`*hRIcIa zh%56=cJ!9*sqhDDotjRG{yWp}4^zh(JvGwxR(Wg(p4Q5T`|K4<$32|_i_>t1TpU8@ zvwze4Fw2LjIaU1@II{KhmrfZW_B^v<@#r#7{PBk;f1~5dBgb#L6x5_%Np7H!?12+o*V!YIvy5b_A(* z-9I9y`erV1V#LjGsOoS7h0Zs8VJF1FQ|2u%j>2)vl_gO;b$F5M?M~|a!Ew1w0zS&l zB=C26&s|1-Lvup~=RTD(hn~rCInnusFV>LcW&~>kVJB8c!2l_e&otJ@{*8FBtM|Gf zY$Awkc(U)vwj;ZVgwqQIGg+>0qn|baM1~xR4EYZ9K_?;pfd*hA0KAO>nS0QQ_y`8(!X)(F(FkT?EaooMp2lRz z3vy$7vkqynd;>#TuLlnenE&gEp0W=CMLN2Zo@Tzuj^5(QH=4N!RS)9yBS#spxp1R+ z(L!;pO@uRe9_jRpdeGk(h+<{L4@uG#*%ei#+Sd461` zq147nb*``BU_&O9hBc>bI{l?hCk%m#$?R zJq}=B1lSXfM?4cT#y>-dc^FInxdeU~Xjpg=@(BiP&o!XuA-_hH-#sXY0~}(;Ne+=- z>kv!VI7I(19pa~>6T~s|6GXo^6NGDY2Qg_?2XW}oj$+4?9YtnIC$aO0&ZrYz#DlxK zh&2c9BR}UuE&IN)vWVzP$!Io=}Jmu^0-5#QHLXN_9 z#g+Mzsa#@O+GxjJ^D!#s%A{tT26rn%k{#0!YWZCUJjjYD9(qQWSnQnBKJVcvIep+` zgo7O2ss1ouGL?&tCo5!F6nTCVnHg5ak)CSA>ymND#%T)xh}XAXea|%&ANKBZCSfE; zIH=#qe92TUIu3I+sbRwN;2gr&fw(?507q-`_;k>I!3BMXY~Z8}xj2N*XMY_>R%jYl zIG0D8R5kr{XY1+jzxlIkw;o-&faB-%bw2wylYX|ls0@al_WNz5KjoEQC!d-z_i~P( z)7Saz?<%4$g0~R;CUi2S!?#15J)WtQ&4|flmBavcU|!Artj%ZN}2_Dee$P6^p3Lkdw~?3K6`(F%X}~eQ?WnZH_`e>F^fC8*blk9qpu-mLxctrI?teAS{4D|a6F%nC`>NXu ze7R-*V3-m9+4hL^-F_gb`8Kb|CnFn8fwWi99LV|Ffw&(5g6SaJF>0z&y=8kg9QRS6 zF`#iEG#4TrlmVIqnhKf@nhBZ(LK6~QpYO%94-^K?2i1Yd2D$=tE$DBc+d*qU4}+*p zd=c~(=tIz#pr1hrC|KP=v{B+{(0CAO4v=7R{aL{R>de9>vDj&%D^N_4;r@0($(aMot&TAHR75}JDm^8xGp@wV* za$L@tZ*XH*`{igxNl8YaGJa{d;;b8K#P7llB9OmFE$;>E9AeSn6|b);yz|?e@LS1o zd1t=Cja~N|r=`?eai&nAf@7SzJQMdz67$NsKRM%}Q8&QMk&flbe3Ko$wE?HE1#w#P zeUpY$*B?tU>U`v{)vNn0ntSOAsyJ{gPv#rk*mZAlYT~ruOhE;u{APKgxe_qtL=9}b z`Z;T!Zg|QeUQ8MJwfp)JN^a%%Qg7Pxc3JQ01X5U0+IeBv5*c-0l`F;`;#b3VfsmZ=)|3x z2s9mn^dhMQs%}(7AZEGN1=%3?a8Un`^yPRE^#@3Ao&Y)#ln$bNngGfGWr8MxCV?h{ zrhu|Qq+3q{O#@|vNYBmy<$$PPNjf(dln2TOk^VgeM177qAkxLBflddV0Xh?O7N`K^ z1{H#eK%^h2yu{Ocn_4MXV!cD0zw76;BbOG=e3k?W$K{{-1~+!y`*LNi0c#N@>*u;O zYx(a8KPpq|I+iP@WL>;t!sTH`f?^5h5IUdzX%T`PtEORWS0I3?Drs%FimPbMr5FZs z7+Y^J%5HQYGClM!tR|XiE5$%JRxHR7Z!<#GeoI6FNdTY90pXzM4j^^h^oJEIj_Nu2 z!C%3aj`8Yz_RsZ}`Y_bt%E`jCOSYRf#)KweJP5s<83d8nt<>O!sN75(>EJboPlm4niAf#}Y2qf}`&&-kbSERpcs ziU*%g{>uvTCr5YcPcdIIl}r9f*~_WRe*&zz=b%>#93F72$62$WN zI*2|!I*EtZbQW*FoG3P5+s!h5QU@GdzY5Uc07_KO@$}(k(;r*VIJ(~gK#`7qa|ir# z=9}#3%^VjXwH7FM*Jc$@!san!9ww_8q3S@Kexr@_1G`sm2v&dpqniv==SA%D5i_07VpOV|VB%baGN z5yTobET)LfL#T48BLf7^1)}uyaoFT@yNie4@BY$>E8ZCM6$OMt5te$1`I4zzS{{eZ zB9leB<+yVB=#}33dY9^&E>{oflQuz>3q@38^66Q1miC&KY|`{*exMj5!%mD#%cW)$ zFwt7>QAeqTNJb=ti}ZS0I_jp9E~TyF-UNTDOD<4zF7=l=-gSQ+`|CtA0ONO>eEmK9 zxM$Jsf4Nta;z$ND?w#qdQI&Kl&4}qw>&*fa@DCi}CcnDBE|+?DDH!7me!gqn5)_*?21P@fJGtI~3o(J6kWq#u8Lj0wlLwtwX;RQny#20%Kgl9-c zF>pgCu`wZ0OzPWBESc9`d{o?1+r(Wz>zNPfh+SRQ@Kp{gq@kwbDf#K&=h|N%Yo$b zX*o44Lp9=RC*P?(+7EOfh}ww3pfnKmeJVkBf_?(IA+Oz_j{po=B{~4-S`?ZkXm1Di zfW3975Z@jl#2ceg)}f6q3JP)Y?a1pLSc5;uA>RDaA^e!T7;zBhD?aNaYA;F@Jx<EAdF*Tu1)kuN((eJx3zx7%$%w zAxCm7U%lQf@0%b}E8g6%wC7ceRu48R9_KsrjTmBATlqfIb9N<`)tQ+uU#`KGE0+^+!K>h!8KJQ@<%4V+1H@i#-^3L~ZVS z6ZW*c0Nd^t%mb!51j&o@yB_JXTpK3iA2=6?#)^_}?jq&d2zhU=I-!yL60S)(>$`8C z{dFz<182xLA<8$nv1=2#P7H;;6=>Cr`F$Rik1J=w5X5iqj^Dl>bOnBYRTs?fK?ZlB zf;pgAFGf9a?T?>a<}LlVS3 z?gTOJp#-si&kmyhq7Gup?hazbWgSKE=uV>klTPB>2Rcjn#gp@tDTclxIU}p3ZHJ#3 zUB9q1FF~wXa>r9!-@EoP8lxcx=u)3DUow@8+&@7J7I?v04t4x<aM#RV1BWWDm%7k}$Ixbr)(Zhm*X)P}n+7MuXaF{-Sx3{SI}VYh+!&tsAckJwxHh(VhC~%$H2%BK5dD zPbaI`*kELMCgVosiu!rUNSDX&-nw+rJ`|^FA1&8#u{;aVSo1oIpWal)cjtBAJ0_O7~bb>;DS&!79= zOITTDIJ#3gXTHgf-Z*_sO-!H#ws{ z49=W#o{oq4Q6T1nj%T7zuDQg3g)_G@5WotEX>@v>C0`O}8ZWzWqjZWvR4I0WcpvF~ zH(%*`wEG!%80E|eN9&oGkDwOEIL!3@LCC}GipX%P9G2Qh|Cp?~DaVX`=?+~E%(o8iq3OsanJ6}A0Mp@}@WmgLZB)T#5Xf9m=ljgW>M=&JMCzj+*a9vuD^#1i51 z+I*ke0tzpyxEk!>S`qsDz2mMKtjnj9$!9!#Zypz{1uSQVsT&uUnr~C`jM!LSaoep; z+g5LwdCwwF*T9E%OXIUY<8p1d7*X=7V^w*HeL6KUD2%`E93Xtjx%nLaT5($aUkl?T#61;H@kC$P8}yI~ zh4Te{Xy?^(w4EkQ;200}OR1hGf`9AAEcCE3cRl&qNnN*9UqsL33|!dnrtuA5%&o-5 z69qu%028NJFF4}bthf-poSE(Bqz zn)n7Z6q)GyugY+`+;^S1;f0?=&wfPV$Wb`D>U_z@ z#fIE*#AFE$H!PnR4Elp1^Ti16Tt1U$8%)L(um0ZjmmM2_-4Xc4d_9Uw=d*u&T-J&l zT|-4Cwxy_yu(V4N;3GLOKI&6Y-mCM|hvyD{_MRU;!w9kAC_J@G%s1K5TT^>q?%?xa zoRp@JEcGRAPV4peo870CH2m@WVoH}B-KqXEUow?T)AU`%#d4P*R#N&x#+W^(OhW2p z7T#CO(pqgMgI{rLqE>i!1Q9+8(Sr)tX=X!@oOdHu%-EySXW`-97HQ z@X<|o{EhICBm9ZDGG8*4OAcn(XoC%AlX22*w!0?VTNLzD9~%>HMYOEK2n^HmPwSKY z5C>tVI;`sP#?y^7T(}Wlamm#k$VNfTFow++O4!14Kf&kr-57;2M_!u3ID=9}#3 zE%)qlCm%fu%S`G4ggLEfMWsRFaQV@2yq_(6am070PsNr z+N95fSeN7w(=#37b}Teq_7cvC?w=qQ;7H;@9gz679YknCNAX}%C-FSY9)|tf14Qw8DdM!0VPbsdSaEdkOmV}n zIilgD0x+)@mB|Tj1TINP z_`=bF$^+|tz>ezIvNP}xoC^ezH7PeqXn=lv{_WoHK6`p&&L#*C&I_V?%6!RGE>v!$ zsX;S&c=80A6crg-#j#Vvq3ikdLge``HJw8b4A^o96%aVa!F+=oyIOI?N~&{KHi6>i z#-bl;&NSX{P9BX#m|rLeuFeb(x=EJ@^J55%Co7JLHP{|bi@}-*Mb)24r7hzi-;cBQ zX`FG*@PQZ#myYsp5OR_E1~+yk98Kyo)nq=PqzNM9-C-!c)E*Dd?{8Z9W?6wZ)m^fE z2m+N3BC>%{#Uv4*{1JsDR7dG39PP8<3;6kLm@LKju+5BC12Gqc9wY%GY`PK7~>JxQwgs z{;xc@>$9dgt(J|ZzU`d(>5Bfx-;wauMZa^IGIS8u&zpQ*mg+Ym zqJ63Sc@vX=Hj8S-0tgf zbA11a_jY;yYjZ`_$HOX>}lJTt27|rHoZ=XZPe1yo$`zM zCOdkwo=-3h3kova@(W5%bC;PpZal(#qYihH6Ukwx4Lr|Xal$j_E-GEb2^zQ@Lg%x8 zvv^DZtCaMY2aLB|xKX^tAPTk%#PiJGoPB2SFH46qd>M{H>wLT--7K#MYlh6z?3~jp zD>D4$e%gj17XpN$6AzwZ%sOEBdWLU0>RXjZ)<9!l0>Kaw5X&j;Y~sYqOB1^Xe%-4k zb$NKqm(R+8xUigbKKom7lEIaW!J)9Z#IPA)a>bz$gIe!shZd#Ba-_0M<2&m5lv_Xg z@vuKC4m{C#+nhJS?1|22e``KsE!GroX_-9p!5s=qVHqJKxUrlHf>s>y^wFn3zOZc2 zwlB?`kI6~rGmh!*DsQROh)|Ek*g}J?oW`fq@QE#)00M52pAPaP4;%+vif?}@VzT68 zqiK|~oa(+CEz6q#zjW$`VU*?_&z!z~;Z6ST^<<2}kz8rqp81lgT-t;$1~$6luMu&P z{92p$q%jH7rx-eyb|Tq>13|}t(m^z(SOtoJ-UA&8;B=TCwlIkILEBI$jzfm@LPR%U z(6AGX(A!{mehwqkos6>`j>7!qc&t0lfxU@#Wz*G|Q{0HX%sAxXI=@47!}kw2+>#*1 zT-8C`^lnFS1Qspd{86GPPuy3WpPeMC4nA1y_@=KYxhzGHT;tiDH8AA?C0b7DnaZl# zey-d9tmhZ4J5}ZdyrT6;=aV0~9IT;o7uBK#^#+UO1h_HdH~~k0&O%oAd}5`w+!7|e{xp6zZcFi)zGDe9IVu-4ugHAKR4$CmKqD)TzdY0&8f*V% zDe#bUfhe7L`!VMp^Vzp`&)+|V$^ClXYp5TmW)j044|iG7iM&<$H3N%;{g$qh$$YOk1YvZFU0hc#dLOj<)~EG~Lk#noT~ zSHDiLj(XzB^9Snr#r!BB^T8gj9DkrPpu&>%Evo;jTbEZ-^(9~2mX?K;@P;FKQ8{A1 z$&TLa;X-FQXl|y%z8-8dH1pXiw_P^y&B+T77`^-3CgTarj{-9v?BUC*zzGx$4PMG*n9 z{1O+mj_;>0&aFDWa8I?4kNFg*>e`Gi!(D-`%29}Fxr^AqH~*LMkGfW$mZ;-nzKV^W zZQ{$y%)%14i8WDN5xmQCOFyS|xm}m{T>qaOpM9v~Vm@I}ojqKqcnT-rqX}W0YFjqB z65GAw;%l^lulAcopM1T3NHWz2a&)KmiusbMTFe9o+d499oM=spHBYl$pf0Kw`Km`;lfS; zUo0;v4pm;OY~cEJ<~^Iz3y+?xmpA6`9j^RPp|zM<^v4v8s8YFcf#}`|q>sB?H}{5$ zr*3_}2`=X26^pZ%k6G9!Z=7g@5tvwJBBlt4>*;nI_~yU&OP8WwP73OBW4;9({;`LT zzHx$<-sn79@TvJ)SJ%4ywq<{L***IobQsB(9Nnp&GG8*4i#>c)53pY!U%X;)>Uc!T z`K{xcSAOUfKg~L6e;pU|6-e^Y9MWFup?ai&T-EKop zk&DLkd90}BGej>P%Sq?6e=GUfR8APk#bBUCuhm^(#OA_{(u)vUpdRJ^2Pd^(@~+m27>XKc8^jA$+HtbZFXGMFsKV*E?MZ^D*|Bj5Rc06mjqx#)bucW>lke5c_Q?8hyF zA*l-|9TB%Amrn2}9hL;5b+e;E^gH5>ca>cN4>&Fd@#=ZW;74B$ZM!wY2pRjmI-mXR zmsgxdfIc_Br?$URskVaa>V;X~-}n9~Q&Yuo>3ojgKCZdwbK|3d=yTJ%Dz4@AMr)z_a7QSBo?jxLTw0vlM_P38KAjfw2Jr&omzqF2Pzt3*^`>d`vzRK@2E}hT*ZN+6a zBNlmWw1I2u8{eeem37hyoG#JQn#)x!j1YCHYlO-EVx}as8?KNXNKzKKt9p z<%aE^8o~i@Md8#U4?d+OL3+%H)cV?J1Lww0RYji2>lZQ(#;Nn!-#*R?Z;huol{H)h z5wKlQx7diSCHZaXJms64lJESL(`8&bpZ(i_i^j%MvG&H}u1Kx$78x-_aASPQR~WpO z@XdSf>dbLlkLqoNjI|3opZ)g|Uy&RgLnILp<7=>iuVm-StRv>T8t|HQEI*yk{`T<& zaI&nw$X}j{)nMp`W3H221jP6XmJp}q_WtB`sRzCKNA5R9$e8?eKKt9pNA&{-5P6GI zacqXK93N1m#$T-$yKLaQx2N-n*M{z1$LX{DbUypr$5-Jk_NInvL!KIXHv(e0EniBU zmgRQf?nwvl={Dp8BV=?E9ii!tA1M{o9Vg|LM#)#EFL zHB5V?%orlLGrnF|8_bsQJyW*0+Zm^?l4C0rn&qbRjhNcfFDb_NGI06;G_xE#Gb4!L z&iK~Zz_%#r{~CLwm7&7aqB6f9n?O@>Y^U3ZA%Yv@n|+PJYe{|u zcipt?*s3Ad86jix)A{UgA73F)45XIQ%zzm|1b4=_%LcwNmt>tiYv&rO_R_KZbUypH z0bg`(0NT%IHoF$Ry!2Wl)|TY=ZmP@G=gSS$otBRA>3sILkB{07nj0|QjNry{8}?U& z*AlJ^&dpwb_WDY&T+L#SZn1%{>!>FWUUFG+ zKTeio9j z48_(4q+;!hc?PlCz9my50@o70zwG~OZa@F?G-N9s%TedEzkNA2#m9YJic7`0(FRW6 zZ(Yya{7HT?<6xXRpZ)(7PP6Yzaj7^1D~#A%lIK|mInSSX_(7c+2jkTF?EhzQDr(ze zcO{wHxFwv&Z(Ca3r{wsD83*Ik`Rs2WX8?z8;S`nPRMWsQ))Yq&5!aiwHt^m0wa0Vd zi|dc*U;-d~wElwmCOdkwkI%5Sbi;v6RmPWoy%B9o@>{myiNiaevwR=}VEO5M_P37@ zXJ_O4#1{L{2A;KVbvfB}VlctLVd!g`S7Sco;JbZ1Me=mFRD6~#3=3Mt6}Z8OttC0t zUcJ26wIAO7GN;RO()sLfA6LlZ3&lV0B^_~({%yvkbvYu4i1BTtf8biew|>m*tvwF>s?Z1-!>9Av-#)%r zeXY@ZfeTRH-2%XRV_VJZ@i#b#Aas%ZjegY+X4gmD6YW>3sILFF#thPUB}d zfHt){NP`+N?QCst8*Sk1yQLr}QaYwP<6xXRpZ)FQ^p#))(nDYTf%q(TalM@3ZMpot zb@#Jr)z@|C&*?HQozMREamDIw(^6=aU-Ion>@M6W{dn`X!yhh8IPII)XEP4Qsq@+2 zK2F$CfkHozWT@@#MjN;`KjF{l8r*g#r^~o>KKt9p6~dR-QVWAPk{K#5wK9lN(=t!d zJhOA5+QqY18nL$|ztrw0p8H1QD_+LIICVbz+s9cY#~)QZ+il?SRcB`&|KL7N<~4MF z+wr(19yK4A-qE^zCM;ih`qbkO@5AY_d~`nh+n0~3M`(+wMU7bW@h}1n*HS(%zoEmt z>dV&tVuXz8W1Y|b_Hmlyp;1k2#1O%a+lx&$@V&oz|J%EZ4O2LMmZQ#R|GmY>V-_mD zfLRM$lHcW{v->>fPMXE(Gd`Wq{(Ftj9IH_AC9O7MZ3*A8w@mnX-HE$s=uJAtr}No= zukpD;^C%9ro~(<5Zv?`q=abep{2V;|nfv;4`ixKKv;SV>!%>6g=Ue0ihl;b{E+ckT zjyld?X1ts?yzAZO$WW}F==^^L&OCp>IMf-DML=9%#N9^hDo%afXorg3Pt<+(-1|nz z7*3tf{`Tc*OzEZu+`iN>h9Ohu`~4MGd=VS?UcU65-ygm2$%ULg=eN#hfBX2V<@W|s zF%({;OcbehecBo$)|TYgd-l~U$4<>REuEPBbbj0M(V~{})DoP@Np=-Y1aQ7?w}Go* z@s@vfcV<4#>9X8(KKt93n>G#}^i-LvZ`5H&3*P1T7^$=*$4d@<|H0JGgOeB! zZy&GP{*_}hvoVrTj6no!CB__Ft&CEY@05F6$NTsbN5A3oP2S0P7_ZJ}|GmR&^h)AP z$63aW8g1ac{<)9m_j~?ODoWBZUY*bWZNTd(E~-ck(HDB~asvwc8HGT}A&i}Lc;@J}o zHt?NZ_Rb}d0o(WG^f_O3KKt*j{G4&t{ms6=b@_Gv;e|!3uh@DFr_cCwKKt9pR~8Nj zQr&#=Mg$RXx!Yv}*G^Zj@wc8ZwTYdm^V^P#PAi7aDaZ1Susb?|uC^;nA24EVsoeFc zd*{hH{T}{^(`UKqeD=35w`xxzMvUA6qbsJ`HE9pFj_dmuYF731KlvM{%eZtt``gE* zu0u?vL0=rqMSEfmm8Ifrw1M-LN8J58tout7`%CAy9Vd>ZsKkfIWj`elPA$h-VU<{G zVn(F4BTFALm@VaV=@WN7yX2fck1`IHr_N{py_BcYXrsZ#nJFA!1P@$qhMBW|E#W=* zo*&PCwcqF>1E--6X+DYh953JP<1LZxh_^U^`G5L`x)Fn#?^|r(yFTmDeO_NUq8F#n z^3?h4Zy#T!uM(dzFcv4o#K{e+inGpKt=^IxCpyau?%#jW9>&2qbw2ys$BES)spa&I z7hYjx=}|`zA?J7UIwSU$a6aRC?$T)&Ov+*$j8o^czkQsh9->vg7?!9E(=5V^8&N>wj{@oJ`cQd-lkb6@%xNZ z=d-_koLDjAO?4NdaMHV~{z-bwh^-}D6DJ(};zv)_-_GeWE}hT*_Hl*jgcfxF@Qspa zNu>Ye#}0VAw8b7V>EpNb&Ym$JtV zZcFlff5G~zQ*Z9@Bfro1bUypr$7l8hP+dwrVKRJZ&AA7Y-MmiJht=|OeGZ2rc zwN^{GA70$)hoisoHt6dyna_CnZXdTf!BT{dY!FA{Sj{2}&UH3$F6{kd#|>xZUuDQO z*8VV`@$ub0&XIwl;?yz^P6@-8U5i4gIGE4qddsL(c@{ir#NLuT7uIy#KJnttr!x*N z2Rfhq?c=1yXVizKZ(qPp;zu(gwY>Ivs&$-a-FE&@we{X}83*Ik`Rs2Wr`qo}%Pu~i zxx#LZ9BqY|4)cI}4TZHrfP!wR9R0c~hmW3HjS<{S|BDk^sN@_58E#cgD$$=lP z{Az)z>0&r_z7bPf=3A-U8v7OK6EcSGvW^$5wSjNU#pliW;Mw12ar&I^I-mXR=X)sN zanlMDW6P1TI?akN=NTi`mgM)luPm$M_!_f^7n7gPZ#zC?yec(>bI$NlEq-6ML$=$% zcj33YPk3?CgfIDhmY>dNfBW*A=c$#`n5ncd)-pa-x88`YCAoF1J^8izKtZ(KWn4PH z?YIJd*_kw8S?r@>&$f>1gq0@`-8J#%Bu3sILFE29La1dpxrQaJ2%nDK4-nsf$=b2ozMRE@rLQ3Y?=zTtlw1iV9j$ztS#kp*^mWYAL;tkWt=|a z)A{WGr||Kh8X{A1CO_Xg&RaU)QoikkKceG?j8o_TYjDOE7OOZn+Q7N|$&(fj+!b9` zEY~lP*3tQG$7wFIGp$Q=A&R@Q*emA-BZ!d8W!VNJ_LlN}<`vU_$b2Xxn{lu_bw2ys z&v#{F)&C9vB zfBh}vV4OOi{r@D+Xu(wNv$Bmw>@DT@`%ka9>+(;B9l$skr_N`8`#7!Z1Yohd@x|X% zKaPThF^muHy2~j}wOtf18mY8|chkei{*gHUdne;zygHx#?c=5Gqrhb-PfLF{VguJ{ z>o44VX6eJna=MI5=d-_kTo`}BC~yE>h!8#!iO=jwlSj?xoR^GPTaw$hzptBh%cu=M zbNY-==d-_kd{%o0tqu-;#UePL@hw&!)QTWt)2v<;eD=4W|7b6Rm1uxkHt8aWnB^I^~7lJL{6XOsq@+2zC11XEah;E4P2dX zKIiHFA}`ucVq7|ZZ*choh0x}#iHsQ3cD(L&gV&PW`du<~&4nMoXYQ1V^%He|+wu7^ z!a}QYqcc;X=m7y3)>Lt(Y-%0nxmT?_q0jJjH!=>Eqt0i4`}ym|hlkKu!(5Ziqc3DM zL1vDrI5*kAnI7qw_Q{vuUC%fer_N`8`#77?nWR7-KGdNSorBlebXHoTHk{Ls)7x-kyMsq@+2KF;Rk z87lKvn`RtLxH?44dU6%;(zrC^rDy8ks^`d$o0Rd|_gfOjgDoB7)%ol{0jC;PxP$ZX z?FjQ}f*W5N00y57vJ_WNzwvG3El!`l2SEcBX>SSfL{gjoU%ymZz1 zModCXF|x)v3m;cOqdU#(1C%N5P+1-w4v>plF~cVxGcY-Z56kb(_kZ_6VqHO$iL^ju zKhXZ5?w}+P8RtDf2ZDNns8Q?<>I3Qv>IWJCIs%jeItt_jjR1`XjRTzs$^=aX<$!2l z?hFt$&lR95P#x$}(6ykOLHB@YsGrQCt)Oo~)N$soM?u>_9g*=) z&}pE{LC=7G1*M@dEC4+VI-n!c1~q^NcEUFiKn`?|7lJx<5n>tW*hHL{30ejLoe2RQ z3jrMt0UZhf4TXSmAfPKCpwA(oQz4vh4ie&~gN3N;(N!3VUNJ!Ld@-t^Y8{i zmM9N=9$X!M3YVLLcj$-3%5CIghm>8-M1jqkIrZR7@mBrGBpoU)llVlFr()SW06KaX7G(S)%x9Qv%zCr@#M7MoQ9A4-1XM& zoG#EMs+^!JY_jfdXYopihJ@eAph9OKdXhOb(VA%Nf{e>pnwTDI}BW?9hrJ?_`rJ;xH& zT%O-(R}Z49x9NL)T<_KVOCqHP=K_%&j>d(GUD*K?^|V zfi3{mgBF9X0xbiPp?)*y4$vCV1E5Diq_j4GUImevKw19@=xflApx;5A9B6kzy+8v% zR35n8MBvZu#aen9&ILjciIep8E)ahot81S->!v;V87umuy^=df!|<;~+4A zxXNW=(;-R4+Mc9;AX!m-^xb=sWg3KAv#lG6LHzv(@8P|6G~6Wr!T*HsP+XZ$VN@6Q zyXj!UD59^YQ-k6(Z6)~{ zeEA_X7fu&;g$BaRGn!mV!P>4BY%^Zxe2XWS9$#!Y^V5FgUwqvN8kGz4O?LEVM=rUZ zV3jABVL2O7mCttIBKb2em_kj?t?!%h_{^s-yX#GuQPNR(I){t-COdk=ml>j;j&)&1 zmsYw$N@R=Vss~!B`mp9h<8{UnFP}PJG~l3~eUBf=2@wuLuk+d8{QjPqwDA$wppii{ zO2`)S6q|lc%W>l0t#avzNJ%zJd%`XqnMze&9JA$$z@sAu?9}DLd=K1QtxgueG^fWeDuJ}m_vN{8h`&s0v;{!K=|e;(<6`icX=mX774^V#3TGqEO6 zjsd^0@o)57it^K}^yvxm$#hkadL#U53bCYOyy#y9HUG{ z&y}a|6s~GCB4`fB?2n=6?;p6k*UqOdFEP`iz7BNi9_E|u=#6mXhS8IvGdS?%2}sov zuL{X`)chItkr55!(Z2^+|CtbXubsX2lFH66&oEPDJj{;*F&{KMdQEoD$|j5GL(tgCw2r*^X4{re@*uFwAcGHy@dzefUf_$k~k+|r6&68Hw= z*Y7Qy@$;Q!2l%g{kp=YEq1ecNWWHo77tLN{`!U)ztwUH&e>Qdg;aninpSrym*@1C{ zHxrkP8h3Ev?0iGRo&=>!=`)|+SDiKe=(AOm~X@oyV|o4 zV~BJ;nu7#3gQ$~t0*K}?4hK=kvmfYa&>#@alNI0&2F!IOr zfeb_A3>21l^e*)Sh(|w<+Ew~}|G%7?wvL7Ro8%~r8cs6XFaI+Vh#>QuvkR%LljAZ% z<(!_ogJ_)gW)RgW`hO~j>eYTA3P)osME%V>y+?J3%N-sCrr2a%;drUeP&j&z9sSRa z_>>mK!8R-V{kPtAeMYh(+2??c0u2C>-XfyGqQgMFK%|FyfLMpodqkwCNQT6x{KXKM zB+_vte|nGnNWW2D(lfnBvL~7U|CGC076^y>KbI@wseJs~?*4})P=nvfcG-5=BUDaY zASx5|Oyxu!XWjbG&>=5fTy+tb8M@Q{cIM+>i(^YH8;3o}^%@gvu(Bg0)N~7eHtGwd z+nlSpasH6*C;j7=NoD{}zt-gI?{T_37>}=<(pMBkG6K@?jja59NgdKvyr_JXq{U_$K_T2RK_aBSjzdXs%!Z#x<*{RH@_f==L6Qkp-G{h@i9j=@o zbz1tmo!sy%?6b5V{`TdvD<+Jj#srS+HcFrQlBry*=_A?bNU9O24mVC;;P;Vh?)Mj9 z^3Lt7>(KC6!b$x5Ieq3EF~qLc^sRQXKF+;#kMUk}>635SN%!wQ=hMwUA3}{K9F^H4 zaAm$^Di?e9aWp%G-kwl7=nJAYgY-SM3Dg$QGqnfQR*+rG`X7%**`Wu;5l+=nyzw0K z`5rF}@mlk5?!C6~DUJV&blQTcJ?wv$1R^LPq(9<~o05%0j>`T4AgVXizEGVZTa3#V z`O`Dq$)D>I)h~LcJM|g4FUfpE1H%K3<1+qhzp@14=`+${WDk=HrF@`#p}b;!Mm8Uv?*dPjd(9rC-@Y;R=bifw?>%Gy{R2ngl5l0d zWGa`q_6V49*7s!jvON`8uAVso?=J;0u63>8Dob#P$FGe{G$;b>Hs>_p~E zrgE{`X;C}XG^;I8HcYJOpOmFl-{xaWWM{jY^WW`z%;$EI(r;>hJ>FtJ{Ht;$<8(&z%h7{X5AO38L@S zk6(D`nlE1%Z~Sn%j-Kpi<|DYpVb@vMpE&_LCULGnab_XOfY#SmhKyhl+&KNne%AEi zUyYmQ{70(X1VdK4h7hesw#Wly5A3Q+%t^kfBs=+erum`;dIRbC=BCxH< znIS(>s4S2Vah}P&7=%yXN3>7>j^cm`iQ>?reZ_zalf=;54-z9b^b+I0I80#8G+nH`W~R93p;_YL zcTW{h|MN`oLa!q6`q)yj`P6x$ae-fKzab=cK3OexeYgPmQz!Q6e<9MY7rl!v7yU0> zinOmm+RMebFK!SM5^qM@w8<6%(;%}kX z#O>F-iL~EE+V6{}{`sNU(CZVV{RPtgTKs*%4)MheKO*gaBJJNu-VS8-dGw(6FNV>k z6*w+8@yhR!*FAM@uRT{rO#!YqI$uVFOOE*!&}_F48!WKpE0hte4TN3vsbuG5PdJNC zBf$njTINgdsCXJ|;F-PQ)4S()|Ba@fr89nkL+E_=Z@xZF_s_!G{alYbSX36RR+jbh zQ@UH_lRlxltT*B~A%2_Ha5kmU^_iy!C6y1zXNPLMbnfp6*6_q|DR7d&#+vkR|0hNkDGV;nl4{jE66)Pcuc zZ0>KMnlvfsuRtB-yrOp-LGkJpl?xv0q`nvRxv1|&x|rq`$eyHeI@*7n3>pF&1)2aN z;mre4AAAjnw*Amvs$$S{pc4@Jd!QSUzzPiHZ9xJR=;ZlfeEtFLavTO=Ps709@?Ow+ zP<{^$79uW9;NS<6jRJqSS z0Exr7K=c%^ew?`M?RlktJC~;6r8C}e2%XRV&6h`0)8gPy%<~z$N(@ymUscB^8g1bE zF?CeGtDo%l4yQ}`L+zc;XaDALQ9+2+k2<`-dcUBDRX*|R$7|vDK3cVG+0cPzLi9#A zNR#;{J9;yF`e<``u!#1m#kM}G`eLV+e!TIBKGj3&wrsxVl*0_DG9M4amHE+x&4;+- z5n!t0S*{Z7it-u^0y}`pemzrj^ z{H{94+Ah-+E7=CUz)z^I{)y5G{nWij`q17x=$V`W%h7~y_+p))Ji8r-D&S+qxyEtC zIKiM8n{IH{N65)6+AlT(dpe>Y=3qJL?J@m+U2mXjOWi?zOSa{BeG0Ew~Fg-x1 z`q8y5w8n_$0-y?{uAzpD*6~pVrFl=10o8T2J`Kac1cbu{qTkP$)O7>PLc`Ddkk z;4K}?N$0b_DW^;ramubNI(pjpH{L$=1{*lC6Bib|a?HK&b2^Me=d*t~|p|CaZyS?z&MNS_=OG>wJlExdjYJB#eNJl2q%8roJFqvro+F3I_ zB{-9~41v^gxGp)phv{-)ek^6<$(p`(Ts(>fL0ON{`kDabO^)TDW}-7RnFi8{F76Zux979v(xa$|VJIC)XUF$Uujf_-n`OvVIs8{U99aNy5W?8G&-K z$|X9FqBemtbiDB^*6Z}sNvAV0AEsPX_fsT<-uMNE4(9*OqD(>BUAqMSD20#hh$w9Xv2iCq`d_`{->BoTQAYbiy9EAABoIO2Zp}WT z^3OI8|7_~(Fpukpdgo^j-+tda3AF38y^~w}TmPF9Q0=1>I;arN1(HwN_-aF{L)=i- zZ$);mP7RGWk!4_<_e=dw=1Zn>vD!z`@gj9dRfev^mB$lTX*l%$@6KTkk-a{7_gmRJ z@44Sps;A<8!ohqQsdBO6h$bKH{i<>phTlo9IXNsHf%6xCzUKCw9}jl195{XED@n^o zYx-6@F^UEu)$zoJV_U{S5%;bd6g+yt9q()=V+@Yo=#MM&B~!WBvlC;8bbU(wcbc=M zi4WczMkXo~+k{5xh}nFCP#IQ$H@{Ur~UG;l7OzyNFUK$GR+;+I40TYq@RdSO$$Hk z`i%9M?vGbmb!z@oVEzAABls5tpfvw~r28*`-X6vOp#)TWBxkgB{-1Od)t6oaabER% zuci{Lx|jP-80s1D9X*pX${1EVYJ9^N>qq2zJ7-3jA1fm=J%yE}&V1iIA3n<=*Z2f$ zv*c1ZULIkwj~X>RWMdE}bv;7Dj?a2I&cZiX%mfJ!op;Q9lO4U$3Op>gD$j5S+=W=x z6ZYbx2l${sNPa8J#FXt07nK>GG*{&l7-N-BJUnT4JYQb@@;`pk@i0FM#C(X0XOai$ zdy1Q)vD%L!&5DQeirSL`Bwp2Z7%i<6=jP|!^hBqN-e>(r^63EiFrUJxE-oJ9{ACkP zuD=qiTKFB+uCCYcP@1G;BQPk3FUWtJ-Z|{0HM^dupuJ)Qq#@p>>+nCZ>S@al%owL{kiXr`x70%9qTdXL6iBI^XbZy8d^XA2Q)p z*|Z)E>oUpZfXHt8v+Kdo1w4=9Q-7Bj-+F%caTWdJ_v60cYAMgHqMnq_r?|<@sPK6U z{WZ=!PelM9vhw5yv2I4{GGh@s4*w2e<&LOBSnk)>*}!qkl3xZ58k^FH*QD!jUUk0d z9T&&U^7)*+W!|CJan}5$A4_#mUDtN|ibwL^=y_o@f1NTRr_lK=rtc}OgiNrtH@ce1 zlnqu`d$Dx^FGoNumvz8JShyaf!uRH6`Ebt?kbW~rcHt2lG#)b38<*k@lj!%V3 zU0&-{o@aW_uEclVt!K8Ir}-e&^CoPyh+Vcyi&-ipc`~N9?v_dNwt_&bD zRiEqxPD+>MsOyu)SslgiY0vI|#Zi|nWqnVwrg0PIGd{lC#%b!><#>_vwf=;b@g$$p zQ7nFA&*zW4zU?U;5AzuZ-`j{MDk)VTOu@QaRZfYBoYs~mf&Wss3*;JU=Y8vMd#U=d zhd5o56KOl0&;Gmui}yLuVf%DOR54ad(<=Ij)CfS=rQwCP>N(PBD*i~O6@R>T{hD)5 zetTBUY3EQGAVnRFl3Q+lTUOM4lI5dM#x+Fqq$eJ(i{h`tGzd~+9L zU)3b+8?8E_k^CMJE2=Jiq5hCj^befzh9k;1xUs9=E+{K7*a~*?1APUO-%Q2>l^Z(O zuYQU{4E&*R*>~S=eSOdi1IAEWq>p3qd;bY{l8GUg{{%Gc7}_OZ?GGkpwQkQ>r7hg& zgl-3n(Ph^h-`t-((N~3CHRYbLM{Z4?fbT|E1}1sSGmm?h)bwBq(uRd_W$saubD%cj+9N*r4Zhu7ueakZkdvZPH@}pm{QCVHebX5Jl z%LdK^UcUX94P)K6TR`HU=J@t-qBmwiW$oWCKdE*3UF+-7H|vmVUe<9n$G3$m(;F(H zop)Kj5`Szfd=t41o7OtMpGV#C?rZ1ormlv?HOFrgJ_Vav?zY&#wa;y(jw`B@p0R+! zKh5!N;mR<}U2bJzs3_ZdQ*kAQe}y8Li_wvuMdf zU5B6Xs*a2KwsApF6Ffdoi8maIhpY|}v3^}{1J{QiEX%(7%$HBoaWTJHT=5b|V6~p5 z(?>GkTp)Uicb>rfm+#-Rxx=fTa|UNqP#JDGuFRKA<&x_urEHR$qH{19SmF;>$b(bx zkwib8St7r4j(U~nH;*1*#x#tk`ig4JxKy0mfs^ntPTISi4B~T5cFyiB{yNG1*MwIV zX3^eWa@1zh_!jdeQ@O;&nTr-&ZiAhKO`o1(jNgQ?B{riB#~)x&q?*29jIn);kkC&w zB2&v*-N`NE6sL9;sosk&yf)93#uFXXt`kn?D-h*l8*m!K&;$~1sjZH zzkYMhMK7M+Nyo+fKZC2x9|)lRmdI3GYk`aMiSsp{of9ZJEW68wBPLV+lcPKR8snGPFqm6uCK2&GCg$ekC~Z>Ap&B2J6pk5e^zIaxoG+Q|L`8**YPo5 zf>JJRz(+?QRd}X&+*P&l@h#13S$-RrCy7^bkKFOv{O^A}(!{{^mH7%Z`Pc@0hUjvu zy);=$b%C6!Ptve?j>-|2J6)ep_{@nbPxxe?1D>PxA>=6h0k|?>GL=gk@a4~(Hp?3_ zj*_a7HpWc152wJ$*dn-cK5uCSXMr1|M&FL?vn=_e?s`5mUx6qe+kjIW!Z7k$#aA<{ zbveFOve`5Ijm9GU+o@Udm)3V4mVH#+x1#nE#tgP?)nn1W5 zGXGEDGujOjo6=~g_|~<8kJ7$lK##P0^S(VfZ_ zD)q5?LSthzACQPy!do|H$@$jakN5m$#_Fl_Wk6hvH?R&>9c2FKZTa6T3mB{Tm1tQJawzM@Nwj--0J7F zj_=Wt->sSZ=|Gywv$*E?_VD3Q7I(P?nyUAPo!UCC8`s{OmUMiNCoQ1xPjmb>;4%K+KJ%qv8rJN+`2J|ZcGHsKFYN3Yrs+HBxZLS{_RsZVzTP9x z&coNki*aTgj@qELJuo?`L8CMM$kl)t$1v0C=5iL#K0f68+Jk-?SW=@n2}prAZq#9h;&=Ci+XH3d(w&(s~$9dcg!wgKBvcbv-@ODexoaw z;r3;_=V6FNcB^0^`Kvv}6Kd(>uS)YbTKUJ@s9UgO8bX<71BzesYA5 z)?G1QGL=h{e97_^dunLpOd4u4d^8z}@G6ci8V<6d35&X(=$G_{S$~ZAtw@&-^A!m4 zF+L9S3^a_-8~skJT^%^1b$Kja`}E7VUG^wu5)5bHaR{By{<-)tcMw*ob4oZI2u<<^ zL*Z;HuI7BKITjFAjiipHQ{}S@xX8Ic^c3$ruF<)rI}Tm&)4^MfpfX%fT$xYrt1iBL zrdL)>^o4_1D`y5olw|%Q}pPtU2rHPbmInN9>&O;iHSLqqCaG(HjTj z%6!RGE=_RADoryejKB!I3K3B~{gL{DVbEbNMcPNO~a?@c*$)EwC zL7>5)p`cXIFwjU44K9xdoe0VRO#xBwdM0Q#=uD6YR1PAWW&!9z&|=Us(9IxP7`6`d zJm@XZ$DkiT9q_w*g0Q7oV0n!|7fX0Si$H$^JqCIY^ed<@D(M8!T+p?kXF;?;F$EQ> z0CWTB15h$5mlyO1s4FUb5okSVFwD=ZL0vF9cmb$OBH{rZ4XykdXaN?skHWcpzkptW z5?`|)+7Sqp$^p8((tc3O?b-r>f^&iBDPDQ$UbW`yJrAs$kZuH(;f}|Z`SiZ(nv|Dp zcTKz^Q-_zLdf(l;{vH0-)yK|j41URJ8E_mz=d(YS8&$cBYMq(>>He@B(Kc(eS%XzM ztV83_iWxmOd-kQjPhh6ggQsZ(!6-RoZRllJq zG|{up)K6}BChH?AYSPi2-eSJVj^21(35J6_<+RR3o+ay?;WKSLsvqRk^-Y^J9PoCe zP*1cv{DI`h6R^FF*0Tzv}pyuRxQJ zZNXs4lTp-`~h!Kh>ty-0!0N0 zZD=DQiAf8^jfjXKF36%4L5dqiMT@wgqEu8wQ2}uQ*XpB!djXfa|GsDDo@DMc%?-Yf z@Bew9KlACi_x7B*bG|vV+}USG1HUivB^f%O<%!|4+GiJVP`FMI-DBD3+N}pY{oC(9 zVuV3Dy3vk=a`lUa5i}|dd?@i%w77xKFLAhBNnbmV88L8imO5n09A6NbO z@&}>&)~#Z_5?_*`^I5)6xbRXHh|9xXms;%vQBogV)bDDq`|rw{G~!C`UW8P-ruYec zS9x6x_J$2&j<&A=v%|eq(?#0=#Q4?#pPjuvE4pRpz=`k7pm)g?m{*-I*tqZ~Ju>-9 zl*X9F-?!A|K^IsUepr96iPHK`@aQR4J*?#`haZwL`!=`&E6G9h+A&fxC^x@1ykSu7QJwq$I^zKP2af#HJa6U;rgBk!H;z&m z>@N}{wB0P}J=15eH_5T7y?4;LUs9P$j^g_OifNNCn94=bJJj#PX&ND{55Zt6>#u@e zw)@5e^uK%UDXX%kJmJ^%Ghb0H9^>mDIv!*f*^wpY0q_uo5 z43agX`DE7N*#95@ZwJn*v!}En*^9R=>NMrk@2=CwPnb`BRHxv{c1;cCd$2#YIIF@- zy)n=am6TrpseUB_O?_cUfoQ*SDqv`QvLmQ7C=+xt$N{2)i#o&422o#9HfSIy4}>8a zV+_a*ngp5*3WII{Ed(tCJq%h4+5~zZ^eu=I81)~W0>W|=gC;Ir4!Q$GeMcXG4nX9d z2D%t@6KFl?chK2ruv`V&0BVzpekITbP!}Y|g`no>E4m)k5`9H?gPdv530jWQJAlMA z5Cz>CDCl~ipJ)L3i7rDw(dt(4-x_ri#4Yt1g#nSvi|q--{}n54?)i~%`F1`2nNL4i zb+O`quq#wHB2bKZ1J?Xd8iFz4oFIBC22q@--^H5GQbw*Go4Xlo;p7`hhR$cXq903& z)cnv*G#@dSrpz70D3AGqTEA>a0MCY(^EMxLQS)n9ALG&aEN>c5cUwHO%4FzH1V&G> z?6dsW*Uwy&eVwR7kWR*<^GQaoX*{NV$U_tMNiVm@)A@kqFD9j>%#hlmcyvC?o5o|> zCk~$K1n_+P>utsF^~*JT^d%lDg_+Md_}(-g(>_XBO7E!Yr`KeA`<(LB85OUV-~Bb~ zc*X&()brT&`$o|gU33XS@y;}+J(cyvC?o5o|>C(rNoU>2H+BWH@eU3yI} zJm=Pa9rmyu#-a0B-ZT!=E+!5&ezqroTspRk&S$x;T{JwEc#*#c##C$l1fL$%O_9d&QC-{p)On<1 z(wgj_(qBlSYJzZ#N9VJ=X*_xU0IhbWe#Zdzi_i*Y6<1{fxW-Ofyt~(cqK{cGCkLS5VHOFmkgEb&CkALcV2z9){$n(Rm8`ihk( ztx)jQ0UtRhh@N77Zx2Z;{N}euPJEL5kz;&1UrH_CThVR}1gM5%ohMOvrM=#MD^j=o z6#nrg4wv=ne3mPAG4)cddfC|WcZcDT(?j7^ z_P_hmC$}AT)|#24IegZy^I5Lx&+%i5N-<2iU+1%2 z)1Qa3AM>4~2*U6f`TbYh|Naxp)9?MJL$&PO!@I0s=QpL_oI)P4fU19c0{Yue_{96u zoKd4VeAch?S+4#5$iK1dUpUSF_s>4~uWx>NvUQ{WT%B*HU#5QRcuidb`dg1$*RrAO z$=qCs*k9+{=_f(}`#*YpqdM;K8Ir7{DUE8lgOfZVaZHt&5Y+l< z#dLdnobtw%!@s!g_r0u#?V(B%cnM!?Z;unNU9^1peVg`h_^e;&vs}?HX9vj5 zrgSq{(ns11dmM#_rwqRC#FZY_!#H$4%T*lFokK#6aD?#!$H%M$aO96~-e<|EuRdfw zj6>(MT)~lpRXPDZNvP>F{W^O)v`caR==$-r?>T(duk%^1=43lx? zAOj~)OZioq0G{)o+cx*;7Z0Z{JmDCR&S!ZAc-C;Sx|)W0^1?udV4#(ec9N@>&h+~%z7Ay&S!Z{9EyH5UDhO^ zzkFE#IqP=a^$v&6`gK0b75zhy1Y8(pEpZG*b9FMNvYP)3IOYp#y!4u7Z;z+@pZ404 zdzUq^KE|W-S+3y093C;<*ekYHGzU7&;@eVg)h2>tapiy?#`c-XdLlS9KFgcL!CyHO zNEKe-^f7L>{kYG;C9fSlD0OEV>tP%^pXDRax9g#;9DTH19L{{47@6&b1|FZ(nT6e% z=0AFx#>hNQ~se76AGd`Wqa(U7(Z=aSs38lwi*Lb&=3oragUfce8~m{ZVV0`S5CS<_~sYhVgi8>^Q;vKjg&5 zZDN9sd8TX_Z?PSA0SAU5BJE###!!T1US5kIZa=km!66Sx#8Di~hj)v!oSP~p#}B~j z-e9EvJq+KhzjThh{v$WG-TlxbCzY}ii38_DYJ8SA*5A)pDh_RxKGbrgAp!kcAKdQw zxvs}s96syU`7Cc*KMo0}?f$e0Q(?Tw_Nchg+Fybpo<{SyX57@}nuCshp$Nl0!eLkl zad@D?e3KoyS@4YPAwDiN;SXrUA`UfO8aLU;$F-i)>D?b5cL^&X{j|HS&S!Zn{g{I& zaEKM9rbjhi<|csSmHS7A9>4vLHLQo@Md!2J7Ka0KTJo{t+E*f8QSFj`v%Os=oigdc z{JLPIAB*jx^W)+XGchA`SB2LwuADw9frFeAL{H)GdWv#`CcT#o+|ZR|cb5EGy5nE( zI!>p5;K*MKT$wMJ%Eg>U>=4tN-Ez{SI-^gGm&{wN=`$7K=>5ebR`#CX@L*uQL>etG zn6Ic7j~K)+@cVHBHb02Hjp^%4EqGd*mF)@2NzcN+8ZR}#L(U1JraeMkFpYtEa& z%Ql2R`W4Kl_f!a;sBK%}4cy~=}rHGB%Y(v;JAySoy=m)7>9=kI^J zPPV z(#Rh<`9_kV^Q9E?-GVM(2%Thz+W>|k!E6wF|Vc;H{C#=6z6edgK6`=cGI zCigyf%AHT&zTh|7w?N{cGO#*mYJl1M* z{gervSs&xk`7BQe&xk3J{xB6!AIu82t4F^6#q>oLqaSy&KE|W-S)LFc*e8o7p~9)@ zXnO*9-o5OHqyD)4ahlR29OKdXEVsuam#?F}q{NzazCh`1_I4^bJay!-d%pXQ^)fD< z&vJWQsMln9yk2}!>76i$zgxS2hr)M)=$;BX0HlupF1ho(;$HU^P*qeo#-sCD&h?30 zUy;8A+m`#$3tHr+WlKTv<*b57)<5fZdwV>xy<6Mn?KV%~@L9jkXL&;Q=o>2LdCifQ zwHZK#f-kSqY9Ff8(T8Rn61zAT0P?d-mtAt=CF`!Ib`v?u2UN~8Uoe%+s8Uy12;H%~ zX1HK#K;-W{_#wOS{-^SH$`{pVC8)TMRgkis>w(iQe-0kBrl@{)u$Fbvoqj#@b!9o| zjKId_Sespr5w~E-F%ZWY_}o)Na_4Zbn}%I|V!kjI-=YVF#{D@FAh0SB;|na3TAkq0 z(-s(-+QV}(iEhZbJH=Y@WjFlTrS)YSUIAM;`9_kV^I6^q-yrwYDgI!wT+vSb0^%vu zAGX!<|xwq#15bnK&OD{chX0Le)}NM zNDvJ^UIv;DqPd3;f?foD0!qdYr?sls(#D|f(C0u@sTha|t^y?^AqGKvLDwTgcSVNY z1KNstgk)DF&1ne6(r?rN`y+_B<-qn$+x^SGUGUB$^fDaXlW=9eU@Dj4ZmdfW7Pu?Q za$La)S>=~s?#M571>D2SeWCs?uXj8KO3AxgpAX+jD55xG?VnLSy~i&n-7;i{@Q91V z^N6AISsnw&5E_y3l??Ds4U|Sc_-ejy01nk2l;>%}yt?ms#nMwgUR&7k0hO8L$bTxX z%oj}MGSpp$|5RWD z_T&4)_1V_5F06Q+emLCb6D1DjOK$W!(&L_j&G~$jX%{Kvv`{vd?fXgwyQccf>BFGf zzXA)dDOlEzq-!}pr`NqWU!+&RllLApxSI5mJI>V4e94VorGBZdFVbH&+I6K6XMpH; zQ#+~>dU>DGNf&+76IsYIe=GAYD=uWWM*U^=kN@I4@vZbDO|yvKL2of1uUH%{(41g4 zLqd*G9$&E^cETQ9=0YWunPuhZF5!(`)cjJT;i0sMtZw;!S8YCY&!)`-d$Cf93-i4- zKFed{F-ubkMtHT<|CUGmYTM6R)-2gn~ zoFIDA*XyLCx8$d{T%SLB#6sFWTR6H?Im3LD9l6Q;We)#4Xsr$wK+}$@I2j6A{&M8? zzJ9M*E-H>5;uphsU|bc;tahSu#|_$^V;E(l&;E7I2T4Yo!@ixo@q*|2P<)bOT+El; z=vCsfsE%xBK)%#?O1s;>o>ZIqMa^x043`GP`^Dm^I7#O-0&QHthkCf1zKU7?3OXEDA&;9c<0l=rs2wQBKU?@Nmi9*QUC)BCEk;=%lc3D|Iw z`o|pwLAM)cilNs{M3|U8f;t7lqxj)^DTPIKnA1R{k-m*bfKas%&&;F#>DC~+Q(cJG zX;A&=U=Y=bs6o*ZMBi1)59E)^FUpVfTe&PF899n);&Xl_p6W;zPp zdM;WRVQ~3S30&lyAbQgC1IZlMK0A3@&q;T5r+?tc-yyg%Uoe#mw-a)GL)??lpuuK? zCQA)5im{o(tq`e}^~rTuj9k3R0~judROJ{PPx^XKyS=$V{+BdHNzN~7m5p;{=) zMY+mRPE{d4r6AJZR6B&?hVmfiu?~3d0U8dv2J{*z3n2ag9gj@(6EfD@$gE>gf8;en z@M5Wlr!9wPI46jnV*O6{L9Vrqr~6DMf8^vFNrujs(x!f=X=)gq{msGy+j}l>P`HeP z$_Oem3NJK_DTN2S@M!pt_MA5R`KQj1rJuyn3~w=?{HTu8VYa^rn{xWf^2g?Mp6w zI5?{f6}iGm#Mmc5`%o}odAwCFJJTEhS|65<@Xtf&S!ZOIQ&>WR#8^&@^X$0;{{F^nGe|8 zqu{17_YZyIyLPOHap-)O$HtN6_fMSU3ZliV>aR{f|He1I8Q1;jFCXUcS-;L_c@z4} zJzgAp1y5=`bbZkN_kZHqHu$f)3u%ik;aI=UXL)S>W;t;|xkvUISnW`g0FG-OK5%Vb zNGyl6;L!Q;ahRP*@Dv7dI_PT7j&OoUzb{t#a7*{C50pMS|4fL5V>{@4mdCaOH#0(( zcvu7d6dvnO#WQ^u)PCIF%Z+oNo4EB%sz;F{|J1%{fWivG6rnm@HswoKFc{ilFw#T)$s|5ZG?@tE_gT{7roet-xP!*=}kU8lF#|JLstsj?1NIa%?x9FQw6XA*QDb zdyvIQRtF-zP1Sq3jH7xVw>_yXN$pGSd#B0}w>t?ORnRj*)OMwUxDRL$s1Q^FqThNW z=w47Qs1DQ&KcE}P4MO*Xu@iI_8lkjtOLG*ab3mN{=55e@D0C|UXf*)+nT9lvMs8o! zvxlSN`cy0VT|g75QU80zqX-nv38E)GJQh!l_9Uz7e3lQ(?;D&ND07J1h}2(1{~>4a z7yyp7KsL4Z!}NK{`aR<~R?knLFl$*L)%R;()P67`ESDvb!~B5DlMZrRp;9pi zO|DAit~>Ec6(WMtANPA88pSu2!%OroV>VIW`~4+qfke;sBl}Zbh|@CNiMaeA89C;Y ze@gRo=XdCt|L3syf4Z}O3X_Q5BS&|Z>(3-784)?Y^K(-&;aRz`Kfd$(d{@I&UbB5v z!=v9sj>BRZ|F6r0=lz%eC=2NM1)nD|27Ns4^!=nb*5gzCAL5AP_$LOZ^;mx6@kkcy zU4Dn|{7ibt>HkaazxVpTq2u3+czKK_sg6W%{Q46RxTF-&cMj*qRD6k$2fotT4D-AU`B$Kb+5r z&v~7miBDw;^VIi=Pw!J1M0c_~JyUyyzVXy1CZgy4?myQ8dj8SBH~%i=oYwU4_LZ-{ z|4;oN3zwSyNzQ)M{6pUqm2a1SIB#+Op?)OFGb-WV{q8^10+qnU{gm6$e?-m+q9=WR zQ>&Q=85cjjEBBVw$vHRoBcF1=PwG!&zT`%)`RGP2E~i=aj)Kx4hDWgyxh&}SdNHjs zx7h2(bVkvO6{G*40OP z`$*lraU)#Jm)z(zVO(P9D2l8KP}J}B!zaq`1f_qi_CH@GOG{#_O2WFJ5T=8@D}s&uf>@& z_2l$u46e~p!?bx8c8$poV9k*^GYzu|ailLg`PblW&R>PE*yB0lqYu6do>4WAl@cC` zWu4D*J3JC7G8;|MFjwti#R2B6VJ75gcbQzjS}ax`4tACMib`e3YW}OY!JXGT#c0u@ z+0K(5TDv{N1V(iy%74r^*^yh5xJ@ex!wzvx9q%r{mIZQ8B6_(B#P*!~s@0zKEuuOc zkKYE)PcfzqDHwA0raSJ&kc)7Pi}@xya%&nF*13rdnlb0k68lcfiZAi;NzJnm65~tX zBx8@$pI)Al(sr*-D|n?ZNu;CnNvTxlOQ~TDbxrn^$P!bc80Epa8D*3NX^)4pV0jVN zmssZ;R3(7p#eTbfXxFy$Ce}lCqLNMLv%C=wnlRc3g%!s}bJBY}dn}pQ>*K$Qo{F41 zL-Uqs_L9zT5=Z}_3x@{l=7>2Tlf$sPQ@Wyh5#6brpgIx#Pic*ujAi+}|N8eVkb&1I z-_Ux3T}UUqo}hTbx`AY0HD6V2w&r^ptE6>8fj5#2??rE4REPVeTZiA>@5@_fylF-b zhO$L@#C-f~ak)Me=EcZ7Ic{$N>sjgSPzR1Nq7^SVvRSdGf{pThsugr z7l`K{&baZ-U)t1N&QN6ZB{kx+ydX&H=!!?WaIz}a&wEieM-F?FD@)}#X*FKpa(N4I zQ2odWqVVaN^0PW#JLR+I1}=1bOi4?)bn~k7O|hZuSm)?h5x`_{`XaczICz6LL>TEQ zcKiFf0yMh=+jxkLqTI#V!&I4ic=}t- z*WC5Ws$Y{oW;~2n=d;`<{s*|Rh(lJt;zqxveiPVcZ`Ze;aeH4bn0P1Skl&;O44uz% z<-2WGb>vbLh~6lRd=Y)TISoNy%ir{t0gJMkMD#o={MZn zf$|qQ!bkN&<_o5BiH8qOv2t%QEo7qENm*_z!Elcd2Pax_RoUPobyK_CG3Wi?J4NQP zaeYVUGqk4bg|gN!>Z|=Q2N;GF%~(;7HHYK_avO|%6#&py2zn~AqP!9rWM6B6)3V8KrMf(p`RR=d&PLBIBfv&{#mDd zwP*Bop$ofGxlE4k*lomMzF;bs82Y2dUu2c2wceidPW*I}`DK#v%Lo1bI;WSCLp?zU6?NdP%gB6NN&h4H@G)r^tMh9l7QD0_9lE;P=q6 zC$zah2+;&-7{q$(G`+F%?_5v!6UKkCDO=ae{D?yHp^;vk8;Kd~<}6fexmN#i{Cq<} zesE{ojI-)~WA);@Out;`GY;#zHmae}h6C6R5Sb)I%l+NOlt}WYBE3#xK3=YZLCG#$ zFO}^y4pr8x$mXik|5s)EpZ~oU(Bp?}&-Cxrv_G`JV}V{MJkbYOheVu8QW5rZV!uHU1 zJXB@2w1ZlGV#UFIJ#=6mpCj!&@2?@Ne|>Nz>tP%^pXJyO%k2{z;5!r?(MRmVK|96x zqT7JW%61h3;QC5U0=ULH_k6MWwk~s6FXPhrERT%~roj%aXosUBi!;-)FtjOrl?uL` zPwnk?e`(eoBb)v8DC=i@I-ljS@xgA?Kiw24ysW0HEx<+238JT1{q{*G-qmUOErY7b zA35%)*7;Iu7(hTHpNO!~u<_U{09z7bD_Pp>M|4=5!!TAHh5w3=qYm}|oo%<&FFt42 zZG%lk)DcAWZRWFnzAN>AYzh+TEXQtRQ3?4~?UDAmHJ)PCd!Mg7e9B8@i#M|#URR*= zSsvAf#SIhOL2FYeI^L5B6X@Sb3WL^<@2iv6OzbVn!%aCVWB${e8eek}U*w!1dWw~P zkAG%E$*%{Wvzq*ollDBq(D_mtJN;&Rip8=qY9^q$AiSzL(!a3BanF=hW4pIH^D)*V z7rc%&bUw>t$c20JAysq&coFW%#U#jtyw#$l7|DJ9H{^O^uyK((7 zh1Dc^i};GbMZUK zv7Pnw-}Sguqt#WD7qyxHlerTz`gY)-eh2eK0Lmp+y5sa8O$*j~LHO(VIJUG;HFmcs z?AUq9GXd!{x;~Bh3Iy?(7!GS1q!%+ms(tA@!8%FKE(Z^)KPtzm?~D9WdPvm$yTYl0 zVigbNOLBxKSv*-U#3SP0#&@f){r~;DEKrSrD1K<)>CA7WwVmM6lb-KL=dVMPPr2#+ zeCpN~PR3z!BRZ=kmj*2-#!-5`cA|JB! zL+`S|QwKb)@2Q^a{OXFMbUe&w9DGj*Pd=t{NI;hFdEmSF{h;BuS{iwaKRSD+XZfjI zSEDkF?8AJRSIYzO8`ZuDxwf$bvX4xlvKPWn;p5U!7Jhs-&t z#xvdCx#yPEZ$6^yXMR+(d{XpNi`Ij>CAJ`-4JXA`q!A!tcxO8pyRGG4#=2xNK2p~* z$(TET)tg(KDaNq2fBp35$7_$cgEBQ7+kyF#8@(zxs0b1|3arf967nE!{;Z+?E^Zzy;%~GnJa`wizQ(jJrambAI zH4C0;-QrcVAYnT(e_wG?5ofjy#H&@fays5+gQq?>#dvn_%3HqLb?=8d9_IfK@MxBj zA*uO2@PqaHsQ0(kA-|_>9veRB+Xo^C!g4-iejI%Ai{mUoUyZp-Hy`?gmnuLJI{^pP z3!ET|L3*aX5p^EXk$?Su(;v=F9l#cja8Rz-`GSp0G&5m3#sKO`lM*$(RQza7FR|)b zchvXYu)OzA+)NYYK9&ADKZf3Xv?pcp5(OiwFKXUW^Hr;#?D5PU|Lo;GzSC<} z+}Y6ijHiiqj@%O_iYv$E!y*Ep8INuacX}bUCq0vs?V8q&_)>~K zZOkH*y<*gjXfB|Thn7ip2(x3R$i8WMrxZl#^q-uki0afd^>?>wu>S5?{e-TzgIrJK zTy`b@F8V>xYWj_Tx{9X?c*r?H;_3SNDaCm1brJIMhX-#U+2X;?-=23} zcz%}jD*PRTEAz>Z>hdr1I_Pwz@tCaP$S*IVihu)5Ok<#F3nHHs_ybgH6E&4EUgq*5 zo=&+yN_uFnqH9Dowv$ zZtTKlmou&nFKB(%p|7npHBfzt^fTXNM{ZXA{L399hY%E4KrOd3@%zX*LE=e^k6GA| z|C8ZMn>{vQ!2OodkM(Yop7#qHSwJt($ez^a5G!u>#n$9^U;H-$ zwx6-z0{?*)P}?b8Q>^t7{rsL?6^9w$pLyz{`^NM;hVv8E6R2LseElb4r#{q6-ClPQ zb&`i7C-kZ9Hse66UgMr*V=+R3 zb%`!^qXVcDh}x(pg1UfC2Av8z4RkuF2Z;8<#1tRnTu>iSU(f*1AkZ*SK8O~)Tnuu7 zCV(b_E(1*gT?Lu}ngf~#S_HZq^Z;lzXf22uDO*7AgT4Um0sRGPfkN?UP#4fypj^;} zATMYdXg;VKMCV-5w10F}8)=BVPM|)Zv7oC#OF`>FJ3)scQPD=n<3YE8)`50|PC!9E z26Q{opd+eL!{k|NUKMrZQcMZTMZ-Q1K4P%VLY>!;u~kH9+G4>4LvIv?EBS({T+k2W z3IrU{9v7M-E{>p5I>q3B7Kq!Kt&q@E9L12iL3|z!9?{RW=xooaE3(NSIl5Et0rLe@ zxuCCd0#^4q%yl@_@Sp5@|!B#xYmJfutc4kI%vTig!^!7H%I^XrsfZw-|{*s=_A$y6d&KGQ4 zV)cs+^NmF5D(7{Gkx(%QM!r#l8{1n>z1;pm=( z(vkTlJ93LA3`{w}_y`uC7X+;KI=6+dVF@hC(W4q%-{5J!Ah4BKX ztI9*HIP`dG0M4I={oZljqlZ6UhVq%*<@jz;JTYH#qgQ$U)CfvB=wZWx73}g2{9bsba<4n+U=X3h=SMhvRzzPbK0_i8;8P{$wU8eoz>4^nwgLl= zo+-}|kt4tStlx!)1TF*3a1!wPf6hx7h&g?vADTe9bIgTrEL_%X8~;#g(oFED}RzA7votF-IWzdI3Z;?kh@^>_@%oj}M z!urj-S+0p`yeR18Izy8w-crAhU0Yi5==p_S=s0KM(BxLlOR0P&M|kMm3FZr?a=~e# z#dPMi1Cu%EoIhFNcMS8H0NHC84;(Kwz(GjZF7&K_558>u*_aDYd^`st;Uu0EL+7)+ z5sv)wKmdE=hjOxqlb=M$ttX)RD8{LHohAM?F28xvn&&I88BM>R9Nnp&z{-U*H@w+qEPK1OBb0T{tN^H5C}wa`zFe}AlaIOw{0H=Os%xcRI?;z%-dKFb^F zAMP#-PIZ={gFa9el53XDVFU4snl5qnks4cxOnDu1i9C`eZ(ZsX8+mItpM1H&zN@9|R#* ze}Dbq*7yj2*Hi5CmD4)eSoob|GQBXS{gj(rFMM~QIW=CShvRW&zN(X+S+AKFhtS8Q z#68%LAsRaILVQ!nAGMVzUH+Z+Cz>&0KaWFg`DClSy=bva8Lr{4dh#K%k=b-J` z4|d2yoAY9{gD0ZBbcJC&eKXpT_o7Yq9NI`|h>rRL-`V4njF}fC8Mj@RWIT-a%0Xy* z95pK0n7%sMIORCh%kD@qicd^6F5Q%BJUirLE#@=gTKBBQwc}74h1geo9xJ~5iT7FrX*p0<|LfX(&)Uaj3e#s^yBK% zOCPIfv4hHBa*T)hk{i7;9y4D%6nlv+U}!5C@;w*C@l_K82kBGG7uW7hr&qjRdEyZS z0FG`MxH4Zbl?&rQV}gFUQoi8C?%YWMOhYwm?((H-+!#+`TdQ4S)k|77`~K(bJL-xL zQ}EFEH1icG;;}DIJoC7*6HYKxhV6^WrsDfY=SQ2z$;$bjyyqg#C8L=hm_#ucZ8dlm z*@psB(|LUYIM?^zb;R3sEnkwqNZO6QX3S3vC _g#%h*L2LmKnPj2inw4&Ezm)6~ z-+lDiH)iVgWB$J38sevwZQ>YZ!iFV*-ZGa6LbX@MQTDhpUmsoH_Vk*a-X1#e5wX zr+@ywA`c+pWBUe5`;laa53ZRDEb0GftDW@ulBDa26U#bZ+wZyXccx;3)dqN&Z?Yq| zd@QZQL5!p5%y{%fpw|JPdvsNmc(8#1ovbA}IL}5LXBOfYe~sNoZT#r5%dbFhpmgMqeCvEEMgOJPZz3C$t;;-@1L+V~ zMS;J(s8m$WLT07eU7R&l?!4fn6S9M-$@2SQJTShBc2;~;rcvRi_P6z3D>;J98LLikFV=RF7xA z$&TEFF|ag{A~O%Uj`qz`O;CjZNI$p#=|wecu9p&@o(U6CDrmp^=PeK`eiGHn@ksvZ zS(Xyfw<$iERKHOljh~wG*A%~T2>)H2D*PPIzuS?2$vHt}4}D*s+9A!1Rx5YkeBW19 zJ3ccbgW5dQf5&|MYjH8g0dbO_*m+ibIYr%89vwXdd*vc~(*!n@I_4?&YP)b;h83S) zPpUX6**Izb?I3ckL4=R_f~j1FSUCiHYkg+F_LG( zROva48{4VQ2FJ$34l^E_U;n~}87uGaY$hy1PB@q^LycYsM=8BD<-$)7Y_%de{M>X;{@dh-`gX`&WAf#H(W@E} zX7?F(q#IEt7OR@pp>yZ>jSM_cywHB3=^c{|)_2JRXU!zjt9Gk`oE+gL8GRq=E8hU( zea}uVI)434gSLooIoM{IlWgdGl9A)BkQ{PM8)=AEvAf0Qz#*z~o0ZlK_+^~6z`^^P z4$XLd9HCO}T6MfNe$g}+>o#lftKZAmJSGo=w}YpR8PKI!aPUR+L*R}8QT#GrFqKQw zI7eWwXR%hgpHCbvh(*(Ic?g&A@^_Wg#3MzO@W=o2JL>=Z%y;q=%c*=0hwtQHeUA11 ze-ckkhndKqRvnIK4iJCq8{*A?fvLLn5S#XRYS|0io;$5*t!WvO0;7wPxYdfB`at@)kGRQh~z zKkLSY$;Q(!-?I9>6SozoflrR^l;4>zn97Cq#>A0D({Fsm4($9v=j~!Z9oqqT(Kw?e zpW>uZqZ(l`z6Kk7#%;;Qj86vN)Nu6b(K|ztYmC446 z*Cw|)ef}qFbo()1fg~PvT>QUCXR6`6=y{4pt5JowIbJu~;G#o%+f3i^<%(f#X6d+? zzi+r2$Eya89(!#c&d|Dk^cBumG6I! zS|9_D6hBly?1l8i^~3B9Wi-@dsdsIJob2fYk&K?H-mLatES)vx>B1GSzsPYzcj~`j zKK`{h+I3tk2%)`1)y!$_af%EDs`bFaQ{$H#q-g2y_w9KxZ6ysc2`6y@kH%+tKF+A{ z_#6d(d;qdMB5^yiXx5G3p!Pc1<)zvy`w!!R%Zu&6V`rc0177is+1llMexLE^e3qMd zhP$DZjtP%^ zpXCu8PLHX+pRWvkhGwrgjwlF)XnY+wi(Fo7zkPKAcxL=OVE98lpA%ziq?7UJ{C&nl zElPKAlnW<4(U(!RQ?IV}cKT-Js=G2a?xi77;TV_BXL+J_V*l!QdP@R$u0Qmt+%^u(6=9i4Qd3ne4SwG{``7GZzd{#Vj6ToxspOu+i zUigKk~|pxgDNCKCE^}-`iv?aS6(G@X^RbAk`qQ zztkpxZ^X)_cY9MyWFrpmGCrOEKf%{1QW2P1UKE~bZ^!&2KDc(^AzyA_9E?-vv;1$^ zQM{_+s!ssdqv0ujrvxTH%TsoiScDRPSi)lN@MloB3061Rf_OiFv+PW8?e`U|> zD_Jk&()ldkH(ZTlRITS^oMn&iEZ@~_UQO~*H@>%C4C33 zKdF@UF&>@IayvZzy`GZNG7Kf4Iw;%G@=IBT05~2C&$hQy?wQGR&$;*Y*I6&)()ldk zcU;!ERP9!u0KPA-2&_DA&Et*QKRW+!<1=4WzvC4&84%71B75}7YAO1Y4b0>FZDcJi zGc!K_e({sXwK=!Zyab(3e#u4bCfcktG)BvA#9)SFu)D-nWR8oe={)TmdmQI1=4s+p+oNs2npyH`a0ME?LYkDl}UyK=%(s6py`7BQW&rrWF3Q3Kp zjC1YnbK!~yQ%fKH0*wyz#-a0Bo&XM- zi({$3^g7Sp9y3=AEx2KE>&Utl#-a1~0S7J9>Ng2n;L~Q-gz_+fE>-qrv85B3#M|(!Td0Pa4HV!!#ZU*O^2L_leB`^X%D99 zkFH>MFc8GyK>UgtZ#7x*bc(26>ECQIYE>zV)gGlmD8d5X)`V= zAb;d!`bjc$zLYlleq-8rv8RlBEY0}{YPq*20sRMFy7RrvnWf_e(Dpzwd1_zTVB2= zBiDRA5k@ML+xWbM5GJ51QJ0>v^o7<4@nLgUpjx^@ewd*uq<~H zCP-t>9|B;zZPakZ`ra?DoqW*0@_uYoKhyb5;L08E@~PAMEp{1~V{ezwdVcxYXXoy0 z)IX{78|hb~MI6mbb7stumB{}JGPNF5ui=Vim%f1s+urzU-fGs%=}G6aJd&QWd;u>O z$cM13AVh zcJVi9t>pV;AF>Pcqln~FLb#NCuHwlYWKGYp(oKiq-=#c0>x4C|m(z{TXL)2bXMx}E z9q$Sb@fW+j>h2iW^hZg?miA6f0(b(Kp5L%!;xXG;ALG&aERW#95VHUj3kwi4VH zVEcKbuU_@WpMT|hetom(x1v8$Uv6e9++^}uKi{!pfB<0rWp{}-?A%7DKPppGC)6vu-)gH8bPyzDM`J_$sXAR3@N6+{X9 zG*DO2=^(NximhpCdhB|EeL8r%O>)~k2Y&eiUKftjqt0i!U3!GAG403NuTu*g6s{9Q z_gL|t`ps2Oy;zn1DC=PyI-lk7aG3FrT+3*z`7~#^y(M+ztol1rjcp~Ryz6M`CE^FwlaJX#KJKSozL=kIHKu<(OBCj zr3LnO8B=xM`Dp`}KFs zBAVib`}bPoe=6r99rn^&Q~{yWW)bt zmcQidC*G$ro*cbFxR@`P%Eh`bcw}GnMpY^m$3_i@UZ1MDDA~w<#5H%*13$e(-xzX? zgZYvhy=pi_!^N!8MK?)@cQwBij*4%OyfMkfD(}fJ-8#yqX^`a6^C`7^hQR( zD{8u_x4}aime<{I>eB^7`%g)c`Y643L}|f%$&FqK4_7WD`{*~?FTF7`)lT7YRy*nO zMcUdedGG5(ons!A`A?Q#)Xrmm6p?)5xUp!CB1O#?wK|6YiUscY&g1v0`H{n8ef+u`^&R`uRZsN_TOy*wLa3yWo;L5 ze?%tsdj2%|P}UXqtuggQI#Z^L1+t@n7mkkBJLg>UbTag6JL` zjvY}kE5h7q3Z3AzcLA+360fRws(^=TNKO!yq4Z4EGj(0l=?8BAe&El?MFyB;S&MUS zG(KJvPV9|9#~_Mb@@VWIW~&)XmcGtOD`$9MIw zZ{aeZ?o?l6KKW7I0Jq0q|ZFY??!eD&kitPK#Q_6BWESz8NGMA1B`x1^+ zlTXj8qx~ncV8Myhaf+oywBMH4+D&c;U}V5E>8F13F!Xcy6b9KK1H|$wMNSj_ba|~J zemqS%^#4uBsT56DBO-ka+;Q`epG!_<@7?)=b4U4p_92126q1sfO3 z@9*yx8&ekG)IHf)4LLB^kY_}D*SngI*Qyf0^ZGaEpFi@xA6-rsxmphoeh^ErGwT-eXLgy!0*IBF8WamwDmCQjOYF?Dqb$M(_rEKdjr zLQ`?{DzUf6!W+(gbNY+VG?y)1nWyM2=CgjjCxRnTZpBdx98?ZFIgl9l(~s%0{F*Bl z-Fh%}bi=imH=~=$H~)>?2!~utmQ`M&WGEDLRLYpMh^^&E9dNK73W#i;0pjw-D2>Xg zze|^ADDoLG)es8yf5H*C}$^-$j=jp6Kr{ zjUmra#5>B+~+-yhwtg!zg}@o3eXg@yfc|Jzmwfb{Zs zK~v)ddU*7It60o9Jl#KIkMqj^x=4+O?U!5Qff6)Ll&VJj)ZNhGpxR)vG4l5_9(sS{ zx7YV{QR*-ZKlaV0_-DTU1FZ3YriU{xmuigZNI(=1|Bd6@-SPW+fX)E*1f2=$1v(2v z?c3fUEJ+gQWYI)aS`6L?(R0Jvpxj_>^$gcAIWZW+WO$2#C zlRy|kH~gRg=rT|cMDa_LPEf5fCWEGcD4kIy=W@^$pesRFfvyHk1BF4?fTn}41f&fpgTc}K}$e) zftG@*K+8aPgYE&{3%U<wP z+6sCTv<>tY=xxwDpm#yrK|4V2f!+sw0QwO05$I!39q1F#r=Wj1o#TnMD6>?tugTZ~daNDJV-0P8@TeFO&H`b0;PztS753ve&n>^^Nr>+QdNMly1A z$0pFbGo_7y5118;c9uo6ScI2l0-pEoL)y|pItags2_p_Ea)PCX{ zLromvNH6_zoiEt9#M0|9$E}LB>Gn82?l$|e8+)`lgH>^S z>3o*Q#GxK2EYeV9wV7qyvoZlZr4_e7v-s5yL=&8JG9H~D7Y}xNi6o&WvYeXVx?XE< zr}d9ye$n~X*QonJIL4*(Ssv3)+3pE09NEywTuMQp;@X%1t`n~K@zLiFA4lCc!Z9wL z&+>i3MTZNSFRHl4&9JxE<)`0w^S9H69maYYm(FK-OkDZp<3rd?wVZ~~wX&0;skj;v zz;#x$Z96tEJ9!@KWn4O+GcKXlONT|Jc$FXlpKmWxH#>G>TFauAU6&_ znBsN+IKjVnoB&nVX=GpZ`&FAjJaTKiL(ck68f^Gh?t9bHe zTiY@EIR;yXr5H1ldt7?c_kGSbw`4R9f^w>tGhf9*&zAXv<~%}L%$w&b58-%@5x#(U zprhr5Q}NW<;0auiV$8`L)bQt>kC%3l&?9)5FGG!9EqKhyi}K*5*oag-fg9r6r&WH6 z;XHiDlXY9K>St~Z8NtK+C=&T(!PD42{k`R(Qf0ZbCH)w4;^V0)NHKQTJ~*Pqc}ZC( zY4%}$Ts*PtqajkiPn8-TeLc*YSt-W!Gux-;=6O%S(57%yKcw`-d>xN@uH$eV8-fa{ zoNStdEyEo70W2ss8Ri}pP1z~)Mr(PR3MDioppN@Le&?^AuSb9WhuH-!>Sc7^IrDW~ z&`cW>()Ji-SP1UJQQsk&b&6dfuxSKN+%77j?K7xoy#(I?Ba8s}dsz)U^z)q{`o7RJ z=~d^&eh}WeX~vd5^n%edUzZdVDY+uUni|zioWT z<7tZJ`HmEjn$HVwwvV69H;mi;sHYPROA5#K(fKU5;?v@%5gP0KxH{k=$M%X9U+>*< z%jeTGPC1|TF&>@Iaw{G+zN}zs@B+u%+*|D9?W?NZ#iiHZ*h7yu=CgjjTXDpXH;IhS z>BI3-MP3&^8bM6^rmnI8w-Booyj|zo$K%kMMQv7`y=^JuVY}&kmRs?v@t6oY>pash_Od3q}AXM8%JWDDq+n4)cSEf@R8-%ZuG2|pU2c!J(s+BMN8JtcGLMRx8hUd)rv;N zQ8CXx{(hQJ_Sp5ChJ4C;7>CYhxfMqw{;VM2xeCPbl|J8!gZfISKHmW1^975Wmw)+a zL6^Z`3CB2eKFewE8h5bB?ZEe}$Sn>TM66&TDxwAt)cB$%Vo}f&ptTR8|1omT8Um>X zF}_;hBZTqd>#@$q-ZtaJMeXTZK#uN7xH4Zbl?$IcB@=c~oI^q#(zJfot)4>_`NM<}chYox%vZ6|b9{Vuc8tLMUr+yPeS6#@Ykh;pE)E3od}R8anKx%1)#+yEbRO5B zdlE)Am`{FGM_+KUZ34Bx)Q>{HV9+0Q40pSVv5*lTjF5bb+p(PgiJN2w$anK!af`)c zc{~~WN%YRRsGMkkohZFJ;)Vr1I9;+J=y74MJq+K6uzU~=1BGqEA1~0Ci)rx)LB*A`*dEv7_xg1# z9<@2F<6^!A6#hZ|jW&hEM#HXR*p`+v^5h1tQmOSO-h#w}t1batuT?JU-fZckSL(Q! zzYn-#TF=ZDmi1z#OYH4+d(U~-E$DqeEiV#|XY%&}N4~p+`UdFC)Tm|D`07<m82#{Pai=~m?xirjt4yf;X$#<#J|{&&4_|M~Mj>3B^Y zUKLLMz9d8Ev)r;D7!JPg>-SIexFan*9xk%rm<1f`C9rw7c!UlTV*h|8`Nk z;vP>PxxHZ_-t8!%8_$@0uq$Bd<PtIX*L?pTnPC zeb*(WkX4v+!dC@3*(YKrJkvlj?}LU%HZ!YTa$4bUU_avZXKKW5y417YY=Etu0 z*vC)jBToL~?#`pya@a?Tha(N0&+?(J$sWwDq3sW{{YB-J0iB_czX(SeyNfBgXJavY zu)GM(a`B34hic%lv%|QOP6G>*FFfQ}Qz6}xjAISvGY-C!9pttPA&w^@%D|Q5XCw4- z{M`E5s&fy4Otn+ty;eKv{jKSLwlsbnchtFgH!u5@J6vZV3~EO(AOBih)ARY9g#|&k z8zZx@lYc5_EEUf#;2}huUg%lx@2cy+cJwU|oJUJWgroX1)uMI2VBKd?G#PVY6Z!^XkGznPo+kd@b#)S@+rFdHS1?^M?&Q=^56?cyvC? z_XUqQHo=c-)Px`oPLMSfwVcnm-x`0h%Asd|E7%bpebLpdUryvW%+UEPk5vw3<9Gz@ zj8fvJLtC&xc)q&`N1>EW6=Oo?i)wnWSZ>9&5q>DXD}lG{g72Qs8<}FPKjglOPft7l zRZ5fO$ZnLbm@k;h1sfjXoER4hNmQ3mlf&%QV*eDmzKGKMKQ)fu1{kQ2I0{5_G$~)U z2XzE>24#Xy201|V8+(Gz22p;=2IYc=fkuEX1{Hy5vRN7ED$wOic!?^ z;3wz2+P+NJ&wPt={A1CNc%^z5`3Zygch_rr$phKC0mS{jCtuzD#i#Cfv<6E!&WAdm z<+g=Ge|_lNt-Ol=X9I0Z5xNr z`gK0bt#;^J9xC%s!j|L3jblW%U35HM zFG?{s-0<%BZLe-R^;Azu$6kim`6dF`u@4BkTS5%^XbS2jO8p{K9R&wI61S4USghQjCnsfv2Y&{!}L&2lH7!-=n(Z z2_|d@2P!@866_f4qw_mxuLKNm`RS`I-&E~W_;7st)VNZNo|CgLpWe21;%1r%1;^=y z`H~yGHi^rUO04#&x51HD1RSG|c_in`JQe+Ngb7_34-9DjMM;@fA7C&d_B zv%ULMHA9cqaWVgI;ffQ3YI$8}gD)^K#W+1|yfuHo!%IF+l}PAD$> z_gH+p)nArkyye{eef#Gx8>Qo5{@=mTI5w^A?0Oqqb3-Y{u^(r2ymHr+Gjv?c|691? z#G)F16^~o{Zz%6kf1Wz8@~m$jJa@_p+8sl>ba6{JbUw?K^0l8U=$$J2`b71KrhVp5 zaRq2Z&k}#Fp0Mwam|EZEiqVJeeK5^bM0Z-}$b8n%chm|dHnZQo|7w4gtbfb;LlSBc%x64&x8R}< z8*yN4q-(TETp0*}$}t+R+X!6T|25^E=h{=9QkCygxVrqA>>_Bd}$n!IV?1M{zA9CE#BJ45HQJaS%M|8lVI887HT#PrHs3n4GwWd-I-linaiHe!D|UJPK6l^A)Ug7m+NJAL@$FLk z?jgn*bKdDR_vSGVQvWPD!b9aQ^9576#KmKt?o8fQ9BXWF>;jIjdf)oN*RwvqPshQ0 z1%h~ti$k2gJO^@e3r+>VL9_!zMGuS^B$2w1?6FJ$xil_7$d;55r?Yw?hp7#lUpYiB?mdC|2 z%qLpTJhz43QSmeY52Xhui0;%EPTwANALs2qC)c*kN{-BTl;!JzhR(-p!l5@g=njef zn)`d`>~G8{EOAqp7q;NVDd3`jQ95?3@D|q#E7w}_P*XxQ2hl(yOoi?$P)Z?Yq|#PK*VSWd@NVm^y2gdGN@3**N4(x0`Dzjs}K26i-*ZZTgs z&+|FV(D^Lq^TBgNJqinl1sa#lpeyP9QTP#P*O`h--#+CJlpR>l#;gB5xN(cYawc#c8i&Bm23w!o% z_tNW!oB}>M*3W#&jb4>{N~E=rk8zYq=1RI!cqRS+RR23nBl^MBe9>xM{NGu1XR0wG zeEtdjFLk(NJuI3InIHXy@~P?HneCY{!5zd$nlg&0Q_~wNo+{v>nlOt>A2dG8W8pw|1kIpVmv>s? zr_b~DI4)i~>8Pbw7F@`BIDT|K%WZJz(PJqmYJn$SdZ}2FYHVm(y5X{~o=ZzJ6;gRY zZ8r->@s90~c2gM2fUY>_IZh5M4K=s}`S2%lo z&iYAC`k9Y^Ew0IWEh_S~PK*+9)MouXK2N9=Qw!8>`wRR5F%vHblO3=IPHw7E3oVSh z*9-A+R|EH@W7Zv?{89P<`c9H#+{~BU==E>n9*M=+{=Tk2S$WWnlXznQH&xW)&iET_ z@Ye(Xh^MAZy*Trf?{xgkk0O^(e-pp6yx5ZvezlyN^`h1OvGVh->5ISG)vm`L#>x3e z=d;|L^n%?cXmbEeal}3tbjTg%2>425>nBJR6C`c%irVhXc!_dRwA|IlIeJy68e8+L zzsdKsTXVngi8PKorDNus?8wbBA4tp`5 z_C3vMoop=p&M}$Zc(ZDS`{XyfoL@i%Bpls3;>vu%R4!tWqdef~?+J#=l))h}>Jr5y zywPhao<19_c8Z1Pi(Vn)%2TiYs91Uxcuv5T`3e;Am>?d`=$7`-Mh%Z1Z)>hdF=nhy z%?@An=Sc^fiaFkxuj5fn66qws0F~4qwT}fy-pkhXOnHvdH23Q?tWGsjnzf&>r~8CO z^gSm>>(eRyFkdj0OH`E{k8u`XiZM-U<5ORX=-&|uS&g4M8ysC9OEuo{tl9a&CD~^% z4l0)k2lEvO;xP`6NPR-K5apZdce`|>HNEKZQ@XpE(SK~0O^=nlTtwdvavVR*m)z)8 z!Bc>9iOb6Hz4oKu0~qZq+aJ);3cPmFmz86#l=*^+ zr`4-gJi1-zm1V=9xbFL_X5Ys8$S#CO=d(O69$^=Z`znCcc&gO!=;@{KD#XsV`>)xw zWbB~>s8Iq(b80C4GG8#2i;4$bWLS$w-&yJ?%PyD4oJ!ACxbgS3*Cwl7bR6`?-Ntd} zKeOwLNc)}gJLP(vFW9)m!Xe7O0)JFwS_a)><_y6o#43cr__o{NYq&baIH2cS!S4=U zI&+8#fXBg^Z?Yq|C&jeQB&vIiGL6jdgVx@vF@S45-Ry$TMudiP}Mf#L$ z`jb$bWqt&h`Jm{G;M2hH&_xs!-c{4P@p^n*m0^tE&)a)VpG~bUsW88%oW7W!2rl`J zFYwcRH!-(DL8RKL(gx4=r&5j6Pino_vFpvWex_o^!~8_>$T0zTFdi<|PML4Sw^Og_ zDMr7)Tu1*AveDt1!wtg*pEx}I%w$rnpA?s$>)lAWk@(D^Kn zm7a1-e3kxKehQ6%x64&-$z`Q zIzberH6PB}65oCm&!ifk6#f2nVfnf*k2isEx@SJ)<9jTeW_;#ivynzIT7?(cZkb!- z<4J!u)z}&Q@`yfnyg7>IagyWqAoC?RdQA{dllD^6TP^UZ{U6j+m;kCc1LFguSFYP~ z9LB#^e|TcUiQ6ak*2*pBN0G^=1o5F+i1X#k&|_r=P=!0&ZQPsjaaI1<()fJFyA#GN z?SdJd(y`r`Z?Yq|1aVpIrl3^q)&P9uoFFnwtnc{njOSj?`5|`<`6I{eOr0;KvDa59 zT@yT~zn>R9o0!@^+2!$4XS1cf5Z-2wtE|U@Z$`cH!yT-bzTb4(&HrQXF5sfr{s-=l zir9+Xirt8fErN;(28t~LDoRP%fsKvbirw9f-QA7d-Ti#d?jD$(i!6HYeeUmh{tU18 z&T?jV<~!${nVp@PJx7}^r$_s}#j(EOYq2;lufOCP%o}9+Dd&yj(B8K%<~=Gyt}*Y& zH;KIOTjq~8UA$Hd`t}9f#m%q*`i=@c+-vLZJJ%l+tB?0WSiTwW5#{r%!93VuP~VkP zJ`^;(K)-y-$&jvnAAKQK7oBgi^x8fF9Ovn>pCc{Rxpwg$ONe|B*LRl?hg^<0juW|} zj??;raXv*?k37?4w5xl(@O0j)8)SKD)8+JN%S(RG)ZIC(e`PQuSzc>2acIjcG({q% z<+?F*oYz&0C%^B??MI?q^OL8Yt z>Xbh<`+TmP=VXJg;<|x2K9}ioxpGX&82Vl^x{56?Ch5N8ir2P-$cKO9`T*heSC_Zt zCDY|yr)`4C&0AJ!EMgObSWoe&P1hy!@Qd>1*KU5IwE2A3zcQGSEbp*b#L=PONVK9WZ{UjM~m@mvftUTwO5s;=DFrO17WI5^~YBm9z0 z?BK*})cMu!igA8Lw|vXW_q#o*HL{ePzg)gHT~4Ro{Brr+9YZ`+v>69dEL za%3FZbUFPu^M$^Aeca@QUoj7LK3QBd9bd5~iIWs)Svi+nzKl2mrn<7nV(6p1=NEUz2qM|9hL>*py_92}oZ z{M<-4$T+m=a=IZ7XCF`fr!sda`G_(R2j|{?Ufd_9|GZHjzirXP5#9FG@Ll@5W1j45 zB$p%O(5B1jV&}rnwjRwNSULM}qQ#w4@?w*A^bwu^dFhXoXpVsG%J5TU-CNahIo&YM zpXlPc*)Py-W5CeJ`zd5x+Vtq+5;4XuD&zYyAH^cBuz43sty!>Vm|U)mOPemI$1=aT zxliO`RF0|hEBL1A{7Q1E_Vkx4lbw~zm2qj)<#csizs#?{L}k3)C%$DIS9Hg9jZQw9 zm-p{zC;(#x1yWs7g@YMr(B+l zN1HCE%f-ojiHb)&lT!nXK2O)gB91a)rBjEtetK9gN5-K|m(%5vWE_n=f&x5Z$QbqK zd$rr9^QD{1jZzt`(+A1r$#}Hsa(WE$=t9$$Qy6cQpQ{nXBj#@lG1i_JAW6wH_)eQ# zIWPUC-e}XsYsC=tyEWaNnvGq%>3&bBtG(jq={59iv~af<_i@(b+btKaRbRi2j>p>F zF^(?{^G^%;ePL?f#7bVb2MMw-+FjFdIx6zKicA+VsR#MRfFm+)I-|V^D_sLc@-`}? z`*eX26Ifbqa!{^3^!2l ze)aw^^sec86zaU7z{KUps>?;|8pt_JZ`rE4?gQ7JYYj9~(UZ$UZXP@n2OA8QkjMQF z#3h$&LAuC`Er#jhxL>(%x}3L~9lKyV&-|!9AEU}yrZYREA@*_0W>nnuH?{{@*>PRc zn_D5fi|+{Z^25n9aV|(d`*22b`*nC=ynTp!K(is7^=aK=`4XNgtL%?d?d3mOe>)TZ z%X*+q7q1mV?BkYwM_Dy>_40JrUvM(~Ad4Gnezg+vbK>9l9xnC`qFRY_tQjEA`DQ|9 zi1P^|f5dlnM#km;(De2+vE%d%Piy*j)RwJ zk=sJVC7x^dPwjKuf4j1HvA^^aCewL~(GdH%#jd@PM*#hg{Ial_vnAwqc$#?Sb|}h7 z#4IYQT%R6~Os~(b$w7-FF8A3f-YW(%*7bX4NY^E*9)4qe49yuuZin3J>gUH1m+q^& zdVgX4*z|T+{poCnhi_IjkfG?~ji+eS<@DIc8S{2$6f`qe*Ov(57K1HBJkcGO?Yz*Z zUGIE5_M3?pGKkli@hH=EiK>S`h})>1YvWbdhma?x>qF4J%@w9>dF`#w->CW^(^aAB zp2j|2RsGfm$(%wV>usi|rsLc_(sS3>PY<`q&pR=W$ETl6*9E6~U{9)R*Uq?IGDGyn zO>XJlWyz!5&TNQBZf9a2DDp;~uMx3`xB1}9^WTIdOsvgUna(VYhTq87ziel^Ubze> z#MIl_)Muu*GrwmM7rVH&Um%0g#~V-4rpxKEkJH3!*3kT`_^8&9x|O-8V$d(9@_fN zZ9sm$0iy8*Z+<0e_ytrrbC>%Qmp7*C_qjIq?QXyQDlhZt)>*8%HeCiC`*>rn-_Zuo zLe$%*#aq+$JaE;VF4MDBJ)_NUnJ(j&<3EVssGk2SZgqX%Lfoe6dx;FatQ*#THB%e6 zOqcP>aqQz()%R$EwPc2}zF#IzS>Hu_Wg-@J{)fIZy&l_~u4i|gymFj&J!CqwG#Y+m zJ+$@R+22d|qi^wL$6MF?LL*n7E`~k(VU`kE@86rQ_lFl}om?fpxwi~XAAdYWn=Yrv zKJJ+7eT*x?!onffBhv@d^*?Qu5Br858h=B4w-$p~kJLQMbX}tA;SbissQ#OZU%kIP zO#G&{gB?CU&bPV0e3!QV$aGccx~H*^U$q^?5VR$8mD|H3;+5OOV-CDTOzQ0+?4#-R zd6(;9rzvf+4%DuXOxLZ1>ftxmN4q`P`TGV0=s(iLLAzm2hIxlGmi4IJC)3+Q?pM|q zQyuHOT85^NpO#lO>2iAPx)d6@yc=R<5t!GUj@rdEfHD&iC5PDXVKOFFQ(Tg z$BAkgpT2%)rClGHF4seje`9^L^G+Me=}YGSJi3m;8LtX8FAm67)1ODd6en8MAgF| z#BWspe-*b;{U>fy_1~<$d(T&wGW_NEO{S|t);*1V+^YKjt6-UofJc>Gdg+Z{U<#4K^jz)_<9*2D{%bBd>QCH+8`ei$PjUHSy58^G)cW0t z`4eQdiLCe9bQyB&JoQui{qMlW^iTRqxwZ?_Tc9g}uAA^+cwtLe@QvecY;g|Epk`qa|d$k04%I?_Wn# z??X8YWomuCw=VBF*=G7m?fS@c-Abq)eq(*K^%0CEq}aWyE<%Shb6MZ3nVGKdF4LzyPwiH^vW!U|cRWR#E~m#n-k9rqw866w zb$$Ot{9>?$h%37KJ}cid`wo*P{3X9-x_G~O_=EV3>ie(aR`2JRBs5)5Dxb-5*X^}q zZ*4u1>FSup^Vr9&s_(xFmibLZWIZuAozGt~UPv;j;@%3{&r_K$VpI>&#@kre15ALG zxI5E>J4HL{uceDBtZ%!4HmjJ4j4L7*aXp_hr+M>tqZ(@ClIiN0#Pi>YOV@r_QGZ@U z#3Jsc30h2jw>N)tZQL?l6|(N>--z4j>ase{5W}ZzO#7!Hy}Ko;n&9>!ZJaXwpNuo= z>YVZQ37e#*>p`y%^>%gJ*nF-wPMQ7>#u?4k7UOsy#Uftw7mIh44=RvC8?Q|N2jh+A zY`O7v7M9F({+`ae$o|f$Tjtt$W%@rDZwzNOjpKGnZaVG^^V-`I2jh<6 zY?N`_7AZ`}9TxOTnZKZG6K#IW^nWn!7|tRX*X!_D#Qk+{%ClA0Pi?4;Tc-bmaYy?t zP<ZVbiA+9<=$5ycO_eGyfXbCj5pe& zuP_!Mj~^as;??#yA!2#9asEx$b;HKV8ym&vb4EU&Wx9BcdieF{oNRTZiLdy$rY|ec zUb>q?qx!rR^C<`spX~QloB-12s+bxz1oKp`M<zP|KjYG?1n4%nLpd~0$+TP7=(hUJUj_lB^1IsZ|;XS~e8 zH1+f)s_C1OeA_S9Nj?3rYWk#G3o>Y@KT=J%?U`(wc6#E}QOiG-LbPkqs_CLXMD6qt)%4Jv);mPjs^`B%HGPot;=S7UA688t|F&2% z?es^g>1H3A`f8^qPLm+Azs9gmp9aKZ`5}Fw6Fi~e6-+t?)|TdEZ=UqUb< zj(_TYX0hK8_c4q6W5vCD;`*w%r(66`CO7h+$^6riBnVGg*ZTq#L555s-b=Ym%_s!~|T;9*Yt z2xRJU%uK8(18J1EKNWEbH##1t(a2mhST;QseUh<)2@NY~%?eIu1#7T^f&_G%L836|^`( z-)47MIqHGD-#e6lWqmoUsW0wKD+!SwvLCPf^Sd7F-6zF;l5_*v!4OZ;rt6Y)$DZ@%l$s9{Z;cGqW1%<|>yX%R`$kr^n*=Ec%xO&{(>MyS{N8`}UD7 zCs3Ut<5Myk#}{4sY|i%Ba>}mY^zuez5np!7N2bfTAM5hg`_Vt@!l}Vd<)aW z669(cCI_BRgsExuh?#T?c2EH+IVHUj8l&PR=m-i zDNt{3hhq_M>!Y`}{Ma<_p*CKbF5{HrzZGu`XA0DD2WK;#&o|9$RGyP=;v#L_GF`?i z$A2sC7|s-^Eiy5 z#FjB14^_)eKUtsJ`R-2b=YNU!iJ=h0_br*OOH@6m+L3ai^+aEq;BpJ(H@yMAUfn!I zPgKUI5sa=cMdXP&9+wdbl*O<2OxoWeL%NZMWy*MDx+)aiQ_9@lotYkL3Lz0I+Ui6@lX$|(okAjYDfIhk%qjvPh*yGncC?z(nS?W@Zds^fS? z9AdDAs1wn(Tff4`ZTZ=FYi$M_Dv5ZVXt!Rb^RLmMYrC0t^sD>(cIWc6zOQqAtNKoK zQDOMCKW%jKuE_kzXB>z2d#K-<#7gp;FK#Vs`ud<)z8FNC8DhUH({+ie2S;xo&-T7O zIH$!zqrPSuonL#US#I#;sk-wep=3zKcJG&G;-t{?^lvBTOFL+BYFn|z=+6s@<;rx` zB6Uyohq9a}rbQb=9$3|L?Mb_f`fqG9l&QR0u75~= zrP#gehT6JtYA4jD%jvRhCXHa+9}b! z)sjaMm#+Os;*#fw^VfGA*MmDQ0z~&1R`RIG%F)lmN1Ol)q@aR%pigfZs@}+| zo`-7(s~UFpjag79UMrTbK2Ix_y#V3Zg9zNlV?2Ra>3GPBYzT%p`7F+nPDc{rPKt^U z>p*e!59V!hJuM5FUeAKrw^^l4G(4UnK8P5^C<%X&>AKXYhv?R`k*{x{Tu=3WYYEF2 zpJ}#HZ~x1)gV{!ODA1yNfHm=p!9qV$4jIx7|3;2v`-?RG=q9!hT_bR|K5m`pq*K=> zWKaD|Eg6Y?5ZlLL;*iS`Q&T{_eYg}hy`OLOa>?Q;8#6_S_liM`5!VyM4=%GK7xIBq z?TR%-`=8<_y&4cF3tiw2aSb6D;~=(`Z8(RQNX0f#3au~#;>T2Exg&I#FO*x_8nPOcT~;{*E{mA(?!3AS*Zpd&#$QVF{g^do{^LC_}%+J%d5Epsc% zgZzq;tSIv?p(x#K6yztQl@Ex>jnB|rY-B6=#^w0QL_A^<<+|F=$nJY)nJ7Oo$a0kF`qZe$--;)il2jiD zg%*!FzZ@EwDP_!umF^wp-cVbPGCe9X{j)!bPrOt8d6UW7^ykgEVZl4k`5m@h^ddx; zbuIL(qKr4BYva=Q`s`_F0+>j2ts>28&NueQsvXw!YTZU9%q-L8{~E%(+$ayBjY$ZQWOo9xzdHT zl_BPmR!u!Ux?4Hdw{6QRw5?U6Nn58zj!rciHEG_qsck)HvEyY3gWR8l6NeaNoYktQ z(j9jzl@#S`)9|jrWfLe>9qdlj_1dvFLR=tb5cwz@D@je0a0r-=x|$S@I~Jij65 zEb>tdB4R<*J9hWFHU)<;W|yt|pHbu>-Xn=bIgiK}#69`#9EhoWM7fAd?}fm}rQ!_n zAt88vCi-WazKTPt00uQ-ZcU zw$_8*$7%7~=Ri4-U-4icK_ZMB;S?c(qLDU!y^D-mbn!Kmg~AxEaDv*CS?aclv4( zgZlW^ro8d_7QXiA>O(u0*)6H{%7`ARl#>a)8x@(6q}#pry0sK?mGQ`=Gh9!o}YKlq4vykNxk zQ(4xCe;7nLrs7ei>k?HDCXa)nIbN&o=-j}*c7s}tYS=ZgZBVP8IAjZhJYKV|XdI{Z zcrA2Ra^?A@4uxO&22SUvqPl^v!Mc2v>H5^DN0V_H9k2a0LQ7^P^EsUOj`ltI<7Z>f zFXnbOOGO^}8K%qQIgzFw48^Zb`diP{-(y@V#eCi;lWij9%yEzB14eBsBDNVZhLzm8+Y;oiwI8ZOq$&c>OMq z+3TNYPhL)Lk76vYbIEk^8ujqYxN7v^$B}$&$k1xj35(%&eGhkAA9p&1v1hB0^RnTI z*e>M$L8j}MFaP`NIE;*r?tS8wq6~!J8N}O0#4{A|;Op1-y^z#v)ePX+i>H5^D$NIjVeQ6h3bfxBH)y&^B zkZzX6-qvs%hcmlU-4IhfiJF`7Gf@`|hik?YRR2X+#}XQ*>(^HG;<%^3%z?P_`DNDp zPfYmJ@`=sX_`g_dos};+%9=WPDyk)PHf_!=h?DBP?OfI66Vr1sOHy!tO*8CO34MXtwwng3S#s3Va3H<>2)bMpVV@vn0r zu6%x-H~$M$;>zcLp%i`{gQ@Zn=gQQ_Tk3t4+)v4KsOqK2X(CPiT>YB3=caQYu6#`A z(SP}hxbpcgbKmr`m+%t#JDvyMlXL~FE4(AEc)E*M(=Ea9{$~2y<}rMR<=Gp<*$?FuYrw!4;S3cI8M=C zp7=ddh&6pxth!z4vb(u5;`la;Pn#cClE0%BZCi=oBgu3Tn|kJK@Iz}Er%ade$?$al(eklT_>7vt#iU7M!;Kf3qHG8M}ZuNP#Rc>VwNA*S;AyLl5``Do`U%R-io z9BW_qfA#-AEgzZpB7cQYh)$on@=plQEg{+t7vB#=TS@YBO_m2qaYHO};7`lvSF@J& zUpAFPKgQ1;0!|5?DdN|kCUk9;j;u_G!QGG61_bzoj zPV`GI23v@FqK)UWotZK)zW><8Wd^MEG*l!Rk4zWuR}UuQF}h|T-lvYoVuFeDuQkk+ zJa@+Cvi#8AY8U-=h(X39)AgxQk0#;~`4e?+n73)$@rcd#BbFB1*U8A_>&5OtJeU8= z>2c$@9Qgl24ydp5Y+?HqgDrIRnf`9vc^;Z3fpT+aDR1jkiIll6jWVUWv1qU8??()> z{b8A|PmOx4@8Rw1-_xp=le3lR2TlL4t(TWCy+6_0m;RHmB;Ch}MzCGotr~ZtnO%2X zYacxV4Sj!!xrIUQhg~Md9A~>UiIm1QnoPOjy=Fuw@n!}Yr%czUMm_#noVpI*8V3fo zH@dE;Ofrs7dwg-Yo4InZQuxqo)BGCB{YEN65uXz>Jt{K&vzV@*n7&RfTk$r&PP#-B zr}jFJ#fVgj^?7M|N4Usfyn%n=`ub! z{^K~K%~ehLYvR?`)9{|=%C$=)^5-Z%Fp0LF%5)j09REhV>SG)ARb5>bFe?A4G3Tpa zXewn#`elU!3T5v5N_?qekohXp^{G*he;TJYTh(!XB2JM{wh&`+gs;9%ZqdhFSyb)P zsCr%7zU^+0@SAZ)9Sdo4R9#P(Op7_runDP@c_o6fuF287S~|^kFVl^J zH{@QvPIy05h;?nN>-z{n%UuFnQ=BrHqop^tBom^DRFlHpT z_Xtf~+U;ElHdhi?E}qq`Pu|FWD3kMkv7e7j*8~<*J{rXpeYPo0*%eRojo1!zeSwd*c1^={GsQ-J^S@qGVz$;+N@$5%~# zp2QS~zpfR3(W<|q1oL`Xo}nh3sRy_F{96PuXW!j*LU58TwC8{2x8alLcrk`Nj zj+9R0Kz|x=Z_?9`9aKSHE7o7O&o1&;UmB{J@N|peb)w#c&WX9aI?Xj#R_C3V`Ob|= z9$#kZ=OgRAOgEl8eMY)=^X#ZQBov*q>H41)1;qK1s41e?0IS+Q_MYy#jtxAbrWpF; zqeljZCQY0i{l#Nr-6F!+5v$ivv`Z(}QRFL=BG1e5G;a70azMQw$P{K=ueAGl5ni*v zr#(-fd~7d6)xRUbU()6Ds5)Zh=u_Q;UiCbjbzOBkcJuJ>#Qw<86~z+XAol~|v4|sw zSMqJ`65S~-mm}lQrpxKEio>dbuR25rS0C=!@^9qPkuDeLcEp{T1w+PJZLaD55-+7L z9K7GMcj70tG8YrE=#PsP<+34Nq^So77UkQ~-__fyiLY;cSD&8MgWS4!urn`VZ7mM2 zEg_aKK403gd^!J)*S-0)Gmg*toALf^Oa?_6iwNGAuj;$zAshsW_jNM&JblYMEAM9C zLq>|v7n!b0R6SIu%c3q~S7zrMByJ4mL&h~Q$lpWu2jIkwaw0x;Kh1JG7iA>2dvQo3 zVwL?UiG6~&HYH9;iT#x58(17aioCLbIKL{+=ck3ZmPOY}3ag>J$5rhAMgLsl{IFPq zY!H3m(cP>fx>U48F62fYxOvEHi#uQA& zG)%_~%!K&Jn~gaL!(7b6d@R61EW%?rvPT~|!;|$K?9M0ncF5(g{;|i|g8m{98 zZsHaqa2t1U7x!=<5AYC=@EA|<6wmM+FYpqt@EULM7Vq#LAMg>M@EKq572oh3KkyUc zLp~njBLU2i5avjP#1LO@lOh?CBLz}I^iOSp)JTK0NQd;ufQ-n5%n*H!$$s9m^IY^9 zn-iAEh1?MR`Q=4EvCAHf)a zff$6r7=ob~h7b(L2#mxijK&y@MJUE$JSJcwCSfwBU@E3zI%Z%dW??qwAPjRc5A(4A z3$X}`u>?!849l?sE3pczu?B0g4(qW28?gzSu?1VP4coB;JFyG95sp3Bi+$LS12~97 zIE*7WieosA6F7-eIE^zni*q=S3%H0&xQr{fifg!z8@P#Eh`?>!!Cl34cl^Llhy(n1h>rv?LqeD%5fUQ_k|G(B zBLz}|Zrv3Nq(&N~MLMKM24qAgWJVTbMK)wd4&;O-av?YJATRPEKMJ5A3ZXEHpeTyL z3dLcK5-5pMD2*~Gi*m3*c~n3}R6=D`K~+?PEvmx~_NalHs09bqMjg~eJ=8}7IKl~{ z6Yxf8j3%I~d!;Fw!3E9H0-}${R%nejXp44mMSHlx9Uka_j_3qWbVe6=!5cpCg&)Md zME(dsAcD{h-O&R*(F?uN2Yt~G{Sk}-7>Gd_j3F3`VF!|7)!7e%di|PuoA1V8f&l?>#!ahuo0WE z8C$Rw+prxwuoJtm8{yc4z1WBSIDmsVgu^(3qd11+IDwNmh0{2Lvp9$IxPXhegv+>s ztGI^ixPhCvg$Ufn9o)q|+{Xhv#3MY$6FkK;JjV;X#4EhU8@$CkyvGN8#3y{l7ktGx ze8&&`gpz>mAMqi+TbLms%#jF*kpxMR49SrKDUk{mNDVH5DQS@o>5%~$kqMcR1zC{| z*^vV|VToMGjXcPUe8`UiD2PHRj3OwCVz5GSi0j!UP!gpex^yoCx^7p>!3O0~0TodR zqI*Ztm10#?gDtAV4)&;lny3W_)J7eMZrtdqO{tFtpgRu52@TN*jnM?oXo_ZVL34!2O10B#2o#2Vi=mIZz!w0_bLs$4C0D%ZXH*`l2^h7W8Mj!M= zKlDd124EltVK9bZD25>f!!ZIQF$$wG24fM5aTt#Yn21T3j47CkX_$@~n2A}KjX4Oz zT+G9KEWko6!eT7JQY^!AtiVdF!fLF+TCBr*Y`{ir!e(s2R&2v|?7&X!!fu3P5B6do z_TvB!;t&qw2#(?yj^hMQ;uKEf49?;l&f@|u;u0?73a;WBuHy!7;ua!s8+ULQ_i!H% z@DPvi7*FsN&+r^C@Di`^8gK9x@9-WU@DZQz8DH=f-|!tj@Dqv|+dtwX0nCsP=17FZ zNP?tDhU7?rlt={&q(&N~MLMKM24qAgWJVTbMK)wd4&;O-av?YJATRPEKMJ5A3ZXEH zpeTyL3dLcK5-5pMD2*~Gi*m3*c~n3}R6=D`K~+?PEvmx~_NalHs09bqMjg~eJ=8}7 zIKl}H(Fl#v1kPxRW^h4sv_MO=LTj`^TeO2K+QSX*@IVK2L??KnGrGVF-td7h{LmHt z2tXi$&<)+u13l3Tz0n7K(GUF*i~$&kK^Tl77>Z#C!ElVgNQ}a0jKNrhVjRX}0w!V- zCSwYwVj8An24-RwW@8S*Fc;hy6H!gE)l4ID(@%hT}MalQ@ObID@k|hx53Ai@1c#xPq&= zhU>V2o4ADt+{PW;#Xa1|13bhdJjN3|#WOs|3%tZDyv7^6#XG#m2YkdQe8v}i#W#G% z5B!9ZknJDwkpN~$2y-MtVkALQBtvqfKuV;71yUmo(n4GhO^*!7h)l?gEXay%$c`My z2}|TcZsb8;s0Le9 zhaK!u12s_#4ycVfsEc~2j|Omr6B?os8lwrE(G<<#g63#}mS~06XoI$B2UoO*8{FZ6 z4(NzZ@I+^Hffu~t17G-|EBq0FKm?&1IDM@2Ku`2SZ}dT5^h19HV*mzX5C&rihGG~( zFdQQ=5~DC0V=xw>7>DtgfQgud$(Vwvn1<4)_FymeVLuMwAP(U$j^HSc;W$p< zBu?Qp&fqN0;XE$jA}--FuHY)J;W}>MCT<}Dw{Zt|aS!+L01xp9kMRUg@eI%L0x$6j zuki+N@ec3t0Uz-RpYa7>@eSYc13#gdv;8AJ62J@zVU9#dj3h{kWJrz_NQqRiKx(8x zTBJjIWI#q_LS|$^R%AnVq7VwB2#TT@tWX@*D1nkFh0-X4 zvM2`|lt%?rL?u*46;wqv*rGb@V2>K8iCS<#ZPYw>E3`%%v_(6(qCMQ;4i9udN6^HD;)%|n841M;-k_-l#TR~{83e^20SH78xP?yX zjvnAPC8Za7gIjErzUYVk2*v;m#2^gD5DdjIgkU&EU?fIiG{#^oLNN~GF#!`X36n7e zQ!x$GF#|I(3$rl?VVH|~n2!Zmh(%b8C0L4OSdJA~iB(vQHCT&vSdR_Zh)vjxE!c`} z*p408iCx%@aO}Ze?8AN>z(E|sVI09x9K&&(z)76KX`I1XoWprsz(ribWn95kT*GzT zz)jpj1a9LF?&2Qq;{hJx5gy|Sp5hsv;{{&g6<*^F-r^nJ;{!h86F%b$zTz9c;|G31 zNyPS#_(%XVB!oE2TUsDYZO1qakd9n?iV)JFq2!U+x02#wJM&S;8ea6xmlKufejYqUXIw1X?!!wv56 zKnHY0CwQVWy1)zG@PRM<&=vj&Kp=w94c*ZLJ<$vNY)9#XzUYVk2*v;m#2^gD5DdjI zgkU&EU?fIiG{#^oLNN~GF#!`X36n7eQ!x$GF#|I(3$rl?VVH|~n2!Zmh(%b8C0L4O zSdJA~iB(vQHCT&vSdR_Zh)vjxE!c`}*p408iCx%@aO}Ze?8AN>z(E|sVI09x9K&&( zz)76KX`I1XoWprsz(ribWn95kT*GzTz)jpj1a9LF?&2Qq;{hJx5gy|Sp5hsv;{{&g z6<*^F-r^nJ;{!h86F%b$zTz9c;|G31{NOYm;v)gfkPzlbgv3aKq)3M3NP(0{1q-A` z8l*)!q(=s1L?&cL7Gy;>WJeCI#)I~kiM*}#*2@TN*jnM?oXo_ZV zL36Y~OSD33v_V_6gDcv@4eszj2XsUyc%n19zzg2+fiL{f75)f7AcD{h-O&R*(F?uN z2Yt~G{Sk}-7>Gd_j3F3`VF!|7)!7e%di|PuoA1V8f&l?>#!ahuo0WE8C$Rw+prxwuoJtm8{yc4 zz1WBSIDmsVgu^(3qd11+IDwNmh0{2Lvp9$IxPXhegv+>stGI^ixPhCvg$Ufn9o)q| z+{Xhv#3MY$6FkK;JjV;X#4EhU8@$CkyvGN8#3y{l7ktGxe8&&`gy@Ji9^xYb%#aY~ zNQA^lf}}`>kLS2TUsDYZO1qakd9n?iV z)JFq2!U+x02#wJM&S;8ea6xmlKufejYqUXIw1X?!!wv56KnHY0CwQVWy1)zG@PRM< z&=vj&Kp=w94c*ZLJ<$uj(Fc9e5B(900T_ru7>pqpieU)BaE!o6jKXM)!B~W19L8e; zCSnpMV+y8X8m40gW?~j*V-CVF7xOS53$PH2uoz3Q6w9z2E3gu)uo`Qy7VEGc8?X_Z zuo+vh72B{KJFpYGup8mngT2^?{WySwIE2GEf}=Qw<2ZqnIEB+VgR?k?^SFSExP;5N zf~&ZO>$riNxP=JZ#vR16wJj5eB#uGfnGd#x&yu>TK#v8oFJG{pSe8eYw#ut3W zH+;tr{Dio%FCO9}0nCsP=17FZNP?tDhU7?rlt={&q(&N~MLMKM24qAgWJVTbMK)wd z4&;O-av?YJATRPEKMJ5A3ZXEHpeTyL3dLcK5-5pMD2*~Gi*m3*c~n3}R6=D`K~+?P zEvmx~_NalHs09bqMjg~eJ=8}7IKl}H(Fl#v1kPxRW^h4sv_MO=LTj`^TeO2K+QSX* z@IVK2L??KnGrGVF-td7h{LmHt2tXi$&<)+u13l3Tz0n7K(GUF*i~$&kK^Tl77>Z#C z!ElVgNQ}a0jKNrhVjRX}0w!V-CSwYwVj8An24-RwW@8S*Fc;hy6H!gE)l4ID(@%hT}Ma zlQ@ObID@k|hx53Ai@1c#xPq&=hU>V2o4ADt+{PW;#Xa1|13bhdJjN3|#WOs|3%tZD zyv7^6#XG#m2YkdQe8v}i#W#G%5B!9CS*nyWJNY)M-JqKC2}D*@*pqrAwLSBAPS){il8Wp!3xD;jS?t{QYeiw zD2sBiL3va_MN~p%R6$i#gDtAV4)&;lny3W_)J7fDMLpC<131D74bcdV(FD$Die_*@ zbF@H9v_fmNL0hzgE84>i?(jedbVMh3qBFX{3*PX7FZ|FI{s=%Ig3t}!(E~lv3%$_? zebEp75sU#Ch(Q>PAsC8b2*GfSz(|b3XpF&Fgkl`VV*(~(5+-8`reYeVV+Lko7G`4( z!Y~)}FdqxB5R0%FORyBnupBF}605KpYp@pUupS$*5u30XTd)<|upK+F6T7e*;n;({ z*oXZ%fP*-M!#IMYIELdmfs;6e(>Q~(IEVANfQz_<%eaE8xQ6Svft$F62;9aU+{HcI z#{)dXBRs|vJjF9S#|yl~E4;=Vyu~}b#|M1GCw#^ie8o3>#}E93xS>BD;v)gfkPzlb zgv3aKq)3M3NP(0{1q-A`8l*)!q(=s1L?&cL7Gy;>WJeCI#)I~ki zM*}#*2@TN*jnM?oXo_ZVL36Y~OSD33v_V_6gDcv@4eszj2XsUyc%n19zzg2+fiL{f z75)f7AcD{h-O&R*(F?uN2Yt~G{Sk}-7>Gd_j3F3`VF!|7)!7e%di|PuoA1V8f&l?>#!ahuo0WE z8C$Rw+prxwuoJtm8{yc4z1WBSIDmsVgu^(3qd11+IDwNmh0{2Lvp9$IxPXhegv+>s ztGI^ixPhCvg$Ufn9o)q|+{Xhv#3MY$6FkK;JjV;X#4EhU8@$CkyvGN8#3y{l7ktGx ze8&&`g!nN}Jj6!=m?0s|kqC*A1WAz$$&msnkqQ<_jWkG$bV!d3$cRkHj4a5CY{-rr z$O%j2LT=xOvEHi#uQA&G)%_~%)~6r#vFuUF6LoA7GNP3VKJ6qDVAY5 zR$wJoVKvrZE!JT@Hee$*VKcU1E4E=fc3>xVVK>6D2Yay(`*8pVaR`TT1V?cU$8iED zaSEq#24`^&=WziSaS4}k1y^wm*Kq?kaSIW+jXSuDd$^AWc!)=Mj3;=CXLybmc!^hd zjW>9UcX*Ev_=r#Vj4$|#Z}^TM_zCetzIcd_1TaHFm?IGqBMFis8ImIfQX&;BkQ!-_ z7U_^48ITc~kQrH!71@v-Igk^U$c5a?rvPT~|!;|$K?9M0ncF5(g{;|i|g8m{98ZsHaqa2t1U7x!=< z5AYC=@EA|<6wmM+FYpqt@EULM7Vq#LAMg>M@EKq572oh3KkyUcN4)V69|>TFgfK@U zBt{Y>MKUBu3Zz6TSRgghAT81%Ju)C8G9fdvAS<#VJ8~c=ERhSjkq3E^5BX651yKlv zQ3OR%3|1%(Ym`7qltO8gL0Oc84a%beDxwl9qYA2`8f;M=cCbec)I=>fpf>8DF6yB^ z8o&`wXoyB=j3#hKQ#6AMnxh3;q7_=B4cej|T+tqGaEAvvpd&iL6P?ioUhswweBp<# z@J9dw5rl5&jvnZVUg(WJ=!<^nk6;YIKn%iQ48c$gLkNar1V&;MMq>=dA{65=9uqJT zlQ0=mFcs4<9WyW!voITT5Qe#!hxu55g;<2eSc0WkhUHj+l~{$cP#W|eE1zf}>T*eh# z#Wh^V4cx>nMBp~=;4bdrJ|5s99^o;b;3=NrIbPr;Ug0&~;4R+aJwD(gKH)RI;48l2 zJAU9N#1Hu6AwCko3<+V5L`aMzNQz`gjuc3VRIos5q(NGwLwaODMr1-}WI$q8O}D9M&j-k|>4JD1)*n2OE?}1yn>OR7Mq4MK#!> zI_zMN8mNg{a6oO;L0!~CeKde0oX`-B&=^hNjHYM?7c@r;v_vbkMjNz6JGi1f+~5um zbU;URf+sqo3%uYBANax#UEz-a1R@CC&>cO{6TQ$Ieb5*E&>z7VfPolaA|_!nreG?jVLE1DCT3wa<{%7nF%R>x01L4Qi?IYtu?)+x z0xPi!tFZ=au@3980UNOio3RC3u?^d?13R$`yAh5(*o%GGj{`V}LpY2hIErI9juSYE zQ#g$?IE!;Qj|;enOSp_HxQc7IjvKg%TZq7I+`(Pk!+ku!Lp;J`Ji${u!*jgAOT5Bs zyun+%!+U(dM|{F(e8E?I!*~3^Pl(1l;vqf~zzhjtjzma|BuI*6NRAXpiBzyaYNSD0 zq(gdSKt^OjW@JHDWJ7l3Ku%a97jh#H@**GdqW}t`5DKFRilP{-P#o4Mfs!bN(kO$n zCjnEiP;Ebkd1{X9( z3$#Qlv_>1WMLW2nJ>1|94|G6Bbb=>3qYJ#?4IlWz4_)Dp00bfk-OwF9&=bAT8-36h z{m>u57=VEoguxhsp%{h`495tJ#3+o$7>q?I#$h}rU?L`AGNxcEreQi}U?yf^Hs&A< zb1@I|u>cFP2#c`vcx3ahaOYq1XNu>l*g37fG6Td@t>u>(7?3%e1HJ=lwV z*pCA^h(kDxBRGmq7VwB z2#TT@tWX@*D1nkFh0-X4vM2`|lt%?rL?u*46;wqv*rGb@V2>K8iCS<#ZPYw>E3`%%v_(6(qCMQ;4i9udM|6TGI-?7`;0+)6!Vg{H zj{pQB2;I;fJMZw7yZy5!5Dyn7=*zXf}t3O5Ddo%jKnC6#u$u6D8^wtCSW2a zVKSy*DyCsNW?&{}VK(L<40ACL^RWO6u?UN?1WU0D%drA0u?nlP25Yen>#+eFu?d^8 z1zWKV+pz;Xu?xEqjy>3meb|o!IEX_yj3YRTV>pfzIEhm@jWallb2yI+xQI)*j4QZ` zYq*XZxQSbcz-`>YUEITcJitRd!eczaQ#`|SyueGm!fU+2TfD=2e85M1!e@NJSA4^F z{J>9$M!Vu6J`%tT31N;zNQ@*%ieyNR6iA6wus~|0L0Y6kdSpOGWI|?SK~`i#cH}@# zSRxm4BM$k7_3kn)+m9JD237}gR&?G8=HQ1s$ z>|l=?sEJx|KyB1PUDQK;G=L+V&=8H#7){`erf3EiG)D`xL@TsL8?;3`xS~DW;0_OT zKu2_fCpx1GyxvCAHf)aff$6r7=ob~h7b(L z2#mxijK&y@MJUE$JSJcwCSfwBU@E3zI%Z%dW??qwAPjRc5A(4A3$X}`u>?!849l_N z|6%Vu;G-zMIKF`pf`CLs0R;)YAEAoWgoKbtNlc+5xg?w9;Bpu4E|7pg1c6wPs5A>2 zJ9g~Y0QIk8M^r#;Udwy2f(O8Z;32RH zJPaNIkAla*gk@H%({ zyb0a{Z-X7+9k3I;3*H0ogI!=Z*aJQQd%=g`Bk(c!1bhnif&Jh!@HzMbdSBY60`!X!8zbu&<3;x=Ye)060`>$ zKu6FCbOv2OSI`Y~2R%Sf&ffnX3g9}ET;fFWQg7zT!e5nv>U z1~Fh1hy`(AG>8XdKmtev7lN^192gHKfFzI%E&?ea6{LZ5FcC}wlfe`)6-)!u!3=OQ zme6Rpq0v3Wr zU@<5Gmx3i=DYy(Q1Ixh*Pzo*wSAZ+QRbVB!8mt0k;2Ll(xDKoaYrtBt4y*^)gB!q& z;3lvE+zf63<=|Fu8@L_Z0qz8MfxE#*a1Xc_+z0Ll4}b^3Ltqnl7(4 zA#fP{1bzlbz%Sre@EbS^eg}VmKfzz%Z}1QJ7tmszA)p?p4?;l$5C$58aL@>x1{#AV zpeZ;VGy@Uf4A2~$30i=&z}cWBXa!n>bHKTv4QLC_1MNU0Xb(Doj-V6h47z}>pd088 zdVrpw7w8R4pbv-weL+9a9}EBk!60xx7z{1|L%>il3=9V&z(^1cV!$X63*x|N5D&(H z1ds?W1Y^NCFdj?*Ngx?q1X4gMNCW9$BA5gwgDGGtmk2o!_)U;(%UECh?dVo(Au1xvtEa2Z$z zmV*_b6kHCj09S&mz)Em6SOvx54;a{f!$ya_yFt$ zAA*m-$KVt2DcA@0gU`U{;0y32_zHXt4uFH;8}Kdo4tx)O06&65;4t_J{0xqOU%;>6 zH*ggE4*mdtg1^Au;2-cWpoMxvKs`_&gn|Yj3^WAcpbNUQ9}orl zf_|Vs7yt%>LEwBa7+e5`fT3U*7!F2&ksunxfKeb8#DUQu9*hAAAQ4;$#)5HRJeUBI zKr*-pq<~bA2GYSqFbPZsQ@~U(4NM0!z{OxD$N*-L39>*okU%W`Wtj3i5#s z*g*l91028!T%Zul1@k}=Cqp51-KGi1y+Kq!75M&t^wDA>%eNT2CN0^zN@ECX;JOQ2r zo554yY48kq7CZ;GfURH~cpkg}UIhOGFM*fAD_}c#6}$#s2XBBk!CT;MumijUc7k`o zd*FSr3+x7azz1M2_z-*qJ_etFPr*L0AAANr2Va0M!B^mGZ~zWlzT7a{_*`Ot81zLl1z`39eXba8*?LZ`G4?2L3pcCi}x`3{r8|V&t zfS#Zi=nYJu4~PPNK|jzR3;+YcAaFhy3@!jez)&y@3H;Of_b0_6odI-0k{M#1dG68Py#LmOTbca8CV9E zgB73@Tn?@PSAwg+N^mt;189r zJ3!O6n6hOF;C3?nOz(E`ruqm2l%V|_ch(tEo3I$qm(%_o-}8(o`&*0Z(do)MrPNNc zToDRC723(z)YN2$y+C%jEV2{VeY(+34u`!)fRP{?#DGyC7Q}(kARdeX2_O+%2*!eO zU_6)rl0Y)J2&8~ikOtDhL@)_V22;RPFbzxxGr+}QCddG0kO{ItHjqIM$OU=80%n2P zzzXt#4cI{em;)RD$!oNeuz}G|8ttUfPM)0Y*b26R=fMl$MeslH5_lQB0=9!!!E4}k z@CJAjyanC{JHR_&CwLdU2i^y}z;3Vyd;s=>55Y&^WAF+16zl{0!Drxe@CEo1dK_hS)XbhTwrr>nY3`Br4Kyz>=XaUXwXM>iY6=)640q24?pe;BLv;&c# zJ?H>Bf=-|_=mNTeZlF8p0eXU7pf@mqJ|GJ81^qyOFaQh$gTVPx54;a{f!$ya_yFt$AA*m-$KVt2DcA@0gU`U{;0y32_zHXt4uFH;8}Kdo4tx)O z06&65;4t_J{0xqOU%;>6H*ggE4*mdtg1^Au;2-cWkZ`{d0_uVKAQUtJVW1%h2aUjK zpfP9ynu60oGY|pJ0L{UfpanP!oDEunR-iRF2b>GqfVSW~&<;d`_Mijk2s(kzpbO{< zx`FPX2j~fUf!@Fb`hY0V7xV-D!2mE23{G^f=OU9m;$DPX<#~-0WJnJK?X2`Oppb# zfedm$F31BGFbm8ER*(;Dzzzz)9N+*>-~xqUE|>?3KrxsP7Jy5@La+!d1|{H9ummgx zmw{zqIamQo!R6oza3#13tOQqsRiF%91Fi+vfz@CQSPRyH_27DN1Go{~1n6G46j_h& zgUbTk2S+w;D&6x~x9w{t7qy`EFvztAbRW!eMJW7KxDSr8S@O*;Ia_x>ydLMU9;Ih{ z-;ZAlzw1D^7NOG5+Xv9_mo)dGZy&YPqgmkIt}=NAJ@AF>e2dd*vD=)_;*fh~% zx2j*B9c{z+L9^)gPiYs7@oeKheG&2k4IGt#OTiMb6kGy=pVv2T z7doLZY}Jew+WDc_HjqLkmU}6Qe}d2_0bk>l9hySrIEU?%&?>NfCO(>bdFku(3-$3< zCJ#cNWQS$0IjcBTwmB^>%Uszs+GftQ$}~cx<_FeqV{5v4bsUSj^wL$Gt#ldNq4%fd z_221sPN;O?aPE=Q%l_>C9(@=Dt_h&}ljVv~_(?NoI!(#uTzQ<`oNc0y6sKBjS#nGk zX@bD_;aGq5Qv>*i1B&NN&=&LtG_FRO=x$IS%F-BXKKdaqpk1K#{lglepVCyFld!5i zbnK73n+(58&=x+AK48xfDG4`SdFXuIGc{Cdjzz|Qa-Jr2=@%iL)2g+!et#Ef_=sUr z!K4||54V(Ie#buPm44GgMjUBfZ^_b_`q71r8|=r5!slkTY0~wT7n^T8?aa2nO>NS9 zto+7kvKy5Rs3w&Fwr^fr|MuN}Zm2ZlHP=n^-adH8CwF<L3M}LN_D)|{`K1E^I1#y`pYw3Cma9N zxdrs;bB2*Vb#C*jL?G4!%17{Ua*UQn5nVBEfc=PW7$>nTTo)PD5NlgMF=@oj_tEf@ z;==Gt^#IE?v3uhw@1{|5uEpm0KQX_+YI4t(;uA!D$~veezcPL3oF^Rhx-Oh~_8~sM zp|aDkf}H(R3o{+E(_V<%$ass@C8J_8=g6ZR_IXZJSEe+(%WRF!le1=1mkuYD0Pg2R zboACI8-8RTnrkt0<@~Z}d^l$J`lt79vO0%-4;eY`N3vX%dVW3jFs0==>@Js8j(99LpsrLC^(#zT3qlDWoql@IMLKg-G6m2G1tX8xh4p)jir%-mX z!NhTs?K-{6F}Z=#t7tUx?CyPAD6Ws2KQ(OWjs`z?U1@tHQ`=(bsLtcPCC{(3zUWjSAO3p!TJF9lt^?cpoGoI7pTq~0+t-r;zt z98qb~%h}&oewi!VT!Au;s8@K`zf!85Pws?!f>GE8T7NFR^6?FIRcT?Ko)?V5+4(a#m z-a&NA|GLeJiCMmjUSCigwQu#MhHkkgc5jmMZI(=X5xU!EM^+xX-#IcWDiiN0I@)qm zWV6$5qqF@?#DD*u26Bb4T07y*Tn8kD(Y;9 z#Z_$bSVF6?*=L+QSGG#!ID^w~eUHHDXPMe`_Xl#PM*95Da<>B7j#n$6kerfcO0=QE z&b45~NZ5_HJ5pt3^f}2f&YqE-P2SHGm3 zoU}YSMb5H2vb7V+v1NO04?>?IM~bf>l$!3Y*I6IEJScrUrXza^{U^GeQ<^_zJeBpE z+$*rXtbYt#)a06I8VXY!>!+8qzZk1YpPm!!E@kjk&K^~)K1A@Uw+;oNPuk^oM2}eU z>KXd{#d6kzw*mASW4Gs`XNMkMK02Fb8{Hc#r;6pTsCQsHUC_F$yw{VhXqvI&*iL#m z`}@^Pdp!Wz%ga6yroei9cHJ=3jFsop)H}to9(pQufP1wlVb+ZJ~{6H>gB30o@sj8J5wwwDoYmn{|PDRP@-bT zL1MYz)WfH}S;3bROyG~v9^@B~m8Ky-*cA@(tmTO}7#>*~Rqr%;8 zlU7s4K^u!rt&3QnX&t_KmIEPMaG!u$l7v*R~f>Oyg( zXMJePa!u^sRM9>r<=zd?07?)7=bP<1z1UV_|7rKTopwz+qwkcY~nO){g zvs0~vadZh_I~4WvPM?nO>jZW{zqnsc`v<$y`fs0EJLvF7kH^zLaHPj+_+_~w6n?z) zaN7a4NX^QVaRmt5VPJ1leVBceJ^H2f8`I>0I9F{k3xFMP)q((3Z<~#K;hQA7bhI z8}XsqXCI%n{GPHk(`g<8xx;|;V!0v|ekPh77Nur!n$+iePOf#R`!5%{V$q`K+8xE( zIifyM1HAR&I;Ry3JM)7#dq-ih{@k(Uvp@S{%?_H6M~?MjxhnPi`p^evn`pLLvK2K^ zGZ$K2rkH{P*_MsdM18hFA98FTeY%m~xY2U>-kmf8v7W`y%QrB~iS|N3O~Zzx@`{;AIvH9b0j%RT8s>BVx^gSUb{cx@pIeN~Ty zvz0nrqrZI;ltf^n-Ht*}%ExRsU-e_&?d@*+>!sCr+Ne6Vn_kZT73&4Haidxix0%$) zTgRJmYeF|6aH2k?gZ$eqVNydW`90rZzk@_ zS;FV5`M#l~m$N@!V^u05j7KD8I&l+@yYDzlwsLbl(c&yLTdl@N0QLIp0wr%(_A|KyC$uVI`bCpq`7Y7sJiNgUzRIE;V03CzM|O* z_0kjRDV8z{pxJSf#g=WKXHs-zokV@|F7URKFMX!pTymx3Tj^!JJ}ehhQFeXmlOkI& zursRA<+9tn)$!`@OG5(dbF*vXiZ37A5T@6M<<-?yXimOMutjf?mg%EwqLe+bbkW%axte7onNXyS+3V>jKf@zXUU?u8}$4Ui8sOS z$Vc-sU(Qan%~jhOIXlK7o0U`d;WwE63*}?dfcn=FfcntXU#32W3DEt(1VA0LrQlxh zF^EJ)qrown$G!j+FU`ZG?#Db_M_U9s3V}97ptRQXEOgGVMMr#12lV%QV=mzk%+(x+ z`I}jY=Th|HQE6=1i}}87LZs!65NX(FAyT=sp0pQ}K-*&sabs=+d?&V{M0SLUl>U1u zbl`e!d$hN`4?q{Hp2H_%?(z0S<@kRd9W|-T;pSI74mmlfjlNWf#BxO_{9qmj4L;4a z$n(_N)}D%|!E#IvhRxxpj-%svsHo^s)%hGkR6*^MzU+9P+B@DC{YYLFrw@b9^(CuH zn86%NaU6?yg3-k|=Ga)E90^Y4wyNc&3F;McoVPjO@K*Izf5Wk%F#}(IG=9Kx+VVbj zgK~U4Z-YANBsxfJ$BNQD^(u|SL^rLk)T@(YLZx1je-7MK7%H{2f7WDX-WYH#p!>TFWGZ_9g66baamfY9 zYn#v!9fFK>9wKufvLr-CYm|1w;L-vNCWUuIygl*0#Q?OEF?fd|8FS$?5iV{xd#ph_ z_$2zm`!QwntPp8tdWiJt?IBWrXg#S98cVVxw_}x+2g>IJWqX49#Zb?kUumD<`SE@2`RcgCbpNsO2Djt1g53)_w27x(FZUoINLnw%f0olkZx zfqor-%3Sxu_aDA}t!;P;#b2)Z)BKgl$${rRe6S?<=7^Se9KmUdQ?DUJ(#zSu3i%+< zY|E8R7UxW!r%hpO1a$qR-}WH%Yd!ME%hsQ@ZYjsl`swBDUmg7lvU6q@7SN-1kE-Q@ zo_SLO+wt-h;qRA!HsJ%-gZ0$Q*}uwqI@M|IGch+oE>g$v*^aHSP5|9|#Q=(z_Ni|v z&W{XRKImULeNGC*ievrsa`vyXen{tRSuU9AR9;;07*Y$6o;k3-+k?>euj%m%-?(Oa z1$*k{HPIIf=H$vVb7h;XzRM#jE!IyN(*oN!^ylj@`RMF@6I8pZ=|JzJu$=YeZSeN> zER0cfW-Vbc}8G6?kS$PwR_Cs7xj9wyasv-cC1|Aazw!C zeiZuB^OYEVq{9EE!HR1-t5MA~l3aY)C(9ms(vMDv9w^++x1i z2LC|%M?E_|VwU4Tz8boxZSAX*vws!zXL|>{j(yNm)I)zAr85KPn+cy?yzapBL+BBi z;?#5qk@Rx*uflcst#QTtJvbw#3Kse--p(d;8T_%pd!L(0BEZ z?=(t#Yc4(7RvhcAm$QEr^o5?4w+y0P%gll8I|}4z8NbinJ|koCOOgB&m>F%HKmV_nF;C4F{9IFCZ{ANk4{OOGIL_g zxb)FlkmcBNJy)LPU*E|&q0-H(p*9gqVqmV`9=q zE8pcH{dnFErKg&vo~=8wTHHxMSYo`?zvFnT5>2TV4)wpgA-&1P01C_3Jk}cz4%^#e z@0V}T`jq78IGR_>az!Zoc-wch4NFGI=}uXhJD6^BS=4v_z32BH&Gpv9*Zk;>?HV>a zJklJ?&lpILdeDRAf(puRWqQz(Uzl<46m_8!$`PPwUy`wnX{`2nFbBu%!WL6Em3a@E zN${VyBi#&FyB6@3J`@9u3w8oDN0%C}3qd5Hxk8ivpZ+_3U&&JH}3EuDroTy`Mk5sr`b(aYJt5`8=xB%57%DOg3oA)`@tCY!OPd4OViMa}X~FPh6m z<%-_}E9%`)>NoARA4fc}>CZGRVoooXYhw4N61~*7uhf^olw-y8+6Fx+uf(`Rskqa) z-zRrXAG2W~`*8VgqLZ`#7_-G}iYavE#nUnT%Dn)NEA@uY}>`MI#ez+jzg9F`YpPZ^M z*0IsaRbQ;JY{|7*Y+hQ%n=RHthpZk^f(^&NPZz(woY5Ke24}9k@XN0XXrG+ge%7lX zSAE^_(^>_#EM#M>m4R>Tc-B!U!GRoq1}2Hp^~3<$(oGJ{HdJ3P0NQ3-PBpEV(o@c7olGs}S?cdK+D_C;mt*c%F^_4?(X^ zD}Q+-vLIACcuUJyTKAqgX}@ZCcl<0@0uX*G#?RAmP3Z+`_Wt=6o70q9sPua2w2cUt z>`~MAV`&aAMffdlZo-4pQ za1VG6ybHbq;n24$NCb93-*=*KKagRDfyIE3DGjK&<{ycSqf9+Q#_TO%%1WG|px6nDhB_+61^ zy|Bi2U#w$(KGr-Pj(FnmZYl2O4xNnp*BOp*4!N+h<#3O_GS0f@!@g6K8Af+&pY4AM#1;qAlUx4~z@H-8q-1x2^wcNPwt|trCXcu8a^##lI%6Q)= zi{m%rWk;?YGday6%jpGpd0*`yZ9)Lt{+GG@*I(;LhDptiJh$_`^YcG#*F_xyeNWSe z<-zNty`1Z%u=du>kReGnFZpO%I?hRTx@f;hyr)Ah22dHM_JNMs*DORTyYAtg*p=S> z_~MoS^qewT)mA+&97nU9juD+#v?e89?Y(|fzw~-~e{@`MLx8o!l+#3glIMBrqp$xr zrZ<$ne0cQ4w%@0WO&+IeL~T2zC(A`$Xy02OF+J5Al9 zmqV;LH4Q=}y`25AimTn>GTW4UR=i_w#WH0DR&y3M%0eA!jzYYUmOasoRXgaMQo!Xu zuPCrSYrl#exb&%XTE0bb)VHM`u3oN)@e@cNtP7?bD(Z1arw8Rx@jir3_~77YpN;vo z?e)sZ_+dTta`yM5hs#myS>jbppORwl^6YCI^NbmHEsC1d^apfx6-VjQ0;$PzP3+!y z>oEx{T*=&XGwIWYPAUPMKGJ;u`b4e@lR9R-Hua<18@_s0b2?kK3)L?ySEZg`fBI0` zi1sK${8S%se&xDBoR@I-?2Er`Yx@#!2C9y>^n9A-n%KP&uUW~iib=E^GOQj&3$&#c z+p_qC66~-&3KoPaWrp-2#X_Rh`>hDbKOgiq-6l!zZ~yL>@E3gCQu2z7c-ia{Mnk zU)QJHL*!#&cw97JX9-SXI~QFN*v@a>QugnM*{yF@Ze(#TjW;#IuUn4)MdwS86uaHU z@kiodil4@9)+7Fx+gy>;b?Q9lLy(iH%Qb&`?lE|w|8jvtr5{H8_T}KQ2lmlExg_P3 zq)@$F^~F7S;Ps(K$#^y<)3QEV4}oXQQ5fZb?Y9T|kDV!pb=BA zR_Zw%L)#GivK;?fNi&%d}69?WdQkz8L?n@O=fh{XF{6GZgKFa%{QYExRmm zK8ty8(#GE1x6o~@;#eQOoc%rdEVU4i0kDuNmcr6*Yn4XJsU)S^wknGTa+20eDpkE@^$FtAIT2!-TtWxJ+K`o$iY}t-`g3zq#yN9Sgr_#pUU*( zn=$uy0DP+#^f-$UWtDfSjq&9wllwaMzbX^!)$%L6^G`O6LgR$u^P$CGcgULX`?Nu9 zFSWlBBI)JqpKNwI(E-fnb$(LKbLDJ$IL#ikfTc35KrwmxW8(7|RVxm$;+Fe7g!n}_xKvfPipv?8v> zA)`UXC*N>u?^E$S1R(0I4^RJpW$B%Fe(TBt zfzpTCRZ1TkUoz6Cu2P}$aK(C~RaxMA|i`8-=f_pl;cFMcQ*&nXWQxF($3KjZ*dL2J(Alz(uewIEN4A<>%L1- zKM3KZLD<=t>)Q{@p+g^sG7W>Ks%u}MRc{z@6*K?u0jHfg<@YA7=KQY3L=6z>!E#OP-q5!R6PAkNZBHf90S@4yyeE&$uSbE9fVDRm?=nqL1K`mCx&#;?4PZT?`*CaTSl3T@FhY z&FEL=XDd&3l%T|Xv?B=p?&`THVqk1>6ziedF;vpa*u~<*-L;Q4p44``*+NZKD zK2KkI`p#SCtn7CV)p6u#8-ib!D?;HX0YkaSCMJA~0g047&SIPGRR0-g$9QWtJth)A z@+<07aD#U}LpG;ts9RGSbSOL@V-Mz~= zJRVgtF+J?312+MRU!VRopIh%ZPQCnC{$H8CWCy)F5%d-F+df_T(tV})yklFta4G(* z!+$$28d8F3=!)a?Ww|DHZ#?DS^Ndfaukh+3ZXfbdm#QDQ)Xw1XFM6(5zQH@c>DyU4 zrQ@n0cYl%5oSGBGsrjN=1v&fs)F&;^;>gCUJ1$H-qPg6otQc6rbB@tAGd_QrP3Lw4 zVm_p@NbRlOMMA*!**56U{i5i;L&vs&pLl(fZw_4F%=mrl&>7p7|IG1Fy+k#RUe5mR zlEn9E>X#MO&z+hQow~2C;`@|iCSkbDtG`xOuGa2U4^sKwhVNmJ5e`7#C7*1XE{$m@ ztytP{f$h-Do1UXe0FLqsm2;LWLgA-^UhexxPl|Y2C*SXVkS;XtMs*!tg;3UI7vJe< z1sSc+PLts}fG(gXhypZ_jA{Q;EEo&u!TQC(0%$7lQg9u(18fFwfv-Ra3?2zafjn>> zphYTv2Ln-ni@=MZB{F9r_ynZEe0zWuh2snu<~49V3Q`F&%u?9vPF%=ATu2%&;u{pC zO%alGe{)It5*fsdy0klTb9`I86B{W>cXdKL)LoK3?~U)w_Ln5*1$g%%Z5Na?|QduRT>?8isGC_PRGz8aTLt)NywM>G#qw z>6fI2(gstwk{^)N%6lJTe(rWFE*dTd_{uk%ri4pdnjUy$cIM2hZq^D9*B>lb0uX+J z&NpdxbvPsyH44th<-6OhJpuIEH$7aMKl7f`PhY#@{N*~mST3lf>{dZ9e10hfL%t3) zY&_pV`&1e}&XkG%BL%n-a64Oan}0h-WQ0p{!_yjF^6=dI=j-%kxuT@-Q!{-%B~#S1 z+wK1KjLr&|zHEAW%#4&z+l{1zhU4^RxhnPiR!>hkTm0M{g(l|9Z2|O*y0D>i=7ezv za)(Fn8n3B>BCFJAEZ4;DO%?Q16I(N3IYQuc&bY(B{R(ozrT(A&eD<3!Mc;9sE}dEK zR!G~af?jHQ(FVw}we!odW&NZ({p(k5fqrjZ`SL|y+%)`vUO!E)1?%2aL%#xRu~w)N zikPnJ1L(H{FVJ0<@j|)#B4Y(#sL7;xKu{?m!o-SiQX(gZp>76tOF> z92bdS)-wZou%0h17-6S4N;H4cb07TC%(?G}s4qy#jOM~UALpagRlAPVUsKNgaSEe8 zN;%8%ub1Pmn&SiP>W9yj-k)bMy97sb{@Zg;U^_i^a6-bYK@&%EBy1$?>Eq#D^4v5+CM>Te1%ihFesYZ3a1SO@-)ErT6{y_ZdP|E{*Y4V~huSG}v<<;8%N3#U!^O=+ zv-DiWX_f-KX3e{)dG>iW_26=BSP$vGz`2hB6#1Y1fgF-LG+D-uAgJ)a!gzFge8^-qaT`XSD}-}uhg$d zQcas~n{6Ybl_LPQSJeG#X^Bzdz&LDIbzVzEH_UCZEL=x%-T!t*xaqs6(JNP-ntovw z^^Q851_PBZ+$upt;+OQJar$KF$LpC+dupAFnnW?*?Sa3T@A!U; z*Bh8T3*+<`Y)F6nhVv)$coT&|_kAqKzg~{C@!ab3vLYS{kMoFnWIW(sk8RMS>5a{X zUwiezOZ0lM+)D}kgXabKCbG#BFA`Zh0@{vGJ-o(iO^LZSyMv}^(+4RrbRf*HF?mi``n75H zQ8LEyJW^#nDw=5}UPsYG{_Q!~5iT7V`{;LfHT&=gZjTkm*THg4?A{1bx`$D*?1(V# z?Dsl!YNy$S&bs>=C^GRnqBr@!jy=wB>GIfxQ%Yjmj2;uNs>;{Fa`y#jJ2kuxL2df< zw)fpG!hB-AoQ@?|o7draWZ_8)@xFdj0R4*! z!=-~QpZMVJBfVbkre3Q1{*&dZ)}G%Q>R&hdj|}|DUQo6%j@PkcwC4Fv4m9Bl4LLT=S><`5o{lS6M%zI--`syv}z3!@xcwqL=M{`HGI ziu;?m7wr)Z``xX)uZwe8KbC93x;MV`^V?YJ^b_-4_-6n5QKXT(Z~uDBhd1BO3Xp!J zrC!ed0reAF6j3!%ukrwTZTme;dh_*PZt3-Dk0%dk12t?nma{&*^`)0b6?cWp4ToE` zaswM`luyaJ%H1Ix58;Y(@gX?_G`xir3l8|E^PJg zztJ;$T8DMpm-VC>Q}5eIG44Do^4ngi=ig2HNxAJ!sMtQ!c`5Z&7l4o%ULhpvNo7<<#5v5_^^#I znv-T%{`E;%7B0QHY{>qhIWK;q*N5e-2XCvOkBRziG+yXEzN3aD z>bWg|o<*hMQvGj>Ux`n7^N?Ooma~4mb?eFVYEm&%H(yp>I!g`Km3_D!G2`d!^<+8g$J+{eRyNN@m(rsBqAyTKrDG7NuY9*{XH%*4?+K-;H+}zc zBsGF?bS27tf+kml!cPUgXuhgF%WgF#^zB;(`;|WC-A@vt2zrGEs2T@S z+-j=(KACi?4d*Y8%EG6(Yb*ZB;y501>Z1{-lH>HPi~L*Lw&Fa++v=o4usV@l*fzYa zPJG5W!CN4hv@z1cV^1-UvXpG-&yICb&N*&l8@vThlyvZySLkZk-(S9>YawbBn zvg5vDFxSZCx+>=c6K-{m(bulRo#p~oa^l8KLlV$7cnvR9;oQID^Tt*xxh6SoqpHlv;Ngl0gU*lL?N?#7R zzNv{G`Y?Tk70fZd&Z~~BI_Xa5)MeULW@mkVBOPj@$Fa0?ptPaus7YB06n=I6S*Pmc zlj_EKBAxeNz3$pd1AUpLaK&;*W&OWqV_)@~Xp`Eq{mCAVFFT#=*Hl~jSJgILkJncG zCsR0q>X(}IA$-{(P<+15F=WA8K+OBKop!-%VI1kt0#x6K=~UUV!5mZBx&G3g>pR|7 z76!-9+sckRp7Oe=PpH39lWS(XQaIdq;qCFXl^AzTu1^f7y89HrzdWiBSG1qFuRpG~ z|EIJ(mhsiL{wGs-{_+EtspEA$by3gowNxeSKzUIN%U2l>bUvkluk%>fW3~0CgXqWm zyggR>RW}~8FG2a4_bE;E=|bsvyz@L%sC6gi&sq=sBn^;kQdPV7I^LJ;WHAZle<}}# zJ2fmo^|4qd`>M8v5a?-J`bgHXxkGIWE#rS>Y)l>00{aus4x|sVdzK&tr@z!4) zC$nE|U0<-_h;`}7YB%bi1be+F>ouN8dUH8Fk#q{Ai;+J9S;+9OsRewsTQv>yL^%Ic zXd~E;C-b!&@4o)YJPyF=Z)}f`1x|+c_e9R$f$SH^|M;Z35o=vrKy1%W9uE_|)u)u%80{+S_`T6tzFW5)C#^c!+IaTk$Mf)22h6M}@oZ1#J z+LKc|eQWFLjJ`*0S@Prxr!MP<%I*#cZ{Avw`4KzWqP z4&`yqucWiSJduB8<$#X&=k#IuJJ#?!z80u%8dKh3j_(y1v2%H&t#SWv^5h7W`-;J6%jNn+sO$7P&~>mZ&^56?A0N!M^D)&qhtI9fmURvGTqCas zYpIj-II(^f_iK7Jl&>l8aJ^cU@FxXWq*I+91A}&&A9Cn zx154%`nslLp*!c{V-c4T$BAKq>eQ!{KWmaltJ>E% z)|S$j1FmmsqK7_AUttAvjIZ;mBdboj(>ZmSc9q##pWjG_n&@#X?Hnj==sIdrmI8%e zU4KrC>g1E^#(5&0_g}s4+DZd`nWb>Wa!2{=zh+}DQ=*MUn~3uN^1d%S{g>?_UVBw- zb0W4a;`P+!zP^6Z|6h|ngfG4I;rlwKu4SikdW(6#w$rYz)8)SsKIK0#ohrNTV2-Km zTz_fL`JcCyg~9RjwzA`nr@Sue6Y6i&l4GN?moruFOTZO z740YP>yNAL|0ykxWqh@*|H%}dzx=>uimpf8KUUXQ7xfJ5UX`!|*03#B6+bE-Kpf1YaB zR^96%n^e^+5<>B^lMnVx8=(F4Na}$NTz8$GXy~ zuEIUuHaivL_mx*q#q0EUP5$a)?!)*xhHb}Ne{r15ezkRd!Gpnd^r*|Qt9!l1dB@%YzS^y0uSM`N23z+BdtC4_AHO3{ z=4(0Lef^W!cE>Nr88MRusEs_)+sPAo+$WIj0{Q#Og+_VyWtEdlCZ^$uoPTR-)#Kgv z)l`2v|3tV3F~8KtH5p+T7Wgk%z+c%VKY#xJ1^bBCSe?Fzcz#XxPqusTnp~@Ku3-Vg z0;i@0jP~TzOxN1JDx>dF+ZH`J!mG>rp|X2KlJgjYuVYwtJo|rjm3pV*HPw}^PULVY z|5Diz^D^nHFHhvp`I-Ey;`Cuv-DSdw-G45VAkvAZ%+7%-iw&$XLZlh$6wX|`MQHipQ?sk z-Q(-R7JQw-=tTLP3Fde@rn)*;_q<^B3g)<~*e00pPNrk3n(w)e(qALjji-_=PlUXw zx3lrTVFAMeh6M}@7#6523zQ&Wx?ehTO7`Jx7lbL%#Ne0O_=v8O)Q`5^BJyPYSguMvzscrYd7RyxZ5mxv zAUiDiFpSx1B59f>-(t%(rN~Zup(9H<2qM{(ZOLy6q{nLg-)03aGI3VD{^W7BlRX)oEBHI!=5EOoltn38Ht-! zY)W@n6(2cU2`Uo5q-XhEU#;24p7vj;4aUPvYziPw=a%>Q*9x+PqCXZ}>j z#nS4B&Q(HJ??K4UEZ4;DP2lT@%VgDIa>|$!WcOtzsu!WtGkkcM@_jTeAJjjlK6S=9 zk~Hy-M@CTOFE}=I|JeLR2ihm6_A5gx$W>oS3aqDQ`BBlIN4dg{w@*{$KyrI!`Vy1m2cMH4keIN!2d6T3I5<{WvH!#~l@$;bgN zIm>0S+f4E1e2dj$c351+<7Jn_k`-rmnd4&n>N_yWp=DjwwrTckb8(U*!IGPY z+@E8~c3WAJ)+0{7j-ruaNl<6|^Ivi0xKPf= zdyszQVgT8I+PQ3O4_QN{PAh+T1H01V{mwrYKlgUim1IyjIxY&oELViWPomA@vY4%C ze$x}trdiSCjVg4xP+P?2nQgf;6}U{RJl>uyr`f6IO-3{9O0=cA?39(Ia=`i(jjE_0 z^-H)NUcVt+iaG7schX1yew6Y6IoeV=W4R&}egd|`vF5BiIlDq@?96gl3eXmBL|Cj} zWUNO&YG1c?ZKT-mz|Eo3l20~GpL|`ov~onx-?m;^bi*1=LCT|~AIk;Rl-+>(O)$^3 z(;nGdB4i0b8ubI7}dDp{KmZ|)gqk`zWApJe;N}n%WwvdMsuc<7MWBamPm3n?F#82rQYqdLN?}QfhC`s@xciiTS{qpV4?q2sr zhgKOJ6X`+P=;iERK@TebiXK9t!@(th(?d%1PLJ~CAp-|dz-9Xhn)k&l&)yv_4x@O!~(tRA4p9t)eomv1i zZQ^!C{br3;GabM$RBovsnw;+4pDJ0qUg>9)L9wA3 zzfc!Kn%VQvKMPho^2)~1)LT)9{Gr>hk2E5F_PN6$<4?j6igbXImcOL{r`C#A+ZiVIw(7$@#0@em@5{=*ZJ zc(c`-Y0g4lmTok?(?4RGclzt^Ly{+jN%y|cd*%G|{^)iPeKvCFhADPnxgr#PQs-Dr zb90=^uogXLWG{VtPWe7qN5>MB1F4OszHkF@4xs)t?emuQ$?-XA?onm@%YOVn+5f-p zB4Cu7wC7|~z4Im0A9JGqUsHSNuZwNLTfM*de=x_0#~+LRjfjNn&&{Yes2s-liTI+0 zmwexJM05wLGs*EarD$^fsi|_VGG~G6tYoX%g=f+E7{)L=vhq-eI!wuSr!YCdlx8m& zXU@dX6&?c=6uPuZ7J)_r(v!wv4onY|L_J6cBVAzx!HMZwHY0Gle*5Qn+oxWbejNwF z>H3{c&i=mBHP2p9fH9{kq--PtImhHPUFp$8zKka}bBn8!t_7K4lBkD~u54}3b`y5FeT~ctoUZR= z4Z5>^&;1x7RUN16PMw_neWq)&+3B2TcVv$@+iuEf7*&N+GqS7L*eR=6T=bD<^4eZe4Md0 zED($ZqEQg2Ur-y*?ShH#L_J1d#`XXE(mU9)E0$UPK8Hc$Gqg|fa=k!tipSIchC8t= zV3Z#G&fw` zTA&=k^EgL&q4)F0Z1@pJaerL@?E9bC^G2A|Q~LOs#``-A#gs6`Val0uAIx%1?B1l( z+ZBaYdYddQ54XSB^q!%^Zna`KGBMjKyQlMwm$NN}`8?|{F-Z%dHs|+YDxC7n64T+7 zd4BXx5zX~G3($N&OpR0K{L!R+dX`CZ|L8e0y~{=S`hWvU z`O?p;D9y-`J~Y0=az!ZoRHl!rNjlBko|GrsMD>)jebt8{Lb%56@wI^XoF<~!JKs>A zA-FyyO~=lE?Z=lse)ug;L)wPmkL7fX=={}(F?h{(uFR8zDybRMsdRhKU(Z+&SkEn= zFS_8WKJ#8@T~vKTB)y#dgV!@DCnvU`(7(17=Z{i9fNjQc8r$P%0r7c9^5Vex$@#>> zKKmxkn80bs`JUzaE2%<$vIUWyB;&qJZ(;R+P7mL{)t7R(;+FR7X+hF{sJ2fsK28%E zn-k0eVtLP4?tlIzseb!g?~h6P``qPO+I3L+W+9bXu8G~7DwcQ83{8{wjeyqNNx_W! zyCbjToj`e8@2~%#)bk}HIhUQv{40~wx$J^DhK~()OJUYUxWUG699K09oG9gm^9*nG zSHby8^rw9)2bGlt_UEv~9Ns56pQ8_#BPj0ME;f}>~;DV<{gr5o*2{t({>c;Sgu`PWTLw?V8pbzJjwNiS#r1T2O!$&B?R zXxz)G4uvHYVpL2Uv(R3#HYFyhex?bSaEmuYM7_#Z1lH^0r~l|Us$KS*953som$QGc zdZj0N>s5jPczh+IG_YQ4UYxl2$|i+0#H2VHf1*(+y<8FFr&7IQY{hhpIDcn-5b;lY zvgunr{%T3XX^P|c^>X(27k?~X&$nbLukU!h51n_F_kEN8{S6BHiakA=-hIOx|8hK( zuPArvQXAh;(Ab7J+29Tuly={G@>}JZ}oEa_qGEq z-jN~~Sg|gLx*Uv2tZV5Uu^rl0=0Cq|x}mwW_2#0O6)pA+FV#APqz^r3U^(l-TW@`o zg<;%7t)edF2#?aEw&wY0>M8vn(uMz5(@lNHk7T4jrzsuB`{c*xko>>y#Cm1&HQwdL zSHA60&s6%^_Lu1KoZ?hlhDdrj`+Mh;iuu-8okHh|&+QICFLE(};`7yiX|nwH{ErHA z|6W1|!qIUp@yl{WDExTq<(+?h=_Kk?bZuZe^*x%jyXo!q+HjOy&*|mt@2yWoJBf81 zogQA8aj#Fva@K>l-uigkN7N+}Cs6sO_vj*_2d`&z zd%gR5HHM$4=f(hfQrsW?K4Z?~Yg;OHGyTu`OD`usa;T4$>R5e~81MUGDIS)^+6#Hv zVlO?SR{OUXh5P32hlXtGa+n^CD~|Qh%h{jf)bya0;aDW9;ibpsAoTbq`MRwKhIiP@ z@vt6xIs0>@njXrEVc9GcG!fG!dQD(^?Aj2qcGSMyS2-TmLoa84j#ASj1+V+NWENJU z$Mzuf82S7Qw|@F^kBuA;>!FvkKS!zQp+3rFp`wSWZ=AW3 zADGtn)^!{Y>!FvkzfKP|pH!-ice^0153J9>QK{34wq&g3_*fskoc(qB_|l}`U^0y6 z#C9R-hQRt{CT}17a@&D4g-3C$k6zCHI(;g)kET^Q0u=jO)bEJ^RP8s=pmv=!B^i$w zk{+rq*fCt4SwQS>ZAX5g^oapvd)lY85y$iP+`Xh#bZ$N!qB!!Wqx5n`j2~JWJ<(~$ zoAJ0U!NSLdPAt`K%f{VGl0#hz7carnL3ks+(2DhiaRANvq6(Goo07}D`#02%)4CbF zt~hq3gHyZpKd{L49CvW&zA6-VS1hMvM5hfWs>|qUgNg}wSKpLcV8&|l>T>?$&Bd8$ zBxcK0?4Z79jo}n|PND2{Rh+LO#^G;2P~IkgMjwt|PU&Pg-xkoZw8i&@L51sH9lW^AsU5}#13>pY5m9=#s)KiN{O0_2Z~ zN5Z9sTf%P3k^cUd?Myj}@(0WH_7w6*oF!ZNxBz{|h^Ae8zaF3bA0OXNTUjJ_80WvC4tpXO`uz4O3kA_72c>XpeL&8$6V5F^z8|+`^(MHi(Cw# zyya^=>qyekBZr#r$))4Ssb_>qdb#S0Ir2WfbH#=dbavZHOs{=+1=c6$XzQzgT+a7T|zP74v-ab?>s(oi~x$&QW3y9^Z=#6?ItA6PBjm{NkCsX@#JLfOcZGG{+q+2ts19CqW|CH zbMo$q=_1|heILp1D@FDRl{#O&`vJPjXXdoSQl@*0>AfU!WRr&YWw|00e!RXQw_H8o45Yt7Sf8q)FbI)#-_Qdg@GF&e?fA#vo`=Q}I+SU8=Cj3BSL*(cT zYKK{_2!$U(AMK{yBjI#Vi>toaP)YH8=TK~awn0yS{alKEW!k@uUVB&>`1zsXs*UO^2v z9O*&!V!0v|egf(dCtJtyct3ZbI%KHO0Z*ofr-hq%WD zsb9=vgyNRchW;mif*j`;^*{AjJVzfE|IcBF=Zoiw`+O{)E5;@6^Km5OV_7C{DQx~< z+~;$|xG5|?M%?FPS*G8L=ZJB!oX;2I;(hj`t?0;~oUicsT=wTJ%f)lZkL8r693RWb zU+>7zmkV?b`E%U7rEvH>-m(s~r6MKD>3DyRj%7#Z*Osd+ERyT}SjKYR)>IcUT;8Ya z<$ZBm)40U*`F>24`P%3Befd>YMqyRQRrfr7T)x6#TkDUlOisu73P*o_F#mHnybW{? z9mn`Omi;(9@qga;bsovYb1FNgs`5Z#vcEolmeW?;uTK1&jx`CVs`2WN=j-4t`;%_u z^m4tf{J(m1&3-v7j=MUciFF5uCx+uoCi(}nFUAqf@yF^Iy0+T5zGJ0tZO8LpzV_O- zr4gQC0mA}@1q=%q7BDPeSirD=VFAMeh6M}@7#1)rU|7JgK-DdvUw4L{HPM_zniE8G zzJeK7)E@cbXu}y6IJGUHFE8TNQdtqpg1Aq|iU0GyG51cips|0dSwNikR*rc@R7PR| z<$v0z{4c)Ob$a=PUBhQh=m@dm)aPyuB)y#dJ+rK^Op`YAY81ZLoQt(6Y}s;lKU0z| zE@?ciVva9LD^ta?>0D8-!S8s_2crY%-LIoy=F0hHC66_eE`9&NpNsx_bS|wuPLAID zqWMiMSA@b(Orgu3g9(y&XTXsUF!j!qUXYC?f6^SXoRq_pq{-Vf(SqeNuxJRJsMiji zUeTkPDSFW&<9|-vHfP(eFlp3-lis;5`={%UXbm;3RZe=bTnSY8sghp2as|#W2Q)v5 zzI$G<)7xHpy)yQMNkjY3>V5D3*}D?BsH*mTaDx<#vPH{^vT~^=Tr#vQ5JWH$6x>SF z5e68A8JYn_E5mHD%)(a7CEC#}u@$XMD@(1u)Y7zE&^B94v&}5+|Gekkcjnx~FoWjz z)&KiA{GNL+@45G!XWp~#PsV&s`>>N?UMx4H{%as!eI3Q-G%?bWrZa^bxl#r&zrElW zDxMv)=z>2#jJ&;u$93r*hFLZ&$G;Zi@ z8QE?4Hz(`Trg9liJ{G>`a!n?C+yo$WrI2g~c^k&u&v zNbNZSFD(0Xa!wBWeKKRqx~=fmlj<}lOsCrvKJxcK5PrmWNAlnlGa>!4)qP4G^1Wn0#Ph);t1-(hmJxbf^( z-|df|oW%=4&Ve74@3EZy<$DPKZG%c&DUK2kCfYl*DJQN#0j19eCAX;D;;Ect(k^jtP4S|q;Sy+v8f zrU{gO$j}Bel%82Gg~}yVdN%4>iFRz@DZf(7=hmNE^Ov&kyBqZ?B>cR7Z^yI-J%2#M# zpg8d0eSuzlb80mCQDNFsJ!_M~vpM9;+aDv(v)DDSiMVlF)re^qM2dq=Jx{mnH+1uJ zm3RS$d9vJ)`mbDRu_d{)aVE8^*vyap_2?|OUSIAr9`7YPQLtJ0m2UCtF%Z9^L6PFI zS<^pt+&}XKogd5n%#0@=zr+G3eD&J;JM812%`VEO2XbvkZJN@7wYYLQma;WCKQSUw z{N7~a)BP8BeO>3r@{s(}N(zdd*o}m0f>f{#br$E3iXD|+jGbdyc7(bnzt!KHOSnSSr7uZrdcm4~+)%;BC@P`A{1p?KNrVQYeyDn18DA@63AXx)XkT)QBfWST;h4vRr4Z#1~#(mgLBFcx1ex zC1z${2*(`$UM&ZAeP&(PMSfE~R^115?e%Y;{?M@(36Y?Z+>SRFnXBC@#gk-bmK(YK{#P<@YRJ zU-f*1c;UGjqDOgJ$(I!2VVDQY4XOXC@Sr3{>rCxA6SLgL-cel?CdN0G^dEvx#)}bR zZujOR-#NG2Nje{v`L zKU`jk9=DhKY3bVvfa?RRLhvcCju2b3&rg}Oyw?*tAC{Aws`3AJTflHr`RKYLchqu! z*jHA41uFNiyl`s&jmsvz#~h3=nh9Ob_6omD>_=uqC%;f;=jsA~HD2wl2cL<~A#)FW zcN`@JX_${LXM4ZbHd)O!H%Y^4TnBAEmhJ+XV)S5RV`X9oggP*hy#(I%36{AC}_I@qShaUX{b6#K46=q}@EQ#~wZ3WI6NUyTZ%dX~nQn z<8y~^g6o66Xn$x~_24t7U(4=xln)(i$=P19 ze5&ig=d`{3HsoFZ(@ge{k_^$9Vo3Tcc*9#C;FKa{aSo=zZn3lEs{nn?QTcYz|Is4D|kUX@^ zumT@)d@cGexL%50ixBz6XXd};?Kf2C!*b@q_t1Q35X~6XGpn{49;X{8dl*}es`Zfl zA^63g93l2jN)*dpENjuvOz8BBs2;*{=Ee6q`Kbj6URLv)^4-DpRMR>_%sZ=xZAX{N zM4boA*?+#*i-#6=^lb&e;TQXTa9(AnM2O9o4sb^gThvbH#d2~}HTC0FcNnVieR&9e z(XU5{iEC%?8F5FqkFGQ`M7mMVQ^dS`a&flw5PmpAsPb*i6`|J zSN`PhFJ3o$P7?L?=X>$?+J@QzN+PQ{Lj{Wv{t?Z2i`2| z*J9AhVmG^GRQn=o$=O~>*VL9Pz<7|+u*!0)`ygiI+r19-PnUS)_FUF>=h}Mk`svS!k@f++f^U~#PABa~lLTY&<4hGlLut^c(jK>>a-m0))Q3umQ;zRj2%b5q?>&GX{ z?SIeQ=u7VVMVn&#bw_UM>5gR7)x&A8p^uR?^7olQ;q&hb6LL3@+a%+$5{?&tpGN*! zKI`EVNPkC*aYOhVz9#kXAs0xG6psl!4@M6+{eQgLVEzpnD1)2az9nKjlcNSnmrrax$-kAol{}G3Rm)G=u;mtPpnq_B> zq-Qd;M4c#bLQ(WmsT2(fz9f@OECJaN*~ z@@xNi70XSr?`Gvw=q#2)RVFX4GvVzTfZ|E0eKo1>L|tVx4jc_oJChFUX$RNx(E?&>K06CoD24HLI`!o;OJ!$gI*k@y6Qa?WhuL{#QA73(6x zrma`1#ThA4(4_H^si2!pHPBaKKmK3(ggRqxQtXMpw(F-$cMn-;yeg>gfq1aoN5FjW&BN(aTIBGc<>SHubaKi(nn5&A3b~fM z#FH&&(92OSXRhy11-OBr_VL>VepH^Zp6FQ*w{P2TiTEPpx_`k+8akUth!#SZOEE5) z4$pXJwqvN#TlFYz zy{9p#e?cgwt{z?Nh$wvR#k5Mu<{ zI9wJ-rCn2ilZxb7deAH;4B>P?^NTXvIb8RL;8Wf-T;#s9Y|^og)oVor?dmH8lAa7# zpIl1)7vh6~i(&_bD4rZeGVpv9%J3@tU)sc~54}CT9BK8Dhn5blnRc8~XHYAOB80%-$^d<27$Rq&Lc`ZCfHxC!166Z8pI=Ji({{1m{m;Cq1@xN-U z{`V=xVH`9rYE=S0P~%1UiNSf0`xOVCX*uK8+5Ivpa>Eec7+hH{h029^)QT4rBT})@ z$>YLdkJgwGXx$>EVPwTJZIOQ}hz5hw8iDM|@SW`WSy~*%U=A$j?X{4d%a51A+20N&{5>H<-U)1A+3hV63R_7RYd37Rata)}Vp^77f&uUh0bf zb;(H|s-61G^|=2Qoi+T9|6L8J^Bg*yr1eJ}5OQ5<`SFd#w%58A*36F(UmqL!`TI2` zBGyzH_xG_}*JK*z^m-=R`eqEaWnjgo@oz!_W;)3U4Vkj9uZwTb3>(fLvy&StujLvq zy}yXwAAROmpZrqsI(mu?L+eh3XkJTh*lOb>mhl03-l8#1p$uH`cPg)8INyp)0zmmg zAYP5{oRagpSot-*N5&|hn+jcS*jjjno@bAx#8}8IKUMpcrnL^u>%$HW#FbdyOd}X=*Ta;}S zvCOKZlaz+lbWiz;5l5{)s`*vi>ESZnbNb`OaKc$#G^E8-;Q=JR++a-)Vf2 z;>*#DGpc+1T$lU7`YP-ChIMc__oM07;rQF|?thmC)O4NEE_k{wJ3Cz5w#40P{V`+9 zjoC6(!#Bz`mh0M4(lyri8OfKHi}This=aTLH5}pcmdAOB8Ko_*$Np2|e+)QL{zL0P zil9HSG8ZI*jJx5cR2l?IP-h{o%FkCtcvRmcnoONa2t(qp>i@I;G2eU z^`!RS&bacTVf+f~Z;d8rdn`}K?lLr6#FmCyv)l<2dn*noDIDYQq~|7+xTyIxMADEQ=beGde6nva|9%bV;X`%D2HpSr z^;9%- zt`&6{nF+qX(>2a(OR;smiAYd?*dWdl_fwnewsGm^(P+ z@#ikXqqyX{;>pc#dEpIuCPRGas>`Jqmwq-O8jcuvOyNU`LSXT#g9UGu%pkLBd1YHIQOi~Gm* zy7yE15QefJinlD6LgiA6e|`6d(}=3|qG{-d36>wlCxnY1C)+Dum@_$r>s!o|fIQ82R<{cR!VZ0N2CHknd9dM(vfl%nyYN z+6*~((>%_@sc(kNK2vV|=f4hc6x;fEJXojV&T)9LG{sj7Fq$Yac$NI8{-O%_uewj^ zSZzkkiq|JtOv7p<>8pZ+uQg42;Bu-uUPud+^EQe;cWMeD`JSD4 zU&dO*C$SuAeJiX_JPGZI)>wOp%JVH}2$9>4+Rs8fhI9~v&gp(}aPM*<{z%4m=|bE* zT!>roBR@wk<=c~m7GRM;w;isUPsi9Q$`+tMgP z9RFv8=zmIcan-OE;?~z9Ma6)YBJ#Lsv9`60K&m5!WqlE7r%wh|4cL zTNFInK`egc0+D)IS8>Pm9^#^hmaxnfejSG@n=6tVBNnPQ9k zF%f^;%ffl;zeI=Puf&dT8i&2Oqg~jhxBG^*IH@Qs<;uBX^DbN)mfq)>M(2%AZPab# z%to`j?QC@N!Al!Ix#!WwZ;m^$$(euL*M!0!O*6SJa~i^n<4Hc+M`Y@XCuGZail&Gr(tXn_zoQLL|8WiI z;Y0IrD9`77p9uYxaQZ9XlHdR9rmlIo|4F^5VMx#F|ABb0z4|W8_NBn{-nR0hgm9(O-_rxVE)Wj?={S4i|gwydY)P zMNwk?mdp{ATWZejVl4NTeMZz@%5vR(Yd@syfi$OtrlaXmh>az%xiP&YJAX2rsLs+$ zG>Bu?(Bwo&H|qTUj!M*si|>2mj`jJsT#x-G z77Ed4H|lfAVPf*~Fflj3kyw%5Slm9NiSYDpCeEB4A%6d;g~(5e7T%F3iOSbc7xv^% zqVpL&#ml=;`GdZ>extUp;`;c*h3dD|zCsmIlq0+brc^D!qxe1JuG7l99yp!DScV^R z8kW;Ls`1s+>A@U(@i!EBFErZ#bAx&js9sE5NVian-0y{=1gg9ORbBxV3Fg>M=v7>dE zXc8YLW*3Bs{D;Ft>gF(U$*GOR$lONa*H;>e8%}F1=H1a)#I(6gGcdn+>FmVHc2#F zPsX@nm}usc(>tmed_|fKd-o&_OLo|cOFWKD2hLbZ^0;XqcY3c9;QVBCG6Dc50U#cF zJDBX2KH4{G$uS3<2nK2By%uc*{jNUerOx{O)H^m%{h17gH=kNu1B+b-NOZt!fm@;Rf^CG|1yBx-bkcXXm&~}7h#6MWO8O?LY z2A|J`*TtsimbTq~=ZFf@D;c_n;mUF;R4&&22C@3Nh&C0(jLBeI58`{3R}FZPNdPE) z=;NaCcONgNzjo546BdtXizc%)#EbOJa#QTPS^IZ-d)yPeAeG7o?4{XDZiHDLiX3Q>V?{w}Qf-4D({SA@yG+69;xsrIm@M z*YfZvFv59bI9VC11$<-PUdwp47#uqM7IyjK&Z*@m-oic_;n-a0a<8@Dsc$j!*mc`Q58$=h8D73V*ulaw*0o6SJ$q%Z9T?#@OV3uZ|>~;7r@$ zPQ=!mIJDS!vjPqgPagj=++|k||4!c%D4!%ycvJe~e24T*&y+8b9fRuo^i1CdYnPIn zf0ZMg_Ac|7R=AFJV1 zSr1;L=k?9VU%EV&{bl{=a<&ho9~o~bj7;6oyDE>^5ux={{>ZN%|GI9^AV{l_$MetX3mwtPhX-~ZN)`M4E>!SI+CV8e_+tzO3)x(s-Ig6>y>k4c$ z>?r6;85~Ru!2F`G4i~EX#7_<1S+J*aECC=pF4NTYTeBNq^Tiz-C#8`+8M=qzkL6OR zT$mr0kfk{D@@aSR0^iQeS>+(0l?xD@f3z7;7sQ&=byN`6; z;*=>XzdY_(oAEWr-!P%e*`9xYLUw=5^YnOSCk8yX{Qi3QyL`%syywb?w`X?^J%kBe z&i3qYy33J-B?%7N%mLjf7?-9e-_N)3h_Q$M{pp9EiT`N++WXia=Ap~kzHS~E2On3A zGm{NEYQ3SV9z6PNi%dBA?(@vv9Dg|I@_O)aXP40C?Ouyw%J3njU&=pX$As3)konUW zJjn4Dod*}?dC<4jr@)!#MBJozRDCS3hyN!euV{PjqW)*I`|Q6i zXM2nPDRxiJ1iJ?_6|N~kqeyDQmY6YE9@%Vsq4LSd4y}*MTP~VBt$NTO1`mIJ#d7As z_t1QdE!3Ej%BQ9td}iPE{kEms$F0%%u$+1DJv5&rr*|B)v4&SsPH6p9q`q=zhbDO# zxi$=kmo8`f(0s7qv5*4M;H2tDI70JTIn^<9X6B=7*gxi@%h^6OpR9~Dzj`d?aT)lK zNdU;7_}<6Lb^#rl^81kG*O1*^Bd-ddP}QQ{74#1by+{4ZESEy%GB_>4h9gANurC~r z6im(G86W(Ln$Pct|KuL~-vrN8mnp}DnpeACa5sH()+eJ{IUj5CJGU+A{l@r;<@Anf z$bX;bGNUzY)qK7z*ZR8ytsBq0?9{lN@@vlTI{Inp0QuV){<2*4lb*?6sb)-eNi0B5 zYL4uyDk#ttpvH&jJnQeL-$*)8_nrFnko(~D2QEFE`yS{XhMEb>@vp_u`U_wJ&JRh< zx4ZHj1Kh>VTqn)qcT7lhyIjUDREg-NlHXO}%K2-R#s^km@wiNj3=<2Rb)hLa;)(71 z9%=l*7LE=ilBO=XtSTn;rZ%F-UFs}E$%hO?E~Ym!lEK&^E1{&=o$D+pNN`doRzV^n z57)nE!FA@Bl5f=)tZMOFapt-U_k^u^!C>XT)+MhOzszEfa~!6m$fH>dH&tFW_24!7 zvR1i2G;2#!#Vn>SdA)e`E}^~j%w-yevsJjUzRI1}c%B10z1{!a@80{`O*wHhlcIP| zF-(`UJ?7;Uqw6Z-qt?kgoCL!Y627Fo0Joz5*JQ4`ib86CyiqUo3 zyTESHlb@>jMO6r1qYJ{t2Qm9<4JT&i>6KvFcYn8@B52x5`!bRnd)xBTK z8vGvXgL$xAp&%cvJgn!}XsqP>YP=a;Y}Jd-hdvm-@T0Nm_RpTZ+RR8P-ozl@uv|K- zT!>HTb8Koe)8~tjljIjcHTwUmU0u&d@=aZCHOLz@@K4Y{1tK+-S3J%Wh!e+q{T}Gu z2HDZoKwbHn?hA*FE)Vwqk$e-(y#~7m4gB32C$p#$idjFBe7YRL^-tZzt6^Vdu0Ts_mG2zT~3rNmkv3e>Kjde7`T zz8n8Rt^Pw@uKG)3_YNA-yP~%!Q~Zk=Z~dJSu%m&h=*z>znif+xtOB3j3)}p<_1iOl z;dxY44WoJ~%ki(pWO?i^FIK}kY=i7BIto*^3~kh+FY%%gGYoHsDmTbM(x;(Q`Y*Im z>)Vz1UBoj1AUEil>aps0!0XO6XT9axaTmnW7=DEbUC#DtjvS}mCa=7e8do#>l%j29 z4hLBJgJUOH!!yu&hl>wvdGM619htqS8a@%vbHJA6>_6XSJTmq?pzROPGf?bt(`llZ zpO!O`<^URRmf^l_pv^xjidJ0bSMoMFLd45=bT5U&oZmozV-*p@rlI{5A}po z+4eU=S-z*Hr_peq4ErA_UJrQk(~>*?*mIEmr#tnRuv|KzTy+1*=QIrf@M}*wruI_e|Id zT@Nhxd2Bvd{kQgismf5(ZwB;DCIOJ~SvyCX>^gL4wk__-&JXbhkM!PIc$?+)j%tVp zS4e#4de=I?+0RJjQ**18j~*^@yQ0OoL6iI5IcU={lpm9!31<{PST2RiCDV~7&uFLZ zCNoeUq`iq0f>a|NJgyL@ZFnZiuk`jR{a&i0aM?}&^RxV*o)@X#dcNE6T7w4uzi6NW z5nC;PRo-gdN00y1zF?!Msf z{@cV?4W5ytb(|>xs;3@F^RDkx7p|!i*_K(5ynZQ{Pwj)C+-FfRsj!f9fRZ23!Pm2QCKUfF1zVcP{}j#Y)iH!^;4g zv>p#60KI`kAPMLLBm;ec6d)C#NzpXF8HxMVz$joeUO83V=d@`k&nZ)#tAPJOH)p zi-8hgJTL($1t^hC0YN z-U3zvZv*cDtAN$O8sJ^vJ>Y%dU%&^zT3{Wp9{3RW2-pB@1U?2f0h@tOfKP!fz*b-z zupOuYb^tqp&w$T?FMuzBuYg^^*T6Txx4?J6Zs2=h53m>b0oVup2>b;64EzH83hW1d z0}cSc1AhPqfkVKb0A;*kKqH_r&;)1-Gy`a_rU>8|pgGV2z?3u*1+)Zcf30ZXIN*4o z6@achaUyUMa58``ltdfg6yQ{#Er6{~#p%EqKn!pua2C)Gpb75h0Otbjfet`Npc8N& zKzm1B0N8*Ffmon3&;{rU(8TKpfBm=m}f`Tnh98E(0)3BI1Drpf`{RBmsSZ zWS}pQ0;B@{fGdFh04+io0HgyMz(8OSkO^b~g8|y#YA7%a7!F(sTm_5(Mgms@qkz$X z9T)>-137>L$OZC%e835e1;zmdKq24)+&~d<4d4O1Krujjo{a}40Hwf0U=naGa2;?x zFd4W3CWc_upC$cyaBukyalWT-Ui+QRspMlHNd;Td%*j^ zzkm;bwZJ-HJ@6s$5wHQ+2z(4|0yYDm0G|R|fUUqbU^`F)>;QHGp8=l(UjSbMUje&- zuYqrXZ-MWC-N5(29$+u<1F#SH5%>xC8TbYG71$5_1{?r>2mSyK0*8P<0qT?q0~!I1 zfhIsxpcxPjL;%MC&4Cs`BoGC(1dauwf#ZPVfmXl?z=^;~z{x;spbc;efUVO+Ti`U{ zbl?mi1~?Nq3up(>gxhm~bAk3i2cRR+2{;cpAGiRp0T%+XKxd!}&=u$gTm*CnE(YR& z9zajv5&+vNi(bHGz~w+ZkO1@s5`iS350DJdX5uM8D$ozO0_YE<0Rw<^AOjc(3<5HN zEMPD&1Q-eo1L(lLD}k$k5x_`*=EIEwMgw+W43G`v01hA*$OEwDpl||XfpI_qPzbmH zH&6sz19$*0Pz;m+0hPdfU;*$nun>3#cotX$Q~`^D=YZ#d7l0Rmmw=anYG4Vl6nF)A6?hF;2D}a| z2UY-Y0B-_s0V{#Gfp>saz-nL(@GkHk@ILS_-~(VSunt%cd;rxTegb|5 zegS?3_5;5G2Y}y!KY)Y4A>dDd28zRgMnGer3D6X12806KL;)>tJ@B5)FLGSC`m1Dpb!3bX~VZK9x!EzbaAfHQ%!fOf#yz&XIVKzpDA&=J7a z=i)rzeBc7W23!bGKTT(#3(ytl23!Pm2QCKUfF3|k;1b|cpcil%a5)eUBmljEL?8+1 z10(}|0qVa`1^NM30R4e9U;u!vKt%>H5Eukx0$BjIS0o)1P1(X9bfxCfwfO~=afct?5 zfLXwUz(c@nU=A=Bm zfaif1fER(6fR}-4U2{;Y~ zp*oI?OFVedam^KY+Pv^ise$MT&&}B zzHv&Gf_%FSSLRWp@zBS^Iy@XM?ikS`|AE`)-xNi8Ak3)%@nE?WDiP!g}$0_}cV&N`@3(qqqZz6!E06m-P$CKeV`A;~S=4iWjq}-a} zL;B5!!{>0`JyKo`-~DqmP=Nqf(~HWC(+b52ju-q)caB?;=0~a>zpuL2@O=0h(DO6W zD}_rF^UiuE8S5X9(y$%>f28-L<<61%&)+rVXRL{adtDk(>m$=1x7J4j%_H7=-M*J= zHrl`JW;#f5o%a1?x$cj-sfn+`fpfsj$|=`UXe%FMjF7%n`Luq*$|q3$dEE((?@#X2 z>pB|8AVYjwJ{Kb(+G& z15|HiImuLGtvCAW&prxec$xig{iIbNdcAq{f^d<4=$X!8C!Fy|Iu$lB6i(zn%cW4c zSpAo$!VXCz8eZciwf#_``CltM7KV$HTin)ocGL4l@$YB&-qT;7v7N z#4fVxp%xFkA5;C~$yaZG;RPRxHBZhuh&f$}rTn<%Z5?n&QjUPXBs<-%${M(^@BEa!0I zJcI9e^@z-0{a*Ey-Qv4y*YMn+fnXX?>m$px`iNdHBX=Imoqp5Zw_P}p;~L#*e?*q+ zeq~@&JbU&;o2-%fDkfNPfQ?%*c(qx4JZQr$o4)~mY? z`6<084Tnp^d{}OZeYb#oh=ln@8Sd==a`;as0igczm`B3p{I8m1^tq3}tcL8i#JrKc z?w$poolXD17(Bv!azpCB2K3+GY_R_R#eV{HDW^*KHzXD zea;#WU=8QD-U_kB)FrRi{!8XrWqn+EnAS+kRIq9}8;g|_#@n3* z_AyShwkFC&)5iQU<{R^TXueI~+|}vQGrqgSLKgqjCI3r&`-}&7gJ>E2V4fA=N$Dv8 zsLKr9`DD@SXRT^KYub!s=p7?`G2Up(_3wDUI_w7uKg|vF2iOZ8*dR3@FUJ7nKb@Db z9R92BliSq(Wq!k6u*UyD?W6GfCKO)q>D+!aXO0ZHaSE<1mqO(duzduf+HS@Uf8JvJ z00b^hsWU!S(?v}PUga-^i?x%gUY`0%r@h(Zsn%!AMWyyD%MDlkS8Myx*M6==MdgwI zqE$b7{;+%r=KU^wZ2tacWn>Q_PH$)Dwev!*at_ z|21H|skLsdHZ#3GO7%^O5#%kmugMqAzvV>j!B1;&uSKpDshRadWKtp~OSdARt_#XJJ2I>Er z24e7oxxQP4dP&*Re$n$Al`VUEdD|?CD{6f%?)A|1@$a5%`eyn)tL&^tj&Hj)Ios3z zH))BP#;M2t{egK4VQj~1ycvTV^Be{qsz2mMnQ2e^v~Pkv$r1p%9|s%{@VQad&S>#u z+s-kA?rQNh*^#084b?kYE``daj(vK38``LP8ofNUo(@$!)^&SM({}6y*RTH6XR)zN+%5t_P2Yzk7GV8{LM-={#7@{_{N)k1hdt#J_26zvRHNEu;`5w- z$or;4ukJU}5;bWIK4C(av%Pr^4Mwea_%ycJp>&m8KwFJk68?#7eph*FX+55@!WIoFwICifDT zbW3el?y3imq_4WIAOG!z+3XMNLzlCCAbljdJ)V-HV(gsm8SFBH3jvqwRTQM^r)Xtp z{lwh3Y&K4E%4dI>mo8`fK)lQy?-dr-biBVFJkGoB>H$k*wy9HaxMq#|QVaf2Uv;Z3V#PW=%bKEjj7e z^Iq@&@v-zR8Rn(S4O^_$FwWJp4utiS!>M|GkEfc&LrYOAaJYwp@RC+vY6AE0H-(l9?=&h`n} zsNr~>M&G*)z0Lg+hGxRD3}Amt*M#T*4>@GuMTmwzImL-Dm%GIosFve@IdSEXx4)x9Hu_zx(=!1|$@A+xir{%l_(e zwy))HW(mgbT<-C9o9d}Ux*7f& z>4NI}EN6fDUd#W4j8v~}a4H?Cg2PrYglfE5h8ydl^!?C!`1QE$mp?cA>9On&>p_>Z zeJviyK(oh9yuvZjXm6-`5dX5~OZvD3x!LC7-#dM^br&r!l!pALaZ8q)V&9F;?w z{OssuRUgqGSoINzN5zyTkNvuM)-5^@miq{p4|Vat?!y))DvwR;gY%dLo=d8Bz46wv z=`V7`pzxt~JIm|G!>^0XZ0z8Nk1C*8il2e{b#*uY)BhWB-|A~1ne~nTuK)D#X^)>r zbJPOqf#L-9w>Jf%0E$&4YXXprGIuKHNfrT+A$N4Q^#9fO0@;!M|Ef{z@A)74(=m;S zEN_2|+|Os%ye8ttZB-+7b&V8X##FqW(|h!FRf`RcQMgb#X1T6MI!vDCxT8px<14-LP0jalPiJ}f^nKD4bl zrWxdx6iC`|MCCOr1h1N&kzz~wU6-}rbM?$Ew8;+)^J2Ln^ zIWm6K)nuyFJhFBb++?27n?lzo6MDR#GUtqgDNKd(e<}rZIotbq_9;bs0>=?x>$n2U z1}rM!%*S|k`{S@oVCZxnkGX?+4z&G>^W7z~m#nYDTU_FC*vuW#)nB5fyXE*DWa^3! zRed7GaS3mp+Hcu}Fg-r7ocZ(J_d5G?J)$%RD^|?GB>E@Sr<38HAqleCq<;;ukwfLps^b04>IW-ps%Is)V?5Ol&oYugy z!^sm&kJR5WZENt~v3FdgaBWT9u=b;2qxIjxa^}zXdi@UkEZL>+1XH?fCh~9F) zM2;_U+k*d&iUZMN$@QylO?d0wG`*Z-IrHaxt>1xqK(Ra9U0_S;-1!IytNF*S5PU1E zjur3b-gIbc+(SQ|Z`K<*-(@-T%Y5TJ6#f(oba{RGAjHwWpx!bsRTwFkpcAskJLH^rlO!Bd z>s@O#o)m_9zhU~u_xm-vFY;V!SCFB57_KarLghl|hhvLmFOC31RX3pkXC>3eT_UHC z^qo+Y;I+GK38WpI%a(&<)`_K$k@1D9r~UQd^Z20rtW!Lf(007iFdtpc_Cfg2jC{2E z+%Bm-jh7nlr+pq;PopM}@w`9qy3g2O=B3No9!pe;5P5R3<^vrgsV=kG$#W<)HrDtQ z^My6u>*vugUl}3xowoAcuisidd&0$6OD}K5mD+hMXC8d#ctX|CoD$5vu?;M7lwfj4 zo-f-NfTL9G1xT=N3Sjd?H6L3AUZLvobJpFqb<4;m9gjD^r+XM?d$FAP@EviSj&QNN zvK{8R<#LIa6DOKYawO(E3vx`&CA!_79H+}z1!kVgri>%1Jd3`x>Mu}w?Dx_eiIIhG zS2GU|PhHOTL!6EYUfTe-%WN~+29y*gx(nPM(3AVVdyQ5k(awQNq1bfS0I(hJ$fAn> z;G!H#B$j${^jB7%fy#v|?)r1yN1IC?Wgg5^m$Q8>o|I)};#^2xTT=%ynZ3c0B7n<- zGVr5vC;^~*pmy88cFpP8^tygdSWCnFbUE7(iNi_puADLMQaZpqFlsWN+Un(f+raH#kLki&BLjrAwAe2b2r(bJ>f$`R?K*B4|YXLGH{V z)GN}Q*&a7?IJYau7&Wtw6UBXPoA(rSZ`9GWwkeQF=`EzM1E3xy9Ai&x7>Ba`vC^f%TH= zb<-K30rXOa4>=yCd}Gy1t#q|I0(&)Xb9qi)(033;Y#7oD@nN|XDi_W_&5S!M--C(^ zDq++IMThppR;03gjjL+U3({0&t5dps6hGrXSw3Fe3Wh3k|JNZVWT!9 zrEP31>;S8GeW7MiFDwGaPQ}|VD{PcL%dP}6})cejSA1!{$IYJ9(mh1f3XYQLc zPH+SxBOE0m`lbwEJ;m)d%H?>->dL35Prv!h>I-kXP%oERj!!LSz`#D1s6N15OtUDc zD3wMnZ);5dIbRHv59KfGF}bj7+Z3MPO?RxG6D&8K_1%uNUf?ZqyS)BsW0rb)>G#(7 zq}Qv+^Izh}&+l^ChfB7|O^7jG0oiG|vfM||eBeWShd8}xGvxGly2g2Jw00GJA_b2A z4p&}re!7cVIYy5;f3N1B5qqq>^mw#rXoCbkhMEPo?~dowBj`hGFa5JZySMd?-G#oO$rw@0rdg02zE#25|ng zDFmOg4c93zyJ{Q;cSsSInB+0q=&C;Q_XXES%(@71 z@+onzzWLec*^ioDu>UOg`)oWZ`bb7YT#kj)vAY2X$q&?cEPf0fkKa1$;BOnG!75`SiED@=DP6l;kjLY__cA{)oNCG3lt%$p^FDg!!Tl5B8&jBdVUt!HY~? z@p#zwNHJmMpU+?U+Op0)<(tM_4vIG{H^si2qNgDFkW``krUF-vH?cp3Zh!PzH~jSX zTBNsN51(#IPfs`15S5Z1r(rBi!JaQd*q-eE-u0ixX}+Je3G};r zm(VI9TjiP zQPXY8uffyp@@CQEq4%y|GX1jZD>*#cz(WcTmb3qSSJEwKuTYP-$d2R12fL`NU-lSq zv((bQ*c*Zm`Eh1S+~j9o%c^AmjA7ZXwd8EC@KN*I0F)A3Iq1YKz{z(Yp6beV+vFIV z>5!_ovi-sJwtsVk@I3y_wg*~?OSsmx+Qs z-9`5Ftr}jj2ZHOT{FF#BYUHIo-~BT7saB@P%!}pBhwnNsYX70(QwJ|=|4VfUKCx{h z#nKh;=N|7a8*`Gzhvm$J?+PDO&ZRb^tPw#l)ri_Kujv_;42>H)) zDO4_s|B6165K)R{fT;Dm8qI&be`QwnvEr(j-V^Q^_T&o(C?H@c9g+VmmqO*@8%edy zeM^hz0hLW%jPx%!SLwakNWeaKqQ>-7vGuwr!IIrsKE zm5xx8hVHaJg5{>zceC!ems@vs>9CL(}0x zm$Q9cJg{S!%WKD&n%k9(O~ZT%OpRahe_F$l_L}Pgha(VJkF83T=dsM2wDqkO+duBe z{u%lS6S|!3H9o$<4B2mIljEUT?nGpZ)W$K_9B%ET25@rWx1h;l*<1 z!}s94Bq1V4I|Zhf6lc2&jqK6V{v3u`<>X%iK=(lP#ot>$*2r`w{HOXU`Cpg0s`}8q^EY(6x}!LzjPe2UpUenT zZv5xJn*L`M70UI;OvLEc0Udrb1`m|}X?#P3MF`a&@pt<#X5)69;4>3A@KRF}zAyZ=$^fb&42#!SSTLS%g@6>D~?5r{;89 zdiGbtDNa=22a-LvJAEGfn;uxNs`G}94GE`H)&76^xgmW1*`eP7^wjjjd5X?@x%nRD zLmA-_(mDZG$_MmyJ8>6Bi7r)xqEDN3>pPd56=_NrlpnBMI-p#9^+=wP=bJYxOImF* zca}S03`Xm*?=JFc*^KtrgL$ONs4CFh1~O`WU{?tK`8}h=nu|Y~b6)oRUKJiA#Z&%H z{8=s?RW3)!-!i{+Rzz^U&gvB~Ry5{X;sH1Ah*|u=AJpz6!}?{pA@yJD=4-}K z46%7J)vGwLIz=?>4Cy9(0JRx zvYT4`P&1RONwQu`HF{mnzuCwRQ?OjoE5|9(DTRrb*}i(T>VGBtCw~(Fx>MYs{9N6q zV&TmvUgX@6L`U07L-#Pe$#PTdyQ%&gbH!x;s;{l3)=zh}wElj|d8s>b`~TzDJV{=l~sPE;Qj#vGcgfUU zPH4rhf0BfWx`vnFUwmNa|*jd?@@^Aa<?Yl(0h~X!KGDis&!_i39w9!zdhYJzZ!Wyf?6#I}Qa;Uc z)opsF&Qfz0Ev6CWm^pU8Ok1)8BfCC{D8swVBc`pD2hE!!9nJ#3i%#z{sr<>K&B`0P_E;v%YziKjZYpZD-CCIbWv!GMWfN zc`&s(XiSCb8|Xfh=V-^^ehxrQB&sjb9F`;?9T)+O1889rbu2Cb-Uhw`TEb(R$WR14 z3;Y7myx4`n=^#UA!^by)99RQVZy=+_QWtR%2)&MiZ92wy9!LB9WDxohfu0INHXN+I z^bG8a0z#L7(0CB~3WVMOp~MV~+l&OKLaZZ0Z+_$Zg!loaO^bK&yc^t32opc{4ig7T z!$gZ}>^&6LNX#1ANbGtAggQ4CiZ4P|{ny2a@4r1qG*3ETYU`759gbDJN{q#Vng`+vjesveE!+t zqt+v;v~o}%*Y9w3lo+*s!TMQwi<<4F!U=}*EGh?CE``d)-zq`3gWM3vm_lmovtc$( zu(Zy!TUI=x>0sQ)*VPkM;`wf|%A zImLGxzmACUk4qM>o7foDEsP`@`wZsC3i~aESEy%;_H{N%-`{+Hggt_Uts12a#Y5gwk<`bn=0S@GlTPu&yNx< zuc??e^5FBW%&i}Md|9qgm5+asudxhAA*}LkeO7S3MdPBxyz46eIRD|_=9o+Ae0*7c zRQbv!D4s;DUmt_va_O|ncU1_!6|N{T^qe(s?)&q~&nFo_&BvGJM~^S|K0{ZLT;^1V zeoNa0*YDbEqQs5i!)-YywD{>3jW5fOD&G+L?QnK*zM>>bT$#M+&*BT({y9(M%krbe z*Pj55aySz!l*ny0K5PoXH?}lNoU`t#SKl0;dCUZ=0Kjnmz;Z+Czt%Io)yfXc&8}+2 z2$k=&b3*7BG#)&))%e#^-H%gSnv79>Y3h?3Qvdbv_$txWB&zWeG)Ar@Sfl{2xcUK6$#Nd%g&!U85FMgi-D9EsW zS#C)E*Tdth=@*1`{Z_+it~XY+53b+xPmUFXJ0-k3dr_Z>)OSLL<1fn%ssDO7e68Ft z%IsU~W=(VCx;mdAu0wF%^#0tOvAdjeJN-`2WLVF-+^|*03*0Ujc6u?(VKtp4VdHEk zt)d=RQiKV=b~z?k4hLADt3vQ9pByCyPD)Anrq{yVIa+*WIrHJWPoJ2PQ3o&6#-OC~ z8P+klo|aFE5`E7Yu=?BIzer9sD@Yu^EN32kuLqw@Z-Gxemh~W_Q*b_eZ$f$W*{S_E zHIB_$@`~Xj^IYINdLP|MH56Pt zt{XEAJZC%GPumvW%M3Muj`fN7P9!q$M-Px%I>K7OvL%Y`ISzO5}VF@s{79gH`#Q4EN6H5ex&?@ zY+WmzuEdq~S`~tK<(*Mt^}e5HzFb)}R_D!f=F4}v?$GNf$#MHPMLQA|t2~EY5Inwa znu&JG7xUY6y5jCudVFO$^W(cuzlRfFYsFIQeA>0(Nv5v$l(;WSBtO>jm=k|(dBs^{ z3?`iZS#C)ES0B&Bq7s`t*JrR7iy6<5Bi~cR7Aio)|6$rc^B$Jv&M~m31Jjd8ZAZ_BzMNkootsyiOiO zhzl)WUkC5$WGz2SFSP1I=Rtn_@xnLF&${}F#Pp7akCYE~M{dY+L+Zc!^bwSYZ!13( zq_R3~Dc7T8t-SPkj>{j85~p9=W7x)hi*s+g&G4I=-PGP@xu22o0SmII7l9_G^6g zaZSnLnNKShY;~<>K9nA0ZBCQ3y}4G~mYI)(EGOtk9y(y0A2feiOg1)+@`q zSoIf(&&o&JM9fI-OzM?}`RH=CX9j`!WMbV|cJbgr{cY6g;8nPl!2ync(OpBY$M`() zjLz-9|8g+mXSZxHrO~IYs0e!M>A*5mt)ptPvk?^5iWoPW-> zx_v}<|M$~woSH#-VWsIl&5x^sJsFDkf%<>ub$3sT^ zasa)2y=TGN7vlT(RY@>Q4PQ)%kMFUgM0?3~zfvcKJ1tTBv%E5wiDSuFT*JS&^K zuM6pDm1$4$WWUM3u6PpjWR!^g;nOc?blN;mk0&gLa~4yJ|6kcRJV;DZf5-A3!Q*?z z{3ww*aq`N^>$Af3-@$UrkHA0m`W^M%H$2GiD1%=dpW=J^e+R`UuHU8{-$>l|y={Ei z!YDDf&+S*ve0SO@G3Q(B*(}Fr7UNHy*t#_j6$sk0ik5U3JNaAUbB*SIpmn+HT0U5E z;9gG&dqQcJ>NUEY?Q7{VAxCaQO3@Y@j2XL17~9ogzY;k{>^0g$h6`#vr}Pr5egg3u zy6=qepWgd{vjZ?AgL4=(x#4<%a3+5BAg9&`BQ6ci>x|duW)8jTg5%j==B3NoKA_&D zdIBp;)l&udQ2e2EO?L;73zS}j`FX>ic^!}9V28$c{n+l#^XZuk^U>voZ5?{T#>B+a zOFKPhQ@o<{X?st^-qX;c@ukWuu2*PYsk>)vShH(BW|kR-dFgVt52z=dmwEcT%1jNv z%FC?bC)S3`e0&x7{(M89%c>S(od5oW@hiqZQne)0&x_h`EN4D^56%nw@FwJ_tV9hy zqc|RwDh;_ou~?T&F)o3_!#G-pwh*M9VH0wa94@c1ceKi97x<9j^rYuI z8H=&ruF%%V^WhEij9l4BPZU2`E*(%VwfOiacNx@vp>;_2Z%DV~ra{WQWg-;_(Ca`Ev&ryeHO%3fQV(PQimB18<{w^jQ}#ePg-atqylm13WBWnp`=SM@zC!K&{Z*jwsVTcXA3_kLkd_DZROQCY{{XWb5g-my@vJD{)2l8zVL1~8dy|=fO&vMLdB|g!Rk2%>X_C6OSymx-Q ze#Dy_TfAsS0OrGTg^GOi@xkUnTAxXpy);m_i7k^30(QI1?U?%7i#o@~#$pS7ynm5= zB2F~`@vcukf+R2Kmr)#{ZCq&1F%?jhpI~~gI1}gqP@ZxLkOB+^#sX7-xd0U=yMQ)f z$QOWl0L?G9Ll2(;QxG}h5l9`NklvVAJPV#)d<^Cfw?LR9uPKQ}9@7eQnOmcrLVmNL zoe+J{7QdmJ5Q{GtA~_A~hM{i+t;|PO!7mP%>cj~A=TDb z3(KVg$|X=g_fZZa>6;qgQUm6+;upnwUC#DF;#Z)^B`WYC z>vdN>_}p^&InV5U;ncI)Kjx#$*}i^y4MN=m!5&f2 zmtP0UAOE-_@{050FKDjkk1WUM7UR>WCI29)Y=9+WXa54qE(7hq(;?X(zT_X*>$(3t z_N6G%x%}1xaX%k-T&7m9XSsz8{t3)SR>1sSO#W_kQHF0gd@B_`q^Cgrg*~=>{BUxg zv0uYl8V+Aw&i2Oshv=!vz=qzm<2w!d`mcV$anyn%CmE%fkHIv&$iKg;9{$_Mx+WAQKe3bDXa99M+t=a$U{8S;`LnT)GQF$v zh)W5rhpZvvrgpsNSjwuUVII1i?d#@|Mq3~H^ihTnSRd8(;4y2wyJO=)t7`Gk+!Xt6fzyXCz0!a* z6_=KAoK4_CCIJYPPKUh~C8q3KcK;`*z2nZ((kaWO1Ii^Zk2=z+4GkBWod{6@H#mGs z`vvDk-mNV@JMX=bqmNVjg=yT2<@Anf4v&}7|1~((BnOAocr324hF_rk_OzS+nBctX z^jXY-A;fl&|RJXzM-Lw;^p@`kvRW z96 zv;iMJK+C$MVSVXxw*TuqQ@t5DEyIOlW(y>L!{r#mVr0d`#q(%xQSDlX;1x$ zBF!2PNdFFCQwrLU!+Rd+up&zI`DoJis%<;RZh@Q(>!0O@)PMDzk3O z2lcU*`{g10AN^L8IPd9^*FWFy!8ac=y=a0vAxKzJu%B!G-|MGoa_JC zyAJp$iZ48u0!bhtfCxx2^d9L&Pza$UNC_k~0p&;za+2i2C4qn~s1y|y0Tsa##Da=~ zf{F#i2EmFTQdEpszz$Z>zxw~a-Fvyc&E*o5V%fRhx3l+lcINGyH*f0Bx@PFJPrmYq z9_lL(>KvN9CEpQNmseLErnVlFTD)`?+uU>_525Q+@3Dj*7Lfi~Y5KMyCF1bOkA+B| zPRfI{J7hd@>DEZ~$dtq1Eq%Uc=O!k5CUkGg`dLZ(977zIMJ_seQ}?wCb%yyqzw|dI zqF*5IpNHP}``U&FLf5eGLC5D0#!=`R(Qqh9Urq))raLlXhh?D@;st)`uKKhGSDE-I zl@Ex2bmhSbS8T}q8r>1iQ7=O96S{|7;z{z_Y8XR4l%WMW=UdnS4_>l5kbXj~K%6`7*I?MAOT&Eos{UHww zW8A-P^v$*7_H=H!jdVKtHXMbn5e)}ze@K1<$GePZggt92cB}5^NX3}2%Tthyd`ui( z{{Dk)?#QXJI_RJjBaIIx+tx%ER?6mM6u(+0Y^WIAAo3~zAI5ad@(LT_E3aC(mkedU zX;T^Fc8xpwMx=V@-tW4(E6s4W1)Yv@(EbQrBN`5V_)Kv-r%b_@%YEckfP17KoNwa8 zU%7j_O+iTTN5f{C^G)am7PM18e0cWQ)CY-->4zoz%E4dy-+foT?T)oyj4`J#^a`Y3 z(&us@uu)$YB7Hj1TYvqV2OSq~i92@XUM(OFIv=6ROqc6^o*#=cgbID}^i+&|)JZ9y zk7lbs{AyR#YoCyGgby=au1kuB@&i6bzzAwuThd=L_J>!250+iZqb&DubjR9fZMr1t ztRCsK}zz>lO?=Z}MDkT;{;l17%#@1T3{ ze#y1FO${@@7kKEBuK0fV)%C~3Z47P@KC{7xq$7N;@?58VtTQTbJMQS4k!t7D_fGB> zzp$Up!wB=2}4-49$@Bowudh1itmSCE&t8j#^46wGaGzJI>M(>uIXcZ%Qrie+^<1_ zUcd9(kMi``)$cDj{J_R`Jg1ZLZKms2mGZ+U?Tn91jayEq<3{p(JmbCWUt{>SWS05%Dp&8qsXBkw>h@n=w|0l< z5q-7`gw8NV=jXXS_QdzuJ(D9U1~*GS)fww;$JAMJOq-8jN0ZmJeo3}3zZi!0`Q8Wq zs%KM{d_T6>wNJ_^eeQ=VbcQiHY;GTyhi{*wzohR2jwPblXcFJp)VBo2dNjQ!m4z0v z+p||M*4DO1=a_uS`<}))Pu96SQ(5uLb@9^76OH28)S*hy?zw)d95`5*%C09ms9aH<&^`uE`C{M>QwM* zrC~|HD1p;aUX1BWnea!GYgTzNO2;}sof0_R=cb_YK z$GQE@yDoX_`6^BJf8Sbkm_EPjA$0Tel&mXAmbC=@z6jU3@|9eDh#q@|>)U;LUz05L zy)~{0Gdn3yW_nrwk2ic-@mO?KDt{;w%2)EqlJ)7;l0sy_shlVBm*1obUF^l_mCD~I zb#wlRoWwsFocfEKG=KDyk^Vm^PILa8Y~ICgG9Aee@lSTz|HSzH<&VhFvNfkaN6q;o z>o~}nKfU%xlcxxDO~P3I@kzj(Ka?@^h-JtsKgTD_lM#9qA~m<)xCT#b+{sAu&%_yn zo5&~M?^rn7yN+r`uaIu!)jS?^yk)r}y2v;MIQ45^NUx}qxQ>_CipFn+vm{WK1m@!c z%aiv0#Eo1Tsjrjdo)Kz%^UySS`Q0n4{WG7~k@R7tYP;KY)3sIeQ-92)bE7cmC8Hd+9T_-J~5SzSW*9EvFMjDTI*C<8S`rW?q={!I)S6?y+cpT>^!O zLdy4;<=*nm{4np+zv1>Ul~9;E$kG0}#Vr4H94+BEiO@Bo;ZRb(OYPT&4KldNcf36{ z-GS{>a`cy~UG_BYoDrLoJ2S(9c>a#{H6M@iA;g(=SLl{+N#ImUpsey@)KxP-WnDAU zCe$ZupsS|^t%JMPuBiYRfV@-kUy_YrL$yymp_?+#* zl(B!v{NX-0Wx4sdAogJUy}tH<`zms;9EHu7rVQHBzU8QB<-TOl&#@WRyI!b$ok=O~ zIYWCObOtxN_;hDRnrBYeJhvM=GS``*f0m$Bxi3qXjC8Bq8YO*l&&}n&BB_Z@u=1=T z()w#*%=y!zoaiKP$_Zv&K0y+QK|HjxT#vT-LGOCBQCqUdu>LgXANMh%Z53xMLqhvA z{)vj`&!qiNzNf5lfRp)5(&j!HX_(^{y%1m0WF0Fssc+>!!x+yi@}FVo%=hWk(#ML1 zD}AR$Ih_)SLE>WXq95_vyN#D^jA(*u$6KECRfPVZ$kGx2aJ$_6ZRIUIr_+0OVWsH$ReX2H;m&kw-{H!M^_g1I zzDW_=*Pc3ciW^@MOG}=al^UCv(>KGFI@OWZFVB(Uic8JS!?)12y~U0F$>KG>?`@L@ z^M0!1dfd8l-Qb}GeLalOx2e8L=)#}){9Hm}j*C03<8y9l4sE(Cc640wkl4PCbUQz8 z>t@(O2!`@H5&Mz;S^E;mX36vXSAFBYyN6%WwNv!jJWpC@S5?(DY4ocxYhEa{c_vC_ z+(GDOImV@O6}fYgHoy?ue>%3U^^8Jbl9V%|oni+#-8s2(pIKkzbzKER5ngo!(Bvj-MvFezmOc%5$}1 z;P)n+lil`AEKH0+L^7YX7W{3gf8FF37tYAp;Yr&#?%n;B^2g`f*0`|lbFXd7mi8rm zewRz=`0L~1-7~XuU9l-iLxyEL+}db+>`=!H{i9sk-x0}ixWmZD#COV+qty7jC;F1;jrOL-6(i_fwl=VIUF|6k+8y4#-w0_6|o&oV(Ld0^#_E{{`n^p`(u zD~sK-^5<0Lg#UER`NQ(TyeZGIJV}``%KfOmblrhFGgMQ zrw>9C-<*C${{NMGD-!>|DU4BHHtz|nFEP6@J~Z&bF=s~&u{ZY!LG(rFX4#afFT?X3 zSYyd8JcihvSp)RZsIv9NU!EFiaxT7^59|Mlk-%C+BjcIbdjsps#IR^(i~i(L_|I2$ zkbJ3$`)OW;Zsy9MFPcsa#zrp=cWggrPPRQaHGO1O1_;`+$GEJt0nUt!VHs)tT&am! zlU=d8AxiWr6C$5);CJbJf%)CMu)2Dx;X}CxYD~STk%zHJ_~cjU9&(9S7Qc>M>{kQE z@-neP6QRv^u(u}$WBZaMk(1}L<((o480}!u2Z8mZ<@;f3)|>8T^*8h^`jHE2;Y3e_ zu2a27gPuse8B6Pz;mmTxrnqwL8L=|(tlebR7jI0*cSe0GPp6F6rF|`_h<=*K3gr5K z)i1<@iychgA6Q?GR*q6n9QdGWQe>B&4|oK|J7`yg?je_W0rh3H-In7@Kgs;b-DAHI9q_8p@en)nlX31gmYGQ2ZfD#Z}$1KN6agNw!v&S z^wa_$jdmw+Nb72O5{N+nmMgx8oe#a)UA=X|%Q2UR4QTmWAC@a){kHJ7aG!E_BMR3| zK=F!T)vWgqW5YfUQ@roUv~Mnbb%~xb=NxITgsxM)$G)h@rpAuUam3?gs$8_#;wHKB za{Ff3v!)JnC%aSAT&b}GU={M*4z2vnU$66fBHm;2a$%iW60js-Nx+hTB>_tUmIN#b zSQ4-#U`fD|fF%J-0+s|U30M-aBw$Ivl7J-v{}T8!^BDePvZ$5>ED2Z=uq0qfz>_tUmIN#bSQ4-#U`fD| zfF%J-0+s|U30M-aBw$Ivl7J-vO9GYzED2Z=uq0qfz>_tUmIN#bSQ4-#U`fD|fF%J-0+s|U z30M-aBw$Ivl7J-vO9GYzED2Z=uq0qfz>_tUmIN#b zSQ4-#U`fD|fF%J-0+s|U30M-aBw$Ivl7J-vO9GYzED2Z=uq0qfz>_tUmIN#bSQ7ZROJE@$(79-4QO&VwM>gLcu03uXjy9lA-)gEODZP~X zb=2l*F-ybMn#&sukC=LYyU~~Pf>MovKj4I}5e#8g|}aN0;s>2%P#NbaQIZmv~oZwll+#oa%OFmr@b4 zezZokSKuQJKO&+;AQm_uXaF<=qJcAjNFV~J4%7l-fT{qmlTJOLZjeiY-+iE7n7{uZ z*KtV;M?JEfR|5Gs75zARXJGvpb4R#3d;jijuKmycJid({$NliAA42!Wte<)H!`FBe zB4hm74dyBHmaYoGbLMLlKwYTg0nZ6uXPz^k#qmGmA;g*WLg<$7UjhXni(YiU+gC4G z9?t}_-?XWWal6Ll-xaQ!KRe*(%Rj&Oj8-h9aAG%vu2a27uU_bOBR1Zin(pZ9NViXS zy7Js=GlClRgZXKU?XQXZsV_n|%hRhbgYC0s8ns0aS)P8F<1_v@=cWAj=L?PZ zQ&$KhjdVJr?ba!JxU#}an18E39}gz_vGzV+{fKU%H2sKfsnk*D<+nxO8?L%Vu8w%` zjhe&SdIWM7eCmhL&2oZ%40fg3Ge$eJ(p)o=+^+nYvGHz)Jy+WPDb7p>ZZhi$?F4Ov z>8`ocb(q@@M04yRQDM!ORBP+)yYUlpzvEpD-I zaMtBTlRR9DT@kwZVf@*Z#4Km7KCa*~D!9q4C$uNDCDawM`SjT~G5*J2%bfxV6d(<$ zf99L?Bn{U%?sOEm_=Z_DLF%oKpJ=pV@$#iSr(=JCM>Aa`<6y8WiCLF8Qgf4Y?e5%* z<8yN2U3po#%BZK&5But=zw}%0uKGyd?RU`JXim~M)8%>@>5FM23z{?X(ftu$KFsa3 zrQq{v+qy09zc}seRhQ~D<6Oi-`zmxvU;Mrq&aA1iL+sA10d9MyBX(qV8tPz{lh`D; zV?cb8C!o2!$oGJ(;*B zu%2v&9$nYIPQP9Yb~;BrskhkPh9IdYLO07Vke;}5a!VBDMCb|gnA%$ns0~B|9D8X5 zu;0PHU?-qI&;#fRPHbNinp@|Y-_O3a z~S!@CHByP$Sw_^&dOPay5&|sI?`L%)dcF(7g>JhbP`3<{PF5gj4 zPg(d8x_^E+WbDd8DZukHKdc=5)C2h7y`$YfzY2++BM2dPnFtckBp~!J<1^B$+iEBQr zJ9I_9@F9Gf>2f_FpM&hv?K#@CN(DI8V>H$~-PZ?}>zJ=1)e9MIuDx(s&9jQ`*6){m z7rO8%zRqtF+9!bpXS8cY-;3=&dl&>vz4-CM!6K1!^h?$k?M}* z4_p26(agxb6ZL{Ad|q|gT`;Km+?Q( z{lbsXg%9y{eiH0iX&Da9r1qcg$f|%{HOeXMsla@xA0yS})h=@HUOyrHxGZNTD!{-dK)c1r&(d=EDf}r?T{PypsiT)&TKEYE$KZq?q3cxdQRip0-I+U} zLI&PwKl^MbM?Of#)o5?W^D3_@Y08rya%HA#WE^yU`Z;s5Gwd@lGB~xgDRsCjAU7kQ zhbqA5lxk;m35`z}DSQZ@X1ZM0`ScpfKgp&lM1*4J=RaM(Jh!}Gcly%@GQSc&gikYF zuIqeq?0vAyo_73P8u@GaO!@rnsQ>!3>t8xIPtq6u%yhY~^Ebqi=CmI_bBM&4&)X}& z-=Jj|^jJ0S!=aMC@MosWb)CN?hda}m!{NvN8IDXClH=xeEh3bBE_k+lITjvVRO8nj z_Z$*FgikYFuIqfpWu>OO+#Vi>IC9<2)STmHRg1C^N8vZ-xxoDPIU1>s9zA#R(D!=> zv#&-+e%Zbhx<)h{bbj?whEYz(jBJoeL+=Qdq zrrdT$vI zf%RqWZ;>jZVEK@sO&2bU=HLgM=&{gss`pqieJRykR7Sq)Y!1v9Q=9Et`t{H%S8<7k z=EPo^>2h7?OPjmN%I)V$&7)P-3tGT3X5?#aIeaDDT3sEeRFwF@@=aUD*?im6LKl9- z*ZE3t=B7Au{w!Y!FO)B@@6(o5`|PTmt1~?ble;LCJfRCe;_G~Q+Z$zz%v<((Zy_Ld z{7^Z39r`0uz0;%76IpvdN~vnD3V`r@Y5?&50x1*s^>K#|!XNMo?{dCG3zI+K?_z_>{D=szFf#%pGXNEI3aGh*y zA094;AEt5M*CF{uVc&X2C3O4BqnYl@Pm+t=U@huQG{D@hEG%74!xWAyLm%qt7|^6? zQRU+(`WCh|u-wvL30IqPu71mr+w{Rkjl;D2)6m0WyFuu}pZNL+!3YPITBLesKVctW zc$ltv9X0I{L3Nh(SkxIVvtt{NYqHt_7kO|Y{MJBMpaa11_`$#c;9Q_Cz;SuTMM(U{ zHiXb{*>WBU6u=j~Xt^!0Ud)HyOjy_duAW1WU2GevOLhzHr(Ou%6K#nndNC=_nc-;L|{N29&nVA2os`mC^ZQEJXBJBo)L&hM1n=kWWkZ9-)XFul3w-IS2I7_9YuBPUGw z%Y8;U6<2_-hP#e7dini%-Q<4Z%S@N+zI-Lm%*l0R4zOorOtPm=jrAicBR|=%g==LY z4v|r>SuQwWHW7cIGYLeB-)dX7ABfN_}_i`S7FQ_oDqvLOw3|7DMRM+A!Wcwm#}g#d6aN+jWnLq$u$WtexU36o%+#VoJM|(VU1}S>Be&jW29N< zmIRCvSc^YW|89TRw;XeQAM4+xwZc@Fh8<@W?hIGg#8!GWp?AHg%8jxcG9D?%LMP4W zOyyXc6qs($Fjv6lf*dRN#ZAHZ+z7mx>#-aD>S<$of2VU}x#zh+>_S=P(@2*%{5_X3 zoWJXV?hSO!7?&|zS+wZH0^ zRz=r$yGX#;e@@@;TfWWx=kD)?tLiEDF1z)z z;@Mp<)1QFL&)5zZy7{?G_iK{V!#rEZ-Q9 zF$^EMtnz5Q$2zwpaJnV184O6dZvUBYxivztgo9P-Ehf?q5 z_s>eZxYS$uzVqhozx1^`{`h!b-FVLf*Yz1K=?EWYx?C^CM~#b@QD2ECp-yBdq?P!zW772KN{ZI$K<#9Or9i)F4SlX#@= z6q`f)BQ)c9gM=4f!pncl|8o*B>Pf-3f%T*qdURF$pK3Sy$a(B0PjXy~!Tzq$&0Kg@ z!J`}c!Wey13B!VuLS!iGYxBB8bA0lj`7b&^eKG!*F!Uvik!GDAzXS?!i?pW-j|A2e zbr|EB1G^sFn=qi!bDpHco(SE{K_ES0*z)wlnEyPdPKf=m^n(&Sxz0GBRq&&)ewfF* zlfDaA1@Uq75A1vMqx~MXL_dUX=GN5SE@Qkqc34(F$Mh7JDqjOEJwU!GI+n%7UXejC%5^vd#&Cu~`9SoD9t1dQ*W95$7A z^LP=Zaof$)3UbyL9Tv&3ymS1_Oqc71ajP=+>m8YulZ}@^COfq@dI4?}`xCA0f}m6! zXw+x({+8LlhpUGMb?!0hoO7<}?%B`mPIUe_E+KT>=HvADM&t7`GVl(h@kLfoD06@F zY0!581pxP&<@<|`fZhOK3gWwsq{je!$Bpkr(rR+;3;Ut`PoMl-?ypP0IBvBR`a!wI z0ra_NhPHhMUNqf3?4ybJs|NoPc}9n;Gq&k^s=qH~gT4x#VT>-hZ+wOmOPrI^ojK`v zK`Ayq!;TImw9_4{ufWhl8~KQ_`SQWM=X;JxSb)3Z#kaI|*`4nk`|1=@mpg8~xkZQ0dWxeUIF=Wo zoB5Dk|0s%*ciXVh2)5nRr?@>Y5f>sJmfNz%@t8jxGi3g-obcVyQNV>j3xGn31{j9r zMe0u8XSu&F0i&L5hn`TraRBAZbIM%aGsLNC^y1sS+Fp{K!~CG5Z^KdO8qshN-RK-U zFgtIA9j`sQowKxgg8o@{yb&)GF2?#sRr1x>LtuhtJPeAlvMBM&i6If{iPhm>zqV>} z(!9pHCe(&OrM?Q?z=C$_S6_wba_i&I!}IL&0Wp7i%V(8|8QO2^CR1mb=DW>wlouU! zmM#n!1KbdTZ%HBWLkMsY{I;Mq1uXaHB(Ms%Nqb;nSYUlw1$|m}b+@DA8|+x~f+x8q z$Or0+(9K+k-eQ)*?eHv`kHt1$lkp0hJuB4_n>+(wqXWS}>z|eDo|%}1Jv%rLrpIX3 zqn#*J)El-Js6*5pmNV)ReWN3du-wU$KmwvR)=zwy;?Kz3_?~4^gs(mp&b4XwE5AQ< zZg=sfmf;cVm9V?dy5q4Sy+%E(r*)>RN`S4P#hxN_{1bZCTRjX!FGGkwzGG*?5ji z$L;>={l}f)DZHT&X^9;Ri}ckS^Y^&Yt3;^C2j?tK9<{B?Z|S;JxLptRM(AeNeRsk! z7%S}6;Nm7Z{T!1WZnq=NqeX+AlO3ruQ?XS|uJ*AMv;I&A$YndADZqM;c8qjF@`^t7 zfI3B8A*3D0wjS>hz2h~WGrUok7$2R)t^e~LnTDk2rT(|hjCQ9_wZQsQ2>rTZVx9Yk z6hA$zD>q_+6a5joPW2wk)}H}R>{RWXg$@9XP_wr|0DIG z*bnN0zq}Wk=m&yn;pkhgViK5-U}AUDtNZGWxxHNky?W!DyX(DZueYhMCwk@^?T*mR zsm5cQD|{P-JHc?{jv@9em=kv_s;nXQ>}*Hc0DPG>2R9WW6OHvR<6-`bEs!!!U-F${ zEO%-oP>5tiPr_;h)|2jcS6AEHCO>nwYxNB-4|_A=Q%{8MA(wb%+m~eQER+Pm!1x5x zH|q8b>-p>t*yjvi{>=4fA^7hUe#64i`?t04GKIB{*Zv8;gfY*FPtv{}0Qm^D+4O05 zn)RBtjPG4H2FNA9Q$kG*_U8rMj6_1w}2nPjws4G}-}g?Y(*VIDHiB!A^U zX$(UrG@c8M=X4B5$G8ajPg)?yIK`RoGsYolGfY{|7+%5%O?=Xg=MwI(`ensg7TuU0 z!*FcUa(`b56o56Ur;egL)5QVIyCQ)5Q7#01{vn4Qr)u&qpX_>Y-|e2at92X7qnXaI zbogFif4AG^&Oy<2&B#JWO4~Ip-?QC`N=F!`Kd$i?vcyqKo8^IJLu|72hiFFF1g9P6 zSWpbm8lXKG0E`2s1IqyN4^zV-0-t@@3hMgWtwp%L7-)G$i2A;$GpDE2V?$radF$eJ zYxw+hIv*h=be-xw>f;R9cUJqd3(VF4d}}oipEGe~I8$fFCctcIpKdnxJL;Sjc-(kZ zuj*>X#cRIVxp>NS&o<^-eMS2zbT0?`na)RoGbh*Oo*9dM)}8ns)L?vrE+;lIC)u8n zI{@uV?;=s=N^Wk3!>2v47JM=P;{f_nC(8UwpHHf)I;oE=7~i+UBO)L6L&%rV@z=)< z#-hPIG-XHT;1J8!L3Xatu+_S3rDqJK-Mj4!GqEF32Vrxb#GJV4c4r1h-s7@n#^D1=`j?Rg zJEl7_7}tD2_$&sWM)`>z7eZk>TsrcdrIn-9t_4Hi|NiH@Ch7d?^Ei~B&>5%EX&>`V zMy67HQYFTrHq`b7!@k;{z{dJHyMACkionNX;~#wPo+D=$n)wjAkq4d&3!Y`6^0!Qm z3UQCfCAxvHeKF6cEe(%S&##YpEC1OadrxCxaO8_}5xPb+97>hD6j!c2BgH<|k;R!b z?BFoM!EYd-HQZ7A!majV1+!L`f2DFqW8j|&<(6< zr#gSK3w0T9cci$quVeBm_{45d+4vr>HhS)eExoH`>`=!HZwW@RPDn{f8s_FPSrr(b zr{&qc`QHZD+5!_BMyRhAynV->s!?je_qz|MFB|s^1D#HuN9a1$dmM`0s=aH06SF3} zyak4#Xmcsg^6WX=W3=f^SK8t-zC~NYwmR)R$G+I+XFGy6pK|B;2ithHfjR)|fwO>m zKz*PAz_|jBnZy8%fW|-*pefJ{Xb!XhS^}*A)*+M+R86ZdjCOi6uw0wUxo!YR`i8!z%0y+QtG5o$^BOLey#Y!h`g3m4pIWGMAR=sMMV^tESv7b!c# zk?R;aVz90ug(x6QU)C+Wi1P3xDnL8vd5Fdiu>5uM_|!|<0M?Og^HGmj#sc++aM^Ny zQUXT1wiNn7S;qnN#U|H*p}ctS8|~IEuda%|eXPl4ujN0R;7O0Rmii%d54ptC^<#)5 z6U|SpX@bTI_Cs{ytH+qz)my_I`RQXCJlHz7Gh1uA6e0%E+wRQ*^EDqIY1uaXikibd znw-?#lkz_JUj)XY+vjmJ;jZ$MyAP?0S;^xlbn~$HUlc<+`Jq; ziuv$_zlkjZm#fX-|J6ow;+AbqywA}{*JL+5@+b5X#ylrFe_HC0m}Yi`C9PVJ@aFO* zbfeD{V}bL4c|ao24q#nMd(FC%*Bb$>L-{nUZ+V^dENQG~r7Ysqaut-oLWC1NS=cJD zo*afAP07FV?u{d_zGNyJCU8{rS`-+6F!e?E~#JozO#Y z&g+)@a}qGxl?`nI>r0*15o-K9wQtDl-{OkCtVH2NUxcnxy+>VNeA{zcXQN-9TQkX? zpnp|Qr~{%WY}Z?Q;?08-ab~QyliK;#kJ8_XIVVIlyK(m;No^z4%+H+He|&K1n4efc z;iP^Px=!^TlkJloeKA6pgAQoP_=1cMNsZJGodL{Vdsk`Ueq_3_z1PH|x^D(}v!~GD62XmhA$eYed7r zVDI&XN}i&e!&ZTxZlaN&>{wrZ%(e*E=Y zOEw|!>9QL6QRn#bW0p_*S{RQQvTJP3Gj1HlJ^`KZBXphWJ(k6fAJJ$x8Oza96F+A8 zY(Fzfoii>g`RuKZ`Y)hOOeg#ZU8j1FW%1)}^ZJ*Qu^xzNA6QP=b)wYt;PICgt?se! zRga+^4;H9LLici{pXq!_lTzBh@vbz7*5(|HuO?@u&cs+hf=l~lt%(owym0=PQR=}y z>++x8+Ul#yY*@nG3IUN1q3cxd5%U4;Gh!8k-u55j#OJ({9jUIYG>%ZaGQfy&NOLo8 z6@Ici1eQxugD6#fMT_Qd|D63!S5K0XUqbhCqMzw zg|1V*M=yKS14vaLIo8*aALm#nV>RmQ#7@5QHSd?uy-Ach@6`!c?T)WA?!{p`Pr|Rz zy`1W2x_%_23>i#yVC6_HNO8&Xzofj(>=YM9oAGHncV~Y1%Z7bw>BL zsaLC9y{j1froVZ4hZ}F++K$gb$FWG3AE9eR!$Ir|`_1S+Ym?;Qin*zU8iS*;K9*bA zZx_e5JNtXb9$cY`6 zn~u2{t)*UPnXcy&p%#WD7o3siLrh? z3VG1Q0p!PAe=Pm7s@gmEnM%`t9iFg<1p|(}Q2&Ll5est+r-xBRf zm^O}b61wmszSysF=RJnHvW!z7g-{@~U8CJ$e}TT`POk)f%2%(zdUFVRmDoG+!lWyP z7v*}`7QGR=`Dx158*h8ss51Wa#T+MXlGI&1rxRcQXB|(L1dRGp=R9A1F}E|xL+AIJ z{BJ{znI&t4s4tv3GSf9O4rS?!pkhas zgL5>oz&SvBpaakm;9M!6vkSm}Z8xAh&;vLZ=n3=!INx(V&>QFj!~uPQc%UE99~b}( z1QLKmU=VNtFc=sD3kZEC=oc?gmx>D}nog2Z7bV8sKr@319>8EU*c90eBhM3cL!u0c;0$0`CHQf%kzA zfdjy&z~{i%z!Bg_;27{5V6#E5fp8!as1DQu>H>V1xe?F|XbqeLbOw3==L7LT0x$#^ z0gML51Drpf3}gUqARo8_xCXcmSP0w-+yUGJtOC{mPXZf(mx0%S9l&0o7&r)g3;YcH z0aQk1SPiHRoDH-9+5 z280GfCO`wA70?Cf3k(Cs15RK%a1F2sCuME zTn^j>tN_*lTY$a5SHK@Y%}_ie&=W`k9KbAKA#gwN9IzAk00;2P4c7=-*J}Q4;tV4!bY{VUtmoM}p5$NPjfO zoW?4ZeIabwIMfRhU;{5gnVG26eRh;si&@hdMh3}s|JY{gTsw@>4l zo&%rHgXb4fCSJjF6+!o2gYA72`nv;l%r2DkJ;>Mhp>H25_1OW?K0|(g4t@F>_2LoO zj31PG@hD{dKh`fcH6z5PE)TP*#Z_(U>1dlejIpC`Fw{4}P#=Y%&S`GL!a$q48-_Xw zhPoyU_2=i=)Q-M3_0~X}DjsZ8p)l0v!%#1Pq5c+zddd`=`T>UeHW=#RFw~7;sKa2W zE5lGXfT6wshI$bU^>;ATQy;Xc-(jd9hM{)DP^Z994~L^ zfuWuQLwy$v^@lLj39EzDJ{am-VW=;Mp}q-*`VAQBZr=o{H({t3!%)wIp?(O4`ZpNr z*QnW5^t)}d-r?@-kwB~*2FhN?TS2vuX2gevDlxV|}5E!rKb9{C2> zD^*fIHK?RobgiT|46URdno>#qQGoMhmDKL_mDGf{DyhL=RDyl4tTGx^R)yzPR`C~B zR-{LS>07FOck6Hriw8ewK+RXHC_~^!q$hW+;_uN`mr$e zS^aQzq))iI&JnKGUl*>XtqoT%;TyA$VBfC}SOYYCNQ8=>9-*@Dj!-$|! zshVTQrPY5#s)%k;D&7^PE?gC*k`F|w4h^cQqhqS6hi|E-hVHDUKCK?Da)(E&-*1jq z^L9qV##UDkjIFK)+*Muu@NsqZWa}Dgp}U5f`)mz$M`%s8JE^AXb!ScW))zI^Ej`Xq zi?2OHy|M2MmC&x13ZGp|o%wDpmDBc2)%=<>Ri_WmR4cmG20yjc;A{-kLh9 zRrR`RNN!zqY)@U)srOkb=mCsNMb}e#m)27)4%Jh0N7Yx$w$xY7?hVv04>wRLjT)*e zmo`+htDmjx3(i(8!ei8X^J3IBVU1Ml>l>+E)f%e>w>DN|&TgXO9%`bJx;0e`wlr0L zjBchL`?8sOcy@F3Q{5Koj`c0neZyO-`bS!-@WrjvjBc%!YkzC?>%2CqdFQt3mji9p z>?Q5gmV{XK&L6Sr$*0dz`P190rd>OzEk`@3OEz^>_2+d`2S;>Pdm437|NFj+x_Dbx z6?IQHb>%|Sh`yErBf}wajN>cTc-NvV3xZ1u59(|IJX)YldBefnWv6yoT293 zHdAHgU#ec3c)41cbfs#WFk4+d@M^Vw=p1!;!aOx1?^<uyyCD&MYR9Lv>)*X~qr^(<7^J#mk!*5f`kcgq8+)aSj-KAZHo z%4qt8+I#pZHM-~-Rpa4}s@v_G)%S~DQn^dFs6!8KQ&((#T}?UimfG23r~2WNch&!% z*{d4X`9R%xRk14gjK)>wA&51C?snR`)&A*7>HhY#YC7XuEb?6WjjxTG&)pTU*x}9c)EKU2MPKe6Fog zR&U$o6Z+XMnwV&do-x$+@rqTC%QpJ^ zD{UWrG{^SQ!Ru}7Ll@aL^jvBieBE8P9Y^l9t#&_b>mB*H?eGg5Y%Okn-ZuEsEw)z+ z-mpd9^N#K658t!h(c@#=wzXf_F6;lDte-Jop)8wZWq z&^jn_P^X}?fA1MI@tuA_OWqg~G~kO-K|yUM28~+i4BB~CPEgg?E(^MC#oVAOcP|XG zy}T@_cJ=#$zL>ivsDATjf`)(la!~BYZv{;VdN1hOA)f_Z{K}D_n=kn-=@N7jp03;UOcwofNVt zAvYxZvpFHZY`ZO_{|^s_q)&b>W!7zsorBiKD2jMbWV(Xv`i{34>T>c&i=2X zHcu~cdi=ga|9j?oPg25%(7hb!XQlbjW-oKJ$?i1ofQpfiwI)8y<8v{nkNVv- zf6#@)GM+{AP;&+LTYed7Lv^)~Cvh#BBQ3$s^6|Yaqz%cb* z#-)#%_+Xxp4|K!S#W&2-ipaKAYtHG=YWO=KX^!$BH)gs<#-TJH9{tc5=sOc{;<_p~?J2CTlA1hL zrO(rsa!6Bi!8o!W6uO68;_3NjUWX=P>F3C>&(x~8Lfj$xlQ6pc_kIUl|LITf-}XSu zt)7(V+c26dbPu`23%uSnF(*FVk&0Ok{q3f-VOgGCzreWmZl;f%vd0FN({}LRp2Y`d3j27|YX9=n3T+2heB!R0iaItE5qpYU9CYo}aU5Qv2SZ({%x;CqmbVhJ(NL zL23F5${~(iJ6^l8#}0JlYC0k1=}@XKA7h{#V}a}oBh0d56u z16a?q(#G(zHWzpYd<-+IyMViaLSO}O53mxr7q}0&A9w&*1w05m1Uw92C|W%NJPND< z)&dxo*5(k`!CwzN0Xzv{m|B}t#89<*26z^D4%i560-gsp11|tC0xtnC1FryEfUQ6g zunl+>cnx?RcmsG7cnjDLybbICb^>fL?E>Bfb_08Wy}&-;J>Y%d17JV!Ay5o_1RMZ9 z20j5k1wI1~0*8RlfiHkBfv*4zovUwvZ-K+W5#T%Ed*BD)N8l&mXW%Gs4EP2375E?U z8}K{u2SCGT1A>5H0K@Mp6sQDL1~3$_&6`HRXOk4e^4c6~6#QxchUm5V)Ee+>0vN8> z=2p*yUmK_cVEA601=IuT0~pFz+!yL>AO>J#r7_S1XbLm~ILwa`B-IjV1+)e*?62Aa z?SNPSQvj+x&;jTObOJCXpt=BEfo?!|08<3&T%ae=3&3=NHn)pqzp4)q2lNFv*V_;1 z4-5bX0to<3?jYa-U@*YB;Gw`UAPE=_i~y2>6ksGU3cwVE8Uu_4E(FE_n37NvfQx{O zfr)?}m;|H(X@CQm3`_yi0Vi+?FcruEGJ!0>1!M!$05^~WSM0apXp0CRx3z&v0+a4m2ha6Pa9xB<8kxCvMY+zc!N76VIwTYy`E z+kmCO?Z7f%IdBJXCvX>VH&6(y0PX=+0`~&<0rvwB0IPrpfro&Hfz`kxz@xw#U@h<% z@HnszSPwh_JPAAnYyh4Ho&lZ(o&z=ln}Fwm&AVj(o`#;HP8lV3$z1bfpY*%v#Ab1N1zkX8R!CZ z1-b#QFj!~vM5Q}IAQpg%AG7ziW)iNGKL(|BqyFa#J13_euuQ-b-gYROqA`UBLC>-q-!nL&wr*+*pWM$&d7(jB%Z+b3T~%a2_97 zs5v9uLn@&g{~OPFuP#+1^`CoQ0MJo<^~k=L+q_WF^F8)m=%}~U z6QOHF!@<9vc=c8r;X?T{)?*1%1DBuTs?qA=4~u(er>@$}yr;VmARj{4h=zlIKD4*{ z9M}}5WdAD+BoE7?jfl77r8{4~ip$}P$t5+~oOAuzpEaCYNl%=MBl+cJd~v|;o;e!(+T~@V&dtIoGv1Gby>jUL*U0_Gd`ssdLAW@8@-UZgUYqvn zPwgADy0w_+boD()GhHL&V0^a*ShyJdquY6Rd?|2i-9m}u0 zFL-E7r225vqqqG2d8dOlJqgu?&wLZQhg{;B$GtqO!uw{pQl}!X{Jc4+-)hvS?k->X znA;yq!T0;e5^wBqLGRixbkXlW10MMjdI>|GlYs4yl6MF_-vBV|q)>j z`BnD#{BH#Q9=GHDMrZzSy!Kx_&&NZHJ#6px)f>)tcEt6y(5D*J+P$zaJ3@VW<%^rT zJ#|ss5M~tIQ&4*9jnH+f_Xxci;h54tKbvjTT+F3S&CxCvuj`Z+MyrX7vs@NuH3wC};^DT=-M_L;U;jo>i_6XoF|PkG>pjPr*#BqqjnBloo^3ulmOaaz zS_v5IlT|sscDx=~p{{NIG)PUj@ZnV(P%gS2Y~OaoqkZqfQcum@jl87Z3tgvrk9z&f z_lpMLBX>!5ZOa18-NtGQQqY&g>?A{T+|g(sD*2WWFBf3v*hzsLOf)K78^w`s1t{|safBeb&UTEy1DlE7(_ zfU*28o#|VC&FjUEqI`$Ud3W#96-{sAJPDnYU!m(%@3BJVHyN9fcy2M*v$U7SvctNT z?MdSAXb-{GzuFn~Wz6Ni`eL^CEoVij_b%#qQ`>rbn--0(pxNm24IQ@Es6*0j<2ma9HV34h;L}Ms(%By*NRu%9FXs}Mgd<&? zgyDbDXZmt3bYnQ78N-lfIZFb6RszO$a-A!D+sV{%>hMC8)#p03TU3nlJ#R+*z+(~L z{Ls>qUX>wLQ74r4o+eJ1t^Y2O3sdjYOX|8~!8U;9&P zTm;XT)$6JBNr~h%yxP@FanqftOf1@E(hFz9Y_Rv1Lp#50FEKiKG6or^V5bfKSUPMIOh}4t{LqL z{%T>EZ@i}(!0Wu1PVU$L{rivR{K>{6Q#N#E$)YT}ewTGTkrF6GWKw?XT;p4Q({PPA zno~&ypSk+U^mC%sQ`1`XxW;9lt(RWCjIjI)9l?E^cdNNreQ26r>~XtLqTTqK4?c(E zNX)|WZ*2808w7Fayc2)RftsdXLC9Fv$SKhYTSNU zX7hEwujZT`9c?W2N9Y>SaHzQc44XVTK0D997U}ErgwOOjf%UwoOSB5Q@aLWro*C}s z7%83bDRiCcJst<2SpnG8))5MyYv=j42OLOlG9cecJlZ{4br>-Bv6#3|UgWwMI^k33 zI@NnTPCoJ7wNytIKTYjhEK8Nko=Adu%6g9VU0LmBvdOLo>j0Kh{x7S%8tKM!+;URf zsYv6bFzzQ(<9t>A^?~(0VSa=mSdr7M8m<)ciFI#3G*jfZ_9T+ ze)~6`1Lg$p9o!Vgx>S$^NHj~=V4CvvSPeW4qY)=p(fg2$eqRVWnGcY9517W$xq zpM@KsosE*PC84i*zN#^?`PF|C=8Kx{} z3@>4XCO+xLa|!oX{j%aLi*8JhVc0LW+}~FM1z=6=%Hf-R+XsbMRNoQT^ZUbg>@MDv zv@k+F-Ts!XA4g0c%XQCm_o1-St_WSHdXE^l8DgK3;g~)wI~T9h&T`;&@NB!ACPQp3Bq^^Zn-kv^i8wwk4YaLjjHv?gPF9_`V3=$>2K?dNANudzAupr^Z+=A z_70E<3w7)g5ek_FkEbSY4eb*lM zMoxcEmw@Pp(9Lowr5~Q9Z=xV(`*AlS;5#u(0lrtm{N?*QE095aSA_3dq~d=Y;0uK1 z_%Fw{*lyq$v5fcPa+xmBHGel9Z+L%k{8MQKU|jSgX{oP%nCAu7LVpf_dtktbR*|#% zUpZM5o9Kto&2lKEANu#3vG7C>Y1R+({ek|oPuUuv{b&nr_zo4{o#A^mnZQ(l?=|uL zEIY6t;W)Q27NG6n8ZUv{ATC`%fCr*(POwmOlRzp#W(-=eQ2f z|1HkAE;4jao(Q0z0yyZWA%ALNEj=z>W2@){Qhi=FIhjeiOWe*p^;(ZwU(xh5W zqosF5s2$C}NqqT}H$Q2cqUYE}2uQsUx^|c00KG`Y$BZVq@*QdY^D*;~WzR^WZaCaI zvPThv^Li`Xa#z0GeZ3>R9^#g_j69G3c4=4mS z0SACcq~8a)3}C&+cN4Dwegd##*+_6|w+zsy?_QiXtL-9`S1hjEn;QJcfe+S;ZeFpEpet`I}Q1XZF zHgzz^rhdeWsa^0gWs~e6wH|9WFPRpsrqvEno3Phr*R7#y&j;8$6B`rfJRYv9&8?y~ zKNhJP4v1F8qiU+$U(ZzQhSgK+a%0rio13eLcC}NV%;>6ep6R1r{&KJibB;qLouLwH z&sGD|Z&&+!qSx9+p)^@z?eeNznNO3?uk&_h87sCnK`V87&_DI_SrxGump8qA`$4xRRy{XD$FpkjbVKx3c@&=hC}GzVZl zH5=Xveruo&&=zP1z^wjjzP~UD&yosI4`^fIm0HJ5S@PL?0+cVRl#=y)sE#yyCO-3v z_Koc*`k{c)&YA5muQ8lBo(qk>-0ROb-e8j<^TI7V6?A?Rt2`N8(@FGzP9bTQR5a~H-rWUPVB4Db*lFm*uHX&pKf6N z&9{pFickHdz7o`3mQT`XPx+s=m3EeN`Yg}1y?iR#Q@+bX8%!I^>pYh-K%eEFKI0^q zuB44qEncR@_=OMSb#r*$BaZQv@USx8tRD9*w|o!Af$K4kM5wB{S7#PI8lgsCf1vg5;Kga5dm3sjVX)bs z5xQA+D7ORS@%j4c4s3^l4-9+GxJW?@db0a5Y-6*{&Ato!E$p+fztRY33b1d|8em_f z1JDKFIMew+Jdgkk1yTTvxTs0MB>=~sE(PWQ3jquPX=@Olfd4Y^4)7`PGf)LGiUGO- zNx)QKKJWm*y~j8v&i%CF02iBm5>bivN8@578YGvZ!SFOXd(r6VU5#?2FXHn z?jD1o{2iUTS&i^cdsBT63-)Eq<3$+$(%LO-v#<@qzGG*gIY9Z+#)3`1b{3CoIZFcn z2?-S7DaF1Plw)6)-cwzTX!gS`UmqCs1B$=q#J&pMLoV^ku&*Oru3S#T`RtqB{YhW@ z?!fglK*p=W)s0SCaJx*KT+{;l>rZ)O(a&JwG@C)Y z0aK>+X=qnyPuOn~nb4;V5y*eu50j|H!6#+^iT@cF`w{@6=bigQ)nSttv<|r{T~it9PYK;DvXXL};IL;W z+qv()R#>qkSf(=<8&Y^~D1;Ik=ZVbmRP;afmt}&EKFc4UiaIWOPM?lpMej+I`*@A* zv?c(WE+yrb<&fjoY>N zfqLz`&`C48vh)Ps`_NS6ujmKu9c?SQW}cHFW4`m8G+v{V|D*}sXp3V(Zx67(pnee2 zHf23R(DsY{$LYV`8STib=K||T*s~GpwK+L)4d>I?tJJU4c$OFM#Eq`N_VVg>PO72v_7zDdHzuxW?m0Qxc)T;~j%3YszFhwK$ms`nK`Z=9cf z#m8KaLnr+iq3cxd5qg64XYn&rGaPuM#h&BJiXH39%bFq~@^K>Rr@!FUQ$}yzZ?g#e z_3QEN%qoeIa~HBwfRprvu2a27WBSH~&GxGgZsAYK6T9=y^y)`3!ZQ8x)cW5M>hcnM$#KEg2J`yf>ijBkVIg{oee zl~t#+u+DsAq#FNN4K+EluDbcw#_FD`h)DG*S?6Nbe_SlnQO^l+@?UHuCC>I=3t&6| zwl#T({badfc?tq3FP1NHjEi*IUCVhTU~J#5Eefpv(OVct-Sg# zbZ^Z1SsD6Y%2XbYo=6%-T_KJ6OOP)0E^RCIfOI|`#{p<(q2k(_HI^spl<0+}ClH1o zXVjBJ+kEvT4dJ;iFno#+C60c{A|w22q(xbL_DG& zo8JtqA2Dx4s5x^-+6T^k>KSu8S?FfA%GA?RHGzJoSziW$Y_*%sQayeDjrwwUyRW_| z<=bvfdMiR@KXLh-sToTyHMg6EZhn$7^~GN!8aJEu#T=jUKkEu(eIftF##rr4qqI)U z`BFq9_NC>{!1^-(ZM@$+{PMNEA9(UHb30S$X09rtFaAu;@#u}DY1AFkq-{aE)MHk= zQ>69Re50L7f5%sE%yPy=B7-&DWeg(77_fD+MgT~kaCy4 z-&cOzm!t^Siy_zXcig|H&YlSM&g&6Bow;&FL<3K|o!>^}IzFNMkzY!ldy;E_J*&e7 zDNgxZijs9<<&A65=CTbK2C$z-4%xnA`C(s8`e)HN=R6(TeVp%Me}m)fSfZx2=h-&k zTE4R0Lu!O;O@L-V3!oLiM{Eah#G(Vh@p<+Q*(c!KQg5Iy&>u(u1_Mbz3NQxX7=#^| z3`_;Gfjofg|7HX8fE$5ZfIEPDfz`lzU?Z>v*beLiJ_QZ~{{zBcNNNF1fDS+(fa?P% z0@Hx20e)xoA>es{-yQu5;Jys}#wNdg$?s840~P{nfgQk)z*%Te#{riBw*W5!M}WpK zT%&*mz$<_am0%y>Dgdvfs%T`?cwjZa3>yQi2WlbXW&xi7DagQWKtE*SE5Kl6kjM)+226Ue?9?r(woM25y9LkA;6=O9D(Awvgu#`;KP=#9uwdoO&0 z2N~+_3%>hfE;teUS|CI7lOPLZ=#9wG&&K1OUOUFWCS#o^GPEEYGM$e73Xq}2v!M_3 zu_hB4dKeix=uXJ!KIq&d$crby=O&D)ZN>Q8+xTAVdr0Fm-1{Bg5B?47DmQQM~K zHnXYxPByimuT4!Df%kwX!N+DPEQef63CXG?$k%9JASP|SX-oLj@h$)!K`R4NHW&t3 zRx(ctF_)AlWJgJzgzVD#Q!HZ)kE|(a2ZegB(PtLZF$~m7y9cVHh37S%GY-bhv{@ei z&)${5H&J~5DS{MQpaqqRqUBHuXsn=upwNRtk*m;hhzAX6Xd`J7leDy+^{#hO6uhfH zMHCNIRKx?kQAF!q@TwQ$U2nYq-?zIjnVqIdI0XH(lh51PyqTSO`{p}uW@lz+DJ|kr ze2T+9PPKH%r?iPr#E#OU{}g69O9Pe$EDcy1*nS$QLsH!TThv4rIy^70?i;ij{ljCL zRyAxI+i<~REvDW#qW&NA4R**w|C#%LyfYm>hB?WDFU>mUPI3C&cq^S=Q|ImK>S65V z_Kgyv_5xi5t^J@jhorRH11Mo9I2kW%K8lW)j1N1Cu}{r8aM}yLKF+mztB$Uh_PoG+ z^%mmA3vXW+2`_4z+xnj*r+x@wj_`->u-2cU{tfk+xQ{}<<;)sbguiTG#HZ2mQv7j8 zadYaxGe6CD4P9weaK;Ps&8g#=Bu@LHY-bm9Jdnzq%bm)VB*!C+R{msP#HJ>f{Pj-cf z?ttJ=cq5$A-4nL-JHts7r(4-55&oYC)!_cv-pu&ij2pE-vjVspxMA6l7w7*reYhS~ z>;Xkne}?(0x+36)yDnPPNbM0l|BeDp0!;_q2FeHZ0#O<7>SYEM>@Zh@oERTfUq;7A zBk*(gfv+r|Ve7MD|8HsJ5aWslKA5jDr9%XKa92f(6$u~G3b?>oFQaR2f5ZhXIcLT@c&#s~9NX(Hgm)CGx!4>i45 z{|OUh129ysjU8i{TfwM*0n9Sx%XF8TdH zWMjyl@LXyd&XYiFPsoO_-B9fbf_6zK<0SLv=s2kZjvhJnm=D$;Q1Q#Vb9Hrbd&7KH ziLK!TgS5^q#R;_s+%KUrp97i#ngBWqGzNs}S#92)`XgM{IJMk1YM=(!bGx%l!3pV{ zUSs3;>zX#C3SV+#hc8p7ytfp5a@4ldb1(BXrgQ*K#^jFmIQ-gZz1=;*?w{-Olq^Mx@#L<;da~j!OkYt8@!xa zTH&_)IUN^Mzu;!yBcN3rzB zy>8q5H}=z5lHYxkt-kBkFJti=9F5XC0iQkSC@Zqhc02R%-EWtZ zKeDj|1y1>I>3U0&l-7&U7y(H__K@1@o}k{K4A3DU8fVM`jRVmbLMf;kbQx$d=qb?0 zAS`v$_A_+Dr}c?Hfb!AVzYEk02JBAIF#zW7Xt+NDeFDSQ6^(fSgIK8$=4UJfutAvT zu`cj6tOuNphltD2i8#3z#=`KB@!r8gJcLDX8!;Gm$5^b5n}$9BlslnPh>I@57}+fl z;t8z3d>`uz+a`zuv4HY8XM#B6mITrLiv;oQ(QQO}eH+oU+iv2yYjzXWL)wad&22^b zns(xWXLlD9ziBUSAKO8cH+2**K9($Q|Dv<_abBv}y290!x&yEa=tbJ?6Jm*c~!aG-r=4)t$r$|8Yw%9L` z0{*`_6m_eP+c4_C(O8q^EDgk?fm%dj`?{i~eQitjmA_-u+$BX+zqIC_nLqd4bl4^s z8927D%-5LG0roZY9iv>Ik9I$c^cf@5zKQ7_R6Adz?Tee$Hc4Fm((S36+9ipx$4~nG z<1;?qec?wbT5d<+NOqq2k_g(VEJu;QB7hy&BFeF~_MUn;wAPC19!W&=2Q;2TvtRTa z*#|`P3Opv9jdLuM)@(jK@6Q9l%!+!@N>C%{cTiv0`6AH8AX*AU`_|I8-Dur;J}UjI zARp|0e<}{x{NF%5VFbLe`}DZ*G=zE^Lgm2jcZJ=b-W~H=D75)_uzjd6z9}{UdlO(_ zY1NTvlX4;NMC_$I6MN#iAj2tW7cN8m#aO%lB)-SggmokB62#YsB!~)of=Ize2%X~WpM z#)>YY`L|TjCk7lP5`N7S#l@3F?f*^` zyQO$=lQmS%E$ltv@c)~OX7Bl4QT&=CyN@CdJ-6#z>u71ftbrQ*WqaS49No^=!w&aL zIP~WGl3#x4+nF#vaBT0HuQ8>AY-ed>I@QSX`%ApffOP40J&mXCM9Pq^)9*A=XqX2x zt2v5Gb&zboSQyP%R0c%st^;Z3EKtZP@F)r=Qw;tT5TsDa6i&|eP z?5k_$o!|Yf_Vjq5IjXNTYNYZtHV$fi&GWh3-qH#uhu7eQ^IyG3^!#ff--*c=y!7-p z=TH35NPz7H^EqAiTjXD9cT`|kAr4pV2J_jM?FHEra>OG?IwB%RJUVCF!h8yo&*{JA zEDikEH6XY1zO?A|cIci-qGH{KqId5;{ziKKBggfY`8qdzRO>C8d{>|h>(o%e$X;;2 zoW`uFe#v!AJ`bm8omm>#bu}Q@*Ytg(*Vj#`&nM&z|7qnVbIN)B2G>{StD02nE3F@) zIBI>R@yGVY#avIhJta2tj3}08X<(PsKn?Di`^EJ!>MJQ|PNx5^E<@Vs-EsWaPxfrV zr?}+Q`dZ-kn)>Cky-4dB-Cm^kN)esU>eb`>F%O(Y!~5jeUNB$hhL39gh4Y+FAA)N@ zeBX;=Mae1jeGw0x!YI>tJ;!isV|N)0^DfA#+6`xbTB z#|7bO`z48k-uO;?9Qd^I>am~9f9J;^4I@V5j(cGAk@@&*a>#$WJy4$KDRp_A6P!VN zi9Kj9be-ZH=gOgo+cK|1($e@I&F5n(MVsHD{t>2Av^kzM_#_|A^Yj880HV1bOsQ-8 zT+LGOabK#Na+asZq+K$RG4 z^E$XBgp;OTr1|i3v-%!lR(g_X7~64R&tv+!Z%juTaQ)B_(mWvZHKud`PVfN?JS;o& zDzO^V29hSh`eu28C)hEcAxo6*{N6IT{+@kFp0{0r~`|6(CwW ziXxzCISR7ecF;f_(qKE{>utt|x?Z-fUy2xWbHP0|e?0D?`bO?410T%Sx#6Q`$68re zCYd*^S=9Ssi*PB+lh`M^JPo&{ic9WXv|rQHhtN_S&Gp44gjePp?2xx5^4KuJ&KJsZ z)yI&_cYCVn`&a2j_JZ-Jq6%wn0Bixt#e7be{dncl+8;@Mz0 zZ=KOCMf`oz?dK)gbMAcuVdTipl3dK!n9@O)%k(`HT2pFTUyya6xt!8hwbAT!Q@fathr0B&}l)^YL5&(=S1dzyYd*znn zq5l>ppajX);GEmDx`U$Qq8Ydu(f{Z!%?r-o+h-`1alw2kY3;NHE~xivcc6EzyGZzm zRNh=}>w+7ppU)<0Ac#BysD2 zeOzOXehw?)b;ovt`Knkg?8bDbeJ&!YxS+P5%9ngDbNWy4Ga!gF%k3x))F2~nPnrfr z$3@nmN#a=7@Wb|Ax&Aw?5OFQzBE(k&mvN!Icc;Zv@u6I<{Uuz;wuEg53Bt zU&Ye2?H=7{JxsRNEm#^3kJJ);uZ^fR(x zoG@R_IW|u8?vjcVnnz9qQF*u4Pg3);{{M3tkmnPNv!dfY`06#*8FG1jqPgzRnFFqMmRU71&dn`hi)9%IIh5a#bG*8x{Q<`=y8!8trFT05SIW>)c@;_mRor)vU2JwgpZ~T0U(_O~Z;7%DI1@vJ}xNMMKr_A_R z2K?N1$P1HC7&rDn@42+YOL+W?`5IF?M8Ze*oS@UM!(*r6L&gP*%g>_}M(>jl?dq-u z3SfNrCPv3c1MstEy6fEI_xk+cdw($FgZZjHBjIDT-{~ybN%)|$rzVq#F~a>UmYx1{ z82LoIqU|7k)PNWtbp_G!(G2|j@K)dMoo9Z3*B*z_NKn{*FkfRz2N@p|oaJ7BwM~Xc z3;SVoccc`y{8YDnYy-_@Er&4%I0qh&p#O{!j>A63-Boa(sfgv@t>4c2gU1 z)5_h%YvbFA>e}|=*X7vDb4V94;O0F=wj3M6eEB)9accDXFtjL1 zOnqhe??r2S^ysv_ua*qg2j84GkyASOq6A>5E7%n(@) zuZKYi+|HIwi;f%8*NununK@|YAD@Vtg``q#o_ZjTAwDrB7YA-8*sBa9itB1YEKl8x z=<+l}-V;{!SbpvG&f}+cBr6(j_nEITr9(t{#<;z+?QWAn-_f{b5hK|Zs=F7NUJu^B^(vQXaBrjb)|D}1SoSvCvZvUCD>Mt5jA{n|JjhEK!9Nh=?F{r;v zc-bEPRwVPEcd}i{KQ206=w^SaeRjcnJs)buZsOEk)9ln}L+|U!`ENQw)q{Cl zCja;(aro>RU(D(M+vvr6>gjX-%#WJ?oH;Is%jt38*^2Te7ptC-T_YkpM;K?E6OY?- zJ_k#SEA#0(3b)+WX+W+gDaFz8;X5%&ymikz8K>tQ`@@(NUF(bw=BrYe@EOKOizU;s zaH6Iw|7UzK78oBKhwLH|ITj+VGY#alQ7%U+cOr6J zrX0rq83*K3KkJ`za=mJrZPwQ&WKQ~813l(E{PuO32v0fdm`77{U!K`RAMVuJA9_8T z`Kp|e^)=n;DlH3!t*;PexRCS~?>GfzPh~~3HbX%LAPh5T-;DkmKJC-+8E7RGP4~g$ z1+A42>78|tQ_V4t>nr`|=XEuR+FPY6|itOwQ={U^MVPkJGriQ|B^!<>xoCD0$qkPRYV-G9K>Jw^0c-@f9M z`yMKI!;p~m$9#hw@?`x@4LJQdZm)wr_=fLS*#j7i;|_*A4$?HoT#o8~1X<1`ar}43 zuDxngPC(s{fcYT-jFVR7h_*QauC0e6TC-Pb9$WjL%3pR|Ux-iTK>xXpQ9R-iQ8;6W z{*z;0|M&m@Sc6;S`Y&8&+^G8#6qhE6yB}M*ch8$H7}+6R*A3&B`8qdzY!x>KaOVcI{KEJE{8? zFyEZIc^ux<4r(u{hnGA@!bzlZ=kg<;h{~4w6@1QozLx(Zipde5oqWzb%QtI4#z~bo zI!+paqjx?1ZYWqd;sJI40_K}jkA)Ln{TI1k(pni)9%`MZxWpr(wu9^hk%a*$VLLb( zC-o;s$BFPIiPt|`b=+UGYYtM^p)+3y|T0e>yGgESyN zzcvJ-<0R9MbrFAd9sGL2MK5cG2pPHm8saN*w~CVp&#rW-iWen0?Jr?Pwl!>97*FJL zf0TK2A)m`W@hum>24uX5%IJ704kn48_ZvIvg6_jlR`)w#zM6Bqc;T+CiWhEEs4e0C zCY3i4IrUuT@wLpO|CZY}4anmvL#v|WWfAankmHqumj>rAQ{U%fzA8=JcnNoLwIo#B z5K}I1#scAma76zZJ3M~I|H&uEzW&cTZi@zFJF_MRZmQB!#G9ih-g)GoGfLI>`k1fE z5;ty)F0U-l=2N2Mct&-ScyxeyA_SHj(>WYQA!RisQ)7rWBvk zP_MQA$FG5UL}mQsUl1KXlv3rJAKxtvF=bHXv>ou4xp>+&;*94}IuoJORuU7aUC zm#)6pj3Xh;>$uY|N)m_sdD6%}Z?(%&_g`SXs?Sz&6lpUCT)ZuKQS;uK|AZxWDy~R7 z#3Lg7@$)cFcNr(+rTNn6cqzCfNxZyUUG<9o*IuCR$H075aWU~CZ_a>=cNSh`obWvm zCdg5kwLgQV3e$Um>2=ZZQga#B!*z1pe&N8{@#_8z%-2&5A7kRh^fvyE#|vSBo(+f? zGu&_EyP*FZMn2K5Xj@1hvVAGIB064{0Z)wwoPURVM34K_{Ti50Y09ouyzt9S(%v3) zooZjG9JkeRe}sLx?3pKHg7YK$!f`pA|Fh3=cNM=LHyY{(FHrGf-oK$4c)GOzpAOIc z&0nbdH!xq-TdR19XEO&Rrs79U|DXCVV}L|)5O*|gTC<0AKi2*TYN?v-P1W_$aYI+ntlQAO@}_6LQ1?d&^UZn0 zjT^-f%Fh*vH$<0f*`2B4Am`_Oo;f5qQQa?r`DUr2jORw$JOLNW@(jI6mB&2pwg~c0 z`)tAqytes#jzWiO4=uo#1*wJnkp(Iapd;nNQbIxaGD^ z1F}8#-5eb+4ZzcWLpJX9-l0Rfs{1K0UzMWOdX*Q(OQa>*v2dg2BmZZ-Fg6%39EaLt zB62cz=$!b>lg}xx<-!_}?aZ=U%(y8*v^_w)zk)!x>*X_hymP`4Gu8bSm>*7AKWh~? zkv3bvCCfn6U;eM`w;=1U`G02psrxNtA$;z)13Uh)BCSl_Z-Mz+p+D2+3$5vo>H^mX z&VzYezvw?d|8rfF>lk0RJ^gwl#?MDtw?)@q-K}_!@yU7P18ok-Rrf<+zA9TB_%rku z$$GWKBkP5ANB?xg;mx28jm&(~8tzJ__0-%0dog*HP3Ise8O`Pbc>DpFr@x7oAr>p3498S(uyKW6^gS`5xzx&J$& z-+$(PsiLrQ@$kJzp3tB6?;aoAh6`G!aY2RB^Dk;q&WFW&T#kA;Z-)PLp+SbiLF)mMSh=_(8)l*H7=Q#|-O*`CB263|o^t z4Kd`QypB3=VOF>6R;F{lq#u$><#TwndTf-F3}2Hx#ml1WC-aF^vFVLxzq_*T#%vY8 z%x5{+k3$|A#-{m>%`xO@Sd}U|Jo0_w{sm(Kv=<#Y#t-v#Zul5Y9(Ad&)I6Kys=F_` zo_tTj?j2SwULJhrP^XbK%fYrUVY6&WXq zE2871?4cyl!L#(3$Abr^=R&&ECY_FjXQqqQ$Hjgu|84P5civy zuXDpk87Iy{Yq{EA~kdzo)l9c-`7FJ{Vwtnf1ne zRk+A{lcqim&B^N^8e_;&wr`3UbJN2Yrw;$|GqMxpSPtgv-0(4~9Ie)RbALuWZPt%E zFIW6zlDKp8QG@!|ypyZW%P~JJk$xu26=A>D&^$~%06^`fJiks&p-~K`WM!tPQpW*a=V%KOmw`i zel}Ii9@N*l)W6Vp<1bu~n7?Imn1(d9OJ%*($B?J^`Bd>!<6H0Do^k*D4~>kuUNe8o z=6&DR$eaVdSs~Xh# zJ?5*DwQ5&Xyo61RmV_)L)#B*v>G2tL0Kmjx1OD3(@6j zT9+#N4!rc{*RwCZr_2z5?G5v{TCT9^X`!zbG32UwB~`riW%nzO9`^Ies{LX9R?8JO zMJ?nicrm)Z(qBy#Gta)QY~tIUJnH-)^S4?qd9o0R)Ps0@pgD$It6xhM-n}|^_D}z< zGubC{T#n4wx#45nxHsfd;BS(zZf$hE6~6)eyO(_X%e6nh*8=|rKP;Jkwx#kZ)xacQ z=1bA#qZ|u*JaFnM<3^KN*Bt4Ow5akmHV#`VpHdx6@-@Vg@2ynv=^cf6opY{wTCESv zXSvwlQu&l>VUo|cF1r5e-^RM9*-2l&cXQQDb-t1LEEoH6%h$@}V?7e$`jPT-bosK@ zr;7ROuRZv>uihK)Gz8%K!F-mB{jHKuDrDIX=Qo(;6T&>cw*>MZT9#V;G_ zXSvvKRX(0%%5l!|`t^^&g&xjvvD)9^^mdfb_KEW2z7*$8S|T11J=g7ua|m+(xazg& zxM>8grY%3>=<0VD_|*AG=0lAp7ZW$iOXBNE z;?aBlTw)KF%~R(kna{drKPFz3Ny;6K7s5h2gBUaNvl-n7{pT?9iFQTXg4;H&YifKe zI$nmpiG7a7Jn~(|yfsVJ`AOzenzCyZFRe^gs(7KY+*Ze(IQHeTXP%4+&X4R1$K`PT z&pyZ9ReagLB(9H+m$J9<9r-&N3m+VIOLujilKHCMTE$DGNlRQD2`^MuT&|RUq_QGh zar?n#OaJ*=_UU@dZM_EMes9)0(eY9bJk4L26u4o=&+n`AmdsZri3cz0&<(vxq2h+I zKvnsKAfUp4|)2R?h&x?9Ts$W!MpnXl&F zDsG}pW+IVgAbH;D-#(uy>oMIJZOO(x5T4cf%(R{+YRm>fG&ljJLzT~_VJz1^qOW!?bzQGQ8l$|%=3eu;b3ms+7k_xxeZyV*b zm$+RX=LBzwQ;%8?kMF;J1wp6qWfQL4JkyeQHmM)9>^b_`MEiAYdCiNe{H;I0Hd+0=)hp zrBM%J`9xD}`I?60cDsA_&2$TzWBF7*hsQ0S1Rq(#B}jG&vE`N zpUUU(xaH#l_xdC1QJx3P{4ly6XFT3nTzlhlb>ECUGC)`)w=anB#(a$_9dZDxxwgD2 zpVRLucY1<$w=LJ}o$GR8`DNC{J4$ie&=rDz1!M~BR*{>MxD}LbU3YpxW9d}rZ=eMOo(J!hnn_rSicZa zsOvT;{+|nGAG-UP`X}j}oL=6$x8UocLbTK`HV*VS9YJTwBzH-H%V*dXvfo_JOCSg3 zpA8}(>e2EkfU;kE>XrS{S9KOC_E#VL@`2^IrXh?RWG};Jh=kq4cE!_aW&*2$NGs>PU9a-o*H~5I8}>?1L2j9DqmycfKmyf8WuW()C2@< z*>1OYUSZJdx0gDz9b|C}t33{LeQeqoU5>0zv0wH%!%sP4jVT?* zdmVPSk*{rn_araX$s%t7SqX|(kAw&(yuOFpJx*In#yZ_e8mK|OT#uVRH{(N~vQphD z{wzuS_IPkk)}|!!`-1O|`fk*N8P^+y$oOEsdK)e9QRq6wIo2~S$B5VjU$xhiH1|!Y z-m*O*>`;ExRFI@pN4kKzg7yT_64{=h-k=Q7A)q0kY|wbnu^<=dG|&~GyFf33z5%5n z)3Km)K+l7^Ljbb*pMuI@K-xf%he4M>m2eB;|hX&+!!}o<5|EitN?4Kgee`NfNFQ%?~jCD?Wrv3`^)ht`! zU$T#*z5YWpGsoo=c@LeCV_aAZpX=jhMV|CkZM6E>)FnaGU3uSYbV=vj2f74~aD8uF zuGI~yAu6B4C)z7rrS_o9>#71P2o$JtouZIdD$uY&LKPim$;Bm%|js_kiMpgLSE(iWhcLmG56+!Cr2Fkqd zlH4+Or>AXodBQ^5K!bxSf-d(oQ$xNTwl{GnGH&CVXXs2yb*w z;>*u#U8)Bx8+!YZL&>g?)9p)J!F-(?KH_9O{uamTNNsiWBR?^f{-|qLnlQ=xlILTJ{96sGSJD29MM|m9;^gLm6RyiGb#wmwr z6ek@-`mA5P@$yB;UrwLWmh0`BZ_V|VpEJZ!Li|2$^~o9EV1BIXm6h`s=1*^DDC$t8 zLFLbU{584kilBFn%k8$IN}z*P;CDJ)0X%GY<~aT1?X#V3RNg$dlSJ39Q|&yO1g#Db z7OBjr?8s3$%8veXIElvRYCQQG>wL>KAlIvcW;0%B{0t^VBu+znzGm#14FgidQMYVP z88>3p_-X?${SZ!gVZJIs2rt+_({FbK0gv*j9`8I4%-Lv{6NZcG*dWt;^_vtq2>2w& zX3(rlPpMn7ytA0_`zzOU?pBh(c%Z%z$-#X5H96gGjkj0BXxa*=jTu{x2Le2*BXfXv zQbo||FZTw5RMkiO?QHGM`=Hi*XVy>6)r&N_>av9xUi{P2{D(S=pYC;JE}J;*##cxn zIF^g~IyZcbELW(}X;rp*B*E=a`uEZ0+VpT|VN2U5bN8#-A90f20EOgYepn*?OqUC9 zC}=9eAeJtYeXi3(jUkG0iqnU&D%b#+dzZ%*z*t*>-5&shQfLIRe4As)SNlk3F{tNQ+;TboP`y$(MWnL{0=-F+e;=mgMODI zFv!-j&}|c)^P~oNY#_g=s9=(xj)g|nOQid%{~@~GGal_M{_1|+g2Fu){_?e9==i>v zAHE~~OusL=eQlxmQLYlY4?N>*_cYq?EtldO3Cit2=8xun0JReYgOrg8;>DzM-lR)< zUAKDbpZoNGf!kt|vn^1=`N({4kqy3D`nql`ZE2ae=vk0bLnrgSLs+dTm{O54U#jB*As zJVPBi=1jvF-5lyYfytN3_OEWUxjfZ=ZUI&^Pe1&SuNDt^B!R}v$Wc2+c8B>IQ#wd+ z(z?8walv?W5Q8;i%YANJ;XJz!@zr*c+BO28j$UL;~&xSG4yxrUz@kz5e+9)|7J5JU^~xzRj?NLAiJ&^ z_$khEZ_vr{RXaju&(A;{NA*>F@P9R)^?%znP=h4cj?DNo_BccHVI!8;1XhmWoT;Be zy%m+u;S=m0*BnfR*z)ZGOaWusFj#H#gdaF+5Rvn5j3fVJANVEZ(6Y6QIDO7v<#Tw% z{4s*$56;r0kn2hDU$O5$^<8nc{mBc-d}@yKSNR+sG5->0z~OgkLoOVz1}ChCra0ty z)K&GkYgy`9dj5KUk>;(K&*`!sQI0^+4n0)(-R5zg;=g0-VOZXuDZl%sx4?nQkD7mp zE8uh6t0|6L4x8f0|D(p?t48f*LzImQI!x|4=-&z>eKnNx}|eIEQiYH@W^tM+5OI00A;Du7)~|G zA=<>2qsNuk`+AJ*_5tU^a;SU`k0^)F?+tn#UiU10fYcAI$mLQSha68o^VQt>{(EUE zN^>lS%IENia+EsCX9cuT@mVe!6oRV)F+S_tCTqB4e9{mV&*jEVKz&($NJYchnu5U}=q#C$CQ=};J~cGEOK zcrHkvGgJG!bP3hVL=g4DX&i;df9OB?JTE|Txc+dR;{OQJ9Q{{$Mv&#jsR7xJ7bKeP zr#ddT?0dXd`s}`MmQA_mLDoCjQF?A>zM5?Th6ic1641a9y9dkT3cYiJ;c9|GScezG z?Q(r>f*jUcF(pu=8ncZPKg$=21hQpw4~_e zw&LE-;;gHl`{?8jMb}Kwv(fqsglFa(?2yNk^4b))jh1uS{nex<+vwZ^#FFb%eT@7m z(RE&L$*l)Hbs%TJ{UVjm;ZgIqX;xT^D$9|P99<7|LB@>V2aYNzzL)c1IaEG}o8>61 z4geTj8ip#gs5Llpc`S(`$1-~taahR>mz?^s~y<&AI z&9=}`BIVC~&X;{-jX7q$unX#*WZ$Dqq@QEA+`PK zpe#@gNHcy?1S}I4t3hKB@hy-Kjptrng;)cs?Iy$wOx_GfUw07Jmu6uu<)kzr9zc&f z9gFoJfh{->i>}YwUx-W7g}A$y5FhpyVqjl<%k}`>#@?5KwOs>*C^-o6F!1$8rVw+` zvCTe02>+32pO1z}Be8xr8*9dLg?KVgi0S!Q|2qzOOccUCS%@!-uug0S?&}1s^|cG} z(i|bqb_?+d>{i!Pz&``)htGyw=YxMSxS^Akk-`xB@*MF(3Ok#unzk%i)` zYuHWfxmP=pesg9>G?N8O5JgN zQTZGmp&hL7`7kdTz!Hwb%l0`Wmxf`?*`q-UXw$%|a7aYfTYVhzxljH1xi9*iIEC|P`BXlK zN0U$2TV%=VkpSy0D>Zg|UTq>W#W6Py0Yl164Q{viMXsuL@1OWSx zd<`+=Ys5P7N2@09e!=kPFHA75C;7-OG2dW^yl@YTtg$v_fqC$97aH&qU9!Ro{~Wu+ znO8oW-cXR`Deh{0%va^n`xE1H3kqyF7%P^jlZd6_ zv=o=)*W-k7l(DB-FKYd(?UpPmryTd<-w*zH_v1ziur!)pn9u35udhjW&33t67zi$K z`sZMQjNRjK+KRB&LK6ro$;H4+X#k5Z3NeL^)pn}Yr-qE05yB3Y z6P@pF`1A~l=0lKAk9vuq_8_{3;?Oy%l!(({41%RO^*{41A8jC%!1!rU@T0D;s(Ck6 z*zUUUvtic^AL=!f=Y~%>X1=P^*6~w_?nnU$*2fe{x0<#BtahTOk3o8hHSk!@g1yYo z6NCwR7L?bE?0#}mkKtv#GSKDF9Qg@Y$;o_!9rEP<`!qX1Jll;$L}>P=5R}dRv_|Al zE*nJHQpYE<11bT{jP>JHTd9#5=7f3?qNY0D;G(m|^ylpVTXnjFk0p6s~4s;!;PcLh1D3MZ`p zHOQCh8s9&iQ+?!d_Ts!0aYnzhj$BeOvNwg1Bf04QnXfUW1LvD>F9~&(DOhg5i_@a# zOYsl5Vb8?H1D-=~PIu^5!tL9FuZN<4Xsl<&P#7k70=8*GwI^|Us&%=Y`RL{ZCe03b z=?S+ar#cs{mktz89?eLYzEQ#YszWbzK+iy`skTM$j*`@KLJPPYfR}dbwW1vZUZh1 z6nTR5R;Jd~w&mIV?&^GSy`@-o9k5Nsz#@9W#v)zwbIE4NMYze<^3waGa=S>`oqJv7 zdrS6r+v%K~F5m7g_8M!KHcRh@y-j_a-G5KO1sNVxl>pTi1SV975n}JzHdLdZ04YE=~{A}ugcd$(T_3m z&GR_i_DZL%aLf#wEITVLgjOK3%RDb{K1OQPyxoD%I9G* ziBVn6dK%g{wmhjbIvn%JZV%kX`XN67KjyO>?6W-i)mY+IiPyxiZi60nWIe2jBj4J` z?#iwW{C>QeFY`G+_CxO*@kzD|uiuwA-TKRl^e$y#g@g71(65l~X2Aim^^i03i5qVi z{l_#_9_F(g>}!^?q{0!*ce;JHQL|w>T|ow|*3{7^0Zvo>X^caThi1L-vg77=j#A}d zKIhMVWI43409^nhqC8$vb6{+J9D4B!cbwQY&#lVAe9oVJ)SIApRE~{?9`ZbR6UP}a z%ELC=X%AKqL`yLyO)n7Qoesxbr{6HMlCqFkJ&5gXdcW9me!KqHdvofGZdT=FKFi1c zR>)~mri`m4amaV!Nh1%v@9D~iRQZ_CaYR6Q`C(v%(Jg@Na@fxq~&(32IS|yv>|33s`F#M zUy{XV?e0j=cw3Qff^?6~eE(pKEN(0uIpC^}z2VfO9 zddR=$7zxAMTRQ4b6IssEKr{_l^+neX)kzvVvz(=YXd3u0)EAO}N3=0iUv@-3(aOUL z`*&+V?k8><749d}+M3nq!DarXPmj$ig-7jgYt%O5*5_~5WBuGH^~`u6nP z#C)9_K8E^<+F~-JZx~)&h4oal>!!B5jlA6KKhaO5yWA1=%c{p=JXvRvHL$bVy&Zx7 z$afr>OY+cj)xS-y$kJNeouz@DRbRIBes=_pt@dS0OJ&!K&-2tgp3E8`?EI7CSXMn{ zP3z+yJHj4>bF|L>YZ_PsfqC9A-5Yz}u&VN${%7|r{)F#S$5(<-`5Yd4o->X6kM;Pl zx3l&_7#0lBxi|cbhxcy%L2O-GiPg#2d(qel8e4Vx$6#Y2%%F$fL=5d5{oj};Af4=p z`e?P!j6Tb6O#@at8P*Kd7t2{1h^7InzJ#@7wJ%{^SZ9$nu(RsRj_6-SzT?PTlE)ff zjI0}r8`i+isxM&)VxR4Zx+9Z^@T{@8y3tvg>vtG?)EVAYqMkH!Cj1Xg{~OUZhE`7fY# z=gVl-7puPPd=&n7B=|4X7t-dAc!sf__y0S%-C2@a^(Cx%tGz^6#`Z?xI+2if>* zR1sbe95rb|F1B69CA49X@$CV;GpO%!Yu>NA#ur=eyAEsj)%wl*eiTsTX1**loo}t& z+I~^=odiSHWk`$ln|X3&Ouvdf>=>jVT?X>Q$Ck`;MKqgxGjjG_t&wy$>tbviD(KSZ9$n zP!BfSqh(V4rh2P>uVT^vl10B8(ne&iSoO&eBe{d%(|g~{H`pPMw==}Yg8qRM=0~seK%U5~&BVdG@X|eptWWNfF>!KIZG(@NvuK8&!eL)%kNDq6SH^d<}|xs{U3#lq`}zc)fb< z`$t?(b(36I5b2Nk8dExivIEr~hk0Mh;(6x%=INdMb|BvOpORhv!ucg- zD>o0OFmn31cAF4i=Z24={I%`x^PSjqIDoIG1+dF7_B(Ty;LB=$*K8E3af!U|*(S(C zE*lgHPqn9|h^jAagBvb;qo`DiNjviE`e44n4tXJY41J8k2K;_}fXEpVtq41J228lA ztuo7@;->!GWZ{|C*lC}WN1xT(*dQ&_kc0Ul0gRK798?w{`ZV?!Cq6f)e@lzFfk|_6 z{MhqX$GNR_+!UW?F1J^ZM*}FaI$4}B<_?$mD_JbPwDz&-<(F2|_fE+1{&39Kx#6QE zpQ8fbY8vfwx=U=@krX6m0Dy$sNZ<7$Y%+EzANrO`B8c{jqkbT%h%`#yIwN_yfKov8 zO-#Zweba)zt3ltCz$d)~KItXWK=cva9w298fN36etfg8Z-u!4;l+P1~d*d9y9?o5i|)@0K#X)#1v2=s0cI_ zGz~NzGy`-jXeQ`5(D5LAYD}C6nguEb*+H{G4p0e*>eL(%)r~Tc3v?1_F31fk2YEnV zkPmb+$PWsDXwTXTP$g&{s0vgKqVM{g3OWsRI_M10nV=fbS)j8)=YY-yod-G}bOERq zbRp;>(8ZujK$n6p16>ZP1I-6r0lE^j0CW}TYS2Q^BG5IUYeCn6t_R%!x)F2}s2+4P z=oZlbK(~T!11$#K4q5`b19T^7Dd;ZH-Jp9w_kxyz?gQNqdH}Q>^dRUV(8Hh=phrL} zL63qS13eCU0<;RW8uTRSDbUlPXF$(_o&!A(S_66k^de|2=q1oP(957#KrrE?M$2XJ@(?Zg&v12h7))(ji8@w$Vp@C!uw9dGw2@+_`-!J3U!r zX5*LuQtcoGe(!3#rs>Erq&Ce_Jc_OIH8u`~KBwEATjq4kwP{CZ$#k#3B%tAm^W79j zzH^#7{gHBqR)w{sIbW3@Az%7b8A-ueYf)-&1(BTy-FF=M_I_|ZmTO5Ia=noA$fCnbU;d2qWw}&7 zhsQ0~M0BbvorY9qxw6iVt*nq#?CK8MFIm)9st{YtqU8{?2`-~%u0 z{zOJyJ6)b|y<$Gg!+r$0!Yr*1-V$4MZ9RzbRdr5meRUss(N81%$<)MZj`gMTIXo;x z2=8H*Dwl#WN<-FL3i{iWUp9#RNcFM#;bZo{BXDymf;GqTseBF(3loQY64qopk#)XV zu69VA+T((~gm~?#SN5a4ZgiaI?$qn|)pSlyw-;?%@byp{Hw*;kp+%fv_u!>>KR&75s&Qs@awg?DT_N8#+TYU zs{hQ#Uy}>VNdq>aVNg@~487Q_A8MnhT}bPLv4r*O4z9f-S6~1Waa8#l8;4N-TFy3nN3G0T0)7pMaanbVS>N>ibb9Kj%EP_A-SotoGgHK|cRhOI znOh4obcl!kg-Mk9T@XwO+eE?nC*j?eV8bLzhNMEXrv;!uUSY zE;W}Q;fmUE9;fxyC5y{@*S0q4F0cuB!@m6i-AcD|GC}T zxGkQV#(ObF5HLoO&GV|TmDk2?G05v=1Zb!rz{WmgZRHLUxmvZ9P5cg zOw)IX%PxzJ!wLD5+J1ZeJNFuJ(E3gZI5L0BhP>pseyiV!ps;l}UH<-{2Xe>IIXPYK#1?!#v}HfoT>dfi zIv(FO^f>5oRU7AHy*2@dvW$)D%< zd;Rn+WFgWGIj9}2g&dsE8t^HP8Y7(KOhkJ{j>}P7d9t#d&fChR4ElFg1wFIBG!t(b}{86wFm*GMNih6qo?PBDu8e*kKHNvb!_V(=)Co6qHq@x)N$m>r z)x1LYq4x{8tn=-GQTCu6PqXwui;EV4Sf9<1gW5DI&(>Votid1cbw#nWgYgw2zE_vQ zSFa1np-o}oyL=@sZPM5ln)kyOm@v;Z$wM(6_)Ir_n%j)Slm+C!97SJl1`=^VeQeT=(s(xJ+|=U*!s)!&|$r$@C3GeBL#?wAAk` zh5d_hqv=SH?_)FMl;t29l=hbetPCe(w4!D*am&1<+U+0F8t;yXIPtk8A9ZB+i zwb4)s2on!ed+ZETb9kyvdp z5ItI9Axa^}bpy1qDeY=%e32Vda#W~BLZwXECmoP>AAeMg*Y{lsBHygli|V#<5s)u-=kKXKKU)IO4<_-%1y zzQ&XeCOM4~MJre8^;heVv*q9;=5q%ZFC*vGsO%r^ItlsyMQ*Di8A| zQM6N&Jh}wBR0hQ4e%5N_AFCg5al`&M3{Rhb7Ux6yAa{wv*SV;7GS2m!vDh_O5uon0 zZK9X^j_J67?O7A#kn^EDW5(xE!u1fE?nfP8F=ZO(AG!sqAFS&*FSDXW(SU3RRs&C@ zW57q#G3#3%_e&nr;gc6Of3twgfP7j3+M<=PViLtj_i0 z+sd#?Qwk|hagCP)kX^@BcTB6b+EDt{`+MDzM z-b{QXSuA=ZCI5uFAMfi5J~_&R>MQd#rgSjb6>3C7&*=JmlB~~q!FHWi_mUPaoS6`&7o`3L9EZ!kcah|UAf{>8cdeMo22l*^QXT= zHd$_8Yj25-*V}LHbnh))4|L;F&FSq$TcPqfyhZ;AL#b{jHTNE@yrSvdQg4tW>Fr3k z^Mq(6MnZCXl7e;Br0;AH`RaK7ivFF%es_P9b?U|*T~mzf2^&=I%s1E}k44~dES8Yg z%W4nK#t6GCN8@6%96Z-tjEY{_F_V_tiErOO>Y`4YzNTe(nj=|BVwJD4aZu&Jgm)#T zzr7y2yU_X4uFxD`6w$OVBQ$0bKdo13}Gv4CRmjQ}&T+DWS$%El>wGnk6%%B`=(QwFk(xs4d zYVoYwd)Q)r#DJ<@1Bbt}Zuz`s)iRz3W8mWw6TuB8F19`0J@ZQbp^Qv+5#{CAd% zCDpE_0r`1$DBhcoHSS#g@$Ef+y!|$wRy4*P5`@ZUEryB@pC2lG!D*umV^C}JVk!HCxE3NG_mOQ)0YtSc_1TV zJra_in^QRf_?(x-vQBrf2GWrqk9*VrC%m3$x0BtIX{_9YBaG*h%LY-|spIYS13QT` zuKB1SdEFsz>*MU<@qXsh^|A}&NFS#O!+VU=V@y_4{23q_N1VQ#7M-`oSL5-2x!yL% zxWA0KDdOY%7o6B-zZ3msMgo){jcYTX(`Da0pV4w2e!3r3N19Mb$Aw%TDJ#SC3CGV* znM~{L{OyxVZ&Skyr10ibXH<_?uJ<9F%lp~8hWP1Ttyf9>0_vELVTSYKDHcR=aq4^Py@^LD%?SeEw7iVdo;HF z`tys!e?G5ak&nxt`~;wZ`C$q4Gg|pDHsE#Zt0Be)ST0%~SXeQ;+!e$dZ)34w1MBuM z&tHOh00+I(BN5t+1(Y+ z0z35L_XJGyni-Fq_0R>0(7aCu-axd!)#vl9gFA`r3FmaEOq%fo&jV8aRBxEi`LZ9% zpH6srBsO1TwB&l-Zf#zMS{o-Yi3?dDYZQ5Czk>!)Xnzu%|J~z*J&sL(aS_jN5zb41 z80O=z$;B-Xy&5@)SKUEpE^YB>DarUw>J8>4{&->*zW_KIWT*!=Ejb zFSH6ZVAEw>BFUGsDzApup5mR=tK2` zDy(_FzxheC9@CLYFHqKMyl=Vr^i7TMUq5tq-sH5Ox;<|QK>KP?yoP1{3gPQRZ7q4GIAgdY=d@bPoIgW5OO zY`0Te_#BwxEXSA6OKe5npxte@uNhC9aZR?K`t`N@_d^L_7oAEmZ{ z9La^%{2{)^lnx=ejF*Q^;%ToHVxgVS>2S?)IWz$ktjq24GDW^f{gyua9C_!%7rp;I zi@pTn_;F0@*P z#V~lrYjQAA?(hOs?&&3>qe6Dz-(;V9;ih_n`hfa^4gehpB4uQN`hy0527(R(9SpL8 z4gqC?4h7M)@?g+mAlk6y2+$DFP|%SeEJd~U^@0vg16lieZNGiJsGmzO^SlOn9Yhal zZ-U+ey$xyvtp{xYy#t~FsP{ncgFXN?fj$I%1o{~C3FuSMM$l)VO`y*~Ux2;@eFgd& z^bP1+P&4Q|5E<4VKtFT``h&H3y z9n>C_28Uz{)It+9;=m^jd&`{8k zpkbilAhNyGA4IXAlO@E@j(uLQ|XwVa_uRmDi&GnY!sa@Mp4y__} zX6V^<4(-m0i|auw&!!mi)Xq*3XCL;+!bQ&>a-J#=^S4PJ+eGKQ@C|55Es^A_dnvlU zGD=cJ?`esr6fOGTL{&cKZ<~DRJUC1JcyEQrJur;r#Yk1PNskRLo8^r3{B^mf?{6g= zzU)NLHRK4lNjNfJV@ijxTIli1>Bdf}=$wXDYZZC%mI_`q3`f&SKfGCKJu;B-DJ8v4 zrzE%P826FF)VS7vT?4XR$Z9a-rx=Y2^_z-cNfuuo^7NOPz7(T+<4brZn@bN~JwWLo zvW+DF2+#!3ED&|{=@IQh+gYDY`1Be&4#~!T6XaO>s ziHz1Fqb_@4416E7!@bZJqVt&s@fT!4jsoQ8K-+jK_CdwNN6O>SAM{9V3bHfx`x|5E zyW!*%QL=K%0ptI;@O@R^%%?PEhZkmS1p#M8i5E*OOR<}vy(C;;qo`iSLD{Qe9CSqD ztNZD1y>7a(tvLJrWykvhDWcyqhkr1#^Ha@7Q$q;HIAFfc4IkqYhAd1VXfO92X0mIE zuZ877F=_ggaamuPBGTutJKfV|k0KP6=1`1Ud&PW%9r8l*@OLC~{oX)8-}yAQ!u0)M zx&2x#$rnjql<9-#-{1Fxet!=dO^Sk}`^dnN`5IF?w2-e5n?>RUf&8K(yvUeWg%<~* zEDy#4P|hw-(5O>kJ8XRAV1m=`L1hblm7xK7u-tX8hxOW;+&5pCyYBCtBQ93uX1*k{ zcG^Pj379}|71?JK5~mW{M;k}x`zd}S_WkTL?7Yjm-FMso^?sPY zRriD2)1LTe4VvZk&lAdOysMc|Yiz(SW|2zMrxU z<*>cmd8!}m;dTbZv8Y^hWX@HthuJ=u-_tbu6gQ$$?oUksx zC%LNnoKr3+z4BJB3*^)K5a#2r$%Wrb48JEi0ncRUBNVzysfp0vk(A{qTOYPRl)n0$ zNEx&r`c>CeH%$5INfHu{;_Zzi^EIY)2+I+AKQfXSrswNs$Pr5)$FBSH>W40Ds#NvC zd`SfDG%QC8eN02sI;YxrWmMM3=BBVdHc^2be_*>3cvVB&i}$M^d~NlpPGZKezxzM* z;Hawi{d$fRjh>sCuXDpk{@??B$BLej$Ghe@gJ{_YhaQ$^P4s4$M0~$3oJxFWRM%NQ zvh8GEe5qKmB59x=N~HSB^JkIbYz>cwU$}h8x5{m6w21L0rF=-Qc(k+JzeEFS`Lre$ z)d3>8UbGh1;%`3<$n9Xwhv9aR%0eAytQ*@&Y#4pjS8w)6$mjkg)ir7dnXgI~esHyM zlc*0MYhy#9#?Z9RDdnT+a%7I{Bu=iI*?;ZO4yPI26RpmZ9L$ef4(uyip)Cvy%R<*K z0dc==g(8po-fYA8PNL1NA2xNW+b?hJ6g_9|A246%hK~{SGNr;Z-s|-l!|d89ny#vF zTr7AB54CHF$>o>zadf@W1*a`_ty^6&_)wNax0SoM;B$C5Z~X&ow!(RKpEkvu>-Kt_ z5LW-hR}C&;eXWj1jwctcU$A*xX#b*+911_S9NI?)gq(l+#@Kqe=CawxeRyVvF`Pc< zuktxu(u07u(73#EiDx4R$tjxoMuL%H<4%Ct{2QFeDw4 zZ_TFY`1eihBnnEOp8ECuU#+3F6Xe*AGhgS1k8#MSR|$UnGcNT3pmMz+_8sA5we_pg zU+Z)mH6V}o&-mPo19hLT;=(TCh!Oj2$S=tpPxJlc7zfPPx#43DW(w!p3LSP2b|Azu zVK;_7 zDV>Dv${v#wdv{p#y3xR}ewfd4u-}?IgJ_L66<#ZX$^DA@X0u$Xo>GcBiR7|Buf1mZ z+wajDEpjXu^L1|cDA^OelcQTbqgf4ia@2M)oWho!QTs~}C!dJaN518@O#>OYT(<92 z?mSl~r>vGEt>NP`F-(sf-8$dF8c@rJvzP0LRZgsx9q+F|mfZiG@m=hFM*q6$n0eP% zPFvM!?p0?{o$PCf{I|hZ?|>E$V>Qw|yT3%+Qq(+WIMw6C%(R1E)hfs}#`O!l0sO~$ zFgs?jOLW7nZytwD;LAAubexdfwBD`?aNmM;5aC&!SIv60i)b@qV#%j7me$DTgDS%Z~I+`sXr8!8x^Qv_6f9%8AN|h~jej;M8&vG@zD`tS?pf5iYk_|F8z?kv_Kz z%`xmQiE>`N(bKO zftDfa8%tyUPy5!^q>7*e-$TdpR{aae+FPcRJfppiia_{#lJTw+Peh)yhMH^$trw>j zj$|a;Lhr3OgXI|}xldX#8NC%d)G+=4K(txD_ zO9R_e16F&qJ+*12Wof|DfTaOT16!+s&HF}vK9a{Bwl?iZ*ZouJM#^hv^R{JfV@t1< zpIPPeovnj-^Ote4rS~3h9#%X{1C|CX4Mfs_Wpg5F#o}2Sury$4z|w%F0ZRjx1}qI& z8n85AX~5Eer2$I=mIf>hSQ@Z2U}@mLr-6D*lBw%Lx8yEpj*Z9~H{KGh#UD2xQRVWX z_XlLB{+Gk#^KC6>IW75|%U|ZjI*(W8Sn2$K3RlZVUYkuiw%pFu0Pm|2YoEl{%BnT~ z*4|Y;F68$wd^Yp@4X+@q0VIE?@SE{B&v|`A=cIAqlOuV?;mCZADINIROEx;e`wTv} zGl+K@T7Eat^qs;*#4R(&e9`mbAvttTj^fc#s{op-ae_z1Y)4MeEMvcnna7nJBGQ1NMbUX8^ zoQ?|mvW)g((sX{)hik|mqn zumuuqvEzH68WjcmsyyXcu_Lxvo?^!ecCbC{SRd+BzH{c@vpaWkwBa{gFh+0y(H z!;5ySv=q(E0lZU3EI($~ZTHqu`PfnMY&%Y}bai>@>iD{@geYVp2g2||^EcUW{xqr_ z&?sM4^Kqj}>}NKe-iM!wgMRh@YI-o4j&7*R+(E4{;Pb#W39ek9OVbb6oKj{l*6Muz zMm%;?a43bta=dtMHr%k_aN?w5CTMYdh3D2-{Xev&o|m2BQ_dgyKVIcaXK=giamxAA_88)aNG6{< zb1o=8x~}hEnOl$Y%Zufo8(4q%{I{$-wsJSO{=TifIafSFIA5{F#Nc0YtbQkKNZn+YVGQe*;NlI0>WsM@oWiO0`$Aq9ENs#oECz{t)?hWqyfF3qDg>{=h|L0A01KDnG4(c;=Q{!-25Qy=j+z}mKO^UD6 z@@sHwAeOEGoCfX>xV_aAJw9hGnD%MDU|A4~Qysia*Bk+#u_8^bmx*5(Ih89@Lh5C! za$q5(M)mS)kQ-DvpfPXcdO7Qc0nD}k&EB8-zPJ0;dI5~w8%T5vFREz0oTtI^KA0+Z zFVMuw+3+mZ2bCwq$Fcgx0qlmK&!1u+R=1H~Dg|+n{1RQnfc7Yk1nq+nP%KZIBs}2@ zQh0mSFbT@cnsrZ%n_y$X?zcYKT>sw8wW)dpgTcV^M06wCh(VXemf>YwArGv2BnmF| zwU;{rwI$x%`Vg%frGO%?=9A5Ql5x#CbRety>zt$39G-U>Rh)#2=oBxRgd!fUs;bt& zL|my(bN!=14ud-ij=$^4wMW}n#+&7?TMsQ*TZkD4if|EKr$(R2;6i@EbvsV@ zOU6-+iGq^rAD!AcPb@Q}J12!5FIJU5T{}-z{&em9$pCoRe&ha?OsIEh|H|@rbLy}z z66@s_sa~dgSny(%kM{ibBmB|>UVVCY#n^jxr|}5J(F1BVqN5*C(XB9aw^=@H3xO_R zP9We81RY+d2A5Qp0l}kHK=bc))EV`121G)*vt3c#?>+bZP#l+68t&pce<1Pt70oSG zVt->bq>ta30~$>mXuN}l_8~31IgJf{<&M{y&auxmns+|8i0wPk!MjPxe3|I?%?AeP ze9>G*zG`gc8|w{runY)I{Mab)qqpPf62v6Bv&*CWI=kBg4d^bfC)nC^8;HS5Aw8Cx zm48K39M~Ehkju-~NK-5aqFqc|q;KsqEaFgh#Q~86UA4R*Mk+I^yofob?Aww9+q%41 zeLI#DDl6!&%8M136m45@psSV_FRHvmd7*6998l#Y$`@5$qP$QxYYrsaZ(9bzY2Vs1SPzXV2Q-d5D!*cUe^%vd z{n*!|p82}z-!@i1d);ln9C=mmmr)2oVP6o}Zxfvpg-0puAi}fq;e>{u=7+Q0;5G(0 zx&gO3&h+^ML0ruqaq@YK;Ji4mvk~rTXy7+cM7C|MfH(A#c1w?G4VlNgP{6%G!rk=U;S9G;7YyviuKdnEuVs~u z4IljQzW1KKHua*1^pPL&m*_lF;SmRS;j~gbBt!Qs;;3I_=HCWL1ow@n&S318RfT75 ze96X6?|1t(Z`2-m`EEv9goEe;1a6Iw1MVydXhHNS?iXmjAwG`gS8Plhb zZX`%Jh;EQ0MjRZ|LUn?q1@s_Wqh0CDF?{61le8cf!ebQSBtt51iUY0p$8-iyNIp9w z?zYCM%1c{0ru>T>*c$DNm|kbtlPQnnhs;Dc#B!C$uX5jcI3Vt`&Ac(%Kg9FrsK4Bt z+nXI%u>AI{*KF+Sx-&MvaO;C7-WSj%5BJ;Rc!cOO=OX<>v={>s*jlUUCmGRj!=6(G zqm@!PL4tQ$ArcW+lkz@`boxLyf~EGj=_O22m<~OO6PgC_p7!s#=9Fpb)1Eo&#b2ui%lss|0FhhUfV12eba-Mj75}P>e#((q<-XBb zS;%UxTHs0FG48SW{LcC;jqUf?Ew}f)t^4AK_28V}C>KOG$PuICz5~`cMnA(o)<~fR zOv1mgB|iT8|D>@G8@^ky`JvDM$}+-}Toc_OM~pV$kD_ZOFM!>gOA-E8LQ1j5Q7H4I zu>X!qr0JCSPt{IZ^9T9ZR$f}iq^LU*2g2|%RG+MPHCnG*t^2_5?w5Pm>jRH@uHTe2 zeA8vh4w6N5of>^c>XS(g^>BSk9o}u>vFnvX>*XKinje;^J3KSo&_eP^#z93O))(8O z40q%>l)j(LD5sT8aUjY8Rc@lZK$|KrW`3wQYYyxv{YR^>i&qB7jZCZXL_}{wZI38-{br7a`+ z@cp|RZs@_z`Dpn`=+;nl^1>DSwH*8*zJS6w_k<_WIZ=2-#-)+@Tg_1mlec5+(;V~M z)sCRs=Pe65{K0Zxz8m&SPuE;-zvcupP!G2;^S#wDLFe#zX2X5V=6T$P)rs*wKjiK` zibKoye&4`Ec!@4R<<>35%fAI;66c#YzMUB7{s;VU|3RA`8Q)vLiQFZ6N8!|5({YwO z0Jrc0(_`OziF~5DK{;)FM|Y(E}hR&mBNn9feiRKYBz1~MDITw zu}8iS>$8Q1JGOUAz#U~d2Q-?gpz*Ft+p#I^#lGjh4OVu?y76g`k1fQj(Yey=#O|%= z`l{e=OFLYIUQ%9aFRk%;wNg(gpueN7q&(NW-!5xSfBt_L;lT2Q=~Tj@5HptE zcMQgT&f!=0%9)$K2JNWyz6!L<5?yzNZ?eJxCq&G~f4e*$Xknq@<+rnI(A0)Jv=2}` zzrwaQF|KR&KJK-9&MV5MbP1PCCwCcFi5GV%YPmj_27loC>d@WktE=~DL4LA_+>gO? zGBB@Xm8?H;pX0J*zHh;~$1lF`tgk3dG*jSrjX{@jM7}RS+9ud(OSAJAMm z0ld=Fp5t=)wE#b-bWbOec4lUuB`{YUrJSaB_AD2bzf7GUKX$FEPJHuQ(yN^xegyC|$xO z)5*OJxCCyQ&wpX>C&qR8JMOYIvlcF*bP1PCC-(@hsaj*P7WBKF0lRUR?sU!Ja(h9Z zL{5q2xj6|u(r7(t?5&jfu z?)nAp>Q>Cjg%g;neSQ#au0%Y`0T0%_IiN8et9tn4^bZPG?KRWO0~`L(w@fGZ2%gsY z6}|gd$S@I4_J@h_Yw@I*6A#IqXkVEn`%tM;;Q=~M1U8+IwC z^azhkC-(?{r2L99$DCmq5RlsUjev*lu|Dn2|8&Q+!iGDx@68`2=3k%8U+!#vpn-oE z1mz~y??gwMs3Lg9{Pg+j%0jd2+;EvSG^*2lLGq=!gskP!gyD(!5ntBFiSZ3MW!Ch! zADuc}=VKHf(M4=%r`nEXG6jBfrN8 z7MF~1bVNLH6H$(e0}=-o!aJ4s)K8=HKq!mZ6Vv$o+NJ{;`|-CY`)nAO&h{*2?|%Hh zQ+}!bNSD^0;1Acq5nYO&75nD+?328%avwa5(*-L6_UW3}rTH~~F&y#1gNQhq6X3}D z=Rh{napoC)AF0}uuMc?md?4Z=dXhMDYup}JVM%$7A37%(W*KPW$EI)1{J`^1`1(QU z5m!%nE-Ry_jV-?az~GF3{O9*?_R&*BIEaJjIyL%?&MHQDFg@fg^7-n;S;kynU7b4^ z^^2z)y1n^+2OTHK!oYsSN%N=C6gt-ytBxW%nxs1yN!O0Oqw`i4{KUh$GrGz7Bl92;4@Gyh%XuKjr{3Gf zfkgS!w%A(xmh(^cVRXx6vU)c-Aoh2g{*d~aS1sZF%;p@%j;j3S4h-_ca}#G3Z94P= z;w$pMJ4=bsjc6mrM338BYcKU{{IoiIMZF8=m2f884!e$m`MITr&yJE4Q630{Ov87g zkx71)Y0ZI-${*|4V^b-A(3I!faZK6dIQ zXq=_;wf$Tb*QqT`8NegTfhY2`Nt##LusEGv`n_$@{uR3nwHZm$|CvNL$Pq&?&r=-p z908}_T_4QzIYYRaU7ujFF4GuTmYcTZG5RGP0bNOZZutL*apaO96Sj@^)D;bvYB;!X8quyI{K(23E`{-DTod05b*0Cw=7_lXj zKQd3-`{i;x^o}Ok+Z*?e8ZHYyOk7`+YVeBsX!3Wr)xVto*vIcECFZGU@2L29hIr)s zN%YOgXB;0ZekbBo$GBVN59L9;6jc7i<4(u9)dQo&`V(W;_g?8~sC?)+USmvF<)J+( z#41B7zuLpiXqYfqX#vU6x@^XxCz?%Ax|NZGM ze2ojf>vERTijHom^zY<{>`wH-h?JkSOGoU&4zqyI%l(Pt`K;k)99H}u`R6}QtFF2_ zgXXvq2d=LnI*(L%w2j{!B@Z2jh($gl5z~y-ujGN$W2ZVw{Cco5vk$*%MD-60R6`KQc z{@_OUaiEEx$YbI&ndpX!-t{;0yX;1Ol-V{8$obQ@(AK^wZ^%SnWG7RkS;rC$6U%*P zpeLI@#8)&$y)*D=TYh7*`O_H~DbKOKBs-=f+B+lN?J3T-=8wobw3C**b%S!?L{zOR0OX9JpD?i z6~kdz6r=$xG_O^2fO(z;&*;RyB^%G!nv(UEXnkkRbsvwt@riMV;|r)gKzD;D(K%6g z=y>upC#31((w;%{hflcqWlEQD$#im04p$!3 zbrzH25Q#XSz45yE>#s612QV*tYWcZC`hI+#zLc2H+vEBxq7yDMb$lkizq(^H^D27&jnIUt5rUujO%h9GnjJNN*pMK zbAIIiZ?;m>DjCIrZNh=B(#I5Wh<0L%6^-1sS93@FrtLK^6mG=<#R0_u#R0_u#R0_u z#R0_u#R0_u#R0_u#R0_u#R0_u#R0_u#R0_u#R0_u#eu{e*wXvD5~pDH(NX`W$!mzk zR5~gRF-~Py96%1J^(RUW6bGz1(Ao8_7{6#IG*&cn+g{Bb@td~Syim9m2NVYs2NVYs z2NVYs2NVYs2NVYs2NVYs2NVYs2NVYs2NVYs2NVYs2NVYs2NVYqbHM7njl`k!^ElLh zW65x8%lsshKgr|+o>7Y`8Na$u^-P8X$>fh559R@#*)6-N_m1U2d-8|QbM9CqDmE() zB$Gel*-xtevf^Ur(bRgo&f~3$S#e-naA0SyL$~F(Z_Bi|RL*4V^81#?ufi)1C=MtN zC=MtNC=MtNC=MtNC=MtNC=MtNC=MtNC=MtNC=MtNC=MtNC=MtNY_A;H+UGsBg-`gO zj(o0@`k$vQ98`Wgngd8b3VHI9nqbIs6 zSr@qh_n5*f-S^sjz4<;>+X%+SfV(Y|u}$tX7Gubd`~A;1chT9OqaBsLj=Os+y6(zY zk;7XZa#U-1T2ONa-9E3qJio{t)bP$~kG-Pa`;X;w6=;Of8#I<_EaRxq4d1Dq zP~{D|(lJVumx9~P{rg^!1m?xCzcF^|yRVF7;QsXMKaIWY9^0n~ zmzQF#&gXB;bvSD@`*dxd!{df=2Mk6^eIB>7ag4pN4u&W^OaVN_{>U{(OehO^hCLZ$ z33#G*Y+a)70>7TOXFv1FqB*})+`5dVw4#%Ha^IDwIb6cWL0}PA!yO6u4gM>tUjDe~ zj5m+Ryg;S5W!)llof>^6hbt%0=yjGk{qFjp5wr%Mu!D3l-~Tn>ni;YFq6nx+Nk`~0muK4K}95Rrt{`WKM zN=E+uMfv-QE+oyZ=Je(7w^w*wntyZ_s@xifpRt7yiulo-01qZ`z)}5=cK0~2`z1O% zc)ksRC($_w;bF#O;)h9KMI6KKj?Wj2ezJCD|LaS7%-PpS3(L_ifP?4;IbxV`wBk#o zVi3#C@+5Hly-(B36$jP5A>$x=1b|^l21n~$VkWuGx+gw=GCoRYnP)s)cKT7-!`TPO z8JM2|jrC`Q&Z*Idj;n0OWX=gYW)ujBw_0=Qe#HElb#MIiH;f#}9-2GO|JH@`j{9_w z9)52yFnyv&Q`T*I`uSSWSpzlq+>jOsPS*mykl(5CE;>g9Uc>M?D6gX{_ASGZ`qxEG zJ+{{GL?@HN;k#%jcV)JZ17i8vD9K62lihf~a9vsoYrf*%H-_cd*yLYM{Q0`F@QsuQ z*zTa55M4%L$SH49>_YQm&-eT4rb9E>Snh*)JAZIegXRqB6Ok~)Gu3kq_nF&68n;#M z&e)8l_Z_ohqKzF{QonSc#V_tI<086@Yo<0k*XP&ldSe&Rq1ibS%~clkYmPd%w;JX! zAt2Sas~$7sz%sHA=wX9XShxA}f5tR&yUn}dzI*?gwi~{HLOi>{ljxi%Jgjj{^93Uq zfJp(Lmx6>LLa{vcAP315`5-x|*G}YsRsK+3bYik9>LfW}l|M-aZId^Z=WSwF#Iu|~ z5r=kKC?9Y*LiTn>rGfzmwj_V3-Byh3JPyeDV+_OFm7rW++{vR`5XavlI0J_GgkGCSZ8{xs#; z*vjkE@7i?oqUXjMsSE`n!1Rf3N*rFMYdA9s{}1!|uYkS45h$6b`Kxe3N^_OE8#J92 z;yhRj;6O$BB+p;3`!t*(TK%A#s0&;?RL-H!ux0pco_2KpZ4WBlJ65E4Y_Gm>XcfCI2 zl}VoFghi14fL^sgK`IV;g6?{cHd*s(en-&f&-J*Wwk>o)Wh<8JRjbVMOZ6<9z}O!% zTIOax5C4-MSibn8KT=;k#-pc<^M@$EL?=9CQaL(QN26macLZwlLI4HYriy^Q)LU(z zTp!{=WI3jI+G`@8sT^P#=mVPCXetXBH{}8OMVeBrIUv?|8()ksFQqRGVA+RW?7sN# zy~|~JA-bGGGV+45qU1#8T-SOR>$~MI#qTdH1ouN;9)6PlnDS4t9HOHBCDCU{xs5dNgG>y=_rZfUN=>%tWzn*OI~0krtg zf#w}K88=_QB1a1EO`xgYya8}weU<|nO|18@&J)+QpFDrUQ(yPFXFTFXg=PvoiOz|_ zBU(P86bj7^tz8$}lZIE~^9`e&{KwLnQ_dgpJSCyy*ryep+~cNi&v*L+!6Kitb|x&s z>8wlRN$YHOZytWm&!E@#NNM&e{rC{h7nJ zCKS2r+_1DCHz^eOg7z}aqsu79(FB_CEdhLq^6T;|kG*cs@ApkV4KouInkn!kx=xKg zb3#F1mD}Ut|7RDu13~+wdC>Ml%dac3KF@f~T%T`%jw7yBO`XBmEvpL8!Vr0PKKj+9 zyWctw$6=_@Oo1oSIZ=2-(x222^gEnE7!%f&%=c<8$Scj`%Jqf3K};hIn)tBs4Kohx zhq%Cf(}9fr_}i0xS^%eW&+qrRX48-tPE7>|P}pC^ehASyQFugfz*rB;T&Z7kx&xYB zK!r;X?D;-tD4@9}d9*sou*bD%ACOk4aKO*F@siz9@3uQ|0Y5s1At0tp>uw_fw$Ktw9&wHwwbfj}7ACnv1{eExE7rA^3#e)% zV%eg#`Yg#{mjlFfoD^Dywk8#w{`T$hJ=yv~^e5V_zImV(QPH+32gGu}Y(xBV-|+bW_RxOMcwR3#d~x&HU-d`e zRPKo`e@rKo`__X!NK}=3ne)lNCn~oT6Z%6<{TJ%D$l-~O;m~eO-Q%lLU4#Qm00*`A z*5R{F^FRxR6d6S{W!260s3IjqYOO=O#E*hd5?)&yL~%)i>fi&p{&~4^H2<91p_>QaxDuUE*~En^PXY=)jZT)t3uESbZ+D2b1Z< zw|1->FlMs#if5UCFZ0LN^`SWbvI+3NFsbN&e_if7|NcXD1h@_k>qDXwE;6P58O^^4 z^DX@Ua($Rq1gkCh%sl+TANliKk7-N#U+tBESmB6{CfVtGlQHEmZGBHB4drL&=72b_ zYWvk(uI2fbbx`j29QTj&a&Le1u$`L$S+Cj|Y z9MEWzoQnGuuKhf-q~f8cg8D)-V;F4O z=i9Q`+zwZMrLTXle61h*dek#tXZ$sQ)j#_B{jcp=bMI3|DiguP{x;D~iNi~&qZ%d- z@w80boC4!xn9$S_=xFjZkE0O^RTw^4tS7MSq=Ck{MEq7PS6FsY)4VzINU5#E0dZeT zQ+Lc6T~4vSY#GsquV>zHLl1V&N6Swtg`B&jc67S!p+48ldUr4Gm*j-#oG3gJ$qC2| z98u_~tH%l$)Q->(!?J6oV$rSq$~3(`(8~*!8B}Ou8-!X^Sgy7tEio=-@7f#?%Wq|m zG*df+{T{4SE1`0ow@cPtHgLaoe%PP7D)=}2KL-`o$5_u3ofCyeWV{tUbt7^$O&LE{ z6!sSR>&l@CsMY+?EU+_uZ25-2n$S zz43(0h>*UI=yE!d@6#KvSo6V?wIF9e5axmLdoAlJY{S~4MBa#Yj7xrRPy8y3;=s1% zz;XaU{o&Mp=5j30|E`5{{?mK2?-_jZNxuz!^mY!N$}!R9?~%%J%=urrAX`rQLgYI_ zKSbtHS9!Op(~w5=_SU0a<@lKn>N_e*ka#+3pRpz z`CeMf+yA}b+=q=%#Q6jqXAs>WM~q1Mwisu?U1M6)!;nF9r zNWO6FOLJ^EMy7EPj*Afo&g0^k8RvI#W(;d98)%&O#d)bgpmCoUE_%Un(ypNK8v*`V zYr(V{-vHTCk?dPJQduCA{LuT>9K(kpaq6F~7--I4;vbD8Yrws5{In}ZE^Rr2<{l6$ z<}cCdTgZ%;zs5K+-u9-X#+Af3N;96h1RUvmO9#dOUW}*L`~SZ8>}Q63g7Sk3)9MLN zqI06~NaB0Ri@1%;bZ*%?z=bLYG|G{@PIcpkbhi4rlhgjQ@Z>w;$_1{_#C#ySL5>)7 z&P*8|#~AX!L5+9>pC4|U<&(&8WpiRB3K5Iq9Ku<%n`ir{D7dtxo&g2oL(mJLBFci!O*g2Beg$oV37MHt5xoI| zbP)hMAAr39z)lBXmjkf3rBEc2X zQDOUp3h87gH>9Ioen+}eI~E6;;B%-Q+PG)@`n3h>-!o1-_|3Q9o^bEe%dlqB@7Tlo zmFS!(JWTbgT&aS;ow>Y<`)wN zhOeRWnz4_$yvqNpH|>?ij!nPq(I3y*JNtB_lAj3SvAhypW=@>{OH2Jeym1-+@W($* zjeubgSj0p74E6;&j&o2JNgG}x?Ged1($Ox;Ezz(Hpqr@ZolMb9*{wOS5XdAiYloZV zMeaW@19=*|gfz5{v$H672iJ-Bb zCpsqzk2v)_*6!uLX<9>&FY?j@g+b`VdLF5w912lKtmuw1jIxaV8La2Ak3+JJ?F9B` zkVgJ647!sBt5QjDK&-p($+^(Zl zMX&04opU6|#7C58R8(fDZpSi#8Wp*bU4G}D)MJO@Kp4J;`e*E5bGeo4`N{*+*w`DV zd^_Nwl?SfG$`cgLw-Q~aMxXk5?#8q#tdaFX=gf{rXh+t~!s*$?js{-7Y1Y*accI|l z9D&yBXQMI4w~_3k+@pMxiFABNQ>^phmD7+;VUea(d=4xFXOf?Sk@4kc8OYcCPn{RO zG-&#i6hnTfe@}Edwf4zRxud=WZ$oj`QhZ^^RJs2^ZpoM^6I6$yiSJ5|lHpu(epY}t zk|So1FGtN^rL*%s`QhI1NjKj>c|vkTbU9T^IfCOra=h+3e)$ApeBt*z({C8NUlY9H|@)qE@kQU;X@JVcDBAjE|9iae^djm*k~|Zg@RHd;`BKmHfJ zIN=S7>J6gn)aWxwy!?U^iMi!IJU=5!oaBW`DY;=vwq2t3hfHdN@EsMkNBW!IR*@UI z(>s~uSDCRnAl8@T4v#NiOAbwA>r-ZaoA!eC?B#}hQF$P`oKgqNSEO86$rY7R5d+B$ znbfBt86i4_A-SV>bQk>+U77JYAj(zqxcG9l5#%m>{m+BvzIgS5=Zt8n-Xgl3T9R_b z{}HY5I-E|tum{fg!ApdqRTlPu%ypKPT;Vth#hvzhcJgTRNE~8FTo}yI}^rFgr`YJv?9&24i@g!uqLixeA zjoLtJx2WDhnM1oMbL0kOr8<}cVm-C+*!Xg_0pxD4R}Y%)KRoZlYYZGzPZ3>)*D-Px z=}xuU$4_mZC{HLmBtJ@?QsTVnx&(M_Kcus?W6FE=&X~DsqydcNpXi-{mkYnh*R0(5d~ME2 zV-wH0&GqE_jraUv6a=dOiQZ0}1{-1i0xos)>X&Y|W-3H3*ZXpM^iFjztWrj@A=L;Sh$#;-kQ8i^LPbe3%5@`sPmzy0f_kMH5@DXrTfx|~{D*AYy;7h>oBB|2CGs@a6oMD)*T;Tu3A9uc0FUwVc-6?fB#FR^@K#1 zlk6b5id0l#$lzG(!Z7cxlqeHuC;5?0B~Mn|Ya1BmaXaY~PzL1?{?$5ZuZ4Bs5 zpijMcL38B^u&?RGwY%jP-7=Quf-xU)9~{x))uiN_&k?Xs3)Sg1EdWcCaf@8c z{;n#kCN^%fmoTJE@(~94!2HeuO=TGSAeAuap0V`4W5CK9XIy;dti#qXK|88c<0;cQ z86IuCPc9cu#J7tV%7q~g!nf{}#P}vXyY$yv?>X>FN}uq_baHPGzB1Uk2M6Z+yby_1 z{YPlEo(# zCl9K@0syKnm{|W2U8hE$di@vKg#of#SMLkBVJTvSmhW(TLVj&J?Dpg$!vojD6LD>g z^X~xuS*win=$wiFL_fh~!}IgvsYLGa!ghpP6GTG!S?VXwTk#Wn`8k zjs5ed*MImnH1U{svEYFE(a2At>(uB|&d*3L>c>{&IG=+3D!MmjHOTJ-@4VXK z=ZEvA0v#2u=fV1h=$t4#=={G!?UU<6g>}%ys;KwCJua}8FsOk)S*|dsF*U`{%@d+B zS)1XFa4!MeD2q9uQGTe+5&HqR6}`|n$nz=&<4RwLv=5W%PGJe#*onf9n1ZBf(){A|HuvkRwL1R_F7>h1w2(tz))F zyIBFm}WYlCf?8fT{y$okFq9XYqx=xKg=V%ELkIRSD8N5~ZhYMr)B~ikU41&=-a>{nQNhN&KVBp zUG5J$lQG}HjBT_t_Q)8Rqp6OMvDWj36lISJ0BoWj@(rHmENWNg+cfK3BBbaZX= z;X9h3KLiDA;#F{N=FM<6<~{H&u;cGrIJ+|VA)LASJ)CFRErp%7YYOXSPhqq3Q`m!* zDJ=7h6!yinDQus|fxbS4z1h1PduntyW;?YT>)qUq{qSrzmho3N_VrQS*?nhrXCFM* zovj_*gYDz)!Nxq>gI#|>Pxf1LPxfW^UTp8CUTjvc-mGeIZ#Lr4RQ7)#rm|}n^NYty)UX;{eB-jM-&xgAAb^^ zzX}gad4VpU%We`E6OK&+4yI`7EQNu> z8&AK+YmOHWn^TZk^FkQw4^-&h1D-_ZMBzc>0lemIqE_wp7Q@AF`d)3c!NC$C4`zsn z!{#yP2i~uNa?zXvXT(t4>1DX5grw=-D>VuQsI!R9qaiClfU8hE$ad2S1RKQUc zTrGnq$;B+M83)#@hyxGV{bNSU+!cVc*PRDkIqt~W|JwB_y@cR7i-?2h=v`FibCbLd zkG;%S6`ban=dRZCYML)NNk1&S!ta?>S08NDPeS8oDdoVN%H_K7@f)p-C4ba|fUbF6rR9_m)+-t(f*M}dv zZw=Ies7Q{8u2ZAWEtjKGAKbu5V&AI2C(4s9*?QV?{^2{($V8u_T@M-i*%rUCW7)A? z!oVc4yl?5(63-73BBF9mZe$8xlC~OR9GSOEI^cHdQEb0fOXa;)f8s^;n}ximcXzBbS2t21}6O#O?>fVtjrL8RDzZ32z| zcVHTmf4_de%6S`af^ITbh-VKdy+k+25u?Bz2;#u8*cS-SaPx`2a<@kdfIZ~!AztZ_0QWkuMu0JgxWwA#R^@(U%);np8{)>ikJ*MJIQ{17~FT8wF4m(~APU!)18H zkEQy!A!z1{+^%Dg|K0jw+3igq?0vYAL1+vDz7QS#h-#WPzuYk!Yh{r&_B_q$E_3?) znmx-7<9mmP!iacMLy7S`^y=oRA3rzY)E|uq5YIrsLv)Il%!GJG$HucH2|U-lb!5@< zem9>;mzN-(bihM&!a-(2JY!x>7}-mOi0ijqV; zh)SlDJC&<)Uws)&3I*)EfaUvrb%u*kxWW*T*e>buQY>xj2Sh_9w#n%v4zY9kD22}! z^9Q+bnZdk6z{EBoFc7K9DY4#a0lCAdazLXA(=+Q?kAiUfIttRDbv1!yoO1 z<1JjgGi3sATZ2dO|poCogN>@>I>4?mq%as zV($09@AZk%v7~$>deS)X?8*oVm{Wj&BtOjwa9|oA7T℘g1$&Vfv`hOo1oSIZ=4T z|_IbRBm#`B?qiE8rG8G558xDj)c;)tX zOTfn}3q+@JHog;0OfME)^s_VB<@~`u3-U;x&(}FYJfnI^<}1;y_(ox^+!QS_2eLt+ zt;!F|Ipz`O7xJI@OeT<8DLLO-c~At!fgOwkvC2GE9O#VkPBL;ve#ng1$4JC=DnAq#`EN^{a#)HZo{3@F6E0qy z%B^d2KrSzo|EY#7kSuoXuZWM1zA3&h<*GQ4m;-WoNgN`!k7VRh_Oqqsk;2RI;=4?X zjojLAGU1c)6E9umwtaD6YmR5OC(d+MIiPq&6YbP@L_4hwLp%A~o_M!2Vaw;y$aM2e(V;ANH%-6o!Pw??W8oTy7MBvTX|vbYy>LTj1}gG_l-K9okWGs(5xh4#@Qxt^-e2S+&Jh zG>R{t8~IVDnFC>X#r6i<$<2I2R?+9JQb(B;u0SF9FmE_bMomTXiM8gVQElknBt zXkJ%?Ym8yb9LpS^!anJC@PQa)*jLjwziAr=yVG=qChjjHx3VEPau5$+ha4bY2wCk`0*yrb)k@TP`Z|Y`LRU8VYOcEo6|!-k6Up46g_klhfF7T8Am=Wn*(9b2?c%nJ)W={3eypB zWZayXACL4tW9cK8EErDd5I60nrAbvnW3IrX{3pPAb`Jw$@6kh*MdL#Zv-#gnTu2)-~1b>Fq&D1KU z{NJ%Me~2#QO~@ZRtha>IMM_|cBbMkeL_qal{nEtw3!AI=7c#@2V=xxUX8~7>$ zDAM|!Y-LanLQP5WGzs`NO89VGjX3Ch1hBGYch^qcJp4=8U92mTYne{&G5A&H3;DS$ ziTTy^Pcwh4(tq#q@yAX$cGvGHeo9}ale?Tge!dof#g16f7{XoX#fvqM$a6FX7|AuZ zr^9YdjOV`cmQO#}t+15RBRn#l+>^&MW*i4(1Qc;CmvG_#*2t?cEdCsQTE$x!WWP%) z7rj`1VI%eN5mz@T_e4iOqLOh~qc^oI&f>~9mD6NN{7d^u1G8W&jLi)3&Z z;v)Vv-C^cm#*^Lne!z8UDXjU5d*8rhS06BE@~#s$k3u^t9cM}_y6%edSFIJn`8(!C z|40QE0o&|+%c2YL@D>QYBJb=JUM#o6?u?Ib+{!d|@$;FJ&wnEH+4p&R3}s;8c#7y0 zFPRDPwL%8>$wPB3)@$qTG3TpQf86z3YW@5{`}~k;B#hNc4_K{8bizYsE}TXIY{=tB z?&QN54=TEbMth-m9vm0pDx~c#t>!n!K?K-G=qN>U*irHAZ1IGFfmpt%Up^feklKMv z*pmF&lCT~43EMQPRggN>e{1hg+&}4giQ|B@-|Tn{3s*W1QZAwg0EbhJ82e zR}fvNMxT*#ukT6?*o$&YOW`;@I8((a_t64h?&IhC8OQpJvpY~_C^tcQ~)b*0z8DNLr5JN(C~HE1rFnS@Dg_>VDIQ>1yTgEb}4 ztFQ9-=G%+3d73A0BKcnk7OJNRV?I%!^bLD3d6eGM$s*VSM%^?>u{1qt_XkhcbP? zlrBb&b)`5@e9i$koqcqlMRe?^(Qc+NnNI1_JqA%e;2{Pu0mc7-u;XEv{P1~kzG>kT z=I^(f*Gao0c+sxCZ@-Jup?r|(u^#t3gPtSGO;o;2gK%9n8$UHreb zKlQjt$3uMyn1?m!gon%|aN!Z!A)0s<@hp?@Sn;Xi>ah<^ntj4SlpgU(rjvV&eBxIL zYK2wBxRL;74@jH0ajz6u_I^F*l7-w=2bofCzJ85gXWj4S}LhSUUMsh-*N zv>8t`B!+cg=~HlC_=mgQSh*&R9d^_3+Yaw`@2=EW!Lo?`A)>>pNgWsR1s(8*P-6fl z#hn`dkq3Wt!U_;$o?;oKf$49JdmVNKWWzw?87z1&DjfIB_5_V*+2LWeaEva?0KG5h z;h_HpdOy(ngFXQC2+-Kp!g0`SB)M}R&OG#n4jjs|@!=p4{_peKW# z0vi8kC)M#*Hc}w|bGrqoDa*ce&r;4LEpp zjQ1r8uh6N6Au^mvV^q~Vo-jNKXZEv+aXQL}79MuptP^-(c)%y~r%dN$c(e~ERR!jH zX|06M>i?A)=eA5g_Js?xDSg5x)5*Pcy)AGIh9d@7`KoC+qAg?;Ll%Yzh;I%5HuKF2 z*O=V9FDd`yfC@^NaLIIXZ#ynKECA4qQ-#d+X6kc^>+}CTxZtn-MqeFS4oUcAI^m1v ztEnHrkDwMgNDYkGzJvh}svOXmj#YU$a`Tt&ql)%95B;GcJThH(73B=^i1m0(NIa<6 zzGOY0m`{ggm-(Cf{)SZpSAN>s^`<* zduArDbI>p0k?H7$%8WWm{(TvNgej5M$zPtT?{+N|LjD!(a50ECJ8{~-5mimdG zly5A63_}c5Z)Uun7*}9!zeBRpPl1_aT@fy#8{~-54qT>+b9?z8NSB+)XLp(<(jn=z z6ja39GY7&Th*+NK|9Sitoc~0*iA-uBF@_T5ShUCR9+OPHeeoElt7%Gb~RUqu)&^tz9Vh<;-@#A=q9!oLgTKtkL|@)egoX!sg{mY`K7c**o#^BerGp z-aYN(e$J+I;Vf}f$d`%mBswPwkJ$KWJry7<_azHAGOsK48-(OcR;q(UBJ#T<>!cMB zALak@ugv4z-M|g!KW81+n|*fS(|KTJ1yA%Z`RlL~t{8?dpb$$xcoLlxg-2}u;S_H% zUhxt1d9{feYzWZWkood>MdX!e7oaGs;=oSJ0lB=0;|5h;c3QDeA0C4Pa(Rj2txJ>J zQm&Kri~f@J+ohSKz;!4G+Ab{d(=pRS#8*)VY|j@P?3+8qa-Sf_~g z9p?*ojxT9X`Po+ay{*#SIV3@SWqUXvuG^dSb^LkM@P{^*I{x=R-kS3Fi@v)=PYwU~ z#Pyv-moc=S2aLC`t;pf8hKWIGb{OLn*LQ3LoLH7}K%?0gG%n;SfW?{*9M$iO)$45R z<+39NPX6}Z{xsh~IEfD4O)4=?I7tGIAqy6`gM5w37(KW+kGkxe`25RWZ(|QXdfiLk z=Dl};%s--=K*3AWxacU8=)`%sFE%?({LKE=%+H>XF8*gwI+U?Do_-CNzOoMvd;9ni zJvYCMc2vkue9ClAhDXx4VV|SEa9wApn9pk^Tyj3we`aH^ghqvndw*Xf=QGg>51EN^ z!Rj5jc^Y7e*=*uh{de*AeXj#tzu!ILs#Eq_yNc?3l0Tvo9x~g4D^SRfl;A7JDjf>ZqDt^jw@Jxd+O&l_SowyZT{j{?|khC9U0*wI^iKRg3ELXXE`j|_C(iT zM%Iuc%V1@@3+^?oDCF09Q#`T8A(U^#C-Se%t;>N}`GY7ZZ^#spSzm`Oego&ILrXV^fxAv{^m0- zJ?f17FV3L&DSeqv?yb{@!<}K<3gv|;7fpX8{{By=WxXDLX4-=kKcz3z$-Q;@1zN}t zXBoSl#(*65VG|e#B;v9CFEO57N{iQ>ddXWqQ+k9)rjvVXJVgqjkdS^}$PBNVh zXLv*qErft1A4?M83Afl-kC(ki%-{R!xwjYzA|9MyAv)n8vo)SF%@1b=$jlLOWc(SQ zFWFDq*dyy^{e9G-f3CX}3pgmkL3EuOeYVB{2X8~xI6UqJ++uK~34#zm!U=F-><=yY zV%YP$A3(!Ijswxibo7g=H4ZqrT>#JkeklDFo8$9g-7_}!?1#aR&$;WUndd?)U4G4^CfnvhfvI*7`$0RW-=?9% z@CAYb4q09)d@K{wO}4&C)?ci&6rHgwV1n2lBTrG|{J53M1fuBwczCzU2RYyI960Rz zptAC>yQt^Z;y@S@qIr;lG;{r6)h~2h_QdTy9=)Uq_lKgwa@rG~MCU}|F=L#4a;}|E z`q+!%6l?wRL3@4(j=s%z^JyW?J`L~obNV%YLy!kfpQ;Xd9Qw#}8N@~S>JLeb?}@AC zuljP5wzrIr=mIou-2!~3^HauwP>bb3PAA!SEN{qDRJ320%A!u~xM!@g9WMpKMt<-e zwJOWR5oNZ81F0Z5a=DRZOpFg_YN>3C^zGd)x08e6gRq?x%N5$=@n(DHL087F@~123 z4&05T>JgqnN>01BoT~ik+WE5_;EDZ_-tdlpI#b(=?JxZaO>MK>|3x}!uy(4F@#5Ne z#D{$c#6{Q$4`Bu;juFkRsbsv0za7hc)eh?Xl%Zv}Adr4;Fp|FgdQ|bpj|W#?iZm58aUE%jDPvUa&5T z)kbsyc%2TxBwu;B5;VG=701$;ugyakdu;5;%UeE9XID2(4v)%7y@-Hae^3fvMZ3&MMH{u z%d`);Sx6t_wc1~ovEPZFL4BJRis=u5^ocGc&8@A|pRUaf!P(h#oXi+I0y3RjoH;ql zhgdl7JYxL7g(J^;U&cZ7cH%JYnZr0lxtdj&_?(Ps`Eyg#gO?tOxKW{r=VTC_6NN`? z{q+nm^y>8TUHgGwf0LJtNUt#D<}Pncd>m!h5uFIes-dBqVOoz>U{o2ds$;3sMYB& zMR3Yoz&@#=#t{Ods}Rmx@y~O30;QV2yv7ZGOO1D=ozCEaV|@MbNP8T z_Sd^-cK_?6Uq8V+H&GEzqU+S?b4zgM`!$Vlisf(I)cE|w)Q`>n&(QTXIoTx$5EL2* zz?0~lC_G}~3HfwqI50D2neD$wVHz6GD4 z4I*6(k=8<_b0E_1Akw=17&~VaggKhA*Gd_4xfu(>Kdh7PXYAE48T&pfh24K~3cIIQ zH@0ADH#W)No!xO}54Pfio-FsDz1h8+`ml*9{n@}@ZEW-2L)o+M?#XTn@6UP;8V#7T z*__5QcHBoE_Syd~X3yInVN1{ZfxY+V_>{d~za}N~rCqz_zqqp7oKr9DJ~h0w$DAVv z^lE(b^WK5ai*~tau&@7bMdzpQ`SQC%F^`~lowX3Yk;>`91o^mPp^Y7Mw_8T<$8j<`S@Aunf?M2k$)}2Y8xRPO<%~ThkMd4P0A~UvB!JUBc@EcX=Jh zvD3O`Zu*Sf3{G5uIDtxGGM$s*QR)Z;=0i~{c6dS9{q`KE69v8uPI}YqggTOXOJU7d-1`QGxb^t^f4}O2 zdsAz^(!)a$WCud&Cb~|IK8YQ~x5-*C$K&C^0(R`~mASo64KJtG!-V03kzaJa6~^CQ zwIyNOo92!lPUTP6&S9}0Tq~7lt9r0<^VM_K7d-VKeHGO=GM(Jz@(fFis^Bv6Hr0a- z<%#RTLl@rTzVelCBj+p=E}5Pbt|aQgFhoT4^sowZJ&65dXG#eU=vQT}!9~%x>vt_g>fkIwC^Anl_bcO8et?Btb?RW+i+!O0tWgAvx=#_us+nd! zS>f1FFlYHWwJaiEghQq$!ZB5A6i~Epyh&-GiEV?PXChU%$D+6PnV7P(wn3ttl+H4j zca$33x3+K}xO1$>fDGi~ea{~3Pk-xA90G8q^Q~JeI=NRA=fHZ$pnHbf9|{y}aBR3U z0CmwkI4IK(2O$MQ9=$`+00F36uaa`ri-&>eR{+hu;`A~C$x!#cHAL@Uwv5WdWcWM65 zbveWjtT%A}f#?)3nG^lK`2ooK=vi3-IN=p9!^66DddTaA3DFX-r_l%?wv!uAijN0_ z-1t=PF`hsB^24)U+^`RjNgfxQS0 zsITn$smFzQPk0iY6NN`YT)7_2 z;SJU6@Qf@ef=UX1zFHU(6y+2fR!Soh**3CJ9&DrJyF{{b z{&W;5E8Y@~%#KQHM~+A3PuI>}l|NlOf8_Q5T^nuZp~E^C$Cyef4#eX?3pi4LyT%*s zZ{vEKmJxmU{Nsijda!doT7J^%KW%VV`@Ns+d(shEu2c0`v2TatW1{QS=reK;b*{$^ zUHyQ)$mejukQgS_@K$!8e~g`RY1Am?HJJAQ zl)3depz>$y^Smu7?g-;Fqv~tRXD9Tl>W+jg+9^H6s?U%aN@ljbNMry69OvOW(Mss2 ztemj%ZRZ}YL)Yx{;;GmN5#5^v_vNXh=E?41!Tp-5hvuOBG9!N6&r{Ht_W25q()`cEEx6sJkG>g`jCZVKv}Hl>^#pKB4jr8*}u$^@y@x-+JfBSvpeszn$nj z0^t$quSq>ySX=53;<`@5Z!?&LqjEuf9L;ar*q+m_nfl5b&rQ9+U>M;bx&VP&W8tvw zVVn2OY!vWda&rH=Wvz`J{AtEtp6byvDvb#P!b9|A@x)EV42Xcr&sxAkFuIIcsyAb3<;pkQ@H~ z=9|k(K|J{ztU~rV(T6?PZ!8|cwIdXtT+bt7#DH~x)pyc-61pLul|&4<-^6CFWVlG2#x4mfLY%4@n-@ACu2UKrqAnlj#Bp~c1+x*0UJ6U|BBI;7j< zB~`wgexj6heBGE#CwCoJfddwcYEE}RlMzn#!>S{=MAIGAR|+->cx>mI*RkT>NL-&+ zuqWI@d{jT)Rvq3gc)+zivwltmIx57|1D-_ZMB!o0C)fm~9mai${kSDbq(8j5Y~>4+ zuKj}AAiX_GVMG^_=GHjrn^q=@I5J@0CB~Zr8ci!cJp57aL7CZ0Uy=Dhbe_2Ih=(IO zacY*2jDIA?adAcH?A(GSAISV5x&VP&lfw~ZO{{tj`GSf}{muL?yOAGdb{q$4pa5ch zLjBc_i#c{oR{3g0qZnj2`JMbJv+Hs|mb0#$hlq`I*X5`}X2k)qf3zIhKU6uOF+ZEG zTEhQ_YX-tmmA~A9Zuia`cWvq(UmuTlROk<%GM$s*Vaz|lG!E=e(|4xnq(GkL(cl<| z65O8V4~FXX5Mn>F;Q!2cT;K)&7u*CI&(B}Ie>$79@1&)x-@WmC9f#gO!gVV|*JF)7 zX8ba51Mm-^7f{&?OQtxywT;ws#4{y|-QEzLa%1i%td(%J+HW!_zp!Ws6ALtRF4+ag#FYt4eaQ+C6VPLtS3qhBHo(US4 zG1Y+fgFYSfg`gLKz8Unrpq~Q$CTQ$r{{ea+Fb4SsEIA8aP2+}D3HXct)8?1kr`ujW z7wxEM+#u6+SH|M<7rKME@}B>1ZUhkf%cYmb&+ld5+So8p_jf-TU3VsY5?7SpL^sG0 zBR-yr0G|W~-(vaPkN`))_cnI+(!F2Fx$5y#WE@0~05B}^aZGA}Z6>(8)mZ5O8%*8x zFjbvpnxC$3j?W)VYT#Exo_O|*ry|Mg_+bBrL?;jNap8_Vea}@G0#LcMU1lCnP#Lft zo5Eh~d+ys9_c;eI8~@Zk=beIO1Qp`w4NszTqVTZX=aR3%0StcFR_o)ZM!yPib<<9y?Nf#Y7Dd;-3JLVPE{ zljxi%JS_3y@Y6G?L34)q?m0Xf1cvJ&4QezeEFQGNxg6poKGs}r&QGg-FJB(JXXz;y zOobIKx}yA)>ExaaPCB{^HZ22w2_^hJ!q4b1A`F8`cvG)1=ereOvx`UmeeCXUd`)-= zuS_TRWbo?SRP9+3QXWMZo`i2%68Or#U;EQTv(D2O#XwlXC)0W4@Mr_R(TVUCEK1D3 zPal8(){Qe>$*1%QpG+tBHsBkR2;YVz@KwxN?>*gJm`&*uKABGLZNN7+5x#|2Cgxws zquCcWzjY}#fm{(jnNIF)z;|dOe3@4z#`lW-+RD#r7vM2XToFE*PVQ~McUU5PtCGO? z-QA8g-+gl9nUp@^lj-E%27HGn!dJ66G5;z)T(W7x#h1Q|eP&dM&jnASbE5EQ1HL1y z@QL;HuqBD>>y{sLH{4P)FwbGs*obd5;3K*Kja!q!7pbp#cUeLy)z>24wO5<@Y1K}z zzTuL*m*2_!g>X@R%XD&23a?h>fO7>R#|-G_C`q`D2yKuc*54gD@1%bNA*MP$`rego z%K#j;XHD1G_xd~U_iv!;G5_OsCY0|s3VYMFoL{*=Ac7r@M;K3Dnwvv(cv zQ54^Ql2Aeq0TB=}AR?%o6on{=q!2<)AXF92k-H=Z$z8ZyAYdU_0F@FOqF7>&ii&`W z4Nxrbvw#H!RE%Q5f`W=77XIJ2d+%;`vbj5|{B`F(-<`d;yEET?^QP?V?2M;qh0iE&^u^)x%~jvG+VtoCH+tUiz0R1zpnSt}T^ih) z-bYFSCKbci**O>j>v8)hDz$03CXk1W_bL()B;Q9qc%G7((EZ0R`XoR8)8c{j&SH-L zIE`c3h2z942_T=J0b8Do=dvwtby;&4=3BdK)bP7kmt9PGja)5&o<~`(38f91iu9>D zePYg2e+_g)%UNhZ;_ZqjCErf7GZ>!R5)e-)9u)j*qwD@T>YXk0xU4yTZd2uaJVG9} zVIGZMweP0s*_H0qa>s@S%0Pq5kqX6LxUYg1O8hY6vut8q@?z2>pXGMVpnY;=U$j-_ zniw1Zyo9=!T2ff#pXZj3Ct!#3RqWlt@iD`F@19Fxr~8j{xv$$Ngnp;~XSwQ^L%{dB z?%weE;`;X|@1NBxgX6LCgzD~V{<#fJ!Obz3o`fusQT=QiRv%SVGjnm4mB*^F?Y77!{5A3N^Wt`aC zB)Kz0qGH~)3&)+%d`G!Ie^7cmk?Jg`b7U8=*L0t+$p7*WbBsH9T=@<>7*hQ5`z(r^ z`)<)>(cUMy;70;K?r0-Fw83ebBgnvj$_ zk?5sU888#L5}+4JR|D4ovw+zEJ!4%9TnAha%mwBF^MM5bwefBMZUk-u=zZ5Mz(Rl) z7^inPw*j{Ui-9|UJAu1^yMYSe9^hW!KHz@f0pLO4A)pd?77_^*+5UA7mx_hf+6%^(;J|=h9<`B3*eQQHrIa={A3^nNCo->X}|y=9T*4<0tN#^ zfT6%JAOpw*h65vjEMO!s3K$KH0mcI3fD3>Nfs26g0KJ^N1jq*Lzyu%%Z~#sq7svzh z0h&;AA}|Rk015#&Kp*530h0kQPz?Bh5?~526(|L!0n>p?fy;o)fh&L+Kp8L-xDvPu zxEifIES^ zfV+VT;2z*!;6C7f-~r%4;31$Aco=vDcobLyJO(@tJOL~Po&=Tw%YhZZQ^3=}Gr&sV zS>QR~dEf=$MPL=M8dw9o1iTEa1zrJO1zrPQ2i5`Wf&T$-0B-_s0dE5vfQ`UAz`MYE z!27@^-~-@8U^B1<*b00Ed<=X7Yy&<8s({ac&w=g07r>XmSHRc64&WQ$Ti`q3dtfK< z1MnlT3)l_(1pEyA0_*{P1%3ne0>1J}AWCFv15kM9&5*P)H2B-~z=Cffv zj74Z?klK^SI2%|H{SVSW}?cA z>N&@TZbrW%{3au(OXgE?+GU)d#mnC{=nhHIia2pkZnsO;oYqwIyyEz({9fam#(r9; z@uB$Xxtir#0MaH9f3n@}nCf!)@-wDjXjVZ%@-&~5h6(D6PEji+1gq zrWTHqPU-=T0Lo8ofYX4!z(oM1?f-x?a3R%?H-qGRF{p2$(1}Rc%Nn9xfXp!c1k{tA z(5C2v`gI)2_G{4Icop?fhbXZSmGE;{M~h2eh!KBWS6iHPPONCqqoL^1DqhUq(pq%e zbgI~Yd~Xr|=om4)$(5q*&uhfj=eLb&`bcF|a`cqw@&_J_NxOAo?H2L%Vo8rwc7l@j z3=>H2XBB-5(T@t$bx4QSwiUl*pV3rYzxD4$_wE`pnm_bmeY2dxlwCmIyp!dc?!*Z# zp}25*g?cpIvi*~eDgQM9pfXM0jo~)|hg7JL} z{rE8ywGoQ? z9*XLI655FEP$zeQo=!#mej3`QUC@^3hPKUF(Azl(_dK+1lhNiIfO2Ul%B3uXdjWK9 zhmGf>T~vfN*)-(UtI*z?hj395{B%FsSx=(PwHk`qfHuIVXv^)w@t7!aR?8@Ho((fD zr$veTFNqR^FO3o>-3I^JD6t=nyFxUi-a=#L0yF@!kPrTTI$Aui6ZKZ77-7qg5w9$X z5vzZV5!a{H5_jHFOZa}TB^HgZE$ywbOhc;opxVq8jHQNF3JNGpyNIVaW=pS@pC zymfnhF|eqCSTMSw*gdR~_~?Sh;)6?@i0e`It&NEnlibb3qCL&UoW(7~gA-bc`9oWa zxJ%lIp0~F}JEomjcl*iW`n--}NkM0E+v8`5R^7XbQGfOjpTsAMCokM%7v<#%;VuY`ykzadpZI z;*tt=q9Q>ZPCG zjcT;yx2W;~Cq+*}i)zGirO{une>nQYyicR=>)k5mf;+~pWa1p{{Sr6LsI{GAQDnZH_=LDkrz~lj^lg)7PgX8yKKAA=Emk!A{`h+L zyw$2*^GzpQkX^fN-52Z$r`)x({p7VvPTAh$zD{?fZ#q47*?=>5&e-4ms*cgU*3TKG zWjQX75?~rsF3|gR@m#Q9ynpdRYMP2N|8aURo$vzX`e1v{f&K2lUVz4v7oF8qTsipW zyxtEyzZzLca});E4=neK10EMsHhlpWOnQj#!R-a3UCyam$wm2=_;J5Hl`#~i<&F&v zRDcH8XS-G#?Za%GY0K*~I-S33b*-EI^pU)%Gol2`{o;V9+6VuqF(UZ>fu0MnOkU7t z^3jh!1gq=1b5Iz<{Tt>}3Mj*5hxB(O-H{IeNOHHrK5z{z#U-4dTjDzia!CN1Hr3|6 zrDJ!UKW}$@{x{LJzodWkY)|WiMg`=WP}&6MhY8Gk>$Fe80t(%2{x1aZaWPGGI5oqE zA@{*Ajr~XU4+Z>V!zfs_evqQlxXAwxX5Xr74n}LiYeJDUyf7? zn&q3roi~pZcPrc@r-37pU)Zj~wIRYCKXP|%g=}fy;51NEd->o(GhW5{hNYZ8*k`%r z*Q|lVnLea<*1eiGH8Ze|gwlYTKJvJZP}f<AV)jP8wWhU*Rbe>k0$KZDw|@@G&N)}FZrj&}aU@P9*jP*Yj(U(3glmWOm+r01Ha zxF!8JYCwH%z$Xkx#96j?aB5Z4M{YNp>C{Yia4}m~MWO+-^s&+)63rc*bIK77kCWc9 zD>zP?(ulr0r0-&Q{QzS0_e&eji_Te2pQ~$*e0+Tsko&~}FZ6ur!Ew=ifn_hOiDT2Z z(&yMr7iKjFJDi{6eh!_V%iA{<%@&_lr_&$H>vMjl`jftMV>yS*e(3y+@1R{ChbyQ0 z_YBnE%5iX5mjBOb0H4(c>?C%d(N5HLY`S)6Dn95}Ib+F;^)y9`=GabH?iUBV&~`GS z#O=mh3mNW$Y4j<--)89Inx0ST8*T2h4@6?^SQ_|`YoMn5@?TVoRmc1nQ~kj1S+4g) zJ*rhge-~Ohv2mkUAI^RDP0V3Ij_SXD*s@#`N}Fomg<>gUXNK36=W^T9T;5`zf2O0{ zl7dVu3r|ymXwJ&VtO>oI=XOR=YVBDX2x`E}FF{>UUa|5^P#@M_bq!egC8!g6cD3?L zP#@M_bq!egC8!gtehKQr+B4Tc1&l-;k7j=6!As>bTi!qT5dS+@R^V3oy+DQZ+)H}Q z{#Jj_m%X8(`0mWLG^M>*_xW2HW7aR*Pjw|ZIxiYqmTN+36Y9A)u!{8*=SWu}&9SRJ z32O_ZVfA-A&2W|g5I>r~Zw>f8*JszJoD&>pRou0=3B_INKTh-aCDsoi33@7k?FO4AH=+jd+KD%K(Ewi9Gj#riQagJA8Y*39HC&~BS zsbTp09`N+Veg4?-{B#bV<5%T;oa0aNcqX}=#ew^l6?l|*>H7)BtVADgOct@c8WVtR4ZvE>j z_Af2MYs5lKA#X3RB~7ur3hWaKoch6`$v9me=TZ(H6mAkgJ{7gOfV|%QoQpCOeM9@c z+yQcObY2H+S*{7CO$0pfq7#dh`g?q3y|ip<uDkHpMXIVXR2 z`8_HRmInypAX5OSVGf0SBU@&4iVN$-}cSp#x8 zQ-$;+eI)_pW4dvHsm2Ab|BGF*b5^!(?|_F+SM7=AbdKx>WR9|>_DJp4J<_LHzdt#~$LUEvwGUZNr^_x7Z@Mcl-&yR-%C}>U zJIYT5G(^s@j>lfaPmb@~fqi*?X*xDDY3JOwzU8zWiss0t^+Z_i7YDpiLz5_z6r-7j zG9;-0t5w+1V6*kNdkdy%?Wa7iy|CCepr~Z1)8}>N6ziAD0!K?@Y5> zW3Kx9m(j8V;*nQA{Of|o3+%K{PUjb0O|Bos`YP01rS%~OOf5<(w!3XfSmb01CN6f^ zhGKODPYyA{$#OXp*CITRsxzNDsn+y`WHOp#9;%#=hv1=2t4uR2Yg+U3k@d1D0zNyV z=6AjSfk&U>_?V9>=i}*4dy!rz((}$hH}-R!#l^P%ZmO6ZHrSJPs>~zd`0#e~@r;e< zZa(3ThGehg$S1pHxh9l0{&6_^l8k;5=~%DamQ`f;V&OY15~-cN2wToSD-|AQ&sPbL zJ@oL&zkmB9N5%S3<$OHLp6k@OkUB<;w58Z{@&hY)k8s)x@MP%3(kmD|hF7FurR6GP zzRGMF-fk}4KIpOZdEMJ_yv$3L^YM_pQVN`QcL|mWB(jc?`CeynzNdh)vtga{&EQ2Y z383^a)7P~<`^TkUU%MrpM~-=^a{Vasm8>s*xE|@5YGH|3F@$th<`w-@JUdY!qhQk{v+V@Cu$dJcQD+hq@DU&8S)4^_^`4f>FH zq?HsD5Es^mT+WoX4zG{Id(Q6q+Whxu2@cIM4^_^`4Ln#Iyb`@;FQbacl=*y_&(bzV zK4NmT*8Yt>p{aQA`lNKa=Bw|!^nT#Vp5CoG5zU^uVasw3mwnU;xwI~jI|q$Bw~MNT zBwCmz&zX`r>KvYo+Mn@p5v|=u`8?FRG_`Ra*VVDuH(Ngi%YkU?reG-$aU6i9K(zHz zPK2KTbO1U5SpGw+`x4<(1=AnEvLD*oDB18Q0aJl%0Gdnx0bnKY7VssoA7}&4=K&J{ zTJH`^duVH}(VAoq;89>7Fanj?3ZPvrtZN6HTpR1l0S??uJ2X6g2DagbzQ7H|qCqeW z>zh2=2tIBm9!XOlH`50<^8{{YBI?8v+|1SltbvD{`4~5IBW~tBluJ+GW)jcGdMs%; zHVko&!5S!btQ%8^^<2=I^~7xC-&?U}T_x5zdjVYE!MbYbV{218N}PRilz2TgO7xl- zCHCGFC9ZopN=(PXaJjT-8tef>Z)f0^4fSQe6T{oh)L!*2S=QZ7+VZ!Q$n#l#S+)WN=YJm1|;bBIFZztPQq>0u;5N zDzN2xY);$odK-M&o4HpFe=1N8F;7*l1&+;u^6Wna%{7UlTpqMMDLlX8y}oxpth)2- zcTd$B5Wj)YBg>f=`(gN@*&&g^MKYht2>9Ib;s>+7xV`a&<&*UoiBA^zu$+0YABN8; zpQ`|^#~>$}PhvuN{UmG}d+B>mY`0DKM@W3yfe*`>2m4|8_*d&Q=d&&XK41RWPFIpM+8Di4-({Om`=?jq8{%>2X)ija*r_u(0ibe- z-e<&h4)$aGa>Iq)D6R@@=s2$jL^6Wqjtvc1>2qwPLrpBK^r=ZR$A;WWpJO8(YGP4_ z1Kdt7NBxASk3fA%`)a@7@jbfEjr(T)(|DZH9QjeAwqUtm9PrR)@p)2{ZKH}D=nTv% z$k^<^+lG_gnSdW!l5`SRZjc!}A$7d&3VSmM(luznbgr zD51*vcy&G+52qu;JJ4;XK2zsl=QOMoT?0uqKXJJKUwukHJq`cA-hq*K9QqaH_MGwP zzw4ixZtDMk*WFroV`;$BfTaOT1C|CN*MM1j?cdhsiCi1U-kAxYMC~=|pX-YD{{Jq2 z`|tf(u6--KYks11TI4@YjTmTN+3Q{#L2G&>D0 zDe*b50QA7zOiyvK3j+r9aml#80^sMAb-j%Job=QZ4`eQ>BWmTIxivkpshH8=iEqxW zb=AAn|4EK`(flqf*M!pMKzV87xAB6!*yGkh$;MW02cubB%^ga6u?(T{{kQBBd`_b| zOTt9&pn-U6{rDPkgr|--Enw#_wpzBIOXtd6ArRH15fY%q`kl;^QP0OVqw~;d-}BM+mH6i>Gly-O|BnBKNJRiVd&Wi3>oxz zowiYKuQSI(12j;mkHNq>XMeBP>2 z;;b!Ny@^BGc`?|soMf^y<>zwS3$lC|uUZ@tuf+3>dMjJFNVCIo5bd44=TVBU-ybDg zp17me1zf)p|2p8sa+wqDoAJ_K=4y#pleUcSo3oRQywvnu1Kz`%zvZZ%_4CeEege(m zQ+tEuesRDv<7JYbHNG#U`;G)uPs<1puyziM2Fef$=lib7q4QN0?5O0U{mYk%ZO32W zkDcv=-0usKato@BIXfPQ+lNov7`v?14>1 zdi2=)9PJCc!6U(XSps7Zq4`w+FN1S9lU)985s9u8<+QuXIcLu)qva| zQaa3NKWaHiVYY6va@TQpkLs?Uspo^n$PFx4<2AD%vvP8z3!k0a-RO1jYC*{TOR*W@ z^W7bdvbL<<)_j29thM|}{S7RSh?kV_Lh)GyKIFI@Q1clbD{fc!zPBGM8`IHmq~y_E zu$<13otd73`AlVFe9zJ~Gd!Q%?bk1FRzK-i`X-4S@u7YXmTN+3W5!391=`Wn`GNj9 zPYFKH&-8fosXQtW2A4-06<%ic)UrYItJgh0>f<2Q%5Q=Q? z`NPB8RmWF)xc+?M%>Mi=O#EttAIk&8{5z)nB)h7Kmu&BQ!HZlHK=GN`*WY2T&G_iD zfPIZl99Zlrz$i$%Ku))WEF&K?yBadT^^$gZ(Q~=)g80yULM+!vNEWANlzxaimdCW_I-XzK#_q?s+Ej z8zKxxUOcue*M!o>j8D*xf^6jU+Nkg_ORpPW{ohA_ZR{|#u|F>2LFvVEiGsFk#=|VV z@DckYdS{S@Z~NVO#fJ3C9u+>lD#!2o>x2#GEm!LmmPf=(O0Q6Sc7YGMB!KSUEWIi| z{(ArXt!az)(g|?nQF^gl6G|I1Jq6QCWn;`|b4DBan5Em#En?QZ_5H%~M*cX7Pebrw zxkN?VHRBU1-Lw}Gn3F-yXD!EsPq#NeSwHo>#1|e?(~ad3@iIv_Gd`8zLoNxR`!`Fs zhd+7c%HH)}{G_h`fuGZj<#fI5%=A<}-I$Fr-TI9U&u7J_cdT78X5}D!j;lFNH zXy1&FE(?^`FeaZXFkgf}0J$94tnf0kr$fBi=>E;@>EfXU)5XBOgT_hr z)C^~{oUWIh86Sf^8Q2)@sr-WQe5(3>|60NHQ3DeFk#f4RT;@XiW_)y6z@Cx|F!@-< zgo#f7%odo%1<#YXmfM$IFEsKpv!_n2`Zd1#B1b8|3npF-peL5&ufdt|GP5UBatKMb z_jTY$@g)J|o3#fPT(@yd)GOn5t9He5TxM{l{3N@Igje=OM!lKY*T8O%_ODpJI^!|L zzF2M`g+FGzg7#GtD`UC7D*|2*^~~6O!-SW+%I&&XXqV-Y@G`Tr0V(>Ga=B18-l!)t z`zpI(-T2$yX#IiwTvZQzSRM(V8tn_DwX;s@fCFBjTgllft7M zJjk(Ko7vAvwVwIA+f5sqex=wC%Ol~T*pHS(a=&ikCE|Te~w!|E9PKSOL_hBqWz+6u4PcgI~`}#yDHXCh{_AH zYnDgC)69+{B8$Lfy_RQ(x3j8s^~UdtUi!FdXDpA1uViNj!!ywyKK)a>^(*=&X+_<} z{)QmwwK??4@<@0F?J!c7#&T_41Uw%&^QH4IKBMq7{!ov2Qa=OBBjKsqsog!rjw(}g za=A8kf>Cc~_Lw{1+2Pr%e%(uT7CGWW`G)11P}=Bm+ot|=ec-b{Gp=NR>3R;~?SKlr5Y7Z=-3Q|yW5 zk?@f0DUd{R`s|H>$0^f$*L!SEaU*~6s_Bj9nPzz;JQRD;|LViN4DFb5hfyzP_VRP# z+*?;qXwyWtU+Q0Ec_e(y?8QI|fyjDFaE7;=xiepxxuW|CtJQLf?RbSrQk!3 z?bytI8tki@?iioe_I$;DSRM(Vp#7+9jQZ)98=lV_Grz9N=-r``#@&#kd`0yR%Qd02 z(PK2`b6pl_w-3xrNy)dn-A?KemfORd6+UKmbbCqtcl+(THCs(DmP=H$T{Avrc4Q!h zD`h*%&kJuy|MNVZ@#pO^(^Xz9kBFCKN1^!a1s`&u>}c70?nnEt^6ZlaayT%LU@_)j%yAmqEB#zXer9&{ z`NSJ%y}5e5o5paFBRi*gfLX2yrA?%E6_O;vs{ptiSOuOGFQ=>7^WfIO_Z>I?n&0=R zcE)mCZg8eNB|AG1eq|GldNeD)-uHDmYw?A556Sm84CsDZ;I3G1AcsF@{DO8Dj-4@| z#!U*(?}bHs&TY4K&yV>;430d~I?FYov@zqS%L3(@J|C<98oAu4Q23bH-SKaCYgck{ z(#`&Cq4A;jk}Q{~XuD>7%*rz+CAXtG6@<61h0f1AUisn7$5i`bc|?39`!eIP6g4iofX6e&p_mb#`zb}4R zZAYoMi_f(gC3cn{bO%Om0?rBf(A z`EH}0%+l*FciSoJUmf{E1Aj*crx(j3;S)?Rm5p({{H_T2?0)vE^*z7pTh8Nbh!3?l zSsn==C7)+aa@h^-f-;X$FJ|_WbzW)WvT+wqpIbnc9sRIRqlN!?V5N?a21`wk=7mvuCSz#B%1vzM0i1gMH+GDvEfV45=CD~OCtc>l;iee)#v-F(# zsrS-*KWM+Ar9W=sMOtRLL`mEA^D?Zz!5@s-{Bz}JdbJth^;6S49$yjOVf$=deV*=E z4N4EO0v_94KVOh1m5Xamt*3p9x8tr_;>vAHFQO~XtlN4(%t=wHU*1jsbh{f2o-Eg; z!7WdrZPUBHifu!j_DL9})!lSe=8>MH2^dT7apM*o4ktLu?WK(o@N4|&V}Dnzm|F1U zJ30r_<52Kpd61dDS2I8V7uonAZ={FW81rdSi7_9vLXeogSd1NBS9~%1QR@3hmeV=1tC`Obe4suQqulU8quZJ6#O%{fRappV9l+_CI3<{#q=z-*_3tX< zl4He$<6T;`w+;Gb{@OdnJL2gCIPzLy%W_R9Z36s;*r$0)d;{IZKKlf1E?In$SejB& zSb`BZm{cn(-<9jj${~_IZPl?1x2{B+|I5rVE~N8R+W>n}x2|2gVg&_Uezvx!#a4kW z-^XUQov4(YUXqq*Tdk98ixpSr|1hujXlf2Rj zJuvR>WCq&Y&8a0`7?OW>17p6MGu@c)%-X+mS9w$Cu9#NlzYR^_)UIN=dLMyxENG&6 z-?WjgqGEi2TU3ItM?oSb-LFCZ z<8p4D#Eb05tel&=ze)4HJ%63a@zZ%!ny7L<9-5b0gqsz8dPqy*G0)P=g8Hk8=Q(fh zTGXuHE$=Z8=Bdj0_@VPOei1J}_mp04EH6l}PGEC7){Pu@?mpr$yi;YX3z|)xolJk= zh%e38&2mjBZGz4;{V)^XMufKaYck?gm`xlneIkF4fKP6m$w?m(brrPZroey~lUWAAr4;eFBI*5l>&TYsF*aymzL0Uq>eW`>*Cbg#}r zhy+|j_Dk~)Re}evb9(crMPsR)mdl5#GKHry4?w>eO+~-!o8SFs!JgS0p3+NsN=N!G zkmdMmaNIV}q7`jQ3NSC~@DgW<6SX>5bW*F`Ln}M!msdbha=l^*)Z`E8l^px}ztGzQ zIadwoP_9+O`v3U90;IWIOt>nv-IUF2Dwgl-_59$wXWx`>)9;q;hUKabBCs2*&EZAi zL(7rnVQnCnWIff}C2IJG^S|6jeK^DYH-{ycJ9}q^wx5--uU2y(-H^TL%ki`8=shdV zpd2c9Sgz_S0{g-0U)4<~(sGCLKY`Moy6U(*U>~A@jP`4C^7%ELV&(LX|0FX@ zA1X_zJsStmcs2S@=|VdCC-oF6?tkkulAN#e=Nj|1xbL&34x~x>Y|InrZoN41+NNSi z_cxYq`1|F1Zmg}3q#(UezGgZ88rqfs4K_oL4(NSb`;x! zO?j+>=zj>u;^qgl4jI`LwHay5Y&_5cI00w}bOO2p=K^T}t*)2{Tn=Cyx(%y))DI$FeooiVMSkvoN zA;z7F^~25);==wy?9M{_4Q=gTrwj4!%{aaS_P!Nsh}A{E?)g#T$}6M9o9{&lThC~b zgaOHyoEIbB`YuL%yQ-FOuc|Gc__>bQ=ZY17+3Je{Sq;T!-!>Kv8pn%-t;dN6y{*Na z(Fvl-s*YmscAL0qO`_!(VOzlj#=L6^Oz_5F0ZwB=+fG)7Jgo5Vfv`pg}aZd|H!Xr zHSF5;wZ>!@NOEl*vVUSeK_t^L>0mC^oSCfJNtWP0qXD_R?OGnXycP4BieHwW{r#iE zW3MfWJ4rJoE^k?`DlS;wCgY7=A8p;r3sCvW4R`jHrkhGdJDQ39}?nSP{stj*TPEc*!8cnq|FM4 zMVZr5G7bHRoo+GOuNj~0?=!cz>|Ev2?N;YQjoo~6rrvWv64qwQTg+%kC z(mM<*UCs4nrH{E@juoj{`pEC($gWk}=Kp+*%R#;;J}&=PWps_@!fQZHANnRzb({{W z-1>jyHK3-CJg=c_^VE*xwj8Gy{il4ua%L-E$1=-5I1Q-jL*p%}UrsKwEPWrGZV$&* zYWh&!!})mVAGAn;*DmiK!HGS~Oisr0z zIBH1{G9op7toA`jbshDCYWi69&rwf;kP)is!|gXJ-{?7&>mCk-%RQF!fAu*3xBNrX zKuzgmwXY9NuZQbud7R%Oj7uPw1W>+E=LOt*cD#6I!sFlXTN2yJKYUKhU-Vrt%jtUA zC6)L*xvqi&+pvt$E%4OR$z8SBIHi56uZ?8qFR(EU%~M*FICRRBjz>K?s7}aDi8qG&&|d;c8~ozJg-|SYWG;V zsr98CFY{96d^}=awEBVv&mJDH#IE{yrsEK>SzRm3Xy0;2M+0hkNd1x4Gr`f(eI&7{ z=|gLcQ2JPD6p8kZ{5fj+v_zD0S$5B5$ z=|ayw^ekhw2cU$1$Ymp5x&P;Ir$@RHKHVm#H~Ep~Pq}@*3+-UKHpw3rmckObKvs_M&`OPO&Yk(BtvtyXg@@TLs(co#3&1 z9ay-uhb^g~Aj$12)Yd{M)~}R#&G{ufuj9Y!+;-vBrLS?k%uAK?@d$XGWyVYX-XU{u zXkKx9nu@VEU;WL^u?v>)TxrCM`WacyeAqYRHOTIsq$;T&5?Hn`Dw8=54$JZ_4Okj5 z*MMBUbow)NKHhrWk~=4+O#I*c@5tBnV< z`r69Zs&=jamIll5@#ow*v zc$t?f=i?FZ8s>C5^f3}93}t>r(c$%$Fnr!4iS=6T;P{!JD(B;o^1~|EUWW-k`8hAK zPH296!T-x^UhEL_{kT>93`YE@eaLd=#l9K8z;m9Im}d0`$H8G)zNG<61Lhi#>y5bj zq4V)ZwTN*IefSj*)Gzy)sE0OPC zZkXXY^Q5d&HD9w_jV022tu`IZ>T4@stJ<~xTN*IeKqbWd+_J8zF<(1yjNVCYP8Y&A z?%aLljpIexZ8wg55{KyPM@|ERp8x9=70sG25W5!0RavPhIzmuqBTBR{oVTm=5(^2e6{)at`tT<#D*Di>MK zyx2F>o8BLBVC5ji$8mDlmTzgm(tuF|OYxV>o0Y9Y=jXEH<3+!R--&*>(iOvfe>6WI zz%J+Wu_uJi=XBMG zMp5z3t!rPPeRBFdoDHhU^`qwbyjpw5G)L0)p+yPt;-joJzwG|# z{TH}BMEyV19%8u~zFEFDYY&+eM#C^Jd5RO?Hx@a)zG+H8%TCTivfSDatpRmjyJk3D)-CN@x(%&E>*#++1Cf+x2cr!+kI}x_e_3`gar_sq z36(xnpHRI*dZcoVP*b}~E(39zEB$ zgvI@G>6pI|Cvm)G=NaSem)t~~k9lurA%6OOb-m1Uft(ce7Rk(uR1mT;@#s9PL5#PR$sag3=SDhj{D`C+U$~ z8NlUd(fRROyA#E9jqc>%U#?oPdHAlL{(`|@jEW9^xq9Ik=Y$k2o^9*zaQUEb8gYX~ zF&z9^yGXzV6o18oUo9v{{2cxu$Vn&i@ukx7;r`=u;4}aH6r;WL8$3j_m;B~UM9!&S zzLVH5UN~NS&X~58KtL$&gx7ptct-YANp`rNh%(dUerpAlR zEw`?`Y;e^h&-!&o?~y6rvRqZE-d;rcT!dB_hSg{j0*)$ndbJWCO*gd8@Et^{mcIi_ zY9NDavjtY47h4U#rvIE5Wcz1XP1jiR1J{6D--`6m_LH3!FW&iO)7J9k_3q{RitUHx zDg#sd!9cFSuq`7nF$v;6oD!VM7-Rq-D!*5d*M+J<5>MMS)%6zPH zQcZz>=D%!LE5q0oG0Yh0c=FmcMQfO?KE9<+H8~$Yc)QX}4bPb++LNzhRze;>6gxO{ ze#jpfFD~9aXV~oK@h!DRGstm%U^(+;|3G*LNRIT>m>JCS0hgH^r{({18j$lr_R!Gw zve&ELZO! zLc0o@5K5(y9(~awtsSVClxk1Z{!`n4R=K36!qNLL+tb*Qq3vlU?5#mX$KsJg-WHAh z6xp6wt}>6%o)iPZVzKBy!veBl%O|!awjuUa9@hV(qXF5TDo2O5r`S>P;?egeZEZJd zZKw17^w^$QuCk8Mp8V#6b~$>k-M+wMtFf{};AZ8M8mIi9?TuuXt;w1>GW)VU?HwE1 zp2m)e7rzYf)NY*j``nBCbl9F)uCk2Ko|O8oX0uZ5iQ*$WQJpN4_sPEG|LS$t|3lM& z{5?;<3q#ve#khDeDyIF}vz~bM+=2dR*`8RgvWd{1jGY`@-ASdBnH_OlWFKZW!g9Hc z;%hAb@M=IVm&(V7wxeCJvy(EfIlc3iE<3LC(_lMdxytT9>?qJL8=|@kXHRPU^q=jC zkMVyq+v9UA|KKzrzu!%_8|_JbzuWTScyVLB4;Q`A<;8?1{vHGB`=R$lELT}*1&;K7 zcZ9RRX*YSn`(J*)E9*=yLoIukHDm3|8mPb@9+xpE$Cz*9PSxM<#&r^6uj}$#cOYN4 zF3EX+f%A-Ly!zD~y%(c=%W}Us;EhhS4M@>nzsb|trIi#E*wS2Xdx2}Z(>BnZ<8>C& zb4~%)k9L&gIEOk5J>F>uB~-Z|h$PI8Z2$5;UB>^}4-=GiSkZvoj@axBZ9j>Qcrj`B z;-15HY=2(0AC@b@i$k&>j6?N0^StOfc5t|sJ+UT^O}`AZxI7x08`_@e4z6n`n$0?C zb6|aV{T)(FH94J2PH&gu`M1dKb&m98`8-9Lc5g980Z?C^FutG7GsdruQ>O5KIj{Y_ z(=Ys~JFUk~j>?fH*s@#`N}H^ld=zjPBuzu?XqX>{_zm&oOiId`T;jsA@BZNlHjwgZ z|F9OOCx_0krFivTMyHpi;Pi)C0iX3%3BDA65 zYm9+M1gzIx;7yM8N_Nnl1bu|~WAvKIw7W8S@WQ8VxjdHBh4fE$z;ZfAc6tS;B(n_z zS6m*4D<`wWo9DD;l}sqM7Zw%JAkam)nE7;?6q?T*SG@RY^y624ao3BtoY8}r={DEMTB6$eqdOZf;Pe5NnJ_?K5{ASx)E3PA|Xp(lEu2$`RF^r?@!PlT$(u1e(Z!;h~-q ztd-hBh}a`+FETgcPOi4@9aCF5UCNOz*PSkqAe;+hWUdO(<<7KByzL$3~fwD8soNf4LIB*>`RAF0|kM)5dR_rN-)! zQ2fUuewORf;1==oUE`ZJ?asCMi*=QV3Y^OES4=kM6Pj;_)_+THBgBf{4ZrG&H4zIdv&6s^_T8qW%oZ?_`!ltUf?vPpF)00U!xQ2fzmO28I9=fEmF3 z!23Wv0-OM>2ZkZweZXb}{wo5{N5K6N@M8#g9Rhv>0q;e?51k16K;A6qCd6BKnLK`k z5F;lFk$SBVXFn;#t6vB)`qU_qhKjk@_fewg(r7XItQb-6$pV#17B`_i%Em!{`{p6+a zm`A2BeEQe9;nPpnthsfIn*J=8C}_JT=^qpY27gCp6BJ+>zuc!Fc~S50 zyMBnOFP3w>><5(-$S*a_#}}E-WIKzUV&rS4FK62uZ_YY?%v$Ed`cmb5yas*QClok+ zn!@}i%H>Rj!o#ebS#W)a7B9S+aly$T3p-T(%9;`4B=BN6^I_jq zKlo0jTdIAUZH&v8?xg*q`f4>vn`{FJ zb2Fnw*Nb9=j^}+SU#lJKbChmSi zoSWDw>eBNcj~e=2QS{zNua6-;a=9n#J9AoieSd!X+Fpg8~m_PrzPjq*9mRlcTr<9t5M-Wq2C|y||5kFgaVwIBK@-H*$%`Bb&`0|S0E1G=uV;8NJ zqqh%F1uvGXyiC&Bw5X;}UxGvIf>)W9<9ijJX6gIN>+^q@_Vbr7%lf1AWx2{TWcvEk zb7=8|34Gl;NpEW|53jeGz2@||?fK%r(otTMBaiAkmTN+36VyN;e;l~psOOSKzhYc< zjuRhs1_Nca8lIQ3uQ1++nO(kn%TYZBEZ9*{$&`aR0Kt*cI=$Sog)&ydG2?YmWRV{8;W62fWNt zLzD0TnTNK!y&%P2WS`(Fz*D8Om|OHp3l%8{Ee56`Ftn5Rf*-jgK#Sj`UGvUk_dm4s zecP9^UMN4XTnj+jnCit}-qC3r0Zx~7Wybi;%8gBDUG&wBmwb2gshYNQo*fWB%cZEb z-Jq!+iv9cT-VqEwNgld*aX0Lm>WSPb}wf**|>zK{{Mzg-F)`oF1Da zxSt2lzHGp}ZfWh*dX?pTAMBglPf!$WcOH11;g6sSKJ#CBb@=qSxAu_A=ePB2uGViX zXWr}w$p-R6P;@B#BdGI;LlwaHx9FPi_gAO>cf+T2@6}!{zgSLT$}V^_hx`5_E7Ros zls_x{{Y^iu-P^Ibf8VQ?XDpZRjrNb+{h60>^8F;v4u3zX_d7jH+|O62pR}4WB*(D%;$@?WP6w)$)(!N0omBW#A6!{wl5ue}8@cIPUL_oyQ2Z z{A2miy}!uHK;pDny3f+r7%d|`+4zgV)&I^BE`yTxHuk&wwq|r}{!e2(= zHKOL|`J^$@i{*ZCzzZtJ-(Iv0EXwgOXsJK5Vp!xz4_+}B*?l?rhH-JR<>C26eQ@%K z1|mIUjz31?LvP1f9w6f13B`v=@b~)EQ6r~Y)lK2~oH(uSAJc#REuH5lBR({rEz1vt z54~&FRb@yrEr<#POzC#G#x)VogLQ{;?ZL)*tY4?559x^BeOd0<(12X-72T}&gC>C* zrIT4d=(m|gjaqK`VhXd@Z9YnvmvxO@=!UgM#yh zc(6w!Yw*Sy7gYdU4#(YM9N$C7bAi&c@g8m5W2><%erx|^kJZV;d(l2Q=A+8>qe5W( zL@p+&rt!(#WlcTNBTL*g;zu7Jmt~)VvELXi(BDn09JnS2W8}0TDzIgKOC#X-@Z}Tt ze!IuDpW|nKs+^C9=9g^8*kHVAu9+Z}|I9COVfgg?^rCIGPPy~dJdU6Fsd7Hf<5E&x zj#SL)?e$;=SZ$3QY{Nt)}o zFZ6AB(Pis6KIWs!`8YGEkx#n4SmslS3pt&{qVRk?pMP~?zc!ENb9~H4mGkkieCUM( z%zPS+(jVw{`O@sJf)cMY2?kb3?>hYfRlsMS6%p_({;X)i{Glm1%!7HVay}k0Ppy!c zq|!6IPw#Y_(azNG>L|{PYuhaPy3_rC()%59#E-_!vRo5Nn}PUnq}1t1P1ZjnDfO{| z@f$7wxw3t&1P=-~2_T=ww$a!`ajp;_W_*@SyG1{3>fCc;Nh0l&qw{F1$~7@I{xK%_ z0>o+eCVM?o=~EhQs{N7n;z`;JgGm8yIKK?wbW6P5$cOH|7EsX&V@oa_MMLStZ5=b8 z-!${~DLN0G553=FIh`ZBKslfn0(kS6k()a*-$`cWh4GZ)WR5@cj_~n+x^KbcTOaJS zgyWc}?aULZoR9N&9eAl+46_~LoZ>8?GNl4HK=B@~_8`Z{dg1@I=VkysETM$D-tuEl8C7k;WMrp~G_TJOT>G3blOWz7K(&Tn1s zGUhkBA1Z?|@LFtZvvV8m9yfBqH=n)oeGZia8kI6iGL@AY3U=&}@I&FOlG!gqK^ zIUiTzraEz!2&pD6mf(IgP$OBv%ITeODr0O6w$m?#C?MYn}7mp6IJCc|^b8V7jv$ml<5( zzEkY({)Ht47*hfx$ikN@x|7S5gnNwlZIcMkp8 zpg=z&=etV88}7axQ!ZZGd(-1&3Yz2eR^@zLi`V6K<^;yRVnm5811&eGzu2D#&{`|U z1+4$Xd&BeS(7k<=zpt99jfthWn1?D4%_H6JbxcJAygDB_Ju>ezrbjyj+8$U6o~`Py zqheG{ozUyU-)vvKq1qwK=^WXSUg#6bf&oP(c(BC48r>Eva1!YuTshA+5sUM=eB|#( zP_kIw|W#WyxIu2_f!fbN&eX<0Ap z6up?W6MH{&|1;xTWj{+C$x%Ah!Gy}Xk8d{L znUZ;GCp*PQj(jSYS*{7Cjk%o$?Xw8ya{MbJh=28(wL2S3x;&7-bskYdl`{p3KMS8j zPw=3%4xy~)>`J5kaeB-3;YY3a&waq&pcmy|aui=Qwk+3#(ngDKlFObA^Q3bo$ZAw|W^C%(E0P=Vd-dGIA^@ zpYynOz}i?EI0iJZ2pqURU#jHWgw@g7b9_~kC{cdXlkXDUMM<}fI<;{63;BNTWYbMy z*(~>q1D-ZAqNIqPIq`X|-J#9!?0@1(D1PYK zE%Z!Jj(M?Mmj<_{ypoEFFfj{14tp^mzZx;QeZDyYUJdR@YdpB<{CkJ{qb6R|@4@mQ zBYn@5S4uuQck!OXh3{4rMrF8+(@!i7>WQ9*%F&rY${hQ6ym&d*JrTR&t9k2IzV>|C zEB)vX9Pw#|Ez32bw4rnZ0;!`ZM@z)f==Bhy5&=;Bayy;kjP6O!sVQNGs0yH!|6&MU;0qAzo-X~3le>rd+Kz3aT(0l7QfzN=w0DWt0 z1BL<~;1*ytuoFl?Aw3pY2y6vTLH|!F@V>tv=;2xzyNsJ#0wm)GzXt9^M?@|jK2p&b zJqHc{0eJYBjLPgeJbavj2al)l;6c+3jK%{;5gs;PYKgvUJYclLgGJwV_^!DFo|!rc z@xU3VFT3Hp!Jb0=j1Q$dB!h3d5HmB;A2n8pzwCG}DZsbTQ^D^lA-dck#OW0Xe<|iv zdKuqZe~53ZccPD~Hpc2FM2X72$g@a)eqJfVy|bN^!A@{{A)o6jFUZ`#?D=myKrNah zpPn07?iU9@SQeNmXi*Xul@gevFbWT&a# z)EthsLW-~a$?*3(sQ3CcbKiboBRvn2BR>jTmTN+3qqRr$mqdCO_Gl+&#lj=KEYs$q z(uK2hz1C=2W$H#V}%K3N%Jhc8ana9cq zcocr$Wx`3T?_a?2Fb`GE$HVa$oq3LSs?4L`itzfF-1OU58w|J@C5i5shbrge;dmsC z)`Kd=1#BNHBj9o8MOXjWJE46CuRkL4qtM&Va*m&U%D;N)L9GOQW0>nI%|HQPh7&m6 z#HWnU|J;Wo_k(tBd0*2vW=y=`YB~saGZfGWTbAq6;MN~6-aQX2#D{J+>Ic9Zxj;XF ztpAnI7~`k93Elr<4S4l#_U1c9PsfYo!Qz7Y_|Ui@ zhZfp>{!>xRYkH9DSxQ?f$0;gQP3Z5Ayxxt&xlI9TF;M->x}EYl6NM9K~|BrsN^Nfxs?&IO@$a8wV&2lwjetM=+ zGyazW`a`wDnQ8as+uGB|cS&vsea1#D{OP&}t~%xF`AxUK zLi^;1KW$YxNy&xfug!fl)H4MJkmf4Ds3iF=^fok?zf}?N6E}S^{+aX3e$!(Q@>At} z{6P3o+3fIoip+RcAVB6>_I!9fKH5lJkd$#rALhY&RONg;EYDGHXW;~=15G@Ax+(gg z+8NZPTz~EbKeB}+fP5~$<#8O(7fqhsx@rVHzG#m5sd7Fp^Gop*c)SDbg(avw`U4QT|}LCX_aEyw&puXBB)v?!Tr2H!SB1 zDX55c&%{|Y*W#T}+9FhXZGh8Ixm*SL6#%{ap}K|;i6i}6E~tSr>~cOzUt_cvb-Z6C z>?z@wwBgIn`)kO4o33##Pgx!eS>KcGh3gxtVr;`p><$=7IQxhsy-WI^ zy#Td$=-u9jpjm-qm*b>y_>V_+%N>9Q7U5jBkFu9T+ea1bCvRZi?>5%&oPGPpdL&d2 zQhCC1HR>AeBO@oLphSDZPO%r{(7*wD+SVtbMj)Z=hHQqc6H_gTeBcXU8H64P`v5;+ ze+&Et@c)Nn4q!5HFMzHWkpj>=VFK9}x_vZIxa7#^eNBK3g0q~Y0l6M3e>G?~G}qU5zuMMTt9F%vlgEE?O2X z>Z34u^si_!u49boHatdTUJ)bSe=J6P`e}@~v3V^KKctqpW>ziH?3G&Lt6H_i=>uzv zrZ?0U>p!k7W}Q(-l$F&HyEfMm&3e`qofp*=CHw1&z6G&j!?sv4WlTLW>w|h?%tiG@ z>NoYp$ad^*v*Lq;XGySy=spjQlTwz=;}% zRk%#ek7oTD)V`x}J?L83`YuRUtpFOU(;lGbF0$`lKtBLoNLm@52Y(tcA9xUW8Q2cc z+tVX@I z4xK2YTB03_7Z?|{)Ad+Wek7g?fUbydC2$*X3gUSZcmw+n<5((y*8VSJgUMzcbDcELZQ> zm>;x3m$o!CVz8ox{KS|-%XZVXX65%37{F_=zjI+D)IP~nBeDJ;H4RiCCN95s!CuHt zk^u6ZKrSGE-*)wDj=L7$*J>ifnj?FmQe2hmM~(e9soJ>FK>4XHbz(1|9yy!V-IQFC zn~OC$?9_qH*URnnbsIwSoAYM8aDDhr!XsV&?)`CBJp{IAmUFo58|~RpzRUbZcsxD> zv3@8|NpIXQyai<^=?r46O+5g)0px;dHD64wLRjjZ6Md zya^rn0>!6ebPxRgQ#ow?Jw`Mj=j)31Lg(x3jq&36TQ00S`;tACYQAQ+Iifg`BSw-w&Oy>3;X#GVAWnw=T`$d*}9qD(B-7=Ij2Y zKCfNQ*X0O++d1hU8r#KXYu86nf66-W-JfCqwsI5JJ>Gux_;yt{4;_A6igq%$BUsLS z*bl)=D`WJfIs9!Ohxv0N*L_rnQU0MinZ6C6=R_hw{l2FFX90r%7jO&k9&kD?rZH^e zP+5*d04ou|QUq`*0+@^d8aG3|iH^U)9fcU!6JxE0;Qe?Z-oxFFcKAm^yxtRY;o|}B zx+3%gmBfhnuWN~JKi3gmx7HI=erqHazS&Hi-?WYRVEw7$(!4}5bx(%4ZQNur^@$4c z_WJE&`!~r^q{o_`6G5>?C)e-lKIwq;L3*f-iXF`?O&>J4 zF6fIPNBuy=ljWLF+K}G$?@_hyL9wb9z6f<jU(RO8uFX)+AGHqb3`uNsb^aXQF{p$kQqy*Edu@a$HidhWat~^U(I3UllK|`6zx+$JNnqE#Iey zLS+x}X1N?T?HkHH-JW&h4tx-D@b#k_*P;9;-H@GAxv7?&hZ63;<=Qgb2$y?vBs-yZ z90~W-)xY;j!#J5KeXHo6y~{Hi{cd0OG(As{BRioj%eBAK#>7sN3p^9DT+^L{lX0G0 z?pAye+D^sxcro{-$}TfE=CrB(pdJbFAUkEb6t%Xim%Bq;?n(ZvrJLme)yHa>;r<^; zxk~4fjhf}*aPj<`kC)-**e)}7RJRKUj_<{T=TE=?AA8pUA62pSZzvKJ6-hvB7(peX zt|%7l2}vMGAc2Hpg(X?YO4wa@H;`akJBnzqBDPpi6iciR%Mzi zu{k6dx1KC6kxdEH?IZEe^lSc4xJ;Y=ZXAdqK~i3yM|q{p6gk*&)q=*hN7N+?{5%vZmSlLv)BOLyZ;+8|KkFzRp^>@~O;;t{u_pru& z+|9bF-`AHvF#Y$}_L*lB!1!5T2tE7LU$bjvWskKHD_-NHJpzyZBK zpZj@gIhpxsH|yvQ?-c__?&0H;qXO*iYOx32u&`nH?(Qt#~1oA&tj#@%;j??17gBzT3? zJ{%9@mCjIY)H$8yDX*;dRn^wS@A|U`$gAOpbm;rxNdx;MY*Sb^rT@YH3d=C5k ztJ#k22-p?CcIP0#5I_Z>5>N}61(*+b6z~y%=W~hxrvR|s-r5!gE(Z7y;8fHnxhSZg z0ak#Jk3mR(5OEiXz*czc3J|e9Sg;k=XRpSlrDdoXAHt;}^L9c!*fjenI#}c%s5li@Xf{IkmjZ{jr<%>=8FVch?1TzW(}Ln`u(72;O96a(S^u z1=l91YyRb-6dXb0Wxp;7N+mx}AhL02EY64Qjz&AUHH6`I;Bo=nr%RA_gnj8`^;BAZ zz?eUvV(=^Sv*tIq{NxQQQD;S~vp2UY`+o4kBFI-|(;K<{Ug>tm59hImWZ$d8`bO{y zseO1(OKsxE)Y23WdTWDfBlVhu{IASQYb5{WM#{CwF?CkuC=N;&yR__sA!+5B7hceg zFV!XHZwA7pJh4<9PpSDEdrKbPaR~-| z>eLqR`mmp{r8}7q(Z^Gyg>owL%etFm0eyVMxm?bTaDNHM3ar;zlW??0(pUpw$g@H3 zYwC;e*rx0P=m+2!4nrtwcL1k__5kz;>$pEBH$zd2cR*)DS%S}rvXj}oB=o!a28-D;B3G- zfLVZZ0kZ+;0nP_B0OkNL09**T2yijr62PT^xq!<6^8l9vI40#>rg@9WCw*qbh+zx00+yS@~a2Mciz&(I_0sjIl0^A3hrWi8wPuQZ=DZup;W{w|8;UCP1gPN~a5-bPv0F{jo~Jo3e? zzW266rbEfNMequ#eNvPI_xzyaC)GGb3-%8inYTLwjsoyZerL$YOMqU0-|!#LDOu0K zZWv%6Ku_02)ohBJ;STKvUI+pWlr z;1QflwM}jceIY!)f@M)$r5Fj;O!HMqOKi$d6*71tVqjjgytD0Pp0oXBz7Ql2iDw(a z_GEj&9)NxT4}kSc8DI?H5CED^)qYbpBpk|zghhE^c$6o);eP_{DIau8`Ji91BVO7m z+VMZ-hi?Basu2kh`I*bZa!~mI^1$q`t%ZEuKl@D0P}^76 z2X(zz_@SPK&iOUL+t|d{EkCY%DiZq_*jNQd;f|u=-e_gD@|=q=IQ_vr$IzJNePYz7Q z)7J58tDBt%lyJ93d`wGAssR>Ko);lKRFWU&IvnjToIdc_*KRm%-}CtgiuuO(Ed;NS z+K2Py_BlKK=mVenjGu$R=|FCq8eL9rGXX+R&mIYS*lzROY!&ppEwZc^HhH=Gnr>Ov z_+c}K9dWt$lpZ7mief_k3SJ?#59yIkOt^4T#A9EaUtSwgEs}b#gwAb91p$*_zjSYxW)lk_q+(`g@Q00 zz(XcuP=UM)I0M2}0O86(CA0$?of0%e3(znfjE-iUa zgEFjl@L)#oTQaQtZ!)Ym3ffsKuEjlgTeP=+ozvcG>f6Cuv!a8wps}NM)wvs4`(NG3 zdJgy4Juqrx>%#V3tkR!1wPqJ}wU&R0yTm&8u-=@%l~wTScGfcw_O?o==33q^dsx{I z?`yrY=uqpf+{3ILMvSpmhN`TC-;Y}U&NHp@kylyM4qares99;9I_pR4!DD-8H2pj> zWAm|RyUtIW^W`jmV4(tNsyxbnurscRORF>o{%IW0>(}SGnFcB!kgR@fME(2D+1}Fw zXJ2~2b;@O;eigifj%&^9S3Gl`=)J}7Z#By;nyC$@(q(&tu`(Ud{|E>4epb()Bn>P_-}DQFTd9IiSkR?{th3`XXfY2F$fd&F~FVNZT#wANdbz)te=xp`|f{F>t% z(jsM6#3V2}_4FpEt)Tmjww?X;qKq|n(@e$m^K0T28lM*VjR{RKSWPVW z!in*D9sJ0+HZ#Xf5Bb&|pucOi@A7Nkt8F}L9%-dwzI4D>@CvDYSbvZ8O&n6e5#9?1McxuRgmwP}aB4cKmF!%&i`!nTl-*zb0Ox z@nOAc-^Df9TT?R;FF>ic@$6a^_A!9OKW-;?{LCZPCvsj7Myo75&uTjPJ~l~8+4-K) z3@`So9_6fXRdBLBHRvgthM88ekHH}EuWCd5uYK@J{~PCT{Hyqv_)Wanw-mo;DqaJI zqZmNqAGfnR{n9QMV}Hoq2X^_8VSerD_F?pkeYjOeDe{QYY~mFfpCs|Kzy|rY6jcl$ z@vmw_`~!1WpR?J{TRuX+R1&|5w{26!Z*zeC0*QY@-`3Or^ZrK++-F9m)0!pXH}P$V ze+1uWtZ^LbbgXFu9h>&$m*teVy9-9tFAm+k@@FSM%=0~#f@b(UC zE3WNaxeb-33_dhTMhE5^AE##OV=_2=(>#wV2$ zZ;mqLG{cL1YPyQ*_yDebmuNwaKNOPVJ}&v4YtSX{V06tzKhuBWrHt#@g|oJ6$Sk;4 z;+67i;>Di%R*2Ol&(Of6ARcC`!739@l&}m9FNY(&z0K{Hdi{%G&a@8bRcOtAO2U`; zO}y9_`@A76u1xaR@bQnK0hq}O+@|22SmUemjPOOL2g6g!ec@^TO0>B#cog}`+|?~V z?5DB6&xO#pw*CCA1)%rChh{HZI_|jdLc~M83}F9I@CvDYMvN@-jH;;clunEwO8af( zU~QODD>VUM#xMQD1vXmk31V99^x8Vj>(b^kD7}0%B7O9q50J1}Mr6GaMr+4wx0rG3 zqK%)YnaYkoqZ!_|#eP*MeOSbbg5zv5BGti~D!Wr03WlQ|X~@d?CUk_IVkn)ifxER% zSKo6FsXY9Qmj~Fs?R5=)O}yB*NLNvysv?L_a$Z!2IpT{! zo$Q8P?Yp2n2wvzBUFa$e6ctpk5Z6YPP>6ja7_Q5M;M<~;1h#>8o+W&kGSeYprQF6F z2MwP#Cg*_O?#242mXFntpM_uUTK7umf+x;)GKK4;ln=q1u~0tLc#=g&RUF9$C6$~= zep4PY0g~S><+I%uo0KH}oAQ*fNt;^YKqD-qU0JeMYB|Z-Gt2s^=A?JdTGIYJjv=U+ zXOt7cE2Q>8JLbWlAR6{pst2!vQ~bW+-T+=i344b4q6I-BBIU40GpNpM4Cr6(s|*JC z=p>XWKg?s18``JyoLul)th}l;#E!0Ay6p2MQvP%INnQRK*T%O!(&5LC z-rVw4Ct}jIHF8k!4mz&c1>7^(AC5%%08xFpFB$=#{82yd)tRCC6mqN*6@|B|9w$D~ z1NDup^@UM0aK4>NZ_k=QXKVe#Pq$d;J#A@Ly|fwBGcc+Zyb4tNkbfg<{gveqFrF+Q zj2p$O?OYuiQC9%jj`e(;xv#q)&UTCSVi`6Yz4*xTUd6EA{k*p~TJZiZH*D%uR2=NH zz7)J2YT}z;HWW_*2Kh8*zUqczpupt;7tVew5Z8xP24$r$4?&pyG07u_F6E8pWJ*uh zg#A*dD+l(T<1gIw-BVYL8Ri7Wi4&$v@Mat>rps43*oSExSNgP+00X zh0B69{z}}67Z!_xa4-@n4Wn}4?2x_JOiveaj)Awsi7KQfft8lJozEjG(`NkR@C0Qu9ni2 zQ=LDV2e|7y>#PggSHac5BXO?b%}t)5ho(g@K66~fzpiU^GKX3(P$PJ{(N+0zHJDe3 zdMEP!FlQv`0n#7!m15^2=NCM~(Ec#~G6 z+!{59XUuRGhiLz`=0&! z$nhf{$T918!JEXn<)o<2S6M6b*-6`*bUkl!F#SKxftER-_Z#yHQ9b^fgd{S{Lt4&C|p3Lnq-P*LMJQ1A+=eUj!Mkb1x0o(r)(C98k6;Qmx2 z^E}9J5kq*>b84nA~Q)-05cJQ2R(243A;)zqr@K*1Y^>MxBV07iXE_Is7~Dv_nTNaU4Kv>Av02ugkFLD$u+HP|z1V4xq}~v`7Ns(3@#0<6$|=68 z(f}Xs6?csYhw;n)Wx=nDzOHTKy1HK%TK;Zs_5NW0BU8&q1LUW(uj<?UR&_M2$M!7p)Gma?|Np3OcCr0SwL=#dOR+xTk7ARaPDk0%ZaNw_x6h2nj>)iY z9l!WJhWpIytZV-B*dfQ#Ol9*WqZ!_|ZBB>U>BHBn;}qB~bvjnHfsR2XgWjDt?v&Py&HFon;+)<2g82jq`>5-ukG&5;U6f{u{pkiS4iz+(xJ{` z@&Hp%Nv!Mq(i$Uvb9~KUhuk)&&ubSSb=V^|162In=OlP7YGq8?PX|(8@2CjZMxqtL zDL(8r)$^rsqMIKkJ)!Yg)}VIB{CMuqy;qNQBIbG(#|?r{Mo*IcO*#q6OS18TjKx`h zF!>G(;!&9Y;}(vgHG9*2`hS`O|6e$um)oUP?s99^W4V>+m#z48zq4;`IQuRqfl_V- zZ>HNlPp1{v#MUO|r4fa!rT)9#wzDkj%Gt)NP*P5*i&=M@Hm^SibUBGtyXC~J-^+Yi z*5jXlvG!-r&;K#&cfp&KxaGt>pQ}kt()rwU{cdtI{XfkCn*;j3rk?)P<(58EbgVys_oCF(-Z9uozrFZa_qfg+Uv`Ck(+L0aOFr*EtHx<) zK0sr{eyZRlKG7L3&y5uaBT@UbLJ5vQ);hBf_I<>9JI8$sY~SvYMot1UbbVfa73iYM z2QYt<@$0M?@}E7j?D8B~D`f}Y&NA_0Pr7+N3fGk3fQNHRN}bpA6!^l?F*vM+lWySx z95S2COB`bGD14k5aMQ#4ir~a5?$*w__zTapaZ|Fa72AyK^vlk9%l2?0QD0l}Q z*MyJd^*H1)wE~xy;-I|0rZ(*3)MN5>J*Ls@AH)M}!9e~I(kjh?zcUA7NSu_{f#KBU zH8YrHUG-7tt+n&@5wY=ry>}&_xL+b8WE1p=VuTegC?IypNwgV z6M!+T{vr;<5Rb_3s_CiaW8kzb>-yqTM(%gi+)EB&WDuBZAm^DtP`ykL)!Rfav+AlMLx#WCFFzoum**f_gZ9*!JDs3hpKy!&)s#ai)QtC zpVwk3W#?ChW#Yx2@}Y)brIYMyD{y5-m`Cs@g)YFX(%btC6}wJ9qX zD493?+QHk{#5WPhFLjxF$gt3k4q?=`1zm!7 z5rscV=R<(h*Ud)xc&QdHM9L3TjVQvU2vGX`>gp3y)71pJXRmnsihFmty8D5%?Gdk> zGZwrGRQtH+SL5d&nvs&MpUxO4Hj+0CR?O6OGws$z>0#?}{E;x%CH}U$6?)q0KJD(G z!2!M8X2#s*)|{8CJ_+++rJMiI?#AwWOMSxrHTwyIH@W66w?=W**3cRupsbIR?SEt2 zKt&lg<=C!0ly%&WZlry%ZPMRA%7GXHkoI~eBp$ZUPWMqz|5#mLkEuT0 zEgy|%W~lyuT@hs9mDLZCNtv^TTwFA7!QR3!DbFTe>|N!#G#tXZi(H`=_Ia@{51XOF z(b|w2Bfyhhj;u3UFW)sIyO!;cz3O6#0=sPX}fHyNKcdHL#Z_WQVs&(J6(d@}K3zixC1x7_^df2Pf^JOs-4DB~=} z`hC>fmWOw{_obuX1zIV)P3>Trc(K>%QrB44@qUBaXkid{k`MRRPxKXrgS-#jUQvsP zKV7cAI@`@Jb9}M{bYHaB9aBA9dX~vJK>8DcmvBXQ_b1%@ER5cT@{(*kKpxroBB8qf zn|29Tt(%1Rk`EG=ska`|pX);C`Ez4QhyMSK1A2Wo^PJS>muWlqmB5b&d|CU|B&Q=z zx$2G5C3rLaEWfRvpKD%{^>IqqS#G+_^Er%j&d{Bv+%Ugadui`U7x&c*-lWTjv88Kd zTx7# z@1NE4E$>`6f0EJlab9ya==mFVBU&frwY# z1ggB4?di_IN*rdG>HldC{L?w0m)oT%w=6690P4x=zm4nO3jDaoc{d5)SZ*zpUK20& zQf^V}X+_nOAH}Y-P&D~FO4dd0`a{->S8tB{4w`iua9|-8u3~$@o`&_x- zl=90>lI7DXCl*JeAzhmFd-C-1ly`CJd4is>zjfkUE8i{oaMw&HLTrgpax8eELv&q^ zNe?a#SGVgI1iVvyqww%Y*napU7anxEWjZAe35&W;@7lTUa%Z;NOF{2FHG6D%#%J4f z@9PM(&?|U7Y?@7a;|0zrYG%7F;V>Ej;#i)XsQFi!Sc%t21t2bdzHJqn*G~xS7uqov44L*`?+UxKX({MAMD=>-sGp0*W!wbvhwmV1$aq? zeF4=~!E-@QFBiA`;+@VBK_74Sg%h>+h`n7}grNtp@}PolL}AwZ4-y~CxRi70|I&_T z_O;md>UjK3t3QDQ3lOHrQ{FYH<*D)NENf-SkgLWX^6jnfJG6*A3Em{}56V-1RTUlx zjbIHbg&a{<2vqE=ia4 z7kM@4-=s48;K*r<{=FmdP?G&hV8{e9=zuI#ED{F6l@HO!YjStgb7UqMTcziKhTwYP`ym%NH z9cD|bkH2Tmck`cd>+=`Iu>bg`=N25){@MmPHLsGIpX7xs5_UU2*B?cbfWFYKwf&xw2#yh3UpGk&~p zST&scv9Qf}XvjIwiw>2%lxD7@FeuhhTWet^GwSPPjW?!FM>XtE8u-=iGkQEU+$@iR zH{)1`bl59HP5>>XXA3g|b$>t=UNU8QlGjb;oIE_~`Id7FTb)F{nd`@~o3pHg9)0?NPD|@Y zkZvl{!}2Y7h15OtWL@bYj15RiqlvKdZ~$n%|efaw1@c zq5s$WE!J&rdf8`TKTXch(%&}soKsWr@(IgnrdsBFO}s+mBlMzrWXFk53XcurkWU#- z8~LInz80fPcmFB#4tKq93p!9dCpHuGJ@DbE2dZz+vU+^^YM|;U-y0_#Mc> zn*-RMG8H^;v=xB;k{kf(+y%fs**<`S0EK|z0Nw#r2{;ZA1Iz);2au4JfNufWAm#vo z4{!Bi)pc{aB$1}g|KXWhA4uG8i{Q&&| z?8hGrC<2TCj002w^fGZh{@)LH3GgKV+X<`zfTIBC03HJT2sjV|awdRh&<{j;SOC}& zJR~3gs`3Ex+N?lkGsS)g>zHJA%^U+ke*c}6ULF=0<-zPPGTq0WbJJPx?Hk!mc<_ia zJkks=_GWpogA?O_wO`L^G$Vt2c;(!u_@un(`BZmr>i$_7?01-Z`q@MG{Nhcvom71RthWTOklM$j zC&8D&xXc3oqTyhTbDcT8nfXI}`RRyB+?3=e!GVm#~Cx!Ruku zY|>pG#Ykjoa+>LWedwNWpF97}{?ZcAy-n$?-YYg*S$B^^xX>+l#;vPnbi4aY@$RSi z`Lp{KY(J!YNt~2*_EAxttA48B(|U6b=;gEF0k^!E_oIIWdAj?ooi8q5+xhDqoS<@` zvwRBPjKP!_yB;0l4PpJ#hnw=MM)spRm>R;;pUhA3EbUu%C9P3~F zOTWwsXUhBqb@o#PA1BZ;tS6n#>KpQf{Y~MI8Bh9ungjo24(R=tnJCBX?{nPKlBy1W z-PCdaS9TM78UOeVyx6lG>-%dGgYHUh%?!wvryO`-y~q117k~~u9>$^1BdvPYUEi4V z@dKA-S<@cv{6y?vPwo=X|EPxj-Mb9EchS)&J;QZ#stEwfi{OdV zl_@U;L0q{Msl>JjHP0T#Y0AVV19;2@=<;$H{!3hXxH{cSo_EW+IlrE>Jj)87(rs49 z%)MTEr?(wS3>xVcydE~qCf&w<1Z?V@?hRL!t3%CnZ^}7w8$#`hK)4n_`RDu&+i02z z+|OXn5fN|VfQtL!`~>T+f11+erR)XwyczjHp6UCKFWT~*Gd+c!FVOp88JOV_yvaXP zUh*p|eW7SU^|M{x|2lD1YRqi8uYF|F0hhbh%lwBDLJ)yqslidtlkmr=Rm% z{oc$NC~4mXZ(|c*Q;sPk+((Q42j4^C{WTRqEay)0ho>gic&()MpA%&waLtr#oFO>s zl%Z7qwV=|*HgG`izZS1d-Oe+($gmU3r>&`1brt_pZum9v3XP8`HwoDo8Y&A0Yxvd{ zRUJUa?GskH<=0$4SOPkq+V`>_#vZtMFYd>q68ROpjZJ)o4%ho%NJS%rN$*!swg{9p z(OGAS48oXJe<26-_POCTw_KR*;a8BGicK#)#=5QVZ_he3id+cZBwggfSyzg;hry|# z8ei1D=1SjkZpsV8qnxy)%=V6M)9qkO-1_5qy&cSbz4h_e+F$JB!x#6XX<6abcsb|2K;PKa`TA&-(*Q6$0Zyz$>N?rb{-^j8i zFUULVw)grSu+oWL%Aep}MB$H7{&1g;vp?SHOUR@_vT|pJCI5wI@}D}(p^TAqeA>KW zIH1dK-s;qH(g-;U4Y}rpJ+nsjUF}3Kaw2$>s%CP64yWpS)~eFhlGrqB-_3B%|7Ly7 za>e@EE?=hW^#4D~ffxdie&1J+860{aVVPhI@Pb`QTJb3Yd+)m0|6>3gM<-J;AcbD*T{pd43+@WY#imv7%03^5-pR6Nt>{?( z;&(UvejxBvLa*R$Y~tGjz44tk(jSs}Q}Ic@iQ?XKDjjEIHvCuU;kl^>gCA!8G4|~) zc)Na!*UC9O-C2|;@Mxyqo&Z5i@hTRuZsjHsnwH42&kTqtRJOcL)j&y z)qjrzdbyd~ihPjDqwas|*~5M=&161OG5$0`}4UDB6x+=J|-Qdwb9Z^rQs@HSlc@e_olou2$5GUxU})V z!~v;a*?xcZiCa$Ck06u*fABUF%Nn3h|6-fSsP~5bRP4|z^_k$!WSDXyOCIIEC|?MS z*pEP#)zsq27au(50a(AS%Q;@s2vJq%WG6WO&GrK5W@`_!hC{oyDt(-j`?;H6X1SXA zX_nP}n@gU1>OYI~?9;`G`agkp$J{EvhI{LZalG9ZF7ZdA;4hfJXqH+ z-Sn{CAglqMy$76i4CC5=&cIa}SAX$QPyT^oebf$L!7HTpX_ZfyRPf;~+A8&wQlehU zMHs2-CDO$@Xo2I7{9FY3*{s{?VRjEXOe| z+_jUq>S`~0ViFIpaUxsWDP)I~1C8n7eB>(7snbCknjCwkW9C<_r{lHx1>0VA<(FOI zO({vo>jqxznGb&?9a>6p0>iR$5U`|Y0qE7~AuWxLJ<}8VI`#Z&G3@7k@anFQgqB<+ z_eC)b_J;(Izb>_|=@}YvQa{R98^I!&$d|NR93M;EdPI7AZGGb&mzm>9`ulG1cGDZ* zKKmRA!yb3HYlav5p;P&GuQw1K?62{8_`#bpHQq{Syj#mtUQm%=TZKzEoD+dF;gNhN zUvs~6msfLrW+v#p;h|%m`2MQp^U9oo3h5zV1ut}n?xshbTgD|t_7uBLOR|2Zgz;zS zB;QHGpAr1uE=*l+7a4L=h19Y+S_>FIdj_3a-=EUqo;`jIt)ZF9=51XcY=by%)8AWo@SanbUfLKal=%ma z@7iI z*9dwa`rz=BW^KJw4r!%w`VGGe-o_@rEz#qh>?;iv`tbtAa9`A0<&AnVb*47hdW!I{ zi#m(QP|SK!>MdPQ#FjSw)f{L4b>CfI{{4{Qn_YagEyuR} z@P1ms!?{bfE{m6mi&>Y9G+)3DaSWWmN zbk0<_izVtkbKYSM=zQ#lO(VZX2hF_A3G8$DXT2hLJ#3muXGLYGJjgrIxY4l0j|a#{ zVRuPzs(*$(eozmhVJL&U4fAVi@W8w>@+>YNF0KfQiQzROA*5IOX;PiU+{ZSGHa1bS&+_98bt~1Bl^Rr|jX) zt$}ZDb@g1(dE<#seLeoY&Yw~~s7MFpTJQ>~eH=Opz4eiDe}KdCNnu~4T3sd{4f}o5 zocBY_dnlOxKdQ*fv`TZ}@5q6eJgabPi@Wz8_~g7j zU#6MLE*lxm@V2dGIpwyzGVBjU^C$aM;Vtn-qN76?y!nO(igEpSq@#`okIe8fib3S}i0LTBbKZ$h>@B3kIo+;%UBW#a&zh_SX@4e;R<2C@!d-A?d z-owXxzH$IN0D1%Z0CoiI1lSqS7r^#^7eGJ2u7KSDy8}FcJpi2VV7tfpo&kWp0lZIl zU%-BVfq?x17{aSNb`OD`2N(n>1Plfg0}ca}0GJtNfKh-7z!<09+)P0GJ5i zh^87q<^}-A0iuBEfEj=j0WrX7fHMK-0L}wk0JsD&4{#OWTEKh&|Q&g${T5HG{Y zS0N?xdTD7p>&!KeQ8cZR@5i3D)8}(epqWbIHSxAB@*YzicD((anHSq822Ijyb*3~Y z;!Vc)=T@Jwy5s(N-;fVfjF<1N3tl0$Pa?hCep3W`rFsXo$cct)Ksql*xwMmLTaBx{3C*6I2UHGGnJq_R2xz|l5EF~ z2#!8<87xL2P6Qxy ztupB92)m5{`Z~@Jr(U>c!+qUrfmTZBGVx-c;IoUaQ9iy?T^cU*@pPL*7TzPn_3@ta zfHxGW4%+QXBLWio>bko5mW;lI7o1%C)&zlJ+%%0pFX79;i|m07=OK`Nuo7m+L5R>!e@l>esRw)|(_q*cotXn>W-_3G@@ za+8;Z{`0(sPfySLew8CO*30luxe>e>6XgalJs6&%b=TzIPlTkH|gq-$~KeoB6u?eE!2aF{)bs+?bsF-}nCY$tfz>?*TgF{J_-52lk!@RwjyXtNepfz{+yiD@y9^luiv~ee9H&E z*@OKms>1=4Pr)ms_KDB6dir}RaJNRy&{FoDx!Fy*GUc-v*vLmc>L+}czePo>O+#BgtlP;dpfc>9hQeS{) z@+RVKJj{7`>&2@nH_Kolaf+L?{@>$33{gwH(!Y;;{)uytEaP1d&9I){=a^VDp=w69#KV|fs~8C%Qgay=)m)=2gAF>Mlu8RokD zkHN9z+k&0k>C1y%KA-{V{&dH8PKVK&TfXS5mtTMVP39LB^$dIkuaMeD$~))fkZpDK zd|pqxpsOb;dB*=wTrcMxBL@Kv25{Z{P(U64;^I1&RO5vj_^&!nmVWEr7qCuV*u>0h+Nn8b<@STNt?cou;jYK zA_FoP6_|1@csO^d7U;71hprbkc|`_$r}}H07OWAzg`S?dt>@>{!Q6+wnR__5b0|eV zk*g+Nq48;f9($0$PN7X1`(m!Fln1mL5r)vWs15WzGUm%?K3n~RbPH8}lRgvw$LaG7 zEt|HtD?dZKxbu^JKjx|IlPHFLw>x^DzP9APo7fIeaW4()VZke;_Gy8C&N@LkmNF{A zIN?_F`>k0YOI%v8u62*hey!*G>r;zw82suj@pTzH%uLI~OB^lGT|B_fZ@*za=T8P7d=)EC3J4nrmU6uga1d`Xvn4}Sa}epd0xG%JO8`F5%);V#6Y*W!)7_fuGD^5+&{Gw>7}Bcfv?~dQu~#C^W7 z5%H%g4-EF&9=W-3fMvTGoYh}g47wKIyRk5ui1Cq<&xKy+Lv*XeO=VjP>r(BA^mb1>jWCB*0`qHNX!z7Qp@GHGruA_Dh3+5P3~n zxBze=;3B}qfJ*?E0@(k&3@{IHIp7Mwl>qK{zZ%d8xCU@7;5xwdfcbzM05<{_0B!=@ z3|I)b1#m0iHo)zGCcqtlI{|kA?grcgxEJs*z#_nXfcpUt03HPV8}JZdF<=ScVZbAR zM*)uk9tS)DSPDQ_oNThnHfr8p6TiMH10LH0s1yE|RXY&Z8jX57=$=Y+`(OH-=0KVQ zX%3`0Kn}27mGMRO!R~pY&0*ISAoqR4XuWjJdpU#KZ_KWUQg(fe6%7L~_KEd%*FJ5| zhq&g4bUMBQ9aQ-MhHvfxi%56;k`8phL~|$rQa#N8KT< z(~OZC$-?t6$hPr z%Zb}bJVJ+w7yHz7U_u@j1mVJ|z+{pnm!ZKk`&l9{ji9Ro{^v`eN%ZTdUmZLAUxAaJ z82)q-tv7Sr%y;mn7mg#GNo0F2zJ>Qk#9s~!q=)zXEdf0e-<-qRWsnED{c6pANRP)e z*e}rSt-OT)JDPg6GyUgi_Gc`=rM>AtPqWYYc34N#eu8En$n3U}8GcN&zhUHyohaKn zzq{tQKEHKdmrnOy_({7@h0oM8z;(gnuS>PS?_}?$D1VLkO8%D>xaHC;r%j;u-j4?O zmdqQr`hvc8v@b&Ayt3eJY~o9L0Oov~J?G%;GIy`DNy)XtXarM9pUg9#3iQT_;FXDd zHx+RLVn^9VcRSucCZ2AXuLR}~IY4(b6W1AFh67YuIULaCxo4rfy%9dj`sZrM*Tz@g z{7GnSkMR|be~}--n~ZHiewwd;Ivxi?*X4y{IjZgeDMJcjeDrh_4^CYU79gGVuRnB! zZ^{Q*?>gZyY?cGT8^O0U@0@&n63c9++;>8Nl*9E=^vAqdU;pb9=il8A=O3irj1{Mr zm(`G`6VHF?gN}<2^_cP^c#~f($bC!lVlNUSkhI*Goc!PVuh%n8hozRAu0yk}Lk0|g zDE#?TeMD|p53rsQyqUTd((!zSEtb#V*x3Fmoa--8fZj@WzIS)#Zb&AZAY^&cHn{c z5?)$Qb0E!u<{X%7bVfOknO6T@4lql&*CMU{nH(^Rz(cy&ei;hlP@ug6CcCI&@GScjLX%VP&tW{*WbAj+F7NC!m1Zh?jFZs} zZ`<1EDe>Ye-eASdqcai7D=x%d=Z978jz1HQxW7v7MWLU;z7+*0Kl|mvF8l*UJp*6C zE2Q>mVc(<81Y8sxaV`xOFZzDaCeV{Ae`dmdVEf%R8?*bzdf9s$mB;5VJ8xkxI|qM)JIaUP%|x)ip-gjAbwyA;wK%9g>T4z!l;>nh z-*?8kPk^!0?l8dC0M>s!0Hm8{&TrDpeVBBsuU*ru%OB19fBgN&E4`izO>KQ&_iyhl z{P5`^^Nudy0Y9i0Y|Z-J!8?EB8s(yZ2hb;}8{$0`;o3+vKTug649n%w%54t5luz#G zZU7w;4=r~Dq?UXp7R<-!g-(=fllE_w85v zpy$LlxX}xWWr1p;gSY=BzS18^zAlL818ea5Nrn@fAYH2M>9Tu4lC&IzBI&Y1*_Oo1 zz|C~!X!evNrmGP^|CF~SuxA~W4`@l+Qj~<5Kr;;M|%!cGA8x7QP*%nQDRaHSr3K58rhfRZ(HTY2-%iGG zK3&E?-rM2a>(D6|f;SmTxiH?Jv&V!OCs+DVb+Dm>YDA{6K9%!Dui5DJ{-*PIy;+yk zqb?@{>r%@J1E`)q`KC*^_)m!h_Ny}d+6*uDN#w*hm1YZyUXPW{NKHo*=$u{VAN|(K zH?RBGN47+e4$7JO z;{-=DfgRs%0X#3oxtVPoopl@S*)63XanJAwI*xXtBz%dNc->yy{eRVU`K&u3wOp)% z+*H+{cTnG7-a6tmC!@L|;gk!(n|w$r7tZ7!E|m2L!~SUfp3UXtkMLOXjI@wU=AFou zo{zLQ{}Y#1%{dSQO2!p)Pf9H(YavIz6Goi0U(Mo|wtvCq@W=2^IT5@WLn=9;+eQSV zw{xsFr0$@sh?#DwB){!{?tC`ogZ>3aGhsv2BN8`t3162t#`AYkdi&CFid#NnU;WgM z{Oo#iw$CH0!^UL&bjUV4+Bx+B>?t3DH~FH=2Pg0%ytNB~u7*R(MXGzd z*pFpf!0~eyfNerwz(7D5fcHbq2Ye2wKnAS=Jc!Ks45T$eu(rs=T~3%dzXX-tQ(K~a z>5X?~`y-6OxVxze_hB`_&vUp>DL2D9>!u9r(24D=ou{<7HuVvZ${rt?xp+B0tIEthfRTP*V0!-3`@>WQ}I86GC@T%`%gOowg*7$ z)qfO)c)y8rHT+LMlqvSBBwW#HCtIT_d4|<+;TR_Scp%Iy)x1T2eCC|+8 z@8c`A-|1-RQf{G!LA|E}^am$B!4ytZuwsp_fyYIVE z@7UW*nNqed>obmrx44qydPS1Waf}VW<+XM?&Yh<;3idJP$eg^n{x}fA#H2<&TijP^`x(CxTZr#c@sCRV4=W)6s_R_`x56%E{iPV>Le9yS^ z0Of!wfO7zM0zL%n0zo(#@CD#R2**AUiaw|)#-MU|2OW#IQPG4@i7Y{d(GimYXZ6IM zL3DPW%Eemp-j?-Z0q%+(i@T0PxLbM-?tgy3vY!4L_WNa6n_Q4#1vYADoq9z(EAyE4 z)`ep`SVvyg(K>8kCu?kJXKP4C7whX8n_D~oC(DZddn@a={ySI?EbC{T*?&JP)^CVa z``D3IpV8A4-%x~-j_)bQtj7pc{7*&QDT49;G_ZfgGPx^&bKI;42^^2Hexzc#pkH%+ zPv#5Q-;#J>beS23ghM+~I*xvI|KjHFpzHOeb%A^Tjt>c(1gOIT>deD$UCi|QM%@-Y zeb3KsqM3^F&##GBXna^-Cf;MgR#>$aH5e$Jq_!|doTo7c)ejFI%S{e3fRx9aixTCL z{5RiOiGkid?s=!rW#bBh-FBc9;5||R>uD_949P-{QOk#Q*M{1I~1Sn z%+o&u|CA5Go3TJ%c^786FFeg(>65E5?dOD?doZ2ns`e5~6~wyAjTx{0pLLJO3}u35 z>LMT1`vdgx1N)Jb8`go8F{vNLpU4`+795OmC2>l;w2=7Xj{YAT8bQ0r&D^=EY_Qvf4ltP&AUJ7G*r?r6uilb^^hCS(87`;3FohnA3bj+UQ-u2G4cQO|1-e=k)NE) zQp*o{^?io5?cIA!_>b`IM`if28D8v@>~lb~>1=f<^hKiKU_Iw4^mV8;po96951`I6 z&$eg+3huOx``d9Y8Gwu>KRgLTaDH`G_)a6jNvc$F2-|vUYJk z@aSSH#VBOX-9fde>FJm`FZDji39!F$_OhIfO26IddM89lhv3bK66qKk84)ax2E#t( zBo|*j9XsN`gsF!y({ZQX)xF%!XV$T-50;dmzJ2Poed(|4tLN@M_2{RsAzf6|Gw>C> zLTaA`eXe`jF;u|0l-e3D{VApMX+oo0?)ul-eTkW%Z~IP9z1siEY-{Derc{2uMaN!y zcegW~bTGdK?*tpy5_H&4304FPg8^)>UI6dpQ>t}GR*mdii`=pOVg6(Iq1qwxh<$a= zXLJR0126^LBSV?t94gx|&c*fy>;%{ausZ--CM+`cKtMiV2w((YG~j3e`=uek@qn`c z7XhvX+yQt5@G@Wx;5R@Iq@_P#IG_e_9^h`kn}Cf`Rt^Ll2e<|B8DKAT+)f6(1lXek z!UnWMVvh&>4roB4JxKKHfXgzmrwIukhJ+U&;pGsH6OizSk?@_6=!IK=W{ksf(c$Zh z!OR#m)c0YsZww}m_SymNA%IKzB0h8iFWUpO?u|GG;+}bIV9zVWTQ`T{4V#g8^XG8T z>&19z3etjnN0zGbRe#W^%QOC}JV7#4`wh}n-2hD~;*o5nM0ftiwU+Q^Sac_D#jNY` z03CPqk0dI25LqD(EL44E$_Ci0#$%+Dcs)G2W%{USFG^1napH$~-JQ5krZeoc`ulTW zCX&eV!g{^u^^~|o`)SsvYf#?~zba>|IVZlo{g&C3D*N3j)~AA3NbS=?eTs>}K-6i? zm20!yYC&vpBW2sB-VR#I2mgs#*KJn`xAZUNmSvK4JaOrA3nrx1U%~;sAJqQ_ceypk z{S7GB`!0Ux<%@2+eCq2?1JDF2S#AYy5}hcwgM5?FSwwlQqMJq(4846l2{`swSYGtD zh5aBZ;&mneMHf41$M|12^S|kqxU@>n0lhvSw;;7#EP~uTwYXp1nR$DB&3R=i)@76n z!7HTpNhTMb0&gIS<6l*NzVGX;!K=j0?> zqwy8ILTaBu;b64JKUi&V^JvdKqmHS>5X1F;+4G2>Dj&db*Px@pd8N!Tcyo8@P&I#W z>9ZYXef;j1aj~%t8J3BMH>Kit$>ayBMiiBJM$}H7=nI!lvR~2zrYu!IR&70b2Y6;k_fy|bb+~SNnVcGpJaOD znW2T7%*cKt=}xN+&jDR-i|N?K6=?B zhMWlAq>yq_IHG(!W_x)e8vTOtC{g1p3d+VOE*2Q?$PHw-rTGHV(^}slnM}1+#!R~T zpGjmpr;mS#PpdQs{#Q5<10m85ul-l*^1Bq}`@@lU?!F>){lbTg@+){VU8T3BtD z8>+nik#Z_D%RF7Wyb4Fs`u`dSVjxJ$YttfkznN_f*M;Pr(mL2L>^HmUgL=l#IlzP>-Bdd}c>7=C>(E{9pB(T;apoz%W-^bIS5I}Ea%H?L(SD zK|kxrd;sfRn%T$J?*kpP=}qCg2i(zK@{KySdRT(TUzc*yH_8|AO%6u=xD_cF7#f%q zEUyi5C!}0+;(8Z8_CV`&lrLT}XVKW@*PC<*-bDodICK=%VIYFH#)o_T0UV+W`=SOR zF}M|Zws4-8d=P%H9U;H<`#|T4$q>me-tTZMpOfO5c50L~o*0W$z+ z0WJny54Z=g6!0eCJHV#MFzyjA1{@1GAFv4U0bolA^a#K#z;l3}5bk3Ej{$N~z%Bu7 zjskWuU>8haF9XET9~z8|-vJq)g#y?M1-=lITQgC)e1Sa<^q3iGp>l&?cx?`Lz)AB0tZ+>OTC)&Na}ihDeB!W$KHMWqu;*tZ`LzZQm+c$#wNZ_ zy*kDhj-Z7@`Gu9TJn|qZlmv`55L^~Y*toK zOb6924&MHk_{Q4@f2i6QF0b|TvO1_70Mo;M)*{3!;btHaEZ4gID$Twf>{+kq_G>l! zJ(k$*Lkw;tf9f7>Jze*_P!hc7xJy=D|Q&dn` zT;#aQfiCHri})pcu9GsKbo)h`J*xR;>071Qe})E-{D}c1ed8W$J$)yD(fCmMLMm-K0qXZp3AF8b>bzaBorZU6{W9)De` zh4dDCBgvDT3*Sty^!F(<5|sfP5l3_-I|HKK1HUG0upu3m<)X^s4fjo`f?DWMQr;XXjlo!Dp!LO^lc!riu+nZrD zBGYtvPs@$T+5hf;y`EXLEVbP9d?wrKwY=S%vGDc;kr zUsQdAwu1Ex>Z9q+zT4=Q@5uK;FX3S&KUFS z?>|XkY?rXxzZqWaTacHb0qj9jJJ4*oagNh^MhB(@g459t*Za%W%TvqoQqcWVkAt5- zuH@32cb{y>JRch6SnxuR=mkMh7arp^&et zA}A&&%tmCM-d-{S>#QZvrdjD${ZEzp|nbHpbMkJM8PoiaoDAucUHU_ufV15V_p5%NP` zEoY6W;_KiSsa?6!+y#hu2jMWS@O-+>>8Z6P)g=at=90_Qqz{i4pJAP>ovSmT`#8?=c>UD-r63H|gWDnQx>n zCu_i`FP}be^_wFK9=el<)S<2ikPm`aNbS?YxGd>7zNpS0;WM1{-iXAr{0cw*toa}E znB|Cb_)?yTllln8v`WGOy+7OaO?UYrAKB+?#A5!Q$B%xQ-e+gc_#u`x`&+5+=%yVw zE_k}p73F4Rt-rF|UK8-}>CsWqXgO8^FyRvn3<(A&*Z8pZ4Np?f=f35pgX5R3fLv6( z-j#hmo(npccR%Hz_m+(u%zXz`q=WJ+c!ktHEzp58N)Zgp5`;*7BJ!#Q5jRR-`mZS0 zjfhqFvJ`xw$_FrRbNouXt^0qoZNDoQTqiVA&p-|do^Ety@?~VmTRFvfKeq(MxFA>? zh>orH1)Lcdd-_EUa#ejN{Ng$Dac{T2p7hmq?T#LGPE)YhAwtUM*A8B%jb@WR)Wsp5 zSw;1t*1ZaXRlb56KaYecm4h$&#r4ZN&?E6tUdapHey(Ou&QgZ-^yIE?Jv}#Uz1Q4* zo`_yL2!5$pUZ`$#@b43eH=&?E85*k8A=*6fp| zXKfqO^IlQu-o1|aXcK4pL-CBXyzk&?)>Z52(R0Vm|DNw;TN0n-k6sVtz2}y9b9~(h z|0fTdvfto`C-$kn-Y$(dfH>9zg4b!Kne?_gzTUfeyCvm`vCvFev15cGiE7PG?5PuW z18@zRbsfWJ%DLvnzCQm`t_U;}#Gj4>Il`T+(24h9Sbi~}4ChymsSxX%4H zpbIj*0B{E2WxxPr_zeK=(O(I;3PN!{D%?9z*fz_=U8@kVg;>DZ1QCCP26h}GJ`oYm zK*Yx*;(HMBWJLTnBCbCSeZ<4Dzix_Uz4d?X-3fqQRedn_s-0HcP2A|vbg+ia^Agj?tS;1`+Mh}yPx~!Xb0-U(eBSBar}8xv>UX; zw8pM+Bi=3VoYq+Ky=jdnK7V@SV;4+s-1Pj-8t4CLv&Mg1uzBOv=Wfxs{2N;~cIw`$ z@wV%?ZhY%Ik8GTG==O~TPv5c8AI~XYdBbjv_ucXM#_Fw~)OhysPj9S!_JNI6*S)au zk&hnHxObbEH%@y0$&KNg&uH9n*+&{z@A~D&tm!v5-u|6krd|Eqqo(!m`kraGTz=EE zZ$5hN^dnBbc>2um&)@7fNB?@WD?j;_&40S>C0oqd{Ks4V^!rE05;wNVsv-IteaEzx&HNgyy9oGKHJP{sc%bsJ^xeI zw{gQ$z8rgTyQiWCy9h0xWji2w**!}iX*6j4LyI!xfgXzs=@C%G&#fwf)Uwlk9Tc+@{^nzpLwVS#LAG3|H6Tvi|1y+@4R?S$`+f z`O_RX5{q5V16@#Cf9uD^DRlO4ue)-O)1I+3hnrpNM9UWA;@hJqXqUJ0R;fl~B&I9r zU-OI3`lFuyzIX1@c+}#}t~lbIw`{j_9EW6=$1{1nRpOhGm5&LJ%galPV!CxPpG?1; zm&?V;kh9PAtqjLtv#YLe8PU#0Yvg_SyuaVO4@vw{Ojyfp;-lehp+teW+ zn^kvBUT&_5a@D=-y4TNLcH{EP+w;hCsabAHd^>uycfZO__fd1_%s(b~jmMRr@_Uzl zPP4J!x;jlxH&M4K(@gX|aV>%B_G#YTo!1xZ_tR{M^0n&reLs5hKkt5Q*%!~cJj+js zue**N|CIY_UfgqP&*G(n%U2CA>0dtByRc_)cung))z$r&>U_%a#Ky`=b=opK5(8zu z*zKOlm+OjH?k^nh)*XNFt>dnp)t*5-!rWZ065oy9Ix zs^;5+#;$i>6z8gYW4>p{a{g|cZT@T4y}LB7``weS-G0XpKkf1DM9O|b8yS#xzo$lES*TNanroA1QTbN%_O{1YSW6=ClPPl*tx z;G6FW*f;ul4d9>%&yA4J&L0xtun0#)$lu|Z2rrM&6CrQDSQ%k;gf~QZYlL@4_+W%{ zB77>s7b1Km!Zi_o5aH($?v1d0Sk8!WK!n31yduI-gtH=?8{yIjKZtN|ggs)zI6K0L z5&km5zeKnt!ee3sc~peAMEG)q-$s}n1^mni*GAYoR;YZ>z;zK0jt%WO5q5|b@of>Z zO^$a)cuZ8<7e-i|2i@`8=kFh@;DqPzWA>xl>qx$NY#!Mg?J};~+ppRHuZ{lnXw{{}x1&dUhYk#!w7f4`dd=SAcvtnw@q(aJR>upWT7Q%YtNBvCLKPd7G=_?AHRJk9l6O`FaT;#;v}pBpJR?P_xI!0KooJQ}RX%|Nr;CqAq7W!8};t=1H+ z&uYHcKXUT&K4Y7%#y8*j=xw_n_4pUOx?Ml!e6xNm@zr_f@J8}IZ~uqjIrvg1svqmW z%KiVlx*sxc+pgw*;_R4R8rREtrgHJw7vFsL{A)*xUaN$4jf>A|v&-_5E$5W`=JRaD zs^LTX4;vUOTs1%a+fD6q-Z3wD!Ylszkl5pBb=jX5`6=-wAEjS+X*F2W zT8Um3?S-};#BR5a6sL5m+p)&>Q|IUJcRT0&|2gfr50&)F?^KU3<2SNiZ>+t7(Tb^B zey-TDv!3jWnJrVXOq<`|)OnQe+?W1DX-@S0l82I? z@^_iG{JpX9Wjg)ePl0NEckE8B+G2KOHGj{Ep3nKwai2Tm)BB!&cUhX&G27OSdVCpQ z*5k4rSP;$G4(G#lL*1>aueZGeka@Iuwsc)B*o4W49_jk3PS-9)uiDg88ynvpuoj`uuwP7Y`H{Pt%(z8M`KW9KuY)uFlZj;1w7M-va7 z&)aVGn5okp`E}1BAKm@RTg!a&8f0FHtjCw}?Q~;f)f&p%_oIP{p~{KX=A_mA;2R?! zx!h&><5FNpI~QwX{E|~uyH+H?ZT$hh$eLI`FXimE@ zKI`>Oj>rO=dAhG%wO&1K_s-?YdMvlI)%N9Ap7*}9FI@Pk?{&8m%Ko%?>ZioFqepvL z9^<&IeNH-_OIy}AIM_GXd@I?SI7lob7RRq$Jz%WnYvyAo|J`?p@kieAi61U&T(GK~ zx6XW}cZna(PX^Fg`6lcPnfQ~Tnl=-Bq%yXrZ|&7FVO z-|qFK_QoPT_lsY-#OE~CuDxG!*z&=l;pQ!Qv4=9$J$kyX* zGG4P}pxH3POIF9j;C(}**B92s%u9Z^deY?i?ccMj@u_zX{OZVoU;ZZBV$UwiNV=E! zW@P1~UDssV%a>*oxy`Dl`4-Z_c0JQ>K6n4_(fgSzExoM^kj!6sZX#!0>XIC;|3>w{ za~j=)Cs18)N22^>`7PyrqWa_43;yA$A9(f2pWL>cr995rERJ?cd_AY**V{uEFOG>u zB9wC5*n8@9KmEzA7My<8v@e#jllj~%a$Dl#&yH@wbSpQ)R`>hQjP$cB%RSM0zW(GB z5B%8BvLEHXb9R~jR`FTln~{}|tT!_c9s6bt#bu}J4@Q&Lqz4N<&lfK#IZ<*z!#5W@=ANRX{X*UErQTfT=wfdV^k~8=a z3sle79N#^8`B@+3Yp+lDAO5bNUwB0GCd|ld?k8mVDe?8}XFby{L)H8CCcH0YvUVN+ zH}_#FYxQ5{fB$#&IQfn!H)%XOLiV$6$@7}!{?r(3{QVpM?$(?l*ZkUi+-B#;kjP z__R;VTKdRK<9peada%T|V#hx3Up+W~&XIFl^QhN@57o9Ue-GW%0_VjfrTknUhWcKw(~o8*|NU&HS7r*{5@n%M?1hv)~xF5 zZ2Gr3t7<-H9N1aT>*vcx_K*8!5BmP+J~Hyt^UrB#q+HJ^@g;wyUn}Q%bA0dW6@7!< z^A{}Xk9H(`yN_Od@(FSBY+3s<*^-{2lZLvFj3$eRhU4VL>b};T>gB!6zuw=}eS!QP zrs^K5b!w`7{2`2A7nv;OeSNJQO>}(x!gpTwyWvM3_T#c_rT(tRm+@1Vqbw|OpGou0 zOyi1A$9ds}&z^dHe8ZX}-rs-XD^}FcTa@^cuhOsO@6dt4p=|bH#qtyThmYzT?jPuF zx5M53!btRs*EO4vpVd#_=C%dzeO(@gHM`{9VfL+9}FUe)YQxwp;$;Io}(- z{MfReHZDG=&2H?xNaZ~T$E@m&X1IHE{78h7{tgFsuFv)JOga7E&fe)!e}43i|0lP- z+2wCKJ^q#WW@P1KEd6pFzH*W&rmG(3oVN+-Z@y&3k)Qqez>e+HDb4gZkIxccNxC_h z>uQ1Gog3A{_;!j+~K3w zlroF72gU$rd7)rb?8uWVj8i8-Aaq2#asc~iUn_7OLI=7+}|@cNR8)^=jsMm@fa zujeoJdgk;k>sh@buIdc;&*?jHuqWFH@7PXlh;J4n9@TtKH*a3M=cVgU z$pzTw&iP;e_G5o=U=C;3I-m5&aq+FOt@97n`ngbXW=1TjZ61F zX#PLXKjINte`Qz7Pl<2Ej(yh4Pu%ztMSG}k>FT_3Zqe{SKI9bl_r0bkniLuwIB_s; zNy%^5%T3lrCC#z98+y0|Mk3){uk*gN9S-X(H}(CitPr|x!mS7X_&FB`eEch`4ayeLc2SiM%_n~{}|difmNUYEPAS`$Ce z?YdX8@CQ3sp0&vZm}*^{YWyE8f{afnP`%D~eQmv+sNQH?{jQS^xc>WPvocz5)Zye4_^SH~FY&Y*YAO31duhe7p_%eQy z{0!v#A>t+R3;X&8N3+?!S+=>`o%2{1q11D`9od<`iH=L|{>eq}U3k&?|DNB?uH>&C z-x@o|f(HDM=#EeS*&W`-$KHTgw^9lOj z|G}}_AGF!0pS-?(fY8ccw9nU$uYaZPm&Z^qjR(ZzH*8KiBR(_zJU?+!q+jNr_fO@# ztL1IpQJsGE{g{}%@ro(iPj?v+dm{Ot0nd?sk04 zuA{5xul07piSu_}q+jMAuk31`bC?lxEA_z@mGPPXJjXWD9-sN2_mauiznHXf`m=60 zXv5o1+&PD{EA>G=zBP7yeGsZ~*n2`>Ik2hLN2e{GJpJnn67w3=`EL$)bZEDmi^Y&Nj$KjbyNo#Dbh8`|~YI!;Dn90k_R!h1X`(1hE z-sjHzb~c0C>`Hkl@%81{czHRpXYj=O9>DnH@;vWZ(yGtf-w(Y&wYEz`lbN8XE zPC4#tAGl|<{h(66)#J;O)XU5Kl}iWWLEfctqPXl^&!028$Jn|5)qm{d`MDzUd)$Se zT=(`{-~FPU+6k8OTjEPTO23|;$@X9KJN5c*i->Do3m&`9uRIsshrVAezZ<3~FPXbT zKfmo&uj$))cFAcezxDVszFuDDtX{QZ`O>(nVB*bV$9bla<0db^nZ}-PeBE`+Wu=coPJ>gH{#L-Ck=tI4v?^Icp0+0^;if7>^`{=Kh##y%yTl8<_P89#YG z%30aY_8(@vqB9@$`-Vm$pZ#C|%&xtQZg|%-+XQYy@QZ7n-J%{yj zvH0YHf#JB9v{^V};*FJ$oKM#8d7PW&p>=;t3`AGTNA}BbbA*ovT%dX#a<}6<%SWDv zIU-WLKFZB=jy*glZ5;i{9k;%D?)FbF8ELKKTaSw`_lQUyG zD*4@6@xy1iefge0xunc1%R(tLd3>Au2zg9Y?kmf@lxO#|+-BP@+egTAG&@Ado7{5$ zB@Y^RiI7cs>=t472>Bd!KI<|g!k!WKj*yjfE@-w@vR{N}M>se_yvDlu&WyvOe`JJ3 z5sr=UstC&>P&jvK z>-^u^n6{*UY;R||s$U1%r>CoNz)c_BZ_$5u|G)R$77Gwv{z>g#Xp$;PX#^0G#@&(ghb*?*|!qrb1S9;xrw z=FFdQ?7**gxa8{frMzZ;TKp^VqZw!q)bsJuo)ydERSo5sIq&ysPFdYfHkM7DkIxJ~ zZu7S-ea}w0y~!@~v2A>o_-16~Bl8iV-X73sgCgzrFq?-V%||Kb9nk#tNPL!hb|mtZ z>CBFh{jzP`ZLioiedns?uKus?x_a$TKK``NWc`|5PPavTmiT65ZArgz;^ggsa=r$tUnd`?sCDs7SU z4D}zfI!nlcBeK!2Xd0=vGyRcBKkKwy{*8494*$(#@3~;Z3(Iz{{Qb>8Kkn93zIR)1Id&@j z54GcCb{$-rnx`|tkQzZ|m7fA9a=)|9Pdz}$|P_?Wz-8_j>~I#^r` zZr@Sgo@!mBk@+k4F=llB#+kPmHLjZ|Zrns79x#Dw{k+vllb4T7bm#e7_HMDq=f7Ao z&??_skBcwkYvp7132~$Nz{vn%y$=a2j9`)m?eO7ce{(4F8 zvrhZomRseqLw1?ZTwh9jGqUoL9@YDmTieVd2Zn|g#mTZ)9lGG?qvsyFWd4GqUp05h zyt#{xo*UUxwWzwe!O`S<-78lS%z5mmM)7ex8r>lY_{@V1|S@9F~J75j@DZxANBa0 zHoMMzWM&rityv4=Tn+W?ntsST)#LKI-=)8xhga-BXdzKoAUoV?9#^d$iCVz|zzax~K2QEWQO?H!S?>Uxt!Gmk6QMs_bb z;F)>atMR-SKl($P&7Xf(Ykg^LkF&kE5}(slyLP*Z?cz+UXxU7+cg#c~M{Q^1O`NY^EU_ zaICe}FcRM^^~k!_oxjt#``CuN8ehKqP2c*^y4&w6`AM@}k4yY$M%n|py^njvDx3VF z*~5$bR}c3Nye7}It&15|x9jO#=3SqczaM&m>h^A*Q>Q-u8~o2%XYSN<=^f?xv|Zgd zhT8Gf5ozxb>B&U;N)j~jhuVhs@Mqh9unuf9?o)7Ef@9t=im3Wd`vWtKlHfj z{=vFhIT^P-j)i^YjTdxXdGlkQRhGMTUUZ9b@n!s^pRQsMEQB-n@=A&;%UG8MoF*arygI%Pnw@*>7BQHII>dB#|4p(EGx4klrocRNwt2z z`6<1yVly&fmIhL#Tv=R+OU-*43$r{0e^ciyb0ul(kW zJv5r ziOTz1e>`XD*WdB{-#)&bk(|fQ;aK9^(WAY3KC92Cwtv=q9A@^4RV$lUNUG)SqFR3H z*P%0!W4`mRFZtT1KKk=_Ke<)%Ge1X0eoFjkM%n}Q{ES^XD#uL|<*Kv19XrzLG*P|= ze({vgY;na)Ppjvv#6JM}>bPLOE@oKPhYgXxbeJ6>`ze#4U%xQ-_1A2D)@O5k zcG=J4tP2Z~x3!Q$l!-Ny`-hC$ZFyh{GgesgF3 zCfZ*exaVh&`qBr!o3~svyH-A@HR|zYeCPT)?)=T9>uS!UTJH8ez4P~-s6P3^7k|<< z{h$7O`hT=Dkon8&rzO4}J=*KcU&r~KN%L0S&p$8nmFdimko`P%&Ul6OjUlbea`6gnDOQ5&HelvA2qG9 z_PrPWTh8$ASvRjg`kK>U`ONkOu*}~ck#334X{udGu6uEuYFjxRP0Yr1%eZ(ONjJNZ z_$=w4S4+P)#^rPyB4m3V(Q91wSO2r>$lGuKe6{|}^A;sOr>S7mNEu>3{N-L&Gn=;Gko3xwFfDu1_Vt8Cm(5ApOPBdTL3&GNnNR1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ Z009C72oNAZfB*pk1PBlyK;YpP`2R{RFk=7! literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Cache/Cache_Data/f_000010 b/Covance_UCO3001/browser_profile/Default/Cache/Cache_Data/f_000010 new file mode 100644 index 0000000000000000000000000000000000000000..e425fff2eba991072d8ae9cbc7b150bdfb471c0c GIT binary patch literal 184773 zcmV)7K*zryiwFP!00000|IGb+bKADFFpmF!UWLtHj|!A4nWQe3DIxmVj+44|VmD5D zV;CP=ge)X7sFIK`HFaM5cL4AL%1YYjGxN+mlZ*x8x>ziB7mEe3x3_aad7SJV-cT-f zeoLd}lBWN)x3_bgEFV*LGZ#Ca;|+AK4ohI?lutV{!wJ7*X~J(Q7yi!9&dxGT;?-2J zgv(T2->)>ySi=3C9k0{%1|3Hxo$^dXiv^8Uu^m-^+ZnVS_q}`IyPog%|NJjBTX9v{ z4pL1YCw#_k@XphJ?fvjy|NjM>Ql8PBxe&|D-`k61Yn^2Q<6e=R{nrnB|Fv6IgpS}f zoZzRYyC~h^lvpbs(;4G5wswhlT+(E=V>C4}!v52G#3->2kB(oSyn6lP=}$kOy?J|n z@yol*_aA=!?e{S5(oRQW%tpc{UCarhfe6QAcYtjfwB2w#9%5Sty$}+cm<^>=tWv(i zXh2`QaEGlyH?)fn&-fUW;X$`W!!_b~l-)Bioud>#O{0wNxIQN|s33AfNC--7!f3!> zyzoLSOY`x#Cubrin;oHJy2so!|3|G+EMAJa(qhVu2`FF`Y%Lg|P612GvLC({hFOrRn(zNySlim%e%S)w;vJ* z#GGZF>qRpCl93g~zWE(E@DKk&U4HHmcfafPhduY8TSU2}=XhPO+wHmgMU+Rp{=n-F zyRPFEQC;HgyZhblaDQ0D^hnnm_PhK0eb0oBs9+|dROsOKqoA1%&W}{M$Ub8{TCl%q zTqH)>oW^9=EmPA>kX>i}o*a@V`mjt=k@-*SH5`*&lu}|PYD_Is(uJg`r#0^Uba{38 z+KJQ;CjOlB1!_U2krod615p6fidr5D*4(_a$aU>+^1tLUvy@n+8>}_&9w$yGYfv6XYdbM z1{$n7eWcL3h%zCW#VL>J1L06}5}WXLjd>XK#)MCh!G9FhfWd`$d(eZ5)DVUS**OI( zE%KIvt>+!|4hH+)L4RDgU6JgOhNMo}tMU)VV+S@Fp9=nWokzp4Ig87gTF+yxq)-r} z=2Xsew827m9iZlvgM#}u5D8jX8B>e~LJvkF2S9`-BUhQBKNu6yoU3_mVv}ynTHS_{ zhe{kOX{dyul7&hXDoLmWp^}4I3~DK;g`k#!S_IN^*6L4V1jgfTUgP)0ix=Jj=-hSe zc-%DyA8+7X#+vvpStKnHICr3!>T?%Z5%M4{LQ-EWsx*k!@#~k|@a9 z-SCtA8R{RmSNsm-?+*Kpqn7*(|sXo1ZqY`AMU)S#TRFKW(7$lg4AS;5YC%_|M3bx6+&` z3T?Z?gP!B;_lLuOOQAwlAaS};_}>v}(&D*Lbh=smU(spW5_zIXb+h=tB30H(@>Egl zX7O)edHA1GYkPQb&^y@gyS@JtVr`cC_q4iE?q8GYM!A1YsT<|Cp|D)~6u-8pMD*M( zS-Z{aNU!AbHmf7MCBwJVIydsQeX1&BCZz7&Qx{ zW?|GU>Y7EPW+8vMQ8PDc=0?rjsF@oz^SWl&3OGjXeuc}LlyA){T2mL zWf4^tVP+A)t1P_A!p$rkSe1oUS(urHL0V-=t1PLRWjns~`t+YMBp0y8f);rW2BBhK zMk4x^(R)O3IkQA3qe3osyB;bhzszq$mun2S8C{x7yk@jp8CEvp2PJF4K-X}#xfT#4 zrbrnZ@JMu~DQ&F#H!KHh5Zg=xRiAWmWLOv0qe=lL&WMh)(m*(}?ZRZrNk#)2jzqvi z2@J>Onn|n?hT}oCkm zjVuLjbOn=dq#;XL%Pn|&kNvmz7`8z`1O~B|C^&^1N~}yoH;mt0()5m|KgvZ_X2C5b zra|+rVbJU>k|;hb?3uMS^4iE$)@l(#XouFj3U8xZqsXIKggyw$GmQsAJ528=NXY8~ z_Y?^dguwOqGqU$dZx?*r`?wc;y#Ltlgg;DUUIssQkU~j2rgtAZ)8sZ+pC3Cc!5{Sw z!^gc$M1oB}?xEo0efTt7x7Ba&E5EL{&M!{hzC6D=yg0r3`Q#7$aj&TKbN1cdjiOpf zOqyy%Nwn0qHP9&$l4jWqv5ugbKxrpSr#R2k4vPsPdJx-|&2fS8bX{ZMk|GL1BEXzT zBnXvFi;{bZQd|vHmQFhIzVzEa4R}MPdOH$CAfX zy*#0a1Ct}2mR;lOuQN^ygh~W(HI)-GrJcs!3Yya`45biQ2xD`MK#;T=qp?uTh0RbJ z(2x+46sX*F)Rdtk1p_N#DC-f#0ZPi~kr>mFZ43OQ+hBoE{+*x}gut2`XZ=Z7BPVi8-?NEL>&nP#&AnWdTwZTwUw7kqc#9x#5B_NG|=3-kdxv z%aR!TMaZXkVx(K2ESuWacNX?3R@0PECEPk$LZrx=;~IAbTi$i+AwE@vT+aU8T|^1Z z^IIxm-`!QrB+pMMl8SwvA9WVVG?E2zXP#sNDvH#MD+3zb&=6xaOb?U<7UN7XC1)+L zSWLNKvquXoO%LZwSy^U*wTy1)SrWw-SR#$4Uo5bu3mT=DG*jFttoh(oHTe+jT>VAl zpF9sj+-QvuA|}>~XLB|amTxUr+1v_I5O$^spGKk+EtiW&6bQ-3aE*~;S{ln`y|}WF zlLrc1Z2(rxgpb+CwmGghLKQA0V^Q2C&kZ?zMUemsQF^mdQyj0?NJ>ngM&s|Ru1NqM zDPlwpg&YWmTdh<1gP#~t{Abqzjui(hIn6Oe0>e9s7zhl-Y+iw@P&fi)l3cqK|HXc?2%8ckjNfN=1FF38sD>9nydsIX{GiJg(E?p?Qs*U&T0WC*40(^czc~JuC6RO!rL}k|4cY- zwdCJ`hX%iSRaB0jIH5t2js#Y`mhWuKSxT)^O_Uv$^N`{-I>PWEb;3=H_j3lF(Z#IQ zl7Bn$4qMBMsX()r|!U@U1z@ z#Y?NT_c7p+V0Uz9n#A;DxTi&gZW5LGFoq9BuUV#k;m5MiU+7~7f0ti+KEh`rS}g;P z4$EXc@Ec*-+vqL)MOgMqa%KuYk=>`Vj|vfMi5S(t)9i$=ZfP1_FDSCgOcsWpNnj}f zcs`RNB)cdvslKa>U~Q|(0;`EeRpcz0MhjXL4B=PuCKB_`GPy?{^t-t2*1~3rQb?+q znh*&zA;~1I#I|oIux-CUS9%*gpo-_0WfD+J%W|Vs%9Rlx(-F6AtX5G~iGbTlSbBXV zh1ZAUmnx}tQ;-x30*?xpkS&RIeNI^A^!_nt{o%@D>#}dftU!tFmcSePHN^- z{35?zMuJ)xD3u>tr<3AQeV(LgA~SOJr5TKcfvHbpB3c+C8C9}4OX>feIGL*Pkvd`- z?o6e0lL9e=C5cFl^pcP4b@p1V68RN#IW715%@uU*KQMWYjcxKw4#e7zKy^Sf7Yjp5 z32(J1YFJ=4jWk1yWiPiezBkdbEdC~1N};;I&g1tl>>w-}a`?0qaJ zC_<0NlczP%YViS# zI3uQ3xD4|^1T2*La)JG)X~IRsc;-KcSMfeBHBOKk$d(*CGF2+yLg^@yP~>7o&lpaA zu0d$H1VKucYMH`nZ70uPK|(Aemv*I;1e-{liB1VBlHWy(2_ErwdxTL!ehzqunfBld zl5m%hG)Tg4lr(H%tnm79LO}2(_E%j%*I=DcovtU9qT4zdyBF zYN$8{UN?5rSm9jDl@TMnTq;UkSQB!&9A}kbH7)chsR<;+86{&jN=iFbM0k)Wm_-oj z-bZ1c@1jUTnO3WNcU>*>Yr~#tFElmr#|c$FF3mVO!?ah&)xGjojtRxSWS@@>UU5q| zJkm_BuYx<~IR&cxEzW1NjEX#W;8x9o$Ih=O?=DZz-xAC1xZTdc0z=NN4Q#PWs;+)vjdeSXx8%d^y###Z?9CX+pG zVl!C~VI*tXtQeT2!F0D$i$qO&DuuRM6{0jfOC>68wIu)0({SD>l#)BTZu&D<6=;Pg zwERY_9;VPL^j6EVDIu0+i%}z+R-~$IHr*vQo!DZR*ur;+{BZZ|VnF2YW(89B+HAX0 z469n7m(!Y9m1XB;NzI1-w-Hz9;#C!fYEwY4b4SbirbtaaxK(x+Il}9dG>a<5HI)Oh zD^ah^&`;Vtds~cQvP;PA=J1vCRuXLylBY#lI1lv8f_@^YmkK? z(JbXp5#A*v`$`Kd63eQ0Z;*f$&U4-3O18M#Y>{`C z$r7nYufC8@~)f9O}$pb|( zhD`omV>s3ku>Cx1`=ma7?r8m=X4Tq{(Bg7%pZU>HM{fea}2pVrOo zh8n-Jdg?b!-j_!DV@D(xk(f7h&T{{t#_GmGh%2Ib&HzSK5hV+&6H0tSi$h0EOMbbZ ztD3r$Y@$TScM@XmH?91JYHd)tv6dAiLr-fE7`83gb$`~49Rahf1Yldich3r*q7)L) z%&#(gCDpEVX*?{~(OsWbhsVCY>Ml%zvfj0}7IvTK));$MLPZy)dfQ7$<#cN~Wfc6X z8KN{FCXH>hjg1onrn1lH)L+UmJT20Fl;{<^qQw*cjN%5hy=m;gl=YtS8RJYmnyh1^ z!N(30G>rtMyM(-U<9N2>Q3G!sMEZ=HHx66?Q)>wuYLIz*R;EfD^Z+-7ut-n@@ivM25|NkDmefjY} z`eWdXtTh}_qIwNN{+`GnhS!ulb_Bg$E+RoMsSu3cWaNoT?LHFJ-y8oo3O;5ZFGG8R z|NF(>4KOZfx=a>DD%nV;*)&?Jly);^4Ie1kLmm8S4}PTNNkRI(1=h!pmM{N+^)a=4 zODY>5x#e4223DTq4K3f&zeU7B5piIx;crUzK7P!<&p)R5N1p2f`sZNprXKLmrgzZC zkCy$T+O3pW{*98oPam@%(8v4y<9FEpnEmjbHkJKFiBnhcQ?*8hv>sAZSr-$;h!jP& zAifE4ukDPWaSiSZhb#5_&zl||?MPS0kjSW|(>b19yLKKnN& zPPKrlK~amF9YIQdYZ%H(-yTSa0};8CN_{epYI9jeXkjjUk22h9p&80>o<|gA7)#aO z9SeMjG7xQ70S9%Z^-(^xup$n`q#DW9I37tI*S15F1*_`hAJ21CMpqgbQ*`+&ZHz%} z97KW~A_2QD?7A46Cc?3c>p>_6;F|IHaIvVyU>Ri@jVtu;@aUFimiDI7R@1^OPXs(1 zQAxHx%Vix?8|;vm=4F>;#mvPpWwwOZ{ez;ZI7A(RUOc!8J(W_it`0 z>{4?xaH~N7!?dYB6Ax9@&bZyC%Gph9uMz_t6ITgQ3AbEUsuB7{g8c^t&j6Z=5)Fbp z$SH;^`eTslC5xuM%3-afKuOXP(aJ&{0)yHI&{zoxfs!qYjjy$-h+M9;#>vF-S=${s zW0JO7>6ndDniNrNC~LKNtCd#nngJ)7qB~{LnQ*_Y zOk`r0l*XbRXDrbZp;ft`C*>1l6ypiEnJl1B1S{bDR1X?&wX}^v4;l@)YM^q5*%+}% zkVGICxPVk($kb=s1tyH4TN%`f-m7(r@TtH>?5J83>?$p??d}>as=c&&iDkHi3395) z5M-5V*{TnMSI*z*I8m#9gYuf}lj)hFi?MCRSdhv|B8%5<^~PH2%Qxo4?t7)b7fm3R z=hazrND3jI;$j({n#*W5VL=r7(I^R`kO*yH%M8wF5NIsW@+-ty$z9SNKeG==L_wrb z$e{L*jaL9vp?~~-Q zIYC(wXtmO6rw~JG+>P-KX8I3<=!}waYVL!{kxN29QO0dKa8U?R&GEMGfX)9ewZEl# zXN!03*|XK|d*x7zD7jZgBWFya0z~qhx3yZkY{GpsI!V4bw%{h~ja@GKf#%Z3X zgw*|LwG#6at9m6fNhRtk7NvG31=$NeeO$#u$7z3D#k1Kg%!B&-dNvE?=X86r{5IEl z*TOVuO_XJ%6mQu7U7@3M8;R*0-3ja~{Kz3Yr&wXh4-8rIC=6jz&_bSTl1UJR5QL%sv~IFZDoKFDhI@EL0HXw@K(z*)7TXAdynUvR z->AKiiJV`hHQQI(gOuMGF1M9Y>0*uHxLH?WYRmJo_}HBoRn?|Bo8Ej4+zq%C@w|IZJe74^ zjl3fX5zaRRScNztl{$&KFJGQG?)u z5EA((A`WDF*%FPjS^-@tdV^T5R?te(oWB~0R%@3}P^7tkoaco)wUP`i#y+2%p#);( z|EE)83{@WNpP^Lk-&Rp2@umusXJWfC=v<&feU4<;!3`|D70ul`+G;6Ld}rS1^etX{n6}a3Km$>mu<{YJclBhR5|g6j;k-X@Ndw1XfD# zXqr(AEPeh6tSm{@&r(Vm3#yYzA(-BNnmwwcY9{Dn3+N5VN5-U8{zZsy>p}sIUJRD7 z?5dfkwiK(;)w|Y8NvbvO`m?3Jo0+%gpG-;Bc6u2ij(qEi#GrAxj7 zO4+h5$SZ-KuC7#DS6BL=Md57bSI%ZB%|zvJ>ra7YT5|XauvDoSmsrVD2Yhc-j z($m=g4p>(B1^Ish%ZhVI+k7t3F3odSp_nHzegC+mSXNdXh4@{yEtOXP4`A8LNKpS5 zV42<@@hO$Hr)iSkC7$_W4}*3V=`vR|=obFN^%U5dx&cWjO}Ma(n94ibuaY74Gh zGX1XpM#`aSqD;uX{CkJw@=ZhWMk=TNjcWI=Rb&pN!DFtA4OCTN>2qLN;U(cK)KcMp zDB@%|f-m$j^RFRVEPj@u7?cB7=HJ6IVrkRE_CNEQP)-w2_)Zwk6TtW#O@)6_OSsHG zrEp8dJc(6M9oLTit1@(c&;1OdEMqq^P+VA<`N!p{`Rz!dYV!qyXtlKI3+NiAi-d0@ z3hf}ExA6<58T(fhJ*}lQqiYb+a(gpMo2P5Ip~C+{VIE~0`ReU`q_@EF)?NPc05?#e3FsW~P=_7yV{=+my^(Lbl4 zyv`yn{1pYBBuoE-g5IL_4=I!1XIY6|do6GYL6nC;@l};%j+A(%v zHEVWTxXm{4t)zT*4s}qw+wGAy`(^6<`dS*6BiYXI8imO6@Q}|4k zN0wd6U=WkcCf4`%M~=|dl_1Eng>7L>lsue#|Gj@z^id{bY=7k6TRwkYif@#<5=CCt zY9W<-^pRUOv#pQ3=#reJ7^*Z7>HvGnqU%NB*!Np;zCqyUJ62`R9hU9zMC?R6*HKD$ ziqqeWrv8p)i(;QIBi20=bCg_v&hw`=ev+_cwzbynTFLciYm^a7ttYPpTwN{6_us?S z)#uHlnQEwDnKIt+SyElPy85iw8kOb%-+zxs>rv5KF+NvUOBpi~>EqM0ZoR5JtZNri z)xT`DTqdcYv4z)DWg(G_MHesVh-6S6cSYMy@Dx^hY@EcS@QBwX9o7f33NonBWJ!ja z(rmSO&fN6e-e9GQWmadnmBo-(b{@Vl(^i%xAi*}~bbWVX2%d$~ANw@De`t^p! zjgl^TuFm=s_O<;M5 zg#|%zp6^Nxx2iYKQA{WX)<(1)*Y0%sR!qq1eG?F4;^a9SiwTlMqA(?ij5ueh9*`LjJV`V@pt6xjPis^N-;!^|n zqG5@zu)hsW?PNs9e3D9dV&H9xeUxgnGqvMWu5eZmVGOD2+p6fB6oFfp@hgqbh)_t> zV90W18yFOqZ`O<jUBf%p3J7p|BZc|zQuDc8CYgb+a*#(4ZQee|hNL3Pir&-KSylnEWd1Y}BP=+9IDlY#S@9|>5L z+0JKvrc3%O0WlR)gdys4{89c?=NHd_@#$g}QzNKCcgYv(&jc(NtLYd2M!@~o z@o`?G<2HKmZw1^oWXa|hld;3}|HK9pA1D8Qg9)K}iwTb-y}{JnU;3x*CCKKh*=(_O zjiI)7YFAjuqTA(y`j48Pj~=(8RVfo28_G8Vec84@rm{U1S03qE;it9@(^Lv|7Wrl8 z)=E1{#nv4L+9~s^8+*zRHH^E26kcg#p6B%~E#+)?wJ#Pk(n@`)?N(Y$M}gKB`ge^% z-%?@WHQc1hYI*eN-xss`=+VEFG`->yK_^11B+43dDnKOKVsb4YYp5d64?#OVD(L3g zpqn);+4PHlB_O$F!atVNGtGp5C}2*bSpJIW3zfgc1xfyU&1AkdUH>!Nzwvg6{|3>m zTM%jzrZf}&8xRp&_-`OilcoPg35saC&3dNhZ((S|YnUw}At>KI)wSEZn+uNwz2KDoFD}L+{wfAOe)T-6nY~q4HIWbK!WS4BI1ss zF>kfb43E$#gaj+Q!YGndXdY#*FH(e<&1N*EQpmiM;Q!5*{#yYejd-R6>{|gc?u~%t zxv6909QhX5#e@e`ogxp&xg)!v_uqMQLGZG-POrMN9zP%W!*b!JNcFJn5S!aT4SH;-QZ1~n30E0 zv{*n&9y(G@frLDCv}OU33Z|KWOoez1oG7SZMIJgz>O)MdjI-sE3Ja#im5o#Nu9O7} zV(Gh{ELf6ikcz8C=Z%Xsl|`5Y)3A8^DF}<1Jff}E?mVEOl9Nw7x|Jd+TCgainJ>XE zQI_IK>Z_MrR6D;a>BXV43|y*Jd?pvNTDVKCJn5`5ddMGjqFgk~wnzfT{fe!Y#tljv zn=5mDG2%(9g>)Ib#%qeKD2|m}i53^D>jj%0E|;fqWb z$g+z?a!=#)l-)31TFt>~ zPedf>hjbxRG;qthI~%=G6_s7cGAe#dGEr2iBUd6(4HeI$Rn567S-sBi8@;}K`STkp zqBs(fY(b{022{GbakEO+^-3L;@@LIWljIAdFO%DdaWh_)+{_!ZEV^FM!<9%*>#GY@ zQhk--Z*$6jWf@b~Sv5c}iXW>Mvn>^0=$mM_6}q5l#xfxVidm3ynRv-=IE^>ap)$;p zbV?6-!XIywRkl&LN{r8F6w`DwNsT~Z62E-p({H7}PnIu}dw$Lrj~m2M8r3gFl14Z5 zjLoQEw~a1rWVu|;X6&Jn;f5zEl@$CgSqXJ{n2}iF{q**h#w-%l0KzTuRJY>l!CEBK zXi>Ch09~cY387@lr6lZ)F5N~CdIaCUKYJNHRyeJcY?&#!&g8tioJVnT|1L?yChC{^ zQN5HFqvh1GuN5DZvqUE8_>|6QdXy$nJdHAOJdZf1n=?aadb1J={&Nk%=D03XdPlj? zJ$OfFDb41Vneu@zk|;h?w6>*ma+?SmH|L*z8*r7Xb~D`}J=@Ftjrq8dUH9;>6-^(t zQ2lMr1YIya^>k`V|5~y1TXdd9k`VrGa-obaW^xYG*xLBk9VjwG1#g|9ytCITYvS>V zM31^I_9DqdgV+lg*!4nPt}55qNy&|+zFbd0lR>|y52ECbfx%Cs#iL-;tV18v`dPPI zwiSdMxlCf#gSP>e<`FOH_3EZkl}?l~H7gWuqRvREE(?`2WI+3-BzZ|QIgQeKh_6#BZ=l2I@r_J6&ay+Pg-BiBs-rI{n)&ZWm{j)yUAOMETS%7 z^2Zw!o6XEgvJh<9iPAK=zf|`}mmOw&!8lbU@HQ#*mqOMm&BM?_HvrM;S`wP^l@N>R zsj_|QqEm=r(U5eE-oHs=x-r61jW0FNS4nD2hz2*;EVZMUwbHv4BCH=QlX_oK8egjm zu**(uB$UdcE;TD+%Z+e7t)AAk^fxLrrgoZS+2L}jM*FLZlBW1$nOE!nr&+StMxGg+ zuF`4>9VeXA=_Z{-akA9Pa{XB`?N>>9AEmLr4wEA5UWrpBVs2=9u~^+OewGw!WhGtJ z(*avE87rELC>5Nh+nOrKzlP@`Wl5^U{-OM=c!j}Ziau(2uiMOO$m(@TnNi98WM(RCeQchC1vz z+KXe>Se)M&HjKHtRJ~Y-8|OrCQFYb;Kj{@dBOK}HL@0Ua+)#m7XOSddR!cyf2+(mH ztS|J@Qr3{-TUKu2+SYTS@4!dAFhd~GDGUJWK(o0hf7X&dw0O~Y3}UUE+MZ?Q7=y|< zq5g@{wL8iIfRQkVLsPZttH4Y?qMb zy4nF4dwI^#3W;hHVryAK)S(OA(KVg~p)a(Le03N5EQrJBHzYo3D)rycJU`N}!Cxi% z?FLYtjMr{ntPF2puH*%ipjEnUe?*G;Ojh0?!>}ZH~{>QSbp|!35*|}$8 zzN5NaC8;l&HcOM+9gWc{QGeRj|5$5yidHcb{w3&{Q%@*G=eWS6OjUP^Yd{(qH}?%D zdWJ~$UA*h@ilR3Zt4j1zaZ4>lp=nq(8O5=FJ;SGvZ8VRc-cUlh!gWn!@X|^P|Hv^|64LC$A1aoax-lHQZ^D zpe}?F9ku6moGcd6GNUoF3V}g)8iOMjSt+_iP5Km_MRHT#Lr*(;s;J|U>MArnO^m}d zo%<-|$a=Gq8sdT$1DNg1k`<4Q@s=^^j%AlKD@8_q8xW`}Dx9Qh-GPe> z`|+E5V!V_D7x%={H|txCn{uk*yHYH#X*bIAbBeI}!cv}J+}G^p$S5!CB80p#l3yFf z{XN}yai2fMYYpYAdqT;JN-Q0j=d4?;*TwT*WrZK;hD$KbbJvmFsPOwfx>v8lh&(^K z9}6kQUfz#s(bmiRhP#x0j^{^;(B5sv=nncA+jy@-ALtbQt>mG8vBeGXNY^f~+Bi~0 zM5=6fANM*xjCRsH{~M(Z=MMClB8=hae&Z;WgoSTZ{Lk=k+-mLX?JQ2Z#@3H&243D9 z8!Xb_Hv=VZ_ z#T}7+ST0L++PqA2@#s3G(HDKyr}dix^L!ainRv8h8?Bb5VYh&i-Cd=K^GxlQsPsJN zw)MUlhb7dz$ci|-jhZ0&dVi105X=LfwpP;U6+rEfsGsy(dSV z={!wtX{%L+I_ZkbCHV804vP!M_T`>DbPAuy%CBPQ%YEg=cGQ_OxsZL7wG_eHvTa5d zzRfBggjuk$63{$n#yE=esP=f4t9g$?T=T`R$%O z720|BqXy=1$^0+(P{l^sTwDD%UFs;Y5p$U zxT~Y^8t$YbnO>xH#vXhQ^<>L@3e|kddlAKv$huT%7FO>N?4H#L$7(J}wJ2r2vcle^1w;7yLse0%&G+TLhTovZqt0eJ zhRuBx|20KNoy}MbEPKN^yItL$p8QJFY||~J8pJ|uN{v;b0#|p6S24x2{4)GPpIv*C zT(brJP>K!z`CPB0&EBC#xn$<&mpQwbC!FT&B8hWlML(ix`k0@d=qmH`B~7Cp33)?| ztYv>Rf=^0)$$zh}R{v?s1@1+!6sftcq`6khI=;MgkCWSFq)slr?kG~<+*j82$9@APnsZ39N1oLf~4$T5+VQE zqHL3swhKj8mEMJy_hWLPUIeUT2N?TbZC2&2>TV-upLX7#pP#)yy|_Aj_wM|+tIN|r zPjI6d*4~x}T!)aC_Y)&$yX|iQ$R<6>`dkdwg3d$@Q)hn7qHLnBX_yIhs%<80q4B!s zwUO)C-Vfh~PnC3??Y;1=R3h#lT5P9voA$qMGi`UbW^20+_P^StbkEzUX3yJ--MY2w zB#mjR2Es%t-^`$@Gwa4a`aePV21*;BHtGLkb8Yu)_*Ueg@*BQ;CGP*B_XV!EWBUIX zM%z^n=RTWSdtRFvBcq7^D+BWnEfs!ewjz+?7GS{qDd<$aOp!Js!JGuEHCT;qnn1 zucu!BcZX%Yu2)w4tP$e@YuVjDDM5cyqSbHHB9*dRyyXgA{R&BWw(nO8mW9`FNS=yk zuKlO=8h+n+=t(y82hpCj@C(^hSC`CLw&A8`3b@)$5K@wiSm1<=@1%LYo2oUE-i*t0 z^Glu1+p%n>UdB{+MzY$n!U^lBD*_P4Bh0Gn00bfAk4Z|>fQNaG_=gN#Pi3f4A!y~|sc@}yx#u@%iHY!w$Jy0QuQE`)b74M>f+(HT zaQf;mo=~6D`>jc+>+KJQ7`z{h8cRzosR1fZMi$2h8CM3g9hGF^(YMRCS}WBx^NlX^ zy8H6M4&(3)q~xm*v+>wfn-P@aw3AUaX{!tS1aU?}J!UI#8ieeFA;*t3x4ES7a(T`&P>xt7mY?a4aS$4!nN9MZ@vf>*aAkUli~A zhvTt3C?fRJ|KWH%EF!#~ioh>kbiKClUEW$^ z+e~M1bNb?iXtTE4a$!h_ZAYyZiiiVgkl1#ppUcS9sW3teA5D~!Vz}@~`6g!#VoOUJ zjKCn*WDO03&KPIe{42L(6zCKNI?Dla#=3Ti#6X1OF&VZCJgb{S;z0g{AZ!~0r4#iE zb)?)@9rfOA$>51PyEUpsz*ou1>krC@AHDuSJ%apXJZ_-QfbK&?A~{;4Xe57$iy4u0 zn7geA+U<0tjzmh*Oy%(57cXAuCxl}n%m+AWu~kzb(*UYq92HbQP^=ML^vAdfFe@(K zlBqG_#f}dvxq@2h5=vXG#+ym1;>qS4SJ*F#Pi1jskX}T8s|S>HrTQDgbB3hWE~$Rg z`u*dQmStk{EJ;ePWF?j>aa6p=qq9Z|%x2m@!raV`{f+N!km?NT7#c3yo|0y~Mnjb6 zC20S^GVyw95c~}l+VyMOP4eCk2+_8O_j0nei7 z$WiC5xGr5mi4rXNK=?vRJt-a)6H`%2FoKeX3{<@BsubH*Y5Gh45C#dU?lLx7-sobo ze8vd$Z32xBrbNndNC*qu;{B7l#y0UlCKG1%Fa(*m87IM$vw0UGLA)Qh?coeTq# z-q?t0wOAl*FMPoQ5vpY3VUQm$m_`pJG63pHSQ)Pp)guN>BZL(Q355QVKZF7&r2*wWB(myy;{>Q+a)mZgM{ zSCEiDN?jp>Ob4cg_M+sBVl)l@rt+3gvyP%lqsr`3i?#bB{H$D+QL0CgQjBy}c+F-g z3NpzMoE)VS*LN_yEY=0m*vOHDwR^K8)uNIdpB79 z5>RA{>r88H3JD2u)H~wUE#yZd+fHy%xw`DK>>kP11^+G-lZZrXgA!f8y7nGo{iqL> zeEgeO_KN}1HDj0(6nCzX3oiVEK?gkz)R-y$GTBDH<%k`i-wDOLgP7*B=lE4IkhU?%@)Cgp>aigMX929e}$J?hqUp!af|p09*(9 z;JVNQ*Mly&UGTu|feUUwgyI$y{?c6K^;edHwzIyw!3DA-BQ2?S`XyyRBD{GtzZN?s%qC?}C|3ot3E) zQx9+j$M7Bw;WsjezsL;UnW{puzAJTw-|W9IeECL(t~^9YQ0gsuDkaSqlRv)4{+H?^-}e};!DXoF;fA;equ%&Nlkn%@Mw0MNNx~oGw7AxjY2Nnw`_M1v)~xN;A2;nD z^yG(b>_)XE6J&ePl`KeBcS#)hu|9HoIsQ>)WHa6HC8vQK!gu72{Q8r;kzW_Yf#1op?Bd1v_mOR1$S%Gm%iuzH z@#o-e2*1idzi7_>Rv~KuZa|U08QAtk2*uAY7=9u}Sf+j#{1n2U@=t;E&FmXo{%w=X zpZqH>|1~643$z_6o~*U0#z*VoMfq)4mq1}p?T)xqA&1JA+PnyALmllBLdut414(kU z-32Eso>glm4uQ6NRbs!HcmTBBuM!81#DN2}J*X1*n~5&a_I{N(Y$kd@+rujHpqbbO z+CHcfU8kAa1KM_-Dw&Rn>(!}!nd*XTr1t96flTc-QU`Ua#FE=@qz>y;i6$vr>r~HZ zSK`S%0MAIRYu=ZL^15bf*Qrw_ro8<|Y7O(gL{--{Q+sv0`w~~(K6LBUzEQKpRj=Df zt$VaDan*Ot)PVuB#8v;mOdT5SN?Z;0p;xCK7&S{=4ZCKlYYfA_MApGUBiX>m&{1R9 zZ=?_Ewui17MHl);`axa&P-4s-bj@_n7>!|9ja9#q-ruj&CDuG|ze@M|P3j#=#L0Q% zgkM`>>80k5Wz+RqJ;W;4u{7|sWs(N2wn$Rr{%^5H819Lo^%Z&xnqz-%yth+6W?4pT z8Zp#MD_;q!s1e~wnN)}iLP+9s5;%~wUDQJWc%PG)I?W&3oWIy}QQ+o;~SK_Fv=DVz7P{S;dJCx{mw-9DA0-hpH&l?_W$>sI>`xxkQ!PP*qIEvGT4_Pue=2%GH*e#ZHDK;OqPoR7LIO%C~%a< ze-}hSSA}jWE!Gxo7pD4(xMCluz6=khuz)3bTEpDrj)nOic|TMyq5DAyGvdGvap3kF zD?o2Jz;O4iC88shf7)T?lCCtFj3nxZ{Sm&^TRM6vS0)^c@LdtFkart+{Xt0F0zqOE zK}D^ZdK;}fO2$#E#q4C4kW?9C)V9(v7Xh>Ne%Dez6#qx7rGr6;VMUhe8Fu81<&r~J zI&#LV%GRo=V9eTb07rOL?$N53<;R5C-NIkC)#7Lh#X~3%k+jX!V{HkZS6txcFAf96Dc88Sp=yvCyk==>W3NAKwS=9Fr>z!M9V5C- z5{|HKs~3!7WyenmgP0_8i7`}9BkK+uN2nfA45FRlwR*8@g<(1=EmY&U!iqwm?7#*B zfuk54jQs-lepzIEJ(-f&FO#Q}GJ~$_Sw(ogDjg`+)rq&6HX9B=lcH?{?c9=Epq&M| z14<`zbNxHR{@i$Bk3Lf@*Bjou(KNuQU2rOyVF7iQ^;n>%y!}ZZOQoW8#7=L{jdtswj0{A*;Wh5NYaSJu#jx2b{VqW5Wk=S3nxhS zSppTQ&MMl2%qE`X2StQ>rL|0DAORlD)gXd~RwC3m_F7#`ybNd<%mW&RBOxcr1l=NP zyBPEj_GSNs?jH@;D6Kfmbd4BP+YQw_pWJ-hRN^=e)J!SnS{fwPTW@jAaH6IUncA=X z`g|$b5Qfc%bEGt(o3~=70S&S+B(9B|y!g;`l1YLl?qHOSiOw4lq;BSqu+E%?cszEC z%v)>M3l3xY6NlLPuX&XE}Nkx`mM7m~9Er(4yBPRLNX^T^_}k6~SnbrRM}t|zJAjzG6rYvE$WYxG zVEV{Oxeszl7H~q)?4Pz9IdRI}>$Z{CAN-Ko6#sYE9qD@@jm=axLsq8z2kVha%!?tD(woo11^q{x6dFl_Ltek%k|ER0 z(ZR}jW|WYqve?EjC9c|TThO3>ycCU7Ld6vCcbM#6F6uozfD|(V4X6i-U?qLii>69L0MnqvWsUwEPw;XA`r_0tr zk@e?-U3Xs6*+Si1FvFX1)y%SB>jkB~Hb0eAW9dY0U-voDRuT1aW z5eKfxO-YM)i0+uR zt}*;UiFF-ibkJL+3*&I@FSLA2QRMj_bVSK_^!W^<6YBqTdH%Me6WC0>6j0np@H;Kr zK@?ZGM)iSGxlE&zDebHz>Ag>m6dcO^Ykk~w=G|a#{||ZYRyP=nZ@ceC-?l}2 z+oQYNqkG$<``e=j+oSho4~vs|HD*2u?KcVW*87lA)QNN@^pn8hC*@CDl(_Z-2i${$ z!9o9Ec+i9H!9n-HJ=h-(!Rrt9`(AJVpa-tk8+3bacOTs0aNzX!2W}s_2X24hxr1RJ zyg`4zd*C_UK6t$YZ!q-sd*C^}Uf&sZy&iP;_dVC`dtC>-esAC1-yaTo;10Zlo_lc6 z2ha8T{ekOvE_8>({eiRZ^!CB)dBa|>=kyMscQEXC2mRg<-2LIffww;x44~%>4;*(e z=ncX1ynScjdTtMTeW%|W4hR1qaew07wyiV{p#O@+o5unXtZ>mv1=Y#gq)nPMOE+1~ zr6t%#B7-Uk#c@pDzx^EyKoX?r^nTy_-ua!=#v=A*Fqj$4;uC*541>{h?1g0Ldy~=B zn~Xvd1in9>Ovd4isN88dn|Z_^PluDq#2*D@7>s;B2)toHf-vxB!FU{wNf?gCVK|&l zh(8|tYAE9o8TzwP=mnF}hy>wy?E9n8pOD#X;!Q$t29^%0#B@3);b=0Ojz(b^kYExF z$J1#r42bV}KBOoD*;zCZI+%^?ZL z)A7ik1m2hg)7jJ;k0!yCOh=(N91cf5@%>2Bs zJ)X>_9`VCTIP${LP)&9`8;ypcHzZ-;PknDVnoY@QJQ{hEU=$L6I2w)ve-ip698O2R z?@zoD3BB2D7>+|PB;$!6jK{OdkoY6D#ZylKK^O#TT@(<^CSEw4O#OgNW}|618U+*L z52s-edOO9W6vMXM&pqJ)1f~c`?G+AzCW6d!l44vaOO=WlYk7pAe{IU z)xJOTCd1K8?UC;X<8TuA3P`7(KMK_Z!kIT51`|)Mh3AKp$vBuP&{V7Cg=788AB7VD z-O)7kyrD+|Kb(w5=-@>HVl`@@kR1R?P! z-q@Q?XP#Psp{HgrBtbYFj=~`D6zC2;&!3FKfcWFlbUc~{6Q6|R@z|fuCKCmu!Fb|@ zK}d!{Fr3YXLvKX<&g2`~=d1_cB9F1pQI2nag1*Btt;!XVt z@x5>|_J*PFD^M@mEOs13BSS5~0F!N@?FdU8pHLP$l z@u#CP@%^Fi2gBibLZ+k9bQlC`u+vd6_55)NpbJYloDn}92BR>X4X0#08V*OZ&>NG` zSI2nl4W}dwC!yz$dU$6ocYtKHz5-Rxc+n!lF*w5qY)Vf<53W(qw7yc!N{9TCo?h(CZo^~N5Pl`p|7Sr3p^4`Rq{9( z6Mr%cMx)VGAzgnuQ*fn*r8ajmQEL&-CNqBm=WQGW{xlqi6A~(@n|V`pLroN{jz^;@ znT^6pFq!>xIQ5Ai__J|1osMQC90$Y6 z(4USJb_&Pi$;cm0$;=!3Q-$n^@6EiaAB_Bfgp=W9JPAB6RFhHbJs!`f-c?Kl4LxI+;!;WU4kOocIcn2I0^jheM(ucrx_Hvw#HNWE6PQ zaS$k+8Yo~76pV(!Bv7|?I30~1?EKO9i8W7tB0gjcKInjD3&z zlhG_3&1SQJjKbm2ANmTXtLsf|p-+Z>2s@BLvW!Duwp7|HkjF$sp=XzKZsU_yrecoL`sH6m)7!|`M?8~KibEh+ZI`#viuC`$~3#SC2Vl?vAT{@hNW}|5U28p3RR@bUed~Y~W zNMDgzYAU1I)SnVXj7&T=AL4t{X*ik%6OYUkEKQjL(cwg$li7@flW;r@C(~d?d{{tl zIu6Oyp9EnzolO)T4Z~sJds7k)J#{Vl3IgD!QTTz3{n6B)`U)c|MC?t5GlfS-s#4$q zjE2+EWH_9WG2s58!rq=Yn}(CIuc(RHaH7bGG4V$V;f9mpm`r?s7EC9KMDPM{tVl7R zC|FR}rMkjLzNf|&D!?5nMD0&j#XKIw|9`hOJW%3@2d6lS2d5Rs{^-r4FmOnWn<JOi}W#f#=<)2)x{Q zx5jqpFuIXaHP-iWfumj{?t_jO@mO=qt>6**v-FVxJ=orjzLa4q73UlwPHzfgf*P=v zj08+XtU(Zt3(~R=0#?8FWYxi+7lb#f@G}!%u}3MZJTXE$wB?DZQ(hpgjRhvSl3ZK< zvr=ih+FODU^K6?Wsg7@=BcmdGx2n6c9_m{0)}8otyU`wEAM{N~-no86T%^u5xC*R7^i1C2g1HX&dbrHCx zpe?6WM1rNhm4eB!f1g!;RwTAp>rL&}N}V$WSa@*GM1AcV(VvN6uFLE(siY-eVSK}>Seh>+F(?EyO7hB2D6ih9mvU9Spbr5v zY$R>W_QjwK-i;Ua@94!q2NQ3tO_|)N)Jp0KPs4gv{4my|$Mu)-*V1q#x3&(#ft-iA z?nXj1aqECE48hf_7Phh$C?OE>-4u9m8Gm`hWXf4a*AhwV8!zmy$oGiU?yz-1_^Hb1 zP?{r^t&plk$2yo-r}LOz4h2x^!V8RtX83GW{co%xgh2* zG0UEi7#C$-9HF@3;-J7tzxV9gXqgQl)-<|zyjY%W$f|!bSRnli-@RA69$eS~`9*wOX04 zw{eyo{djd_g(F6#^`G%NmC>7`XuG1ay&^VCFWG7?z}N9|MGms4z(o5%2IF5O2&3Oi zb#n22&vlK{TZxO5T_&GdN1vqt{IFLJUb!kK%en(zcc88v4maAGAwhghY7zH_ZJA_8 z2aV!l!?T?NN$uWDHVo?Pl5(JM(`wGDSWAq6-%JF~aSOfBKQ$NH_93jQQ)io;J7&?6 z^K-VLJ-;+Y|ID`KlkX+VviQ96G8|XYC#Wb&l!5f_n1Pxa4U=JT>*574GeLMG^ z$oR8uWa4(es&t<^(UH^FgkdY6z}C_4W#6GrAIPENBF-)zB^%cAcv6qQD9}54F6p^J z-Qc60Ive%JA@2sy#aTifF3uA5^;?_@>RiRCP+#x_OSSKE_5CR2lCR?}b=KyWV_^T+ zt0Qp2x`AVGm2&MCq}rF}_A4^urz<3hBA0Oi#r1QqsiW4MlXTvs2oa}@r1ZwDU&IRt z+RF&1)}jgp|7KTEO3iO#K+}BUxqf+qQGkbQrZY+h5zPTJT)=`^+5_br&!t{cB5|Qs zvAc*`WmN)P+qO!SGe4KG{Hho$7vq+4@KY5m_u(65%S}_ojdN0|C;#hJjn_}5q0Vcf zyuJ*UgS-93Uw3W_g!ARe>f~glZikbTJFZhYxV>}L5oTG_dWXRlaGpDNtGMDVj>v@R z)Q@}h0Iy{k-nn#-ZC$+Sb@irOh6lD|1M5ie_3gt8%dPvBL;~M@8JMuV=!<@q6)nHW z>GjRMzdkIq!|lqwuYxs=W1mZQ3I2YeFNtpo+ZX%W+NC4?G7w3!Ba+^nGpVY9Q)mc1 zotXql>P90;AO_2r*ocHy!1BJyW3-{LQAoKf!q4Nva8#S6vP^ zkUoxviFeRn`TPhweb#ppo_2p2=#X|8FD@0u7OV_`MqaeJ#zr9YdGDRf zb2HlRFk!CyN^0s~Lag&YuGA3#A1}ZXl7u2&I!aT7^$&wOoLZX5WSwmDoa2S_b0U}% zISOyDr9;5S5%7{}%~keeOk#C2Qm6k}(F1)X7S5b~+3}QR)aj>+pMLkKyu~8N!F^|b zw2S2hz3221UpR9e>clDY-o}^gEtiZs{e*mwu8ZP6b>3!fHbx@>1Wua z4|4GWVlp^5s>-P$mfg;e%JIFs*pnmAKl(8iNB(T$9eG{^{~i7C@|^=a{Zi7dSKxnt z&=};-4J!u!?jxD!&j&hiA}+}5?n+0mBzmcx-s8e}oBQ*MPRBzwBEMfz-}CPNc}4!X zqKMJouQ2`Ipc=E|2Vw0%L~y_49T)QMpI1>8UfcAk-41d+5N%NT^bp8Mif=%;_4^fh zVMdu^1Av904u0vRj1`(SL@~I`x9+eH@n)lT0#2f%`j0o8w;CyQ6f@`o3SPvSX{|{S zeYl9Tx=AQkHP~IUY!w&hO#Z~K>sSDmLdI*R8Odr!OSW3rA4|E4o|qQivQ)=2Oxt~S z)f{A1af{h7O+9AW|E#eM>u%1hp(KLd6lyQO3^XN&ZWJ*cNwP6P;{ekTp1t12Ttq#e z@a!#|K=r$gGgX>CLOPaF^n`TwPi`9*5r#fC6DS=UnNKQkVKz$E_}DJtx{dh*XF#dB zqaI80UXo{$e3j%Ad1d2veY~_f{x4Uy<`4jToBF67!Oi&@l9UnWu0oGU&^uQM<2)Bj zxhjdO{W4vF2v0H{=HTCkIy(Bqu8$N_IO5rnNaRt<&J|mfvdzC0hh?am3!Yho&0Mm9 zrc3{=s6H;vk8W$ugeCkpwkV&C&5-B$1Bq~+_daMXq;-e)@$%}`$mQXZt%v|gobL34 zB8onIs0ce*k{ODwfCvudr~0tSCV@%MJ0K^x?MmzMtCvr{tl7@E;|&5zDIX}NJkNd4 zA6lQzFZ)Essx;fM4N$@kWQ+JxW&iy4!;?2}UcLG7_|?k~zr26-?!kvQPaZsa_T+J0 z47;v$T~9G}m3t$L3IXiG1`w4G9JRtPb%5&C-5G*f2ZOGK-RgT@uVRCKnOkLg5b?m# zGA&D~*mWH#w+hXoH~$o71=G8Zg@8%}^u=NpNz>l()LkzC3Z*&vQ#*Vj!l(!toG zS>Xl5&bAMOEUDO3@erUI+OGPuY?iWzP_lRy9xupqSP@hmNXqKp#Hp`B2NS#66Fbnl zRaZ3XzR))+xk*{PIZ#~uf3Q($W23fA9wl?FSXs8vx;@LyERSf6cIc5@rYnWL75fAh zZ2#5P8kk23-J!+~m$)y*7`tu>$0SBcxsw^b*`hVJ_S|5P9<=vLLfvYJcDs^upYEwwphEzMt)i!kHYm&iHL}K!fTc6<8#{JXQ zGm2_}Ymi$C&+rl~5)50amYeio=V626|JB(oFF8goAo!iVF9+wBgG?9bWlW&07v&2} zYFB(D6_KMGEE>lQc=G5>|9!CC+OHKxXu1cgrxX|77@AjILO=#7@B?`&(L_di9qp^Q zSy~vOJ`GNQ1X&aalaG?3hlAH?a>+AB9<(Jsl0LM&h1%4`!z9_VSRmH@)L*~hR<$|8 zHp!`jcU1niX+6Wk$5B?eBfmW^``}2+UQ*)*5p3V}!eb&DZ7-cOF5>O>+8$Wd ze!K1Y!FW3+BL)TmAa(b*idmdZYk~hqwN)weG+w}E8xP{`wlM?C4lS-*0P0I!b{ixs zdM`oU7o2MIC|)bhI6I2P5m?zdxTKrlUB%ia@W-e1AS7TNbyQ39MqKU5a-|!{YSTyS zyer@;@hh&};(Vu)LNqHNa8_QzjX?)pXZscrj48VhGQE$>B%3kG<|kV1

F!`0r4@9kwf1pQx~@0nqnee_8`ZMXRAc!n7f4aKphKci%_2d9 zux8^pf->B7d0B>+Wz2;S%lTDOpP4dZcehA2Pswo9=#{W?H4Cz*2d^RY zy+qg$uo7)BktoI%&!;{Wk}AmNurkz>9gTw4V0Bp>+%vA*$)g>fhU$Gnp9N;KP6fJ+ zH;vVRZ;T?3dA+vhw4$O0r=e$Pd zx3MAIJ`i9+P{It3?Cy%*Lx!;H{&qDujJSz>A1^-9o7k3gHC0fnxqp<3gfqMP(N+P9 zVD*Y}TMl92qcnrN%HA{OsGyy1upg5T(vhu)<^l%AuaRmHp)G;8Yv^QGoQX1)N(|G ziS$kUz7H}!eZFyss1kM%*X11~&;OS6A$dnDl_T z>osKjDhDca$yNoaMYIy%)EQJ3q@lfK=fOcVQgf@Vg4~hx9b$q=pGbkppXSp{l)pCtNGVc{EVJ)%D(61p!~ zw&;#Tn3#T|KP9*>=~9WOls-|URaS=0(aqUKe}Sf%YP?WPc&kLI$(KmvkE?zEMIvb` z5e7^D&Wua_ep(Go4_8M>wi+#!e-#q{?dmW*uj%D)d5~4<5;~*_pltAoT~kV>@4D#M z#@n*=)#Za5YlLt9F3a57zQVvY^8G_LTsbs!#wA`zgd>RuH4xT9onK@rPioc@cp(su z1RmJHS=VC?Das$st6AhZv@6Wcz(ZPHSK49-`l}?IGN0U7XT$^*vqo(DT6qFdq`8$_ zs|;!_BqCdfs+muCb5^ZW*3y}Ti^A5SEJ_bs^^`;jj7DYMNDD!&z9I5y!;DRH86jP_ zGDV@~avflC*u>e{H`_=$MPYLbcq*l4ZLnv-5?FOnBq(3970z>{{(^7PFO~h4AQIpA zu%+k^{Z_qq24aSFBix>hP%}Y{aD~3RC)8M5Xph&kTpPXkqzvMgoSk(>17k27TjAF} zJz#54&JDnafenICNCU5X;? z&L3pgVtuHTZCMtWg55jcG1s0?DP@b2%s@C&m%SOxr$K341-l`{03IkCG7(vsbr>aU zS)b#Uy0wN(TwcIdL3Ih^f;>2-H;?)l3n(L3s-dm;HHa|)6Qx>PjSOXQ?1-dsCm`G~w& zVPXq3_V0O3om}i$f%WmsWB+1vqyi<0Tr0fSMagkg( zWO0f8piOvQK8!M zcb&_l@yKm3^^RY%WG}n7J4tqLWwP7dQdf`WQF6Ic$E>-`8kW9#5S<272)^WeRP`u@vTZ*JiY*>1jt|pTKnQ5=L z*2<4}a-Zr+T3KD^IT4SxeEq4rMk1cv-rPRj);Pdwam(TjORX&Opw5(OEV4^3qiwSO z)UH`&?nPI&QKjzebSE#Pz1YS3tShH0J!R`8-EeV!OT9Y3D|datw;NzmeoR2rOP2O5 zZI%T@i)PhVBoS1Y2Z);jlUUFjt$bV20>1;xQuB3tahtT2RCiId7sOma>ZiWAqP-|c zCTJqcOPbU_=|+(18inVH3_Un)-k*t3RO3w|EW4dV3=%;YCW&C}WCrPHXRY+JGp%+} zi6KQ(4oMkk%aZ@g?uePDmA4Uk82WijkVKGJkW7%DX(DPS?WJWJpoUc%dY-4rewR_1 z=S$1c!@i=$w4ysBGK=1zn&bs13)-sL7&)s?#6T246_skKQrB#)v77zvf~8C?*o_)W z1QMHX6Pwzha76=ZDV-U7lNK~|pkfYatd<_s#7I_xTOx>}EZ2!x#}aXjweZcVwHF;# zWTT4BeXT1xn$zW~^brjv^EU;_^urm8ZVIwaE)^Q6slL)73ZuzVny7x3o{kamU+yK~ z&?BcW`wl#Uo+W#+aqyfWQNbT?f?s8#u#2zN-4Ll$Gk~!GIb0fXb`B>t!?C=O*j=Un zldcGxA51A;cTcDw+5R+Jr~K4D7E&=`RmKDTY-DGrn3N^~FO$vQdcHWifH#U8i?0-# zi-hREn)}%xGg`2@omX1E5L8*RG$T8ZQ$T3YIy)hiRz{r|YsIy?tcKJ}7*^JjD_?Om5YJp!ao_e7(Q>5_g5|!oA%;0*Bw57|3or|oZFjJYii*?Zc<$Y& zOmWeM$z%lF?PvqdLm9-rAp>GmE|@*Fh~dG>lda+Wr*#kJV`?g-jY&e2&|Dv*&=EQOEO5YIVroaW_)hScQ zI7#FWW?WUq;Z|w<(cUPrR5NaGRDz3!0C1-Pq1>nnRUh6iW?0QmK&d9Fdg{=OLW0Dk z+~sN#Kq@5K!s<0$3xvs5Q1p6GA-2}zMuCa*;q{ZBAHVwW?t_ELPEg-B&j;M6&S#!+ znWWD*4oQ9LB-_oebxPt>Ctj}=tMz>2=!lQD;Eg&?J>Y&K(N5rkoQW>&HgK%ux{lMM z@XFYu^h&s{bE*}WE!E&!pTkb;A;c)OaNzh_t3&?DO7An3t}{9B8cGlKSe_p`>%kxl z+n?(8kw><|3e>$71-TR*Cdy3<<<~6DK&ZK9>LU6q+J0m5e93*1_$2jL^U{*Uv{9Po z8NGL-qmOF?)_KR%BEI>#wp}H!v``2!(({ep$El#sug~8;fA{Lm@%x{j|MLFH@$<(H zx$fMiQvu$I$d#Z@6glK=XDQ2=`byx^RNs>3KWPf^lI`Y$fwT{Nqaa{Ve*!Q+7vxK) zOjprt&Faxpgo#QrpsA7`2t`(&32EFCGcxIDLU5$p+v!!g+3jhMC5W_~u9z zFnRzydtYj&Ab}TEt)G)4)0L{QOOwxBG08YOgGUDRd{7+{syZZ>0%6yEBT(WKD-+`g z8EKo9Y6Nh|KmnKt7$Xdf%VOliAZzAHOkS7xyyEHaX_EzA$H8VGB}^nfCI?GV&n(g^ za)TpN{|IWSi7L{zUVr)&-JCPQQgsjYJRp4Qt)OZvNbiY2k}A9{2hFXbluE03o}(v1 zBX~i13s6+*b3p}pBT(v-=K^E$^Pm)Ll-wH7(*Ll>4dDD>;n@p;wzdzYM*z6b2Nhn_ z=n7R^%6&yJSp}&57WEW?jiM2VTgZZ+DX_GvRZ3u1+PvY_<19(n?14zc^<}cpwCcPX zM)g{(1_P;QLNiVZubsmaN2Os_Dj`29>R07QYHxZ{p}TS)7ivu+iHWS|^3GbOrwHe{ zDg%f0fws`@8Z`Ft4>58>qZ0 zU=ty)>g7Mgk=7aYi%x_|uHx*GKI7^f&p)fQ3PDv+Njh-W0Sc(7XGU&XsJe}&JI}Cv zh+b5p4^Rp4tY;gw;EXu+z#Uw?>r&dR8v9w;ud(Zt#gdiYJDu1Vqzo=nc19U-!0(2v z+-)4P(eK4N-k)E{T6-=!(ytLmGO10Vj=p>U=EZl>QHhM+zjt*?rhomMJ zJJi)6{7I6r&FffR*oKF!k%JDE)YxDb%Zoy*(AoZPs{UU$>7MK&-XvFVlEgx*PaBR$ zIuv5H6Uc{n@V2V$y396ulFckw{cf*4PhLLx`Ca5hksi52OwQW}PoG3iJN3~f!8d%sg=FcP?JSM1xOSSN z4euZ}<`2R$^k~R5ei&?$HOL9gpa!v&@%ln{j~6JRF<}t?3RmpsLou*dfYje=oiHii zfRlktJ~5%S1j&04eRXoa*akrmcVwuX2QJ8Rg>e)kdFucib=^SedF5Rru3D(nP492C z8wF5Yblvi+^vlKQ_cx03?@{`L>-O5LIk=27Q3>aKZX%spei!^Xr;mkJnJqwKmggoW z=3p=YBLXucO!h5HxQ08Wa=<@mdOo2ULMgpDjWhNr%OaFelu%YW{jC?nz%Rz7xXB|v zUV1B{;ZxO3v;gU_PJsueeIl)WO1k&yAt?6L0F2;(ReP5Xsvb#4QJ5@_Shcg|0u(?@ zcYt-%P4Po9=r}~02K)hd67N1og8TqT9CQ~9CmS(iKusL*U&^xbggMyO#`?kLmwU{0 z8{UmOR3URLy%ttVVp=#1Scm0j^x%{( zS9q{XcI1-N2d8kR$mja!Dg1h$Jw=5=kZ=9XUTe>!LQvmzRuT)kZH2ba!_Q=jZkEhU%>Nm&a=ySmv56~ zmtXF;lJB-GPj*b?iV{x5_Bv15-+P{_zSapmseh%;^5o=8;GLYvlauu1M4X(QtsL@} zQzt@BA3dNBT0|!&Cnw93lTCbl_Tc#G>c%JI!s&nQJBu8${;KQd%afC<<5j-=>%==g zIr%aapI_)69?z*9E6uAC#zNN^wB%& zoSZCSGZtZ#Jb3%InR{|F zsPo@F_@SArv-0KLmCAnb?%kWH)$u!Q=%IFo8t0>D&tJ4g6Cr@~GoEHL-^Q8Dg}hMz zAFB_1jNtt|PtJ}NJ!pW^tQq^vM4oImIYP_+@hZpYIWxUh%$z@0c=zu}$_U5t4n8?b)gJ^cF_-u-M=Exy-kEO7#qzlR%5; z_~c}R7ch2fWN1N`e;u##J7$ap`NZkHXYXFVxO0z_SDfBcV}u~11{dXOWO2&k{B$p6 zBCsm>LKVC?*{I(?tKZANZdU!1o0IJB$x?F=M<-YJ$V=1UztB=4gg(yE$yFccCxbEp z-?>L#b9!&t|Ig|kdD?`ze?U3N#yQv=mB(%5%&6miar&%!qdp#wM&Y>P+wvT-``*I1 zS3gUW%SR>@DuRN2hNG@b_Wk$1mybrlY)pJF2wj$s#$n*8tN$UV_s~)yzc2n7;J^H@ zZ)5xirB8LbC?ar2+GqG_BZDjSi^aAnVl%8sQ#gSDL-*hPRxHedUd)9^R@P3j=oMD=(j4iG!nGctdFOkvCsq#geJ5 zT+KPELqYmd1MgKwvlW=nqs zg=SPWsJ#hoC^#iF%*w;-=NsF{7WB3mz^g!ImSR-yH<$?R+=-u|wdN4#t;&p%YZvBoQCO<(icEBEglNlTQ3^IT%h(L5di?Vjfd#d`N2ln(Zh z!#57biEQ6CDIF7(uUb7&HX{t_4LeZYWVaHXV{^R30-Y=6CMe)MWA%2d4^Qd_HbNiK9lqHr?AG&eVH~C0#0t>3+H`Hs(wbtS zj!?CAu8TMY1i2JWebUW;~K7&K=j z_eP9v0r(^ zn#XmSYQS~c4{tx`EJ-gNuIjPIf@HB23MJ<3PRXYP`*r8E3I<0qCF(l9|)SQ{R~wj`klApBXxS->$+K7 zmx0%uXX1#9qsR2)AlvVDNece+KMMMBz_Z_9zUZ>h2gTcL7q8j-H_t&d-6RR}oZ+@m z+kjH#Q>aaoGv`crkDF(OVfJ8PX8)*h4V zqTdBY&*JN?DE93b)feXf{}vga>uFLwc-rSy$N(h8DXZ`PR0(7T{5G zsTV-azSn&;kaM>=k8VxXmq8bl()yI`dgs)hCvxT zf82R^%gg>LCy#3%ZJi5vNH}SPNZy0`d$R}QUZ@MA+61`k{!#jTLhO({XBaP*Y!xk6 z1&;m?=EFLJmo}%TFQ~&bJ#9;WnN<%4|5po9YMGIgBwdT4u59fs4hfpvGD0vEE=N`p z{L5qoZ)GW!9RS2Iu;vL(4OjlZ>%q`&%T-a}ay{NX_jS4>uNh&mK)*ncI?WUU;%iq^++PdVX)T2g zR3`*W)ooAD7{UfIt8e7okB|6GxdoN(5>5bmI5-@9E_49Zb4zvt_frzvy@0t*UFlb$>DJjkCP_*PRuu zUrN5qPn;8w+;_HGj-_rZ&#SiTN0~*W{qGy`_ie55&3~v_gw6*4Lmf;|2SWrRYX{>N zkEEG?DJowk3zwG~K zbxY-wlan(ClX`Ql2R=n{v>=-O1MGql*LU9?Rs6$u<*z0zcjjw2y=MdJ{1*1s?B={J zvQT)zA&!3Q?AX-q-G6)=w83s~I!{5p$My4}gGm6I)gAlG1WdE5sVa{+QMnurCWm;V zTD6{cdq;H(|8-AY?c62N7aK6h;BKTK0xKNYQe2=vmrM<(zl$gxQ=`Bwk(|I$Oor1 z9lSiHNVZdrw$W|#k9?fxy~l$rN#$dvcv`m69#Ok%fK)~-7^Tnhyfp+$6Am)=gcF7r z$9^QCn7qB1#0x+ARV=PK`c)8ykM$3UBQF}dLbc&{?GUqdP|TvvZ7+_tI0^_x>ocZH zwjvoVO<>bJ?V`P+CbkuxU&>Oh-D5n@d#psk`0!~$9mhJLW{m~4cWja8 z9k^3LVTobP3ss#^VUOya#}X=UIg%i#uXG+iB1xVZML1R|!l`8_kxl2qbsa?zMd`H> z-1y!42y&KI6W^|^VVX8%(X#nIvm#)Gd1hA2E=pQO@j|Ny_Wlq!dQzz+_b7d`5Rokg z%JbeIV$l*TNI+X1thdxWXSQQ&e#Y5mVfarI4)f!HW$SpyI-_m&9S64_c%TNv|8007 zYAd_Hy%sY5a-<^)AMHiT*2%fxU)kn}ec7cZV2ZZrAs+{O!T;W~w@KRJl92$@q%jAa zX@ycA4>nA)wS2taZTUKuEF-@{vci>br6Ni|p09Nm6m_C9&;`fjjxbR}BxQ!{gqvfT z>IWWC#s)FR8y*~L_gd;a`xRXNDzy7UR*sqA1A1d!Qog0XqUxWPAdRqPxS~k?o9Apfgnvh?Jhu;)DXQ2`fWtt)S%fR< zr~|SLSMV4}YE_&eE{sOnH^bDCN_9EXbtkJnTTTxOMCy<0wmK|I?Ypj{(^I{>u3DQC z(%$d^EP;8-R*mRbd@!GdDoUFx9tqcdXKpy~`yeTj^f!Tox@iDQmYUHHc1TIOA4_~( zSrEg{c&cTuUPQ&`tL}uAVsBT7aiJhu!_d12KOD~SKm^;|JTqw>Fw>%CYo)286BMeK zA^Vl6*|d?tYK6+faqY|ZWm}a^w!<)&+MlfNXzjrK4hCW8p0|vgYeOcr4IRjBUCZCB zk4D&tTcpoz$+LO*fFSA)m{2#5?=4Z%LDsFwfu<`_Fr;D&#o;MBJL-u%N35^#x}%d6 z=}mc5mRPVJeEwxVc^UAhc8Cx;ck9fCa=yyDQ|Fb?bj&Sdb{-j|p@{MO2+&0ZM^Csy ziJ(S-8?ENL3cSWq$`z4TLTcG~--qV=&anfq+d?*HL{Tc|B| z+c=YU`tcBxYw8%CSODg7dDV?~t{3QX(V-01YgjxTIJ+=`nQA>N`ng9>7mjt~IUQHP zy2*@e>Gka=h3sfg(aqQ7g7$oMb+6%u{%q)p&0PP8DVxVMUT*Yj!1W@&{pf8YAL7ci zXyKke-_s3s60yBjt90hNy}j!;W>Zv0pP!*UU7jx1)`cIf2Ws)*_llgl?oJQxf})Hf zPEkrxLQzcDc$xB5o}(DlLv9L;m$4zpoKzPKo@kkXwHrOpUo}0z*_Er{$V2OhWN&o_h8F=jV;gfUcY~l z=V+(u!r0^g)wp4OE>@Vt@Wz7YCGJ8O$MjNx+j*W}{D00V^}ucH#l7>Q=(u-DQr^5V zeLvU%siq@KzaL~wYGNo`wx(v$5YAp0JqWfr()Bg1UmkXt*CIv^2pVYjr>IWxB$Zh6sEWxa&Su4S8CFHCBY7UYY1dBr^K@ z@Y$wz0hZCfyHv!g^~hj7T9eS%Q#p~8Bs4390GuqJ{X|jx0nn;QDgyIzi zOT7bxSqdqDnjsnDM!Y~$Odt_Hd#Q%&qQK-L&Kk4)miCfi*efS4s(#6*-_nSrvP}{n zwyUnW2CtLnU$sVIdBaH<>oykWjehDGKPX8+APa5*TBu(-6%pU0&B)fc1a@_K=eY;UYn7vGxT=e*3%+IGVaL|#Y-_&ZS~gl> zBIER&$qv$w^T9UJPCZ@M`cQ}Q!g6pRE29TZ+-wT)+|)^sQc8ap1p#xj+X_4bk4~Ri ztzgu9ruuveHfnkO8!2qt>mePiRW0O2%FgoqKWrf5Q_$PP1u@SR(H)L@J|^Xp1$=v$ zn0K*GlDr#-m&CY!KhnywiaaUJ>vBgwLRnem`(;7OU)|)ot>@QJ+AFKUq=>PRs9R;1 zJ9*t`^1l)R@H13H#r<(jd{m?b(PQWsZLhi+2GBcrw7vkps9ke=QR*C5i;4>ZE7(=~ zRaa?k8ub6;Mmf5bI>v9FTS>AYU?bI`j#)KwTW_xGsJeFaU=slrHsbv7jS(x(#H!P@ zOfce!Klx$E#HF_a9M{UW#GXre?5i^D?{WCp6Njx?MyGReU(Q9J z2AH*#GFX90ve|sAy8jQ=w+B-pqOQ+rIaYaJEMz3+-hFy}%;#leywTYCf7zIr_xt?5 z>~5tfa0TH)UQi3(|0XwSyx~dI^ECcAO}?n#XMD@l-(8$#S4p~2zxic+uAQsYq|`I9 z>I#APzk@mrY?_Tn&&;C)D5TzG`_oG<)hJSyG5M`g9J*Zjug@2<4p{Rv*`pKX=t`~I zKbn!N!4B!B9j&&qesY{DPA%_Kwv;O^#-1N4y|Wa>q z)uX2+qy6Ua;AIS@lo>vQ)qDnP@ENK74URVVuDkyRJYwB%p0jyrtAjXAmmAFQ!Z>mrO& zg>O82OoXZQE>tl!5yl)x(CJQuFp6DWap6vL+x zQGyA)^ukA0^9ivP_dP`y9h!%+=If_UfMvmE~mCl;!#D%j%J|Dm&-*(>d?=F&M)w`Kmq$N1{MydG6eGNUiO+ zSc+97fV0`s-bJ4GnCqS`){#ijTJilbK(eFfi_Z#X7Z=ec&o3d8n~b&!aL!%#9Bs)? zm%PMUZ&RdbNA{RpqLeIGI?oE-3PwmMrs*;P-f6eoFO!vGpSI>#jInlr4C0exn-P}$$XTkz*mx*d;{#m;?-vMg~=0Qn{Zm+HQos@oF0G}G;C^KVZ%T)7sDU8mD zLUu4!&}P_`4^|sewvD45CZ88(1d{9s$5CZICCLsKxcGzD;c#iGHJsI#UxO_NG4LOp z{3htf%12JO_s524Zc_=B`5D?&PVN?7w5gu#=0=oOg5mo?^$s(SjifC(;^Ii1AjIhx zW5*a{hy~=jD5kM#jn~GhIL~8D%J~0uxx$LW>-hw6`k`*Z_%SqAR>W-Ljd?jG;NqIM z?Msh9+pX@ldNt50y=v&VQp9daG!hJtk8k)gS=poLDG1b_$d}0qd?fxiV@rs6^N;u~ zLjvszfwd&9+JRCQ6UB?_eFjGx1$~tRb`KZiZ?)s=XVgNdPLn*hvQ+OR zqshXL084k-paUDq3lbB>A#S=09sBpMIRrE<3$E$%7AXs(y+mzWp35GkKY^wY;#A@q z`R$_(Hnj*ZAC*`0?0yPY2FMc{GtA5k@tQ7Kie!q`m`J>;?_F6PV5_(tXaQ0UpkR=d zmOIk#XLE5sb=_X0PhlDXk24kNl_LLs=DKl7Uj^NIwT=$ANBf z;oNm1$0;!GvZKuI3)kINO=ddwy&B#Ycq;?jWg?K0xLB7y&MWX%11vzwr)RrJqXg?x zF`gp@pNJ83NfUBPz5D1hO-pzr*VMazS<|EKi?i||t&tq{$c8!|JTSQKaz(c40PN^b zf?TK@^xAc6Eq|o$!4#7-8uLEYJmYTRM=xV}F-T*vNiGr2^MOy!>4hC|Jat|4lb}YE zE6-Cr-}K-aMN=Fop%;qsns54jxU#NYHz^+}JR+q7E5M6IpKi#h>#70o zt1-bbgmz59DDhTkacum%DAR*T`)A9`*SZ8*mBt-1`ixTtP8PPUjR zkcOaX+e+oqzrXK)uD)z#6vQjoDJMsM5_E^jx*(^Ezd7PKQYg97cc84ONHy}Ks5BuC z;N`$CKvy7d=DLimX^*?ELXLD(^^@n?o}%;-ph*06iQCmm1@}=x*NWa=TTj)v*5`Ge zKL)=FF-?}C=jFMy<|vfe>)m*WK^%9Xf$Rk6GVY~T^T zVSi5Q^PH4doaXc@ci@`ndcy~{Tbt6Nec?rkCFKV)AX%m>Vk5GQ#%30px7t%Z2}P2_ zHN5}kTuS@-q`YNrv7^`4`AJEMrNmd$t95;U;V8lS20rjR0Ys`OEzHp-&;M4iv&I;4 zttCbT>B&6*Cu4ph3Sz58(Ug~#)ef$-qKu|7*ruhN9I98*UJpF6AxxSIskhkX`QOm& z{f41=hq*w-i~l!P1OL({0uCn5zqHt-7J#-yaH@hL*z)`*t_5;Ah>tHAKfjRq72n7U z=OD0wrkc8q`y_G7XYH2Ee&I&}Zdr34D4+jV69rMrJ#BttO|5B?0Ov(pq&WYu3c6^u z45nu1tX=n?#ZmRjlvci=I(FNp8l8&Pm};v6GpsBA&3(|~@TFWWTFd^wQi(LdlTyn0 zK>I13e;kP9Q6kQ^d@VbC?N$XTr5_dksJ_z_laB>?F)(fl7u7HNF{+DwBuPrQ3_U7y zF+p)!MRGnA03XGvse4;^)g%Q{Dr1cSSJh~ek~lrkAWjaFtWs8Pp^_{AmW|7eI=Tl( z^|q8N`eksH#ybQbnpjTtz>r>P=!0Y_jZ-Uzd(*g3O%JGmmIvM6DtH5i0`X>MbI`!_C0+@wddMf~G?Z89O zOsg~*Me79L2)bMu;eoXbg4!`w52EjYb~(hk*U_@{4NPUFK2&+@=roOgdwqGDY+YCX z9dOCg7_`z6U$)X}0rg#^X+#q-{U|v*68Ku(8zAwwgAb)u^kGHX{=}}S^FfCkclwD$ zQ(ROBYoFHA4x%+x>sQ=r0jjWO3@^YV^|H}C1RrjvQ3=vgiNP~z#;V}fCK7PjS0!pz z>nTi>@TONbO6ikDqf*rF&2`%;OSvk8Nw-5A*L@p*GD4k9#h5;E-JY866L`=Qo%4E9 z#h2TpAphB?WSvsKKD*nr;X0OQKSPKX#0C(!@%2TV=^!ojr=ni1@JYM0CX;KUap}5Z zfxr)0&nF$eBK8tF?L>z#T$w6Bi~r~^!s!DOjxhcH=As@+74NDZrlXFX2sLHDdHkh6AKY&-I{!2sEH}qKDTLt% zeGUUhn-qNbOH4RLVxU6~=Xv$BF`DzVjy5HU4g)vf8~UYuTG$|!Vr+&Nj`;x-&78jssTU=QVzB5Ss^p+eaYya9Dj->5eA7yyJrAxk)O*bkt5{;3=idF_bYpn1 z-X@vWAgJ=|g{k&WpE$K$=1S!FMlvJ#tFK`)Cj4#qb zW6Ps-U~ej{LTRN2s5P!*K*n}@W@2W78VHKJ!>pUR!J8{Y?#o;^E}76wF`;pFAj&{S zsykxPSy~hpAtlgb=1#U!P-xRg)vBGqvtQrnmjq!VTRhnT?4t$X6soAdig<=xeF zTjQPg`yAVtJy~)^-_H@F=czh>0vs>ew|oGy8*O!7C+B&y26| z6T5bZvzF;r|AK|rKQEb#^)I78L7b}#zP@mXQ_sXHVJ~wO)YSwiVc)*&8H8-H!=lhH z10bbi0Za;!1-TR50CjJq*%kq3;WUK>C|7qd(WY-kVy7iaM-JAJgyABwRa`nF-kqld zO;?nGg-cu=31YBV#EChJQCeufZAC#YE#~+%B{xk4MvHhpP0`IIlNZS*a(;O7&LR7B z8!@A&mPN9_1=*={ah<~7AK$+E`4&}KEo)VmZyC{C8!@b?qj+!={`}s@Ol{sZpe3rB z8)zFBes&EZBXFU{@H9yex-l1s=KdtcoXYAgr`HIsTyed5?l^N!zYIRH>kLUv3vv^- zgm+yJb`Ois68!q8fBOz~`ky6|OSZyADGziVg;bEW!~b$ffFT%1qCrU8`KQELR34s| zDd7v0EF9N~RC1q3jzf^3+8a)fQn3&bQ_M3s{S=YotSSj)K`J%eTHaCB{G5U^a?Ne1 zgesiJ;P;m=o=LfT!~Wj0Oy>Cm&?Nm`uUt*IpIS)y(*S}TAkg$>S4cI8k@NEH?=N2j z(BQjwuLt44t36nWL9$~4v4IAyJlC+r2K#hNdTfwgi**$rnGFoIwF8t6GA7MHpFs)K z5?^UjSqu`9vUqb1F+|r8as41}+k6N#7Lk?+&3BKqH@5V}w2WwGFre=YNL>g%*F@Z}=??Sf0T<(X6`>Umd3s>#L8Mas^i zM=7ecyHj?Ci4N}-RjK;Bh;;cz;oHg<=M+d4E52NcN{skC zMHm)${&U)cNIpNO5JpyAp|9G(?IkXZ#N~BL9qsW5uJ`)5)xA7T4}wfKPVT&m#FBUc zx3Y!39;a2%;d-=}Cgyy<*O9JOPH(luzZhA5um-si-C96`%EU6EIlrR{T}_>TB(26(Iw?Y%C3%Lam2o?nKs@a zH_%8F7lsM`@0-2cXY%M2WYj>{R{dB$FzelYm|B+ZrNSu#E9=@CSdmfqzPE53{iao= z|4XOa5w9hV#C@rXHd2WlANL1aa;X68lRB0mqBvLwHQ9C_&bTo$5hiQU(>4<>`c<{EbE}5yG+mJWr{H-_R7TB#Umj45xiPkwJzf9Lh}Q<9_fKww&ucG z)$`m`SNAoByV1ksRoWDKcRcv1n@^4TRe9W~r*GB*o~xoyDN)RLDilbt_itVt@V3A^ zS9EH*d{0wUA|l$7Gb{wcksv)^9k)!zseGMmw=9j`q^ir`xY#6DFAP{k&r<^ALuAo1 zKmZgvOev6E(c6@C(tJ?|VPBE$One@^{_U~ivj~ zi(|jx?ZQ!{GhWzabi|@_>sI_k>OC=sQCtpa2ctRWKr`@66) z5TsaT=XBq7@0ThO^Nfu>JiDl2|G**U*V`EQYzQd2Cx&G(J|wXqsy0A|!)|?IYlEk7 zGs>uHTpu-o0i zaBev3Y}+1C`MavIgF%0(n_%#%g8fp44dXKY0+57gFyO^=`aHgO9*jGb0PvbM=>He% zFe)Hu=aJKLjc`Pd3b`(UL^|ddEQ=PHC7T+p6xOZ?XLl__1v^*O7L*~=F*dr9>A0H0 zg?`7rLYESrt!W`+Yrmjo8y%KzmE5Fbyk^Hb7iMImyMdcTtWobaXBZ5DYDXXZ`;@Aj zUwnvby(+%~3=MtoA>QHL2Xx@cG(4Ihc*QgFGjKH@tR*$f#+W63Cz$v0U~us7@#f+~ zF&u9$TqSj)7r@c+mHOt*z4||v3)2Tm*!O&-zW4C5<36FYIX|Fyr1T$gKruU@I2PZ_ z5&u3%`nUQ%AF=NxI-o{ls{$a4SONbXbfd_zjC0KO0|kCDgfI**cu*N}{nrdMOY}cL ziaJ)<%pFVMznejpm>*TG4>F5YpAb>6VzZUFSk*ubxvpeLsEmUxjNlb^tQz5Z2ZC@{ zx6MQ>*PICzWN3t&45_Okm$9e|mJ+Nx^5jS=B~OV-l-o|=JjwNcVw2~#uc1bf+|%n~ z214_WEQP-C?m{bGv89^9sKWERGd@PB9&2R=*|aNFwt*PhlPc3LI|a%#YqtZt4ti9? zHhyFZL2h!C?N=kEDR`uh^bM+-8_UnJIknz3XW9h*Vuz{`Xj0n7H&a&W{;m%+pJa3C z<2l8}!Xpc?@99u{Ukr1szNbU}eKC}Q@$7MUWs(#9HMipk-2-{13pOL@`oGYJ1N2?Y zCkxYkF&{5{A9Seg<9xiR{OUGiPnsi+-AI$>_+kb0$4Xj>6(J(ry%qwp;-p!KV9F3sKPQdk7SdlF(lDhG|Z-qoJvi(u96i$ zj<72cZ%>O=%CHq{q*>kY&tAy$T5mfvkAQHB7O_#FLqWSQVPiVZqzVQOm~Cshnwk1Y zH1t&qVwrPw_0U#)#tW`w{wPZy#HhlY+?PopO`IJwql4Cx{d{I@L)ZKaz#EQacA2&W zw*q;Q&^EHjLnBRKM(Murx2jNjnkP=290vdZJ)Wo&CPIa7&r>PNrGBR!m+SRq?>v`^ z8Ti}?RSgQwXMot=dCnCVE0Z<_KwZZWuZ8$N&jZTWEbA!=`D_jPvtaod%X?)39Gw@h z-}IQsHj)dK_M%~q@X>#gJ2*McTNADq*C|suUl!rwI)eqJSdy`$auxsin!zdDyRmIe z4MUY~!Hun|Z2f-@eW`UXTPi(0W7DlzOfNEGE5rOz_0@C1m0^Ee&JqNUcI!c@aHQF#M~7Ltbwn#9diQJc`lLw6arH%N5Mr< zRrp1_+R&DyhS~+66y80brWK10P+b7cf7&D&>O-B)O|qxFP{!E5p>7@mLm6!MDL<@X zLxw|S`5J1@7lGD|p?!LhAy{$}G}OtLf0UNkBhcSgjQB~pR za!ey$+w%0_fC%jo?|V%nzWDvhdyqCD*Q~6?NYAGQ*l?8 zLRoyN^@|N%a&-xxYj*K4m*?*H>yw;|&+sLMdS|Hi{ur;hV88e;Sr;JljOFIX=7fqu z|2*fJJcnO@ftE4+lJXSJ=$CsdxBXIY*(W)%ij{Lst!T(-Gjk(6G*)0!Mz)o8v^SpS z^>WCEL$nn{&GW@nhRoD7LQ_seL-Huml!0+TD101FYFEunzp1AWtS5T>Am|XqtW!_X zxgw1Egv844bFl9sAjnVgHotT8&fUCc-XZsIhty}5{Rz=-bi zQ+;Jnp&|p;F`D!V;i&dj?;4UfMt~zUrAeVK*RXLtz=*;*j)F4lMekBCi{cHtP(u<; z;gr$Dq!oSVmoC*@EPTZ*D8y5k$DVj8nCd|uO{S<})H~Z{p$gv%mlV0< zx6or2quJIyY_DRih40wiZd^Zlzmnk>`@kOiXRbB7wIy9sfMHj(-q^;7&ldXC%=U#{ z;XATJNAI2l!9p%U7fA+JEO2^$CSou!ES{eUw+?iNj-hi%#L&HJU9zEN{u~lMv=8Cn z1@=$|5OiL=s`EuSQgRdF$l5|jrr4H*Rn6Ig7^n(aip*({;(!7B*3g4@T7H-Ix{d{5 z)+6N90}OnL1#*lxa3N_}nZR-Nyi9vtd%o#z*Z)n%0=3-t*i)b~mVCl+BT)h+Y69vZ z@R`zwG6qKICmGjMh_JFRzU`o+^@*7c>u!aee7H+=aSQn5lo(i9Sms|tT= z?C6IfT>ujG+T_x3YVBcig%@F6c7T+u27^g$wiYXcVDOhjSk1=^z4vqml$!r~F7*FI zIe*=zJg`6rBUM=5&vcoXSU8hW6r{)3)qvvcf1*bCs_($FcHv!x^#Bp~h zuf5gQf;h9qA40E+Jk+pZHFlrb+^tUUc2`)fFf>KZu)#=TLX!qSywn|e+;ND4+9*Gc z4GxZXF{KD-PqmynJw%~T^4;zZ=HwIbpP9j0whrQALAI9Z+mJf(fai^s+}QZv+wpJY z#MEK6IM6I@u9ws0J90jIuj9B_fsIOfD0w8&*P5`ZDMnYqghvVtLZ znK`QPllHOXB$@WkaST$k!}PC10J+%c0CN{v-l`7B%~fRi+QGvAO*TeWufL;}qW_+sH(ovHW-~&xiHT z--F-peVIHMrariIf?C1fWj_=Z)|qioX7Ky{0!L@O;74l~p&3tIH)_EmA%yOB^_5Hq zgWseXk3#?V!x1ED4hrE3EegI8EPK6{uv@}e4$=n8=npTc{SulqUp@7>&vv_r3;h%_ z_$3)HHfwr0doPpcFP`5|9fD9j5XcWc3r1OIxbx!8FI^dQ-0%AlCe!=~;^YxVd#~gy2?w2shwV88BeLygv9u&!{a8gT47o8TO+73uASmFGBrK zA1MvY{{SOLKj5)w`&||dx+`QPGFpqA+d9%fgXkR%cX0#d$A!iyxK^4MNu9nC?3VDu z0It@7+FIpGxXLX{gT@crrxBX!D_!ci8xr(mD6vTE8PIE@THNAn8|Hj0|)bLwV`=G@YDI$KH(^KZ{*l;fjjMM~ez&(@4 zz%Wqc52G*vWL%#Rdm8L^Pb~j#Yu(!FbHyxLa~r#xJa`t>*D~DhHm0fzcy9}^4@YxH zHwv(~wxJqa0q*_{Ri2t#2u`2+o;C-^V`(jyL2t%^v4Le*%>ckyxe|IwWJ4MAxiupMd%fIvaF1r=ADY zhpyM~&^pL;Kj3IW*D)tI3`wl-B-5<}gsmY89}M*M{?Po(?PFKaSYVD-Sb;7jCpxf# zIqK9%aQyfy6&64p-$>FKaVrH5GV}J;Bm!tzAk0AbLLV82WW3w4dc^vZs`fcmt8LK+ z(QR;kN#hnq2e=?t+{>jMuFMQqVU|K`n7w-~Sj~@RoFN=by?ZiD5i&bRUya6rCmCaD z!hRnNWVo;5()RslN6#9y__7xNTLq5ND6R@TF!NPfRT++54B^Oz9vT8$XEaTLq$bWLF|C1&&=`dE zGAnV0i(r6Z^mS0j1XCJfaWTKV%^8;K!6swOi9dmU=JnX-L%-ZcE*KkyC6Z$wMRH_9 z54j!Nd_;sf$wm-iqK8EIOhW=sYcqu051|~or9R?r$=e~6F8PQ^WJ3?R8$xMngrp|U zCNY)TAruHV&8qC%?#?CnXy=2$Lly>3`Hao#?^xm-rM2>uPx^i+vHSh|Fh^;qVWlTA zRIC~j8BjC@ZN916dr#=cY<(ahclwAag1O~34i1?&WP2ms9&?es$nOH_*Kq0t#{CX6 z=!6&PJ78+*^fl4=uI5;(8XXLfr_4teMgZCZLfZ*1&|Zw1JC4tAxPX!>!(qgRS>N^> z5wsG#Mhu4vIj;Q)2iy?%-1yWr8L-q+vxm+D>f=NbjggT#L;<9H<2Fa zS=|xvZp=(sK@FyFG|TR;X;Cx=uvXA4h6jHO9^#d>a8Z>9;rVYC|2ZuFgciQ+cA?hM zcYhpcbcSneFo^#~wcru_c3n3>LMXXft^cdNi)|IN&oX@_QP9<8qmFA=1ppA3jbR>G zZ^DqQRejbWa>ec}gF>6P1f%R#wcOnU&q2QnAAe~Owj1OF=Rk+8{G zcS~(Vqp2=zUu&i{zr=1UeY%8f)A0g#c1g_MnTirF3YM!o>{#Y37ASS$en7#d*tVzU zbUK>OCZCTN(++-d-MM;y!L@D4SUQzIV2_Ri|S@*9^ zy~-Q<2n?mx#squhvZezqn{6rvgMP6G(+Vg_2FzNJdjLL02zj{MsllK#bqyjD+}7`6 zeHO7VjhzD(vjuo}(=?EM^#xr*dzYo|Unq!5-QuyLW~+6}h9LDe18rF2f3I|4ptlP* zn!e4lkBz^;YnNk_uG1+X7qaWp76AZ6Q&1o26%)h2$x9ejW(X}swl&JLaS_JX*;5X_ z=5bLTshk;)V0BL|3MBYCfsl`i(L9sqf&i1I!tc(LXQcv#!WTzI{javo73@4NRUEZb zL&)d@Ty))A=pxZB7kRC6-+%6isff?Z46tRh2vY} zF`9Pu1FSTCRzTQux!m?_4hUxC=PkTzVd!a=xxN)~k|fM-zHk6N7GkR)RJpdeE&H(! zsH)pXp@vz2S>fvVDB*mmA^uq)$;?>Jjytsb!kiUmMlG=+FO z2Lh~ktSQPU^IT$heTGjq_wupqQR+r>(OQ-AC( ziy91_RdDKT*GyR=Heu^m?AYE1@Z0SB{Sb?7&WNU)EZpO6*SD9O@j+tWQ1%2;2=`-U z$-S^04WAkJr{O7S8V^UL+Ji%mnT{~%&BA~NGvtU8(^iAuOhXqry3cRmiApBpn?L%6 zlu=V942eEVJF07N6e_vD2p&>fUjP2xW zb7@E5-|y-KztG}@nN)xbM8#!1Klrz)^TWZ1gBV)%Awjb^E{h3*Uv#tCopHK@xZN@n zJIPLWLY|eyh;F#~h2jrMOv@cBcPn|eJ1LHqyH6W|(CmXT$^VdWdE)>#YMYNo|5|MS zSt;}5$7+;GHA0YnRF{_1(~T*S%iX8VXp_rqXPQShn_?r?hh!;FTcw{!b<8hDvD_3p zy4j$Ssc!h+tmB(Y85Np#Tz*IjC3CuBACi@nt2Lt=Uf6;c-GIYDq3HKcy?R%)TOYVq z1+y@43{4GDDal2$rn;bHL)D4USGv_2K8Qf%DcyJCw1_b$+he|FI&peooSeiI0T_t@ zvoPv0TdZ6zi4X?Zu5?=k)`111`SPTG@ACu_k-zfTM~09{`t$)m=swH%kiQ@iC?B?rQeXK;Qw7@(ZPD6OcGiyD;ccpeoe^w#7i zK;_aO{`sT%ar4$sQP)!J_l23ZIa^f7paXKD*ed7hlBi)ciiWWwE|FT`dUXOarBm-e zSm9_G0P-Dt)FB5EN)^I;_7J%&3UdrcIHE#|%Trkv5eocFyu({SmdtYSv#ruqZdoLn zW=wyPc*PWO|I(+@^CHvR(z8@s@U~`5BeNO;hhds@f2S|feN$85ry9NlO5M+pt@_`n z;&WYv`-wp&nO&xzOfN&Mjr5D@xRX?-k0k~z)PgNdz!S*y8e|!UGnU?v*ehZEX0(&i zoMQJbOp6J2TASqr8!^Zuq2zCzou>uGfi_3VXazv6cA5fjAgesNf!`!I%u#bj@e%FN z)$Yf!B44}iP-y!Cz;54m|20fzupocro>kM24S+t{?T#skU@mD(6^`^L^?A#2Zq;s< zMG;}SuY)sfAJzcDw*^?#3gP|{jpHRT5V!X1ULr?+Af!%mc@D-_pbk5=e!rcM{eush zr1iK8WxhtUJe3yg9x(n2@=c0F*J%mQ#|vDN@T9TgiKmigfJ<#X z_#B~WW>V%jOLDd*5wMqv6UJ18GlM&7#^aR6nL+>6Cu&wXrME(P+A8K(>r$b8g4dd4 zhCId?;a_CTjWP~2OkxfiQ^zcRS~HJmaVeJ3g7n9Kw{4VgIQRjcP3@cCyi4i>GX{r(PBm~a&?LETWy2fR z^$2d2fASQK@t_Ew)0kQ;XN54eck$ZYGFzj1x~%Ydd&@cXp8jO|k{PgcmPn!JGGq<) z$9+OL=qmKbSXh6|1_N0N(67HXx!Yu+r7#!)SByLv4ce^VL ztzr0TDz&f27wLpui2IwD*h^ z1zmw@)E-FuFzOxW^3)g)JOE}0Ah%(M-tDjgB79n`(ugiUM;3&cDw(IzsVV%aT&-9h zRUl!!-)#B?jc-#FKcWWE@)6xbG~K6&k$OtkMe_m^iijIT+|0)Zb+ONzm|z56^Y+8r^Z6; zLUe_1cPz*$czYmrG6sW}EdEI6%6dE<4C)Un=z2xTw!)wHmcT1$!nW%4;&%7R{d$fiqyD0-lne zxoM~~j-OL9U*KnSA2Rq%Gb8y^hzkn;qrD%Tw zT^F6G)Ah|I6=&3z)LC!afG;{QtF$oOf+S<0ke?rH*5!(e;vgEb1({%-l8F^vu@T*D zMkPN0AjaYVn67*|x*}s`{0|!DVEyoS8ac2bBuO7m^S?2ic1^kp+7Q%@-vET!yO8c8VvkzVRjj2Hh0TOK$k%NIu>;Vt%KRU2o zf&#$yw)SFO;d`{pk3pZ@NtE1F_)b@Jh(qx2Xn3UJw|Ve7Hr%FJdVnMQ3y4BZ>Nhd| zXLqc0Kee?z>^i>c6XDJtVT@WM+LG{+euBU6D4E=3KjJTx zOn$yw|?G+P>FI%Cn`C4}6Yleq;n=u9^rT%^{&;9SGRIxl&g>Pbh znF?30lADwl_{ip;FK__`&lgy=S}|W>y4QgD0a@M=2ejjUZF=S7V0 zT^Z}?f3N2)u-^f0>3e^01-3ZUXz#qI!A&|j966r^I-zx33X1A= z14YpQk!5vTm}^U*T_g(Q`1p*j3jlrzzQN^dKMc_njqm!MB-EQ=1!f4h5{F%B>Pjfz zlUA0{Fr)BlV;4q#Uo_k6R3qlBSfHt4;5F3-oA(vcZ|eqQU$5dTR~58auPXRq?1qXE z7)llnC&pbo$s2Z|?y;rJSROtl;FTN1p(KMJfbko!tml&jR)i{fq(|s27wVtJ$Xvgm zG<{2cW{J-DQgWfJ2pOR?s0uQ-%G`$nGUOzzl0Y}UXu0ZDGo@d5Q5r>0IrX-As37HJ{FvD;wN^eL7dTZ*WcmAd~*Vzvp!H*X_|Ck>@0<`(zje^CO{r+`PoYi11v zHU|5z8F)6w3yCug-2!|ppJUE9%u|HTd`wTfn)em-8*;~q2IpXl4Z;$oQt|JZgt z!2E6wmT{E2+l|q1($LBFDXddL@ee<-TL`7?V8ACjD?XDa|sNY&*E_@N&WR`3QwvwG$0^t?r4{)Q7!dedYU1 z7V$94DHnbLHqVmw>Ep&=Ffc0%1f%zK0q^v4!*Dj-Df7wujdYed`Yk2%*lH((-z{Gk zYK+4PEn<#l^*p>Z5wM2)jj=IF-2t+<3%GaTQ=f9&G8IsIWz@9p1YNIVft)%0azdg~ z6ig`VSlV8j>*lp-mz7mp+*W4h1KCp$ZC!|Sqr%7tcl=EY!!va-i{SODjtv*NFR3yY zNn6X$##@K`uGxfv;Q{6zS8Lbe-q zn%X2Abvjz{V;Te0!rj*D>V$|$hvXPx^kTP0pQNF7>n?c4|Up>5x$&|Z8g1|%ugl@Tg%A=gPXl* zDNFs*jWCD(0vaHjN#%To9Zx`0_HqJJ4amx_&siaSIhn5}2{5C{YN9_+-RCKMp80m1 zO)4F5JBHiv6#(Ns%FvetccR+xs0s#_Ic--_mLMbS$-_@Q!1A1_J-d+qkOFkGDp$JKz|ssAGNm>!5f^jt;5fSq2~r?KlX&BM`&&nBp&Ycayl6E}}fX(^T` zEK8h4)cz9gG0lfJ*%JgKpag163DNZ>les34B7GVm1AZLfg9zSULdzc_ROw|7~vM@FB}GB z-g%lf&0}|nH4ju(IoJGKPt*W$K#srE3wpQf9t1XwMo@Hwx8|M#KCY(m|C7q%>uS^2 zM^IT~;8`Pim<&~LTpRPEtLC)MF*#JT?cOnOZ{So_#@!AwgjCHwwb%IN#NFdM#*Be7 zw}uFB3tka_j`G1^d>C`W<6!NB;+jx7XT=?0O#y%~7~^V^sZ}yCZ&Qvn5l|?4x=Hnm zDiQE%0B@l4g|o1`Y86?chdBdAcLojy;De#+J}=$#;lX)h>%ut}p}}A;+*H^VRrmP% zSTi17Y3i$U4ycvH8*;M#;7)r$5V zOG&>U0S2jgTh=|iV!>~N(Kwd*eX#W=KX1DiRP3=0Y?cOh&R2SUL9XtgESJ%VK8ltyUpgOomOhBLD<)V@m9bmKbO}ePj=L>lgv)%LzRQ!Q6WF*wc$3Rbky1^N z8qIf$N6uN1iV7FxJs7UN$?1~ikFrANi9q%m5kR(!iv&JDLT*r>BWkz1ED)xoz|YM) z?XG=WcqbDSOO!12Os&yw_Zy8VXqgTMaa}r_ofc_iA3QpM&(4Z;RUmUB(?D+Z+6mTj z(xq0q4`^M#l5;O}Qwuch*RncLzS^oo;WvYrt3^v3$73~|803z4tp8Val)R%iBw5@EYKe7%>w=vvCSCwi=|pC8RXrb-AC5P*P|?6!*=m zAOCS@w~OIFd6X1iO2+cF9{&BZMK97jHeGXtxV(wr6_Tr(pMQ0uFBC&vgM~ zP_;nD6KxPKjHHmSrCw4UW{FVy zoOy0*zv{wZ?z-6Rni-!3up!O!DI7md$JYb=^Aj3MVDD;DOMIuC*EHRL$bjj;=3=#G zJ+9bkj|0knSk5p?diQd<*>JH+B7`rcnQhm*x|J`R$M30(RbtedhLQ2x$7(aD?OB@P zrGi`j(_cra(q&c{;I-*#fmK3FbrR0&ga2#sg(=*va9>AQ_`M?LR}3+;$s10@Tp;GI zFwAUg2)92lGxPk^$ZW$w#Vk<;(RW5;mF;$~ygb2g=6V+kaMuC@Lt3Q|i3oQ0eq85f zN4PbEcZw#Nu5VD#5cPJP2)hf9BmOg`#g3720gF?x~-5VClP893J=3( zbk!|z1Vo)x=a0}-I1H&PCu(c;^F_5+-`nukY~7A^S<5u@iUh7Oq$+OW~_H(>+)1-@6Vz8c*8Cfy29(-U(HQ& zU&eMg1&?)C;k`jL=LZo17i9{DB@Juouyj zKNz%pINHHaP4w(EkDI;*^$W#LM}^YY_1vVwNE>yPgF&l>Pw1>wkDa&lQ8U;MWg6CN zCQnxkL&=Cj7z|fn&Hqi;k?kpPtFNAf$5&4RcnQ(>hWYh(CjkVPTWhz|G5C%mv2&ma zmUrjLX~EecnRw-p>!t)3mtqM|%WA)cPbgr5xJiPRbT{Br-GE1(3Eq8k3%@dXw!MFE z5_l4RHGai&uF5@MUNqtoY3OMx$wTdz|xS<#e%T8Sm@^o4|eBo;oycOtquG}f zHYABu(kR0qHG`6nr<0!1i=Ii{V;4)tGM4p@W!|I0(@YLrB{5CI`zAMh&K6TO7~Et( zg#MH3T5N|k$!HAzsK|Pt3&6!nU#4Jp)c|O^$$qG{Z($?pi%gTh719H#X+(Sv7RH?d zKP>Q*!fF~@f!6(Nbl-|Dm9&e*fz{eXMv>L0Lry;}M4JgynrLK%_6{gcb#pJSDnsYB zW^iy+T9uBkl;+pC?txJ;-YXdj3X2Z+!HpuOxWFaa7Npqiz7#PI34Ji;~W6$EEtKV53)(zHWjj+GfDx6uVOUP)MVp= zjK6^%%9WvoC;<7aUmL`gx1f147^qo1Hr%hwA|p{x)*>9#g;F&bNUuFpQ#UA$)vQbl zWcf9IR%ESL6{?!Qo+L)5ay*&4x)!LyvRe~}^v75>^k*QX(gO;F)g&_fop z_@hCDIA8=p*O!Vfi-cV)*JZ}6P7El-U3djKO^AbCsC~4V&GzUD>@T_eT;qO$#R6gG ze~l6a_8_>NU z1?FcC6vx7TM$qh zMolXPk*x71kSfxjRN!^`jOJUYAQjf6hgSxMm>K)1gJHGW25h&pK;3og&4Ha` zW;G(~7^i`kqfjs8y*Gv7ILC?r>3{`!UBpid9OuM6v~d@!+i9?yE&E)Ghb7P0ZMT;r zG}X(xyv zxrKj7{`VHXwWwMhs9DOuKjm=Hh$(XLNx%a$N~H8678nqqeB!Fs>jMCTN$_+HCoxqx z+$*W5;B?j%|6bJRad^`R((j7~4oK)OvfD=8dm|T3yaRB#ihnK0??t>vI604bF(YiZ zbEbc2FkpQ`el39g{5D@ZTDcA(3@b94;I}kJyWKr%*%n|B`+&wATj9GwG|?2bHwsnK z+K`|MN8d*X1;n70nHppUV`Zjk!7^WiwJ%m=tD}s(N|7!T^*~!RbPtR@p`y7OapQ{~K2lX-JD4ir#Yb>2MEYZ-N2*Uq zEXa*>gQuYq3ncW>LbrYV%q}(Qq5lD(*m>a)Wt6^tRRJn1Wxl=(s32M3oLxV{YT*(q zYnt>?B6Qc*{4bWh&DXnK=@g5T#!= z{5XEe;sOEW0zZxev+Tm!Tl2cLcC<>g%?ATH7|_8Wx5M?P8?Fsqv0h%TSubZRb^$x= z##UCn7y@r>S%uO+F~y}mI=~k+KaTg&IZ(I5edSyApESlbz@cCUmYZdh$poK%UKH~a zW5A#yJv~t=J_~s+q6$^N7Mhl34N^Eb*o@ObnDmm&7dVH%veeIUbAew>$oBTrr)l(k zgzw#daQp4kH)&*F(V>IB$Ht1c-Y~Gj46rOqmM2sQwyqJJThIH*CWz3?nz|Sp_eo;w zL@9jTe)<$ELhR3(rVsn$)P~rkGe&-P!bw|fYHTFU2O+8oi1&-+n6DMfV_xErZA;65 zr%;sfW6;d-(M1^T%V1rYeVW92pwG6KxxBaxO-;+v8Kjym#PkVU5{91xz5;v73)Mcq zwh;3uE7FT(vo4pPV}>K1MSw`>krIw*)`NsSs!Q$xAhtd({w$cfy;S^+0qIiw83pah zN;_}$8(myN&%0qUdGY$hs34jvep!a=Oiw;oE?D(knq^R@o(*e^9Lf-PyI2t6U$CAN zBFuyOgd4}x`ag*K$m1B{7??Wz_?YF)=m80jM}1g}uHv$c6~ZsUi5l$F2yUC=z<@?Q zbfX>Fr+O9Qkgv-I!D68sb@d&iVrB4HAwr0#&~68ttmc6QY1d_}r>?Q?Hf1Y;pr@>v zAwz+fpD2o+Jy=m`pNurOTin~%DBfM&dp2{P>wvnf0 zVA2lV!xuQJ9RR>j5!k1m8_WN%3!tQBuCkkEsp4TKp7g1KQ z^{E^T`hED3@Zx38&Nw^gVioAy)MfPhu`Y2ixF=)e{Mi3+bBuPocjvl~Fc)tNmIFXU zD3-Wi8vo;lF1cUoj?(1`Sb{q*o`kfYFEGVLnAYG11}4wKBH1cZ(a zTX4P9G#P7;8z{85(WUmH?}lRdUGyEQzzBE`UoYcl5i*yqBK>}YfCZfF7)_gS)yoOqf3&H<{ZI$8NeHDnABLLo2%t672m1e zN)vM?637_6(t3qro5)zJq6&X(j{_sj4eU#*PF|I3W===U2%8lKU_G6G(!;&*o~S|{ z4xKoyMYh47yj#{2-?fRUzVpnRtgx{20bvdp28wOK$4aY-f!0#l!c)Q$Gw?{RA8T*H zTOcL+d5I}em=kZ4X&n4fa9fJ=FdV$_QR9ykOX45k#u=dVBV)1-sdFrfS(p-B_*t(o zwyYsFp9pWQ^L0p1kBV51II>RKeHa_%2>iNp4DR3a3QhZyJ|TBxOwn$qYA2d4Y$?p0 z+TivgZ8l|OoucB)bX-mI%lKW*0?m-_8 z1~Hva7DVEL6rmg-$czv!0^P3QvxqvjU)Svvgw21`ET`_n$siio0vR{Ot6kAmo0iIh9Uu!2r7a!J4j$x6rkA=quZR zFbwWR-NH9P3;)BSZcoTOg0dnUwVDngjiyI9+8>b!N8yP0PaoUS#8&7l+km|$MmTEB zWbo}~GE5T8WE7x8y(l$(VHQVVp>lf?@-mH@<=x3VU(|BC4hr#kInNh%{ljl;@gl1! z*D>H(5L-U6eo30p<74oC!H?rNVHJT!u|iv?`8?IMf-ZDEUVsa823EdCMsyb-B8~eE zW99iV8VYZ?;>9-Y;$)~A}j3&X8WV1!V@1y_5e_s0M^#S&8sQPo4gOPybl zsvZH+Jpuxu+TRQq;#iDlM1J-@=D<@3Leas$Q}-F+r{!F^nSNU0x$tt(uEQ1HcSd;qw8YO#^0dUy zO0wO^LZ$ncn>%k4`iWiuaN*6O4$);_mWI0nJ};)mExIP=oEHTXWZQY`NB{7iu|Ub-=0EYRTPS5!b+079lw@m! zy6LvUXDsK(9DY~$VM#6}e%qwzYv!xxC-k3{iEp-k4QBH6aUsR#ZN8on)v zB81Y8d~fr$rtcxoCzr=0$ISTj73yuieq1z54r6rDVOn2cJE<3kQzE&b|n$c1}}4q&`5JuuZ^@DNbYy>Q(K-5!*UGtX9V zue8$mxqc5VLW%snGI28*L^`d3J7v7L5zuxo59yDqF1|{uUeX`8+6z1SL5c5`_)du* zmiTRne<|@_CE1$(rX8hT<+Ee?2Q=TB<(KMZ_zNvgA{?yY)GufgRj;hnt+IB+)o1y%z$tOgWlaDG?%EC4eQ zB&&5q!|7>Ej&s{`FrN(;#R-jX-uh|x!#{uA-J0A)#BQIK@~EBc>PtzC^NR>SE=iOz zaT(z!rGb0kVin;VWd|Us2l9AcCLawfWnLr=(h61hkH*W|1Eb7?W!32i)&Tm7VU$Ee zg>ciOtj+U>WePNGv}##=YJblaW($BnG#l?ri658vNr`_e@r@GyQR4R{0W^1({#NP@ z@>;P?+Fn&g{bL%~jCF9;=X1AsBdnKeaLA$s_K|msVlVz~QG`hz@27Zd5@hn!MwzYW z0%4!kF>Vi{MYpG@`D9W1U9cJ-D?v3;z6Z~ZRRbEp)NAw`%-u{&bs}??J*8q*(iJ1l zC%65capN;M~yoH zig}-3A~`Znt|N2kHk_^S;~2;v?p^Oy2-i7sCiL4McdS{H(`Dl@InmlSXA}*&ibXgQ za0mRRNpyXzKQ3W{`-FTcXU4gOYTp~J?5th9Lil;PHxgac#c$=DEy$O$!h3;_%W6M8 zOom8I?_)h6_P%-y>SL{xm4TQvc z;^5!)R&`|De5}u7w@a?vBL+1$zHYC;R&m4III{IK^+s81n+G@FG!T$CB$}a`EW^K- z2&KQ5pvzdpS~W>uPlvS#Uxl!$Y|A=`IcV8#*YC$nueX}74^+OfZXpC#gT-6zDg;Uy z48B&%3h*4qtr=9D&(%UVVXhX$d1QH_JM8-Zq(oT9CL2?8 z$d-%+33jIuaxlC{R-!EwU<>?G)`d5=YrTBKC5vNMqalqOB@%uzzu~1l{JOFHjmQ( z735Woyp4v4tf2*G1c87|XFQn1{^4MJq1sCLV8CXvQFyWnFMr0y@g|ym_;B#y!@-R$ ztwtX{WWx`&Tg`@FO>nIFCyrK;URu|dB&%;Jq~^RRy{g=YXnX|j99q?YbB6+%vbcV; z2k7Ei`)PRf7==*YBHKe#Mo@A%op1p(zkzbjv-Vv9@5!aU3FPTU7Ht15wtu@EsTdlp z8^^NF7NZ86h7F_dqpCLN24{QwicNs6<5d=G2ORbV=6sV3quyBojyT}@$een2N#<7= z7}V4F=ixtk{J0le@wt&B_X+8J=Y{Lvq29LlkDvd4y00dl^o%2yV=jzV31~WeclZxt z5+pq9{p08F&=m4$nyqJJdV_&Y(om9stU6tt^Y9{u;1ZnDgjd#l8G;tF#Q0`l1e#h#(Cj9q%v!CJ_DM(%l**7n7GO&MX$ zmnvuhwe-h~XuK;1{MP48bjO0BZ-i$19SQASuCUI3#fps-1v9?P)Cse5eohNO66d0~ zfttYVw+CvodLQD>+6)s7RcIaoWfU!%{N09{Gk)&1Zoq7`K`DU-?A3L&ox-_ioAJ8{ zL}5o}chl?DF-EBhUw|M*y=El{a!K7f@Gt1b9pCVMC=h0Y!Pk0NfuQ4C8w@xY_3O5_ z2;JlcEO+^S6rYq5AtUF|#dP1jKRF^!UlsXU|`} z{PorAH*bG?_x|@kZvOD&t)Kok!Zi|x#ZMVyNumf-GM>^yF{Q&HppN7uKRo>Bj?L); z^C9`?^wuHaQzVB(&GVms{+W+%4Stv`FdvayUTNb{zY9&0!^2x6u2Uc^tN4bVUeuv( zxf0y$LNoI-TX3Zmb>f~NZ`$ktM?Ak}1>G?)9bD1xPaNn`LRyNp|z zkOgA(E@~Uk$!2*0*STwj>lChS$m=YthV0=#UfzXX-g`#YO}7}HmY6zn+5@}eXjapa z;&41;LzS|I&8a{`H4K9Us^aFjAsi*2is+h|F8-@C?FX|j_t?)7Jil0W58VC%-Kz-Ily9bDQ{&qco+_ONQauw$|a#^Fmb*sIC_lm8x&E4bqx&bH=E~^d! z21qJ!=tg)?02-*O;9}a?vU-OTfhl3QAPQ_D>_e$^h>|L1Iv>K)aGU-6ha=D>(nQI@ z;Xf=3L!!ap;2%Hxui1rXYQ+MD&`kpAV?CR*q0;Yixi_P_ZGK@3EPX+QW0@E)vLwg* z83WT(Jz#*FaZjGU23yNAXZmVM+aztw>b9`Gn+R0$0xCxs@%&ZfhS5I8G9xj~;E~Jp zdw^!OBN3W;k0D(P%FcqzUBh(8DlralXX6xbxuMuS1A*Lz#Ry-~0{8&b3bj1BTB=Vo zO>jAm1;`lmq2vmk7y7-m0Js&ss3Q>e*Jr7#FqAmpV6&P=fbrSO{kD+F*pG=X$;zc; zMtsn|@f#b}103sNa`IZo#8TvEnl;%mYCc)mJr35P^YOw@DQggQLA2*tpcdi^ZWZ4U z#2V_j$YKNY(2qIsBgz)2Cik}$&WUPi!5XGfF4tW=ynHaog9k+{Nd0N91t`#P#D@B4 z!ZI)b=UJN9PYQu;!qjJ}@I|uW%g?cD2*kq=km582>rDy1m(Al^I@*+bwnUu>PJVkF z|7FFrm$AI^NanR9w?D>t2Ad|9Xpdpcf-GiZ=?tu@_syIw2(NsiO(&xcY(VT7Dg%Xx z8(ZfJcd}lLg?2mmw8I411N#N4&z!({0#?L1oQZjG+wOL}L7@)@wUsBw+i*b!M<96N z_sY$|xe#-dwzmmK6_7OaSh2iA%+T#*Hn4}c;uj8Toxmu!K}auS6|3O{dHrCEir*OL z1`{r98=T!u7HiEdufTyI3h^L|tXtI_D*`Y(UP@R0tSzT%ODLWhaV+SumwUV*MV=>l zDHK0tQ-|CTI##3>OE&+SF;d$DKAYzY)DaAqFAB}wm=$zmjvt{m=zg!^O3_#ZaM4?V zhM#rU-qZOF=#uwkN?H7&H*;H5hsI zxNc+jIbXms%LATdY^T@Fer^uasnku@w^9-3SmOQ!M~0{TOqPHo)7GEz(+R42LbtZh zEhgYsruAaUHiiqWsZG(#O9AjQL500znRoblcjjuT)R%?csgJTWPk2_L)+(?zWO+lG zuq0bk$6Il#Ye}uCwb%VS&gH3#>rX0dQ-jp*tBFgihx^rZ=J(f9j`g{FrpNQ^2{T@t z@}l^Ll!cJ;uWv|aAtJt(ESR!Z+Pkn4=+T;8HLSNy@BVf^Fo2R}@wYSHGo$pk^Sy>K z`}S;s>@E}mlykNSgeZXw#WE-7W5bk%D~JdOJz^qp7PE#^|Iy^IzRBiMV_`=)@~bRb zIMf#-TnF0~rjMyu5rL9|G4Wbc7qiGrdX%a<5CkMtzco}?CYaIKLh~l8P?2(O;ui21 zBxttnI=-uvSzSg1m-$SZ!|2YXVW}@!c~@iFe0X`ClgbS(jQt1mUt ztE8U(M7D9c9TaE=rq6o2CBe?L`Vdkq0i*z1hg`ZZm=lE+`Mro0@#e&Y%_A^DGnRbD zTu%h%c|2xlS`V1MWtg**wnSD>2ZFm#DSGF*6f0}hR@tuBUJ2Y7IVoKoh}#2a5Ws5l z?1yh3-Mc?}_4fIjN6+r3y>~R%*J;1^Rv6b|#%{xcg6N?${{Qi|_M;Q>agq(|nI+z5w9VT^F!-8w&Zk4yE?Wd-!@sh1AJXF-SQ!~T!~GUGc}-rnB7*LL;hpaNekvf+bu^5Mjd!A3M?80s<}?Fa zU911n3umi$#%b^N%SRDPrPuew`}5qG)$t(#a@XBz5;Fu0xzKMrUNLpo;#73JWCc6# zElp*mFh(Plmdrk3he;9ug=Rj%N#By{V?%h%}K zJfL%VgU$t~@uj$g+k$AxI~|fezpi^K39M=CJO&HkY@?`=bcWSjrM7 z^_*F-f;t3enNwK{F4L@rQEl+`VSBl(sK$^QPsL#!;ow|^gLC0z8P+)$3yVqWoe=O2 zu#H$c?X1lKe?`O8bqzC>giUKVEWl#O{3G&V0d4)SJ5P^j;181DK(~na#zT3-($keXg&)2#B?24gnEY=g{{Q7lP%# zym|JN2%HnHPbns{ySmSD4)05IRKA*!NRz4~vwSj|e;%F6j0KKaPO{+iHcwA)Z5}J~ zE{^^u1dgz#w)*AKOpT0R*O(=|xJUEP&t%4Cs@bu;4A@3IqzA<$*n-rZZ{<0vQ?AA=)Y0mNe+tP`FX7rAD3 z4895m*xYmdvSCcTg7*YM)oDiN(I&#t$wdFTssH?-|NN-`+|qx3if~kHsE9DYJK$)| z_1k70;YjK~h0;V-gd=vUFY^dTI=(oiYaP3$M{FG##i-K^pJikV*a**M#)=2IJbh#3 zI9Cg*2;c1<#|TrB?{<%pI~H2ujy}8%=1t;@)FtYJd|I4yizv6G1+(^)PNep63BV>F zPi0oF*~c|6)JLw^X_VSM@7uD$C-@kz+_Pch#ZGtaaq|_O!rGSO4>-49HIP+)k*Dl8 z&d%dwgmYp~_Twv{c{0G^()Ukuv7;QI39ifCwaS_pF9|Q+$jwuB#@3oLhV>5O;kH=xn!j zb8isB8Hw#vv)r39T-H}m{Sy>secU`eMa?p?=ONFc1p%6%1Plr(irp^uzsY=o@YZ~! zmL1+4uV+wNgsp>tx&=66h2nymtUyk@k|j9*0}x)OSYD)a>!;R|Cy~`cu=r-y3m@>~ z7P#ckn4*9I?wnb@FlMZtBl zdp><C4jK5Y@{ofl_=!E!K& zxmk#V0rx91{2iRKgF)O~xIeu2Ta@Tm=qi_`$VN-KmU)Cg*!K4daXFW}9Wbji{a{^7 z!SvARPGs|Fuc8H6B5abI0*FL7x-En(#S(7w!Y)gXRFhwKT9_U2D1&RMfbD>AL89de zRo_?y7mBTN=$Ub)I5W9ZFc|9EhT&kCZCKzXDX}CO&Pjnei8I1ca@AC8+M1v7tfcF^ z`ZZR}iv?b4!gkqt2NwAM5{p%?9T%H4T8w`v+l$YIy;eS?g~E~AeBs;(ZlNvdb|cLRsjq}J1@14P z%tW`w|A=sOEQK1K16EFy%6a2^VWW@fDPLdK(e`_RVMC|VZ0xG47OrldId|qK@|2Cv zI6EI5nZprB06ZS04*Y6Ag=x7_(oJZg&*S*Iub_|gsF3Rtn6*bT&saXnX~s)k-A$M& z3t<%9{0SD6e({V>Z1*EbVW$|rdJ`Q~;r@Cs*yc7T1R<=00Jq17Y=dzGz zjYg9np|)UMq|Ifqe{ky2-ak!o#*59GUZ#8&83AajUvW%VAJLrCkz?cc$5n-cEoHeV zbU49dT<9w*i%W8u#U)k&U4jK_kxib2GfB+s`8O)F$b0^Xu(RsU+>s%89VMd)-jODF z;SdR)cp$6H^pRLzUw_CM->cl#4G>UEnlqz`y#DVL+g_-eY74vtq4S!P*Bo=!hj%@hUF$%K#w&Q>kM8Vv(4l={2tnpxCZ^ zY*^CPJvQY3`LTg>a-PKn4wx9Tm|sIOON6jWKC{bnnP&x1LgD@UvA%JFwKItpq|W4F z`uRS=&1-_2w+U_@P|>_WMd!rR(fa9XVTdf*%>N%Fo3Tx4WNzIFz5QzR4ODi6oaIe& zHb?=cS@ z5>p$(y3J!`!y%FZQ*zE0SfC0Jt5Eu%4*?tkdp#cv_7ZM#xyo5ld_1Cg*HBIWuvX14 z3sz7mb`@cmEqCiMx;WxN=YsAmsKT70e#%IN=7XB_>1 z)Y7QodCcL;SPd6~DMjaj882d+zJjlPFjK})nqA4eS z1!}|D>K)HkOg+jfq`z(l*uQ+ezRUCFnk5^SFTs++R7faRd*)*uKgKEO-6 z7s*i;gU2n1#@l6?=in59ZBmJq?`WD=C~akpbWATA%3;)#$GvEnfAtbr#$4~FuU!Jy zY~RKq(!GtFN&faNvfG8K$;s7Ee}70yGRD-odUkH>^A?F{Z=Wf%vW9wr%wjn-nwpJ; zMLPmfdVShp6(UWn`V~hHq+4-lY97itfQ$mfDA~eHzih6gG#^I)h&*h^GK-m>UUtnf z#Sp^z6`<^YpEckna&$!VkzVnd0PlE~=Sf%d@!Z`OS6mWT-Qsr1%&EzR7S}CJ8Ze)( zWWF;j@JW|W?zgNiRokzqwqtm+s#It!tsL{u{-`1E>>gBZ?@f)}6gy*i8@+~+nwjlj z?fSB1HBmWvtThb#-q{K-JMQdo zfrWQB(`V~fGZai@qk=IpGJYJ*^Klj{vcwrV#sxXSl&~!3gdrRYLjAm>8g8b{lC}y& zEHL;6j42U&@>JclO%{K|b|b?Gjs!a&!L}Vm!xBgT6AjB@)H|7^DQIc+wmrv>5K^#d zuZl3$?ZDY!5XU)roy8ey?tdjW#BfXy?*E~eXUGh`qfbM|M9k4(kOQfG6{%AS7^HCQ zqCgr?fEQMh0%&+lt>F5Nj7x+|l*SoZVor{6PEN2QD_rO?6?#nd__!hM97wQ3E3R2Q z)Z0%O2=hLP%WLJ!cja2- zv!$8xJD#Pq+m(qvJfUj+vF75l|1jJ$_(X$2tyj^6JPBDSMl9ZEyItP_?oEZ6^xZDD zzsT0&rE+3Jrh%_)o*D5vTry%$Bc-JkV7xiCdIi2+yTlNCDG^q!UP4a8HLP=mNv48C zwAMkL3NX%a!v@R?BjX4{Yg;Ej*i*0r0I|9sLJxQr8E})qV9#-o7!1aTB2hU%jopJ7 zk0ykW)A}Cvin)COB)@4-j?gr$%mEp|ol-+A3Gmz3;bCuWeL+|HX@zhW?6P8k!9ZK@ zb&jwiOZ`~7>Jhp(i47ej(9-t=P}a?QS8@|AfDSL}wCZbV<=!Dw49npykSkn!5a}_I zA@A^YQ!8ES7AiS~0cWUJ%Nq06*{A-q{VH0 z$E31Kp~jAoAPMQixZaV_B zRVo!XpJ4suOCPS03 zjfMsk67mv>-~IjJ03bn%veTLS%=E@0_T}K<;H;p0@`9ZOBzTn+0STTg3;2B(kl^Q) zfPZtHzPboVaKe@W3Ergo9KV*=0STV5G+4}~?)#M#>Js4vFnA#a`oyDvxP%w0JpTjY zeiDBP3XjXI>G|RTdR}5pNf%p`v^5!X)bgUL$ORLuNECY~3YKL433$Z?H&kAHk`cH0 z<+12fD)4n^xFJR#rjx&d3j^dbZteHYBfq>qmV3K@>3f?Q09MZ7D&p*p*IIq(5KkuNgGjQ-~-W2SMG3#us78hm=0| zA9woBZMxB?n6(iN2ev?0QL>S&T;buBEzJEbOw>f|h2{ZZa3x#i^OzgIho$ zf3wjyQdc9%Q|h!%23f=fvxwq_EZ#nC^ostjCXg3%$+OtBQa}&_I&(n#24ebU1N57d z9@e75J|S=|Kdoh??uOBav;9oC;)4GTiRstLNWb?*q#*mW;a%)UkG!-Z%1J)Io&0?% zC+n4R24BWN&;+{Upu$xJ8d%Sr4&TZ3#cP>$HTUqkqkGpdp&SRyFyJf~N+so|m%LQn zObZ{!89W`TiWvRdcCnM|i}*P6P|tDJ`yh3&{*Ix4LDW-C^}$1faH=4_TFnio`wq#LY$%JoE!PXXqGP?ctwJU%f<+4>Nu}@Pv~zP{oP`gL9d# zO8wfPfpI`G00^XAwoVEijyVf{fTr#(1^k~M4)-#CZU23Y_3O&GJVQZrPc=-$EQ!*x zL~8@2aq#W(c2LTkXMyV1N95^sjHn|BCj%(*U7M|8TgJ`JHabM0hJ{aBwjAZm@qa*#9n?><|70 z4edjDTk?lPy(}7vfMww;e7`<{2z5p&_!A2V$E3iTazsi0)-amvJY@+@?%#Bx=)ZRp zuUS!YDQK`C?RWO;JN;iUSQe~g#Wj0UE?KG|N;eH|U-9gZS6pv_+3@?Jp_y+mNN;Iy zFbM|fo%vhP;PD74jbHZA!8hQ-W9NU)9u%d%|L4JsMOyZ z1E__b%i>C>C{1IJ|1}vL=>PDp5gNcEB?Uu-trM%TjfD9C)|yWiMBQJ|+k=Opm|>C} z(#fp6ub5erfWUo>V{~ufK)(*|Z!Sy9ONjLvkVHRD_9qhvH}286w^^GJWb{B;TjbRy z+8wLw#4i$t2-Q*c`iuBfL+g|RmkjN^DyhQc!KSy+f@^duLpLXY3i+7P-q!*3>00NXn`6o;-w_W3t;9wiv+O^@tQf1n7GdrEbnH{ICVaUXo=)wwjlGssIHQy z@L`7SzCiU=7i&kPa2C;%1!0uU_ZL(BZDIIwr7fw8E_y29AO zj{{x@j23Jxj9ZxW&GSFCaE(4kgi%<=&Bm_2-B`2SqP=UvL7Lgq8k{EXv9{K??NSyh z7UWFc#*D~oR^-WD89xCDu*Q7NaNc-NzxjfQUI7!Z*WRquyW>Dl9t_5!B+K9lmgH9O zQqsP}%_azlXt@7%q|+e<)B&+)jSm@{fv4^<&U;(*0*sY=7ru8;0#*q60pDBCd&)b5 zSpBZx^J0OG*BEQY-7=kRLcCb(w4{mj8$79dX$5_47Hq)F+Nij(LtESE^kqB`zy>y0 zRK9UE#9+%H3O#w9^@Q*Rv*zcYS4oZ-d70G+_+>^JQ5AV*EC2dnTCf;mb>+dspi#MBRnGMXVVbqUY`(xHNUH+6IfL3xph(?xO z9*}kGAWcXcw^bNVk1_~g?9ATb^34jl?9o3H?!FVcchBt9X$W6{15vn++-&A-G2In$ z$TIiUf-+#+R}Fv(55O9i#6~r3aAYSsSn-{3R4?JX_7WO%K;s*4a`*uSQ7g8&oBhYY z31o1C#sB@QPhjjsr^&}|p8S=}vNgdR~k{Q$wVBNv(4OwjJu zI2bWJbu2yz(C`8E$Ku8spFGtBzuWM>w(7(10SOF`c4agyI#8ksVNoGP8V`XLxPGZ! zu__FL22M&(mg2e$2udi!wN$q8@M5k!cPR#rlC~@^QeTjP5hb;}JQ!I{+xCMkK!|nE zs=(wx(%BiKzhb+f%njUj>JtOJc4*+CV@(;Z`MI+hr<8JQx7@a&nIcj3= z`YKzI1}D)%lPrbB5m_&eNV4o}5QJy{3BP~JOayB3C8ITr{FPA)PaiVsK#R5jlF79WZ*6o&`jsM+T%7Kd!_VD=%4 z|H@n}Ma~ z+v6X9I*p@${pVKB%jYjn<7jd~{``3S`q}f}W7lRJd^^$q7Z7MX-rpxjZ{9w8{`RB& zo>UcivrpHjav3`gGpyBH!*_E`XR|&>2EDmdx0Ww~r*0ErQB82TUoyHj2kYqQRLWfO zW&8-lQ}y>Ve#Jz|r6}V+Gm~@&LoI z&?hE|APD7Jhdi%uj(i-=e&#$#ZY+6Yy>vsok9?DTHQX6O<4J$5JDcn5@7Euheo z7BbISb}Ba;R3_d7nw+khFCs|)`R{Ft4kuug!<;J{|GoYJfKq065D2cPb{KXBl6YU_ zXlIWVfjI0xI*0p!YT#77kcEvV1G^8)R&Fh?hh;rW7fs&)*5zB+bQ=p}V<(|}#cpgh z#ATzrcYPC>g6}oa!-*gY8(+7ItZg5^$};A}?(qr#!pc~XGA$Sr-fgZ3933x365GIW z`C6*?yyRy&i;IeKDv9*0HyZ4zQJ81fVehx-D!Hw3imzB!=X25ITP3v@xlEc8mOk5` zOh_@aJg701u^|b;eP9hpGgMfH=U5V3me%~u2`Ro=VH{f$vR&0)iKcnWXS}Bol7ykn z`ym0&wkeljQr0<#rI%BJ#~x2t-)0z9IbYf4eb&(z^Hi`=54?1*>{Q>*ie&mSTuOZ@ zX7rgv87BFT3wW~$l9iIq=QWxPDNQXl-)zj6gF{qM24~K}SfVc9u5v~MP5V{XzD`9E z&rr|(D_V%Jb?Yv6+`4^L%w1d8_^Qj(T#;}M0uyT0DAf8okM4RRWs~3YMr+CeYr6F+ zoF%l3SKzE+1(1bGnmAVCAka6fcZ1V%ez2&MV3eLy2z^VMS>hcd2EysSp?Y&!_2`x~ z?IyjsTk~7ZWYnQ<=qfHD07y5z#4Y5NT5P3%t8L7c^AA}pPLg1r?JF4CB5*I)RZzt<>4RdI?j;g|Bwb|Ho zr%?mA*=f|64|&as^IYDELaI&Vvp(UUCZD`_p?btnZuwl_rN)!LGOrpy( zo|M2=(Y>@@YBz~~v?j%;05@c~9k^w?8kaK_Ciq$^fl${0ejU?fisOTC}P)QkCQAtojIi{5Ulx;Q% zrSwZSOJbDJ5>^ncbjg+N0k}v>7$%1Y->hbzvp6{{_YP)XviPSAcyvwQziWD0l0x_S z2hi3;0^7BYSgYicuAmbmRi-PmeQrCv)@DWuO`S+CcC53$Vk56uO$fD1fyCG=<|r-I zBA2YNyDq2U&z&1lKL8Ud^aGD*>I$1T8eLar7DEcbYw9N5u-oaIP0ckaOanxws4y-R zh#A~gOJ-&dHk3d^CQx(pe575fz7Yc&P!6mtA!y(^FfYs?s6fO0R4xM&ytUl!BggH2 z2~LoRq?4&UESwxrI^U-WE#^``h%JXM7$u|NgW;X8T8VI51|(}Gf}enZB=pVxJXw%* zYaaX@vAJ3}SxQ5V&y}MZri!w;Sa>QX4X?y81`s19*g?z?0AE0$zn_;2nvRrDjTom= ze7;)HRf--MgZ}OM1Wyk(BM9{89_Sn`lY$Ag$4xX5;aZx@Jp+&$9(}4aH`nft?oo)!BhzVdu2908@8H1sIsX>GfVd zaE$jSc%0jnaw;5N8LKbRl)_W*P=9T^8i#lVG%{(m*gS-w!F!972Rp>m=1ulh?HLUf zuSDV4bajih%ire667NWBtlHcgzwdrHk<^QrZLW|ZrF_O?#HrEDkrWlwXxHG8Q+7y9 z=GbWj9ZpC|oraE8*l~G3)QrZJZD(xXdWRE|(OPlGJo{|c5ANC;qB0DVFkFQpI5pyj zuDQK$!8xJZe@qbn;ozGlce7#jZTuPPrbdd=+}$Xp#bNEy%{_CaOPaa1;}mP;-JWr$ zcQZ_6`yA>%p@dDqM9*NeLHd8GlhY>`^b|~(#PvN2yY|he{is*)8q2CV{il)p;)Eq?b9gM}4jcoQ0ye0+MnAXW-n~bM|vQYwI z?+!(MDU6Y#VqD-uIa4V_sN^_iW7Sx=fC7;uiX;|m80r=`)XJ_|xEZLe8H~L-j0C8W z9oA7si$gY2BP6ICGi*ksU{oXV6{G6&g}glgZwb}j!PMvlu@Pvr@k0rhr(Q-m=J>F& z%1Q0rTE|9ZhXr0sir9!2V}_dswraFTzBO)AHekmyeMZ|i`TD;K^R3{hxkSx!D(i+#5;pN zk?9S?h`jijsLtX1}PlfrHuv$0vqKQ{H)0eW-#Z z#)5zdi218XL6M{k+bdCMx$Xy2fWG56Oo_U|57 zWYjJq>;CGi!}$%f$Im*m?Y-~y!JBuKAr_6!b>LYtsV-B}TTReb(u-8k@qSH$5!C^T zV$^;RxRY3zAtsLC4?GfW*I-STe|x0$9D{(!dj~6f25ZMB-FN|e1lY$1N!rpg01bOm z&~@!4so0vry%1RRZO{ERnq_oU8Zc^RpyXqbp(d0K=qU$!t=W>okXdG?%y39tQAe$` z-?un!di#>ikZHlIv-K8chCg$Ev$pdZzw-va8-oSY3ThV{yJBGLtc!U!3nXA17q-5` z>tk< zy~E`_!-es2H(G~GTX90m)Y)P)W7q@X@f)k{ufH_MjWB8F?dL0x5pw}`R3w^_ty16O zro~s$>pWwz_sRz8wo~IZ;fH#}8UsaxewW1^37}uM(c;8Jw3QKQ z4u0noFFa(LHo>`V`Nwn5U(`h*Z>)6DS`;oGcjA|sCy>?BWI`33m55I~v?91F!RSm6>H!R4GStoRN$!DJzIe_`F-+(xCmV!Qk#Hk1pcRC=GrRAN{- zB~=C9%vwb>NS3TrU%4cO@d5x5|Mhl4v@eYH7Z)owWwfaB6rzn0t4b_!M9xZgI(j21VGuSd80jJ!R+tSX#q`1afYifev|jw+AHaO# zl(hzf=WYkb`-@rdk01uL=_!_QJ3ZE?K4(3+szmX$QNdF^GP4SkWU~=g%6669Ha-@d zcXw~)^-lV#f-9hDTuQdBykZ%eB%|itn(23IM$+w)4Lg^h6yD5FUj%9)HyJSr+o0wX_VSug}Uej0{Gve8Q1Y*amX-$#EiLaW1awu&>ncVG=naNHg*ul(22WqnV!VbJ&XR?m@{rcPUW%&7?WZ!S(9i*V0#BsPnk!L(k-On9qV}vDFqFz);dEr zfLvl{GCeC;^2s>tYJ+SuroMDLvQAb)`MB6MwxUr5?j4*10&jG!>+n1^KAv2BVdp%K z;TenPY(e_1Rcjos>}fGE?(Ge4*<)ci>>7*hJ~Y78_zDD1tivd)y*^(+7}Y7d$4hGy z-`>SpR?^J!1DZdc1I7Cd4gBZ?!6Ft?p>AH6s0aLF;YEse zPTX9w3bfh@r)Mcr7RhjXtG_f>+UDb}v2v!@sUNlyHl}by1XQTMT#dronz5X}2znWUh^_i? znF;)a5(Y%pU|3e?Qs}u=muT40S*m$4p7DK#4AK^n; zV;QUGR$+3Hc6VHKcU)HB5}V;EZ0Ee*&ugAB88oMXUnLi;3;JKTw~kiyK;6ky1r`3% ziVo1Lp541*8BcbBK(X1Nq5}edrxE>bF*{SVmK>W9wwFoSwjMOAf?Y667KZzi$zk)J zu(WGy2-YESnz9nqwH#V9G>Y78hKYMPgL%K|Z0oe2ysf0g5fW5w9H^oDKoV=z08nQ_ zEhl|2vxOxRfEnK(-v#gi{EKR{L5$AXVh0*wQLB&L^po{vE2wcz-RrXMEJdC6!0O1T zE#jTV&U3Z+fwHJQxiEZiXx%F9rMTLXjTnFKwF!?IR|~o{?*FC{iwO-id;60Ko@#(r zha5vlO%DnVC$ou$g{I%@)VU~kkN5iMLex4-GQ%TPFOT`Q?ioC_X{T{-73VzIiML;` zFRj)G@qwzR+*|jM@~ND&v>uSV*zOrfgC+d-n^a5G5)XlF7kulHzsBF)T}s~5wP!=9 zlKf4hARIqWi6JXGCUs2=YqfVktm_U=*_<`cSyIq_@Z0E8z{`V070*+!pPRCIvG6E& zDn^#{-mfd#;FUG~ZaJYE5wt2oHS0<5Mb2((qm@2$z#Sqx=TF+%>`@!DdThMe61Lf> z#@BSO&TLI;IxW}syC7ItyIyfGle3R-3osG>1mDV=W@?UH-Z8JQ;;gnhg=155RqOR| z3$e8VP4K_Aafi`w)nt{XqhBSrAQd!Bqn%JS*U&VX@)`)Hyk>Asl{EoEY|a;r^Uq29 z_eIY{@n#bQxa;;CrZm1OlI7Am{VwQM(=8sD5oPEiEzS}MMU86`o#$7n^$TjkSoFUL zYBm;#M9IMfS43~gbCK;nga6;3z@D>)r|n~DoptKLo~Wc~n*(|mfRSJ5!nIQwMfazw z*=yxSDaE&11JaXamOqz{^%)vFi{oZW#1~tCn+hJvR{og z{}ad2*|Ks3zby`M5BF;hk+7VfQjs_3O`3E|F*7ualMI@wyj6Q|ue;rA z)>$Ipj=qnST-H@O{dR}%mFvvIDQ~{Fd}hBzJ<4W1?;&W=!8f&->)(l455B2!YY#dl zeMF8OvW1s>#@t*R^^nN^zjgG*j?tT#w!K$@2a@+Kw;RXk-#g&{#bWy~*uvV)MK$SO zRNl=5x*=xj9YEbV{mE1`%?URt4pso9pdHIR3FNjkvMz%b8Ylv+So3{zk+M?4bmen4Y0wZIr1r4jM zp8FYO^%ypr9Tk8La$h-*r}P!g36O@5%QVSZX9&|G42Q-(7A3P1G&1pK^VxTTUqAlw z6ip6$+V66V8z<&2h_YjH8*jwUudK)P-fY?}cVk0#T+#+MX1piwQJ%cVmngO+L8Bfs z`tD11R~i3VtSIu_s5s6*$@K&+g#?rrPz?xgHsCGnD@%h2K+tlWkw$UrHW<<-Ad@>y zw|%%zTEn9`br4o430D(!J3@m#&GXf@86T%)cY9k` ztLKn)vpG(Y!lY;&z_;=SWasNb-oyndY&Y*pmKk3T#=vqiEt~7VbQH*nvU$1Ch*_c) zo(Iltgomj!kfO`TZ+JvA(oXq-hv5WJVI4q>tiWAMtJs)k1oe!+jX74BBvyl}cUoBm z&X)>#)2ZeTSyGYqcJ!K~G>^{0Ep0+4)1+Ca#H~|F**sYoduqSSQV#-le~am5@)~!h z!+orgnN7A#!z(Uo?;h0Yy^K8#D1Y82g6sR}-luD~TL{AI*V%fwb!)5$*C5MF*9k-% zI2Oje(rpT?pC@^KddbB_*~@j+^a`cO{ZKRO!C85(6|hSb(W+#Y#MC$VR-Klz9Hxqkd+PkpYPlwT?5(ypHq4RaYe2Y4tKK`=%I|Crk>*+;76@%@E z)MyF>#5pKylj#p@4>*0@rX&#BoTT?&({&JG zwBwStvX>PPe5E+c680X^h*1!{M$1AfsqU7{*tbV%lIMtFY|YawX&q=$vcM^wy< zh3_7xF}ZF+Ff|(A`etO_&DfIU4ce{(#=B*QJz0&ou!)8N{eG;ysVNEp9W<#v0e2LZ z?ld1(x7050#6(SXfl_NXDZ}RR3`soa>JB%n$_R&m!uFXynNIp1wHITckw1bVDa4)< zzS)?oKScYJ!_la~cv|oKelx$122$!5K8U})*S$r*HJu%X!Nkv(%OvH>&)=R})7#T} z7X>xAGyzOFE;K3(%r!C(Mq(5^i0eDBEo#U2aiE`_`-e_NWY&O$Rc+t%QuZOm7yT+D zrUuPJ1quaiVH5K~bx&EPW)EggQ&dYRngDiT_z_-BLB=6I5M18BmTZ+taGFv2n$b_v zj@MRLSU^h6UTPw&3UKH}`)aIggK}+?%Npak`iZ-!i!%z=(HebZ^H)$Q7y@_Yx zsT45!nCCgWNb`yFu`H#72*U!MR+CY#_w|(AS`e@57e*LyR5=kEiOg zkT(M!hKP;mV+au-WX1-1M7k8$r7&?Go%OZNZU)bbLKetJa-ULU6~-OqyiW35-o(QR zfgk6qJU9NKOp?-nf+Sbw{(;1mk`S>8vTSI+;e@0zFU?<|1z5(F-ZPz4uya-vtXRsN zr*}Ff;{{YdmjzTlFOn-}1C$LX=7TlgjYd z^j;<+JCnEYGnGpQZI(p}e?a&LKkiIvm7D?AFu#in2H9|h!;iZq{Jl={mHtspbEXCv zU3cah*d>$y7%93^7qJ+ z?)^7J(AopV(ogKJL>%$)a zx8J&_xRkgsgZmwNW8cNHO_RC=AfuYr7xCMd**`)&G;Ra?QsFQh^5`-tpOf?pDj7)#<_igDyU?yQctNJc1+sR<0B)%x_KnM5^Ey7tF

!7K zDX6eUTnJYDbo%NgCaBcQ{^mw#?8*vthXTWr$$maDs5!v1GU}woC61CzE)~m~j!GBo z2FK__gBC$5A2@r%yPS=K5z+_eD9J9^tiD)d4i^&fCiP=<$&w6%(zG++@KnjS@$Iaz zk~e;J5n!{X{))ad_CXbnU#4*JLMYaT9(n28bHWqWN`u-Wr!zfr&^{gxyBvzLNCRW} z0K~Z7r!brx`rlqdXX848H^`~&&ca)%j{*R5&aY^=Ws88PWb&0qY-(P zB4dQ;b9P?)_Vm`@%aBDiyX_ca)mb}ukf64s29Q=+xDUIu5(xeXry>jut5}eZ(Z1yy zx1$5F{@J14^zoP&mGz#yLpljVbZP8dTK$sqzC^>fu9@l(l95=hgLN28YALhdU-`s~ zW>O z!tf|G4?cM4@oW%0TC0d>RWRW0E$C7${;q=Pe=xCwXa@bOdEym#E%dnT)qHxl>|u#b zc}?{`ft*=G245e9q5st>S>B&J=av9j=+Ss&5D@!od-uCS1oF$+FGzq)C9a&JcLV9)sFr8G zl0sb~Jld~WMieQk4)-UsU=oZ}tnet<3r0v#;SxnGOd_=KVwLBAu%tk^B42!`&2(Mi zH8RHFE`Si8v3OnK=&u`d!1#sW;^G%}XNW4K=n5h>{d}X|ECGM$4K*P*s`bn4h>qZ46Xg3&Oh$9M@FNEZ6qC_gV92B@p?qnoss&9Q0C*034_sbKPEh3&# zO3yS^Q^yc|#miFTcH8=ZXHkHO4GO7iU~;Z;G0$)qo(rVRFLYuPXF7rEpB5-?gr;tQ zM5jS8(%GXMG2)%3kSkDUKxZ>yll9*iK3<^pg?{2C3i!5q9u9=*Q3_#{*LL*rJL4?X z%vgVM@c+=Pf=*MI=1@>x%rUHxwSe0L@vVlD(4U=Re6( zu`F01i2D;YNpv`|j1SU8k$<1+=N_l%qu%(JGEMTQQk?S(7DCj!O~F}R7O z$S6b%DMgY7(!BR5)r5#VN0JtJ#ubt{mN*P$t@Z~Ylcc8wh)EEP09P4*Oz1Afv%56@ zB+!p3#zRWMj}W>`X+dNdzSZfZz{HC`48Z`MIiobEEN0{~DKDR1CgOr+u_UFE1#_Q8 zRgu3^`bUY{x?NvD*!engt6X1Z8vBwDof^icq>mi_0^ZQA$*VB=+=I_PAjh$-`DH)r zYGF7$Vj2nkoc4rU)>!Z@yLf)PM8RHi!Gzi~E_n8W(Q%Y4`7i8l6zsv(@n8QH{Z&3{ zWZkz>BJTR_c$EmHc~%)F9vq!c6`N|S*e_FM3onR=&%MBgCip!if28EMl(3wroUUIc zE0JEZB3>t1cEm1|Yc7lUHWE@UE8^x-tb_U8=#P}n7vwkimq9A}J*6TC zP3Px&*&wiu50Mr$eoHIzdm5?aqAu16`^@O?DX?_v0!MJCB5*6Kl8chg7tRxkN!V=W z3owA(u6deVH0`UFlBmegZ)xAz^4R94eZUEQt?O~^(m@s3hf7v4-NzcFrmSuwSFC7O z>FDlV$#xAAG+FzH2?U*f4(}e@6OsK|$ZOsT&e0C6+P4nOp2b?{23Q<=5)|CTLHsdj z)&K1Z2s@sFUGVb0nKsU;XU&cZ90O3z*@CVw6OrYth!ueV{F+QIV^Kl#KBT?SPqsdA zs|B*H8G079Dgu637}_86$pYpCY|T2!IeMu&%j5wfCO~o4y2nNCYXtw%VCMnUHCi@S zI#8Qi8bs)|B6I6aqg_&<+bHAb=d54?q|K@cfx{~FN7@Wazuy|%UgWha$9i*b^&7Cb zL-RmyU_b&(N(CfXmHJ!L2KuAm!Ghds#IAUfqg(y8-@$`5m%%Oo3EQ7CYpT?@`&Wk!Q!$%6`G^2lex3aR)xPZOX@=~_vZ=6BSRYirhx$vUr}Pm*^@-xJMIAaA?J zBg63GZ;WcE4+!V$2X649pF#jefofuwh?#ee+%cN&;`ZxB-F+saF8t5+SzXXcKZr5B z{y7J4M=avyQzHZWv5>2!Chq@sH=|L7@pQa@*w~8917P02xEJUx z%e_3dAWvDP(Um!XC1vDM1QJSPWkH7%@+mTED-Fg*nErqsnV_sYk+KwQAT|Ci*bbyz z2AFtv4*2xbAlM%KPx6Yr=j+i9{J;nYo%e^Qr)TwPp#46t>Afoe{h z(R#SHc+iB)?wuQOAwThD|FX^gjP6?))ZktXhEUK|{lL{FnXiq0q;(BO+$XsDtQI&1 zV7_SyR zqJi`9sp+p^q(;HOyMKbFdM9UanUv7h8Dj#F2FrB59H>h+01j7xD`Lj!t<|YKlG)w% zie2O+QA+R6sr{K;@`1PKY{> zi_?5Nv2n5Rq$d}YaN@T)NwVym2C3Hc0?Q#37wvG1PQdmsk(O51I_$&Y)t-@{+Az-0i%gH6XJ(X`S z&f-rw$s{X11oZrtmnuHbN!#(E-;Np3>w93|8_}!Wdgb$r#b0uZF?+`MS57XImWqzP zP)`^W@y~|30zSe0G?F`W_hY=;^QDLMe4D|GaUI*EVcT!{Yc-S-gd<_@fs(8`@8In> z3O`4`fCXO7$*L-1bu&9y?>!KXmUX?0-SU-Fb~$8eXz+<}aZU5eC;6&2a5w>Tcd)5zm=dgY@ zi8(>S58p5rV~!80(Ozp=lp!(RpWrRGAbtM-z1R?)&eWm6VW@`YsoCj4Z8ct{MiCHK z-tIq>tFxT-U0Pj0&=lFUkInXyB^fJ>KzRQU__!;yl7+jW zrOAf>ul2FVP~K)J{Vb8?RGXjsjaL6J5^NkQkX0f@-`S!znAP`0n56v$w(&drzLD2~D0)Wj@|}uFbglo((z%XI^dJi$uw;= z>QZM(kW(>F7i394pd6E&qUAjR`WfXIlgp-`-0LBy*?2WZUS4OlN84G=T2J#sdKrd2 zz2^{|gOp6Y2KT-m8TE{vC#zhQ@r~o@Y!!(==7g6gtL0J_ie=mR*P0L#Sx!6nKFytU z?9b>va6tVG^UX$A+uHser7HpwE}ytIY_07z6AgFhSj<|nCcd_^zMxte>)B>J+;^rvI=c*2qqZ*llax#VfNCv5a zA7^>EL&`YR4@QWzVR+c!eWzsVg-lnaIjIlvf{lPPa74Q|-EC*z@NRKId}hkBd|J`` zT8<8RMy;jv;<3?YHP58&o7D5_GIsY(4535xRkbV5qwNd~-aP`)bf$K8285gK%XBq` zYZ`1s5s+rrtWa-NZglDTT`oCadbOR0Ssj@sIsXDDXPoiETF`2m48UZY83E*L)F$8b zcvu(?)!ejNH#AO-c3-dnGo6kfL||FBx~j8GY$(Xn?+Dg)JLh>7JJV9KQ_rwZAF_rIbZ=NT7!1qC;BX+y*F4r@VaLF%yBF{mmVjUCsf9N=H!xR?Cn$Yn)+SebN00Tl6(4saH>5anLgCU zr3zb?UdS6>zNjIt|LA*qA9>#3wfn_#ec;zIN#f;!#!f&QQq ziGDlzT%P29 zevpkam{>1&WJQzRK+(j7r*0Bz0?Lx3(4PwaYsjy6j$%+om;igE>XlIZAODe$;%E z3{-Y75Got2V-c{+q!ays?1gY9vN7DDy@9QV)g+oal}Q*3U$QJWx-H^ zV@RxpHw=@!WtnI=4|y{PAcxvzV6iXF=0`i(9%zaC^%)GYp5ZXG&35z$X6QUcMML5B zm%2}FOyl!+B4g)Vu*}yO>#<{Xu@UPsJOl2-5_iHSj)M_coy&*@ z9gs72!G%%9SG)E=?^->#YtC+t6x3I*dy^zA_j5`sGO+wYsq{eN~czx$WXoInQY@eP%8JpoN@g_z^tknblGOu!uCikGa~ZlpttQksR~pV4jw zHfmtY z|3#^2dYvOpOPqnm`Xg{2WOXXHn1gnWhm#n6mI$e~7L~aqR7b(a#lr7u;`k9O^IC#6 z53+)vtFeHtjnWSZ^qh)RUb*itdUwlD-A`NT)0vlc#mX|d;Nn6@R_&Dp}M4rSJ@?b8iRU0ib;lBqSt zxRumQsh!?TKejZ*m*;^A%G6%K*kecQR9k3!c}`FTr;6(r=hH>8d72HF6)@j_5IcgN{5ekHxQ6_=|8D4qK)MnS3qv%X+1u;AxJ!te*a1 zTqY`BiGn5BE5LB9Y1;%PF77&ci+>Gv;lP241z0j?5%;&`-43V0PQ4j^AVnKCE?f6esNMXH@ z%_5j%!`jQBDHIK)h6prZ_XI%Dku9HdwBJB<)oxQKKkXbIa|$M|4r#A6+1|Vkt#K5! z5+W&}2ebtM-X-u{AG;`u6ke<1Zk^>}nB_nM97SKAYg#qGL&kc?v1kNdXZZ|DX;L@K z&6Pi#_?OFZZUpYNpaigtb+-|L+^DR*pn0AlsBw&6dkFFZ3}`C&{Wh}fWtWpjU@yYO zik(V-i)hQIzfWjc770KyKSz3R&7%f~;Ul*P_4?r2>w4!+abBA?rSj@(C3u=BHn`#H za`5EWV=~Yf6Pz282dr%#IlCgW^9|i+6}|1X&BO3_jcXra(!IewbPwCy!s_KEM9<#N zkV~dFr04qZu76YQYp?H1mM^WI?7Cbnml~z(8=JtL<|R$sE!=6mHCR7m_h1b!`+MW; z4rjk2{X;k7Jc=HDkxPCR<@}oIy3q|6nY;m$CIq5_+U&%raoB@X6i_d;k3(Gc-@e=l_*0)&~{d_50BtkJv3sy}&hWwl3mE-x~sx{1cN4KkdMz zo%w0sLRtl`7QD~^d0RMs3*5L~(fMbIJj=Zq1CMwuPlYe@M(w*#GXp%)^|>?c8XpZLkQ#rxc}wYH zhiaJHy^*Sj596==?RYd*posnz%WoC{^bx>5vm0l%E3kubQ@O@O*i$_*Dsx*K)EWD) z&PRgh$~5<7HV+t*7)WV?!M1eB{CTx?$b2hsT^qE4+q2vXqJ=?zsyg99F=0d6X#5J} z=^d;-^g2!s*~}#}Og>n}<397znyqi1GjT8hi&9rR2zFI>EK}cSsOQ4vZz?-&HfUQx z$}d2=x={Bw*!Cd(%!g=j`91UNH}%Fz&I&bN=BpyfgZSP;nxb6gNf9*t9Odl@*Uxe! zOss^WJ2?(Pn-MG-DQMy7QWUJ;y*_#V{PoADZ{EE=tpXyp=k8Cmz|NkrK4dkCPXZ;E zMqq=9gh*sW(ncFxHk#s_&G-Mrdj}+;(nO6fKNkue;BHv)1dsP8q@+^+N&LKnZxV>Hs`N4n&vDY>*sm6?%+)t=^)(f;KB-iKjawI`AM z+h$-}Z%-omcg~<9WlKkRey?`tVzU|UlZ5^m?J(*=c>2ylHj#5q%P<@!Gk>GKU1{x5 zQ>3$~?M3LWNvmu%=Zl#8;))+T$1InK5jaNh>o1A0H{!LG&>s9J1iY5Zm`8e80J>LP zphAC={qL{`N!-{+d1Z`6k1Ny&Nb9KcRi~%mTnddPzOWz;_Wub#DsuxPW>%Ofk~N1 z<}!Mo8*`%s(pF6?E<^TZn5$_BE@H!QN50T^j<0;^B8m2!%eC%UcT>9Sb(UD&Z|8#h z=+S}`>%M(< zLh&NW_^J%zpqASU<|6&tb6#r~{L>2AZ#8fMry;N&wjjVf3C@!A(*+=9Cv0c)?Zibz zdf_2n8_2z}y|a1idtm|lJh|feU6XCU7xg&zCzF5lYZ5?U@b7glj3j0e{Po{?U-Blp zpJ5)u;u1-VZO|^7#4XT9ib6E}9@Pm5*M+xYJpCPrBV|vFuw4y540G+HC$R5Px*$!^ zwWL06@Izqojv=_jPg4Yr&?%@_1S3>X{rcD@t_)1gJ6Un|6Q~Y$7i6eIaoV4bnzevrh^(T2ktOV2O2K*2;c_LKMX#HK~4u2 zuI*QMJ>$XS5g!H9LF+)f(qG0V(&1pdKONLd7u)4JCoA^q14(=;GZ*ZM8w~n$&D?eODr%)cAr5C0pi zO}K3b)P-y_JAC_W!5%!tT>OB}BTqm8Mx?0z0pUfO=pF4Zt5#`3_JQj>Ubo7-u?SqN z{O`9~=Ef%%5L#U;6W_)1=hkENk$rC(`d&Qnh~DN-%+*3ac_1KSPab9D&uFJV3*^6} ze)iQ&(6D3aaha6PT?O83hOGpI@n#bkrkXRbuF1aH@0xu$pKrr`Z@BN9 z_b7!XXDl`@A9lLYK)B{uob#frl}#~u57DotihdQJv9UwZL#q3|&(%c31a)X0y7U}x z|IJlt;`4ZJxVo;%yZ1PWplwX?MC(qtLdHqyp zpL3Dqu5p{~8JwwQAH;)Hv&9J)%f^Nb>bMXqAlm!|A!dwdKwrvm)IahJ(v(ZFj-uKHntCO`&&OZdik#GTO zz&@1Ar5~;VU?OU2MR~VJILuF70IV_wztsi{Sqt{4RI*4e7{bK($V1x1%#85|~(ft(Lt37q{ z5v~tshJMS*aGx{V@2>wL=QLu2@a7wtUsMZ9)9q)KH>8 z@C@=aXUD(n@nLO;$?#No5NnRj>1836%DK3(t=Sj|Hg3DBU{TIxk+SEvOI|R&HgzOw z2Rv*m9(6NV2GzXrnjj6VZq2&$tCvs68&ro~y{`{GW|77hKe$3l<(jy7pl73?Bdx_O zDLv;6vL3{R^H2=#jj{kwrMGsb<;Kf{+%Zbr_$;HW4pUyx`s8c0JFRa66AH8b7*g5{ zs7?hA0U9O{Q%=u5fj>A5Q9>Ceh|_Y;7r3T_U4RR2hqvZgTvXT?`^hZ?KvYB151lEs zAHnJ>`NYM=pj;Jfpe_?NsEZHi;4uVz)*qwbv2|H0MnOCXM&P--F6&x`ME^2?KK+FI z`}RxL{ribK#?iTdTHkJ<=3a#X)n5;;gem5RVlLy|YhkZ$zXy%C{fpH^{!yK@cA4$l zn9}F7PExx{+{rb}^5hn^i;;FQOm@%SFK6c8uG_N;FxM^}Qcrk0qo?$}8?sf}?aNk1 z{}yf2NIg|`K_Imm6Hj1k)I(s~6n6tsJ3+N6Yg;yqMQ2Fjj&);MYg4R6;e-g>dEwMy zbLP!G>tCD;!kUAs(T(>>TURrE(XvWFzN@k-Nkn-MWRp0fo- zit4|lMq%co5vm*iZPtV0W;66cpux8v6HVbTG(HYni8B=oOt$Ctz@@3jW$w*_rHo&1 zuZ4RFdKdazQ#9*YH`Sr!dW%$K$GRitL~Uv+{F_F!ZW^}ZrqOpuDX$n}y?0~1Kl)Z- zL{ra#<(h7&U*TZBVeh^$94d(3<=ubqLhq$)1U!<_Lz5Sn9B%^>)nFfn=axBU+!OWg zU(arA?XX^8cr_Rbe47+-?)suaN@YlT^P-4Ua(0}71EQ^~mV3+IrW%1rsHqwVK)ywX zl7x1`wmH7ZE^4GPL$(JI#ulpzh)6uG5tg2+##q5983h9+2g$&UZ=fMPGZ@O^s$vuj z5|Iu32@HY}*C)p;nIH)%G>tsmC){3dcKMbCyXNd>&uLMz08c=$znyqttrr$-aw=k% zz(yOaHIh~IiQP5+U!t<}^e z9E&&Vk`<@P8Nx_v((G)B+A9S?rQ1nB$r|Mv7?VXe8GxT@`H9kWVh^72%IH;Z5#Jbt z$LIPP>pKy41yyqPQkKTrwTTuBS=>Yuc*{PoSgFrK&6s_7BoNdIyqDbR1-M!2(GU@a zs|%z@b+uB7eGhlYdv}UWat5q%%RN(zChUVt0VBDs$~MxtSLX`N%M^yAOD0!yd`RmMG0Raws08df!4 zyGLK9e=3#7f8?Y&M)7aC;jG!-;JIl8ZQuTreNVdU3>-1iJF|Ay)_R%jt$pYu*OPYX zJ*-kctHmWX89n?_qe@HcQHj@Z-W*24v> z;|kS_aHt5kZb#G0gzMo)%Y2o7LQv9`;zVI{haik&Htk9k9kMdQeCtC9^aSca>hQs; z3VE*m$|d##aNgrfZ~*2hMZyIa7Zsi%RYO!Jm+IGoOHCkuVNdj@aiA0!Aw@yw3!nu_ zk75H}BfsTY5lif3p%o@*|r;jbF}9I zWVb9Y8nMaBtArF~?YKcL!w3h*dJqkX0x?5dE-hhNCztZZq8M0CZ^qp$XR_N2D)Z%s zHhy4no#YS#QXg-%*#rTOlzb^~Sn)I|8N&Y2sTmPrm_cCk;EIct0_6%d`zQPE8!=*| z{W!RktHLB|BFLp?$(>2mD?%6*1eplt&ont!qhm!TpqRkaPjXe1XhPus4ewDwS#XC8 zzwik7o)=63&|qw(rg3Y$GvvC#P0=m+YP$5oBi|z;a{iEQK=DS}It`YrxJq&^J{f(J zTH*=8UOgeOiAQlMZ^Vm2Uj6E784nL+-5i?cyeN7U<bn9g0j$%pf=F<=8HP}>ftk8<12xQZJm#9z^g`XDQF<0e>FT2tDI>Day%!6^A`Fp3 zZGQQ7TJxzX?&d4~XzWwSQFO^QJ$C1m77YEquE>uOI5H+GS|;jJ)A6HV7L5MVdv4sZ zA-gbT&rAuoL0o6dcvI5o3o+~C_O}%)?o5P`I3b;d-SRdLBZWt+9d%>GrcX*kKznQ1 z!G$i|SW~mt_{m)WyBQ^oU(*Ww#oErdmmu!z0O_|kHm0o}Jez2Fy)e^5Tn+o6yYjGV z(ooDtg}zYB)tTW4p?!V#eksfaz#3Pg|Itv<%B(l|Co+0!x)HApG1|wSHf#2gB3~?g zs0t{Ue5r|Xb|v|jmJPiNVZ21Yw8C63J2wK`9Td(}=kPr2F5QMdbea2s2SAm6uCoq89J0?oYzJVq;a|mj4QQZq^$Aokm23r%cl{t)~ED zQwj=SoKMQ*UAV^WR zbIyJKt7|nD34$Q7v9Vu&TP~ETYBSJXaL)a?L@118Q_EB9oX|miRuNi>bt!tS4*ZF5 z!p9V2PXd5;)}3yx5k9qFT6uC?8GjLw6ai@)EH&(@PKJgzZ~yI%<9yH(SV_vxXjNfl zkT*DeT7GzTGZ!Kei9G<8LfL*GCQFIIbzGz*&~jbRWH9zfaHP5OQ9yfI_s%w|Crn2H zt>#*}T$2W2TMX4oZ_TS*pN)<+_4nE#LtEw;^Lv%^ABRKsC2yS1%N+DGy~>cjW-UwUvM)6`Z z6|?bOQPl1+KD={yuP>p#Xc4#wo|jpcpQ|j-MKVx@TrNeSr}w%sXt_YU`N@J%2RDM9 zm%X?UfLJKg0pJbj&IdBC<%8ykX@ zz^Jso)g9#VrWDC;M_S{YkVe=Ye&k?N3j2v+*zanQ3Xzof_ipz^lh-T%zI{PWl{EU2 z6DX%yvGWFfiY4ifsNoFH8n-l=?RL7skg|&fq4t>nt$EC2VHeG<5(t<(7qX@S(Z1X0Kd1PJJ`&1*Oy)q|Ftb1>nm4=a zdB3liY$59yU9))^^8->YmGSMT9r2x7+3>O6v2eRAKdxd`z7p4jPPE7n-56V|Rd@pz z)Z_F)h~gN?gt=RhswxQ6vQzM)G1ouGd<-rWsP!8{8QMZ7;6%Qmc! zIy4Q9iEmS78XHBoAWW4Ox8n9^Ko; z=#RW}GCFrT#N!qZSd-RsW);M4_W=5(20^d094qVjJDFiYLUK3?;>94TbJ@{kuz8PtNov zyU9VEff46SYWWQ6{Qw71o#L4l%f3kq3>NEHDUlK@ zchsK~GzGSRB6fn2=jup~;y|@Avxh3m`m#P`W6#gLKXbs&nsr#xy97stTY{(hq^j7q zG9QIwEDjWkJ5X28JX~glI=wyc@Lt)UH?dm1+pNW86b+$+cv{oOp+4@Ga`Bjft?sW@ z3Xb`V9-@APe(zwuam_l~Y&h0z*aGW`Hn1MKGilw`(z>Gru$CcEmwevRkok{8qd|cM z12R00jhd{Lu9xykDyu6SV+$D7Drj%jFaHi}b@z_YN;Z{0KZ@(P+5D&Gt1Dl{6s@<3 z%2yvp2(@sw?>ahHng-t!UpaY)B~H$TbijRNFy*)lQp#h4ZYvp%d( zw9ISu`N9x&Ydyk{oR0>Oi%M1_Evg;V-1S~KtkxIC@*zHnIr=V1(NOX!9k0NPPmE0g zNgJZRZw8loyLy(MMhjD_pt(92_FBPPX>;YY1OXn_luiRMn*}p~UusX-zHOt5lLQyX z6bFXT;55DxyPdzFMtyAx5Qy)n*X*|uxI*o?@EIG!g63X)i}LG&rpcL>_K5dTHv_Zv z8!9>;KIYcRZfPwCViRmctD0Qgi3m-l5`{_5G21T;-Im8hqL_7*ytPNrA71xxf!-# z@*px5uYsQp*&7#{y=MacU}N*`Q1@q%3$uxlP8;NB&*%0oAEU>w#W%+AC7q)@;^NRM znsM##fVsUOXyyIA?fzWbqW)rYNEo|Z%RuL5wLT*1J=|f!8z1DfEomKJ0|%{p^*4B} zp5zz|G$K>8V~u}cm0d&KB99x{EowzBw6E+LP{DEPh!KAO<$zl>>+6K>jRbX>yq@-xP&N)q8QH z{>rke=cZAg^9&=L?r*D!r4UIGqw04513aT_nGnIOVXh%`f?cFv7K1B&$cWO`nmm)EBdTOv_eV%{RlVM?@jX0?_p(56bR0c*d6SQsKW*~e^{l@a8EOAnc zg+HRbHk2v-oshP>+Z9lV5>ef*vP~&6@G;Vf7|d5<{`rm8EYXA-kw9hHTFD&cS9P0< z-L84fpJR(UoxH!z^=X;K5ZwonO!#%iw25zeo)xH9zbLXzey%qGLC6@rV_%KnpEvlA z-oH)NwXuUQa?-i^Y-jp$*cQLbQeMh6RD1NE?*zfnLu@@mD?0OHci!g&{B=&M7z_q= zIZF>7-L&&Xg9A<9<%S`Zd|S0@W=?~60bd>^wX&$)V> zj*pHMl?&1zan7@;nt8q~=HikJLU7T%iKjhu8GBuZVSm);Jl^XJ-eqT1R+O@IDrcqu zD>y4_dDBCm_u`;}6_6|v{})FY2>*rgJf|Zb)OY44tLw#x2YI{{P#1}P81Z0}LOxqf zPOo!&s+OXV@mhWrMcFxx9(H`*1T!C~c*#%Gfh-N@K3~O2cKt5P6j5{%{ErfT9~W7s zf=CV0EP+y}yIm0YP))D=*snKmyamCLhyo8R`nUGGWx`+OL=9xpfPH$?ZZ}_-y5UFA zAb=Gq2(WZfb+5rQt}@MW*fvfQCvbW*<0NioiVB--0c%rjx7X|M$)fSfa3pztAm1c}@?@w zINFLYdby)%Fkj30=U~P(yN#y7st}7{RRuC^@yahO~D0^NI zy$fj=4#9&|yH8>jM**D>B?gJO+$>4(Ov_z~NP7BS&s3^QdNS>Ocy~4kD3e}D?~r+& zv4Bz<$)g~kV+qLxYOMSmDE*~+T#x+mfoLsR4c*pHcRN#uOl!tk6jBqd#AQrzSdqBv3f(SJT7)A;!7?0?bk9+_G!n9rm|Uo{=g;KcE;6wPgi zCHUyS{`1iz7C=grx$>Wnu*>h@I#ZNJUI)Q{1xKcnqu{%M1rppPxFa&jKnOkO#>Q% zjsMP6zsBn)fz1#MB5#9Pf&)Y;n00*dPtWs7u-5u+5C!E`yj}+tWp*TWc4Y0Wa2bgH zC}~GK=Kitr$SW9|@l6e|qz5tq)$AE_+X3|JHkzC8AgB zWKl0TDk+=Jd|+}+gf&)=54lYOU8$?JV`gPQDU*lpp04BhXRKU9S;2`U0i@1g6%1p;jaO1J@zRnzodwrt`>jH*FnWGyDq3O!RW!KII+hpm*RX1BR>qt28jknE832 z4P|0*bqj(NPitw`rGv7Rr*@}y+mEwEyoZSSw?*XuW)FAR5Y|6>A#=sJnY>-fOF%p@ zR*W)0M|vT?$ZX>j4r~PRP64JbU6== znu??JD7XlY)Qkh8_O9a<$|P7T|3+)&>zusI*>5>}le4cm`;;^NslVhM8F9hs>!*LB z7HZi=7z)n$r;O0uPRkB()2GS)0liSGP`~Ef03S;zni89_!pxcboneh_r&U$59-IiCgr3ry)3 zTjk|SCdpa^GxkT$r&FtBbPE#KD>+~7c4C07Dz=vm)*n{gI^$pYRL!axn`(6ofJ$HT z&V~YDTuwSuCM$NLdzhBj=x6X?@nblk(||Nj@CQ z$A9G3^dfB@M8W^ar*g(JUQCBG7V}~{nz51>(;sH6;KlSG`eIB3%jmcyaSe!Fkc`E& zuB$s(tm9?LQ>Lnly={`6m1$~A`T3~!I2Ytm zA~0hROb}8NH!1j^`7{MsNy!UL`E0$Q#Po~+xq$g)!af&8c7+1ElTY*|Y^wj_<^t0q zbj%g?I642bn8e<0j$;32nqhcrJeX%iA<8^U6PYeQl-7Q~+r@N3GX9;`5|~$_LsIq@ z3T1yZuH`pcpeP7snb{n>9l0(^%C_hsh_Z@3gZ~6&uUy1`5a;;^taq%pGo_Ks@Hk7q z#A})Ket!Sk%N};p%%OOsybM>Jmbf z$=jU$DE@)bqs{l*64%q&*h49V6e_E`vtR*4w|ij=phS_viRPxP2d>wS2qkM?*C0gne- zA_*8U94HS+%zM2+CE-=hVHt}xyD9m{>%l56pM8NMHF*Y@14(wB29#}hIcZ#q(B1@p zv(me}$?d&O9pn>jjKOWLZm{)^Z*)N zW)SlS^3i-yzZMt{4a2#q055VpnKyao(*<~^76mD2pCi8t!@n~ES19;}`a=fD85L`D za=IA&?JViy4fjvG15wRTqqf@i2!g!{R!}FcknXIop~X2@uAhl5V~l?_NXv?HP8nX zcwGGKNxhTc7J4H6v`WLhv^FAAg^${KgGxrGf!h)1D$Cy#SspJ(i;gWNFoUM&HoqQ309dT^6k{l<2mvJ$7BbFJmhi zp>uaCW~TD&2iSJ4RM@?t!!T5hk<@y;s=Q3h?(9pqj_=H*c`2A}AU7A}(VQw6*i_6~ zV-tLDJmb9(G_#g&DT@^tC|pIHvQ33>d96R$+)$Ipmw{y`UXPK8h_n< zkT+P{xN8F*Zf@zKBfk$cv2URaqFQnrE`C#FQz){z2buCkH-*nbv<9CS`{blgGnAPR ze9%FJfOJfi0wt6tJwU3=UY0Xq3de|7c$;>PJRJ$SSECCgU>4eBI?03i|pken% z^&W;00ESp3iea2`5v6P%=W0`kNLG~EyzW{aTh%W%Z`2(>@Rc^G!1RFnV%b#InzA!Y z$+^#h03+Go;*-5Aghn>P5u^Jtz_~fyllBF83McdTc)bz4KdRVf)fM|=3W%Q4L6Xg3 z*O)yM*ig@)&keLQ#<5KDf+$3SXhccX5Afy#hOb0KfYhs3fmWto+Rr1d2g6UbbYjIu zH4W@w47Q3BlB7bb;K!9nA@a%;#oO&LsAg^6-ip0(AS`YKV_Uu^FG$KdB62`py0cTQ zLlep*1d`QZLk5-L>mgJEU^2?Y<6;>hlfUsi<)Si@^#}E&=@8{EkM81+p=kuedJYDMF|~$8V#BQ0@S~+ zBl2a#TvDeUV=FElO(n_7`aiIG=!F;RrA5NF109boqHM{vX6ZF3F3J`Dim_^eWAX|CnwV0V0W0>%Jip`@rS1VivPjpW$w1~RSAM`f3 zt252n!mwYMN=1$5V5JAf0RgaQ)FpMc8d>**X{9J0b>@4#o_NZd7vV`r+pj2_ub51_ zbhFoUefr8IN(Z+1-&qnV{X>?J>xNYcW_Cw_H47n6va4UpETz-o3|vDW&B6LAgT2Cz zM-a&~xAo2IFr4PzK{L5)cEp2TtAR~`c=H2{NH0@Fh~#_Kt>x7ceD1}ZrwK;!$*XuN zJ``)pymvIWZ!b7XR&0afBGgsh?MDA#30}b3%5ddPMkEVNCH#8&{Q&@VR~yas`;Cm;Z^;u#>14jpXQyFz zk(#6^9KFjnN)-5ae7UZHe^3T`W{mKq5_yy|EZ-N|>N+sMpn_2M2jNfJ(O0&HZN*x! zqkJD|QE8zH2;o%J`N*UC(d(9}pn1+T`>&zFo7agQ%1S1Um1m>7FE|xn;O)0&loz>{ZgqFyV^hy6Lze!<#G+Ro1fj}ahix^pV0dK!-cGy zxgJdMkHmOGjcRb9f_C${-R>j#{(%qlpt7uWQtSO{S_HH2bzca}Q2G&rL0riASeOrl zGJ$%3uf+UwA%BIjO=RcfxIAH%<6GZl?5#J?p?Q2BagxKTabuKwS8g{7U9 z$O$6V%UXFhN85TexD>1Si_GqcH@2b1erSw2WGm*qsnhv&&!+76_wrv5O;p{9Uy5&c zwtnV+3!lEr*?QGbH)Oh&DQG8{CuT4^!qD8oD$aM@hqJSN+hlrT4g(1^C)m#h(@G!r zRv9Ye_-kvEf!%QvhRF8~IAdgn020giizq-ZKaSUOnMP1s`Z7~0yBgbb3+gmO7xpKl z?4$z~FEP49i&FMiGfau8J-@hI0QQEB@qk3i`sd(pz$3Q#OhLKMRNwG^Z2kd3iv~^y5+dUjvzzqEM%}Dw3sxRNT1OpQzQ3 z3PWPagYT_xlRVn@Cu$Jqnu{PJqoh%TT-wdS@LmZ00Fl&J1YtkdlvCQ|^O_7*mLH~3 zee+)@&=xT=#Xn@EL9kj_95Ts=tl&e~oceCISd>Cx9GZV&pt5|o8(J#2R|}MCbRUiD zdf>a=kg`6?qvahSBOv5b6Z{j{uZ)5tq6Q0jBa%q~{{&GGUzXW=qeMWDg0WT_p^?h+ zqm-iHG%l|t5Trk2bUTkr;Z1jx9dQWV!4C9aM+$|uV+lP4T7YXE9VjIYf4J3-vC# z==Q&hit079>togimqxFPnKLtGxKeUK(jy)?(N`HE8E#wg*sKaZ!eEZ|LznUV^Rmb` zX>vTz)>#p$B2G)3bj>m!yaH0Mz}1S0<{Es{0?2z7phi+;T0^g=Gv)mele`sZY6N>d z-5o-Q<~RFS31#T$uA@yM^R8oI)7_5z0r4Ja<(4pxA%=IDhcF4vdk9RW%_l|(`qKHG zjc;^95}{1+{>U#95ZsE=F}O`Be$EhN)Cu9B47^4`9d7P+MDiP3l|wWlTp>7sL-t7H zGK3k7L5hEL;bkOW?EGKHO1TS~zLFx#cMbi^72KO+l1Qt9LcH2Slz-KHg;)s$z$0h4h} zWsUnIWk~b!vX*n|1tS*9cf7SAO7Ls{nEQCZHU{y$}LT}(MeDS}D-SF;T79*V(Cnm?cd<fV=1v9)94C z*>vp~mKfB>yLOG1^y5`$2P3L`Xm6DnSex@s=Z~fd;{eJw6k)1Z#*0Z|ICkVKoq~=t z3~rqiZf8Xo8#vThYo@E5L>V_6dVJ_KX!4HXuqt zfjNY}24K5)VQB$OVRjdaLaGS~fD{flqfl8s+lPrLVj^i6b|OXWHK$>i(g`62FLpa; z4$xqUHVu>_r4?JPcq4A%D$Yr^VT%=I*@kbciY?mIDj?>r zfdI3zC8-S1+QAxDKy;#EmIH6E@uX*)snSzcv1M1NuMg|Fz;K9)U9CEqt^YB85QZt7 zb#4EJC<~~*{bgmt8r(lwIv4iW{%}4I60s0PT`TK0_M?Zi1gZDj`irm;yG3>-OK~8R zVEFiE08nwSHiHY}BP$2s6^oU4vCb~z_4&MzxuTP+0^v)rj!{=`(W_18qXf%W(W?Dq zZN-I*$_W3V2MkveeLMQx_`c4T&Ct9jSt8ETPsXD{Cte5Uh3s<0x1MV`R-(9yi_fhX z)_Y3a+-cjArRx>mH@LPx5#XWZr|b4YxcbSBAy6>$Gkx`wY1Aja>rq7`XfqS1fPd*VDlOR#_V z6Ks!QECY+Bh3rjv>HsBO3+s<^S?2DNX6}kemQp&HmnGTOrV3}5V5sPVpN(lHSWoUL zNG>O9xlBbe!JAPq8V>(wz)-5`Y6kahR|V?GL(OPqRaG{6;^T-L%(M%zB#IQ~hcT-w{&FbHA^^c3SV55JPS4e9ucGpi++`*-b)u?^g)S-Z_#l3We+V2t1FI5-k)M8|TFr4Yfu zO^yb11PQ+og@Atr`pH3o<%aDO0mN9>9F*z4%FTQ(%90EI6I5rwO{rUL)@p1A$_3SD z(>g0fjZ`^3gw-xK(O>gG0Zj!^R#*~{}`g2TNp`95E3K1vQ zg;XM-gREo8Y#lU^7f#k|C>ru0lGU?tH_3WmQ895Z@w)hGxNR!mmp`dV-OtoO*@4(B zqGB4LU>M9ueFuWcI|pHiO16kf9%{cwUKqQmSlY4pNH!Lz(IaxAe5N2Ge~urT%@28RQ$K^-J|II??0nq7&(} zHsw(V^yc3+%a*p5Ep7JU&@}8~Rj5W1)!wDP!5k-64U8%U!iBJ+mGhn=X`v4lu_FQM z)|7$;jSK}Bx8ws?as&dsVkH<}dk4CizUY21EWv&*M0%o6LnW^S!`k&~U?MG^XrT+@ z@BIs{`_w&ELc!l>X@ZEcByC=4x1b(LLD<|{mWrfIBAqv2n`_d=jcHC`PmVCEgI-6t z3jEU6RP_TOm6vp6L*m^#T5Lc9^oQLfobz;I(r9i5xr90}uo_UMn+1A85%)AXQScih z$O1|u8`gL*2%>P#}ptA|+HqPg$QxDBF#%K?L~S?#qUh zGz|Nf`rqA-l)RV*7r~5W94aLf*%+jaf;`oVz{~hH+o<;dT_z9RqO7cA9H$wR7&yxu zgeT^S%I3fT4Nn0K7AtXsWw5UT^SJ;!G4Z}uvVumz%K9M%PK7sJx`FULmi}ifsl?8GQsDHsOfM< zndAUBgOI^%8DKZEs~d|iQ5bAlgmydj9d9xTD9gI0i};oC2dQTYF14B`zsO`0ui?}y zr^O5aOwlL(=pU@y8@!y_As&xr)Ho=P|1o@=Vn~8{mTmZOym@TfjyDzsBjF1or<)mN zbDnsxyZAAiR3GNYvA0qIWow@7f4AS}xD;t}438q#0Zit6w_C$L*#CyjjOyVY!=Qh% zgFcSKuwPOPf&l-)y)X7=f6dWrK;jKKP@e>ZogBl$`fKx|IV3%sB-8sRLr)tL&A>L( zM_O}OS2C5yn70*B_Cb)*kWRk!Ih*Z6BQl>3XC^qh_R4XK`^voASsu^f-mq~QPGc|} z`8cq>VcGkkWIgjx?}xItmZ^w~fU>0~4u8v@YB^Adl&tA)mmMFo)T^o9xHoQ2$%8n|lR?aX%d-qLfQW^=g8fgUjpggTh!ONzuYZ zw=n3zkr=pufV0F^K%^i>UvxOmWO=et8CIw@m{A**0k8-9;#i?o6;;If^X5fxh$O-~ zvH=4tNlpqGV-ox8jVfg#Og2hmxSAVN3h ze}z_4`~g6fj{Og9B&T1j$o3)<6|NuHs;whNU?q{1DW)hJ4YfY$OPZ%FKu2-FQbh8J z?K6#r`f1gIyiYyk#3w5Pg0CHfsByDQP8xA>K6FA-0(B4FB|R0!hHQQK0j9206nqkQ zHB7Tq1eG_K_h7O8H8B;-PT!;OrgbjY=46G%-D(#dK@s}hif=95NBtqYN1WbXL>Wjp zamCZI2*a%Dbo1s=6VUYrOCi~SXU+i$=`>4jA!=e8Gdbha6vbLGV+D7zCyP5|+$M&6 zK>L6L*wyl1kcP1{6oU2NyB&#nttPx*MJFqE0r~VSbEpzeR$3j>@;qf($3}*QeZ5g1 z&ITgIYS%OjO*bzR+9dAJE9afxUPOwW%dcP8B1*MDDR@d$#~VzRw+v@z)|a)CK8t@4-+_PX0`sEHdbO{^$(6U_mJ zCuSKZ8CO)(0wWn8J|-C_1v)j@wVNsG#1GWZsfcKj2h3D=tt+7>DOXcO^(-n<5DY3ad z`j7@&&Fhs>T(_{ zizM*8Li4=B35{Q5BC_M_BF=NI!wQPJaKnX30tq250aNYU5bW7ZNAaW~?A#XH2cTaG zJEWa-t?m@6n%w|sv7Qp^KKymWU+cwvna$(1QPO@}@#&1cSs5o{?>a7fX{LJRD!Wd5 zmtr1oO0;wJjODB+%brYoanIBo>;W=wFI)8Dw1;v)Pu%39ka~VGrFJFI`{;QdpRb&% z>sNz%QkExWDZq3S)aY8f-FJm)p%2IakF%$BPAx`w2JF;bx>#NW>_vAH{6`YlJR|UM zxyNfjue7e|s@w0S4H~dVN{yZbCc~~iZ3D z2`KwT5IXsf$4{@rFhwyzWqI_EibnsJbN=*t;$8g@<3#?UqS1de?wae&KHJqH6aEyn zB3xmbAYDta)Wli8&j9`di^YN+sDW@n5S?c@tJsHCBiE^&(ew*B5ap3Vx|*=nIhd#z z0B`-gY9Z8P;3M4%zS@vqA@h`u(F9nlK`9fy!CbNqw!$-3^f`ZqxxfvZc|j}owHZES zO%;l_K*)P^HB&>m$17~*@;!k{fX{BNb1L3j9YuLTMJX+;#@Rt_5G7t%s#Z-q>m zI5L>k{Zf|7nq5DxI`KrE+H{sw?C%5NhITW3Tp<*$g1{HdO4NEo8=^iP6e3MTK_@Cw zTC@0-IKK*@sJrOI)7!HIlPDwNyez+v?R*udsaQuhqruZ>&rd$QeBX&i-b^H=6G9{x zldmfmqXPAhi@5{L6f}}h&agEEN$GBPnUTO=eV!G-N%1J@>65E>E!CZKT z(f0wvx5HJbFZ3`nr5C434_8wp-&0Qr{dMJU>^@N9Z=1D}CwZ=?-7Mj5htV*Y;1v`i z7cr(Y!zCon-w(#Qf*1;BWlgF*37MC3ku7={cA)8ZlPbA}I=SX=09*YV#|OJpCX-(@ zyV>o0p#~gxj+smxwkga+yap(go@+kn_2zN@AK6=knXo{xFJ!zeOYEcJ--(6(+=Z(b%jWO6KIQ7S(=3(D?#`a#Cwrn5Q~bs06E z1qWQTM)O^GI*v#N!8%nrZ9^4Szq7 z&MdXyDDNj0)A@sGg`^-t{onunPw^vjeQB%UD6*>_bZ+*gliAxRn~ebZhNBH5 z0*LDojgi3Gsa$wwpMK-y+wD?)+a6Zt#rvlfZJk!8y9XavW3euUiN?hk|GCM~chrtS z=VlZ1N33XQDJ6#Ryjz*V!Qzl%B?Ou-U?8ffgVS}%IFxw;gEh2EfHIC?B> zM}28iA>$+4;&=qe=e+!ho4&0nvib9P6qV!t5I#gNe;AStkB>&R!#&~gIC;Do9~~uh zt88!6WX2W?QUENGb;vcs&@z_vIgin{G=~!0Kd-z8JgeTEJ!2~ubN9!}PRF#IF$Hk? zx{oy+^D<$jciQLfK(D8kvYh8(nERty9bn{a!O3d3BMW}-L{H4W(TJ@$S#Ym)OaXV@ zEv+4Ye6*O+FkB2|f~8j|TkUpx=cqR-$KEI_+~zHs`#KEC`Yut}+nhMZPI5taYRM!l zSI#n)vK8}pGx~H54=z=#Hd?}g2+XIk5>&rc3ps?sa_X+UgIp~~wbYvBZcrc;c(>xhR_-YdZ%pl@Z_*sx!aPWI*qcW<8GE+s(l_c5cEI;*5qbS-57i@L z{ww&Jz4P#a9D3O29E!+UamQ9!N5^-0fDL$iKXV)>4#T)sA%>52$Hj3;C+6z3m_->Y zPz7n|weX~OER>q9kyvl-Z;&@*`e0siH$zBk7Ov^9KVtE{ETQCGOhM}#HFIwB`I0@; zJvWq!_MWkH)1eT&?NA8DzWu%siBu&RrE8NtQHO#48crA}bNhQi=uz-UUM(Lfncg0+ zvt>5O)1{unF57=1zkuO?&vfA;3$lZw4RLbHx2;ppnkNbEIU6me4U?_Zs;SjiWyJ-% zKb6>fpiUxIHiWCx)jNiEM3TD9V-C&(H}|L2uk8zwf%oh2D01_ ze0nF=v65fJ`^;_#DB)7XnuODdn1JiDl{oHVj3Y@hXnCN;g$dcw4fndiQoN);WI^EX zh;&h>Op}j97{?hkbtMaVMOx)00pJ4keTSj5+j%g##iCu|4BlaioGHJ?nbu!2;HOhL zbC@p{2)94<@bwqI6H*~QzsRJM~|(8jMl~p3eP@iwd9<4w_O6aF5a)=6x+(j zA_~@`EZwCr6pyjkV!Y^bZ=J5dol&u}gI{sCQ(5Zdf{zgQ7i%J+bPRa*up@T6k9Dwb z>ce=@$*J<=zDoqYzRERsTge1{mIrNfk=pJ0>2CLswiVkf_EAy$qlzWobz4w+oNQ`G znzH_wN;3)w7Mu{lKdi{rhB9(*p8P;2pvlXma*;7%_-2sEGKZWjiwd%`QHo{Ys_$Yd z4u}k&R-I#FclQJU6!S%Axx~J$V{Xo_-L6jr|JAd&fOMF^z83=w#R1oI?VO_(TQ3ee zpj+19R~h)5YiqEuwqQSZFSW;}tj)kh1z0SuQlCL>Mois{JX^0X^n1!EL+h|`)?xEb zcVcS_%MXoMLJS=E%u8-^(WRDKNz6$+@Z+_1yRs3k)oMss3P9wt-axG)A&k@&@hTfRK5fKON$_JM`=NU1en+t^toQ@Y|+Ebiwj>%>B=s3 zS}&+(9ffW^z{TbTg6xDfp z#9-3cOpZ3WT~OWfRFRJhz!o}hGvhi*0f4%G91a;uc8)I?mZz09H`%f^$wg(`vw{~; zmL21vB$t#G=ytCopjf+ep4zg}#bg-0BlNhS?Dqws?CZkSZMm1pRdh;34tlh zSee#8WD(jIWB;`bzJXKqtlg*J`KGS7+3#zKr%x20FNi%~tldU;6U4a$RR=RMifkQ* z*0}LzrMGm&ZuZ~t>wohrE*fGNnmzRY{&I-$?F=45*=j{7Qzh{ap(hLb{6$76I~$Z@ zsU^_oP!M@KV`qaTdzGm-STC3NhwRN@o?Yqv6(r(vqgm-AzlkYsTs!1dPZja}vrLyR z)HB(Lp2~Xv{BhL7I>Mz0{9FW3yDk@DNdEcb$Sv}wd;*BhL=T!>E)YSW5XqnrrhIyX zwU}5qBPw2^;hdPLP?Pq5?tN}R9h#SD%tOtE&X~}Xgr-V^v}AvFiK!#bZw8;mZAnBe zr0M}p7N}jL336ddPd$e+`G6%=e_a?hKh>ZLuuEhNJ_kQp)L>ZU5+aOcy3_(_|8lY0 z_0M1m&d~G^6Jqi=JaWodY~jiE7j9Dd_ePv00EW2-8>ZLjVME=@Br2J`7i}u`>m0&i zh~U4^38j9UQIdhiSx}cf3I0QM#nk-5sq=f%LnH4(}(rl4f# z2J^oux&El$)?3L0EmrX)`b+;yh~c8biBF?o2-b^9SJR>2 zG$P8Irlnj2OtP(B{6PG2{rvju+1bg-$;tK8r*D&g9KRa9Jvn{;_Q{WdriyojY67XW zMm*S*qWoi35D!ByI?srrhXC=s0aevOv^ku-iQhQ#zPhR?rL*=cri_W1HJi%?A&LuX zsD8I2YG68;SaJ2^hy}xdjsE#h@uL_1qbJ*MG78w}|B4?e1@vvxiH|}AD~kyT?DK;E zwyDpu*NYlq&#No}s3>{76lV$G)D>bWZax%iu)NwsS?ED`mVQT9g#jc4Gx^P2 zAVBa^fV)U2-BJ}B5wy$d&@fa4ot2S&aa;)d@&IE#dU8RK-+0W%jT?yzd8Gd^>*+7D zy`nD@a{m6MF>K|6{2r6;Up;LiBI3YHn|pDC8`=L=9~ezymHU+XP+L`6jMUkEtK?}!ZS?IlON zGqLL?Kf?Yb)PQKd&+?bzi&(o5yZI`XsphB{wqdNI2ZH&O29zxS)?R}lE!UL9Vb7F25}oSbIi<7xuo|3n2~zGGWIWY)=8sLJb|k+E!@ zxYtByDL+d&=g-3MDkXICIVHu2MrUbdG4bXN$$9*IF(|~}X9=IPcbdn^{S#X*NPiQC z{j)lKRxXHru+RCNmL4P|Z0lEpM6Bf(QD~N0zHC>WujOexMi-kkY;E1FwMz~~fLtsb zYRehS^$QCtruBPMf?chO?7HXU@3kBDq{;phiuIr}mecz%DiHZ#9^XP{A{`$vY87HG z-G6|o_Fp_gxYI1w-NCn#%~($gPS)7gv@)BOA_i~bw(IK!9h6z2PH)M}MZFhO zPBt5&DEmeCcVNsoCx^ZW3RbsnuSC37t0#J*AIVfI^LYnsnDA{cWvK#|YV8&)QWse+ z3MEC!)smbI79v)gLX@a22=3#Po(-08p8ryQDAr)O{IViiTlTM0+AYf0byR_RdXA05 zqdk*y+k?7lfZ=GY|3*O&?AL{!z{}O31AAHDd9ffriht1AV4kJ(SP>$*VyL=5U35yt zM8d0nUg-03Z>PG=%=tVFNms4Imm*F?5zI7GPl#SyYlYt5rPrEcHEemW7PNJq#xx9L zLRskp6SgL?7G2+DrGjb1kSJs6=q+LiAilwoz>V$3^c?PZV=6sCJ0b^%?hOa+2(mi7 z$jFLtjb&Po@0XJG%GCy?t|Yro4QpaOQ51T#?hv{XWf?C;z{GABd`Lg1y0HUoy#HgM zW^OYrxCBH)fB_!+60z2y+iSvJfqk`&s5KV6#OV}n*0ks{teBuCBCwuMt7VrpqWaSX zpU!F__;k?-;^Qv{b-V|p2G&6=kX*1T#3Brbk2(J7Jl3j-QBFLVR`!v|8jOfZ&D*m$ zvB~*<@qfBa8%XI5V}R4g{vS>{gnMhb^~w2p&(>^+df#nTHRu61>Zw(%AoBjhyO;V@ zm}f;H<_fa<;3SCCUc6ps*COdm(RH-k96?F<{}-)>-Un-+&lPa>}4hhnY8Q3KtQ zH-DlH0>!=WMh-B*5#~%djwXX~I zX~8}=y-;5lVfb}1SgbduD%9T{x_|Gtm7g>0#Z;Y_pW~&#pDD6$Jyr6>4q6X zYUv~AGP{B0ZeG$dVyg&zJ+Hs}(VJfv{Oe-3`(@#MElf)E+lrwgT`!MStt)mZ;<;vC z7|zRp5o>88>JM37X#N5P^`np1gEC&kg@j3BpBDU6_uHnk2fQr@D6NOS?9Z5dUBEw| z78FrlzAh}pEc;ad`4$_#g@zvX?01d;1sBu6m`XmpI}2u7={+8SLh1^HKhnGCk!Rzk zVR+F|dLRr5F~S7^p^<|2;OSJ%5C(;} zo!M;^j%M{4;BSp`G*Il%n+B_JG{65Ze8>l~#Jy#^(Vzat>qcv~U9;b!Fk`?kO`e>? zuie@z2i~+$TM?j9qDf06=~T_Ya&BWL>*`Q508Mf`rz1LJ`+iegW^0*#E+fg{M^se& z6jbgE;%W_)^0VKcy?TGH#ee*3@bdM^Q_A|pWC_A?ItdhX0b4rCtZ)G=vvRd#^MVL; z+m-mYc?vUcj)8dvEVZX7JPo=ip;bj*_^N^>WzKoLMC{ID9fq27HA*dNZKBB60`dIV90*}5Z-&;hR|`n_YIRO z&Aot$PV>p9Os2>yJ8pvA<&MYp=)h8%@Sx`p*nCXiMu5xV@BpZ_fE77y-6)Z@2aU~p zpkve4OqjK~=rwmGFdF*@JaJkLF&_ie@#m)Y0IsQ`9vrmJn(&$SzA!e1Q^Hq-Fm@F06^*H8etawzie9ZuOxQ zu3=+B_U76?qq4kyf>QQ+P>7{0RdK6jJcLtgBs?By;DL=CXyHH^y6%4*v8{`D1qW?K z*(UMiTd-7a5_=9z&sXeh#co#Y-HN?ju~(}ZK)0tLnl?(d=~V}!Fi~vrQfoF)OBHM; zW&PXP)u3VLk%Kk}R8hY3Rg?~`Ws?k)h>HZljw<#?muAxBJhspkobtO}f0Ml5I+1swT{(YfvtnABN;kG@oP-(?^`LOO>R0fR2;0T-Cxza^7*$dc;HCi7Ufm-rE z%f_MEJ|Am@vgwSad^k>BD9kvuDCLriX*#o3vFESltcP@F}N0&pQU=Xyf@yMM z*^)K{s>9r_s#w;=1nyn|Cbkd|C-XBKI zWoq9aRcs{w(MU6mmwV-;0c9!XCn?mM5WAg~Bw5NcCV9*XemiG5qKAs1@#v3D2Qotv8V%2Y?Rk znj{U{5j8-gxF3zt3-!9c#`Hkif+jQ!HP`y93%;0Q*m)fSvTsuMp+>o4jS-pnF_R%v zMs>>DUEMUh05AiSccHg%lvcDVI|!tn{V;5}w(1*ZndeJxRTY$`o&)%By-@3=Ra!mE zYHltvBDi9Trz{oM?d+D{(1rH|)9mPEwTu=^iVzdtGP}NPJv=Rnx=VGt)zYgJdT}k& zB)hhyLND^HP^GJ6by3Q6xfUu*%@|A_0zFo^k8JWa_?)T_P#xvNVm))JeuPv^@)USukR%${w7yv)*q#nG*-S!i|78kz!#7i%+HkV4TxUulcJ z?BZSJYc9PXP?Qwr_rWXXKWhl3^{gy}8Ma;2vg_eOD+kR-RhBnDxbd7B>HF+`mXpzt z4I2pK&?HWhCz#XH?1yyr@xzZp_QPne7r?T1Pry2LSZ>Vhpl8~Emb1=}C(0e4t<`IZ zV+#A2cYXnw6TJz%042mUB7%<5)EI_FGKnJdt;Wq6tJp!#c-{CbjS0hEOV0UxNp1VR z)qyj%^YXSYjCb(Sf0@xdvXIeU|5{waWzkcffMK)!`u)*9mF2u1uy^;e$l_!kmyoH0 z6Im~|kM)nu8@IRk%BVeg3|@JbL_Re@N*E5N9GC`G$3CR&R1rhrd$ela0G~aCQ2!>T zG~h$QHD$a%Wcw>=p0B9_SL=X*lvZr-+u-PRfk24) z*V?ld$-QEErsZ3^|F%s^_D0uiS24q18V}STRKEx{Bi{T{e7346JGtcBLlfMLmd4T) zW|Hi7b{EXtw%CbYy_OtssAJQt?$}&7+%d3zZ|b^wg*J7c@bhqwtxG0x#53!=oIOof zbV5L;#_FjqjTcY+fCVNjfCV7q8C3=-1r!_H;#zry+^?4Ls_(z9M#qOb#QPQN1vPSn zCxBO#9Vb&X5>-_v2(Em&;^Y$IY8yPRK~_c%c4t|ZqiF%InI!b-Y;2yu8w35#KWN^A zguZ`|He?npc{WKL7;VK`CyUjpw4|kHbvm4liQ*}S%dFRA8nm|~SU1m8u8zO)}+>CZq{o!svY}YJd}MKHTzDw*-u$k9cBB7zt2xwi(=TTDV^pX z^U2*Z&9)GFQ1XT?GubCPvV|Of!A!ik|B{ME-@3)VVZuBnjt-$aA0CT;i9qgss!a#? zKhfA_ntxp_`6>Id0CA(d+>m}bdXTZv8x68?LNv@VO z3jSA6F$kf6rMq2n(WQsctyYOIm(D$OwY=*rIA2nBxwHT;73=yyFrZv6ohM4r@$j*x z)XOCxg3a|wJfdv>#dk|L=Sy#$AJUq+-uck4s(HTD`|@@fhW#%~qKpBO?sjJ1T`un^ zi$%lG7?50l&z4X$#^5dXN5+|$dGSB#U6bm+Y~wT%X(UT8(qyoyLsP;~9tcNCvN;qC zu)#mzpztq_k($#q=l4pwi;|IzL4)KE)hK_Ab zq5wd}f|Ul`q}f!?pw_X;L}(u+W@;jf?$T58N+i8(qx3oAg7KzuMk}Uj+$Tuja8Mo% z??|C_0~?GF;VfyLx&u_@=cN|<*lm>_v+_w=8wXnX4@Ma_A(=LU8hwC~a|S|y^l$P; zBqwkIxJ~Kec{}e0l*LP}7N@0(*X#GUxrm-Z_LykvJPM}S`<4x`@}Y0hFHxX%ivuGz zOL%DgROONs_HtCRsn^+zD;5*K6Fd;$OCs5A)We7_vmUi45l$WBJAj!LW)}OL+X)Rr z(nt7^?z!9T;PyT93y}=SRN<07SiPTp&bvnrwp2q`XURm*{Up3Kx0SRN-2Ey?%nHmJ(>3AMOKzQcty{M z(E-~UpbIDp>K5T_X$>wPulLxPF}rNr*CTXt`z*y?!p(+14CpiO_fH2Gm|*ivlT9hJ z6e4)ds$m|%sg?dInPkxq`%&Gs21?F@U5@hcnK33h1Q8 zbTs4fRL-WO8H?@tE7=I7ddN8jiG&rJC5pZEtv{xH=fCqyaG0`f;WK&w#Qt)Q#fnXk zFRc&O`Wx!^RV+p!WtuWMJMgU@ZPuUZUF>$-n^@$=Xqw&MIRWtM3Q(fjBxf8-0cC$E z$fDa*mi^JWDNvQ8#`}o;eU<|^dxwdA3<3a7+4T|=r2gdFd-v;FsNOaI)5tjDe7|Jy zTXwVLEjt;zSn|MBL^Aba?JW<(Zs}Pa{a{~`CV9jyB5F`vwU5n~B8 zSF@`LrJ13ivfEi?mipR6auqd7z?d6hm~|8w@k_wjaXqLwEwbyq4gqhi^X*V0?|2l3 zMDl_{c_+#?yz|3YqMJVEl5O~Aw@X;UlSy$riX;YS# zNfU)0J=u_yGFhG^S&n0i(t#}B7qLubx@59!#tTMj(7xp0;t&;-nWOI9Me`w`9Mt2A z3f8JkvR|!)9V+z^9j*exx{H!ThpLq@vp1rcAzEEzVe8o3q%0=U#sNUT2CTd?ay7xEo!uK5YQc@W2(Rjw&n@T`CHBK=V1tC+L}Dx$leP+*KfzHX*!Sz^suTE zvOAr5S}3;o3lLOZ<1)A^6l}T_|>5l#!bXiIEJdFU3gk`wvx;O#z zG)jaPG;}l9e_Ig3#XkA0wStUDIV)q~Q2eK@7RFM(t(fG;BM4kaP@myg)HO(i&D|)t z=MM)*E+Y1TqSY@3FFu?-eTGdln^Ia(SIT5T`Wf8+5v#RoM<{$t+!|o{GZL2eLV&NC5SNHO${>0UFS_mHe*JR=~|}ZT-~n4t1O-C&v({LWr^^qv7a_) z%(&Xxjp+EE=Qt5;Fc>Jxf7&XZ+Fw==F7;RfSM>DoIKxo2N|U8}vD;3*cl*=r+HPAaxR&t$ykEt~}OnEtjo$*_iN|hCW|MZqC_9-K@@%&rM zMP3cERFI&dw?T;-Q?KmZ5)5*Vb9{DD_n%e`qyiu94Z{8b)edXxVHJ#Rk!1=i6=aFa z*U*~Y*e2%otQ8*$O>8wd zGoPFc)y<0*M2_9SQtX!oVQ2=R7q=Ay3GYkdEbQ4 z0?j*Gc(Tq)!L(L#vpfo-NZd#jOvr~N+3vT4qU#+A;-$*+H`W4j;5i!AFR|aKkJQgg z06@@su#FXV1vU;r2rjZ>E}q@wvJi)H1`i@9rk&ql#$-REJzn`$z;MkFk?k|k(t)*w zAu)fMdpvD*0S+E(4T9{hV+a!je)w^zHMf0z3QA&ryW;VtW_)N7bDSk_-icg9m%Xyv z1+Sicym)_d8gy_RAKrOMJR_Dn^X({Pd6s&^&?kTW?5q2qeQNUH4)*a|GcC`V#QL%h zk(3J}_jDNQfa5jcOP2D#U{5z&{hVEi-=(-F1qEBL5xk2#ihHF1M9ZEpp{6J@0R)%V zQuTo+ea(#r_zN=kE6S#+1A$a@Y-C%(GA_Y9>BXZ03oKg9&sZl6cbX_JB0>ZgwDrA3hbLM|(XY~n(DI#J(DvPYuEUO3^R`#R zz4mZBVlEJGW!5KdEjGg8faG*A%&p68d!fh=4{`n-KemOB^GWB>l2*Ki5~ko8kY_7~ zaM)c0jB|Hptua>h+ngsG?a@ZUDX}T7=5DovDw`xZ>;hcQ>H`mwvpPA~^0P>?`r!gT zhcMYgNx^v6ot@f}SI^SW$*9(hHjl0k((P6rS2*@r)3=iG4Q#U#s5-Rb!7|)9tM7#w zi(N_U|AgXJqE)!DbxBttB9vWhT-B!6^A>7?k9JwXdWa-FkZ?kvOsrSN&S7r);gcs2A6Op&`mQJ@ z7sCV`3nsrU{7voUSM!c8v-e9BtTOY$(R>U5uMFfw3;90-tdru^INq?4x{5%%Zsw#V zl&c<8B-!xd?4HXP(e(4Rum_iRyMc%HS-&Bb;Ft)j+Z5)(ZB(!ic|zvX;>BwE8N#aH zWSKL7DN{v~)03)#Jm5wBNfx3|`P3f*9MT22r>&BsJ9dj|LA_$~uaZd4M4pzz&Sxmt zrRUkna%l@eMA#?ysQZ;hO-JkOM)n5505X1;KkW5hR2s0WhW+%Lx%Eh8OrU*CWb@_A z8P#3=g1V$XT$Tf_k-yCyXUlKqT!LbN$};d%ZiLy1og8(Rru+YOMH!PJj7##voNmC)P}6q(8?_}e zqqJHZ0lTprm!$TeWZlrAl2jgfHkF{yMdSp=RZH<^kzX_Yc2)j2I%c3=exLhUn|t{0 z&BCx-5ZM-3ZnxR4niZ~aKed?rN}uH55MGiUR{`Os)VxO#jwhw-iAf{RbBfTR9m+#? z_$%yzZ#H}OKxwzYuhkY9X2Ep96XTo<^z!P@8t#N2Qq*%|sH)aYDTOg2!`Qy=Lmn*+ zf<#n1jxlot+n0Clz?}M-vk9xMN3(hpjwcnPlIE4d;tpLQQ(|EaZF1E*ML&R*$f-Qm z0ajhyoL?Vo{+&P`ZFHnyZ^yn5%nd>#R67 zNkU8G8;_e*zkd~E%xvj|>7|mhtk?5%n%jG49j<*D7}1Pch4%LWHHULfkYdrJm0XCN z#rACsX~l+|Olh4-dz2ve!A#_5EhwQFZ|d;4+fmCV7U`R)ScH<;*@n-I$UMpl4WS1i zoant5C8s(egy!u~on2JH4S)X-7ZFqE({KL~7L96E$f`8M5EJCI0j_98fDWgJ2)c4z z$Ejd=9aDEOi{MRvnfp1hUj(Ti##vo~Ndw(mB^AveC;bwUmCA7I_M|Y`qOJ&nT44r2 zn8;pFam3n*v2LaP5#(%{L{sLw4MlyVj{Cmubrs%je&eg7prtM;+bL;@x;xep<`mo2 zH>iMD6?AqVuo%?pzq4$Q#+!rT(A%qiMF$s#4Qz9|VSqm$hX+Ucb zFL#FrlkY)EB=^ssu2OKf1-4FOou_f|Q7=2Aq zoq`-=@PFMu`VO8Ds?)JpL{Go{2Zbj(Ei8nb10wNZ6?vFr(x@ApVEiU{1}!U%{{cC2 z-`Di(KAd-)jx9!AP8of^u}ly>50|1R_k0g<@?0+e?xvRbB8^oxVVL zyWL4(YKHesPVa-9#VfEJg0)4T`?7MQAP)g44>&7mTXjgQov~9Sb;I0tP)-gsIp-Do zm}?IkB~jzpE~zo3?Z}eIC|$Cg#UHs`?2i5cr5U)xYiB&5l$Y9*kTLgQv8l}+{|W)! zTnMXgXDXaT?OM8`+`%Zz(#Irg>Gyt`)8%$MCqK_A;#oghE-PR@M1Gu8l&Di(qDS>u z@kXZpMzhy%9nkuVO1Kq1(c&&+?(hP%!SHr_G1o3bff4_tnn8Y?6PD7AmdR8yon3A^ ztJ}sYsv139#{LbdzWeZ0rFhu?>oa@M*CVfKmM}_q%+9mTEEnkp7@C>L)6lXu>{;yh zpA81fdomycTuQMg(E#FyW%(BaaF|E)xjGN~3otp{7|n+8=xCVmj2V@R&^!8ec|Vlw zUiPDe&$CcVIfgTl$$r8AVByoj@?Oz4srs{wraYU6M}f*!DPdTzHbbpfaWokGb!f`} zhe}u%cJz_vnSl1u(Ji4tu`lZLD<=K3<+-9g#wu*4nN%mG1Xzj6$ zRfvI(?QPdWk<^VDmZxVYPfrGQV!P0$T78e@n<(R{7U@>t&CmY%ZCVWL2v9lgT!u~} z$y1)q`*!Jv)734X_HWrAoaO!?_&XT{12PDnk|R9yZpD4SSVXb73%$Ye-g~;d_m0$$ ze1040wMhoS(YM$xi=)9{y)et=?`nD1iwP8ZhM>nY)Y?8nH3G9l+=Y7JhFY(vpGPrY z72&hx{jgfy1Ng5Rpj501kU;n0WZLX5*}6f0b(e3Wep~v#tN(`GbGI`c4&?8~DP5?2 zBp<>-@b7;;mRq9?ZJ-%_Jx)8Rwd&QT-c;dVo<+~5fB)7DQ>b#ey=-;rXka?)w68>% zOjF+>WDA}ahmC7ssm??$t5u^iFO^;Av6z*lqB8sU#2F*Wp*t-vn*_5|0JnB z73}-UljbN>e|*yaCF=h%=>NMvImA!EpvIWbVe6KSQEA!EhVWcA9h%I2CES%D8^*>sw94p?q9lOv}Ou zOW`R;-=*LuE(tGwiV_~%X1`Ir%~BhDtw%wm1kl->%C)Xn*tE3(^Y`H=DPYjh9R70J<@_IPqSHVFA2chEDJNe!Hhkvq3~OFXpnXg_qK8_Q_wg!NdduRN z#b_uFDZ05qhkVFsocg&X9;_lBjhw+krU@d*&~{CX29|JH>NFVE@3OqD!3f3`0uyev z3nh8ItEtB^;U%djU7KNqpXO@b?UZYs>I9}(J1w{tS89DuQ%969Q%gWt@E8MXxkg5_ zuXuwsu4W!Lw$fyzAwOV_nXVq95{Si}F|)~3j+S*e5pB zI;m)%`%rp};;824!(INKRWGx$dYNs!!NRmi{nA=L*~VTn}+wG@0krWCb8I{K@oL3Km z+BkXV`38o^n?*?i{^_IXXHNN@kzI-QaHSyj9dvX{w{`mcIb-bHjlS6#`4Z`-6uUiI$x+3fi zMG`H9e3^@)(8ikQh4nOpk8Qg{bXowwy-vu7n{m!VL z)h1pQdVU%)2Lnt_BOmvA5vTxw!7UsZ2EXCJIvU|3yUdb@affz` zliY99oU&Q1N6ZW5gFZZxufpb)J zf}!j=K-gCvAgq0W7?+n}^XM%Jr<;6 z`54|-`94Gv7(jY$gI+%)FaH~MBH_}zAFAp!8N|916PE>(h z8)&p$jvOvMePgae9K-3Iw9qBA$Cxr3e#Pa>$SS~hWVUlVsO|$KGxvdgw-@3|bx&v) zVD2pT_8_Y}giWC@4j6ad1~PSscHJqvJa<>eY^x~nk+Z+wMDADumFimFarbEG%Ef5| z>tw%C-M$MC*DeUNUhhiyT=lh`qKLBiR@@_^fr`wEC_M8OrL3>#+k{B5bS@+&a3=E9 zW&vd>``3+;}L89m*a8S~GvDO(ew5AWZCj73out0j@OU=&(KN^p$W zedl!MJxLolRLv`#nQMc;Z=WorwmrVk?-t#WJGZ}sqq1D4bfa2h_q`@P{ZzzJ(pM2k z1G2nWNm)~eMkD)s*nrx8%*)$?4g98}N?-d3Skw^45MoefF&hxW2r)xqS6%baovceQQ&FJU_jD z6F&Rrpv1we%ggJkAbJ!${q}#&(x6d1nWe#t%hR82A~cPXsSoD3eGeVBlOLkxy^Uy; zt|BlZ^OXMWyJ9`}?$abIDCpydPoCV}-352g0+G+3JRJ-MPm1*%d27z@UWj{&2HwCs z`p4gcqo?K%dj4I^X2tXGV1}Ou)1>GhZDu@4!oSRBvtjw&6CLy26P*qg*YoLut#grm z_e6hwH}`l<(c9>OT%N?^}A9Xq37Q%Me;CL)G>*Qf+A=S@_+;v z6#eUIF!+b3dZB;q{tMlDX8$z8Y^DKv^8C9ebMwDqJ%9c;;-@Lylz5E(f)1By;LwLd zq+g@ZglXhv*GU)=ctg zR7k}Il=%dfgZ6o9n%$jXHd84|SAF>*H8#HsK9hi#s4mO;7dqv0F8`@5 zWTql!z1~?0mL89#|5rObxbLmc%e&N305YBd_beMAbrwxvmIf{fQ?#N5C(xNf3!1Aa zplmv32XsJ+Wu365i#jztv!QPXe^r%6`J88c6@C~-gy&@*@)wWabucs56&tynRNB@uL#YJQlg z&2LXcBCu9&Sf<(lmsCnL_rWsadEuuiZt+J3ta?0{5J~0us75+G%ns289qyDN+eK6v zR4IojM2D)JLo`GsK?onB($l|)z(h2dE?-hf@H^z2_wbN+4? zRaf_GPNQz`zdBduvwCHAwhRY6%UJ&A`rX?GXRQMKd5THievxT)1&&g(X^i1lju+^f z%%YSh4=7xxfqPV#STHjW(Ghe`D^^srqq$XKzP_fb*X&+Wd5nHKKk-iMM~^GT7S;i~ z{m${us`X`KC=`=kO=gpA+F6Ef++$-`P4Ba()pGnZ1NZkoF(~MI5oMnXZzggt(YBS| zs_;H%;?8>ztH0&UTd=PZgJJSjYxKLCus7tJG{1)e_Ys%!eex}!`ifmw4R_H1{D$X+p3U!_FyG5 zNayNJTu6^AE?Qs^KdtosBG7anJy7hLu*x=?S z`m+nHz2P0THI?S6d$P6~poSDi35Dq2gFRF56(kl1lHCI~8p|X_U`DBSvB;(gpMGw5 z+D(1;yu`!?)Yn8@60^CT8FBgIeFu|!vD-t9TV(A2XOsAUX1ZD=0|A`V&ct1(euhiJ z8>A!0tpJGuDyBoWBOF$BRLQY+(UU6K4!EpuOQNLXZiX2SD{H*pou$4Dj7-FESEjw) z`hwo8Ub2R!z1(gOvg2#Tx`&3HCO0WKA9@`%Qnn=-4e?Ix;m;8%_j-O)O^a6$Gix5f zLtmb<__&!U$DswzQMa9AU-<4fCafVBYee1KZC3b9s|UcdFNR0Db?vR&&uPBh?$JBj z5izzmYp?e*^^L+A#-SQ6KwE~#iVn3Oe-pD=v`VCTwAy)0FI|_Vs%*krYH=@9^6dbZ zuCVYt^=s{shVpbh`)Atl#c_DfzToe?^W7Kh$2t~|S~dnk^}n!K+^OvKWOHg8UB5T4 z>>a}3A=tH8Y=Jt=omcp~9+HifRZavhBi~=ql>xbDL~gg^3C6k?UHhwzeRGUu$g z7TQR$C8eXA5-?=JXM&h{3WPs_>9+flZaCJuw+nM1y5E(f_TnaeI@erG?G!RqYcg4>5~odF>YhiNW9}6)`dlB zzsI5RDl1G^z`#SXk`q*x>|W;4RGLNZGrB3Yxt>&G*lxH}vm8V8XK)gFb zYIY1>smC*q;R6;dqT=!{yUN9qxVNnPY zRn?rN+Hr<9<+pz<<@jHI{r1YJus{l03&v_r0AwKEZqX|HoQb;(5xFm^Htj>0WVF3a z)MeyJ*Zxt2&+v{O!|@>4e;}5WVb>wGWeeloF%a*;8x{3Y6!Z|&!f?CF$%d^ z=eeDLU&pm7P0pg&`(_iB9xV1>%M#lqqS*>(l~gOfx+Xc$7ZhBe1hZVEH4cWmH}`D^ zwFxkhCG_^woA>Wou@qUsoQjRLtXs7;zSY*g|H=Q8AqRbe(dQc{I`j}8KGg_$7AHiG z*?2Hf+v8{gcJ0zxvS!(9a^^_6zr1p7`;Mh{nb_I}j94FM$hb)Cq@Zw##UVoVY?vlh zqvE=#(N*o4w$P2Nf-8KI5`e2-F||VMNUve4hU?(Q!azVgeG$ymUt<2&m-HYA(myds z36o<+)O=28I<&}xyf8~5)zFI#mRyAe(?n#T6APaX$-T(%FoPul=~j6{B(1af7#nM9 zPJu5WIh8>QxO>|zdVO|{h@k7BgX+NnqVrDaI_RDZb?qmK*^TRlsyg0WF0PNH6qABRb~c~qs`aQZt5Khu$*^H=J%jORhhS6cK>?ff=4hA}$AQ7A2NLe0uY~B0jMuK5@O8 zMy$Ev=%;sY-$=PMfwk-BplGEePAQ+>yuVzsY=364WLYc2h-L9(wPi8+>bB5s_hJiP zD6WgzAK)9vevH|KO7h51>~n|qXeV1Ok%}hDnng73fdMksdaz#Q36+&MYqLIR+(j`v z#{5sWQjKgwE7bbpgCZo2gIzXO`@qg<+!^hU2PRR5TWe&Z{8NHEXU8y+7p?@>D^5*X{*-i+Yd$<&t zLxM=P#w4*0T0!98j+!&&wrVE`d=C1p$=_~w44j)DkHP6kt0axM^LXQ|^Y-?L)ZMJc z4pNq4Hv5|Xs@9#QOZl+VKkx(FJqv%j)5kl5cW)u6+A-t{;}CYt19`L;X3;d*=3dXY z_p6Rr(h;WN&08_%=L;sA-|B6XUmmDcs!UmsFY1SPp!1z_CtI8 zFscNI=md(K?7A_Eavt@Q=$0i3i*FwgVF8cfUGbV`?9N+h+16!B-lpUtCGS#lmA2gw z3C##bRBs@V!9}+Tqge(!%->k5R7C|MGjFZH@-*G>D|SQZv~K{^C$GiB8X*F-Vj=x@ zi!Ls`lb6@$mlxjY*{k!5vr{x|y4_Y3!Q+{CqL&3aWY*cX;`$nGGxfE7Ay!o(K$2e;imh(M6|38n%PWx>#<%|7Nvb^+WJ3JG;!w+gV3e0p9;HS7Ydn}VKJ=^B z@SD1QBx@CIyol=l{t{H$*jG6#SiV+F0GsEIYCr)X0XtK$-5!_`FlX;i3*S1$*Ab3; zLgT?%Hqad1uORRAzw(Q1ZWFs!-N=4&=Ahgi>xH;8b6=Rzt{%Qm^;T4S6P&pLP-u}) zO?0oPD3ud{$ztmJoW|DohlM1?SkcvG5%8EuOlDJ`Hv)bNW(m7LNs{XY&*p_2YZ^|L ztvtl&evPQXs%a+bv`Z!WrbB3>md)Q<~lQw)Exz_HDQ zMun@RaeSv5)wgT0>sBcIg2$m~<>RI!mf=_L$VPggfO0D@oP&#cWET)AgV@1%RprT7pX(KCw3|_i|{yFCfux74OaKE6{n6l z?Umyybr`6e&3PeN&SHIn6(py5ua}SQ(J~n#yMXHl%Uq*?mRf%0^sB?b*EvuD@<7vZ zI-U%hbjtmL+kVYSIJWe_x#%~+UJpI6;zHO%ENv_g&v z$)lKy5S-V7=Ox%~Kwj)SSyt_A*D1$Wjf$ao+(NI5B>9p@sf^b35m+MGDrGsJ+WUL~ za1_-jW@;2Mv7;=_C}(AfG2xYHpx4We>o5O4n2K~6O{Je{fB_8?GSlZdcM%%h!tq)4&6ZXwB+)+vNjSHEv}Bmj@|#K8rsoL z%Y3yOt1c~Hbr|_>S0hF$H@(!gLn7RV0o#3fJm4`AjQ1)Qy7@e=Eew8Qx z)0S&JzmB$}n}Q`XH(O5MA^jd}dPEs#aR3khZ-eKh%-e%Rejl(S-$$f7?Lt4unD zsvNR2M<)6y-0_Q6azV!v648SJDd+$^D`M+DZ>6q$Tz5An)8VSuwWzEylfGad=op#~*#55UtGmZdBs1JK7AFnq|e?)XF0{_~5Hd=+w%_*6#{J z!vUqVIQAJ>R@SCgx_dFZ6{~E@PO=RCzSnCL$|MXtC($D)z&%)Nu}MElST6eo&*rNn z%2D`evSqT$qXhg~LZch=DJu~B$~(m7{n_Zl+v}T`mme;!OYpVvRjsbMzQ*i1WB{ho zMcrdTAyU@maKKq4ir(~kj8d9aXN=4J?vPLGzmv$eNQE^RX+wjqBDr|KN-FNA$iI+o zJea^$oYjXlk;gIsvlSoMiCPe3Jq>ytC3@_B%D@vDBGy$hctLrj_VCfRSxGdz)4U7l zz*UL8$UwOO!aQ&-U9Gw^;7QsSKCTAcD(k|bb_J&kElB&8*>Rd3xYEujErO?-?gz2B z5Q?u!c~NLMSXbULbnXdXClVt21V~4d#)moXteuXkI6L+;`or#R*1)kfbCR6;xjkvK zFM3MlB?b>$)^{g~XMToB4$=W1e77ntwAbsp>sQ;V`}($X%4RhWARplYsw*P6MRr&L z!oM>6jL#eS@~_Gl6|BK_4jK4g$PE=T5(LVtfzGR`Z8E-UKO?4>tZ`(fip5qZDWm7X zi2w0N!h9K+bk@?OcCFg$4ZgEi9V6}KcvIHsJm5r*Tm&-b^Et~wG4w+b%^4y!)K_Ch zG+ji*)Tu5dF2|#{x6YxH!UI}0X?wgQ!ysrHNCw~e+HbATss6!^jZ-Xpqb{%wv8tf> z*g24GswPWMH#)c~h3JV4&7x$IQV&~ z3!pS$eq0TWrx~^o&eihK6NuhdF~0E?vSH5IEKBliFu-Kf5P~E33z3H88@XSIRN`)A ze<9+Cxl#Qak%mkgxnE#tSqr6+`-MnDl#ARiL>dB8afpVEa}bdo0ol$jR!m=w z%i7qA<`C1@Ec)EJN}lqZO`CU0d_3NOGY2Ob_{`J9!`MU^sRi6Ay{CggTA-5bKc?^43(b7o#Y zR{X}Kz5)KFFpt(N5WT%i;g&aL{)!xdz(pNHyIIWvbKtYRnZsuXnN<;?n0% zT5Yb!XP|CkY+m3UTl>^hKkMgveKWg_3Rc;N9DwBDZK@eQqXJMNwTou(u;NF2br0^k zFrB9AkOiZkj@Z|a#=fwz`YyQ3!0+l|);rLXZF4WxF^hjVw+M(ZHrU~ds|%--6!ar1 z4+o7QD2>C8%ow3m{`ldMsDo!ZIPe`gnr6{qjl+^wOT(i0OKd%-!I{Vmhf`V_8qfWz z`UB~7vdKJI4~W`Hkv+emWv=Ki z=#XIzF;d9pi$mm8+J~;d`vZnb8zTPBl&-*k&y+ZF{%T;3o1@OEOHvu0m1fmALw=wc zPw;@yc>Xm>i~)EGieIPt&kOxWQ(G3uXim7kXqV2d!ix-G=**Xz-1K^~dJcAf!!^UM zQtf2Mx`sWV^sEvFW^^#jzN;e*BRF~tH{d@SeWvR7ed93lI^fSUhTrtkUqA4S`lDsNflr$eYby7<6UQZa`(|vR( zs!g$;`4wwW0|C79F=?F4A$Py+>V8-*l6DCRfmQ~ zzSX||or9(Z;MFibjYH_TixPxyG?h4LAIZn+h8>=^LTiP;7p}q|tn0VuPD_oGDz(aM zQF+yzX;RcKeW;&lzQG95`v~J;DV9FGiW=XceS}G?{TXrhOW3`y$nGi*Wo1nHc;{d2 z?fh$ZmQJc}|4&Bv_1;Q8KqZ};Z75nvVJ>x{KIAS^zag$Lx2QVdd0e3C0NRmwG}5UN zf@&&?_;@9&JVEe=y(iv0yzQ^u&|7I`kJg)){x*&2zVC(*R|zP>y^XX<&f`ZKGPllx zfjqdiH$)oY-mVsq;>J2SRKv2jMUtoNW|i^BMyB$VnAtZ&p0W=am#ya21Xd4-E8qw- z>Q=8YFB>68V0`uHpq$556N;|!*&&ZcvvE(~0R#WB!D$L=K|Z@b<&4h}h+_980r9I5 z)*4(-D`4#g^&FetO{hM`WvA#+?+Vzc4njZhr<9o=M3$Ja5?s9R8DMCn9o_oQ2*kv` z728wA>IQ^HRNR*Fk{JU84>%}I5)*VD6BvjvH*?ky1?qLvkN}3QeP;q161>pPel2DS zySrHq4GL9QyA7;}-J7)W3ih>kOU;ElZ{-F-B_7cY_>TxTb0)vPljqq?ycElaa0L%K zMCL4#C&fuDmhvjfWybRGmz+d#d@_Z%^7B|f^@N}DQhQ;segH2?ltsyd@Oo() z;|88AOY2U416f~1Y6m`qEGCuLc^f8UQloRd5_y#%ykBXbe|nfJUqs;#IkDd#@+ABQ zK2IYVLG1528J)fV>Fj+tFUf_7S!MN^hrch$@8M@MVp;s-img}}ACZC;;7!*qVzmoK zI?TtU;D6Mj_UV)qQsgYWBG)3lEu_d;I9(Bt$fjI|o7)vn;ulfDRC840QbE9Q=Lg1? zQNq_OJQLtb^975hA`8z&NfI#+B_qZp${3o2*JLGm5^iM9)9@Dt?v(!V_p@xOx&$;J z%p?K5H&xL*QhW3~OL)dc;KDk*R|H@3DDjsuxq-!ZA@0KWgcZ|h$+T;=@K%-tXhQ@` z;=}v5H}6h9-Ml@!czyjQe9E4Y(b>i6&H2Uk+54YP-i99|a(40Z^7QQV=Ip1li)%Oa z_fc7r>4=WCXZRDC21bdP-Js6OWY2A>Isv+Gi zFk(vw?M|{NkHuYvv2LCH{!-giI`FF|?y^VQc2qa)_p}CFGQxq~_Q8uMS2U*AJIG9{ zY|xilWzy{*ug2mlahWBRaKAn}UOap#m~R}ep{~X2z=5uEPVR#xpMC~g1#k+4$sehX z0>-CHMhUUbTIls`n4JOR`~Lg1vAKRowb}H+_o)@hb_i}s2CB*SEg{pMA_I}cH%6{- z!(&i?b3Xk!7)8!9U*h9A{Oea5vOno`9xuEo6WK#5Rz>KcLy5@|4j=ZVj#UQjNlSA+ zRhByOd)7}Qy^GgXK9)%?AGDi3FnZH|6D1}CH}8dzdeWV&U3Iw4HzY*YG2;v}WGaL9 zcvp{Aq&XowR?ep$q)a>8?Cgq3{6FbRowe!;-fsQ7!bhgj58xh27Ct%{?JjjHIB$*3+CS0aLoz*ZVS4dfzFNdXxYv`@JWKO@C z^D4wBBj2RHq}iW%6=LqI5I5uteMy;Bv+<3`pl|j(2JyX*L2}Py(2x2-M|MB=e0ntY zXB)fkG3Xb?F|{n!wCP*LPdDB`2&d2EwB1nJLRlqBQQy~Tfh2E{cO9HSXD)M zpydJ(uYcNT`?g`ynFc|^uWB3*s-Y_St<8R8QVEoQ`hq~YE`LX~%=e0x ztHwL+G{3Bf#12F)VCJr9*}Of19N2Ya^C@+o#HUGNMWbH*PT0^CwT9B|eWzc?Y5^>= zLSQRecAm%0E18<3?uRl{*rQKmtuzRi;TK7Qh8B!_y*42@{?rNpfTfzD`uVY80$%Sc zh6tJp1LO=Ai*+~x)P%1nMP#=k$^n$VvlzVj8UoUif*T>YY!R0Kp}FneiGL)k`$Sj0 z3&SKB+4ui^ZhwA!Zh!nQy@Tw~#mC-4_6U{scjCv+PH4U~8Bs=`Yj?-zIEV!+Kwr~m z#+^Mjc(}`vr`hSk`~FTdwfPEw!SSY8E!8S9+TYQ1!2l{?#EeQkXb_IT2h)2YWI+#( zj54|u%O#6Pph$KW<;jC$B~~E4c&W;IMq0@PaG8xxA};{o z1cWEn`>U2^>E<9(RLu(2{kAlKizl*91R(h!Z*QA2NbCu^!kQK^Md0G7a- z2w!!(dcDjlxHekVN(Q%>ef0)XXfXxdb!{fANFSHlnc3dv%d&K?#%6L>+0KyB8eFE) z=E|I1uM6H-7XEAUEqg{7eGai*eP$S!-Qn&!iQ@S2CE)g{y#&g3t8yZ!YFD&-HP4NU ziVG35bII~ZiX2-Y)&a@r_&4F_ctUtfT`?ALKh*oKs}w&obX5hu;)x=2qc@iyZ_eJH zy*stXMB#7cJZ^2SOR}4Udl-r1x;6Kw~4GIWUq{LEj zVUiU<_1{HH;_hEt3vFyi8w%T!IHc@Uq)^Oq)C%oD!)tEi``{J~9BOk6cZ{L5%7pEa zLYv3KZlR}aPocX-rKXceQ&lxN2YMK!o#EXHmW|1kT^plre&eWY=72+<4AhC{kZgk} zDFgTEW+;t&d%(}%T^3*qmhst)6)j6 zv)~3~PhA!otsWWom@1nURqVK0XS)mCZyi9k$LjDIHWz$QFpb(zqz&{L*%Yf=nKN)t zP&2LI5J54jYJKRBD37L+<)@L10IqR|1l1K;GSup2oq=?%t`7Rqy}UHt=-iyu+1h!M z)=S*}f-|%=beGwbRpqql!hMhlu_V8**owX5(_F}?`0T9qeXV+g%5+p;;&PWL_?zb0 z-`&7{MRqM>W~*_@M0YjS1;> zkNGGO#;<~EEdpmkIzV+-zjiDs0^88*Jeq#C=0A%{&2U*QnI$GO>Mwdd-=9*319m@6 zRx!H}nSKek3JQv_PgNVD+l0LYFEJ*}$iwJ{$05@GV-i*r_JIVI*05k|1^;z`zVRAG z2~2L(V1w^3ee@{`^1ULd=fRuH(KY>$lN;-qLe+CB(uikBLmbT%yG&=KpmsR4-?Zr1 z8Td#|YC(%yc|QD4eE1D0&XWiLbgfeTe*zu4f^DuJe|_|y{{-mpR{9Y>MBgAx;zsQM zZp5v$prF9pZESz4`fnsf0XmFucq6Hr;*lEIsaUi82lfEqOL7Ee=CBWaj5k-{e~U}~ zyr5RblY+^2<~Jgnf+e#zqL3^Of1iTWJGCt4BN0U!nkh5KZgCwIH`z!vHO1ib#|s;_gZS8&DE~F-bcMoH+&74I6!J(bhoJ9Mw<) zDs_eH&I)gx3f)fctJ0)F1i_61IU&1!{5kUH1^h|%pLJn;r{{%_$&WhvM;-m6j-D4Z zE$F(SXNt(N_0Ge5J<*sxXKRNc!elObJ^#|Y9p?{%kwe;H^i3 z(<^dE&*whJSJ$QjVlQR7B~&CX$kKOh_Js9s+oFnORpl>Y`oRRy=rZPJLH z&HUSDX)8@4RcU11>%~QImvhPdOI+fiZaJi2u`2taqwG3)Btf^TBx%gH`k>6%cNkDa z9&=g=1b46BN)zku2BU|msIqj-{%e<0wk004M1|PmjJ^)>+>Uu%1CkU>2HwjBn|}8A z%)4!!?kbhuZm}0-u{X^{QFt2CSyxneQO-O#HWbs1G0E3HCW~J0Qr~`0lEl|0qn>0z z%x+h6ADvvCd!N~Z(+J{eoVYulBoI~)Wq@#L^pfVFmsBIcoMbiLizlYjRi3lhi&vmO z)xMboh|IOWifHXyO{cU~qE>d=Q-YTZjWh1q0}GK9m!^05!{$bvZ|;r3#qRI!!cHBt zh{I)U!4u}O3@+H94yL^%#&Dm4zBn3k+1k;7a*VqSGP}O(FvkFdudRtGWUcMWv~i~* zw{AZurEENyI0fWu-+*#ii%eCL&nbr|shi)muEW6rU;A8rl4Rs_yxlT<>@%u@tj+U) zz?Ts{lS+%8RmY}kXWc7V8@&##=`0`1pjhyk^zmfqsCv7Y^h{ruGS=8 zlj)j*hBCZGYaoqcO^P(iHb$62g>?W9an1G8u}LNqiG7-bzEO~?!Bx6sZR zE%F-1rb40`4h~$8cJ~@ii;+CS$DbAknFxoU7QVzK0fE8*<5D;E70-)STWw_yK0Gw@ z22kUD2H?3V?%@qTLG^F-E+HTkc1M+a$oI}Li$;^r8a}Z^gK4`Llx?s<=1$Z z@@2O20g{2;f5;O6zXBh&!)l#_*o@*rA?XRxmMyhu$odsNsS&5$*5KUGTIV8qxY3nt(J2k z)oSm%zfw<~i&vuX{`%Y#GYFAFMv3>==LlneW1>Tl{M&9`&Qx}_x*)BNyjDL|cmZ^! zB*~g?^blzygGbOIaLW@eAF3RsYX1I6n82iSqF8#%Vl7ET@b-d-F}+>r z0sI(AmZwqv+22IV<#`-}Be?U}n2Z{kWS9qyZ^Db~JmTuu5A&e@AiQ`Xq!j6i8a)<= zNPl|fyD?@&@o2X!29MYWiP~7ZlZuCNuLu6aSr)5-jwzr@ySiHLSHRQxOWj0zw(_0D zqhb1%WHC&R{Urcul9|D>@E3HS0UTKZ0o_z~f-~z=Yf(~=w$1_`)5Rg`t5wBgvQ*y= zR*MP8B+;~bronC!Q#TmQbBxXLd+bY^koE$`Au=LaHH3>^k01NIi5n`-AYBWeV+`11 z>J!o*%fNg>Y}iWM_$>W4v6u8CsM-mk6*Z)yD9s=ZTj22_JD^l5F8F}b*T*|frjhnF z6MsL_n$`#(gAzz9IEZ4glq}YSYQdN+i2RB~`koyGf$9|$+*#04~3C)tF6ty&qz&X{6&&zAXHVtTZg@u-I<>WF6#e8YRYxc!(8l zsa5|(WDJ1l-N?q;=7Ir(Ujx~|!`X){W;33#*q2>IPpeRw`XoU-MrH{*jZlF(1iE>->EAX7e(`e3$ zw{V|pc!!)j_fEA7JI+G*ooGY%x(4?iTLIQRnz>>z%*NkEt0%Gq42PMR8ZbwPDhjKX zfvO~cIthgsI~(S3djXFRk>>JkB!nQ+0clUNp#yE~OS%+bLPRopDtzaOH6t4-mf?UT zY$n42xrL)P%mU3@5Po8w+DkNjNASaPD4d8J7{Mkk1%^NXtw*NC9ECoj(4B7#O|Z_i$;fa|kQ*C+4K zR2r+Vjb5Ffy*(YBLHe`TXBVf4pwpAaPjW4zb?T6Lw0zaI!zA7uw0DNq3Xz}}l94G0=M>-VOFBl;c#*T&B+P{L z$9Bjk7!jnAdpaVlPm|rKzkyGavD8NpyO(IE;J-B!f%}s$rULgUx8lAlp>a~t(ay1q zZb6hWK?HG-Kv#+$#6y_)LfwOf#kSJm$++THFlYn_b%YdDjD-pAA5Dm)^R=P{E6ona zRF01(ax zEjmH5001@5cy%us7jFpkM|q87_Xe}yfg`mRl% zUKLqmRaEvk?Q6uUwJ_jv^tBB$a`>F8g#-4qYFQ1fckhpWbmX9bDbC!|Q*(I$B$vXE zumfMp=yQM&z-4xwLhSg`WY2|jPY?)ZLKitACZVK9LnRx+E@3gLlclg zKFBl0_&KdJ9S_3Hq$z#UoT2~sVw--KU1=ww4{vhz`>i?n&wkc8=1p#Bl1G^?c9 z4EK6S<}0S{sOGyqQH@XtyS6|wnk#mt>HlSj3c!0o`qHkQuOfSc?{c?l#aFrkl_3Ve z?%|=e-BPQf*Hb-r0@OXx_PBfuBm9>~914;h0a184H8k}+ovT|#MN{8SN%y7nGBZiT zcT-)UmIP>Yl=k+>C_=*~5Jwy2Dx=wPUFCubts?HwLcl;bKbm+~~vEl&I}=D$*B;n0`LbPBp-1IE@J}45`%%_FOABhCc<} z5u|n7Hd2Xj&pn(pZi`{dQzpb(fO#Ef={}f+h~-VuSV9P&O94uZU$GP~Am!;*w|)yt*RAxmbp; z<9an0)p9=3^VgIRK};NzG~y6)QY_h2zE?-18tATI7lJ5EraOp4if(8PhLc+H|Fc?f zc5YwQQ&gO1uU1I{E6iZ(H?AYRc%gd2vpFm}NMc3i*TS~qhdB7Egl3==Wqn(@cYY;u z{ZRT!sAjL0KN?Te;pfyb^7Ctu+BqY?TJ>)E5E3A!<@)?H1CKWWE#M<@#_~yP)fU$@?1TiI#9F&KP`P z8V`+SwK%iwR@NPw*Sh%XzMs!|77oZViq({b10q&3;Tbayt;ns&W0u=5bSv)r+I|4p zF#TyAU=eB1G|W*$;L)d2`(*d>$+RdCDW+n{;t=V-i166z3&FJXZ&&G(uWJ?l*>kLL<);{WmQW{BFVH(_$F9}tcFtz2cP4!|L#xf^bu7bVEJ-#2 z6_a#Lj|Ky>Ueob}+^T;Ko0*O%O2oWxblebGkEnTzhl7*d%L2g-?_u5cme1&=)>}_U zKtcC6V#N?CZI{SoF4z+^6Bgtyyvcs_-D@!h(^;QM^-aor9-9`2RnRJ{1Y)Qpqpqss^>L%@S(FsE@T0nLE2(iyw~egg zN^-WQow%sA1KC=QLdD~foUdsYbP#AcBw~&TTG__{bYPV{)f9`wfSp%*U?z0TCb%T` zd&)h7tL5Ok)!IG+48FS$xMHXZ?JmY&tqHStwD8~{UT?Pt2cQ>0ZW#|~Uvi8?&QU$=6SM9o9`#}&eyg6U{2q57Q?)A(tYK%CeOlQJ~ zF7Z~Cs3mirTGgs&C(Wr>jD{n)&IkhiP_;9BtAa&ox&}*Dt=y-mlDcKV=2lDN{kq|< zO{%$**lONuD7;E#YQ65_bO*qq=<2rHotc(|jgKaFuFGyO4CBG16{Cij8288hH@uJ{ zf0%e$*890@m)!@ej0>xocu#cOyPK?9RI2V@HdpX!ZPu>cuImw5t*w9*h|Amd_JfPv zP%jUyJhkJr8ELoC_Ep}`=n;GNT@}D8Sp|C*4m5NDML`fCOzc8Q#N3yMEGSmD+P2Wo zFvejk8oN8>0EK*K@2{jMtoE4!c;X1?hUN?qa9AoWw+X<^3istHAu3^sn z92Onj+}yA{zqtwX5)*-kf>L^>m1s>u0r(|#LQ&#jPOVD%@J_8`MsmW5to5EXlp=b! zDx|l}#hS;=AkwK0dU{0Q-3+?sfz=Nvk`BLI1ORzHQbfI%-&Op5HMYjUNRKcxBP@4D zI4f~^qYZg>4#Ht|6t3YYB&#)L$INkDtLRU>rVnc$6UjPk?tzHETz6ZUq$9H7#Z?k< zZ7tE6Xx&Pr$gnXLd8^MNdbd_#<|ML#BM7WiPhT36*|9%YYbdkWNqPxI6bo_pR?N*# zr|)gKsv^)i(uqH>4exO~vcL=Vioe>OA4Uw=zBSP@Gt_+XTjnBNNympsp{kmCa zHC4fQy9JC80isn9-B?CS9P46ezTF<=!7}ITX!@W*Rf_HQparC-(OYgu#&*^?76MpW z*B+A*G*3Cg9_8B@ukBSzf?f#>{)U$VJMC_loCi zChmzhie^#Hi6?STgPt?#o!u`Jk+U2P^X;}#sgLwgXY|>%R67BluW}X#-n-~C^NLjtFTPV%OWWwf$J+QlG8Da| z#6aDN>NX&3{4%`)r3HVUfiOJs(Or~hi2Ut(!9ed<9R=$eq7_VQDtJ~f>H(9RTjl|5 zy$UNlQ~}YVz&kJWJh1yEQ%m~T^M4jAFXi)v^cK;Yd8>lO9{TBgbbfvLzW?Fk{KpSx z{qs|#ic+&?>pwrmedQ_uL1hjQ6{lr9sud<_Mw;`9)5 zJ+0bRGdEB=;N%Xeh8Q_k-Ha13K~)!am}EVcolP-g85MpnpnE9VrIMefJ~rTrz`T!<1q>j_^a+8#>lz>cO=|8qvmU@?uP4XZ1oXV7i->1F z$H8Z?Q_)YIJ{}Hg?$zI+3E3g4p(gxTFw^=(h|eCV5*_0Zfz#l+4u*kW@5Ezoyfl?K zfVRJQ@UaGw=*V;Q9V^?7#*S6W&f5##)N}F!dnl@Hov50pQDJs_ls$OyYMJnK zvs~R2B+CNNP~Pc6h=O^mjQ_r3V5bLA9g4RM5y=jb1sQlLvRT5X5)m+EuI^mWY>qqR zw0z7aLx-6L$9k@1*KySgc8D}2wkIHMgI4i*CKPRLGzSrhL$@$BP*L{aOHx7e2(Dvb;W%MMYv6I)`^USVfh?1Nr%V=W(0nz>u+LKsl%YAu4TOyIp` zQJ#6J$e9=2ij}MrELhG$Zz1I}eDY+$l4W3>$*gtekAT$@HTJ_+Qg}PlZ%SjJ=Tdv!!Fbt#@VP zJ?*u(mA^BWXPDz_0S2w%7-^X$B52N}qk64!6=>2d_+pjbvV32|bgbL3R=e~Cb6<8H z`$%>xpW0V|jen$w7eXW~+FOE&exv}{Hv6(e!r%5T;VZ4-``AP^GkoM(Ebew28zn4< zD_s#S)gLKt5ka?7M2MhilucQ3l5y=9=@n?g5u|N1Ex=S2p!nc*l-O?rEe4+g2E_PS z(mUm)NS7;X6QF~%ffOKyf#WuH4%gQ3>dRh0bM1R&r)9-72WRf)$BT#R=e1BjnRJ`2 zKI=voOx8^D}8mQZ9|F7sXDnsfgK!_vh|!)fLdkRs2m>C#Zhc2`1%)fMFJ= ze&_jWag^(sB%F?ozcXj*wp&BvI*5*+IXW#n4orHzY|JK|hy^-AtG|rd!~uV;Uk}E* zWuEHVL~&`{YNXU|J<1X=&aLSN3o?;iK(=$m{G}|@NNEM-YBUCl=5H2Jabc5b1-c^4 z32$Zy$CKIzZMJjG(z(6gqIIMdZ9Hu{Or-^r%&4Kx?Ihzc)e5;#XsE+XkY zh?Tzja*ZqErO^XmjV+=K-W{@?>grgH$P5?y381UP#4^@R?$*i~pOucYkgh#}Y<=zkh|qolhaw2xHIgY~7;6xa`D9 zyE_k$?R0uttMyPKWTPX4Y7+8eB>wNWa1Nd%*-4@~Q;aMa87nJ;$OoDNkbUb=}Z+w>`Fk0}{6~Zy zB_M|#jr1SxO?&bn@Lg}`Mx}zehnx(tg%~i|+Tb>?xMBzE)Ln%TMFwXM7>*taw4tAS zc8ZG3#UO%|%YeE;oEgjPvWf{o>YMwLuV}WaWqHH@!HUn-BBD3-RT_Ohd+(O(8Yq^5 zYZQ>r=ZYQ$id<*zl=bPM^=-$7H`k6UT7fbuPGkWZAa9XVo zw3PdoE?t_Q7-{G~ZnJgQlCMq|w=^gYZFtjP!`cfSyP-~Ri&l+xfK7jDRh-{m)#-8J zX-t39Hh3n)tz_BSX8C25*XI~gJss}q3{K#CMQ77g((AlFTZweIXFxKZP?O|p-83eM zak*L)KbF(8mFViohVjr1onVJ1#xoS@{*wADUqY~yvz5?M;IV<7BGCgD<&WhwYiF`U z#g6-IHr4UqUH&>(iOVs`3e8F&glu;qo%!4N)uvE^Ej!YInX8rXYYni??5mZ?(5|Jd zS?q@;_lC!K>NU*s*V-BX5}IshZP3zpPy%A8_+lM!dHM*sl1M8BrwmZs$49h2|WfoHvNS|2S46A zr5;cKhFsOsS4K4ZU~)z45W|WEX4c$QGY)9@qi@@5# zEv>yMRINZGUG@0tunqM`f$5ERCs2-SOp-(`43UVGmAR4lRi@K2sJ59#O}K$sTxFa( z@pwfJwEjXHM^(MHQ7^OebI;$ValtuQIzB$1q+yGS98~G?xo24L)2*)xK^2skv2s56 zC^nm*;D?J3?+?Z7x~#OBY4f9xUO?4-QTCYZt%KX|Ov{4!Z;*jf#B3}l6p{jD3|Ijx zvtW0Fk0O3o#gbw+6gu2fIL<>Q|H7^zY8V_}(cD-Q$sO*QaP5&atfP#iu~|LU z%l>j3LyQE{P{5zQ)n{v>UT@KhC{@eNqKLAFo>}7xfYlSBq^5yA>$wP$LUjgCb<{(^ z;jA={wzJZ|v*=pNWgVrsLcLHgM0lM1d-~rm)c?r~ijC73FCs!&(~P})I*HA-m9lbI zmNYat@{c8eGGFgRgXe>2$Lm~|v;z6J2AOLM^$u<2-^d?tU8qG9gwZ}88i_iL8GWu6 z7Y13{0kqQBQ{^RtGd5%V7W2bu2`Bp(VtoB{;r!&cpDKUe16~hqcwJ-a>)%(rV#NR+ z;YdsCe@SVVP0DJneFa$vO#G48H?>Pi5 z;suvL?a}Bt8{b+CKFhcgL>Il3OlO%ba>niC_iq>yHaOj0>ITK$VV=$JrSUx|jYde= zW?6P@A!ZwbFC4Z!coqqE_cLt4vs8B()T>?EGuyNmHP6y#<4Bb$fPZBVe~u>4e6Sz( zf?MCHdXNvmSIxgsPlln_p#h)ThN!_5rNg)du%TPWXcPd?t3g|56F&o<3oP<7+e2v= z{eNq%dZifLGZ%v#RLbRC+b-7wbq1Yk1Rox)m1(#A=fKq7F@4#(`%NJ4v`3=om&HaT zHrZPcCfbGyv=YkzL7FBoyUE!BI{2qGneR z+_8D44cXfiz(2RXt>;3U;yk{Tr(jd>p3;HZY4iKfh+k#(u=XhQAC3ErMI2P~!zL(% zXDSTA2!>fEjMt3Q!*-qx>+1DbV|-a3X=&i~SQ|}hMHc$|9UAQ|#uu060Ig#N{;Lo9 z`c1bxQ8IA!0PafKn;@!b=+C|%4o0>zr0Q4$*E@brI1)yOW0sT_R9bB^Lve(uf}q{@ zS4AVROfrK2$sfvG$fTj~v$f^pL9_`zJ|cH(hf=U}s7eu*YQxL(YW7y7f9i1syoW$< z*_R5#2S67wIr#ZD{!%5T&%@>NV}8S8LcKyG6|PTnc^y`Lu37blSKx~J(5?ERykTB7 zNyj$w`Co56A36!aP8#|vW+(gYHvY@*ZUFb;;yfms&DUl8j%+r6h2XyQm)kaHpv`8S zQG%6}Yvu|i|3CQw%<8QM2#jO^ZZ1w)ibNR>IlIoDO2qPHDbaK*}~@*W}MTqKwei2m!|ao+12PY@#gKp_J8&ynuKTkB(?0 zxlijE8-K1As_&2ZE9kz#&FP+-SZ>`U>4T^9Wkkd6gCQ{9>mM9t%g4O~fspF7Tr4m} z-ul;Dlv~A6S1!FOW>i5QuFkUTPq(8Hd{r(%TWJzr*6G?m4d!aPTVeG@y#O`syRV4* zZp%VVHdhyvzpoqh{O!KPKovcM=+qgK?vaMJ@CZV~tt1;ysLK{-k0*Tf`RsjwT)cMf zu=TanqxPHu)(@9#JZWePsURpYELz_KBMBPa>Gwrq5Pg#{>R#s^eyQ|31(m$EkJab1_sQT>MF(6O zt2IT&=aSFDFB1rQBAeEc7Svt>c(*le-f9Jpk~{TRV7ykR>s7T#S*TAn_93$G@e~P+l{6X6cvbj&8!9>5DN>GJv{HQdBKLZPvC-c20iY+hCvHthVmyvwvwy_zPi8d^=YV)_!)*{-4b3AG>F-y|lve0vzx z*6y=wrFybeA4}O&+fXm7v>rU}9eO^0(%80H|KMSDLtCBsk(Lxk41w6q-+L1(GKn4T z>(h;%*YLeD-Ns`)(XdW4KOrv2zJT{VQB&tq;+tgg1%uQ+k3 zgy6Uhq8+&tL4@UEP_E>lzD7%ANQV>cFhYgNpdJ%K?d59J(^OEV^DSXe_#+t$xd$8n?_`BQUQFOxJDFJoMsX#bEk? zhU)cdibl=66p0`9fidqbyebb^T28?+JfCI}uLoBpNLlalhltjuNU(^mrrCXR!){82 zO2bo$GMUZBdL~6=CmIxNS+Q9zSrP5TGLr`pn1Dt*GL2jWHX96wP}X>%X^Uw~z1tIn zVQNz5Vc>llL*8>ymP?|aUQn=mdG{O~W>cRg7>)Kam+I?)jdv$0`U^68Ey=;xBws9S z8txw2NH-=8L7VhlH_~EiULF%%A3Q~j$`;i{S?l*`G}mTQu8csw@>XF|uv5R)3Y{G9B*Hn{vt*EFJDPY0Mt$Y|9+8wdrAx+HUu@t!T_9 z*>IPnTl(rR)*0Q=h7>Kw*s>0o&j=^+e8I1-<+Qvr)t7f z7FwUL4gWL=!Rtc|+suli2e6dyp|OWUoWgZpzxQHPW9Vwq+2ro7yU@_1kuOBp+6?n& zQ)W7!Qp>mFIPPqyPv z0uWIQXEGLy7jiNjCp_#@SlxC&qh9`DYi)j+w>z;JLg+M$y<8w9Xy`koeXXHg z7;b&{W!5S6t;&4k;=`3J-=II!wzZZRURph+)ABwx=eTo&@|7$j=LX)79ITgqXZRQs zGr$SzpA?_R{WEtVt!Gmmh3s3y=i$I^>(5Mbm%dZUp?m7rOaiROow47 z8t91Jt8(!UyflanGVzqo1+tNli^$#OyC5>(_g)8Bv-BipABhYxl)zUjblDKbd_`{yZFRX{(w3Hf|YDG!`>?gGwon3RXT^9_p*b22i@B zdVF?yesO#n1q4VZ?Q@TB<$Y2y4B7PP>4zJnPYGm#^86Vzxvv<{9m6RGNu_(A+CMg| ziPmdJIR|QG+aNXn2XkS9zw>4H`Qw}Ag2~Ps3t8DPdwGG8&u(~Kvm%=8e+Nks7zlXu zmrv85h|{XPs#sn3&H;%)`uJpqt<^l00Dj8+K9&;X-@R{EXAM5j>SkjeR}a(lY$}TH z9>v(&8_s+11MFpOn1W(|#~&4(^ts1&_?z;khv_MA{s@Vu+4^%)mjC#tm_^+~9FW63 z6xSafqDOJlghD1m_HAX+uuXu|6|nTwJAx9t0K>ig$E65QnEo)9nRjPE?qg5-!EiT~ zWHgFuoJXq~;+R9tu_)BAqfso_-QbP7B!CL}4U5UER;wm_yUy5><+6W?tyimJIxx(Z zH$oSOC&w0F=k=Lln^^H7zkh>E&KI?2On0fv*}DZ|GW(Fr>*OZC2ZXT5Ye2(?adlr-D@>Ld27>xvO^MySY$M;L#D+JLpJ_hym;an=3@hm2olHBhYSIMO+q> z?3M0Dv7KHgFI$DQ2afQ0I7<(-t+8TaP=`)sr2z{$i{Dn|P3Muqv%BkFif=$2tp045 z7>qqEBOaf=Ws|pEJi9@o5r|sCO}p{CupHuJ3yn!<=YvjgmQJygfh^rT~B+BQ56mdCDd%Ic-m>k=4ROytsNSR z^%489T1c*zU=JN;h_gRUMlmuP#orQzKwyG6!n|`qQfdnmqtgn$`~sPhi{kYnuj@Fv z^wWOc<%_TKx++&!*Ow9I$|ke|_R%n!Xea9oje6(jsl#11CrK4=S)s1~9@o<`fXW- zl=l`Xf$r=Z^cRFRCm!{?n(A>{#?OHnqHl7q&6?!S-V@Y6h@x7Dt#ufw=J^5Pv@^E4 zxbN{$XS&t+*r+9(mY}PsFfs|0M;MuW`&A>JGGpHbx;KIS0G)u_l*o*^$YwJXCh(5` z^=)3QjTxL|%aj`r0n9vAHSQb>s&(2rL=MlK1)XHeapYb_#|>Z-AwC*O@6mk44}w8u zIH+h+*3h7ZP~2$HXt&W>aeV@Yd!%{`Mm;8R+);?55%ADa~=7V)0YA7fB&_ffz%QaWW zrvnz%$9IVxyInNIja%;QbwSgf=gyv)sWH)H2Qkn3XkQvvnFRA3G8+BofBc#K?{D#g_%Ll30e}eXsW!t6*ejFVc zy20`mZI?@sVadlhH6Wx8gjRDMM3oySN;ND~*`l|VmW=(rrWbQH-RLh zd^Zs92i;WV>Zd|le;Qk z#yJFQLSG=7yAyCTjr$|O=zHLs&^Z0JUy3q}$MgYu3XiqvL&>L!cC{E|9M}5AbzXxe zrH&>sIT*&nZWB$Zo`{QUj*V4YeD6RlpnVFidF>fCs;b92d&B2*rbxe5kE2odqb)0R zAEjF+(U7NTryc=j*z*5gkcR7g3SirK?{*rpS{lOzHfS=z;Jq!ecIQg8i|{^Jn;^4a zreKS~Qs2Bcn?CqKFDK$qfW5f~JzS?-&8fXGZz}xt}qcFDou1YPsE`hq#0fYZ~z)B9v?0uI;WjCHk06KyVTA&}e!jhgo*) zR0d*o!zw;I)0x=n1IRsaB4jM--Y!XHLwk%r%7hnGW(8Q9XJ;|lp95b`-^PR%-s?|G zYm86m57*Gfd%6W_=&IZOmpDp1&|F5~v>p~d*WUk^5!shEM-JGNnuCfAU`KPE5!yb~?&BSJ+?NLnO%x{8)79uYesd)}Qo`k=IDj}y97 zAQKM5$spe?J#=8?878noF8c$*x%Z!iZgs3y2BPT;nQro;~ z$bONSoPV(=ejdj3cIYceDL1mCmS5lUOZmY)p?_{6(R1e2( zgC&5#t(&YJBOsx06&mOQbpz}w#|Avo!G$#wSTM>LzjdZ~=S&TPm560s<&ujleb%aP zv^OV@&@x0owj&P}?eoznuHe3`wcy(%hKHGZyTuNvNVFzr@ergYmqq6nQI=yq!GrB)#yh{Z$g$UR9(}eDEN_Hu8Tc7T^4d ze5>n*@pq8ZQ%5PY2 z>1HPdEeU#1Me4VCA|hHO+Ixz^1E6sJv5)BYtyd_=j3X2-!6h$J+cgvzfTTLmIJH5b z`(XIIZfHfQ2u0v6fjDYUwoCx?M0RZU3H@!33=k*yW4=(oaHpGXd`$KqyO?u*nyu9_ zNWG20$UAqdxNWQ_lS|c>xZvIJJ64$6DQtAoM99seMGqi<>(WrBpSvlH3XWP~>_D>zpze^nJB2^oiB*6*f9S*5POBu!)IeJ%ZfEG>5?drALx0k4X}M&Z9ily;s1nyXi>MvdM0wuz{pu7foZ@QahnV`IWpVu-K@Y)zjALXdWqXLo%rDA8VLAPk=3B8XY zOFP=E5^KDm_teP<)jhHyK>>ZftROLz(aV&QB$O}{R?|Zwu zB;AGM4u%`{n}(W9k*SpEg^dX;(y9s0kSR9;H}gBYw|~agri%%=*+h!eH~J~trgS0S zUi=#pwwG6zHof$VD;l|C9S)fn-bY9a*VQbG;_?4PlN}Phxati$^5W(H%EtfmYO?d{ zMIsdkB*_6wpTVaX`TbdAMZIDJmRUz7L47Q(LB{pV_NwpuXC ztP*4icCH@*2_3@>AWxi?!mrI^qj8CSjV$6jDX5ux%FKHNksK}|L39LGN#Ci|^mTr* zHAC;Q-Sl8Iwak~}HZ#MsTW^-7QEE&rg-GA6xRMW+XJTEWX@#qhNL!19H> zhMbN)`cp@r#3xC?YJMeHwb>}vWV3mHg@hH$7JXEL7t}CRs2xs#Xg&VD~cy5hWrj3Ed;9 zM{8X>0KMS#2aFc3&cB+Y6LCLfsxH*HTjd{`9>7Y~pA_a?h5-HcWTL*w=y1GO%!Jy< zG5#13t%@E+Q~hL$J?gzDGA5d1G$fQh{3}S;6S9gwlsD{W&hAE|RdNG7bdUn9Vk9Y)vEwG-!X;t3x z0=xu&)zItA5`y}Wbd?xw`bDX8m*Vt))s$=JL*KqFUXe7$xvd`cRve8^mT@nCPVbk5 zt}Gvau(;JT4jW=^yg~*_WVRU`(YH1tqSH{E#NJkn*|R*^l#CQRC|#Zzpd&P2)^(_UV{``5FOJ!G|9bF4Iu51SBUBY z%CnQ?;?t-17bmBehi7M>zFeN4{CZ3)D_aF4-{-t|9__3WUhG7d5y)uYB^cOP&ohn+ zej90f&^Y2nMDsbwx2@3f&Gk++h;}MM%g4U&w{6t~-(^G~WjZqE)>nkk{Eu}BV84tA zt-t5{X+HZ}RORwABKsABSMlGK(ZL8pa}>`m*j%QZ%5n)xd&QL=7hEbXW;7}_u=LuP zu83$Ps}+j~Et7nyM!YEFTy<%GRfMiulDSo2)JznPX~(Llx+^JdgG-2cTi&v2kw3iQ zw^>cYlbBV8+BPxM0&+KyY7D?s%(Ux~YCsBW&=*V^5`>j8>~3hT;Mqe{9SMgebAj%o zp)>gm38stE#*{H#nq05D^j@`Yy9v>V-&_IvM>($P%G1g?Ev%{KD))FvKL4km+9=D+yo1({5gCS3 ziCmP$&&wj0%<^Fsp?tH6;eEDVEhdzXLbNoTIH8MM{VqZ){U~f{Oei~uAA3gypDJu#G-a}Ij6T~CT}aOnPQq$!>*p%2p#^!`B*duoTMr)`ApVqS+};_xLF#O$no z`<|;E9`8;LBnrD8fnMZ&(g*eVg54i378loCT-B}Cgft}G*2Wx)=QDu3dx|5{^O5R} z_MC?w@U`tu?PIcnGgWwp$}*lE9Mz5XX};1JB@jJ8xW^%?##Y8d@?aa&Zaf0F#>g;( ze^8qk3=G&$vpQiVKfflYQUT^5o;L}S(k)tJn`HeS=UHN`T@g45sRm2g!en%U_B0NIx}{s zhJdLh?b*eicMhczv6Z)=5s^t9>3mGGGZ&Ys4ZnEhhqmiEQfh>S=2?w|!^o`O#)LAu zauGzOC9YOak1j;)dRyYg%6r=ISrb4pR{qNte{p1Hr&^J=aKs^ZeWx0o1`jKqAKx!? zQLq9M3w*OxOsIyvZ@ZmURP+RAqAXj_%0*dS-joGPMZ)VhdG+-}S+Iks$g8hW8Wn7w zuNE?*YSS(?Ho44YDqtJ&$tn(IL*woHD72bV0shiz@as$xx}3+t?w&APSNU7V9^E=^ zCr$bORxjwd<>0Jnxoic&S2I*|K-5|F*1Pl4jyQ|5#@B#}Sm6TCN+VTcUf@{~1fH#2 z;8~9GWp!H4;jW9C>~+8J@U;X5CS4UtwGx2jS;kjQ(z;lQPHB-!r$ZFi8kACwqET9G@6&QRn0|cPZV7o|8jA7c6_My#E^m` zk@?j}hyoLxd_4Vp(O0+G#3u>A5@p5Cz?3H&?$RUa>!REBdkx)V|3SR?0=-xZFS4f+ zwRD-d2_Gd$d}8BeTdu9&QS}GN-~w+k_7m(bl_5e#?O^_Z&cdKK_7JhF$^2#@RqXOB zrc67&hD@w3>%&^UWmcy}h`2h{y@=}xt@;(?_7vkfA3w%2;e`vJh*E$5sSkbD0#$%h zDfo(`U&82GTB#6p8T#2hq0gVgKA#j@%X+@6bNjkt1(&r`gmvR@AY~9Z^aV4cGSk5a ze5|P6jGo{S-G*L3(xL1L6|psBf_wKB#pt>A4_7_GF?y6d5V|4k=~cGsiQ)iVZjC3= zY#}Ln>B4SYI7=XO0PErm8+;hpT-l_{*;?Pslu>wMB%O;?H2c5k1nNU8S}_tEW7f7c zP?{Gp#8@G|{0}l38J8#%t%!lB=m}v5{p%7gbF&G~eJ>0uw$ve>dg3L*?LS@Q-DtIu zEX#%DOAA|d5FeI6j{j8Xu!2Vy*eLesLqCF{Lf@ZO^7BbI){U!6Fl9h78oevpbi5jI zo0?Kf6Arcn7qpC7p*o4Qg2+Ycb;d9!({>=?N6m*BmHU4kjs9vj@(UM5d8Z0$`2dP0 z7i92D{OsSp!C%tBm>2((IaYP@OdFGBzhhwkSY~UJy(o>A6}#o^?nTYyNqvexj`HfF zTt;-6KP<|;NY^~9Nr!t)L!;fL34mQL4`MxE^&`{bFHs&en3}& zSW=U~BPlC>#RVZLd)hIgSJ11qG36G~XJV1ZQ zW9=6ic+ucNAk99you8bWG;b)gMEjUs3P0*}-83%y+g-&a^KFf_))C?mK-{}Ud3D7K zVq*koc_X+MLlt<-AiwIKWu*T>t2pH7;ApzahPzr6Tak6cvcHf2w3f}}@8HyN%NALd zUCHFNR$Cs#JUdFze5M3dCE7Aw+{TR1;odOIPE^O|GM|0DsPY-aF4+U;{C2TWl+f(! z!9y9doxlG-f8WssB%LbKi=@E}K#q9;8NngN(UK%=03f1Z89PY8YlL<=E290GB47uv&oOL6wVKJY zGHDVp<^StNDcBn(F;q#^1c`jw(b|rZqpHk{SzgQ6=#OnJKt3fEyW+L19u&uK=5u+j z-zJ$)Pm1gpur|F=e_PpAk(Dyu`!6F{!*0Pepgoom7|zs`pBHA%&!e4_BwzBM*hAQf zng~!J?|ChmP!EgV+KB2LLt3<`AY1s5QAlp|*nV2jlbX%{`eoEMnqS{Tv< z8j|{sYyHzKuUW85lGQRwxuM>9;bLD0kmW{pSu;_X=fv~`396pUeEOUh5naQesi3?_ zxe1K1?~fd`PkGiJ9L#w2__D0jP^4-4Hr#>jTmj-lvKw`#H=8Khe~w|%T}XY5`xQNh zgg5u+No_w+_-*Uz9GuM39B8StXSHs>GOuLsfoj@7ZRH2p{w0OA#N9;_KVyIcoBbZr zw#Q_Bf36R(`B)#u?qGN@w@>A1m!_xRBN_X*a@%CJKy{D(Cuz2hvfeg|u>m*vhPJi) z#`=9&x+AEd2<4~hV8n#}0{LH0^NI=6`rP@H+)vxd@7z?*SYA9t zbj@q{D;@4O1me40PP1{e5?=+_5ky-3O`}_0^XY;`6W9N1FYl182MQd1fVJmlV>@fr zG#Arsjlp~`ru1-{ty@WjJ(+8!v!L$t#J!!xW)t_nh;on6{u;4Is8m~t+5cv&Iw|US z4HjE(SnN|sHACMD*s)}ef3_N!4K>Fls64!a_*AvbQ9=#wwn2;cEH7A9U-RXMvcUR} zNu~B9DMfrg?c~`D?Qd<)I#jsmDMIuq{r70}x8MwE5U1uKRBXohEwf3yBC0=3Z5J+s z8ED`MohCl{5-#Y(ZBC^4e_~Rj!U*ckHO|F)L#fQZP89?2^m(dY+&o!0&pMS<@mHU! zf>m5xr6-C1bF&#wFwt+=Ups?!tvxAlERdc$=$eeY7RKH0>i1<{fZ*~I`mdoG@NXp# zbqTcEH@y|S206iI6F)4`gF}NzWJkbFW=E7~dLoJt*5gmSEx`9d3oo}FT5n}*14h{f zyEi@cbIm^falvzUx650N6unGA!uJJs6#rbIIx&1b!ZN!mYO+IyS}ud5ZS1}tD5Td z`(+Vn6njS8v4X_}Q5_xrntN8&w|_Pf{V~g83&S^*-6Yp#Enk;n&adbi-K=>jK8Xcl zZ2I`M0mP@jQ5fc;)b3?e^TMfUh+?r@hbrO4WV7ilR+Kp!=z0uhc;KFX+^p4qow{&E z)^HY^7@xfH1jQWYOSQFRZGzcVo@l{t-f6|aM{cI@RGHa0=w@A%Wv@(6`<01*XM!+Q zCMFQA-KQmfgU2MxvK&Zt7a*?8Y7-JJd??DLdMHY?6Cur`&wyED`=k>p$M;v0Faf?k zb6|C#Y8TU%Pu6b0+1L+uq8FG_)?^5=Nn~`Dt=-yA;7G>|?awmhSalL3LBOxhd-6?sIqNY{*M<>-O$TZu5z%PB&t*}Du1uqj>srE|;)%36f*)I=#aLvobqP)}aqHA34 zNs*SoL#DAB_J)gC(8xSUQMhl9_Ylwx)WMb4dPBgmYIe;RhbL=uV)E;VDE(+6C%Bf&?_E*(tr+6#2 zjy(mIxBVW`wblM;XoG}0>dde(!;t+@SQOtD_t)5(h)i6D56kXUE-$V$D7z5D*S)~f z6IMV1PM3mp?G3LPE);;FO{*jL2670`%atgi&cQNEwdadDUY6ra;WlxbVasD2RHwC@ zzew!g)}%+Y9p*4T^NBN(Q5;w6Kts4pd${8m5*GjDjGG9AK@0L{n{Ej?xRx<9_S+DJ zLcMbd+7A(OphH}6(y`%AIVv*#4+D@o+C;mPw|nnl>TDB_7HzR}&dNg%Rl`6w*h+`! z-g=}TU-_2dQJ_N~`_@P2iY9P?gEa23uoyrFw1d|!d{ctXN$i*@@buSkXb2!z-MYo} z_Q6#?9ik1r<^?Xc_TsnK$Ph?!Ak*>WX%y`bwxg{eHpi<@W#jWIZVr*#fgf5EYxM;% zaktS1(x_cpHlY4o@G>23%{HVz5z?2nQQ`96uH$VJ^bdVtv=lz}TQ|84lW?o||3$Y( zUC%#yU0SACkKGq4LY`>O@86WG>4Iq=YQ+$B?^F-i9^KtPaAp1l*90DK+FnsCD7Tp_ z#5URpZqg9qD~B|Zcw{NC1nw>2`}WUXn9j~gi`RJ@uiN1$NAt-oo%QZg*1CiEAj(G` zL}?$y(MX!>rX`i{bM2S`o5h$0t_yshSU_60G z(F@s6T^wpnR5Wz0_<5B6(`~EpX+!DVjgBBR7TH#!k;X;=DrnS}Y=HTL@Vaa_7>#V; zpAO^_YY!c8SbE{PWG}V@v)h{ok!{_9)k}n?)n03v#WMRTjul_r>6ZA%QMTzbKd%A? zadKAl!br+}Lwn!qp8DA|G6AtssOV%%3JS8YUJ=&q3|_Kj%-(A8q{Awnd|0IiNqZMB zuB%eY1s7M)s_!O#3mvt(cp}}^JMg1N-w2?Vq3CJMCZo~KJXU{D%otdEk~-DqNth)R z?|qk4PA%#Wjd>P)_T8h_vRv9BzklP--RDubIp@J*@Ii3*)EW?~RuM`}{abo*6(140 zx{6(gXC3&UuIxi@|1J z;Vt~xiZX1R#i384T$DPybf{ozeGAu-m=Ithb2<^O(3wsqba0ePf`?sO*6;I!SY%Zm zbK+}MjJmjM%-0$>qHA9((-4w6O!3H6ts{2jvv!YvU<~Ja!G_P8Nh^Ih?G-HniQ%cP zF)5c{7lpwPE%60u+tCP2*&^I+}Y=%C8e~xLm%`DzR8~Qa^~&ybp}?BsBTz0-!DmRO)8p9KJ8$b z5g$JheIs~>Bb@d>4Wq|ad@uZ3>Q^?@*s=7SPHo>J6K&wq=Km~N`{=9gn_pO8DpzLk z@jG;QvLVi#&1}bePf#zD8742|6m93>rlb|s63&w%E!DOvno>dnqAuY`Xr8TIT*A>v z9K^d>mT@pJe!Yqz6KNcCYqDQgF(-r^0OsCo;ygKgeR1;h;l;_PkKmH}v&Q8l?Nq%5 zv1%*mwFpDRsTW7|N0y88p&N( zx_-}VIT{VCdCckd7C4{d_s1WOKVD$QdQ<Kt* z-Mizn%f1UW<{-W+>{v>c794yM=c2RRM!ns@13ym55oG}lQBL*Y6Rnm1H3 z#Vp~{+)Xu$Rae!!j>5Z++TeZ3s(D%6A&Ph^~H?cIfFnz6_S2nljXe1tg z$u7Jp_ODBL>*8B+Ia=ULD)|i;S83G{y6%(#9!0yxE*>=&Ze8zyj z#BZoqu7z>Fs$G(`=I@>4U;^`MnP{1j^a7tW+}fI$m>elzrv{7HL?=oKjK*YOG}hot zV}*CUGl6Jd-<%8C$82ySXrRl8`D1M4Q{Q_ znpz`4lif3bMz6Y}TzVDihpuRwIGQ$X@l7x}W9Sl2(UgM87zP^;$}>sa3VMn7?>!bC z=^GOFUBW^W5o#Hauo~8=Vp{`W|>vNTe9gS=twpj6ZpYO&9s0sNYAb_aO#|YT9PJ1Nm@&47A6?aWJ_w+l97>~7!d6y4e{NR z^2Ne1NS?MIfz<>^DM$gSlki%w0=%iC}5vJU(LEvjg! zH8b%iWid&Xc~UcL>0^Zu#!y5LK@{6(@15&r0&zfHS__WAj?Zzy{!D*=*Jg8G~JB;|&+)28elgOyQlSTs%07$iA@Q133&# z%6si*)D#FzLL*M!E(gmR+M6)#|A+b2Mn#P%(w|+R?dsbNG*9o@3pSxlN7Yw-DA>DL z$!xP3s>{cVi5kaR3qIy_IFNP_=?3w>_L0Kg%liZp3YjyA#w~r>4P#E(V<5HpJE^iNzmYUbqB(>^g3i&T*z) zg?=*LtBu+a`>Ok^4;qD_Fgb;UGsXm&jCJEQ8OJ@N!u|DvNgeDfG`if9D6s{#2CX)Q z>wxtcU5YFg&ghb5!Wvz&Erxvxu{XqGa&aI7b0}VbF)TR=8E+m@u` z3D6E!$QB%G6u)UbzS$A#6?RDs?;&fbc`r?)qXv{!lA%ME<}=dao@F;d18PlIG13qE zjjBI8z8hY1L)Gh#%BA@T=asItd5fk=)u7&C$EFoJuI*X7#yY+5Q!1TJeUIEFR|Gn6 zdo&VYm=Goj=gVZ<^Vhcyo91UC8i6M`jU2N}sSfZg{p4A2O} z_^VA0WsH%Ht99I|*d{BD!12aKl=(Uh7K>=@Z0aRo`ZSF#SMJ0v7MK3m8(kl=cLAn4 zt;+j{#)xJV5}sY>T-fJ`n2sJZ12=2|feH3*Q|NNUXcRgdCG$ltB@^**ml!M#Q`$cK zP-t@ekx{ic;>Yt(9}~!)i+|Qq@o9XnXlFv#J}6L$j9s#VVDiHlA!F7ch~xO9_trHIfLxV+J7J-4SIp7`)xf|IQ`2mas8E#^oK#L&S%%GSS?tAr4i97 z_?&xjYg`vj)QC?}s&P^r1ftN7j1{%%)QVc`a5xHpdOJxR0submd zf8_V^F1=YkmxSId361wh-?r(T%BA0j z{RD{CJ|vJyUnD4e8vIP%N_R#~v2dih2T4UGTcD{Q-t^Va78H<*Hq-Ne`IAd`DVGcr z$*AA&`3;xpUv`_Oi3xq5#qX!t*h|qKU>$$C%;n}W;F}UuI*%3hPF=y z%|YM|fA9Pk`%i7OsdbJrm#aE$g%Jl%WZn3P!^_%{_6W=R1kSi5pjfSdS&l|S@IJ1Y zJe03wVkb&e%~?!dWiqid29cZ1H1dAxZ(b{3-uo$Kep;=ArQ6ck!q$bkJO(_2p4qd3LHMYMfMth)NC>Tp{ylC^y)=U zY`>cybk%z(4-)Fb1mHfvZn`uv;s+pHcHfBM%YFVwYkAJO*m zpa|BX-(E9u{nMKpY>#)DZtQ;eiA~)H0mtczo5qCEywFht(aRDAqaUVO%ZQquPP0f` zgy}3J@q?3y7E=OAbFcL=dO}ycwLCc>7bl{`PA<^XJCqU;mTwTbFQMdq>7(neVOFeQZYEEatd{(k5{kaP3>>6DOt z-fH?LgnvZ6p*ivFlbeR>0IA=YzNIzvJ|9RM*Y3lVwxt7MTZlXA#fAGYH8T(}19s1) z(cbs07V=8<0$zRCT56}C4k%22ohABHJe{h2?J@qvld{z?xaUQ0xdCXHfZYMU+_sEr z`;q=HG>g$$ul6noi$i*y*C#?(pjC^nv^M?_RJCgL?rdOO`_@RKkxbhCBU7oP*=ZDX zaqbY$;dvIvBzvVpYKUx&VUUikT0cDwCHS7q-ihA>gQ)RDJ(7!6!7#ySokDJOBbbIq z6vA91-&$T>X$}Nj80y#gQm!gisIO-A@)%9|#uLih+JU0{Sjy9?oUytF(SDw-FFu`K zzWMa!V;aeF`5g1x9eujE`1IlO^JyAkSmo!dWz^6*TNiA)g5hQo~T zsSw5hy!*Z^muD*>U^)5|J4*MPR#M}0CcpKSx{O>KPCuosiSqn}wirc^Wyo7;V~`$e z{gWc17#`NxfwlR6ZSEJuknO~H^CH^4VKFgEzcWbDq+^w3N1+e#Nev;q1BWnk9wT}N z=|#jrEV4x%_&m3_GonMtHE+VIg9&lx==m7CTZ^)pbc+Edj>xJPijmmvFXpG?xHTyU zeaWQl2dd2#P#mg`1eZd>rtH;Pbd2M>j%79VLq4kA&9clL>aFIab{6%6n7P%ohNN@O z7Db(|$8uuo#&XhVyRru{OFO#EiX?78ciIIRS%Y z^~V^sBoiuH3pAqwHrs5l+TMxLXxM7N?FqP43%HDSBwd5#JY^ORRYTAss|S5`?@`}T zQqM}T!}dED=uMwp%%8p4e1!knhaBeXiJC*4sYdwbQPr*u$KgraW)%zrD2mHDMI868 zAedorr`l7*J79?V;}Gk!5QwdB#}m@fQoPphLjT|%c+3OxRKRd{%U;`Ww!uWv`jDNI zwm$hbFuVytK+ea#LhycAPk2RjgLyaj@a!9HwN@~l2HwiFy~;vQGEXSq{KT1I>f53! zoK2~zz~APht`RwJ*^hT9uE6$t9N~G3CR&IWwjGO!>ZDETSr4{W`7q0Lf`wKEn4$BQ z|C{-(MlfWXwQkqH!FIew%sBocEC;VIiCN1+jM=3}GVU(uxq0 z#vhY%KHoZPRrScUZFSGQRbB7IRYiN|s;oP8e}rJ#O^X?_DJp_ewc()wxAu+j$}-4n zW!NZtnQV!w58q2{;|E7V6~4jz2P_Fc$i|bjd&1Pa(MLAN?az~yz*u*Z(7oN=mz{cT z@&+A-HOmro%H3fsygD_YR@2X^l^Yp`F`UXvzs9_JewiNL=P2!c^U4%6-wFfgN7g=V zaUzP6?jRRXJ9%*eJ+m`~^z$W{V;qX&t+9VuYooCAelK}*{Pytk`-_IqFjzIw5hx4N zHw(XIMCE2Po)Fs8E8DRBZ;5hvEa) z&_CwEo8j7zE$&tSY6&F`3bL3PhEO`jxItRq`iTLf z=Df+)Ag8v!5j0^zR*$Pm;scq`G7cResbf=zA&g3ZbJGwjX}6+%W`&N@lZ39ChQx%P zooC~yu4WO9)cJ}g^y|5Amxbr1&h$1qAEGTL@|b|?0+NbSX-<<-NPun0ysU0&ut~Pc zhrB2brK~PYbzAt4X&11r*Q>Pir5g!z6Iv$o^VxgbxJJpeYnzQHzKr&Y$wOma8|S@V zA6XPRdjN(~di%{m_%oIyWn&30OxkuX_XZ~~_l$KtM0|(DFK6dA*0W4x`M$hk)$6=w zF(Iz8tRB`P1CxSx$*f|zH1SsAD31sM)R74t8(FZs!AB8uDE02U-r2E32sI7nH!&Qa zj2WR7cB{1pr8@#FndvlYaY-m^;D0fppInBxN6x`VChyAX>;HjA!M0_^=V}pGy_#mH zunF%6pT}$ftcjShaz6Md!tFB_I=DB?SH`re=+zaZU5*(&@^%l7QxzU3ZFAzvsG=?O zKDRwXx7=WbcD;S(z5C47KEo|&j9B^2lpam#yD9xVr9Vu4l%k%83fh#A7~90~h75-{ z`ZZ+PpZ~H;W%ifdU0P?mbd~Mx8e}3A;~E`8e}~>T?)$&4*ovjMB`*fM)OjJa>^I7c zQ31aBWpb(WbcS7I;|Y}skeX-ZO0r64hhY_t9_N%Lmzdh9&?(9kn~!P6Qg6{B=%rxo ze#o}*HS?+3-E#Sm7V1p8Rllvu8=%PCV7~WLwGCe*`&*&^4F5)Ae(OKO@CFHzmdT>L zilbS%S`-*OnTulJrazdM)gaoD6yM-T9T1e+1=B}2g3wF_B2sNOHcf1{tFOu!Fz1lF zpLo-BTu3T13JBWstp7mWi?X@cACPq+;eY z_sI$FV9YF@)*y3D2D~2R3-Cu7a54B@wFeNM6zL$^Q5&!m(Seb8DR3sda1b3&?9KpK zFF>x7wzK`{1m!J@{+hC^OwRc~{;^P};~nwxCbRJ_dJO4T#51pQUygw1km03WttV&rbs+vYHc0|a&%Q*iBM^F<#tXTfoAYwF%%-W(XQ?=!MAd;HN z1Nd(;14$}XlnTNHq>yT(aRrb?KjP}|h_0ur>2$&BbhxV};bZBp1^CR>{08$4hh~Y` zk0i9)H^y)bI&aASH+yQRY4Cc%XJ6C)loi-o4f&y5)l3h$EFm*D>WKYCp~bX1j~HRH zGj6*lFp~Zk^rL6ATK+5M^Mqbz3T82BXb%cYyBB*n)GtThqt*AANPJ9~&Vj!ym#wae z_93nJjr~Di*W=yEK9C78-v~6i65_nZEVJB3KicurEe6PBrBO-y6MTvoF-e9|alDO8 z(AeF30TJ(FR)N8EB?qRDWWWKN3yt8H8YN@dHgs*!{ytmOY_0Qp;_`KJPc`oeeIRPrTDYXKF=;P`6SuPcvFeuLR zy_eu-rVbjAvpTFf%>I%WL>ox&POwPhNbn}lYlAXhU-LylU~YF$F9cE%rc=-a&VCNNMFT}DwSjn49 zbhynhv39;(j#S|dEBNXro2orv#dEQ&p?H?xEOUM(GS$O#uQsAwV~Z@hoGx({c4?&xmwBPa%%cByc^^^jJ%TkQx^!g#Q9!Q0Q9iB9 z#Y(cseub8BS+uvi`@bSciV(Lte9z`G+adJ|S%ZjC^)JN3m zrDEGKkh-PbT1L&MHb<(W=umMqyLRneNQ@tHEqYiiwDz^zM!ic`KGAA5=xF0u+|j(j z#}G%Q{k4k+5)*p6!j>j@L1#j4IX`d(num7Xp^g7#M>sXc(_@>)(=>`EF%Ia5d3)qT zFJuOO%Ip4QLR)(X1170XP(9(OD{T+FT2X!eQhO39uRoMizF?ngRzax1^vhk+DWpZo zYJDF+C=MtHK#*2*h+(4rG18xBu!>xvn{#w~JYiIAv`&qZ=1XVke72(ax~Ctl8)eFF zQ4|M9ES&>Ma^h6v*}JK`5?EIC#XM=sk2PAq92VTBalgfNh`LuhBXS4x*#CB zx#EI9CFm$HtEnVZ;a=Jr!}RTD_OrUIY9w!FJ(DuLO4O%B?m^spL>m+PlVxtQd;Vlu z2srJY0)afe@<$&5^b3dy_2zEp+*mvQKs==F8Dd5iZj$U?*6CQ2n2_K3-IQpczdz5M zW)h2dwnj^ZbUab?9oQ#wZM}eUQBPNm8io`s>P;iX+OS?56Q1NnL7HYCc+DQ`8Ek+q zCc#bfgXXDw=HfG%Y+l@~smg>&v*$KQjTNM0j3~^x^1g4>%dg|vHuU3pTbM6t8H(oL zgwICRPo@jXi~*d!Y@Gg{R!zqCOK^=XD@Na+$DEe5a%N}ivd?Nj4G^h=RrVkwZ7)8F z$!LVP1e5v4YH6?Yxb^I&DSDDb)VJk@*v8f$NLYWM)(io9GC`^|)JlUMy)#yYA;-1p zfUpsmWKvfAiVH&Fs*XnATG>z2c(@0C%=D-ey!cW~++Jhh@3ovxi$=E{rOL z?8h<_B;oa&wv}1Tvf&=dUM*|I+Zj80+bsKOifLrR(w|jnUKF;(1mdZ)AE*61*2VUn zQA_L%dGN@JsC2kxH1d8VX7K*fnCvU0>GS`&=Kt3~uCwCv*-6T%2@s-wNs7CdFHT`5 zkWRb=`Q;m4F_bWHb=H~U;=mZ*@=dVl2)4ZEs5_(Qi2l!Q3#ztH6(pE00p(&aUz7&C5!t2qR#(C_)fQio_hTr8k@onBwl%k-YsplL|!ib}Rv ze8_9bs`PCRztq2r@+!T&rMZ;37G|cuP^7308cD$^xR$w)@me7z7|E*@Ww}(S87AX` zLzx;Abrwq%xu8bTm6|5Kyg2!Ae0KT%_~W~aAJUtpA|gJ`=QWe3nuSU~mq3`#D#pYc ze#1l!y5~0~HA+2w<9~p-DpmSAr+3#3Ig;XazF4HIYj99B(W26a9Dc*RU)Oc|!<@q3 zZ}XWV|58>^8z?uG1!ecL%4dclzo-~{jSpJ-rzO?SW7t7e-YA+mUEC&p2Wv zQcb(1w7$-Z^6v2TBs~(ovZ`Z-)wDF?FnG=q@WkIDIqO5*YVQ3ZY{Jp$Dkk*8gD?Ji9J+p+Hf#yaN2A!zK3^_B ziv?U%Ak=a~^X!=H^Nf#1$NTM7&gZbqHayar7QEI|G^Z$CY3Ef_U>2FqbcMcgwtPWr zCW?#lD-&tqy*^fnx^MP=G^&zIKe(N#@Cgu<0fGP&`E1k+;FHPPhn*ZO)9BwL+SgM+ z$`}f!0T(qp$vTi{?pOYu6qzAzKnP`Ck66)})75+qx!}v$*O*YA8Cr_o<{781pW8nt z*JZ7jvf0EXQjC5+PfH@-GPTi}0+O+9T2W2~q5V5A;+zorCq*j0&0{+QFkf2LX;iOf zGgj9TML3wl*r*=g=L)1cnGwi(>?O1qW$>Xa6!Np|mL52Q@icS|SOxK>X;$AOk#VqJ zX{=;{xe^+j4jYa}K5A^UU|0~C|$FyWL|03k@M7FgrDG(;RU)@uoemeY{rZC%fr z$>-2eb=XHS3y%oq*>PY^>zytmDNmp?9T01|nlAY4aJj^EO5V?5mR0`m1Kgay+s(oG z4Y+_z9B7=4{%*zKF0a9~1-~EU%jMwY&EQY#V1$Ma?ymXldY~RQP*y=^n1Q@z1MSk} zz6|ElB!iPHQC12y>uKmHrODq(8uLujM_!XF3s71>>YwDzp;^^IROI%HD2=#yo-dcK zgoY zu`e*+=o=OjeQcuhuY9>w`=y^2vv0+Usn-?4*$%W*(m>sZfk|YPL?i_Ry-P1(P%sm^ z#^axwd(aU2YZXHt9>a@PCNeYaVnCDCuqP-(^jLeH1ySg{hnUv$8yu~DSwn`_OwTi` zuUs}RpUque#eH+qSUgB7Nl+u`p2T0KF{2_#J0Py)wc^u_2KpYI1pBQXnPTb3a?+4y zw#e&x@ZlUq6V(cx^~f4Dm^b-7lDBpCmtE9_7Uj*Mje(mnECfO=D$1J(fB$Z*`EK&+ z>l z7|X5u0kV$j96Z*Y)%iCV_EP)vT<{xqd_Qx+Bhi%G01d3uBunn{O2m=oRR%itF)PqU zZx9=!Ju;B!i8)}pPe?$C;TQdV*O1(8cx~L&tYm)JY1e>_?cb*KuT#n%sC=N}f$|5V z6@T;TgIjP!zp{svJ?PLuxJM^NqyuE9@&Sxn5h|&8$ksY|Qo4EoMkk#;Xl^_(|D!IP z)|fp^XqCwW2LAu6#bUpLK&I+tz@DQW6Uh9eP~=^<)^CW=4r&myLVcfA6gtc#iX+O5 zjX4I+8&CF2W4cXsX;zwZVWg|H8}O^rRbw{Umzzx-%WQ44_^+FWBy-{Uztj)(-UXpk z=Q$RXWnSdVEX&vd{>Et8DWfu(3q`ovp)yIlUi5S!9XlTPG=I<`SF5yspym+OY4Jee z<&m@Nbn&pA+l>DPRt=uTLctdNmQ{)gwl0UO2V!iOJ+lVITv$nO)!W4OP(BcPv5fyZ z1slB&=P`fSX5M_Lni2Z9&?;ivwEos(Jkgn0Un75NzB~>zWUGgm(Ah(ruL5GYRCS9^ zasCi<^od05g8S4tL?UAca?JGc7Nb#Y(<^n39k?4<*ZPw}AxoQ|EIbd?rsc4w?PazL z*#)mH(xkF=_GEbWBxP{+^cZGFV>uxZX9PwtrKW$|7{`D+Y<>i6fLgWc$Nq$gdkkKf z374Uf#-Txpz|xII!!JnBXh%95@Do!BYPED;luLPvG3xn0*rEEV9S;e(EX>NAWj>QS z8Nz+?l|9r78T>@B-sGL=3lAO-b=Us{<$=2xXSY7=zLAgL_sTlloxn zITK#k?X-V*uE5uM{oYIP5aXPK6VQ{V)B(E-RF@(F?;->*0jB}QnQH$7jcs19Vy5Xf zEsNwj7KVN=r5CNiKHuX>(=;A;{19&okIOQE1duZiT5CxHuTuC{UrepVIn}RHMAVh( z4Z0g7R%n5cJOQlTooFX(Fu;eIXfbiPEq+Zr+*Qj$&F5)HWyxtpORHeFjue`ZI=-2* z!gGFx4P;?yDz`t-9Gr?6EfsIqPF}}k*ip9BS-=l_M#-)p8nB=&k}12+Z#lTAt6f_W z%D+VdrSdijE&t{t9(3HJ&lbiSAegt&Z>`8aYP?3HpuS!%IJhe91&_P%nVd3o z$&S#c!I@urCgF7~wNb6Jbrfhy=`0>GQqsxsHA}Stc$Ls?fdAZHt#x^?l?f=_!^ctN5ohbzQNW@;Z|FBi zhC}9`g%9$<;0-3n@&P{!kB-PT-LEtXwIO4{X5KY~p-a6P4;3oa<_g{R#S@&-I%b%J z$<|iGhWI@#O8}mNs3EC}5%bTY2Wevv8|bH6L_6R}4OrEgvaa$Y9gMR-1#XvBT1!Uy zd(75&svr({7BPcH0Zt#p0PxvhuwV@4Z2fkqoo$G*W?&)6Z)K&|G}BC1ZTd}hh~+5ohEH3~x2GQ#CC1BsW&Kvf5iIF)1VI?~E{?T%{wOadMx(#A=& z2AkVb1CpVXN^?ZMda!hMp+iBaqh+jf^;TalS8{`^{nedtb|~J$8?1)6E#ZU-=AVfN zyaBh_19>JC+^Sx%!j5808UP9hn5}U_&R%mIs%t47p=)hFfQ}Lay`hd%lmp;qXYxUQ zj-&QoOPXlEb?Q%Jhx6tRM`nkG-C@TrCx9cVce`MHzdF-tiL2eTE5)6asvL}y7Wvu) zm^<_qW{lH0lj<-y$B-7Re@Y|fQw3q_N#<_x8CSsbYGoLLBW@%Exi@@y_4@VY+w0+* z$Fxp;efjd@)%D|7FP~gJRas;DgHNc?{8gN&=~->(>Q2zyh?vf-(n=$nt?9fbYr#0J z@*btA(VX0opER;7ZH1|mxKHtFiEuZy{LMqDbq2oHnN~cQ?}of)zO~h_Cw0CctmM8bNVQE_t98xot zdQT_lvg*D<=~@$+YkpFuM+(rwh=_ zeE~IR7MJdJypq?!H8~h49Bv4^MB!ALF?rTc27~NO(~4q-al#Hlct!;|&jOo|1Nj7-tEvrM3MWUV|tD#{I9q)E^ zzhE(_-}1KKD(PGr_b$OBFvPeRvh8#s;wa;ZItcJ^54H%TxhOFA`>}e%ADhTBI@oC_ z!{a#Is3%B(WSYiOtR86tKoMEl_9VV~|A!xFum0zhAUa92h-U#hUETKbG!{|sFOT4Vh$5YLoQ07n)RdtQV`mwl zA6K`%)B7->NqT#%m2Odh{MBtw{da1AK-Z^#_i3;G$M=393e3WZ#;M1r&DDSQZL6;! z_IMR$;XDghi)sOyTUp=K^F};rZCR7ZK-%Wju0fONh|})A;!q@2Kd`s~nrGn#(Pfy; zMH2W`=PTq~$jgmo4RQvqFD_oacpYXr&xrP1{3J`4LuuToBC!nT{3O4bAKflvL_Di5 zZ%zW02W)O@+beAqs|WQ4jBoY+$(HRTm4-9&Wyt>h9}n`IdGB@^C%Lw2Hb%|s@4Yme zpWOF-UkwWN{-f9H^#J%7I`vUcgQ)&J6LHK?k|rEMv0P^9C(iUTnXltmBzzjK7y>YD zB>$d@q)K;MI5z#=M?FPnKT2;I@_T;oRQ(_Q1SKD+270%rP-=6^&=070d!L~nQEzi! zeVzRD9}mN%l!tp{HVaC zS?r5x# zksU_f5hCQjF#b3i`Nw}BZ%^s>U@hCk0^6>b#kH;$c=%YuDOv-qBpO%E& zJE5yZn(%6bACEpp+f#bK{FtAU^N;xaW3>Ig{7BA6A9L?`tUv4De=YBw&?2j52o4a= zgO4X4Pw;uLUavoTpW@F&k;Vyn2dNpW!QaxEY zDK#)Pi`DQ|7qh|A*tWDq@z28%DAF!NIo|Dl9**1<9h16pk+lY5;jb=|6w8VBzYjf# z8AhPNKrD;-Eaq~%6iJZKWq2D19hUNfPsK8fgRG8EG1=gR&{X{ugmQ)@D1p4x9e|qq zV1R{95QI?klUK1G`XYZBz65DfU)ARilHD#H4ERrCx9ewv0sqg_KJy`%Mwo?D$+PG1 zu&gG~8f|-cnI2ws=eLKLwTGyOVVxBwyIod){v;Zb%*n=;ZuJ?v91KhZMD@l|uNx~; z`NxnUwSm7>1UaI=?1@>xbcv0|G^7QM=u|846fPd-LKWm$yv@I28HC=O&Dv_UojZq7!z&( zU1jBj=CC=Wq^JCQqJ^^7(h)zUXqHZkT#>;yhcZD*HtEPU-uOaNIvmQFYLc|xgdsem zf+ekV4ZxgmpPf`Vej1uZIN27AJK0YJkE2F@r1Iwn@~bYQcA2Xj2HH_{+U{GhX3K<~FFpuNKdjkhlc=$i*9n9(%3*aOdCWg?Tt@m|~98f@<6BoySUs)t8b4O>E9DN6G;TWA8o8<=Efd>4(=C&b@i<) z4b_6aDPj&TF)y2|2EY_tImj)>WUKIZZsYrR0KaoO52=={+J(My%DWXvTgP1U%bO=1 z>_rY9!R}0Z1ov{QBS^zK%syb|!YEbhKU0GQ93eH?atzl>Rt0CeZE1caP6dt?e2yGN z%!PvOyXF!N2DsTjEd~QzfSE7e)|bFDV6uTzNHcC%s) zrH&x%E$7%;P^bOJRT?Fvb}=oIS&Gr55OJgqi9$!!LFrAyIOb7rE##sn5|~HNc=kYq zZtKuQphBW9Do`~MOv2PF??a1p-QgLwFI~l%_9_hqiBV4hw}Fd>3ufn*H;(vPb@82T zv%XKLaGEbmTA~8=&7N&Tvf}<{5N2Xk>jolLQ&|V49&tg=V;v9!b{ox zpWz>BE?F<*QLitSt2C2gBG2|pr-cN!a^FzA{I|23H;&F7cq2?{NOQ^=A6d(e@d1y> zl7WUv*5_fK(oXjQ^DpNF!MIN!^jg6jXaY;sE)?nXK)Zf zBG4t<+d520)pU~y2~B6|dY`jBi}@|02zckmLh_|5KGjOmrFvUfE~?>vj$Phpi6QD- z0+Rvl6&dEwkT zw5w@Pxi%qYj71K)9ND8@?`w7XGj-?`nCNZ9;kPz07=+g6Z(h~$geD5lmmB zg)^1HPGuh%4+dA5(<%81rftu4FzBB$#-@V-zQn|+s%j239Cyw4Bebf(rj`sT4p1W- zg+z!qVnC5S$ET!B_lBS}0}*N++15I0;X3~}|u{IlFe65m>?^V@N=ky99J=G^c0Zjw+T*P!H4&$YIQ6LhU7z{)c1#l`{ z6yTaqT-J}pIKrs9fSeXSpxR69KX?)_lfC*;~^Lu zRt|Wnmd>l*g1%4dt4w|6#YARYM{F?4Hd5hqxWGz$$T0U#Go2>~j)b+;Xs6>tM@T;b zZ5W)c(^Bgxaps@#2L}sU_~l1Ow88lE>VWV##wEE>{oO%6X7H zlK7ggoO|vu=4?*3H|qU1)vT(CYGVs*KO2Ku(P|nUKa!d?uI`hv;r0G)b#&k&A6o2$ zi6>K|xIxbFrj7=sNT$b_&<*SNtF*eohj?qZF93fVAo6+BAm`s`Lp(dZ$4!1#gLTty z25o!x_QiAU-rJBIgTY?@bCG;HoU0DH$#r`D)a+H_itcp^y{bem+gS}hZ#OHR2MJ7- zpG`fZ6P4qHO6`E7a-86`tFeR*D;H6-xX2gJL)mgA_1q1Cr21CpO~ip<+p=Wx3?~eK z!h$IJ3hvEw^EZ&hTUL(8tQ(e}uHb>2czH3=ZoIKiufQ96gJ57uJ%pD{S(B#82Ll9= zlI(ZQfS9@lBvtkz%q!vw4EQ?Iu?~T$osQXV`p%jzX}dc>dN+eXe=`_}!Jwa5dm~;E zS{C|^9sOjKj_E6$Q55kog83p+(m6R(IV>$>yHtz8AlBiCX>Ez*#kI-vZ*Sb(eJr5CTVr7%Fv0jN1u=kdHcgMq}YWhLjW1fz>u_w^dv z;QqaYy};7SKdp3es$a!`daL0u#uA0;8cnN24X}2L8kl-T%_+ zAKBWCr15R~3t2Hs49ir|F2fy<+ekW&I+|U}1A{rEA{MHdH zSs0f~$FUAUa%MF(lIDx|3W6iNNE0E`11{1V&SjmB(hiM_u#hRVX#CY_|Iuwbrp-=?dJ zbe+6P;te|Rtm$yX>PnaE@y=!k20WX6WyD~FRklo$=J=3pyeH;Kn(?cdv#AQ111Qwq zPP}@Xt6Wb&rT3wbBAFAFZdH@j`M1BlNg8c*j7&F0K{W8NUZ&tfb+_xgMOyqZvF|2S zJMhW1=nr@8&+~K|#ySxbVjTJbak=M%&`gPKuRjN)5vpg4Xfhs`6er9X+?_#nBuz#r zgvjk<*7s@RiHHdb5v)3}ltcb)dPXo`v-y2g{|$SH+(KzMG~#fS&;jiz$9&f zCT6;Kj^ExSh;B{KS5d$n7o<`LKA^wuG15WY-Mpw@@#RBX^NxEuVUl9Ol8$4Ux-Ed% zCu1#dUsM2Lp%=ye9r4pU+=kp?%6(t>RI$SECzZlE<`L%YAS<=f*%e>$8a8}1YOetsYQp_vr-3L6P z4Il;s{RNf`=c;A^9>v{|g^FNuRS$Gcc-T9sIu2phOw`7J7b4T~N*>2yp5yff6GBt= ze1kbn)fgeFC6-jroPl4D$`YvdNS3KKxg7s9ZJ)R zjn)?+NJk|E#PhB@jo+>jO-Mb`)C;pLUE63CM7OAWGqzc(S34G)1Y@$Jw~4J;*kqkh z5_+}4i6Y?D{B_i$tM=Y%uFVL^bcHC&z~+u39dZy+q`F08Di~@^4yJI7XvV~mwU|SC zPu{7z&GnSSFbkaIN)OK*hkI=C(W<0v`-oASE{O#52>xXaNyn25< zy!!3(2(50yXm3H0wb`;hx5< zT0`V453zB-CfMZ$qHMW55XP7=NK+_+`U+gzXa(X6adQRci|?_p6MCEC%R(VPE3G5+ zS1hRGn3UEYbl+FYOdCZ=qf#N8bsV_ZtM<0Q2^ECC*+8%Nl)TMHB z>&aAex!!AsZ|Z+E)eETZLt~J<+xdDOGrNSDS-h;IIeQr4kiCsCp+emO3nu7{^>00q zUw$sa7%%AchNul&(AjQ>V;0hto3A#JsEv&2O6#5Gbm|s}=-UlZI~>s|kWB^K*7oJn z`vSjqyHoyGx_4<(=}qR3(>Tpk#nHY2_n1{B6nLkra0*VSaAAM5Dz$P$-gfva*~869 zjwxriju(GU3q`MXp=>FSGd>q-qGSDD+gy`~jwB$gkw4z;K5ej6r%`I0#lb_9ejd&t zprJ+$PeKv%2%-%{QSXrfs9qsZBhsPPYZ#Z>vk~Zt&=pPd|%R85ZY$LIPJ@lK5t@Nb#$#Hrt2bC zpbmIF*cw~?ZCO%lx~@-w0sOM0A-hQHn2CnCV<6X9D$;|7I*CwA=`l%LR1`DSj_-e$ z(Kac?Y(1UJUT$zoISr{`Vz<*?9o6xCQKhS|*XE0q^kvudE6$X@!4?w{=IrMP>ukzP z`r_cK*~yB*0GY^WsL#|F3@MIVR`-;D!wX-BmNG*Ut`qFY6o&=F{$K=a{QC*DHTy zq0DX$WWD3~@APlv{BOa1D%kNU2@duIJ6$z*95&hskGsy-@u^$r$mz{*X8g$5#rpjC zH1Mflr-Wwg)bAv{Y0C2B@4xHrtZq~TIr}|QOQ68aK%0fLll#Z`)IYl4*-!<(x@Ja# zRn+YRhTuh^39zj@4tC?~&Zh zg$mIw01M%^0t@(UJKkK))7I49aeV44$o#>9%tO5%pLRe*HB)y@EOfLsKL6Tbxnoc| z>wl~BG8p{r0eiGQKmCR=ADx1K^!oIk+^-OV18Q)T4?x;iwu^xM(~}MR>-Rpr*s%M) zPakdA=?}H!Iq=&%G0E6_0gD%wG_#Vk&(-dd^VT%MaZSAdWOu}CbLRL^!e&rNt;h=@0! zb#G1`uZe2>Z#V4mh8Z?M&smag;@s~HPJQk35CEDkpp;%4NJ zk+uq~)Beb_$mvMk)r@JgPkR=P#*5eJ5T2n`LW=`K=+9i^1*ZsXq1h~S>ihp$xnt8G z^{Y6XrB*PSXtYllz1UH$|M>Cuj1|If^F=XetOtKd9BvJR$grv=^^qAoGt!^$o})IObpD zxtk~X*6>9V!xu@)dYf9jd}jkn`sEL?2e zm@ZUxL^GAj_fs8}mG_&*wQjK8NvtL^NpDYtmEnUcPyM9dBfL7&6yfyzQJd!4Kf)cS zx>Z$^Tl@}627`?8_f7C+Lolxa52zV_fRs^ncDoi(!fv+Cxr<@;#;QKu=;t^5^hbx1OTkwrhnLNO5ANix}Y1<1ScK)(~-8@ecsSUdbLQMsk@yP z&?R^5g9f9ddF*88u{&#>xzf2_e%>4;ee`^f(NX6ZHTAPL8@tzpNIHq5I}Wro2U?a2 z|2gO^alUi+5Vnt~B0d~N^;R=RP)bPy}#I>0NEzqpP4ywdEc~%ysStb7r9KA+RjAVagdUV{0$GIO%MXGnp2uDz;}Uy z!ls&{d2RNaqjfbG$yT4F5QB9_wRC-0I+wU}HJ-B&b9#c+7VNYY;!ZneCMQ;V4NG<} z#hj3HEZNT~Se~fATnD6<>FUTqq7^FwTw>{i`G86DOC5BXt{$+21gGFu!JUp-^VJMj zs|q@T^a&=EQ|ZNFGB3h8r`tHp<#hq>f1>M91_{J((*A&=hZ+IY(38CmfY<1L>dmH*&eS1`3q#eQoVNQSDusx77 z1&$}_?RC$1Ci>8&oYUj`Vb&ID5l4^s!zkj;K_KS`voHw&MYyh31_S>AYbI6EzmOd! zaw(O6R+Ngxd+npA;O|Or!g~?TxebtnIcp?qtui$tEpi>gVw6Tj?mhl>W7I%#}l&GKogwQ-Zw9sH^h z&JHAhwV9gV2w+eN0;5zU^Pb-RUYhjKk!(l+tEH!PQ~~W{3XMUrpYL`*V^D4Kwf`Kw zDpt#eS6Vh7Hiy({dfd}(KT+qKl%!g@J3?djZY%g0AsNmQMM=2ih$15?Lt|?EIH(p^ zaWVa5{C=TI9VgIqSK{w8wSLyYu-~X#d)o%2!Jr91MpSR#wXv^}SKr?Q!PfC=>(A}(j9Q#-ja+dTNySEt(UhgY8YU_rl*6$gFak#f(Nm)|i zvudC9+ap3W^R<#hYW{{k>z~rx-$yQ*2DwJGFhwJOpO1-L2jEi!jFHcrD+X4r@}*IQ zXf*)#p_but#;MOhBUB-Q>Ll_2OJ>v>9CZ=tQw}6TkwDOI2v2qkmt?I|>pPGoWalxn zJPVP(SLDb`zQ*KyG!AYJa9Q7FsJa&_N8nXR&MGUAW#fD<{5pQHX2Vw4@U4!cFbShM zS43fhq-%O2BU@99F(wCt_qd`;H6e?vyQ1D1+H*lhws(|I(u6~ubr!C=h#aemWSI7R zFgW>_SkCX&FUBN|I9SL4OW+&$V%!7mGpJM3JncuXQ;H$v(B*L5mnBtmNb}}I&5QbF z8gXaNj^D_JXEuJ`Sea^oxle*dj>|yKeF%*OtOwz~n>3|zY&09QeHZd#IR{mTdMa55 zWn7&<*zr#7iDr>Xi-HQz<~&jv@3I)26Xn^IB@y1wC4^>Pnt(P)Q}fAQBcs=Jl>C z(Hzt{%oik7oq~piN#^R?16pxh-c|V6fR;A5s1Z#~ml<$8Z+!>*#G?VgmQB1y46_V^ z8?Xc`h~^z3mIed-*vI7jmAB4>PpL6-RQEOv&yL^yUF!_~!5IVGx_vmd6uxCO(VVrAS5YMZbF6ZKy%4z}TlQGO z@|*{nKH`dSk>p574A=OXqkElbtpw_{WY^Hrw~`RL@v$3>s=T8-yY*=;TU2*&k#|0D zJdr;(wn&&bc1h|2&##i#Svt>no~t~O9IwnL3Q&^DV~BXARSC7!RH3H>5>xf+*zL9@ z=s5Y{@nxYGrsBzcf9eBAzWFlI@uff;=m$Ue{_k3zH5h28sOnOGovwMtqemNE^sheA zrcss)q7t11BY>+k(YR&2e*ZlL-osG#y;g+6iK+WuYp_98&AUzLACPuc><*-^7lu=x ziIG31?^2xk)s?EUo^NmldQvoHSh$SBq>?(8gm&w^B!65nvE~5w&{6g$q_A0s6xOk- zFqRZX?3Ntg|1PcOp*~87#t{m6UilEjGKuig*K%%k2gdL!AVjN;{)stqjRb(LlsbJT zL`Q6VcQw=~&2Yx5Z!Cbh`E&t4T$b-cHPSXFr}uySk^cay1YmPykjy@9{T{=0QC|}K zI7~>syhh~A34{;ih^Fq17!xbQ#|2szIfWxfDq&>E!<10zt0>dqCg&tsj5ycXpuCyGHuGuZCF? zt0u88(c1UMd!~KuHt!x|HAfR|sOH=Q4q{h#zX=wY*(J*(Aa!1C_hbDTDnE4CKlC-pV zZ)=wiY7%3blJiPSxRQi9dVX#Nch0(|Io*beN?ID3tba-Zmq5=314s2Hsa0>1hU!hy zRJ}>ssyDo?dgCg1{I`{aUW1^Wnw#0W60>8o-`WNcu8pL|IR_>Ey zxz@f_=R>CRdCb`-O#?d4xm~^w2crQS{f(T1s5lO%9G`s5k1$|1!cOLbqMn277$O08 z9AW#`sNdYN&(d7#Cw4oDf#z*9jS6Ptr&64;>$W!qz$O zjy{6nb2#T8y?L6>V;-(V{?VJJ%X=pjUZl;MAJ<2w_P5uZM#)EQm;ccdDdf7@CNk9t zMaWJ5c=GWC(rEwWqj#b?MG0KVC;w8*5HHePR_TL*s#1NP3r}SqB>^~q)g&~$cx%I8 zHunu-)Di{MdR)#elvRWk+3lP!#;c#_w>9xqr;;G@3C#?_uRY}0_iEvLdrv^n)))*j z1DL8pS&g*oS#s-TJSwIf&wX!V!x^*;i>jc5Mi>E}^Qc>ajoz&2+^4@5o*hqHU@zHL z@>>adFJis`#gDEq1=3T+&auM$&Yr3*c*EzHw=1kmP&5~aQ1l>|S(?m$x;J=mVt&H8 z(J@e(T*zNH`(y_kV_@4egi2DDjmM@ofv;Hip1GWaA)o34#@!tC!i4O#im2z5iAzl~QAS zJB@ybwlFzM%tGnEUahbPA*vE5q48m^#Dg>AuIp~iw5N-SdY3o}9cI*y&yU1?murHN zGvUcphB345x715ncq^Vwc_Qs2o%s*=IS7csQV-i_!3qEF)b~l?cM;F^y|%|jC1?B` zyZUJLI)GN=VTz)m|40HXo0nIsojYlmW>X+-o^x5NwrR2R|0MfDWxq`2P%|)8w#&~5 zwB~Fbk+~brfKL3w9DsesR2xuhURNu@F_LY=XN&*S1Xq4HWcHd;o>D!C^E5MBBh3-C zK(w8$g{6$US{R28kYwGp72F$2ST?7jotqQTNC8r+nJ;FzuciW;AlQnM`@VkPyApZR z0<4JaI;%$02n>kq!?@OfC@nXaoXI}hn?{kSlE9l)m`1Z4tUj!jG0AfTT(kt}(L0)8 zQXT1h6(--n;#BAp-_e*kU5B;UE`6*hjq34Q-x&>lFbQzxd+RJ*;l^9n^G1hA?u&GtKUBj5_g}>%7Wsll59My>TTe@}QA)N-kz-y$d#-PkiHuZiq(qu)g z4F-xbGTd%Vtn`@BOl4(mmXSr1l5QG(;J(_N!2rMYG1=|>2XM0*Ks;aj!O$m|lyuz` zNc)39=G&7)hmFijXbG4+rW}M7ASJ!*kZSjFzd=>*cKv_kk0Y9NQ=_FadzA8ouk29RA7F=CN@JUjsbEG4G z94PEW-(ztg(E43eg<%yN*CdsuDQb79p4oe?hX9copE2|oL^Dq$3D2Irees-ez=;)# zw=!34hvq*>Eg{fSNyS;$df7peksP0^(ezn1l4DPRYo}KD5tT!Nq!l?{LC)h2+|&b( z9r${z^bzRWu7du9J4RNC)*kLFNu2?b=bASN3UqF7!0>2kM9@s7E9`3(EpY#ol=RKl z8}E0t?rLImHLa%nY42L2GcMPX*`1u*EJmS+=nt@MWl)+)-T_-9FdV&1Eq&xvH-tF`&I+U2@XFKPO`dFOD?#M`jsA)ES^6U)8pR_68R zf)`wS^Y@K*6{vyfN8Ew(Y%~Td8{a?Yh%}6s2q=I9oaZ>BTl>;b^w*~(UB^6{ z^GTR1!mK3fK8dV7+ErwIaWO2J06V}6z4ZM)V@5OBSd2YRBYu_qt|hVHbUE?dk?nTw zH#z@OcsD!~vkgv&Cl@@y`!_%qd2t#>I3Z=bOugfY%MLX?xP}nwya%7WjOS^5!;LRU zBY!ICh2MJHJO_eM?gihj;`+YyTiF)s4Uk5NzSu9KfY~kb8j2i@-<|k`UKnTcPoU_* zm_WdV$HJ%EsL(Mnf*=3(SN^w>l=M-1cG^X9!k+llf533UYB|`&i~@`MVg`EQQ;rjQ z+8pG5^x>p2(<+4VfyL6HlJ8zEU8ZBX%Cl(bU8-HpMVjQ^!`D}uTd)#SjGot5NEk&n zvaSLXm(gr&ph#J2FnH?IcRqdQ(=R^#-Dk#4>g!XDXYO#3s@L(E&m?{7GyKk1kJTt$ z(l0(6J>Agv8~Tq8{bfUc_US)-`q`)N{V_d0eNeBrj2w>n(+$KpVF$7&6GGhtvqR=u zYZM(N)UTBNzxc#i+janI1)4+9!RhoJ!Jce7vb2dLyKwVr#TNERrC+Pd($K81ld}v%pVrh1lJy)4+^GYy7vAQ5mlw}Bh)=3zHrTKbE3hCw#Ao;0MYEkRxXKF6VTrs z8`*6np0H*&XW;URJ@xPQxl0`s^pn^$!ci$*;2`TGQ~g}M%VPC;7yx7o0Ax1+ zJY8V9x6@8DyyXdCFz8RyWG1pDMh`RI+oVM=FU*g1n8=seKzD8&Fe1=w8x=gJ*{}+b$r4 zeEO?TKlt>Y^+m1Qw5{E7UyB+3&1d)*pGmUs*8HANba(U@|7(QShang&^J$TB2xrJM z-D4Is6}ZmgOT0B4juI0{E{xhyj}7i zB8dXNra70x>4GoAr&(I8f@H0lbyMV;X1rA@Gii@QMP9l&>Dsx8`MQq9-!n1yfAhNq zbDu;KF~+1DRzR-nX?$>kY9)1e<}-d?g*h1c;}J5^3D8*cw;3lSFr4-e4mFU0ap-EXkrAz#)B9-g7p8(`)^eOw`TUXs9WP%+aicFLMM3D}6V!{ugahDO? z+88*3m(}G;Zg4i@V*(UQLt1oHgYucW`<)uU`b1kp>dyl7Nx@+mPDf(Q!ZrTYABizo z?GPrd>gCiq>KNIOZV)QP(J>(KcwhC@`Vfx)Cx_eQp6S)@f?Lw!b#h!Zqf# zo7x(9z$ja@=eij8U_|fi$=Rbcjd_@0BQrj9(!h8Y?CQWEqdIz`)B!0*6&M~RV+QQL z%<&kow@%s}h26CeYWtHlc6aiFueK7&EOdj-opTcvTwinSgCAgE2ESS-ud{T;Gr2KX z(R>P?gC{QTwNlv@c#^Hux?u$x`f&bp$WYGb>cV{zhw~gTnB#$^Sex)4IW1^vL)(WC z;Z$94F?iZqb^V#j0Goj#JxN%vMJBK z;mfPnuP@(T58phdb?WQOmlvWrDG2v|8r=LCHy?WgyLF2-cnV8RchPTjU&@4h{S-J$UQVTLw zKi*aWHsjiFcSg3IU4V^c)dhmjo|?F}=$~uH|Egq9_0)qN5GivVIJatuE$ijTUxyp@ zTw*u%w5mvO3sNV#aopxkx*PY+O>fXFI`~_8AW++2fcM9fd)Ho)rmMYS>2Pfw57awuSEgnNT%N2`t~J#IM33O}l6UYnBiy*;Yh>q`!Ze1cKfKx%bQEo8i@~mvkxv z&>Fo6B_|MCLM%byB4N1Dr`nSl59P!BVU(`q>oAiE&(!5@v%@H=f+f8Uvv8SX^`fn2 zMT@UTSfVz%8DlK>p1*o{arx%l-T>+pdB5iFm>$|7TGPZJJpRWJ9^8=%=P4*^;5|gj zl9W2oY|yp8IAxsXAp3a3^__@QYHg1pmZbX*`%}YlY%6MFvXA@I-EKPKW5(De84T1<$7I6jDn{yopds2?VR#|}{)kY7 zXGAo~B^gNGM`KO#xML>Ugf&xIVfSoYafrSrN6Cnf$E@$`FvGke6+oj1Zs~+IA7wUD zP7NA*G~3ehL|czI-bhGv_+>K+P^UBsYn5_lbHKtKup#}$h{N3FC>!?~OGeqas%~_2 z`==$IDsKveTrDbb^7$RMievC86QDP*ppC z$p~dDaBAj~0RNBCQm0+C6xHWKd#lKc>6GXBtcc?coDAMR8OqZa@uNYwxGIHbJX=4w=yXl1XFD(uNIl&z!Z)0HC2hW0&WR zlt7juzf2_0{=qknlJ}(vj{*Yzi0^i8$|t_r?M}b9zaOU&FFR+wH7lnT*4@1TEg^1I zw_1T(ohgCY0n(+b*`M)4bI*bO0@_}E>+0Ze<2;GFn#OmweM+pOet0N2ry6`8e?zyG zq0s-_q$Y8Z{ow{r?`Y7t{!=X)MCC%Gv3%-Uf;(0~M^&%e{A1NW@r`;QHpb)tu626R z9H=!Qha-o(k@4Mq7OOwK3Zx`u_le&>7ZtL(^I(88p?Vc+Ntx1K z&T?b^$9i^=Dk!TqmZ(O2y0aBjd~AiLtbuZE;WNhr!F6S`(nd4jb*Q6EW63!=>*^PH zXr{Lud!EOs=XnwaZEsC$T|--1 zRJPQPz0GRM6XI54dE7w*J-AOSVb!FK^S<5;SB zsR9S63Ph=yw{Q8atfSC@EL~<|i5<~r{a7$T-&GS84NFa2t!>RR72uDbL$4$iG$ z9~`pz;4s5Yz{{ZqkB3PZZ={&!Hii(exU?U{P=NT~X6gB;r%74M9E?XU$cKRXeDCRS z&FbvxWdRMtTMKYl^%zlDsljHeB@wOh(UEo*qf-z?c_LOTE|I0()tk)tJ7`rk>ZzRl z1Q}_fi)l4Tb-|1f04W+{OxRD`QpdRMGkbBVQM&qPMuQTp7t%ymlG=CIp#->r)_H!VqJMkbXtG?7Fo7z&S7mn4V%~hmXQ)l*uZ0wly zR^}&7s8r?P&eW(bP%B{&Vreg|#wK)7EzXE|eW9Aqh%~0a+vC2jebET&ly5?rJ7y@P zXlpaOR1-rQ?|^lF*;2}TK*>ofzIweUcEEt0u*V}33J+)e|Qw+W7YR{Jlsk5JQ^ zM&TA0D|mjXGu~((tio4Y!;jSmXb~n+%uP1c>|G}VIJnkT#Gl_Jt;f*3+5qVGO2U&< zQC}6Cj}NdNz-XlR;dNZhMKbO^ zQKfqp+Iuq)Km>?#LecFa`{s6jefFlam9oA2dQY`*aq4gkgQU3*c_7N_&fKG=oA?#< z%XI7#of~F3ci52?qa-0TJ5)r|c~A!H)5I@vO-|98LZE_zh{~&JX-kCUJkd{d?GnWu zt0k{Vx!1R(pn21E{oBwmj^THG@t7jcGO8!99f3Uf66shy&j2ZbfG72xRWE8STXaC! zs=Oc#Hl)unR}eW`7Dv>v$f~TJu0I&-AMx zx!g7g_^l>o;iM{3^g7_w(T1-mQA^+}I&4zyTh8T^G@J6_B3(ZbSuTf?ue3Zx<&%nS zq(!G-FEUEh%^LAo-0&=%#I*^MAQbY7EPf13KPOE)_u)KID6k#?EZ&_%AmjZfn|_UW zvoyPOUsd%Wn>Hi$Gptd_+_}sz4=+RG@ogS0Xl!UU$@mCeqw$%nhQh7G7Iy%BY4rmg z&H9W3o%||!!@)d3Ypc!nhQa#2LeqCGlzoO=2a>8Y2?jZeDr@dO<*XVA=%DyUt4_z6 z6A>cDL!=rtm?7>D2RuP^jq=n0>{J76a%lj z>VB^}Pt?ZKwFRm*vTzJUTCYIrC`;eEpa~#+1$lB~fRTP%i!B9hx7kLP1#v5|0v|g< zZZ3>++#L@Yv|k$0(;xW{6{yc<;`Yu4%+!p8cL)`bJH@XULSEACG)+GVQ#Ekwmiv z88<+NoA<(PlS}ib@rlSUp_j-y@u?JqE15Z}8GFU8Bm4E zxk_d!Zr=0`|HGV1gRCn7yLwla4LHTxutQqYWc#=EK9bd*BusjfEM4b3yH<1F?YdOF zjOLWNirfMBrMC$4cRA0l63MgBc%eoapQhS_8qgTpg37SroJCI@K}CDR&Cba*eIYpTlPZ8f@pJNg-&>UD<>x^dloNhKi^+6VFyOLGY|AZy!(tPXv5ae1gK zn{TE@_W_~&#(e^JtJQ?v7jyUATI;5WXt=#%eS2m0_DV0=2x-r!h@y!CJc>5qB25uR zQ8E3b{+p|hNhqQMGLwkkB8tK^R{!Ro5JmiUDx_*5-b~XRQMBfhX%?FN+mB+IZ35zDNR4+OOTSIxtNEOILyJLGEbKw)Q{zY zulb}3+~rNvCHNO#LV+chp)-ct&jmPTH-$IVuP}!G^aoGoBH^viFRkx5OrloO8d$Qe zv^0y`<$h0#ED7UQst(%KOq-=yvCPq!hL^4+?cey`HoY{?HFt=VqQlxB-F~2a5Y_o(lh{b%6Js1cOLp& zq?uY-Su7{9YIzom=_mCg61l=#ZY^*S5w2FSWidCMuDO^fX!`tF4~(NRE!4=RH&yB2 zq6v*@v^VLzW74&H@@n1i5W868=#s)6Q?mvOm12w^rmD|PTF7Fe7XC&oIY4|U;>|ME z#0Hv(Sg8LL)ThO#0;ZBofn$rrXR%Q^E6y|1N@kk_&eJJeQMV171OL37aGNvVfB(CgDV%LBVf90~(F# zVsBilu5r!widh8ITk#BVUNYsqWeBkX#57CubS8UY5ec>SJjNI*b0|wL<)?W!U z_&7`R{J4U_j&@aJ^EH+fDbUSrQPA<#kTko5re234>J3fE$-4(wP5fHVS?qSY3$>Xh zY9-)0-NF14tk-JHmug(NSmW?gk$iRc=~SrO=qufu^*+$QZsV^0bKU=HjT4$V-Twk8 z?Q6S!9SF0iT=%Fkp|hg8Ls54)Rn#3!IBrdNk*-!i<^0i3b6b-rShF7tzyvSWc%eGl z?VLfZfW%ZUziN~kCcztQV+7Y4Zk)?%WFr$Q1iV@T0S2MZ)g>-@mP_Co0PVF3lPH`3 zRR!*j6#*p06pdlk^%QJt^-{c&;N+$rMRUF>WH%RC)qR!C!$eHK6>{r!loX}9E+P=_ zp#`0NIT%<7ZFKZ)FlstdtpJ<}Vu7>L~Wh%u?Os(gJ1Iohdpxu2OWs5Vl;-C3mxyjI8Pfg|pA>QYPA=b=F<1uV`VI!Zwa6jg0BlPxpzOsl6!uqmX3h2`5w_1<@C zKk{r~6mZN+pL!Ow$hUJXCzmb<$Z1`)?3(|(eAIG(0&Q2iG^9B#ItX4Gu?7t-8#HtQ zu@R~f6;i~SNAoU=9n~U!j&s&zOkF$9ow+y5LNIyxXTh@#<=$uYmk_Uz%WDmb;DcFx z>XQf3BlS5Am#a|B6PlR>$+IPxj6<$*4Hz=+0cECLE(4K7an39P%Pj&+sBJJ1R5cZ3 z)HD*LB>`4^!ehhU4C84LhmyaO%f~vSUMbL+3?f>{Wsn=PFtqd;FCpg2;jP?UlJmR* zDkcMsl^A1@n_dJChKj&ixyp+O%}KB=%WoJahha)H%$kfWt(6znZySiTrI(7>XHM4g z$qvc|vZ^7OH0Y$NAvN>xvIQUyK~hn zcy$sPXso+9x+y7WH>Lo{a%B~stbex`jQ$A}eb$L~!EGq;UYDBpy1uL*&Nqe^(Q@^& z@73eBf!JEP%}DPP-$(sd5P5N<|cwxNJ7=n)`3oHps1N z97YjH+TF=z!|Q$E43 z<|t5rCOzkPRS@HZye|CvLZzh%q+E!6De|00D(4r-nWt}4P>lF(QI~rd-Gs?h7yH$1 z;C04tL|Q=0AKZ*#lBQpH#O|q9Kw+dF!f-_(F+ZrM(xIOiZ&)2eA+MjhWxmNvet{%;8eX9lZRxEj1$mjYfWE0i$)6PsxY`w}A z%-b2|UYMClTz|NS*Wz)w(K#O=2fSmvOe6jzOPA{AXYtK`B0wR( ztwO+a9N)MpswL>)NvM$AMwQ?Z>`A(0?`dUH!=|D3A8t_;3}0`a42?3IN(%uTAPRt@ zoVk3WeyT$?5wVb);8RfoD9_pT4Ygqco~Pi^ovl@piDzfihBtbR^iDq3s-8J}bz^<+ zr}Jkbhta>e(IZw>c~lksbOWdU!a9z>)S(I3t@hAk2T|qM8D=OQIbjr4sWu#AUS}&X zAMzwpy#We`QyeOC;}fxGqpLuX*dij|%YU2d#Z8xwHj;z#H=A;=5Q+TpZTcw8`QQF( z=?SRt5>Nr?rK-;tH`OO74Xd=*kaiQsA_^tHN^%*-F}t{N5?_XD<+Ubw&K|j0j|vgX ztK?~%PQo~6Pu)CqnBTbxm&uLD(gZ;98SHe*^UGV2OZJ+>&LunxCBN40fUZTv77D+< zy?pWd`t_U3Cs)6+SS1Xve!IMW_wwqW?=G*eF4!vhO4x>WcnC0>IaEdKsfO9S0EbS1 z2wHI;>TPyoKUArW_zzWTD{w-UZq>Qi`>BRrM{`KuL3uOHy-VItYgFfWLDDx>-b`!N zd!kU4t-J3fiQQAfu`ZF=Kh*~1p9{{v@P|qCxRI_ENGz7gWR;{TG?q$O!*_3={HTHU zp5AV$wTBe80wlANCgO$hM+=B>VQzxQnxz0&L}99@*;0?XN|hX<(mqKuxXw7o37i47 zQ>}aQYSzlQ0{nVABTmGMoBNC}DfeFAe^^Kp)k2k;ELAB5{_2Q6Qim3X`{hPohmX@F z;Zym7=Xp5i^=?m!*^Fm7`z^Hh#09@m6{k=Uf;#5Ig`x#G$7x|EubnhsYyCC$TCJ1y zbbk5k>#H}H*Uv9svR~I`*BhmuNJBeVmqBb3nw0nIF~&2tRtZZzRzRK^8#+mEwCjqD zT{?-s=u@3$>`JA+xEu~2KE1qt`{DKFkX<_kFGRjF{XB%^G%8~L#<05Bn^2?E7m&<8 zsn122n@`U1tI!fUI<4Np=a8e@%io6rf>FP;lhdVh_M+|-RDUz}Iy~sw{;%Krhke`M z_x*0?_NPDmai{coA`~dF_iEFMEN1UB82HqvQce`26JNf>oaHL#n%$~}`aQg5OZEL* zEGCRg3r04U3gSnzWQUoYRixW4@5^5xrM@HwPTSb?`2T&sajQi_};C`7L-GlY6Bb()?Ae8Vzy6|6ICX_>B!_I&>oJ~MumwAQPU zY$^gPN-Lo)=WoNgQ@Wky)-Z+jG7M8&+7^VRm~;8=p=$4UP7!?Q>5CZgYtg4HzKPRIkt>mvm^FMf7*F_ry!j=noxFST&S3Xf)ZmBELeYiH=+#oxkTpT^+YL|>g2zSXw}E6x?@f@V!Bxf z@}D7P<4g`jp4UJ8eMniHo4WM&0VLH(=zUV$D}&#MNupv1w5U&CLs~Pw_y+@K-oAw+ zX7D#xL3!}=fYl>I1^0!gKk_g)s8_z3>9iaY%6(dnU5c+ICQ6JZp50$D19(H(p;l3R9V9243- zH27qW{d&$Sm-b$nwZvsntbDurD!v6D6np#ebC5An>#294>6K68Z~*r(-x85mCgtKM zGk|lU;59gtZegpe9YT=1q0S`AAvhjV7P+H-IWTpn+k<_PIJ9N;Q8wr>Q1f}MSrLGv zM`d2T-c6{c?G%InVrr-EWC%KEF4e9NhUYy_5-1Hre>9>@i6r?D!W{fDEV}RV^uyb8 zx1isSnYj!TnO#`lfwfTt#ayZNdwEQQjmq+Ms&7@h447b57bht*yv}HJA%Yk8v zaa-_(x`x3J);ha&{V20yPV2At6HOrd5stcv2(nO@upw>U#CK+~2!YUQG6v4;Q)<8K zPx+8CbBUh^7_-4B%yj!O*0WNxl7?V!LS{TxTuPf#jGTJ9U1Rk@GnkCn#oLc>u1-H* zzCHhZ{66@5sK4AS455pmEpVZ~MS3)3!F0&t{HOEx!0!d0p;UUp9v*`$0d4~-$H~H_W;Fz&p!50M_`5%yvim8!nzEBAyPUG) zDgPu0W#`j|IJ@A7;pkx=yk;r?i)U|LFF<%Zn@t7zi&qZY{PnlX5Znk5=UWswJn*1O z?KQYC!fJD%|Eu^mn^`NeLXXjg-oFv**qMhBFwkn-Kr&FY{Z)Je9UZm^k;jysa@C9b z@Xu`aFrSm-Deaz5`8l-rc*;ICT!jyE_7LZ1Nf@WUHonGJp=)3ne=i6Y>7B+bV>j?> z+$Mp32+JWQ%yR)(*E%t0lQQuvRG_IcVPi;ir^Jf_#+XU?VyN(XGWaS0jAWsyts+}5 zzlQ8|%3ljYkFuBeO57_PWGv!?m-q_5Je{(&J7_?wMNWY{S3s(hDIe#AvP(fu?TDeX z*>UBK&SvM+R_lD~WYn`6S^N9ci}RCFCT~T-+RtVNGHta^r`{wN$BqU+%IuA8?$Uset0_ODUa_;n zp|}jIhuQIkX8)Hmz!lnid4t($a|R>u#q9XH@iVOGKUs%@m#edY<3G$!8gq<9n5fao zNN6g(Z_MIO&zK!IelNq+d~8N^?AVtdo4=}xY2tb#BEe9 zgUIu+tJr?n(4$We)jPOHB9y&OA=JN-Cy-pTq+UJ>BRPE|Zz;<&57bZxVywvVgtE6& zaz53JT7%EMM2~}eZyaWNgp;y*R*aJkV50T8?3Y{e?izl6F+U$K;OC#_E&c{SXD0DS z^YhvK{9tpMpMRL2pF8mLH}exs;b&leCR1W+Ow4;`>bNy;7gMTN%=4*t^&fUQcV}WOnZJmc$hO|EqO9!!wWi_8JNQhdUQD@ zG`P7i^5n_LxN36m?|gDOrF2dy+-j0(oJMlWA~^s)fp))}Q}XZ~LZTF!>#aLLc$~?| ztb3S!htPE*?Q&7XN)807<_uHYr z*V#SjT!;I^p#^L!_I}O*yHGFqA~J{a62}E>Of~J@&E3uIj=#0Fx3}5Z-`ZS(8-^B! zk*s(l`%z|76LqaZH^_39#Zoh9zX)*TZ<*9eCf(2i&ha=tO>aaFQ9_W)CMJ({Z04v7 ztpc+H(=fOms{#e-hO5d!sU)6>EQhJ6s-NLf{={qt@8wM$AbhO5d8lQ86YCqPH_!lK zAikXvC-AA7xwsKCEWuyJH;7qxF_M`YOw@ADABBjn^@e6=*K!WS8J=8RG<<^F=3Go7 zX^+WESzz01O15Mgi0a2ojtk*JCEZ*A9w*7$+iMX;q9T1;&Q|HY(_AJdEX-mi5Ou8p zu%P6-^xeoy%&l_S$qm7EmP%gePKg@U0a%zpQOI7aR=-uXYwCgb+^7}zgJcqE0$qyx zY8Muqk)`+hO6Z(Qws9t+c(6Q!hBCXg_XxFF1KXGr-CTT22bD6wD0~RBuMmi(C<4h% zup0GU-8cuMp5yV@p645Kl#JZpMYd0;l=&gaO|x3o!v5}qP+2_4?ZtPs=wgMveuk0)H}g zq#MG8DSm(+tg?NC1E^^3rdOPacbAuE7xhUOXRGH`X0Oyv!odh&mj(5CbfC`sWANQy zekpDN!201#=E`(`0aK4K*p{7VsPdD_!dRcKY)qNOS+S&zV*7BUZj<7${yGTg_-n{1wp$KI8fiD&{I2J6)qVUQ~UOcc1H=&3#j zm)mppFsDp}1!O`YtngKF5D1yjSyx9IO;^McT>@{Uw7LfQSRhdiFD@3f zh{btHcAaJdef)hCD*@wuP?Z@?jF|D*dMXLRIh~t0M%*#sb$QxzC0w427re6(10KB#l9Z%HmsZ z5GDyxG*G(d$|#I=Lk`KZF4O=)ysubX`az+s7Oqjn`iBIiOrm(|M$(dM9w`*+@C!Vr z%>zy8VKxG#)Fa^{(WiyqP%l?voHvJdEDFvk4aA)F`jnP>rjjqJV$@#^j-W#DM&3fw zY5K-QH)g4I4A)Tc+FB6=xz!>Wm!x=aMiU%VwOTIzV;ohVftKcF5?|T)>Q`}OVtQxB z=5^`2((8dSzSZZ#vRk7K&BY z*`34KSv_QQZjP`$(LXAlYU%^6R&%-@v30>Bc7sEKzBOC79u<+2$O&9f8%<#5>qOmy zh7Uq!GNP~I8^Y_<0TOH-BalC84Av=~6WaY_cat0b03L&5HPKnl#f`WR@Ru(S0um%M*uFEM9UH)~dlUrWDy@ksAqvoBxrjs6R23xD~d6OKslU-SOUS?|l2 zjlBPo(xc+@22}Cj&%b<`W0rr7$L7XaFX{n)a0$T+^n!#FC1+p0L@()=FB@~rjPkF^ zNgi&blI@}gFgaT5Py)Fz!@2;)lofH}9hVZU_u}YZcBNYkCXf5;ERpi-#PHeX!aEO2 z8-XGgw=w?VU{^^L1joVGki87As^^sPtdqA|%DI(f!W)d@B+5ieovlmCJ7DGIK6KMV z>7rAmFJICrk-fCfD!wJ>_J+`%FD|~ND!i|4+bm_$M$YO=y&QlgT$rCEVV)Cg!|A8v zye-EfZR`2l9?K+Yn>b`L#byDI(^O>dENf~>(tyVAEx&ugt7m2do7czE8LBT1W%j+ z3SM(A#{Vf(7_f2fw1kOH>d8LU{9oF$Z$wcW9j=m7Qd-1xcGqt`)iGaxjN1Vgtt*NG4du*Zi*J11300c}Qzv{LMDG?pd%N>j1KBlxl@{z`}wCjB6B?(D9aW4k- z;YlIj7;pU4^ZP7a@oBSfRpv`VIs*^z@4K?~$~1Uoi+jucQE&R{(UHSO(Y}^hBr;7Q zV>sk^IMM6$7f`+~M=r*6PP=PjHuDb$rJ<#DL8p%z*J3C$XR(5th|MI|8%x;OuA;6! zGFyK;3!_*DgOM0~6%lsKCX0U?0Q3@>m6-NA{ca4K+o0_HcwyKVy`@J|Hk(QCi9<5J z)?qOhO!9~+K47WaJ5o+W^MtLT25z9M_%(EBzihNV61aUR)iX)gQ`9J$mWN_aaJ*iy z_-q~b*XaVdl`U@j^bq2zr~Dy;(4CUqu`0=D34j9d6t_np2}O2*(^}a*{^4n*6hjQR^7oLxiTu5H{{BidpKRZX<~-W$ruHE{w+{8Bezi{LshAR_xhRGg?-wwoHJe&l z#`RccDh-!aaMgv+2~chjU@)0i_ahy48#Y$D-gIS_M!qM)0$lp;oK#9%0Tg zzi-O{c)uTvA?Sj{+R@om@F#HEs{m`xz#HT_d2kyCHakZf6d=%Ad^?tz3R8vW)C1w-ZAQPDdC=*cw4`gzKvObDcn8brFvaFMm;{bKW_g##@%LFe^IqhktamgB1 zP2+T8y_^xc({o`td40-1jo5kFNpj{R-}qQg?sz$4_Rs_GzBWKcxlkl{OEmcflA2fc~G0$wUNuD1uy=xI015 zO!FlCCMOE_Ss4T)SnDv5dubNkyo6aeP$GL1st|ONC)X+yHj2O;R*}#NW8CfWMMX%w zER(T^6C+@P==+r`h^%t|AoW4MI6z3a&nXt?+T=7I=I4|Rh!fAYYaLR!EU*V4kbeD^ z^N6gN&6+t@yn5LrZK6O$z1W(LR25v!Ev@PnH*)nI_QqS1LmN-}#mTOQLZKLIYqDxS zmGhoCTEaybQ9LKIaJ5j}ESX-Yr!i%gD%%<0CbSe$)o+&M(m8N8(>)}ARS$uTruzpm zNGxsUaDFY-fnJIi{MD}_zN!%)0y5NTyhyl|&Sn`&nW)iT)M+n%AMGI)B2x{t|F5kf zmHR&6z{*HN@P;V}z2!Iga&bIwV~1+`F)LUSD)+V_4yLcV4a zYy8k`hDVtIFPJWGtA+2vWFo3*%kUat5%<-2hKs~NM&hUQQxZ~2t;5p^?V14#a%+~c z1l$qU1Br&T)!IDd&Iu74^ToExqqHacL0QFGx~f^S+8$eOL2xAjVag_aauf!!;d92c zJ888@$m`5=JS1ysaR?e`NDb+medHjgjN%QrSwSk(tc1D zjfX_6ab6@8KK8n1%S-ES|5#DgSMe<;iW-qzgITT0Bh?cXl;%V=d%z$R zuKH-TZ0Se-NCn^&em*A?rYMVe&J&*T0UvX-q_F{)EaM?d_=M%0jJfV0>~Jr`(2i?E zisif*fP?A)9L#2G`O&yH=m+%@WMF2EDaIkEEv8?NNMtXrJdxT#eyNf^ zwP5#JDkX1&9euQc_!WV#4=HFY^VleChS#}FCQ5W0fK)`s&ydzO$dqKGq)}yInh#}m z%kgcfviP3(40YiD_JL+ng-VbP{V&UapCc%f%Yw3wx3jtbhyd9L^E5fz*+ln?xD%<2 zB7Inl#|vr85F(C0?4TWQ=VaUS_xznb{fxG}9kgrT_4D3mzjLA={EoN3xxc*($CdVd zZwKwb&%6DTeaO9KQV+`V`gs|K-}!v-&foj&`zJm?+T7dqk-z6{Zf+eI82+ATfS>q# z-rnA>-v9;j?U&{C&Bt*+|&3 zH1fAT`+D^5B7etpX;Bua+dz%ocmB4w^V#1!@wd&8f+6Ye=ziWsK2XQ}zVi=G{DT!k z9x`rrDj@93XMg*|JZ@Q#2eyjF=J*Hj;hn#GQsAJeVX$)`wi}CXfA)9Y?S1yQ{`o|PFf1@v`}Sx022e@{P0>v4%~!}3lF&#@>LS2U#~!B zW^}^h$lNNM!*8WPU0>C<6M$;gC9jo&l+^{sg*W7ST}AThqJ`RCrJPM$UC61L)k?X< z6~)Rv%}MISRhF?VPWKJNiDC32NTniHNy17cCo#peI8A6Y2BR#dHL4qsi9&6 zNrel_d`HTRi;~$E;G3F4M4ko#djJ}Nb#=a@n$l!N%g^cqHdna-w?WOX)ZTces^992 zbydG7^3_!Rp3Iwm#dJlR8dD3xF4H_P4W3hoH@GFFM>%2Y*~z$=BldlU(7G(dIXndI<~+_ zggVs%$A>V_koq)J{R#lI1_4xT0}bc5!!YVWzZZuE4Q3P5W=ZGToIWa% zZcNIY8i%f$)pcuT%1W`lu@7@$PEvZb<_C%%6$@IpaPjuUqT_7jtoqB->tU^c^V1&j zHUH@au3pp_U%A|Nm&bHY0~q7A!y$c$S6wXrx7yeFL)vGZY7L}j`IJCmk`&wwa@%0; zX)??suuCkry{JA-AKP3XHGtyHYAmuA2&I`vT4ASo}_<_20};{T@a2&@B8Bc-`mWf_8|}RtTS?tq?w@ z&Kdqbb$IM+Dckz5V(>#yOks*+ z@A?{s$&>BFl*JrZZMZb=&(ejoB*v7~NY@?Iw1aL`T>2R?3EI!mS<>Mq)R7F_skv1D!RO8oSil ztV~Q@;t?rw6^AG0^3cFMDO&$p;jkhm=n( zs0$D*Nl3gBM9lpEswO16UJ!@Y?9(Z`;t$KRkeG!|0cOo-z}q!*`%RlMgN0nFjNmYf zbtAy~jt%&=(a`}5%5Gis@2ax~d1v9KtDE^o|^<(%^4-|ti zkvz6Kc>+|Fq&EoDi;V$4M(yp+9%>)#p!S}R+M9b@sJ*$Zv+nFIL2hs9FPohmoo5%dw|2KtduMMCwYN79 zP<#Ji54AUUP}|@1QF~kG+TS-1TYFn5>7e%Z0rGb{sIvqbQc(wO@1sEnZSJBSw7(Cw zl3ROdcOUH>Y@uyXUg~V2gKbFP)^8oOv)4hJ+x|Xk`&-L6Z|>}N;LA4JG4<YLDSN2BgEW10V|F(6ZwDRhYkKYN zBY$tVfzJN^?g8@mcXgYLO=x@bU>|g3bMA5Z_HKlRy~4_;k_GS*@f-iukt?$}ko z67O&}6OI9z)EFS;89&YElT^jGz@V4};~kMeBx6CO3>P(FS#VJZ@x?oHLC!#8_GB*AILfO6vmGDx1E@wH%<4oSh zxxn3;x6!nSOAp4xHWoeHx~JwDg1)Nxq+-;gtV^+~4u`4y-!>?h_rpU0XpY+G-!F?g z=9Z2Lx7C|25z_*nq9L5~97J{2$N6c*F@8z1m)xh&J7X^RD+so97iMOeP0eDgSe&1W zd@R#k1Q`R>A;}6jK?qR>MHa+!d*L*jJh)U7>SifLQ5O2Af+sw zGo=YhM3v@i9q>xbaTMnR6O&hOC^3IX!rX=DwefAEV-<9m-4|>C-&m%9n}iTONHP>u~Tj4<6=B+=WRsVa{%#H^my~v9}5qT&b@5$OTLF=XzxfpgvN}+#24Q;MQjU zF={%E4L!Ock_LnbJ|MKcA`?CI#rDw+!6oHr;EU};(Q1(`{i{DlB8;vE1v;1p8a9PS z)X4L^CcrX0w2Q|rCxUl$i`=4|3w4?*k==y}xnq8(L%Tz0GX!WXKBaWdMurx{R%=MW zDcCB4OSXalykpS$R_qFYgWlCE`SR!$w7~M)%a^5sT8#+3w9f?t#7v0Eh79xhoK5*d zI37dDmtvT+lFADoY`}y{%Gd;tFXDYX%$btocmPjk**cBjMM5ZxvrOK_dZ8>qR3`iK z*Eu@{@?!jQ>RC)*PQ5yYFaJ$`c$j(?yE*+gJ2$h#E}Y8rvi$e>R07kH=E7mQFfGhV_9@BQ8Y;F32f@ssX!E{s0jc%N`qr`DGT1 z=u-YPzRAK!T*^B7!J0p(tX|oi{iN}^)NGW7$F7RkC*iSoyvlM-y@g@dtL*80{$K;` z27J5X$U)Ys$z?fG9f$g~{U#V{` zt?brNJ@BWTe>gfPa623jU0)_A%7uV^4|>oxE2T$*q_DMErb94Wa$X*O5_v;T31#@B zL;wnn3@kL18Nx5^X(%;_lC$bA3R~pL9YV}CKjV3x?tF6Qo|&MOvQNN};1`&4zPu>t zv$jcV{7hRd!G2ie4T~cQaEFGsD!Ie7F!r~n8ByZ_bq;&;jXg}kC4pgtv$9~uHUH-v z4%ZCBkMy+EoS=y&W>%5n9%qfLrA;`^X1bRhhgs|v(7-wS%H7OK`6Wp~Jz8c;b3sq9 zKcG(v`8}E1dCMa*X2*2SJ{OQJewXFW@HFUF%K*-c2TWGA`7O5>YA+=@)l*K${InS!GZ3U&lTG(oJ4kfs_SX|p;sL%jdE<0z6 zQkKv4AmXncDvaeC=c3hu*rR80dUHHc@?6-@t=7+k&Y3T^Xct=bi<8%Vc426KqpYq{ zzFAI}(ucQPuL0zmr__k4F0*i8f}ohE(Kj7=K&SDzpLr za0WRryP&L)UNFf*zUH&oPIc?OVKEdVeJJJ z@o92Vm^BroFC%Wh{&pHUuTm~jSbHGA8lw!3L7Cuhtz}&I8uV;k#BL&JRjw?Y(vDtC zR{5;S_}bdriah@sVqtx9-IP4oFkWwMU~o3clHjd3 z$r4Z8E0Lv8;ZNu931v2rNuWIY#B4~DKza6w)q-GZT^NGz#8& zCW`9Yg)l>!frC6A*nVUK6Lq&%;xSwBa~G`*x?fraDrARcOz8mR(rnt}E)(tsw+G;H%B}NydqNrJj`19f^I>J@wi~-i& zP$@Ghawf&oxS@>vJ=5jdL^2Aa=oHMeO=wV3PUSY#l^7Gw9JBTBp8y(+!komgfA;ch z@PcCl0r&0et&9ZE2DndG*@hV(=cwlRyg8?JkzUb(%~s}hDz>>2;}TtPMf#YLnnkAS zaeY+{zZRngyRfU!?ix{c@XlHVDNg1rlU9!D2#rdXwKvYou8mv enBtfXjp6VOyPKPvtN#}O0RR6JJ?bVraR>k=Mq;S| literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/07924cabba2dbd71_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/07924cabba2dbd71_0 new file mode 100644 index 0000000000000000000000000000000000000000..8a49d2d53cdcde0f610763d3d57bd1e3e17c6b79 GIT binary patch literal 29784 zcmW*T1$fZsMrlW$91tzkGF>@=9m3EXURitQ=vs88w z12InLwoLzDtpEMDqI#wOza7Z`7o$mO=@Rajk&2g<#zEy6A4iZT!%S8{+A=^cL&^yOP9;IF6k3QvGRIh@I`eOReF8bKgMaEVx+KwX# zZ0({r)Ibx2wQUs}B0Ps(`<%HegpiSJln$szX1yDmK7XJ#aD5RV{;DwI|C} z=TR!#RYyv>>Ty|DnJT%eQDs-PLsE5DmBe0HYq+X4=A#>j)kSox=c-9fUDdUjtKN5V zRdi=pjlfit?c%E6@u@5KySXZVcUMK?YY$g7?n&QXu9}HmDA=3aVCv_phWHC_`ZMnD zt|~IXRha+TL$S2?hC2y=q#pRUTlF8n@>$HQIKXN0R>j%F-097C?-cp8j% z)j%wrz?^Y#qN{9^$QvIfllv4`6~zu*M&}u>3Z3byUH+)9GPX;x_4h$|}(C`3*`WH0l78(Q^u1rN(M#$Y)~cC#l5Nq zm90h_9R0Qb&{YiIZBUgxjCF(>o+a)z#=mY*)mnM@1{6x z!=VCh+7jrdeIahTjYeT^iVb&DNVJ=FCb_9@Q8#6$x@jz0rnzYs($n2^B*RUAm35P; zoSV8}b2T@uY2u~>@M`L&XBgAWP4khbxtpe8TuV1CL}Dv9m2cywz3qtAp7tHw6w}d7 zL7m9CvzzL7aZ|%SR=H`%1~+}hiH&YLV|G_zi@Q8*?#jyRuD$u(wKdpXnc?oL6z8s+ ziSD}ObeCIUcP&Ukw!5+`yX#dAckQd^t|86bb*sC(&h&Cu!td^K3}D+J`p$A!^g?&7 zUhl5qd)!s~xVtW#b61-S?sB=}uI2aL)##(PSp?*;wY8&mLp16cNI344me{eL`LobmQ=b%l+MwJB#)W+({c&ZihdONZkaM4h zraku1e2Y=@tVZ?AZ`5S$#1l*{VAPTTqZS1kbpbPjjH(k%+fbtp<09^d8TA&=!;Sia zoe}JhG-?e_M;Ub;U!#rkiZQB1tWn)CF3zYq*cxwCsRX0W;$KWiG-@uYIgDxqyVIxu zoWxZeNiwQRA*0q7G3tF$qe6?3Gd^Y*^>e0Cwk)HT;udme8}$oDl`(2MZj~iR{9ewe zd+1W0`*5#l)MgyOBebYw)QZYReL&XFM(xFGRIF-LPb^1vHS)(we8iStj4E55TP&+- z)Z$u3ovLlrO*E-vRA7Ch+Tk9O8yHmvlkp6d8!|TTHZrQvuSS(*EX6D2nrc)KPT|rFqpHs&r&&gxTO1>^jq;vn)a*q@MJ_SQy3D8w zD~(#Xi8a_v-L@Dt7Rzu4qqiF6y3HtmoW-0yMm64NR1f^R->7{DsqtZ>`d}x1JHpx> zWlgd7IL9n*W6}wuhMwX$IL(-6jLJC2oG-Ap7meC=nHvAiek5KsYTG~5>pI8F4URkb z-(;Q806nn*Yi}8K5FKw*e^j_f{b0UNdrZb&d_eUF(^cdd0CQXD_Zj*B5HR)e}lUn98 z=~D>tLQVRCPT?jMj5KL8en~W`C*~G2$z0qde>BFi5+)T+HmNOo!jNjxD^$!hNu^A( zq8TorX=!5O2rgn<8Iy*WCD(F{QPIS6%%nG!7`w7by?-{TTQ!raRX6FMS|$yxZPH$x z!bjAtZ_*n4z|00F&V}i`rt`F+VnSR-R~w99bi(cfhN5`=3tYK;|kuP`w+(b!z3pb;0;dvY0_^) ziH%Q~Jj|rl!%f;Z#-xQ~iHTEaIF9uh&paoP`$Us=;W!>*!zA`kHmL({V#pMezD_e~ z;B=G5U?t*anDjRuq0USm&tg2(o@3H1jLJm(4O_(KSeF^1>;Ve6nl;uo;N80-7Zk$iza1X=6J-DE37rL?lV_3dqU1n zIZmFjUe7s>@%syo*H7zw{{L~j;WoZw#uwUuV@#8$s(X5>G5W*D z%Tsx5o(e?HXxEt!Js4!2R!R&BPt-ujfjPR5pmiCCpU#L~YQ;UjvYCTS) zZZS`J6enj4$LSPLL)RoGf zs$9iWU4Hh|KD4juseX8gqBT9$p%(S3?WqZMh*g(Z*o^x1JY}lyDSw=3Oy4G+n$p5k z3$YhfTY73t8}e;SzU{~tJ=%NfGKzQfR8T)^)ZbIdzkA9yfIc{dC+IuSQ^w(*T7n`Y zJ+%k3M|tW3CXV*huCbn)JdK)T4}O{Msb(`h)n}Hc-eAsbPpv`!Ijq54a#`T1gJ{2n zd2J{E9iCdelltu%X3y@bFXsKEmxL^}X$>jd#cs7an+O(qm5* zeD0}O*J-3 zdAzhGFKy7o-%A~_D#T0MP&L#`rf@I$p#^*+iGd#YE6PjzQ6kz)Gh@8848d_;>WuI4 zUaFhmrFWTLO3o%0vU0q19NDG3R1*U*5eIM?#?oHOkAN~>s$R}Z6L16<;Zwm&!=Q>@ zih`+b68lzOY8Bjrk9%6^3oDK$A;Qo%B z(zuOY+Vhu}s_pesBb3|crKAI13OeGYyXbVxOV3VG*E3$)be23Xda2HrCqnY z6!D09BG+T)gRS@vSx>w)9@jABnV0Ik@luDk+<(WM-h1gba((d96-@s~j+pbwOP@Y7 z@Bh5??F+T}>ZKz2%&L&zte~IFT2jC)Q$e#51I@aG-$KnQ7;e_*2(ymGm}QMKD?f^7 znbjFrk&cH!Q?y*z1@TfbI3@U*D{Kc+#u=6GVXA*{z2>rvsz*~p20Da zF>nGcMwzu09mkk8bsT+Q8gJGvoPf_nv#Q}eDor+P_!Qb<=Tyd@X4X8cLB1Kx4^6RW zrdfk$F;6(=nAHjWadn=(z zCl6Fu!5A2a{3}^EG+4#jtY*HLv&O7jc!AvOh=rBdh8OFp*9Noxz(gF}XqMY1=8DZY zi0IAK4BgRl3&+V;vmPL08*7YVIKG|v>|j2~*~yw=w5IEJ9ltRdRqG=l!)IfK3M|6*2wuZ)8^Son?S9iHPqgng%8 zF#MqAxPi5@=zyz54-FQjx>?i>liV%()o4+BEcCG`cV3IS26G>`@dDRFxDB-^Jj^0n zxJC6b5or-Tj(a$tB^&bgy6mOa``EwVqHza^dC(${Ll#}b#-kP`9<%5aem+i4C#WaVPg)do%A#KA zdzyAAc!qkMwdfrdp0mht-lBupc7c2@TD0R5YjWA5HCS}rqV@k;RPlyIEAjZIMK^A- zmUk^`bdUKxwP+d^Bjp)+KewnEj^YE{URcx$yKn-<`k5J;ZMP+aV z`QA_`%)~2vN4vKcZO2h$y|ZXM<|5yFi<+PlE+h5>v9K5);P#Qa;t(#N(kJ?1H4;8k z8w|x8Wc+85`3o^I4G-}i-M*3+E}_gf_F)Msey1L|?`oCZU{!1Ez;`#Rio07i40lo8 z!>Yyjhy8 zLw2iTe5{%UyRTITF))Ds1+DT3w5k-g;RALDSyegMs>bLLV$}mw4z=nm?jtJ9s=640 z3E@_4#a)z)uqr5$+%XSbqO8h{w(2oH;C2jo#uF391glCXTJ;509E{<#YEhC^?F(D= zAIcZuele?>6sLU&tM(>a6`Nw!NK8(($|udLH|bWHOImdaZW&h9M$t@Sp>vj1>+u;0 zIaa;Lj#5_rR@$nk$XkXv!BCcQ@eN+(tV%+6492<&R$a%HN>;g4wkizu(Hcjww<_y` z&#?VMoa$C()Uc`&M&l?t)ug_)tXhHAwXK?4$Ewu2R;@u$J*&#rx9TK<8d&uw*5O`5 zt9%<@d5x0>#mb{REoK;_uGv2Bh zSc-fTs2`3_p)OOcst31eR&9jqbgNQkaE!w_huEk(*QzPFg<|uFg;AJ0pE)hC>eq!< zHC#kKi#aBiSe0uTV=lL<-3qJz#=ezSg{-zJ5kYG>#$jK}@sH;STW8fE9EJCKjv@TI z!KxA)sq-eQPW(kqTgVy4ZPXo|w^P?0`Dt%&KtAz&YH&s$0|-FHrb4#|+M* z(nD$jJz|{4j02aaR;8iXbH;i>Enaeryt1muYpeRdo&&P!fvZgw-E10fwCS43re>ZtJwyw$O@0=e{_wSFbZ(o*`q|V!k4<;- z+SJ3}rs?<>Dfw(_j_r7gvH5M?3sV*K9B ztB*|s``HxuJ98R9KYYfRfi}eqriOpm)bmf9ei_DCNFHfZkx^_LZBxE6Hl9B=Ers`3 zn-XwwoJ}>x+w>R5_p z=X{&GZLrB@GxIoL)6S#R`It@dczuCf|FLQC4Vz9E^j6JCZ$;MkR$=7r=B+Rc!Y1rP zV0YS}DGK)RRxB=I=x^Sdgr+^cwG^Fud8P&Avo9(RvbG#Le7B~c-d5pElTNPnk?5)IQ-fDua*t^_Y zr(j&k*sHyDaE-S*ZSdAjtl#3THCx%g!&~=ud#lV|Zyh<{t-lX?YxN;-Jv`y9U(b2# z{$*y_Exb+-m3A!TQA=+*H7LW_03x|T7k?peD?8=Xk-gcF-+qD57 z;pSsk2`okfU%MvY(NA{0$FLx~7NTUZU9*r7V%G?K#OzSJ@`TxyH{7mKXcJ-Aq-eVe z$JiB-$k;{g+E|S3#qGL|-6iY_OS3Dsyj@)@*p*tzuBt!VmHmrd-K*R6sfJx^YuXiD zi(G5lRl1&?_uzK*Z$!Vwc0Fst*v;$;X>Qkt7IrOZY1dO^w6SY1exO8K=7x2+iKupV z4Z%&kYj2lJ2fN}r+tst1U0L1j3hH53rQhs&i?u!N`qs;?LjCO;G|;Y#gYCMF6@SZUrrPD0ZdVI*#Y!a1 zrXSwm&pCEE7ch?<)Co^fZ722EW!E^ILF{h3isKKY?_t|P*6Wa6&9DMn@Zhjr9gZ^Y zG1lyaT}h|xs&d+{`j~!}@z2@y9JR08HT0HU?QYv;ykl1n^t#Koht&CzUArFB_lcd) z!R@;GlsdiOxOr*U;n#M}c+YyG_b1xp89IKpt1ry|*?IqF*FBW}X4h#<`C->*^!4-6 zHXMd2kB^Sz_0ds(A6>$!{61=2&_}I3*KH3@Pqrby_v?#(yYomO$ zG}cFZ<9swD$w#w``Dj;hA0?NdU9ykou0$@#uHvIj_=;84d=&nRkEUZEUe@x_@VY)q`qf8O`}=6b zNFP<3;-e)G=^Ny$ox#4U5$&s~4qq+8Ag8Yi7xGoH!oJF>;;X9IP}NueRrgh$8r-5| zEnju3ShyP?Q80*N6me;yoIl#TG6((uL`vFRW#0_LpxvHL&5gG z8jTrf+s&6_+EeH9>CG%9mR+9Jy7nc5Y2=o?DmjV}EWv zd6`?&KIGP4c!g*eKmBF)(-xbbCffb<60Ji0v;=QT`srk*pJGeCx$*cPv@@i=JylVe@UadZoSBBGh<^Dadrn>s8SBO9F zrTkSb)L#p*r-Z)_XZq`>(*A0Xl1uzKN9NCS*I#w>=F`cjeA<$jPmhb{(;sE>X?mS} z3hbRv1zzWqPxk_HTUkKKYYJ%D(E|E@tN@=;2B;d=mIzQ%a)8QU57y@ds8Fc@WneUJ z!J~A5PL~PLhH?Q4D<7aW=v^T|H;_~*K$TG+m8u1(E>da)s2pD7Rnq`vwGL3P4go6O zH9+%l4SwAM6p1;g+A~0dF&nD80s4UO)ojN$OkW?M;Ty>v9}w^t>$WvOwa^^L zPq@Z258Xuf_eq-2?bSPRzVd;bM(W0=4q65`GCQw`97Z<2wm|Z1M|6t6|ftrIhRRdM0RiL&&tpk;g z*KlbQsKqGIHc;I$0iQ6xU7*&&t9_s*;}%|^N{2w5fk($cjlld)fx3waoyh~Gy98=C z8g&g+dmO$#v?Wj#w$ctgw*_iB?xN6ka>DT)fvU7KP)%?g zV|NFt-=097!=`=Yvp-P74h8BF1|JU81%w<4)P5X48mKGqImTSj0`F1kIQ2WhI41*D z@^qk%UJBGTjJgu2=_qxTxm*iWAFRiWTjYH&Q1>4MD(7LKS|Rocc|T<>F%o-F>RBM4 zO9yKBYudb_Zf^ti65BomD*R)h@_!E0OphS0{|eF}1ek(Uz%xkEsA>+<`hr2K8y%$U z$w4w_1ZgM!&I!_eM3f8C^7292jQGkyTz5@-ysH%?m)b$DTW;>VPXhf;3CPTHqS2btvQ(tV6hM30AOousZt&>j9zzgHU*$?xP~YT=P}6;qLugu-%-ddMEwxr9->knA&NAHDBcvJ z7wF>|qVceJg{VBf!DSc%MEbKWUN=9=W z$2Zh06{2x?UOGe<%7iGTc8I#;e4P+otsA0Ne}-rQehdxKpkd^NGQ&gUIX6Vvm^Uwk zb5S8`eIkVO?4p9sA!7}`XFDQQ|M741qozI47=eZF6CR5Y% zA*zETuwMw#Zx^W@Y?rAkmcVv}d0!9FV$}YZJn;e*ZieVI?!xOf`w~L+H#%j8>JmK5 zgmP{(RP(S0D$71psuHRWzl5qk)>IGGuCAf_xksp${}!sv=+rY*f1z!!P@P5Z-l1BI z4Y-f+KA|dv*+}Rcs$Bg-H5J!Uxj%7n1?vZds_LJiYBC{IJEw>8xn-!f;xjU4hUySZ zvqBYvX4p47R6cV{YAHil~Yo>2Mk4ONSyq51>okbNvv$Fb{psGi~z zTAd(14rAiUP<_DUQ=#%c9jdvwh2CfAkMy(Ti79vn)45O;xxjubLjQ}j$7ig&9I89; zy~4QYiGQ);TBz%FAe)kH~cypNMpsOWJL+m`pJ)baL@(t5{RL>Qr zCODWkOr8A0Gyt#h13~%2bQ0H5=_kgiivoPzaqm_EQ;|_DLPE%7}{b!nk9s(MPit0 zIl|P>8K&Yzh*d01O_RfPIW>%H^ushQojPD%Npir|j4=KVgz0H!n7p#shQ~Ob9j3oa zg(+X@Fu7F-QzM*2iHc!bg8xvn67xjYreWIOBTU_Yqt?BM*(Xd@2T`{_=sP@2Q$~lW z`PeX(ox(WNX|pm+i!pR{7@xC+Dg7VDd%+w+!}Ya6xN0{Hm!omGe#JTzY!a^7*aq*W z;cADEDA+7qHE{<;n}_RZ=WvC03D=;mZ0{DX%%S1xgTIFnYecxRriE(&3QZ4JHjW`; zX1D@og=^>ha1H(|T)U8eOStlGCC_g;X^1y3!KT3c6b39x@C&D!vmk@R` zT;oyjRJev9&&6<+!a!`o6Xd@X&Ux){^~NUnTnX1r%)TD3D=2&;T%I?>b^cMfERVz0 z`UyEc4cFEe;rf8(FR2Aqyb9;FUW8twa+?T+wT;l`ff0IzN`oU5JtRVVhezl?)EXI~ zgi#S{FgZdqQF%&)8sZ)@r$y*F%FmAA??;4&t&GqQSXM=-(1r+=+(=ujhka9os$mIE z<1;+|icmTRV?3&Cj?fl-{on1D2>rA*LYq!RXz}R?Z9vSK2(7`zvl0CJ8lhQ8zsR^S zU5b$Z4 z#JLlp2l#?%cO$qSCqjRt$bW3Z7)9zR!d)ZfX^50FZ=~AdsDGs1=Z{qHf|1&awt|{7Za%m^&&N)ex!D_pl{1aRe(pUNEup3^13}z3)@F3yF;Yx9V0ax z{d+|!?)ONIK(hgn$~!1hoiKB7q~48+)XlY#Dz`CG+fidvq`n`Iy~GbJJQ=B9 z&PHk*>Rn_$sCX$-^`Xm=>VX2+$RCl{8RLGW_Tf~XD6TDxQi@uGaZ5%kPe!!5W=1PAD_U(! zMQb_gmyT9Dyg`++ySKZ=&_^W3+-lMXUd3^8PPcn|?&=1uD42sE})nmUzVI7Sc>H zGJD2oyKjs>VP&ou?LcPk7|rpEQM)|c4~*eC8Kb|0VpK0UMx9^^iQ#o`j4Xv>)Vgqt zB8tSQZwhhHJ~c-DU`UJ6ujw(0D;c9*6=U=TYbwQPH@a4ik*!{gD&hyc>&Iv^-ZWs` zhB3Uqj?qNCY8}IS>KHYe7NhC-Fg->KX2j_1))-CM6{Cw7x;sWw5wIslz4wyKz8LL4 z86%yF(MB9V&(kp~^Mt;*^E5_9pT%h1ix?Gr8KYPPe~FRLS03Z1A2I5P5SLi}id?R- z3PqqHR`K>&b-^F_8(}`NO2T>!_Knpw#O8`sCv3$PRLC8xaVYH=6v;2*0x7?Cel|Dt?&tZHFDu0_P^3F<_~swK`x#mYA}R&UTIjxn$fr_eY) zR;#fCSqZUfni#9=DCCIcoO7%`!Rm}vGRj~qZs7$sB{5#1Sd}astKIM{602@lg$t-v zG*+`Pq9M*ATgg~;#b-3npkA1j8LMwuu}aS-w^Fe@ zFJe`{T&$kseFbV%F;+QssWV=oalKfb!(9}vAFGOJ(tsM{SzGGSE>_u{Vl@zjJJT1( z5!p3Xxw|p@p0 z!T#Os$GSc2N9n!n-xsS!`(xGqXslME;jvhCK>p*@`ZTv^SPT4%@n>Vz;xe^Itt+e_ zo}>KLShc&xvGtAm!t)0;#~0T)UUSFk8NOnWTbypX$MGGKIN3epR2eQ_aaS^n zj?*zqocj94X)|)=j?-Cm@Q>3nxaW`4c9e`DfQYG0gw$MyYj zT5%vwhmOX{aEy33jEcwOwERSz_MVKB<7S*j;m2+Ayc4G>cjHv;UYvp-#;G2*K8n-a z$8mc7A926LaV{ZFHL>wqoQ8cT4`aNtaL5#|eqQnV!x}Gl|9FjtEnmDI7K~SLV7&SV z#Va{DUNghvbrqu`;x!9(BjeSqSiH8PU~0VT!#gcrfmjUJlJVMt=M~}=SutKiDluN= zc#UZsuao$_Nxa6wuW7uxG>g~v=J9+M9Iw^z>L0H?xHc?axrfKA^N4r_jEvX7neo~I z|Jm`ngnyUEYx#&mqV835s2ipfps6@1g{KUrgRh5_AhgmXg=I)aw9k z4koAvdLK%V%VFw(uSXKp|7e0nqUf;%tvXKs6A21D#oW#&DEwdI-b|4BR)RL8(d`69 z-bv7c$K>&ZJgkXIu_dZ3-Xg=E$oF#-_1Gs-6Z0hM6`J@b>TbS770aKf9K1xK0^9~9 zYDi$B+``x%o~SwziTu4zRG*kcUB+G55)x%{B+3ta5u22#MuieJr*NWvDUzu3>4_SU znW)hyo<$!-W+$p$okX>)m&k7eB=UX4ME!}RhKW+2MAbx7*!m`_azEnsPt?ePiE1z? zQSA{mI8pm1kpIL)Ekuh+i5fI5QPrm>su}XmNL1ZfiR!&5QDZP=b)tH%P1GN7tV`6Y z^@)nvkf^qs5_NcgqQ)Ic)NGVJOn%67BvDVW{$!%YUP@HR%|so!&EwZRewV0ODDys1 z({KiBKPGCri$m_N4y9s^!J(4w4jsiM4DfL1p3$K*`*z5E=So`?OYn%AMl2=jO7b%a9~A|2WlO}`k2Mih4F8zM?L^a-Y9hk{ZZO2Cvf zhgzjO)DtsGI<)M6G9CH~&n$;F;WY}Da;OV_M@(slek62*azRn4wb{aX5`n-p^2D> z3hk*&2jM&HE_g)VjIJ=~W$xZZ>stZ~S)(V^@k^uv3!IL4gt6{UcdAJqryA#V z@_ia7=YyPlm&U1e`JB4>lT#^yPL0PLlnZidM6i?ZK03K})5-Z7r{U3SFwl#Dryd~q}eJiJC zv~lVczF}EgVz(o92d5G`GZwyeacX8aC%?nuRGS`7uH&L6=zx5^m}hUNeESk-0CDgQ z%LY0XJ(zw&oO(9QsYb({YKOcdnBz#N7LIc2&SuI}z z*c+Xy@)!FyJN4&Ir*7;BNAnS98H9O+ePsdrq6U02l`krwr>bz5x zE>f#Y%;5@i`kVP)b1DMokn@jIJ+C|U`Cq4A-*RgEL#OPIoN9(SIE8D-e#~R6!p~2f z>Vnfqd+O9>yvK@XPC1^F+Y6`eW3)?>GF+4NGxosUEs5_0BgSxwZp#%jZe}9^edF4F(_L&Nwskd-bItt zAEVQgGzYayCaD#!A~2Koh%TF?j^&cn7x(ZUYs-@_##KntCuCPj(n&nT-pWa8UnNN+ ze@@Z^%&L|o-(Ql{5S!puom_AmIW>}$P%}vfVXU2`@^xr~0(GeaeCsja`bj$QYmzQB zPSWNkt)16n63e;ex5Hi>Jcm_KT?PtqTFf$|-a^aQgz6038P((pG%c1hAaWOro_ zJ(BdbcanPbNz%06lhk{8Gm(5mQOdvhHLj^`C=O0_ej=;-;#A`WU>sSlC>F!QE_y#mXAqRi?PYNyEs_^ zOOn-lX|lR5OV-@2$$XEB_}j6A`5#YKffLC(gPUl6GFkgiC9BVwWc7Q(oY3KEGN0`x z%k3F;dY;UA?PPtmq^PJhMH6i)+U1?1vi>O=gq!(N_&tmiO?9T|91;qp=q7_Bt^AbrDy_PwocKiHYpn1j(m{6LyBHuUau5gL$N+7^6Q%-mtiR? zi8pW^o}yv6KY}qwrKtJJ6wSrgRphlgMU&vZCPgWKrKmg3Z%)yIttkqB%9uFmnyMf} zs{VCPRbG!&Ei|U;iaAw2mQ+plPt}y5R9(c-;8aaTKuD^3ho-80SgLl%q^e!1RINaR z(y3hEld8A)xooOzegVK=8TEtmZ^Gx_J5{oDcpvo zYCpoKrm7KkPD|D3>8YImPSp==n8SXQotvt~^HOzheyY~(OI5G^shW2nRj#*Fm4UY~ z+)34NJh+>x3HMT!{ybHEk@zB2C2SL!G!^KWCTFKKbwo(#G$mmx{JN48rVL5bMGXBTO;eHmXPT}~qTSRq zxy)qS+%)Z(pQdkEw;)Y>QF>t-*Z!ob%HlLFUzMhZn6a9i;8>HU(QDIGVqKb!ZcCHL z_B3t7F;v-+rd2!B)Oc5#P8~^8g`?E?GxLi~R}0LEO4oOsjZW7sw1`R9tJrjncBE@Z z61RoYH5+9Mr^}g~uEn^Rny!0z2e-6z3qhP zu2MPayv|Ek$1=n!m#*pM)0I#$T?ZKRs5&s0{8OwGZtx|uqRUiC6H93|^#Dqk~V z!>f6w^5Zr(w9Ax7`%JlYpfBFTy(8lwuv4ZQz}`7iK{$xyE}8s$o2ll#Gqnw?`egDN zGLz3TGUXhUsdU^PO5b6bI*&V8K0H%f(0Ej)cHualj>%N*v6<>SEmKbrJ}XlLQEySE zrlaEGOw~u~l1x4a&(uVe-ju1DDEU{WIv>mAeM6?29M4o2Og@pRLbozC6#edGY6m*p z%~XGMx|gY(mzf%bBCj%43a+o2%lk~7z_>4&I*ox}Gc_JXzGZ49Qom=ajBA!w;+i3g z>({f?(=AJf@fcOyv-p00mgZv(z9GdUOXaX08OAKlg~ODk`sj-3xST&r7XoNkFiRa_ z3CvO;D*aDTmY!ozM3(O3=g2I5h{{sC=qydZDU^xH(nY*QK?mFM1Gk;TDU`+US!Jm| z))Z$P6fTjaxRfka!^M*1l|f!Ofy0?udWmjXS^66>*;%TMeL2h*<4R?zL+LDqmCce9 zY1OmT6nAT9DRd%pL!+7GhhYn|G#P>G84q>0W~s!sEb-%ovf}26Ed6_mKBu!(6RT11 zOqN!h%hFl2KcA%m*zi9W$oC>~|7Cvo4*QKPCI8P&)&pm5W$8T%+|E)ue#Q+Hxx+17 z?-J*JmagJ8avo%9EM7g%lJ8UIgoV$tl<+)Dn{f;4UbFp8mMWw1JJuPw-e+mhrz|al z*JtL9Q~zbj_61+FbRJ*-=UbL$ea}+WA6fbhS7A`L3@+JPh-gE$4&f#K@ygadYql<6 zSQu@>v(*_BaR%=&CnB5k^4yQiR-GvJV-fb@2mE5Pm4e?f3Pt0xwGEE=Y*j+@glvsO z?!;_GqU!%Rvh^Apld?6gP_{P1HH|h%|DW`1-GF;$w&L)vY_=v>&(@3@+1iWPn%PQ2 z%m1mB&1?K@?XH)tdr0^-Th;LpYno>3Z)CK})`Sk(+KLlhvh@aDU9%N}WSqiB{MR#E zLA}TiW3UOI`x9eOw!R~C1mmIXm~4JSAX_u%WosEe!vC*qRXmujE_ie@Teef=a-Ljp z5igPN0xnV?*e_EnEWjq*_@67;>i>7PE?>>oSCqPut+p71O?R_(4bL8C%lA>XIy}$T zB>eI!TmA6s`)vJ*luy(gA>YUoKPgA05Npa&RkSqc=-W>@3N4VMHi0>sgvxO_>V~vL z_Ty$!jywzHs9}*D4a1}oIecd&M;>W8a^PV`j(jq6bhu28ULk*#9A#h{_Tzok9Q{-+ zM_n-+C2HiT5w_qqd}`;Y81B@~k)>Xa<~PdG5sYh+!*49+$k`@Gwcy%5M{zjSB}b;7 zIZ8r6{~TrG#ef|74`llvIZD8pp*i}D^({oe_i*W`Xv&aFr=j6ydH%G%4mQud|tLZ+#t0vn&j{hnf*|HH(P&SAtONIhH zImv+}Jv}Y+43MD=*~kV(KtRf9K|r9TY*`{xmaMXuY+g16Wr(szS-xNY*Z<|ZK3AHP zJa_KrPST6!Bv0P-$VOL;$4VT-V-zasQGK+*5X{6zoCOyFRRJ;Ri|N>b+vrf)qX}qH z&7-f8@u5d$YkHKYjz@KHuYpG;8hZ4F*Q2YZM_qg#d15{4fvK%MdOhe-V#uRX5swzO z^~nFJN0~c#R1J%}c~qvmN2_{x)Toz-`-45&|D{KF(Xqcr12Fer13YRx(4!NBJZd)B zqe(b}azmKMNu*=NP>=58w_(Kj%A?b$I?|&oqdmHkKwinz2HS89mvAQ4qw@1STC$LK z_+^ntv0K?TE@JaG`n$uUH+S;VQ^Z4Kj zwMJq(agqNjwY=d`!+X>f`|f*m2W=jBG!7RYd6elf%hBkGhi69l3?(zzH`p3wC}%!H z)!`{*s4K1%HS`2;7ejGF+flxRq1h!3UHDfiLqkg&I`_W8v(^UJUswkzmZ6_v23=XH&P7knL~Y24aRq2*<9A0XQ;sJ8*lXzEena<>;{dhA=LZe-!-zwMuACZ{lKV@hpUZTKhL-qf4#?W~*K1)oLI!`;azsUMX`PU^wA7AEkBwwXJ zC~%E^fU3Wf`yXukx}m%`s4M=)*_(#S-7?hqFGCsVbjRQxX@l!l^yi+zm=cC=q4q;V z&C&l6d7|`VazYzSK)$Ec67OUfibFSyL@GKwGc*SKUXV{#ubQGI8fWwBRW7fra$dDS zAIzxWRr`uw<*Ve?_R3xz!O$vRm8t4gy=pAO>i4|b2dBDMv)=b=TMe&nAoqt}{fu%o zy^6!%wY{oV*DJFjad8VJ8+lbc+ROOHUZvm=3YuQVJ@9HpGp{ydz3o+1*Q>5rhxvZ5 z!m(bx9`LFXmSG=mpk16-eQ^kt$|1KY(7bnN8SpQ!YiSFN!NT|Orl zbnfg`g)Uyb?CWLBZ+z+19(>&2tFfcJIxxnoZxg(H@9Nd;>0V9Q=GE36rfy(XBUABBOuZRx%Gc6VlUAlGb~JUfm#N2?*V|N)KBmI`Ouh4^sV9R>WgcwG z9bzhDsHqOaOttvR)E{4)dVq1?m^z1dN1FNq>DW5TRQ}PXT45d@qtUmfMq&?wV@#bw z!Lg=NupC(uOuYeng2{D9ljqk>rQs;Pn`A1_bWqc>EH(A%GE+Tqeub%nD@`q4XKLVjQ=?IHv#H-a-%UuA`!WEnVNu{yU7osJ*KMfrSAKvInEw5 z)%%dCb;nKpbCOzIHuVZWUZKXQolc*T^Qx&qxQwdTSdOy4n_7Z`f0!DEzwzF6ljmtn z{fzcEOwGZkH)(sz)NU01lUm&|)$bw89+|q1;A3*bEp&TAO_BGhsUA3hjTyvvMtnq` zlQZhSpkLUBA77H=D~>Oe`Nz~ytixzodNaz>SGe(-rQMk)VM~RI5DR0AT6$c}($nIWCYP|(|4mDoOIn(Sa-}S-N1M`?a=c~f5&~r` zEyg|UEla$2$P>}!$-RQ5g_SI>^;=xqw`A6_^l4p7X;>F+@wYwwH!bzRAyly}O~7BU zeU_FXS5r%0;4oG;vsB$Cch^#@7)uY(G}cluVCf8^<1GGGv{WG8k{|c5sD-7ET3TE$ zV7sk|*_t+OEL9C!${n&a6t}TILOc{}OaBquj-1i?Q%hyrTY89H9W1V0S#r@G30R5a zxR3muEPaR;7>C^`{~7xcM^WW-OUbC#+0qvD>OvimzbiQ*Q#ZDUAHT5Vbhk7E+ia_lQ=e}So}Rj?WR(@?=9^? zooVd9>C|cl$LlQmmuxXE1a(2_6praRmXcB}<(+G(A(~>wkIXOOIL7g%ro#dTnY2YqPqcL>1rAm7_x3F*@`)WVi!NmiXvL3Yb9Wo!XwDCCSEM7m!zCBHD zXD!t{XX*TTOYdIfSi>u^P zZV8_Xz3o%YvOYaU$9H^s?OmTD<$Y@Xo=@N62-2$ibQ;BK&;~!@4)T5AQzzuE>63v6 zb$qH{*QaV9u^hhoK9y-ee00S~JVvpGK9xfstZC%aef)z~jeR-*UlX5x#rx508`TWf z#dLZj(WPcc##y`(9h z1ro3W4^btK*qDuD$QJKY1N6pxTtbQFJ~hV#>_P^rx1bhC!Exkn>63{O*nkJ9*2>5I zRX#1nO}x{ZdSN2c@EFzG__+Uyn&KMD1bqr&8jc}X$fqV4faUlDrNhKQ5)PwaggSNf z$?EA-$#KjVu+^!xt@&ut#wNb4zu*h;@}97*8=Y*G`^?sVa1%W~w{@_y&G(A7w)U{q zrH`%D!L}|Tafq$Cs4&#lsA0AehTA$l%2tB}Tlpv0>WJMFZDpQhYd!YBo@{GLqOIXc zw))Jp^)oumveg&Q&?1?2Qf!4b*qRAvqpdKmq0wer<+s@Sd#|l3`^W)z&~Lx3V+U-F zK4|OdVOzD1kUKIk{5MvK2UOtKDU`fu~o}TVz|ksntm3F2o}*H| zuA^%)jv9AzG_^bJ(YC*%H5fP0(ZNAXhd8>3`@mB`c+|gf{bHdR|)H>-X>6D|7 zPdmz;?x-nVA-D3xC&%El+~>~VD&NqgxR zD(-VNdcUja1FrI4a^>Q+%dQGwIv!nNo9Wcyx~nWVT<({4wHMA!S4(fXYVjxizT@g2 zth(zme!463o~s4-+3o{ZW1rF%gECx=L%wIOzIg7c*bAmnFmojT+pmsg z{W^rR@Ay@)6Q6e{Ru8{6;Ym-w^7r?v>oBZ-__N)7^O!xXV_>5nbE5s_TWvqT}AFFpd#wuUGST$H2t4=#(H3B{M#pbAz z98jMv0gc9U4E;5re%k^nxILivb_TRy7dh=_UF6*xP?miGRoov?qXPleJrPjh(*ae& zs`CMTb0MIqmjhaZrB~QadO#B%1vD!oAkVXax<3!7z>9z!%)o>!aY}tXPU-kLSDd`~!>Pq_nz)21?k$Z|mt}F&*_iq}FEDiW_SRv~B6c=boOQt|qt zOuX!}@fun#USIp;)vtHF%<=JBJ1<@<_rz-_zTQWSgYl|yHD1YTt~OE4H4x8gHCHyP zx$1RkuA-Zp^WK1<=64EeSGS->^bG1jzo0q}4C*kx930db{5T}2(Zhq9`c;tUNrHMm zfhlHA3aZTHplVMEYWCEiqNfMBr#h%*GlTklR!}$B5odi+M>Yhtabr+9w*=J)30s5O zx-F;ydx9!)BB;yhK`pu;RLX-O&rAfhAyY`6%pujz7Sbh*&J$A8ydnLaFQokWL!7HD zdpD%ho{)YpLQ1qlIyoSu4~B=7@2ik}7(OGU^Rq)Lo*dF4TtHGvNR{SYq z70(vdAzVOG_ONQ?2x}|ibMZMImI%xLW>{eyM$VF9H9-t!;WYA<3aca{Wx_gHKCJgE zgteq{Sg}>ZJYO1C=O$s*^@nvSmURMQ)oM*!C=%9Kj2sx&8SEMqW<0^L)?qh>3<;~m z(6Cw|*RZhO#934r6;>w{8y!|f972{cVYS29ar6ZZ62cmcY7@e0h};vyjJqDzKXWE%5G& zu(GZR>%(8dj73hp_J-9B3()&E>y?P8&f5_ks~1tF`Vs!0A5pMFM4xqxXg=b{MD!yz z;{|ezji>>}VLGyoi|8eqeiu_EuuSUIhFNL z@B0Yj$w#yVCy|cA(;{ktj@W^U(`h#|!h0klDmfc-B3g>PsS*8!;d3K;jt%o7D!L$| zb7;FTqE4$L>Ut`o<7XnejKTkj=m>5h>TE>S(E!u&6j{$jRP%g9tuI7$rcv%`o*vI0 zM)4ZXpW6;!&*cC9otl(mV%Lu7C2Q5 z1{H@zCE*V_QW`d-!m=Q24Z)8&V9iquITeQ7no#;>=-LEUH-)mz;Crdj98y|9rqq$Q zTWgN&Zv&sdp`1P8&0cUzO7sDHf5jM}7y}`DFns+1Jo*s2d;~o{hIPZB+9!}O5?=ij zx=Ge&uv~79g4ahwcd0)H+DPtLs3l#-LmwGD0X~yw6BTcY`mzq<)`ROCSpO|-mqi<3 z>1Nfo6*kKO$=?Qb<)k#*4qL?XBP7W&xggDV!meHLi%i%J3#8;8sJ9Q=iTx)?mFe>H zemE=B4!{?Za8Ubj6jsWc$Dprp0z$vQ%krO;I0-{#y!1Q^rr%)OIfywAW#kvRB(45{ z#(zQwDSZK)GDn77gmF^)FK8|M{^yeRUZz}z#S(u7DqU4xxhen3JJ;aFKT!O-#>;7` zdjsa*gf-Ib77UbYa_}yklbQE)tVr^GxcdMM57jd{C`fHu*XUs3+H(Ij_>W?!dh?#g?eqZ$5YG^4skQ>0ro zP2Y~D*t^k`mJi>HrqPgSu8xbwJ0Y5|yfHDF#7WV-HaVID5;G;5x8$z8G&P!|@|Qf4 z)@c5e^*f?jv^$!tJ<$x7ujC`W3GCh%P3Wg+>dGj|KB68SRgI^WL=qzsdvDjLX5F|fCifzvX%vVlbspK738 znqo+b-#}1q$P0NVU|>VgK$_ke-^eo1SG?H<3gv5goMWJCu7MxI27Z>|5d%}jTwtJK zp@A*3q?&~kOp-OyefypUeCb7`UYyWFwjDZx73n<@)yqn*3m3`bGn$O$OqmxqQFbz`I)vToLy+9S6dX+HX0sQ~lkg zV`8`VZI9~RYan}{f%->Pv*a8%@TJ84rv8fIoNAX#Hx2Z#20jz}BLiQ^KaX|HJXPO|8d+4#$Qns4ZsbM@BOk^Z@y8jdCTrzkDWi@*Bjpo} z3{N(4D#gf!bR*sjBlX=z(mY0r_>D9R7+DuG(jwc)3wblgNK&qmbeSQ)=NV~`Z=|jC zs$pbXT_f&#M*7rOJekzUNLFJbbLB!4Be$e|QzJ#2DRy%sJETr4qkg^^8T6`=n+vMRkzaPZ6im;)!oQ@J&ZJd*T@!mx3`g@a!WG%7+E6g zq;p^OL4y6&8!-+s@{xQ#)JVCHjr<@zh8YFMk!K@}`n+VsJV9%mXk?Qdk>Zn# z9G_=o=6oaP78q%`&`2jKveZc2S4Kw3;nhY8))-m7)=1N@jr_FEh<&}0cHgMxZ;iCt zpx5NqcSbgDGE!=@kv(!!UfyD4%vK{$C2fz^C*SWiQe~f!kYxR&I)7H3@>s6!H!|{o zk^c@E>3zh=Z<2D%i0z`0(^BV>k@1&})Vr=dyJzI0I35`JR-zsnsr|@E%_m0oN%3b! zK9E=cGjdmQqD&OGns~pMNyn0j)AF~pE@5I`NfSk5Oj z-$cj0CXUFU{;FkwiHTBUpo!-4qgV&44mmYMIi{F6CXJ?=m^#g*_k9ydvTTNl;1?!- zmXcqZ_)NaqU?Sr?6C))1dlPe|;}0gfZ8WiFlZkShHAj|g(fl1IR{UtP}nY^lI{MF5vYnW+J)66SU z{ADxaa?vrs{tr7V0ckK!$y zFJs|FB@1mUTUeNCp+uU6=~eWctWCGDUAztpeVrEmlDm@Y(pYKkw$NFQNs?D}$TW%a zTj(lf0v0l4w)_!PZ6OP<$>>ZAPh?e=h0T(YZJ~FL#>h>1DPqy*7Yo@17HZ1|d0uFt zdsVGPB6TgylymhgG^}soVj~MX8e6E^#KLYV(#*o%))r34@K-EUZfC(SOC|1A3vFK0 z>$0b#g^Halyw%yl$6YL3l8mmZS7Lfu$b84b;CC(Td*4EnzUoUq3#R@SO3R7?7F=U2 zyf@aupYl**$62^B*}}G|77l!=T+0<#rpx{n7T({ibxYw^3srVo_~)X9K7U#G;gW^) z%UYLwBJ-|UXz`EgxUN0DVWFJ7CSTsSQ1*d({!l%aD-w95oKGzDcxqwYGp*;jg)Eu$ z!ovJ0E5Av-Xe$#9R@_D_g=Q;bJ}aXBlC%3FCMH7Z(JCvT)#`A7WeRu;-v zLdeQ@SyoO$NOQm+MmHl#}z{_}9 zR(_We&8++^jhb6oA-7vtY2Q+@+gdp;$*)@ZOib;qw2}E8tQ700db(JNdP{k`TG=4) zzh`B;nBTY3R|fXA(z>6OnEqDnxs_3Jcz~6HfmXf8D8H;9X{F_-R;-^{Ns>?H;3zBM z(N>yD4~d?p+GOfVK@1xuJQo`KFbhBywB(a7X)c*UBNeDE~^4dsfmOSouQAJkoI>L!VeV`BcZv zGp*sd_Vz#J!A7qr8-wLn$&R-1fx*UTxh36=Hoi95=wh|8xP%Q`NgIu0ZETg}a#Nnk z={Or%rECm|w=qhN%g1&bdlPIlNwRU}B^$xAHU^fn@wc2RZ=+HL8{H~ut_)34eyLE| z#srxw=jD}D)t6=?sfvwpay;Eeb%%{;pN&N_(r@EHz(#&hdBmM(V|fD`o`yEwZ)DTY zFdH44*w`%5%~W@5jeW(&5lLug<9bKsd)vlYso2BDMA_QYhNG8_ciypaPEvcThWBke zmnMB}`gvv3&np|-B{aaspn*27N|ix2hD(XTHge^rL=CYKFIgYis3GfQ+Q&AYO4Uyk z^D`Sg#weDU$JyvBb;jFRDR(B==rGYnt4TK2%ah4k^DG-Lq{bY@lBfkXddm8RHfAic z(R;Ct;_Fn0{JdUud}Cwxw>FA=r#fZp_cm_)puO0nSYq9$e#xz$Y`p%njT8HAls>3E zl=*V}kos`a#!@*iw@%wAIBTPky#JexALJ*A|J_Dq>2%Jd$kD-P=hK3blm?;P4N?r_s{1`rvaA6Eb0>wql630QQUo?(|#p3u!elH%U_mem}$ZPb$qZD;|mZImNQhYBz3@b&M8KvkVf#s!`x3(02OXYo~ z`0$rf{3PeDlw!lxQbb)V#lV}T82+pjhvnOUOR?&|QaqB*#IrRz9-ASae~j_`Yl^3h zIiAI0vBc9+R!J#qJh3tHyecJ1Xnb5eEo6{Ao(@UztQ1G-c!rdTC!<0<{p3_yJl&k} zd?O7q;@KaFCm|Tmo!ofBdGTDzkLQ{XQipShJo-?wfYdp8)wZ8FG z=@(D2{_*$*#xq#{kR^i@>qEu*D4sDxv8TFj2;{=9e!=f^XCK|H3<<7pz@7HJJD<4IYib$=Jn?}6e z>1wjGUa~B923YOv6pzi$gW`6omasFiq@9wncG^jWIJ-Xc+UYBK@peYq?HrYQ33g6N zN}`>0vZ{i{rQ5lgVb^C|JNa%qrM-5F1ndmUvU5;IX50BH&(34nl5eL;#7_I_c2>yt z8k$?r&Vl-N5*yfgPuexI>vtGC8yo9!Q_YdJ&FuWy%8skGo%(H5-|Kd|%bZ?zYQ1A; zlC*f&PI4bRZ^)Lub}kIE;~s3M!-sZS4z;sTVm`KW<`X-Whuc{rb4J;@EPsx%>kAyk zmSa=wj9F;sq;y+iXW*B1wyv;aTWP1$Dm#`9cA80_@04q!;)r##o#|T@M;dOk^WAnk z(L0pyM?0^}a`{vK+GWSP+s=-?cK+S3m`7B%jFsBI*qJOp%jdt^xh|E@+WGB*ohldA zx4+cen|9um*|+T6y>F+|Gduka2|E3jz*EUAmcUT?s(1oR5)-&3W0MnD`ceXS#8EbZ zqp1nJl$O9>RT8jz6KF0w0||@|CU8c^gc7KdmB4#4DLa9xd3sK2gcDd>kiau}P&I*O zH4>O7#cL)|u|WboWM`uUX0}b>qGWYQpk=27E=cN|3A`(_x+E~A3`*cLIr?z|t%oPDNE(e)?oU;p?2*?;C$L=lPflRR7YP(ysu(L17`QrtU9xz6 z0!_b3V6GT8syDk6D7Gho@&^(qcQAo&a$Tk$);y{6i`IHEfi2SDS^_Dz6X+?c9wo5( zSpt^l3HltBNM}PLt0mr)NR608#!H|`BAZGjVvbK_+DnOaEStzG`MzADKHDd9L!MMf zB)3wcz86YlM&(4drY2%bOQf1CcPDaRUJoQPB$TN0MTz__zlIYTSUr(lva)6(59?@r z-9%`b$cvVVI**vh^LB~6^JXF&Wk=UU+VxCisVsO`_4H1psf?1={Zxy*F))!cgA=Jd zB#|}J@nh90nIjZyR3f!UCt?_%NN`djAIc>exge3FvUOP^U#v{zww(Vek;JbP=_Ipd z*f)tBl+7Cwd1Y%NOQhoVL`LjRqa1q^87hH&>cRd*E=Y$1i7Y&n$UoBWu*MzL z+T^oii7Y;m$W8hF7sWoANYbf9n#l6A>X+R5J&~CY6S*ksN#gVPB(6(eUlQ9T*`Gv* z%p~?oTvigZr9pNQ7o=xy68-X%*dYzVx~-N((dtRW)JURYeZ^^#M0V38otI1EMe8K$ zv`J!Q+a!K@D~SqSlQ8y5BI~^*K9-OA=()a0beD(nR=*_HN%j6oL=Q;fzLXiNn4c)- z@FX6OOrqPUB)*Zt(TYD_@h9l{Nl6@-ok|~~^jL(})^ZaDy%kCP*WWJUBHpz^XD(#Z_;f-XBZzfZ+TQV(sB(qSe^;F(oiuX>k)~I-L za%eISMl0`_Wa6eIb8}8IxpVdWf@IDvOD1i3G9Rr>=Iw8kL!93y)BDF{HcP4f$t*gM z%nhk|NY9DouyRS_kz_i_Y#DnhnN#x81Fp8;ZNaxIaw`*;nh=U*er#avY=xMo8C&n+%<)Yy;Eo{<7LI*6duUr5h=9% zEQN(Kd|V1YPfEc)S#joR&ioWI#kxF&=CXWq3chVA43^J#rtrm2DcqKykEhV>bPC@{ zhs!B6x}U-9wgc*LGGWb5~_{o~%siXO)>jDihh5Ww9&>rE*OUWu~$=N3Y4^yj1Fi^|(Nf zC0LkBud1nJR7=(SQ>y+Bq%yEpDtGFpa<6_WTN^1)(^U2}Po=^usdSh1?NX`!TB^Q} zOQlVxR9wAN=`ZfVdi{e`HptpfQn@ikHIGf@-^rt==hvw$+N$~T*6viw9Z02{_ztF0|5Pf|rSEU4q@GXZT{-nvDnDM){J&Fq za3hr$4^pY~FqPjQYi-X``9bbJPvx>P4ZkUkk}+wxilotBT9r(rXKWhZ%Z|7-X2qxR zmvpvkY*HFSq;lyrM#!!*X_R;=jjms>tNyhXvmVS}O z9VxaUjZr((I3dG+Qe8i%@x$RXj7QSwb0Uq}C)1cLkItmg{Esx|%c?6He>08px6;`C zB#q54Rl!oW3g@${P$H)a4P~Y@k5pm4^r%*aA6~73@wF7<=cXYQqR8eC3i@|AQJ$mPG&aa~Jij!gb1UDx2GQ~O3b7o_J+jlGpldwEZ$-c8qe z@N`z*OXsf4ewxnK|I#r=Ip`xpWsej$IA~#Xuv1PHb?|X92YZV<$SUDrLz06R$qss! zb}+ZBgNx-HG%xQUEmhB@Irv>FI~*L8_zVZbrIX)*J>Vc!rpa$X2Mt0FS{FFzDk+5y z0L6~8gOPK!=6Mbx^Bp{1;Gpnx2R|=z zP# zi_=Lz`CGg$CpZ005_6rrp68@&RVTl{?4)vSCsSoZT_-Q2|%{3DO$jS)^Ne&*z7IV~ke zt9JQ8-X5!djMEzAoZOTS<5l+r)jiQks*IGkrYrXhC-rAJxjfg2d%of=P`ss1$}dyx z^7abVxzb7dRqCrOTI1yES|`gkI2pIm$%#!)YHn7qw(7ZUPBw3MvT28t=$*>_lat23 zDz}tA>%=Ml{Nd!lMfF%_{H2;C`I5$5c5*~6Nt5eN+TBqPCGD=0ELkSE?x~LZPTrUE zPqc^sI{8$p{pX~q?39?O3I0kRyv-8T^!!!LKqkH-jaTke9)0`57FP3o@cw z1~nUH&{9e?R!o^Br<-I@r>VxuzE&BWcrAl6?K2o7!#Za$MH;@L*X6Jzbje_(%n@^s z4BmS`gHI&VSL0-xnEPkYPsYf@AsO5ll|g7s2FJ%{@R!UVm%(azXG#X?vvfNEQus{}@$}IklT4KvcoREl(K~`-l*!Lx7?6Wbr<()yC`1I zMa%jwcFV8wP~L0i;)mvn*TO}CRBWfZduTm9T^y7PQuiGftz=st7nR<3ar6@xNh4gO zO68F*x_|28to$vRqg3B$7o+5!j2-J@p0pn4;w?EN6(+b?InhO(sV+XB?qZ$vn4x)c zQ!;0{s5jTe^ee?u(~M~aNPqHZb_ zb8|V~jXS~3JgHdPP1iDR{(Z^K%jMi0Deuc+?;>a&C~X7s&&-bI=LDAmYbbj-8kNL>-sA< zGv0G^u8;Ip-TmE6lNC}h&`tBqA> zOm{O#&dgH3=D3+C?geh%U+Cs9Isc{lyWFks#nrpjZq}@EQ+}W$p`MRon5y8d+Y>R)c| zJ$IA$uht~%|5GpUV2SeZsT_*-P+;)zrOCrhvxnC$9>O*c4aE}UAyG!jks=*4;3;zyyf!fx?m3pH9frcvWJ86w6;g*%shN8s~dWF(8$A^jXg|g>fvNF z54Dw6E+ws?55RlVQtVXbVDDm&DZogO~h+3lg(9uGgtVHv(x`?gPe^ON>h z&dTQpJ^X#hLz~0u(NPbRj(LbW?xEB#9@?Jt@Uv7q?cs)me)X_KM*rsF=z#^Ke^UNY(ou z_RISZJZyTXy^=wXJnVSvp}|uRS1ewAui<6Btc~&VsEC)hih7AE>7`Dr7fYg-hh=qJ z&dUxtDmBV`8C}84Q+X%F%Z5r`eyZ%HWSW=58M^g)Y3=i}SFQxS#09;)67rIir`w2^ zg#{W@=;gnvUTRfW%o<*Oj`dQrf#x^#GP9MJ^R2x!ZsX-uSs|ldQ9bRvOnB8xqfTBH zzv<;#7cXt!@=~#zm#%MnIW5Dxd)eQ^OMXu;CEoGU>Rm5;*@fymT4u<*PA@J>H9dqLxR{JRHr&UrQZd)ZBpFgoydxP`v^?*u}DmleKelxeSzF*)YeWAukf_;AACcdE zd?lZp_wn-|KJxxl{c`29k2!aJT)3z4_kDcy$j6??%J;92eQ|#3RP-|;#m|3Iw345l zseWRr_!%UhN=mvPuXK0#S>yEcFvHKsZa?XMzpnfDb6y_j`6&$Rb!ijvv!K9Fi9$by z>VCeJ=QR}TWj|9TSkF)8`ij@U&sq6f_BZwu*VNB2IoixmQVTzeTl#6&-p`^Adaa|M zCi0c!cJk9%k~;gzkOJx0#ZNEUF0QVABJxNq-TVxc?Qi>8*2B*R+0|3Ezo**!sCL=k z*U$U?{EU#o{(c(E4zUjOGeAa4g+YGS4fgY7h@WmBXuTh4{>Q3!xSyX!_-XN}YLLID z$YS;D3-v%&iE*jc{H6N2%#Ue>U*{_PEM4y>;Tu1_H~9JfJ3lpk@Y8IIpIKY|*tYpO zwZl)joqop4j01ko9rV-akk)im>pkvgwVXcTXY?=X*GWI4&S?KG`l)qEYm|Lg)c>n~ zK9WZN_?dQHeH6n@KlN_;*(fs}YQ2xNzQ@{AS@hJ;)n|TQd9LUF^K*~@k*EOmBy0%K zP%Op(i84x#m;zKa2k2Eiz(B0yc)B+;<}-jmWv0W##0Jdn4N1FS9`pj?>%g%tuc zk(i1aCu8M!N`M-b0`$%ZFigU(01afTm^=ac%7S2k%OSm<8DN6k%ngv4AK(jFC;!R# zaDa}50hUz_kW?)|u)1oM4K-9>UDa1#^~tyf0cJ~d!vOW=w?etu+ zua66GNIsYnVAoX5ofhC%sW>CRB>8ow?#~XeYEFPME0trF=B`msHwPHHC7|`+K0#5 zhbIAAJq^%VmP!3*0VY3JKVJlx{%?Ta|I=|pkZr~wW^<59mLSE81Zi0`$REXmB*g}4 z9~b1X)QS%>&K~52j7ki0Bq>PM7uWqaf$yu9zAJNpBV;Q)bE0 z=0RP<9ptxGK^n9UGNFA??=PyaV~~xVmGjLYW4i>2?-`_BuOOG-31S}*@K?cd!GlM*y6{PEIt#xjYzvcyL zF<-q{805s~L251vQhG^{j$f!Yxh&C3Ro|CEDlHE(MV3jaHCpG-TIYVPQ|cZJGVzes zdN{}j$AUCD9;Ew;An*L6c{hXfxD}-Ec96Drg2X-w(&llHee%Oo)g2XLuOUQnQ-}{` ziu@)I%puH{5ZmR5RJVp0Wed@_WQecIg}7fn#2XbttW62gs#1t~l|vLu4Ut+UM2~dE zkWJ1I(XJ5h$sV6x4}|zYwq}Je-9wjo}5HN@HWAyPVqm@G9rhZyrlNavVBEbAZQ)_@StWz4`3bEVaw z5MAW7lphje#RtkcEX06Mv?i%BJfz<%L+qBKBSXyiG=z0bh{j_>Y?FuMLqsNO-LiRd zNdLw#gkfrkEpku_r-fK3SEeiO481lpM7$i5bJAp%V$Kd>nG+&!ZitWPg}5WL=ZE-n zf%^5idc8EHa}$aw$E3~b5Wj9!&TS#~ZC9;(RLkBF-hCncd!3NJ=Td(UX`O$n{)@^X z$0YfZ)+BFV4)OJs5aFvKcHIk6P*6oGx0Xdq+jz)y0yvFHA#x|hH`ev z`_g}Gg*HklS;p2vhcL(Ka)x8Uo)w7E)&zAnfz+bqM|j6RkkdmN@r20 zOcuvq%Hp-GES6+vaXL4P5zVtW&?1X)%PgA88aeiE7Rm2r@xh=h>MhD*(qheDl0|}a zlGQ7+c(5{ym^E@<^Zv*pawUt|<+J&-LN-k+W^<-SHWgmZrf7p~3MOSUVsbWDXJ_;7 zrfk03oK5wu*<3o1jq6Z0bEWui*|hvUo85Bp?`)jcvY9OvZe;V;&1}-{XVbS*4x20I z=-glqKYMbB_2uxf+{w=&Cz8W5>0L92?_bU#y;csj>*p}OK@R;I<*=rE4i9^1e6Jiv zeUQVE4|AycQ4aTp=8!imhZV9-7LCr~=FA*2XXo&RY!v&P9L)1_XgEKIEpkk{FUeu? zmpNQpmP6a+IlLn=YjQ|fm&0r8b2um$VUOTFJmo@K7 zE_H6?GWB6DXCLJ<`$aC7iss=eo=0|xJUYeaQ8gh??|XTA-^*jMGmlakd3+JfV`*+4 zH}dir9nNEXr#yb?oX0l<@_05dkM4u=*fBm2>%=^+%+JHKFpv4teQh4=zRsifcX>45 zn#b&IdBkkbqr$N~-a4MgDf!~pJg%S3W96TD^uLtH*2|iIC68UV^C)sRkHIn{DxY)F z`OLHC)45bWE8_DhZO_;7uG@0?jFyTO^66SJpX%xP3~!aM&q(>Yt|gx)vgeh2u6N2O z_(nc=yXEuC_T^Am~!!9_Db=D zFdxe9#4tsZ!#pk@);W!^&SQji9wW?9S)Q&rjxbZ4VGJ2zMtH&;@P-Nd!c++hGu*TPJEJq+!`tmzQuVaG6CIw@|KFx9(; zSts4z4zsp$3y_yu} zs??aQo=gezRNkGX{>~25Z=qr?R?H=eDMh{rvt(76J>O~{zSBO)i0>8q2gTkPX8e{g zzibWj^0qMbc7>U=J51D`FvItU*?%C+<-=hf$=651?2rz}!Zi6s{gg5%!(_uMF)I(|hILz!PVPc+!*+v9&bc73* z2<4I@yqO%~7b#a(_si+N+^P^EDp7` zBit18%m~I=5$ey5uu1mG;5n*)ZiK+R2+bBmn6)rMo23!HSsmfonh4R~M|fjbgq6G1 z!~GGeoYdM*MR;;L!o=SroH`ew_Ia)E57lrX!g`r?L%qMLdTyzfyXy75i2kiXgkp~( zw0NvuN~mH1gHsB~OE17#tAO6M3;0uF>KD+oK><6&)wqB@O$xXuhnp3U(4v5m(y~ Tyi#{p!vCA6|4YLE_vilr)mUhT literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/245e25c90b49f498_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/245e25c90b49f498_0 new file mode 100644 index 0000000000000000000000000000000000000000..3baf22191cec2cba6532fc16ac587dc382e38a1c GIT binary patch literal 112688 zcmeFa33OD&);4^4N@rjQ5HJD6Fo=MN%mN}e2?Pk2A%=j63a68Fk|s%aNOuC^Iz&W7 z@FHVyLjt4$=F*@A|*>egFE`-_Yqkr)m$i z_pV*LcGaowd}q-M%?f_~&0!cu0^S{-SZ%?F(Y;4v*KR$!Cim>ot7re@{=Iwk?AfDh zx6T7P-!vd8X<%Yvw{BerB;RyX&(2-CcIlbevs?E8-EQjMC8=BI&I5YjPInt{?2M`N zIC1f{ChX9AXMT$NW5bd#Bk>XYF2}p)bH;2Cq(r%;^Q~9g5}aFFm>qC!33tZTzuIm$ zS=Q27+@Pf`#<|L3hOvw_r_E_$zQ&92xmVj`Onft1&TnaJv%su}uZ~#jvF}j(XGl>Z&@9F%d4_Sm$z(VZwLryYkN$2M3il*qqU<+Q`-c4?7rT%u%=O!^)?uW z`NyAs{%L9Fyv35WWum3b4zhf0#`~hxFp@=ig2{W9c<15l=KO}2v$<*5!wZeDm;}Qa z%kQW#)OlC^aKqAOM1%PKPkobn73$>%0)_rQH{Mw6EzHa5l<6zDv833Y(A97WEcla< zp=q+oic(db+sw(3TdW=bqho~{EIp~Qm-9eJYHYAc94&3J&ettj@%ZX$Xc&j^ZrRCV zJS2*a)uSd0oq%~bf^GbMq7>4#n5G$)_|)ts@7<6PgR1^qUvYlc0C%P@%RSsZDIbRKH2lbKkQlNbmTc`}LvZo_!uqhx>cyeoUIfxJN1^K#NzP}^c7`zva;OXbXN|rG^M4fADrvOVsiVXmS)cM@##v8Bl+lE&%L<3kqX>^sgp`k?ZpJ z&vkio+*v3bt_nAr!=GoLfZlT416%{&>ZG8Ws$%(^9r5fg9>I_YcoO{Yci59ww{BCH>oe%V<(L|sJe3M(39;0E% zfg;4j-@r}u090w!;JR0kQn4(7jB{cLK~XAgy&kFXlrK5t^bci47xyYwQL*AFf*9H3eK*kQrFcVg3J!ippw*^4ftP&&ya zw|?J>JY)&KkXTgYDmBbaxWUFPKQp}p+u+OayNlpH&Gjq*)s?pndXrQ!MELSc+yg!N z0qI8Su=Sw2vdfLD$vs%gp-)N)xC_ifKu0rtr zDGJI2j*W94a)faHPj@MbFG|kA-0J&nou$6K>2!8x34{Yk5ZJwM$}ggW76*L&{Z|O4 zuM$kf+7@Xvi|e}Cd_hXwy|mhPgF0d(_BGe#92usrq%A+vo&=>KvAH{U}c zsKZ8&SUw&M8b+}PL-$$SmXbbcDTpQ%{1pbV)FK~SJ3wjs?A*zFSy+gXAl(HgN$0%; zHze%-E^U9MmN+sd!Ox41vlm3rDv?wk)6_WP65&rFk|N>n81s>bKI_^95Ca*3 zA{Pc}zuVkKX~9uN(hr`*S zLQ`UZItM2GYbxD`$DdRTOH1+U;cI*s!<>TxTHKJXt^P#`X6D2Bj8+(?;YOJl0Mo1) zx5wftONIh$EMu!+i_JpC?&zXBGs%sY%H^o8JiGZ5ZnB}H&pvlM?aq~z#ZGCMJ1GIO znKrphcsXGfLCivyW-Ka!6ToLTT-BC>Vsl5(>o!r8CoCCstrT%;KBAEk851xFqN2&z zN7_M2(xUHamaq@$#fsn^7vP5QQ(Zs(j7E~<_KLO@xe*t7A!JE+>ePQ$(ntz?#d4%t zi6V)1_Phh7l%2=x2_#Prz~(_ULn(H4(ctZD@A%@vEQrl8*RcS4D^J^ZHzg&)m;P|t z8Lmv4pZOXZ1jOhHOS-oE5mX>dU!j?VFBHJ?vqPOkm?h#p2(TOm2_B)u)fEeKX|ITd zGV^2?K^MXe6ocaWqHB5z34za{o@{q!X(s1QhM7$f0)BnN?V~6k3=gj2`~XbV6)-!I zUs(IbhNq9w+Jl;vVFuztKO-5#?1hTc1)hqA-wXF8hFIWM3{Fq{-0(=D`DmKi?EClsKY47yn^oBD6`e;{vn(!?;Rx>Z74P}DBQLE<< zY6=cSGPYAS?|9c!&7_`a8iUc>!S!Yq!u(EF^cXCh9z$IyDl2FNs5Dt&INEi~)wGc! zcY&|O-Jih|+70;=!^O073uwT_-aM~wl2=9c{aw%of?l>BjXb&J;&)V$5RGuWK)(PO zAUQO%Ubka)+0XpBt|B)k2);r%yV3!i%!;AO+)GZN%ZAG?^kH(2P2=wK-Gl(yE2JBG zLp7`4Cw<1SQv`#4h+r}YuAWK*Nh42wK%OZNl$Chk>dX@?g!Be3b&sa>id>V@eIs*4 zAcV*+%jeB69hmRRF%O`S%nk8B-ix7<47rjE3InCW=b2@y!thtmHYOi(;*;X_2VC$q z;KL*-C_C-Dg-_$uPG`twX6rt!JmmUKr4Q3(=5j z^|+DK9%ty`ku%faq)trTK4lxgUcXQNAsiGuyzoKhcD5K&&;I0_F_e1sLA_%>gWoY!ndg)+fGdF$DqlY`q_0d!mR zo83yZ<^CnVQ6 zgWnpmhQhS|74ek1@Z2e08D=&FB-jFhilTY%Q0`v0JIg;@4XrYDVVFgzhVi0fs^{MR zLyUNhMJqSeRfGvP+M68ANtg=&g1`iXxBHv?K&~(nxV*)MkUBitQ@8=b&`8CrJH}ET z9{(5wPkDw}#wG)18)m9x3Ld0GdXuL(%y7!g_;e6vGp-!QAR-3@ zKZ>eykn5KfKAQw{OAB+|UJmVOLofWHC+Zh-|1ZQN5=4o?A*Fh5H&1c~Ne&rs(*Rl) zJsP7P&N0nw)gy+t>GdXsl;u&Tx(W0tiL^jO4#Ob$KX1SjC^ZM-LReDwmuHbJq7(Bi zd^fw&ilLUV=bxWTw^raP&8QAnQQ2OK6DqwLMn}3v&-2$;j4hF5$rK z6#MQZ_WEIoW5$n49gvuwJih;kQNz>C0AOY4HU0Y|LJ1ykQju>GW(Gu^fj?~R%z$+s zjWC#K5bg*SIKLq6ndzI~q!7_skr6XfRb%FTIDYu!K{w00pAgX*+&%`ieBofsDS!lHpt`Zmj5lRh9fe63=GXvZ5g<2r-<(aw z70O90XW)ieDIrn3Ju9slsfsutsR&^xhN()~928faU*D820yd6dPk2Vd%*PFiWB-Dv zUKEEgHzw#H4l!W&fsSU1DrdK>-as{Y{Fs9d_XUR0x8mBYM-u>ni-A=IWKSd@v^WjW z=P-GB%h7q@l*uT=Jj$E!hktDOB_{?q;a)s`xV8aqcVQAzYDgjY%`jzI)`cT_QOfYj z*`6HGOUDJFt)I2aCA5slg&c#^4ReBm4s&04i_nu?Mcy{>Pi8~Vmh;6{j^r)WuZY}1 z(kuf^nP^If9@{HLXUCBt?A~bu3YOVS`b$JwhWWO_ z(l5E{AB^Ww29*b@y`oMq-c5dpWnt^F)IX|u{d9^q|b+YF`oJu>kq#fMRF`B&Il8CQ)p`j+x>WGeEOv(2}QKJM}1;bumu^Lksvo zU^#A3H&c5&Kay4<@}~ijSkV(@zu7`^0pZX7(3d5%>C#oJNMS@FXC-XW*OV{BHqWu9 zFHJ!Z8|Dt=`m+4yizJ55I`4;%kFv97s)>%dT*+Z}kMQ3p2hkVA_$1X~&Oj@i57#y8 zprRu-=|Z^q1k4IU5t_cfczr!KU7A(3O_?WfQx3?Rix1t#Dgj?kPQH7D$ViEV+Zx;? zj;)Secd(cGAzSta%s*rn@DZs*FumEm{7y2BL@X7E@JuzeV$`eOQ?AvM5y-)-`s)4* z&u(pmLbxsVZOmmjw^UisB%vF7NAphB1{+7Nef(c+Ke{_eATzDU=-HwsWq16Cs7@Rc zRh9xdLtIeeCmlbyXdsCrM<%C_Prp4id8A>c;YOK2edzT^I}x>Tb0Y(#`EEJ?GUF+G zAii9@VH*3jbjxkJ%GF9BzWiaE_8h>FN)Mn%GP?r1QSGyCwG5N(^GbIQFXtCCGUTs1 zKt}@g>oyyC770BLoIbmVQEk>uukRg$l8sI7Ma2X1V3XCAk_mrGlwT;gu0XYNGu_73IN-~C4 zci8%_@E$VJAd)qhsDV}RjpDA^)85vBh8z?C{Sz!gj?DeG78cVcI55bmI*Jo$FkrD? z&*KLeFmot#O;Vm)QZUT@O0WZ`*Zq(kk{&qCEmEjlGRyW%M%LyL6o@I`^c@T73o#?{ z<++&+6`5&~-VrvsQkpMhnwH&pBf|;he8nOOvlr$XC6m!x|NNAFLy|c zY>#bHK7#IBR6vX_B44eUR;tpt{f)jP+d)56Ju~#19VIsq-`LSFwWE802u2{}D;k_W zY^eD%alpw;2+L~1iEL(Z5gfXbADW{lqGnQ1&Lz|P?a*qV{R!LrG)U&&fxrB~VyR~_ z@?*6MH_C*aO&`6?!zOb*N@mRD_-i%<1{&_nf$t{-he7(|-ykfR(|lrUgAp_#(JO+k z5>;MP@?5-rd1oT`7Z=iF`%`JC%!7MzlgJmhEqja(1u~GSpaY}|;VjRtx0PHM%77&$ z8{f@8*iBKma$tN9T2^(!6NQ~9IiOs9G*k2nk6$*&q{gYc)fc_wIGQ*WzQ5ro z;bteGr=eVIa_V)CMj}svN;QKS;PfgzUJgq?D195IHknwejVA^$`$zep8>z(%m){+n z+4=!FRFET)v-^)eKx+&-qmhN~Ophx+xYk^Ts$d-08s@y;Nyd7*$BNZfWX+XLH2i#T z9g>5}Yjk__3s!&vn=ZPLLPjxB6RzLvN!<|jLr+()N(%9dNhj8%SpnKQggZ1pWWFWA#@m6&F8Ny{t*4zk#1 zlKTi*)Na6>%>uC4Z_)P8Wb2cBK2E5$OS@ZY7T$i~Rd?P6ehrb{Sd1@3IAqX|_1OUai3Ld}LDzg+$$a!}D$a%nrAyX`| zqL8*K#c}BK*FK>*d?1A&JZTAdelh7?0mLq2ZSjY^0rs0@_i#V9m?wIMolD}W2OX1T< z0^B$GVpAlo$IrM+W#-KEpxj&ibUI4dA6DlAA}*8BojDaS>^9%fOM$|Po;#2s7ZP$uqW3ku6d|#S72i=Ml zN3#MvLDGx=;^fE3=Q`8(G!SSa=?(Yql!NN3&@{U;9MoB<2}rVMc)R;mKU9lYKspf0 zCW{@$yy29iTuKfC5WO8p_JY?W4v-o9;>U9-1MG^y7J*XI5IQlZfsZo5NybmEHS7r- zp>$eGOvnyFjxqyQGI;iSTBIN8vC&=?7O!MW(37XkD7e7srH96lpC6oHi;)ob%{r(E zJP`Qo*j_)fS7du3A_l2F*%~x;-nK>sqOyDD+KJ{!oJw_m<4?}w-ZnEA7eEc`NqY0E5?W8n@RanF#G&K$E`!mDLq{d!zPUv8=7Gmnh(#(f z764yH!?%+hdkbYIyEHyIEAaa6Rg}!R~k-B$^VT20iOyd z6L7(fn)dNE``A&dgU~b|x2Kt%(QdQ>>KpfF))Yz`V;Myw7qTN!{D@%e-uD0gmZ)hV z^bICMEa|XkN1VHk$YH2zx-2IdX1Hq9yi)U5$=2}Vf(%4+txy|61=YnLw{JvCR!YHy z3Bounbq2ndS53c4hA7CyF$mVv*=eXEF|2#DZ9`(n_hrHt%W`uvDFc38)rM&4Ifi3z zV{Vblk7)_qi}@HUfd0leAO3(LG*Xb9=c5SATeDT+rrYm*Ty|*mvI37B;ON!~x%u{@ zex!@Qnwv%-GH@QL^t`q7+{=<~iZ{h8!d-WIk=t$N>k1FA7qLE!DY(Ir25y$nzF|_k z<9;n?XrV?yHDSrBPTW)y6AWYbm-n>gxaz@53wBEk^ko+NG2$RNMw-1jT2dw?ap29> zyXhdshJc`Z1IxL<13iM|@sF>2iB>EV3e_1lmD50SLdoUi$C+=^RCGR*^E7h_8HZfX zru;la>H`r$^2B0SK8OrPZJPJlH&68yRs=WAD9ii;)E%)!)(G>YWEB{!$1j~C`rMGM zTjq5hu`Mw-6OE*^o8b${KEt+Nx6Cf}JjppF^9h?yPOPn6cy>h&ZZZG7CALNm!ueU^NvCmI*Rx$2Xs*qU7dd8KRlP zsYT!zz4B@oalriG58$rEZdEyBH>ZIVaDba}PyG58MZ^Ii-IJMTZVGbY?QqK@6!9c1 zH&xpb#O#MO(u2w_nb7-5$%PJ4P`nLr92iO_9KHcH4Yv;lb{?!rs#80R{}-vkRmnJ@ zkQ#$prf*zb#BPTK64$Qe{y2~{1FV3!Z05!nUS-%XWzR|;n|>H_s7~ZhzuYG7G92AF8w0YKq6X0icqQt1h)72?p*ayHOL)6GlE9`y~45k zz)c0x$ny|wN)Ksn21N>YcVvgl46zE_E|N#UiHkBp`#_)b#|Rgic{eM-HHty|$b?Bt zILHUnSz;yzAB}tFMf@TEM~*KLTQQ~UmhR1*N%=#>$H(@3o$|w;7Vb>dydf7!XfSu= zK*@EY2g2oxuDzQw1LWBuT{_YFV3u&eX=2lj@aYGDS}yxWKH1iN^*FLL9kVC z*4sAW_w*7i`)f}iEHl`&Cf6VIuxS}`TU^kGqd#F)Jt+Mac~?!N^dVCC-uzNTPI7IO zHjuB>+v@tJEl3KpH;(rKETUoRh8t{0+v^7{XFGeOt(ctWLP2kc11Nh5}%FaZp~YXND}tmnjFJ3io3 zn|n}92STKgFHOm%LBQY2xN?k=*^oO%JS@zJeN7FHW?!ljD2M#K_C`{q#GntX?E~dJ zP?SAo>|2RL*iMnh5H1SK=*YjAk5EdG__(~57K&1&3^~G!+-N$ywHGrei3j86gk}$a z!e~gQJ>*PAqytpO$y|@Bm;<04)0;I~L(iojA~3t+LKJ-U{P$97DapNY&!p(eMA5vr z_RLpBBSx}l0%4%1@?Q%&3;wZDrzjvJK9Tw9qfGgUychlS7TA@=g)r_3lI~O)-FR!P(G|0 zx&5Dw?X*3)2MPOg)TU^2CP+v{@6SuSO9iMY*`aB+J84CbFuuAE;WXZ5xiV}X;wP1pkD?X&0yTLDyz1hxOf9aCcPJz&mfI(K%=oBQmot zuD5yfZz(3kmF~%$`%NVt$gk+c&!<_y%^28+fu4&CN`2hd{!vth0YH!KV z{?ple(8WR)eo!HsIztF{Z}V+=Y!HJ{^9a5W<-NZp{6rCmwKk|j&|6KED4crd^pnCR zD@VY#m`T7J zbGoXqa_6rFtiUBg&PN$sdzlKEiJN44Nyj$pXulzw?zl#XabzfDh3Wb_)w*@fo2_7v zkc)#sc7to_=4djFfOp+*e?C|p@ap0EiWdIH$`I_vj{o*kurfMEc$w}Sk)M^4MLRZE zvk_45#kiHq>_y=W~E!RFumne>uUxlrn4k*&i{Gmt1VNM!rY4@XrK2}xv- zNIkX>m3BXJSxjN77y5!t!I#ndG`z7$le>Wx|ZV2 z_7T?@v@H{RYS%6vKnx0kRR=3p+YWO-$+*9I?!&!%gG6|4 z9ziAW0?~K6q5V)coBctoH^Fs^T}xy+S6On`cOJNnZX>wwK|V`_wP#j<+vxiA1MfhR z%%kO+x%fsYbo%9T6{X<8<~g}E4wNlW2qB@70}n2ImyN`dfs7pYh8FY1?Vi8 zCj(|2%>)RCA6zwn2(cLfs|YA0k6*J8f=N3V^CcZka3B;sR?i2_%P3^U(YtQx$cnH7 zv9B&DJ$M$ei@J$2{jskd+)AL4`6JRf9TH3PxSR6=;M~=*}YHsT{%-yPB z{ar)K$Q%>gw_!{$w?ac`Djn(7cQg~>CaooCkWAQ8i9ovb-&5?Ig=V-s`N9R?i3`A@ zY3pz4_m=cY+McuA!EF6wlp5eO-udbUGDYXd+@(1M1%QX@4-~k+q3WfhNaVu}*n|*# zIvC40FnNdvY#u%M>lVSLjGBW>Y33Bk4bM0@`R^7#kP@DrLmmlD$X9lFwr=Ark-3y> zE>Z)7-T4Rv{AL@_knvX7p=|MdE>xg=I7ZBQ5p5L5-wo3hWXfbz|Gy`OkJXyj;h|UKPv#BJ4c6J@N?j`nLJR>_Y z*T+ZsrLCLOr3pZweGYv(na#}d$?ZkvGUXWhoop)hc?CC5FlyV+LLlyUXidC`Hxc2d zc(I#W=Hc+5s?zhoO~e17jbyn?0$8Q@n~3%WaLm?`_c-^66Khk!@nva@Ui)mpxsRMHT;yaGAE5q)y#r*duE+A@{ z$EHnRv?i?H;GY6#@8NH_twmLaUQYqsWx88Gr@f+dJJoPlyH2=wq)Zc6gxQ zGzGu1>+V04=pt&lUykzvxeL(T57e^C5$~{d?A^gpUe9*sDd8Ty_q$zGP>p;mVktf> zY8FWap%oVot({L(l_55_xr$vbNQf#CUB0*CWfGc17lA2!K+cUZ8nFVx*gxu>Ji{CF>L zw)LL*V7ZD%T$6y!+>Sp|woR_-)s>P)=TnQ`DBexP5PXwwN{>+R)yGL-+}R4GfCb$q zkM6ip&Ah9pTtuI52RwAz_SC;x(2~@~&Msyer2xboZv6FX+40n)v9yG?sL6<{!=Kk* z0s>e7n-E0XKUXAh_|o<>tk@qIzCiAHo?&!H!H6^Kj zmyL`g{B9)P#3QQc#apGE!O)N!dtVk}5E&@xy3E0VEfXzG8&TPfYW0Y2Rqfu)#lb3L zPn~bfDup$VsxZt}Y%^Lg?wUs1s7f7k1)p1EXwX6lCgYo%#j}_+F!7`Z3x~20j~QjW zyY~5OfT23>6{{8ww1U+<#_K)*eW_4NI{YqGBFS?Fev;`CP@J3vUrewd;9irIU{(g@N1 znd29WIAuIagK>aZoJFMxiuUYlaz_(`egFg`4Emo`6L6Hj+f1Z{Gr1_j!y1B%640hy z;dtU*yLea>0g;#tq2V}F0ZhWl!fL%Yp0A+0DE7LFN^!V_cpeQ~+RSOFf`J-jHl4ca zpH!8{{}(Ys2gwaEZGGk%550k2Bp;NVo}QcrhM%IsfM>h!Ko0RB6Qr_nT34uaHwv69 z>Y6R^N#Rx8_?y^u5SmRh#}X4Fnf-tET`T7H+(jv#kV?ap8!@8XXl0n~z&u;G`^ICf z*(YI!BAuXOPb4F#1~NTj+E-*+BvBB$ivv|?WiiCSFz3iW+?!>umAkOaugM`mkJk4t zpos@ZL}j67q{4lC#HUw_7(hHA(Vr0?BRa%cR1KPOa?c-s%3Z_sog#+m?PEyDG$iwGvQJ1~=LhIoPzc4#37okKSk?* z%G-aZ{@?NbSNE^H$LlNay@-4N>8)WxKUrU2^ZWnKH}MkRm7o8KhOYac>il=h{-5F^ zeCYeXOZWe;_rKSU{*ydI^%MI2?_gNx@5*@p@5=w~{@>yH@78C%(D&cr`@eag{Qcjg zuW6Hy|LU#l{-6BRJpG@f`Tqu5Z1-RBQR4_ro+ldP++}Hz?8-s#_Y~gZgiU*d%|6E7 z%WW~N2BYwV1{MQho$(Flr+A4IFuU^rOeXHs0hsqhm@E@#mO4utAQm(LE?-f$mgAO( zMcLxVZBS=?c9iE|CYI?cV}W}M-u9LbdCI4Kj7eZ;fmLx*&#*?56NHJz;ZROg6S!lm z3D}fP@HiID6%Al8OfW)xTLWw!+T9)iLxVso!WEEiH4`OAY5~m!z&NlWDIIevpcqAo z6SnU{fjU!EjFgqAp06pYER=+Zs#VwqTnpTmT4MSMLH}q>7wz|i{f(F!DKT+&AU1j6 zQz%S{=`L`#7;nk^wf2RJgqWDMqL?@p{UMb3m^lzrM+jm9-V*2?4a9j9f!MaAp+Hxj zXZvADi*3<729;WL#2z^i?!3KDF2!v%Fs;BVE^1#lB*Q9lsw!>Pibj@_s%Yas2!yBe z@eoV5TpoE#}73|U2 zf35|@?Ni(eA=yi|+s7<)TMe6`bx!f0s0Gy(BDx1}3H6|3fs&wx;^!}+P-WssT-;S= zUN_Rjg*wH!9hFW(mhQUiQ#+%DzF6s@>Jf zkpeu5w{n^GIEh{u7X1QWj_5LNSP?WVY>Z?AEQXyAuWCn0ttvKqhpt)sb(Y7)S@%R$_Nc16yTQ#DFVv5!yuHD`h0TqI zQTAowv%(B(dDtwc#flCqq&mkEKR25aA!j_D*%6&;G_W}1nO?Qx-#lT6(W+BYN+&~2 zN_EO%=nPERN>f~g(MiH-Q)JfVR4AM<4Ux2wrg3|S%xxj20skXR!=^M47b~4lE}V}Y zt+>K8v_Hv+ht=XOpEu>9)d>qt@PO24ZLh`g3eT3TK}qZNf&N|IN0FJZ2O*{k}XsxsHPA)Z2Mpt zc^7TgJvT#kQ5XM%&yGe5cC!^=Y+d(ypVM3=V*|ZH;tBS9B-I+7Ej;?Lw(16u=X>aE z+?CRV;CR*GY_?%-UKM4#&I-%k+wGFoy08A8oXSfV?bq36LD{m;FS5kU$)r>`^3Xad zP8~JKU<0nn*zpDa;3dQp>)gk9>3W#lNNCd%>%75|1>Y)OyE>F(q)ZUwp)?&NyY}~t z%HXh3=*ut7_T=YtQN})It}uKWE=P!~@wqdUj52%=NX*AOh%Dn>Q*3IG=gkn6VJwii z*v*KG+2?biHkM0`PQhKJ(T_tkT0IyKcBVuWQJ&f{MA?_x>NK^(Ra*8&*%L1r6|F6{ zy-}BnE>&3^`=YAubM77Mtcbd_41GVLD!hj+;^xY#sD-gc-KfgHP`>UvuXQqv?r=cz zL~+q~l$VDr4`*@M<7EuiC+( zvltg^fH8R8hGF0{yd}^(7Q~@8gvSgwXb7$Gc_|cVDCIN&ca@wRQ6?_b03FK#lU)ge z?9p&x>j?{6$cO2}%dfUKR+Ze}S@H@p~H0Y3MXp=dE>|S4UbpJL4=F(YOxBo1e}ftj=eh2d(p+$E^LG z-&*_6TaZtAI>0Ai5Fu>FVy$?{YHz9reh&?WHY~**7e05sFhD)afMAV3Lq#WiL=w?U(Jc%WUG-0qaE0gH+ixekawv+= z44=vX5gmx$)dRP7hxRVj2?`PoV=dkSp#^Jz`xEXJkNI)c z^NPJiM)@2!gkdxTF80`)@o8bqz)z7tnG2&n4s44dH7Vu92mmp8qJjFNvb7e_`oXZZ z6b(*aqy&_PtrpN30L&b!fgZLfAl((HIk8gVHTT0?#+ajeC-Kw#Ga@K&738)94<;VY};kxLt zjQx?q;O@5YP%ssT{Q{7f>1b;k7=F%GsKwW#e^?%UzzQSS@PPIFEJz+9+3}1uimC50 zPCC)sS(~`W<1-=@cMJ#D*1-DBEX5EGFJQ>V(UqYbp)&9pSqthUAhtcKoAHiq4w_H@ zrlB$c6;%UDHvgVESf8J(;cl?ZnI{a0o}a|vGK@Mk!01XB0pOqpVlcgF+k^zVnIiRw zo5IpSVSynVb!%aHYaSjYpRY;Z9;Se_!m2oCX2Jdnzj2DR7oSaP0o@CL zSA#(JYaq?94?tJd0@?zAOB#s$KC!I37@CUQ+1wGL`PEq96O7neSn57)82`Xqx?+qf z-jcQVh*(lT5Sbmsq?I=jnBr<-N(Yw3i*?H#cC?%psqLf)Kuv1_y#|1vo(Un}bLxY` zNM0R6BesSs8EW!=6gR7dsR~$bd{$$EIO^S&Gn)fzu@?ftr^2Ge5x}kHwXh5ThDpz9 zED*<`#tHIBbXp&{A#sICx2zbqt`5bdT;oFEnXyc}M)pj;R&KHWu$8Xy&#l(W+k|Vh zmf^m%)mtng@lQY33^!@5CHQPn13d@4r-9h_0+4r~C*o^VGQR)Vx?%@WzqZ5r>rQ@o zcbE0&UHnqE+q!nQB-Wu?*FBq_&5r;e&JYOr3WThU1v1~N8&`_rYeK23A^d*OUj3pL z6vRE@@sEzPp4iS0DJeV*)7gr9@fjbACzh>v7Z}o4QbhA|w17UVuzvIjdH(tnYx$>g z>?i}Y6wv!lAf|Y<9`8d@%TUBIObCAlr1f9YK%*iQH`)be0^}g?a2piAY@p}q(FXfC}eur!x(Oe2e0ud1F1z|{}>Qm z+^VJcpbbD_hEt@WD8sp^+^!Y}4L-s!y&Y(p&v$cf#Mc*(+E&aJ9N5?KT5{1c3l%UoXMqZ;!EuabjRGrp9rC57GC_)uSqdG-_A=Kzv158Tr zu``Cz>#PQBZ(Ag%6i5sRFpPFaw;Et{XfpwD<0TFBOBjGC3@t&7c1HJFK>q?ji(fU+ za}EH}F=(J?0Mw%vkQV?S1c7>36njk+d(YytXDy(E0J#4*P3da3iR@`03|PiZwSb2H zZWx39)Ic|c2?6gH?F<7)s~@30saCQ(Gsv!KR{Q|+(Lv^y=B5{Rey zLjA(i58E$3jOkMXW(TrIM%d@f6JS5%nAxE0SuOR!rl0AtfQs!+?z z@!6*a*g~l5O8~ecG|kabVLA%_S8%P zVU#n(FBsr6)Me}g$mWI`>^V(K3;tz-*Pz9Lc10tL@h9GrmW8y)paxn6pu|w1Im`^f z6YBIv<9a48R0?z`Geh*ETwYmyU)S%g_&y%tFR%Npc;a($?UmOT=V$d2*M51Oo$|>$ z;u_&S>mPaQ+6TmSKwfX2m@MHZ%ImXVo!BJGF@s@!YwlS-uwslyV9)C(Mn%i|+48#8 zgO9%=%JbxP!w$(^#C3+e9{BTtcg1yyyiWRYL{D+e^ab#hTy^XF;<{K~AH9FEyv~u= z)=jTIEXpz0Wc}4w)h!X%g@$oA_%e9GSKPmQ+wiwhZ=1y$*Pyq}YLA=V8>@wJ5B0X$ z!{gfawmBl>uEUSI)`@$hx6N5EZbolgcy!#%-nNK_akF~cB4gtE_qIhfiA(Bjs}mbH zx3{fs)3`akZS|VR&FgKe-y&{)Z(DSHt@N2DpMWPS*5gQ0dt$gyx?aRW2HT`&yvu@UhR)B@h^fv%3B@|5Lrmq1&Wp@Df znwxhWYS6|1bl5)YJMysXJNxn<_~or1?B~Uo4M*)i9~0g`3U!gs#)o*F`pLfQSPj?z zqN1;L@doM*38gP0{f0d(#<`xF>8r_fXi%^TK>rK{Qo5*jlf^iLcTHWaIA#Ctln|cv zS*eSAssnZH)7}Njp`j?1_@eOC`{Q^^z&OUH6rT=H-UryQ8ej}1Uj;x(Zw>SmVCX(I z%x1t0uLbiv>bLEqU^w&d+HJ%Z#^uF0Igw8(0}B_dJ;3fDFzv4&t#1By{ej^H>)uH`sz%s9| zmc%ft0@6{?R#Z+4C9f3O@)qpxNw`vxXD{2={A$Nq4Kh8FHB6k!Z&~SM{4bspQ)d@q z@ZiLWLf7F8W(&s18kFc=+JHveL7>xpfv|H_GEPi)y!4Qxp^@;_49DXS^UH}@j_r>) zVDM}H?U*;4U%09vE#k}S=v_DJV<1TnCDoV1V_V!++5a2ro48QJV{qTrKtxnnGoiBV zEXIqXAAV197f$Ef==0flKe)%x665^A;=;%w)+g;9EwLlAcom6vrw|a=FKA`_V5Nv; z;fiR-#LOkWJ@~wZr17Hh?O%3}_>G+L@`M^ivAl)G&kl|sG4G_yT`9nQ->n)y0tVm- zVrOX3PhroA#)V$Qh+7~x4dqo;TBB_Luo(Ega;e!`d-S%=wi@9}0Z5tjneieykj%+L zl?7PBTobp^0xV-th*rG0O^x()?icFAAhjDMd%nOQyrei8_&kXgxbUc+)NSuD75He) z?nC9#p_&!W>Hz>`jMP9q!U05Qbqy+$QUyM53k6a({s2H4XTkOcBakk<8MXMDvC6S# z6;15GD#x?y9Eh5?t#kbRI=?Jj@7VVSzdZV$W6x&Rd2@?n%~oNLk*^#nQ(Ui*&W*<3 z0tm^%C-@u_%7Suky+D36{F!X-g~jCugba7LUa!$WtOnw(qKsV1}a8 z9^?or_YCnMeZHO}_ErEm6V5=Q7aGz&gpdlosNq@w^rbjmwdU}>_jAXJFQnq074lD3 zy;4*D4tT_|#H4~4yWy0LJQ5d;%FdRJn$yA(Bb!79CC%(?*E68iqfj^L3ame%X0MR; z%q))+KiS*Hje|N!N%&x3RvtIl8ddJP6PPOkA=pFx?NMOptvw3he`?X%A{ad~8`Hou>{s z&H>0B3MBTc)8VNoz!PoaLPY_=-IJDf?5B*i6s%!?-4fC@m9+)OUwL|z;o1dGcFk1W z$nib2cU}O(KH8e0{>3fdzm-JV;3?TmxBSTvNo4{0ijFBbR3oN{S>&QSV3g%N=&(N+ z?fMmz3TA0)DyY-_@gnMR-!@-#WKE5C?&f71{6=4($X6PqquN3~M4wdUu0_Cn|D3_t^Dx@GraCdED6-+SSwm^elLfe+m!@7}>pDP>Zj#FNV!oMN8YcD(unK{IYL# z*nwC0<*_wkJJ(>^1&DY91H?I?*I@xQyePOqx^|a?069`sXGGw34kwO(v%XJ(WAlX z*n#4jPz&gH08Cw_f&Q)Yc`X$s3xM)!0X+tQC)a48_7R}OS+ou~tN_Zd1+;jr#pt(A z164^0!XAS|y$xVugaqyC{*~;y^oGTl^_~WN7NbHaR2ZPVHHgu%yny=a-`6lb>;MWC zpc6p8T0j#wTa4i!XrR}v3MgL5A{;=4wSe*g&~S?eTF7)BDe2jC1b`;i0@?i{fJ15A4VJpfAFu3138ZTQyDE9+|(M&e8(#fAzDH9llYjp7>k7`N^L zrt5cVZ178CEt#bbjSZi`61oOi4_L%+x}ZoHi0a+_fMduH=-n@(cQ<%!Hj3#Yet6pX z(lbtU-Cv$@9)HeR&q%nq#5s4V6Wx2pGUqqT_~rET&Zn2N&fCkKdsaGamV}CzoWH-s zqVHdJR<7okjcc6WuHl!b*E$!hb0Vew`Ww!}@3C_EX6MGuESmm-bM01sS@W@T=g0i= z>(H3BLhl0g&ogxb$tuMfknwPuD6<=Tewxf{P=wn31D*Yn<|M)bFtV=$nf3s?w+0v|y|Do3Td9G* zbSNM_&FTQ4`)UDw2!N6*4fG}{(NF5}>3RT_g#xM0^9};}7U7uSh@EBhKz#i=D}2su z+)eoW(eOEQ!fB|H@8P~|{qIts^cb3_&Om>ED0ii=2L<)L@LL$|8pcaL>_&J*OSAjzJ`4d_K0V)|^Ee>D*3@KDR6TWy=xXqEUepUF| zR|L(lB~ve>3Pd+w>|JL42cHW+{d~C7mau4f_`Fp@aCNXCE;>HT-&qp=)3Wd=YXY{) z0WP>5W5&|(7nTz1H%r5-#1~=Ws#Vy#Ird!VWLmF01XP>_6FhK4$xp`=NYfhALR%*u z6XJ|o1-exYOk7-53X8>xfwID7a-ub>GkFEF*cryhiH+&GAh1cIcfxRbjhyI!NL1DwoBUcs4I7hCIW1F zs077U$CFV!tdIZwM~v2?qjdRwz_HldaRJ0QHbsLlYOu`r2?UQp~~ns^=xeG>h4S zB{)#9)ht*aG6)&&R<}^QIOquuAT?|E`6%(5Nq%23W=lL(i4TH-@{9PwpB)yDC@eB@ zRYUL353m|v;4S3`MCDJ~_y8z}!^x$C#Idc0-A$vUNwLH6`77iTjqPs}8L%J2UV1)J zPHS$IY&8bs9mF^LHLExyRN%vL)jV5OMeiCJvW&(KjVz+B+@A064AgdE!TgyzKGlV1 zxS|}_S({WHH}=8iExjwPhP<#@aACK$cG&UES6CRHNZZYVUCnG4-IbT@;h1wtj^>CI z1)U*#QB+4$Wwy+!e036jN-pt5KjfJCvFl zVXgtC=SFHSKXlBI%W2w(#{lfn8ekmhUjxAB=^7}`4j|gFj)HCn(41O8@uRFp?>jV5 z1O`C~rH5D^kTo|HD#Ak3=dZUY(|`Z3O+T1*Brr9#e7)VMz)`<;Pebu@(e|IDL928k zOprUZA5@0O*t|MLKtFH)-C~Izk-;9rp4174ez}_COtr`G7MPGO)Hbe@1b2eXo!TtL zBO?t?^b!b&M*81M7^SsI<;}+4373q!DwHZVqeAQgzE3DKTEMHrdNcC6^5A^7`T)y$Ff6cEs-Kb}_8! z-Z<+n7VKCE`^3%it}|LYNUPK^3PESu`*T^gCV zP($1R4spVyf&qw5QFG+U!Y_7Vm9!Hc$}wECJXYg1yj3UV{sfw$?xPsfjV>xU3XVf_ zgBfqe)fjjR{R*G!7ofUof<}j_Qz)`*AnU4-NzLkX|^Kj zUWu#*TXaPifT&mA->{VnWZg9~;fDq?XF2bM11lY9UmMB`pS*YR*LGs=*G4oN_Yf%z zoP6lt^m%PSh;_#GY>~tHE^?jtRYG@2;y^2b!=uP{iaZM9i1s*3dA%2=+Z?7F+{*gv z*Ac4@3ez~0jXt69}Kx~zIv6h!W7Rw)XiS#fXN z_}-VI8p^L`?@M)J#MfDM?eK&3nrL@d`$@E}`|L&uer$t5R`%D2#6hHd-W5LzD}E@q z#yEu3_+jw?EEOa6BE_a6!blL`5wVDWR0hmgPQNh3ql;%jN}v2iRQ?HszG9;8b}g;y z)DPXq^8ogEXtxtPV?F@Doj8Tv(p>J&K_%nZ_YtdplCcI_QoZ}-_zw|}{v>p$H$J|j z4>8e$I98yHCqjvc73E?OSU6d8_Msh|QHk0i_yF`|DA1J$GrS+_5Q58%1FJo{Hbxo} zjd46rUB!3TF;E?MzwRrwwh2rG<<21nS8~Vg;xrWvU&FzR=aWS!S!K2Uy$wu0V>h;1 z9l{32b@-!z&VcL)69_*4JIBOrbVDTNsbY%V(NTsk(xL11uR;`kT0`56oTs5pL#Ano z-tJV{YWhi;#4-yS6RTKZ(YRtu|@r+KyVY%{G+H#1*%0GC~I+xbzhV7P1!|>>= zeFN?Z5!UunV|q9YYflG`C8&8kRE=W^9EjMI^MFhCJb1=RC3pt#)fChGsVPQ%oV01!pkP60gtpyjoI!e6x-@4cph8tC&6wAD`o z&tw_}l2$MK8W!R(j)TDfbSeCSEqgFyLWC`#4j?%0L<%p01M z_ibw7K)b<*0JfqA7?)MDw^@yX9UACuz%T)#NzDb!%1{__V8vJnL|M%}e`z(A0iiR0 z!uML_Fv_2U1HyQ|KQXKqEu^FXXkcEW*Ps8L{w^~YKR<_`7vMlO;pFu{({bV)VV=Y6 z%E$K%oeiKu?2ap*K@Ub^$*v>2&=q#8HWAzEncr40WD)zLtgAUB@ky_+BnX()DdUj5NF4SZG*^(A%tLJOm>>;%owG|p;%_C^ub{BK<%Ya zWfd}poyoc~P4i}`vVyY~Jo%2pFzPrR^-WYYEOmw;&X=zM`wQ1)`NBC#ouh2a>WPCW za(K#6c?+DKlUHfCFAIyZmp7PZ3A=V*9h|swOXVeJRAsq6%2u(gt`T>Y1(m8Ia9tH_ zOSJ>gBDwgy!-&T*K=zNX*d5K`h~pJsj6}{^#Nh($5zUknC5zjU)6N3&LkHtR}16VcctxHzM+`WP(s?I}NeAbz|uI1c%- zdYpi|TANhlOV?GOoYP#NoKtsSg%Q`xvLo-TI5#KOa4^gEcbXggKAN`~&Aavr`;5lH zS&DVzHN)CfX-wyAa`|W!~3xj{56OPu5+c_V1OT$ z<&U=DpbIrr$8#L-6Wb+Q9*pb7q3u>2Vdhc z0prh%2z>D#Z+vc`AiqbvztEkDgWvHxk@NBVjSY?2AMf&q@a@U!6K^z_))`pzxj3z{KctZb6Dq59Z`=(y z3(jWWjnm(9FX1$}Fm%tNO5~|<>WL##9L!i}X;b5>C`(17FqnNpWxaikoC%fn_hEBv zbX?<#yeeD6r48abqJDUcsNZB+jI19a>c_HX9PQ+aUZ7p(oiLFhTVW;>uNa@=orklz zg@CUx#xdyN_JqO6LM0e;a8H>{3)Rt|gW0SJHJiF3^SBMSmEGL>mv+Meb>p()hd6&z zb7*5Qf(&eUqNgRB=zfOtj6KQHH??5M9{(t4NLGz6fL7x(-0|{YU3LEe8#*3d5q7C4?{P~QI@t}dG969_?u|YqhI1rx$qmed$(9z)ZWKhwE-*HH) zSZc4gVaC2V8~SsVby=cx+n4SO+c6eqa26TKOFgQbdsAF@WZzq#^4 zo$`8A@s38e?RjU<)LYoyh%TQMSC@DiEE^M5^-@~d*;mf4In$`lN2>;%Jhk@h$uo^s z^xC;A>RivNlV@V~#5LQR_sh8^yW{F^$@}?YY_rN=nq4@7A@O2){fF#L+i!`w*ym?Q zv#6hM{^i8g>rO80Z(LK}Q4$Q>-pIMF+o|xDAIH`CDDPxd>yH{mY|TA=>f|riCY*`i zo`3d?{ko`1Jharl)l*i8D!VXWB=d%Iv278zWg>*ze}xgIj&%K=-9wpiQNi=Gov z)(ReYXjt?34|wv7wF%2%dmK)$Qnt4QMz%K8_G)Fl@Bd5NvzIpbD^vS0()nyTPL--* zFy)K>;tmXGci+Sx`-7#wHz2v!;J;%*_KA&y_HyE{?PUjqYi)M6GS0R$?_8CAS=Tyy zVK`xvE`=|@mIf2CgGREQU+eTaW2+Z+=H|+?(NULfZ@711JEKwgg1EW_j9KP_o!n7& z?v-2(`(P2I@@GL;;ubW=X+M2I(rrDw$z@l?wfyiQ zdoyVsw&wXKe!kEG2IGit|6$aHJ|}D~qfXp>@|V`@PAwd2Tq_M`XQQwkjhr8MI~{)A z_P9FR@=jH?-_|JNquevFnClbHw%w6`?yUWW+F1Z?EBSjIMyJnUD;`^ITe*>jfS03V zg5eloZyVnEu+h0uLW8ohk3;Q6+ln6Emcmxnh1$y99Nv}yk#bWjLQN%jR2xU`sYS1B zVO$XWMLdk$SYQfyK0|n_`y-ss(iL>Qx1QLJp>|^$U|NQ^*T(W!beb1aZ zGjrz5nVB;%<2w8=Yv3PEd+0;(WlO0F1xAZYjQE?#cPNhShmwMj>vAv`h8?#tf z03^h=PcJrC;4kXczkB85w`j4+zqb&i%xrobiL(5Mn^L3ja=Yf@QnF|wSZ*q&DtR9k z6NGM1RW=Ug{T>COG?<#gDCk_Psm0tBW6;eS&(+xmWLz>fIomFogS?cL z$fz=nB=$9~7q4RdN~x(kjlSy?S6D0>j>^IQW=QR2z0@jMr}z*U7h*f57n^$~`Ud@Y zlnmB{Z_LWa2r{j%3a7gD;ib;!sK;bOQ2aGpwHVwF3Ep4*#ec}x%zLkLC6~sazu-n8 zE*9{&x?NUi9LnNW-ibE^SALP%_`$7Lgmo;-zz+;!=pLflT){SAgTmvHBG@s0$KZE! zjJYXF-H#}xEyn#(rhWKwLERT)#01wlM_Y^PgJ7jJE&MNb$b*REU55-(L;G^u)bFUF zu@UPyhuw+#C=@^&mlyN-NgLhQT7_2bshxMC@mh>=kMqL$bJ$_ua;3B9Jzu&<2Vn_v z{)~VraAPI=qITG1r8lhX4RvpnX;1%iYKJ{B#!np=&YOZ0RrZ=WbW>(vv-k=Ie8QUo zE-h+{+|t_%Y!2NM&^F*)lq3;@?6u8~Yp(C3bXt*Uj#8iLR(0Wp3){|j4*cY~$TMeO zym01x=cg^7Ex6d)W&4@>P{kT$dZrJ5r5j%9!C&e2H0DBEVw8`g)Q_BhoNkTZ=mSIo z5Z#oXF=jqGTVt?QI}#yb!M` za7BV1HUUIhKu#xa1?Y7>NVwE$0Xb>HXpc?ubU@DNbM~IVyY3BS>oN_Q_{}Q5I@izu zqla9A(n0zRsJ@}6D)K!+H7PGzOaj-2m9>1mpTuF|w6enkN2?JY@ii&_ei9XAXyi*6 zs6!+F@U^FvA6EF#|+qnM~;gfZp-~IRV&!1*tq=$1DOQi)9-?Z+n5>2OtE8 zNOMpXFeG5gLnuk!UjoIQ9u&zTcM7z21rxnS*J_jd*9X3}o>7ylCF^~w>!Fgcl3R%U6%cz* zPfV0=Gf3STBC}-!isrQf1?n}RcIi><@CX{93)Q|kG8;dHW5VTcVeZ4H5QLT*pn-zW zz9Qa35L#<>Hj$^{{XpwYd9*cL1@|gV~~tO_*K8*ZwVP_<=%%n!Oa+5RK=Ek{!LN zV}Fwxi+JmW2(W&s6T+)^VF_44nAIoY+gt2DBI9TeA0?}okHRCr%Y9;$9hw+}BS4Y6 z>JoIJ5X^hc{#8}ivC#{SlIhZ&hu{ax}IT z%KQJTmK^{0T9Q%SCEG^SeQP?aE#kepZl=KcY)S|{Et`*(C9K3)4NX+YpE+TU8BxkA zFHcq=HP9x0$5{^l717}94jS_I{C=% zF}`NtB$@x4wAXk@y9TUn1#9YN;V-P_OoZ2XNn1vK<#WwDz{Ur9X=l)ogPMV8lbxd& zCGISA4>??GvPiCU9YX4#j__f%=Jcw^_foCNb>u18ztBkzFM3+`YHAc~)%%#qIU4VZ z)CTBN%Od|>FVHdY#gC<21{8f3~F2;itHl zqiAGW(j{7qC^xdusKs#G3gwo})2=6)uYRlbBAWBZ;J8=(B^ymQDUupvQVMYKCJL)? z#1-2P(nBEV^7^TxqC}ZT;0aA(&{DVeh1Dm$$m1;LU`lc8!2^#_isd2~>f8vmM-T#w zt3grf!AOMT{)va%P(1{H8a6vSPP=U}V#?%~R{0!D^t1`6BM047nm0QEr7*WaWVp?^6AdhHOLxS;#)kceju%SWd)Ixirgpdd~Ok3|cO5 z_ZhnMY{zTG{5VRx2EFZm7V@GY1EgewrInu-$-}-P))Zh&G-4rL{}!0{m=85>^k1=$ z!q5a^%HB{`d=^w?px4up~GjJI@0|({#t7= z7Q`77O);kZ-OZtU`=9p-$5;U-tR-?!0W9L^^cG7j9` z+`kgutGxv+7tW7D)P78qN%|pUkmk^q)=UXB1*W%zUW;D=$Ya=ee2Ki$&A4yHUibz3 zpED)1;lcIkE#VV^yVN!r6KyCf)+QPZ*EN<-WhI9JVE8u0*Gm0O2KUz5rYHeB&A!>o z%>L^X1VyhhMy{(e`)4ns!Kx)P+hB~`iF!q)&ev(n+V(c?W(uW=rcp>=WnE_r-~$nk zNC`3|8&|@QfpA2q^4u&-j>4``*Gh~4bP|N))G;VyhU8nIzFV&g+aH-wt!ru~mo9{E zKx1XAu-+M5z|tXy4fUOy8=DFI?Q#q6Y4HuIIV)FJ3&?qCOq< zSyRk!pQ0w4KM6B^9M^iA{bKaz^f`9T^-+#{1dS`t23KUY(udr}B6kDbxl56`>xA5$H>mQUwKV&gc37{D2Ix{HDe@4VDBM^ zAL(<*4mKG9faq~{Up0r`t507B0~r&*ge^M>X!S+U#iwrlJeE4pf$jtj>l1JrwO$?Q z1EYPEYmfkD6IcpT5jSx>>wb>H3Z@lU%nCjw2*V2QQ_beNP%f6UKFmuI)+36h{9UtD z_0qucF6~K^KECez{UWaf8Oa0YzbUc5Y6^@~+csh*JH5@+0YrmgFRP(6oy4Yx z)W}$spgxRb_sA=L3>v*D`aVl+GA2`pwE4!-|9+k0+A#bFg|3pVZeXiBUO_L{BY>91 z=&KS;IN5{E8iVyh5VAC$<;HOu;JSm+&LP-c>^#H5WP+b45l_E<^ZJH`T)1C6>7_&@1I?pb|TxbeiU6bd^Lulms(xh!fOoS zwJr;en54$WhrjZ$i}ykN>>=W)-QhPn;wjAWh70slmlnY!5#g&eMQTZr|Gt+$SD58gp(2!T?tjM-BIFx4Ga$ zfIjsCMF9|yEJ5`q0g}V{j{w@^1?maFuwD{mFaksl6Dk369MJsVUOi|wGe@xrKq`mf z(b*(cZu}OKIm#?!ueN&z8=r5&T3ewU$fD`@_uP>|z|zXVYn>%Insd~Y@%YVh?V4C3 zo3c-xJQlFNvpQ3x*w_uWTplG3CfO(Qip`+w2CA9;FPsnXMw^cM~R3j-F)gJ9ZkybJX zU`A*OE|%#`ECJ(GA%0lH2SJs^sRtPQHTXs!HPz%9`Gu4b4hgyw6BkfkHEOj_jrvm! zyHi_NPqzN@AEzFr_FY-waGImb^8M7yX1B5K-uZErHeQlL)8twX_Ty>y4>c(t;^MqQ z7_I>uXZK66J4y(FMB411@Cc0|bTq&yj;DhbcJ~H1P;YP@UK8ETyP%scH` z0+eC$uR_=yS60#9Q8Hg4@iRiDP^S?Q5i;B`7@3frJ*k#UwAm0#w4t%mp}khpuB$e- z>k2&j_+Sso{xFMNj*ULyv-^DglMg82m#zeW{E&-&*!|KCfBl1$$V<#sJmg{k_M^lS$_h3t~>?w_rUFd3QLdf?Umtzn5^F}*c1nb^QrycCv*|DsahEWdOGap08w zPDnYGe)YvKdS^lFML4G~UFqlk-Isp%cmM8BziE%Dcz=MLSEx4(YbY87DN<$So6YES z7oTX@!I5MOSHT8mwlJHpF|xWwE7Qmh<~|avPGg$ubC5qM3dmj65isUjlk(trsqi!e z*5WuB8RI+P_Ukns+qk&}h+8H|)G|{YkDVL^Hc3r>56}TG&@upSyk3H4`Up_C039U( zc!3-MJSjnJUQNJgzKYU123V69>^(q!#`&zg$9UW%&!ChX{s2_77s@cvq>Py)QLk9) zxV0}qKLYf*7ib;;y(hasz5*n>jGqAd!UM$j(d?Q5$M#GCBlSOS_4~h4rl41`mX~$} zmzQd}cBLJ?pF!`S2R&Lx`VS}_yGcjw`FUTQB}M2cpIN-1xMWdrCSNNgsLA5}1=POu zqW0iyld|V#nWfFB6kHIb4@u^TL!f-+g*pyIQIEd$P6NTH=F8Ih9k8#xV6y;O<%aF5mas^XH$+EJzVU)> z2E=EcE48xD1S6+CIci8Grvdxc3)UHs$!^%Wt}<`3(j%;ba>NUk56DAqm@%$B>kCNe9q7me2? zS-KZM?FTQOUI(S~dTPe|zQ`m~1JtHhEOFYW=a!Vhq>$8Pp~EAj{OCn(bgoIMx^ zecLQpkYZ^A=qE2wBLFWikf0EQs3#KiCqT!&K(7>;6my9L1)1qYH0n7+!79n_FQ86% zp}GJuwN#=s-+I1aUS{fVfPVG@6$3B>ivhW2th4|`^;jC}#+?mvlAp|pVYp79d@4S(D3(ur$mrVf(fCIG87`(yts zr#eG+xXU$5C{SJf{jfM{P2!*=Al+|J8}PX^oQ)4KPh>ActtEQj#dW$&HJUR&hL+i5 zRXyh-zu(NEWLn{vAgv;|klB@#&b+zb%p&d`#S2Ro*vBv)uS1}Sa@?bIPCWU>A?od^ zUQ?B(9G$Lx>muby%gdWZLS^rQR<9Rk?sL-`%OjK#F`@-ruRmYPBA*BsB8SpSm)N2? zUs6B8?~f|Z!;%*;GmXhw;*r0twV{_Ne|%+-E`LaS^fynoP$kYSwC64uTUqL)WvLWi z0L)R^yFy;JQQG-9kaT?B;_=0koq2SB%hJkEs9;M;DvTw(kF;v0WR$<0f7U$B! zPTrh728m+C?OSeAN^tS^{&tM|VvMlerAoSjCV!nArqJ+G%pBhj)RGE0b1c1PJAMw@ z_Dc|qO2xN|(|j*RY&9d^NLwk;0OR!p*^a+jkgBMZjO->5b=MMP1ZaXD#A4Lc0Wb(F zr1ddsKKwnX^;8foDUfs52FZamYfK<^y`Gp5#;qVVq)PIzPY8p~bd#Fa4CD;;+(z;h2u&|w0RN|zS0A3$_wJbie_OIg|j!27Eu=!gW#{uLYXa4dx$#Ld?40IB+~ zgdMv|bqWA-ng^0LfUgH;M76{nj}iOhWVeGrLCSP5P+*No=~*v9zY>V53@J0JXQ+kB z3@^|~0Iq3}pi=~*BU)qucK~Rn7icB`qaKo=voa;gUPpjtd4c8v(EAYyY9Wx`Bn$@V zMh_4d;Z1;?SSw*|LWI=a$BT@G0C|%KlA>{{PneX0FG$?w7{sHZ6*RKMLIIlX1!@K0 z@{1B=hy{p57$;H+1L$TiP|S9davB$J-(~_)EtIxyI6!l}K)x>_TI)L!YG z-j?e`S7D=#-HzNby6?>Dw6Q2VY&MvQreG zI0kHG3${XT6>b%%S$tM2T{^YGp<+xl(`L0qAMAEFCR$diCS#)SO0#NA^k3;?HYNtF zwD=ek16TT5jEO-j{d|py9aj4L8529M4DdH52Codn+-S(kpg?0{=*kX3#>B9d9Xl8k z!&e4(G$ux@3<)+SMy?DEF(yW>3=1_TMz0JHGbYBYj0iU-#;%NvFeb*WjEXcSc3Bx6 zWlZe4BGJ^}6oWHcO|iyAH89Z_MXL#0ugn6^@V3OMi!SwpX0_7z}fN_Q*;?9p6bXy_SboSm3xtY5Dr1t$81CU%N!4Ob3?btdY` ziJez=i59DB>I~VIqYG0Ya;lrO6EaKbJsuT8OTt{O$px{^tt-CR~)DJYYyK$==Zl%qcI- zJiPxxtHhkeB1nD~nd}g{0d?97bry)C%K}Bl<%vtD-Xx=&8?5Zi2&IidJ48Dr(;Io@0giIe`5 zY$Sl6AY(bsu09ZMoAf&neT|IsO$%l zfx6&@>JhCfPF!3N-N=bXAX%`z0BX^Lgk-k?(l-X&d&F8i^~TFW?#< zA!Q>u1BtqL3l}sb)!`^#Q2O3v?NPshwp~w;BQR#SDxrpS}S7=>;kSz}!WGo)yD? zx%RXlFn@Vr;_&|Mi4qgzNA3wqNwP=Ny?=Y4csKnJFx`_R?ue=0GmiQ-fL->0kw<7a z07sG~XeI&^adTGMIRk+D#|!mcFIBn2CQ+J?ShOq^<3NC}c!Aad@KCA*g;)ThdSOLf zA^UO=Kv2=_1K{yA2}(Bzkd!*@tv7gq3<&(#sh)X=4YiG_rU(F4UL z*Z|BH1dQZWFxk?;!%9fl5Wq|xFk1CJe1NJP_5imZdcmAk_(F4uIbf$zEmqsPZEKvUq{I0dRPz z1ckVc2bW?W36!q~iVN@zF!jSE&d(@Tf=i{C0hpf$jFyiV4_B2LV+Dx0TT;8RT@^3{ z?M?)25i7Q(CKv@O{$5l{LE)P5GU+4Ggr3IjXrKbTP!oYTFhQbPd@ut|6-9Q8V*m>D z0{sNQjENGokEX2&B*#2s0b;&3lnbxOl*fq z&Gw_9g48KU)Ht9z>QO>drvNkiruKc{^Dl&au??dg7#{0*6<-E1@q=<@9lsV7gFPtH zl7Qmbs`8&~>bDwQ0i{;H9#XY4gnCp1`Hpy_vGnk(=H|4lmE%D$L{Ctt`)ZKuugR=k zHVT*=MqdwDs0WO+)l>jFV=)Bhew2w03@05T2Us@%73PIX%~O@HN(730R~L62eah`a z8#{U86pA{A&~TpTYE1&Qa4%{XK`}im*rN|Yaiy+GI-59YpC^PFAKyv>xqe4eg&i&*GK_PwE#x#S5_8U%F;y- zV8*oTb~R4`8hZp+-|sZX1@|OsdzL{>#C;~PKqa>QB{7!#W{c4C=69u zA87TG)e98(kgC++;-ELo0wilg9zfmnAZZ~2vg}cCZiDUZu##H9=f{^qUwD~#-}`dt z;a5nIEw6;`ewF8@>iH_3hylTW_$;4f4NY5#*QX+cx)&+**(jNN*h1YqX#pu!2XNi> zICfaeI3Th%kyPD>wLJWB=)sReDFjiV$Z9t~#B(HKvj4sX#1izxSR}92n^ol?F3$Q? zvj_r76B*PMBLbh&Lk|-2`5BPYuYreaAfE+2nRH;4eIMHLBT3`oR4f0^hW z{3rC!6=5a=x`Mm5KGh4vA(whroXdyr4m)!nyj2;v&$Bp@Vm*;uWTLks(L{ZsqHwk& z$@w2j$=JX0V318_d(J!yLas8BX#KeQNBQuI_rNmd_1k9e4BlYW%Bb$i(9 z?M!a|qE=r%tOsmZE9(Wa*;1h*E{jv#a)m-nqc)VGn~*h_DP9eOK_w4Zd@NBCCr?RApa-5{2xC&m_jgRuK#4f6us2*9IB0z^jPgt)ub zQmd~h(~8R}01(YXV)P-XNnNxR)P{Re+XhM-k|i~mG(*z<9!$>30(&tUqH z_4VfKIZ(>bQxYmKD&4Fc!sV&*o;@Gld_J6%jUp;Ylgm(*4Qv}Ij`E;LzME5^wR%42 zjjb*24>Wa9Z7t!yJ`#a`>7~aa{(LL~WE&rkIJObf85vhLM(o{2cYfX$@xZ$g9gt#& zt$*KAg+WQJoq8qud{rIsRRep5#X?6VM*}SFmw0RkN2B!|2_^hyj#=59E99l_^Q~{R zlMa^k?+w7l=wWQy^hW@SYLO9V?V=mO1YT0sej0IU4{^KYvxv1#5il`!G)27rV}!+! z@$HWh+fUG=FHc0gd6K@|eLCXo^2jJ-#>)F5zqvmWS!=yN^7wlCa`%SFy<6yu;=lFE zNn}=ce8{)oM_l@z@QRv2hjCCR{hCdFep=mFt7sG=!b0S`|=&& zc&t8K>|nmTk)>m}c(cFX43J)Hegsga7wB&Qv<3-kQw2!29t2=i#(9Bm2VlcP5_B(t zh&`!aJ^|=jFVO1%ggz!gqu~1U%Bk)0Ce9VL7i0rl3HUwKsR`S zMgyR3k|2#hBth978~|vd7pN-$hc-*lQn~I>mepqfP4WVr1E6Ay1UY=kzS9?06Ht>q zP+Wj3fiXTQal>WkP}%o112#nulXey$o!>y)@`!V=`gG)ne?(HvHw0%?$!5OH7d9#t zrnEgi2hpi|qRh&<2IP|8l$4QK`^FrkSaq=yRnrW7<7&++p5-7H? z1r3mUeR#fo-Zm@0;1aEf4yh*=rAGM*uo)hSk?oRHIjrZ z!xNyE<3()(C`~#eS?ESA5J)zVp8?AC0yzM9^@0Rd(qU#KE-CY00Lt?MeF}hYs|2+f zMM^TWzXD|U0;K^Ee@TLN3QTthnY7YLVDh~%bFVTBnJ zqtE}B-g$UU^jB->3uK57Z-SRqET_;*^%Nc!dhpFFWi%2m$GS2OEAkUCsUyw-=J0?~ zhx#A@13OAkkWqkSv7ZO%7Cnd!kuw44jtNTr5c$Xx(QDTU-et4M*}8T~Ib{V4{Af`K z6*GAyN%|LXe}Na}Ye4lnxWGLquZw6nTLL1JJRH1g%m9NLK2<0V>vmgw{_1w|apZ0T_}bK|Ra>(Ht%f1gO9a0F~)MBHuFsi9sj~&wT&*MRfg_ygF35^L>yw zA)>Oe8$q;OPgLYP1q2Tw;sr0b$FWiZt&o7yi=+Zr;Q=J2`U@a~(p?=8M*!J6RaPQ7_I!Rr%)Sjg+e{g6p4-`S@v0d4@}%4muT>>WiEX3IX9e^n`^#Z6JFeF3!&~UOP#k z(s&66@JDosCSu;z*)>9v*ubmM9v1ox{h}*ja+6X}LjS`eer+89IvPwq+ROOY@ zJpeShKu07BR6FSN=JuGDmzbsb(N$dVawaMexKR(4FW0N(8Zr1r2CkZJQJ>~Ye z(rL0-x&pMq1H?P_KLF|Bl&~UrX@xSB!mt8(zXy;yfeb+IERwKOCa7L&HB$9<1Ly%S z(8Bh`l>N4|;(<2cYjF2}<<^h-!sYF9`sx z@&b(k;O)f%gb-&f1fxbI`-L8Wt@eT)0_6TBGOc|i3Ia*R*%P4u>Om}IMh4gydzcN~ zvhhRg8FKAm7D1YB9ff+Su(pwPK2Vv`AqcyoH$?m4I6f^24`{1|8sQn|Q*M3M8<2jt z!K%6st?xQ?D5b+FL44L+iTR=`7AmXyuGkmuqAy$TiT(H<`tsbpv3u^NFF)TG`_c;f z(zY`8xmEN>WK zw;=ShIOX%&lTVTXNdZG?;}Z7AC@ge{0l{khfA2b*8m-u;#2=Tjy+q)Xvn<0L0CcoXLYW2$LAzQ2X~ zFi%cId1R=4c}n`Se+uOuu!cG-8a$BcL7&5GVqd6^g{yK)ZEQ;;eZj2V8bOEGv58c& z`d*|j-uIID7faO;ml^bEr;Vvs~iA6L{4 zN)=>zt?k>*5L}-_&xtI(%Y90SaL?*jZ;<;+kYkdpptu7K^gchXq_SH!euy@kMEm@x z&oo<)nc3c6)$9xZK}ht5pC68)o^F_CEiAL=50Cec?>z#)QQbnqKU|UjJ1x5zmgiV# z)%Y{2hs!@0Je7R@j^bi_867x)?=0XV&3`Umy&paWOdxmf+h-{LR+2!Zh?S`6#*Ja! zvFE!#&UQmIna>K^a6+q+I32S;(~XETv&kn6KGZNZz0C}>ZMu=7#n1@^KK{*N7WQ^v zbKv4OxyN1v?Yq?-w682NNclPm4F)ywotLwoB-Myb+0zS4DxG;_?YWqQ;WBo$g=mXA z>NK_H06Jh`EL56Y8^uLF03tu67rE%+AAQ0{`R_WZUE55;zbZS>!GP83HG!};O4j=* zl^cY$!Il+MNk8;K>@Oe0(mcAciWU}7BcsndAH;tBK`a=-cUD74)Vo@@Jw|HCo}Z7? z0B~?4xA$ddfH)jVok*E!+zns&TE-*t<*p;X<19}Hk%Y#rFU_E~TJ9{Vuu%XUb{ZAR zA3F$VJu-GR^+(wLU_;%ov3Kad)NZM_SB@TMbz`LO36ak zCDAWlDL>IyN|(|@@QfB7>P|>B5_ZHGTr8uRE*Atx-D9{mc$_5uyWYNFuGSTfR#d=UFviiBm}Kz?ZVAx=~>q3q&ajbiA!3H)MS`L4Y+vT z+mRyod!sDTgZ}UYFfjwDW}3BNq?Ce-LF)jeE>CiSyebb#F4$fcfZj7|bpULZp!#;{ z^#JH$38F2GPY!RPVMiWjAXC|aBW0=B49j+8@u0*JVe95X(3baC|I_(z;xW(eenM&7)_)IEvG%gElCm*c zX+_NlUG`yYzFOuTUc!@Zlkz=bP2aVC|TxqRj* zD4<=jis2zT0bnei#N#53Po_cf?B-NbMk3`+O`F<&Y!CeMsaii`Qwz zc}{!TXnHVVz)H3dZ;@73Ebc3#iEeYR(1DZzM?o$ks0WQTIQpiB zUQWCH=Gi1ANBJ~y%nj}OKm*2R@fx)yy2gOIY3%al6I3^G=vldaic_ngDR&WyqlS1{ z{q=?3R6cZ0%S^n2C7Mc&Me`d&NqiaiS0M2--|2uZU6Sjx^ZnWgJVX(GX2;jntCjH$ zjp~wk^^SOTS-jz?DIuFi^s=0K6exbYP*!E1KBEWG|6}^3(x0&d+5dytk8$kBIQFCe zps{$;f6zEQ={s)RxU9;40O1Gz;7Pwe{pm@+KG*c2{|6DZetieiYh(JbALBCdqko@1 zeeq=MAR;g>ojn;hb`1R(JC0rh<*^E#g@pb4Yyb10gS6zFd8D+(*+(e#5r^J*kxD%+ zVSZNLT&&%$4>Vg1CbRX$I1<|PgSQW*%3g`qJ_=59)C+?D=}QldGp8J-VlOIp*q2t6 zIr8uv52Mk=Ao?=ZsSd+G4<%!V-ms>p^`U#cI$irH^%VBJ0()=#rF;3cn=eq?MAa!P zaiAWfK(_{mJWd7bC@n;%wA4|m<>9{){8v&=sXx#$xI2|+ZedwTkv*$-R$dCz6|2`j z#q?`wp;lZ`QgjP?DX_fZJQ+OpanC&WCsn0<2ijW6;;i0DfF(m$jS8`J_9s^6O$azo ztdwF$pktvOB)yLR!Exj3nBwh2Mi;Y{dH?oad^V8W=xQI%D!nZ!$Vx*#|fU-&ztYZp4ucwlMyVONuiVRIA zAD86~pKKbH)v-L}Q63iKvFM`@>+)c7otG5t68Nr2ii zZ%*zG>zfWB+7u_h;iu6D|CxN7!_o=g+s?5oC^TF7mV78fY=|BcEBca~jMD$(p-o;H`nBhZ=QNhxnauELhCN0n;s+RPG#7ZAaNC2l**F_&Be7e0Ntxzjh zv}OYTIN}4aVQ!Wwq)d%nENp2u`7BLqVkM-w36H&?!L(#$mpjlrDTW z@dOpCp)xAk;~@2oo*XX=&essUaaxeWrX_mBKPyqEn@1W9S2-?FyrFDZioI(8aoKqF z+4O+fc=Sc3A7~deG-;6K&tx$WPrepuGKtQhCNhiO=goX#_iX%VKel48ZbNLp4&c$? zi`ag1#e0q2OnGav(*U97;y<%w12q=}+F`$M&S>mS%#cxqNJw`Y)lpsPy-7E09K)Iw zf}7B9pRYo4s2S54Am-@pclnVL{HN&IJSxNdVisy=aRt89{n)v^viW^EJm>c>ZnW;^ z_gUbP@p*V(b%c^?9B9qFmn;U?C_o@d7oQlp@7P8K()#wfbnG3zle%5oFZypPSKN0(&F9g*32S>T zr&{eOpUjdV{DfU&^NFs8Q`BWC;kpbsLD zLUI9WIyPAcnA4328ts#AH2DNr(v7NbhjgRaKfpKL=o5&qmJayOHyHo4qfnHM{7vBF*qLILK5&_XixkXmK5NhZVc~* z7b9%=9huf{$ciAPByIX!xEGrW9|Yg)uX40hAN~$MPu#YR|3!dhcD}g$jlWQ0w5boL zu`ykN#;$ZA8Q{YsEsj$!M__hVr!^>j^dXjYmLtZomSe^-Ze4_Ca@?R%^`j9F2pGca z+0QWgdBiM#hSE=Tob5tOYQwL^^aw7dY>Ln^+1@q|30%%^1hWm2IG(m7K#@^?X?&;Qre@@uk*E;{m~Y&=bkhz=2i zvjzgg(X}3}e>k3gqi_9eP^u;ywSSPGN3IijY80zHWPUOLTPr(_FD8e4Mw$5-*LVcr zL@1&qwn~hX@YSAYo1{&`;CUR~rcpHgWLE1qXNgw9zm6}iu;npl#ms5r-QUo5_z2x* zFD6e0J#>9@KSZ>fLffRuq8xjf4XZ`%Hg-m!O&nY`x}*fUx7da;03s{drr8TJ7nj;5 zYNa;lW!r@5lPB4bywf(?Q9x{z*>A0cwZ!X2Ll@O<(PmCU<(eWSu|_O5k&+mLOg|wd z!A6<@9W!Y|0BD#hK-KL)V*y$xK$gb?4TGmR^ZlmuO~LK*ijq&M!ecz?afOx;!N$B+QY5_S7-rl>utnZ6#4 z30=2lM^d+;|6z@(zMbU80klCRRu7kv$3cN;c@4ba8j;Q#)`D3on++bRz(Jg2Kl$rY^gKj7uXbW9_AB^11dGl1s*m+-Ai5 zu->tS_N@5J^w1UGR&j3!5)Y3!#u9L+;ObAvn}7o?C+CrZWGzegzBU7iUCRBJ1fe{X z0GS}!4zHGfOxek^m%<74@7a;hH7i~ULNQ)7J808Npr8)Rbq=>&S%uZJOY*@9ypH@O zkmCRl`=tOWdqgl;yT|at9;!T#?lZix54%}2uqG4KubS+1JO~oW7SLY;L#4AQL2d*$>Fc+9G{aAB(M<|I_$9VYeFqo{ zY)IKh4OC#z*o7rjV7Qk*_N+$PE-7>1>?Y0Wnl$|PhVaP(*bXH^ogkZ74?NJ0X2@w6Pf;ZnC|IA>xDnvRa1esPzdA z>K(XNB{Z;Gjcck|yJtu9^umim&$q%WhG8$`Qk}@xx{wYG z0giM86`)1PVVqRs?jDG|gliBVo^=$|Qpwaq)9#|~=|XCT$G)~Rb3#)VV+tMDRjW1B zyW%SnQhW3$r2NX7y^_Xm7~xZVdIXWaWHOR1C(F|&B2iZ14*N9xh!yH*UDjN6Hr)l! zM{}tJjJV7;=udp}tp9WHjO+vk#gnm>Qxd~zk`<2wy*M%?__Ig$_EFVhyy zD4Ay0@=A)GXy9nraG%BvwnyuqPcOu2V?DS1+g{s1YK@I=Cu(IB z^pS>F{=54PBZ>0+cC8$4U_25Ul8SGQcHi5I@-!|cQMfF`43zA19>nXSl5&beVf1oHqw3IhsS48>ny7*)``bmOFQCOjfee$ zH?`-HELvb^`#_g23GWRex~jjmjNspoawZd@P3M+?101e8IPyzBkW!OM3{k5BwYb-$2SN=$oxSTsE}lnc5Uo z(d1l8l=^}+vX${yy9}D4|IzWSm&EUQ!$;8lfAy&hJ84vM{xP#N!-uq$0wvW)EdoJV`qaodK%mstRmHQQAZiIr(QECpWiixUeH%mZV0Y2X{~^)#kq0}#{Fod?_~`)1Gr5B(S7)TeJz_BTSP%Zv1d1v zv_-%3x0e&Znv2GsgUJ_sr@rRSK@Yq`SSxI1+Tcs~&iyhwm;`F2#$8-lYFQO%2@2*J z!8BX8whjTo)#}l$6b7@v|)xgVeqT@6iV79-sBj2bk_D)G&<%t}!UoKwLNAuhnia z8I|q0IFDWf_Ed0r%&kpB!hgtLvz+<_42j0Wqm$>Lc{Wydja_QBgDM8sW=RdvLiIUL z1Fat|CL7+jalwKzqiR(%`$XLl2YgCTY5*^oLa@SN8Z0;#}Dibv~a zOfkDaHGA#HGajLuT~f>@QrV;;L-k6oXd*o*QGD)Hpl&wDcjhR5n;JYr{aF@wjQvkh zWo@f{Up%{KHZt|U<`kBv;OOE0q9Lk9e6=pEgd{mqe|#NUR-4p@Q>cMh@r0hz2Ob38 zsB2xLL@Kr$xvETq5>&K1Kz_nNkwj*@f%15e|5K7jYunLx-W${?F~-DD3N4Vee^7Ug z5UC2*$!?91G#;gQwbziy&Oy3_^xfJ7B=na^2*Y|e-D-{6Fu8b8^Z2-v^cI_efU*YV za;+Z%e{~(AqpVj~*MsuklJeUToHBRaaN5K%MC-vbUuK|aFM{d|2-?NeDmP2?v~K|I z%aZnz9-KDJ2EnLa)?^N8gAvMW1Hxr-a_xG=i6HimAZE7qdq@a@tPsv9l`5P>TnN;f z)9ed1XC*W@zH6g1jLLs;U6uAE(7qxWU7z4$)T7vNmL|7G=*6@=J}%dMM&YDHTvw$# z8Fbl*2!BW$hi>@bIQ69!m>$Z*$rtW~YFIgXXFAm?&5$#eT(qgnW9cu-k@+G-Ucrs=`F zXN$tAn8f-Pg^xLz4drf&(Re{k^^?VF#?Le&jlbH$M~%u$j|*9=eu-W#!#k1RS4EX+ zbeAJHxI2M_%MZk=qU4Zh?+4wCCnW8lL=mH$-XqrrOk3qOLAjD5j+6cn;x**F6wcM_9*~M z-V&htb|Cmil(*W09yVy}02uwQ05!A&JqXa-?Lni=S`Gk{cM4ErJJ2eCnC%TA=mgbd z(Ut(RcefN2X?OZ8TM@AJfdF#9sZ*HlsrC}oYLI-_gAcCP!xfJg>hKVrB{ z+ahF{tO18RC5N!yX1&{O3O&;iz$ws)OdjpeFMT^P8*d8hAdnUT6PJe4$+uCDn1gFZ zq1_r!Gtco>zB{lnlH{LuvQdm71lC4maY|-<37$^PDPtyGr(5rKY-JN&4jQhMr(qaxMM4xcnLYvLjfny3rsx1Q-e+^D5*1)*4pW+(ZP=$8fa7Fi zA`Hz=O!>jrNnhhkm*UjcIP*nE+a(hn^T=i7UiC|s1bseTZ&oI3HVgGEB~2{`tyHTh zPoq34auGNcX;NaM!RaN#)s`p8*KdB_tn9*d6<&F{D#~YI%;m7+BmPHl z>x76~k{7mo&444`+dl~Tr4+X) zW;cCe1}`-E8n>7`#G3F`{KJA%trsI3aH#Z$3r<~(-sBT-u_5FhHMYlxfx81P4nOsKT)?TJf1K{T z{Y-s@()B9y-omC)et*HNoOxB2l57QRkj`5H^Ki&kkYG7lU}d7B`Eay?;EWK(VC>nE zzVEekvOXpKmp!6dpM-h{&Rm`1TIArPw?G3Q z2hoyBNKWUN0#uw9k9vezGn&A0bsY`tfP2D$1iScVIH_JA$L$aGHN5?Z`$e5xp!jLv zfB17L`9ztJI%^lxYT_H*4@K)%clE$r6>1N^0xK_}B=}U@oN}Nmi@{QyK@_xJ%HRgOMVYAA6xjJ=N zoV4^+H!mm_?pvk?Suz7HtNaXswb?+S4o_hF-RQgg7;d5gOaguqVXCLsGPmjIz(2^q zSzx!9rfN=FLCc!OU0=UBfC@^>p$<8>Vhmasd{$Z#++gw5aN$+MrB@Ay9vho99P780 zI%vMW9h;vFNsX?>j+7P~*<8LWo8;pt&UIE|R}Vu@c=B&H0=6#}H!+Pl5Pr8`lhjj5 zy8a}10vlTa&OVk==yCAkRs5&0xgPmsPggdlqrpEsi{iMUz}C49Yqw^hQ4NV<$CzRZ zS!vfp45PRdz_Z(G)ESW^KFC38>j3;r%XKHDm8Y1LchXGU@=-4*d3k0(K}GpkR1`6Y ztH+4nZHB5r$sX-a?5xm^f@(kPBx4m3#ekJ1;NI29J_X%R1l{_pW!A%`!mL`|UI}dy zD1YLjp5C7N9#H>OR&Q$he5O6Tk&W`ndUpAMn6eOCJhUG{@_KCZV}VBU$si}YV9(LO z7mfu|FtlTV@BKhu6f9A%aV;$Q`)J_$V~7xf+bAFR{Z&5%zVw5*&&2@8GR?c`1+f>b z?$NW#mJ+!cZ7*N3!$h-#&DFR#;l9{I;6b(tWcPZI^&ERpJ@*{Pisqm_38I~_v5XTw zmeh`LGYIb!gt7I3+9|0Yk`tq8S%-o5l)Mc|pC(WpO>mTRZz{ec9Gu6ya7Hk9ZRntx zHB>Vb%FAi$f#Uply<5*a62y9wy;lqnZ0#WL0;#^}`dO;@S6e&i7-3SHak1RhdzHo^ zrqw@VM)cNC-dv{7a> zoY80FBOqF1h8Y(uIV&l^6m2=)b60+B{?M8;Ov)Fd1b=HVM%7Qa9tL*@T!lL2mOq=W zxsQ}&EeL)e^r?JynzMyPOe?fUN1K#)#|WPIFjqh0^)D3%MM-{1Ze=<9hJ=^c7>iiFNHzx)IQ|x6UzD?)Rwp{aCjRDYl~|7_ z{>t~oPpr)VSp483=D)EqR7KqM*f%f?i80`Wa+@T&2B4nfbF=20<_bhsn;m1s3;xMyZ53+i_#YLPb(=a z=-oFxJ-zp0r=xg*tDsjIweK=cB#c=GSx$e-e! zQ*3+c)0z}43;f;fY2KT1LuIxYBhiq78oE&n8k&-Qg zzN2Vjww#i@B{teKZ!1J;+DM>$%_vt36^;tj6ihKtW4CE#I0B4*m%}o(L=mo zPhVSMKU-mcTj4df!U49zfwsbevXaVDTd}qf#m~0Kp)N19<)NZGZFv>8d`CepcKpE+ zLSM1s!&d6Zr44|#!ZMqqr~u5^iqNQSB~BY#SLWa1}lpSRyGxAAcaWL zmQz_#0Z~yFosM!6pWT^<`DK(t8FI_CwNuLhb*CMh(U5i02c)+-X`#SNDl15@O9d_! zx=YVPi{NZgC@zQQEGYny;!5@(X%UE~2m*z=;|kk`&VaTnV7)Ok!6I}PMbL&Qj2vf4 z?t)t@Q9o>se2Bzu!;ZreIK~a%P7XOl6>vW;RBD@6>_An9upDJnvvQq|Qh4GEZMl_Y zP!*&SNr#r_A}KsVHO+T8DO>sAAT=L{h*S3Mv{RBT1+W#^3Y<$y3sHZx0y|Y_=s8pY zAd0kdRBZ<~t`!%g@|Rdj_zwi3*-D&C3Ls$m%W!4X(UmW9kX9;Z!v@wHvi}&eg4G=8 zLsSL(B4o}rNFxipU+&AVl5vLfZxMh{E71DPz=_$oxM331tDVv~4yEyhR2oF7z3(cb zS2oCTcMt|w6vYE(3sCflnP_NU0FTDIetq>^Z|GQpSyI z2UsxtYouQ2gY(~XJ}c(pIDym-N*=KcJ?+_Z%@`%I(1x~RzNVfw*exn4W6Hk_qO+q7 zJ0Ucut+LFCcMYXvbM?VDnm?hxEa-w|9VX>)KssBmf&c0FavkOdZMM=$-s;?#dewoeG6r{WCOad*kPOIh48~9l)X=!bkW}X}T4K($diCvydNm|b zZ^{c_0@?29A=CK405-u7Fv7!gL^<*;uw)eLO^S<<)0a|CtX8;Zh$THS2a5f%p!Joc zR}FJjPpK7@z7mwg_{B|%%r|09&QfV-L8fP}V66tE^j+B{kUAup3bdFzW>ZNUI$h6p zX>y+;&51oUGi59`Ob~5*xogIOY++i78jA{g*n>qpK)>fX9yM6kwU2B!-oB>wCH0FA~2+-WTnne$eKGBziEcT_-n+oq?6{)$BHHVKDXfgCjL7Yee)Xc z+JdxdMUH9uSk8x#8;4r{kmvT^O#^g0?aF|O>@mKSQ)BO8fo2;nCZyVSI}Rs84qr<- zco`6G(evp&HaN`GUdQP*Jr=4Mdg!CheRncs)$buRxHDQ=THdSwrXjU&WNOI&mOB zl}Whkp75!V&`xHYK%g5ep0MXEpea-;i1@-CHxVNfOKxMoS3i({6ojy2S|(1X$h?L` zm)s>1&P2lcN`DjHXD&y;4F5xtb(G%fJLW%1>1CB;w=~Nf(cgt5WqQ~A3;p?^|DDVj zZ8kpP*X1xZao7mO2?IRz$>8#dN>Vmg_T2&nsVb zBzL6?gGXj--&f4mTN?F5 z#_0d#2b1rV(-_6NW8#iz7$2a8t|W7dAX*G+S#m4z)3o{;rf@F zmJMnBEayD1dib_2vueqyo0XHq@=vDBQrKk4Nw%d4=vWL%wcf3-PMzDU4oay`r*zzn zkmR8r_grqmH&G~B^rx!Qb&ue#M#NsELLvA467Y6Zlw^(08D^cp_EzGptA4yI6^_z{ zUOW|By@mobghcNuefD;eFdx@Jwz=4RUx3Z?qGQO^R_s%iwEZ4ZL*8A!rrW^TFH&mO zMi1RbO=rv0tt_k)pUJo9v2xvhu4!uB{hxbkjCZ?%ixP)}`37Gp`lt%p*Ue(^k2`9#%z@kS)*IgfmJ@^q5 zi0^2;#alrmx?w$Q4}i6wq{d(=)p)FEV(G{QQgKKl`DYS^`^14~_k`WEms0s+Z`kAe zcybvsHL@S{sXd6)j_Xt7Ygk0SnE!|JCGxI~Mp_4PF|n%4QkYbrd|b=Z`>YW0;A^^Fw6iZwaIaEoStsH$GeoYdca zySEb+hgMq3Ho;dD`nK4+mXT)8h0BTESluykFp;A~sx4<#EC_;Q`InM4q>GQ^A$_J|=G3=3z{1BP%tfWDkin$=3oG6Y+m z$qBMX*YI%Qcl3~?oLrZNvTu!rKn9Q>cJHCaEf{)MLm|H z9#2t!O;Jy!=#<=5<}lQ=DY_1Rm05cchuM5D547Q~M}1FQkDBqbM@_>r^_jk!>5Qr* z;9^y3O}p;70ia)8p!Tc2u2s+W;!`0 zbP%rtGaq246~iLkxoK5@g`NA08q?GNg#G#teR;hq{O)D!uoYv5(uc9nm&@yO-G~hQ zDl_0^U#O1msQqAW*ZT5Ls0kI7xayzMP_L%i41?=($WKq4Q_Vqk8?c1C0l96!giiw| zKlmoqb{d=3Tv7L3Gxg|T>RjBpzLvZ$kce(ECy(I77Bp)w8_ddACgk43N_^~|@cs9N z(`q0QNSnJ!^}P@lv?(WLPFdH*J@R}ig-y+lvRzf+XOLVt0-$lFaxAIcDln{OQ-0GE z#_7$nR}j;`x_MDKe~<=(6GD)WPW&t`3~rPc9}C~PA)MwnFfP`e(N*hG`)aL#}iSCq}JU1gsV1o#T%|UX(~{iPoK((CbRU@ zyn>px1X(#B(Y{#DJr(}e)BL=jDlWYxHl~vGL&Wu9{ghz+Dk@p+Y(rl+%7!ruHg&6p zNcEKnH6ns)Wli(MWU7_(=fj_oTR0zkeHC|`msNe1Y$K)%vZ2S;wU2L=(i`gW0Z1|p%b8+)M zw~?~97da}hmJ-VZvCQQT{AV2CXIMJ<4(b`mo*s)Ou?Q28hb38dD_FLUwJ)r|hW>IZ zW-;tA$4iQ>FfpwfR&bHi2Wznw+MOk(TO1vr8(ia1~my7`Yf;CdLBRe(6)8{wmFXqPD

H7)ljkD9r;dA?~CPk2}eTSUNO^c4^z3oL~w@tfGIxgf@ryGE8{8 zpdY#jMXwL`S4NNYZ@;3dljW$L6b*gM;Tc$%Q>CckrEHU_Yg!VT8`k`j$lI^dX2wV( zGVZm(q)f7I&$>Mc3ro|MW|fW1Do#!rnVfY;)*TA%Wn6veQh(ayIVUx(SIWqF3Af*o zl)Q9K)?9?o%3{6(m)6VF`dH1%6=O#5lzG6)gFT(3{q;d+tYYHZp9@x4Su?7U3~*) z{Hi_XE=i-EE16kN4U@;xpvCVjgYGTwl%GO7+)LzK$9HW;Z?p0{F0PCGQkgE&cZbg- zFK0#08x4h%7gN)iO;DOcWb+KGSyw>V>{M@nZ=!)w#XECw?1uH>ObYBXvT* zANXqKEA%^SNb*R_CuX`8`}*m8g3QA(hgx{QjSF9*?v#lvtM|y{5uDV#GlMb+I&WB3 zZ)%xcsy4Jy%bYWB#N1x=4n_$h&V0RyY~6Xox{aMYX2$F(nO1t7g2&A3__f97AYt%4 z3ywQ>?~&amoRi4!&7t>@)pu5|IYe4cOh<`%J~7Qt?_5V_IL*3}&yP$P%E|UUKI@3X zp3aJ)mIxoZHSn5;aV{oq72sB9AL4to@0o7ILrqEHDnqKvWmSGY*L4Gl-vAK z*ZXMC4+b0QLf`QrkKWRG0cCqm>Uk7zhq`JOaBN=2(s>K94q*rwp<-Wd=u|_4N!(mY z&xS0WhlSHqZn^mP_qKT4Pnwfeo;7`LFZ4y_Daf3ocxg#K`z{_NgAOwH>574SX|QZV z)3Kr3nu~^n*Y!V>M<(E1$b9YU+h-GN^RkkbW+f-Ed*7Yw50E0)Y>G~Ri|-^Ap*xX4*tK4j8##I2;fjZ5yp z4C8t14*2&n?A6q+mUY$tdm!9?3INWF8ib+4Zq%+d^$mvXH91M(hh)MU3)O>R?^aVY zCzCR_f(HQ~1CJm!t47qQnE9g&{@FjIie7S*&n(8ADrN|=dKOD)Fs^_Y|BPMIhsa?P zd9?iodw#`atiHfIwV1NQR@dlSSP`|=>hV3@RGE2gN%Q53`b3x#!OuTSR^aH*#n%R0+jUIA!t4RXuE3 zM4#d^Ln+QrfQ|$K((kAX?QSm3nv=*B{m8_*_#V&n|HydyjdH_`X zV@oEGKE?o9$-aT#3<(?^`M`0~Ku(A`djj31Xr3p!4=E%f2)$B>`3NO@(*J4gOW@DHAPW`LMWofZtOF%WoZ};PE&TN?1m^JsnApsrH~~R zr6>wTDT+$>|9#GT@13jqFTc;{&*wYmd!F;0eRFdNd;eYi+)a|sma^#uGbXm~KZ7rnXNT2}OP{zy zy8i=GEWLVW#uWLNro_;+_uqd=A$3L}Nd%wvnf!qCI9zNpY&3*1#s1UVeS2PLC&eO- zRoeIMSLTeB38eKVLhzV`e|tp?MJt`GC|T$jDr)P!UWq=^J*@YTLrfWXkG!~yD!U7X z`sYjBvH%p%GjlFvN8%PC+(NZ9&nxionpuU8RyB^H$3CW~(GfLhIP&b<t7jvynBn}>s(orsY5=wxc!QQi`zq6%m03{zxS%E+Wz69 zu@tg%^ts{l<0YeB?91)#ST1?0NigXLrccJLEUy)WSO#2d}Y} zDHdZNO6uK#8@Ebr%2jr=?CndlAWn#%m@~75lpyZ4!|#V2ac7|=+8z9&o0r;Y#}FKa zlcQs^(9UMbS;lj1+ij>`5GPJD;+yQsRZ>$chf;xKCfF8ytdn(+ms%7n)w24&nLFhn zRwb;4l;Fn?aWK8EIG25A#60QUVP|{Y9^7qOt^X%;zLD8eSOF;(?<(e?^*{0RUnfQf zFH?1KpDkDW6>sy-0X*-O_741L`FhMtM&;_&!|C?iY)l~+V(X>B66!ILPqM6P=*9LKyuR*)U9ju7ESIcF{ArE%GjgHzXsY+~N7Alkf-B$e zUq!pVA}taB?2p>WHlh48=w65Z-H$v+w4iG7>bn~8;SGqnY2t9**AX&8&XZ9AuSUE+ zbOoYw;VlR0@R{e6MXP%+Xzjf};R9*AZvi;9mfla!E#agV4uH~@xoYB<*P7;g9;U3>HZTufhktQ-l$ z!c)d8T>2<)>TwXt8s7L4KF$<6X$l=|i}e|SLsht3Y_NB(D}CrlIj-7kq+FX{J3M8; z5xD*%We*9jRB-RvZ-omTiNz>(o4v{WrlaixQrX>mjhDq~r$tlYKnexf0l^ap9mqU#VKcD0Il#>Hn=f|nP0dJECzM{8EZi27hLcYRY z{i8{{NJ!DkkedTYmIo4H;Kaq7c6Y%rL=7s?4>Zbe+thK37o^=gVu>$K9Q>h~Bx~6g^*7Z!4%B&lh zs#W+yQ>`lRF-g@}H#5metnV__lUcVgx;pCzObyMtlS!$;x|^w)!n%j4Rg?82rgkmX zkD5BQS*Mx0by)W__3HBbrhYxvy-b7ptb3b=4OsUvjT*AF?Za~f$vSTJ6I1k z&6{!HJ9B4q4xBc3-N|~0X>k|p;ihE^)*0sRmaH?)J$G~9lxcMj2fj6}Td^K(?rqI_ zjA?T(>#?S78`h7Tc5PXYGxxP)J>J}ZAL|LG{r#*bnhxz*KVdp{U_IG9(2;ev>GS~W zDW-EL)>BQF&a9`I2fMJ&F%Lb+db;WQ5bGJHTUXXI&BNVT8`J$^)=!!q-C5_FM|!Y+ z$~^iA>!(fHqpW9{o@uOSn_fLx&oRAwv7T%C^kzNJ^zFlXzUkMO^#aqsAM1r?K!4WH znDhax7ny&0g15Y|h~u%WD%n&HD(FEbg#Iq;3i%;3OD zGa{1%C(L6bST8ptALGE+X4FX5E6nIo9QewN8O?f?89Rn`o_TyM>(yr5uJ_| z%7C7{jFKImILpa7uRv%9rMzQtiLnsUt;~e z*|47V59Z|!tba5cUuJ#YY}&~Bf_Y^V>z~Z#S6E*(uWn}ji`nuj>tD@lTUcK*ufN9n zvU%fm*1wspZ?OK|Y}?9#x6Jl!tgo0ix3j)#^510rhj}ZX1Nr9dw^;vW-g%q#HM8R# z)_Jip+aEVG@~L@4;j;yLZ8K$h^NBW*nIh@a4ZQL}m}Z{?~=ce7FZ@ z5i%cr2(u`ey&u6WO=jO-m}SW9-v_fSnUD9wEJxs`>K|4s14m{mFq>%(cHbu*v*=jRPA^@NW*h zj0qJ56$dsbL%8IH1M8LCUkUP(G7jN!6L?XX7y=EfQzn*TK-MY~hY2?#d4TZSk%Sw} zmF@&umOI(FM3|gFu3GD$|f{F`$ z1hgcT5c()+0+odSmCBT&1d*jd=A%+VdxDlGADovfgAbiW)*G_2R7PkY&~j8(C?4k~ zk;)0}2kNIpq5VMvzjo2dzd`g=T;zQ8l5NpvjaZbOdO1N*0RGn2e_CLdSvDAT4w}XbRO3 zIsvpMr3l5HG^Q5S6#4{cZK{P*SgK4Nsx7i?$m-%n3Fs8idf1QvoeEl?>It0&+JNc{ z%>ivl4TR1BZA1-)V)9{bq((w<$%$!9HwwkoCFUk-jJOsnb2Hr}vZo=tg>Du)3$zK{ zB6K!rQ)(h~F6gb)ROmd=+vrxIxShhJ(rpOpIc09ARFN%)><+qJC_arg&FBuHOF^4c zGofoi@1*8J*MZ(ecM5$Gv<2NI^d-=i)I#V6(7UOn(3e5)p}U1{1Z_q42;BtQnpz2c z1@vBOEp#(z8@gBMtDtSEjnFNi?WiqMyGWV)sGZ1OhwOg3Pv{$LTn7Rqw4ceU^7WzJD59%)T1JFmPhfsX~X&$9VkcV7l(&$l;Cza_*X&^I|=|w$3 zW+>B}dWrg1Q13&%g?-LTDk-k@T3*!l0vQq|hRuqiK}TqM&1Fv``mxER7Kw5BfNb6ik@_K>MpK32fW66~X+m!RolZGI%Y)9K=|Yo0XVMIz$)JX23at+MBpIO^ zG?$(P4Lpu0o}yf#V?m#$r$nJ96lT%WLTiD}rddL3gU-Q;W6(OFb7_vyx}fuDuF!g* z^J$*Y`k)JFzR(7s3u%GShM>>TLZOX77tu39Zv=go771+(`W!tg6j$My=jl12H-j#w z=Y`$^x`Y-BZ34QKmI!SMx{Q_zy%lshEfabh=n7gcG!=9utq^)U=qg$%^bXKGS|zj@ z=xWLn+8lHZtrmJG=nJ$)=-r@e=>?(pfUcvpLR*2pNb7{Q27QTM6nZb{dU{D{8_*53 zUT9m;muZ90`#?9+%R=u5-9#IOwg-KMHVN$jx|v=94U9pxyh@vejs)F8uZqG$PbOk`3{G72eCBSu67{y&f$rhX$^)camTHR8ZzUl3Ygo1Tgti)pily zc!qKpos->!7jCPHDED`@0Jkt*(Up{WpSBX~BxOFJZ6L|Yw}*61HRVI9tdeytHRU6! zqLTNkoV`>PzfUEhh6)*F+Gu!iA5}wK8Nm`NFbst(MLaB+j8|}(!TqGw|AR92>Y)5F z)l&W>VF##Ah#jPQA$EuwD1S9^Jxq<1KUvr()HvjNgl<;uWs!YKO>py6W>D8w*`JZ@ z;OaW6+UIneR~|lmv@LA`={`ny*Nk-g>)3=h8W#M5nn8k0`0$-(rc&F8r za8;&MEU6ag*vfYtdeXecX9n*^pH@jT|!MfY^CvPOlGhL#+3i^fUn>}y+b@aQs5yCBhP<%`2IQ%JqtYaR-!IR zKSS6TgM*jXZ>g_U@_OKU=RZ$lFqW3mO{B(F z^tczP?dnh#}_huW?7CoPO}UxeVW{colEcC`RU+RR^+FM|@2G%z#x9G)~K^c~7vqqhpA zi}83-=5Kl%Ik_`Dc%oxT#_iy_6i*tg!}uL2+=F!(?*M6~l9-o!$(F1$uZ&7c9-ck^ z)@s!d6%G(HqDX*i@Hq0Bg};&w^#3Y+3=OzVl%y(u2}zSENj3fo5*;N;;uDad1)5~ui+UJ= z6)Nuoc?|1Q-Y?0Mb}UcvZ7kzG+w4` zR^Ru(uT~9J_#4VYI{0lhJ@5AI)`a$TSe#w)f zwbbR`lsr?eD788sg;0+VAn&`ebmoH~A1EL8o%bsrX1Nj$d>o^zHYWdm8;cKa92$INj4VoORikJrvT!rU+bF!pbaB#OVNuVAkl*782zEhTlBz&4 zCgCRnZMdfp0)8YgD%{efR!X=LDZ+gd`!BXS?BhSt<33E}N1-xNz)KXG&(~o;$l{l_ zP@^Uz0SX*ap(^x>`&KURg;VV|t_U_fSng|EAcJIfR@q9z6XL3*PpC$Rf~lNj{rFGV zD$2Q?tCKelqLvP!^9~DYEJp9(!;vgwewEaWQ*37OX1ZE4u7x0^uAoO zh!3?un#!Gg#9DlJd2M6RerVRCz&_<`5hZCrfxXJtGD^~j0v{O(=lYh!sghaw`SiS3WFEB9c@J>{dRkPa={#D6mWUuuO?anp5CC z z+#iHJz-`GrC#)0SNB)7rI&*vS4-wXdJCb`^*n`}O+%v)+;x6QVFRUv+MDBOOx^Xvh z&kB2(yOVoCSa*Je{C$M=;57306ZQ!AB7a|Dk8&S!&kIZAe&p{ZtS1j3_eWv9cp&-v z3+v5;$v<3JA0A5XDPetiIJw^n>&KboekSZZ_7>cu!us*fhp1s-eZ}8x(lE-0gO>z(V9I#)oaB zPsi&s*a+cI3mz+Pl0K_)rt@3UgE3^-XXr1OYF)42QAIjg@3;7YrkC(maeHGPTtuNM+AQ zGO*&;cyVnO@E3?hCx9;GFNMO3d4`V*g-^4HzY<9G?(cj6#z`JYVsgT+Vu!x!z0M=)bRIKFFUhwDXOq6&Pe7x_0z#>yIj z)JMcJ;OC=>{2pb03wG>&M%<6Xj(yLF{TS@n@r>BNf*sTUDK9Z`vXnWt8W67c{7RJu z$Xv{e%UjNeW!?bnZRmt#>W0kVo0!S3=NR^OEOIt*tk8_0`=)A|5qz2B*kc{w1uXv32y?pov=kF zE!Fo9OyoUh2d7BzLxcWXRnwtZ>0)2BuT)Bm!d~eAAV9n=wE^zrx?X_T!Q!7JKN2do zO+%q#tMvaIs&7{)q}|*olr+@B(BS)wsbVM)Y@FI$p;UHA*XY2vaCl|-0lZ7Ql}t3{ zz}B#QPm~^};g?+*8*?mRWt=y4a`@sK_JF&Y_WXHJ+yLO836+gu829bTu z-Pm0(>;!jb_a$K``4M(s6!s0LvAa>@}wZcwu9}Yh}`*Gj}m2;X0NP9txH{bE^ z$UVBtK1xT&`kt?N)-yZ^*0X%ov(Dimwx6vD`kPyip>>V7tvqcQN&LRC)?OpKi_3DNSY9 zvNN1xm6l!6`=$?=OthzyOy2dJez=LQE1nAjSc;Ig!4BCqr-Ut z;VdIr++*vrF-l`O3KV-zdId}z)YB_N_Ej+Pji1g7$ydW<*wjUCz7FooI#EX?BJ? z(Xxo$wjFm##O_F2a-WabW32tzh&|TYp9$Ng6D~xa7h+#To?}P?Cin}{G2iFF0+mzR z*&`W1kT1ymp^Wn(y9HuzKL_Uf8>>~fpjf=k8?O+(EoKDhD~Cj(2u-5H z$gT`gk=>R9n5g)jLtY`_fQJJWDUchS!ziEf_)!jPt>EApVrLOpf#g(lJ_~!O>wd&5d zp(&d;2ZOVAPGK@o!}-ppDaAPxWvl6&gU#-7K(m(fW0bA7b0NxB$N4$RR@cD@74cWk zxfErqk8ctR+!{DnqHGPFKcZ}noWG)MH#&bu*%~|Os#9)q*ulIqL*|vJi_jcWruB}4 zanQQh59RFvr1VLv1b&m3=d&_U5~=Ace*!S7w5`M-zJqlr^Q=q}VyQ>T#QO#PWe#O zriD{nTrz?!oeEAkvw2*}CiZExiMyRDp=`~T*zR$vI_}fLS~*Ep>8a4{6|EkNx7JQ| zw0xxP4Vm*Dp&Cwj78vcS{FwB>{Q%YcPj`2#xE`e1|LyvkxE>~4s~(zRMu+Wg5!XXh z-wBm;c$I@e?p~*%9V}$PYvbUswG_WC;<>?_{xAA%om-;xp9(g;E_QF$j>SF(U%cX- zFRys9ZbnMlIk)|%CXVSiCD<0j{m$)*pvzMEbpqMZueJNa-AlnS!k2{N-)`Dx2h%-UWOhnw5b}q;mh67c5Syn%n7J3cAQ#`^ zkcN7GeFI>IQ<#ku4*yq}nFtd*HQDLTV|eAJ^e5m0osl;DBjAIaQI>xiSw9T6VO+O5 z8I3?bqv=Xx^Cf49GZyu%@xDHLsPnjOU)XfX9_Ea*{EJ9HUSh5bXgmVKu8hfWd}tsV zZ|So$oryL9*p0~^;XGmaN$|&Xu}cJ;|A6xokB|c4mjh#mUl3vYk1$7fcGODN~$z^4tmS zqPWJJc+9uY9Ly@FN9?wDyOY9pc|K&JmrZpRhJs!yK_@xSU}VNAE%0g1v*0+U1)k$P zZ=;+5FVmeRAun0tRMuGvH8_B`ah5yo>%wN>XPDe+!e%;o4n}COBeceGrwTL9T8vW| zm%$Ivi;nx6u*0<8QGg_QjAAN>qRDl(*rKTb{*?2Y6J(eW9}>${j@)@xRl$FLHK8xuZBE?(bXo=bSxJ?kM7j`$yJ&v9mAA zeMyx2$JTwRgBxEX>01`%e%QJ%caB84uZVL0%(}01j-u``?r7{H<*ahP2o;HoGjgba zJm*U|Lk4WMb0Xxa28wizQwBvEKp1$*_zh|(1#_c--|GD9-{v+j5I@n-+59T&w0r?11@7L+JpG&FMDxAgXbL8EF<_MWD+7m zhV8s(iyHMVAPsl@XBswmq1iP24F2yl{NhP%8ZLoL8qgM_((s#&^$KK?hK<&S`>Vwk zm4-i%2E63T-sJpc2ZENeqo~`VxL$F}N^wDb&=^eaufgkR@X^8X!65i36wxR&bi(1a zjx5jV()cYNt3DFyPK>NzaGI=B$PJ^R1SM{+|3pzF+6i{Vzap7fIt>ISRpOq!tiO&L-DK7qw;=)-W zb6M6N6;r#uKds?#71x%_rj@D>|A@EYJ1V|D(jaL;_%VCattsh?eGlQ;_{OTZl1NAS zG~DF`ozgI2pDS^BaY#HK5Knx43G@F0P&P4b;}X-#Hp8c^D3eKC_yqFo*4~J6LwaBe zclS0aV&l)cszx9`zmfypf^^I!E}GU*!r&MG~R9Z`-94W4P%wF-| zO#Le1NE)g(QyEfL;8|Hsv`tqjDKoF!;;erCN+_@D;?KH=^wS!q{kuH&7D|-3k*`o4 zAYO^9bSO_!?LVJ~uVnKk z=?%9hw5>F_&$Vrg6TP+;GHrRG&ZS(NwThT?rT$U3%d%q2W@W`H`QZJ(|6}h$$?~wk z6oxxkBQjQ=fBD4H`!6g8KWP+WeThu`{QG}cDxrnLl&~bWLhv1f>rXvjV#lTV*3Hw1 zgI%s$mH!S>5Kf`!$6C9vIGZ*{g@66ni_x)u#of!97r$tEu}NAaW^s+Re#7#xzLzsE zc1c$Zw8FU&-Eht&gW|mk|Rm8C-rhC+|!m2B;**_@k?#c^THNA zaVbcBbZQIyicZ0QFElTuVV7|3!fEyFUWz0}(eq@IR{1g57$BU^f^>va;+2p5m3X{b z@%(!+{*y}#;W)x&CB6&N_s>%E(i2_6;gF+q8ZP4kSph4EG1_NAjNvqjDLL?3n&ef& z2)CrL->}rvl``_mEgW7!N<=f*ym0EIjd*c~Qy320 zGYiVlOLf@4)QeXZ6262X|HHk`OM}GW)u@*``74vuf86^g`} z0uz9#KyGnFy-5D#!M475wnC1;c8Ta9$Wh=Va2~h{#FjvIO2Dx~3CVE^tj&SWzz|?0 zFrma0xXb{X4J-nd18c?87La`4G;mo2MM|P%fF3B1A;1J67g!E#0#e}C7)S+L0v$@i zQxA~7z*t}guo&1}g4$uT>nGmlK zR1eT}AOn~HOa*ci5c?vK<-l6tEW*476seA|fK3Tf-T83YBdSLeronm{)`U_hF(4VJ z12h3z0_}j#@Yol~044#mf#tv^ARpKVoCG>UHv^aewzsmK5!5?4O|6^ z_>hP)K12;919gB@pf%7L=m|^^rNtn5J_&CNSU#{1I15|^t^!nA>bqEJ1PD|Bl7(xS zKx3e#0J3&KXP`%E1e^}iRfF_}>kwchFaekZkZpl^1UL$Q9_D$N zu{F?1fvLc9U_B691|1k^2TTC+fIYxjAhs;>3p55&ftF$SfE1tsKq)9Cpbn6lB4yVVEFEY9 z*ABoCU@EW($c20pumd;<90g7STi})t>;m=yM}XtNX&|;H+7)mf{Hoafs2`vVPyt8= z>Hv*_RG=l$4(JT@1cm?&;6D{;4UC0-5-nQw4}CfFxHCQ3Lz8Iqa>04nS9+3j8+*I@f}7dMzot zzTz(fZexW^1<3{G1B-z?V5%t3x5|0&yB?w~Kt8Yw*auvLJhnCxQCs3}TpJ$R!P=v? z#4tguN1$~aI1Ma^(;AW|T?B0M&zD9?xH5Vx*46RZbVUtkC@ z5|{u?1#*G;z+xZ|SPyIg@+FWxAP0e?z)9dNa8Vqtfy7oqlt3Av0+0+e0Ga?Tfet`d zpf4~47zs=O7S~10Fmo$Oe_afg2duAzVDse<)kA^Q1K9)dLExxJPlKEXE(6y@P^2={ z06$QrG6Z!hOQ|)1wK>ol=pf=AR-6uN1~3+w1k4bp`5=pdJYYSr1;__>0sDX>z;WO- za2~h}TmurSNZD4w>@5}OT1Db*j#OvB)*5C9U@>?eT$-gNVb(cGJ>0CXOiATBD7gtz zj{fZl%|r|37K>>ypfV&fg_VE!q(~jCM(O}=Nl+gT#wFYKIx6piAF5m^mHITRud+ln z{BLN>Vxjw}@M||GdSkE0h82gnWNI9m2wP!EEPL_qgHZHtQSaa9&5JE;IqVO6Lh^yu@wUVSh5;j{f(*07=S0 Ab^rhX literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/2877672f9e30fe66_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/2877672f9e30fe66_0 new file mode 100644 index 0000000000000000000000000000000000000000..211638f7124047974ab5aa175b1e82415279b9ef GIT binary patch literal 18180 zcmY-1cX*TKAMf#Zo1{s~Y-u_`R-vUyvy+yNq-Dw8TTvMbf-Di)4n#oNd+#YrKtPlY zGG*^6piD)k?4{@PJJ)soI9%7uG*9mPyPnXd$%Ec^KKZUh*O#wMKqbiv6zQ!SDp#qR z74&+mRLQ95t?qxbvd>%9U$t7$=dYZZ>GxIhW>m|lnieDXx|O)Ns*pl z>!ZDWwYMKs8~{Ij4o|;;4qrl-uVBp}_5U@*4~2KWfliY7Ei9FL!{EK)&{^t?fR>Uy z5~@pw(a=){jDc_E&O={y6j!PD1b$yea=lk<&0xMoZTVVEPTVU4rP#P(n`0b!q-PH24GBNbxJ+kQwsX zRTw2Tu0adg_dnNlu4TdvSRipXq1<1}D|h8z>3$1d{|$w2YrUM6T6bXfU05ZZ?m<7f zC5QfjOEUE#ERm!~@Xuo~Jb^88Nb;V-`e%Bs$yd)|oJ78W4_`uG@xOv9vR2whM$lWl zh6pOj57OTl!3cTN6hSlDBg4%R%#dc52-?eO$&HSnu0$1xAYQ(evV|k?%WZij-HJr; zZj5dvEjEHISthZG5tNgQaz|PxX*9AR4RfmrDAdfH6^l~_Q+rvFBi&3&^;xB zsrCpiJ0fV19>F`ZUb;FXDDREnc*O`3vLdJ@BjtjW%GQ0EBvbMtI8-HqF;ydIQ!RqT zHzRnjx@s4H%?OT4eC-H^NXI%6tgIVB$$Am&t*`nTM(~*olbuZ?ur`mNugrKafZnb=4dvMlfMg1cu4#Z*~Od=BUoO z5qvT)f(`Q{XudFl?FS+-ABv#Q|D26r>$wQr=OZ}yTLi@}MewzBF-5XADw1;MNNN;} zWOSiO{*|8bk!(zeq(xFB-=;=#q(UV5X_3^G3v${SNfmb_4J6qc$vA%`?W;xd+nbSm zT|JWLl3z2Dl~Sa3B%jO9I+6J6M)ImrBt4o$QnqO%i{*B+NLn?Iq@(n08A;Sz%JX(4 zNo^w8*DjKO$&#J z_fqn;V*VRRX`_MW1r5wBWS~G{0~d-I7+uuBY$+6Dph>KOoie>)&Om!PBc@TG6ssuAo;bdf$U@hd&?O(E91)>m@jcD23n;m zh9vt81mupqmhOH7>jMT-g9bjxG|)>t6%FLe5ArO_Ku7&#+YmCaUj~N_Oq8fR1NHI^ zY>|bP4g4tGs~GrF9!OR-154zq8mdF;)->>r92Q$`19R&bsM^#(Qz_g`Ju40ITwD>xs{_kHOpN(|GRaL_NcbK1}g3| zQ0JKHldKa4zLVJBG)pmDQmu0Ru7Pg%46M6vpxgrk4<-AddX|jG1_nGa@U7UM8dxNM zKhyK$g=SpP$oxV^R!K@>BX^1z`69-MFV;w9SuIbB8TDKHm(Aq<4+%lIYe(`pKtljQrBh$iw!^ z^Py_!s9Wjsk&$EK>}=$dE=C%BY-Edk+{4H~xhEMtjVzS+d#Qg3^wCVj_?eL}W!^v| zrM@zTRr%O>$HUk27*&mXWEmja-^zq~2U3?WDkB zBeCBb874l!1rwMJU4Q@uYLX}(^M$-SS9Y}{m|*k&Vpbtze)0OBi5@%&PvVeMn>N-Qv0^f%R?hq z#s1jHj}r03NR6jPsy#QdPYS;@^0~b8pOJqgE5bx!i-}JQne==yaaR767DY_VDr%x& zjEU^h~q62IkHsly=~&eJ0>Q-Z{oGA{=md`@w7M5tAmMa(z~;X(=x1! ziD_c#YNCEO6I*0TPZK3RHPN=0iKEiLkMj35F;=SfGtoqT5z7GOmNTCz_5>5hrT#<{ z6DOJU^VdY8ESX{=u*k%IDf*p>Z{_>-CenX0F+?i3nW!Q^$kY2Kc0VxT zer#fboO@!T=2H{5o|*8zFfm7#{;N9vGx173CyIxX9T~+E*&_eRZetX6Oi_%Biqebo zC~R`f62%c$6rZ@Gcpw$MQ7o2CV(>*#BQuKaSy2?oj-sV3mj^jfw8@PkHZO`Hav(p7 zoJvvnszec0HHx~`qIgRRzZu0SIZ-`|Dm9{rsISIEo*dL@}vZ6ert8 z@mael{uK8IQCw~xMaqX!SUW}Ws=xMsrnNF^u;LBT{h?7@`z8v?lf0y}41W-4Ml#jZv64MX^k}ZdR|`)%Pz^43=ekqPV{|iq`wo-+?F^9aOJ!O4=We zBKckvo$g1`TW*Q(pD5i#1b59L3E1AW!4WTrOeebvZL{mp3yv z#Y~Y@Gm|Umn5<4Svt2xPGrb&Uu1U62>!gXx%=>a&5btiYQy(+MWm#V{&Jkul8ENJZc_J~R%-k7oX4^zF2ftIUrHU() z<-jsCpKexN<-&yd;lob}AcRu0J$aJ^%myHIvKacLf;*#Ns8^XFi28%sTVo2 zTj%zGg)t{B+!p_73-jdOc?<7e(D@YeMGL)U##PPZhW5!xDSgwzSxNg-bCZpKS+L)- zP~wi(%jUZl!uK`%2Rax3SU4|eMd(zoxd| z`ckbVRVz(0MwK89Z`m7xETgeS5kGOKIEUjzBUC+v=^{x8eW2J3FE1M;< zvFdK2wQpHDD)FtX+-|FUA6dB|WxH4zD_gr-v3Il5y}Ol5lF~ypd}`&DH0)*7_Z+Lf z=UCY;!M;}d_fzj*TAB2fl^0U!Ypwm(N|zB@BT=KQ^pcvRtt^)ZW303pYo+-(D{JNX zc=a;P%4?}Q!^#?om}8}@tetCR%6uz57Fa2~#>!yXzt&3jIxD+>v{K+F<(I8LTe-7A zGv1_FV%euT$h}{!ytm)V$pco3AJVyz*>d8r`a5l9v0RpWXRYL2uu@+>{mse-`BmaB zS}8B>E?N0rCS2C@K-NmF->poP6@OTHD$nAgscMU+UYTg7$|1R#6OBJNn$IPaAI(wO zP&t}PRibgc8O;~6t9mqn8qqAN8BLQG(e#y^meE+=(tXK(I~sedXg(GH!Wcf6TR+E; zu_1;N8)G=KDTd;kV<@yGh95;wPHxM|?J<VAhAF#Z7`8WtLHlAjB-y{l z(DOhHTjjfhF+4mR!<=I=R5}sE;*&8v5c{bZc3+O6=vQ3*)r(9_C1WH(4$!Hzm8>cpX^r;72bT)J6|^?wy3;#M*G-7Uu8m&G_DKmJ>c z75^3Esk~1dTO;GJ8shld7{|Y+I9f)lDFB3;^Ig=VkCr2FXq;7f~2mEow2jX~;9Y-i9j_bK`oXU&i%Vu%x zmy++rv8i1gQSZlbP8N2I2W-o6-WN;I7ZKj!!$3B zhSF)idRQJu@(T6+Qyk;B#BotdZHuGDt~mX!p?>znacFNGy?%|O`Jp)G$;rcUoPQKY z%Huc^U&Jxt-#9Kw18nRUTZD}T1{)nsHr7g}*+yTBjh*7Q+IU>pMx`P)#ul|vG{#0N zDHChc>rETIBqz?sP@9coQaj$p8A(pCu|`&u(YiDnchhZpjcFs-Wuv&qMghN#L76rV z$At@Y+<8LOV#(Djm|Qon~mz-ZH$wqAKOUkY2yRg(#yt`{x)0#Y_$2pMzeu7=1TNe zHqL!*qx@hSt7OJ78#m;S5jK7JpxAPJf{hV#ZJd@)3vKlK&c@bdHmu8Sv|C}ryxvA* z>G_j#ZB!hwY_>6ZtKvw#Z8m<|ZXcAJn=MK4xm3HOiZTRHYsJS_&tGhgZtRqk(8pX`zMhR3s1 z`izff$D()&E>?`?@$_36&n{W8Hl9Z7;+ZLijhfBwcna-_r}V*iN*#))liZfcN3>6B zo>H$@+ znDj;hZA&JwLVhllpx50A+>z&H638x>pwBoGm{LB0ttkmuQxm8xOI-;(lK1=xd=^a5 z`z#4ul=Gnk`c+9_mn^TAz>}IC`CGfggg5GCK;8m*xy0=eYqwMIIK&!3^ES5PR ztDYVSG?HP`qPJ?15Beo=Za@O%KTBYhwEar8O2!by8kRtf;RzTfw#6Muu#fwPhiOI1dhs@J<72+fq~-R zrx_eb;EJ?4n84h_3H&X+k7(U7^(NmQPhi2x1n$burxg2i0*Pl5XediBXkK#fVggg2 zByd&MlE}QcL~ctjZz9_z$(Kl*j70WIY-S?UrEbMUu1MGHM0)2YvP0^IbXz%*f>jcU zu9`^MI*QXUk&2BH^?p_&uUjNivt=Sf-%jMzhl!Nwn251kBAK5g@|AqqQ^$HG(pjF! zhrJV7BUSn&64^JAM^a*-Vt%cdgA;i+G?7lj5?Lqt!xewD;*Zhsafuw9oJhhH?VYaM z*@?81S922CJvWh}^AdSuzV1tn1&K6Sn8?lwNfb^?!s|(*Np2FeWp~vi%+->pBCvl)g67e;Y=qB|VB{5Z&Hcle0X%h3~H>uDpi614mWfDWBLaQV;e2|2(eG)}G zCDE))5_6?;SLN-dc-@oKqvFZwfk`|buDm0Xh@Ftc-5E(_&(!fbNnBWxMC#HczFeNf zN9&YB96u+~js z?SCdw;IAac|D8mgM@dYUGOv>OCb~GsrI)QZH&Tk@OD)dpyyBFoTAU7Y@$KTA=vtgo z-HLNzXIW<5FH7u;vb-yX0?G7?OJ|`>;vNV|{vUGDY-fhVY zka;_kS@df%_htWyWICNqW}URTkxczZ$xM^e=5kmHl%t76Czaz>$#T>vRSt*09Pu5? z(N-4rFGt-k$}vSsk0{63apkxmU1pb~_m*-jm%Tg65&Mf`9VLo#n~cRi2%v%TxSi zd8UxU6$utipnl&A z6!tVpq0Cz;be6TPQmFE7iawW0p=G-ioIO(LBd!5@{PPsn%j&OFxHCdEk4)j;@hN;g zMRiE^Y1%s@g;CODW(s|0r?68zb5ba@T=Asq4=K#ws{Qie?i5NLOreu_52aA&ObU~w z*KaALTu$L*Idd(AUv6supD8@PlfvuADb#$D!o_Fm?PUrZ=OOl7;QdN-AVol@VhJ~@@ei&A+Yh1RDsY-cJbWzesxYkw*mj-+Bdno7@;snj@~%6NHt zE|n&~r!res+|>HJsg%B#%I@c>Y<{Bx=8_e-T(JU0vMNwdrb?4=1!hZ^$`#n~P6dqb zR-i=h3N-ki`4yNhJ$F~2>gfu)E~Emlu2k6B8>+!eQO%0cBfHh zPa0#6r}5*dG&rr}=hL`wDUH<2Y0SKyM%^1}jK7)29J%pl8qQm3%#iVar|J5UG$#I& zruUlDSpHCZU!<}1zch>yc6!P{*&~GwcA6UP?39xQ?R-_p&fdayGK<(*pJ?ZGlAW%_ z?aVA`=V~cCO-kEIP0_JbI~S$A-OeG2OSdyv+WG9*{B}}glKd91Q#WX*MV_6GlALeH zFAL@GN_JXRw)1-}yZ+AESzg=DCUMoV^J!f>*W^kQI}hdirgpZ7rL^H_FuvU5ttd}L>i#B{dPvWs1x727G=PxbUypK|;QJ4plW43i#% z?EL(-owUJrmV9g1bx(F$54ZEvcsu`2u+wd#o!A+6hR#&av+RUt+j%y}PX0VQ`{&!K zvBb{krCKXvf3VYdjh#Ac?TlZiI)Buhf3`DYgPj5!_4O8gy;Wat)4rW{EW7M9*llN< z6ga549=6l@h@A`a(=ofQSF*F>gq=4|+VM$0$v>@H&e(Y(1oZ2d`^8=vv3YkM$k2Y2e_yhFagq!K}s(t~GJ!`Tz%=WTX7}mV;Ms zJLuBN!S#0>jCt3=>GvG8ZR4P2X9sh-I4IK9!Lc3=5_>xMR#x_Puub~)b1+QO1~|Am z(7`iV^Ob{NBsj>yfUh0=EguYVQ1)8~`=#h`2OH$0k($9M)h(CguCy7gTF0o?u?{|* ztUOa3)S2es#!LsU+1fwH!P&(QN-t5J^3gKYwA?}K6`G;UU*+Jh)ee@dcQ9(BgOi&a zRNJh%Y}K)C4mNLhuxW>b$eqghtAhsTl~ameaNv-?e|K>3s^%$EuBjGDx~?@h92}MF z((tx}Ru42UN&Uw`rYw~iI`~E^|L35Q?3Cz;bo$E}c@dS)q5|ox zmyZjkGf@7K?850Rm91irOXosjI=5wUlGaL}(&>~gpN>~<$qVU{lFr)HbjnpoCrcJM z)A=9^VI@Ri@(@csqP)r#oXB(zdvys-yzUJwid^epE zt?~u+=nITbK()r}mbiS5wFRhbp64fW2-ZDa-e3s6gVd(@% zq;q0qI@e_OsB~6J_X+8wP1Ei4bS_J;nTjoyW~I|mei7@Obo$9?dA?9{TAq&S`*h~7 zOlSEI>1>wXYqU?EN&dQYR>>~$Y)t2!?V8Vybc+3=Try#AI`a;vvqricN#`@UD;dXh zex%l!bjF@dr|u6rHAQy{g=)gPttk+sd|v2FVbo8GM&Bh!>e@Oeyy1QrW5mD zI<0ZCIKoMMq?31zP8OP+#6>wN8tbG*F&$5Gl2yV>lkS;L>=m7SoaNN#gih|~IH?$N z@|~2-ck)3cCq3kj1gkiCSi?!-+D@9)ak5*^%M$GoU7Z|~ zD^jbwlVe{yNgU!NMamC#()k-F7bIhtlh1}b872>91$cj_gohJDrp`x1yjjY{(b6t`{^H_vii_&0E>hB5bg{em zO%6C*#5!FJl6xK(nLZbbWt05lcd;Yv!jkWzue`45qHrx2`{blNsx)rtqMe+S5^uX0A-82}D;JmFaq*(Hi^^@)TRRs6K6J6O zqYL}TE?qC=V#+5jF7=dNs=JSiNwQ4x`nhN_*v0fAE~1CJX#0&zuLoTGD9OV#o8d0K z|L3B{SjC&DHIrTRmvhrJuNf}JiffLGPv^S0CYQg{e3!cP8M0=#(#5J(E=sR>|A1MSZaxaFHm(rO6=|A4sXgF5GhHh}NEPF;ps@)NJJ5Db@A6 z>iWaQJJ(!1eB~nNU-cww|I;jRV~%k1jU0}2lV@=AoypDJC^zq!-Gr=e>WMkpO@a)Q zqXpblD(I$QAvaA5yV)uAVzpipi@8aY>GDUMn?^P_6XV@nNN`gp(T%5so8E7@xglLk zyIEI8Ym(h`so-X9nwxTVH)Yb@eCTxRno~FN)!e-Mrkg|ZqJ~@VVY&H1R@QU#xW1eA z4cv@r{NFLjgkzUq_{os_%3au0Cpy(~A+ zzIKy8#LX(%`Hh?CVQ%`%_z`Z-jdW9Ml$)tz+*}^3n#L*LMCF*|=Bdn@?B?1OHxJ~$ zscuHia&vOFo7QvPv|He2=|VS2i`)#5A8Fzw;m5IydL(-O}~fOfQPq& z9ujkO8}=|aPiyi${8!0C^(u;4)uY#r9;(&V{(2s!HurG3g@*<$RYNNeW8U#lznzB# z?LFM;;Nk5LJ(TU_q2os$&dT7<9u9QzklWQmk?tOvf9zq8T#)1*9vq)}=<&ISKjf3a z9!d=H&~B)QtUX>o#ssM_VD`;9`e_F82XckVOu?PJ?3HEam6{IH5atzqKA^# zJiK?;!=ig0Z1+8!dE{Z>W6kY}hl)?t^E1s@D!)*jQW`HEBD|cIEe0<}lb28BL$jBa z7B8i&UIOw^)X)w{tnaN%*PVrKHnwN=kX}Xt`nO-JI zkJ(;+p5rBLuGUET`C2277JA8D?A0|OUaEeloKkhEm$g!GwU;J8D6jmr){FN?FLPzc z1~0CSIuDz?T$4##z5KRK=VXT$_pe@h?e`Kqs`GHd%eN=JJd?)fyi7aq<;evv;fr3r zm#;5-+5fwjoIg~*+`Qps#y?)JJk3( zkN%RJ=3|w^$CGp)U%7mw`Fy%A+{a~kmg6Hoq{pRY*vFhaA4T$g7^?XAQC?N`@y(k) z%GdGHxvq~3a-e~a*hW4E$+5;h5}W#1(9B1x);{L9@zJ(}4`)XoVR7x9fD1T4omjk_geA?T`5XtZ3qk-%YOFtidWz7H|&p-3g>2uZkrS^TLyn}uGI>blQ zZ+!f@z=vm%>XyKF>UW6`(=s2e*Z5ex)<^t0A3fIl`1vOvRX6x(yv4_~tv;;Ve4N?g zqts3xqh-oLAD0gKsDD^BAM=rS!pBNEd(y}7Q|j}yk74ID+p9jRU-z+I_TAL1{_^pq z)c@PZq}!U?T_3gY`Pe8^o~Wm%K88Ni>}CE7AAh~{@zyIH`_IQA{DdR?gbaS_iP`8U zL59gulb=dae!3O*^QB}L@l#7SNo0(lPo#LFpLDq{kLAN8KP!v-DOJKxei=UvCAzHE z$w)bo?5AouKRwd@43d!3PhHt6CbyqnGAH2YMo^Du__>?yCnML-B59lNXGtYLfhww@ zmTIWuXH;E3FB|!((!|diiEHksRSQ1{q}|(ombUT}d{>XP^Yi?Dzy2+VpJhG#JorTM zdirTRz|XYL{FMJfeUJ3>-Y7qZ(d+0Vc&e!bVCoV)zo-|c6>UO(Ud>gULQ&EkNchmvzh`DL3tIqawV5kLQ4P`$tT ziM^zr<-i|)`d{(0*uF?ek$DebM}Fs z(hn8?k!JWzGkor+`3paFUiumTO7nW{XY#*(F8-%;O@M9208vo^#+d^YE)bwu!2rJ( z3Xm8Rpml73BT_vsz$jaQ*D@?2z|q72m68I?DjA?xsQ@3A4zRLJfKp`xyp$^C0z}vY z7@YxK=N}+C5MWtGfCrfYR)-WfKfvNj0bPR|Ah}L}PIUvMH4f<7+5o>b4^X#7fHAED z`W~#@Z3Aq4U-8-p7}+5}T-N}tx&^q=J%FumfOq-@I4G?LDCTDY;y(}2;HvL*JcH1I$M3t4RCT^fNJvt6kiyi z?Vm>fu0ub5iS2fU$=Ia3sLz#{)Dx5uo$Q0NwxA zzPkas+zXI@Kfv1$0>nHG(DGS;eX`+&>W&Dq*AS$zDaaQxL4K3RQ9+{2LAJ|LsbUE- z%o?Ou(IDTK3i7CQkPpfPS)ClDdAT67$_FWw5+tQUkS=M8A)6dQBAr1#kv(2L?ho?0 zY|RW}%2F&T8Vb@P9At4`kURN7R=gRce%&CG>S;~=Ak~`(8Py`F&mV()^Hz|+Kgfs=f_e`m$dW!m?)44wN=EbxGE`8fKPkvu zxj9*Jr|7Y%LE_}FT#|;<6mxnI^Nb)lGlP6JE64+xK0C-Cb2P7cn)TwKey3JUIW8?% z206b~IkyGbw_UaFQ7wCec=iSP>p)PSnP|R;)#o3o|EhAxaY?$ap5&t&L4LRyB=lF1 zT@Qm4cpM~AM#_mNLEd|&`I|G?Y{|fB&ERFx464Lt&_K3HR9ptdWQp9fWzaf4gD&!1 zauPFeC1vnw@eBfGGO(7*pket8w#&cLDkX!P5|f(29yuqsrHCVgH>8Wya%M2rl|eUm z20wZ-NbzP+AzSxzG8j@XL)YA95NeQtr*Q_on`F?bWrnVGQJfEyvqJ_Sb*rCS?#YKZBYJbbP7mUZJ|b&!GRR42(ZzQ0M0iHp$fu88|j&uy?caY*U`?8I0JY znoeY}_GAX-PGvCntm;3PL5uSlRKJvg>5mM~M`cphlF15dCK1ImsaYbE6K`blZe}J6 zD`s*wJCh+zGC9~ZlTfov8p$d-{&6NrpJeiR|4eGn&t%*J?O&KlytI>*%QAVqJd@~E za#{O+&m?>^lj)@^@<*A9G%8z>b5$!+=FN%}tXq-1aTOUdz9N53ugJ%nD)Q6jid5NJ zk?RL5;yhfDnNs+-iZr`ek==6j&x$y1Rb;x9xl@r3?^Y!BQAK){%VKl+EWMAF#eR1d zG2Se`k_Wk2WQDU>B0Z{Q@$;Kmq*c$NMx881*Uh4L{VY~>&f-ZIt?!n_u+OtN`b8F% zzRcp`z$|hGWwA`Q$^7A2+?|?5#`G)}$wslw$RcW17WHOlu|(PwVTmihDkbA#(ipERwFME?M(W z7SA7MapFamo@?2hac7fTF`FU-vKc#6_rJ+z@~CVYj>%@q*lfNSpUv(G*%%$G_B!_l!IaG?z(a*OW{d~(|fg^`v={YP4w&pN>TMp6N zb0~8>hYwHWa7GrL&*Aok9G3r)L!aw8Y`vlVH*?r^KZgSU&xI zYIH7djLl`Fd^JCpeG78QTB!Ala~brV)=1RqTUzj9f1E0@hu@$X!|xSh*g*?2dXi2Jz|mX-4OK`!n8$>sU;Tq?a(T=`l4dzDM~ z*QzfvL?L5{&*dj`h<`01x>-X^DIDTbkr02&q@p2yiwRLTHbkko5PPL?e26b(cS4AQ zNg>397Q17&HN_Si#AaD*_VhZy1xanKVYnUda5G@;onA0#s zkwzi*HP&s@5MRoSW+ARL*Pa$3YP}m`?0X?-9b#3R5Kr2M=+I7aJA|mxF~l0_^ihb_ zokNuA5+c7xh@qcoofPdGqD4RTFGB_^?-1o38e-jW?H>`M^GMBVtY$SX#9vZ%yk;^X z#0&X&n&vw_MDMwZxj-=&Dy9@z6k_3u5PN>qdH6}^L5BRS*c%jkV~EjPLY&$f;>~R# zYVQg$Zg+@?Js}1k2yx(Gh#N;jJe41ghS(u(j)!P?O7oNwr$eO6{xczpoe%N$1$`~! ze+zN$qGoX^M7z5odW!2_h_I}ZC-*gz2b!TYc@|>&^AOQ5LTn>URAiVd<}jra!?aHd zb4p5;)Yql-wcINcCNnuq&2nK*mk(1iHO!I}Y$_!JzVwh1`Ve00EIaDi5 zT%9n3<(s-;4%Z8lS3iuQVVK&D!fX_K(=Z=53-h~dd^^m$?}YhCTD==){(E6o$;~!l z-0i~5mSOLQIr>4EO6?WDgW`8oeA(SOOu?>Ul4O?@=pH6f=F49nhj}6cJ_++n&oD=1 z(5GR3?WI1XTkkMG_6hUp=V88*fnVtUpfIn#4r3i0#w+Kf%uw|x!{yjFVJd$croO}u z5A)Ut#go(G9H|;dg-I9_ro2p$kz>Q07#G&_CQL(lYeJa06T=jpq&dnRnK@bKU}_lS zv@mt1huI|iWWWs7Ju{4dR+z?f!c3bRrsd)=>sE$&xhhQL&tX2;6=wNv&F(;$3a8c6 znJ~}Kh8cS?%$ZAJYFt)7zbpThFl%Mn9nJi%YPqL6{?UvdhIQ?Fm_kp(G<~KSO0aAm z1CsN|Nz21gJ&ztW^7uod>*Ud>ZXP?t*&vUe4fD7vM;hl5-!zY*(yVzNGh5_Quw@?o z-_qK*^BCABk1Kuhu=mSjnhc+k$FZq-RGyYcnYnp&zI%VX?dRBTg~H} z9eF&J8`tx2-OR)GS02Vv`P3<$&*?Jxe3zQf-3s}v29~p5`-C&Q>lo<<0Id z9!2PXS#o3HsgHE?fB&2~x50ezW!eAc#tj(vdv1LBl}F0&KGiOC(>=G^fXZ)8Y5D*5 L>0hM(e}DcD?I4k_ literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/318def2427171f8c_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/318def2427171f8c_0 new file mode 100644 index 0000000000000000000000000000000000000000..8f30cc080226bfcbc2d5a9e616595fe1b8860c1d GIT binary patch literal 35088 zcmW*T1z1~I*M{Mj1c(s`q|_l0+>^Sy>vX2BQ+IcFcXxN!sk^&Py`6fe?k>~*&-c%D z-2=(lXYIAt-q6Sip1PfuXKDNWho7V(=-98^c)qAuHcyUXd2{B?o+o#nTzT@A$dMyg z&f>+rMRR8>=`EVASnk}VikB*uGf#=)xr%vm=gL*AWC>3(PmWSKvgge0_2$Z*+enPF z=>lf{FV_G5TO3jL|Gy68|4Y%Rlyn)7N=tdlNE0B2*l`T`%Sm++UtS8YAbD{Bx3RpU zw4{=B2t6xvPBrN}hE$jSLDrg5d;Hs3%GO2tf*s?eObex0R7O{9z)d_swMEiEoJY^S zQm^ZhtB8*_VIS_JK~W!#z=2{u`WNkr`=~d1mGF^&DIaA-@3KCsQ{G2?F!MJbeQxd} zQwtyM#4)&9`Y0LI&}Sx05QDZj4LX2l=?pp?YEagU25rKgOa|4?Y|xP`1|@|V)D4$h z1~rc`XkRgdE}~>{gN~In=xG^)%oPo4P|2V+$X3;$!q^XcHG^7WA-Ys22D;QSXi8&) zIyW)sV+Vs0IvO+z(^00ALH+TiGv9YHD05eX;_#!JK@EFwZcl?|V-Lc6ksHi?4XTg7 z@U9>8_BSZ!0E0RXG-wBQ4l>9(*dPzK51}R)h8a`@d(eLbw?`V(dz3-1$1)e{k0aL! z25F)}1F?J(HRJGPg94|JH$F`z_h|;@!Y*7v$5{qN%{D0CT!YrkGbsCfgN9-f919If zTw+khMn2$A>^p8O^?ikeME^Chb_sHeGL7|TfI)(j@4XXQ$d0rZ{ z=#@cB-c!p5gB~E}Bfa@-P!Nh?4Sc_{b{K#acnr%ogVLkKcgFlM$oZc^eQ*s2f3kmk zj9O|i>ZH-A^!`TuVKQnzhMJ9kw95$oE&^*AX>VZbJL#V?jH>Th-$_5+N2IH{_ zm$56_oi8Sh*+o*|A+z(HjQKJ)#>Xgj)X+}Nt7MRHkf3&Bs$rFr}PPw(>@8M0f?Gh9kA2Q3<~pRS~t(x(a!s%P9WVaa=+5 z8b-~mY1A@2#Nt{;eW`8K&PGN(!)Hux%-l_=vAI!=S{OC1rBMg*9*5c^{Y|Edf% zst4K+H>$-*qn^M$%BaKRjmj~B{qa9jr~w(KG6$YbX?Eo@-PSoSjFE zg+|3KF)G_iqgvtgDx<2dCH@AZPHZx2#AeoP3pH*vYRz_|l6O+WF6zW}jNHq9+D9J8 zSfBIEcY||p8CC2td7uw6Jz;NP+*9_}Gv<0hZ}1r{UK*9>l~H|Pv*)n}O+Okn;geA- zKO1HIV$^)Iuf|z?Rl@44rC4V3)uTXPb$9q`1M&v@Dnn*pC1VGUWcAfHm#+@EeRU5F zqJ5PV<12T9uXbniRqb59Dqg@>36Po*KG16N2s$45y?QcW8wv2D*tHk!cis(S@9eq`|ldtOc zCa*re%HPjdm2q{juT~84)eU4C=Bu5!`J%q~B@ zz^({CZIAR*(HK8f!t_`_Ws37tRdh`9(|A-&_S2m-KfT0dub+H#_-Rpo6!%l{N`87% z%})pF_-RNJKjmu0eXSXf-`efoo8j(%#1W1akTx2vDd_4Ly%&_%(*Bw#82ChJk(DMk#3luM&KJh zjr7yt@qP-ML_Ii-9h3dEc)Fi5%<$7;B+vGfaSnB&4jRw()1di&T7f$VTR_gJxyVlm zi~Y2Aqn}3Zy5T4LO+WRHHOk?Qn+rYgc+?^jF&~{^}F%uaVdS zw~Oy_7^5ToH3Nr`=4KqWAvoG!edGPrI>BE(a2fY;Hql=IJ}Le> zh36=n>aR~2nC7pISmW{6T^!BsuZB7O^$kaJ`Rj8Y;^*~O?R@@<$?vZ^g~+MAzgkoz z4(e3#*TsS4Hqu|MP<9k~!7-Ziado`EdQTvy<^IaO!e6N?{S~pwUz67RtKDYi`O9C$ zxBJU)x4*mx{OPT~)}h{Q>VE34g#jilu$$C3vq@928_zI3t4YhkOj_bH>2J)AFsW7~ zW1~zuic5GDZPI(ZjN!akj>Va@4rk*{x`iJJCRr0rYL;YD7feVtX&$zxm{c;=r1SU( zlhRC@kKa8eHGsowQW#F-I*w&Csd9Fc*5@?oV=j}Ta+5DU7cuF#q9z3vGif>QB3*Hl z{=nbJSHh%yC8-BvN}Dtjcgv73`j<87Av%@gdn_q$l3xXrw&D<;pjkzeR#h_T6N>$2 z(tf-}g(@cXz)BSVotm&3pRw%^lgd=(D^^rDX=x3U&eSyN4jR=m$yL{+Hh749^-L;_ zsd#}(^_d$F8km&*Pm}UCG^tu6&ckh#XiSgr1CAypd7GM42veH#eQT3^+nDqmU(leY2 z9%t58{E=o>4-Cajk6Hb_W@XN1))-vPZq`TC$zj&~+-BMGn3WL?aU!o-Ir5p+8a-ev zVAdN{C~B5Unq@~5{Efz?m=niv2|G%gHL?t~lqH7>W_~`+dRLL$Dw);mH?z9@Zr1Nr z&AM5`tl>4y+K)5%jM{b0T8CelUC*p^_05XJTx4x%*2_j_^=WKYS`)MC;|9JoHLGkJ zv)*<#%cl#upfA$8(!=g%RmTGi?_rjsr&(2dnRN@9`_NZB>&rR)%-Yc3tXu=kYBA8P zSNMTdgUl*A*sPPdiVx^Igq((&<;5brL$hIKokI8F%!4nOI>M}$BhBiDz)|!QV{u@d zS&PRrAI_lu1p17Nct4RIO(F);O*U%}PU0~(O=0X*v)bVfhD;;J8DYDuu>)hgqB1%Ug)OjT&~Cm3t@a2jecYN}QzEr&u3cMYq$; zj~%FchQ8xFCY&`Z=>mPeXjUq^{LMOCGOPF%v;M)etLzsPdqllx@{GKnv)5j*wlDcv zLH}3$OuRAcFC4@j%zI0pa2&Sxod1nIi+lKqS>GA|A9I>5s%o*QA^IWMYEd{=;u5mi zEJ`0}Q51^c7&-@8G#H<7EW{$a)1u7CjU(uo&Z2>Mj}D<0l}K;VqKp=m$!yVB%cLxot2j7f|~3jRWkoE9y~Wzj~QMeW=c z`R5^LjKtae7Nsj-Q6viCBq|oMs1-_-v}g=wVk?@KvZxbkm9faLtVN-iTaNj0wUR}Z zDqB<+oqn_E0NPfus4rgQ2fF-j(S<)O>Q&XET-Aw>*|>vtHRy9qizd}#&f3h0t*Bea zB6D4fGU8N2;x@8qS~H6lV?U}ix2QhGwW7Ax)YgXD(5ST^23f%^K_>*S+i)EWn0+#K!jn z7Tr2%QP)G{cG#j7D0jr7mq<89ACcuawc`o`Ptco_tl=s8c$)oqgZ=f7g%@Wn3d3jk z-eH~ZS+w~+wIb*d_58~kJ+|oD|2(m1%2WFE%%c7;*yk@TN`mt>{ld(57M*|3KL5!6 z{mlMD&=-s9p%si@EgJEi+e=^3$s>TMZI^uxQs&i=MXVqzcs|K2^8i&IuYPTve z$SRk^s$_J=ee?;oYIAz4wq;-(o}y7ktJ-5Z%4D(fx~Ekuvsx7yY1JCHRXb26$|`e= zRiS8xkT_za8~%#7>LBtaST#G*suhS#CP(~Cv8r~eRn1}dShX5|c&)r{WYt)tWVdQ* zPHM?zReWx%j^PPrQ*(aVbwCcMA2GSji1N3Mf4EW7PCf6tV&yERqo|h{keiVR$A3-l~om1)BCkn zP1tPJTs_lsjcr&(l`DIAhgU)ILjp&snwQJiWMNRsG9WwZ=VkxxzSnxoXw3>sIZ#YgOzM z@`3XyeZ+QrL$PO8O~efhd0|zpcUHA~&-WkbF%(I!_Vn<}6?7UL`&wQLH*&N`e|*QNt_*Tkk@XxP-IUU0XtsWvvDWh>4@ znKm|6L;kilO+@x~HZAX9(@#|HXw&!3HeKstQ-Q8Fb;bbrbhD{xUz@tZ)z79+18p)6 zvZ?1_n})-0h)so25otqhDu}oEg%QJ;cce`>ku=Jt=2(dr@Qh{-oIFJf=lQvj-&cAo2Fth)-1Q_0Sd1q50qcU9GHO2t8I!$ zy)~@OTI$8TbvE6_E2P^%EUd;3yxK^=HrX^3lW};nO}<;G6E2yG}&X*B5c5*z4QvL_Hpiho3b6SDZ@efa@eLq7;}WY zPte1Y)O?D)ik7E|b%wmp+H@O}&e>G|yiJ=gu(qglk(&RuDe@9~2qiAF?ig^zrj)Dn z5_7I`{JKrk@csttd();Ix5@dgO|kdbf2fNI_!l`Jun!-y?r8sre*8-hap*C9dBPq+ zo2NEadBz@oZqpIud_g=Ed1=#cuWUMqldoB;w>HgwZ_@`9|G+u;{i99uKiTveB|dW- zJK_1l9)iBIhG>Pei1^0O4E7`Acbl^QU>?lF;{W)$!%KWa^iTQ)<1c!S+gPsv9Wn&y zu`xged;`=4Q~Uz-rzt>fu{bzD=`sYUb0pv69$w*=o3Bv;iir+TU`&AOVloQGayu?S zGqDUm6Nr}>poLhF5}=&k0PV>hpp(dxBS2HJ2;XuA=xOc%eM0rT0a}TC`2utWf8-C) zeKaq?ailL8pkHWOC_t+)yKsOmRSQt9>H+!}V`>DbL(KqLYXxXIzSRv-zor2ijjt^N zRI_7%wxUS40G=}i=oHHJ3Q+Oh0onqez5!}8C_vkW2PkN2fW9vXP{u{{XK{eaVi4|O z{@MV&#t*bx7ohz}SRbH1IDxng0cy1|Kv&UtbAUQ+BhGeuhHm%=)prEw;BI=ohkEt~ zDE~hCvY%cb;P}A+O*ll%!vXR?5}+H{d^|vDCjxW^znvtfQ}h#sP6sIBOn`c#&soMH z{2cu_AD|Cdd?7%divc=}9e;rY0D(5UYGD_01lTnh0d~7q2ig@LWY-lO zaoCj@Y}Xt(LhL$>fnl5(XjYkxkwlJeU%8dD3{6U`n z_=>e_W05%ugEh7EXF z->#5`cI`vAMjXe6#;i{hyBaqozvk42y-3%Rx$w4)U9oNLx_|=h>?(^TxZa-nJFs>g zsksyNcV_KI*?FvD*LZw||7h~WA!rQih^e@WOk+8Q-LR%(N^2EcQ6O^N5Wq^X;03yU4wOSQvx(3#n<5U4JgN ztNs%5S<0SRW|wmXbFQ?j%__UD;lOIU+-vPhL&Q4vI2`NQ|9FY$4R#H}aRhB-58=;E zcIDknpSRd`>MwHIM$Rzppzr9olfLdEhu!pg54rEPtJ!|m{}4YH$H^ayPuf-e40{Lb z&axJl?TSP>_*@|$?8dpPjJw9q&MoHrhrChhww>2j?TW!HT)=Itxl4cX3OVkvXK)@B zAJY@)3G+N<9{4=Bs~~c}WUg2A;x&8Zja@n4+STs^zh6GGUp{d@nt!(Ik1uxh{>ogq z{Ed3P)0dz83@A|l8Uj_pH&7Ezfx2N1R1-^}9;2BpP@w^V8X6L)vFQReJ~UAM(g*5( zhCp@87^s=}2l+DvswsBjImTxW)P9_SHA^7R7XtMImaKtVhxV>ODI!n@{wF?ArxOBI zJuy(eDS^D75~#f1Ko!ass1n%&bq)J+1gdCGa?C}H+=0q~7HFL(P^+;W50N1saZo>h zpyuFV!9X1@6sVWY1N9w^TLr3Z>p(SV6R3c;fvSp0INUB!hdMJiT6PW8G1TZDC|eKe z?8*GSsH=CN2KEhZAxPgI6983>~2CB!fK>aa-xsY#kpmL7kzOjMIG%k>z zpFk}~(D*>5;?jgbRht;7r&u&8P#-3f`_w>nnii;~(*sp$MxgGY>&!sinoYiQ0u?(q zP?7TjwSGQ%E(}zcO@Z>+N*#v+wfi`IJ`t!Cy#1S8Zw6}c?LeIk4^s8GAjQ=UQVwM3 z5~OGh!WJBWt1DyB7~$Q5l!VI|-aSZD(6~pCmZM|OAoW8;uOOvh2#mdhivlW<3Prv9qJDW()eLP`h;4;gY;%Zkdj9RDKBP@4$}H@L0UbY z`zHnI?BpOVo))C$(}Q$$Mvzv{3er{-m>r}SbAyz1UXT*d3`Y>WfVq|gsRB$(gOs)+ zNR6-^`&S0(3{0z;du@;ouM1L#O+mVYjoX5>Zac?!1?l15AeG)9q+^GIbnS4E)*cDc z<5NNU^FojwU7;5@gH-cgka9l>Qngn>di{Y~zXWN_e?gk%V-Ho2~V;(^bsQ>99oRRkq*s4s@tJa_>8$x4yBKFC_{`x zW6&zrp(zOtcBthThYVvKdNj_VYU3ShG=VsisB5xAAyXY{0p~P_YE5^@ zGt;4F=#14!oy&Q6hhg&^@-Cu|UGxdh@%wK2vB#kaIESRY4&}j66xzpqhgq*94mH6l zY{S1t9cp)+c~7urryR<5#-Yk*9jc3&=b8V4LoZSDmP5nuI@IQ#L#F!3yo}2iteg3R6;d!*0}C-1mK0{LqQM$k zELai6gEazyC4;pNwo<|R6NgZ$Ot5B`4OV1DazXLR!PSiesT*0RT(8xf-2ks+#<5Tfax5G}zVZ-{ba4^i$MAu3ThL{+e< zN{GHy4N%Kd=QwcZTQzChZAPlf5A_?hnx%lsXWi(Qq859$ZG+(GYdQq+=nx zo*1H&=x{nj@6QnDY={nB3en*!K?NAJJrMF)OR?{ zPF;n;;#3eeW2)7u+3B2WlisNfXqw5XZJC`)m&K{!IER;6omvy-R1ud`DG^RJiF9gU zG-8-L&Z&3U9`97f1gARScA``HlZcbX`5vdI*Vq_n7_GG!&*4CXqZ!pqnw(EkLWVNsrNI8 zH`A%Qcn{5TsstutJ~GdCY708frT_SX!t=O|k2tr)sb%XJzkzr=xDUpiPSxMdy5SAV z?r~~09wNtHrzRoyKBr1z?tZ7rAL2NcA9kwoQT7K$o^UGLNv9fpcWMDLXGo_~=z;7R z)A2YmooZxCr&*qK3a^wTJ=4>o?uUg3|z;RL31)?P^Q`$)UsX%g}2I}N9{6b zc-IVS+dqTW9?Kx(*$ndgnL*PH8P(IBk>}qT^?OuCEyBLM8FjR1MrA3LQEgFpSw>!0 z&B*WjjH;a>lTOEH;%6a~p61G=p`|lvX01$e^~$8IZ!;;lYgYNL&Z>OtvTDWgtonH( zE7vuI>36Kp8>Vde!c-dja2l)ghpAG5Fr7!uf?+y{PKCo%wMdw96$|59`Y>%Q5vJ@V z!&C%gaTorj!gRKDm^PISQ*^m7twXQ!VY-cM6^V(usQ7!BY9oKOFqOqyylEV!VlBhe zvt5|-bPm%3+(2lTFvVdWI&=+Fl^$UljEVSxW1NOrH?5miw^-GdG55>n=kfN=Q^372hnxY9<1^FC6z22Bjt8w5=XSJpY<%7Lcni-Sl%H(bdJ znG1&&h0C)focD6VH4Mk_9j8xH)5UPE^9t8;6uc3xIc}GJz#Z*U8ZIL>&ZR{OF7-=v zX*)ubT{?j)m|NMUn;7?-OY_jGii_(6U268bOS{m!s!PV|F0NH@DW!%>6Kc9Nww6o( z;h)+ZtLst+_|$W$0%p{ADc_$i#WZxu(8#51Xbu0yF0F&JiA&|+Zpyf3E?sKwQmqy) zZG&36R0wb3)5@i#$lBVau9$=`SlGs;^{}>esRX9tE?%K>J95K0__udy6c%=H=?*4! zqz5R~$)&w$(AlN7IEKrZ*Tto$sM(Dkba&}GR`hVm-qWQlxYx_2#NIA7!GS)E@9WZP z?CI}PrvZ#d=fU)12z?#uQl<$m4Vyy!(_Gq&e{pmM@n(`I*32Sr)R;~DIWD!I>r&7> zmmVQyp-YjAIEL%6EOu!C-Ylhu%Ut?~5v$2>4Sm|=QZ+QkB+SPZG~7%~+`!K*E~Wp= zrFIyG*sU&=MD}eimEX=-^w{CjN<2XJo%9ALcezw?w@Zz15?ApHdG@$86yx{0GzSs; zT8E5PX7OqZvM;Ws= zOP=r4~qfMs3g8^B9eNDEY$0wNWmO ze9M@3^!B|=ud(A3`}MO+nZL5n{Uf+OJ3>bgW{yx+ON0_o#TKEB;Ss8x5TRT7B4jHP zq20JvB0`T4TQ))~%SC7_QYuC8c|gYFLyZXe)QnIU6s#SgawuLuLe<+cM~4Vq#D`81 z3h6=|6z>+nHLk?#9wBEh#`lg;nLZIR_GRqA2-O@Mq3^>ZGq3sdsu{%Po4>RxC2#veI zx$wUpp=J*w)ER+~BDl^hLaR{XNrXD!1#&-)&|+-BfoBma{31eI@a1KMa=xMu_=2Br zsNr3No}%sN2<^i~RQ*Dae?;idpAl+@tG^;NN0C}&h|~sT_l?vM+zW_QWKg6!hD7RL zB)B3~CoWQ>k|LFoBU0-MM5=3@NR@6Msi!?6WnL4hx`!im^IW7RUWiou-;r`%j?{hh zxe}=>Xmgb@*CN&XNu<`ijO5>*NVWJGshkG4is2%r7~NWpoA`)4|bbd8xa@aRvR3`Q~Yap^O7jBg4~kB&1cBmx))3wR1R@# zQ>a_}BHcX4b?Y)lc-@+T0@=t5FS5JUDu-L$(J-f5BXhZR1COyKuUiMuyfAYWaqAP7 z7j?_Gm|Gzjg@>q9+^zF)lyGz1xm!(f691ukNw+58WhuA*F74J`WGLfS{+e!e#l>1~ zU9U|Ya5r{qUQ@SzHKRvunWw#5Erz*y-okyu-5NB4I#7C~TUF5q!$!H~GnSesxn-H} zR&gv?;O2b*x7HwRky{HFyVZI%wXY@KI=6z?)3c4td%&%hr`)`s=~ms-^c@$G?TnlE z`Kj@&Tg}iLEASV-que>SYT_a~o_A~a1vigl$p4~SwQvlMzv<~E)(nAHSWhfN;8nM> zpb47aa%(AS{zG1Ph4OdYI*SLe-g7G>ZXxl$TRk6h&QrH0J*Ph}+{*QuwR^*ucW&)R zrw?w``$WI+r=m2#CrUO$l!l{*F-kLiqm<1Q#U<6;7Z9c2>`{7)nyFE`h7LuebQzY? zQM}I;r3KgrmEjorVtCmoK0g(um*t{Vv2v8!{Sl>pSXVVlyV0(CluR|EbQqayF|J+| z*Y8K^PU9%v508?)O%!VzrM&H;w5KyUbc<3wtn418t?1ArN`Iks&nTTouU=7FicNTg znBGy!j=4zf6D4QgC{4#LRO&}AxQdMfqEuyAlp0MUubEL?2NR|3_=+O4qjUu3IZ;YP z6C9WurQrEd3P<_{Q7XMMN>^}vLzD~~qtswil&Wne9)|tT)+ohqi_(N$^mSj9GVYI3 zv*S@3iVG-yB1$K*=VX+g;|p4xA_pAB2CMw?=ECEn4$n4v1D~48#xz_rnn!t;-?N zdW5RZXf;BU^wC_;7_AN&qcs3;@e2`|qjeg$P%#TRVF`ZA8m&KZ0e7$}ELz*}G(1}M zUD0ZdMaUZwttnWH4en^|fnQX#W+5$_*m!~|F~mh^Y_y^<8Bg(7T(ok>Ge0UOM9Y@Q zSS&=7)MzzJi&hO!wEB9Z)iE12us2KgI7o(c>W7G`a zakxQ@TK*ZMckpc(BM<(>281_?(Om36P~#Z2!DoawiBWajN3NzZdfqWcF`Z&Gs5AF> ziBZwvG3t$LBZxIBMr|<{mr-m+j0Pb4%or8N3B=BhQP`XqK1&m$3Ai~oMy2P)Xao*n z_re&RME6B83Rx1vwfHewxgtid5w|`@ga3-r9%SAYqYT?)6pb=Cvy(b@#c1;G7`@mN zqnvxm5d{v!XetIBj?sQ}K0*w{9VJh^Mc3oxhMOm2cuX3jvAB%r(=nQe@G~(Qg7lYS zR1yQR1<#QAat!YY$EX*!AoyyG?%)NYuf^!$^%yO<5u-XcneSGNt|G_n7+LPb=;D(Y z1w3U$M9I~9~rA}s4+TLsbgZ5A6rp)Y^>hn$GBLvA0MmC6Ju3=Qmpo( z-qcvlMx|-7s*i^#IwMvuQEqN5zk_3WJ`$^62v`%V?3;+UnX%Xi$CgV&%c)o`JsYb{NIVy-b+~jsmdA6knu9`@m>cHHvC4QQ zR*kR5sv}aa#cDY!UXN8HOhA?!v3iCoH)HiTD&LA#KZN}gt8R$A9ji6Ciq3cF-Q8H7 zhW|a{-jCJ4_>LJ5$O&f<_K=(($8zm>tQtIv)sq*oy7Q8ryrMsEW7X+XEZ5e?>Kbx> z<9wLE$0`qcVw~c195IGCS&VT?kLcIsW*Hg;#5B}PBYzcT8@u67aOPj@o{>T5GQNFIF-P{LX0cSd01X7PWMo#M4W6T zL+s3JQyEr-8$7wG5^^8+;f961w z0ddMOC{7(Pdoc0F#OcoZIF;QTr=6&_B~Cw2#&LaHoL=J>7N3sOALrw=19dLZ6I8ey zr@GLUICVqT8`OumTg>q&P6u!%eLSBbiC5lx@mh%=$aX(o9dQ-UknkX0xiA!mZ~^5W z#`EuTyxKmB*K7QTA&=v=?@7ECK9AQOq`Zh%XRJn>m+_i|4~TvhudvtgdW-Nk@fz?h zUOw;RRT5{A{zJSPU^!0WE82e|&(HB(^BJ#q$o?gs_X*>536;LZYZ79d`4A!f=UD?=xJzzJ|R4P zg4~%C~gcI2=N|0tp(5Yy}ha z8tDp=N8tpeFOs0nMH3WPEI~QYx@3Y@qHd`KwZS`7E<^rh=~V^#vMoXVk!^c|is3k7 zb`ob#f`(j8(6hS!chHLg1%wZbNc!+LBGFZ4PJ8&qTi73 z+XUr&M_inP;eCQ0e@;;3mjoWy(UWfps)DZA@+(2FP~Im|*$s&*f}vREpQyViXik*P zlBkT>8Iq_kSnW*IE)-3dsCl7@yhoR)Uhv6~s27OHn5YrxnK_ZqRWm+IqH1MjyepC4 zHHo?wk*GS6iRu8eJ5iyigeCYJMPd?FE;f@{XQ96^T%{YV}XA?CH>CTf6&f@3=>i?U(ZYJu{9qzlEsB!la zRsIn*K4yJT`WZQ3J?=kGRIV3^+VCn-;ja^wgvjrS3jV=uWcih-_Hg?o=}$NfNs5BY zn4}a(k~(21t|2-&N!hRwgF}*Z14+&#b-;F9Mfr3|nt)QFNm`8Kcn_sdQXcfhX#7O^ z3`zQh@)?s<3!^e6=^vDfNm30Q#EsY_JwvUyBsIsy_#{q&Y)pR zlGb7uilrvWH!VqxaSPc!NxY|@q%W|0lavpoF&=mE3d6D`X$uZ!Pg3C=N!klb&Lnlg z8vKnKxso&oL-HgkG+&Zh=TFjKXj&ji1qu=maU7-gbNoP(8XQbg z+v7=Ejru2&)DD?XvL^~Ot-yPl*rH`t5+u?DdGVqI_w z-wnw;zf9H({JX6KPy2)DJEm@}S$r^(rJ(HEcSF%lQyMvqJ8y~bo+n~i{il<4771sP^$7o7;=IerioBA{Yg)vI=MFjJ1kT@0)~|c4*ZpKo zdyuT(A0~5MKgSXII9YYD{RusInyfW=`;DBwGY(mQB&#|$|Cg*0Ka({TW>boa;fOg! z7tz<6qM`N_O@d#>6pck-rWDo1i_9sSo+U+(!&4OLN>RUv6y=LdQE9YBE_aGW=UN#6?iS6uGbzhQcZQ`;wxU<_Aw@$fl3%41 zRmQl6DLRe*jZ!oop^a12sY!}xB}J zQdIa~#$d&(6m9)4MQ>2?7qx)D@}gj$RJB2hZ>rh{r)n+!3`tc7q;sZf6dvPz`cwsG zNYw#cK-Y|^dX5R1QuQ?=RUIQaCm~heVNOg{e4SJcLH_!w8jlW*Q*{MzTBNE(%T#?q zwN|N8>r_=msm{d1+8(JI)RXh4rfMisW~Hh%!e^%{6&F!vPO63>@7z?CMUHvoxG+^o zi&9k(RS~izRX>-K_p(&o#gOIXwJKFh*QBc4`c(Bi#F)dW>V{rNQsr}$KH$f(RP{Ta zs?o@GB2{Zna{j4Qxz14A`BcUHL)<&5vfWM9Ry4Sms<`{9TJ)4Wo{@(=P5A@UR0i)+ z#F56|;7Zfe;51E6pQblxlrc>YGNmbZ<}{VSYh=&L*RV7Vaiz&On)_qYR4X=(f5+3* zJ26dH@Bo3SX)=4#6pH;w%9f@E+0!&HN1Fb~nWl?{(lnrGn#LkeG0s6;@ieumm8Rx( z()b&SY5eV&Gz~+x`e{<{G*w4q1olZ&rM|@Nm!{DJ(^PLzn%W|MaGDNGBLB&0T8w5> z(llsBnySuBQxjyEm8RNr($s57n#N(;+BEf8pQfSkY)I3ZjcH2Ul&02O(scA-nkF1c z(_EA}N`6RxEKSd_@pPKTUrv+zPMVJ0V5e890aapVKtc$0I+3M+LCX z=uu%mkB;Lq2KamQ(B#oO_?kUxiRu=QmIZi}(e6;bvznd&!h1TnBz~6(&GR^8hTU~3!0E$8;>Sq0m`?fFYTzMgNMg79?k9R z;dMdgMB8!na6EIM`UG;E>EYTnkE+5n+oP}ZJUTVsqnjAFz@tx#>Gu+kuA$FTkD``) z^bvk5JY3&R57v1Uu-T*H$2bok(d+~@;n^j6an+-rSb5E(`qw==d7J*;^C;aXk6NKS z+@C#a^u?n~Up;#L!=pDp=@C}^q6T^8^zo{upI432d(|+5m(S&Uc^%u!=kdMTkjbk% zS-i^c@@gXHp=^X#qawZhEgCPMmGbgBvsVjHKF+HVsFv(i_B5}G;5k})yqfFvs#12Z z2IuzbX+f`g7bbp5uWsNmCYAE)Q)#b!%XpO@z0snqSEDO>^#rvmd*xTf%irJPemH;k zss>K{;nmG*%w3%tV64HInqG~s<<;5RUhSywRZMf{#m5$2&1&V<8~leAt%==+*zLSZ z?Z{mCuaj4^yLkCKwqCXB=H+t}^aSmYsV8;z@+zbcaRv|v|6#>IuM!4x-Vm=|jPR<# zNUz!;!zgMT?bYHjUfmz-)wA(lotfZO#6_Ja zlrGXiI?{W4U*3ApwLUB4=ALu*-X|GT?mbr(@fTeGBYCI7dy&7sNrNyh(WDHtXlznP{EgCf_D2<;N!<*S2H-Lt;RiqQVqz1Mp28V0 z=>V=`YtW=FA(OsNHt7oHq?lAFVp0riku{ZAZ~?9~lWI0IX$Nw&Fv;JNeNeI$bwHuk zUKm35>C^5vO8vmo#=#3h~sM8FS?jZ9_lRidw z{DH=^i2ob9xx0}b)G(`ZO*89+m^B+`QKptzZIOXfc)zw;pJ6ldC76|tACSppRtQ6J9CZyd zYkHdXq2H`}*o2}@&3cRzX=Zh9Zq}1H+uE7s{KPEJr)CX9gHC37aT9YtGwUCW@67mc zbTR8G>UTBkI-X%&H?s=%W^82cV^$%|#G}v6TJwcjJHIw7%UCnNfta-mO~;w_-FUM) zOfc)x60=GzHLKsZX7yTT)>qhxYTubP?`Jb>7%e%D-ZXQplUZ4BF(0?h{N`uYNzA-s*6s&pefiL=B9F`( zi_(wHYVp*}c_q~CnOW0cGC!Ft8VFNn3(HAc8FxOlXk{mhHsU<~*O?qqysJfb@d{2&ub&Hzpv?%u;iw5nrXwN~5oQExHdc>j& zN12Ng?2BiATQu{Oh2Oa>`tzbiAKoNa%){8*79GfJRhcYSoylfZk?dA2%3;-NoOs8o zf_bc(R@BORTvkmlW7ScNENj&alqzRczw%c3D_GSWg{xTgTUDz%yRBM|sK?4N>Q+5K zvd^k~hE?B(t-6Vf6suODZp5ldsaCa0W8C({0P`nSUBLr1?P%rwhm~`1tSZ;ls$rj7 z)$$Aa9bwhC$U4fZ-*E_!v0*g*jJ8Rp&=$UV zRxO!t)#U}`z0In=zgsnbyH%MlSe1ka$a2xD(YSKSs>zqFO1y2=0Mz==s>axfa(Asd zkN4kLl?qlmR1wU@^Gr4^&1_TE>^5~oi5xan!;i?9%f_-)Hr+)2+%}ylVAG?*Hr0CH zrm;nAYFN}JXEmFKpl)@WT-b+7HEp_rhgeg~rfjusdQ;b?&NiEtBbsPa7d$|6l1(p> z+iuez$nLP|CzSQu6i1;ZHkHFNWD5`%GN;&N#jJ=;!Bm@CV+cB@(LbWi=pPS|+=4t> z+LW`iO@AVH7n?rmYE#K>HdR3g3Ege#hH^b@GT~_5Y%OtaZG&!#O4YTuP+MzdwVJa45E$(4N<3yFPCvv<= zqTH@TK0hR?o0qMJQ3VrZQHzvF7GUQu&EV+Bhjmp(#n6!;qx@ z)00$iW|F?0l_cBjBpsQPq>dR$dNVIc(-$PE#-b!`EoE2p(sun<#?JcQcD|dl>w8?R zY}fXxc70dVt}6BIs?o%*&+tK0JLB7R3oBFYa-`Xnfl;mO+J(NY?HY~7>2?)sN8iZZ z-mc=ffHj@%%HGAUtX*k~N66NVaZtLuT~QS1VOJUKfVrog_i=W$?`PLWtn6>+vx%MG zmF-FxYF8pIjHK--yAIF9-7I9}YLBc<5y1BbdHPicor zBk)!khi+p_MTh=HawUfzS9Yj#6^AC{AiPx_I*JGQpf=m_1{V_Or;dZQ#vK}jRSg*j znHxD&7u78erQm2|VoM@6?1$e@PPl{K4u`5b9cqDXE^@|1w?kb$4ps0ulmJ_*Lm%T( z3x~>2AwR@t6C*|~a%dV#|Hyb~^|M2bHaf%wM3fij_B(XuAZ`9|s2RS;2ZtP5{+C04 zqRU~2zQUTfju7ur`aMIAc#Q&Q9WuXljyb`h^A0^i$qNo8A{l2<>Y_vS5WqB?MdnKm zg)tVNU8a^;^RGjH;~sKdai}6(n1H+29eV!;^+uta>#YTkBeJeSEJ-_xo4$lc4Saxmi{p5XbHPL=6PJ{XU+cs7VWhC1~c_A!hL-*_i$ z%Q-cBzEjKa1Vz_5)pUnbJ#p=TQ~3@O%VA={QQSeXBREPuQQ$bW#X_vb*|$zOHRz;M z$NzTfCERD7`V2#{_L5VlaO*1dyyjHb+fGeI7%PW<XQbh0Fo?H1E zy44W(Y;KiEbgPTktxG<)I{Dplr?}M((^|RpPP$u@qi%f=cWY@Ix56K}m9?E)HLvpOLbKv2hlgx03Jg zZk61{HniF8)?Ad_L+*RsitTrEoGQ5;Vm!<{;?_=_Mvu=2qf8<^X%|yLAU=9=Vm}G23B(;^uub+feEm^M@^& zJjz|bquOv6_UJQQDC*G@lr4th9&N*w5+2Ph<rt2f9?m27sNn#QlJOUw4Du+~V2^hF&!dwlGR&h|7=eFKf4E0I zMtJl+Zjbb+^=OZVU=#X%&Fxr^o@4!Zk9tn=sO=2$!dYaS=}{>JFdtiS9xZ2il=O{< z?*={EJ)hhbcv#nyIxXa}MIPC{^{{@YM`f0I^cwA#dpPdaBMaVqPaRgVZM8>}F=Y+= z{^U`Obsj~~4@Z9XX!9=~T|~1@9*x9~Ez}BGwt7?obCxhgpLP1>Vu&NJ-URZhdjEAVSjqG9Cz>%j}CjZ<%mavkCNjt z+8p<2HeR9736HFAo%HB59H;0PADpHwK0eF-nD^E>j~bt6J2Ebj6AE4Ss5EN)OZ- z`o;~EvU^qB<>lI4UcKk@vhJOibu7GE)zqua*bwllM#!trupW!UUd2+pdMDylRjkBb zTtnMbuX^Jks--awKEVN8N6u#Si?YqVN<%@UfTkl)S3lj`48~?K^mN6IDO)sugykQ%7RLr=NON zxsz9~dV9HUA3pbLHyVH8)#%|~?H}dU$Z=kd3Giy}Os}SH^=ixS4(}rr6&56(AdZCCq8+T ze7c4?cAwImK9zL&y;bx`ogH zpPmi$sofx-nt$cfl_5SoK+*sCGzS0R!(l#k!9}zl?$Z_&9N|+-EW%^hNBT4jyOBQ1 zr{j2Uv`_Q!J+h7S>0JcI`}ls`$GT=du5sqmU-){WPx)s0R05;%{x{@`HnYhcMd$eV zTSlI9X^S2i+qhRUhXq`}89|zUI?>d~}_*H+97MS{J`KcrjF6#{nGDWD zG;}SqpHN^X{cc?Lko~Ex1rB*9%=6w+JicI49!EH zyoUPYG6MMwEkPi^!J4H8$F3M!QOHpIT|=GUGxQyHzHg{-5&FXDqJ|z9GxW5$p-CkS zeNoa-)>4LMpyCIHHlTHBL%GTrI)_L(L(6avd&<*a1>%IO60uh{w6vtPS}i zr7bbz(~k_5|Jcw&>}+T79hspJx?&tw;|T7fUhu0UD?q$CA zF%Hh|H+_^_hVv=U?`PEM z1+P1N`jXdK9zSap`&B%zUoG)*KEKAi@0Y!ZUteQk3BL-L^{ZZazn-Ff1-~+X=vTaw zUwfYGUn6k{J8Jv6Rt0_G2i!q{I(~IP-g?1K}&~U`{8%`^&1jgjE$Ne_QeLg zfWzz8DExuUKKe&TEWtIDHs}je@FxoU$p_=G9j{<+;#Uu>!X*@K>Q@sC!!Eo)!vN!A z175=%^mBa$zkb3kR0&Z}WZ)FuP4+81GmA)|-hmj-AFB^JdG0vexGryW)Ja*z4YB#4An1>_C+rlp&hGHWgpk_-y#}WFq z0@qQY74^ad?7(BxZtdqdLu!i4D3|V66f5P)0=m{Apo*Ua^f#`fTgQM7d>Y_)gW8AkzMu*P zf=Wh~U{LR379NL!x|~cKG!6&#b6QZ24na-pN}p)+MNn%orf*OO`f)oT$Qn^W-9-L@ zv>Oyu?ZH7^!UOdEDyZW_f*LwBs7aH9I)tH9f|`t?Q^{>wP-UkR*H1w`$MnOqSwb3{ zHKcCYLW<-JsZrjLD&-4lRsN7R76@tNyCG$i4JlSNqLqBT{EObwL_Yo z5Yl*4NH^<+^jH0mb~FfSQ$zY}6jBLGNY}B=N?-PnlAIykaE0{R6VkWdkWTnQT4029 z4wL;MEkxxeAq{UD;`;9)mBL^Y85mL;at;cqC^GP3a7cr`3TX-+VZm(r!Q?sggUWO1 zCxbTg=m&kUZxi=76Cd^?{406>Mvhx(vpb~on6ihwP-SmOBld;l+8LF))>(W~HmvsL!#apl6~cP21KYdO zSGTY>;Ys(f3Vsn*`JrLu9v#-)DPgUe8djkN^tC9gFL4#ez76YxbzybF+D&13H;2{r zH*WWY)&FEz)hefGM~f8w_Hl|Tv`lAXk~i+z!QPej@FMpR{AME3m=H98v6`zIo*iZ!Pr`rny|rk#&y zEmmA$oQn~Se-zQ2XA!xdN7VI2M1@{P6vQly&z7nM@1*J?e$11q&)TKx5T4`svQ$l2 z&Moe(NL8nmsoIR9t5X$Olgj!lscNtxRqL^Td#Y?ZQWeG7ovEt7D^*L8u{%|h_N40F zy{UR~H&w~^Qq?_Inu@%ariNILu7%UI6oreVDTX!3T{KN!pz{Z5>QXLEf%0h@STRjQ z!fEQ$Gflp+XidTg;xAu5y#o z)nID6=1xnOYi2s~#G*CtcUq)6a%<9om?#Uw%nf?qAbo$G9!&+OjoWU+zv< ziKFQ{e=%L(-cQ%O2kD$^m9C9hqH<@AszHvZ&S6BpsG8)D>c0X}6)YI#^~qx&Ms>m+ z)i<7~CI_NA_GMIc21ixktEl`KJS(cxbE7Jr5!FGQ!IXJXRh=KzB|N~Z1yPw6(?8B( z(2}U~F6Tb3{S=jTZBz!X;KjPAYOarJC??<^yuTr;AQmF$#;6Lzzd5R zsy}e!OqAamqjEi>57c{1j<}9-&!W13=g*^R^CGHlSz`JgZL-GH9q(m}>2&s(isy*w zAkJV)&X`QOV%mbVJZ#6q5;28K#uURJ$XzNXCz3G-Cs5#nm`WjDE~aCZVoInS)ADLD zrPPSAPC`tdI%8@Sj_F(q`$S@@--@#!xRs@6E4GvZ2b7uP54<64ZgQE`2T&3K7i zqvNt+3}zzxn7Ce{$=7l9!BPA)mcGWtb!}o?lP1O0U~-)IxN%jU8rL4&L5pc|4Z%@Z zrpLKnT3pL<3>WeKjJTSkJ$^@(nQ@tCu?>4>$GI+LT&3n>eq1Y%e?eTgF?eBIFR*b@ zTt%0}^$*%CjjO{?aea0?t|KSoI*#ey4i2EJzHw;!qpxhsnTgojTOlUetU2yU)quX N-!9AlZ}9(a{|}3HSAqZl literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/5073d0b38ee6c87b_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/5073d0b38ee6c87b_0 new file mode 100644 index 0000000000000000000000000000000000000000..0c11425b958b06380d6dd6fde6270be71b4e6eed GIT binary patch literal 35308 zcmW*T1$dL^*T?Z+leF6DU+j2-W;V$0Ehpl_*}kxX;KK zXEHcu{co)Q{dY1?`TzepnEx+BlQPl;+%GHTD<@5YXyU|C6s#cCM|?#oypoiT1Gs?| zm8GRsq(kUkl|D73uNYQS`WM-2OC9l`tCXXg^a(pANLdz1v8amf*nn$zgc^&b!8nKB zd!;^CBu_CvZNfg>L8Ib+8ifNT{PX}FO8TiU`jqlhKp8(}M&I&&s#noZ{V?k%KYeWJ zCvz)5?Zi=dTKg#(HP8gnZT$2n&f`p5Kc%+wQxO#E>Zjhl{WJn)`}*m5KR*rV@27DX zGLW%``{}n)#E0O~e)6B{50*QpSHd7 z(_s{Q?Wf9L{q)sjP*Z<{{t7W@i`$?Bc#^@O!=VOc&uq{p?8#zK-K+*3$!1Vem_a>o z-eXY92!r;OFz9cTE@{xw(gr;)XON|`L5->y)DAhS8&nkg;jCd$Yb-*ynv8*N^$hy0 zsX<+v8T7uBK?$7=8iN@q*TtZL_|%o#-3-dw-Jm#p>tRsiUi9s4&>ZYRcpqYerN2Q9 z@dw@vVBUcS{hSHfS(bOd)3+o@!9wZ^Vrc(};b#L3ywX7twjPK~ZxIDlpHWHS-P1xxk>|m;%=# zgA$h-lzD|gH&+@oeiiYrF(@CVtu^Qr_N_Ch!+PdJ_6-J|#dS2?Vvy;8K_`&wAZ=m# zlQyRedU1}JuNq{%W>7jBVi*=+4W|5S(9D|#HM_-{qu^~~xnof1eS=P7|3ic7KVhEd z1}%PJ(9*Z$^3I^Uho%I?uIf~=x5pC3)SfhM#MvYA{s!KAr(~P?3GwNo#QCV^rH8(eHa3haV z@A4a!QoyJ|1&wM{*r+o|Dr(eg3@>KXT0B5XaihjzHu{wy){;iuhNm>=5LU*hJ-Azz zdXzJ&II5std86**w+cqtD;l*C;gyUUiPXwQCH!PmWzY$MjgakJZx)} zxt&o15!k_~7?i^WwC-fo(auI?@6P(+Y7e8H_cUruFV>)zL>zWt5*X`oU64raa~ z?2}>q>oVM^Ug$W|s8*wmdIawnqYh6rD%T|T$^ZOD4#+f(Iq+mUw`UmDevVO(=NgrD zo>9$kW&zt#@}Gn@l8gJ+RU15A;+yot=Vo=@=kKtMV`2V z(RvN9zuG06qQ6(M{2l^q)BlZR+JZ6tQVXkM?1|QMtxl#FE7}ftJdmn4i z{Jl|=J{Yy?qfy3BMlGy-nw`s}OQ@Bb zzIjaAmCvNm{3eY?>4GLrL&-uWO+;E@lUiaAiWD*FXfeh{q2eaJD`nCjnFA zV(ZT)6{us<*m@=%Zfw%JCMF$%t*J@R;Ma`Yu?QKPn=})XTAH*3X{}7E(8i?w?U<`Q zeL9$w*wLhjPSmQiN%gy!)UdBfqi~>~Nd*U(R29GB>p)^3L|#KpS~<+5tH?6Kq@5#8 zx`K0~m~V_pk>ePDf=T73n$#B)rkk{Q2DO_-ZSVo!(yiTu?O4~+gA=I^iTNVogzEOI&g6%gnzH%esk*TBsF+MmT= zBeVM}D9m5KqeHmAw&EnRdi?bayCVFxJf(K*Rq6Hz(YUpLeI z^&A({{bkDKuf+vX(qAR3`0G^-e;uetOwIh2rwzy2(jGsx^Vfn7{`%0#Un!ma)fz{; z`0G}8V(v}+$koSRr_sExzrJEZKYvB__t#FO4)j+c_y+mwx556phk`?x2b0loD1A|4 zn7_6mdAPq8A;SoNjlvgv811j26a5u7g?w-dJEr<;$qavGn(42@NS@;_<6QDYJv5!? zuOSQkwGuZGwvd=nd$GR~miTM!Mt_ao$Ndxj`sXiywfVHV+H9#LQI4wXMvBnpmTlh0)fEwox&=>rfCqN(bF@F94 z)h!U9n1TVSSA>`<2B=kK#zDPm0s4C|v5gK;8P6ewlZzS87_ab?Y#gh1rDnw~r=D=GG^^rj zGr#{?kFC^jn^_aF5_d3uyIF=EW@W}X%-?5L;{#^(z^@0*I&heJ|7liV>_*R{tm84( z7yD1JpK%+%oiuCYY4*h#<~(awvA@_8e^Y~hSnKmyJ0KKpY>u;HL7#(l3F8FwtobFLu*zeN^)36^OQ2hZpK#z$9h0zid@f_Kn zm=%vqui2{xi~Nlic@P_5(LCHn1+ztO5oEKd9NOD0vIbhT&}GqM^bh7-h(%Lj%V3c^ zlSM7FSoF!ucu^MpK&Kds!s9I3ieJ(!>V@H$<+EsDxSIXAg@LC zd=_O!V;s+KQLX|OwM8!&3t99Em5N)W(iS<<4F8~M8Ro=MoX3u`7L6`PF6D`#l7+{o zMQ zqJB*+N^53OLtMqD<`$K2XVL4f7Ws7}7W7A2cWT(vqMEpik-aQ(^|q*bAB(OdYd`9W zC;jO&z@iNUEy^>?~dVz2FeTYTHhgx(3m+%hVhY{0oi_);vEjGwCD_;qTMRy{N19^)fVMnXHgk6#T(4t%wFEY*xSfqhedgJ zvVJh`vZ&MvYJHOR!6o!K#r)WT`lqQozGBiDi<17L&VO5!if;d~4(BZ@dC{VO@#GTw z1tsp2FPc3e?x*avXRPgW9xE95g2%)wi~hht+{FCX)CtF6e@p)_>{;B#cg+4u`~R5J zVpVmkRgEzK!8WVHu?pvr!){f^K&zrq3`fy5$f}|EfTJN+Io(!eMP3|1=L}X2##?j> zwW?G`s}^Urs$5p9#v^}r=0aS!Rqf!4u&M@ZUaP9&Zj@E=(N>+sycnx~$5B*@waS=8 zd!*nG)XHtu(mYme#2M7hYgIr#V#a8kDQH!OLRLkh2u`4KF{|33RB5ZmVHUQcc^Rv^ zpiVif{L5Pvig^{7AD60FRi&y`_0i=gs}7)jHLLpLCBC8C&sP2Qi&cH9Ta~9K<6{nP zqC+j}T-&NCb(pg*b7Cv%*R#q}->S?w*_d&gST((cRZFlR)mmEB5EI&vTU&B#M{elR z-l~hZi|ie&%Gc4V(s+XWove!JPmKpyH5LU1S`|2m@o*YX&~LC+=FwIyNA9s!?Zdor zR{evi*s8;5zm0nAB)45w zE!)i+>><{@>=!J=hJB2UuLrEUe$cA!hluU4RVz{9h*i&#aFjYC+c9#-MFbwFHYZra zlhpAP`|&FK>t8ExI9nBlk1*Y2oo`#U`3|`v=sx*8V2vJHb@_iDS@qjv>h#2_fzR0I z&#g*=`z7_ltT$Gjd&@q5&;I?${zK3ws~VsUjGwI<^_AGZu|L1l#?Pjv2AewLfYGM2 zXyR|vsQ{Y>n{Aqa!zk{wDKW?pSXn~M8#zqhP5pUB$E3^eyvTDHrq50`~G0<&~>X#-w?2a*ml~~X^&0b{WkrKMks&4 zrW}WCia2W1UA#igW7P3DZP6cLCzuBnPTJJ_lugf0+w>WA&rsj9Hf=daEzaB2@PbWk zaU0z((hi?4+4SU!O?z(H6#IyH;C@UUu^nGf;)zX@aTUX!*;MC^OH`yI7>&vj2&~ zv+D;MH@B+~yshl2i%n?VhJGm5&aN6L*xs(m$l1ZJ6`kz*j;fvQ`r6g5%iZiM)ZMPG z7zDo_b~W#BS9f>@*!5wsUB)4H^&V>1Nca!4t0*cXZMa>9@ftrcY6SC+w(A;_#@N*o ztMClIvCM&!Xfe*N?dUkct{Ic)1IuK)_TVIfr`q*1-lOs~yGBo^9d^%P{+V_y#5!b| zO@3&KeRJ#@I+r}*n{QVq48WfY7<-{z8Bu%@Iby>9elE6a7mlOwQfiB1sJYy(X;^|a zE9|<9qN|7l6@OINx9g`Db{)itm#o!myXL&L z>m5qIqYr+5Z`XnkcD+QYkKD&j_&%|RpwFx!+TaW#zVMjAeq{b?SN3nrgZWtUACEgc z#}`C@r(Q7rpys%N^>XNt!J&snhYFb->W1I^9s1SmPSHPj$8tZ;p;=gt?+J{T=+Gi8OmQf8xCgj=tL0Fq+78+3 zIJ5#^>N_-`xkF>|xs^k;J3F)$#dI+AC4n#gF|gLI&=w5H#^j28{=%JX6S)` zQFDhw2X|BJJ>;|3p@RFU%YJHofb$0(nskUU4?7fa#G$L$e9WP=;|`t1PbY}!B=tm* zQw~L(cBnV{ouM7V&r*+b4!y&YzZ~-Y?a*QD_=kATJGAQpYjV+{by#}cp^g7KROyC8 ztMT}zLpN@*mUkU$bdUU=Iy4i@Q1BUXKX<4Zj^P7LFC1!xJvfQHFC7|;iOBfMp%&n>8o}q}7StKw8N z>Z3J|VShE&1)mZ43*%IGs#p!DDq}p3p;JxjTg$26(Ym%%3+gyksIF7%5K+&ma`l}$ zg@^`Djlc%nYv@!+W2g3^M-$FtLsQnLnNv-h6JJYm!(L=)&0Kih&Z*e;PW^>K9h@qU zrMS|O{5!FBoyoZi`FCaQ#yEMd;?zWZM!;C#)L>xgN%ge>DZhhvDFK#aJJLKBG# zStmL54W%YKH5)6CWeWAfvFX%hhEw%mn(5SL7-l(Da5j4!>GK&I)fPB49k-BoA!A`2 z7AzvC#ZLXY#Hof$iDwymV!2c9mCU)ysdm3Rbr}a%JLO&LR2m}IvB%+B&;G}AL~n3v z2#z6WBYOzHZgMLBX6n4fsgr*Y(>7v;c?Wez=bhAb7cuOn)_aJ3uTw4dv;K#8TpS~Q zEIHv+&C~21tUJS6TyQE972tP~c(5C1FVXHYkDcqx`7d#!%nc{+tvVHh+4u`Lu;v!^ z#S7%R&7Q$IRDMWJphwK}n0es$)TzSA`<%I6P>YxBkylRTe(ltNcl>^N&wlwpf3*DQ z)Gwc$>ie0waN!I2e5Eemc?>8}4-A2-WD3+|bD*wT0@chKsE24_4^*flP{Tt4H9kY2 zCWZ!TK*m7b$rPv_nFBQo|Ds@)KsCosJjKMUf!dGLuw@J6^+KS&!J0i#>(J2?C`AP7 z!2iSt>Qq9YY9-GuW+Ca7YWq!mVx?;rfmY%zHOiywF{J^eW0pi3J!M&)S<4-jn>@* zbriLF2Fl)xJbN>LAM)xOsKNaMb9%J;vfGfqFNU*rx@m%k)4kn-QogGXr%S-Dd^r z`W)h&8>rZMfr^|TsPzkob5WqWZ3>j%R`NI$sNKh?^YK8X;PpSmdM!{xZv^U0c#vww z1u3q6ka8hYw;)Ah2)5t=Jl$!7rU>s5q$FIx$euy^4NZFmX$3m>4$=Tb^a)Z5hQZi3 zNG_!J3sMVoMVJ0T+JHUiI3P&CDVh{az>E;oEfB5vxBr1h2{k5*}NcSpC6=u%dU4RWch%cV{D2ve|&>pNUph6W)nO~IpVF1^R72$zW(m1qj_lP-T~@ z{p3=~UtH>5-K9@8Tv}h#rN~;uTHB>E^<2CLcWFQ)`ZadxSrg`N=90I$OCMUew7jKD zPf@ImOZ)Ky`P-5kHsB`W+qpChH}S5$OMV?(O784ZuWl}t=^OPBt9?b7V`tS9<>qCK9W<7b!p!T!a? z>o=F~q0E0Sox$`UE`3J7&|vMrpRi;M*3nGCI+i(D7jQajuo{O4t93-MIz|R7)*GxR zxE~d)-O<6i922aivB6p&AFLHg!P=i3tl2q&H7{?l_T&pzf&8>95UgtjgB4OZSc8i& z7nT-fuHwNOULsf#C4)5zfu)1B4)!v^`W1&zrd+V*ln+*9Wnw|es=?ZVZ&>qluws4* z)+`*r%UZ!2T{l=cehpT&0l^wGHdsGT57zRB^oR1Z;|8vI1ZS|RFICqxbEhA3OT5V;zM=w_1;9cUV&N6kaDszr$6 zThX?4h_bg0Q3C!#hjt;lhw%0x8jsm%+bx7W9iqpBLUd&m<4g`wi)kTxu{K2W)`jTL z^&xtRXInz_+tv`hLG|q++KiwbA^HVdP<&^I?qbTG5H;HyBIEuL%|)35AsP$UVe-KR zr2QG9E|_vOg!dCebON1Dh3M^R#yJzBL+3+u_#$y#3ekY8Avy-fwGb7&9-@{164T8P z4Za(qfCnL(_BcchUxa8TPGZ7K?!OAr^&jMfpX64kpIhTG8^;Z9bvC;7x5=#}f46QU zTYy`=%x-;!%i`807_4puVKb)L+?tcYt#%pR+JNR++}f7atqj@R8i})bp53iAVQv-k zxRny&Rvg(Y^K-a$6N7WQbpZu) zyR{T|^0_rIzgzJIIEM>JDCk!HLT(L0Xc4!bV0}ze0jIVBC>*8?a`;ATcQuA4$@pf_wH$AXhU!%DP$iWKRa&J`&H6c1wQGl}J-Unv)lcI?m2+yS3`;|K z{vXPFjiKtbH&i1JhiVf(qWgtV1z!)<)5oF8@+4G^pN48FcHk&{FGJO_ct%a`mr>P* zWmKs#88vHCMjeKAaz?Hl%cx_^GAi*_MqNP7w;A>O*Nl3EJ()6b9akpJ&5}u3>Sj{w z2ALGzCX?=W$fS|oGpYT+Oj>(1lZFYl|o@UhuVe1bP!#NhN*h7Fy$!` z#`golw6Ro}a+VHLF^tD81e6KWnX+NpR6b166~eR*eJY0O269wpOw>o^pTkra1#5(< zJYM5f(=e529j4wL!j!LTm=@wHLc4`24)f8edzh;A3e!+b#y7O+O}vQc6Q&KQ-ZxAq zFsfge>I~#O2H^w>4-HeUVPQ%c9;O0#iv}aY^bu`Gg{c>IqUGo?b;A~1855?5m@zg? z*T;n^WMY`c;tpP7`lK+upThB}VO%Q|rp<8tMs2VV_mMm;OwF+j53p)F{Sh{U8X@=0 zFm=Q#?41>+uSl95rrTIFhc!Z-xx|Ld^Eig&C1IMjG)zm7b6J>5FDHIHULB?nh*`^V z?7*yzVH&-e9Pj~Qf3V)$!&D2+aUA9LglX}m9By*xxr?H~NL^8NLk&*XV)avJ48BX;`@IBg2(8DxA-e!Zl=axLzS>O1QGm4OcES zM}Hhd#(CjNUc_8Dv^ZS8rQv**6Rr_Bimy0zf}H*i=Q^)&tw7YoZ!)bL=V@4dlZ`N(Q#bFys92u!-StanvXWsJX|N}QH!5F+J(N=Ju=qxaIJzz zDYZPBRNJHRbv*hH|JLPPeUCc9uYpIEFtedY1%CA?rm;tcCLZNLTLd)qXdT?mJgNY1 zbK14==zL3$>a_A`8`RpPB6tnIHXbcQ_O>2%#}s_RqIMpwhpoLwr7#V*@B&pk5F5@S zprc1)u&9$qH!-C%H9(mz9_>Y=t{%0=QCz_MZXP{G?H<&ir$<+?vX@8B-X3Mc?LHnQ z_VuV44)mjae~(sU&p?m545B@{4y6{usOxZ#vP|-5#Bbz3-J{KTfInw4-Ynw8n%TsS zT5}kGu16i`c@#9?qx(o%{gFTBj+}cDsHDOdhPIN749PEPHKY_yF9AA+oL8pflK&- ze0w|^j){9cnu~~i9`(mx*m8h;4ieuHj~-#@pC0`K?@^Bq;>0n=LGW>EjTU&1(kB?_ zBx{Ykr#vcp#-p0&J@Q@f=oqeI+$E1@q4X7UzRKRjM$EoNZuh9&1NOv2k6Iz=3AsIG z&tok1q4YBk*G73X`ZaCdP}{d2y~K_W?AMPTW&O-P4~XFU>*Qlgm&X{sR-RiZ21VSst}>ANU0LRcN}StceNtqS35%8P`GY{DxhS; z2-R%Q9GxQcH{NxLP)Ik%LCGEwT;s}kJtO4qL;JoFD%USU#{RS&9HH7nBlLA-goZ9* z{M8YCm&v0`0>OzR_L+Yq5SScyp+BXkGHHbto7<_Jy2HKcBdP>rn-DzZI7 zy>>^a?P2CU6QK!z(H8+%BGlqugt{W|egxNBeVn?aNtRViav|b z7JPahq1-R113uyVD{^=fp~q!W4#@{0J>-PwCz@;A%nyW}HHbiOza+)G_ z1h*ZLiVTWW=a5J}K!PVy_2MEmCMi-Wxgxc$P^7xoi&WW;k$T)KQkFH5s((0A*Um<2 z@?VjP|0hzO3z52meitKk5$!I~=5nO^K8n;q*p^mkq63-_NqGi zVZ<1({Kk{>6tAocyef%>3%z^};ME$0E%s{B60h2>Cik_Bx6Z5J_0()5^B(Z3^+_+E zXL?ot6m`en$Z^`s=ltY&#;X?Si3M}HRjwMP4!=Zc0M=EH(r$F9 z86|VAC>=)DI<#vL#r6A9y4f^}&%>kSY!}7aMk#-XDDCM=3_YUM0IPaNX)8MQiqaow z+dE3<(5Fw7mSGd_Bc^YZa$+7*`$fs!KT0!j9aRPp3oc>fpeR)v5v3+mh-+39*TF<- zJ3gb>oG2ZEWp0!b(F_OXMJaeel){m5VU)_Qiqb_K+Ylwg#waz~6r~!Q84n}=XKR$= zw?%2vF6z23N}2aZsl~A<4aZ+7c|1xdu;)aSp5hZ)og@bQiK(Ze^a0aOM=9t`losF? z`kbXdiku@COvf`={)$rWe>jh&7;v8U_>2t~qjU!$mzWp5@GpM98l`(EemzRbH>f$< zVCbDFZMzqxyZ56M`iLXrO5IL!e)@ z>Y^o%qp~4d^^o5ft@BuIiq=Q?`$uaCCIoOFJ-%+VTz*Z6^mtkF7!>!_TKn6MN-Wslac z_zO4jdswu#;cbmo~wo7K@;hLLNDXFI-S80|sUZ86HUJx0+e zhtoUBV^@r(?vBy3Ju%9?ml#p#K#Zng$l)06N7o~afw(`36R*+z7_s5ni5Q-f#%Me) zAo^5{CL{cGjD{iO`52YPU~It?WW5l>XTmY+gDnWY6r-DXhUm*Nx_2c;3$Mng-ZkdC z9-~Xhbt6XBn=$(PQH&gqS(7K!`fDu_}nIC^|k?Z}DwH ztU6ANRo2O|syHQ9d(mK8tmdG~^jI~-JrtiAtLLaNFP7iIvAiCM)ekt<#46_|#@kF= zY=mn|tbWFFoWW-V{1K}n7>da-ZjDt{Y{NHLw{aWUw#RDA$yhBr6RS-~JR7TZIDamd z=X9}}iz4TlAC?QT%6u_aO)tf&Gg2RKP+Ekl@Gl!L2){U7(<+_#yDj}PE(v}nB$b5DNb#1EOVUR zXN{8~Tbw#0C3~FugvV(++Ir&D7k&|OY8V-(S>8CUzv)DP6&bHmoR(IO(anF7pE!p2%5RR-PSn^Er|&1?xW+9`FYyCQ zPQ~e$b8*^%dgrMLDqV+~u3l;9g^KWy!+TV}YOZlBeN+%b+HIH5$vC!;^>5> zxB^Q+g7Tvamf<3t<^&Z%d(6ifm@Ek@h>lo>3ka|#s4)6sHLk;DOHeU%!a6jzC#W+% zqPjCdr2-T5I5a^Y5S}qX-mD4oVG7EMIzg*Yzf6MK;SH*mBmVN# zsuFeCmY{*iu{}X0a11d!8D~#|hFwa~lUoTY|1g2id=pgQQGzNU=y8I=Q1eNGzTo$# z)b)9Sety9kyrd7JUlH%?1m%9ixHt>L+XOxQn4ri{2|Tx>CSMX%4c)QjM}l6UqF;&k&J0QKQg1 zYa-vRrhT?V)yYnKPa?l-5_LHuQS~Ad)d?1FqC!yxOYski#U!diY$C5!6XnR6sMfg> z6`Py*&qOs3n%K=B8f^any3QUhA-$_EK$eHBx+BkM194&%8A;Gu2m8h zST9kP@B=~h6EzKQ8jw#zVr`YEsd&{ok@pc3wFwu|Xl9~j;lr#%EuNjI^@yI6sG0a< zd7{p3Pvm;rL`~n5sPh=PH&HVXwvYPkCx-)xI(RBkI-RJ^ID}qj5;X!D&JhpJ;LpFv z{~zMImZuW%cZ6a|klNhz)*b-{34Ms#qJa$qBdh9v1KlH5t^gzdP5iW!nL31vc) zv;@cS7Rs2UeCUs{_>PL1lJo-=GbgDI#$-v-zo-zCq*^$LtFcLXf;w?YYKgz&lT;%y zNg+u|dV@B}%!3U$jm9ZST8mvMk(wk^T9TULI&%7w_*_3ppWsYSQUR33MBKs)jL4Cs zEjXAnNkwxdX)mm~lhh4s@DFO`Nzz;l%a^3k0!eCHFiC%)d7&f~D$IDOSR_d|5m+=y zUGW*si%~nwEuN(RN+hXBNn$LW#P5P6)i0l<=XhU{dR0nNsk+o0uh6(&lK#S7a(eQYZIw0!_*5nL7&$4d#7n9E=sl`Rs2(>P;-gu4* zSCZ83Dtqxi)&SNYtP4)!t09@!n8|vEZx~`q)=mFpzVn@|)yQQ|mdl!~D)6%<^Ig+q z&A>Z*vW`2F)h{GjTj9=-taJDmturO7L*`_ygn!m#?Zi>M!*9{avcx8<3_imem#m3+ z7Ej;AWIe^;g2{RdYZ=DCu(HWYDwnLe6_Zu0QnL2`oUGUy$$VckSy^f&Yfk-Sef>3A zIoc*`0c`D(mA5@HcTColPRV?(o2(T*l4b6htZ_KfJ6Q$$Bzk|#gOc?e#fBv7 zm!ZswlEaeq32lZa^S8^ARbh0p9*<4d*a^ve-k7Y*lakeJda|-FNLH^!$%31Pnkr$JBUyJeK zyGhJAj&rw?_2V|{bthTV?L%MRQR%E=A4qrf55kplrSr^+b3f#zj!!6nU@=hN3C_ z`;wyP6;l*fDMiC76JM1SRmFtHDLRFLO;R)wp-ofNrCEx0Hc#PN#}uuFZ9t0l;S|gR zQ?vqCN2Msk=oEDxlcKP(DN4lPIVswO%=1!o0e6sXeu{oul%hW?g zpzyvFRmMN?9Z1o2JVDum)bnVH#-2>kar8SyEfI1$MIFx&=h+k`Ug7 zDH?&h*IBz8w8z@JtQSh%Pf^haw86?3Dcbs9ie91e4{`y2=|#bQscMH5Q>r=!r)n*J z4M|leWN@cy3?AZK##9AnO4R}Uh3=VC^%Rq`r0R1-syau~Cm~f|VM$C?e7#f+L&1ir znutzKQ*{xqTBWK~>r{P0jW(%L+f-FYnXZh7wY^d`q&NMirD`}*W~Ztx!snza6@R1L z+*FM~{&}e?k6iPKaZ#$07N@E(sv~4+s=hBH?&Ybvg<&g*>-SVGTa&5^>r>VH5N!^p zst5WUNtNH9)B)d)rfR^kRE>X(||)rgC_TVy-m)j#!!=2d8Oj#x%V`lgw$ln zX&R4wCFp~=l4)vJCrvHurSZ2R)A;)_X&QkX4b!B)X{w2)2<(@pD*YLEK$^x5PE&&+ zX=;!7p=mlWh4`nYX$e~VmZl*y(^P#{nwlZg>@?M#o2EWX(=-9o*QTl0`ZNuPZ$p~a zY)n()rZlzPlBPcorfJfVG|fY~KZy?+kEZDfHl9k;#0zQi-b~Zc+uVQ6{dZ}ai?Z+2 zG!tjB{$rYE`T68;@Tm~i8GS11@6$0{z@Px1?wNgh1Czz4)~IRqX}QCv%ub(Ta1O2@ zpN6=6>K*FStc;vTwM;%OLv&`JUdQ_MPn=JC66lxc)0kX7{fF56K7E3vfKL$xeM-gj z!alVs;!`ioF6z_D|0(X%H&{#fv<0sbUfQQF7>L9&KJ_f?<8PDrG`|94SM}*^HJ@t# z;!}YdKCQ=Yw5;h<@!CFBMPvMl&2@ZwRL`gJ4Sbr|h&g`sDI*Rbq_I!sv9KBOwex8z z7NTN%>e7K+I{A1`qgnBRa=`#8)^C@bDPw(Ns(#JL4)L@-Yj?F%mJW4;jM~ma+geT{z#U-Drh11oyDC3t-*Ht{klrri1P&Qqra_P#5zGziG zU1KY!>k;Z!O_zVQbp8ex$Kn1tUA1uhmvmjL!Q3^;0mfRishzHgb<%aFZn}0fOjk@x z=EeI~>6+apU9a#TR<>pAc8uL2U8$X!3;%UV*PL$Y{C(bZwds-0cPFR`Iv`7L^6ZnY zkbaCah;i^ARt`>A!ch7ROV_he>1s4OUG0!*3^|TX*OGDRx-&jqPyVl_`+#z)`r7pb4SPN;Fvg-97{d07^&mpv~+x&E>4J3iAm%$h3!Ab>GkwD z9i0)UMd@++VJ5lG;_=0C>aZkEla|Km@v=B+MV#8LjMIr<*>@FvuZ~k_Esw2>)8I{U zI{#-JYc5guZE;H69;Yrln4g`@+3q+M-Nzj6r_Y1T@8LL=KN_dNacXsf98QtbY4SZ2 zr?NN#*FSOk{%o9HoQudYtm!h*K-1;~>t!d6WBCio{!S>WV|K-Hy{qJi+2S zajJfo*#3*tzZjXp#Akbx60sRsGMhLL*QCMuOqz_O{3f-;Q562zq#>wP!Xyt=(xki? zfZe4`ypJ+zY(1+Ir z5_a}S1)oWs43qlcDxP44pLj8*fl1Hd448BP*RdsNQiqU9KP8%U4bziN${#i8=15N*_xQ-Z^}L>){HtJe{=FpGiiGZla94CY26pZ+1jKZzA>ptTk6!# z#Q6#2kJJt({fPhI?`YC3%;-d4T}-m!G=A!8(kwW;k;Atpz3ydF&)z0Y>2Fe(AE+Nz z;3SF;FsaJ_s5QEy${^}A*`#~OIK`wd(HVzOe=70+On>-rnn~YHH|bXto?+52SdSl8 z)l%Ajbu|mu@X5Wp3SbxxApiZkYJfr5hzF?npsreBI*uXd!@5d94=lxPlzmiJ5lqBE zWO`gz_0R?LaS4T=)Kv=N>eiE`UOhFn)l=k)dMdWNo*q>(t9(^6YlWCK4d+p^nprK8 zjx#7&-K=)lggkL(rC|j!n9K@cAWovDVP*|cvp)BmRSO$YxS?53aVpiU_KnSY7Gqm0 zvz%X<<@v^}L8#N#EH7?jMmw|q!Kn6(4@U>Ho}+e0vu@%A)^;*0Uw6hv#vW$n#}qvI z)~r?EnYHsLvoeh^^E-%HyU=i?S&K%Q)n>F=SLT^je7;$|7MRs-p;-&@oU9dDaC-pQ=Y zcbJd6W`6fG>olg^Gi&!Fv%Y_9R-q?mjX;T~W;JY8G&y>SEHFD+Wr+M?t(7B%_WqH(zQ zjYUh_TC@Qd@xS)uh$0;=x{o&~)rr3G5E;6&9kY5`bOv>LTU4NrMWtb2Ltk?4$9_XC zs*i`rILxA<_;)xtjIgNn5{qWy^-}U(X3+#>S#FVKtwlX>be%=+ER}Iv z69dd&S#=GM(C}+3??0@ZhhtUgj#dr&)~cr8(eGfZ79jIbtG3}Vo?`tl`WERUcIQ&#L;^iPHD2x`=}BtV#i^9jXv!;AIAz=4Z62Vpf~JM$v3G zRl={xlf%Z+R5snlhdFIJm)E8z1#GHT(54ZEY^qz>CTAs^2B2nTn_Sq3a#d}*hR0Y{ z&895XZF*PJruH_Q79$dGQwKakVuDStk<)I|A!K#fv>K)SHpP&?flZ~c5Lp7mg^bBI zSur(iQ!vG*<`{tXsq~LXBl^c9BsL+BrZ#17Z_{7M*}@o67N8jhFbS zO1w&;7oMVdwRnxJ9?y9%@%j@t;^MW@#I_pongL(Ucr`+tIbQQ{+#0W|c#O=pczuk| zP!lespcT4f5GLRktib~et{<|I&*z7Db@I}e5wEHKcvWo}ukC?&H3`M5 z+62Z*s;?Qj5>#ePf;NmzP-uJt=P@Lx_oM{no06afQxjyHmY`$P6ZCa@g5J$c(4^T3 zsxmi0TZ-G&xP)E*m9(=yxt;Ik>{^D)PqXWjR`iXWt?ep;OIX$3uB;vG%G{B*c!DgQ7zZUf+Z93H zE_Ri~4w$>zc^_w2>t1$kz|!7!KAYJ2UD>X}>e_QNoIl`_# zun)IK+0|sUU45q5bqk+Qw`%~J|6GC%R2Ng63aRCw7f&@D>yU`2jQ*g z&~ZG%r`6exceoTsKQ$bzH||hBEU(Kr$XL&zny74XC>h7=6I%kYVL$wKa>6}ycQ{nh z=};4Fb&)g1xE<=~ap*IjLvgUBIP@j1G;yfRc=AJR8Zlz%T!$v2#IKBpX1_U9Z-YZz z7)7~pVZTG?4$|h3LyfQupB{E-@ezmqLWiRc{eV^P9V6c3^m~pR@fLZ{J7j+E0&{}H z7ae+nVwW6>MR*Tc#slQI=1^IP}l#OZTtVv18gr#iI-l^Qu^ z!&mP$rq3o$rJ+W1r~brMRBho@3a(@Mmrk8V!q-lX>*&;P*x%KuhsfE@snRgxAfDmn z_fD1UNj?~bHF(jFJ_b7V7WUzc3*RUw>&rPcZI)9D@eGC6I@NH8Q(bZ6fKz!663bCy z!ExNfC&zG{dLr*hYKu8ogY)m5a;o2Hr%wLu)N8oUJJk*YvF3_XXK?2_^}OL!$Gc8V zK={5>ebM5HQ-fi7&K#li8{$M!x#UKr>@FqYs}EdyQ`Dt0#awDz!lelaR(7d7Y}I%i z7fdeYsNqtymPlw!xl}aSrEZvk zdZ{kOupXC?uZc@_aJiXFxthB)JLb}EjQPUFbx~Z3YwJ>DWbEKlWgP74Qugm%GNE`s zmz?*HCzo2_H(W-sQ7$>~Gj?G7SQr0)C5CY>S4r{E^WeBi(MLvnJZn|iQ>Py^QJ-e>d;_j8wO zym09R%rD6oi{H7Ffth}t&8<0w-1?-LTLHAg2&}|WJVk-xZduVBeJ~Bb;|%!1TIG?5 z?wEpYxPw-e+!}?(RoxnZ7d71~Q_HP9b=|6q2R65g#=F(Q>(&*YTW$Srxs%=Mgo(}E z`XJ4%aS^vZjkz_yg&R zzIV&f)2-vZ+-lg{tuZ)_vVFLZ6S$1!ecgJ9zxvV74{n`8l|gQ08SK`jk;IiwZLkGL zaRGr@ZY`cq8)R7E)^AAO%-A@OO2usijZ4f6#$6@`_Ym42IeGzF)Sy@iLrzaF(| z<F(j;aUQitKP-IjTMz4_d$bm>dV18Mw}*3yJ*wNsqeL9R zvwj}s=k;0A^teE~4pFj}m_N@ZF$CyJwNxY!7RDQl~jQHrFHD0uO6=dQ@_u zM{m)3v4>-CJ+k24GU~9LZ7V$*hw-b}ceO`V)_N31FC6>LqfNhibQz5{dNc$(Hd8BP z+Tu}B)IbAV+fLs*xQ~;#u#>oV5f5f#|9iWc-#s4AN%iOkbHFRxZSHFE-%+2^Xg-tm$mP_tYzWV@`he* z!uo($RYG31!#ezuZ|c=XG-yU!jKmt8Y|g(Ue+I~$;_~sk0%D46EO?NNXBgD5}?MD6Yyc+hSSNn&0HDsih zV*Z^!xy;<*&^536<@9M! z9v|nY`&9aKpH@`&DJ9;gxcWYRKk><%;L{CExBHap^r@K3Cw~*4oK1bI(AuY)U3_|q zxm|rK)Xk@851&5!)~9E^e9GM0r#lGs@##fhpIY_vsqqg!T^r!jBNYChPs8yKJ|E;$ z2V6$;AAQ=4e1m;zin(|S`w*W7VK>r-`g9T>5A$gzmLbbXpFTohl#lPneXMQf&}%Y8bq(x-*%eCoO0r@^ST$)|r2*zDsxE}yb(@u~JUpIlgi9NWnmbo8b`ie)f3AJNc_jD~h)GWgBWP+5GE#n1@+meo*?Y=%~0 zUv@)va~PV9JUI=0i;GD8z|bDl$Yp3Ia^*JE8&?s?V`v@%9~!J(YH<9Dp(XhZ#Xd6B z{$oRnu(P0{0)^-c!wMUE`iY_EMGTECYUsOShB6m7G#O<-HMAbhOBl*g($EEjOB-5< z2iQ}F{yrm4xXKZGc|-Fn8vI^m@cWb@UtL3A)HAdL>s$ukA&|e%P$wKjWy8=Y+(p1| zXen|vFw_Buu(F|{>H%U88ETqn=n)zu8%hfsIt^Ef!RJXs`BM!g;Q^>8SdRp+C^2Ep76n7SD%-rdkzWb9$65d1g=XFo&ZFsQ$wOUVB}Vuk5PYCg=+Gt3*# zy!=F+a1)hA80w5O7%-B3uyPc28f|C}&Ou|i#Vu?YYiR3ugU?yic_Ot#@+3pMQFk)) zH-%bF<@q|D{L&596QnLEF_Y)?EJNdG8~SjLp?EaF)J5E1%<~w>mJsVQ<_`Oo8|u1( z=i^H9!H{1K9mm(J44pvt)y&UY>b8#8$8XesgQ3E|8ydQa-2PxpbpF#|?Kxt`aa>38 zX5!dR{5uTw+-Ybq`tCARaSyLA%-_p=?PDCA-)|`E0Yg6_^Fc%X4ii6qKgR19ADm#G zPZ8%CL$&@fboQ*F&(HI`!&|Jsz-#6r&*#hJe}(51(ytmi`mZ7DbwiVG@Orvw=p9Dh z=DBl+xKQT-&+n(y@|mI9cnjxqp5HI1(<@$g_~tdQvs`}GEcUBNZa>$&^y|w!ehn|^ zm%Wf*KVeQ$zY3J{t5zAmo}=|=er5dJuUI+1_Ezw#PDQ`=;AADg5-R(31gER`)vTId zLvR>7s{6TS1$|)!?jdgtzuF*oEx$Z?RM#(SJ-@1&c^rPLU+YlX#@J|wL3oN!;{7U% zZdhaY>mlBusl%`R@H_qb6LBuaMpX~{Vm)5L;q_}M4k4qD{_!>D;RZ?=^o8;G3kCe- zgOS*dH!wHws|%Ln3JN#$s{saK7ha)mfN`-NZ($Dlxz2)Lt8oVvLevxKID?N8{R&|O zb|FKOUlw%50-QtsWWQYKgSEJe(qX?EVH!W7Mg&Uq)xYiVx?0{(#yv3+NX#ZXTfjfbPN{2}sd^ zZnO!g>{kK(jhpE7bwCHc3GiETK$|-S)V5ndvwH`00pt1vGzaDT2J~aUfJXKY=+ut^ z*+vGGZ&X07(G{yva&$oBu?v~U1hgKz5f~fL;&B1>A5VK6!5f^I98mQs0d<=e(64AU zJ)rJ*iN@))n;B4KLqO9I{5_y3uEM@4pmKi%^xvLJzhXO9Fl<|wr|5s(>^PX-h|6;KPzJk2GXAY_fKFAVOQOw5M ztU*=G9#nGqpfXnoa^1$DR-tv}pnBjHnp6$yAKb_Pss)w3ZcrY)K#qDrjm8~wkaLoP zdf*JInk%Twc!=-aL9TZn)Fy9G`%uOgRQ^CviO3WT>LX0W(@;=X6KR9`NkRRV8kD0= zP!l`SCt7?L)EW%$8PtJZ-1Z5wR#Z^8@nK)u^$V(c|Ddkm5qka*)X4!s4ICKM*l|G} z#=!AGjYHuH^lbx<#{Y)w#qz_~W4S?hvoxIU;A$AY?xS;vD~iP|TE8h?`b zP6d_wa!?KM7J04&H31K<1~vcRAnUsXwHz&P2Gs?{Zv}PzVNgFm4rXap%#@Y1nhxqSuR%h9mFGkUG2y>66#oW=PZ$L^CF; zBOW6ubE4khgDi<0-a)D~+tCds=gNge;>c2AOepH5Px^2yrKBw2rcnXJ!R zCo6A{WZ4!btIhUg4MeBC$trmyS+_9sXtKJUO4but@`lwWe^_Ob!`k>oSX*0#wXJnn z!_&N)(5=;Kt?#X58> zkgEA8P$*SVtU}JhsrnA>KTTDK(y0oRNmbvnsTz=!svccaW58be zIFKsSl~kpxk(y^{q@H+LyOFXPjbv%tNQE~w;u?l&`lU^pcD7H`z|LuU)FVx;d#33S zzU`gHwaL@8s85;(_fONrAJRB)FHLbHxy7_GX(~N7O?4)uX~x7fxu&FX{z96TPD|6j z)6;Zw9sR6N)8P$i`u+Db<@_T}c8uJdrp;T@^!@HM6+ND&iQvqklwse~8GB z{!=45J0qeZ=@A{oIgFnfQN>viUBM%~nH`bo7y8Eq^qUt^?#0~4jnxrZ*F`|F=M70^Ix!8`!MWae8 z7F867kh6GHP9$PFP9g87Q58q5bW|tGMHN>*s>PL}O0E)Rt%Rt)aYj`yDXI&}>=TZv zb~D;Sv8aY&P|v7NV`r}@>*Yta4!h8&PgF(wM%5I#`bAX?XHfpfsM_F@!BJJfL1Y;k zRZ9#TPA;&GjH)-Pj*2QCxkpF2u2@t(v3*=r{_#=HorvlmY)_9W!^|kxB#vqadd-Sz z^z0~e8P(A_=z6QB8n%SyYYj`SPf;u8FGVZ&9wbMZNY!)gJTE^$zB)nUUFJV(}lVybmE#x>w$I&IHA+1=^o;|!9HH*Xc;=KuaT{HO5? u^6ctz{=}q3eQV@h@n7??e{9V%w4w(Y#ZG1|F_HZ{~P?j+y4VUM~O)Q literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/6ac91d3e212f6092_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/6ac91d3e212f6092_0 new file mode 100644 index 0000000000000000000000000000000000000000..46172e4d795ebda1e04f70cca6740db5f993e4f8 GIT binary patch literal 30740 zcmW*T1$dL^*T?Z+leS43X<8^YO5H6fUW2x{vjM{y?k>Zf;Xd5mogu?zxa(jHcXt`~ ze*f>T>$4<}oco+}-zjPGq^|m1mi^HF^A|5kB@y)Sw>#XZc#$HdT}6u*D^{d<(aeHH zGm9l>C1)2cl3Bb+A(tz=P;s|A+f^v5sH;rrY6#{Xjd??0b$mH+>C5dU9-CS|0HxK~yxR!*7#m6z-|jMNHJeMDE33RIHZ*oW&_ zMySPAqyy+xm2+xJpE0zS^e^()mOA2oS1Gxh^by;~NqHAYk*JF9SdV}35H%M{gK!4D zc1yjl(2J5D+K4^4jYgRs8i9RT9=eYX*&gbH-laU`UB*Ls(5JkI>Q(emU(BfHp${!R zWNPK1KXDjAtvwWvnrMRXHXb^J3pmx*Ly7G?l!3Ia9_rQ0L%*SH9}hk2>!JSrJTwM_ z2M}wRhkhSHe()RVA+Jdu$}!nPFR*$Bv95cl=WP!?cwdUwTOXk^$hyGsX<+v z8T77`K{1^T8ii>n*TtX#_}G>E-3-dt-JmFZ>0wago}Amupjp_30=>x%=6(h>#2QQhzffj=145Oc5tL-HFnGSI001&q3h20=!hfhEMK)1gL93}ZW7 zQAUl9F{(>E_mhme>oV$w+o-(BM$P6Y+-qDfV$|E>MkS;eH89nvM(IYKLR<->USU{C zqt@U)5;Bb%gPG`?MUL4<-9k`l_93v0QM+)bEIlY^R3@sRUU{SL;r9wgZK!DE=b=%< zkyzQNm}*8y0|P(Wnudn2*iWvBjv> z+l-3;lR9=7bp<1L8&!1=V;-jOXNZ55^R5|{^?-5F7kM8t=NR{hHS^f0i2?mjMZrV&Zr6Rjau=+DC0+?=9xWJ%Ewbnu+-|Qdk#h#ol!aWri;i=FVPwhVhpldTMPGPaS|yQ%^m`xMrSOfLzTzH60ULdTJ4pT6wBM8&BRZ5DqeHyq7w)Zo(cWqs#cuqB+gqekRI=?s#pV$1aBS36O>Q% z)_V*}^412dc6sY24i)rPq9Z(7xz}(6mLbOdaGUr<5%=ntIEVdz3SdN zH^^H_BfZrI=B=X3y_LAaTfr;6HEErMovj~olWM7m?YjG;tq-*#RW0Fs-NiE_`>V^sNCe6jR1d~c9nsf&LVp5Vx^YEj~ zq(*SMO$x*bT*2XFld2XpXrWtRyFuO{W~ z!x-4#k6sKgDPf>V)d!i>5E}<`{t)hC4RQ>n?%zx@4mT;+2$R~5qIP`5@zL~P41J$q zQiqAGiOKYN3Xic2FOg%KNx?XYi!)8CF^jb@$0XnRCe2xFQq)qD?8{B6xXPqOo9Xoy z`nA=h@mP-A7`x3R!*-MM;0)&OF{$xBlX~En{U+@@NN*3B)CW89>tW{T2y=(M$5@xR zh2M{xH2fs21~=+(HGDS#RL$V^%q|x0+>fm^I&N)+6}(n>86eInBzE+pLy(&H5NhtT3~_qf>-g z1)|K_f}fJi>WO(p&9W9VD-RmuXmPU&rI^(gJz-2U>m@2>nx)ca+0hK=(X%8Xsbtlrhk>h_~qKh`kopP$VdUfZm_IEfFaTi>j;_>Nf( z%*xr&tPspW{>ElKYhqU4re-BIGpix4;$w5O%C|G?Radh-x{(X|A*nn4`PHmixP#$6 z&2siKt443Lt|4DvdWOgSIH$i^>j#)sWT08C2ATC7nM2GvhRb-1?nB9Cm|1Qt#A~$p z&8*}2bvW_y5mQE()q12^J>VE+*1mCOEgDaJoJ7M3%-=+MF^T#no3#ta@BpoTH)|sr zPBE(kZeZwCvnC>98vVyoe3@?6pc!V3!z#qjH0y6XM4egWh4|TK6~`2Og!de?nxOVv zvu0x@ob%|ze8$7>1!fr*lEWgiR>QKytjeg1XBf8Btb)tTDv1VofVbGU+^kc0f_5v& zX{A{Ks~CH&S!K`^uQ78I>vuEpw^H|Zvx@%7yu!G{tWw9AgX7E_E~Cc@a=>=fKgoRH zGbWreEAA}waL%kmbUV*HT`(*Al3D-a@nzN#vhL9jGs5w8$98@kqcQ__?q}i;Gya0jE&6s72nz$QdJX zD%GN#X%>Yb1IJLgq(yB|sS{+_=+WMyOSpsl9V{x=(W26LjN+Xv3hqaL`&*PU zz#_*$;@~76qwgS#Od~B?io&BU+JiY`EIN-l8efnJ?_YPctlPHp`+uvn_g! zxpOR9i~e(&zj@@h(4vEAzm-1xNliN}TC$Vg?;_9LtP{+~`aP_ntE`ECExf5^Q6N6R z^9FNs%c4!U$rHZ!$mKqLePGew|MSqI-yc!mV~YknWo!Tp2 zkK)l4x6#+nN1Jl_Xlrhc!y`1w_R;1u)N{c{4KMnr zEpDOPCHCXvWgk7h;-g(ReH8hSxXAH{USJ#kL)K#-O~h3Ued?n+uYJ_v4fo&Dk9WjF zj`u#gj2R!O5pzEh`x8C;&qrTB)7LLPDxBAY+uqr9Ys*CtF%&Gzr zR(*=J>S(N0_IRuEp;(qxopA-J*;bXqfbv$gu549M6{{-YS1iIQIO|vyh(GIbUVW?f z;dL{szN2w-t9m1}l~r}I5v|*B9?G?|swPs~TQv~{J6N@>lU3hPwX;>9yIS>kH>=XR zTh$c<;nBmY=KZYdj-dWly&q(iaj;drhFCQmUPG-afyzi4W>q>~;X6kB#<(M``Ui2N ztZIoBcna5O#=vp37-Q8obR1{ZvRNa$Xq~;827*1g;wprQKT=Xw>W}YORbuM zMOeMesyisLf;>=hC1YR$@~yHe8Vy!6H*2UDbJtpR6VH)zJ+ZI~+wpt@{n}{NFigh5 zO;&ksrdDjhLBwpKXXuWeTUj65th$eq+nHmGz_CB6X9xA5)K2CEQ_yUeRSU5mgLl&_ zwAsVCd#y^|XI1X~^yQ#c85r{yc^{>R$Ef)@YZa|e5bGp)pR(#YCY`pb;Tfwoon>xO z5%ZAuolQ;936~J}o>*9d_wf8cU-1{t zqw+`2!x|)hqBj_h*C_d)P1euE#B@BsJ9PU(Ubu*|U)hJHsPv6~;GV%Qr_rv~*nw}J zb`|roYXt6~hPPcy@BxV?JFmg)DrmNAD4rt2V%Ky;`PfwmtuY@Ct6g=l1BGmMO@_^G z*D8ly1$^zgguk42#roMb8%}?_4q{Ls=NGWcJIJom*pBzu9c)*X5W5H9%UZ&&i|{OIS8Wu@ zBo;bn*|hd&!Fx1$;s7*;dBhZ4M&7aP!x2P{BS+jq+IaFp zz6o}HL8*y$&BQX~okag|WGa1`W>-CUPPc0l3^VLXoyi)9doHn2eV$!YaT7)76ANQ7 zZvizewCk5eb~Ri~K1)~=OYO?BoH19})o!I-e`DV&yF%C4m4x86tZ_KkvHtN4;p^=h zj3e;fz#76Y8|^B-i9T<(>-Zn!w3VD;+D_lm`A_<~gB*6!>s{o&+pZRSng0VkFOHBu z79F#z)=Ab5)}CT6F4`4>3h=l@KG=!VmpSflo;%kV^I!5tnd^4mXS6EBS4y$Vhp=QaPdFt`AlEF@f?st_YDqJ@^omT$)T%ehniU&dVm&IhXQO44fA(sY)*&9 z2RPI}mqWL6JJchOLo@I%Qu8|09Dm{o#^-ZrFHXYe2M50|IP?XU{0^-}#~_Ck?9jgd ziFW8jj6=0z9r8?Y@VS6P#oZ2NBs)~9phJISPa%gg3zK6JVia{KH(H@>F^5)R8}1@^ z3USad)uGwAo9@uT42Pbzbm%jhwsEL^TZbC8bI8`-p&FQkgB=_?(3P>#y1PS%@$;_^ zS$k4vFUIdpU40xH)X$-y0n{{*^Y97d200WvgdPrasON7E{WOBHkTTk#!eiJr)}g%P z96WywBp=zxYpeKr0!U%f}2;l6q~!dLMleN`MYM*C{rIA5(A z&-O{aIyKo>i>CUj`P z_f->Y!`>CXItkM%#$MyAgKK@&X``=hV8d2lt=-1{9lpA|+gD}x`s(ljU;Ta1S8M+A z)q~@{`sJ*z?p>l6|M;r*EngLV=&PE~ef8okwSM%~n6JK?>EYBeTs1m*jqH@&;Z#11 z_I0YP)2WU408c-siem{H_&YTT4}Wm#9YzE@wFo6boSKcqP^U)W1LlM|l`Gt-+!0QV zL7PaYevfggP^?ptNsL{@sZB-MUd*X$*j?PI@N}o*Dmc}(qEl&=ovL2VsqCMe>R!XC zk2RfISIeo8pUJhhQ)TKo`5oM;{*5@Vu~Sc*Fm^MiLYq7FzJ*guTRQawCEGZ)7vE95 zEwy1iZXmjyQ$ukBZ`(WN(ZQ+s&QA60=2TX9r-FMpRryz^-e6r%r@r=bs$hSo1`l%T z!Vsr!VdXHVVuy1(iW){c)q0FmhOtiF8|PHb@lG|FK%7a`HQ6cuDNeOQj;T)7ndX#h zhEpxj6|0aqhx70nzs+^Zy^uO~&?h{>k2~qdE~h5oG~#wURSd(Bv4?F3nXkW`YKE2A ziu;G0>TrZ{k1}V+ok~9GRMk^X)yIr8jDOatXQ+M6so^)BYIn;i(`~1Epw}I?J)qAI zo!a$?b00go*1)MNPw3Ng*3Ap24!v?}<~!ySy+3k1o}%L?r~1PBpOfF;oVtrLU!6LI zso$OYguVfO+Kxjo=kn9x+B4zjlWBt7eS9rn&sJ7=zvZDpb&4MGN_>R8@af$HwaZ z`mct+>eS>G9e?&$w>ti6P}g5S)bp3KvA=FK@z=hl{(9KlUn^SpE4mfOw)R*4w*HF2 zS#)UUue&JF-d|%e6K%Wsv!?y^XrRBYj3CZLf3=w6ujgz0HD|5A4z2Uo>n)6N&|epE z?K{UJz$1so;+9tq{otKLJxw|E8BTK!87w*UW_k{losmQJ@dlciL!~eg^N?>=4sAx~ zIXSc*A5mg1kMRzt7w6E@wH&`bhq`TN8;pPEP{W-$^b+NF<^a_4mCZLL+3E^XbvSG%b_Npb7(&D<<6-x=!t@Pa`KuWr+&_xQ!`yTRiJiG zO>3T07x8_6PCb5+Q`6t))E{_>7>@w`VGYn$M}Q_f1M~u|!UD7uuS*2zL}q~E$^ zQh;Xs7@*p<1JoW}Mg*wZ*Z>ur93aEu0A9-l@V-%idhQO;@Ph%`h!5y~F+hIT0`%lj zfbu>LP~#^7T8!;D4A+YQbJuTDhg)z+lE zdQ>E@hLz2$8Flh1sCQoFf0b8$-Sf+HReq(c&9CK0^6T5t{Cut(s2{Pec%YI~0#z1! zu%T3-3YHF3NsPr!c$W#(sj`9ESUynU6#}&uy(n>)Gp+^9;i9kh&49?HF#nHy@cFVAEYU`iRY-=AxNj; z-7!d`u%J_rZeUVp@<5p`LE4Q*U4zsfhj9^ey9MbHYWEdARWO~jJX`787O^)nyv<^4>n-tP4d4R zqC~1 zcNeU`5NHloeoL@oP~94=4F!T#HzruuQi5eI8LXZ7yHv35A+mh1R#XVq79>;&<~sl! zkGDSu%cFL%x*@%8uqq(CVX$hoXN*q4I)}Gig5}?hILPi1%r#QP`!!fOdUJfAV3q3| zEMq^89TcqELxS~rc(8^nBL1piT|w+>@>>(E(^$4PSf1;G<+DCmv#=Z!HU#T7j%*B8 z#ZAGQjDL{0IaoEf1S?}(uzKzcR@;M&dn#Dt&T=liuLP^b-C%Wv<6bb=H3VxVN<9o# zCp<;bN5NWz#m|HF5#L^t>+4`WLi-QF+Jkeb@sVDB3Dz&)g4F?+zXxl!LbT8jqV*`~ z8KS>%%NC*#-w<{757B+Z1cj(xRES2!g(#s=h}NcssC&H-mF*a!M?FJiULB(P2SfDF z=@3mk8=~m*Aqu(}qTA?uDMXjh?lQ;x9il!DL$vx?h=#lfQLAquDr^W<7S7>!W2jc) zAACbW&rtP4s8^^;dxt8@6siPssGg&bB~%k(^9fZ2e1+W_stt&;g{mD6;1TZILwP%a zSiYf>GnDJcLv_n9l-Glyx`+|(P)$c#GI`)>!BDj+6snO$LUk3Ji-)RZ31XED)q5<< z43%eAsQfVscTq1pRA=BU6{-|8$1!|GtV!)s?!TYV}*F z7UKKxPz@eIUMM>8x7e2$roYiCGfWp@DI3Q7r(v3pJy1FJp>owQb@(Yv{js)2n09pyQ?(vp zTJdX`wxCnbF#UnHy~1<`y?cjg2{z&$BKm}>Am$*kZUbHd~|FO2s9!(`YHrbZjXRC809X6y-5 zp1omeaU@K`a2DA|!*mS0j)mz7KBCoe;^Pn|p9s@?OgR}Q-&0|lhnwhqn)8uyhCDG9 zPhmbAro!jhkHzSJf#dNB>o0}rHvBI$E_&i$th^egyU4s2ruggR^DKBhlXnxyu!jY6G`F3 z#zXubL0kkxhARw{@d$rJg{x>ZV)hAF^}+OR80U@**VM7$YCb+(<)$*u431e9 zt|b`0hMe|&N8y zBtqMsN9a9Pyr36Y`7(mnnUQ*hDs3Va-ZoNO21V*6Di4WN%+N^f9T}PIZaDSU$W zACbzy5KKhXEs@%aFaNvU8mS+)MQZc$NG&-Psf~y|9jUdra3+#}iz77~85bBA=8KWa zb170yFGs2~68?_VGE}}2sV10!AFf8~F{=L)sq?6MEmHjv_-~|oAmn-wW~3mK)NWGx+~C*`9QQz1&%@DyDt zM(K2=C@roWrGnL?G!0ejM)6)zlUXeU!30 zM9JAPN^{V^SCrxhL}?V74UAIm!BOgjSwo`qc1)CRtcz0lO;P$2H8)4;+p#Dd_nT< zXm!SAJVwl&XcfUQ9KcyrxErmlXn!wSFYpyZA4F@dAx~MX`Do^x6x{ZWjKaU==h#IKSXm~Nwi+0;Kyj*i;UI< zRQWGjlMwNl$KRrrsu-Pvmq!fO8ph}pHW^}c2SLUd)xrpzL>|u=)x`qbfS*^4GSLZ( zaRp}Y7!^ksEWst%O)<(qd(6ctc$#CBijG)?#U3fJKDiBU;(!df)8#;7ws zpoTq0r5rJO6cD4(d@*_#9HXR=7>x;y(X_A_HH+c4NQ`n6jZtN+EJlsRiCZE@xk|>U zYi5k1vSQS>bc|M@ewi4x!)sJ6M=s^5yAm~SjnM!kZ;MeDjv(SsV(g01(91D;d^1Mn zAH?wfaEwwO#;5{(AF=&KjKW_s=BpSLejTF+A7T{pF-HAAk@tTw+Wb96&r#7MRs{{Q zTIwCEn@Bgu%4&(#pZ>A>h*ddawF8+sV>LG*R_$_eKPZ;xWUT%Uj#a&oSapIqG?v%Q zv9cA6RqH~riYy$fzNy4P`?Of~gE2i;zhuNJzC^5cRf^STtgRfY-RN2+R*rhHs)X9LxD_cLO(aAvH|Y>U;@U9q}=;k#os4S{=N z)q5|w?2Fa@6S30CSZ%@q^gI=-vX40zx1YqS$kSM@e;%s>FJcvkkk7I5`@&=V@I6)? z5$X}AUy#EPr!WK=2)jE@DJYBaxQXZZEjdn`vA|LY%E%_a(s4XL;#9wUoSxxbMS4{!PNnM7Z@fg~dT~07J1A5?PL@RM$A=>_+{A;xq^U4UW^Tp^QB>PN~zV7vJ#b^f>LA%XX}v z7pJ`_GoPL=h*PhHaXPVs{kz$Z^?TTlGJDy-FHVj2$Ep31IITj%qjBnhe8=ebDQ-_Q zANUs&&%~+4CHjw_FEfvLh6-2W)b1*4>?{3+!>YWef{IL1vzrY>kK;NiPv&?<%`#!Fh|C#3_igU6|eDl z8Xd2HW8+nNU%Uq3+WvU0JP@zHj>OA&lz2FVO2^{0;&{CFo`{$0M!d%0`z`Xk9j~c( z;`QU*c!fNOS3PWd7_WJc;`Qo3;(m_j{fKzg!ltkB8u5)hObN=uU*-h$^GVP!dxE_3 zBxo!gc@y-YK!QSo64XC9K`9{#niY|tD;N`*pxLM!m7r!t6SNHl(h^i3zUc`H!V(xt zBxoz1RZLJ+r34MF%y?B2G_G-iPGCTj1dT^P(*$*CmY_eIC-9kdg4V#Ne}eYl>WBp8 z9GRfbqY@N2IzfYGC1?lo%t_Ei{JSDSD^@1x4oa?0&{I^}ouE-j-;mahqViOSy- z_*^eRejbTxhXl_=b@WTr8vNp)s7}b4BT=L90B3R~%8@%!`*0TB^CapCCge@jr{F|& z4&j`bM16)iHc`>_5;YX54HGpUoth@<5?;1SRH@d9`iPos5~a3@s(~_HiH9{k6E(OO z=TAx0FeJ=OR9h67m8e9VL%G?B`VGbBB&s|L%_YYLiHcj8sC3kT|Kdb_TSDGT6Lk|q zmyy@XL@imJs0!;6)$0Jq986RX^!_VR9*5`yz8p?e|09VSjUq=AwfY$6A5T=!NoqTj zsEB`wdm~ZSn~B9nw%?1FVQ4V zlJ4Y9Qqg=#Duov)n4jCgBn=Hpl4m&EBa&1nGKrttN$L}uq)WI1M`Du9t|SFuFXEDu z)Tm&R<`zoQPlc0oE+a_;Gm|tH#j-dDQQ1jqS0_m=>m~8`F_QRxX_9_Ja>FF4Pm*e( zDI9&1RHYwr`zLAipd>XIoTT=M9+ISelgNK^k`|%G?@1awJxMiYB&iv4&rDL?*-7fX zI7#C$bxo3bu1nG|xYj3W^@b$HZcI|!%}F}6KS>k*O41yZJ4AlSbvQ|nvEf9L#$QZQ z=#3;DzQyBLJbs&`*(m!iNz-u}>pmoDhKEaD2A9&X*630RFPDzsA_jW9bl2q4Yj~Pn zYK>YJmzLUG%42sa0%zd#b!o8ErCtFp&B(=mRL||w5`^b*=~bjl=c8QO6~lS4E{!VW z(pN+lcj+U{DJ})4x|E2i=`OX(aH%I|mT+nL|75!K1(qzAHscivly<2L1|YVKOTU(N z@f}E)=2jqfRhLdzcd7PIE~V6TX&rW=Wi6L7Yr9kxjd2K@>bUfz0OKtEgLO;0FcebB1BTcazx^$>Ndy5&{f&G+uvjvPO_^)rtCb#wFgiQH<_!_D<( z^aLG{w-U>ON4V8!q+9KfdlWT}c5BfXw{DMh>+yKE zPEK$ucq0A4O4OX>*6PV_-Td9HpsCa|o$WK-`ZC+Cb93BUG1sku^Qd(``&YWvewABO zSG)CgjayphR@?P%UEIL28;QNit*U>pZ;M;M?R4wGw&Ig&FznHVb zZvAkKIXq6xlg#gFx1!IvRrvzFx=0O|sp)U(z3NsZ&Z5*mZuPw8)~A2ndUeySKOeZ| zeCSp)%*9DuMfM{eV>PNhcB>0cA^nM4m+%fNpStCGMsCmDx`(kI$tr0`RyFK_muE8H zT}ak%e#x4K>i)@UjC077Gg-q?I4D_Vpx|UVF$jl4l2s%$SrcQEwGj2=lGP6XA}k?U zlhChVvc{oYp=8y@QTP@~R)37mNY-4`E|IKOxPqWejz>(nWOXc`tiHI5cUV_}d@-S7 zvOXfaaaCxw1HUBeeB)$oX+oaOlQpn)vhuZ|Pi>RAri=PfvwgCL;W;XFNY-P_ z=}4^3$x6rH7~LgV^O4<^8hRw_OYda$>XWSL1CrHwApOHST*427l9e!oUZWclhSH~L z$$A09^kg+fC!9iw8RS2cc<`N-tY2p*YXkDkN!DU)#lVe)RsVT0&BuM@eNjx6F%l=> z|FW1WVkmat6=Gi%Q!~uQdHB38rjqE6)p&x)H^tNdQ*aW-x5ZQ(ov{?Rkmp@7)quNL zaitb7t~%+()u2gnQDN*ro=PctkIOYv)b8gLeQ3nCW+}>UnW8eSQ#2Gs+oY&0 zo?uSf6#av7?HC_f?Njs-MLMMD5kBFMjw$l%#@H})Pmw>S<6VywZTvMwe~nI&aZHM~ z;1DW}P0@;RDQYo3MR%5@C~#?tdM`^+*X1diw=IS5dlCOn?4bT*DawC5MW=BC%}=Cg z|H%~fIh~?@kEsbAo}}8q$t@kgr3k zUSfW)R9!{UKB)@mn<|eHsVafjFpNyq2;3XRm}64ad{wIE;md0BT9c~Z;k7nZseh!Z zJI-xM)xvG5ig?19IAKUrurW>ldZj71cbXQN(sbFHCO=!6rsPS})ZjE-!0?bXO+#R4 zntF$&sX};~cE_fvUFkHfM1wMET!)mVH>g%FO^)(uT2nnuPcZk#G_6IUpVBn3Mw;r@ zWSr)ViIkRUx{vn1rD+*FN2F;#BBrIO5q3^b)7Tklyf2=n@7Oq({U|ptO-tsd>F$Cw zt>2fXUi;HD|3I1yx6)J+Z(zKgrjfXRCry*?rYYlDn))K?d74V#FND5K(@o_1o~9b$ zFK#F|=HNe%bS*WcE7m(*t?+{>U2)g|hb5h_U8n0`XS&`6q$?>`y2j*ASFt?l%8pCd zAQXyES1BArRARdBqg{HsR-!>hy4vFns+COF7lc$uS0ngWOjjtD!>cmm!SG|c(lFzv zbXBQAoSMWzgIdJF8&s=JUUkxCZkMhz@M)i}mL1ZSzhk=Gozm42p`Fu}jBN<$N=}$M zG+h@kd|0}sA^W#Dr4ji_*C!DP2{Uq-(|MbUnb# zHRJ@>+H{Rwm#*UL({*Hfy1f5P*LEC5)g9?ty)#{nccts(;dE6zLXSUDUsQ%#U~Y7V zzTr$vhHj!oY=&OOWoWD`LpzeWEtsJ>C|4*$?vxBI!G*L8-NjpYre`Q8!chpNPy@}- z4MXue7GpDB;kObQ`XMue&*Cyvx>N?Q^D@-2EV0UGXhww$C05GNfyx=GT{S~VzcW_# z5}IQxsjvwpwS8hqRh?Xt>%U5>&(xCgn_g1OW|UO=tdcrEyQEspEvfJGN^0tYl1f-q zQhNh4^>a|Bo(E_0H@h- z%}mY3h`O0NgkJSBH4-K2XDV+qV#B9-rt;wyHnz)@cl%6vcHmsRgI7n!K~SemHGs2o zrh;)0DP1!8_cl|_duM7pR`bEayc#2=aJd^D5a z8#2}8Sf;vQ%JEDUyqT%t=yy9)JJ8`yruw7P-At8wk*UEb{4!IeVR%I??=p296Fz6^ z6b60C)I=2inyFPt`NK9J)IWT_);L0Jky<^KuJ(lhLd%+ftni^|gb=q$C1$o2^(KR(&oXV2Doj0n$`F(O-?F&U@v7S$uOH5ZTZ zHY!_nqB#bOu@B!75Sy)348RzSkIPn(_-t*5DYHEjU*wTi1$Y>))c;@-LSCe>L3)l+@JQ$MGM%2nZ;3K@=3}ApGep3X{ns1C#9R z>{6#7U8G4->Y_-OA}lCK?+A)Wl_m&F2a(R7&Vn>idRdz9m-oCc=X_3fGP%!v?vu;{ zndC+}>U;DSIwNyD?a}b1h8~?mwniRRf&sI!M{j$`)ADFal1JYqd$bi5n|TzEPA@el zW($wPsL|S^UvU{#+IWVx>IypQwM4dtp~ zC|c9dC`_(vaL5io1qBz*KC*gP@_fL_@tX6Lpgf#jp++ zQJ{sP+DLC@C{Jrcb7O{f;p?^rbAK9ouZyAP$lT3PB^>BwC}%%I)lo9VkO%*KZm8%N ztRHTu3J#7ml!1C*8ES)Hkd6}L4K>DhNJHvGgTH6VVUnTx=rWmpk$(zp@$NK30W8Ep zWS>C}xH!wuE3*xaUSQ}aVYY(ym}?<)uf15Z^XP> z)W)k|Td%UV_o@n(boHuqcdu6V@T$=#Uap7sYVW6B-A0Gcyy}N}FZJ`PaeuFl4)Ch! zK(D^WNt7MLYaBy5mJjyoF8)X%&gWj8K;>axWgFqu#c|{{i`rl-4&yumbG&LY*Q=$A zXopOTz4`@-Tj(F>uxTq}-sV+_ovcHfU0%&ZiQSBUk5|!sUalWvd)YJZ^x(zhBC&N^oL8cOL2#-=sm?SsSm$pY&eH( zQ%#jb0CTVv7tnH=sSmz0Ij3W4*Br(-*JK_WYBi7d=9`LNY%*VssW+FHdVvm0O|G>v zRUiNUNG+DLZiT5yNL|Uct4vj1V=9CJIP#0BO&d(5quEANBaya+dLheJQ*o$)Cb+Vl z*lE1Rah%^l-aE+$bFuHGUF_rCruOeObr-qznd*Yh`%U%5&;zC}q3J}!&eih!ss;WNifm6+=8SnYDwYpE&koP}6{fx3T zeM-VVwSB5m*Qed_K3NTkjTp{5~yj>eD8y3;0yo_32}* z#e$$u(L|qK3Hek3KVT28;lm`K`rrU6Cesf(VLz@TXEWmBt>!*8LTvNt8u(FKSvlZE@NTTr!*KbpW0vqe!y?I{ULQ|=hJyqYft~Uh7KKl`U@30 z`P2$K(4{ju;iHdyD%ZuQ=Y4$4r;ks4+J*N&^J(;OpZ1ONY2-K`-{<-?bE;31xB9eY z8{^pS)1tjTeRGT)j}!BxPi4+f`?EgfyFeW>+TlH1bme3mwsu~hmUOFvb! zl+@7Dd+%GE`?lo!z|u9$Xk;nbW2uB;$=||~r=_Lx9V}h{#L`2|?`5e-Z%fg>mfrr< z(xU;EvJSL#6Yd~O8G|jgPqEbeb4ypguyhYazqB+4r}54(OWlx;*267rL4gsLT4FvP zqR~i8!>|kCQI?M5_0g7Q<40s0XX!Nr##@}*w78ewQW_57tFJBPn`$Wzqfz)f#)>x6 z89R#3u=st(IA_uppUh&MvuU${Z5ERo-d|!V(^5;%VJ@@O_6JKnab~%t{VOajS!=2P zI!hx^bCab%5!hmJ9lNC*TP@YvX34-ZlL>?t{;!868%J^21PIlkcdL+O7l4aQoGkgXD#Y<-Sv znQiUNV)H$bt+FVV&DL1_lHFF{9JW?sZ%$iva@m@Te7S9XiVH}7#nx`r$YX0Z^5nHO z5SJ0iXKNt>uiDJfV{^@ctz`vm#a^@3^>tg{V@F|Ig^Cahql?;lSj^Vr;RmWD_ zy0+4=*04E`!1yg&J#YY(Y+K{;Hv)cJKOj#NTix(GRy4I$EkN$Bt(FP4?x9Jdt#HWJ zNf=2s|EIK7FxgfRcd)p*t$HnN&P~v7OJcU7O>0|~!?yB9Yz@Xu?2Qo*#o91_Bz{QF z_^7R|GVN^L$ByVN_tlM}LZr9XV%&6d;M)--Iz@gBC`=*hmpab)Uct0|_TdT(1L``B88%zbSYfgdN} zNwGBv!-m+ph=N~|E2pJ^4ll6oJfE2h9M9>D z{}RU(W?i;*_)l96uG;$M8lR`@w*JMqzc_Yok{4><;rMDvRD&-N>)I_!li3`?U{#k6*vyJ%fHx#bjHo!&5Z& z`85i^BeO+(bjCtlLn)hBNW~v0&Z1zVUj_zY4gN;ykYCL)4%=`a zm6C{!nK+Cb$$rJ77Z%_=;+px@4CAo_8K~BrT3|MgAa4u5EDXhZ+(VU?ey;uUYZ`a z!|Q?pb!-*T0yJ+OAbvo9!yn;+ThV~7bquI%r-1&8>*&!rp#2{O_|7w+EjjkxPS_b52yonP6#OL*8#1=E(9h9v~*HHLsA3k zJw2eG(SAlieeeX$XR*!ffFkPynhs|}Kv7&qqfG(5yE&kLb_Y~x4>{l#`tA+r@V<{Si?*Y|1NbbnMkUs)Cb10y%4>P`F0oB8|#{&wT2WimnQN__| z+{Twx9p$X!$V3Km)paxhH|sfEYwzfe$5BWNc{!>u_z4tC^WyEy?0)Y*tr2vbhT7bX7O6t9SFcTK=l5_4!?me9hIY zw_HUlxVlr()#XaAj#YNGtBR}n)m(k^o~!ZIUHw(l)uCFh(rUZfScjN(UB%URbsfJo zAXXz+A9!5dFkHPbT`l&xI$^n*Yr8s+Nq$%JP_Buq;Z0qhiRP*#hM>q`SINkk;;JZS z;pq@pDWAJa#RJTpP8>{{K^&BuNt{`61h^csRkv`L@!&O(=uDM*x?P@oi>#mmFaMk=T#(m4x zzgT(OWo~^})*V+1@6zu*SEC=(76UR|jY0k=uDU&SRqPqdObJ?sXyycU$9)8|Cg?fx z=SxuBs|jj`-%uoff*K=Nfdt(~-NFex=ORI~;cJ_~ccckgq@XHg3aTz5*p(%yd)S{f zsKVKTO34}2s6s(qMdKntB^C{8BCeuTv7lNM59&4w#RZv{E~r1=4C)*@y%ki4GC>`{ zskeiAy(8`By{hZ1!I zqYfvk_lZP3K>hq7bu1WCnZ%GbwhigG_91QS5K?NFkoMzI?~wBJ327RlpN5psKcrTJ zLK=X_gF{M72`PDONcSd$bY@CO<-Q3?--gr-C(!1*kc@dDWttz-on^$`7}6~q+7wdn z%^{7zQw;t!q`q52di}SMs%{Ty;SO@z$+mcPcSzaxgj9ZSNR9S|RQG5|g-?W30V~gh z^yS%*rd$YVHI`kZpY)K%KL}|?Mo8W#A$5NmQo&~-Ihcm=*^)H(l_aI(=R8UJxP6ii z;t7r~Nz#O+EOBR9lDhnmq)jNgB1xf@Nou<)NwwD{X)X3`Pf~nZk|H>_BT2P(CTS67 z?Ml+b-AQ_FPm&(pPEx|1B=yXdtRk-`s}9zpd!b}4LZKqbiee>l7fse@==w&ox|L2= zpiHs`mrd3e!DRLAl`Ly)vewK`){0%p+Kw;w5MzI`s$WXhEHzW>OwH6EPii$&4!fD^ zcWI`go0{?bh_DuP3~NW%u!i;w>t5fmI`j|gcYHc9tWo%WP*@{|gf->!F!#BH_1-v^ znErKGr6-0}dvaJar-Wrp4Rft`SU*e;>(3csU0+L_bzvP`AJ&EqVddT&RwInt64sWj zVfEV;R@~9BE~JOG_-QosK+T7Y5!W#;Bch9V@+6`*Pb2D)C8{6MCTmnZ@p`tX&Sa0O zc#fzJ;4D&eMpZpmR9ldohxNE07gexCR8jnn+$E#(AOSOQ0{P#Fsw85iqdN9(RPU9G zYH7u&5-Uf!|23+QJWmSug>=+PbKE|llVkZU-iYjh! zR4tJwC8`oQg>u8A>WE?^qAHIA$Tljf4>5WSV?q45s0O0S_^28p?}RAx)<@MJ+b2ck zPmOY&c~qydeO6SNW=FLeX&5jkstI$W?8~SQ&trV^*#<}O-GZo^{Seh;_STaWL`{9 zv3`C`MHj|&8f_NE)NxfzA0LnD$jO*4VBmjaI*1#{bSkE5h{sesM)uP&)jShZtFtkk zY?Sv~Z;vPUGw}%B!!U#EW;agU6!xIkDoRoQbN@qAA3_HCF4tn$3>M6505ERDk{EATIq<$=(N(Q zX%S_@!^_0R#z&S8k1ZV$7nzWjR=RYlsI-z%QL!cCqr;=3<049imx{5{`#9^8eFp9e z|65^SG02-qi5FD+b4 zri4-=khe6osVV|%t5JdKI(M~QrDce8P~J5}VpKWxS8eL0g@5YOf)*m+(1BWZ6oD)w zS2q!G?L}>R>vh%IJ`~qa1U3wyFMo?btAD8dAQ9L&m`eVud!yWjQG?+k(AJ0@Ap$E@ zR;Ea!kOf^oP5`kOBl+z-x#Be*K>#k;ApjBFEd69Z(;i(~)^}wr~##}8#U!l@k z_|M37RnLnWXpGguoNLtKmYz*zbDQ?v6#>V4lurv+j3-*Cb)Tv{5P>E}-iP{lP=UrQ zE%bjxW3*8AG1b<>@&ETkf30p9lb(veBE#jG2o!lv(OP(8{MJIJ7xe3;2;_W4$F*?X zDF0dn=DwkIT4p7|3p@wMPQF{MhnHh(AKXaaLgF= zO#~(wmfuC7^$+T;g~*?js)bEPOG^uZo<_Kpg+K{ogBJQ)(LK zNdIUd&YQ|dSXdzG~h#F{NtLhL;KH(Mu7vso1-a??f z8m(>_1rzjr#uP0~D@NT?E#!=GUpp?1nv}8-@F-1<%2)`zG9t_AI;iu8TLs;7HPmQR z(L!KtIu)p7A#kiR<*2IbrTQD0S~yfg_o1YZ1WAzs5NeX^c)HE9Z2 zO|=lnt=6f_%4V8{Oq@$M=2-}opHH>4&~<@@>{zH{T|~7O>-$x6quUBSmnw7(&CTI{EN2P_0;9HJpd^xPb!I>#&o_MalV zGZq59{@-=|wc2}wLT~E$RFZM}wuR)mYa#y{?QJXtHrY}UJ4=CZeB-)WNSeCwQ$LJ zss+y`t=d*~U^JTU$%1_LrsP=uFSY=sK#fag?lu7URi% zf~7#iiF8^Ej+3ah7Tz2ACtC_!Fdl2+i{UxlQle&12`yBaZ7Fw+0t+k!YAmArTIjWe zW-irnEu&@2Ed^e$pynGa1@3L67TfgW)aAYOKnt4=(842@0ctx;A2e$mt-)=Hp<5f*19P~6y{g|G3{Cc#QzM>3t%!jKf2tOeU*RH?X? zz#e09Nh^UZMyFIAm-@$er-k@Zv|I~=%F;wFq?e-xS~zRCR~Lu1OTh0DfcE!1j4bDCNS&qWFuniRN?`Fs3Z7&o&~-BXm|`WcU^;!&LgGvv$1E#ZXYAHO(fL;T zwS!J+;kr?Cg+3jip*FwxE z>i5}7V1(iNMbEHWqF#R0uP@)JL3V3_g*j-Q7JPHk>s;0Xe>+ixv$a4;W4-os9&7!2 zM}^$11%`OiHE(NyhyD~6WGzrJg#1FS1+qm@^+;=hjnPyi&RXD?(K24IqdXGGUklTW zJBii;=}A;i3mwyFUwLbRkP6hTqP4(7V?t$Xf!HcETMG}XQkE7PSEKCJtp%!Q&;c!+ zHOkep7N}{w(!w{Rb8TyZzV&EReQSZf4al>hwZLKJ*w|Y77~Pv#3mj}lA6i-q+-XfU z+UUBeJ4XAztOYI@!R@RCy0)h(ovj7-7@fQ5xYR%+OA9gGXt5SH8qIrH3%oX>dRYrB zG}dXsx*(9Y*`XI$qV^c&UYmA@pOYwLq(}WIN7UAbmXT(!zNo=LBnk zOLJ)YTx)^5^Qh8%Yk_7)wxxO=mGc_P)WW&7RBWBKz>4)$ZG*MIiH+pC$y%WPW(wY- z>#b^Sr4?Gp+D1EfSqtRZO-HqG)hNBkT42;(`mP1PqtsOk+mBJv256zdfAn4p@fJ3J#m*`m3E)1YGI?{^}t42J+zTBkLb;78-ah`P-K>kK&r7p3t!&Sk#{x%p`U1y7H)i| za$jr&UVNqS?=}MSj1|B2ysNDL=%*G2i0vOAw2)v)%eAn__)iN*tf``nt-u6Z5<6S{ z%N1L3H7?lO3Y-g}uA#O9?~J%`TY;se&jcs898p*a}27wUyfHvhhF*{hQJMv=G{Y?zOZP@NG>F zZEXd9_NCPRI)1gm7&F9H;L=b^9j3Rd$HOTw(^g=HQFFGfz^pmsIM-I7kWp#A&P#3D zLEm@U3fS$Um0IYqo6ham^PpT0(hx1IJW6km*$Om1PT5ZBzN>1dX}=b(7%k7*3V3Hx z+qbp?J&hMyh}|56$sHIIAUb0ZYOZ8HeJ@jkh}psg4)nbEjV_hm`-*A{W{a}?sfuId(hOL zdJdFLFUqThmAxr=l$}7=(eywIpADxmb^@;_(!R-d0;iXe^9r4p8e~k>!l{+ieYc&! zH&uMEofJJnFCW!2K7Q$Z~>G?sm|6DaVB znt#?atS%bQv=I4)UVqd1srKJ#;}1K5!apfi3lo0PTnl@F+eQUTdx7y*6k=^JP~4VA zY2kt$J#n-bh{#60vfB%|<)mg>Se}dAbK47abfN=Vu**YbUF`)X88_VQ1*7%riFVMUa zb=JZ%<8)-Uf`19*}z_4gkjUz zUZ9RKw~6kf%F&e8w6YhlXia6?=(?({M)$7v0{acy?)Cybj6OZ=1#0&s$6odVd5ugh zoa;@+`q&F(7#+2+X&BWUZZBXzf;_Y^+&Gh|`>T>iQZ+5KH!P>v3sg2HPqi1wnnp>} z?F9zSpto8mGm92!;rVQ;Ge_4>Mb4wYwQzVoxh}L9Xlg85q;+aWrM$~@ zZB&>sZMD5X=}oj<3+*;jKP|j4!nfKB%riD?VZt8jeZXGejFIP%y})3@_prS{rg83w z?u#0AipE{G7kFhvUe$T41xD6QT}RdM79G%n-5u(wg;|fN&r>}gD$}^Eg+kBhx)%KZ zN8Pos^Em~)uos9m*1puon#%W@dTL?!8%lX=FW~u(8o$@ai8^aM(!y^e+Xs6AzfZJ8 z3;Dj#QY{SpMpwVv3q<^&%|CVh)yel&-1 zx^!L(ZuRL^QwM=@f6*;16mC!BwXnAX1$1@$GgFu4uMhh1G$wdpX|4^D1HX2g~IS70=O8n~} z@N)#UALSsh->@CyAkf1oH`YO5mGN$zgFut{Em+K> z4qDhWpQbHz5a_aqa&B}G7-F2<IV)2UyQFVjsj_}RLRRxV7hTe3(pcMGRaY3fRS9> zQQ*9>qokuiiBt+K?I`fKakz}5KvY>;Ud~Y;-Ay_6I0odnJp2`8Kcx}BoET3B|PKAd$Dn0J9nTyhdvdYRs7A>axfx#uL1`##w} zauUceqMkSj^m$HeUpNVTGfup863F?Q>T1F54fTBQByhl}{n1I_?@u(~i>|LaZnXRA zBrws+`HwqVSnf!JvpEZ#F)C(v7MP!dUTWb^PIAxftbaCemS)BwCuf0PE_6@}_W5X1 zFK24-K`l7#q@7x@*+qA?Q2iLq(ZbsEH29W|U!5`5|Ib+<;}y--!r-@b z@Pl4Y<@iW%e>n?G&5`Gi2U;jllqzfCMk@KF7-3y~{m z&iXt8|1*4!>;0*}uh0oC+(E&~75q?1}G(1><5 za}ls@PB*l$xD91#pQEN}{}I$p3&kc;y{Rq&ON`WME&@q2XqXmi%%qQVTm*{GrLpr|1Z);i zRV}n#NY_^BJ}B?i)L@(Lx0<+z?r5RlKB|4#MPQ-fc2xIAojFE5PPhovIztPzaQQ6V z{OBU!`-wchy9iABO?S0WMO^2k*)%RW9f_*hQ-mEL|1{Y#-1csfvPFgIMr2PrLjNFRp3npI$hCK zz&)M1YN38*TB?PeRj6wn5Gcul-aRbam1ILKAt#=qn<#8qIOF)LHAubvtYM(Mbf zjH8NLxHySM&36^JYP4PKD$r*c?Oo|A;IN9Ct#%c#+e+27&}|#F*r{_<>kRwdt^!l{ z(gQ72+DF^=y9!tyAjg9`Kh?-sp@j#=h?n_`p8wF>SN0LM$fHkY0S)W6?p%Viu`aD=w;>h$3ZQ8H)3+Q z2@EvW`qx)80|?*^ScSWGXe^@30&}{{C;lwcNT8)xG33&xd~(#ha%ks#zxT% zEsTn$qOooQU5yEGZUQ9|X_OYyl4*T0H-R67IK!N!s%`T?Ttf~bv$Z% zJ$j^t*d|o7nVY~v!?&fIKxbn{D>s4uf6*~5gms{)T6kc1c61Y1ZKU*d6BuD!7^Lf{ zY7e1>TBtmX(uV82)mY=G78;GD6A0S?gFcg?FHQh78at{ zTKMKg2}Rrmh8WX)+y(afl7pYSKuKdoh`Yc?qfw;0K>ui(nBcC@rE!-##?54Rfj+5p zSPQF4(dTmR0wv3nRC5>jRg=oqa@XhLxy#S`)TyPrz)s^p8+U>F9cZZ*=5;39F1kLd znvto6+C6EZ7FzV78~xk`eEQQmEi@fOtF;g_lzwLFxK!DZWHr`ZAZh~rt%WDXuzBtR z7mU5jb)D6cRrFR1_tud626usG#!M{?-b`n-uzM@j-Rmx}*eJZ;U0~=DI1GOpmm%Nj&~o;Nl_h%IFd9A+X=@jPMX>5<|zd;2cXcwU8c1 z54F%CfqEu+2plldll9}&fs&Lx)kDBBjS5%v5O`IU;;MNF1Z2>!+8zSs>d>%y9s*Zd zlUExL0qc$w+tov0knvA94*{iI`be@}t%Fv>{s6qsuqN%Iu2D@7%=5L%l0XyHH^I#t$Fz^xp0 z)Iz0dG+hfTs*_6%Pk{x-Z7me7Nn5m#RELIXp=f>D(ZW-}x+Udq>nTvPJxsm!c*X%RrJ?p zPk}8);C4@eE(dA17V?~;g{M6QUK^#(dJ60|?9S;vsQHHbc~606#!M}YzDC!ykpCfd zd92q}yNz|vJO%dukFq`Y6qxvuDt`17m}+?a^b{EGnD>v1TIk_QPkr+WMEKFKVtEDf zrBN#_+^I*GI^-27*pY4>Dl9PPEjfQLEYQ%f%H}Q5$Au1S;dvkhM0g8yH?EfS78sIB zm8yFSOgH8=^%mIGnrz#63l#1`wY4zTSlQ28;FB?NsJB4P5j0;5L&ng_3El#(6Y1(4 z9gnh|OEFroUqKmKSh1VJ_jwESGZq~37FcqE-fH3GC2D)!TVS)%!m z{9&K1h(Lzn=vhSIX8|f(u!ullB)PRIBGA-W+_#8+uce5j|4q}hP-qm5pHM{LmeGE0 z5rLk2Xq6U@9U$j}MFi|GQ28501ST6r9~KdK`G`tCEh6yJ$>)z)XCHwn%_;RSAAvE3 zcP}4-b;frsME0ipT4+3qR%)T+E_!juMx=2_>W2|k+*hDu2?{FdD^NX+LQDJVe+zu2PZ@ew-dEs5McP~0S73fMI-21t z;8mB}X<<`+N^R&XaJeznY33^s+=Y5+A*3I*8=#-Bwi@gI)$yy>qbPo~uCw|*k^Y_L zD{$5*Geg%+rOu);TIe#Hde8M0IAny)^A*Ukit1>g!v0 zsNywWfvHB1+r9$6_o%ZLu05uM&wK@P{Et4p_7(W`iOPNU6}a=2I{wgoQ#*|JKYazB zTKoMGVdE!|+mV8^`3dwgYUTD5=-@=#wQ#_hX1MqXJT{uU`UymMP=77>2z7UU=J%t#OO6PRYWMf(XnPN1+vKY`R@bhM10fKyqz zo8c$WqYmxY!n%f(y{(@>ZDU0@KY_5nsjn9NMp2*fegcP$ps9WWOPA0)E#%lrnTPxY zE*pbS_zC!&q#ft{1gy_fx66J4Wv|jiEqu8_8Tb7J<{GP?`3YQpLxr;Z1de>8-T8|O z*cG6AaYY4k#Zx6MOgA!8iVDm%+LtUUu%iK4H!LcUuP0T}{;^Q2W*Xg&6ctFjN@KO~ z^9g-?R#c$)|7hf!q5>PT=%*Ieed+Bu^Tqg{4KvF4AA1x-qD_zrc%@ z6w}IIpvqsg{BM7O4@Srme}Sc|>75p4?xib7`~|#@(zuKM0$Z+-T=f^2d6RD4^%wBF zN3);!3#31#iO>86<{3}_=PwZaf@W!9;!C>z%3og-$6w06riWVS@P^W}^nO)iqpKDs zzo!LSSoMM4YhmVh+WVisfVD-yAKkPt&^W4voK^u+!#Y3?8JDvM2n@2RPw6~)I zBt4pH7Yh(*V|W)25QsDuYhRWKkoqO*e)#}_cgCs;0Rp>>kct7)Jv~4k8xJ!A1U?vR zY6J-EF~VvFNY7dU^3-_OMDJT!Hl^KKIBgVb79c~L2goPmaN7WZE5^9L0`$2$0W!~U zY8N1N+6U;*PE+na0RpxA(lISu{F^)n1_)#tT?PjTZ2y=1hXe>LA3<4}0s1;)0n&IR zZJQV%zb6Gq$I0Y8D?nh_Y&tVX_e-VBrLXe>1d1=9lM4d`$}Xp|D*^<58{;kpD78XrYf${Ho4V4ZB94wUF&PmAV@s(D4mz$qEqgeM^a2 zxb}&@eGd?D{6UAcaM>vHGeBU>FZ!j042!@&W?BXcI9kzY$3THg*(fc0pup-})F5}D zz#=Eg;~c0z^AM=7-$YlmaIPS^c?Aj#GbVZm3fw3{<$VGLW(Ck{Ewl=xo?7^y5f&UM z@Fs%X69NSqB~pPBfdY3*lTX<|fyu_!@__=sDo}@tfdX49Q9RdX|bRmy! zfdV6pwY>uc_8EQp1PWvt{{3_>)U$!~RSO#j(LpUl4-S-m{|3rS_CB#xpZ=#j#XV>N`;mO3XC)UTB+kw9;>MF>Og^W#=>=h0?*ge@~wdaV|E70 zZtLI5A-$%Rm2MX*uK$eFB1@4}pDmMcKnizR+1quWjFYoIfsMC+=juxgp zre#|2d_qm0>V2v6#uF`6eMR-(1q!q`{N4uU-BkoAEYf7EqQ-Hm(S0tI^hrr}yB z`5#r&!Xd-aB1oXGF-{BLZD~oiAc3t$=j=fO1C94uNXSVmw6NC*a0wE)b zYN1ylD&!L+5N^EC!gr&+Z;-$yKPpl*NFd%=6dWXQBA#w)VR8a3)`D9iHB1T;IAc82 z!qAdbs&bG(O(R#8Ab~>01T9>zO695r2{bg0*9sE2+>r7$4iXq;3~nAIFv+OYB1oX2 zaZU?vt!S7QW*N5ag9N&Er+>AO(t|2#VV_~!OFv%qG)8IRbANiB86*%riY|=~5_oLP z9TOz5*61`TNWgyvb(*Pft9wR|*+Bxsj1qH#1gaVbwcs$1`eM%d0Efd>0&(E&X_D$hak*TSS@wBT%zz(%9} zIX#c6zwt&3F&Aiw7Rq0v@z;X{df%jJ?}G&HexS-9gY^4>L6ZM7HUAPMaLLI1JxHMT z4?3oW4L_;guONX1zsc#pAc4jb{Kry@U;#HvYG@rSu-JxNY=Z@IJ5%jE!2)ic6rV3x zpuAy~KUg4-F;oku3s7>wV1eddw6bupKwfWpQY2U)*q3H&!Luke@edX_Z|n~Y7O)GZ zi6OxP{xQ@kHdr7ajylH&3*0x}CI$<{CDSr36evzDN(2jZF|lYZOX$whV1Y`@=)!89pL%G_UZdwgtu_j-4Hjs*j;?6IawFx@!WrX^ z7OHHbshjn>%61Fo+@|}dYHp_^TG+UgzU>MY7_x`X9S9b1J4E@e1q(F0POoq1IZ+oM zQiWGKUp3)1S-c4r7@S2xZ-WJrjn7)JeMh~uu zp&23Tf z7b1|eJRR4OphsnLs1hPotA@yaV^NI|f#J1jx)!R}p=MgRY~-sK zA~4E$rG@GB>0W~nf$xo}WYZ9V)6J+~>kxrMZ785~h(PBqG_7lhz};>}53Ta;MN_n} z(kRv^M1QU^L^6iZ%%LFyj>D+w@DPFJBWQ~jyfdloNIfS?#!=bvAp(acljBsqAJx~m zF(X94YZi^yLdd)j={`S19vkEmCAp)Z|(GM+j+Cp2m z>bX}vc2mm95P`~u{V6>s%EK6`g^V-QLJI}YQm7WroTDC>^nTSaqr~M9fvQH<6+N#? z?(6zI2$2Sl>BG+ufyCdmQVW~@qwf+bU}r(YwQ$ywidlsUEVH3EwxI%z>?qkGRG^Y! z=cxCi+>J~voXEN0$xGXIyh8c1D4!Mg$gt*O=q<5 zy)2b1AF9u_3Y87U+Df4UpDI(!Dxm`7s)fqc>Y-95gBCRi6?oB*tQv<3RA@rAwJ@kD z9d8z@ue%y5@y)4{7B01=4t;g5YI8sG=^v`kxeC=kuT$}%p#tlSL&J4Hlw&6K)xyM4 zbYpa=K>0B=eO#!(z426Kg07DmHq2jrO`e|W=F?409 z!0A<#yjst^DsPlt6DlxzEzQtEfpyekeW*Z@tyFBAKBm+xW4RW}Y^NW4LIu97 z_)6*DLj|7Mh5Zrg5T-w;5GHet^^RczU$Rl_>|p{Hxv88}n1G!-eJ&6tU{{b1XyJm9 zRwzthq!)eHLMLz9S|m*1gb(HR3llgOM7hKCZB;v*j%ndpWSBTdQQhb;0gptgo1$;4 z`Nb%AalH@qUkNIc8YXZdjeb=K)9;IhNvU)?S4pp}rq`l-wZjCe)S+_qbq&%zM<4?SeU>?V?$<`K&z3oW>lEKi?I|jK1^VN(R6Z{!15{NF;&-B-I-24 zGs6TX8~@GH^;Ko&&{i!>pQr0LU)OE{O<$$&Q}(Or=h`rRomf35>*@Z6FoEJ*Y1pVB&4M#=AC0vn7%5-!lng05;|j}=+lgbQ>xTHA#SthJ|t4&ee(#=)H70zF-5xE4yf zQZ+3cG92B*1^OC|^M(s7%|~we!v#+Hkh5R7z+j_)aJays5LyuyF7P&-nnZ*PoQ|g6 zG2sIHVks;xTwn7!Ty7eL6T$^182wA?{i{Q%6qTlPRR@gfrNRXcm!>Xd!UYPJrBhmP zE>DBCu)H#5RS6eZTayYk*8Nben$T4(yfg;4($7~pI#P{J;R1(^TV28hyt|QO4_#js z_&0U=N5`jr4y18I!Ue7lrKZEf_0Iu1*OBBnT0dX)HC~Plm&ozqve2-Z7%os{GF_V* zE^ucW`OF9xm~7mg87|;Eo2F=?%Us$%FI>QXKHbrR&qA84g^!CVX=%8?DkE)KxWG>% zZH2zAHW}I1hYMtEphH@CzA0S7w}i`lW9W`>fsmcleV0B4)MI1HULCi(y^mTS(8q-e zJwZKAh6_ZWr;?ZS{Hqa{>8lp1-=G;c!v#LyqLe$~0&9$&TKM-KoxC3|kobVAXyMsY zn)NjzlIA8{Y}T6BLvD7rg7d80{B}3zzBiQ zK{O~NLcl*FLSKJ9Lhcz~6C?EJ?jodkGOg1>ofMi^EJ7exak5H{5ZGe;Op6d0UYdL= zMhLV^r(0S$RfU|ZMFw>Y@TftHYDNguZ%hlDLw* zQ*|0d{k1T72%Q)jAy8vD{cll(K-dzRr-i6x)OWe=tFl>1jWkEA@|2`K4Y@O?gFDZz7~ZR)p*{rhV4&sp4N~ z*w+Yw&&I;=!`@Pq*ze0Rir>A!_GQVz}?8yp0|mV61LPaXQaSC zMnbMgf%3*Kt))|>bT#sNL<$5MPqgsKXzdv(Yx71*!F*KQD^j4U;aE6QAg?i6d&xUe z(uz=*ph$tiMsl#uN2MEkwKk!V(!-b+6)EsEng++{=c+de6q6Jwu*7IuJW^nJ35rUM z6xdasEGz1K)tGepQ7uv+HG?*4!KD_}uN^6H%4k+EQeZ`Wif$Mwu(26^YaS^uq$REF z5-ISmD>dz=<5Si9(Tx6)0zQ9}`{+n%G$vBc8UrRp3LKtH(Npw#>ZVb6TBN`P-}v+(X&+Me6fnbZ&>~?U6`pNBa z5h*b7Ct3c|Go_~fraS*d3RIG)KlWKi3E0}w1iL7KoY|;m_9%h-Imp8)N}#bbozp@Y z7aHRlCGgA0bdM4^??ELzqXgy@pdJOI1X>rOwO&yI1q;&;EutL!F5~cr+ zL6kT~(aM-8fp@XAJ~>LDadBE&B1#}4mAorP3A9Zo|LRc!Q)<%fT2TV&wP{@AD1oa@ zs7zCxx7yj9EL!UL)aX{^(jiKqen)!RDN4Y#H#O)JC2-nk+)u};mi8yN0Z{@~2GP{P zQ35qb(2&tl0;k4M(%2}0L*vMCg073|YiyVvCGd3ywV4?uFlRPBo)aZdV=j%EuluPk zFQ8HjqXhCUrlw1x1TGj)wP3lFZZFgIQ$<$LBrPmA@~n#z@IFaxPw76W8%FsvQ3B)7 zlAMbY7;urQUWyWEcbPi9j1nmFhT3OE2^4=z_1;AZIDMfyU!w$$8#}&72~@F&{^OWc zv_MW9`dbT=jN4lHWJ|Vo(E|I8^IAx?r%Z=vfgZVOO~Gh^kAm)!T40V3 z8yhWP6Hh&~kUN=br$h@ZEk>`4 zM+>YjO_kH5WlAOe+{#p@R6`4Vdh+VFfUr5{Q|OGs^?i%T1I=caM7rE0%QB^HmG(4X~>+{TX zkBq;bMhk3sM#;~k1rC3pY@eb9JdDv=xb&GCeT^3AVHfkqZu=O4UdTZIY!6O7}*jQBfjBOG$BTyVM_zYBSzZRp`Kc=MpUACjKHfF6xB-CLjBc&dTGI~Be`f{uCYoB z+dET8H(gtG#AwwcMj*B~CH9FC_+LLdFf2x(=>$4DN!L^5m_lu)#t4MYpkZ3LIhQOJ z#t4*KMBBCS*~nNNqd(&uBlir4CA!CIuW>;Oj}5yOI#1$k$56T|GjH^drJ56EWOZPK1b~@>A6;$ zE>n>!F#_R6@oO;xLyh^@V+5YvpxQTM1j^hcn+G~Kb<;NXkHYq`0;?U!B5$lfxqNgf zf2=^mSXvwxE8r4O*Arp|o)}jXV+FofiIt%lbh<{YKypp0riFFJ#m=z;o?YpBuUPre zJ5~ntrIA`VJb>m*jn%*NjFsQhsN0NKfs(W6v3A<*Sa~>?yynLWR9Hw87R3r!EG9QC zG&9z&j1~B_idwFYm4R!>ab2u{yK!0zK^tkg7J6)omAK6`VoR(*<~G{0BUYO3qI0`r z1uE_(`vbB152;hbQN+KV7Cti`^M{Y8{_3F%$rAMSmudVkork(MoTiS^ajL50Xxe!FeD(K4Ix;CiAZ9XE&_XLC zb!vh@<}~`Ig%+!5)oLA^%D0BXwJ_Ltu|7c{Vk0fk!ms00>STgI_ytORs@GGQsM zT~9UnGu`@&L5&8>q{+M1hRG zG;?2~fa8Ahx|k@?`Vw8!!jhZx>QK} z)i_!=N#Ip8ifWN0@V+fw8Ji@Ke>{!W!k~q8d{L4>{9;O4s`sx3FQfNbuw74;HY5pT z-$rw8>3r4ZM@e$-agtnoLY~i(1Tu{_&vjmE-3!{Sg}9gW_p2mZh3&?FKa&JH{i36m$pSg7X@C~C+0k$NWPy$jG%aVcz};N* zQVUaZ(`~0@fpljo=#ngO%*g4MEbzB+#64LcyC;1ulq@jPi%$3?>vLw3^|>-MPzx*k zDLp{1qb3ECRZz0P&`>%ZmMoAQPDP`W1vRPF zMU_exSY(tclPoZ*Ed9_zw(?ZHLbAX?V`#dLQ=P6v$(41Ss!kP}S2bB6S2a3bJy{@E z4f;n5vue`ATFC;{Yg74#$pYgWku**gSl5I;H%%63)r@|$(($U)HndR-ZU3V6?UDt& z+Eei^$pXW=(q}E??oGA(=-wMchv;0@>7kT7Oy{aLkE9=?^xCT3Xqqx!&y>17fu3t2 zZ6b}Fq-R8ZH#*Nq7T7kEdd^Q4D87h>E!Hur&qlT-x+iM!YC5__9}6nSHX5LXq1);7 z4js2j-brKkBnw>GOQrWE3sg8v6OJScSRADxr;-Iuou;Sfk_EmP8_p*S959+(Octnm zg_>$1-&G3I!pUot=Vr1%y<2or3lncA%Z)pF4(?L3H^~CsjF7BkffQq%7CyhFR`2v| zsN+V)*JOd2-^lTMvcNt``NP&SMc|KU zq9vVarQ=sFZD@!Vji{u+VtkIYr>J(XVTYz`<^GP78y((}^A_ z0#}WWJyQg>^rG$qQUtaPrl0?&2sjL(a4p<0yoRL+gcu{WaA7!=9FZbW*%+>M9!Yga zr3jobu4*B8w6570avzr>;A2eEf{dsCtI>W!qKcw8j{hogAxbVPD5$ikF|&>@iP89XVlp#2 zr*nPq;k&t)$9wOd-P=KBRYuPZ3oN-tq*GZ=t#H*@VA1trC6xsX=S>T2%m{C!c_3j9 zk#@@h>o8tZS?O)@(n;@~BsK|6Wtn${!)1YG-xv8**4iv)pIBg?HnFhX0$Xe>>7a8% zsycwE=B*eD_ru55S4xVDmINMu%)9SY?TH}TP=EHG}wdnV$7z&4#kO_ zcn#M^jgmwWo3Fu+9~FKo8$7MCu27@iNV%v{U7;~&yl>E0?$EemJnqzB!53nnOM~_F ziWPnhW;0UyG+6ZqF-K(){UTvhgB5)j6`fCq*^vD*PQ>0Kl_ts(|wU`Ww5}UY0v`w!g0JPURkVp0BB^z3^F9#`xy; QQ1WnO#{9lT^BYY60gtBv#sB~S literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/7e5a106893c414ad_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/7e5a106893c414ad_0 new file mode 100644 index 0000000000000000000000000000000000000000..e84182dfd8a08d3849ff9cbed1f0f20e355ce484 GIT binary patch literal 18392 zcmY-1cX-p~7x(dZn_Xs0(*d#yElrx8v~(mbOZMK1%1{twiO6;$pzOV;ELk!Yl#NVf zZxBIcDzf*~=kt56>-pp1x?U#ve((F-=bSsFY4Szi8y|dAs{8X7CZLKO-`@6P-SBEK z7|f|wEm$-2)vRh+HEUL_nw?$4@2inh<5j;eGbcM#wOXKBR*g`mzeXs#MwUOARXOO> z6kkr&YMC`^WEm9WP<-L(|BLm%KZV9L_`kP_`fnf#E=j*=*ef%Pa8_(e;+9OYz#qlo zNJ-clf}gU%nyc}0It)2ApyaF2xiPG40;QY64^q7uq%?<2sV(od(j58v9q8BtZcDM= zVDG27{WW(0R2~FtRPp0apwp+&?Q>W=7^;2&3B%xxFQJQMeFaP9_HcM>1ay^pBcZkA zjDnidX$amDND>aJw?|>QbUX%qgcA@tsr{Az zq}VC=OvXs}b71-nwq1aj-=UP8lq=Hm4`}o!w3Ct-!6`H4qf0PaYF&m_vhRPcXg_7* zRahYL*Pz1RT32q#ztZzMy!;1>-q3hCBXw@VoLjI;y4;2Va$OGIg9|e4J}i;s2XOBp z7#_hEIVky$Vf_<5pXBqWFkYgc!Mo3)zXV=DHCZPeqoe36K0_2$WQ`0oMln)eHAT@v z_Q(iJ6f>oTHHwaMO7dc&s4wP1Q6$J$Qod*u0l6VBq(`wR-i+0)q{l^(Ez2Y>DT)em zUT#X;WX&rbMRj>8Mao3+sZ>shqP9d=&>R^e6XaaQD5g20_}v*rql_rtkoD5t6-7l~ z6vrw@k(eDt9T_F(q)d(;%Ve3FAH~6HQH-q~MY|eNB)uBNTQ!xp1ZqcdL=x&oF;qI& zi(+N{C`vboVsAs`);NlfWVq~X9)+!C6#Zr9TT%SkRynti;^PkLnOqXbJ5fxR?>a^C z{M{(Jc8=mgmnc%ZDpq&(a8eW#Cr4qJqT1#}adxiqoEOChUq|ud{3u#3jAHx#C@cq~ z==VQoqS$&i3eT@m9QZAY5*MQQLb{ovS!a%>f+d<-g`*i$B$|JvcS1B96QgOB9L-m0 z(HyQ6O+k7z_2rzLaz#_k6HOyY@kKK}5KYG#(fsymG+)$==BX6aj%KA4s~gS7va?<^ zf%?(BXcA4YX3>;y9?fF8(IT2QEu-lyH)KMqX!^H~#{8Prdp(-ucG2wX5Y0XL;O%IJ zbc|+r=V%IbiKfYW(G+<UYQilQMoLS zC3#vj!RgUdkw&wkxge##j;8s7X#S9Xi=vsaSTVne=9?wa+*}&X+iRlveXWjdh~~uB zX#SLSJEEDtJDRLL(F~GrpoR1`BqB5 zRQ!LVDQh&)vao?!MGO=wYT#Tk17nICm?K4E4K#~0uv12qFfdbE#2e@+r=?7S#>$;U z15rr^Hpza8BpVn~(!c}BENh^qP|iSc87x1SH;|KJU~dHjXJkS}1M?+5)j*px#gG)g zfuP)!m(nv}V13X)TFAgV`l;1Nyp;_U$QpT)ZJ=|Gfgi&Levu&&1Czv@Z=gYefi1GI zs)6sNXEg(#%3aB>VPJ`TUQ2mM{n`fJkV9gxYhYeI1J#=wXf8!tsAd@_r&}7>*4lur zt$~tqLM}_ob_Qm*SMNG#P8ap;J;j$>T@CE(rWid8B=%9=pX%{vdOX;`y)Ts81Ou*# z20oZ%;Q3?&Ur$s2WYtWAo*U|kv{-6jsoY*>;H~8bUaT}wdzJQJwR$AezgNE`xIz7t z8$TFm{G)*>8x5E?8Tetdf%mrJ2?X4Wysb22V{_oZv?NM%f4OHG|px#mC zC)vjhd?Rtcsh487pj_q3EdxDn8~E;yfeLpG+?SmDs#!808W{A*z*k~_Y+#Z6^F+^& zXX?%&ej`l-M%IRmG_P#rrF6_Tl9Xd4U8c(UTqE`KjP$5(WLq60?z%>L*HbJR-_S@_ zBO|lqVq+t>rEL=R{x4N3HX& za_FpE>GqzHqvGmnj(COq*lm!dxQ_<{9ZAg%%r$ z`_{;CIlR(H{wgC&R~u=v#>mfWjo8;2Y4e@({oY8+^*SfFHyGKt$w-OKM)t@ld3B4C zkz0*Cle9gmO@7#Gq|!e1@n_}ui*l4+M~wU?DaVZ1E*Uu^wXYZ%bJa-Q8`_uqMlOlt zp^@(;>XDIJkB!uLYGj`jeQxAqdE-AL_ar;YL{Y1W4~v-ed@*rG{*qS3Ow2BBqHwH< zE0s(PPd9PcVWM@0i3UCs8{|E|iGlLBc!MV9$O@T|W1@bpZu3k;g-s;Lv}z{GH_ zv8f41GZR^2ZEd2TIA1f7D@*0}>n4uBVPeYLCSJBl$qls0UOqAKIIkIqz z=I=1E>?adXq~$IX^X0GIdc4QPTYF8clc)PkbpBa&A5?yaRMTOd7t=8l9c0OI6Nx8G zn9rJcUFQ92qS!h0=7PrmVWP3Dm2!WY=ycIU%}XY3-8Av(Efay;CaTFAd3?vj?z<*D z4^2#zvyV*Fer)3U6BE8?Cg#f0f0f67CSJ(Ln7J=G(Poy&7Wq$h8_m=+nHg_3>kYdZ zyBxKeIqWv`fyc~Usq8beST>2lZ>Cn3neEwT3gwt-Ez9L@u9_ZX+|No0#d^)XbV@W+t~VGhZ6C*1Xru z^nBgS(l%yZZ)fI2dov$(F!Psq-ZArgM>DDKnz3~;^J1Xlexw*OdWhB;s>j33T>jFG zbGVu5(qfjGnX}Er%rR3|8q71Z?ng7vHkz?)GP6v&Z&nYss~6v)vF7VPTCtj<@i8 zDGM(vSa`jng?XtKilteYQc1^Tb-IP^;&oW)i0A&JH%4LN-evUiE=i< z%E3e{<&vy)O16^zij^tyTWKqwm$5Rxtd*Biy}XsR@=ltSf5e||WuClN&&o=9P~Xbi z4XnH`-^hW6iq%MKHnwtJhBmeGi!^LzWtrS*Zl!GtE1$k@<+vojVdX0^wYAb(=Crd? zq`j4IJ6VZ(SNV3fvR*#?z{++pe`uwT4CrH}RbMMH{jAzUE5qe*e=GR|ta|;|`m%1A zl@?!Gv3_MGNxqbW!>xozSZN~NBzm%PlSxyo+@5MBZ<^|#t~{mYOe+iI?^()iww1tK zE1$@&c~5;-KARO@NVtxek)^7Sh*pAQ&zr~+rL_Q^PKimEa$ECm6?~+kE@y| zC#38(D`zDAFZE3}{%yr^-AbvO8ZVn~S&7_H@9%0a?pZk`m*ih5bl*zaLo17<)MG1) z<+G<&PCe7!KUdx_w4eVeHa2=h*%&0hO66!99~*3pklWJLXk(4ZMklL{1;uRGirZ)u zYh$Y%ms|2&&cxZsDq-WJcpJmzxO{H6u{Xg+<0Ko`Ua=7@ZDT+g8-K~^vNkG|v(crz z=E`R&T3^alv@up@$?x)7s`5*-kyOdXXgQv4qng7;w9m$T8RoZfAYdaesCC4hYh!7B z8=eL>K5S^y>yVB1jcsg}=%&iMmBzki;wNZ>coU#tk^=Fv9#NbNB;mdo9-HrkD|(Q>?vb@FtAYMyT6rBt7(SQ0hY zMt4~^&&JgGHhL|vQFN{HkYCm*kMC^k{@zBR4a!rt{$S(gkJ^h(iY3;4>X+R9*~VMH z*f_D@M#+QPLzyGT52+8QY%G@F<@OmH`R8mjln;Ni@uU1K@#k$+lnxhcd@B=w*Yicz zNu57zOp+CU+ITEa;$x_8kD)=i7^cZVxt1G4ATNfGC0r205&5xd3{|Sd;CwZPPh?lk z7=pE8SW-KNX02lAFS)H_u)e0plJj~Djy5rTD1n8sd@R?0h$ZvKSdMRu8?uupj-dG0ji{+r?{2WW~{jqG7Zw|zA|4=M* zkH%8vcr1%g#Bx_0Cu7T>saH6Tc}3#*N6r_G)6axBI>^r0 zIQqrM@sn6f#WAs892exvZ*}~89hcaRacmURCY_U}d*hfbD~~AtImMUNf5p-4MjUfw z@Ey&&A4ib~aol+s$CM%^_)|((DnUazTdf2YtCyg5_Y!m;Sb`tq$H65iHMIntB(Ssu zvsahkFR8e%1fQHN!OwExS_#(wU4p3VB^Yq41Vf&e;IMrEZwXfXSAxg#Ht}qYj>l$* z=O1G{|C-`yZH{MwSS<0hmlaaN8c%FYJa0&`Vj3S8PjeY)kEdNyJj=yVGM-QGbvnQT|d*kWzb382%#`CqDI26yX58_FE7*Eo(cqaZE&jo3O zonOQrWoLoGPG^&yb&_SV)8A@mr+9339u~DzrI?*@#qAW2wbMq*#o6^9)lMJDjkhz* zZs(}fO|WxXQWEW~l@;YQF5S+p47=W!+R1aOpB-k`NMDvnq;+nKUe zaiqaEI~%s!iQb|0ezNnHER{dy@-92x-F9~Dwe#ycS_)+_Y&AE z-tGxZkv}E5M*=G(GBAO!KAYd}%mLYk#TyWRJWxB7vpSZ$bh)79~)4v0^Mw zV8F@*cFBTu2{idGfmveMsNU>OpvayC${t9d%)tb@$PJltSo5UzN!5BOfh|)1dIBkT z66h`~9w)H*c>mPl1u>Q3Z=ycI~~qfnwgw@Ku@{2ESVK($16 z$?_VBJgTknbrPXTA}?Dc>T|n9UbIQ1XU9Y~%8t&7wCSG6VwwBC^68aG6B#b8`YIQB zXFwun2PIPRqeNCo`_GlDWDZrV;fd55k%(bTBEj*Ad?Ht5*xW>p%GM=`ELxt(9r^v+ zL=x8|(m`g(;O`PSD4W+O^4iu!7E1Z;i45JH$Prn)M{Dd&c|BDds+lZt&Rk)+d!G?u03)GxVxK9OmU61gPnNaE}GByLC_ zUlQ9T*`Gwa%p~?oTvie@q<-ZjE=u>DB>Lthu|w*Ibz3!w!qt+9sh&jndWzFHiONlq z^!Zp4FIy#1yLA%7UQgoWyGfMmoP@DQ5?LQ4@wt53TgUn&(N!MFyM2>bE7kfX5#2wD z2U6-Y#r#4sha~Z2SQ1@^C-I#Wj8ObBia%Dz$0u=MN)m}vHFt(?=OocVUd&Bm_q-&E zf1SiD^YvJ2El8r-!X$Q9N~UOfGCprI&GM3&BfG07W2uo$74f{9%mCR@GnxIhl1ZqY zOb=<$B$;Wlv}rQ&&6D|Bev?WqlKEcpS|>A1Dz!=G$9Ix3c1)&tmta%1Xj?lUzlZl&{%&nQp5hAsrLTVXY;JN0R9vGi221WKPQ~7d7{?#>uK{$!z~CnL>XjGvS|P z>ODwiij;ei%$G4GIVOGVCApef5`S7rUgnpiRP~Z{lJl>ZiGlfMzr*KDp zIi5n7Gbwy0?XITK@IeaG<&>oY)74&&Y1zx?X+t`X^#Z_eT z+ZCzyUPVSrO23M%l4la=Uy(ng?Z}EOlOCHYa(!n-GIv#E=c$U6d|r{Mq;gS0#Zzez zpUO1JE|ZV@9s{e%z;$8i0@!3^-iZUMf&`fO6u>ayf3FO zr}EP^&HpQvhc{Ds`7o8*k5W1RM72FnqB9*JgH2kJCipQkkDwIY)X<0mt?y+h7 zAUopHm>!?TWqI4Ku}NusBo#}hF;sSyN~72-X>=}~#`Ux`GAn7WGmZO_pOMBjsqal= zsw9LICnpVWZW`6{)7Vopjo4agTxga?pVnz?msM}3QMgMQtz>C$jr}Bzfs!^djRE7d zo@7i(WAUOi?n;sMX$;?)#t9kxv-0{SjUNxEVLXyX?-Oa%I+ex*d3-jFW`CqHM^;?Z z_*-d|y`9GHr)g|{r4p9XmH54KC5mNNqJd14W|2zFk#1Eh@#7nnFuqxdQhh7Y=zr!{ zVutkIU5VIv> zSOV$#elDHQo2GNUV>+3g(rNTwI!iuD=f1cXY21o*?#hg<>73l1PPsklj6Igl_b1cg zl#c(J&bbTer2U@GtSjl%znad3Yw66DtAC~Ax}MHVneb1#u1`s)*3EP-O7~kDdpn)B z@_|gcm#)vP(^-B$oqIClSvp()OUD@HptpP`d!(qrL35*nopPeEgU^dN*jv;=Rxt2fqV*z(J}^mfwO7>W3V( z%6HINQVJXdWTE_1#X*~@4*sa)(BDS~%j-JWB<^|+KCJKHvRrKD;J$p@+`$&{ws6q5 zrGu+-x1EFN_6|170m<*+VCdTp9?GsR4o=G0_Z-ZX*scy*cXQ}_X$QpzD4&6!98`2NS+ip5HqtCf(NS_y+a-2M05MbWmuc?r+ik zt-8NWF?Kqz?sCv*w}Wj`=zw~B$U)b`4$jGjqYhm+@`%uW;)6Atxv0a2Y2F<(v$Y2`Ns_R&Y|MqLY~p&5=${Cw=8F z@w%Mc@;gb)aq?EKlhRe3oPX6x#ad1#$@)4@Ue*@= ztnBY(n+zD>WVoaca&ql6Cr@PU=T3f-&|oKnzHsu7yff5E`LCS(BE?5I`BB~*r5=n{ z-f}^1NxL!1b*yq7=Ok5z$-7gu-c%>`raQSh%ZYoA;>>k&X0em9OO&s?w@kS$chYu+ zdMWc)Ir)3FlO^k&jNa(v#3m;-Hmg5db!?lH&D))9+TkR6r`G=2Nuyu2wv;^Q#3}#$ z;pD(2^;M=`R!)+9MPsfyIU-l2@eL z=cI}3l$fXt2Fh4@X3k(yp$yi``-L<3Ozufe(F~T#R&m58?rcAW2Il&49Zr_ zz$e$`nRH9dU|m`U6)I(rEel*3{G6S^uQDkogN2fio57oT861?0GPG(2H5z8nLW(s~ zOc^g{8fQ?uiN?ylmKmIQGlNoXGZ-m@-_Bs7GKKL+$FC@}O z<7Atd`(@BqM#`g)GPpTBgV4wfj*rUVvdkHs!Aj{lF@yB!x}A~1@6uxeEXJGm^gZV2nSiUBM&C++R=E)N&_%4H0vP--hGk9aW`m-a05V7jKtyv8=p{k|{2(RB+)+bumklE4gTw?&64Sce=2+TugAgNY8Z9 zGt0$C;;8K6{cM-Mk92V-*G1*9i*KZKfs1#lxacJ}B~;DD{aP-H)^*XMo{Qb`t2~kq zn!5P0nPN3}kuT-jDCcgfrMruRa#8B^baC_x7fC~1q)NqMF1mi{;+$j-S1u!5443;d zYLtuF(rUDecjc^<8|z~EI2W}ix%hgDi?z~is^-Zp$(-(@?kpEm7P&aT*hPbHwB8D> zEwjFLu|mqMbkT8@i<1()R(+I%a$Xv()7zz8&u;Ds!`T%bn$ePiy>QF9NwY2 zcDg8a+C_&m>dRRd$1ZB!8!pD*bP;vS#o*g6GVW+!ZWFzo78kS-5hRyll@LNaV|H5<+j&Nmfy`{*(CP@Zgxc6SPR_rmzTBO z6s_ZCpPZ4pb={1w=O(JYn?4QQ*c!QM+}O=_SUB3G<%Uda z)8PVpvb%oH~R1Nd`H)U75sj*i1u599(GEDIE|O25+2fJhWr`tp^4qY zqy!J=55R4;>bGSh~H^{no>%l^&)`=~W)yS?yuw1`kW5<_{j8Z}ISSt9riO!)n>1~ zR60wElOA3_<>42pdd9;|3H|C}p{$Xn=R7Qv5x;pjdR}8LcxWi&Wbp4Ee*VM58-Hq# zBz(!k3b}s6ga4NDkd=~i&%X3A-Mtj+>80iSUiQd2 zN$KUq`H`1iAA9*zJ{aPq)KD)ShIu(AYleI2G{VcbBNcm$7ymdfUrYN*UY1N&&QrXc zpXR0F3@?-9znRK;wrZAXbCu^j<@vSlFZW_y;nlUY>d$H~f2{FRu-?nC4PJ(C_0s*Q zm+y`#&T)-7r!nWfl)micty^9e-S%R?0@yz9|^Dc z*k92{T$+!;@{vp9+&-3iecbW+Xy^BFAmpQerjKn|K3ym6<5wx4<72#hR8`}vY0c_B zc1Y72K6bt8qgPGkQcJNVu8v~Ml7>ERH&UK0e3WggI@+lY`9}tK@=>IRkLEo!U(WUN zk$8W0G8$;UjgHkIB+&j*lPa`beLrF;a29#>j((KJpg(blr-N>fdNhslL?5Iw`!` zN3%6rSN>k-!}q<9c{21zAMTCXhfO{%%jB&-e%q!!+2OxPfR6010^Nh&nl;%M;U%Tcl$~A`*qE`pWo$4uAhRi&P(fvpSk&d ziWT@VRP*z_yr}Ny%UAtWtmmg|eLv@9encg{0xxo@A+BMP3wQ4^?Pf5+26;{hkgAFm4beL8p#f^4)D`o)(-OX^dmoA zK31-uYToBscZi>#hx%#$rJuhR`0*}M-V*#q^)B&aTIQ$iT0e`|`APWBPp|cUe%Ror z`j38^Zt*jHs~_7oKc{#2DYMhh7@2y&&xM128Xi*4NB!g<_p?&YobWT^r0P87XZTt5 z_L85PSNyD(eb>~hzx{kF4gc{o`G)#-%TL|gem2U~N2=+upJ7kbdzt^t&)?7ey!JxJ z{_}H?0FkHwVMBlhVlf6tl;Lv36rhSZK#!sUK9!te0qV#miH;5Mfs{-NkRey(p}dNly#FW=K870S40#vUMpjSqK!4h@_s4rW^t~I_?7|Mvc##5_a*nB z)|YMa=um*3hXee3PWk>8Ant-{mi>PQ70jB&L;QW8uYl3Vu z1~Hq1jJE_SS|~`1!a@Eh5+o@$NZYs|hoxqGkkR%aFJ*XQkRwS!sw4-QT{=jgGC|%g z8)RjUXT-C2dObXNXdmk+Aj)nRIW<&V&(TukP1tKOq3;3VwGz6MK$aXa#rdb3^MLe z5Do|V_*js}$Afe|5v1oons+Nmx7$Gq?gV-LZjji=L0UfvvQK_|ro5v<>@|caY6|g* zOqAc`p*e)v5@Nd?k!scu!)+n@6c6!jnGg@khIpr3h}9_}T2=@#yJCnUsUcD;h3J;9 z7_!M3BH9(=1KH!#`9O$|WouRlQ?_DB@o;BLwNUv_MvJTZK#-SIlI){3~rzGr1Y5wH zc}Ht@%H+N7nOJ&cGDr4I%%sTVOrqvzQhR}pFIBE9l3E+ z=cY{dZq_>6w9fWSM($Bg$1_=XB9jUyGnscr`Jc_C)vuYWiGntCcBSzcTsbD>HOL zW&WN~nfEtUX2a&nRNGpaD+em$I#iiiQuMdVv^Zax-E!%#$~doAW`>lzS($flRVM90 zW%^XeW^=`CeLj}WFP>~-ec602ck{Bzj%2e$dezA0hgY*nubEA)dfAMrpH1I}*{tfC z&7*D_-y@shA7^vqlWeMdn$7*svdJBs%`(|0^G9TJYg#s$GqPDE8^t~|8}saJ8qCRN ziyV`#3$t19O*Yq;Wb^vcY!Kg&82d&Tsp+(QY9f*KihKkvn`he&Rj}l z*`$A zuF0j>hFqF$&1J^6Tw=E8QtntT?;g+Pv@H5HmmBADS^j4({jTJ)^{VDy%VpP{TngRG zWsppb%Hu+G9!XW$}5GwCCyhuG=zsjF9r>^5|SXk80_83~8CC_dI#JZX=Jz zvgfrtZgj{a_)Z@8y5w3m$fM^=vc|kJ^Xn z)Io7Og{js#%v$O4UYONg!<6e5rl41tVIOFm6z?CV)d1BmLx*VHp;~uXnD0ht{>U(0 zN2yoi)T{Af{+8+!)RT!}p2_>u)!!Lm`p#3#1&X;)F{RL=Fbh|N+4H^jVT1NThW?<~ zKPvXdFk`laIk`2=tJ}iV-4$m1?l4h%!VK9TX8(aOR}Y7IENhO0*&*$Yg=u_J{ghIt z!eq!Vr^A%^HO%YhbYCX?7Ut}E_2NR94!6Se7WeHi5m_aV?x-hs)kA6aB+QJbVPc+z z*+v9&bcBnR2xXEYbWDzLQp%Lp{W7{Qx64JyN{LXrLWENlBa}{yu%uFizM%+PG9$RN zBGjxLVRUwc`uPzK)`<{bFTxP{vVMd^4I<<>j9_RSp>C518^zH)!uu^E{2?1(kMQOj z5#EzFZ$_B^R)ke@tz869hX`|I_}dYVyc3~HN5$`?_?;DBc6W_XxO;?T*(HT~Mo5zR z^7s1@9?75&BK*`l!eJTwVT7Ois1E7TH^TS*B7FF1zs|XF{ONkp1;kA*9C8xwSO8JeBkT^C%MVTm!i;yRyhyfd&CBQAuk$%A zYnSHpbXh)Kmgnp9*?hj-k@#z zEMQ(n0RsaClcqzxG7LYu>fZ_7(mI5AZE#SB9 z1sp$BK*=)&RFax!HU3wP7uVkf^uAueXOeZJfRAq$a8ruhDWLh?0(MFM{Q`zQC}4uj zeptZR#|6xiGgXUBeYNMa2T}T8w9LtSZG&$9@1H4`?yN1;JoAfo_g^bkX7M{4=Ej|P cf5lsgUv&IwrTc@8_q+YSdHNUk|KFeg1MjTVJ^%m! literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/80b0948d2b7a7f7d_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/80b0948d2b7a7f7d_0 new file mode 100644 index 0000000000000000000000000000000000000000..a05d8a825d4c9685921a6fd7660636298b0268d8 GIT binary patch literal 39728 zcmXWj1$>id*T?aHleCdGZQ4*M(xy!{72Mrj#)j)~cNxyG;Xd5m83TqpY`ASW3}?8z zJn;VdCeP>deNLMDzOU@ zU-{Dc@)yXRzhItxIrA1Oo3C`4e5G>d&Yi1lxt#g(mMNGsXW2q|^5rUQp8KMvvlm!Wxi={)XLkP23mCPAEH$6*wyEHy$> z6)CE!lneWD9V@CyORGx<(YFTI)RsPDcpd3qWUD82!GArZ+&!fa*giqZyhutw4fMhW zT*U*_UMvm48T8#F^}8&&O8RLd_To00mh#gm>@V%7|IoRNpZcR;Sw97o_frJ=SMpQC zDt;P(S>O5TeH%ZS+xlq-4#U;XPpPPl=7?+Wr@wFxr#kp4dq+PNN6{XB>f6^(zo0^Y zKRq4br$Gb#G!8=tGu8+{{W^;L5IWjV{!{$qoa(3NSUZccuKTIaZ9m1NOv%s|EN1`WoC9z5=8P?lZ>CE`nOgPQf>+P((O z!EQwLBR5zE8q@@T;ME}J9c)m(pAG6Z#GviiG1MU2FoSYp+i=zd!!HJv#BK~8#n+<^ z>OaPy=i`|RO(u}*B!e{BpdnZ>g*D^QRD*(lC2zc&M()!M%8#A6fNrx5ik)Ln;dutF zoo`T{1qO}46gUdc-_W4O;xnpx>Vx^cCG-8npB^YkOnR9mKyi=rX##qh{|73PEYCh2IC( z1=B}*i=VL)_hJ2HP)3yf%(-6-a{kYt0l0(%U)f)NMlCZKb_g|Zmc6CV+o)u<+zhn*Of&8X3lMh%KG>Lwbyj5-5rj8UiEMoo_8dGwAm z>Q#bKITMW<>oKZ(Dvxs*bvLI`H*y*E4w-WsH8&sU;d*|f-V`z_t*}u)7cr`7F{4hQ zWpSfYN*MJLBT5>z4*wyolu_d_8v{y{a~Y#s4;!$OJDXtf1~;jH0ry-M*Ta4`G&G*h8y)aG{UGp z=rYo%wxf-D0QVT94ox&F?)6R!aT%lcu+R3A$6@+( zhWV~=?KPuH-zN_YK;{SR6-;=@o_pk#`w4U6KHj74Q?G*0j2ify*9F$1)mx(`y)$an zd!vjWj9OqZX@b?HvNn^JVR@iQtAk9k+D)ntcd$wK@RP%&4JZ_9Qsyv|QZWRXvhWz& z@n<%Zwz^Ep?KWvYZlOV}Nk`B$j^jv)H)%4SA|lD8ws3n)%9m`?HuTMD(yrVlUCLup za$b{W<09(jW32opRW881_#cWFG-)To3z;+;<%*az4P}a&G!Z$9nbZcmQM|ZGmvOix zbE9Y}lirjy>5qygSt^;-9ry89W#*}FQoR}`ZTa4$#kEZ;T;HUz4NXdHY|^1-CarI7 z(m~i-nDhjGEvX?EA!93(W@1tsla?SyTXJr1(!P%5(1~k0v#u^CMR%p<-AroK-J~Y{ zO&W#$12{I&q#}b%s)1kec`)nxnHmf;Y2|Q}t|0R-ChZu>dT?eGbB-}7W*l=&Fsb5H zllo)AbaJ0T-DgoxyhE!rzVAcrhoER7yM`R*KmJ-T|=%wf1O6&Ab$k}`^$;anfx_4!e9F``)g!2e}zQ) zYc)DY`D+V~Ba6#lPp~uEU)y5*RVv4rCwfucFBLv%h{F;;*|XGL(5R8BK<9ElLmf*H)yC z@Yf<__{CqN@Cj2#G5=_P4V&n%$SJG|C$N30zn0AKSEiZ%I)v0Y{xZ&Gt!RiA^ZYe* zfxlMb1|k=dH|j0+muHE;*8T3U(R=y&n7{rx>#z3z_{;AiwT9)Azs6kgm;I{0`r|OV zUGvvVH29bLdc?SB`rKay{^zf83eXsHfPQlZ zXczo41Sk>P;0zDY&Wwl%P^YW`8W0tr(bx>Pi^n*Gu`vOfiG#@D<~(dgXk35>CIzU2 zCqR909=CBSIY3u&Bqc!45tE5_ zpuh42s9C-MeZpV)1N6Qi^A!qEgTeudFA|`CiUz1*@c@m(0n{kLc(9cWP$QhcUED0i z+!a|*l>n{8F=VP5pt<-L;nf1v7HjYrd8!AfJsQ>wP*?nkt91hO1;ZOs*X99w(K9+KQBPJ7GoLXtq4$ol>y4WDnQYz z17utipeervsPm=(+5ZU8UVK8CZS)BKySQ$DfKrZ-Bc2{7ud|$gK7hRvp!H~coqj!} zcOL?@D9EgZcC!X%F>4xj;SpwJGi!OISxa4J{ewBtX4Q}3+*q^z!a3ZFGwU^;#&cZ) z#}dt2k5frzUBefTS+-=eTBn%R6O&TSnvZR1W|hls)*1YZDLKqqfbVmf)fA3gW<}xz zF5_@+vuflq>$iMnz0Ge{YytAc`;umTSIVs5(q^r|O=Kuz)(`jxh0B_?w;b!ixC&;? z!p4f6ho=}^$*jBRUYW;OTE#5?s%CA$K|Da~YG$pjZq_@L{?4p@c!{bt&FX_yDDyq* z!Wz8C)*sBOSc{02b%z*;~sn1}u(tb9p<`A=*VB=7(AI4*>gL61__{A*aNV77I zGAqXzvpS#;KH&IR>N1WVO){(VWcJZidNPf#u>vpPoMBcpPU8G*vue#DueoOaon-&a zGi&n#vqBb{HE*d|iOZ=c>?_Txvc}B!Ir_1M8g4afB39xy#&0vru-&W(oWcCPW;NSy zR&V@xz^wg;sP|uH^~Wy!beKLKp}*L7j6IE8`1QD1BTup~PBG_cvr3+2Py9^{{-M|B z%-Vf{nqT4^f@CUYErHkzu!qAz%Vhc(@$wg|k( zHJFBdc!yg5u?FZNxu6)@U?QF(>mxJ&rkj=NC41Fik-yO*7ZL(2nulAcY_{k%YFaG{ zu~}3RodPYg23s^S#G(^e=&jrDrb=$E%6UplxI#H#yM=SVA1G`tg8|^RJHJ0wdhqfa;t7pzwa#S`MpKo*Rtqp zU5iH6vuGbq;yoHPvS>ZNVNPRjibn&vW{^c223wT>XN%envFI7T zVD(UoN)5B<7%t)sdJQM15fnaKP&i6)b%JO0M&$<%BL;~~RTi+1A}?qlPxoIA~;&bWc$)5&?JMMGv; zGy!XnI@_X4c!2tI_{)l)$kM}mRpo(g+(RN z829l8`&U|Y3Xjoo6?3k(D141Yh1OeC9xd<+vp2ENH#7ED*09~80z2p@j5{qVdyLv2 zr(d{;-Y1wJ+tKJGeZXf-I%QGHS?d0`McL8wANq36qB0jO`WKHbvVTze9_vNRN96sO zz4wG(KjpQ9!OwV&ys+pG9Ka3Ce@UHi1c9%){u6r`x9}CSKXd;7nA2iaEvr?{FbJVG ztD>+9=a4(ls*J%_#iAq*qeqBU!|)D=!>qD9t;&J|_!HeSSTzK%(KXzvfhe2Ns+w4c z#SvCj%wpAe6w1cDNQ|Tnn3JnTa6;P1;F&d|eSe2ouRWT@zW2jcrs`e;b&Z=>kg)L}R-m31XU(qW6 zN>+tqUS;OT#p+g7uVGaqbpOt({peJab>ca`py&5io&CY8ezmO1Ux)EA2RG2UE;X-b z)s*_o*?>8*1&tb7Wocwp1dcaj+~!tIZ*A2Q>_g2qRyBdStyM!Yp*?Htz#2QUM)dAv z)dk!^w$4@^LcuOpmBS+x>T1;k4DM!CV0W&?wH{U#?Q7LjL=U7FgRB~h!h@{}{+W4k z5|1!o2y>6NYB}OdW64?uk}Sn@NAM7eCChs^uK3`p>oM73R;gYCQ(c zr{4=$&th^!r>)d&2Q}Df)v{gmYBy`y!ydyzY}m`#_`IKd4_MXfAh{i~Y9%WFN$&6* zrryYUgc{)jf{#+eWAyqs^*+HKzQUgT*UB#rtct{Ym~OBiZdtYIHfu%5J=XIdy}WPL zrF0Lh`t>0-d_>)z@Y;B4RSIfh1QMTF<$O-nLiHnlL=)D8QMHl0Ruf16GO*fhj!(*ztsDZ5R{AvU=jHl?Bm zZeu{GO`9^>v^5jw;UStw*wh6pP%*2GpVQm4Dw|C)F*dDr+q4}uV{Nj;+Z2x02uoya z^u`}aHXT4Ak4t#v?6{P0RAJp8Pf? z6|m_r9$;o6o2nPK@qXK;az$;LQp~1B#cdj0!loB^Q_7~oWylYu%i44dWy;x92R~yf z4&nmL$O<;qs>E10jB^OBV$&$7D)VDRHJb)ir(Vcb!=}G6`#YP?Vo7bAe#e_S zHnpm2({emTsroieoX>fSsUvDHp-)R~%CX$00xN9#aV6_mWmCV^HdS3i{nyzvX_HO! zu=fx8haOvO`hwW4HU(@aza2Jp-EEV5pH1JRDJtz}jsrI3K4??)VV=hwyg;2J)buFV zU?3uoF(+=I@^PE`p0Mf3Nt-^R!71u}+NM+3e1`g*v#H5>n>yeYdS2jMe7I=Sqsun! zzG+j!19F7(A+^Oed_w6*HciGA41Z!%{Z}@1e$C@I)b}mp!THXni!LUtR_lhL$Xvp=A0<|BnT6%pWHft5AesH%9 zR0C{8yY^gwHUdEw;>O0J9Br%=;@IaODsYc8(!mAkZrO!9ws9(rywAWQ)%9ud4!74mK z&avcx<7hoDP}|UDLZD_$;u=^c2Wq#^aboDyKz)z5KGmiLD&6SmUNeZhW{}^^KrQrH zPs}_!P_=zp5ckdr)Udf;lZiR!2db;jAmU#On0ujDMq;T&f%@5JLV8>rsGUAXiN%)E zFP|gCI?Dq!&1VU5?TSF%@hP#2+Myb%tR@GaNyIE`ypo8G*9IzbomUER{`x@O^m#_i zuz`87#%DY6+3)mWW1vR(OeG%L6e!bXuTbI^pF>2?7W(1Si`Zu?`*oYwf5ej8*=s(d zh{twNlbv1}iDh@OAAF_}Tka0jVxJAfp?m0uPy4-rN>_59SML3RN|)(?SI$H90mU)y zPu73bYyGi6r8{!m>pZdD3FbXX4Ne8>I;NZsRFgA-+H^Kh-%$N;>iAEfV$QMmQT9Ch z5|CgDHiyTfbfE_)JP?oreK z=nD?sXKy}W|Dxl=K-GN2>+f-({zSefjERy@1NGgrKpnub=j@4>ftvF=P;XG?jaN?vPf)pGdq(+#EVhMbm7^GP~%ZXn-%#-Z3h`2B@!kaN!_bzz;=&bQ^7o2I(C#77Nlhv??B?)tFPl>s;+1rK?}Z z>px<;ado}A)(cWPTYaw;#B`q;c@1h6q;z9_KDG@~x_aHbwh+^m?Cs^~8^n9vARYIq z+%HJ!%JlczOibrD(5vInAf?+n(koa?30?g>(nz4T-s zz2DFA13{W}kZ}(MDd5i_UBRX!LCSG7NGI{#F>*XkFH!tNkfKipsV@ec;ygs1rsik7 z-Vm3Z4N}g(gLDYn{~@n)LE3qqeR08SJ#p!^ApQPtkg8q}(i%Lx5v1!k*;{vl)by@b z=f^>s>9dSjqApaRl#tOwWSU7Q20p6AL^K(h#4C#EdV3)Y_*f@c|0G^r}ES zjLfgR5{Yy0!sjcozd`$1@5B~J| zhgj`HkQVr?BWC|dt$jukU!mkDufWeiN|zZkao^`HvF8`o;&Yx@;eVXtvz%D~@vUVb^EW$jMx}>{^=Ju1n(Pcv+Jkwc0ER>3akyrip-1u`PeGi zl^eZ$h7mVZvFjQxRC6b?8A| zyH=xJJ-Zgvx2tFayVfJRpwWZjqUmc8*sOYU181a+Kb-JIgSl2=wVB{TC^hP zHmuoa4>3bK=EKX5b|rMO>nw_P_Nqi&ipyQ7Pgi=}jhb|)K0Uk|jG@nR}I8 z9ar0R3H#UB2UB~|*x2@z3 z^LF}zZab*?PV(4AFLtwrJ$AL;$9_4;>*@&Wz>;Hj)j7$Y!}?S7>AY7Au`>KF*p&mj zaQY(WUgGt4jd}kif1mQ#dHo>bhF3gsHqQE7C$7Co{e7Mh^WI{w;S8$Xr(QmK!2A!r zVu*f^?J9->Ps!sM^?J@8dtq0;mv#+$!@p&3*>CR{2W{Tl^}`3d`hR3@od3jnKU24_ zytWjq{|v#ZY6{k5bFi*hg4NO*tovvk7_9K1V2ub1*7yv;niw9eK^cQ}J5#WFM+9pY z{zZ|@!D@vacX3YKHG?Qk*P4_p-GWo z&Bfhf!8%ktSWnw{eI~YOAFNItg4MKRu!1@Ts}`oK#Ki1qoSVIN|%QcvF{>-)bhzUc2l{}34jtEwtUxM|+s9=3Y;jzKWH;(7V2P^Xg zuSDVsgiH)pcAT5!ReN%<(mnK9JSAA^-c0qXGmZ73`*g2mGlG?_`b@7|#B{x8d0m^s z8s`QpVP3Fe<_GJy1*~h4SI>>XO6Rx5tJXnkfn7)F-BGVJ;>&-$hFoRc7-j{X|zUuJLI>jOy)`LOhR=KY9I1Y|$q~E6}a4*C1ka zKd&_6a2Wf0If%Iigs8Po4`TO$A===xo7iQL*8pOj!Cozh#vxt~VrMiN?ltk35WPeF zks*39DnzNHy$TU$jSbOn6GF6RBFCmskEtPAGCf3XW`yXknIT#=+iMH4=$sHenHQpL z^SwO8*7y^l3z>Uqh^oT8EJQh0hNwBV`RrR2qI4%=UPC_XLUd?-h`MeJ(GC2*HAL&T zaeQZp?(PXug?%A9e9-ICp%A58_ovtW;~`4-<5{nJ7ebV7&{eN`w?dSzzyq(^&q9>$ z`5UhRA3~IF-2c30`#F?u1+Eyq?i207URj7^LmaB$aA+gm`0<51pYhZ1s-OMZto72x@T z4qd~ZLJq|hb10>n zWEk(zy$KH0p6F2XNsKjxbxw6CY??!D;hgSJ{TUABoaIn!pB}_D$Ucv2eO?iNneX7f z6tCqwStmB(F}~kLy>>e^38#Hh_AnO;Vg!os<=7#IOn-W{B(C<^O8oCHhdLi2ucHpV zJ?>EMlMdB5<<*Ed>kK)bb?7PTU2|yUO@}((a>#t!q2B0whv)9on+FcE zs74{UT&UI~uzaX~#6gs=7^*pyLKRbuTu`P)s5avZ)_xzV_#Z+w3;TVZ*9}#=(G9$E z{}`%tH3xZ(85^o}-%s~iem_*{PDY3Qzg;n5N>|(CH6v%3(k;c%Tw%(a$E!fzFr_P7 z!>cB7W6dyqsuiaCwTb9bH%vY2hpBOcFlB8RCP%X{-Dn=B{Vl@upjDVwwGLBKTh474 zrfeO&JjAo;+%Zgd5!ES7<9%imJM{GGLwxwN*X2=RN_S(jSL1YHeN zk!xXE`7e3i2-A=|VG8( zYZj+6WOZsJP9rg!Q%|ur(y5Xzr_!RGnv0e(PR(#TH6#x4{nuGCkI+ZJzQ!i07w^Q?R1F3l!6X#JRpHoY5yP#8p3ptfk zm}58(PZ6gI6?N)ogco<}5yqEv%D;?L@5(w=x15vrrA|4^J2e`wP^SWOV?;%#o}*GF zr^X_tvQwSVuZmMAF{-LlrK&l#2=%HvWv{_ls9w{_z57o6@q<(AYB3M0)pn{%U8gEE zaO!eHr;0UlYFA^YvNv(+&!$fO^rKS+nz7avZ7jspacAe*@!f z=Q$X6IMrkq{l^Pb+U?XD+(q6!PEA39y-tlnPf$`Ecc^8m?L2hpS$_aCJiWQQ`V-e7N#V4VPhQ zIPW3D_20H|_1P1yk%z*y5%1CKe7Hidh3oOdaAkfJu4a$JwG`WN7&)JZt4pbjnmiz* zY7Wn+vSTu8)})L&1ncCC+yk6ZN0wz&^39Aok2@5_bxkV%NSE&ePEgzvyIM*pctvg5PyDl6@jjj>;&@Do{ zyGN*Uj|i1m9>MQnBKZCnp$3^U>qJs!UUQlCFh7qAWLC?9nbo&&W|c3MSuWT}{$)>{VvuWj#Y}$#__Pb+f@@I{dAu>`0-I3f!7OC&?TcJqhE*z-}*ozZbQzTN=i$>}U>J^LB z0dy}BsrRT=l5t8$^0~N3{a!XwdCEnqB*x<=0?J3~RE0=wtQ4uZ%8^=+epMoM9l5J9 zE*hcQ_mOIVBDEt`2`}-YMWjl%i&WpvkxCm8sls@T#=o#ObQl$>KG=aaqa)Q5 zn{jzer0!$J*hpO)7pbs`ks6EnxQ*wSJ}FXfr*Ld)B=>7ZY7>Hfr9N1Qdq|xYsa9Bq z|FCL0*CTQUbwa+Gk?Mj~s5&cBd+-@4vm=CX-gxu1bLQ4 zs@!tc0rN`whlgt-^$zjtIF9X@^?Rg7Z(>b&hsZzJ1KT217p-s<6?aE!@!m+y+{bnM zBXt@b576U-)C)}xMXK%LNcF;(qmha_8>t`gBhI1B`AB8C>Q$0B9!GqJU5nIiWVs%x zdDw_`H&_>L-HOzQ+mXufAA1KC?niR(W~8<~;+n^i@_P~~_jC3D`o3WesQH#W-!cD3 z^7}+RvGq%&KK(CJhrhC)zOnx3D78YCm?$}8qtp(&kro#vPg0a3b4IB%E+BWMC{4hf z%2CQ$B}&VxMk#Z(D4nhzr9CYdcWT+LT{Iz+$PL%rAi_+$%Q7YdoN|zDZJW7RI zL@BXll)ko!($)@9TF@y)_Rkm~M*C2jZfRF8u~uCzr}% z8gAklYIG)7oJK$wm&W)k>gv)BOzB2#P`jVB#K^<|2BpO9OEhoAD-51I)GzG7!RRG=>=NjEy^8ZyyNT%+&MvgPq|d*oJ%>+yL1FsFz%vDvrz6b>%YQ& z#_yPYlQrI@rvI^T?z_|$DUVp=V_qv5i@hlK#KnEEE{%T4Ij^YoYnPs5`#bjddzZ3& zJG#b**r;0!v0~7cP~J);%Otiq@*i(b|Hv z>e2j-0nW#py3z8h7p>U3g`uF?7%Z@Nb-tS953Oz&tu>%e$FMa$Wb z^ZQ4u;(%xw2XgL^Xw@4QtmfS5kJeuNjanb5 z@t0`*_%&Lcaq(NU<|;;u4Kdn)Jf;}^iCaN2iV2BPx3C!f2ahX84HIKDCM8B`d1JJ` zXpDL_j8TOyF?!f1MwYcPYIG<@S5L=i^4Sq^1UWsP6(xq9vo)P<7-I|Ob zn_HFfKiC7^`W=ZuZgs>#pNGW%>~4O&!1y6<$>HYn=x*H#b?X^wgt@gb+^xMaZhlVT z)_IJ|<qLf>v(r$%e z4DO;~8Mn^BQP!(4Fz@j4-9)B}ZcRo1nr;=T=Tw_3M# z%h1lP0v+i`CvxvXjk>X>9*o)3tziS*YWs_u_mx~T(ygJRs1+)VcB>W!;FmFO`Hgq0 z%4GVBl2fQLtP9*KgM|y-{Las9V@-KvMb(d~@auCs2XI|ujQ zUiFEGeH{PL-*fCC1Ycl(VL5^?x|J0zu>ozaxwQ=S{v}^LLzNqDox&a1Zn+hKYe>HB zR^R(v^U$p+kE!hwdhwjS^n!CQbZtK8;T zJ_Z!4FE*YJiq&`aSiQtBXRPXFkJTk~EfuTtuvUoW_vNu#h`mrnj$t51R*L1b*0Fk8 zIabwb#H#ZTu^NQ+wPLjko$JKPTsKySkflE7HIC)8XR*4`B9{AuVrB0b%l?Q}q0X_| z-Ge-O$Eq<_{S>P$=-MY%f1pF(Se-$?ez97Hjkt&S{;|q~dB{E>R?dO3nt^MmK8Rd= zE)vuI{Bd;q-o*I$CEb=-C2ft>g6*-ox+7MTcG8Evv5MFitJX(i zH3DZ*=4h;rVfV3EJ;n#LJx(t83sXK&$?j8(`f#=}kYJI(bdeug#sOea3^v79A; z}C02J)>RPN)uhT!Y$FSS6+Ilxu zckab1`~hwmF2ipGl500jHRsR7#HD5@Fa z)DVS?aXN=JrZ~Nazki&DVnP64<0o^Rx>({QYn=YW8w|F^X>wqk=ED*crydxBqITv9 ziPHz9IN~%Mli>)B)A_JC-9s&BoSMUxF-|RUC{vueM#Sl7yu>%O&m5=dEO9!4Yp9l$ zT(K12WsB2~IEx!t9T}&sco-F@tgbjUK?f{Gq3AgMiY3_Kj?-@V$Hr+ka>Ow{9^lt_ z#zuHToMJH*5AjE0oC+k71FCuA6qwApScI0@Xw_enD2CmofXtspe4XID%_O$7%ZbIJKG>r;5{=XBOwI ziPJKSTt`lO<5c`A^F3oNvGMxSI9~Od#H%$v<51Ihwfiw%uV88xube(V64Pz)iE19N zbn|?+6VrvXh*w9S_r!EjE#pir3xC@mhE#UJb7@_qBLk zMBeN1vfhZ--w)yy^pGAuqJEF#m5gR6@g!b75%HAuJd4*mta?sQvHAtiVcu){^gdp< z@aZehe~Z@{C8)Y7LC*sclp#1l9YYfI9|FS?G#>wCO3>e#6Z9=>0-s?^P@Sj*wTw>C zY7z#j=Jj$xP#(!f>F6O$|T4K73K0R(EC|&-WUMGkFx0v%bJ;!IvyhFY?iO9RG=Y9g84NFkdM+tiH zBtbWxQnP2&?`49zzf0irFbTSZe4n@;md^<)h`yMhL>)oAAyHOiqB0_nDN(h}iOQ8J zQ5|q3B2jO%B+8IAQQeT1Em8fV615E-T#4!rzvx6YiAmHfccNC{ElwvSYF|>K?s*br zE0(CTSX7+zN^l*fV@2si-9quQi3%*2s0jRo3wT^9QJ%_)x`rp{UWGBMCTeN5L~X>F z8su6tQ8TaBm^sk$=R{>1ny9XrGmP=ZCF;g+iK?_IQ9Dq3bE3W; zOXS|@L_NnhEIE;=AI>CdI~ty&E~t7wQH`JriRz7PS6CksuQA8HMD52ZBxOv}NnF8; zs3cW!CuweM5}%Dr(pQX0NK)yEHj z6}}+%?Id->MLdG%PLlFt1P0Xka<9`@_KS_HZBx%v(B;7#TlO*-< zSwl?M@u}BbV!AgzanF*JF7mn8OJcgH7hXTVN>Vz%*Iwm_=}!7&e3PVfO|b&U@X@Es zyCkJEzW4f`nC_KNo)1Y%H`3=EFwa;y-(x`^s??k>~&YO-$$S=QV_w?v&3a zgGYDZGI~@8qi_-tCXX6m5pE#V-=k9Kilw*=OMpj(&>hQg0d})T#nB1#aSA32xu6S{ z;XDGY9u-4>tid%nY#xiEk4A@k z^bqe5mC>WOnK&NdkzZzy+*v%zi7Dus)uW%XaXi|i95Eh^b9*!+mUZDvoJSktJ^Xz- zk9s6|)Y3x^n2p`Z9{rJnbMt%TEZ|W!tS(4B3wbmF2hq8xMto0j)f`)Wf4EJv}Pei(dBj=%2pmPd^5d>mZLb#-qU#xDL-J(YML; zX{JYeXM6bjHy&M?=h55+^mL&|NsH<6I*)=k(D$uehuqsdDvcwE-@%%8do=u_M~`lL zRO!Bl`+qzt{J^8i2zlsHBsj{@P3D$fAXj%dSUZ7kDj55U$XKTl2sBTusk4HH&M)ztUznBBCsPYSs$>*nXH{C zl_6R4!;`r;B3b?5mnm6K5FL@MIv9n%S(5qtJ6w}BS@p9eYbi>(lKCE!tV_|!Y8aEO zuCTb16^`myihoctK3SC$lKELxvV!s?t6kn?CFCPdG{t}-@H z%WXc+h$gltVnC>5+ zy7|c&bA5&vOi{YC#ye<*bz3^$)Fhyr^2YDN% zs4AK_rsoK3LOq+NXhpLW`87|GtwV~Qpnk^`mFb$IA;{Z}ad8ZZJyMjRCw&=`qIvi< zG)1?DQ-4$)pQ45nQaNTBfI{$PA9*D|XCG(cbwyj|~e_v=8MMvIiEWsPEzw zo!H6oJsih|y&OmReH`DPqNWE@)agiy)}YDJ6m>?HW9*Gn#MA5_{ENwFQq=kadj)kb zvhVN|l`p5L;}u>L|D*S?eq&$YI7TQ{6Z}&3*^tW5gHrVbUog~^svG{P{GFmytwCOM zsvOo-RfnG~mA`?Ksu_3_n5v^esTvTLsx5G4NYxqqi*}h()j1+nE8(9dRXcDPZ}4ke zsw@eqDvyt_CZ=j4o+NQ?a;hF9u@L7KPSr&WDUzz!u$E^$46l%?l!~dETP0N`tEOtt z_o+&#oyy-4Nmb^$sk+r5RdX7#t{+pCyF;oLz}7KU1v;^YE~%Q*HI@5vQnjLYs?0y7 zY8?LTo2nxHQneac`={#sKfl0#GV!!YJWnc=DWfc7I&`MbxdsysSX567lz?1WVA z*GSc+NvUc%JyqEjq^i%NRK8E9s@(om4aT(tjD0XwTX7$M9!Zt)D0RbMsCq0_tB$8? z--%S6g6Cwa?%}_4Tz5WIF&9$#SvTV&=M8ekQJlG%s&BXG-|bXQzmux(@22wkM2;io zeySQ`+XHIwFjZ^u@)J3I<~(HklBzn`^uJV%`kJa~u$a?S8h={S^fw0D(lo-JrYZ1` zNYi)(XHHWiJjs%#8ClbGKPpWzt~3pbPE+BSG*v(cJufWK_0P`~Wzh%{4nbqUR`b@=iBYPt{brpovK;~(}A5KxwYEM=2Xc19sP zDI{rW%WP9nKx9v4FA)LRdzK~01_4nN1!ON#whWnHSt=lV|KItiKdH?a@%CE=jl*^PR@|UMB@Eh$-_ft6LANovltE9+8`P@;WvUtU9C@o7RJDzP zbr=n@Mhu#So*x=?3U@mh^RQEuEp?J~r& zMvW?GRL=L<{=QMIDjWHnVbq}NMxDY{6fzi<*JM;N>_Ck;qcUn6m08EA9>p;G_(yxQy!B%BYXp7+F`|$Qp=7jYeF=C=D{IIX*<8!A6CKQ14Kqz8qmx`beX? zq3UNw?VL*grx~>r9j6;La<)+^bBt<_5_64eJ>RH-Ul}zKGuIl`f4xzk!?eMuHQyLj zeWOubHXF6~7o#TcF=_$)d+8sF?=$KazBz2vq?1NfylB+E%RIiv;|E5~hwq_LvvCyb z9~(6%n@PE{n`Fbf940l&Wzv3}#PHlEUCU$Af5@5Fq>s@&pGnILm{hW$N$=w~6n@jB zk%dhfP|Tz`#d#h{B}`g|_ez>{ud+$UtC;jtHOf^tXp#+N&PXmkx46}945U$KBq~WaS!i$OzMqcsO~lCQ=f@7^-Ri4pzg3qN0UrynQW3J z)ui>NoO#4nMswtHt8X9tuS$I6l1W?qyn2va_yrW9-`v`a>A_>jKyh_USZ`KlOlhZ zbns8c_p(WEKQgH^K1IdHCVlY4q!Uj~y7R)MyRR4{tawchGV85uX0^;^)(6GSYFEO{ z+D~SFb278$lUW-|nRT(WS=Mr9O+h9C<;@yb!OS{}X0F3F^IMQvi_oNsS!0k|)2!M? zvl`bu z*sNShX4a`?JKkz$Rtp?RHtSp}Z8s+eV@EzO$L%B){oo3%A!*83mPE*^F=Yi?(= z?&2j@bfNC9)ZN`ILoeFG%iducuT9%gm^#LRV(j0w7<)By4vXjaj|)H9rV@DeLV zm{sjF%8fGX?=fa&j5Vt(N{l1NFU?vy-mEJV%(^wntRs`nDnEtsz$&CpHEYc@vo1|H ztK3ZTna%dOX1$ni*0BXbBafnQP2?u+}WCH>=AAvrc})z8k4~ zlUdTk15|IoL8&H5iEWQ*fFh&Ux;J96cWW8ITDjV=f*w(rU!1D=wf?tvF4^klJyY2!EY8wZs9uSuajQ zF(E!qnP}N4PMz=v$~o8{)%#_S_TrFM(?oEY_Q zmW1x~2e+~;=n=>F^Yp1#jGY*DCd-$-86PZyt53}OPvZ1qV4MaFiqq_2aq2akdB%F2 zLg^84s`VMK3G_v+QOxJ8INd?^*>U<1J@G3V&0(D8QXk%&7pG6>$LSlCTo9+P@EwM4 ztgEzt8)y;!La93q6vS8@M$x+s)C8mOBkrO4y#{KJ`8baJ|20r!^urq5M&e|Ah#~EyE zZ;|UGi@YCOGz#@QTjaxSEa+m_Lr{7A^eV z!a7;B^#gvSkJyf0+bqhrgS@dG*>_rW?H7w0?y~4SrtP+<@gBzRphaa4S#%T^(c!Q~ zzZ|h>&{2!VqTlZp8IM_X=!8Xg|FEdSS&Kf$<@1ce1&iLhXkm>ii-z1{?9lzTg>y^13ci*D^4=gJ2(4z4u_sF7_Pb^%k$+$hWXyyy%C!1A65SQJ` zt$?g@=dh}GPODxNu&Q1`tELsQ>ZdoYI*7Q!R{dPmDt}3AE9;(HbpX9fTeTRo z%vSvlLv5?>Lv^fr+0d#ai&ZTe(FXo)Y}H1GRon45hIy?zjvHaxPh?-*z|kbD@-?%n zW3pAY6zXbYl?AiXtV&O}sxzkGpA4(2w6$tfJF6TYSQWw`+<@;xt2TGAs#!;?T6VH( zD(-x2)tb&$ZN(*g)|DLbPIs&B;w38dplw<`mI&{aBPcJ zOTM>iJ&q%D2XnN`$~9D0HQ8fT{{2=BJ-|F1wrc+ot7`me)##&ExsF-Y^te@*Pw?Dn z%HioBR?R+Z<+o+4+MT291*?9$V%7V%84E1L_O>Tq_O%IC1@LN1$1 z-}Mu<6Dy8~3H4ozXUZjhtg_`UOYv2;YsRopCnKGqCCX zSvF;0+iaUA%&}=Me#XuPHoeBiOv=K)(57XJsCO~ru+ydizu2^BmrdC(+te8Mk>iR@ zWAWEjo2Fi~DgGau2E+I-{lXqpylc}X6n||~3Rsm~C9nX`ve~sfyIs|D+tmrB^Vn4b z-=I)FJ4?RWbsKNyx9dV-yB-#^%UIm5@g?kPP|_|}4ZB95PE9+%=h}4;RSb6hg$LMZ zv@4g%uGe+!>T0)Z71HDF>W2GBY;4yHA+w5xh6aB(I9NA}A zll^wJ#FzKU?-6-CCXXk~-&4kt)p)(aZ`I;;2_37)>uwFUp<~T>ZNf9W zRV!Wda}wfZXd16w!FcX5 z6ffg++DdAq1qB+b(&Wb4I;F9~(;9QVTVoBH*;qwpH`dp48p}Sfv5wDgtWKGY^?G4r z&0O4AwU##4j82HSE6=g>O17Q!L#W`~-i(YFru zI^f{%ZihZN=umIWIOI_6OAdX3Ay*vw5#6skG!#9rIpn_M&`8w1>yQW8?~%(xhYn%# zbBBJ#h!+k`LEV=Qt%mKDL%!@zt;X3LPS$~Rs(((W_TnbOxty%$?9^hc!%J9mI~Bk; zXq?BXg)rrHDh+)w2dCa~>Udf9d)KKRC{WI+atKD1cj_N(uk6(SkXXg3M^&BbTFt4c zI09dFr%vEL-ZiluuW{K-J++& zeVtBKcRAG(JKf}r$sVV=d!2gE@01z#6sJDK)s{|Gnnr%em`5KmW~oy%Q0^PrL+kII zYPi)YZXT(ExOm8^3r8sPt5eOf7VjQ)YSr&f{f2JGoEnaeQOD`;3F^H-j(CN_e>!D} zy2za1=q0BfqReHd;*p3yQTB>cbrHl2{E6&Wol3%Zbh*Y@V&ngu`UCfn?=Pn+!;ML} zd()}nw-|2}y-of|z~@-{w^N3HoZ5m**l>^M|8pvYb`N-c;H`&FjeO$N3LJUnRH5fi z9ed%_3naa!UF48U)pEGB2X}BTze_s{x^x_4-g7C(`!4muG#tePBvp1P6Swf7ic77k zvJbw(PP|63>MmI^4C67WhD-Hoy0jIhS}q0A!Qj%Dc-!bw6(mKOT)Kx%aV|}+?a~$; ztK-u7dM;h4?^4kQF6FVhQ~{lk-A;MLN5#AJCvrJlstGr|PM6+uQIDIx`dyll;?mqy zmv*2=bC>M+D5?eZwsa{CwcEJ#Gp@nV)}<6&$GQ()I)lcYT$uh#*M=+ z6*@v+j?ovKz#Wu2juVV23ZG(pu>_m(XVhtzhMsZh)E_Rrfagz_x?m(WUv=p${=Uwb z-f*e=KQ2v2@?DpPpzTAKM#K7qc|ygP^b@7!mIpQRx|M{F-f-(>X}2nsajSDVx27Xh z)2+U+8+jfVDzyH&*D)?S}mckxcxt;U#*U+^%= ztVpMnnCeyrzQbh{Y3WvdTxsoAfi`X}&TwlVCV$}OevodNJG<2a*}J(_6GwWx zmAAiJaVR^~Ef@YB?pDbWZ2#OX1CD;-)>Bx%bgM1C#}$;B=#~?6u^ZE-xcN7hK1_AX ziq6w%7lmg~7FFiB6~rNAg!eDEy5a$HUuQg{Zn*Uu>^I$f&*oOKzulah=Tfkis_Rjq1|D&zXFmIQR65?HZa$B$`aSBL z;E|`9M?Em3wMTEHc{DZMqjxhrTHe;9qz^pG+1?`qR&@37cZf$DdwAsN<>6Xij}Cs~ z(Oq=-)T91b64l=$=KzmR4D_h!Ade>F3@Q)iF;3zN)(!FKKm0b7dWL&+8ns4wlxws{ zmnYD#OvVN~a10j_T;$QJ<&;6TuRZ!6&9>7v{=~K& zm2tn}QT#pT00;i_=ngJC^eD$8w!`t*!{=wVq3l!U58JbOmA|l8CU}Z@)diPJdi59; zO5q)^cH*znUM(o=)rF{cy&6)^%Q~lCzBlE0EDU({4bDX+cr~brS9ub>+MPWlUX8$y82BY| zyqC3SyxKC+tKQSRYB!6#@F#N3_Npv`ScDz8gjRFBYCPA=_lsWbTSRV)y_$#xOL%Un zSN5;HtV!=x`4wKhLWfme&W-oViq~ryhjnb*;MG)2+sM9~ysGuBSIHQN zT`%9mlEXdz|35ElJ9~8t?>z9TKAPjxhx8HU9?=)H!9)~(!g%7nr(UI?D@I{4+CTGZ z3=X`YAGv*Mf|hXR@#$3op8}PAYJonOQ`M&rtNB#8x=%Z6_;eIQYWh^MmQPj#&ta3% zrvnI?e420eX-Aw-H&C#SPv4+&U7u3$Z+)K(4Sm{g_sJhm-MEFa4xip}`?wFYPjCBu z`YhmMjV7PgHT7v5z6<(PE9_GjY{6GaK1G`O^hUBz)v*Q#a0Bg9eCmrMsF6xL_y~t_ z6M36cFDkU~DIV!KkEbZt(kCzGxAN&nG-*v)Ou%NGYQz7hlP|7eS;VK^aA)|`7NfBS zJ8`!ioa{awWodDK!=V#-A46~d}@t7=-i1u;p2~es@mD7mwkQQw;iAOv=5Cw z^=a(qJ{=n4(-#wbod4j{g4sSz-{I5tU&v#ZPs8k*m){e}FjQ{q>}_x)OL@+&3YFLNV5zZLoAYwXtz%y;;e>hi0M+pmO{ zez{utRjq?xH+%W@2upkWRickyk$!%?_laMR2l|zBkY9fzJlL*T{K6%t~UfO!8hx zxv$vo>zHoDMl1Zvw#u)U@UHgjgEcWdiRahF9Nys9iYR;aVmweE-SG=fLc9Gc2q#8iDhllJYa;URrLRce=a*?e+i(`H1AZl9 zHg4iE@*MK(8=O5H)BA{DQCp73yguny)Y?liuZU4AFUR~vjH-VnW-Ku(|J9g*#HdSI zYF+ayYGsy6|MM$qRhGB^Vh%Ah%fG}ZVs!7{}Q7z zp2wUeM%iA(Oe97f$g=V!V}r4;Vr~$lD!z^xLX6syWwZi{Dw8c{I5Fx*_L#jn0*cC& zGoZ>@O63YDYJ8UOa|aaFFHg)yV${LBF%9ws6ty@@q5J_weUjx8F)H6lN;1h~E%%F{(|un0(~}in^F3xne+3 zE3(`pM(wW@v+_Oqhl5$%RRW6ozG}?!>H$R+H^rlOh;Sz5+iB}VOT6|<%_eMOTtF}2bH ziYk~MGlUrRcb0=0j5Y3ODb<$OJ04|e)-Ir^^;tgtAfTv9AI3Z&M(t@IlfOfN?{xzT zXX#Finvi7!G3t1h|Ayu?MzzQ?ju^E!OO=lTiW;BgcVbk{PBEFpD8t7wKM|vP zb&lCWj4IM4rU@}BN7tB-iBT)N#e}*C6g3AsvYhI{`wj2*|Tkqee`Kc}$GjFfnGxBwjOElH~$XlLNYtN^O7Vnwaybk7YES%3cX9idUoH<3gg&aQ@1vG7OKyNMyC_YOQ;+&Oi zTgCAZ$5)fp2c>h#5uv;+ud@pwq^HPNMH7UXR~0cUw3Xe;+e$Yd|G` z2x!bU#^Wd2N6()Ftl>=maRS%TY&(70MJ~Go8n7p3G;zq@fU583SdQffczqqDJ^Xnn zpxlRJz9dHFJQC2*qvVAjj`Qye-Z;r?^)!7y8&KVI0i8b|(EES#zQrqicQNMTC5|sw z7@Mmx4~S8j*8)2BzkqDlV`kpqSb8&{*O+jd_r>2aor(4Daa?&6Q{Ztx_3#R=Cmc(j zGN#Wt-s0mI97hWzaQ~K=cM2vbs#TT`3neIOT=5u3i3CM`i6x~IRIEaR>Q+k76Lfel zLD}C=P)3!Q1Jx2#zj}i9<5Z0VHLjVU-*Ki^f?6A6z92>&&9d8+pr}%DF-wS1>$BV; zMis6d(~%feux^Z(7FWU#P55^M?Df{J$fi!K<2M<^Aapvvfj&5i{9hu3K3 zOwb`DxDxa;%x?MygO`2r9iGGKOVAknitK*sM<*=94U`K|7pCDi6iXm?Ou#O@gr!M> zdSM-|qGZzqHNhzC#d9^tK3y=$)aOHknlLP=)1L=rpAb}$ zi9vNhZ)`&ONkL7+UgVq{)OXm2;FO?NO$}<;G|J<5yu`^_L78R;)n{H%-=O{cp!(t& zT4YjgVNmH?gPMoX4?#t64UTO=Rrx8XfA_cKE_y_49bF8r-Dj89aLK^JVQHw1oac%IZJ=ASfekbb!c}pq+Td{E5!YVLz?>_q*0GT3O!-l zQ^w#K<(`K$|3!%V6^3-=b%^tI!&;C%tQ9%J8lN+)9=XCw&Kp+4f?-uD6xO;o!`fOn ztS{aQE3-mak?LXHs}a_TDQR zX=_+FvC~Ffj<6cL!n)-S>y}6k zxScZl!n%ZM`^gK{4um!OU|8-$VHLR;Rv6hYg;f-@@$fQjUSS-rhn4F_m}}0$+K8Tp zNcKc^#{(qgOw>!fkt>n&{1Y`lccQB2OH_{hi7H$uQKjEZRCDZvvv8vF6-m@xG%U`F z`Xv&z5X+UMn%R=n5b4;LBT4shIA@ZI=StGhyh$2UEJ@elERm#UC6hD-*HNxil3Ko# zq`N3qI!XD;BMBlJbvD z(t>G8S~opOMHf@o(j@iAb)5Vm&D3#MGmS)#1I<+a_h!0;|Iyw z**;mnbV$~;&dEBA$9+PM%GVV&& zvOV-^FZ<%n{mII8AX(K8Cd+XsSq)DltN7_;RmaBj$@=UjeRqn|@#mft)!Un*<;dKZqAB}R^wxnCJ-(Zw#Cs{~ znJ-l(-cD5mY(e*8salR=B~lf^M&vJeo9}{_&~$ zc4?|M>`T=yj5t6Yhf@`IHC35vt~S}4YXF|rYpy(j=CXEfu9DlDtKeH{`l@4^_H<3t z$ewAs-!Dxa2Bhg%d@?9aW3X~?nnn*x(~RM1T-Tf?^8_O1O-@tADQT)dJxvQ{q{%%y zjqAA5v}RtK{x?5OH@8sFcWFAhHBCSKkf!`UrOAN_+tajtN1FQYOH=6+X}WYJO<(_) zriJ&@xb8GfTXUq#lQUiQ^Q7w{Mi)v~lQ+}#Z{c(mDU#0nljq(~*J)3>=6cgLHJGlG z{nJ%@Sh@-iPgeql%}Lk!1?hSxGhIh;0n-+ytNNmJUB!L8T%4}Buc#jvF?3nF3a;WY zZfr`IZF9N;_zTa!O_yOyx<+CW&Y}2s=?Y;9@@`F6F(hnD*K)Mnk*)_Qe>9!@h^On; zg>=qENSFH|b)fDea>Pwcc$%)uc=jw^ZJ(#BM~;ZrqHWHIdgAR|5uMK+(K~q}I)V$B zmN%lfd=YI&Y5}(6LFtH+%0v{wugG6EA{P=dAE#0H-H6H}qhdrSt3+h38qum65jCq7 zVI8B0K6XXaFe##o&DbY7qI#_<3uQz!7NZ74bOw6{Mz}9mL|d>Ig9k@cdPqdAP+(|8 zWpEZ%KaZ#*N{x=F8jc{>n26e8>^O3PeL_ToV3-(DJPJ;VaNq5S24L6Jh!UnnxP~mE zbJ&#`QMQEX;0z#5TM@zOfmy zV;p89_qYtbM3XNw)DI`HX*_jJ$k2_+8JaRBL-nU-@R>J5Ri|fYKklIAj0}yy30P-l zXckuCB(9+NtPHh42mFF+vomCw!#3=nm!U!PGgNi~7G-EP-dvoae=uxGhMr^V(hQYc zmZ5WKyF5c3H)W{HsSF)Ilc7r(^hbt{;uf-<&5#Lp%*GSsK9`}o=QGs$LWa&b3eNKM zc=jNhq-(2xctQC8|J}UVZpjBP#?Ix`aC^JN-*Xh${Nv>&N1K0AAg$@;nu{AZ`oD5H J{;xn*{D0hcW|RN` literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/87aed881955d029c_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/87aed881955d029c_0 new file mode 100644 index 0000000000000000000000000000000000000000..232fad7292d1fda69dfa921fc9180bcd24b19100 GIT binary patch literal 55300 zcmXWj1z1$u8piP#1{h!%7(fLB>2A9dyN(`Pj~=_bySw$+-QC^Y-Fa+}-QD;7?zisq z{ODjYQT3ITpjqAveX3H(SMzQY@LBGrNq8W_GKoFK9qspFjBI?)OKlbrCHR!vviS)UnB zI5boBp3V7E=o}|Bp`mk~&~Kg-`Ydq596EDbb-(Wf@%V-M$hLXugf&#_l@lhvcEZ*- z>JVGxt*Y?d3F5npGa9)%DE|I9kFPE~V8|*1du=>Q_{)S&^-(D$I&~hP|3I_pdWr81q@t zxw^WY}1q@uRD1(A^oL za}Q_CGe6_w4`G5Dz>1|4)df}@nxwq{afbM4e46YG z5j#cYV#QA53M)FyP~kJ3A@a>utL8XEWS^^suwtU&nC}b`w@3vpb;g}#YRqzHi1<}1 z4?B~t(y7(lV{4qzb}i>YS=Kq@tZ|DK^)@M&{oH$W!pL#J8RC@Ta)h6!ET`0~bIuSy zZYYnN&Jd|oj|S6RV--8`UuR6a}M+DYe8!oM;que?M!dM6$;B>!EGuOV8LXX6KFxDj2672 zyqPTMOkXJ|vjz2NHtnQASu7Y4WI^Ao7Tl%3f-N{l9-$VT4YOcEI6qEZBP@6qWkE`` z1*2ju=$OF&PPX7-iUoI4E%-zkvso}JCm%<*`MdUqycQ(pv!H)|3+flN;0(nVw%{!d zDPqBD`i~NeS}@v}!S*i3F&DSs9tD?BiEL0wwVM^oOQ{E}NMG85qDDowP8s!x75|jA zz*f$J^^~=|1;dP_3KmqTq^7fvjMzW;F{3uysxs$GrK|85bnH)6psEF;Lp9}F-GX^^ z%(%iXJAh*t zsQw&m!F&TlEa*<{hFQ>jgauD1Y@`K;##xYKJom5ohjXTY$vhuDo5KH|YC)Ts7CfD0 zL8jRjG^R6ic#QcLL@%-++j0w9(y0{|R9(&Eue0Fz1`CF7$k;%Rohg;4hux- zooXyAt{WrvaL@1M*p6~fol{3|a4gjBmMZqx0@2p!&5DdqR0=D`K2SiY#a?k*5%o-SBSOKdJ!;pGAky9*w9yP&j> z3mQ{5hZ@PQGxGYnAfulP5-1>(N?^AehqJgqYzAQqBDuLL+tLMMUu#vU4aZ2HZB<-57l@GdDy;*r5!LOe>h*HLaN6ISkL%-t{C!m= zR{TTX`?;X)02f>xRt~SncfoM37=P_E&cfq6u zF37#m1)XRQ{h}I+UC@{IlG_p&SeB_}t6Z>igZjaq+^9Bgc0t}PE@*w2`{|t8dWqNV zx(i}%xuEME7u0*H&e~ida(F2>Z&wI^Di)yn1-e4)%czEBafR>+QY%=|HmfVP&`HV^ z?1~q(GsG3!Le*imLYOP|&{rxNsVcHlqg;_O+7(slr_mwa72~Kvg1VFJ3h|OIrz)2m zt`H0I8^u{FUQxZN<_htXCf9I9wwkWkUq=mY>aKV+uIf4eO$4FlKQCvY)XIi z&j6mA@(<*Aj0tSLLFzPHY_Kb~Qo;~d%%^liT``=#8Iy*)LVOyb290w?&_q{spi{Jc zk}DQYbw$85R~({*nXa(R;<_4j*haHmF>tOcmeCywn#Z|O%>}NAU8q*CcZC?SSJgbh z&(p>8s^vvj2&b#chjqW^ibwSMx+_NBaE1M*D|#76*$%f{@s?`;%e_OtZ@Xg79qysK zYWX8qh^d)AWLmBtKM1NAVwIQSP>SiMzG?LF)GvzVw!P~70F?$H!HRpz7cK^ePUFrST~67 z#${IAH_pVlLEJQs#k)bgHhdG@P|&Evt|q5MHx#3j^qk5hxnVJVq5;WnSWl}`+;EqU zWOqY@oNo9=M{>F0a~_T*uN!LTb3hB}3~&UAn(6;_K`&mwN9OQ*=Gv>VFN zsB&&tMkgqsyc=fGzm&d$8=BKfdTwN|=!TY5r?P6#9;PdQs+-l_@Ph`|;q`6khBr;! zaAAN-9>MjcmPVP8oG0}m$0*K)u8wm$QjJ6xyAiiyOL-B2HaNXsGpGN9_9-m4Y z6%M#T#2@4Q&hvSf-FSbvVGaFtn|tS}I`qX2bKI@}caar2Jyk7M%=fZlo?Z3HWQCYa zyXYBB&0@upAhjsi3USex8DfQ~6{_ZiTXDp=#EM4|>OCu7Myg#=JO|B-R%=*sCPv+2 z#gAC!8E1uP8m~IDVtj&{!-{Q*szj0%;+*j>D<&qZxonjbRi71(R29UYGOn}YXf{PAfjqY z%ZiuOuZ$HBsbg8yk6l#G3fJ;#3o8y9Pgv2kf)y(&TJedB{b9vhDqq=(1*U4DP ziqFQ@Kdlg@tE#Q6SXSMN#Wk!5u4_eWdPw>HQl(finO;!Edg>tipuQE^|F$A;11qXE zR1MkNl-5X9VZ{%_(U{kOQk$qk>_5%;->s~0X>G-G;|trft(9MBwPLv8*WQYO9o2YN z#CNjd72WU5b?stBwyvBLMRv2IQ4cFJ_OhZO9q7Z)_p>6gzZI1SsCw*%fmZkpvhw#? zD^`>LU@P_wwZbyYiVVZ8NFHfLE2BFrz8EJ*am`0tv1g2GInD~vXS@|{C-9z{r2d@D zJwknGDZL^8sVamOr;W=qtPoXas`y!)BULcY%(lX5t`(aMpLtfyUSvh|5?)iXFH_}K zTCs2w_sAAr)2&vFGnTR9zA?6qs>&bZ{-qVhz7u?HG48SApOb3XY2GVmILEW9$a&r)7nI*c z?*B_x#9X#w_Z2G&U9(~sC12+rq|LPbCilcG-g~!se^cNc?qB-L=+24_#@f4lEuce2 zyL(oM;l}3&yuYa2L+&B6JyL@sbsppQ#vD z1iV#Eo!uc^Eh?B5QEqBBEAAO(t?m%-4IfW;ls4Mf+~MJ^<~iK))ac{u4&meHj!A}R zI(G>F0M#s`JH(eTCQmICSxE1DKm(~EEnRKBP}33mv)(U`qx zG%D#1(cU=9ic7}!Qtl8VN~^MEIQR1EAS>QgP`@j3ji~1zs&f^0h$>ap%^L0y!)mI1 ztT=6aW<~9~Y7HxX8#DiMhe%gXg|cF{k)?q<#LI@NcO!R*Wx>e zSaHF4KY{l&^_-}Nu_E0hwVM?ujK{3l@Q$HHH;=v#7qTh|a27v%(RgsuZ>vBEgY zitfT7a(eLV&K_8lORZ|s z_kj4Tg1TDK1EOLjRhRAfhuY7IHkDN$R=hTTu$`-T;QXH+=vkF}!^lvJxUO`_XtR}jgI@1YTXypL(c)cd#BSab)OC*<#EN;wy1gC{ zyN&PrJs@r!P+bmsKzJWg%UDtNuzJag*rVz^D>5Hb^;mJm@IKDt(Ebyu&`I8tRP~e! zzroj0djGG&ZGOub1sR`N;c`cX-s62u8}F-qtj{A}lmB?HJodmf@x%lFJmtQ5=7D}M z_?rGw#k2meRR}x%od?dn=WF;!zSe%`YaRJ~;eBefWG!DkF#J2`_=B&9zxX&OPc(8? z9oYRAb(U@Ds!q9iVt`eRWyK*XYWGB(k0*j1DuET9=)Te0*Arr62DLT76XKBZlx-NO z+Oc9OmCo$R?<4ZW@+_VR4fVvTFtwc(mBT&Z9;wo^qAB@Bt6)}irE|17Mjc>9-dHs= z&J$vp5t_jBQ3v{!sA?y9LVPIdiG0O*exq2LCr(iD5}v3|{b>>%q$^}C>4{7fR7zDX z;|Vd*ILeAkhHp7fh~WmxdqTt*?iDy+8e;UV=m~M3vQ+ZK1!Kk^o)G7ah1EPE)*BzH zb1u}RhFZeDG&a=qgeY1|jho{MF=K&R%2r#*{j$gt$xA$ud#NY>Ugn7f%RSL^1?NuX zSMnOKR^vB%Ld>SUo7E|{(-u$sAh+#YgB_k|zuOaG`#e#_sLz(!?}=;&JrQ!$6Az3x zZ1rO*<8eOE=);Pj6KVll_M|6zoKi1NdqRAr+Gn`O&#F!5JRz)?RK3fd5Uq@Rtmu4& z&o{nY^~AI5YWH1Fh^Qy36D$0ms!6QaM&GE|Gc|#|VGMrZ2~q2vYWv<3V(;5}NbH6JNe^J->P4=XYLq2;EFbsr*5>6&XA*)3StB6*sy~-)U{zhy=$y~vkjWq(38TN+fbV}P>Ys429<8D zszx3ytudmDaHr4BZH?_|TZ&NdY2VnZjRKkL-hh9-S%=t9ALZTK`mSq9qB zV~`rg3fI9l6gDcb$wO2@_O0=o9X?c@8Nu<cpO;rlW1xM(xJh zFm*hiNA44B*lnC-eJ9yag+3Y;CfguJOi@$WT~j&EX*SF=*0338*ig-A#O|GG!=PDe z0-G|&hW18Z_Q+hGd!EX`ilXyXe^!i@F0f&zahxro+a2iIq(%D|@W;vO+3vyFG#u)tWy z4&1|QW3=3BgDA33W!rCq2sofp4)K~$AsT&{Yj9kxIbnl1c2ZqtTb$x~Pjem4sN3ws zvo_Q_XT!$xHvFcF7r34mZ3w-@dxFv~bH7smD}3F!%4@P0T(ZH zHvVz-g8192+OP|KRk{E#h)$vWHQh5_vEo*kdKK=4$OtcZM|zIda(H2~v4H)S%L`9)t50n8yk1yN`SN+;3jLYi3-_s6 z0WW-_3L!Mj2n5 zdqLFfpti80NLS_P;l;15df}u|wx<_F@m^{ZE1deM)&spDwhmK1lf59m&+|gy0$#U; zsthXz(miADYA?Jtez0xVcwryKuJuB1I!@8+ywGyJ7p_vHjb7-umB-ztBH6C=FIC^} zg#)|1&}O%4vd0Vg_ww58<38BW#~e`O5Ayhjyx?}&3pZ%vF)t(^_rhuV;{?ZglGl|A zo$^A+X)pAk-e>qY%6gV-e@=a17oPV*$^|bRqU{$szDr)%d6|3Uidw@iy5)uS|9YYP zZ7-~(r+2(?`!4s{125EnsMe#>O#Ld@@{Kd7(M&Hcqm+UwdJI zF^J)`&N}=k5a~WDw>^1Z;W4T>-S#RVH{&cu@7FDV9aGRe)K{^qdj|t z;y|*+4xP0a{qr=8Uw!#-L%r#cCNng3{#xV9B75S!Y-@PC*(lmN(d}KxEADokM znJx8`k299A<$rPg>5;P?4vQTvjGgQ+7d!H}+A*9S7**ZuSWKTO$!h1{-R#KjZpUDH zL4`cjG&b5(a_Ff$4lBn9U!kT19$z(geQ>7H1Gu4ho*;Jbxc6_6)EfAlxD|A+F3$% zD{04bBcK%LO_tIe2mLfW%h-{Px)_7lb>-~1MOQ1>;Z)I%2&!weV2{zh%DmRbSJwMa zwWunOPerP!3al7I$EbaEUauN?mE=j#Ea+Uv>X{O?6^kzSK1M_S|zg~YwVasj_ zu_NbOJNka$YvV`my-z$2HT!JGpI_|g^_AzQ%ilQP?_9TEyyxJJ|D3&1-o+aetm=ll zHyV3*<1sb0c_Y1-H-`9mV@x`4j7#s0z8So6KfoJZ1HCbw{-yjGz0rhr&~sy4CU5LB zPP4)@vp4@P?u{RYM;33ap?1OEK!`W?ix_X5iuFeIIB&Qldh`3kypcE68-=oYBQ3i( zuF>8c-YA+=mCxl3kK8JN70szt9&fBPwy_T>ARmuQ_40dT7CkKJjYEah%VypX-;G8s zIahi_ZCZI_D7~cmt-ayZ#v4_QiR_`a-Zc@y1cA(ajsS?p&)L9CJ^uO)qZ@ z=;Mvxeq4+G-k3;Vjj;o~5jTj}V~97p4^@8-=XfaJC~xE(&5w=oM#ix!nq5jh*im zInGy|H+VxhZBbPZa&2hWF<$HADv^DAQ4P4sHK0Ma)tRh55Y?kqbX^~a97aHAABYGV zNSloPY;YGo$7sZ6?W*G0%QUQ;`iE`Q-3LplLl4!L4e6;8*}-J#r5tQ(Zyz)@IA1K-{6Bgw0^4()@2jcYy)%%MN#OR-DhLZzgsd2;NfOu@! zy&Vvlj8Q%glyW$*fj%29z7FK2#q^h-0~6^hP5PY1eGb>K@i2i8`1AhZVOP}6~ubsYSTIPj^d z1527Y@SKXYbYLI-ro63GDORkbI~3De4QB7qhc?Qotpf=i9O&NJfnr@82DYK zr?uT3_}RmO?0p>=IKY8RgVa4%tQex=hOr|#*HI3%80~=b7zZAWb)ecf2O5s&F(-1~ zlN|7y>_Bt!pW;BRsVZf<1EQ(Xi4`l2q}g15dStv~#n3qpeh;@=vXg5;8;$2|m0euh z-42YWvqtiZi=zR) zI2Ncbv!^rpqCr+)v*hD{QRTW=E{^^V9wBLAL!xv&iZI$hBUx>y(Uh-$HFYKkAkB4c2xA97?@xpVkIq*YRtS+SwA`c~BswW|5yo6)X@ zA4KO`>aW^<5Si;JM*~0HY3PUjjr{PWi653X^+QZ^KEH(@vb0jM?0IV2+7AyYYa2g| zF=nu$RcF%;vZ?o3ckC;LIXTCHZU@q;+BR=wNe2gf0GnH9HwtEa3;@8th~ zV_0#|Rb_VbM|Z0~z8emAe+Xv}^?sT^M5*cis7vn+%+DVCcU9DyZy0}9vV6J_+ujF-m6Nm zv-kO<+(AB$mLBp)qa*&fV2n8K50UMJYWUqBVjg7*NcVpwS<&6d9+-}QK2|j{rh}M~ zqO#UZhpA1}W%l<0_3U*zh-shHX7&xmI;H==&9?LqTfNmJM|z0YM)UCW5KHJ?VRfo# zdWiUvD!F`mi0M^S&6?>U+87;&r-%4sjLJSKJ%sZj_4kJK_-~u)z9&7zutVvw!T8K} zxvYF|rH6R_G(9ptQw^S{$0B1pD~=i|uhT=cE1Kc|CiKpL%7azf$P5tE$7jGH!(&1Q z{*0SCwm1Vs++B5<71iIX72h*JJTZ0$1VHQzRI@S$KxC|~TKp9Naiv)RvbI#sTL<7# zTUD`30EQWVcMm|De(H~10a$%B0G2ZWaQzj4sm_6znI#ZuL4oKI7Rayh1foiKAQl*V z^9Dl9DiDYxMOEgKfoMbjvRB!bw~cHS zf>6<@%ZdtBRBcw|ucped;;r$fQ4mD27OF?vAc#Djf-ujx!HV>qRWvK+811_Rp>lUM zh!qozAFOEFL#<>*NKdtn6;*qw6Re2pt%kFrRzKC075$A9tSC50)>sJ1cfjvk|H@D>l*fk?Jukrj822t7gRuURo=d=NfPeURRn&k0@bs5Sq|p`p;NCg~y|ysl3LNb6ODE(Q+z3UF~7NQ~V6>HJU$D ztz~P?;#??jHa})0EDXZrMQR}{vM*L8mT>-LT^59z^mL{A#EQt(DmyE-)AaR07_m`J zWyL27+RQz@P1RsU6XQ5rdUp^O>{ZkD1wmxrugkS~6u%qA$}NP5y242beWQ(gRvks7=7c^Hddrh zP{&y@yOO%eim`vFIjm?|S=DMD46&8aLKR}gTf?bkFvMabORHf1nJySzjESuHV$5$H z46&9x+XN%cn9SZaUa^(h24jqImUU|vjFHCt_B;mNF(!84IcR}VvSTpB9;1GzV2Cz! z)VR#f=^TuwRI@AR+btN^X<7GR*n6nV?7f~Uu2(QbV`G2sV7{jUkI_dtZQwdkHEKo^ zjk)XvxAvhU#Msf}@BXD~#C zU8*4~P8j3%1Vi-MtIo4x(|(otKrqDc!|Dk;=!m+=im;>V0DIz?y2|<<=Q zL@+{5sxItyTpV2J9Mf{}7L7{`notQdV&O=m@k>#Euft}pd6*0W;9UDfs>*ODIn zr_vsCe^GNI{#h_Yx#y}cD@GZ6SyAGJI>?FQ=rG2wM@gixt<>)FW0zl~K#fhCpmF5-Wy4 zEHc)!;zJGPR5Jvkvr({i2t-+TNjo_UZyFK6DI$UuX4*6~()%t*nUZ76SjC zJYKI5lebAsDn!tzQ{}>lC+&>##ZmXKCr05V))jf#*7|qp^$? z}ACTqw1Fs zh)UnNhkmHPe}zD_HLm^+ftZER|6AZ33bD?}?h*=7#OTe6!^TBcq`Iqi9-$Cxz0^Hc zyfRLEheCw94FYE6Mqh%R+hsdk|dW!tMcokRJW9g4zT z)n~S7w@^Iou0FAy28ZIqkWkbc#&Hb~MT=3PXfh@g%PD#+=SBsWg(6~kDBM@6^sFef zM#ZlU#lVfqYf~u1<;|g}dq}ll#f8Ia(UDN3I~s~{#$~qb$xuX|QkzeQBIT^Q$%-dN zvvZ;NWlT693K4Tr1z!$@xNr2n!s|m6O2x~ynHi*APUJxD^4^KK|s(BJpD zb`L|*>xo+RG8AIaYc-w~J>GF`-Ybs}p%5ECs|?>lA)5bEIi15GiWwJJ@sA}8D~+4% zFC)8482T7tu3;$QrlPH35Q*;U72C^0O<;wWrz*>epN8EQ2C?3V_TsUqwQ-OYPw79q z3h@r(KeKTxK4E}ErDw%GUo|x)j9(uM!)0T5Y8b>cqd>MWhzrJx>|qcsbEpxy!XR!K zoAQQ1G%Kv07U7uald-gD7=%kP<;RXR90Q zVz*KER2W1rx?p5G9melRRDNf|AevGyT4ro!zf;+>swR7ZI-FCx&WAxJRC`|fHpD_ZqX z=h&V-!?D=dz&@hLUMf2~o058m!@o~BrqV5{*q384uCii%e^q&CI7GvV;pjLy93!a6 z^lf=`Qs=tIo59&T$=# zDeMcw{XFMHIWMZ7tXO39y~O9yUHWRQyAlp@-|)K{4pH3b&WeAH6*s~m9vVe&g+nCV zRwrI^p5*dMHFzBkQSFWD@-rObxbYVvAbK0#P7x5bjb^MkP8FP09aiMEMBoywbWxvK z;p!TJfi%{Qzou^12()vL06Ze_pYeh1=cy*xA|U1%?p_fPos0pjC}8KQvEr6d zAv4#9>KKby@kbW*H!IE?cUZ9^NNr`s)2tE592|jqMk`hRq>obJte8Ykjm^;!$Q{GE8WmzWSF**ae^@c!Xq?2grKZWM zMoI)kpH$T$8`nEW1i$Z?W67-=<%@v0QXm5P3#w^_A|O5(^9n~mtTV0`iGcWIJTDpn z;aQB2p{I1BxVly%0wQBcnRId;LvBK!ohGF%b|=#;MX%A|RemS6CT=#WZZS%DIbXW~yMf4Fhn-y=3F2^DvjvF^mL_&m|RAX3i znIcZ939QI^Iue7843{DyN*DuJvB`MGicFVPSyuEkHnGC@s=C99*|*eHR^+&?Jnlq7 zTzI0qo<>5nc&37$bNy)BEA@#L%U`SQtXT0zZEYUKuM0-utx>UM6huTTwPipQ#2cf+ zpeTsg!D`=#D2Q)HjZsk$Nu$+YlcOMJ8WpGT_*Bn$$cm!V)Js;Bovrq>V)#n+n-yNG zqL6)qD!efYq8_a`9Gjw0#aP0gp|6J9<|q`RLB<5O(iX0R@q-l}Th&%pWZtGWos5E5 zd`4|xMci4nhP`wyihuu8vsh8+66Zkfm!lAPMK!t_1<`>Luc@VMh3iphNaHE<4fTu_ zm2awxtf+J=3VrD-1^uhKvLf`hTE&X1MyESb5V`KEQ><{iryAYoxadFQJ1eF=P;SS}jk zY9C6OH0+qv2>5 zjoC)u9?=j9{nSWSH14kg21cX3F>_Ef#D~%9&e~{{*%*x-Mzu}R5Wh~S0w<&SvnSDb zZTx1%!c*$cbI}mnjXIa2A*LJUFGoYvHE<;wqN|bR2Iobw6n#rIe#CLpe&Y-)Vlu@1 z-)UCdFmeaPK-A8twq=TeD3Mu}%n}1JAV{sw8Uyi$%7w*XR(K45#$5ek#mJ}_Tr-MA z$6x^=Mp@!x_#PoKe2);7mJkEc(D2R?1F_gxUMvP8xP%(aitv(ZNvRl!e@kE0t)WuChg2s(q{oY^4UU$Bls2G1$;W z?d#6RQQmuMIV*lpw)-*YU|eOzGb8pv3`8zt2rCX6=UGwqVGOoXn@8$3D}K`8$1&LZ zBnI=Jt2?Yne4#qAVx`ggWemhD;{z)qUa6qhF%WN!tZ!l<`oB|7?_(fJ7^hj0;e)Er zE~OLn)oAxA2Ey`LRbjVuiy~6=6ktV+|`B*i;8r zd^W1uVOHw`JSk$hIEX%mrC=Py z--Y6kP+09Q9|!T>SW_VmVvo_OVjP5b9aWwczYU+daS)S@cYnn}%&DhpHIL)J^T%Nl zy=f80f6G_(r^P``r%%)4uwaHdw=E80%5HUu6~p$ZsjLXvt9tH>gNWL%4xEaEz-hIS z6$g#(XW}4AJyQ!^&$>p-7A&#bsR)Ig??AQKjI*=8kv8`L9{c%oZ=z=HvFCA zA;OJdOFUmID5B^7`-=; zAs%_Ck1>ksWExXpk5WvD(&!<}DkB8W7G${}d zQJ|n2$BJ@=)E!oM7gn8E@zrQjgwLn-#;l?|H~lQ83KfrsC{{u(XGPsI>Ln{amQ(M` zbI(v(ZFP+mZ;S?Ycs=O6@qiUM>Z9p}LD<+&%O|Qg5EHY|b<^H2)#!I&B^?0DF z_^z`2NZ|KkB%r#n@n-_W@L$T^ng~(MIP9JX(Z^E_u_r>f2C6Zv@Xn|nXHA3%4OV?a z5+U-1s+p0A5Z8^-QHc<;Yv5Ygq; z;0lQl#VV??4H6+v8T}e2LX0!gH%dgu#);U`M0M(&2(jAm?3)O&*SIk}5hC3P)nQ~J zM9?TTU}hr3P9t!3BEQEq5togBmnT9jU!fkbqR1-sf)(ZWsFAEFxK~wR#YIZlpNLz= zsFR5h$Bo{n5+Oz#ey0=B?o1*wpH<~=^7u5=cyNp3AlKV!^#iT}JvP!FCG!2(6H)j- zwd_?Q#Fn4x4J#`AR$p1+>y-3=tyz)iqT2Z;L990Z_Dh0jZ=~~2f*5H$X2rP-$~zzl zV!v^o6>AV2>n-n8|7gD-vg@R;C-_62wp=@9ZRq zGDeO$Nf3|ctM~;;5Cx5@tluK_YjG09xh3i@D+VuB?kkcY7OzTz+v+5gU8{N=OoH$` zl!UI-^KcTJj_{h(kE5#Zu_TC5leTXXixsX{NBkBrH%KjDB@7vSnq&8XT-#B9bA}B2}%ZWWKj=GXMOmdc`F}TrnQ7-bu)o$cm=_sDaaxA*xPSjad;eL)D&@ z4AFCu8q10)t5x^4$q+**Wu02JJ{clzgKD)Y8REzRHU4li#B8JV5$+j!KpBpzXRKI% zN{zdm3=wum9le(fvHqtSuvxqTE_lg zQI>uf9>r21HW_bOk+p>C$clbOT*(xOZl%1<_H^UoBBeAU!iR_rpG zRZoE^T2obGMFZmqD>l|rPwJ#VjQLBAtDgel@wdvriv5OPgA~5cO$y2w^BSi>gtS(Z zSTT>vwNVe-@>;Z4(VbHGccc`|?xT7QOX0tHb8bePu_+LR$EixJs6JkGoX+*5v>B=@ zE37ls*EuN=C+Di0tQb2_eOj0Tacq&g#){sHRrt~rh>wQrGTs-o&6u%<*PpyLs^Uje zAWj+|S<&>kTFZ)Om(<&<+z<52Sbi-9qTY3N;&uwe$a^Z?rxb{mMmJW3eO3*>q(EHy zs$Ty{fq3&v{ba?m-zpHP5dKc8rfVuh!wjlHKq|ym;}9#_1*&x!Qz7nTR{4WdAto4e zSWzZKjSNkN_#LhaN2T(;t5W&BHEJF!%0;W;tf-ctvL~lP6fvH&qD6|Dotg?!F}oU+ zI~C$-LDj1;$6Z3*V8vr&V#!p9Poz&AC&OP_cZJW&88#hUd_R1gt*lYB*07TaNof#}#VYN)MrztCXzq5Nf|xonPl6bY{Ie@dw5Y5gXOZO}HNn z-=VJk=^^yf9u>Y9>l`BYsjmAyghn1vbr0eB1%;2Q(Z}%ogJLJt^;3A>LfJFQea=Iu z)Oq#zBK89;y`&0W#{PxU<}^yd|EQm@cnH0_s#0!v2yMHka^Ck4Y6;13!dym!9^i9k zB^vqAL%P99@O|VV7tAYk`D0b}3FhHH5Bb-OP2-946L^Y$S`~@XF36DH6XzdQ!*h8G zO*c`wJ%yT^GiZT4o-)GJDCQ~TF!G%z&Q0YhIn7{{4t=j`7WWjISY9naDZYa0fYMb{ zqLQc3B-6i|r_ea#tnMk)$Q(iG>zZl+N@M+0GD?l=spT{An{Qz&JUnC9n~<#uF4msOXk;Zm?M}6LEY7wpFHJb zA5ZDs*HdN;^pviHu(n_gT!6xZJ*CnwSfkJbDh;zJ605 z(XVHDO0U^!9a>+&^&V&rGihD8>La^I7+#nsd^|4HQP~2G38Tg z3$-+}Q95g~KCdn0Z+fD%(mX<`^b3`M(o}N-rF1V<9hAD7B`DoA1zyz_iZvd!>j-(* zQH_1;2qpZWiX5sV^rDhisDZ1Pq05^8UDpp?Ty#iO*w zr1A6;iZDY^x?rliyo9=$Qej>~HOzLD3e;DxQMwqXIyCeWdXuCIw8Zy8P#fj=(MxEk zsnyO)DAYVcX-<3f4@%=YsAQA^JF2%R)$F7mp!Cjc?Cd3!tA~m}DQ!=c8>JcM)lXhR z>wBpKzj_I!8>2R%bkNiv>m{^ooN7JZOX&7uRdk7$^!eROx-V68w|EKtZE9}AxVNio zN3q|b$T4*arR%2EaWA30C%mNZDb@d>m(X_8>5-Sv0F(YP*3J_zy#85z%;qgrGrO9c z!&_+Q*UDMITWE;6UeH@;Mm=kG1FK0pn0 zcnh61_anT8f+N+bC~y2ft+!-}R;^>ag?wU_H1!tpGSlNRK1fJVPm;Wa$~03$n|lid z{Gb}O^%k0Bp8n`9w6dN0rGvN7PE)9px6m^)ueZ0*WmBuKw@}`GD$Pi5p}OWdN@+)_ zk?6mpv29~is}U2z{4M zUCrPlls}_dn8`=z;#VqHHXos>1=O_fe1y)K5#Rd=O*ci0`$(S>J`z?^{aM~es6&Wa zj#7d{bwuffiFEo1<#4H0Q9eSCOmegju5;`ot4;M7AEAk{s!5!W(85;gD(cn7NA8-A z!|{0VyGcLNM`*7pHQh%j$?TZnBQ$oV+B3%ouaowXFJ^tRkI-J@oa-aBc%Hg5-$!We z9@TrVkI=k*D(y`lA%F7%rF6H{D3tErR+H}d2>Crx{ZOj%pQ?+}0aN^$kI)U1?~9L6 ztijc0h4Py@D7{akmZbF+DxXocMX7KmRRN`SkRyvPF5{%G=JXYMl~+~C=PP6K`%3Ks zDyV|5&|p)&qOVY}If_!5%IYpk9emYtloI?@N0eTeNPl0UkLLR@U!f$EyPmI5akCVq z3~sd!rL@t?2c?-YDm>O#s6(7uj#5Gc)e)r^5ZMTG(^zHh;4Ac($=cBu=k@TFHl0+F z&b~q(T~ue3ig#6>C~bkf-7zO-+E8Dib7sUaU!mzHXgKB@{+^;dr{m{9nptZ4TzoI= zny)^gw042ojgn)bTDZs;=e+Tih{bBzN?)OS=C@V8Ld#9n)xI)zjjz;Ms}67V70S3x zZAIybiP-KdD|h%x^PTF%Azz_-ht-mISeKBtj9;qOC?%IwpHcd&oVtNh>+M+KcTVJ)EtzY)s=^rpU`4+&c{#aj(LevdS8_XrIMyPO2H-;rIw}#N<+;Qlopu{ zD5b#gx_(kPzz^@&@{^EYKm3l$PdbO(H$K7ux`TLyF0AH&Cdw2}WtWdG;VsDBnXBic;=Jsw7HbW*ABfAFIkw0);l2 z8z`+!Q6-<_{t#}OzYG+5V7_@3C^Y1)T8h$%_bSJSK%p}q)kl<~zNo)ZN+&_7%B2eu zI$)ln^iNi`Cwq|4Su?U^kWji(sw+y9;goraQdDV`j6Q^yWmMy`K|)>4B9!)+FDT_L zue?zjXvUy4zJjV*F-T~usah#W$Zc9x4ifs+4rk|R)+3$yDPXi}gOYQc z>WtE?d1@(2Z%l!WK|=NSt8OUWKdy3|2okD%M#Z9Z&OAk_;8}AHg{>y%g&?7tW&uhY z%r!LCMHB{HQWyRX68dODt_2CTH$za`a9dqQ>G3_4`##nvbb6wupcL~=^+&1MD>WP? z@3*QIO2t1ZCrX7SI8_Kr6*8+Rw9QxQQ{iBt5=B(IV!=XFOnAj$p&rJ!O0ZBHbKNso zC`&b!SR+_yq?u9&KMVde8GVC=s+xQL!9uwL)WOhTp=YL0M6i&*nSs(?^C~J>sBpCE zj?x@cCoWhh$!tdHrpeU^j|;WTttP=j*_x{PNx?#g%!D6;g|-=wcELgoP1=sZLKV%4 zZoxvCe^#C-6&;|0Q2K9>Dlj-$DDyB?8KqMr)H{^CepSs-+G1{@RAihAMCmuPAEn6? z)mD^pO;X+{wVR?QppW2`a^et6ol$Lf-#XE%vt?#S?x`qh-*-ah&DMaX*Y1J!4 z=x4J4P4zPhfxXqaJ|RN&`>F{jT{5Nnh2Z?&_?kJ7(k-*Pe~8d?^Vfh7p`(M;MU*NH zRT+kd2;Cg3LXt6G(BAAu>5RFKl6#(7z9dBGFO%kXtV`HpqIZP|{cNtGv}3m_u^0On ziX2owqtxt>nuAi2!z$$n_B$jVQ)5wDa!Or9Y3^Bd0HrG?|G5yMF~;{oh)@gjH%eJA zs>lCe%|h-gsvJs}uByitaFO($?sbTe zp9y$_bp~zBRg{XpQ;{g`O5;eCHK#+UstL*K5NdC37H|l?G2a(-NUB08>@jx>JA~#G zRaene-=fgJm`dk#;ChV?ypBZeL20f_twZUb{|m!y=vz-^igXC=k5eIyFkYBpE~1pV znW~IZ>y~N^N@?1uGAKRjqH=Y02wm=>q^CougBgI*(*OGjx53#?j27j+4x{6ke0l!lvsP^vjhbsg>yT4kP$a0oRWr3Rz4-Sqj@ zA+&vrdXLhkajM&7hfwqBY7a`+OokZ_Toc_PMU5M!d1g0CH%#N14k7>FRIk|%yq3fv zhvuow^BuVUxtg;8YY7@JRKCAEgjSmGmO6w!L#yQ~+e!z{SL6_H^JSGosPbynYAwDG zCYj0W9k_lue&!#l(ng0+jOl~Y*)3|vHiytH(_p(pXoT6n3+oadnRL6c-l4FmhEhFq zcORZNkZr%JhSCLd{eVL#!$CC;rTOLr z@Ulawt@-wfL+GPvam^vr)67LvT}Pqr4fPSFDi-ZvhN3jzw0!Rn8flJvbO`0n7@DdcN{vilrcj~J*_5kvs8B=G9i^FNRf}?= zLOIK;JrzQQPC@^Qs(7VPA@9nn1xkNZQAbb;uc~HygbMBURQFNJUOiOSLFpQy5)1#; z3YE%r)M4LHA*Ub41rJTpfKVwE9E$S<0O{>h=m1 z8Z}HE8yPAzVyqfAH5BhN43#-E)Rf(!Lc8`VzkQfTSaMWNJ0B`^;etAF3FCtjSJb+z zSW}SWhN^(lh+FCuN+<8C0a=|whjXZ%C7eRVOQ|(gokFpG%A>ARsF4ZvcM9D%vjdzs zmw{8_f>e=Ur%+fU71Y=%RIZhJ(A6pQ+AQqm6w2RSCH8a*mHbJ)>Ejei-&Z|GDWacK ze(mp+chGWxQyLC(%H6^01zO-2r;LVwpwv*Obc9>bbeL0inOwu2(ij%PYX}(Ol%a44 za*tH;=mp3#$|-ZrDwHyeRo|fG9;cR}^!0ePAEndg*9jOqW7t1p)TgiYNycg zwQA`mr%>?zQOdMi)!ge83N|ZH%Cb+DLaCPNgwkF(53*lnM+0G~ znS^FL;FNKY^`J^byTWX<47~~ohg5s?G*msT#-ViC1RcRTg-A04r3dB>N|}zS%g1qF z=ypPFI_nhra$c>vfi(i3&9a-=Z*bStx`pkAQ6}qcYzOo)H&Ci{M=e9C#J_4eN_p<8 z0Vw@vs@!u5wKeNdYH?r9L+OVHs?S3_HXJnh9$_s)ucxZ#OQ+DhSLz;0@vqfvlpdN6 zZ=6Cq&DU@7T!7Bz7)smTsUO~B9Ppn>`rs70YMt#Oy!hKWx3yx>d z-)ur@xVTakN#hb4WbUVR2^~zQGNgA&X;UzROK6PQlF=p9Gm~16($UPSb{3b=e3K)q zOXw$a1EsjH)M1pWWm9ue%9dUAMd^-l=Wq!vHtw(SFtf?E~wrXatTc=ta=r338gQprlVB)TeTUbro~j2?_5IHO-yl@ z&{C6v(%}+nSxJl!j+)>yE}<=D)spfqp?p=<8V?s<5AG6YZS_MPm(YH*DcFU-Rk`rD zaaF{LeGi?@36v_j)Hsx$7(JrC* z7^WzULp%N|BOOy_@R9RcO@H!@!M3_z}jWuggI%}Szl&iI>j#5K2 z8l{7#OdFTb7;_q>ifvUgN|k?9J5lP|PHjRdS9?_trF0$Ck0>qcsKPtBgl58SbD=Yy zZ}4pwJXhd?Nz=_GR3By<&+aavqCM0`l+yNeNqz`37f}itpeCU-bfCJ4=Ke*UMagrR z>O2bT8Qz%1qj7uy=dbE_lpdH0V_ZUA%w?1Yk5z9_T02hlACENy3(QqiCb;CPd5F^1 ziE7Ve7yhn-^*L3&Mx&>>HUn#8CXSD@G55(XT)Q3n8H&xtF?F6xCeL@t z*9%FebD8>jIlc~a;p_^`#VR}(;OJ_XbX$Yt)LJzZ9kI?O=b-I+mz;+le_*|C z#J=5xWAzp_daFwcY*Qn5V9s``gJ_pOUAUGuwhzw1J&4|gaqh#m?srM=18O+h|Da3C zA67r1wB!iZ<5ATXrEAArlJU6u6{Yki)PPeip~+_3S(ng#`06~?{6%czWtY_W$0b*; zxTMrIJpbV{Y`(6p-@tL|7UuJ|dWll<9haQ>*Cjsp)U^9JCO>e=7a02p&#%X-9a<{| z$EVjS+Z&hEgwGK47RRJ_nEMYnZo`isaXiizCe=-$>|sKUO^Y01LZkDkfc#-XznTSw z!zAzbVN#<+n7lQuN`^_=Qel!*Mja^^Cbi0k$zixqAx!)$hRJETR4GiFR8b>PI%W1( z4HGKpsTQEL#ymwSXEoItrR+771Em+Wl~0{8sqBUOK$uUMY%;}tF?MJVL*cb4=!eIJ z($F0?1gPgIeSyY-VR8(@g2Loa@Ce43p|V4DM`^S9fKp(n8i~?Llh%oOgBqqSN{h{X zl#01jW0WSFzfj5>rkbEM*6c&+lkut-Ce+oeM(MUGP(KXsu?mxVW++Mr%?FffyH$6T zHk;2Vd4;Q9DE(m`qf{GhEi%_pD%?OdKxv#gfYLitwPBc0 zTQe7>vnG2ZtbK5rAt-G%FHox7Sam>Yg?WHd$tJ2XO5@FblwO;vO)(y5V-}-y#}tpp zJVJt*j?x*EEg?)O$o!1bDsva5Vu`9TN|Vh=l=390$F0J|)g?@dj>gBi-KknPaSJUn z4V$`!+L$M3Sb|$5QQdFt7AoCF{f*KC)48o%==hIrygy6r>g>k#t=-bDyPDtEEp**X z>gN_(V9NG)3k@5f#tw7~T^y!-$GU}bjZ>{qIyhdXpWqhSY!0F1o~V{jatjTdth&!~ z3#~IPXS;FzCb#r3@6m?IxbIw*u+=Rz%Y<)p3niL6CMXdZ`U4 zjqa_E_X!so-A`RZ>G=Rvbzr#AZSw-9-h;yB!r*WjGDJT*9E*C`E`)u#D_aG|cI=)-WKd(YKxFT;g~zECK;s<10!U>AT=4KS7!b!i~+8jNwYBqSYXP| z!8l-8GJf`4RTQP3=IHhaTyq*<+o86jbj(EUj1XG=ry8*f`wbQxQa4bVd{`|+soaqW z8GbZEf{&?O*CT`?Oxha}Lb=ThlwRFb^KW6>;Ltsl;eLeB7IPS-@CRze!w8{}A0mVbepDUPL<+4iiD@H+ zI+>R!MWt7tP|BG@75+L>r~&MOz?_kiC0C?8gF5*l<(vGGG8dLeRH}+;qJ-+01e6Y? zQ!h|Do?hk45G6Dqvl^KC#1NHrRFu%1$!hhKD52c*@t6yv z&laj=t7xH|J(cg$ zXk1q~T3YW@Ls05`M16NUTIit}c_v!AUsSJ9^3EBPs&(!dp%T$*`wuZfds@cG-c~U( zxt%(W(wpuoTaOr_nI`e47@^4Cs!6{Xp+4qq{}`eD1616Y7@-&A)s?9+LS?5ZnI0nz z%tf@>Zz^~}j8K||F_N+ZW81EtqI7zP>b^5ZXgGW@{r`*+>bYCx*%KpFWuIDnAV#Rf zLG=`+uMevXM`DD^9aRCxVub3Pi;;X6Re6-wUs1nYjghH0)CP3LO_g#BUxzA!S9Zv|Fimpas^( zO3eCL`QeXPskK>cLXYiJzWZY(0j?cTH4nxLEiuW5VudCiR^J?n6?*ebMW)0Gb;%N! zDu13hq1t8>N}ckmB`D?1uM$yOZ?YDM6Y6C;d>bd!vAA-Vh!g5xS`Chhlb+p_b4;Aj z#)WF_p*W#^F!+dCavYBjp0`!9G!SZHKxynQwQG00{Cr3i zJ{K=^*(+ts@~TLLjUDdxpF1o-z}s4oVOTgMl;El{pDQg_6|?l&+e|a}$Kh&r`QidSO1z zPr!To6U1|o8jjL+GhlIoQ1<0&I7;{bP(B+Hgj{eJK5R^o%A3>>l*Yq9kZ*H>gqsB@ zW!|dtq7=46EkUW#ZuJtS?@p~%hQjOOt1f>UN?7IY^o96xd z1fgahROfVwLaR)(^oc@UOr8vhLRT`XLYWeUPME7GP0p-5vm^@bGI7}wg-)24g%gFM zil{{NBxEg`C_yF?oedWu=eMdTnp9k!FOw+bQC2OlkSG*gN!<)g#P#?R<;NgZCn{0s zdbCQ4!Owx3P1J0ZBuR}zX=rbC38e#lRJy*2LYvG%l=}5kh5IK8H8$A>BnlNVmr*J^ zOtnU-;BZwAr4uH@$V8#$X4Ghm53U;Dv5EM-O``NQmB%Ft`I+qF6NNHQRJ~E!H%Wy} zP85p$P5pz?zGRhVZlcfzvmd2C^VInHi9(;unFWbLITxyZD4jLGElLz>uu@GyDRh-; zh*GK5D&vMkq3T=Ijz1HHq7JJL=wj&hScMi&5~}^ZI^&%rRNhDR3QxlCgOen_rE1eE zNoWzoja19f9q`d)8I>fyFxt#OGmcJ@Pp00lNz&7tL+Ot(c)YRd{)8l5-H@8sAH(fPEsg>D_Qn?vP;x!XrgTu4bGqluf z6^>G0GZLkfrs$j`p$ewxJbVl*%-8digr1mz3zCFBn5_$wgbFNH|De=tiE8~vl2H2# z>g=T?p&O>}-xwR5f`^dia*|XvzUT~iYcl?mBsH!iNt3Hdaw#DD^pMW)U#1a}yc_+0 yK~n!|Gb+u|P-l8sAHS^5>XJK8EiSe9e9AT%bSYn+%Qs5Ao$>$srThOKtp5Y5^cbiB literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/9364a8e737f0d7be_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/9364a8e737f0d7be_0 new file mode 100644 index 0000000000000000000000000000000000000000..75737c07ef8fb53269a902d5241a9c71d80d236c GIT binary patch literal 19300 zcmY-1cXU+M7xwXQretP9O~|Bxv_L{;GMSz}lhAwb0!mW^DT)XPSP@Wq?^Qsg2?&bx zB30=fL_oSCy;pso-@DfP$IDtDCo}h)efHkxLMC@^^tSupyHY)0yfg!q<#}eerg|VJ zyJ|4UUoA73S;JesX3Z)&)qVc#9DhbuAhUX~Mzt!L-WpZ2gVp?1s#U9=U9)CRphk6n zW@dKPoT^oPSs7LRM#VT7TX_2aV*T&W{>(c6_c31o^+&*E>2H8NGQ$LC#HJ)}%M=To zDgu8Nhr=adOAvm^25YY7$f=O>s}3b=K-b2wq6w5%)@@~-RBHx3C8;@NNNstymFCL6 z*6__+TB|3#-3#tWu|8n$uUH=`)&R&F1V4NNPdB+N9jJ zz$V!*d0U~5Sbl*7IVzW=*$&vb6Hdt3T`*UQ?}oa2)d#Wv3du4>e%l9UW%7RbR^kq* z=SN_fynPh<$~ECQ6qPv=JOMT2KPh$+K9?~v`;>Zn7R-OZ*7Fc`0ZPdUxhgIHghm&k zgOt1kPMIkmUxv|A>k71zz5jDn`z{l&!2*fB4i)~^+Hza|mG^GItACW&O^uh+QsxH2m$grI4$2qLV7wTftBeM zl4Xiupp29n<_KEIZW&>TV5YRNYOb7=E0Px#L4AoV6hWMPE#-?w;Fp{7QhF7O;EiZK zN@`35*|JpDNgsOzF$ob=kaKcN+9zs$=?JRHD=AVYg3lx?DT3N!sGvDAL?%eBiV>WZ zy~zFJ7~qBnx0SrNo%M^Hyb$yq6rqvtYNrsgZ3su3KJKV@vS z2s%`cAfZMCZ`M>j;;$XSVTr37!BFX1FM<{IBPiV*#AcaCC*3irSvcxSQBZW zg2h0s!Uo0^G4QYSi8HVv-axBF17D{YI8@0%L8^iJa#l{d3{-U+Xe3Eq1J!*7GW-U{ z%iGlr{87Wemo*JMlY-g?R>($qD#hv=_(XQpGvKdp;AIm7y_*>*-`v0=x!J-%+m;5p z%1xQj%D_jh4Me`K_1hRo>|kJTCjyd(GJwMhn!$Q5}aiPH=OrW>d%jb<4*FQvaR z(0qY`Kc)Y-24*Z$%Z~biG_!a{fWzBX2k9QiVv&+DI z$=q#VkbEzn=^MbMM-ti$Tl5d%4=lkY97YuCs(?H>i z2DVF;TL!M*Rt|U6TX}X@AUpWfRU7-k+(99^c7E* zkplTao@N{Anqy>r$jEOpBy41oMCKc5P+(-UEUaSWCwZ@`kuIcMz*##Vry@tq#Tzk(z1h**&WrpPMXtAJ$qO2 z<#u-?dwVEGFC+1NRrhCl{<)qHHgf+OXSW{BX2G<@^Xcd+AFmmtJE)v`oYNbpVU7I{H*@U&2>f^uQxJfgAwya zBQerU)@?HK{$?ZBC4H;T1>qO%xg6f19`Dq7u}gcmTRHDBlC{@Jy(7w7vX2@0PGbI0 zkHvUixyxtL?UIqJw~h3=W8}xXMk?Gh@<4JPs3-E1WIQr5=&_Nn#s0*|xAM&!PnwB(=_XR# zCJOmXH1(TU9W>EA%fu^rJKID;j)_#6D(7-d)Xy`~MtW5b@CR(o5F}d@z zi47Y~l-Oiqx15w3n@x<|V&b`2w<>qpDX(qUe(hGhvTl!wN_$NNCG%J1{hRWZr}Fnc z6T|kK`0t>J-iJ;6AxTF~*e;tmEw!(j7<0`;-J9Cm2PQ6ySVjFV~u%rui<#5zcM$f=LD#zZqmrQswqlO~(>Uc*d+ES_p6 z@U5BOr1*DczLxLTno0ZF%uvZ%XJ(dkTyLh^1~V%+nklnMb7bLW&EIZj=`UuUO3R&Q z=F4BZ^nACOH}{xXBhU7l>H4dBa6tJTR9%O3T+Bz!bdtr#%)}oz6M4o=8=3dJnPO+v zqw^a7rUdks#@<4J7kt~+Y@}KN7MN-ck$@s`f{V)`XU5;2IIg}pB z2kuDjNtQQ~MY2(hzDR0iMzSqCl0rF=w3cOZFE^47d6C5AM>16Q6-1I-ITByhNFu96 zQonj6uS?Myk&KpOH6y87E0TzYiY>W~B01G0lI~3-`Jq`P<(liY7LiPr`O=`Z=D!}v zdu<|F(l(On?IL+DbKZ<(efvn-bciI-F_PnQQ9kYz$zS4rE0POuN0R(bB(`pmyd0=? zKh_#DdWiBEs^`NZx$;#c&f$?vmlm@knK?U>s5z08l?L-7S+id2ZHUCOF_NXybCY_s zP5t^Mk|DBmcO-ZBMACk*`m!&QCi~SRIU#Q!j3nt!B;D>t(ob%P?|vlT$k~TF_Baxc zy!IrLuCn53B&DCJFE1jw`7)BWuOiuRuu#Ql;VYAc$6~WsXk@jpMb;Ft5Lwhh{bCjd z6t{3dO2k+wC(aTUevl`z7A};s@T!7^HWe+*OSVuf#lna6 z3m{tb7Z#WUag`u+Y7-YLRdq3)AF$T?-BBS-9NL!uCcMDmS*UOA0l$u&0%U z<1*xR3l-a1@W~>HX=kDJ8#*q#J6b5;$-+CGEqu|%!c|G@s(dA?mxYY?EDUVC3>`lTN5m7on&GEcUo(S;>r}+x75Oin^dw9T^enGDXhvPf#>SlK6rkd@>4Rvr{s zdA**M74opYmCg;Uyf5F${)Wn-k#cQp<(v#{YUMX+*v!gOx!c@I`xc7d#>z2CY-iS8709j)Ef%3AsG11sAk@Gs>TlKFTNy5gKC+TO zz^d;#T3^--v(n-#E7q^AB*<5CV7Qgg2rEsbhZrU+H<>iW%AKiJ@}{Y8)0L;xoM~l& z{5?y#&9>s7YvohfInRoHzLk#h-2y957Fv1xTPw>JDVOi8cx38wD>c?wSts3pv@%F; zhio-)!Zh?aE0?>`=cYd8cZTL%VcN?6WfVxRsmYKWXI~x%0b~H_qxj5X(6$ z{bc54_2Zi6$#E%rUHd4hf2nV>;cqLB8&)!9#XnX`-O@bSblb|W627Z_xTk%&Z{?s| zmVc$t11l+ytb8k_p6FbV&!1U2`CRAE3)S#ad;6c(!A7qL8-wI`$uijZ#AsuL+>!1k z8$XzBbg|l4P|Sv{xQ#~9Hnzwyxh*f`bc~J65;i`LwJ}_d$rpATd*W;~POx$PH5-A_ zHU^Zj@t2$`YokIr8{Nulu6&-P^`%@z8)IdbT#(n3m0yaDgi1C>%du1&RUI}AUK{ge zn9s(3zm2?r){*pF8%yfja5u2=VMCk#EwjCSsOIT5UP-l?iX{`R4lRXRlnrUuQuNN&BpP4HcB4Q9?Bd!c2IpdX=9OGkUOVs3q|Tol{z zHJU#AqS+$f?T_Zc!D!|liKgHcG{ygn#(FuLW)ip>&49n7S#cwp zXY%Vm(GiD9;^ zIIQ?*6<=2U6+^R|G0c&{cQx-p3`HKsaQ9UVQ;L+}qLi*wf`)RYY6&VfRNPyFPfwKKS2=&Z1Z)2;LBx#`47go_AumdBNPhaa z1k3*`!4v6BEL#k**o?9KV~XWpb1bbRV_6^;ODr8_xsz>m zev{H~#FJMF95St{GAX>MIR`|H_>uW#oAY1`1QpK0uDXr$*&G)Go7 zwR5qh9ak$m^;#>xH|=znnZ4}Pe9z8!Y5u;Q#6EW3lFfbXTpDO6eUP0FpW12hxt)0u z^@W`?U)rfS#Lh~YIo!@Qxj53U53Cehj!v{Qa-N-&(ruxg0pHo#veb@knVn9{?O4{@ zX)1kw)><1BN35IdOxdD1(qOBdpSRgDY}b0f*m+Zy$VIub(~f7Co$Y(<{JT#v4=ZmO zCACi2nION(H^1AtDHYG!`QwtEN|)8QE9&iSJ8#R3J9h3rv{T`Qo&Lr+UBZjwxnvZH z<8%4GXdDaUC+)-k0fJ;`sR8IQEFAXB<=Hq9pc;W4VL}#__cr`67;1L*ke(4Tov%uauwcmN!Sl zu|)b$h-3S=aTH#p7|Y@qup*9~vS3XdO@54HmKZmvH@o5}vOA8l`{O8cAdYTwQ>Gl! zJgI#`wO)>6v(N7CImddl)Aacp`Khvj9Q-bcmL*%;3Xi8aSlEh?Td;x81>#uD*F z#>O-GwRk#~j%T^7D-*Bx`0?D5XXWC_sSvNvsp6ShF`g~S@z_%0sUl0#<9R4=`s4XH z7_aL`@tl+2L-7o#8qZEyRz04_wKcv@JT!^tRf~9CdyMC0+j!o4JDv@)y=y#ed&aX! z=Dx3dddJg5hD)n{%0=E95YL%G@l^aco|V$^3*{;qLltXyJheu|V;mDtV0=8E%2gRQ zH=ZN1WpO;;E{o@`T=+ho_#fiwBr|02kMSIkO>5(MeM>wGrTn&dhVF{zu&my#HTJ~w zx%l_02m9i=Bpvq0Gw)zL|46?>8h1ps$=65YS#Ug_+p_M2VxNpB;Z!`0Wyx9fOYWSD zXWHX6w#2zq|ytOZ|`@t0Yjk zY64N!5-49!aT+I()g(dJ=@NL=DuLRq6ByPeffMf}P_AnNrd|nTevrTy@>w6f);EFf z@>t&Km%wVN+CKrqM+rQXQlBg4mx?(gfv3X~=r%loAEjV~;*U}Mv3h-c0{f>V5IWNeq zca1~_$o86v?5mYXTDx+IBavSd>d z-mOUtl5ch-@$Iik+?C&sCDHA451NM=>Gj>&@DWa@_WJYUZxP>@Wo%E_cvN!ItLWc?jTWarI87zoZY+@lTRjE33Xt=GI8%JSv%g zCnWRbROKNxr)%!aWJXKxS;>4fCz&1MnVU?JWr`;~e@JHj7R{G;b|q70e=^;~dmx#5 zr;?c>eg8-%`9d=9%c(2L{Bm9M|4Qc3tz=$3N~ZSXWX?TRZ7-5pFZW+2bIp{3&zwT> zs1#gJ^tI)!zzJtl?eu_;`U&UTGWNa16tSTcp7va?hQ#a>IHYv~kjq@<8h zNpqbkJdpgf6s}8sPYP2dE~q#;DR^>IsG6U`?wTn?*Gl1hvlRNaPGOs@d?SUz-BM^J zOZsT+rzs4Sl#wY67^n3lZAuD@zD?nt6j__X@Es`}m%+a(uisKwe<%gh;S~BDPodVy z6eh@%GbuFtGle;_{JO^9PND3b6m~sJVbg1su#~REg{(>x%dSKNnI_G`m6#(vs#Icq zyGoees6?rLm1y)o^D8k!`s}JiwUd=}|4=1fUaiE#>y;?@s}dt_SJGz%dQDb6tc1~) zN<;ZOI+eV{REEi-3aME9srsxjl`op6a^vk(GP%Z%r#Z22!0Q-p&)^11AmqDBYJO%8U* z@xl(iDB@sGQ3sjD9IQ=n@G8+k&yo&im3DBsjDu!n9i$}dwG;>Eq@u&Y0f|j>Fhn}} z9N7I1l4Y{|5pYmH=%7`;gRYWP;J_~n<)6w9+E#J!XB~(BJ~~)d*TF_fujk;y`VOwh zrDhHu$oI`1Y!*)o2mM+)xF+{HI52c{uu1kyekTV*J3DwJJG(hJA!FZlFju0xJ80d* zq0iwR6d#~`2C7au`l*A&&m9bx-h&;i`_e(`5C@CDcIbXN2kl2V_<4eZe&0`B{6i&cV#}inBpqZ`Rja^z~M)vBQCNr-Mej9Bh?B`?UuL9dtkB z;H><7#G!lT94tTP;I-opd@?`^PAczH4jxOP(+;YiS3S2K{B%cqb=N_zoOeX` zFVsIdE;U~|82w7;fi#P7GQ;2`%IIWNl#^qHoK!39WO*?s?TR~D5bf0GBu?GS<>Z7M zD&r)soReWPA<4;^3Qp=&bTZSSInu@Hq@VmH9+#8bJ}2=xPTtIQQo6E}b2Xe)tmR~q ztgYkZRb3}N>pA(Up_2}coP5_<7-)^C#}0XncKrjv7Szj^mdZa$H~{S;v*+pWxxO@!zFc)lk1;5c`B>FaPo@; z2Rj+`rIUZ;sk}ARN%^mx{3fTRKNxFS%%3wQtyr>C&xEBslG|Q+oIRDI@z?%$;RzY3_G;;uTC2MuC=A)Stm~U=T9g5FRSM=^@?(m z#H$)}&B*On`@}H9?vO}UG(ikXX z<#}Wp-xf+^t-N12jnC!2}{FG@i)>a)jo}pGPrXZ6Q#jhIxdGKu1gxjWTr&+NaKSK)A&-teKk(DN@V{u`pHOn z{Bat$hNlr6nZ~hEXiti|kS^>WJ|*7bRq<>@V#i zRK`W;axRvZcTqCQ#nlQfT*)qGNn#}z9a3E!mTgWK7MF_&=`K<;T)da*;$v}Sxp+U@ zrO!oO+>*PwF0w){zLU}gF5ar_qPN_VU{x0nYPl#{*F}qZE_TW9@>o7->SBE}#cS>& zU&^;t-aS-LPZtN|lGJ(6#gQ*vBn)+tEER{j=>C<9v+|c@3|CGgTnv{7GHR5I+0tsX zi+ALVlpE_}**F)qC%O1$ii_3KW2)xKZONGKqV6mgQ@(X^Zjp-y-)YU|T3=>;?_#-> zS>fXCl`c+*VYT`x2jrYITBEr?x`_Nqb^fe6*Qrify}`w^jV^|4c5!ICYTMzWf|NSt zqSI;h=ZuT?f4cbgqKl)KTwIW6mzDcf?c-lAo{Qy%a=Ynb{4Ey|w_Oar<09>@_D~*6 zIwhjg`BJ(SN@rE!bjlS;=UQw! z>2c}ImhvUj=~^nCe_utRPN!x{I?1W&^l+r}hwO8v6XQx}u-x&a zlj%!mk!+Ov{&cp7)3Fw$^O3x&olem@>Fkx$Qnzk8!FDbw1fbD>>2&)cU{rK4)=l+K`c(%I299mo6Wx|b`R zsUM_szK`@(-u=^=EK4PSKswEaq%&h^I#I*Y>G)N;-jAg7lOzpSZ$_l++GIMl#wp$; zjhT|pKshsA{hFE1I7y$I&WH2Txgr<7Q-7DF>$7zAZbdpPSEf^TRXWvIE8jKgypZ>P z(mt$Jt((#b|CUZevF=MJK}JZk1L?daWe%p}mIH@0_EE!;anqIH5r5pKScg9bPGMmOJ?-Q13J^QOg3$mXVjSfbp-%Wyed$W7(K zZVDH1)2yhQ9nv61<0YYln^c)07h~NtvAdZR=jLp@n|cXuJf+<9d(F)?=~>pzkL5Hb z$xV++Zq}r_so-!^F3rt5F1PMub`w|K%^Nk`9FXU=+`7Kz<_B5Pz|EtEZr*O>W^5BT zC!4yd+04y?c5ZIG;l|kBP2CP|TFDn3-MTl~O?GGHDaX2L?SWc*kXzT;+ zm9pb2H&Mgg43r5Y-JBWarp{9oMjl7(&(zjZT6zLud&-Rxhc zJy@!bhn#dj^ zbn}~3Iql|_1b=t4P)7XW=Eym{e%{UC3vPb>(@ndJZo0`M30-!xT-HmEt8R|U?dxu0 z|8}!UZrpU^yREe)=f0cIAGoS zO4FmqLo2U`J#yXeAtvDA^`M7@Ts?+8%*)r90uTRH_E58`Vpj9$J+X)C^)2Ft(lM$&5EVq`c|TeH@A_Y0|Khhqkg+&UE&$;B5~#x_D^w zj)(HyJam26!)Y1P-NU{f9`bs6DE6L*mhXGmEoUXEw+H9P9(sS`;i7yn#6zi}9y$&4 za8!O6?xD*F58sbe>@gmE<2-yL9VdBMJXyI+@o;XMhl(>iOp^a*s>a#skxZMby5^~_ zZ}jyt57y-#-Sez|uJZ8b4;~8EdKmVzYTe?Y=MfJ-9#x!U8go`-&Uq+(#lxGoJ$!q| zgZ-|DQx83S{z!d(>>=xk>VK*|kt)xXrWwX(X$?WArdB@^qh1E+Lo0ow6 zQq)VoSTA2m6}wme{&?9TQSn{|O8b&t7M1c6_nMb|6}`lyco{4oyEHD{%My>5yIwCH zd|vhky?m76WoxEa_qKcaUCQTp8807K(fF!bvznLf(zLploi)7luBlvVDYnGaQEXY< z(94}h%Cm)+vh7tz2h}0}$lxwsiuCf*{5{Q=v%S3}^-;cky*NKrywAM6{M^gfA(}JP ztM5BncZ80QQa$p|7%%>DUgnE=f|o{JFO|zmUvksg;#lL_Jh`yzt?#2{^Vtz3|;RfeS`L4 zqn9f(d5f1nwrWqddvX8jrSETEf`_#a$Gm)f+{;sGddAE2-@QCO>m_{7%lGo-1uwt- z=_U7~@|Ww^yv)4s<k__!cXbA1$qbX;18eay}GQLMm+v8s=stE(#^*J+4imvZ+9Q{diYo@Yh`Co)$oC8=%X6srtItM zOnr9ee9##C#wH5#reX=$1-?`k6(u>&tX2A zf2G`{?{FWPBYfPEMI(K*8|5Q*w2!UQcZ`qpu|BTLoN+$>9q(h!1odU2kG->foSNg~ zow<6HoAcDW`8u{hd-ARNEX&2TNPYcId$!nzd8tp=U$o8|A8|kW=)Km*x}SYiTkoUk zW*^hH_^@qNyzM^9?C>#0rtbG~{(z5$2i3PD>gh2bE9CTXA0tj^Pfq$6en#iWWgj)K zs(-Tgy7u^QAD>CXe|${7sl5{8Z69^-_}Cy*AFGE?)U&5LZ)E;+AAi5_@%l@>_MeXf z_z6e&2^sw~5R1uAybPDaWtiEZhpZ7V zJ;TrPnSM$w(;CY)ccpr>$^kOpP2KiS@vD@Gw_n1?U()du4v7xTJyTrmv8^_bMtRM?QZyK{g0pb zZ~OWAj-N_*{hYq%r|bj8f2bZlRS%!}Y5CkwXIU)uUig{tQhj^nXUe~R&i$u7C%{%y zfXK)I<1GP-77Ea!aDYFH1W1Su&^{)>A*mS~V6;8JD;XXi;BZ2K%83DHmk!XkOn`UF z23S!pK$-FZUP#pn0U{g$Os;@_PbNTAAi&a$0QWKjtO_Y^L4ZY-1G?8dKvKN`-RcKO zZ5q(M;{pC?8K8cv0At$+^nFEZcMQ->Hgs0Zw*!po5+Jr`fVRB?TzfCT1F?S;pxuA~ z`{j&e4%8Zhw8qB);yww`=!*bT2CKHO0}L4zVBhEfd1C_X7^~dI2N)`ciLzKqtW-_Esiu9( zMd};~Fz#Rg4h8t+Xn@AY0(3tf;Jtq|?{aPZtCE7WtPo^&#UMqJ zgCti9(j!$dWTP{P!4>2K+3nSFe~?dPOJ)#rwqi-~P>@#PAdB*Y+$spNyhf0Q^@B`q zpfL@D)NC1KbgQ5~vkvmr>p>2-3G#ZoAZObLN$MD6f>iGuWaL{xUCRoxxPOp49|d_S zBL@VTB`pUA=_044?8iZtexfx82l?nr)g;x11og9OkX=%ESdgh-1+k6{(r8qWt@3zG zknlLwEt@6;^?Q~e#d(v2sw(OXKN^IU|T=W{})jLB5zB zYjH3OF|gBQg! zs2Y<&BiSmEu^E(*#d61NV7Hu+ zn^Me~!E4e(>bNo(m!3f{cLqOsGD!AjP$@^xb2Av)AVc?aXAo+Xfv0H({hDRat#yX( ziBg=mv}TtK-tC!zrB?=XWcS1jicHQRVtxj-7wGjR%5}MN{XT<%D>E?toI$;H8Ellx z>oag}%wW$Zt+Q3@Y|CKeZsl|=gEhx9sBj{Kd8d{CnG9O}oa+8ZI;RY=9z?AWYR=d%F*{TN&Fy_PX=aEcYY@0 z7ij*%OyZ=ItXP`Kqh*;yt&|Iz_h%;I>zT|bo5jU)Su`o1#hGeZl&g_N;rdzRkI!Q0 zge?A^k;VHPv-o*a7FD-oadm$du7g?3lA?cP(c)YdyX5j;SvYTGF+#8<*;M{4n+Km~lRG$@rLtA#kI3fsv}`hFWb>_T5c|w*B4=mQU`{rh z<*0ODn9YLkvbnK1n>I_bc~7ENW)rtMn>W^Eb3iW1qm9|bAIj#_Ilio@eV^%i)wehrFyD-Q%3YxM6z!RSr`|=g@d;4pYbF z@acpcc1_G7V^R)vrHfRZlEd(+IXsiMmgTT)c@Cw%&%rB$<;JQUe5-T#MqcgBq55w+ zc0}{8Y2Ni5YTwFX(&HS?KFMLms~oNt&c#(Um#kvBbc)TTa$K&y$K~pKTrLZoxs*uD z<=a3mi*j0A?3^E(Y1UYRa5gA(lSr)f%0@;O&*P9 z_v?Aw?372~tvv2`%j3kDJYE}@$0+$?eja-l8`H z&z|K``Gw-jI{EKq9`C(UeufZ5Od&pzpDiK&wT9?r3o*55i1Wol{3DZ#hxj8pME#f$ zWnx3@k)m-SK9ybZAqppkcv?23>mMOq^9bphM~Kg5Nvh^JLQHgqFs6kV>JG8r6C&gd zQ7Nc(GC~ZJl9?eoW`#H+?ejt`3WbOZhqzfaM4)^8IypTe5LNu)#;ujfO zUojgfX2TGz8-32eeWu-j6tDf9b52e}D5Hp^Ih7FP<>FBoQXMws-> zFg3HnjLr^IKR?WYI$>h#g&87W)em#9L74o8VT_H#)NK-GgE*RpdA~)NKV?IkFmJRA z^RBdgBh36a!>p9+9m2Rfg_$G6JBK;^R+!3fD}EQn@2dE+t9zKjJ;Nl*PAT+Wm;{+G zf4?8*u?+ek%rAYy9FoBwhWWLx>X2Uj!u-@f%!i-oad4QIUxu*_3FDPBQf`=PlM!;{ zt1wl*4%1M+l9&-;ULUDga#CEQl;7wu@ngeOl!?N)FnKacj*SoN+zHcIUY{6d-lQBTIMsWRX&AV=QHqijct?9=NG_nKm(M%jFRD>*u~fW+wq443aW7w~XP0e@^O z;MmCmN}evDlGHq-@xN=lxc)An&y4~;m&}_5d~&ORTT{3k&V8q(PoC6Ouk*5>+I{`zC8-!TEqir^8x<;9!ktpMu&Y!`$-*Uylq{4| zDyw*r6jzB-1&Wj^P%>X}S4!bh1@o0~70k+4BCB}*B8Bo5cDr3A3l(v@vI-O|1?(c{~POn{~df$>HlvB^8Y1hTw1z>2W6zfWu@^@ImwPANGmVZLreuJZ$-(C{kVx` z47Ip2W1?pj`c#*`Vn_|?ALOYeb-=?eQc73pGi=?Z?PH}}3#2GiK{u?&-*}Ab3#EZL zi=KO=Ue~1HVjkLvy|{~pSsogW{lz`>5baBNs5g3*^pJOH59LJfavrK%!9#s8<7W?j zYT+SMOAqb95d^pLPy(u>F(O)f=r3Hv={6opYU`m)q<8U9&z>Io17&)9=tUn7_3P`Q z(HPX9v4(nR@^IpV-v|%og?pTbye4`mV3LPkVf73TZHMnn4~5S4P&527&qMv^d#LY1 z56#8tn;z0oubu`q@iOR~zd@S= z4BC&U*$g@qXi%P<25rRdTn5$2ZP4ML42lmjs5>qO8`L7ipuNQnI*(E%3_4QEAkVS} zJ%PEBK@BS#)D|h#3@VC!uva&z6&9dt4aPy&x&}>dVo;Z+27TygP;4iIMq(Pub~dO# zK6l}MSA%kQGbkG0x*OD}2Yq`QGz+_tw-@oj+}EH6_!DpYF>il^3Jfr)(?El^W5*za zdxWa7rh zDa1b2pn}+m%jh)Ipzv7+rOq*E^<0DU%`<2yCc?SEpt!{baat>p%dSwZ}(4JwS2 zYpCs7gW9iSF63En&>7r7gU!@=zd^^5{{U^_`4??Y8uaok@m@E`^0z^5G{6wd!)i?Y z$DrxA3~G9tHAmVV;<#&2-~)qBVBaHy>OEzi7X~eSY0%<#4@Sj0_a1{r>vwu8{T4FHjxY4NW-bVduGHM@&nvI%> zyB4FIR-=N@!e&$rhf(bj=rk$}lko}V{ETXgaoC7U*coWlWrSrn>LxOC7&QfRa~f48 zmr*ZKB)3sr@dZIY8Px!DuoHvx7&RiusD62kx{dn5MxBKv)TlFIMokFkd3293>TQ%! zu4to1#TwN)f&0lu-FF#v%Wc$0NMhu8ubQ4 ziy5^B50RK<)M(5^pW?(@!l*k4F2ykfl{RWOR+KU79slx@M)}n+YCewQGHTQ`YDO)i zmf}7Z)i&yL9iw(MHtH!pVNw&~XiCm4jB4D{sIje#I)Hb0)W#@NTci5J(cY*?l*J{q z>S)xFPDbVF#+u@KccWhXZq&#gtWQt<{sb_ciM0{zm;Xkog9&cZTq<(@>*&pu;eu zT8=R4F~UX~b!ePX`Ny+&{%0~dAjcHuz|*PRpJr6MSw=mXZB*_#Mm5Fhxs0*EsOZH; zrK~WjHL9&)?Da+++i2AAO|0K$^4nt6>TO0P>>&P~F`(V`gkF576ql}-8nrHS@ zNgq!w!BVTIEOt*laCoY$ucw;gcc-V;qlllUa^&_@0=DCD9#3rz_SF6`Pu)So2%bZH zq^DjWXN;#>A}rQZ1>!ul4ZBi2H8a1bY8LQRor0bUEaIsVD3R`|aY)YaR154zW~Qf( z6!X-dWj$ps=c&%v@{6a|Huls(_%!jdIhGEg#~k9m70z4QGcl z$4F0wjwaU`p4v3qQ;p}-7p)g~YSKba6Ztzev6o1cQCOZD^05+j?nUdoO+L=%vI?UTTFS zoxOCso0rb?^wJIF@8zXaXx7_HUop0im%{scX$O+}dnp~R0bZIs&`bA`Hi&sJ0SyMz z7sZEoX)6+jdT9Z&{o$qI_!l2XcxmuBF9l5`ADqPYNnTns%}Y6^d+87oW_igtn>ZJ$xbj?d6 zuY1YIT=SObqlZ=Jw1luPo~M+{8%)&{J0 zdFwX*%IB>{1-$hy{wnCLPlXx3h_~vbdMh%`TXi#use-p!R$?5~t?I4w1Bq>fw_2mz zNaBKX6#a2!oVR+9C#GfIDzw~NNh`b+veH`<*Lkb`Cg%CmTP3!6%WIdn-21($xwqD$ z{!Q|J;;jWXljhq^>YLl7DcFUln3l(+r9mbw4mRlmW`&qkJCwHJCjEtrco1RIJG_Xb zUlhlpOw^);W;!J8DZ&Fu`PcUgNwk4WWD#@g?_y-e{O`3;aTqZSy(``}^ zPU0Glq?lACpGoTqnDn8bN#TWv7oUom^mCR;j^ZXQ!);_MVbZU-fYg#E?JY$<7+uDs z8Q55sc6fpQTZuVm87$|ik8@t;k4gNjv6T7eS3kPlYj z6Sn?pQrT+UVtEadmee#UxSmOEaUZGmO)7&ac#g^qmuyry?}sOMIb#$h?`V$3#^&cm?Xq?|bWzuTR} zu!r^8Yf_{ACUwVe2gnEe53v@1nbaG*@cR+g^eF3$eaG3`xP!?jOd58I{c)NY&X`o} z9DCzDwYk9BUo>g=W!B>=ZIFD8wZfm+{x|i#!JfLwenrk(tS#!J2R35eZIce6!yVQP zpYD<4eQFNt1NxvOreGgFqS`}pfu0Z#GSC9!@B%+QHSsgjq#SS9w+6GkjAjKR%G<0t zxP$U0v);ki$E>nwXEn>>Fl)ZktS9K}$1#7iCc!70SphlBYLUyV&tZ%gZq^TUj5I56 zv{_s5YqD8AFcdRfX7zWQl{>|((YTV&tPiN0->i9s%(50XD<>KuxrkZEkU!O|Hs}Fk zx>>K$JcF@{nN=~%ER{0Lj;6SPCZ(AlM{p6_%a}EyEP0h9o{DB(w`RSqM4Xk)>h-f( zU4Jp_muhDHUDK>#wanUwQ}~2B^~_p}ADC6&tZWU;3dJ1cX=K)m#%A?tLaa^AYJltb z+{~(EjVOS5doITB|*2}CL$lZq;<7r>|^fPOHf3pe> zFstQ2vtA-=uvy1(1@F;q2(b(`%Z-J2i{^irbppQ+V|;wZl;LKz8evv)H z#xXulp}~0Si}QFlftpODFS1QCYd4PL5jIYy?G&@x;}(WYHS61Svj)yEYb;hFVWwGE z@ffvd@pv{dpw?WoW+V4}#=xEhW*HWe+aj}8!?MJzN_c^xOU=r+%&cOlk4Jcq{macd zjb~`Pf;m^36}ZZ*B5TbmjV5@DnVZaV8RpPQ)|KRBr_6LeTAYU|nO5D%bThCd`7rai; z|0S=7*Jk~R1Gt5`Z>STF!upQ>|FTDM2j4OCEA9VdPP0YTEEY9FKlu4rlou;-5h+%S zvO6paM==~h7hj78<0FpvTVxNgC^rh>Fgj(kXdvF9W1vMPvs<(o z^IFsv&Jc^L!zaw5D!3PJQA~tIXD}zyqLny;icuET#%27A_R$s@fzxRgWlOgx6qz`VO2sT{jgqA-8jTs)f@Y;H>Wo>aUDhJ6aux+* zPI+R&_6io2t7uXEN)}zIY*FPZ7S%)NpDo&tc2zCvi&yxDuD@7x?pKR?Riid2Sc5q+ z3%Ag|CTmg4qKUPMqYiOk3+mOi$Xw5&oH)^lu^U@7wYf!$un$#RSkwSxTa#}a@@-4L z=-!T6;U4m|x2SLji%Q`sigdK-F+%#X7X2(5h1C8QIR-E$PT?u~47A8J!lI=pFv_C6 zm^0d<3z#&q3-=Z4_Eb4ZU*bZ5=9OVyN^a8O*s3(3pO8&SE$1&=2 zoV7hcEl;v9aY19WRCPvAezHJnz7Lxf5!Oe0E)!=XjYt$mLoKQ81X&P zM|F~X^ghc+sU;W-#Y_6=I7*cAQ4I{hBpk$Lm`eL7H-gIes9HH6O~esggkJ?84TmcF zCb68Z}M;q|IhL4)n^wCnhz{XnCsJ4&B&86)^a!2(= z)ON9tl9&3Z&@vzWw%kVxSNN#cN*`5RMa|auX#6H0&B5M3sX4lA@zFPUZzskbKI*vJ zM`8PX^a~oI+VOV8$nEgt?y?`wKb!>!bg^vNqp*R3MjC6>?h@@{?6d^H^oh zYgKZvRhRI4xK(*0t@;vW)v-9M>lwtwy9M=(5RVJy%5&Ysyf(+R;}rWvTd!ZjV z3CTmP%D@}^!0z;BXO zzu*HZO|fdkRN7(JH0Gaf)qJc)u9@VACfGa6s=>3#6Rx>dbwoe>HIK39Ta_JI3&;^; z|9894s+~B7jK$OzM^R&`Ra3ACtCv}I4@FlH2P&*&4va_cRjeE8uV!u5kT2%0wdyur zBHMb#!YXXX%MH|Pqg6vO35PaW<++($u?2?^yM>ye8+vSIpKP=0A&PBhjWHa@caYCc z@29kQVm$`!p;lLwk=7;xFD#4FSiv#)aenpIQr?mFxH zw^jLX67y}VqVBN&P!Hqr5C!hB5AUM#mC zXFL>pVb#wstvZ0?uUM-$R?T{6)q9k9Papj9!K!&5t$Kx$pLmQNaD8SEL0?!yw8m+K z{L5NfBYTETKhP}Grj?jg z)TWEoZK_?vriU0^)25EKZ1SmX(=z;9&!&FOY#N0xEp4jR$)+tR*4@VMLN=X1`Cc}a z=xx(xc=WZY?I4@B4ztO3icMeV+mv%5^;u+7ISj%b%v)pAD||!ywKnZT>^htJ;25IU z+thl4O;^xllTDqsGR`(?hVJ+WHMZMyU>CLCO+I^UO500a_EGEo96w;w_=Ajj$R_W@ zHeJW2qc$ZUv*{FmK2A(0s3$T{+7xoirk?0?ns&&0hI*W}={**mv&nVdrbF0%fp{+3 zwDS^ca@nS}SbW2#4gc6w@up3y@Z^?FH*d3+_iSo-pZuQLG#yKj_MEt1*whq9@e!Uc zZEA_#IDta1Y#NAh$o|@<=IDyYDDuXpGB|=bYz;WfUa?K_)x;3$f}w`l_AA=d|+ z8lxjFBmN^}VF^CM^AmN&VO&6^&-B9@Bz>Va7>2hf_ODIWuZ)T5c!Uq=`i;1731$A{ z7?z^qcj|!$2D_X_yINrR<>aM%uLv_fRy-u8?SA$9!~-u`4Uqt|$12 zJ8{IB$e1uC*;P8(uCJ)#Vh*=mi&N}sm*1{`QN9583)$7UFzt)jwJ+7K_%yplVM@AP zei?SX&9uu})UHeLEM`|N6wG2QbSiGw27EzMNxME^XDPdWFKyQ|{^SEx^|VVXV*!D)VJ#otjGNZcKJ85YcIMt<~Y_jVSSp~)ub8mwIDa_ zLAF-Rg*R>OifU)qIi$C@s~i^NS_ks)$l7%x=g#Ecg|!=L=e>$uW8CKsmnCG>cVrnU7KK-VOQEr z_Bh;g85>pS*);CPbA?@PSK4(I`&Zc& zw#Kexgsf$c!?}+Aj~9qoZ`U9kh3^LT5PsWeSCLKBd9z(7{v@WY#0=AR>W)r3sOwH* z*hQ^(6Z;;!n(t%%5AwP=O8i)K+^!m@*gIHznzguOS18KE<1+DJ7tUOv-Bn&YH<cr@^~>(i-5d^e&*{(%{DZVy4mHCLJj1x$4(-D!`26JH z_XdZ)!IH*Fm|9raf7MhP=|W_ z;n1(cnG30-94auH=f*gcYpjFUk3-AgJIAb$G5$&t!dcMk!99?}CfkD`e{Rr+x8#F=Q?!Jo0B@FxBSCi4Chp(2QQ%_&@ zLr5=QC1MDSy?y0`yN|D$qYFCs_0@XpMu&dB>Vq2n83)FJv`2e17~-pOfB5PnY7g_( z>*2mi7~!iTm@&#%>&E(O)i|D?=&RF{e6?t*uUbs=)nC(nwPL2Pwjh0$ub$8GRi3%N zibZoAhTnYVTI{QeFfH*_@^W7_#y0F*;j2?HtzzyqzB;tlR~J~O^_0`&K9N+1y z`+Iy<*`LW0bE`Wt>iJ#3y+AIk~pNsU@iI@6<#*{>iBi7#`x(A`}gE zYBrL>oEnKwm=o?)_6VnPL^?GZt)rZp9P3p6IH#hLnY*AIFPCakT+)bSd zYv$C)=1whb;nXt}YwgrN{6LX5IjIMp0ounI|Y=!duXW3E%~h2*i5I^h|9*+o5eJ2f6> z5WmN%!WfFoy*zh_^*ZcSQ>?^RJp9Y4_D7lb7;ARIsgzSrRXOccJMws)K|-F2!vdfwx?N7VVTQ@fwg_oc$~WSj5@t!-@J0_uQyK3{J?sm*Js+} zIXZlCst>IHI{E$0srxAXpHrtX^@mem&?nGO+wm97+5L1Rho6q-^wTAr%I&8{dHvKX z#7`YU{S+1Er>A%j?x$T5e!3dzr^QizS{LJ|W$}L6m*A(FDSnz$$WOZq`zf^u?Na^p zcbcF4GyF6#lew_CD05}`X=rgjg_Q8qa5zf&X)Ua!{q!3SqI6k5%_`@o&`QLD5>@=P z8Q-w_7e7V*>Zcjlk5@JQG@_25QhxJO)qZ{&Im%DJO!d>!NAwNx*RD{1Rgd-8G?%{? zW02cl`Sba!P=0@vtm3b#*jUwH|5o!??dsg3Lrs5mt?jS+b^P^HU4J|w78}ALWsb;Qhn(4}>ytT4vTC;4rgdYd8>FKL%n*K4H{={p~kCq?J zqwmM^@OgBQe!;pTK}tytQW@;UhLSu2-09o zz&AAS8KhMR=@q2)sMb43#}U;hNW)RPKW#7o$B{8ONco2ZDRF3!Qt=M;{|M42v>6_x z9@v2vBZAZwn{jPqkRD;$s36@K9VGv8K^ld*xQkbqIzC7rCUR_25Z84CX%lRdsS)Pm z0TQMJsTr2wAy!PKKZ2%FD-@U>qz+htJu`yz74b8JbO#G&u?DC;oA{7(4$mQBQIMuA z4$>mzTN0#FOUVJIH#`=(j&eXVCTlYkZJep~0abwLB7}ZuoXANO{i%=~w)Qizsm^NV)%Je_#xbV(^V1 z?MCjKL7Ib&SaT~#gC^wFYxqvgt30#wDnFW`FAgC4oV-d{kXOxdaA97#7U$LMuwZ>d zSVXXraS2J$!CDv_tbTF9Tpt>&z=U8O!<;I?`Ws_^4%S?>t{SY`ErYccY89+Zyn#pS zU@bwOHo@wKiTI2KZG*KAKJ9{45>s#+FHxm^u*TpFygLMIBo=fG)-6ozL_8?nIaqtp zuuHJo;Rr5aZr5NvL9On@^n0+bVR?^W*?R`-C*0{3thnC6YKr}RXy2C@HwLRZT3{mP z;W8R+3RVYP$M?;_%Km4t+T#yIZ3$K>dVqUu{hl({WL zJ$8kt%^~JJ9ip-4=nL;_A!>dm>M-uuLKW&8s!sl)dWhKI zP}PkN)yVizCFT#++VoI$s~f5^9YXb_N2tuJLsjoksQx|^stM;p6>}j}!IwgH7kw^= z>N471q0QA$^?n?x)h|Ld_*JM{eh*avLzs%=JSH2%v9ngE+mn9Acn*sWpOfM{Eo+TtLd;GsQ?Qx1&f8zwo!`2I(j?)ZiAo-s_9 zFx(xc=}1o@4m{5nrq=nxG@@Xbu48kNFtsSkSjEEh5zDf|d}KX*^z(4%3A)VM?nNrfxW2J51N=gsJ5pVOoeE!@@LZIB}uOh%i~^ zg{cJQ&ky6ASeRO!2;;ncnChJ*f1F3ksW3jzB9_x(YL4Dmjz94g<v!eC}{8DO^|4 zF)Lh`U?~&MIo5E^$6lx`$55$CxZ3|3u6|fsEnK_1gzM+-;ac%~xVE5Uk8u5oHa)|2 z7QK3fYY8^u0U~>cD<9?{sZY29`i5&7ZlH2M#>EwE7!a?#BlAJ5zgnQ;o62T zC^joxhhd%_t~fNs{yE|Dn-|V`!f+Wjgsb7ka8=(Ft{Hp7m2+RXnja0kR#od6qaa70+Ql7p?*qIF7~Wcaiq^ zg7uffbr=3um=`_p4_00e*L`H&2v@>Q;&~CyXDQ)o^oqD&hpXFv;W~!;iclXoJR(#F zEpQB#3=yh}BE|?^#467SeS())ga%=(H;?hVDMB605t1cB5Ah!TeIhi$8lkx`+alBj z1CefL9^VLkM!YjZLofkOzX)COkI(~D3y4r-1ZR&>Qyj_>p^iBtGyre#1FdsKC?t1; zPT~eC{Y0!-jGyyF=r^3hEvyWR&{jOj8=;?qBh&zGunNicpi(2whH(P+CTWre{(&%r8nDxK=EJpCJ)?mK7nN;yi~ZI9?(`S4%}GSLq0O zR)|nToJ5g|5n76WQKJ$$qf3(r9q1mRZojiOJsGoigsKjrjzj4?B0^KgM5x)g2$h}6 zJTqvsDnd&zYz;B(jZo&_%=eO9!Xx#qexzzOh*WcY#i53gYV}*B-omp{q+Iw7>yfu{ zq~>5de49k7Ej}S{(@538T@-8&OTDTuo-?=B6SOMZba$|^52Y<lh?N)c_Mv}ItFUZc|BD8&wm(!LQ< z`WH1vMJZ`?lI2?itCS}bQJ~uWj#h7YghZ=BXtZX8Maw56S|za{ljn*?^PP%l-9cu_Xjw}|>sh&I z#g>oO4LnEZ3eh@KF7$N-j9yft##2Vw<%gXP zz8{a~Gx=z}!VfGu8LeN>Mr%9jUL+q>ycDf^(B)`#N1p4%kLVlB@gQ3JaVmQZ*R#f` z$ekFiz&E7ajZr6D!BfQEi%~%g#X+1y`TH^2igpiT^a}rB$fFqTeH^0&&th~7iO*xy z1*_2ZMT}CpWnpqG z!nj3amAzQ3x@5&Fx_GSGl#0~~)GHmUws?ywWr?L6c~>OIt+DEllx?vpj-!a&!5F(^ zHRMXHp5BgCxks^_Z;n;!<5-o4?-QPX6|0EX%=so(1>VN$(Wh92evVbYFU0+CtTz9M z)k{?Hh*Lg8oR)gW={7RVak5(Cw8KA6pRp<+PCJp6ElzU- zhV6;dGz9I9Q?Gr*vOi7-PR2>6;hn?mmlC!RK*W|1wT_U&SdNpX+r>GqruNF8T z6R+xV@$!$4*ITqsU>>Z;DKtuq*Bb0Z@uYZpCdaD@ZXlm4o^$Q-`V6}}Ua2U9ak!0_ z_#-7=n{gmtyo%K`MA1Y9sqspiM!xut z9n<5rcP`Ik{k(YXL+Sa{bwRv(E{xa7ogCl8ajf6Vag^T2@%`~?cpzTwj>c;h8XSvP zd*nV&y-#y{hBd)Im~b{;%`a1b)V#u4;swfIi&xw0?6d!Ig_Y)NQC_#0x?Qw$UJxS1;e;M~{0_QIhR0Es-OVIG|#9>NQaU3=$ zs;^I?hT0S5l`~Oe;K-GzM|l$!8l0$pA&E*2P1LN&L|wz^s6@?1o#;e0EtIHj$eW(1 zdhpFiR4|snP&83n@uEVaqAMn9NG0a0oT#yl5_J;&8z*WU0-GeNbJIlaXqL$5;E7rT zpMHtji|fM^m2E_#I*m+J(5OTWoRz4Z$T=rbm+;SuM6FnvsCy{3I#JJ2aZjQ~B4cl& zD&YcL`xA8oqfR9182X$f5BQ%-REN`v`sob){!Y{%xOam(+$4^B)Bq(PB&z7cL@j@r zs4f2`>NP6;NaVA^MEQ9nsVx#clhna4No(+%f08;PTR@UV;t|efPm&`?lJ?^qy5&sL zGmOubq%R>!>J&tb(1s%X$_Jz4jr2$=`vooOj5~KN&1ZHt&^lSNvej@ zT^J8*dL(I3Px?+K|MLBl&qioTnqg-?j%DRJ17mF7rRS-e9rXEJ|FAz4rS zk~JxNvRo{voC`%20D>`qqixMW?%Jvfq* zWp*Vi5c?3HlB|aLk~KGfvVJX)tn-=48jzK&F(_P|K8P-nthTk2)uL`PenS#zOxCzd$qKubtRr`L{D#NxlQkPWuz~EA7(nWn6ss)1|rP8M}&0XR5kX>sOajtGl!gyU?PBOIfvCs)9!N3!7@Y^ti4| zW9qv!t|4>$=2CX-hkqlN%3*#};%n>DB+N&JcGRUkxpZ{#@0v?<`nvetoH@~MEHxa* z9H=p#7-zWn%-N-CFwJu5%UqXE%ya2)jGgb&$3@h8u}fFcXNgPU%Ut>ZujMYTwV?)U zU9xR*sl*Zb;RBi zz53?T>+jSE%YTrA+zRk;tCp8rjkCMeD2JQxIJr5mw?39}^Ea#9%8uS>Sg+O60456jyyc3Z}7?^aSL=E8rS-I~?a z&EGb2t95rb*RW9&v`4O<hxb=LvTMb9J)fPEMlH(}1 z7L9i6?ijb8j&tkOc(+0(P!Fs`^@(n+p5)f;$!-NtC7_w{Grn^F4R!e!#7t z54zRq5bJZ8H9O+gPsdrq6O4I^^*!TO%z3veU8Gi*$l(e(T_xY^Zbji7O8)Iuj~i}% z`Nyp{x82(D$Svn%x0+%uPT@LAJmE1`8GGU7nZoxWQuK#kil(8ee~KF6JaT4B(J&MUPElznBt=dP#F5Yx6%0$!gt!zf zM7{VFwZ%UOPfXE7^v#!|u_&8AMYV7Yz6Dd%4`VV@G#9msrl=*ZAvlZnh%K9<4&_qR z2lw#->&g=^##czuXOyUvqLX-peU($xu1bnV{hXqQnEgwN{C`bR18jz8HDbXXl&qej zq#7wY1XHaPm9I@3!s-6Zz;OaC`DTu6KAs&4QQ33+^wlon-s1SBY#wH zm!hF~iSq4J^b~VCFjl7&W#B4CbxzTIl;}bZ-Ba|fSBiS}PSN!KDe5$U`e7X|}By09u>2zKHP;@%WiQ_RK%_`EHwV(5m|c!sEVg;gI@a0pkEl*)H5Q#A`W5t5v$MwpB1$nHv2 z8|;F^ovM0R2al9gRly)!M*ecC{Jo`AMV3!h0qjK1imCdDE7eogwq~k6HRQRbsVdPT zRi#^{Y6uFoPE{E^!<;s$`Ws{0GCzv9OVwu-Y@ezp_<}z>q{^==bHmUrRsNWc58YF> z@%L069+fKN=u~aNU#K`HRV&7(s`srRg31E0U(FscEWNG))umvRIlnW~Hfr=`>xy<0@$? z`Ewfoo~Oz3OPZShn#SKlOOxuRDHYS|rKx`XG`(n;rs&_&G^A0QvKptUR?9R^#H&_m zTHQKLgWD1ha<@;@Ys~MNrt2uwJ57Oo(&RBbO-1n*h7oBRjt3)|b99=TtxD58d|ORi zYtl3sUTf2o_Gg;9;rx~~E!>u-$Y;!nlZJGK7}NESSGsa|r)!ZZU01B>^0TFDO3rjm z4N2EU3=2)yGz5jEt5}YpSN}8Rq_y zuC>VjYq};>OIMxh%+riHk=i0%57F+AbS;DD@N^wOECF*Bps2$$n=VBT9hS2gEY6$-d84AO4 zcvWIP7=Fo6I%fQup~}@5r#j=HehtRKJN#UWxN2v}+%`jJ;nOZdE!t-&PlpV-J7%Z@ z!a8Lr1=|qVg_tmPNQN$A*w743Ly12!bZs*2re(-u7SGMg(B1_Z`VZ?DW@sNuFUsJ$ zrVLeClA#r=GxP{E*ANq2Ycn)vU51LR&(P8B8S>tdq3t+^Dmyc@dRK-T?at7tBN?i2 zlp22_zvxUg$K04qeaG3@Ox;HFxJyx{vqp z%*a$WL?Ay(q8gf_D~4b)7GpEs;E$r2`Y9`u&*m~!s$?eb^D@<;3}cnc)Qs|(N~)Nt zgOxH>t4gMlCo@;oqMBnXrttB_w0%M`Rhd+bYsiYJ_tawYn_f)IW)xG#tYW$_yO>(e zEv6syifQVCVoF?8O#6beR5LhBFGI5UdwN-%pUBc0+>Oc7!MH4~NXk-d!7L?K$Wj~R zt(e99S$dAu)v{E)dY0y5c%3Z$g`Rb@Gy+BIWhqxv#)eO`Eak=>Y;2n)?{-=8Y)@Z& zfL90RL2$<`)rYfFmO^j{shzX<_clw-dSz)lR`<^0J!BT2Yh=kiC`*~RGmO5&vvmId zYPt_7C#ral<3D;45KwwkdIv#zktCDJOd!c-vrA1uDJs1xbt%%NFI9RKK@h1TARxU< zM>-4A1nIrKFYmm^IiHiw%-nnb|Nl&Yoy^=p3Vs^t(0Y76+M&(ZhkwU9)O4If{iZo| z3ngYcGzcvgIy4=P7C96~-Ng>Rdv|bsj6>!chZ^IvwGMUN>)`hWhrZb7P&Z88?@-lC z4h={D6o)pV(-nu3(B-N_#$AU7quM=(+(><&Tpl~LALCy-bO?i9IWz&)UOTi5b>BGT zN$u1!oJr&4+I^>brFCi-ZX%G*$-E0r&BF@3MxFFd+4vO=GB`B{l`}dOMt4ld$^1?o zE5vq%o$8D%MVu-E-#Z^Ubq8BYI`t3YN;&nUv{N0*I5iOm;VJ9XaXduf$}GoQT>gZ9 zsydmoG=sL41;UCXIYQNE5-@i_h&u{9tz?1$GuPPmI6PN&McoN9_~203HA+o?{b zQ^hT(K0&<%r&{4kQ>Th0lOJL;h!G=PWmJ2m*3Q%i90g;UvHI(77wQ?C$w%eY7*m&&AZX(#UD zY-X3XWp(KoMih4`O$nE}A{mGA2*Hvr&BiS}D&rRo10C7=Y0jSI(vC z1^Tq=d&JC$9!kJVLN8ei3=bvXK|OXsS)biRg5IcvI+%eKvI|jH)eM z`U6){v8781xQ-RATsn;gU%51~lS{v0e>ayNAai$@ilR0S;wfJAa_OVqXCkUwCk0jA+kJPsNv5O1hEW}#N1p%~WVGIBIER0Ao^ z4P|LzXkN_FZjArJVD4T+pR_a71gSe3DvyKR3}x(Ps0s=t8FJyjfrj!9V);-*6>)gD zq35Xmy`h%)4Jjx%){qlFU|SkX-&*RKVyF_#Ylb@D5z=3$ zp6}c+^cU*gG&o0KDA#R+@5&8D&=ZTW8QGuGH{8z*Ref&g1Zuw^Uo3rVC>4A9RR*`_ z=W#1vLAQKpkI`6(qj-W`h1{x(7U+i=_#J1!iA9x09C~0H{={vxF6Y)*G^yy;AUyxn ztzy;O%2v~@nz&!jtpfGk>gaLnise>2uUqbTw>o2TbGP0LyEQT5R^gaii(9%C{KBoY zt=+1KB^}%<+R3d|o!xSDb#wi+Tl>Co>mJ&C>sBw!f2WsQ&fabv@8edZzHW`jX_V~8 zdz?TDR`hr40scy&pMh?jLWLo2r5onfTJx|%xE!{p%z zraB-AOWyg$WS&4%Yw@zTsg8Y3?&mO7v!AIr9Kq8hQ<(;s+V!2O)5tT#R3!|8STWM+{l2@_q zYEu=~nhK#0j{Rn8)9}LP&F?C>{sRzik-&8w%b-+|l3_fV;3K|_Ybq_=SGPM+U@d}TRn%Z*A)PUpUc!D-3 zP0he-pP~NqwQUjYq?F%b&lr1z*Hn!=gEqc>SRvP*i@1l=*cv`4MVc$B@YN88GIbQt~1 zdsMW7M|CQ)4y!A9v={!$9?ks3qpejux`C{pdh{zwR`VzU|JCrQVl9vM)bq%yPv5wO zLJp7e8y@D*_vk~*!(0&_b@Y0)qLD|Nu-@lUg@8xxu?`D^9!29ldN1TrS^SK>xPi|T zJnDgiD3{1M_!0+j6B!%RFFtPKQGG;k4$o1fsYfPeHuGpB8aAgb#$XLjw&3Ro`Qj=T zMLpU9Bj!;{48zaZhI^k=hgKe4MCI0uj~i&y)}wz>_DheNV<*~uMNIhmYmZ8|^XPRC z56{rRHy-WAXWx1>a;Qi9M|d=RjEC=TJ(@Mmqe)vm+VUrPZ1-sKK98oHAjXsQdD^35 z=cxU8kFs5&4j7)ozQdtw9wlYAv?rUT&BZJgEn(@G%9ax9Tl(ZPi}T!;JPj<}z)Xjw zM3<$4h9z%PORi>?%Cxa`v#X^iSkTQBJi^jRd^pn594tq= zF_u1nZ>+_6OpCbyES@W1=?K0bZzG?=te7MO$>8O`daT zvyg3mBsP4u#8RrImR`eLX6cKcEp@@U6_yUHw6tWMrQYi;4MVj}mi~cni^VnWmNIO$ zRQ*p&29_byc5+4ybi$uF0qwAq6;2GnL}b}%X)H4DB0fZRTdKT=WjF)ZUQ2P9hMRbb z4EtGkz*4t^mew7!^!5Zbx@74Me!9#)K#de?fy`Gd^}!`nxXOAI`^VxQ80ve?QWE|{ zrRx^=99jAmt!`MFi!W}{_Likx$o(%hylbiFBi22(bRFR*#Ee_$@RVBP{b!asV?Ta> zP9HDmAF-FjjJmJL4SVs^YhrxEF^HmXE%nDb43n*bsca3zjnuYwrLp;5$W}?@OJ{2| zeoJqwX9ioVurH&nnwf0PL$=JezQH9VzGrI>s%Eh@2U)V(>Wi!JWwW&izV~hB`LVgi zz}B*ywqhUH>hPhhpRhBxtz3EN3nTN|dXmr9v;4Lu6tMMeL0f4H*_w)yg>9`ziz2o% zePrt*LPc#Y!F}v0Mt{YL6GkawFKugaS)1<^Y`#OVW!1FxMJ-!9u+FeKe?b10tKjJ?pW_tt3cFD1OZFpS)W~ z$<}mi#mUaL3U^`O;3QIYv(*UGQKh@BLOpD)Me3fm^1zEza3$HAh#>=PT}ICDh!s_a zQuC3vo?_7`_RIIw2{%!0w5={UgF$211}n!>r*XFC<2*E;SKPve3AVN++x(72ohMT} z#80uc8#Sl0|E5u^=^U>!$#1sJ+#A#dMdol!&$X32&({0%ZPiCZO#g}ZOF52lY#FgG zXWwDp3R~TN;doq0J{bP1t>gG=m8}!#v6}s}mb$Iu^YI(?-(V~6@3uy4BDc+qi7tQG z%+o;3IF9Rx-$ESQiGPQ!-aBm#L;qd2%I@Lwg~fZ>U;7vb7xvpqf56uFNPEy$(qZDq z@5lK3;=L2>=TpRa##Xhnw$7ciRpJ829o}I5MLsi^IG$6;{|d(xW?!{+^dDPwuiKh( zgU{1VTW>MuUyhyI#DyC7IliAz%cr)g;|*NTIKH1#roL3FXdvye- zD|pqsl2^lV7&|I^dCm}h;TPOR_NrdBMb>IwnRr;!tGczks#u%#@YeNe9g5atY_!J^ zJVCztUX?_5tZ{ht0B_OE>D7LCU0(fxPYlLJMU!o@9xvhacr^ltklLbue1%20fg(12 zAsK%mmzR7n2HWu(wHtcX6)SKBc^i4v5JRvFFHzISxLA)jsO|SMC#hGfaT{d<)DyFD z1|P(E6~JihLaLxwb*5VF|hP-NmG58aYP(FdaF$+hLAl${C#c-Q%k^N? z6jxC+>{SF)aTHl1Ub)Z<%W(}wqV$7g9Kwe&>eR+7yNg$aM)5wUPi>p~v=B{N_~_rK zJMcz$Kws3S8*P0m`K3>P<0d+P<`-WZ>9jPf&gd|Eourvb@6b)VtWuV_8fryh8LCbQXQ zj!%&dKFxstcb}rT3dbg&N^SP(zdb&c-%AX*i=O*@I=bJdVF!GAcF3pdhlw4}G2kzs z&K>b-{892d;Zto)J?T^Eluw^uVhlXHOx!6xCExey2!=fHX%g~3^y%A2K6QG`&uRT? ziucm_RRHtwCcR%}Gx`-@+OM=_{5*HWuT^MM-mji`iKZ3(I*WVwu99CFYx-s4IWpDq zYaDLZ_H&KBU-w;pRWkfa!2|Si`+44?UzxV~v4SC|1{~61kljjTCz4UA5D?js` z`gQQFpX+%7nw2`BC20a0oi?D(=>iI645(JtfJ$WxXvO;hZO9(b@DBo-{c%9ivH{&M z7tq!60iCE2(C&%>EvOvOlurU0TP2`>s|9qVdO$mB1hlaxebx%7K%IbYVq0DMas<@C z70@jspf_efKY9W>Wd$_P4(K8#dIOq|(hUO|+9<%>*8vs60OaW(P$DuW1(X-F@p3>w zNdp5)#$(KzK|h!{lYUTo7X8eo%^dncPwd;s`%T1${RnO*&p*g<3vG4>bP36O$O~om z1~hD6K*s)na$F23fYg@)%86-se3>y*sKfPu(%lGf{dPcm;J+ErvReT)`Io%!2J{xI z?ge<>KtR_0fEGPq+=l^;d`4UJc^=RxWPcG*$Cm-+d&O(2I4wgob(}ik5rS#s^cvZ- z#i_viacYchaAuEFrW|p)hg!Mgc=kt}=3udcDxWH-T8LnGnxG!yK-!>krwb}6V^AY< z1$7n&uDc9&!~3GN)Zoe|;3x1$_B&P;H6@br5HY2lZiFmUp7B z&OvR&(=I{f_%^6wgM-REGN@U}L9Lh+RL*(ywIHZoxQ-J)232@%Q0=g0V^E$=L7x4> z>z<(co(`&9>3HpE8m~WE#jALmcxCSyuX;=3)pmQl2BY)dcztvvUbisfXuP_giq~V* z$sSVMoFNs94{75UA#H0N(w}WYN^Td@0X*#1!*L;*KA1tHyEM!y?Fx{D*5Lh8Obq+xi8{(pqj zb8AQ+ZVRc>_K+6sB&J<#i}&}0lx}ZGW%h;S*dJ1@<00if6;fHOIv3J+=R=x&DWo-6 zcA0TfLK^!xq?yk{a=!?v)60-@z6!~Y=@^?XLG#{APzrv{lA!jj6Lc6aaB@k4#x3O) z_m?H8-OmZyguE*g6k3&_FIFe0#`*-U!~X3Fs<$IS5nR}rpz6C4v>3B@CuqW+1bwhK zK~L``DDHlOx@1aJo(~gM6YJ0^SE3dpSDr*gu?m^={;@-eDcWH+{oA?=GyL`h_)YKvDmo#o z8k54BH90I}T9|9P!}@tfSpUon>*hN8Ss&Kn4PpKMdsvw_hvmSSEn#ih8dk5}VHG$Y z)}@rNetZztoQGlV*$8Vxnuy$KBdU=hqKg=oEux0+NAzFzh;rnJ@cCq2iHJ_QBl^LN zXreEo6TKp;Iv}F#10(Wc!1RdD&59`h?1&EHJd)=`RCaDeSMU(8=S5UyA^qbbk`_gj zbt&(0V|7Gz*FUFJ45{@?}Jw(?qo#Ez?HT1s|r1>RkG$@@I(ZAkHH> zV^mc#MYRQqSy+xo1)>TTj4Fyl$XqBY7veAzr;xpHRD}>L8r6wXQGHT6s-@+kimwpm zUe~C;c12Yy7}dpiwh2X5y*X{6SX3i1q<2)Ov9nKM7j}CeU6c%$OZMrMAa7+$3|5jS;s}0^FFHH*gi2TZ*r9D$)h@p z?X#mwH7Ck*vZC67K69fQH!sS*jOyro@>{?*IEEhWjfUUH)Dy?CdNh5FiRs4pm?lh!sm8>ZjwHuadQyz%g2r?gO((N0>P(3- zpMOkCaRMpGJvF8#XoEjdW?D?Or?U)uX2iHICMG}nVgwGM(5#rsq0rozmf`(*G2Ov{ z`7yo3h6OR@T@=$C`NgADJbF9Z)H5}B`QJb0s4?GMX`g1wz#Y3=t<5s1LWu^$mS31WwN-^Q VZ`0%%(C^s)w@dT?4gT--e*m`Hm0SP- literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/a88a45ac8c2956c3_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/a88a45ac8c2956c3_0 new file mode 100644 index 0000000000000000000000000000000000000000..6b8ef2599a28c072d41d1706b87ad16ade08c2bd GIT binary patch literal 18848 zcmY-1cX*TK8~6Wro1{s~Y-u_`R-vUyvy+yNq-F2D1(l&7$WTPK1Cb$n?>z-UKtMz` zGL^kS1eK}mz0v3M{r!&TkB8%Uk#S$wd7jsKg*Lr&7w=mie^a9S%U33#lB6XyuA>_& zRH{2|;!>C|(^pH-c4-p=1+iBO9e^Q|Ksj zq~meuE!TvTP*~g8z6aOoyBI~4M zWCVT0Ylxtdd@lox5sZ@RrU;tLUKweQV3stuM9@)AOKx-o^(3l51o859jnSJIxZ;hR8%YUp|8UDG^M!NAQOuf`;jeEgPh}GlKHo2#!~bAR#M) z+A>l=A{bXSf_Bv+NUR>gJ2kX6@z;vrsKnQaV5oGi8^Nl25tOVS z!M+BnuaVX*BV<=It*u1_{bbfV5&YFwb+?b;vkvO7To(I#5zLVFog#Soegs`RM{u!A z1Swq=tGoI=If6-3A}~zV`sPM(Zl3C#A3+QGctHd|E!6$R5$re+f%#AbegEfd1l!I< z;Qmc}CI^3ypxDI-zLIXHNY+I~QqCNSS1wD$HIgG0BFRsSq@J9Y)6Ph$xFcyO$=*o*@kKJhA4$h*k^EjglCNq+@?7$3MY2kY z)QRLX*;O|Zf4xXvHIAfb(@4rTi)5+XY92|O7Ljz8TQad_B>h@N67{BXwvJ@8JeL-2 zBKb=SycNj~IU(01sa+(g(od>(h-AM!kdNPuWJt$IMs(JkE|E0;Ad*5KsopV>c*aE% zlJ~|(k}x5XwdNNtzx>U`8aBq~YvHE=tJ-ku+Nr$)D19 zNhC9uD&{wle6uW)+sh+)_xnixSgYrLjO64t)i3LIMzU~EB$<0787SY$7yBaFvpJ?DjT;L z_-Lzv>*Ct3*MRV|_F9haQg3(b^{_{KwpX?8Gf;8Afx5?3uVkGt@QuX&uHK5_qH33` zcMSBnYhe971Lf`;cqrKq)dR_RY+&FM17C~nsevVO^O;^RFVypbMiv$_vRYCK8@XM? z$mcOee6dC<%Nlu7%&6C%k<#%-h9ns|lWgQtnh{UBk-9D;scs_$d`6o1jjRnCX;#t5 zYw4I}Br)4anoN@mIY#Q`8tGBh$oASsTy>1}s;gKsp@EUihDK(~rA9{XO54Up3N}&P zrbc$kVX4)^NOQR*&t*VsBkS7e_AMhxZyVVy(QS?NmrvRm`MHCUhaHvsebv=jx6ixk;iw!y^cYidpX|s`HTa4_L(^7q_kx|=>ypYtr zTAOU#XQaY@BSFdhMRoqFI^~)CbHGT?qegz0If6Me<;rimO`E_Yj-^gYMK)OSt1mNoC0*dd;dCVF==aYg!cHE~)-bTctS zEZt2s=wV{3OzUN$#3v@&_cn1<2J}__ekR6C)&3@$%FkjMsN8bqQ^lTS;dhufZP6TAyjAme zn)vo-6VIf@ZW9aT?>&0F*Tg&fOstdV`%QHIMe9DK`VMPNM|50F$4zvQWhYD|oHP-2 z&O~dO|C@;-=hd5w8vmz>MzU7Q{AHrkB@;C+o49k^#20r=`0tviBHzo?dnWeWH{pJ4 zVv?MDVxrbl6E~ij@V+oHPnQ3yI{q{9N6m?BeOo)oo4;fL| zDx1aNi=t*`6g#q_D3BdRD_J4;bE0UM8%1nh6hq}eeiS*C zqVQFTBC2W>^{PejrWCFo#TYqJBZ?|Dqljpr*pkyQiZhL)=-MQT@0&(3rFj$!rG6{T zdozj;TSu|HO%$!$MG9 zjpE+EDBAAV`VU0W_@H_rr=;WID3b3+(dAwgedLDt9z?M~&Og$zCsBChji*s`mQ~N9 zDEVCLe;LKCS5dTi9mT;&GnEZyh8xX15v$ouLyMVhvaXPssKRFI6*1GlsF_1jEY?gJ zaTGK2y*!OG^G69YugjTfUEa+66f;Fq%}lMJ=VVQqnH}P>o9XQ^b49Y98YfL%X5N+K zlIT$l65%t`SxWfLq{~eCGoYG+W=3Y1c`hq6&1{kMie`Fd>A1WRHtW5JnTmO4YRU$A zm2akNB{SjLW~R%@jomvYB32%=~oK zOxiWAOTLmhH_SAX8S^HA!d1WS3 zCcHK?H^Rd2QYX^Fc!LF((L#Qdg;8?MY~gCO1z!OReG6KMFKnTMEGuFmp{PYaLt5A= z=3*9V+AK_xbMY1qC0HnvXrWV*g|s&;OqJhDTKKY*g@vUpyq2nEEv%LIQZ3vRUz&ya z@@8ENtK?BV3-8vq@R58Y2OB6>L*;B_;erfpV&PY5(A2`Wa<7?%w#_Yk(b~cZNqWn| z*J5gGp_R;SXQ5Dg3*U9J5b?h1?QCI#eDbk{9TN44h2GM?w}qB{EJXLUXb&xnkR$yp zifWU|Q!U(`W+8XF);~jaN{v|- z7Rf)eRofg3{&^NYm)-L%*cMu7FW)S(@N}_-j!P`8SgKmSvEY$uD=k!CXJMmsU2kEa z+z{^u3-e^XOxS9n-%iye#dcX3EGfIS7CEvzIzHZ^Hr2VbF$)T1b6tVTqJ@YGJ7idT!zL3%v$js{U8n*Z-6QD?K8t43yubVx*PN3|2Vz(0MwX#r# z`K%oDTgeS5kGOKIEU#z9UEj(l4XpZlWTky0D_bP8iRx~tv2R*AD)DWs+-k3UA6Pjr zWxH7!FWb6XvG=g@;fGc(N=i@F@QIaI(x|spUwf?j+GAyh1p8ST(BH~GQel9VAyQXmA@|2wX*b?ViwRcN z$@7U?^9(DmrRprjl8AX$y34xxR;Deq(sPlO!fREB{JKtcthch~2P*}BRGqSIqm|n~ zX)iV_mRRsEARYj<>Ub?#Sdu@Wv-k!tUjE!vQ++%yJxNBoww3JKKb3sPx6bz zU9eJKI$X5!olN>euNPS-wg0p-SyujK<*7W2i>9hAn)+p;nJ$OqdQLR{+-N?NP<}K= z<)_NgRH_n3qTCO0<5 zknvLtCpN`!WOEF~x5Q9rYYab#Uc}szlRIK4y)%YcKgTd?R}9m3$1q}F41@Q_a7eO$ ziJ{kl7`Dkb2V;16IEH!0VyJW?hNUNCxG(loG3@yxhN6GQV7VMaQwdy+q5nTIthy1y zbNS_F425sU@TSDyiJ{Mf7`wNNqsl9CmQ(Ll~sDMtCK#i-T27~KaH zW25{uxELj-6{C~*mltEsnqvGd<@Xok^Hat6MJ`@1#)f~25pkm!{qGcG$jf3Jkstmo z#>)SS@l@U=j%|@~SPgO9G{*6-DUMcAaV!$EIga+SQi@sPh>4ElEh$n&<74A!CIf77 zv`dU*h1iS7@o9-T(#yorN6w_i(ZvzRda0Kl#{qvF@qsw*XU7rBiQ{T+9H;W)_@a3n zze>q>;@I3Fj;MFzI46rc$8lHQ?j1*kK5-Q48;7@l90TP~Sv)|oK3A+S;utk3j>y3p zE8l$;N6#T~Y>}x$<4F5Dj$V>CDUQ}t<5(h9rp1vvBaUIxY-Svf=ERXdH;%FM;xH|U zqmgu3s5PvJBYCCP{bL*xx5jZnN^Os$WY_hRVGR-#nS#0bQx7Ehu!Zs=uu`#}=jiNC& z+DMsLo8GJ1=q)*MHip@39FscnHqJb6pS@7U-nvwGO5@u7_g((EG}Nxf{mCtG{lxHQ0qYoLvGpWA3Y$i{q$ z{?f*|uWXbbVq>+;8e!v_{58s^4`>uyj!&{NYQBxr(q*xY{@>Wx_N@);3L70(+Awdh z(L{Rvs9c*AM=V=xOx>n9Qh&RRA9vV@+^Kv&+jvKo%U^P3w++u88$0*e`1gQf9#!2k zT56uMF;RY%1;5$2CFRfC`2CWN3YXQlE9&hX8y#ilT^kP`*(mqYMqfj`PK(9!LNW@) zGf2KG9M9r}c<##Rqd{YneF0f-XWe# zlF~7rk7P!tcs~6go_*r!9?w+yOOkrTvr@tX;`v&ReHl;7A@MAf2E&wlxayO=^3KS3 zmP_A>@$6g@Pr;>%u_B)StK!)$i`K={czryx#jr`e*%MEpz44Sj7*DA~@pO?}GWCe& zNv%^_>*aX1O1&HLB;SjtyR3W~&z6_*m|w-~eN+PP8WLC~ai#>SMkg><`~?!&Tr7d8 zxCExWkwE*B39OWjr4sZ$J%QWuyi5Ywq! z2|9<9zy>`P#f z`1h*^2NJj>?G7d||8N2~rOy$KJEpbC*T)lBbTWZEvhkE+pH3k0OahH$`FZtA?p{b> z`jZ4M%Q_NS5SPd;>FrHqha~wDX_t}6K8ejtWTw=sn8+pRo}Eaa+(dRty^wAzCsMFV zBGFY7DO*=@8YNP(aiY$ZCGxsuBDGp2GOTqXr`}JbOy@+5Jrc?MIFT>qi(Y!JcOqTo ziM-z@k+o8#Zz7TX5_u#g1}WxOia8{aXTuWdG9r=nl0Q=M$146fJwG9lgHsbpn5MZi zbvrka4)SVVB75d1QglHgZ!FYfsktbTri&BVRUwJOX-RlJNi@w(Vy^6|nuNJp5|zYV zJ&FFZvqlmJY9sUC&hIMAoO@-7eNmRT#ZVxb{&C6dmVX?{*nP=-BBv`SGo(r~^_wI!UFNkxpE#oK0rEw7Zr}gGb5CkkjUJSPGP*sYEB0<5kIW)GSpFhrb;0 zoy*Z)77r*#z0b=rO-hd{$M^~5I4|AimZQ(sa;%VjJIfLKvtk`9N9}Xvm@E}8mD72X za#X*j+nDlX#+GNwyXC3!L3zeVa^Lc-mKWmhSDrtm?Wpp6D?K)s=f6RNE`{lmRVIa-$th%(OTkq>MdvQ`SOz##2zyf4=}qCKFNGTZ6c)+6 zUg1aKc(p3Knne9q;S7>3J>e1u&sge zG)`e}(-g|QnL<}t*CvH3Z>Q)pvJ_f%NWs}Ng}&k%sNp0iWvH#db{;+dC1p%scJ-M>#^;Wo{e_xGew>R<|8#Cs@(x@S_D zD!qSCA?1%0K9Vz6Quz70=Kr0-Z`%-8_DkFBKa#9BWqPl)f<)}mX>trf5Pp2|b zo}Npk>7S|0m6g{u{!S{T@20Znc`94psDQa-1^%d5fg)KIs4vr{X}AJ&rCa3+{Pb1@ zjBi(Kelt>=GB>A@jzz2NMqZ7X&58y^pZicR|*^KG&9=SB_|8o z`Ld9meTD607O}G-(a!56JKc-hnO)M(}(ZJb31)n*tsV6+u4b1Z)b}fl)MghhQ4d(vFz?*=ah{5z|K60>1wA{H@iO5 zwo|mf>KUMQ%JI+bBn`4NLV6Civ+*lCX+!KR``WH+!|b#jY3Ij@cK)4Yr^jSFv9s(9 zo2@m^u@jza=h-|v`3vm)y3kI|Wp>6c*H{_=f9f z`&)H?o9=Jdyj^xIyX`dGV`sY*IHB|DK&3IrG@g^A~oaU#cf^Qfj=iGv>ASR+>gQm>KCH+TdVx zw1X1`98@jnU}X^pZxwa0D8`}BDjd45$-yZ(Qp!Pm83)5;VzPsC;4*-+cT>pBj)*LCni0|)III{2oM#y55_ zr-_3rO&z+9!9f?(-|ZWB)f1r%VnF`dr{i)&;ya}?OlC<` zw{$-KB%QA$+*{*hyF~R(r;m)1C!eNsdqg_HQR$o*oz4}RJ0_h~^5LX((q`y(W;%aJ z@7animFA?=NPZUUymb1@Sb4r!eOi%@>AQ3mu1aUc_vvhrK5I2ko=N`tbXLo5@oY-x ztsUym&UA|XtXwi_Upfm8r?XbN9ZBa?xg#0Jv_De&OgiJwrql1Ybf!H>=i-;) z6SLFFM3j$jLWSGT+I2m7MgH+Y+qeLvl%Kf9T}cS56X#I!Tf8!<=*-?&Q2= zjBxVlNGBuYp^P5wWRA2P7i$W-C{xJAwKx~9co%b|Y;hNz zOSt&=4Hwl*xj0(drO$R;oKA63Bh^Jpnu~6B7r)B^hl^OJi@|c&<08}NVySGF2Ywej z!!9iOF8ayqS}qFLcCla1N}W0`Ce(EiQO`y11}>}(T{LRsVuvhh=3;nD7t^IlD;FK) zq?BmwVwBvH>1|y6@s^7hZCzAuueEh>G4OpCyE?nDf8^4&OfIH8-l^x|ky0 zN?v~#O^3LcIn+h;FcaYv996F-0CtM7ZN+;DDxqC`={i(YCa`Dy`7Y|>#$oW@ml6C*77q~G; zxEU^oBi-Z~+%5nn?`2heH;)^*>DbWCxW;ZyH*r&=shdS_xw-MS8$(++ zb=tXUDPOjC>snbiS?{V&InhPA2PpSIx6XgL^?lz>{!lloW!G>w(Ieapkcp$*oEzY zadUF69?x^rcD~jvV-~vUu*l8w#cq<8xEUy4%g}G#99*G2Sg9JM`gd+duW~a(O0IVE z-Wv65gZAu4H?w4!)Y$0e~Yg%ubZDGVZZk7 z7wx|+IOOKZ@$f=E zO!ly$oQGe^dnlUf;Yhk}Jsw(mJ?xX~eh;w$4{ruNB|uVM#^ihWuabuvRTQ(T zNAFoZRI8`?^*u~);o*;#9vZe%4Q)J(d&@(E4jvYD^l+n-ht}_VDBHzD=MOxbl_6a{ z9O&jDx4VZTA9`ro4u^EcqwJ|5|Ez@d+8JBWw=zfdG)oz z%Pxsd@G?N!7WcBWgqQd?yc{U+B{tQ|VENRkaV{^*Jznm4y|nXrIT-ZPFT>0BOs}rB z_VSyQ&Gs@uKCP_rRg|-;mz~n2nwQ?L=p zSJ$z4srrp_O4a3F)=9xNUYdTdyzU`AhZ7^=n>cJ@9hr zp~gS*^2Jjxd!H%azh3so`lwab$GBu4|H-ZtAJG+j43OkBAFCZco}~Nu(&Zz~=hJob zKK_trIX?13IxelkKIY~5D3b5PP{qd&@~Wzj;njVVuj`|0Js;=gKtms~jeQK3V@-S{ zHuJHlxsNt&eJpI}qkShI&dxr<@>I-SeDs$cANW|-P5D1o{$9#22YUPXq>qoGlHb=y zL)j^o{yzH2+JQcvf9j*lXR7rJ&HGY$hxqtqsE=mDef+)1hi8fEmcTb!?=l~zZ+)~~ z>tpFUAMxvb^xWWMW%tzh{ zAFJf-NgpFmX`QEij5w#>UiMMrs*eq_|GIkhkB={;!A&1iZmDl~eAKz?W0OpKqBTAB zG3=RoFAHDz_~)gMH(%+w|9l+6PdLI)$l#~Gn2mlCWP}_w`Kc7;r$=EwUr2TlKec7E zM8^2}Sc)h5NtdhgSl&)RS#u za{K8m^8$XZ1$8{b&z)>P8M%IzNc((0%PRQ^R8bAJRYP4rW9s>N+1O8&rhe8+Tnj&K zTKYL49a{T!J*uDJ+d9_4&+~Wv`n?%H-}dx#|6|4L<)_I&KQlh{Q~qF z98C;RDJj65k^y>`3h;jE0ISLbC{;GVOQ}*WK!iPj(HYS1Jp_mj1o$>1!2QesYeI^f zA7E*vfUY?XkX$!FmwExxngnz$ae&`j1gO_Cz__*neGOLb_5n7%t9Ts)jP4X5u6uws zJpx?&Fo3OJfVcVwI4ErgD(0sF;y(+}@XG*G2Wu@~2N*Isz=1IVa>oYPHBPlm2rxjt zpB~`Zi~yZyY8|r!T$vM~*<7u2et?q;0#sWVp!nhd?Uw{NCf6i#sp|VCK)K}sCdo1> zwpwfWRckm9;GEPx6kz<}02~SM+3^64P6X(BGQfv7HSbP@x%@Yzp$ZOp@Q_aa52fbC4Z!RH|5ljIajjT{OsdrGh*v9pt?-LDnP( zX;Ci7obo{mr36W-5Tsk0V#sDkkVt2ck7ch{$NfP*lWmznOj(L0MMFVahJ!543vxR@ z$ja(L8q^CirM|{A2vVa(kTETT`b;#)@Hc}TZXM*!w}PB+8zi}Xkcm?5-5{gh3+fz8 zkY#;?-0c_Sm5k~iWVW;z5TuiwmC~OE`SvsA92}(IS6Y))9TL>fTtW6o!C^tB4G&@& z6{O+lAlv21*dXEYTDNSO7}W2w1u;wxvQ-XA{*)l|<@!{`ou*^cgT%>UxhRchDCW!{ z=2<~t^dAZ`t z3|Y2PHGY@DfYlicmt|`+F#ec9-HjP+mi==1rwkmMGngs+wq$Tp(zj+{+O9Rp!5v!D zPQ{Qj^6t+WjFBq4GH5QHWz^mbrc2H*8Tvi#4DKD!dJboBLrxx1KTl+^?qmk#PG#Vg zp=UCfe^z^NE`yf8Wl-ay^8KZCMrBgglF3SICK1ImsZ}DA6K`blc4j7vD`s*wJCmVJ zGdb8SlThFFIql)w{m&KOySvtR$#joxxV!T;=Dfe@; z$O>n%OnO$!Vq^6z(rRQ;vu+k+>t)fWK^CjKX7Qw(#`nl##AjI?{XC0GUu02V9uCSP zXK)tZ%63^eGK)LYv&fj4#S+;hwpm$3&C&R|S!|W#(sgkbi@wR?#Ee+6P%Yf0)II z7g_pulg$}-Hn|nEbv?-@NA}z$)?e`Y^IIR=JSc!?3t8J#^h}3NGGW>HJcIB zvUx7=t;lA@%4|w}myK5j%Z)YJ_||5#Kwj_9rrNJMc1-iGY2Nj0YTeFe@{?@NKh0+5 z>ujzT%)wbWhl)jV=n$7frT83uf6meO=NuL}awwLb!;(M_OS5yhos+}JP!3}|C;bs3Ex(>);=hz%9<8!z^HwX9p9Og>bH94&PK8Kz^=FoIo4l}ps5WORZGRJdx z|3nUFWXW$i+&Z7biobH`do_n`*EIin4!iH=P~brh17%u7E*B$nnPbW2-D0_X8<$IQ zTdrRBx-FH^63v=1OD3`3o8oxA`!QW_%M6JoC{`a{Q{84$&=d%8CE=R89a{Ov8N!N4LOXd3~ zm(@3N*&-Eh=JNTiT<*xGJGn&M%cZcalE?RR>G&X*=g)Jg^ipwUqx|Jx++>|LrL;M~SqF!u>QgI>nN#XbqpUa+v5CxM$JS!d2 zd5e(FRfKe|BE%qBo~AkW5R)7s4Cx_;xq@JTpZ5iXo0k+uRUK zLm}eBA#PO(5vUeokyNV@VpPo#FQq{35KZcY_*sV5Q_T8`*&sx#h9TxP3Q?qSi2Y4; z+bqNvGOKxrOD!~~Wr*5uhZz4(2-=2N-7dtF_8~fTP~1)-s&o#qR=Ru;Volc&Wx9pP z?-^p)#~LR^`-N!PU+b5lLzH)@@(v5Jex&A)3ek16dNp3Xnh@e2sX9?TnH1uMd^AJ- zof)Ffe8pU(n2Qxt3M>h+cx8yaKWHC*)IP}2jf(w~Vs8pDc58@J+d@>|9-_|f5EJ%< zh}auq$bk?C4u-gPB*ats{%DAu((ZVOMyJ$IDRDYPy8L=3M6usOv_7x0j#4Z+EzZ%Z zZ%mkkabe2KBw>7*Tp2AVCWQ6c3DZd4oD^pMOG0q56cV?K) zvR?+yQvI{T_~(SlmnQSV%$Ogh)l%(|tX~!8 z!W4R{vCq_N36{-cU~(QgX?ZwmrC%VVcF8|KlgQ687&NRvF`o8>V~ zCQ0)adCYE^N5NKk40u!HTjw#TT^^VE=3(!j#|#-cEstZ<^Qb%{k23S~cz;12XJqa2 zJf44>N0$|OI=`I9@SS-)m1|e?a9z*C_D>$hQu)*^ozLkq`FxX_&z%bSypxvCn~r?u zr{^=kpHJD2`E>4-&sn+HJ)e{h^O+(whU7D5Xg;sy__TbIX5=$MzT2A5qiy;8z9XL# zr}HU(HlGSord9v&#iI!Qw>k$-Uey0G^Z)<(c;l^cH!oiEXUF|re8cwF?|k~j d)WOc(f9|MKXi%{9LGPgdJ5T>3!T9eP#ESw0dH;@~Za1|+b< ziG8?+->OJUs!IFOry6}~NuMyRw)8Iw)s;HqUUw;_hx7s4#z_ShNZ8i9S;Zn}p~Id1BQzPWDlD(j{|^sC^e29?~@A2Yvq)BDzLGPZHk zb{s-*TQ?=37MdZVotqBgJWjTEQ&I;vWg@-1oBH%|)2}Gk&rMJJyJ_G6H;uuNpNaL0 zo2HB)KlqJwljkHi<(cfJ=U6q9Sl8Ut`<9#TKXKDrbbRWjHK_N@OW1`x~a-1 zH+}MOS94Eyo$+_qrabQ2hevtcbs)f9g#z8R0lNygtA0Uu{q>!@;)C4P3+IE~)jGso zd$Qei7G-kWb*PNH9+r2PsfxRrRCQMeq||g*Y3zlymb=fXX# zZ@aiFwyV2FVLHlpbJx%K(4G4|+*PoryQ1;Am%Ezwrf(m2&BiVi?n`bk4RBXu{DD^k z8TV&*6&vKPu7lmR4cmvf%V(&&9N0RHIl=u`cV%H0ejdT&k?!g@%3aULG8P(-Bi9M; z(nNO+#&46DGY(94mu(7p6p@H40b#$!i-K^GC0&!B6_%x}XyL$WP|QF47$!=g90fA%_(NkD_kpX(3?^QC8ioQD9xZI83vui%hCp|&SJaEpfQ+* z{@LV{W6(_mmth}*${Mr_x63il@&>t36%8sFbQe=98nnKWfxjCD4M$QHgJQoos0!-i zPIZII*Psm!|6owpS_b*mHfRA3<05L;F=%F8gO=eA7S}WALw$p`H#6uF-eYoe#%#fS zS{u}?jX~qu8uS{*4hH>+ZZBXle26Y~8P@9nkJwVtf zgNjZtsMG&UArIuAN`E|>#{KCAb)0R`!#M^OoNG`EoSaAhg$C7JZP1Yo294NAJvWil zW`kC3H7H>_Iqfj$GDhw;sM;RJIz$am6ZZ<^Uo|NEKI5T33Or!VFzzAi{m7t{CkFne zFjusBYEa2%1`T-5afVfB`PQHb?+jY;-XOyVgXWt&l3z4s-hh|_xYY#0(avKj-Z0Di99f;MD_MJQw z*V#iMUC6nshZ=VCP~(2&)ZasC13gp?mxg+1`7jS{AMT;cI6Z>6qdXKk#zPzD&~|}` z+AZ|Z_Eb@er@U;Q%Fgepy#+kAHPlnCNKaKs z@YMBWPhD_&%A=^K7NsG_Q#n;V^`e%i_BHU-uoj-W(bH3>`gkhoXHPi>v26%_=Xff1 zv8PtA_teNeo~nD)Q|Hcjs@*wHxn1(qio2d_^4wD;zIbYkyfn(_rL}pyv?Ct^z0~nL zFZD0%rO}~Y@{91&fEX{ekM&Y-T)-`yjPuezI2`Y#=g3I#QZ=lGTcVea;W6GNdFfzr zFTF2G|59G6pX#N^G%q#CBz`3?wW&foG^p;SvxB{qJkm?;P+=6~!akb*xHR5Noi=*O zxz9^89(rk^#i#{VqXrZ-YASZ(5vCV1YFUs`OM;C$huI-U)eEI?}{fBZNtC43Ib@7RMr{he2%p}Z`7`f)c9}qBl)sX+y0?mS2MHIFD`ROd469Tq`g}WfRXalU`L}?5Za9{obS=HB72e)1-gum^8eu zNqcbu?@_;@No(*8vm2R|x3Ni~n2SP9O?ukQr2frKN^W6NV_d<@?k2hQAP1EHiI}}j zviC8mW?z%8qF{gOgGU2sGti`UKbus1kV$O@oAeB>p(Y*0CA>k;VT}2UNlq-nD;)dP zq@RWp8y_%rgh_2jnzV16NsGr56DQDk0_!u8c}^nt$tLZ>QQXIdDeRwWQYT!;uxTcJ zo?+79nI?_HN+irO>2Ewhz1cjT!+5AW&!jmhxPTbgz0f50Ma*HbNvq(!)TAnSieHwQ zROC04vd{?kv2VFaC-E2^RxsZ0CIzfCsni;i%Az@5Vb(^DvrWX^LjK!KDzTl~!?44o z+@sX*m`MY03B8UpHnySR32KQ?m~hgh_%qb-tVv1eagG|FH!0^L$0HtHVy%&Vm${^6XC5>m>cP>-*E_)qr7E^r#%w!2kI2_){^4h zT91>cU&32nCCM2haWc(YdDFcWicB0ul`Lx9`2R4;`y}YXF|3cx`WWszbf%dTUZWV$~-WHltw!ZYrMCn&Y%C>86Y*>OHvj?e@j zb;Z|2AJtFt(HobKQgeuf>|7rmMNSzX)y5!9#(rFcv8;~@BB-2?YF6;kBpkwd_*L@J z2&l4;VqmJ`qhBzvD)T_0YCbxPS>OBU3>Me&(R#e8?W2};e6$Qtv7xSyT=jf3ejaTX zG4Itrny}GFd;aiIjlDi-tNF=lN==W%9DpFkg&CYrSi$KW^FtQvTWDpSoGIgNJMIi2xmn6&_FP+%7G zLv!qzZPw5^%oC1zW_7_p9Gp+=1!m=gYaw&Qxc}WQGHVBpAY%!&#bMN5X4X_J#;V`U zx{cB+$ODyrXADe0!Ii8V8m(e&Rx@ABTVvJ@JVV}f#KKB!!?X3&YlB(8U@{JDG|OWX zbH!#HK-&#cMX!hgeN1RWllRs9ji@ME+7La`^rL)KHXzJF%cpE&xQwR&mR?AKu3bg5euA$2F{#Mf=??x^J*3-NT|DnBr;Ck4B3+VzHk^dGlM;J(T;niD$SP#%;Jo zkr5WzA}wl&$;gP}akND5DT}3Q9ijqYwnuh>-4>AlM=zo%SD13@~oVMr<7N4=man_;(*mjP5&RewO0&8;7qBU4@)uQ$PT2%R(MJw^} zx<%J+u$H$iYI2A9J+^2DmLly5c|WzN1rFmKJf2z92D@+!C7xR}7~_%eg+;B<0}oK@ zrA6g%2nAkIC(OnRd_{-X7H!92WWTX!BIcvOTZ@{Z3oau59kH+!@8I#Cy5cXKLzNHo z!)hdbq&66iSIGL$BJ(F=Vg~NxEqZ(=FI+&mFYLoIRQ^gmaM#@`yTPiq*nzJeR+aR$ zY6Nbhrk7Pq@g7M=E3cWXDq^x~7@i>0+o~Ce_OYrc+F}80W~=I92Z~y(nhcB8s+BgY z3j11h5r5gOiu1E-4($F`9l+oq`WLp!E7+HT)yu-~n@=PQqj7e6NO}6S2syP_LY1NVx zt2!37>OWL0#{CjjH7iN`QdaFvwJJW%s?nI5Zk1n#Rj)FwGMBdM0z9&;s*B<-Vxeoc zRqOE)Nx4?N#f~yo{Z!Vf$H-rfIl)k#aq$H{6|71@PYlJnN>*LPr7BjrRkbPt4bc{d zv9~(wf{(EMK%AOZW!18(3dZ6vy40q=b*%awZR=V!zn)d;^{rZikOo$jZ)nwVgfz11 zSFFRG##Z?^wQ3J~HDf>4HD`TVSk=5G`L$+l*p0kx84E8vSQXXLsxwIMWK{($!R5}( zzYA;El{t4~{@q!-QC427ST!CW;We5(u^$@4I$|m=p}<)7;V`1dkt1#*eLQ)g-~_8a zBX^=zv+x@VOrm}`JdL_cx2gd=W>~cm?lY}Qo5e8>=R9Jg`h2UV;RZ@9AQr}8{zB%o z$f_R~Th(|8`7Gs_SY}n8<&3$)st&(f^*8pdv?^@1Rmlih!!Zu~T8@7_MZ`L*hTt%K z*K-Wv#|>7M+DM%@S#|6Wa@s=9Fm9vn=(?S{?jVPq)Or`W@3yMdUeBp>X=sY|r`o9E6|#{8GOQTCdZ^JZ2>ViwNe8dlw)zIcYB zH#uf-8ddI76X*fsJY*cWJ+>+XC7v?YGivdiW8{TZ#a>!9@C|=o-g3OWqd!`|x9W!v zR`vVHSh(;X^Z7(wzVaN9P50bws_bFYM59etOg6Rfw&^}vnQaQN*z}9PO=I)gG(Nzl zf%$B@mEWdbfi}&=zep=!Q%h{eV~j6o(_Wl_&v!Q7H`w$U-i2&hgU-P=Da59I{}W@= z@mQN`$JykOXyg31O{JVRWv1AaTg0Znv8Sj_u43d^oERl+%8xc^U(%+P*or&IpGq7w zPP1ta?qt|>Ak(I&t!?^*=Iw0i*xsfl9c;36w5cX0;Xo&w_IGD&wC!orA=LTFCUbA* z*@yA_GOvC%4IW@q@XyR?5dH8G;|ALlH;I^Al{UHPNPrSTxC|HpF9`Z)MJB9Zkw6Mew%h4rp`xfO2o@^K&>h_d z_-Y+?q4Pjr^+)ZWi37u6+M^R15A)UdUw!os^@jWE#Ry*|jPzA0%pC2jwc~uXay;87 z`Re3kUoD>ItJc$fb#R8SR?PC%W~9&d)swltDm2emv1oyWV0%h+T_OI@GQ?ND8xS6y9TQxLx@o?8+Z$*BG>m zvTI7LT}9*Uib`he;&yE;!S<4NUB&KFc12{^6<^V=?v?CHuVPpA@9oO@!LFV)?fOv5 zuC=x83avw~b?qwKz|MPcy9PF)UsJoDG-K=*c7?UH>s>3mmbJF)F|yj(wHMz|sy%bV zI$TFg2fK#hI^J}&%dL}L30>{#-NUZzo_2-wva8BZcD=^h-gbTIV^@)Zb`2S9*ZHA# z-Nf&|*cCUN+fmG6v|Vk-*yTRfuDj#xsx{uOW)p}riFr-7%YUj}ZIEZ0UG=8h<(O$# zD|E+7B+aECUg6hyb~zU@j~&zrk5OYM_1I+)mj^o--?xm^ce+BNGf>xsS}Xpbl8{L!xdF#l)g{hM8PQ1**mCo%1t zT_4duz)#z75T<;7I+Wi}hXeg|0VfLjscB(9wGHu8=TJXIh56|b?uPqmXM~^rj`Y)# zC_k-@@zZbde%hPhr&%d}np?t8yGr^gwG{1A{q#?opZqiYG&qy7u%t9&x%~7?wx2?B z{4@f#GJaYEb6G$Ai2W#A-cPeD_$jmsxge*SpElt$R@LxR&HS~mxxXH?^w)}3{)%Zs+qV8H)ZSmQID<|d z{B;L~JNj!ZW}$r#e~xK?Jsjk(%Oi+0(O<2m`s>+hf6ZOvuY+s-^=dO?9Prl#T>VB{ z1i0nVSlsl?qwl=(sJAhXKEZCvBX{pSdOahL%FWE9hIkFl%A;IN#C#N-okyF{b#5N5 z!v~a}$78(3sU>-|Yz^(#5^XM!_9?7GWqj}WqQywiq!Tfnu7QIm;=h zMu6(p4NymP8xf%I#|Eg#cjFWcT_&joRCik;5{*)me0?p!%Ooi?nXXcK<(H0 z^!ulLdVpQ|^K(5ze$6S6Uj^#tSKCJURk&S#-R+cL!+Yje$Di|S^`ZPSoXjuJulY6I zJy3nZ0(mbLs2bscT7*5N0(H<8sPD=Ksv}A-3*;PGAkW=E)z4o*$72d;OL74{EM7pr zlq;Z_^$IAsZvhp0SwMb03&~?;A*HSFbd~d`20h8dzH@NGYj7Du+E-pBtni zWrCE2vA6-RvOzjoE=U_H1Sz6okk+7Yr665HN|hj0MMG4n5v2M^s}-aQc!?LygOuGi zNPRj5sbu#cEx;87^axTk=AnA;APvPtd`7E2L0XBBzCl`tn*D-w6jA+yGy?U0rVR$+ zC^CiyspzmECH@kmRJ_LfUxU$X9jVLmOym1!^Q-jnJ_po9b{SY*rnxNQ>Aa%wH?4B8UiGRw#r4_5~19U@n=9osN-eUL_OBzL?+&>yVZ z)*#hEOB_M@T|rv3CrC5)(r;goPNBn}tl@rYg2o4e)aFo-dgAkuAQe6nq#y7j&LihS zkP808`eQ5(W9Zc&?Lxt8L7IyVSbaT6Lnap13;0edtU_}Nt0-Dx0RBY2xrLRmu&`QT z|DwWjEGeuxVZr*0u!vwK;{uYRgS99&SOepNwG{yg!8(Gu)q?d8#(f{Gd1zNXSoPWj zYYWsiSebYUw|2o=ibCy!)f1EO0Sh|>Yb|^_25TyA;2ElQ3f3ujbq>}jEbJ1j>zLG) zJW#eIEuy1mHdr(j*i^4`I+_6gQ^xY;*Yas7hT0{i;YegL^` z2v#k$#w5(gMKs+Qtj_qlDOmab2v#Tjim1)ODuW_hf>miN?a+H$uvXwUifkt*9NiJD zDm#PK3`a43cd!QR3Dy~G+DATr25ZD$!Fqt92ZMDEVTXeCCypKt)+P8IVJ>Kew^J4CUlZVu7< z!Xc_38=|YJAu?x$Xea*84bfdhRS40FiXqyJ#Ht}&cTIb|sS_f%x*_U;jQSy}h@8g6 z?-HW3@b5u?q4{~x7LT~@P-go+8CmL zP-}CDGPj1P_s$TtKR_NQLp1IT?csGfM6K?Gs5@+TLzMdgpe= zdx#AVRfFhIjfxLdV$o2oNe@-e2B9j~IaCjOhsv}nR1FV=>Yr1gns_EuG3P=Rd?8e~ z(EnnnE~3LF+WZ}=eh)&m>S?HkJ`Yu!uc0dD9;R%Z#S}xBR^lIgMG=oM4M3P@n96vC zDcTsOL{pfap`Uk{Cc@$qri%Cit2s>T5p4-m2kgf~+_Q%9R-ahDVUj(J>x9E}(=UwI zYGJy75za8pKza&!;7O4%wJRE?k;TJw1)EBRsdZ^$WrgV-eshJ%BRfp~7==4%kQ1iU zu;+#;6)kZTUr@VDm?q$9*)W|e7pAnjVd{yq^}=+yewf<)8m2|~Hatv2MvxcEjSQ3b z{4nKU!GbW(MTM#Du`te;hpFLl=8v;TIT6O^NaS)dOs&ul%kc+3q2j49)x}wKJsqZ< zXTtcKOij;*sU8l&elAQuou_uNU8Js92HPd(eKkx=QTJc+#4}X79;TDH4WFCrOA6QD z=;8|31$dVW=iFwv7GMulo_(lNEnJ;`2-iTYsTrI%7 zI*q=4!?hF}a2JvN!c_!wk<>q2c?N`QIs%W!SQ zM`Xld6s&XI5( z#jc~_dW;WfbBy>nh{?yp^$t@{gvATC!gU9(tKmwxMm|r&`3xgmO`ntZi*WV)60Rd?qzLtg%`HOp z(Hcik#XUj|P|6UYl^zj#4^Phs4Z%1s9z)&{x`#LT*(X91%@LZ1?v@A*v-22t{33M0 zKSFm=Gf#w?;XwWfbqS2nAiTskgcOX>aa=`}?-(0P@O_~O{fINTj^BeKv;~cWBh(&? z&>i8gDo1D;{zL65%oE+4N9fO95$gF9weCaAei5oZgu4Ag z-;oiTHa0>n$499AG{%`po0Sn-is7px_?#_5ng1}}Gv*K;sn3lfRkv}Z98DwjBi5mC zvq;UwHuyG=R0q6A;TDmqjaw+*GE$GbMk=yfq=s~7dyh!DhDWL&{vJWBQIX1?5vf5a zGBZ*+ID)9zkqVjY24fQ*q2Pr`&TB`iFE+vNQlze9?$tA~wu@3k`zUQ59HkeiGBirD!=kiz zWR(6xozYQB8WW{PQ=>E+Ri{O%G48-MBT7$Eac&fUKcX~ZWt6_bvMNeNHbklPM%rRM z?3!lrk|C6H#q*l(yjW|8BQL>AS5_+H@>ROHW2=1L96aX${Vwj^f|f zD9u6UdB%n5LX-k8MydIwD0M}Z%Ta2E@2*7Y5zhTX{HswKh@gL?)C-~4qO=N^(EWOp zirsQ8R&2#+UBwf0 zs}!wMm7}$!O0_(%g{EO*X_|-+%Z}? zouXy$9Id$+*e6;EKSyg6S`3O-{vpxog4si(^=3@8uCI+&g^khLj#`_d_4Q~ppHWBa zIlf`>@o4>UI$GP%;5_p|-qyqcS*wd~agZ1i#@ZKBDtG@_Zk|bsI5yg(4qfIM)}W z^Qih?j3y!S6OX^fC{3|C3s1LL4aP}qbdS|-1RG*i8zXQ6fgZ7{kA=7nKhIdX&;?6y z878k-l|nZx#YI?+vC2e8%)?1|m|~TN&RB{I@bZpT2Kr$ouEOpUt1NWE8Zsw>{3 zrZrZ%wpcw3h*em@SiKF2RdQ&o#)QRcdU&i_#By6aR(VRqstSHD$s9`&w{)!XWyPwy zD^}6jv1(r?Rx8l3Y^*xq6{?jdmkP|gGIQJ#tDljwHCEX;jL7Z8*cGc`mtytkMyx8_ zkLCPptWqDusv>+Jvi*6iB3>}&%UBhA6|4L2V-@-#Rs%nh_kXe4^etA;P{}P$Mcm`G z%qvbekYS3G**i|#{p0ijEAzx@2V8mMG%p}d9rAHMIF9FJoc<1pQ-jbrb%7}?j@P|$ zvJ{C^+oExbDi){yX~aRt^f(QGAtO#dX2vO@bewioj?*WssS>B%=w3BWwgz#kjBoI5 z7^kUt)rfH$$MOC;PLuJXZ5;2Zv5clKZ(=2XK^b0JWlZl{S+s^&pgI=-{RC6 zVQ%sI5qaF>6^>v-yb|s4>V{wNHzNGvm4fvc>L0Hwh|d$RF4&4osFXKe6HqoFUW;)U zuc3VLDv1FYjjyPbKVIKZDKK93FseYj{zb*ec-6t5xDpkwN2nJauhuvl6EFYxc)dcq z1jfKRoIumWc&)|`WGBU|d2+n2qKG4&bI$Sl0IM@zsVIl>xPfQbl)`vL;#In6ymrI8 zSiE{*70#hf@p#R_u#)i#NR3zfw0Ql2mg(_I&ma~mWyb3|Y^CGX9Usv$i+W*>D_&o+ ztPwTFllIi3L%edj z#A`5$cBL7Me#bmgZ;bNk9B+4kFtB&zb{@*{)|`0!|_^)#z*4S2?dW*>yzA`VlD75CZ3L0 ztBcegbuO`fc#4Xb3-52#9G~11c+H)lC-{sZ9tpbcnZS2Q5@h#IP*u43 zBye4Pf~Mn*IYCD(3F_~kpv}mWH$kV-DKJ6H;aM<2+hK}IP+5G0cXWcr<4H_{{*6me znSBZR8CU;I(C_;b^w;488IBMS2T}QGf>s<$(B9(-a$HZ)7<{`)p0^S-?RJ7{+(}UA z{RB0@)&~ii|1d!>|0C|F1kNQSs5Ul!NzjO|{{pdusD3PeGD4d?ChVacuR4|spy>z0s;Ay2q zMORMLuqupKHBsZ5Ch9nTZkDL=2xy+DZY>hEy=5Yw1t)4XdN+Y> zL8B8jcy^+8AaHJ?F5ur4iCXb{qHZH=Rid7t^6o^9LdKp%Rlzwp_9f~nMjuPm5%fRK zJm7yKQJqgF>bq0)`zKMq;`UYQaE&}}Qv>AQO;qW7iCX?FQJcRc>IJHNOXTyiMESWT zsRI%{lGNERNvrXrf0DW&Z=NKL!hM|1mn2*MB<;f)^bAbWV@xQJq>mv<>KaO)*d%>| zDK1Gd4U#krX^oRK9$lIz=^|dVNm6dxBz-`wc1cqEB-KRO?!?3D-botLhyGKO^a~Pa zC8<3M&rVVj&Z7LBB>jp~bCXm7Mdy*@!X(8nN>T=D!hcDUzAh#2Wl6e$VZV{r?@3y^ zDoGXBCaKSU+8jtyFZBH@Np1(J13n*0(!j$>8ja#dlC_vP^vYHf0*1V$0 z`k`2|&SoZSkSkeZQ8Jr8h|Wn?hkD6s-5{CY21w@nh{^gDDUFk*e#xqh=CJioR@DK- z9hj`qgOk;0NU}O2W@xhZO(Orv$y$t7Q<61gMzU(oOjZlzpOviobCT6}NwUUa+UjKW zUYo36;8>TeRqK-#w;@^WHzn)fpUIl=SF+}!{6X?VzC+1+g!RXhHU2`f!mcOl&`ln{ z&;Ek#72LocHoIv4HGu2}lTIW(%MLthY8%ApT1 zr8*Rn=1>x*WjNF()1ls&RobED|KoD#GrY4M+Ju)VT*jep_!)6!9r~%9gYU^XG_NAD zt2uP4xELr$hibw&+o6y1 z96C1Np?@%LfkW>WQ|~1X{f+)h9SZ-=p||i{?%;Y8YOuy3%SMNC4$%*9(dr0u!lU!l z;*vvOvEpxs8eewk=r!tl)1kcY9BPN35cb}oW*;0n|Iwl6pB;Mfl^S9BH|8Lx^0+xw z*VCzH`J8H+-^urBoSYAG@?9FI))jE-`gcyH1v@nn^H3qgsZpU$zWeCp+D#|tYn)nu zO3_Y@K&=F)iX=Ogg~w>?aB8m8sj5Ys8d}1shZ#=wD^2_|PF=x$Oe*WtyK+u>ly@p0 z`k_q)r$$$C>H+FkbIP;2lka4+9eHXvRR>3YaO$60j9r^Kz)*)ab)6bt C3o!Zve zsmRuhi??l@n$^y!7x;qZ?TOui*qxk8>dIL7(#@&aJ)Hawi&O1-Ik}FDnxGR3^kJTT zo$~KboI%9F7c3v_RP0dt4Rh+r2&bBibgBdLk7ACaomxD`sas>6dNkgt6BC>YnMghG zJ8DgGYSm`OI|z`+s+;<4UKdt#azkYNxc; zsrKufy0D(M8;HHpscL_)Z?jXs?sV$fZYSU8rS5+^_5FUQx*lMC{$kAzIrZI9*6H>4P#GL+SzE_-z!WrcL<5cgfPJR5>sh2mL+J4_D`va$1U>;83 z3UVIu7_0F8Bd5CIBr+a5brEmz`xB=ePs#0>Q+F}eEk#-GDf%9J;OUXVcLGxMt6z$y zqq={Jn&K=1^QLGxiUp^rEEJL=I|k!WXo`x5rD$SYiWZ?^e2O~YUxX*7Xc7h#Nzpiz zFPfsdI0E0|DH@2enJJowx}{Up2A2`+qCH~Er>Jv<6!pg)yv5pzsc+?~p+(d4z6eZP8(E%9irl?{)+MrN<>Hz-+ z%(r2R_Wziob4^pUxfyx3OwpjWDJs~GI<-&XS}Ep_S{+mL3!b53rxZQH+|I=6nxYK+ zjnUmwv;aBXnM1D>eeRp0KK)WO?=MxeaSb8KscMROxPp9+RJF%W*qo_qh_!G_NmVrr!9^6U zkjigMRfjsMdf$X?EmD=!I#p%crfL{Uv`bYvJjUGisrm=w zIxs%6JErObig!xYLwv*^om1u4gR$Y>GgbbWfw#Rhs-R`5>ib)&x-U=F{H>{ckBa!)v4i;^O;w>|sXB%0Xn8zUf1XHHzf-9i z@Q68~)8kY=+f9|n6YBIdmGj!E`fN#4aci0;+tRelH%;XO(=-Iv3#9RT7-^dBOw$=8 z6-m=;d?}Tt>Zxg}Q#wr(@hmG%8(eAnxon!w;X$=D<$j;WzvpT4u92ozKcp$WW}4I> zO{tjPFinjbrRiytG)4cIreRIf_jG`%!*=x|S|T*PVswTDLD zg8k`oznQKqyoTXcx<=yO?Q~7LldjCC>FSTLTe@n3UuIB#%*B6h z8CvF^p*XJ$wZV7B48>zTY~C4sg*Ze1+B5VvAVbOdGBhTChDruzC?`HcgHbdgL%BGL z=%ftYLx+qE{fhmp=~&VYCAHtYG;O;?#j@KLm8@cm>Pd%e$km~g?TZV`ij%BnYw{i zahZA%pQ*8qOzlYFwn(PtqI}UzIa4#W6z9`3bq8js_9a8EtlqDM17YIqE7>t zMxt~>mkP8XHhfyTR1i0@p@U0a9bNM1L|?pxXJ^Jia2J;v!QR!S5F9{iHy8ijy413- zOWUxjpNrR!ECzT79pln29L3{tF4Z0HQvVq)JwoIh zmjQ&%s@qjIx_ts*TcrxYYHCi}wvKH9P83H%vX|Qjr@j4ab06 zF6}_4+b#`6mpd-yK6hydioI~D4BTHbm$xn*!-P*Roy6eJE=@$SFD|V_`d63Axo2x7 zt{Aepemz^gJ+gHW4^hoCoA38$Ya!O)3(~x@RRQafWz5!mI851Ui0+t)iv_cFE{Jx8 zv(*`v;A{n>%KwC9>nZj`W$P}!kIvS+m~3^3&DJEGK)JYVoyThwcCa1aaMMYgBH8?& zRkj9VO-aT<(Nft;NXu3YoG(pYS>%OdIOxjObM(m0*58QB$yQzL%VoZpP$pZQ%4RE~ ze72m(sF|(ixLr3};ggvgn#?9Yj98qlsR&-rc&NWMTcx&TiytqP71xht>)#XfIhn26 zSdGG`vi19!Y@J5Ov)LMi4gYhFe9sg2U*?CeuwTno>i=A4J#gwqw%(%9&1_}jdt5`Y zTin9^HgWD|>oQ&<_g=QfvaMdff_p8L@`su#n4EWti}LqJ@P((p6Jpm;)#w!x8@qbg{b zl%vteo1CL)RR14Gj$UG8N{%KJ$#N3Y=1Jx5_k#R1mFp;D;AE8h{_)=IB?XeW2zD`$C@hPPrAJ@K1g4bA$)P!E(8Jfr8a?m4zAj6K|{M z>bn}b>W;Z6RV!Cbumv~aS2tHBaI1cyG%i=!n1utFJTaGl56NLt zuF}wM3gf~)mA;6cnX4*Tic|2KLk_q(FIVRIxf;17S8HKhN}ibZTdsDZ_3ycwi23Vs z^%sKH=c*hIZOqltKd9%eTqUFIy{tA97XXW3DbB^*`o{-@oO`jaB|^ETcvF%jo}Vx)1QG$+wT=KV&0Yb_EoaB_N_K z8UBHuoa8`~o}QL@2Fg$n*~ly?0s>MH3IYNxWp9xwOIF!SW_j5Zlp)HVWxQYB>-}?G zpDWEto;&w*C+S6Vk|!nK^vK4S7>gA+iiap#+M@<&i@}(V4LA)h0;&>X&<9ho9XHY8 zJ&(qrWp$6f#gmUbDqqW^{B=F5i#rWHifZK1S6+`Un;v!XdE|-ps5>UN@#yuSM-xLH zm5F#Xznw?^&pgW3!K3O}*wv$Q-8@>^-J`}mJ=`Dc(Y~)ex{Z$gJnE0xuk`n*$pDXz z5A>+{Adh~;DO4EDJWe13%M(1hi$8`C=NpgGQEj+K*++VGDUrOAsSUQ`C@$bssz(*) zc(iyv?eNTz_F5q*#W2 z#hF)ph6Xh=lrzRqT0F5^8Jdc8_ar2OEmP5mZVrG!zHXWr(3ec!biC#2M5cVW{UwL(A~b_lDYzHuNnvV&D%<#~ONywc`x+N;0$)H&J$yq0g}mV<#KB zg-@q2kMqbr)lg~Jn1!vlh}P2#{pV+cYcSLlhp=>}p*Kgg@#_B<6?t*q72o?%VpGZIiIaCG!aQFS$CD8YHJJ~`_0g%4Tdt1wuSm4>sCWi z_z=zT*A8N(F^`kDu#>!Zv3;as|0}yWF7_BYu+Pw4v?51A}(&AbYrhdMSB_F*sByAL=n@=xCdS>Z|>D5th2qU=6dxd z)?%*Tt8lDWuLr!Uf~DAtYxp$It3Ei0_u|_^_Fi2;jSg%V*U+((SAV0*=U%nJ zPIUQ#T+q3*SCzVW^}LUlF~9M(SG(~^Kd(lQ@M`}kuf9+8^1Z89GpBkrX{%RTwv+!3 zujcRb>ZcRrc#@c>yefZ|nxFG3|3&(b?=#qEIP{lSL-Lr~li$?l@}|nYYwDL8rs5iz z`rs3jYt*K^|1ot9Ga8$UZ))nzXj8scrkb`kRk@?7>pe|9#GGEHiuX1Z?rZ9uuT4D~ zXe!$vQ|@3>PZCUZ7-FjBH>Upj*3>GT&RW|;i$ zqHi;4i=N5!Erm97S!V%x;gf}?vMe_B9L5q;pDi`j180|;ID;+-j=!c2m(ysMx6}$j69c34a7xMyTWpm|I^fB6#2{45d4ex zubMnhW9nD5zh-I{KD$oa8>V)l*x%IZmZ`q?S@yuxRRkZB8*ZTMBWj8Qk4<&Qer$L` zjHkp$B$J%c;2HhGUMzY}jxRXAQ0}Fv1gynKS$Z>zrEhTUHA}m)T6|w)sRBx7w=@>N z<*?K@r=^wHm&;P!+?G<2KaZuaaS`#aTiSyU^IA$l-h7q@;R@{hmgd1OU@-=b#drUf zmK3%WdBalIB9<0mXE94fixUf@OIUhX($eEnmL^15>i4FlY^5ztL4`7w)}d`#OS#{& zbOC{KmKNd;_LL{yJLHMzisW9&()=nG*ZM84?OQVITKcS>r8KOKw)oqg{+pJ%;~=V9 zmd4>9*gi{3k++$puW$$}np>)2le=rFb&REZXclWJ7_f8-(Qy`kD_SZXZ^@54SkTha z$E_@`7qH#d#B4*Gww9^|E#(VYO2AF*ix3Yb+tGi-eoD^h{F$Zl?JeEM&JGsWt}MCe zhD5BuG2BI=PL@7GON_xTRQ#O%h$E=_g{5Rv?`&x^dUl}>DD)*cA!}E*hecmma=KZX zhOIc+-BOtz>>Hd!mR^>cV;XAqwp6;0r8Ri1uchMfAstPJSel68LoHoG;qS;5HAhhM z(Uu-z-Wc}F57Y_Q@!nWVJ#ZS|CbAAzjH6EDEzQO`=triwf%OwCZA;?Vm}K$y6t$a7 z?S8Vf8+E6!|E5x_X&kRJ=wGtMxDeC@Wm7n&XIV;0wNzlXrABCmX^WU&%yEokOUQK@ z`wsh-Tk7=-$Kwk6gX6zi`eLP}6X>&weY1v|t>xVKjoPobRAPgrQJd)3X10eOzgvtS zK)yJRtBBn~4m-#@&C-CKmPR6Bm!&FuIJYo=FZ*gA+rjz$mU0}h^aHXTw6x(E=PX`7 z!M;r=x6_ttow0QGtfhC)bFAS7)?MH{xyUh`L7y*k93lCNrK5jZYH-!kPuDnyu3LJE z#J@RSZjuk`+~Ih6$Z?IlkBEh)k2$8FP@7E7HFSQ)xs}()cvC)=%I8ySw9oI;m|{LP zF7DG0m>uO)(YJl7RotgYl5hw` zBGjp)PgW0~N{?Z_u&qvQY|TZ>wl?u?{R3Z!m-mEiUF&44!soXB2iMX43tI;|+kCHR zYfE=qU3%L}9c1eQCJweW8_wthv28MgZ1DOx78PKvG2dRx=sY_Ju^6*S&ttKw!`|L(C>buT&K7W(e9 zb#%Y2kq2x&K4h!*VRFY44E@8_*(0`oJWBsg*!mb#PTC5j+xqk(+rZ;X5i=< z7=G8*B$T>mtKWTF-5&6BHb<@SdUi)qNX3gBj;iEx6kEwrw#p9gDR8tB9jiL(i%hht z?&u6|cyachnQ5Z#cSo*U``S9Swiz$a&0X zPw3}U+GRSL@yuatO-Bb`I@~|wYUXRM7G`xdHk+&N*edv^uUf)+J^=S5fs{ zUB|Wt#A@v7KTTcTh<5eDaJ9heD&2IIYPq_Ai9T1eQK^}$5zSr3J9bqXLs2}zRXlPH zaa97z$Q+C^7|F%=IkvCRzXaMe}zYcBUoyV?Wix~nBOT($h0 ze&2HS5-V@JjGykxyyI%#UABAA)#%5x#lR=7#-QL+S6^kiD*23QmKZHT__Y{y!+rR( z#ppQ-=8sWSff%*GHWV)yqbA5*C`PwYuUHK49Eed0`fQ8QghMg9bv#D%zQGUi%^Xred{5p@% z-}b9xdA|BQ&Vh}GS%jd;|$$1kyzcpsH3s!ogS+Ps9!LkPK5(19~;od&jQ-kA)xIY14`-=&;dN^9Z=pr0Zl{r z>wsbg1k`45Km+kOA)vG&0mY9E=-&8%&Q1=f(oX?tN6g@kjEOP?7vxK-C z1G+IiQiqM8fX@_1zj!k!=CJzayY|JIQGm>!QG(fU@rmsPevm8t)IN-tmBn zr3X|6E6)b>-MN4!Ukqq9mRw>x83B!Z5YUV#0ePMV)Gafh!p{P7Fb(6f$0_yoIA!41 zym9)nL!1udDNZho)A+?qac4=Kx-5;;CX`qar@+cMeYPr2b=JjcE%xt-Q^T}4g>Zgn zoNDii(|jcFj?;uaae8BKoF3hdQ_P(>^~fEs;ziFX@;5=A zCkg6{eyLY~rLHAM_&ARPtEgjE`ma$%jQ z7}f`s!dm=ZSh3Z@JYO1C=cZxR^M`dImURMQ)ow#uC=%9a3?C5IDeN2=W<0^L)?yb1 z4-P9TA*|NOJ0z?(aT=9Igw+WpM}}1y2a$bLSf66_82W;SiD3;w^>JY}LcZ}~#$69< z0Cr3a%a;`9e(tc&U`KLTSyIAUjWi6L71sFFF#9sBqqFJX9M-`x{5&_T7E8mL1n;u2 zTH@X1VdYpI);}N7N8wFcmq*MD!fZeu$_qj-yIqMAv?dXu^bu>P(F2NK!ETHh+P%7488 literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/be1066dbf7192317_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/be1066dbf7192317_0 new file mode 100644 index 0000000000000000000000000000000000000000..db79ac986f7ce8ccd5776cac8dc8f5bc7b3d0a40 GIT binary patch literal 54484 zcmXWj1$a}*8piRrP1~fBHf@0xDRp<;wYV)T4hxIB%i`|t?(XjH?rw{-xVzu?yWiaB z`Q1Nll5=L}Ou|x0O5Ki2Gq?Hv!xcagI(Ni&mO;r9MN{(TNiCi`cgeJpd2;5-ovT>h z;;A{)a^=icyku(5>?QK#$(}85_F_5Ha;If0nk!d{Y^izky z>Aa@PvE+Z2wH5#0{``Nj*l1W1xJ-{q0eMOT;|OJxojpqV%c{C;OgSKHc_5Yc8@Jh| z6@W!Ng*ZsvD*^Uuz;_x{9r%~B)CAhmf1QAAoq;dp)fL!2MrE82h$y2HE4t7+x@kON zt1aL>=p1$5qk3EiL~s!&Y%un+;y%?cs)n&*e=+qRE7}%UJz3Es%?WNLoe)Sp%Q&G< zIVbd@>3^ut&75Fu?t~r2QC0-EPzkK4W;A3YS~}r~afvK&KZZ&J0nY=Gd9rfjLxW?$r*<;J0m{G8C~g8 zurr#4IAd=yb%8BW+!;qpIK!p1GoF&If-~w@RIOQ&t*R=_ihYK?nltyRGg=t)S<$(= zy2Ogkb=0Ir&Jdj%tB>uS5!=BTBaEr6DBV%@WyP0Hs&r?5o-%b&(X9B&Cw6^AA&?@7)OAB|6wogreU zs9dbrXtOPz@^T(vrLU%?hFyXO66f^ z(p5UOn)_>wGup1@JSfXLXPh-|v7+84<+7i9k4_jl4md-cGF*=EcFJ-}y*lR%@#BVa zzv&E-O7&{K12*y_uj6Os!xp1esp|A`V+@?YS7EGo&ffiKCXu&JWo5_OC^p%1#TTqW?(@q+g#e(5M z7WBz#!Cm?**n)H99%{kaFbl?q^Yhd-!h&~E7NkU5Ff!JHjtTs8vIP%QEVz?u!6(X? z&4O7uc|W?H%YqMiElA8~LBISK)Guhk8Hz7#!CM+!#DdlIA0-yGV3aX~?Ny9pE^fg+ z3NE1%*`ShYH!GHxvfzP{zO)5Jjf!lYGU^d4CY80ovz!I%DQkHPh8jr~ET~Y4_o3K7 z_-CUw+p03>N2ROqadhlYRiLT`9jYnc>K4qSW5yM>dJPMv*HlZ`hqSPk1z&2b9StoI z&y3HknAk|wY0UL&rW!Wq-fCgN0eVl5TUlUjZ9!l1Zfij#m8Q$oqP+!2J6MpV3-<`! z=xV{se=Hc$jn}(7_gha3diJ*9kG>ZC+n?tjp#B_W!FYQ$NecLajq0FndhQsQ~2kp7POgZ!P8k5WSVV3V>&a3$Cz(H^dbwgEw`X0omyc* z)zv)yItz|(uwd9m?u|{nPFpNkwM`}Lut1dF$$1;sSuuPM_w-(l>nQikId${~$3g9G zsbY^U5N(ZKtjPF8rLbbmQ?>IMp9hrfg?h|>rsgkIo>vz1e$D4Ft)eC$Eg1KSd+)Oa zmM?0q%>^RO!v%|JiKh!zc)7sc?t(|&E-3Beg2wcZLych98F_tOkkQWt2^5e?C9vC# z!&zJ)wg#*HVJ;B&sD6Yx%*IEmmuz5+3z}0{tP66+xnLXZ%BE)Ia6yfnE~uSL`R8^) ze@dU%1;eR$0X3Et$pu}|jCNC@LM}L3#08s6D_a>CbfhC?d8~>qs9DJcJ7`N47v!tu zf~xghu%@9p$O?}}>IEyD8oOYOF`v!QL``GGxMpf0E0UY5vMpU8_O(`p+Hid2(N@K^ zbAbqHuhKg3`cU1Ds$NeQ45R(Mc)#8*$lpg*V#Or--q!_f`@7)kKo=|<#JLSs*V%K! z)Yjn~?+6t-$_1kSbhUAo3q-?tJde?Gz6&NUa6#^cF6cyi=oi&k?1DbDm)w@Pz_Ls& zTjheC8`KZ>YMa#+Tj(TZ3U7Id_uEADntXS;Kq=oaPZ z;fmALq^B#s)0kea2=DER9hB5p6<|~PsY(5LKFU9UV=%_E^#<}dRBVtdwo<}iSInn$ zLtHV8zR|>C9Mf=D3>@og=+PBSBT+zRm~H;oi3hNEibx4I9*jftnHdB9?|FPt{8E{751C1 z=t)PZ!!1|5rP}{;U(oN{u9$O&`{S-FmOoNk**uS35%JU&ODX0V&qeiLtK2_bAx6RN z|3+BdAlCY;U93|&H$>Am@=x!Eof(WkmfB=iy|TJN45v*L7R*1>AsQK~rm+VpIgIzE zt>hb_ddIjyw2D>TSaI37&x$i~>Lx3W#jDq>@J(<-L8B78nw%2dP>fE}b1IYMhQ;)W z`X{?#J*`S{!(BR(-3<+Ly5Sog$>oO6c{q-|Zm6Bl4UzfXaIt_J>J;L7(E+Mdn8zZI zB5tTlr^upZe*|MhL%*PvTDyBrYnDPp4Hv( zg9g>%^=asaH%;Aep}$HV&h@00Mwt3u5&};dN;J#;D)i(cBA^X*$u_Fxxsap z8-7yiepQmKaKH`m$2k7;yzgZ`=GuR+5fg8 zZv!i;HB=4R+mzNwRbj;s!_k=QPpM5*A$C$T{<)PEF0HM2ZhT>Tw6*dJidGCW{MuVF zprabciug`eyrTP^xwc(6pRQI!{$oX>?p9>%X+=Xi(3`jQwIZ>f6_xv|dhCV)R`?CH z^6xP#R+IlAEA|bs!ZOr~48yEQ9$`f*qZ=!}7$-+^y+>KGXS5Y9$8vv+v!d;IK8Gf% zKPPifP;XjFZ^(bD3Sq@*v4z)hs}*C7WvsYwjNWF2xIoU^RUj+QNq2HCd$^DGTJeFR_FK`w=*o(} z52)4b{zEF?5$+l4Y3yRfKSx#hW89~-!q|6$uOG%eR!lmnhMwkg;tc0?RuwtV=fVZ$ zcai)2k`=qJSW)Pj6+^5S4q#y+WRkR3IzTXtJ@76`!c;f2sj1@Ko7ZQP60{im}E^R%CvrVptLI zRyB3DLAY8}Fe{?m)NEGVGs;?R5bq5i4;xAwZ9Hvo_g3>9Has$dt{7QFJxC4Iima4jbm? zR-Som5P?PmRwU=O;W*{UXG1Ha8!IdY)EibbEy!~fv7vlXg%UOhyV01vXf!HmgJ^FY zWyK|9dnp^l@Y1Sm8P2V|I>?H571ZyFTm$Oyhw5C#22rJ|x>>^pF|?-I$BNU&XI9j% ztJbjMw=wfC8$`N#DwGwojVujp5HB05UX5%J$&FP#R@^YYG~w}@*|5Bo4dZRtf;#qIi zz7LO0>-wr({cI4;`>R*1C^}G`V8vDA11q`=QlW#nK9p)KV8uJ5=@9M}nm{Lwe}>v1 zh8ka3F?pD3G28~xmAprAKhkJwHqwR}#!+_v7`1S$4Pu>fniciNsaEU-dOu$En83Y5 zLn+-vwVM?ujK{3lFiF*$%wtho;|?nZO;JCl*&zB)S7TVQ(ny$LgSciqVMVQ(Dq$9H zr!Pj$IW~w{My7eZo>b4+Gv5Z`yg)Ty$m>U|4EM!+y`c)mOI8eCqOvcwK@>6mV#QUvqnm2Nw)0p;GIX0yVw zQ>C4-L9{=qdb8rH(e)Jf3av7>v!d>4^@2 z4dP$p*;PJ|=(ADmkqzRS(fFASV(@cy@C9GL=+;a1lofqnDc3jr`-L_e2Uu~(nDf>K zvC=rk3eWed*f*Y^E*bY&@ynR;ooh~;f2t&#J497?)qoX!3||j-h^)qPR$MZ&dAdVn z@K)ihC}JFCMJFFMkQJYdqkg=d?EWefD{>o$Sd%VzM*H;c5NR3If(M~JG%3Xd>Vi4_mRRZN6C#93o@q&vh4<0vc2N2yw@xMF-`McZg) ziFb!^7>TUdY}Cl<&abPwV^J=(o)u?|+PU2!-14XltQc;b$kbiUoNV9@vA?03($pPdp|Ot@m7A%0tQgZ$)o#UWL~gBB23B-!qpq;x zfsv)HJ4Bv#sst;Z8F|}tFVhnW>8<+o;l8GkM!vr85Z?XNK31GIp0T1=e`Ou+4za|@ zIno_suQ7WRuOnSFCXRN8*gaNFp5_j*z}U-*Kc}n4Gu~le-t%?#BVP|c z^Yw^)zVNwav}7$`-7)Mt=kbHDS-*HcCl54oRvp;=7Il_w=&DY+d7!^ljbX(hDr)yY zoR0^B9V&qpo#?*N%hv;9V+OS~zysot@sw>CsM@h&DV5Ib!JkF(!162}2o3eXsxY;k z6_vw1V2f1gS<#gIqE#>}y3#q?9HS1fB5$mk8Rr49%m_{3`KSZ^N>sIzJRm+4^+3Mj zJik#a%>yT>cnJ?wr+ze%4$>8}mh?a-3M!?lmhpg?U>s$|CBwIz2gEP~c z3^w{y^nkceSt@zpf-&O{4~X-|!fGB6>x~c9IS*=5LoH!n8XIczn$}Wd=XgNOSfG}& z)fRG}Eb>6|5)b5F>VdzPd0@eE5A;~!f$}SPU017d8$BRq)85VM6x(Tw2Y!&-cFuc; z2iouUK-fMHR59waW%hd@+d&V69QD8h;|*K=mIsn?tS+g31LrAnOKpzm?!cW z9awSQ$Y0zOqO_4K%@Z-DJ^3|O)uMtYf-8EWJpDrp=?pn)sUSA6jwg0dhq|8FPwyJ5 z-)w^>p6Eeg%{@_@Hc*R}JO-6+t*Wv4+jwF;WpC?=rR_cOiz;>S#P?2~xYpSd1-f{m zlhKcL>gtImy*<%|g8O*lQ-5U{;EC=7)lgQr4)R1{qXL^eSQTX78o$|LL)4k!93S1J z_z|9HM$731rHoXa*pt+Blqa@PyD^@aI*yMc+jvjxHcqm>6FpIdJ{lD!dqNDKqNcLD zrgEIqJTcE$!)Bb}iE2h8cJEA244kFLvng{t(cb989+}H?&r=y#QFOlQ$BHr11)kVx z9A^tI;`K9*vDKG&VzRN2UA5E`4~)Xgxt3Ic%B|p7jB#wHl`4k)Yn3O0R;ze+&KghL zHD0ml*6}>F(%8jUK@DcbL^`z56E2&SFT2G!#Kvyn^)b4z-L`UXZ&UxVMYePQ z8N=8UJGeeORR%U~7x#!UnQgq=6AO%W?0`MIHb%?6o)AU$scic_Ap#Dllta8GRES0$ z<{BJVYfgAV96PBlvn@{Xyr;PiXVh(W!dXw$JLidw=RNV8Dqi4vUi3uhB|ax8?K1Z( z^}E8?iL1PZH0v5~zwU`C^!^6-;Z0BExXpRq^+eP?m7T3i1G|lrP-#gs*(vp_X)pLcZ~}f%Z}0cTZ&b!Sm4^TKJQ%GxXB< z#)^nvTvM|A_QX26O>5zWgU()fZ1F+?7cX=+Cb@b+{B2cj*oD3-U4R!vr%--O_l#Gp zxD}>eg?k|~!VBJ!UZ_hGsbCa8j`qTIV+s2!mgkC7^VxZcUdWm1h27cJ2{um-FHANT zu-|fd;c0I5iLIX33(F~AJ}+FMKl6LxJ~b=gg-?{Bpcj5qmO@@=LMv!yVRfmR7euY< z>OWSDs-fD~^n&oHrIxbdTV2(si5J93<7;y-h?*VL7FHDLsvO$XspVZ{KtXUtvgh1bRpw(S}(?4#JVUg$-~ zDSDk3TCVrPRcf@+3mv!exZ6}D+m-&M>f60=V3!x#>{dBK2UI;nuh3?er4DUx-&vNb0sSoVJ^Ik}~ z;Dtl9{UXPA$qPF#bB|n6YuH7%ys-XXFOJF?sC7(_3qkh_}3Mti6nYzvx4-kx^UqMek(%Z`cU zWmhY`?a1n5#}zv4up`b_&0-yX>JTgX2l04W?QjdWqXca?KCyd3?5G&38nB{mm>vI7 z#c(^$(Ibk9u%k8&q6v|9Y@-KMILeNYXqCjyqmD6l6pgjxsqu-u7st6Is)h34>->7U(JKE&7qhTICCa)d)^4SreUyWoZ7qG*(pdIfD+2L8( zj?3gy#EzPjt0<329g3;->{m)kv*RP}ETR4>X~%OTpcLm#meL#t{WLtv*pZF87z5dL zPozHnMu;cHAcGO$Mu`T9)TVjX* zGM<0A9j#Z`agFw`v?FY_N@hdW*fEP7YwcJ`FDYW39RuhX`K-5NB>la?j=URrO*Ywa zax=%bmE$Mtc3vauu!HNrljGRM>$02k*kec2ecVR}`CL54xzNHBc2qyjy+~`$@S0s# zp=?=lx?)E%?V__+dEaY%&femA|K<3NlDGL>qrf{VlAS^4joa+1ySxU*D>lbH?maq3 z6&`cF3_RiapQ=#S>A4*RDfdf`;}zHIHTT;aJ956Yqt6GvHh$#Z`^4i=v(I+?`NfW& zUwLl2{EhSd&UO36=N!E8pR+g0yLe-~Ro$?8qp`a;9#d0KZ>0C~#$Z2hj85l`vFW|h zCxbWc2Y91vpf{$|zmz|tH=586dTxx(qfj<)q-FQUHQJlQ8%1-f^0~a>o?8X5qB*t7+zZ%m-C#+d%zh#Sc3G1wd3 zhNwS>aXgf7q&ISo;^#(tBjXqq%`PRMvEE3cOXF0v@!k+mjRh0DAwEo0)hBZesN)p1 zc&ax<#cApuE4oZqw`Ov_vsBbP%K2i0aWQx~>mI4kMtm4@3kFpiRbpHnDv3c2)80Wg7aAn#4Bh z=7Xiwp}XqChV)R0>>#rAR1P+^mk*j6o!E}OeX!2h&9>{Kda>2}sz$7(zjCl`soo$p zc8Cu?QLUls%`hJ%3|DzsF@2;D){gPP%CSCpGlAHd@10(1&%?@`ULxckXkq(TamQfB&igh4IoC8tG99u32 zHs$YFshk4^DmYO24+o0>=|GpN4t%NRz}o5#gx263 zYC2G|j)Py_Au(2R=1*U`aCvo>P&Q4(y}fl(&^C#fo)whhkc* zLF^s+&_+46bs(XG1Km11P^^msAzdA)@Q(xUX>B(Les*^tdmje|^mpLWKy{B5D+a5$ zq3j6Gb)*9=MmgX-+JQ%79H=(dfrjIF%n6+LL$GJC7I*{$O1C`FGy6p6G9Q%0(UQ*3l4h+5PKPY2G>l;7$rD|)5(#dhNeD{L8jaWude#{$)5_H-s+G|1|U79qZ97wU_sFkd{Q zN8!HM72%6(k-k_I<%_j3zE~RXi+u^cn32sFvvd1mcOGBl%gg)a^To~lzVIvPi~fap zUSm;Vp0lVg1{d>1NO4~bBkvNvSVNvAeepLPq>`n5F|&*>LMw1QRJ@WeHqj4SRmB&P zfBIrN?KfW6@P!y&TV?y(7ou_>HDaVMM3pIO$zxxL(;>BR@Q8 z;)mr;{Secfk8k0JEUi>5d!E|1_QONU+Qtu~jTx+H)me38#nXQ3`Y=C;JL6T;$$k*8 zR;$@-{2-33RqwX=!Es1kX2q@F>M1MIJNf_LXja^FRhixV(aq|Q?}o$X58>>t-cR#~ zC^g+5b?Lo<8U9G4@y1*>(@cMCGCIumhge5njKXvHIpZTM&Ms0**7!q=U#B{6_lNjs zSa$fM-Y$R4q&HM%w?9_WLnFr?e@vjHe=IE4mrk1Jm)pk5!F~=^$pLsH`>9VQLd~nf-l0J$s!FV%jIQnSDdC zPU-(|vuApUt=?*)BR#}xqj`9Gh$Zx{usT&VJw$v-m0UhO#PlkvX3g{vZH$h?(nI_) zT4kS@9>RH%`g=oq{I^YY+mjw*=%Mu3V0>n~Tvoof(nCCdnjRUSsRqx}W0A3)6-SMf z*XbeJ70vK}<9lU5^J46$r$UqAGLAK(wJrZ31zL-ci%G zfjCV8?E>)!?WIcX1M#IpAa-{Q#EMRVD7++)-@6Iq-wmpEKt_mDF=}gaMu?}m)ZkJX zA*R<-!96lUWO=J94atPZ=QH8Tg-r16lI8zgR%U_7w?-{HmIXWMEd4sJx_boSg;x+x z`v+lHx*+7r90cc}Amj-P!riDK+=~f9XlxLFep*#w#oD|oTfQKOQpR3ZtWQ(fO9Vj_ zq0w}g+)4)FOsODjC=-N;vO!owJ<0{)wvnwu5GopVSy7>is?Cc0)l?Z)yfxl53W6xs zLUnH&1d*px5at;-SdqT7ie|+eqkWekRPLq*vSPgPgB4A?tCg$>>7mxKqH0fdf)!D{ zf-uae)i(&DsnL%WCyasvgCKGYQi+3uAo3aS*}sMa;WM=wrn<3W2Q?e6Iw69sMNUf!l^u%d}^oGraO2n+VA zY5Rg8vhP=CS<(7{ay!VqPM?i>hk_uQA5~pg@#DD4dOir^PvdV^Tr!GZ4uZ&ZQx#!H z8^>5N@Rr)mX1X1O*~SJ|tiGcLjL!=3#_*Yt6acUbY(kH0nte9O%-DJg>Khzvnw5+UZH4lc^ zN@$@9vEr@a)G`=iv5}=!F#lUF7+s7BtoUNgZygM=mOR=7Bh8r1-ZfsamD&blv~iYo zYZr_W#{Bj?2Hi0xbl^E?fl;z!FvK3Cey3oFHgwdu%+Bc?jHgtyE9d)9Fs{?GZo#m3 zSDD#+JycxJV2H-X{$9cSJ$)Xdw{qIRb)ah0j3yX!*(=mwqiVX(9%ayb~s zj2o;NbyZDgMTzUG+6}HP^)%MAV#Zz7_954i9{s1%9&>L|b0hv)FhsfMst+qh8hcq$ z;)OcMis5fn^LIQJU4O4$vts)v75OJcl7cU4JXfzrE5aqvNi-B>$r}_GFFURukN$r*alT@V+h1Vx=Bf!LQri> z2nuae-FAgQv^u1s&Tx!0=DeE83b*U3>BA6+PKNiR5Qt*5g3_L-_N;he?Xr>yuy-k(Fz#@Ne>3r5v1ArO_mbMO36fBy=BXlq>k9Re{6q5rqQ zITT`@k=-Q}q6qb(!^TB6)fS3&?x9%g6^eVtEB3T^C_;Ty2ft8=|BTq+P>4FwYD9b} zL}CuLra&k}mpZCcyHJR-?L+zc8;ZhRL-Co4{u7F)-P9+x)1Xj%7#xavLqqXuSSVVI z3`LXCp;%7QV>oUqxGWSA%R^yXrP8y7)`TK{Z72q8429RGP+Z;|in@nX3--d{P%JtU zim^v|8SFPt>ZHp%4RKt8r}icbwz!oWC_Dc<0kvd$nFw`-bR>f7)rRQXlocmqD{SGd%COftnl(sWm)ml zuzQ9)cr0pd9Aw2)`p>RHyur!F3Yz#{cgP3L% z$QA~1!FZ8945DQYH9S`s#0_Ip-Y|$}h1Js{920#qmKF_za4Dwz*b&ALrP_;cQB94lUyR2NHyLFBKgy08~&h2eT_)qF@8!~)~@&@c=brlzu@ z)NtiKHw>aU&6^j-?#JykO)9O9bMzGyhaWy8HxI7CHb9xL_|N~`v)s8C6@{WBb*kFlm|IK=Kw z>W{AB5X=8jTUgP)o7&8ZR^8P(wnvX}EH*ZcE?8na^mY~?#Q9OBqI z<-9%|qW%U|ZDTmZ^t~!@UpPe5V`?ya-Y9-N9O4A+J`s-R#uv8vNsh}n!cIIDj!!iC zbU1v@gkvtq}Sug1D7;Sl!?zpLR8 z#f@&P_}5r*BOKzPQS??gM8a)#;w9%vF0WLB*WnP=-l#4=!y%3ve<1>*m*MRc0a4p% z#){)q!CBQ|MP5q;F40OC^_dl}t`QhOW8C;L{bP+lJ6iW{f~cCUuGxw~Pvzxjt0KSj37yvZ%jVao)JYiWNa>D=VI6jX>t$2-GuL zv0{OdH-u|XlZ=I|SQn;tv%)o8&0v!wI9B5cD<(y%MXX34rNUV;k)9fxqa%`jky8IIXf$r*hPmYZ$4^aIEM?km?S5rnuKr|VvN>7P^cs^ZWWds(} z(A6scUakohx~WdQ;=E{nc;x^6_$v~kWcg<49CD?z19S6ZO19Bt&FKHK0=@MD@<9=+H=ro^)*($1p+_ zn-&St&&WPK5~8?qoQ;|piJ)0(*ZfF`ft%HCR%F_$0=7j$3^=6rv7*yqHINn2N7QUq zyfwNUi-b6C+&mEp5pq(EX2oTSIHkt3BJ1f$3^FoYii9X(^k>B;;~6V5T~=jT(Zkrp z3g4^h4l8EgQde1#wxO zicV86Sy6Vj+Rut%E7fmSc&&;;_6@4=#wdt-wBB%Rib54*344aV8g84TP>2Q^jMx)He zXzVbmZHk8YbwU+58O`7Mh{kKn=pmxR>Y|9jb5}9LAGD{492OtKkv&P^Jl?#i( ztne8A9(D|V(TJ!RT%%&qF<3x|iQ)TNCr82Vuiy)6=6kt zV+|`Bc&ZMp_-s_Q$3moetEcH>A;L1Lk0G%T$)RdgSS-ZUaMd_A7Gi2H<)1qiqJps^ zPb@_Lyy{kAj+ZhNQJsp$LPQr+txCi~EH~f|kJ$udjQ^Xt9|1IZ9Ip3+r zpJO3Hzo$h zIEdbcrC=Py--Y6kP+09Q9|!T>SW_VmVvo_OVjP5b9aWwczYU+daS)S@cYnn}%&Dhp zHIL)>u;Vb1-n5A0_o-F=X>kzK>C^N$ESRCrZHt4LvRhqZ#n3%!Dl3Basvi5|AfooG z1E=C3a9V9-#X+OnnK+12&(s1|+<&fey@-QY_ey1b9S0Flq2HD7k2r{|M&{pf5bcaG zr+A3J4S(l&h;Sp=63^GlcqBShM|Ln>Ga`KBA+phW8tA8Pu<`z?J-f}g%9cx~#<8Mg zdbN-}M(+(|h({jkZH#1pQMrJ4{5Hx3@?)w+BQmOgSy47p)nLT|<3?0G#51E-G#^jR zj0-XG5Y^(8Uwk~oJELVnJj6m{9V<>74HDxaRvSCnVoC9ENsdP&x@BZfiRaJKsxPdt zr>cCcC}oUg#a-hSD~4oKo7e-{RpA`*5PJ;wobl*vtYXDQqed>S4b3tJ<%x$#pHH>Q z9}ltFXi^{^qCi14mKEg+sXMIjF04AS;;Yf52p>=Djafx`Zu(hF6)GMNQLKbo&WgHa z)Js-;ET`U==YFBI+UgoB-WUz)@LJG$;{hvj)K%qK(eN*Il@%{qsambMH>h}f)t?nP zI;b>OoG_w0#Y3d)tQz&_HK*Cew*m1G_Xeq-Q#fzRKUKYA#V=#Ww0MZUbJR~(tedO$ zv7+QWwQxT7C3Rn*PVJ0`*t)$~d{#3G}{Rqj7(X1rv}UXMrX8>-{ac!*Vo`|o&&J;rzE z1cM)?y7Sbj1A`%bBpI|&e@jNkVXAoAWQ)dSMI}PaGHORBLNv~;wy`2>0ace3J_S`UD;68hg%csR z8ZXNwLPVEWgDNCK6sxGlG)ROvW%O;B2r<@3-zX6s8z*8%6V<6#BE)LLqfa8lUgO5F zM2K|5RfiFY5J4kV|CxypJB`5EiTv5kL|iuhU7iTBe1&?ziXyAj3s#ihqeifz;9gaM z6&ERGeY-yyy zl*squPDJ7V)UsEJ5L{}eTYY7PuT#?hwPr=4i)!ba1hLxq+b;>Cy^+p831Wot zm=)(TDDQwIi2cTSR&)te&si}pqxu?>1koW>wU6bw=(}NyOF~Q?HHa1Y>#4DBl#22Gl%OnW2QdL<|vXgqwiq+lJfbK~UF_YC`RwT|)tyqzDrb=SP1*7z= zB#0qK-q}eIWsDqik{}+>SMdvyAPO2)S-(Z<*Wx6Ib4%1+Rt#FIY%7u=7OzTz+v+5g zU8}kuOoH$`l!UI-<8Tt3j_{h(kE5#3u_TC*lfPL?lC`MXFj+$$XF4Wd66W>KT^|am9GRdM7Dc zN-{)x+GoUPONOYQUCqgn4Dn}9b)ir)M8BeHG@GZGdcZ~(SFLL$Lo} ztEbR28KSz;h!x(wRK?!O5c~S5k^Pe){u-d#up(xl+CL!~V&X)#kQGfQsR7fHA*xPS zjad;eL)D&@4AEne8pDbyt5vtP$q<7nWu02JJ{clzgKD)Y8REzRHSTaS#B8JV5$+j! zKpBpzXRKI%N{zjo3=wum9le(fvHqL9EGqR;O=HDbW9{c;i0Mu#|L5wQ0#U$N zV@ZK1?5d8j;-b%F++Ry;uswCgUwDvX)RCS<%;sE13fEPbsyX6?4j}pOrXnI$K%Q{4)h2 zUp2Ls6}yaP)l(pf)>M^P(ZD#uijB3@lR7C7qyJK4>!(1t|E)5xV!z?nAcgPSl7ceE zyv8XIA+6O!R?MSvZPdfIycX?Mbf*;l8z}{|d#j#9Q~14P&dq2uCIzDKSXGG?)yJuh z)46_>HbYfqg>|O-Iwu9<MVFuM8AQfV(aflV|0@b>VsStNE ztNg*K5aW$GtSA$rMuet9{0>)zqf+@^OsV{t6*Z3)<)YOvR#Zz+*^^TtiWtvX(IQ37 zPECcVm|YFboeJ@^pz2we<1V3Yu;Q^Xp=2t=r&7wLbSgv!qbDnxmr)}tq(VF~YFA2y zaILKBu%fx)UxjN-HH_nbrb67Trpi_4oT(;RYN$Fjc?=p`OP#5m3bDPOifon&G0^zf zJQZR_OZA2oKaFLrQX!tSR<+x5%#_qYjbz2oj%sG-RERG|%dV*qp50UfRbY-0s0s!dRA^e3Z{G%6vkNILYT91)o-T{#VmofJs%hVH|(x5D<_KQMzO4EjDLo z7G}1|4Um*hkq&9;5D-`zX%OjAi41O*JBym(X+*mD@|Gg*lBD$m1m=P0eCnLJlL}c;Q@2UXs%cLFwSPs#b9?p-JV{ z0+iw_sE#OIF(oQ_2~9Qws(T5IH_jSfLXFK~l)kK`2BI|1UnQf|xSnc<(%+_7pqJ2i zQ_krn)WxOxqjcN6L}^X9+KJM{`sxiD>{iE6x@&fMyo5SMsGlRfgzlKx(OyEiW4t8M ztVbz*tQvsQ4HFXQB~-bg+J{o6#wxstm(Y4sq^XxsPm{YDwg)xi)!yb_LT6g2jo*0* zCAU_CzxNU<)LxC~fb|2zI;w*x#dT7{QToq>cgA?&ftl0A3$OLSn7S!HlrEZ|yJL=E z9t8JLYku&O4}HC)Pd_i2G00204aVAnHE^`Qb(wjnT^sJll560p#akhrIqF(N~NEx1eB(k<0z$jq3WX4%`8FbhAHr} zj!>+rR;R9zPhHi-udYzScdE$2xJ>^C;#9{*-a@aFRDo9b zJ_v5B9N&8j4Kuaddkck`hbYbIp#DK=d`FdxQcx%L2Blh^)qRxSnhjmNg>v;&5h$hY zrE;S*!@T^#TWDQxwf|>tp>$)_MwAYi2IIVimW@|!CU^_oTC9pL@s_^7c}tI_YVKxl zp}$S7tr+(MKf>C1?2XqI zs}I?Hglc71Q*!tS?f6nT3-|~PHP;II2yHKiGyw zGXDkm2(1fLgB(6WXUx3_AEA&)bu!8a|4-{9S)x^&7#|_uSS8JTguKo4c#IDc64c`) zAE7eM)vy*mLV@3@#_fEBCYvYU`v|RUuYT(2BecU5>g*%*)XeMSBXr5s?&l+vx4%j= z%15Z4d4^Kj(P|X>?-)F`v8we7AECMC!%FNg7_>@FMJdB-<+H&@s27~x=pzd@t5Oer zgeIF~X?=yhNvE!4@D<9RQ7z2mD|F!tl`EUC(6j>Tmv4N9&YF?m`U*`qMT`4N-x9tO zUQ+#8-dCt&s9KIvfA8t?`U>T6sZ~+FLJv)Hv@fn}>np2GjTm2{NwKPFoUhQr z*6IrC-PTv`m`)?GJ^0O}ALT2w$CR4xE0kom&+ru*H&gANgVhObb7d5%)Ln`$&lcW$Z4w|#~DAFKW-RrycVLutP$ z{?u3Ky2Z3yW%^Z~8rBO@L`U#cKsM?`aIFqV?((jNXiytmGq^{)j6MC6f zRmtZkWApn-odPPjf}hY3Q=_7vP>4B#Qklx?4oV&U)N+&({8cBEo}0)3KcNri+i*Xj zB$Kt|)=#KooLY`jLPOOFrRNaY7<1D^W$x%F^q0xn z$q(nN@RPQkRgo@!Le;veE+`f6ro2$v40(HCPRuXE{DjV$k;DCjrkmgqm~Z%ds`8qS zp95)Tsp)g^y|8n>`iRon1!@;cj)iLBB0rqV#ZMv@t7R+wgzlPOSNRDoH&s{r$+$Is zQg^L7w8c*-<5sl=rNbs-o1d)Q?k6pFsN)Cygz6tsOWtB#LfSI^soJ2FTvmNT>92C? zI!bNItEUzGg~nA?+r0dR##L8yP;%B#)x7x1xD2Km%@SmcpsF%gogOzcU1n;B@Ekj`OD03f2rKSU-r8FrE!G6 zRGEq~M%9x!*#e}*!~oecDL^8o1mOHX0n+c60Le8YKz^GUAbzs~cs~N6>Oy%p_H|?DumJvv#w*HP{vLwedj=- zAoCKX3|-VRl!|p#2`J_4roKUGpYiS3kt| zrf86m>uc2orEJAiF_hf@_YH2tW3#h#kkG#-vP_WBtFo$Nxgep*<~T}W<<(h~o|~_$ z1_@0zpHaF|O%KUZU2L}l?HoHTDgzlP&p+Pv8LXdQJsFKbgp=!o2Hb|(Yxz#vGsKgXi6{VzE zsv}CH7OH6|75iOPM5*a!Rd-8}$WE0VrE5pkmE%D|RZpmfD6KMIpTzvb@>A+BlscVO zgHc-de`jzTqR*<1S1?wXY(Als^Q!VjQ(Z&hk~w)jNa&?0awAB{-$bHx)fBxMBvjM5 zQJQA1qLlWQib83u>2MqC(5(9xj{*LM6qDsnkWgt8g3<)@^nQ>~z6UA{rQ8oyNtD9P zaFiB4Qk5SE32ijjQCgd#N#-cQ#f~r+9SZIr>S}9n_ZCY0j7W&!bsS+$y#zdj1s-lo$ z{_qMGnpjLaL zRDD7zaExk;l5@Q3g3_#cYAH&uO@R%;LJjt*?kL?mrg9t)7OH$&#iDf9JVB}88FLne zEhgvrV4+%O0ZQx5RW#KF6b4>Y=l>2C`d~t@1`BmCLs43POIx#C#Xl-1N`)mPRVYdoGOH-G?HB4};Siw`MO6D@AwpA)r(%du zPvci5M5wK~<`p88rMgP286q^wOs$Kb1%H~1ej!3t&E0?yp&?h|obZ@w*VAt)^Q0 z5TQmUZKn{SispFt5TVRJDle3Z4phM?{Wn+@7!o3sdAO>K(#etPElS=$tL7+eHaAf! zGF}Ct^sCv2(v(SR3re{rD<72FPgN69$~jGWqf}<5a-+1^oJ1+(Y*i7Z8_DX6xgkQM z7pXNUWm>GNq4djdYCB48m#axA&0VYZqg3>F6^7EmKh%*8AwpShswyZs?x>C^y)YT? zV%$*m|L);7{AK*^WBtSVhbr%*5TQyY0i|AMF-kj3&exbn*l$AL;JFFa->P#cdB0Q5 zQCj|4rNJ|qK4el0@`nl)ETY^fbueR5T5C?D^vdKd8Y<*#nxWL+%tC3axr7p4#FnZo zN|B}~N;AwJlpdK@6+(r^n?{vGg@%~7HA00-)Kod@gbLL$DSn~&JxQn(_E(+4LWOQQ zRr~Nzq0ng61*K_C)fe%hLX#8J*GZv5OPZ^w??Q#rw^Ef+TG~++?;I+$u8Run7Ao{- zcXi~4P@$)$b?;E2AI$km5cIuf-TrMWKkJ4*ljUpQ_@xlyq0j12%Rb`agv{GYHO4DAILFr*vm8+XW=u%H5y&OUv%|Miv{@)L{4bI+b z14{4vs80PHLPt!U{tlr?a|)%`167tm4xs}-sf#G(AEv6HG{XFYQmx^t+X#oyD)V@x zL#WwkH3X$?rti-Vp>1Q;JCrt#SKX&Lgj!5jyHUDoGR$z`8s82nYTPKzGrLf_Zko(= z2nGDAde3&?wImKXI8SAs@4)rE)tm)bOVDJY^83vpw9+B*-TmI!1cKCGyhPPHaLW0Okb4FY*yR1I)rYThT9xMBh9{@SeNk7 zq}zq{4uws1l4SNB+99;_j2d*-AvEWl>UAF5f?4Jx zO1Up6Uo_Q46fT>fOAeuS=IhH2p%13zRfkY7GZ#&D4TXBw)d!T4Z>fD~?%S#uN|pXq z=kH+t;ptsf`hi2}`^V}n+UAM+38j>$nD-R*(=&Vywmx^r15@aQL#VcCh*IyDY9~s? zUMXLcnwjw^<$Qy62qoXDShS-VhSGe~>YYPqlsWvtA(T5~SgQIcH8w$+!h}9$Q?Als zLXAuhlxCJyEz5-os?O8%f; z_jL-T@24K26w%))KM!!qTWB@VDUAj@<<1cG94+vZQ^vqQP->V{I>Ak7Hry#YO|B76 zX#xx36$FlS$}l(xxkouA9?nCa(N39bR-u$(ocanS_jt7or7tI_eJGtWKTpKCA;%0= z7^TsW?^nz{G@pfi0tIF}@!u7g-#Ka-O5KuG_*~2}l6$9`iBhIrs@5K-P>5N9QkK1{6iT&C zXO#B9IgouSI~oMT%w#m%ey5CwtOryg+6`u#W#|=1IH)?Hr=aQ~H6Eo)CipPcC`6hW zDBU-&QOa}__c^AzA9o6EJfl9Ja|*4xu0El(?1s97Qtg{+G)h@-slF&(H=^0E@7bg52Y%1RXdb^H!bfuh31*>?qmN$-v{adO8FkD-cPXhpw|mE?n5gHgJdRvk#^63UR?C8bTl3@)LuW^+cDP_ImC9ZE+st2$X+ zLi0_ItS+G+%ypFFzEFoys-8{FMJZc$)eoiH#+}0@wAi@6#K&;n1mtw#ebz2nky|Bw z95r$l$sS&S-x=z zT{AJoT|!Gu3QC7csAVNFJ~(1R%D99!msLy3yM*#pRcorb@H%jpIP0kI>bivXnT;VX z{EfoqE|`+J)CIxg^4LMroW`i_#hM45eIc zR1K6GnK39GFlE}hgvOdvC{=8yl2NMsz1o3NxAtlyO1V0y`Y5IAsJ=&OStsS`>=K#@ zyUh76c)r2cUGZFj^CnGqmrw(kX}o&4go^f58&FEy%O&|C++08@c%Yh$(y&452AcaP zbp|D`;i}7MtY>&_7LUR40h~Xp-%z@5DvWgrbv2hz8Zu73MrrMMHDChP3@k8LP?_kG zE9L=8TPCU9Q(X9a3fAW|^$Lyt#U%$#o#{A6Lbe%L8#8fyoQ=6pcHtW2*w0XGE{>`5 zTry?8OTJv-5`R-4rJ2jrm&@^Wmjv!GjW||sR%5ofq`+1+YCGm^hdO|E{nLeOLgVqlS-1<)J2B3^c&z(e(r3RK zfetv}lJbYt4=61;jP-a#wL|IZQI}*qrhY~#{c$z$q)TXu*?Pt$bPv8bhc$lzkMWXA zYX0Mr%a>hJ>MEZ9@Ci0uQ`fHJICT^Ac}u-ODfzZbPXFr?-@EFUdpIWFcgbfM_Ylvo zN2)zqI|aw5S1Q|Um(+q!5c~$mq_>#+_c(6D_aAUP&K52;Orh-ILQPD|9N|J^@~Oc5 z;X*%~1%<;U@3-MnvqZSOF|A96OWIQ5l2k?=E*CDf%ZJM$IA0-L0xE{fDY#fET$)x< zBT+hO_EilRD(IyaptQz3K`Cc-)dr>PHI)OU=XI2C-EgVwjr%~jZ@6qU#r-gL=m5ju zl_}_t?Lukj0qX@`!iD@yca#>HYbX_Ns2ZX)-t0%| zt*P25T&SIyi_#gBy)o84IL%O$wwUKARc@j>qO`)?N2z2})dZypW*541Il zQMzr4$73EL!AwW#w8@qbE);BjL}`_|gHo|X)dZy}<^)Q4lGLNt;o|BVE=9-S5V>CR$Et072wQ&oTZma%A>AvaG&MkE8dpF*frFM34<2uc5Y2QQ5 z@8=e}W+wM{3oS5Z2e^fX4^-m@xrHtaSAOH%Lb=AP)+imApwdrt3vDt7QF2dG%O|^q z22D{tX1RraH?3y7aXlor^fd3#M#;GET$QlJEi}t`wz`E9&25wdx2rNc+(Q2yQWX!o zg|3+=DD^s`P9Jp(jX0*>oNx=(I;rlX^wtde3y%XXpHdS~yM^SO@ixnkonNX#={-V?%@-LwLWRwI^ixKUl+Uc9 z%X);;ms33}c!buO))hTMz07-*8dvtnKjtY)KUGng>v)75<}FHD>Z%DSJ@QsteLOg4 zu}4yZRh1Br&`t9Ur5{7pIfqARdzi}Y_6S9qbRLh;S7s*qD#9bTBUMlvkI=NvDg~wH zz14b@#`ICg`g(-M^jB9=dNxp19pn+ZWuBwdXRt@k5An#*p=#1(kI+dobP7HXlTCrC z9-&^-Jo4=?YWp8}jPTB^TJI6sVS+b!WZp)PG}xrpobd=fHuKKn>#)|;I_D9Za$eQD z;1SAxQ`JZ5lgV+*BQ({d+{RqNl7Cg#dmdbS(<7@*i~Am-Zl>r1kI>y`>em+@p<%C- z=Z#0G=v(#GJM1@@`d-cc;1MeMNge;}5gL~!BGsI<5kgDTsj=xJgt}xSkAE zazqHN{!(qp86h=ypYQu2O{1!OCi3)d->P{(h9~1^&s9ZH>Sc~>i@-IM@wM%08%jq_)Q$+D)qkpyJF(wj!9jH$r74HhLX^rK zj*t;YA|&Lf%5^P5D8i(@9wC(5%s}bo4K@EJ9vd9It1{e+5ZY`Gq2#%*Ry>FhYV=U; zeuDi9pUt|b5kh;6GbKW3@iP_m9FG%5zflKK>ibrWK`G}u)#-hNP{9wXQ<_Mj6(%ul zq)=z`0;Q<*>LW@ybEv{!MhZ2A-4K*BQnKWVl&4TPU!;7MKT_tx5{XJxF-??EU6X*) z!F1|5O2^Wxd>NvI24+^H@T2gG8Pz39w!!PJQIe~7l$02%vW|`tnlnYMo*E^Tdp@?g zFiL(jchPgdMakD2RC{#&wkQePt~&o2B@}i@^}84)RH1Bis(p>4h5l@*O16#`%Gpc# zEse(Yb)%)tUNsb@E{D}Or=o=(m{F&rrN;&J5+$FUF{#?*ju9#mt+ss^Bec6!jO=M0 zBU9R|V<^4up|bUi5t?Zde~1x^?4z3Yj}hu?-VBHl+BZZ#0ZUm_h!JKF+#m|sXV)5gsSXSi}%L} zl{lcDp!DS-mEmxVP`M*2@Mw%s-Lo;0?}93i(z?s)rz2 z)h?AF7edvqjs&5}ZguX*1flAKRL;Q(Lg6rIrn)>QL8wr&I*!s6Gi7dqQ2BZ47D~^} z$N33(Pk(}VEm9*;x@HD0P7unzT#Z2K-XF?$eS(k+?!fyE2~v5Z8j8{c_y_WBN)V4( zfKuiyDlbam+tm`38t+msQ2OSiI)T!IE2_iQ1iWu1K|)@tp(xdSr9x4)Yat4kSKIHqbigsQRuk2g3^@C$}3Bv&`uMVEm7#Wc~Lk~ zD5{7`L{C80qKOi0BGK7!0djt=ilRxy)wwc>Le0!`%As`JWEhnw)WVD&gYm%?<2No5zqd)0ex~yHL?M5ZeL|v8=1Hm#N_!`( z@F|HxvA?Q+P}-ZU(#%a1T5tBD)OVhmFh5b~qdC1GQ7Gp^wHKu`=GR4uLJe1{sVIf5 zQjJh5wOVCdpD0vgv)cY=qEOT!)e&6`-5;s2!bw7PzE!7vl7!0ps@|R?{608I;#;Y< zt&@ZnLEI>{4BZYNOqS6};s;~Q3^e1IB>8CS|C}Vf%vqHF7>n(VQ}-q&2~C=$YEMoQ zIyFU=oth+v;E8EGElKFC@%bf5Xu4UB(m8VzrF_#>Ba~X3Jt&o%ktE(T@ijO!OFczP z%~l?i`k7HEoiIh`Bnee8Md#sTSYf`LpCt6y3|f#R^xkY)m?TtSvHAz4=1WwYKazwx zoL6TqCJ9|P{r<+-;3PbNG?$X3s_{c-z#EhCpCqYyIZ2vcNs^0!*{6qgdG{iXh~&B( zxDZMG=j$UgpB~%T$|tzY@%(>XSi7VB}wG>@c;Kq_y0Rs{|C{h BQEUJJ literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/c3850e800f11cba5_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/c3850e800f11cba5_0 new file mode 100644 index 0000000000000000000000000000000000000000..a9bd79b667ee229254cf92730becb157a83da060 GIT binary patch literal 22832 zcmY-1Wmua_*EZlQo=^oMP^CbCgm`cQ)RnrsySwYIySux)dw1R4-FJ<;+k54i`}^_r zIL6l0sP1gX|a{v!=0~hiD`{RIrlK^cB`_OeCb1V+z zDFL*q1gx(NGqksmZfwoj`3{Z=b#{wm( z#dx4A^_>8Wq@NQx-V|W#W*}$_VA~38*#;b>#oK}9dzssQU@x7a)B`{n()2&HeaGR!`0hW>RENgxdSVPS(0o~~t;R=wG z=2P5NpalJ;T-Sg>G@j;NXKil-syo1edqBW_ATM2|r&QwsQ1Kzqi1IuFtTc!EJqE^6 zsV6{9I^p+}`%Y7y0ZT~#9Ef~ zbvj0)H8RYh>RR@tYxIOt17ye~bv7A{G?EJCl)*!<=@)g#B}4r{Mv4iNA&FMgPU>oq zAt*$K2)aves9`Ak=a-=v{iYlRWEe<^;WCsac?A2=P?}7oB4xNuC(JU;w8(JZDnrFs z8S2q?YHyPv(j~*CL>Wv;GL)gQbejq!^EOSR8R^WYs0?T60Zk|-L!;s{gp`n>K}oKM zJf&s0K*q8%45L=%WLTdmL;mtI9IwD!E6LE0M$zGFGU#f^(2M3Ykl|rNuA#9E{hP3! z^q4HoWSB);TgdRUr3`Ib$#Ac=4Cb~Rt37KwRfZ|kWKc}!TIb7fa{=>RC_|S;GVEF` zLye^}96T+9=Bx}o{cgyx|E3I%TQZ!vBSY{#8UCSmDmk{O<%rP8Q7XF}<8#RIhq@Z& z*lm)dW~dw^qvSXrEk{O-9GP^RuG!=$>X4%%g}dY^?v^9oBgZ6aUR;hlCFJ<0q#WNV zqqH3BX%Bs)TxI3xPlwCN;mPE6`c+wu&Q;|YK!vKwv7BC4m!obCIa<+cnp{(kUbW;< z*Jd7dD8?ZSEajl4oXIqDCP zW9~pX!UoCllCBSyBWs8p7lz64Vw@b#33B+T*+e-^lh}T;9A_wCiX1KJ1Ld14$3=QV zUnz8^9Nt-S6sC%E<+w-r7s*j=i5w58=Q25FFXxymi6zB2D`T+4Un zMC&O3Z?^d(M?s|mHL@!(H-`e*aw-r)w{s~lKDPq%DMz3JRf7~bOrwJpm_ya|3N)wd zRKUo#^vhc5IR{%f#h%njz=hPgC<8Ru$c5_ z1?om|47y1xV-#3xQDC@DfdzI2wmTGP%_&~NJK;We)UQE>`1OHiOYITIDg zpiT5GiT#ol=s}lK6fmbMu*;{wDH@ulz*JJFD^NZ|fqitE3KUjgX%PjsQOBYR45asz zRGfLy;8M(+GD|B^kIs>ytO5(mDNwAM0@WyIb&f+5>3R(X4%AXW*HD2xbcLQ!jYbO0 zYs^|VVV~BlaT|_LS#1?K(T-zuP{7okbsEUqgLr$00{v;mKMH)Hztnk{0u#n4P=CAv z&nGbN$qLw}D9~l90zaoIuxKXtf;P-i@ceRpbc32KXU$e{Pgg0hir%hPpurjieyvxa z^ak$jM%I@CHYqS`8|zKp9o#E=y;FfoyA+tdTLIM`1%jw5?cA$Cr+v(W><4(Z2>)BWp<8DE_koeZMF$k_=xJSVphD@r?dZpe*J1sepx= z{iZ)`3ng+Wlz2unl}gA|O59T`Q7^j^i*qQkfy_CTc#}(s0f9=mgOn&j8|h21lK(c8 zC}>n-Xs8m`!;uaiEM6_OeQJEyp=%QUxUvDk?FT9#vA}Ej6sH zMD{A2uPXb~IVxR4iR$#4zEh`~O7y9t#Fn~@^^^#$uf!1wXsASQ>efh!f14=ru{rZ< z$(&m;QoA-vTqIjtCAzdzqGBf{_ED$KN(`d66yH^erL>urbW@^fch-%(Jy}aq_ETaY zEgGamfx$}bqIN@+=tr-}JyeOG!<2kXtAu(2Ycf%ZJ#>L`PGVi=agXM6e-Zec83zX_b3s( zSBYbEjY{lOV$6OeevtM6*FZ-o-y!bjF|M6<9#QXp1tsoK_$4KDkCnJVrJpj7XG)ZP&AtDq#AC92<~UT3wvp_M5~aQ>QT)3SCn)Dn zCHhmnze;?dB$*01wJLPWq2k$8;RgLjHFK#jFSiQW166n$t-`1n70z2!s1>V1d6x=1 zsEu2NKJ1;FlC!xA-CL;egg(%ORw~?Wqe73i zDqN#c?NpdW+V(0`=)ke)G|lL$Lf&pFH14j#1?tn2dG=CaA{FbcLRI>gw0)T)UGK-a zrZ5kxFja-A(^P!ir9ud;oS}kunF^;U_X-t8(z@*`#O_dG7$xphVJ;PLreFu{~;At|Et0`I(Arv8b?%EO#dC_eaBR2a9o8g^!ph6|uOkodIXz@sel8;r$dZWU?EEPO& zRVYfE=<7Qbj=twUkmIuoQ|RUw6-s|qp*qc`m)}%y{ZL^6t)*3enAcwweo=p@@sX0{ zYOJJv^p}n*)hMS@W0G3UUlP?Y&_%5p=k02Aaj5a05?yL6r#+-_t5GUJje|*QWJ^|~ z7OkQ8DQYxIRU;@}jbU^;LyeTeYPgH4p)RIIW^pxYQ_d1ff~CSs!^wr8s5fg zT%m{5uZbG}k)xR!_nWI>ZmEW@wHm+raNd5LgT@VI9>aKhxEfDJs9_zY#w@BnSB*LI z)CicbMnNjSP>n6SINxqHG<(!oP3`xxMh981f7KXDtBVb+`Oq|yxix4- zc|97$(rkL*WsY$g)Thz$8hod<2^#FB*hCFFC$SA>QNA<{AG>Lgn9ezAJN?SgplxBU ziPFkwFq7_;)u4Pi4IWouUKKScTuFnYl&y*e$7^bEg@)GFAhNCoZdy)3^)#qepV#SF zV+{&5(V%5h4FtnV!jm6L4){?8uaa?!HI4fRO-(9^w2=nQ-eITx|asFF&cCk ztHDG1LV@Encr#gp15-6Pvx0N2;U9}*T*%ec|wB) z)bz9llP+t}_=*Nc$aPJFGS`{cEe&2h)}ZSX4R$@%Am$nCK>yIZml{-i#k^nhEWFX6 z0M(}zpESt-nPYz89?^61d}WT`HE8!kgUvs={$Cm-(4^lQ%$I3#hsw&en5fXguGAt! zt;HC+sL|qSfEMm-TJ+4Wg)yfVO=x8nz z>TX(er{3MQsM$k{fSy{O7cEB7`CeM2_tx@f7w4xf!?mbBLJRFkEkbAnogJlxZ?qPb zsU69uF*lkzU5mFfv`C%F+Rb8~RC10MOX$U1<~C0Y&jKw5(2<2&7#3^Mm{u&&;_Ff^ znlIC0&2r|lLJKF&SgS>eEn4iPwp+F6OE1Z_U5f>@l_u@eqSqnjM8StyZ!#a@TIl>y zo{Q63Ot_-OYw}#vViCQ)rA7VQJPV|`t3?l*^O*H`#(s2#3O?sPQp|s>8|{9fh2^Cd z3AFx|7J1*WAMMT3;v{{irf<1cN_)pWdCxuipv5_QOn)fbM=hd0Yq5;-e&xBKLEp8w z_Jil?C)e|f`}~)4LWd4A9s1HON|fu+U!lWjdP{AUI&4zu&_b)jl3Y6Ia_dkrP>20= znX>37-3ZblAy|igdL2g5Wg2YI;kZ$UN+CKt&!>YozYe_%=aDLSmm)WK0+ zhi(;g{9dR-<4QX0C3zL*U6XBV>u`aLb#-{%nDe#K;Wia&r^7_r-(Ckx2OT+pjL|HCmy>d1RNi?k=rEPmKGfkWebWb^m>~e=!vZjq&eHRg0C-XZ(4Tx60k}ZBiUgo=(EwOW1YiIi zDH#B7sQ|1j9e}De1JH|7Y6U=Bo3|;sP5>-*1JI2;O9RoLUhWJ;{H{P;-W`bZdjgSX zZy<8)3&b|!LB?ykaxf4D4+Ub*zkwKYI1n?A1Y*?jKnyt%h_jS@G7w!)2Vy_1I1`AE z=K`_dVjv1%4#e^+fp|}rtARLrKM=Ve1VZ~b5LLA=ls`Hc73gNsU_=%RM(Os!Xx}FoJ89RDVC0<< zj27fs6^wZsgYh3lo(RT(tHC%)_nrr1`-@=6UIwFgRxpPC490od_9qx?{|4hLHH9Ag z<$CB8dc0EV@kgacEwvs?NTboCF|DOwtsa2^deoy_x!68Pk80G%phu$+J=TyVj~@N< z>Jb~JM-RFlrAKS49$P6hR*%yjJ&ayG-Y4tfOVQ(LsvcL<^%z)Pk5iPtfgXFB=%H?^ z$4y$=N{_cxzq=mMJ@m-YQx8{fJ^IoETH1$W4d7S<^%yfq5BU(brFH-4(RrvIdujSG zJz_@c(UsDt=uv079?Pic3_Vh3=`ozD&DP`7JUuez>oIh_0N|10P2l(4A8B z1`IbCaFNOy4Y*F>CIdFp+Ay|@F(50}z{kr5q}mP0<1`?f$ABRT2Arkgi3Y4oG2k2R zOEsWUngI=q8nBuU7GvMC2AnBpfGN{}E>yRIfxjOau)88}S7smDSjB*cH4L!TG@x89 z=GVZ0wlt@M0VO*cFo~*lG9a|80nKP%cLN^vF~Hu}fJOrhs6NPmg%mK@fSdmq5INL< z4K!zz0ng~+7z1Av7~ni=z@g&?{5j1rFEDQ!OQo(FFqux# zqFV+&f5<#<8*t~50nv|Hw;7rvW_`Mm{}h#1D$kVZm(z%) zCL`X`*ia*u=QH9xS@Iik(QHJ%C?lRk8=-X?QI!sRj2Q1V;wFuWGa@>{h%PiK(TKt+ zypM|cjM$iN#83KM*oZ2{jF?9`iyKiW(};F-xPlQg>lpEv5*is%y@?Tz$lTnBPBg29 z5&ha2ah#m(jhIdkDYSzTYbmXd5hLm1U?XY{HDWPU7|yvzFh4p*4MrQWih52q;?Oc9 zvM=WtYmDf<-iRZ#WQ!4%w;C~*6uViQqekR7W< zWxg~b{GAc)Y3)}d_Wm?N^UKJ`QYJK2n6RGoDiewYm@u9^*-Y3IY=T;E!nAxQG|q3r zTH0B_#K-+6yrJ)5CL~9g_*$R|Ga^mcZ#F>}WkL~JWjEmyHSn0wFV4j0tW3B|w|pk_ zE^5LNT2tJFFQwVOj0vc0!td%PJ_l;Tuev65Y;MACI@HR9y6sI^P769QpUx&!rcqS0 z2Xmojy-m2;*M!J^CTyU_gPAME593&)Oei(l1jTq0ypv2AKu>A-0uwIM{*@*yTVujI zy1&i@(n2p9Rkv9$dVAM|nO{tJOj{6wMfwoD zrtYo~9HdZp2pYwQ;5Y>(gkUyhCWhbew!_jM0JTlzvRdxT&!73~=U zd9M(BqP&AR=06;BXb8Ry4?*iuA=pY8qdER~jz59-PYS`A=^-%9VBgt{^Fz>tek};W z(S;$%y(k3v7V|chS`vb)OG9utIuto$Lg8|TqH1a==F`z)q0kf$MPYK32t{u?R5BE& zONGK%IusqKeC1Hgq*YZyp|2K-MRbRvtA}D6rPd0?aEh)Qie1e@p==(C+^s`VyP0Slr?0M%RjjV`$NEl&=zwnY5sBIQFy*hq_fb z3Uv-gO&U+D`-bB)O&%7G>LbIkkcN&6$Eiu-Fihq+^Vny8IO0jWDjZd5)!uNp4uqpG zEjk>IWhcY&j!s<;N9!Bm*h-C_g`>i!aLl4>nh0pKMW8ALght?3{s@#R5CN+v0>)Mm zXiQ7{L?ClO1ZGgdF%g(JDFU~t-TVmj*cX8{bo@{Rg8t=L7b8&SW(1~E^rHwq4-&B`Ic<_3?H(Z<9B}j1Gm(h%I8~&nGkg4Vclpq#5tanDMck8T%`6p2}t% zt7=AAZ8O@^mbzvXt#9V*nP${#Vur1=89m9~m)HB7v7I*lW5$~?%z3OCeiLO5}A#7DEQH3}ao zJvIu@DbpE+8Dxy(ILT3PrbMA=dK8Y8j6z_kDBPVYaF90Ck3#m=QK(6)y0Yzn zDDUMWNu^C>;GBg}wQrp~)YO`-#!Wl@yKgG?S{PMPoj-D-w-e^`fDy zAC0^{qEXRraWrOA*Q3!Wb}gFk(Tc{er_uQIJQ^AQMPqbUG+%$TZYr5J3x8UtM8{kLLp`(6y9?#E#6Qz7$N3?@Gp7BD{hF9x=kF_54(A zH!*lb?XzN#`8Ea(sS8d0AS_~B^Dzb=X!eg7?Ef1BrObk^l0l5eD5t`LYDx#A9>kDS#l=uyLhXOj1gI2Oqp3ws&QP;w-uO!=Q3(C@Dnz%`r$9R{j zY!(_aE}(K-*lsJ=zfH)+c!An&XS*FdCp#^ev&({PyM=1|czZv;J|L7jY=NKlhy@jo zT5v#;?F_F|H!LWAPw0?k z!M3+NKkqC^q3fT8?>{W?3-~DDdRF*NsBgu!239m~B-Cna#e#NL}*9yS1U$J z*7vf)?|`ItZ!1PoOkd&oAS?X7Nj49*;$MmzVnyG7tav5)#@K9_P-vtTey1ci7;B8O zBKK$^KjSXRamEs3tY|Y<=*bv7PKadmyGL2nXgq5(fpwWEm>Gvt%jsOh3@ggb5}wVq z!akq#FA#1lx1!)m)<)81HRqy`HC8lSYsGoV;tf{3*l5Md?ZUX-R$SR*Me)7D)cxE) zT6sX&d(aBMJ%_B2A7-8>g^IVV@M|Q=bK43ly?P*=d2EH>UCE3mTo;8tWuIqOT%e~^ z>9tVzy%m1#BvBu%NT8MU_9NHu$%<}t|GUuR56>ixkQDiAMP)in0kT;1p$YUuEiB6x z3%~7>PT6BIh(1tq&RDFX{bbP#w?ks#_gb<%lzpjZL7`w|Ec{%OmyAECojDd;qGAyd z9g8GdViQg##lr8FWNLCOmXa|g7WGqOah4v@up&b73bF93F3DAq^U)-_Q7IOsE3+S+ zs3BabAB(&VV=+cDq-iYtrbx;+V|zMJ#ul*{PIE}zPUzAt7JmOo(z?f@JRKl)&sg-J zG4!RM@Mcsj;>HM<$Hv0%iDdq`SgfaxQ-qjVjI(2LU($VUEc}K`3eSs0CHj|i3u4im z#?$wu!u~a}P_2u_;`PFsO|kIXE9tSBW6?Lt*cyusbcCF{g?b0M2Zv%2{BJB`Xv%S6 z(YaXoZI-kUvF`*Qqu&=&zqg?m9r$2_ z^P^DXGi&~Z=k%MFux^?U*Mil*f)% zd4)gu>?l#djtd2a36XYOGuu%zN-)RR(avJW9m#2{9YHobhDhEz?MQIjv7GkM2aj+l z%?@pb9la#KOWWa>vy5f?~JBl>6<4hBwZ%aE4w-PL!?0oO1Fr$kd_qs~D z+hOi$$23|^>Ai)jL+zM7%#MKJLgNv3tQ;w9V+;+Yv&eB~{Pb;nz%3;G7)}I(uH|ewpLYa7p1S+!uO#RlozT>!BU>o(La* z*^%;xwUTW4YsU{b{zoHoU<93$JCLprR;V1vQajK^U5$n$v;9lJY_9Lk%P$!4AaGY&w?)N|lveL>OCfwGN+nv8=RJNUU02a=j{ZFIS{(7q3I?Caoj`NFq<9LN~v zzy`_T5e@{5a-ff7@)!qhj&-2SIAP`l2kuW~{*#0WQ#t=M;Va|3=?*-ZA-re&J5$I$ zi~Xq4YzOXAr8y3qrs8uQm`mg4IdEk@Z!d75;XL-z=3)Xh1QIp$@kcS zwUS+o?VdVtiL#zMpnu`OUV8c30e2R2lO%s|V9-Yg-bsEl7XHM&p>CfY*z-j=!Pw`k z1BbpjkoiM+u5t2pU?=8FHU>EHHJcMHvkS7^PLvLGLSquX>qPB1Cqhz$+G$QKOlQ9g;csCl zN*3i@#f0BwohY8k@yZJ`YdCSgrV|xw3H2CP)2Q0azpfJ#>N)Y3X4iKjs)3X5b>ln~ zOBI?3br}!P&8AK)Y3{_!7EaV@DHLk$M5{JV+>i`y>%{4HPNcRMa&>f~MkgnZ(QOLv zELi(F(Ye194<%iOI^mahm=jHgJ8?;}X_OOwEk--BZjA79yc6z;PArl%p6bNPY0P`N zaCfE?k+YqcD)~EyHJZnoOJ*)$O%}2qi-ehLoY1Zney!)8ZFJ(nCLv?H6T^3~Ui*di z7oFI8iQ``ue%)sKyH4bPA~eWyV%b|K4DW>NpPcX;^qKqm#fikPLWOUvE&ZS(Ke$Fo zLAcOD=E60}K7|WPl?&Y@Ej2Ez*Sb(Z=Yp61%_;QIyWlrMQpDim_jVT!Q-H~ZK9Yuc zTv(ph1!F$pbfgPGQ7#OT^s}*#U0CIG;hoEcMsDFuoC|)v;$1k9;NoYogjpr7p6+?&33^&*M(`4&huT^xxj^(g~DCN$i-|g`Lxu9 z)a5R|H&ZCK!Uexy{sDQ;x=*iKR_&5Z@=Zsf`k6h+KCDnzx4c%DWh;16XQHj=3auYY2 zQbF94f_N)Kd0!%{E2S-ndHWn z$!`2Ng=b)%8`tN%(Q*MJyMfoq{1sVro9#xGb*y&DErop-I5t!-0;iz z>c;SIJj;^BKiqin(~a7{gyDbPI13NbWP(rOfnRxvM(KfxM$rY82Zhx_hnybx4U{D3 z@}LauA$gz&T_kxzJn)N^JZ1b$Ekiw6pT~m&d4-HH5Bw@g0t&Gojit-s9u$iZI>&n8 zH$>vId5}r_N#*dMyJUgagJ*GU7cXQbdk~-M!7@qX3=dWo_P|?I*i(jim-Ap;rtq_} z2SuxTuvwz7;X&P+9-NjmspH{ifINt+FKlk&!S|*fe$HH2-PwcpT|8*qRjAU}gIWDN zh#Vl8#(L0ToCoJ5{ik?vWGcs+Cfs5yG{b{Ql3O!*d$tE_=LmV%c=+Boj^i6;Uihs8hLytXhKM`&{Wp2-zt7O@K9=v|xLA{qktydoSb;|N!$6F7g-w8L~dr

+oLQ}?-RPLt-lYeo4ehbt8cyRYG&nUeAb3o~ZTJ6OojgT{&7uBW0-Y0mm(I+&_@M3vkFF%JSgqQQ8b*2|FRfK8Py|`1ui_DtB zgoa)|&hVmSW1%YJ?xvipxff$w2>SM3)a~HqXBNG9)=~J#c&$6v+`|h)FE8r#_Tr4> zCSyV$)}b$R>F0&9zff_o7t@EZUL%E}V>#wHFH*+~hbM4Nlf397*)-FOZ?n8;HCvcB z*NZ3fyr?!`7`M=iD~r4+zF5e!)QiT;ytqiuNWNUSv%-srRbEV?l@z=|2tUQzoc7|T zq|8|_CZ6*G=Y{^4yzr}Z*^9PUyy*B!h{)o2)b6d2@y?4n?}fmxUex;L#RhKVbsYTE8sQ-01uCkI!zf)Gy5|+O5V~vB{7Kbj9V=lJy#G$`re?lBoNt{EH+ZTtLX~OdKIK0V- z!`c!;h0HiiE6?^7gpxJlFs^1C-zz7Ks2zuMb>dLFo^ZQi9KsvNVX~xn(>RQ27RT36 zgq1zx@V1xmi*ZbEVJ@RzjXrT`K{u#izc{S!FVq~u{HWJI!YD?+VngFlm5x&O;c=KT zLeP%k9*m8{0m+x~aY&mOhjo&@ljGp`VTz!b8VA39be1xv2@4sYPv_h-1jS6YBfaDt z<2|Z0i}TKogJzD9GB*x`=f&Z@WcK_xJY2wiS|q5K$MN}Z&PSK1)_URA{y6xpI}nEx z2Zdh8xQ^p-aGnreoQ~uBiQ=&5obc-*>+o2p#CVB9pRzuZHqYX)>3JM{FN7l>UXpm5m@c^myLNMb>dTWSBL!)31jYqdU@$iNT zx`=pGij2oW`a^Zi@pw*wQSmrNH|aIyvI_Ya+ff-?JSN(O4vu(ibH>B$5~7pi(IF)s z!^+3=^KbF+RTP|6;?bjOJX+Th!WzW${o@?J8FOh7k2dWEO^0~+&6gaT5|13y;vric zkJ3wcZI!TcE!Va#9(^_l${q12w=*7lB#(E+!@4IP$M*`u4ltjC@fdSVXm>dtTdu?- z;;OLl2G@Qw9yMItY!8zh%HB_Om*0{Zt6$}Ud8q$LTEElq%tnn>2KPQd3i2?*FAxzBMPBp~g% zFuPzP9)=~Nav|Ynu|$NGNJREbA$?LJhD}byi`hb_J&D+{HxWhm3s27^!gekZb0s!eo{x1>Mmx-7y344=>mRX62`XqFZNW$L8B)%3WoN^=~(3OP2lJ}`eNJ>k> zN=fJ9N!VE;2{9#wQst5`J~IhDDhM0eCgDpv_U|B!>Ys!Q1Cmg9pzv`}5>kdFVKp6~ z#iNC+nMsJBorGnyn+$UV^}HmMpPz(%bcxz76_%_>!poIOsIw{w9VuXgVBDO9`dgB4 zmLAdPJ%Z_c5*l1c!Z~_OeXa@TZg8GkNf;)%^dJeLkCHG-viU<2zJE-@Vw;OX(Ptdzc`{1B5vG1g#_g}knEhLL znmq-!oGD1mB{b2ez^|}T7-dS~IHS4x#G)6wE%5f`EfU*rgP-yqtpT zl4ZA2@cMQN);tt?K25>?XB_jnaO7PIvVBNFU&#zvD(=ZsF;6Qr4Nk>seJb)8gv9m2fZ%#XG{PR02rseJx96`{{lxo<+N7pd6r zQrOFw_$n0xUZ)~UvO6mkvUfsG#`X01eJYxN5Was;Md6=9dB&ae_g5-9{uYkOeaNBo zp}%B@#)m&zA3ErS899BpmrHoXI4!picLIIL3=#_HeegR@IgLIHkQ_DnkUi9gZv}$ zlr&8BVY$x-W18@~s1M%aJ}i+GFX_XWQa=2YWGmxCm9jqkD;bu_`O0&y3PP=lJ}ju@ zL$1ogi7JfMd>AO1Q{9J0H8@61p-g=rCN}T^4TTMjeE8DXhZaqQpDlbS+RBH`lGbf} z*x1&Guy#U5XCH=lVIN8EUOv?9&ALj44P}1AnA>n+>u9cJj1O(c3ezTXUnU7J7>iA2 zy{Gu_L(*xM4?AZ2&|{&Hv4rz2<$RQFnGZ|X3dgqbJnZ0kkPO?&d3SNn-NN{NK3v`J zLx}@I*&{woI_iV$m@xFT52w!v&(8bc_f@j#f)9tN(IuhMRUiBsOY&axA(l>E7lLp3 zQ0F$kmQ23m!_B)sl({D~$@0OktHl1+hcwziU*56q?}ZbLepSEuF#Ed?0Y8KTNP}9Q zhDREqKu8*zho<4Gq(FY&F2LK8w_#~W2v0-l2;o{}8uCY_VP&+?BQ6d5;?rPH5K1Pd zVO&xgGSh{#WzwK8mxiH|5t(T?S3V8t6$C}4G?cBJhTRfNwKR09o`wgK-F4DXzn;*B zv2Oh|EN&odV0_*v4UQ&hm@gUCGz}M;rJ-7x{)HBndoRx-hv(vCga)Pn%9IkV28a(raDhtvuYhfB{Ef=<~ zPs7g*X^`&}njJ~QnxkoGb6SYL#(G>&!}lA)#Jg#@elHEB?hC&jFvmw}*dm$rhWnhA zhDvXRg&(+|AJh1`W+BJdG*tV>J(9!~N=M)Dbfm-x){^PyTq+$8B?0BqQ8_amha|R& z>F8Q19gijFtE9tNEgi!p)oY|G&#n_B0*#=jkxK5R?TnP_AGGu7wFJ zqB4*boq+~1LTzgX7RF|vk4GrfJOiy-WZ;J6Ui%D~J7!>-q~y>Hj2o7L-;zr+G7vf| z1EVDC_GRGH{tVnXC|tglfjl>aXvUH^+5Z;%OKdMP(DkJ-h%w=H2Kv9rz#B=9cNwVm zJ_AQ2=^ryN?2|B=ao*<)O!z9yWxP=&$BYske|+M9HH@kAOU5z$@6VZDb#jawRpr6E mEj4ER_qljGXO8htD(sAS`rVyYG1izc`v3Lg|CIOt{rNvhYvu+3 literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/cbfe490d85252278_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/cbfe490d85252278_0 new file mode 100644 index 0000000000000000000000000000000000000000..b229b4512d81dc85c00272a16920512703742d84 GIT binary patch literal 112808 zcmeFa33OD&);4^4N@oHB1WW)i3?d*RvjmZw1OkN15JNyjh0{qo14+6=x)TW3AtEAz z7a4;iDj*690xBpfDk37t6crT(5fufIc}P(4d!8CP9isPr-}Qg%`~LN>zoFB8PSxJE zYfrUnSDorEcNV|UyzsZ*9fn~f;JvD)`*nO6J-hWE5Z|o_{@fHFpO~DK)N5e(0XGdy zOzP1qzITtr#Q2-Kb{&x1vu9$jq^^kr2K0>Y-mO>fp1qTkdnfkq-YdDg4LClDj(nWB z_*xTk@V(PN$6nsBB*aL3#J1XXkl%Gb%OX*p0{EA<3@7EW_!DaKu?0xZN=FV9)nX z@&4!%w^0^_FE&Hc+}1E!JD10{wOCs_o^RB~Vy~QF57`@EZG=WtRrGCZ4R0N?ylES2 zWM%hiTm5B`{FYyBkE&?Z*4_vZ&NlYwim(XVQb!v{(`L2__L#l#wvc8KRrNO*hI#qV zKmW9}civ*j+A`5nZb!3xZN~e8)i9Dpd4kD%mN@63>=yinm$QXw*h7nqkmv-%8N=_W zFw}WhgHXfLc0|LteNTOxdll;C`u#<|J~!T2;wj3{>73~;ys@;zozTs22`u=NkfGab z#4D5cE!B~?nUle{7(4z)#RxH2dQoC8=c8CkY_O=?$`<2%-I5gtFc&Z!#Jg2zi}4Vy zTiK4*rzDGIjPOfKIn#4KlSu#Vwa^4m%^rqaf#H410q^1uE z!!3Vap}Tlsi6;}^&GkTHX_4voLqMRB^;~%MUaAqL`Rk z9x5$}#CH$y_=;Sa?qRMXa{-%y>a~7vXq*Fu6HDCC9kgGn2y9)x=miq!o?KMy_W6K2 z)$3!0!QrO5^ELbu0nm{xGY(l#}xbKJRBO;7<{O!1VG%Ji}# z_b?!H<%p)zfN7dxiA&9H`rZu*(WvUn^_CQ54RB|Av)seolM0~tK64rHp&Bp_e>OR^ zDXL|9J*Dnqf3l|poOSu#S>OSwH>U`U=>EN7=6*0@s$jr`Q;#eU2Uwmj&F#wc=asVR z7ThQo#l?HpxyT=1X-U@HaInNPMMAN?kn?Tj&%D=ibfWA{otk9m%K(J zv!DGWgNFcP1MFmirTyH@ZYMA%3&rqE8r=ER=?kNM}Z`&1seQ-f$tdIK5Br|ed zzW%u`PmVhag~L_hMsxV{v^M4rODQ(-rhqbAPFjeI9VTQ(gYtv}Cgn3d;rZ{ZU;LSX|)s`rIj=EcfIQ+2#=3 zkZOC(@K-j(mCKV?D9kU}la*XbBR~^Fz$l63%$kbUq7lEV*bkYF0O!rcCcDFD2Z;C z)RxWhJA6wL+GFD&di5Y%ps^G$sOKsL>fmiS3!Yyk~?cqfj7fd;DcOe;3k*`aBtD*1nCiZ)WeTUhl7rQ(@P=Vn9-Reh!1@)eZ&6Wu*l6a&QT|%LB zl1py=p*3m95`H1ExY$)@n455eom+l-dPnxbo8fa8!+o0TS%6ko-a6<_wu&LbTTtpA zm{;JJZX}YuN2@El-ng37gQOh#q!hoq&^$<*p$_XT&pb(wg|1C5yDbmK=guDGnN;j5 z0^OgXpj_bCIQJn(5as`Lm!bHAq#VSpzTehG%FB~ZXJ?jzIek15B z?4x8MMum3krbKd75Ti6)Y`}DNRMHK2@m&pb4hpDoL%Oy87de<&0OvDWVVH&+A?4DYxAH-w++_SxrDk{q{3^sU&9xX=S8%XX(u{bv=Gq|jR; zN2--5l4xho+h0cB<$3b_$&>xid9<3L1UtKU@OJihd`VFj*k+jPSOB?Ir0u<%oD$(n ze>m+7S0>fZd<`7}Vwl2`ZtZ_UD`2L#$V|c)GGO_cp-v*q67e1wSOJ9ujS%AM%7wYq zSHwb@`O-vSLb!oqw79Xhuk>y{b2IUP{(Y?%&L#ce zvj}BO6J2EM`y2K8m~5l~yoDkvHq6N^MC%9B-s#Qh4QB-O(XN6t;aha9W?n)c%0&Z5 zta+CyDL4>G*e9xc$GV+tF6Bhk7z}F%)tgxe^*d47bFgrF40R!>tbh`r(qx6>)!l0q3xWwZYZ6tgA z#Ta~w&``P1o@TE`uL5Fd1C-=v+{Wcw@?AJ)bBobJbNQ(k$%ZAFG+Yb(YgEF zhQjl>JyM4KgAh4F)hK2_9wz75RPH|CPwZ@8hPRa(oBA!tTYd<&OFXSaBtvJ_h@pj*flBL zJ2F=ULWu0Lyqc$X_OWo>{Ic41e`Z6Vf3kJ}Dlb z-vwU-I!rbNVW)k+@M{V?U=1TPA*(FTQ4AB)VZoq&uio5K4ufKxPsGsWH~Uc&(Erg7 zoOm6)Lg)lR>KB-C&%BdpVL{{Om)^=r1l-tg?<5q= zQ0--Zu=YNoT;3u*3L?}(O`@LAeRVM@E-EO=%*POb$&xlE!`vpN4xtvenVll7(64O^ z(U9u(xRKKyXXue9XQqKkotV0P#y)_&exLqBI4F2{;e*WW>@m2W{pq)3$n~1ZF(QA= zkIfUT0LZDYc7K(wq0pO|KfqlCUx^DsPWLssgODRrhNTWo9zT3U+OWi-DPxn(-&p~j zo9VmjF!?5@!lQ(%RnuDxgd_}DW`F-eJt{N;4+K>3ZQf!zui1P7 zI8RrD-x`vJ!nFRCapb!2+$kOzW;OyO$U*~^#q-`F-#u=3mT$NkT4n0OFpE(Q<3*>` zynFi(G2%29E!;5*=4|0wpl-r1cR4}1$i!?(17>Q8&CpPAAWUIZ?d}Bo#URI?8|f& ziRnG!jR32UWu7Y0Zn_()nvdZRydYY=?A!bgso;te<3O({82Mb48asr)G5shI^X{x> z({88|&ZuT2HOw`Tp5$Qb9*^Ec4nlr4fxdL$hM6jff(PlC-t;LBGn_IrJ{^SFj4OvR zh{yrKkD{s^38KWnkWw?ZnRJbOT!FwP9u>)$a22_m)w=Wf%e2XvN``ZP(mH zT_|+ryTz21Nynxn3bI+=L^UQFvkWMivYQ~ z$L4Gbu1HQ|IRiJ$DhY|=?OAEf*{X;Gl8O<|NXAINB?sB&h@>J1b_o)2@-;a>kR`c_<<^{E1A;DUcuA;}X7 z2+d9d?Q@vCwB^V=P|9SKVIJX4_`}Ove$9!-O}LjlA6(l2x4S3_DK(@Jd}fH!EbGD% zy~$;Ga|mkkXRS< zG*C3Z7Y!`O4a#O}&*w){D@6X(FA^(yqU5F1*7T(+h{lGw{kh&OpZOvigR##0@#7;j)=V|gF_$Yo%dyK^(E`;v+Gi=YIMpxj+=5o-du9H}|S4VZt(EZ`$jh#-2id-!Wut(IZ3e;(=X;pKc{ zMuz-VN61K^e%)px%_5;k=n52oEI7FOy{1s6m~vnOuY(UO{bgT%% zo|1&2*B!UME4+tHG>BvkCTbuRbfdUi_O!QkpdkkZK>rMlkRx-ytwkl&2@VW$s*d6W zDhx>M*X!7R2Fx7FT$7aNmMs|OKE>F9)9ZamgQN#ebBh!zm&~&BCL?R}2nxiMZ~Bgf z^o5v_c=O%NhKkIzNbd+8T`AQUJWb2)vXSA0a=v1bgxL#ojpE7Zt$%(-8<9b{2&}lu zgP;{WA=zV_R*azg78MYqi^x|?rnRaxZeQcCNOr&v)yxciW+zDv*f)0cOYP|%z=9D7 z`HBap4;yN}OdN1B6GF0@aw3~qQVfT#_=oQ3iKv+r;B)Epemk@nsDDB?KMOQ-@4#Pw zWU-X982PbUg&XBU&!&%Fmd7r0JxXTG8(SBWaGDSj?qzq|{P`$~%Fv3;pjROZ1wxJl%T+m$~?hXNkRRM3953g#@&uD_L3 z7s-GnB^%$(%QRCIt{fQGlbThN@I+x}at``$F)4A%ZuN!kZ%}r5K9L@z z>Fc#u!(6FQuWy&spF+v=-4+;!%=RD(eik^kFaPcfS{7CdQsEyxL4zh{M$$5%XqBUX z8Ng;a*o_iX(JTg$K64H*N$WVc+$(14v<}H}^dSp;D;Hfna^yvkKw~7$P@Hl#hog&A z;rknX8ftb1dMe6=rYB$LXe9C!s8l)IniU|Orh_KT zrE~&HgZu^7+{CbK8X!^5c)R6nYR*wYjIbglgBfopwhkQKoUOm3@q#=ZSBYshm$b|x z;2?>8Cb*a)6yR^HdWZ~@xUUlbPpw|%Tjm7vvghK}X z)PQ#2Dk>@{8;(KCPN`ufarlP22XZCxuU7cse+I)FVjxmvrEOSWK`clziFVDm70*ZC zwla)7SB$Aq`*Q)6OH1Rb3%ENlJ6h`Y7B9F{jZ z&x2|vmlV-SNO1ED(>st=+Fi=rA*vk2O|*+D+i%P0OCifDI#Glw#{#5P-jw|fM|-UH zj2?tf^D#;SgjIgAA)g{baFdh6k)<>sfy#%BnIisD%iaA8uy{_`XHkW2@9;;J)ui0- z#gHkMSW!q_mFzh9#cQ9E9bN>Yg$TpVPGE<0)R!i;7onY6Zd7qGpifcF(51^)O}k9# zmtdhhFB5UG%a=beZ?a)VN%BB>$hLciuuCvYhULha02Vxh%`_TwU=as%>K!v3Sn~I& zbSZoqn*jAqzuXi~?eQ`0Qkgk3J;3+YKc9*a`iIpyzlh6ZbZ1Tl3@xEu?~0Kv@LjA= zC1MK(mVb2A!nFV&VoLL}YOLenZ{x&F0p3+b-k3Y8&UPNNek{Fn;?Ua?Zyy%{CqnC2}u>c+I)w|?Rc2uO7gY(L`XMTx4&aissMtlliu`*OY z0qH;pnEPMxsgXXU$3}ZpSiF)wfhA9wQFxxy%RDMWK|x@GEk;7z zHzQFIc);-4F};7HRb+d>A_l3w*c)_p-nPbt!dQJOnNPT__=Cg(IJkOpFQ&sF4|u_$ z_(o*wV)~zvwuhMp>r<4l0~Bq3?2hRyg2#{%#aOh1-lC=L+umADrgCIw0z=G{XX6Ip zb`8$#Ec|_5ab`(@tJu7os)T~d_LIM4ftXRiADh2}2x$}tXB5~t7;*QM3|+}&wF9a> z3glpPBDDTN_Rs^jIgoi;d^d-)DDZ&1n77V@Gdd>)ey%@*^gW z14n@toC#m?$OK#<1_inS_#%7Rs6+ZWBIH<)+@KsKHc?Tyh8F7PorAE6UCQ zUF+)aSEE_Do?$-oPTU4MDqG5+FK7>nJ|-y;$`)|(9pVK5(RO}w_-mw6a@OxPO2#HW-_o-a9zd)v%hTmUt+C+W?vOQ}66!&A~z5{Hi0y9`Dr4jq+@`{oj5%>$3F z5Q|h|EDr4FLxl`75seHvnzBSTl3px!yO9`DKjiWL(&mg3vTCx2Kt1&~Nks;v4s7))aCZV;NZ^7qY`q{D>gz-VXo% zj;N_2^bICMEa|Xkhn>BS$f2lex-2IdW~l1ayfX7QN!IX^!VE-ntx+3HMXQTH?$DT; ztb~FI6PR&I$_#WbubzID3{jAYV-T#Tv(r#TVp#WPyGF!N;LU_DmgVMTwhZ`n)f=Lu z=NOK?jk(1xAEqU6FXm&cfc7`O`S1q}p^<{*JRe0^-kPlnH{E{k|aF*4#7#mVxqcCFiYWXJ3}>rg&03BHVSS7rWhNfv)iIdJ*eGnF1Reso-WQ z^&2X+EB3bvh8AiRR1=o0n#4^NF+nkQeRWSej;ncCX~AxZf!@p#A4VJm$4IlcKu^jA zC-%R&dKVp}*boqKZy-4rcpyhKdF zLc+n9Gbz6ek@7%9kUX)(Re(kYqc+w1%$q0s3N3=0W|U=qiPjx4#nv$Mgd`Ohtj8{% zB>LQ-ty|`cs=FZ@AKlF%LuGaP2Q364Y-ckNdq_ujB0D=?T1!m;XjNG1hx0J$_HlVxHdCjFobPAGjT2L zm@`$35m-O~QVH96NQIchO4Y$oghRvDc}G#&3>SCH55=dOTlKbP(r0Hh`#AP!#zVIr;e#v`Q%0phwt3xxHLR<_M zQ4X`GblFQi#PVlJky}OrW=ApzJ)hlYY!3$tv3-m31Xxwo7+Ali*94;XY9*oWHxpGhOej897(kTOEnw!xgnY$~z<0Xbzg>Dy{N5F}Ta?$qwKIe`SE;#dUR)T62 zqwT{JCN1G0A4q43nHYRD?wJ?xhx8vlwm@vfl&)L4H*+TW4;CLA+v|1m4|`g;GgZ@u zTqL1E+~NJD*9i-R%NM4-i#!A5nIT;}Q~RKnaKLF|(~a=y`+-_6`-VT+@FmGP4rYpT zc#1)gRe#poHsSa55-shu7Z8>k>{`?759G0H8FE`(z=y-0u&N&5e#`u;rjh$#DSU51 z86qdSHcA~RP~vTUeY2Kq3bQwk_kJv*Vd{n(>_@xn2Q6nmhL0Gp0~!&?m@l&e_}B5D z-X_v!wc&sQYCPG~@#`H;Xc!C>vhiu|QBa+mFBng#bnJi~i8yJ*a1rrHp+maR~b<@)*KJVHq9y7xNKv2^=4n-^xN(ij*Noc##`Thqv}%1|{)e z+?>$-;ZGS2$+U-@$%u4-$~c+pQ5ACl^kaJS#%t)g^g{$@H(ZEJpU8jFM{j{$SzHL?o*?N? zX2J-89JE)wHR>*o`2l+oD-9~w#m3r#c2os7SKjeNvXr`>BcON;>PY!*ydz&ETng3G z2EsHxAt%xAO*>MDQGReGa)a5+ECABY|9t8eBF$7g`^8MACFuwMx4zZk1!_E`9?*6f zTB7Acs*~IQ*~CuWlY5Y`KSynfHfN#
IqX?LjrH6=SZ&2}fX2%Ox1bJtv1!QWrz zu;nf$a~v2Y7p+d*5ns+Kaz;NgUB?t=Ti_@cST4NP?Q6;-&)45uz}*PYB_WSbaFhMH zu;auL_D6cVE4E9Gp<@IsmtLBcPAss?K&Kgun^vXO*5em$Aj_op;_?}|5ejH@7LC;J z)GM22Q(K~HS+2E|CYos)IqGf|!KAse^1K1Q+LdIQy*waWxGI_Ry1u z9HakWaNuTF>0Bld62flTVrZEho;`!O4cJT|n*r7Ck$0Dpa&G?CyU5Kg>=vLp-f6#^ zDgu-kvx<=91Uea*_UU`zR~lHJPvoZ&!q-k5n;GOCw7K7%mkx1xnp`)%YXx2xEWW`4Rgryn?hk!^E|SSjP4J z@Bn&ijECDb;ci5~Gwz%hPA4U{*QgYnSwWg1ud#Rbzg8(Z(z{q0<5p6R>i{qhgI+A3 zo(na*Ddu`wwD^u}LR{&d%(>rG;sO7PkNB5*eHgG@T#)PIzVVHsAjPzw12(>! z8&!WxhxVUN>w$>{E&QNDHf4qo?A{jJ^4TEmN4b#E?B73M#)%DPT-e{PgFcF!dq>goAvS^z&Fl2`6v{{mp;$g- z3652K)Bj6yOhq^~!6ojQeMkjVVRpeCx6-kxHK~Do>M9)%=^?#SSj39cmCh`F`>IK- z$jng+BQ9*#4HzCPo?}I*#*%Mdd5(seJSKH$O8>+p?CcYZw&rLm6)McWb3-?2xgHTy zAjKl`Oy+b|VdW>k6|w@C2ss~RaP46#WF~Hs=p~)nuA}}2ZMx$cA;yuR;1#Cp>s0U7 zwP?PA79kf01LOwQ(#_E%8UgRR-~W8DCg9b>^%Xt*ot44Zjh+7OBV%QBjPNquJE9;f zC5w7&u4X47-i>c(&ZQA&tBH&7^S!ApV8Q0!eVO!+tf#w3mvJ-c|@U67o zpw+b$Pqvr1#-KOA1v)N2_0UaZ8YXRWQwoAM^B{`B6R<7h!2M!?Vs{6~hY-0ekEbTs z3~V7})%`Cr27m{_u4%wN3uz#vgwC`+(5Z)+=mMm45_!{ zJ{G`OFi!@|II0N{4nMGJ01;v{0#*@FNE*LkAsCZ(Ao?phn!rFPXsnqJn3qtw}zQS zS|H$zr_YCK*TAV;hIg_Ua80Y~N%pF1%ZM5y7ej^=dUrEbF>}IQKm37uc*q!TJz5dt z8Fr|YJ{T*+#q7LTswN5&;~BR68y31UGu=gc_llp8knr%kZng`>zH<6Y?mbIcfhkjl zrH++M5sx0=nOHoB>+$=Bx;;7mTvW`~lwW;tAgu^{J{j`JWNfbL_t>2cOQ|P9??qrH z#&*~sDmdbjI$F(Ts_M*DW5t##OxvX?F=Qo0hf$%NO4TrOO5v!BxI$Z{NH{62s(89d zCJ7jiL(#?8Si}k0*RvYWA4(Nf&#!p^!p3l-%|9_Q6%!= z25dqIJROYX8>l?k12T^s_-%_IQ%22!r8IMjq=si4ocMRkAK4O~oRJ=+`5-& zzj#J=WUiNw@=IMer%M$8L;D>3Y%;r<<(1ou%w@_k^gGc^?DGn2o?z6rkA*GPw`+kwamleK~*K^ft!Y3rjBH}OZ`}-_nC3&{ZKNlcyH?V@!}gQ>b-vX%v|a z#10SGO*7CdO?ThHL>E!Z{c@Za$X$TuKA@IW4ts{Jqjd*Hc|F^ir-tTu(K(+F% zh^6?js97upgkD@YxOP5ORfgEy<|=l%AR($)bm`v8m)X!Hx(H0+{c>)M(TEig#$K*} z;xxlpHS)4Q{^F8Mq$L9jB1rF{GP(}M3Gse$JLwV$*1)raDhu15#Dl7E?+GzoS8gsa zr8kc&-qwHSgXJn7aZLg?b36V>-Zs6acQoDH^GQ@f38U2@TK)_MT{kk0@VSwA6OX9EinmHWgP@#{W?wZEiC`ui31)f`DXwXtICgacbE&)pyHiN=rf98s%ZbW!BDL)ZOJb^g0$ z|4(rdKKT9LZTJ7L_rF(<{u4igyH@78C%;P>C*`@eag z^!?v#U$;#<{;RjH`+xFN)AWC`&Hp#F#eV-49kq_oZ@F@hQ*mM^tTa33P{#yIOMS@MtT9HkhivAc(eDoZ!sS_A60dEQPjt1hqi9qbz zkzk-J&$In7sK>S_9)n6LI${p*4|U!inM-zC4NNQWijCOY9m%lDoa!o@wX(6Lv^vW8 z4-Dbyd_2U`{+y*2Lo89wLm6y@F9#Y>TGUjrhk1sdf=O2F=>zGN;VpZ5k7NGATI}Jh z<>y*p6=2UN0Js?pmq53MDj;Tb$sSI(j@AK61;FkA(9^ml%~Q_*j@1FW9`dn(-J&JT zOs^o1%Kl3oAa0-HRtQO6vfVyrq1$TM3@vlA|9Bm!ZeY%d$XZnJ*({- zL{oK5tpX{)BX}#9X^)lYg<{b!@a2dq*NPQJ#lpr&CcvU;e0bG3N=j9c86QL@9VP1q zkrrX=S^b|B{xV4F25$WoSsD#dDrsr5=$yptQBvDV!YRXwZg?P_@Qh4T#}s%~$% zcVP>oQG|V2=&TUKS`jkKX|cj!1y|=-;^tba>Jhug@2Kae1 zxo|#q^x_KD(EcPN4qA)1eBP9YRwpbpK?72wb-fNPt%2$w$IDZ}gbuD~X(kXbbkWuJ ziHgd(I7WJ&Nbg(v&c`XyiGn&dKDm`)eA$}qq-G3n)#r7xHQR%03-2_-P>SyPSwQ=_Uml3AZ%&#i!9M|GRYN= zJk(CIQ%4Ol*nn#?P6rDt#<`dA()Ccek&vb(#(9G!3%*snc6O}5NSPqUL#aAQcJ1pG zk-=f3$XigBomWu6MH%~;xkB-&xEvv_#;15P3!lM*bsn0Sk9PoB#=EB2)F98BAu7XI zAaT*mh>O|hv%w_iQle9cSsKH~K@zPQj0ZbY!ivdH?HD5LOKp+O>~NKqJrVZAi$-M| zi)~ND#o~+A7RTO*>ie8~#yTq_E-r)ZCsc>_w1wSVRUNS~#;6xj^%ug|w)0wN!{`AA zBu^9dqt~^{zIK&-z3uN|*I(XF% z4#r|!s0GI0bsL6(&+(Q(?^qCr+7KQy+@K<~!RN(bprPc`0Nho4azvQ8Py=)f2TYn0 z2H7K_LJ1QVwv-RkhgMu|Z=x#CX=RI=tHL*&7R+?+rcdpk(gd*E4QJWPHH_R~RpM}4 z+1+ljHn&wRwNJP2L2!4`@we{vDF`eizGjG1tc`Xa%4BTKmm|7M7(W$zG0GVne6PbT zm+}V~`1>+g$ZwCE9BcRz1OF^cY<5q#?#ivQT{v%p$G18v8`}g?&Ki*m&s#3R45KY* z8UUJ@W1l%=%dL#GxSJu+Wv;UeZC+rqAxq4{EK*3<;uvZTFUKc!utJ2BF{BqFYKJ@G z_ToPtsmS$^L!Ef(l_H+6l1F)xok? zdiEfcqFGz5GJEV}B$)O?*8}WQFjx$u{|o>$xt4vJ8*p`xr_33GJ{SlP6%EH1s*pqL zUndm(7K|)31%M~*g>NnZRS4ec1*m8@N`fW$UkxF0SbqsNSD?WquEd-4AYW)TEC7GB5e3ckQNW%j^LXG(YMvMC;Ot!5imJPUfmeHXtH6nF9Yji zDkp_W^U{L_xg}fx(7sx34K2r~Qb0rp!n%6mmcj8IFR4s2*-@Bi7;Ets2rXCx+?Q~# zc+8Kho>%NGGAib{0c|t~4qEKZ#8nIDTqx)I8rX13<}E`xwaytva^>Dx?lnOp#$E;Vn7wux*i&iSE@{KsjqcNtrwVDL?)%4cAqV zWwb{!gS*>8gTa)e{1qV4)6v(qQ2d;$P>ZieFIygczzQYU@PPH)EN~tn*|Cf@il`qj zPC8-jtWDhG@fjA3JDP)Q8({r*mLdp;7cgYw=*m!zP#O3PuLE@g5ZfNr-FU|~2i>QC z(@>d!il_x8yMNCdtk2KYa5q@y%o7Sk&(Fr-GK|PtV04R%0B}G9F__-8Z9)RwOtE^z zO<`%Mut1TGdUde8H4l%H&(}@g9-@G>z_I~UzYdTK07DcBKZ{m}uKSO=$mG%c-#P*9^`9jF38tO!6kLgp$h)NM@wRHIr@ zQVeec=CXz(N5>6&NNgwMzE_^zsNAPk%Y5KzTnoi|6ufTAZA5St#`DPElC%4Z?4?dQs-3xTCc9V{;ZLyxC))8Bf19UF{ zUJU@54I` zcuLpaBVtMYKxB3RlNR1YV2Z7SDIHiAFV;PG*wJ%pq}G#S05z)v^cnzuekQ2-UQ-_& z#^%)_G-7MG;-PNdhvMdSFjWJ~jn8UKU`PGia%OX2E%AUM_*7UlJN&rSq7Ie;z%c1K zjRovD*d#$7iB9bUHEdjA(mgA|t*e7EDc86VcxEiqu923>*UBx{AGgvq{<+n9X`673 z)^gmJx_XO6B>w5=n&T$5wG^K%YoX_e@-z^8UjXtR^F(}&O2!W#TUYEL>eqHyfBS@A z-rZ^aWhcLs@3OAlB^&ElBkNwx&J=_J5N8PZy@i6;#sZmd)txIt@ioD%t2p+4w7vR8 z%_y*Y!s8zuV?D8*A6!y+7^brq_u?}y7*7m)@h&i=uOy4+kL<>$KUy~*;TOaDEHKD!q&S6~8CqV0o8-_m ze6|fnuQ+}0Ylg7_Z)u^J{j{FdWh>cQ^T@I|L*7`Zr#2GbL#T3XFuoX$s-FN;gSSC! zr}=qonXkpaSf?H*g-1_WH(ubE-50D6TokM~&XlW`A>(7`e|m|-8+VrRX%e(Z25GL& zKvBCoEk5@il1-b@V$A$3j>3F>aKG)z2W@D`u$D`P{OC}~^st99+z=05<5LDwi$MNS zAiA(sbMZkNfIbHjLMp9V^)Sr&{_ZB^iti$i<`huEjTFpTwIYQS4VDtGgKpqi|~0vEileA zKLJ3iuQbryPzBUj0U>%YI@bZ}4}i;uG|)~bfT$E&tse)_jdg%Fe1|ixzSlratN;p@ zBZgw5OC6v)0PyY!4Ybz*AaYR43L~%4wGL1v0IE-EpfaqzAQYj9qfni!zz}M5s|6-Q zk;hIOM(;Bku!C)poKhe$Aiyx%8Qp7v(V@)*z>OC*(61o?A~Q4xG1?hD>Hz%<04;yh zK+ibni}b!Zgs+1fptahxP)1Zmt7V27pg-^p9-mC?aB|QMxS*YDV8WV7~$+ zJwk)sZ<#xoQy(pJgR^Qj{2P?jhNBGO@ek-2%LR@>~^@aIay~VXpUT3F# z`i{6pc+dKWpStz|aqXAan^iE_+fSl^m^h7YV5;}O{N`iW6dvVOL_ zZvEinuZZ$|dEKaEa#wMkA+HDivj1IiT`I4Wej3qBTr+(Ee5F_2`o6d>k=IA=Uo5Y4 z33yq4M8E*?~6gw;479JhjKi(G6G&U*T78w&e zH{MpSS?rv6Tm2TX^Wtp{TE@aW;M)0RP0(!crA) zu&e2Fp%$LpJbY>GfQHxOEV zv&VjZk3bi$=u5WEUr@^^Uk9?m!N?TX=MYsF-K`I;01KY!Zva?IFqp_qUju-u9suk; zH~%`+po{LQ^ z)xMU+8>lxVxP1}nH|l9I&i2woUrnNegMv)}`e!hZl12TSEXHZPYs+HAN&ELF1@o-W zN?F`f6R2yS_AXEk4MwTh7lEhVAIDn)#xgb~`*e8nKEQ_60%IuoDga93HPBOlq5IS@ zn*lSt4$L2@->#2>;mp5V_YqqdmzUt=L_VbqEEI$u#y&vNh&otS0mHsvEN5QW@{Gd5 zbBwOUvISUD>tLC9v&C49x9Bw2qLN&PpQmbrmcT>&iXLr=AEH?NMif44Li^W%WnN#+ ziD6a+q@$p%sGJtuyb@%qTd=<;;YvZCxny7Sn;mO4$n;3kFmbB5Wu=$#zj#heon45* zgA*q*U57K6Ef^zfwM6gI7HzZ}gm!u?5PFVE#_{QnmmYF7G7`R?;duOEemOqNvHcMT z6n@RW9rI@M3s*IyMtoHhz3WbW3?%8nP4(sQ*baA9_Wy4umDBmQ`g}It59~3tL_2@9xG-{v^+|gtOU#HYUWMb`IS9n{D|#6>SP3Fo zxFYH?F>{G;H$HD+(|A$&_AR?d{6@}rc|wh9v7)8MPXot~n0MCYt`y+D?^cZ;0R!*^ zuroC1r?BTl;X*HB#4eDVhVrYctP!?Mwtto5 z*>w&?&D+*FetDf=7Or>feS=>feb2FbGwZy$#j$3q(8uss4woycS4ihZSeOFRJo*|yW9tCT0>E1V zpq*@q1lCsseuK|D>HzHqfRUqH`Yu!fX%Bb+Kz9ZMDaKv{kdWLfoyYNAj{EmWUX{!K z7Rn%>bm$TJAW+^Fj8ZYGBhVehTLJ2HRVzjQA$*Pt2D{SY-w(F*7 z@*sV_nIraA05}uQK%y5C(msTc3caY|S^)HAI9;{&@V(~?$BHkd;GPxyPgYi`TmBw+ z#IeL|1u=G`DI0ktE;^N+Eju-*r6pQ+i3G|vv$I{#psk)ox=UAJ{Sh^L2lZ!WMXdPA z-nMQW)WMd74+duCaRa?k<*qw{xzZnmJ=otK0fu<(5&22!^TmyW)ekVS2;S++HB$V}-_K z2u!~MlUWDT+rV;Hxx!?>1yQY>9O@+02|&5(Kure3vjM2DLKevZLPuXG0hCb-NY4K^ z0%Z05nrw{rp3-N;kM(%vQC9=IHnkVc99*6MN9`DFhY6(Y_(h*?I$SOU!~m zWL-5a^s|YbPk#Ia5(1$M<0CJP(9@ zv^GQhi(9>aD;sHxr(`qT@+U)ND+^#NI;P-IjhG^Ok&EttQI_+7!~S5D>o>GiI7_#t zf;w%F7f_G;w)vtXYi7K2H!s`bH~Rd=-m*YDsxPEN*rY0VEdu8I=ll(Jq}2>@{xCkX z@P^#v3)X@))xV7&`bJ>AxD~eDL5nuFwuzqvDbPPjtbUh4D1hE{${2!}*>&#Tqv`43 zUz*xE+{q3Wu^ND$1?_Q90U`k-yQeE^@pb0KkU6WUX`ieLd2}_u>|GtQ{}q0DY)!}~ zYeGVdgx}YMtXs=3M(Cadz(|dJy(Sx_=MYsW%n5E<4O9tew(knXI(t`}%CqT7>}7!E z)&k@5!59D>2mn3r01%BS7M1By{=_GCyoi^S9fAG?z*jHnmJ*rKqr&Off$W-42j~v~ zOkJgc{;l(QtyD`E0Oi*KdJF(huF*gp!q5_D(K_I;0;r%4(Bicgqu)9WR4q9OeGCls zHh_r{5^dMmSF-Ek8x~{Mdm8Xrj0(X}A%ODKYK)HM1=L^vzJ}>(2T(8rodELI0h+kk zVhsO41HEolKyiu}p#UnX15^NjMq4z{LZ$(gEu`BK2Yjf*J*KU7RU2&TP% zB*6T&z@+!z4WPvBngrNwqqlxp*+7#p5@#AIGE`uw@gY-cl+?nA?F_zy7g!pA zJCo}0cpUiRI}*&}RavtcM&gVh@x$3lQXE+5T3Q3k@}y;1iBVL z|EdEt5&(&3HN79#cx!DJ?ErRnFjx%NDY5|4<~$UsMTMJG@%7cu&WfW_QXP0Lx&I@R zeVkLq;TGw*4hZiFMyTCC(Ah6)O2RAvBl$Xz=>V{MYk@J_9|M5CRT}6khXT^mtd0P> zuMW_M04S~2KyR`o`bj-LT@Rr0U?62Y?;wzG8Hx#x*jYvo#Mf`LLg&oJ-Gnb54V^P5 zl!_Yu9`4KD{~;MlkD+Pm0`&I>qgVaE2}r8&7JzhG;jI?i8DEt6-2Ht%9QuLZAV;`D zb<*yyJ8(@6#wC{2bHc2~nh2&FY8JRpE(l$@h-5+^0xj&aY~M-skS*YVI-kfru?0Os zA(3i4P^X2t_&J*OSD}R-^Cz?d0#q`-UL3mq8MaXQOz7fOp*Bat`cGkFEF*cryhiH+&G9CTmu~? z5N%m2RT6+6ssj|&(rP?{w^UE?tIyU$JIF7ur`DM>+<+TA1osEF8FjGTdyUmtigy6p z;mRiaiA}0SKqH7P*h3EhwukFrvs`C2?!;Sip-gi@+jKI3X4V0k2!M=^8t5yrUzUV7 z0u}Ux0|7NF7^;BD)@dkJ+IM>+6BkPR+Hx&Y%)$Dq=Ox87i`jxDI8d4peEK$#0sB$xrRNjn)aJ&?R%0;U0erJx zvx+l91wI^C&9hZi^sbR1%V>P2k%iTh+w*;0fZ8rJm_Jj;r@HVASA^p_Yt!mu#$M>W zCBDjP$P1eV7j|nKhaJy+g@oXVv|TLN+1z%)U3JkOiaD30XpTrx&>7N-B08BO_e#Z( zEAaYR^IJjEBf&Bgom-BMZ5*T}ZNZ)nIStX0P6yP#gQ3)rvKKHBBj87CZAf@|e%R8d z!^DP!m5eqlG4ld*{xyrj&O8DCUb7+Lu28+Dm~5k7jY4a)gIiOkd<|N9ZltF2L&qGs zoTim{48R_(1;&y7H2{2(u7P6h0HO}-DCl+o&8Y(vH_B?n-=TrRFbGO0J;d^WthvEZ zVHT=Bf4xPi{`-He`hlz?fhnow>+MD*j{3FdH4;A;ZU0#+v`QyJ1-VoEL8XX{&1+Hw z^z-&VES9Jd8MGK$QfD0c$px5+zB#2*J>#q8EJUDw?IHN(*IUL zDXmSbZZ`HzxMysHRnCjonbl{0ryp6%kFV&KY=G z(h(AW(Gn`^G_7i5#9y?ASEP%}?hZ@jvd#c(*4<&Nzq?V(3(p6mh^oL9P_P9Aoalt$D#>zjC-e8Z7m|>Qdd| zw$UcLG5Z54b&js~Rka@v51thF9B(x?yOcCJ3{N<@_YL|{y=hSSGQ)me3z}+5XU3mj z*rx>jUyrbJYK^e$y>tTDTOdZ*yKrlMaPO59I0E7ZXE0pDq%1J+nY$(IgDtfTJu#$0 zBBb8Z&c_4cf?$Ng7mWw1pJAgyd+px|Uqp-5-oXW^g|(pMjP(z|q~&P1&&6{Z!J}0M z;3{gtam7C$5D(;Ps8x0(GnwGfnZ!&0EeZx&MmuMgP1$+Z#wIS*5I2BBoKUHnMZ%z@ zVHSR|3#+7^@lcN8nw4iYUc*}%DfcH(6}63GOgFl!;3zN-%?)I{8CPTADe@_Nu3v%b zstFn$rcS}gvVp9dLMBzK1`~%wO&FYq;YtFQy?=)(2bj8Rvcl?JiL4e`bVcWZsCWL~ zkd+H$Jv1`mhXyidIq!x2D;=P!Ey=R=zz17*L$G4EugxAt*pO&6SnGrP+em%Ae4yI zbW{r{55)J>JVoonr*slaZ*3LshBN3=sepXVsGJ3&<1uNQv3Hi0gSy2!%VxzLyM30! z#z8)$O-LwQmNR@$cUx%WuEt?In^&Ku%c_4xLHN$*RiYq@75BuBkG~kvNPacrFGfa- zue0je;RowC)$XqDlW5)c+Kp2D*am~F>~9W=gGl+jD}EGK{7`PKaR{mLL*fBg3P$Wj zib+L;ks!V!ViEr+45+c3eqo4*iD!XJj|JP08p=Nf(^pK?X4lH9PW{j}o)56cgTchk zm=6GOCr)9vw2-@VP{}y@L)faHWvqdo)a-sa_G8$iKMNV^jgRl>LrnA_juj~5iQq=W zGIR+VSU6cz_Msh=QHa_hcmeceFwm6;GrS+{5CY4M18Y3GRz@lkm2o^zUB!3TQM5Yl zer+ptwh2r`%UyyLuJn%E#c3)UzLtX*&nJsevf66>dmWg3+HP#MI)o04>v*}4&Vb|y z6$m{4JIBOrm?4t#6fxQE=p@4z>CpB1R}qSy3TBRQ=+n@rA=5NRZ+EI}HT@)2q!>U? z*8%bZAasTX`Y=>Q)~ywg4?v6S0Cfa_?_mwJN+;8GUK|U8#xub{Y5-dVkQZ?#v!yq@ zKtTsI!Pn9!!+(A%9BRDx>G0PU^GoG(;eRX*$EK9E%fg?0o?nd6b?aDHjaBklli*}g z37UL1xJjk|q4TZAqD7k0iB32dg6Zx}0oZf3z?emS7XZzk&_D;ckWZj%K>!)~F90p6 z1Jnfoj|PBR*#Ja+)>GNL0kkw2NGzX|4mH4ah&FMd2DpGe52C}}lzB|7O^hG!!OjFg zAUGM_V^b3@R*h$LA`Z)yztWaNBv$^xi`uy~vOBh0E)Bt>v-SKuQ-s2gn+nf>L`O z{`aHd)yMFQ+JWqs{aU$eoOI|(+Jiv(VlYb8Y3kFGGr0^*RuEHo#)~x@%u0mnLct^BE@3?=#$vbN{kDDu~K35u#0r7e9bm&;*b}+P6@=g~CSwgPe8;KKFZmGKHjHs%xN7yQt)iYwRvY=9R7_O@WeW`H(nk5&WcNlRv2FU*L z6}zK39C5tji;>7#i#S|>7SUWefeKLga&XT@f@(SdRL{Q(?s>qu4aQG~{eYvn4u2Qw zqfWsZ*@!XS;IUEY_oOP@@*dr*E%rS)ILa2XE9YYM`OrP}{wzf{e|e+s)z)xP5Ge}k z<3y>by$f$L8nT~%ENCQWQ>fIIEJi<-3&Sn0?8(e6(=DrwW&jfDk0^TM(j0~z0E^- zAVhP=`Mj!&*dpI*Z$VYHJ#+*5c172y*L-z;*Tv??gbnn_L^fL+vXDQN+*9>bnB{7|^eimJO zCAe$PQewx^kdoN7!CmXZnPoHzo$p6l;A~d^)O7>ZV%#0B8>S@QF!ruH?!4j7&RuSZ z9}hXwaGgEt(Wf5kG^QnIAa`|a%lk25{56OPuCry_V1OT$<&U=DpbIrr$8j9*6W1DL zmaGwz2sj$=)}7<}*Q(-+lfUl=Nc>b+abcX_8>di-2Vdhb0prh%2z+sQp153pVL{J0 zUy(Z#2fyQY#_{_VogwU7?Utbmi5C#{TSAarJh`21=?la2^AT#6>2i^it#DVc_^D(2>1$N90LQlCk#dwD#4h8 zdrECuDnow`YO^L-ZR&~4<2Kw@dUNYv>J10fjmt_N;`~j`p^d=^GO*!^o|a_7{0!%5 zdy=JZYT=OGzEO~ntQuDcsm5ivHYTF_rL^)hubf$Px^d)3s|KAox%SM7(~Vd3{$yvw*+!4Comkl4xTd0$ zY%pYdW9PQ+Cqr9(92@yj{)y@~A2kl!ntSTxiC?cxI32gW;LK_JbrDr~XsJV;hl=#D zne>svShEZIcHSy9GO#??$$2R6dhm!Z2XrmUVr^GHYED>rYk1(HAuZxQ;K?)ArYwi< zaX7t7>E043+1g;;tCRJ<|1WjVUe@rhRPDoX=d%?!RjQW4R4n?7J5ZoqeG`A`50d^~ zf#hC;|BeRPCpHP_%kjU~mmOfPwfUK);R2=+|$sQ z>l4nj+fi`#jQxhXSpcmo1-l(a=g*-ldA7Q`aw8Q1FGr^Y!!f|#F0{)bqf6t2hUMiS z2kVR06+OHyg|4g%)|IJtf& zO|nT=HpLW*f-hJQjquVV7No1#5IZ)+E6YD8qnG5Ob4Seebc7;I6GUvjLZ5%j*iR501ss)GOA1`iG79Zg=<*9Qflfh zz4v;>85WC%qjIpn1yXxSE43=tDLw?oh1gDO#parczDYYCC4)8LYoqcpf=sKc!>De3 zc)1%3V#$V}cx*IVqv`(sy3hYju4dkORVaBh1pOH|ig2-bzjd8*Lc>rNw(?HAA(--s z$iWY8ydtV&c?N!93`6%2)aEL70qYbVjuf$u@jDv7TceGKBGvr}Qrf29A8FW!FBjE) z(R$2pows+isa}XxO0&ZMV1_)1Fy4*GAGNbDwom((+8GE9~8f&s6vLw=VRcSLOM>j5@~?D6XubUsp& zh(`80=ESx(^;5d8N;F2QPsdeXeE#D03*G!bc{bwgxfd>;z0mC`)4_$8+Pm*K+Z3Xh zBMndYsk0|S!pIFb zG%;?bDNkcqP;j;KP_mjoNl{S^sKs-SPq^s&w*vCAwuuSnlK%z0;&n;-i3YJP2{eL} zE4-cr?iDv2c`|zd@zEa=HPIWpAGDyS0D9E}6!oWGx#_9|tu+8dNlt+-Hq9J?`K7I4c%8ZL<`j+`y>G#ga|lbxlx7Sja6z{xXQYt0gANw-u!B43^ol07cVU{sQ$X zP`kA#c6J1f&xLB=5|M)+!Y|=;w=nPFlZZh}4NylhXkQlZAqK6vE{Dj|=zg&I=6qV! zf~g(M$T=Lg{47URA=8oQ!kKSs_xIkUR=+)2@dc?>@gmOD^kIIh;0OERt{e+D92|%i zy~z&|V$)GJer>HVW{n35FLfA92Li4xx#Y9e=%;@*+I%2Dx6g5@{h}|0koCt4m-T_s zJ_iswJ&3Kz*o?_Vd>z=Ph8-wEq}j_6%~5!cAlXryy9_j_F$lL_g!t;0yCS-Jcb0$| zgjszOuDvC$6EcqX@=~(fo*@~6<=p*q!8uRqy*`+ z4r~^HO*LEu>}<-R+q$skJbDG`u$Zy*oyP={VV$v?L3!_g)si3oxt3(qbNNtcdwQO?V^#L6nU;9`#hNYz9 zPJWt~vWrrKe}8nqa1TcO;N zdD=}x^ObL`eTe3QaX9T2|C5cTnG;EkHYkO-coT(HIO?ipC+Q&&bUOXiF_EIo!|{Y> zFleRQUSah~C-MZ7F^E#!cKE=?G=Ey;%Y#odN=~nxc|$ead)0-v};5L zd$=$PM5sXM6K!aX)*pnm+pY}nFwm5?d*#-&*Pvlu%1T`FJc%)!EUU&Oar$_>3|V=e z#5>5+K558?hm(cu)p~au$%5rXoRmwGoM+~K$Bv-o0(TvuOV4(`TEb7Gv{|9IUC)AF z&}D#>Y_PQO^Ab7OSH&3o^oe?`qZ`-;^B&Wo`c1y8_E8iXzl(=pDqi-&Dsuei{VI(C zFlVY@d}Z+66zTklC2j*R8vOSyY`YkEaB~;BAIo2B55jsleWD@Su)n7?wpr9F^W?iowHyZKkgKqYde8-k7@C9}es6-{yUD%t`p-cQL(97l*q<)(o;V z*cf=h;J+6pwV`Kvo1qsTM(fktd=eQYLo&$urfd!&z;(n&w1HSdO~V8B)UPjpI>`03 zKO=&C_zz5P^B*LC1q?}V3rLs00*9x!1&)lknnD@wGJ1avoL74b+b&)hgP{GGCzJGp z$05z(ZS9#7Xz)*O3%MS@{E)}ciTDz6HBP^8)n2#-2c9=1v*E#w>1|74vK; zE7m5ObvLw>O=Bg8@n6_>#oJ8%O$K+?TCxm$}z8+~(D&{)+J zk)zW`>_WYwQs>LGWo>&4cQb|3MAImuud=SQ_3!?OMx+GjlJzxkV;~w4sysK#k|VJx z)VUDD51jWJZ&RO&Ja{Pj*H2NCjh}=XK8|faV?TG+ zVA^rMDPBPkap1M~fTrPIgc|h9fa*{GA2UT5uJ~0~`^!!!M2t^J${%WT+<7hfv)UXx zr}`+zy#gjwki*wId1b>e7e<#JbD>;J=e(GgBD7Z|&GgimrtxoMpb3Wd#`vW4b z2I$EF=DRs@pla}sRXa9eB0Igq5D20{u$R>knoVM}Luy2fN>DFGvS-9q9|n!u9Ce>5 zCK+?7!#ccU>90?>*bWT;L7|6aD-LY+#4G6Kdil}H7;RO82`787+2gQW2tt;|v)ngM z16)@u8k!(a8$q(8@S>v>^+!<#Nm$QEo&fq7bE+|?46O!jM&1BS14OM?{DY`Xi75c7 zw%*6B>xJ5~Yx`&Co}GveEFVQz4PT9J_~mxzuJC$YScB7oBPOY_@!_vL>*75SpCE|e zYQ|&fz|{~>VSYz!lYmNP=ifM2x2cDq7#p05k%yjNjz9uGho?>4W(#{x@-bP*Pwo#PVmluiXKG)z#`m zo;E*fkrI|w>~ruiT2wLTvTDAoqS;C{l9EwvQEn7zA+sMQgqGrBna;!tFisWXhc$c{ zR9TpMfU#YJ@AFYp4eo(oNEzXbpgS>d0p(S%)_K*d|E*_t8XB9()?fLiSFhxZH;o85RFjVazG%?so}*=XVi5-`-bW=4EjSo z^)y?6^D??%jm)Js6J}RD&li#QP!hH&@5Ckh5mCC#J536XKE@1#Z#AOkIJ1iOj*|Hj ziH{XorA{L}Jb0uIw!b1fdr~czX|EwxXhUPALwnWGrmGIN=?Xl0d0`95{!o)#jg3Cx z;CnE*=6YQf1|P&FF9!uPE5T5o8Nj!v1e>HLzXRxi2WSNV|GH6vW_bxvm;fCo0eFDy06ZZBP+%YR}F8{2VDld&R7hg(annOEURVAwf+R@6Vw2g$K0<=NObdx5zAQL8ah=Abm(O zM;HR-OApkKKon;Sl+nDqUf<*%rTG+KM?7Gw0QuDg8_*zOQi8t%cGLrAoM%u*;$kIi zH0L%GjB36tt=|Cq$^$kVkku~O?m7vJ5P3sz1m$ZF*cL#%<~vg>??y0k+LNP(L~;hO zZ#-b#0GaB7o$n#@CM!LnDk#T1UViDeSm~XCeH(Q+yj;h$V>?%f7FDGB_EPgxsumjMU)5CLXyx0P+`-M_{}?8 zs<MwwP z@&J_pFcWJ5xn`^~0Yvp!8sJv|`dJHF&DXuTEZi;8Ip9iIxc88S%f`mtbaIZL%!v`W zPNIA&51JIyCthT9?fhusY_k0Fa`~+E!(lT5sJfKk_^+vDxJO23(ihCfZ!0dVTsj30 z##FNVW8ckONtP3jh%mi)TrTPm-uF$vyq@lt+losU*$9BXQWs5gJ1alSoI!It41yJO znU3O#C9|{2sq_i@@NecAX5Zq-qe>f|;=X#36!HF;KPsrskR9%H%@PV!*L*i3mRgfI zCkaT`8`K88?hIq&1I!cI%28{H-nX$`uTYKV%#Wj0_E=QUxhNPgYdD!!I3>thnODT@ zN=j$`ysu{y_x6%Sr3-E27>_p~PDBOnQ937|c>M_V_EfK_N>h%`G`x9ZfHt%DOei%0wn*VuhZaDTx|O9caN7GW#5jVEWKtse+tS?%Am^@i zk^^bh7(nbsEioaC+dyhqwd7%+5C$FTCN-@Q$eY}d6qI5PFgM*JaTl>mN9z^v0%o!Y z#*X)U-6t`JqQ!O~shv##P4NKT06=<;1RW+2r6kv0cmp)m12h$YXCIWHqXZ(AE-hpq zfau70`tXjIva|<)_tr?zF$t3WEB4{xR0=JKo2}mhQvDwZJ8_NbcasGDLLjO#q|B(Ep%yALJwT%YxUN}(P7{buXpsdR z2+%AK&@2GPJS0KqWJ;2~E&$E;0L=rS@52(*Mj)+87zEJ2+(2A}Hv@8VorHA=5mI*_ zFESPk4a7zG@w*14qE*78W4KZy9;LO3m`KWeHzbW)>wy{gxx{sg5l3>#kwz3i3nU0V z!^-Zb7E#Yo%wlR)U^*chdzP?WNq1e=!bNvX{5=s5trT+JlIK8IVWEB9_PlYL@6777 zupm2ZHki1W3JwPSEV!T^Xw>;%qm3ZNdOQ3NwkR*usnR5HG}y`!Yz5yY+$vDB_^eU7 zcWsA5MW1M-y=sYG*zB%PG}WjEeWG`bQPn5<)_589iGDREFMXnajkigk7*ONmtxpWB z@%7OscB%36)h7nk_+xG~xF*0~pBPdT7@$uKt?3e|PYkOG>Y`5!uL%y)Cq~qS1nUzc zYeGZxiBUCSq58z=n(#1vVoXg$xIQtqCNe^w*u5qyQlHpkRia^_AsR=v8e;T`s(+$B zl2#M8U!4t};cbak7hm$)S|4q2-Hg-^YBTL$=`;LNo3DTCz{|1zi#r0h+9GfW^#Pib z?SffRj^Bq@F9r{43#D~3;hSm7((O^?ptfkF(KVLgy6uw>_X2mJ$DoUG`wFo!r6-mG z_G)b^()Eti&q++wH*HXo{1bgb61zsUhbad_yAk!|#BMd+qr|G3MqQ5S_@Weuoa!cR zgbiNt3oXL>>bU(oc6%X$NSH>OUyYeg5*b$$qpe7s52g@ zb3hbd5hyY)PhLL#1{vMlU}Z-}C=HxvX%oeR((fLWszK#|P89-Lp#r4UIXwY7s|5+^ zp9I8iqzDicxJ4RLYgPr--5y+I30bJ>TRd9+e8z(-Z4M}Rj?fW}9*1wHySdan${XV$#MSt7fK zbs$J(B)fq`5WJuz7)HHR5s00Nlrl0h-w{<&*$*TGb&J15^%xvAYC4BZmKS?dbqu{`A1a;{7`kB_`U3+!K_N zWRIqM|8hg|Zu%i$dL~KSF+-Dk81?G_yW$2TkI+Z}jwMUbEW{<^=B%`H1_AZA2kP5C zs5?_T>!H#48(y+64mB~8EC2~vSSmAwDb6rE+5+XsgtuP=oliyxgV=F1=PYks9gl5 zugWA3HoX8z0Zs)d+ynFn04?Pb^ny`0sA)j4GnJeb zjbv242x@k*M4j^zww@HxOn{=?lHyJG0w5=rNZ9KVCc7$xj#Q%EV5Iwsm#WIHWfBx_ zk~XZgBxVB@0 z)9-Bvd9opd>ZXsVD|67Zaf*_+TR^d^8%6S*-W zoE9W4L_k(N0?sY4z3paF3;6u-V#xC^5$}6n3OV{R39{|wkPlwrxv74xnkS+|>>obM zCs{+&R^qj(2%+vp3jH=o=GL01dnYX*rD_MRrxwS~YMB5;_GXf*>#UZwABPGl5tIG*tss`5CB~wEt=Xa~hjDS%rx`^INSer?t{4IMlwMkpkk3zmoOu;I zTnG6q?9HSDtL(dwwjW3uYkv%R_-FcZ@2QZ-&v5zNg_m@b9@thbG_3jobT(&^R2ZdJ zjMRF&rABS@D$=?0eJYElA~MX#g|X{$$a`0a?%}^f{#X@i(4i~1Yul53Kpb*ua)!BF zdw1yB`{1q0zMU-US5%h>hsWxdxncH@Rp4q|V<|}IT71V0(sFa$l8Wb&Bib8Pf zKme@lG0Hi*6WX6TVOLrMEdmwmW*9p7Fj ziQNriXO#oD!k)Z8Jh-#p$ zFZI9-_Q2HR{jR@DOn+5yC(E}1pdlWhfdJGwK}FJ^B~xkyXs8>A%P%IvsCdwFlmxAnAXzWA05seK6cJ}s zhWC=74xR8W$!_r}fJS(L{sq7zNdiPh;iTBR)={gkEVq_aQ2Za7hs5YZP?Nf78>o%+ zptc>9HYQ7IFlmOR{WX-FlZCbt3YL~I0N;fKBwtU1(kKr~1F^4ZL#m_%zD{+koK5|T z8(*9nRTDW>c?Q%*dr*4?l(wZwYTzs6{PSOH`Reb<*R!CMp`|2LUSzsaIfBbw%s7Khr(fE>^v0y+7IC-UB)**gzq>>kG?n={>CZ#a`&0=b1Nev z^%*tyMSOjK1hUqCf5eX)=*!(3Bld2kFN*KBtEZ4z&FLZEd>4NCJHjh!2A#!0Re?VD zUJP$&qa?p<3t#;QdqJmU31MIbuHFaP()Q&$!SQ%)w%7@OcOy$DaPek;zY!p<*8B*d zOb^gs09czPs6!PX*?JIvQJLTYx&wfX4@uCy1S0mNe)$BT>peiP0TA-21dV~~&z-+d zfx5v1l?22qPE>$_Y)5Ub_5d}}4aIffUSQfElc^=kqb6hx-wW6zHyBwpe(Q|N^z{W1P1tN}*)435;e;xT`_Xd@dZ$9VG9}{_xkXBd%a~;e#RwQ5uH&_EJ}^? zC15k%5+mC~c^fPqlAt(Ur!(r005r=3G#UV}RtZ|J7a&r_ z68Y7ZNRqHp%~_v@?IWE!{;xptUs{qvi$;OmxX&dgI*QIqd6wS8Zvea54Mz6D1^|9= zf^71PE?Mu70W`-0bOnG%5uJ#$xLG75700*0+~R==`ogI6`BGw*>jX%4q~8HF*8_9| z052bvpmQ?du&imv0m}9OWg+g)8pNex+>wp3^SArnBx|*-+%{8dW`G51L$Xqw0JV7@ z)Sd#RKP5Hw7!Q?8a+MACd%)(q!FUxc|Iw)Yf{U{elojlMX3jPTt#Yr#noleOptR-C z^#>4H;6{X;2!8-xdeTKAcfx%uej^GL1F;i@|AIn}2Zf=hjLO}=N&&vB3Xs%=KLTX+ z06hx8b-&4EA;2lUZe*OoteU}Q|M}uJ1=L6qvJ6jxTCNARNuV_4tYjgMSRjyWAU^?= z=K-<<@XAFAs-m;ZNL*6pKLeES0s0gG?{*35(2JC0W`6<5<^f6rApWuh?Gl)t5He|{ zQ@|8>VCG$gRP|n>{;!5>K&WG>SAPSHogV-)d>+ztNQVMl3y^{!A_#$>sw<=hL+01( zE2F+&8HHAVt|sccx+s$#LrBv-c$U!OJn3uKf1)n@hu&FR8}(%^eSr+|;Z5+0isckq zsh-BeA~(KyrHn%26QEm9U~m@+3eXFXEcOck-Kqt#A#x@F zJuyM49U>olJZjx~!Mki0x!cw)t)Q%6fgddjp<*VlBuW1w?l1J9d>yFX02jC$<@HhT zZDf>vdEQJbxZ>0{vP&T6(2`@5xiv7OuzU6JpWeId+%`O*CXeGlgGRTQK_GH2&3F>78h~{u`;XloP9ueiI%VsW+li*PLvsZomV2#D6)t02XLtykXE={ z2S}R}RwWO=mDvaY=ynfKAhsHRI9aB3%)8U7(LjLi(1L_8j{&l6nyf@}?D^cr=zSY` zwwXrcwc#lph|WiEX3I^fjTEar07LdIU7w2aMubm`NX}p91c&8hXbnU}{)XtW$4b+EeYiBq> zELtEK;`T0qHUUubFA2(|Lp&)ZS*0TYs`g0f9smwGLB}LWs<23aR%k(@6#fgy;JLCC zsCLljjUCZ#FEUx7uHnOT-QT+t`%xfzmzJmy)-xd3oGmk8=c=2kt?Za$0KD4`NbO-8 zAk!B}*kh!HDc@3c#{zVZ2WS-lKR7{?B`6MDlM3q!(7hfYN1m7R3ND_n$x<~-_PPPI z(gU;y0AITV10vUkZSuA0v4N$$*YNYCo1Ly${&{_b-mPye4YA1ai4^WKON!qFN!f*_`RTrx7gy1jj+&TfSJM|oPmyAHjXq~m1L9C)NV=q; zXi07oa-1)gFHkmsoJEKt=Ol;AD6SeM=YWhlZM+ClbaD-Wh1eS-_(5=yu5~%I07G|Oy))z( zmGEESq@UoVd(od0BquU>6XyhDs_DJHyOsJdcTPlkWT^dlO4_o266Nk!OPv)B9?0~d z&(YeL=j&qNs@&QT)7C;?Fl$#U=eYw_?gD83#BHYd7d9MAJ0Ao(^v8Fbr!~jehN~0>>oEPZXt+rtwaLPEQI( z0T<#}Ktu&+RjwaypI&J-` zq__jk^gchWq>4+KhjB}yeSXwu8qFt+Y;Uh>^oIW+IBMfhYon>B8(}pUmD>tN#{0(i z9Ys{4vVy}tTvhNJExQ?!Z(n4#@@G^JSH3@V8u|R~B_+0UI&T2qS-?e_|6I9dKYR+9 zK}~&6|0NxAkG%-mcbh9{UwLAH@>LQV3~J)rFJ(VLsu7#A zXB3rIIr7Kb@-PX*W$bJVQ6^W=X==@WbiTlNs5H4Yii>;@L|(5Ix#-~^dE86+&w8m{ zI}F0VDm&1jfHi1g!rCa^;H6Y;6xIe?R!k-R(EBkzzaK;M==y3}SU`=8K5xGt^VRz? zU(N;>Q(nIi!HXiCuNHhX=#5i0mqnS<@1XVeT zRzW-+coTo{DKz5`#Y>>iKxDWzI);Mk=noWi7}_tn2i4Tnl3hJfm_ObxXcqDfYwS7ZDD+3WE%}T@-YLM%FY`pPsL_fwj-0DfyAU2 zc4H1zOSK~sv8S-(27wIyn{(Ksj2m+(6RbCz_2H+aU2<)h92J{nsa8h}Nnn%iy!*&! z?>4XcX*cU{*t?TUtFWh>-rf0lHS;YN(;XXsH?42b11`F=%D}9R-u-l8!#2tb-#37F zQT=bZWlS)sKhA^LTr2pS@YTgIk{-6=R+g781$EAMZp&Ri(S0knZY~0Cd4J8{-TopT z^KGstl*a7?_b?S}D=#lCA7?GAtit|PqJ?Min=%7g^Fve`TRFBj7uaZ@Dtos7p{Ogw z8y7I#yLk(pxbl-{Q>mHDXZFHE+7+wl9-;#P#^XsmF4Fj98kEdwO(k_y$_^2kY%4Fc z&A{w$rLEA;wi%n&lYF`>BjA35Du7u*TlU8jgTr=S{EL`Ce7pQAwpVqgy$rv{sW$I% zMswU}m@;55EJ5Mt zi|`iMMvjVt+sa(^u)ZEA-_+B~X?NT*hooe$m@ZDaprglK-M@I8 z>L$)StFUD`td%t7E<$nC6EADNy4aV>hmL8Pg;%gd6Z+ihGmet@BKA*z;%9-w4qdu5 z&tc>HwGnuTBK*vWZ){Sl;+tF4rSaCX63PKgLg>*Fbr^LPsHC|NgpvKWHZ{ zId?uOZE^GwN`2Ik*I%GgPfJ*koj(t2x10QpW}U%kej%2G_T11N!>O`Yp|y{JlN|Me z;D312L;b9*<5cX$6?WUQ%5r-?p5tK@x)?-XraBck^0N>!dgu*vdRjla*Qe|Ck5Erx z%P+L`#s74#pkd2JYMZD!<)wDiV-)DNpy0=-K<#Bk=#-Y(%dGkMQ;I*O6_ok|U4nX2 zdFB=|4Dad_7aV{mAHIwleSE-i^-zk`I(R zhw}dF#R&*-!Kg3XYtRKhftX#CPY& zUN`69f#Mn1Yas4EEEGBddl}8^A<5vdZEM@~RFIWWb*Uobu*FB}@_Q>8xKCXyrr6Nr z3UHZT_sXGBT`iMAKFMGS9*aKy7mW-I&Z9R>IzI?EIOvjpEF0rPpXAvp(B4rsPnN04 zlvP{FB32n57&P0Tc$_^eb3x{m+3eo_i&vgv%84mT_;0CJQ8!JW$YI-tL=W85F9B-L zxFxwKtam!UXmhOmhM#&b{4sd9hN_D?u+VT=voR!bSmZDnbeqSr=HwLRCDfVh#i$j* z{Is%08RI$3%h2#4VOF>aT@Q>Zm@hJrw_AdMCK|3nC(Efni;5GnsBLg^sH6bAl>X<6VRr3t=G zJV8NQQ56;IV<7dlmK-k&Zh8&F8=-zac|CLRLlmTQWX5E+y|#N! zAb8Yy*L72i#d{5LhWy5yG(f1a_|7WbNR0(ydf4wj?$fabxaR>Z^})Z z#<50)&?xlV>&xI=YQ%Jch%su%T|T5j|1N$epR{{H2@BM-q!Qohe$2c+IsCpH-1GaF zHkm)*_gUDIiTQY6wTF;m9c<3Lm+TGa7(yUPlb;-2^C3CwoX-&XqtaTE2e~P9R*dOc zf3-tT2|t(c;yS98=;=#KD|vtrxpDld@hnAnGqFSKN1?lgOug zlh*ZFNwwNuF_k4j_({9R7Z6=5j$q510Q;=8d@0?Za{bini7vZ8837FOT}}51ZX}}g zfIf&{3d#AY>DZ#}XH3^4xLGkz&oPa+ez40eB$kb+Vr`2FSaB;2);L5<6NqK{2hK6xn(>5AK{tV;pFl+{)ZBy zErB@7jp+(Bb|p|W9P~cuVkW3p!riq7rH?+uwBB?~Ki+ggKhC9#uF-wfxp!auX9$t- z?7plcugByHE~addhEtbOk?d+TaeXG-Z2bHfL2vzsrXY@+m zSL3DA54&hG+2C>T`5!HRHw60Jf1E8}j19?4K;{NDB07N(t{wbt8plXcb9DG3pCK|Nux4g;WhngG!_ zRSOyq(0TzfJ?5_)n&l|)$?Bhi+ZC0iWfm-tSp=nFsjxW;EP0jX4ogLmy`a)!byQl4 z(dsR>CC~}iGW8Iql$&~3>E&LlDR606y?d?ZKdDw@_##iRC;KoBqm3m?(-7|oy5_0r z*m^WmWTlqXZS6=s6Yp;jnIZ2YI%-nzRPR`m3-*&NQMd16iXN(&-fp%ax^AltN!^bA zhc%|UPLi7d&_v_R7ARTUivQ)O{+){yi&H5@*X#1B)rP;%0b3M}8 zB+`*2Gp#*uMr)ZPKx&7V2r5JZBsV=;i?Ue@Vy-jw1B2BMBNh96>Xc~qnVKbi-ruQv z=}jH^{{_iL5Tw>gnu65EMEt)+5H!u>b{21-YxUL_L2vp3f#hB%ZL!=4>{d5s8oI0Z z>#Z9BS)W6!G&zF_4$i?0OgNdsN&d5z5_Jo!g^OW_*U122LmH?8{NN~ns zcSR|uhg2gKbaue4zE;v zOxek|mBEGe&)JdBt!BIwfMUF6cF?93e?c9V>s)TRvI?tZm*j)vd+h~FA;&==_H!Xp zc8hd+pye$+AOLlyv%4TP}0hiqKcaC574;x5^l_)Av6o6gMsx4oB>|` zJ^tXZCH(vWe{$(hJpGi1n6MM6vnfGt1fS5>Z`WvspZlVjQhe|WY`XduFcjFZ@{gLS zz@V{Vo8P~8fz{tJ4P8TuEGjH%$2F9 zW!oTSM~Vn4N{JLwE=j@<>U`+qoG*;%m__m22VKU@UqnY=S|n% zCBRvQibqkhsb#W*efr=M`tPT&k1#N*U6DWW1A( zpaL`rIZTjh+|>h-kFgQQZm>>~S}J)e(6qa&d%BaF;gPd#%$%?)OE3YC>zdUX>Rs^` z38{m66;Xa=&8~s?X?#!7?Gb|dvO!O_oGed^h+|oeJM7c^1J<{nb6RsvIds=q0($%~ zTA)8sr0(^9E}k%dF};pVYzx^jkMz@m1&bDtBeH<*V{kL-mV@U>K6Jm_x_D;kbelE5 zw8Vi1j)o2AYwS>4l=k_IBAiuLx>&wOPE>WINu9{fahSgS)s3Xq*!Xs`wVXmm((uan zg8?H*qWr$iS^+0A9tjOe#n))P?=93BTuh>HS%~>7sc;{}>raa+#mla_dz1BJ05-lY zKuuyvm4vJYEo+_hLI zDq*INpdSXhR0V&=|9Vj~+}i{mu#xTq-#<2+T4#AxiAFrGTG|EAn%(RdylH(7N#3|r zB+Gk$ZMJ>^$RI1^>pi&q$W_7zGNcckG%4{ktogJa1wEhJB~7f!27^vR_Y~ej$SL;0 z06o~h_oLA?W2clB6bQau^gVgTTh@m_`@lcZ{}rT+g1*uG{S{qjo~cbi6-~{fM5!-G zBU>5&Td#m-$iFpwYbEg;-tZE1|6hG7BTng++`sj5)~!AVw8(~Y^+(*JLg~?p3NA0M z5r4v+=S0Oa{RkKH0KE^N&feIdH=6a`bjGOZaBHxNRNGx0qqjc!s!sV77i$o;o#d}V zpFFRvsN4`-ZLqcjvJR)xF&OuwX$Kod0JlpZx)0y4u4fZ#iz&n?cKl|Nwis~XjtXi; z<~%g^Tuj|iM)C5ULmqgWux8lIv^|*ao&R|b^UIm3ahFt;nO6Io0)lu(>bk2r*7XP{ zwhkg;47Fh4nYJETz|IST9f-k(a?ZLnBq;Zu1SB)JH1}3a4Vx!Z*M>l&Q`z|kwsN?8 zFsX$Jozn7oEc&)-a)8=j=Q-LS-Q%^v@c`33MOI8gfolv3tst%$@V8iRGU$~ZxHyj< z1NKyKxkCz#T+ZJY)UKpH0YjpR@aW{*X_k(aT|@U4>tPjxYonxwwbR-hr-9asl9m%P z6R+R@PmsQVyd)rMuXr^%UQLZx`^T$;;??wcb!5CcCSIKwuTG9vr^Tz8@l-6ckDh8F zb7Mf-khK1T!N4IMb-~ARi&{xPT=d$*kF95m&oF;iL7`mHBaaDbAeY-0^WM-iMTEYh zL0#?Npsw(0P~SB*s3-9KSzNEFy^H&Ug7HG8PqW%Ts9Bwi>nP$A*@ByKo_w?E1AKoO14i|i zz!tR)m##~T8jb6Uu?1&vw5V?(7S9Jn;c#%RdM>z@3Ox6<1b-^<(vq>7`Bp4wqME(# z>Y z?;K?6f6XbZOu@m$14Tnri}_k#T1QE8r2hB@w5$%<7_+E>nDK<3(#LstOp9}rNX7Oq zt}4@@1QqLYke@VIB$3%^pga-e|B&R-+IIGz|2j2Fj4?5kLJMT=AJm;AM5=#Im)*APuY+HP$U68ckWi2L;}x=mJU!=a3-7)}UNr9e}W5J%(v0 zYt_|_p!}Dl{8l)p%w0E}HgOEmy79~xDJa$#K=pZq{9H-YvQN&Eg@oHon` z!KhZ&WDZ$}A`sX{1l!`|I`xQ?LF{iq%xE6)kPre{A)HYvRXB$ZTV9 zQ3Nvyu@Fq5$t2gm&IZu+NdILaLU+rTG6g66IC8>skGxL+hWT}F&OGXo#ts>}kj9-3 z>+MU?d)K**C+UT+7EbC#FOYMYor}8T&#^4{G(4y*ylsLZKQh@WXh8vk1tJ)&1$d`!q%#rf`Xrx{f&azNaP{JtXc+u$lkZg6+S zOHMx!tBR6CqP-ts8}20vVID{(l-UDt`i9U5#`O! zptU;ddH}}0BS7_?Ko0`+R%g%{qcs#k{ibFy-P7bDs5Kz@jvF6bugk?7RF~A#SgpY)251b+7H_zw4XDw5|3vk> zG~Tf}NQd!fWNg5d!hcZvZjgGHIX$s_qO5|O;Z{8YC+H9df$K*MmuXXltd_OlaF^r| z*4ylN;Ph@O9GH zSi|L5wLR8&$=-3vR?w;7cOadmQZ5_9quW?1k=%#yi>z}#+GAINs<>?PDC_-QeX(8_V%77p#&dR@`Rs+qMjTDL zsx>-ppW`Cd9{H(H-(7w2`HR~x`1*hH?2@zRUbuMng6~uI{fGS826vpj;CB%Jt7k6+ z9Kbov-J%U2FZ{i|%cih<^ufJ8_W#JQedOI7Az&sqX6(pFB7n+%C$eQkkO($biE5E12>sVz^ZZ&2N~5(j87R z-LzyPwNE1O10zO>qK?Cf;yy&J^-e064!k9hm@uT73E2UvSl}k~o3<1mMJawD_1kSp zd=(%&1evlfN^kvy@OaYbzy2#nDt5AqEhZGa;C|sBjsipl~5YG zutivMDmiBZLF#_7{~K{S-uX`Ui0YOk)I)IQ>=f4_2M6B-4SeiGODZ8bon!D*an?NQ z5oXP30>{~P)ayvU5)LHT#RF|f_4*iYf2ghDok!g7YUBdNPXi}s>VE1rD2-+)88KDo zQu-t+`ULJWDsSRa_vu)758Ew=?(>zN+!*6+?QwAOk>q4VR`LFWHC_AR&G|`u;l?t) zz+;(M&aq4$MYL?j(&F4w$1=WrBRPS*A8$vFyAVRy?210lP8}8}Eu7WN3yNj`rfC7D zOn=jAADw?o4p6AWlh|%K`Yu1Zo5@v>fS*K|>gn~&Z93NfcQSAm+H7U1RtK%WWzFKQ zuih9$1!c{p4mq!K99kHBR<|X=4Hn-77hV%wdQEWXv9U?>i2>WFgXXK_v0+1()Zkp~ zNNG_^+i~Tt9FmW{B+pTWJwXgP>50GC2-vnn+{85IVEElSlGH0nn*Jnc5*u3q&OW9w z=yCAkHTyT9IN<-cB=c%SR1J_VCPpf{OC7s3>9(SBDY5%M4Y!CA+md zu`k1V98?Ej9~!HOCE_9^IoBIwp#E3gk=S?*a8s zW%Z_}&u7}h8ko0+tY@bWh$#!PLB#q4NZyD|f-Fo)0U6|E7wkFi|NIGm3Z-_!|K0ED zi-HC2&CZ1-e;xPVa02l~a2w_0y1)8+{};a(_qiD0Sf+8TRuFr^>K-ktY$=h8(a!P} z`%|nou(<{oC)__?tYwjw{UMOu>qgdn>_PS1eH<&AgY^jz?TT$_obb7%PJ~-Qc%LBL z>{+AhP3zfqij7I1CJ-+P_6qJz#dpLlaq~IA8NuAOAwy=>Q_W1MsGz9_iW21UZXNGP zXg!JO^P+)ZOW%2aN%ck3&r-#|*4jb)D1*|9i{-A)qcn~ncl$-|)Dzd3@i6_UH?4=4 zD=Yu)Lmz!YTvyQ1ll+JvY>LfV_|^N~-FxA_y#&3dg)(Es34azo0-`l$m~p|9v(iFL z(N^F+SLMgn5o>FPLHT@);I9#5RP7?8qu}mpMK#v)cPlFb1Hj{i%rtIAP9s}mhy6aN=jtFRtV{4d`ZKe09gVDW>CnE%Ea z#e91Oi6S3s8TtRT^QWW~BTGBRZ8l4hJs&$$EI6akhRLg9EEA!Hli0diiRF{USh$FV zl*N2YqoWk71&hIky$n+3iI$Yo&R7fWQ>w7vZo`*~B5OYV?@R$F^p=ATHbs_T0Vej! zU@h_zJ1u_XO9A96$b5XEc_Q%2(!+l?Yq0~>L{uAkP+HE*81r*DL)eB}C_o$SS}G>D zxn+^P!cGU6Lx*J*4K{7vMZHE*Wo6m0zI_)jUYxdgU|MN;Vc-7g>FIr!IP4`0odvyG zZ~ZnChn`IkC0z@Zt@Sp2jRHL+%bD3zs2x?_)~Nujl^|L{s0DokP-|z9(P(`OfC~~- z-wAXKpwA@8W1BWPMG9U%O_E?V-Ff&r)8MyVQaTX)P|Zpm{j3Shmbsg2U0uOQA(7s&a9aSt{+t zHcORdk+s~i7%4CfXsyb(mx3Uk(r!i6)O=ehQp!ag<`dDhJlR@|I$l+t2ac>Ii>yc~ zuiRc%N$rY%!66-Jo}|5a-t&+>TwGY9ZLqSaWMxx{22z9+ExA>dl@JwW(P6J3@!1^t zm|sRYlq0uHTRW_|pzg3?D;u&-`hfH{CoL3sX;mfZb*aFmLU-zUXc3%D3dLo&I!X&c zq@;@dAuR&Y6hoj;cU)mx&>7Hn1*|uQCRmKlq8Qo`g^}wh&0Ba|73zn@UI3BUEZDDD zT8S$7&D7u{Q~~$nLZ!A?OYEr15SG21YF3`ZUItHmktMIH9IAp;BI(eIJS2rjsHO#W z2W6`O9HbWD2y)84jrLixr2v*fOQBgXyK+es@`uweu14cQ-ttYkF@`VdvYwiuan4${a1ACULb zD`cGE^jw55v=&q2oxEfho9pw&N9be98HeDIB6VzcNpm}&H=Ae=SA14c3f4_ zxPuej83Bf5K!#&5hGL-lhDKddt=njcIn(OYx5DexxJ0cfFMJ7PyQ7Cp;{yZO1mD95 z56czh$T!e-p4_UTM&yY@9umCHT&^e!9_}(G@I}e?6qi1bFS}h{SG<_`RL&%LoEq~av zd+(+JIyY14p2n{ur^epJ64?%1Oh_%Ab{tNI9KMor@Gu};qUY0lY;c%qeGO;d^jf51 z=s~*%q?_y8Q^Bi$3#P%H-ptbST>Up4seLU|L;kleU-C5Ne|~BzTb+69_I0;Y-rygJ zvty49EVz=&1mw%9?^GX?HF`OYd8!r}YQp5Z*7E-slK4g@;i`MWr$RzIm2nbbaC^d1|2qhJ4ngscnY0~pO4o;8|vb<{e?{<|QEyr-PT7}g;Ze?&w7 zVC4ri6y-FW&xizQ-1UbJf8^TB#_no2qjeHa;<+8yKh(7x$m=^PFRUNFee3K7a_eU2 zCNTk!F|!O-S#pwPSpvEiT~do@`>R!p`_w`$)oRp^s~M6!)F0g!obYWFiZ$v}Rq3%u zaMvt?+)=TR1Ai%aJ1%%@*0{sWli2P`ymifwXSKpnywHrNW11RyDeW$M<_?lDAK5{+ zdDy&Ph|Tw+Ysj>&+NUaM``x65ygR*3w}Z12QflS~H|QMv9o z-1s=j!a4OQ)~0cx36GN0UChzeVUmtE5{XzDz#Qn-Trl^}XPuSHTkAp}c{~*JS&BTs zWnN0BDcU>0`uBo$k+RDHM=m+iK4|BI_#M}q4(^iR6gGu`q)06T!u`IEC_9C4hPPUT&fZj<#ugTkc<+m(vLT2{uk!8Z~5_L#d?kZ#U{(}~?! z(Fh1Y4lV39?4lyw?9)ddN_255a`*#ohf#;5=iT z3s@~#1#4b;cRP7?`2!6M_ZZpPM+;U^C&6D3+^~lb_kfwdr;x>#UxnFxXqTqzP51k# zhf>tTDeBRbTJ>0pdLl*rF-83)MLnIOo=Z{NQq+zV^-79H$z5X>L)BR{UHodJ^#vS; z^PM~phdUp&eQgtJ#!qfF4GYz0d0P!QeY* z$myhUDxA5Rmg%&+NODxh=c|sNp)z)Lb-1rx>Lgvn>%q+Xm}|wrNOSI5^`D{V|D?wB z)Zd}M{7qk8s}8$+1v{)opP}?)?DGZl+FZ9F1HZ@&cvu+f(w?aOU~cz@ichEs6_+~e zpHg3^j=29@8Iun`$SGO{=a*&DT#mK9o8aSFW!o zzY8S7S29u^PU8`v*pg=JOFE%@{$xx^heAiw~35(VB$B)gvY*QQfq%a|KnJC z0o#rzqZCQ4x%vrbZR~+JoU_tYpc=0}l@m>8X$J&?nsq6%av{8Pv7CQ0?9He6c|p}& zdiPtHO4be%H-Poig7s^tWHr@-zHXWYqZVxIR&^2T%i(HxIMvGf*2&3KD;F$)Mk3XQU`0xG%z+8%Uu`JWF9S zt&X@v>G3_2A6ViHBTO&rigR&KfARZirV)Xb*rL!?y1<0NO3z(}5OaumK+o>WB99mY zEq#Xec*%JumTi9Ei+U`yl8ae0Hf$Ep%DuGZp4+LLuoc@Yu?`bU46#IJIsWJe`RJBS zT~2)p+2Z4|oE9Ml^0A!DW=3Ys<86y75e%Th4Bv(grhI9M8OEvEiq&7_Fv2>nMK(ui z8Tr5P3RZpD5p2LV%$Gc|6>wG;+AE8ya?@aa^<7kDyS0M;rUJx>q8eD^buUc~-cIRn z!8NC}$_zK784H<9;GtqHVBMHD73%5Id?#BM+RU^;&Rkh)rbTCFa0Yjt2w-NWx6F%+ zY=kXylrAM=#JKB~G~XFE8{Q)l@Tr-xd`&XVIAsp@!Ya5o`*ISL$24*mgU{eqX8a`u zNS|m6_9|i<`>5y*~=9j-dS_x@<7@kIyW_~Ps-@|33n_{N?tZMdmaLJWivm6Q(tCU`rAMdlNO6&Y@%%NhShP?CG*7x{q9!!8dZd$0} z-O=uk>gwwnbVAUWe{D`@8qdY9y6mFC&y}sKZ@_$Lv)jBU>B94+vnr@b^Eezd z7t1o(D=9tGo6YhKX^+8)VKC5)fGerl6 z;JeccPg4|?H2uJR<`tNJAU8a@u$eQSyXVV=qhHabV$v{~O&a!qkL}vCC7gekUz|Dj z^R6`qK&iVs;n}o_m@|=1e~-x%F&#q#=xa^J(Cm(!s^Jp?kQ|!=64M1V+X81l^YgQ) zA)RLqxD5GBikRZylSFb>z%^mfNm6VQ2~!wM@QUu{tjfXP`X8DIk<*%+q`CMTpEzPv zcHfcnQj*cY=;p{|`a619JRZl->ysRxvMdo_6Y(`MWtqT?95E^fkmTgiRFsujcZ@1- z2`rFwfnJmfhhOTvlwr#Vpa%IouaS|8I zo12}Qoz^ckeF48gz0emYe<-DWv-LGUv`8HLnl7 zgYm_vvtKPHD|!BixbaiR&76~!X{N_1c+5POUzxlP69&(-;q+to9{#|96B_xwx%3{g z`gTq25z=yEDoe}}iX{T{&JAS1(~K?o3rS&7PIm0^T2CDIc2o{Gg?rJh!Pl+DiJZ7q zh+Eyfi0`r9XXA*6-ZXDC9A?wASP+MOihlpSgV^Ye2|L_XOm7+0)p4fDOh)BVw`^l% zdZrIIO=Rz%yu1Gg?ERht)7ks)8j15u@7V69Lh22HJ1UnIRxYDtmVxLpyqG*(XUVef z-uc>fWW8Pcon?slysRf)Wu>uu*mM@&75g&Sgb?W{m*J#t@UlKP6l|mmedoE)_IZ@; zd8y}7yn&5%ELhq6jAio|VGYADFha$?QrESfOnBT}M$d*Vn~z1;S+`#L>pM$4?kCO7 zuE?G-uMhg7iWFqdUb3vTfPEJal0gTV`*hXdy)?|Wpy^o9ZOubN!t2_f$)gkSE@ZxL z%^h=ywfWge%d(Rb*u8JhcMqpg+5GIeX??QiCD41fOwaw4ifmX?S|7Z|h9lk0vkJ+~ zB}TK;C@-~(gH`M7^6V1ys3e=TqK2U)o4Mxfg6vB6AcgMhFLz6zjtmlzdWF$w9UN6h z`C5Q^%F3k+7>&1I_BAm1E-7}DR1BLk0}(SRZxfOOnMpmL-2wj|LjpCmhiSdmPk41;)qXi-CTGYusTIw5gIZe4q;D=ubzL*YUW?}I9#=!&wIoLb$>l1=m}A~clZf&}PD5Fq`I zy3pz7vh2BuOwo@{oQLo6O#hFLr|&2m`mZx$UUHuV&n1_nXVTJ3{~|L2GssHLU}6V1 zr@v(`q??#*SNKrj|Frfka5fg<|MNWW?z+6YSjX+0+?HKq-7l#qxkR~#P(-cEVzJnj z%NAM|i)qVUDz~ykkxN^tR1&2SN<}FuMWs@dt#tn1XWnymkLrKcj=H2;i@ zKx0tMDP6=>?g9O#cB_%11lP8V#JdcY(nEZpWK{dq3nDH*-b?8Tg3D!a4P>mmje`v` zUF}p$s!vLc?pk)$G192`MnyBXa$UU{9Mqopw){THQAcD`GVx25XnRBy_QB(ki>Qi? zB=&k|9<@Ji>4S`8iQ04M-*vvbPSV*?w##5f`TwQ9M7|wXd#`@5jdcGzq*#Uw&Wx(| zFG-1^)zH8HkV5K2bIeW!z*qMkV}bupaxL?k>e5jaAzB&6gKt$pq2{ z6G!lV9V%)Yym8rK(mibOkVjN9f)~B?j3~PwON`hhamxZw0?*I= zF{dbQafDx}mKJ&i9)4>D;VmPU+6#o+V@4TnF}4Nl+tcr$3|Ad+L_&T*Dupxij_LiS zmf+?svhB54iEs%mfeRX?z!Lg(O7XQ=2wJ^POdAQBHoPtpgZqu8pO4+qdXaRwWbemE zHOJzhnmqDG)Wjd}(j)n4uPn;cQJ>ryf7!vE@u6Mmf1e6CQ0S^|f4C}&O4vy{E^kYL zCZs*$RDfI@kM)u_arf3s-=oIurNSbcA~S%|a_;<} z1Z{?(3;y|9J!)r-rS_GKG=P4UhT-eCs6y<=jE1>vNmP7eJGrtqQp?ji)M5OMQ(*b$ z&$+B<=%x5sy!!5g{j;k#J6CO}^3w+I19qYHXlw7oOVX@mf-ArMFGRDxEDaI=?B{f_ zwzK~Xde_l^ccYN6T2MPyeN#6!yaBNwMLe$hWrd88-qn5hWrf{xxD2O@p}3?KSI<13 zBvJ#1An1YH1cS#8K$A~Iz*0c;qVyFxZz0DeYjhEa)ZeuaV36(EICewg{KTxxG+-Q^5YPd zHN4>^d=x5lN)${rG4#^BDh z-%6G^7L7sdCVPkab;o-Kq_PJNnJSr8GEdy}U2BT=r`+1 zy!0VE`@jSeGnIkK2rk`c(bl^U*?EY}Ou~MmcTCT$Ef>GNQ#NBX<{g+}U}t9Pz=4gD z>*=YrtV^vTms(R(tV>Ff%fQ5e4@@06?H{fw|B_3QxFR-twk?cN7Z$~Ynpum4(D@#j z^2v#pYf-V6LKTk>_jn=Y3wJx0#;CsmZ++^-8P+~it}N>cCcYf&%BFlgYrpZ8=cA^AkB^v&75K2JRFQQ}Q@IlB1XHCl>srQN zg>`Kc@bmlTngHuMrs_4UwW(H>bzM`v8tY_JqdMzGre+P+jZH#L)=f>V1b)}luEqOJ zVr|xKO;RH3TTGoK)*Xzl!}<oKNXTMm3<+PCAt z8FNc}*6F6hEv(0zjvZKMm|Hut&NR2(%7L#kfGwUg)YZum8rdwCm z_nYqBSU+HTbZ0%)+}?xrG}H5T*3(U|o~$1+?6gY_)aw-4*tre9yy zbIhInSm&C%?qogJ^uLSsJTss_>-pyH0j!M~csJ{Z%%Fj+^UOViSU+s;y@&N9Cgon% z3(VjY)(g#$!K@dVp+i_NHp7OpUSd**v0iG1r?OsVMhs`Y+>9K-`cacMlJyERDvkAH zX7ni5kDD>0SwCUY$FN>$#-_7gWyXzVz1oZ)$9j#)7|($(O=boMPMZmt95`j}o4|Ul znRp)uzA%#}vVPJ`p2UIA&6LTk*O{y-tn{jAA;ko9IWBbx&!&CD4b_{`+YWWCkQ%3;0D%$~)8PtBa!te-czb66Lcxw#xT zVdl+c{eqc4kM)bj%xC?QdC0KdY4RRo{jzyDkM%3&k%w8oWfnZbdcRq?fc3j((L&bm znZ=7(A23T6vp#5+F5$p&vur8rqh|Rs4t!!BUCx1z&5B1^e`p?C!GVv=z?Ak5tF};@iC$G z`5buPY*^2ML+0rXtiLoHpJx4)*|d=ZZ<=Q|ao`Q}>@%#tF`J)d{jJ%unf3SPxh<@J zFk7Eveco)_%KAsMeH-ha%#Q7>FPP_du>QpqJkR=9^FjgZi{`}_SYI+Py~z4Ev-2g^ zznhnLa^N-d%FC=Tn^#|9U1)Z_%K8uU+Aa?4GOxeJ`Y-dw>#VPs-EXk|+q}7(b4=;=EDzQRwHxl zLzvacd~^(E4Kg2p1hXcYPdJPorEnXkTt*_h1NU%_lb=FHbHo09qF49sR^ zzWoMfb24YYg?TNRb7x_;AoCr*p{=hY^Zj=)uP5^Z=Ir_gGUtDQ*^?=0P{97zy1QV6Pb&@!t6}u629}SyO8Cp zl0xqSEls6__6K#TG{Ub}CKg}qfZG7L;R0BpcY~IpIH7|;%TgJk_kfn8vO@0#ji+)5 z|CBQ2DPG)C;O3+9LI;CZARoNfDpQdvh}%%ORicVQhk;h6Nj* zXn_1eM}l5M0ikK2Rp}a`qd==sRiUFnt5Y?hV?b-*vTV?F(3(_3=vdGMsws3FXe~+* zIv%t()e@Qknn<;UW`ZVBqRrt{$+-GCz zQ$3*%f;OP~D23I^G{hkixaGjD5nhyl&H`;rjfBnyZ9yAhC7?IajY4s=g=tMULDl2R+)S;-Z6(~=(9J^evue|p+6Y|@+K$=^-3Z#A+6mnR zdJDA|`V43Xx<%--pdG1$&@G_1Qb(cBf!;>93f&6YiEb0R4YV_L61p9<3w0K{1GFo3 z5&Ar6H|i?10JJ-GLuywj(}TK;+lz3!oq7m;3A88OE_5eoFX}1uWzgQ#OXw@0cTjJk zuY&fWJB026?Mr=xz6RQl`U-s=^iJw0^bOFv=uV-#LHpBPLf-@(K>da80lk|B2;B!d zknR@xHs~N4DD)lBduWhQ{C3pbOZOlTdCH{Fy&w-MGni69<|{LV27}B~W+)92@y{VX zjD`yR0yLF|3B~4y8BVD}3qeQFaG`&Ij-(Mn{{&5=kwX6h9YtwEuYiuGQ9}O)9Ydpq z20_zlj8Lr1%veen3Yc*;Rw#pxr*T3Z&DNAS^=mT`W&@!M?=>ef-L8sAFq2)oR z(=?$tyJQ}u=_tIJ%4E}n;#L7}GbkH0@L*7xnKVP_bkH1{DFRg>FpF};^#Qofrdi_Z zhwB`gEfk0IO)kw5dJX7Y$`x7_bRNwWng}|d<_X2()fk#Dv<~P)WQ1zaJbDN;a6h7W znDT^Xfj&YHi$FaHETBh()(2fk3xqZRU4*mBpbbG6(;}gbK$p;Bp^ZV8(h{LfK$p={ zp-n-T(=wsWKp&;$LYsrGphtyX3;GzX5ZVItae7QBuF*43(Bnd{2VF@|2)zMx6|EH7 z5_C1K650xM4XqY>Bj{RMBlITFCuyzF)}T+(lR|F>T}Mv|Z3CK5>x8xiT~GN!+ktMN z^+MZ&K1~~h-U_;ro)&r==qB1Iv=itvv`J`Z&}ZoxpT?pc;`G%m|JT;^U{RYVX8_@8YGJX9i!!Epyrl2ld=u!9DO{ z|5qs%eZXJA+I<+1pg!KJ9OJ1hgBe@c8-tX@K3aUrVFvfVSNl4ZM;li;Z%_rSY;{1H z-SmQFLxL9~cttd8W!|J0BONQFfvcQ7s_j;l5~AF>pe zTZz_CA)`#2j}IQC+K4M7SXKqbp^&AB#|4w{3NABvh_w2D5XN2|gx{z7%AY9gFf|OZ zBh)y=j#5+QuPweGP;=!^680gr2>BkP>y>*++&-d~xV0)Xs2ix9k4ZLgbwgGA6S~PO z4NKJvCBD{bJ@zc~3 z9J+^#?%wL4T8Hw>`I7n|`C*~2sIMnvoAJfqofs|Li)vj1e1`R6@N4St`TEXy8HChD z)WqG^HC9c@3=YDW@?Qb)3%XG6kO21-2S~xl^IrkJy(+-q;s8UHh)dGX686R5;pO!! zO0_~>54;#0q4f13#X09F?JCJpS4oaRYmHI<>js4te@F82qge5{tHd+H2|$T_PuSa& zLe2SsCfYFG5FnYHqz+(6fFC;ld76T;w7hO9HMSlfiU|f$qwihaY=5Nty-0mOA@gV% zxj)lXm8=5k7>6#J&0nQ@Bh7DYztW75o{P{kPWlX#Aqez@ zg5+R#8L#}M=<+gxmmroIEcd)^dR5_84KTmatLUjWN{X>H9BN};c7CVX817Z#Wy+O? zsMdFYz-5}}X&ik44Gf#b>l)$3MIq&RA_)*Fq(?jvw9P+gVTAZ%JTp|{pR^RhDj&65 z`%hXP;lBdvu>Egc_04J-jyUd zc<@BWl8oEIb2XkcScmZ&5V#HNFy0N)NhLC`^^z@FXMQRoDfxKz_&ck0=_;%cGom7e z8}K;tH?XNH3MY22YTl=f&;*_v#m`99q83dwzbREaE*QhlVpu`aGNoc!ZNWhb8M3x2 zm0NnEqapn6i?< z^8C7*vs?GR`gtc$1l>2>!jUP|xi^Yu2K{}*qk&}fO{M#(Sw4PCCB37X{}imidr?S| z(~A7A#On2_pCI}+(i-{ft;GASsJ~xWN)*0_W$;{mSG?}8ax3#euUx!wy$T-+jqrXx z9AW{+#e8n6|3tNJ zkiuWd2Ks*jpFjid8sSolKZ8rl2$$OYIb3vvOCq0w3tFH_;sdCM30R@>L6G~fKIKD_ zJZZ=B6#r7`NpYmJ<5o;Tdo>;wC)lTNKUfCnj_4qq1W+amjEC03Xsktb8?@8lj%4YR#|J!QaScSi# ztk&ZnY_l4mD(|yy=$t=#I&0VGpTWGY(13pdNBVu3+)6(PJ=8CHu4pZd_%|ibl*{-; zQ!EOhF&{?W_hISGM?l_DKI}UmQa;RbMGr!pph6py|B#Kvhe@w!9_dY>#s&XW`u(fr zuUsXMnekQfL8T90Esu>FJQ2XK2UR_NuMaMKUIm>aSX|z))~cj z9hVFZJ~Bp@Cbh14q${#;J;&N8yvKAI(w}2d&qtBplkrfytPx37pcoVJc|oi9YiPg+ z1|#%VAoY~!Epmn4SF!(MtHVD2t9aapiTor~CJK0!Li70|90pnZ%ob|IWF$a=qbgK| zUUA>ZRXshmZ{q4;C)zOnQ?`n7Z{|AWjf1GA zqv*Wjf*Om_HvBtZOno{6^@^y@GX-o4uY6dF z6uGpd09qqfBt&;!r{a)A|+>PAt zg!SPbsKTOylP9gtrVfXM5@}~;BmxqyiURVkbC;t#(gLx#mKL{JbqsTu(*iarr{_(CHH4x89bldFNJ0DL*$+oHh~`| z_mr^vcmcUz2%E@@$Zvfo@e=aiD{e8kOu(NaY%)Je?h#>A_%U)13(Mjs$bDbf{k)3Y zgTfx*HRK);HkF?w_dQ|LcpbU#3Y*UB$=xsPL4KOtcZ6m0CUV~vHiMrfcb~ACyoKDo z!g6>kxo-)Z#oNiZa79xchA6_PXCRU%tMhJgY z{8)LF^f{F~mtT_}j3L85Lw~_!%VRN^Oxab^cPe)t<}Atj=UDxxe~Fb1+7^w0=@oh_ z)SG3L#@<=(d`vn*Qys$}Bf3_Z!G|#az$OZR;#nWY!x_6LeB84xz*7<1CVaxPF2b|V z&SiBJUEN6*F0<*vv}z@?qgIkEi*pl!qUsyOFU@LFp!eZ(=M)!0`;2^$h<;NmyA!NfSgY1O6^F zk>4ZiufdMp&m#Ymuw&n|$bJHL?06R0KZhOD|5?v6agvldwi=+}}|T+|)Ih!B;Vp-^@|$?O5b);b@^5LHAYFDkJzD$FRq?GPXZwZR64s>v)M3 z(~?lE^2l>-tm3wv<5;!!+-&Vb&kn|Zr>qOm5!Q1&tK8?=$LJz(G6j4N1qrDa7<-)| zseG=44XYPXNw)XA#Inn|lfU<@omloXUq-cA-wrIBnXmA9&w49YhxJudr1jm!HCeLy z3bOhd*OF*6gYGMmme;v9V#NGG-xyKGFQXK(4|>%+-CNp1($<7G0epq9MJ6rP_XbSl zJ$E-Ji~6xa|Bb5ESgdrhFPbWq5~Z*g`ae*Jx20C$9&Y3*#10n!B>54o*ftGm#a8M6 zS*vevNYg%U9!eT&VQlbi##Aw+1RJL|S16U;(lvVV4IEw>zJuV>ZY2|~IIuJ9zCXep z+ot*^^oV!ST{!SkSmeD35$vJr))e+R5aEM;RDCl7ALI+jo^DelbSOdy+p4-PDc}1r z+d=p+dLU?f&?Ee-&|5%{q8oyCzzF;ScR+4+w<2vHMrgxyNp~;u!3$vI@T!eU%$0Nx zDEtV0nFB8>^D#Oy+;0EJU>sfzVt=A|B*r94V;&OP2K^)=UQC^IuYag0p7b2&?(9u^ zo|nhj3GTt}4q=~iPj?^DquSJco1OX_b41M@oA^i#Ol!@5nv6%Rx#* z$NH8pd)Bi&8rE}M=vfzWy6tBhg8p_kU}#dBd&pn>pV}57&qMw z%8rH8LSv?zAGXVYu?{`@M}E*tko%OEoNV^kS)OTQe-c7J@vM;0T2E*;yOy2hTr0E& z`)fb*JZ!V$geThZ1*B#MOnEJjncD|y-L=a7Rjq4?#ep3^QSKPUTl^ZFAJKju0*8AG zm6aKMn6XhgA0_rHKN2pnyikcPK#6($EH6TdUF1K*CAP#SXBE*Wql=C0FTIzHK zT>s?1BbBUy#N$Z#U;Jb!0grnLc#2)i&T_s@z+))1E4;yKe*${`=3u0rr=e#J$>JVc zpDj=tYf+%sbJ9=3RF2Y5h3xBK;x~ReKjgk1Cd0k~Lq5W+djN$Vxhvo}n^7ig)kC-X&b*J9>*H5(%?GVS*>ebx~_ErpP=&P!mj85ZX#Mv**?iYnv0Y>RTUEi-Jo=azL| z3Dv*~uLfRa*RpcXYiKs{4k0YMeR&7ZH|e*y9cXUgQS5X%Z$@^aC%sOyC)|nF6xnUt zaaR@D9cfGM6GiqYYk#cB9&PQ9hV9Y`mm|;1u`eReF(d&K{N?DFZ*yRo%B|q+mkdDV z(=vak=)BABGGUb*JYq(#N0U9ofu;TyYTXSe7H{*$D@1RL847)skth_Qsp2rQD??P# zZp&dzRQ%3SuaI!S!-0qt$TiLfD4(kMpog_qbMOqYvk0s}a;rNZhXd4bqCJUygy(>% z>BM-}vwQ;91gC^&t>t`X8~hS<%i7N8q0oLPLtKf@7wj$(mgJnaVv8YG$N4HWW%K4> z@Yc@Pm<-f)zOiXacFsoF>N(%RX7@NCS>O2~!q&j~F~Zi+`8mSY$iWCz6t1yzF~Zga zKS?O|YwBE%ur+i3h_E$x{)(_&>--&IYvG`)&brQF2lL7dnOCANLUTx&);kWyLF;By z-#X-miV`_H?1$XKGso*4bWk*$MX1vo@U09q|Frg^sFM=%}!ZI*_WJ)g7HpZf%4UN zQWmJ(Hjd9JDLUK*UPKiTQCr9LBD#eu!P?G=4aZvr*7i=EXT`ZtN9Eq)R1HOKIyhy- zCnMO=spf<;o6j|DVjn@9xYbDrWox0tcAHbnaUT)Z$w{1H$Sjd3a)xlwFDSlhTi-XtwU*x+vH$=!k9Bg$}?B1*$i+v2fc*VO^Uh!hx zjFfbDZu(D29Mf^ivMq+&otqsAC@*a7D2oEbc^#)5s-~#-aebZJ9QPq%{hZFW3JvP{PN!=~ zXuc=Z&2i^>LOra|TnOFe^z<47j`}#|y(Trl>1F+MgW=if-CjA_+5H_(U{2V5V1#>L zContgJ}AQdPNew|vUQJRe;cK-W07;OGr*CF!C^e&QaoAI-wBd%w|P2>nS1dIatR&QG}a62 z8woR;MmVZ>Vei&nQT(vrx3?(1a zT&1!3lAG>ip`JC~*XN9N?zim=n=U!yoChrbv`CScn5z^`g(B?Am<-2<2BPtnJ}1+e zZWDmrn4AgDgO;BLzt73G{7dkO&J4@H0-xl}wDEimKH15!?q|TKII}Fru1rprGu!fS z!S8qGSb1#Afnz!FIrv$ zMYh0s2}6vo3A)hPDKr5SmPJklX(zSdy4ZQy%Z2j8D*ec}1XY6`F#dXpN#PT*!n-^97o+@+|k%Y%3bGt8Y&VOXXH=;`OatX z#vwWIee}75hYZ+y=TsjCry`0p03CSA_$6v68FQoJQRZpHDP@cLmXW3T*x)AT zYjBKlzGq;xYPRC;6(kabE2iJ)$w-srJ-f~TB7%%@3X)T9xq?kHU2PAx3^{eQS zG}LOVGNi1)v$I=jo38RwW?s3)SotP3P+oN;ob?aMr!-6XcX=ErQAOfLzCv|?cqOh1 zp*%^wqpaNqZPkSGA-`^D8_@5y0b4gErEH>*|CB?W)r3PWwE+HgCNyhO!{$xW8*Wc% zTPg5gY}*)D@!DF*wB?05mvU{}smNR`^^dw;lO0_tJ3Cs*@7@3VKlUz^EDwuKVYt1u z$c>d3UVi=S{TCL6TPUM!C~=c8|Nb9#6>VXiqDx{cfzVO7IMoX!c3ik`{XB^n*yW;D z`R^bF;S`E|w6zP1v1xNu_{+&&jE)T}{$9?!_(jT#P0}JUi*K|I8+H%NdpYxBmvluz zDx4dU4d+}^=;dBQhT{>fo<<4dg_Hb9jwH>VtCu_Bp0sEX%~7!9D{qkVbc>w$6sJBi zwZ&mYrue_7%}Z(6C!D)*T0Og$B8gGtJU2nl!)NQPUbxO$~0as=Jtn@`&)_Oi9l^T02+|*9Fpvh!7KdGsJp(L+LwxNjQ3*gppe4`|*bMib zK!5NwU^j4DOt|d_&Vye9q7xAoXaRHtx+h9(AcKXZgUkRH0&9T+V0WUV>t8K zqyZT~7BB;t2P_0u0BeDbz&2nfu-nFR1nf9)8aM}B015#rgGK?w1L?p-U>YzR$SZ@W zSID1y*fy8RQOFV4UU51CavV4foCgYl=(5O8S$I|}D>+VvwH?qGNCzeY)5^|*&pfb& zzzSe3uu%dPfb0U!0GGs}R5_FkkdE@02IK)Nfo;HUAQ^rwfYv}qpjSBr8U&IGWC8Pl zl|Vr`N&0TE{lF36IB*&`CmgCy0~f#x0g6Y|Ks?|Fl7NOlOQ2(Xtb(dRplLt`Fb$Xu zEk#FTomL9wi1O0S$qcKu4fEkcxm4 zff>L;U@fo>*bN*6P68KzzL3oTrU7}t(()2nKGH9r^aTb3(?n<`NWM?>6@cvm4g%+Z3qT=26{No7DnKDn4M-Ab)DO@R=qo1Nx&wWI zK^34l4J1v2OoZ<=U^b8kEEUJKAQ_Oz0#*R|z<#(Dz&r+=13wS*3e1Xi(bRyYz&2nP z5M2@F4s-{m0r|jw;2aQL3Hb$D0Ih+Jl@MVskp946APvX>vVa-lnJ0f%z_u3H2Al>i z0RGAtAAr6a1cW0fCBK{68fP0ISyMPTodY}!o}e{ z94-M@s>*YsR5i4qYH+Rwl2lEcn%ckZVDAj{0{R0@5xy6YS|7q$^`-1mC0qvlvV_bA z$pe-GD}j9BBAjo93lMfQoC<(lz+T`W5Z3^O0VFh#xH~pLfI+aPH;@?e#Ci-;CxJ7- zHhAp@E&%6YzXVWqXaW2{LPInsAgMY6Hmxqthjwu8Tzx*+Ah1**9heAA17-txz*1l( zkPmDI3V>arWIxCe;5cv^I0sx1k1HV2H4rsW5vT?v0ZoCHKu4e#&>u(z(t(M2NG(+pPT%;hjB}SdVdTq*|yhFc^CXp%@VC?SlcElTSUYE#&(Pg-A9G* zFv0^x!Ot&Nd{V$T!CiMUS literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/d471eae342b04394_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/d471eae342b04394_0 new file mode 100644 index 0000000000000000000000000000000000000000..179e5812c69a9b0e99e1c81dbeabbb9648144263 GIT binary patch literal 31396 zcmW*T1$a~E+sE-=leS43X<8^YO5H6fUV|2Q*l->0F2kMSKHS}%;SR&yVGL)u`>^-> ze|KG4GKP zB?@L0C{eU@{;Wb-uA)3CS-OC$bm>9`O1iTOxia$?DOfbCWT}$LuH=%gqNUtM#yFkb zHsgO|{qMi-hb#U6*FpS$37V9aF5y8LsYqFA0#r`2;|NmAOZ5?5LCRNAa$`SkVi`j% zt}GoyuPXGZA$`Hnn$kbWTU+Xgf4fS_-K0<0K2FNLK#D{abjN!9jYp`lP#T1@=(R`c zeN74~?xBs?i@Ru)>7fzWpXH%{(V>Kg`k;474|$jNP%iW-=b?HPJk%F6s(R>SOAnb^ zd1wcYAgHy6;!y)l5Z=Z^hj9_7+j=Omorf}z*40D3dU@z~l`W>Vbi4Ep{1~tT=c+;PG z2N+avph2An8MGZc1{>rv#2^>84J9WSemAH%c4NQ@o{u!B&nSalj%6-197n7Z4AMk{ z24UGGa>k*_208v9ZhV+R>{AUYgq^sI&NB@Pn`KbS9D`QRH7Nf)gN9)eoC^$!U2IUU zWd_|^ZqV2j#J}30BG|jupbqPp2YJ^UbOtxjaI-<4`wcpd0tXB_3D3i{Icd;~v&4Gc zAj{tdxzP|qF%PRT=^ulp-!iD#ZPps8cZlJxK>-g8I)Qx;4XXcyd7c}z@P$E(-;%>S zgYF^XJvI4gkT0^Z8lIn7GYrIXJcQ*xgL0tc7utL^DBCxK`r;}Md}rTy7`4P;)N!Lx zIlPVf#bnez3^N-w33n|# z!>F6c$Z6CR%*|!gi`+&P&0|zId`93;Mm5A7?8K0~MvV+Ks((JCZlghvQDeT15=G^ zly1~%#1%8@HHH;8Y7PEHLZ(q;FcW>Vh_!@KcMw#Ha|kSL)Nb4>LoLc0m5IuzSI(#h z_@lg0)(S>#K)#Ab4M$=nqhhKWRS9*`wiS{XI2wNVG~77yDRWol>C0601@A1yZHY#s-)(zKt81?)&qek^)9eT0eeT?eU�cjQVE~a}8#H4CP;vVMg^t$Kgh` z8fnxcgpM+*zy$Wj|NKGh$T@}a@nkBGry13LmQjyq8 zLG?9^yWXf{8;u&ViFMjcUR#V>z0Iij9ptsssB0Lx$EYfMnfnOqah7?m)9;2+Sr3^X zeUbYSdjaDfv!|Xg$1`eyk7)JWs3I?n>i3d;j@4-X-lz#5j9T&0DB~xi=9xWJ(#KOv zu+-|Q2M$mD=JeEh6!r5|&ODxq$9DXc*Hc@AJhea6Q+LoP+*5H8o(hfe)UISt)h*ZxZK*UVE3kfXV$rei`& zPc1@HD^HbgsucuP`d#Vbq4DrIweVxHltO|xk~-&1WCcxv)OPZeI|sjk=q@1>qHE~o!$Pwm|3sjoP( ziCS#&RP+r`^|-}+&pma<>ZJlUFL^t>lnq%qy)+<~m-glM((t@q@(uLTN_5EQr7bvt zJV9Q1hMmD)+7{xa%m^=4#s*hYG*4a$uoE;vWiA6LeEtIq^tTIQ|7%e|Gj!dt;By)|i_w>oTM zo!lP+LZ zut{}7Xd7nIVO+$6aFgERc?A6;ITvNpTAYqH=?1>WnB)^{Qj0i~x?w`RNprC+!K6}& zCY{AUn3QDFJpAl3sS%uRlLB!P*Kj1+q$>GMT367d_k~OfD@?rjSlpzlnI<{1Oj?H9 z$X>#vUofVONi%S}Eb(DLIg{?AOL-o{tD;F;a1f8sqLN7~E1UEISyfGXjf&MwT7eQj z6E{}jBewoxQrYT!#qydaEvaQvP<@ly;XYCtm{bN+@C=n3G7s)GGAaMBCKYXLQjI1i zHNj1kY)bC<3THEu+|5nOz#lDn+}0$|b|yW=C-m-M;ujW^M!>(5NrSskSHyKS=>_g~ zBd#7MMf_$`?moNH_15Mq#PqmYCFoL zp7?|lqp8CfYCgfF4iniIld16(o?{taA=@;Qf^iC$W|~xe7BS5>@pFUyFvq0L^Gx!c zZ_=E_CPgi!ey}e$slqCg7Hy{PTd3bwlg48??qcjVlMLHU%7wF-yVs<~`%UVBUk{kH z{}8o4Y*HWW!f!`dv!kpd_8n)B;tu{eVbbtZto>=`JY!PvbFBS&^1r~^UNmXN3@eXT(kN3#wK6Qol0evt9`|ttP z|0M_LF|i;WEioR?@zWC%Kj%!!`I!ty!|2KEh z0cI5%XjZF1X1ze>5VMZs3f`gnP+}QomKzK41}%O!>jZuq&iMF*DI?5kJ<_ZmaEvl* z|2VT2jc0tELcJ}BM$@rLsTj)@Wy4SX7 zQXS^3%beJP`t>X_*S9DaPBdoRCKgR?VbLP&L$#I`HN?0!!SQh0)*oh%CON6q_NG#V)bEOHEFJeMHeu6tVO%W zTQp@l>xjMhWrjt~W?9r{wnc9+caBAC(SI)MI*&LPT675Qw^ENCjfan#8hq3l`;9(2gC<@+I_d4B zK_(xK!y#naeH82Kqade`;?Wg%(bvyMn{xPQYfjqXF`DG^QAaF8*`Iv4w&Jfyp5UXpi9ULl>7$eq zjD@U{K01yPrF>Kq12Gu~aT%u4KFWi@GCrza&PS7Q1Q+2~!AB#Yiav_Quu4AaUzyyH zw~CL>V`fz!ox`FUKH7kHHGR~)mXDU=IWp_`X#8B-EhJ~uSVT=1`zUFtj|wmI(XY#W zv~Y!wdav|R#Z}a5jgKa5^3fdZ{gYaw>lPn!gpKo$}FV)IH7Gp7GJ_>b&t$hqpX_M=jqo9~6Wiguyz7 z41`AytD5(-syl-ETlHa(RmQ zll;&WduLfSWHx!iHP@<6=#Rtm7<;}|Igq)495L>HUl&@n6UUIgnA+kfYA&^E3Kn7Y zGOO;P*b3r6g_X>K3COd`s%SJ=&DyLXU(8)=)or{$_VtW~RoIRf8>rVttA=4R4sEi^ zb2GVO3l1S>3pGP`^xVq+*k;wgD88LF#t0nWK|VXl2PJp0CYXX|yRBM?^%%T|TA|He z`tGwTdB0UT4^WpwR%Kw!U&MWk8XhO-6YN#AKFL_8i2JlvH!=CqkY*n=4RWDKUBhRq|u21YC=re1GHaLyo|M;H4KIHmhRo<`6gSlArjqf`= z$A1X_PQ76KLCtX!>txeGgG~>OHl=ym)D3@l+4QT)ruJCmXH)i^Hgyf*G49|6ZiMnR z%%+HNn;a1~)yHI{NAf(%rWsg@?=g%QYtsVEPq3+=+os+5Z90x31#Fsvh4`;(Z{CE@aSh#yTLYX9d48F6q~-x zw<*^`>a)nEau|#|n778Jm-vbfYi-(xm~}Sw#W6&!x2eqro35bgCY!o!Wt?r)3_b7< zYHqjbz%FXNn|$`zl)9I??4#EEIe);W2?rVTkWJoy*>oM7j@p!T%%)SQdYqU}P)}r> zv?=(MO})_fH0_Y@4D~o`(>p9WXOru^O^2}k0`Xk5Y3C)@iz3Ezk{* zQ1rD;WpD(!-%uya!Yh17ySFy&z)@tqvuPscA@_TmnxGRdBkluZVF^CK^CNY|U$}ru zpXi4*Nc>D~FdT1C{6CwlUlzI)nL z#LKP`xQFWAb}hk2B%18JezPmT*{-2@h75~c(-GxkR{^xfd^oIj)xk~_u-P>kHoIM` z9CqdNwd*qea@rN^XV+{v{p~u0L4owoXP0-7U8S%cAFwCbuF4^HHAaU}yZ%MxFuTs; z0iwh0s*9nR6k*pk+(WTQyMm*L9rMv8+OEtPyB^~M?!*#j0%O9IXjkbZyS|``i#gnO zEl#$peF3}vL-~R{E^JqmBD61R*S-|H;!^DzjVWn%`K8tjGO^cKJ89YcF~<;XKwiWqq32)wDVBwIny}LH5?nh1c!uifnJ!Iiz*4s~i^N zT1WEl#M*Tx=Pu;mm9-mX=e3GmW8CKsmnCG>cMlmU7KK-VOQ!*_Bh;g85`B+*)Y1ZPBT_GqBkITe^T{v@vc31h{xxt+O5I0KSv~!))t_aM;Io!nR+te2? zP~Z-G24_*}AvJ*>G0$V>fyYz3(oy(1bG@JzFWDon>?-)$uKw@%`SPCq@`3(n`O&Ul zKH1ghGjrk6f8_Ipx_sw*Ko0$DaHyiELlaF7T{k<_%;L~Pw6Ho9U~_1gze8iQJ2XDP zq5e4>x|`FX9=RNvfq#&i+o9&zfu|Us$Dw^V1)rZB{J!AOS6K2ov=$wM98$1D`~N4} zp_4HV)r@t>Gr__86%G}3JCu>^P|5rbUB%u44rLZ3#zKry*rA+gg|p^t`1*U(mFTL+#r-)To_9w)PHH$0Qu;;LyRY%#GIF9Xf(qzd2;> zNuIr!zc+dHacEFKhk^!>(?I&+GsX>aD0T=n9Oh8Z-yQm81al!}v_l2QaBQqYxyL#9 z{&8p-e8)SKh>H^(sxi@_$5=SYp?8yseTqX}raH7_nnRVRJ9G!#XE=0Y7V*w@C~}TN zA#)vCH;*_MIMi*ULmpemUNI-So~HKTkLRo_?!J0c)C+@<(=wU!Kt)LPF1VwREb}l>R#Qc zPc@ucSJSDGTEtr0snYeF{0{C^|3>s{?9{U+%-zhX(B@8kXyMe-mQFoI@itEF!w(c~ zOKw!=Uvoew^I{v2620wDuQ9i*vqj)tk+*oHN#45 z#lMH0>Tr~KkFjPaoJv0BRF%_C)yIsp%zw_Q=cs+dso}SsYInye(_N=}pw~T)J*3W$ zoZ9`EzE7Oor{dJLr_|{M`{t!nhhIB2^F8Z{-k)fXXXyCZslKrO=j8V{r|zTlH>XZx z>JO(rqi=wpw&O6&Is9}ar=O1I^3x@p%HyZT`TW#6*iRip{1h4Lrzdz2=BHiZe!3dr zr^S(eS{Lo7WpRGm7w@N;$$pws*iXBQ_$j3*?Na>ocdDQK)BQ9kgSoJ{7;|O%X;_w@ zf=l>m1RSOOv=-LVe)<&$QM#<3W|i|(NF`!Hi7I~DjIUVzv!5b<@zV_K$IDuN8d=v* z$-nxkT7N%{8ttc_r}}B>L;42$YgdTBYQ*?!n#*5{G1%>|0{Q(_xPZS(R`FLgY^>(5 z|El||P7S`IV=aGmtK+W*b^Y~IJ%2eH`|DN{f9-GTuSd=OwW5W;qFd3nwZHPV^;Zne zp+h@=-ABIm{u+y!Xxq)7J?*c@1O0Vv1mjHfSBokBda=e|bJqIn@H&6J*}@!${B;R8 ze$W;H9@#V&cf7LcC+}?PY09QAaGJBpV9BPp)3d3}jBKipx6sUNDv61hhdi^gX)`*{ z$)@%Agkp1fj`ujTIGdKPrTzMB>b9L@Fz(2vhP$$97G9y;?rd6x`zWv{nes*`aJ|dN`ZTW8|@HN+n=Fr5xIaF>hR=HMQj96GurhhlH% z&?VG-n?ozVYUvg@8?wrb9H>X-R$fwZVKmK>U2jf?shFB`yUj&)@6^jKxt5xe=({$a6DLbFdL>ZUt)a#C&=M-%0tDcXmD% zKy&oN0pysIPw@-#sRa%$%qQ34e3~5^q^}4K4^k2?Au%dQ3uA)RKQ>6)5D*`vW0+GV zNPlBo)gaA9n`%L-(<(??q1Hjlz-xH43DOeeZ5yQSn1oMQ&@M>p;L|=xB{2oJ@d8yk z1ZgbJz`J9RMqxpxAl<^G&cuV#U4pa+jk*S@J&xcK=5`CxW7O_JOuq%`8kYAAlD$`u ze!`vJL5l4Yq-NOPm-hXLabu8bpd}_@9xkKtrXY31b$s6(q#S<+sRMpT5MAgBEy?QpbZ7e1dx7-pL>pI~}B&7lY)w6r`iLjxkq)Gy|osk=ykk z^}zi#fDtq}Kw9G&Is^(=^c2!b^7HErHd$G1UxiR~YP6!9@g zc|HeemUl4s83yYw1e$}D*AlE4RI>(aL%v|ujS1F`lwetl2WuCumJHSdM3xKIit@qQ zf`rP!d=7>7cvmY}9<_tj4e51*RURc82CHU!=I9ix^LW=KSpMA@2PJw0b59rJ{T8fj zy=mVkSY`VL%h->$gMw9iNU**P57v-HjK3;a*ATm!_|^pL43@18mgl-)`K%AtEG)-_ z4Z*sLqZ@-&VNy3AL-ZH!*g_QI8=}tsA^I0FK_RLa6{1mbAxbC^qP1xu>RvBIWjcoFanBH$ zSBI$np%DFjCPWj@g(&($h=MMK=q~zR4$)<_yF#0*A?oueM5~{NXvoVDwfY{Sf`(9K z;XM8@hH4f5#&_iR3{^jbdWEW#cc`LFp-M1^>IM2(LNyUKpHP*@H`uMA+JGoqsM_Hm z9^+qoD3=%*%QsYVhVprZP~GthS8 zjIoM`>I0T#hRQQ5RQ?!+`>0nURA=EV8LAXC$8mf^%~GM7faj${b)ihCQfr5*JI>b$ z)wQ~zYV~`l7UIY7Pz@eITqrX#RF-+6DuMa)L%9YPs@5k$xlSLd`X|XB=aGCWl=rWQ z<#ec8pbwVgPkcf7Goh-D^XPmwRJ+cF@-v^Bo)1+W9D(yfsD8Uh?clgfU9l97E98A6 zR7+6%AL7IdRJawY)3^tpJDf`l(^YiJ4AUi8%7k%EHB9rd7b?p+RH_oD4!?w{Kh{p7If+vra#fPSD4PCckeJQ!A3klM4vF_#~dW~4O6y$VVZ^;sNA1% zaRnO&hN;@`VQMldOuJ@;@qTHTw&631&kECDFwYKCESh2eoG|*)+Am<$`j)M#Uv zYHSMAjJ;vXwJ%I9j)rL%&Y{GyFdfJ4<6(M=PiS?5@o^ZFPlo9Orko0s@98kj!)^3F zLw{tPB~DDmGnmhXso(|9V=?+)q&+@k{pB#-h5r@iMNj;LmDj^`ADK786n~R=o`>i#WE$Iw9G>I;WQxay)Mj-iqvT=h`Y7_N(0T!CTNx;ocl_`)hSoF z2I4h-AUIFBPT~eC{X|SyjH-FV^()Td7FGs^Ybze-3s=LSaJ9uk6b%m7A6SI-q2byM zudr~@a5#f5887`kJj^Qzmmk8I@QsK&7 zI$WL=!qo^TQM6*Xmf}CutVFKp+B94TdW5U{Z`8gQWA+JGwZYVG7=1^EYwFl=H6I_Y zvQwF725nY_YYB$0A*Q|I%J`f4UXVvvguXV2Q0;~hYJo2})F?u&e~r)^cs7oZ3%_DL z@->Oj9BhYg(+IW0N91c3p_;ghLd_%ev~z?ax@%Qlv zUYkT{EG{AZWP~On->C=x*DS~V85$cW2@VgSBTbOerLRV1WW`r!a zB6R*yglvzg%M)UJ8li13BJ=?(UQ!FJd=ydhbYJW%S0;=4IRDT5i6R92u zxf!X|xPq>?B30;iq)x*74&&a9)W7(G>GvYJk0?@CQSd*GVVt6L6cL6fS&UI~=ZsQY z9L*J__j#h!J71Kxp>0r<`oJSNN)1DzG$S-hKIu^^i3J%PD;CA)5u$Vl86~4+EfuAw z<)Rc*K1w(63|%Tj=}g5aEv^)${MDi~4OQw!aV;rI|JIArr20|X-GaU?qf`Ojt)gUX z9mVe#QCieKN+mi($=NYVbI`w6l;Q_OX%w0bj8e|QQR;+QL!$I5yO3qF*=P+h8W#LkTFIzF#@NM%QHrG zu>iN==M|$&bi!g>gV{SqMbQOIa2a+}j55$3b8#A;<`|`-BbMM2ye%Wq)5ZjVt(M~of^#3(dRjNS*wC@CaHV?tvzEi6XOV)$ApM%fC-s1jBd zA;+SOTP#L7ipQvHW{je;V$`-&j8>q2=@_-c8&oMvEak|%A~|l2(EucGi%}MiB4P() z?2ggUD=~UOMk$YCR35&MIsP(6;jftUb&LwWiP6K4F$(z#QNGh!8AELOWK#_9{!R*Kag zbgdjKN4;28#1Ht^kJS{sX~4V)yo;NDpE-bXC^V|CzUtaK_?n{W_4Psggv6Z+!r(^wUH7OV9yVwLY@tl|*z zC02f4d5)ic#Hu4gJ>v8$vKitOh9F~{5}a}Bf?>FdaKAVuV*`fx$LTuavc;(rw&4mY zWRKGXln#i~A{@nAC`X)%pdUu#J1XRi(+^b06{k8Fl{-%VpnOD}YT*E`N5<(1>O{q< zCC*33sYYy^{Nv*E25sV*2kUVPjT7Ru20M|J7$?u9I5ou$x`0153d;b;D|0K&?V?nvJ1F;uMe)r?#na`V-C5;*^%oc&LyO zr(19oi&Iy8M)Ts-4zn}k^ern+86}9ZR2<(UajIV~PS5ea0`;mGr;>H4IbNZ0y*Qo2 zJrt-Pr;2FOfO_LuTWZrTP9-|UX%Gr@rZ0{os%xCGcO(Bnahikw2FK~nQ0AT*r_^cW zi|^PmJx+V)avbaD#c3Z(&!?^n;?!$loKEiK{2tC@{a((a^ghn-k5i)qacX}wPOH%H zSe!Z_&vEK~ny+VA6a0gTXXDi3GWAETE374+qx`ivwY$zf`$m0X`9aO`#SqWy_;@|T zR}A)y*DbGjKD!hzrzKvM;o%d{=PTkh4ezY+I%bPkU;lV*LALDiI*Sgu;R1oULgXg2CbC8$~91Z_jU zv;@_MZ+e1)umpx;3EGP16%rIxF+oEsF<<2bjcc5slNit>LE{n7G(laOC1^+U1m4$9 z&>HykPtaamACaK!BNNnlRDuFWCuq>D1noqwISIOie^w-D#mWTTL-ExKdWMR75;O|w zdlOU%7vS2Tpc@!{B0l9j(&++gJ1m<)d|_NC2ABN;%tsYIdUdyKhB|h zu0%b>gxrbx9Gs}mA@qq!)EAgz6BS)AQA3g1Fj3>tscE7v<5jCfm291;PpHu*QEHp0 z>L}fn@vx?6q6YV(|CB@xL&D5NwMD*JiAuzIl%1WZ-%)fXIoTT=M9+IT}lZbzEk`|%GA4wWKJxSGP zB&iv4&P-C>*-7fXI7#C$bxo3bu1nG|xYj3W^@b$HZcI|!%}F|ZAW0McO41yZJxqMa zaU@Aku;FBq#$QTO=&d9jxx@3pmuFhKEaD2A9&X*630(FPDzu z5(av^bl>FC8+e*sYK@u}mzLUG%4K&c0%zg$b!o8ErCtFp&B(!dRLkko5`^b+>2;(_ z7ouF+9YeoZmqrzE=^G-8y7UR=6qkZiT}s5%beCFXxYQFfi@CJ?e==SA3QLwtoADa? zO1abp0}xx87YbIUV!6_?IbbE)<(E~V6PX&rWbUf% zo=amJxHP^IbNuR34(x}2W0%Tdely~0=h9@%M}_v(r31Nia`Eq)OLO|U_}!d2(S95? z9M2r6Ie{2wxOflQrRp%va_RG2mrl%c>2Hji@6v}w)O)c@SJ8KgOJU1gdJnJVF7BP7 z25ViiZE~r^5&GdhS{x%MJh@0MuDJ9aE3UfK@S01e8$4)CkLekb~UH=HXUtFSnZHaI0}nH=j{*b1liuXOrAopWCflKe?3}~PIs$M zF~%?D)^$9@q|$DEDC3rAS+{ba4_cLTYjh>I9-(d(x4f#k`P%^;N4B5cs)b{}xb=4p z=B`N&FxH|?ZMVkPaqDzlx3)KQE21Uy;(aT(X0~zb6~1A4TgGn3*d5$T?95#F*2S$^ z-Q4`mEVtV9aC1)@H9-gD?nR!x-SY3tI0G36->`g;TQNiEH`J|XBiw2<(yeyLIf@)d zyR~SHTX)C0^<=zTrzW@+Jdt`}C2CA^YxQKeZvWv{&{Xo7&heRUeVy&r`8jT_nCsTS zdE`2u^DEtIzsjwttKE9H#x1RLtL=KXE^VOgM#kRcR+T?Fx5cgBce!T|U#!^?w|+X#8lGUxQ>^b9x1!IxRp}zNx+?Tuy}s?%j)!hJAGy^Gb8!mSQQ|Sru^LsMxYY%xk^a=J%Xp8K&)jl7C$<-EJ-}Fx zWED3gt19-w%QKnJHzezKzhq5AHUDHa#(Ct*o~+?07?iBiP;j!G7=$As$to0@tckJ7 zT8R2_$!dpx5SEavN$8h9S>sT)K(cD%7<>yQt3SqOBx^2e7fV(vTtiSM?GaNpSslwI zt1s^3J=T>cUQDQvtWPLWDOo4+5c?`8t9_MZjjo!ke=+;#WcmM+tcKVO&+5d2J1AKr zS&221bqJ=~$tqumHpp9-I>5gk`PNU?!C#Ygp>eXdG$GFB$r{)?S$Wz}r?$!5_eK7w z(LPzj@B-yKBXWSL1CrHwAoasKT*gm> zl9e!oTB92hhEk_#$$AOH^kg+fC!9vH8N@%6@!&fvS-;Ir)&}I7ldQ$qih&yos{V^2 znvZ{x`(+VT!bqHi|EnUZfT7rl*NA;xM9nZ87vS@zh>D{-R^urm-xg5=Ou;D_-xX0& zbjDKLL9X{jR2}XjMU`5#sOqE_Rf8r)mG?+dy-i3_bYcphnM~0v+(d9viW*}st|Nyl zMQyPQ4tI*`V;ww_Q&a_maTx{5rSP|fQWQ}>MFp`FxhkgU1FqCaQM+0x`q+qL%~DjN zWr|9-PSH>lZj+)ic#1h~Q}j2+wPSu{wNKF}6zY(o$M}ptJEq958*{_ZJw^VQj`uxM zwDGqT{WUs8#xW_{g2SjdHbpDOrKrXD6x~~rqQIpo>b)#QU6-e5-nJAz6UO*Eu#^0c zrzr1<6rI5>G(VZ51E*5d=S+(FJs~G_c$&id&MESIMxCCga6LRlUu~%>WKY#(N2+%F zrmAeNR1LmQ+o1r|KLM^QY=9z78q$tlc%><)cbXQN(sad|CO=!6rsPV~ z)ZjE-#PEHdN=t>2%fUI)@N|6rO7chXcGZ(+QfrjhvfUYaJ|PgBP8H1$Q&i!>F( zUkH7brrXHzBTd!8Uj$K3%)x&i=~`+?SFCrsTHz;Cy5g__4of;8@lMx2&UC#GNLNyh zbdAZGt|Gb8RU$53gHRwoT_tfGQHkmL7wyv1wGs_7($yYsQMGuwz9OW2x*Ea1Lb^h+ z9A1@}4~C!9m4+F=q^oju#;L(LXi$@J@D^2T6IY#dncJo7EPUFht7V6DDs#>UEi>NVY>FA^rCd` zS4vlvCFxqRI$aMja}6=UwKiR2*QKlI`g9%Lo-Xel>DrECsIoI%t9PZV@$Ph;I+Csm zN2&2=@{7t)3(Sqq(081T$qQL-+9x zp6MCNj&Kw}NmNHObi+{mfyLO2*Z93yhJMP-;JvvFl`5IR>%0tgEW=pkGBl%nh7v1g z=wPJ`)vl7Eq(7LeS~1PB6<64V;@Up3xT;Jp&b?v9)n{sP`AsjbWiyH^eO7T@m|a}0 z<`&nFdBrt#L2)H4Dz1HjnW`0(sTaYS{5`l#u1{oY4emx~>R@c9RwQOBrckC5DrBlH z@>R@a{!Bf?>gt)ws*$O=7*RJR<#@O&_o~b;zgN^Mn<=sA0o*n3m z_wee-JP7KPsRnR%&QvfCA*D+u|K4V*dGAbZ$Lc?`p)K)Yeld0V}j;G@?ReOA<`cBW(6GY6;)F9MboT(Y8xFl2ck+w9G_trDH|0PqU zH)pCQiv5|X&c`zOy&+Rgj%TV1rku!B{@a-vj(&GDwG$ogWvV|q-Op6Xmzf%jg0C`F z3WnF@@;*~1FyTw4PGiv5Oie_=Z<$(!wC|ZJW607fTsLNMFMgJKdS>Y`9;1p^7JoM( zOAD|T-;nB^rE=JS;-)OkgUg(y`sj)oxSS_T7XoRQFH0R^3(8UuD*aDzmY!p8WR@PF zYE+g!L}#g8OqM3$6w1VA=_1}DpNr%8fje%-$)CmFw98U|tS!Pk_`jO&1Imdi-sAX> zUZgBYUy1_Kn;^X?$z(DUNV3`NQd3Zx(yLMzM7s0^1?e3@5UC;{y*KGdXF-}Ey)Es1 zdFMUO`J8NK=HC1N|7WtmWaduV+75k!3UwWd$B9pg?K5J-0eBjc6Yimx!=Z9chniuV zLC%=qa;S^xP)W<7k5NCtq1L$C%%Kv=b!G_eS#yG9eRSo zR~%}9I9x=L6o;zAiz&E>v{xMpU<^85qn23pk3)as0kT|os1yv0$NgIl<-1M2k^5ir zhX=zj|BgeI?mDy%m$C8z>mNGg!{?7VKJfk%hlV_NXbBFbI+Ww3L&sh@^a_EujEi(~ zs%$!^cHth*Wp!#>cBhVGWJ#yeedJVkB;yDkBT&kzS-6eIrJZVChHbC_+wc~7%Q;mS zgD?i;%R5!0f>Rq%rJ_?_w5{aS_sCP(snQ6%Q^lzVSY6er3Dulhhhv{Ob-spE7iv0{ zyOvX#>N@oyzC_ykv`2$?8aQO`NKa_U|;M z&t^`AP_3m?f8rV{wQ?!}H?X3$Q)lqmmrhOU;?(ar(8H;R$lBAX;;4f|c!tzIPJPgq zd@v4c@FIymhB);G4M#IBtZ`1}S8!_j9H*Ax849d*s_{;zdf?_kr*a%3mSe<%6S#+h z$8mysBIXpe#XPLR#dl6Sm2}3bQ-3@43a*Pzb;J;?x$4we+_^zLZ#vcGu2Yi{yzkUN zw0h#yaMXRyK0@)=#EDoLa-n=?LjkmZ&(P~wLnR6u>QKzkWcVr=>V^81S&vIq4P~ij zC{o?fNKCG6a6gZsjP(sw!Hv%h*^6vcX6 zL9S+oY9ghDp=>P;&5at`g9%?4%rR@|;|_+JB5h|w6>zABq0D^@RYj2`Lr(lR*ieCQ zSw75AB^()H=mqM0Z>SZ1M+yp$GvvTe*oowc27kX2!z4p>(P1*G_(svelz68p4Eo-uce+ThAP9n zZm1I;BjXL~`OZy4f1&;@gL4Fi^4>A{uG~- zH0q0#M=h6X;X!?uVjH;B+3nI*%cTw;mt65Kb;XnxF1;6WX;RpwqEVL? zwQ?!&g-hw%xKs&CI=NK5i%YAzy40|{i|eCZ+W)mn_tEwnm-=AdJAGVo^mXY(KbIQ! zcWDC7pws}~<0MkBVxUV8@mCW440h=>Dh_oi!*G|bj3usF)COB|442@YVav_YE1 zF8z-9EsTwe*tC^=x4Tq$H_Om!k4rOAcrUr{b18Db#kE7^c7*XT`?yQHa31+jupdzW zluNDgH?p3luIF6Jecq+AICFvbsCI?@f=MaFfLvFp`%RY`JYXMS-$R$~;ldM_(miE4 z8a{Jz-!02fGtjBEI)NeTVj>lC0My4{wncA61zs*cd#c5=2W%B#iRJ%5&#vn}xQ>F25H&eN~ zn>yReWa52Oosfhj?|f}CpP#9=3px> zqxm#bpZ#QV4#(7>)jP1Rp)GKY<+50;pEgSJaeuCX#z7jKtShZQVa zX=)OZSF!DCQx(^m3Zfs5|88p2AEr{!WTUAO*tvyTA>CF}v8aYdxW0qFck&*maA_BD z?gg z&}*(fT6WWA;0jOnrKp<(PGqoRIsPsbZ-3 z5Ak1T{2Qi9-8S{rT~ja6?w-lD+9v0^$l(D$KQx(F!_;jQdTgpDn&6u!#E4=~i3Ke& z4l&QECrZ9Bm4Hqdin(Z$YHB3*y&{f`ZZ$$PI5N5QCYxJ!DYu%UC#IEgt94noV#>L- zt-M=DFtCDK#Vfj1w-W2Hy0TmQ;H%=+jE~*gTGg$a$o`32zoArhw-WGQO}8r5c582a zx2y*AjoT>F(5*s-n|a;c%44~i`@yZw9=BFBc54&Xd)=z&cdH}TVL`yHNW5F`1>Gu# zU$751@p*zJNS6B!5XaS*qVxe5K^!=`REKp5xo0>zrSWnxBiw>F|t3)*5V*5Fi2 zeh!l_u3=%st(`EUZneU2{DN(`|2cJN?ban!X~X!qiMH+B`WNNeyVU}_(BVsB!dG9p zRi=YmuY0+9o&&yiYY#sC#;sAq+&VDQtr270e0S^C%&Bfo-s;wt?c}k;twsCY`r#xo zo}$k)Zk0Gs?Ju~M<1%%?h!pl64qtaGDXXQuIV^21VX62>mVT{bDWQR-k3Y3I&uz*5 znWdYU(a=(&(^6r>lBby^XLCzs+giHS-O^Lc?_nu_PfL;BmP&qY=~+KZ>HAx{1OEU^ zF9up_lVqvsU`yA(we$!DzOytM=kU=`OP!H|mcuM;k(N#& z&nQc?u^bu3T6!PeaTez>E$;2Nv=c}1{RB%nrdo={DCGNzT+wPexud`gi{EABIg_^N zK8rkO(`EtNEG9O5y2MhNrIud9TxRKuUo3UQ`4yH9uC%mdou$6(Ee%KYO_u(FcZ02V z!3?&>;P;HSdS|k=3i~tLs+GmoT;#}V>uX#_;(NCCqFOdvvym;kt^T+MZw^}v;mv6? zZ;#D22DX;vwiSKfR;N6+e#WkRw({nuFN`W+>uEt-&kNa_7;EdB!nV>EvGpTL6}7b< zEsNR8@`0^O2o|@s1P`#c1pSpHP8g+$y^O6zk~A^XzWJm_UuO-MTIYI%|fNGY;8vO4%7j;IuaAobz(gH z+}W0|i>+zcic?)}7462p!6~HaVXHBwp=wWCMS9s}2hoyOamhYQdIUU3^6CfeGTZ1aCC z>O6(oA^rzjdr<2~_TN-$HI3tS2KmjhnM;GZpxA7V={dHN=i16S&sGC8!nB`xzm($` z$CnZ7a`qkeudvnQSB}S(buLEU`XYKm(p9`Y!RA8`!X!X7!%2g`9C#Uk{BWE@7GD0OPqKHMhT4moRC7SMyM2 zpjX3^yc#>mtJA~0sz27NT;sfIi{0bBN-;{oz#v*U)g2SEV<5_1|8vD(oW$+(YmEUL8B&)$oH}JwNPKjU&X4 z7Z~)HSLcsemvz>@U&N-UuFzEze3z8UL`;9>L`Xj^lCB+J@V?C$6j@L z!q4e_YKHeR_!Nt|c$3kma+!UKFXL1CvOb>K;nOO#t>9B{yhO7~KAppTd{^10%(Z+n z@d8iD?E-lqpnpDG(ZrQjj@xO_av&!d7Uz?r zoljG`&>pS6@o5c4_x0&uKVAp;bP*4ee5x|Yr>l5`zJq-_^{r1shWIpbl21o4B-y7) zC@`7$r}*^Y4~)Iqr&KIoulZH{`r%{0##Qy}-|BuHt>M?sntpApMW40(immI{Eo`et zUk&~G%<0!{!>>1{UyI#-owod%Yx{KxlRSRSLzzZ?4QuS@*?fK#!64)x=vN{#C;3$X zv+#0|UrB@gO2!k+olZZPG=qLnW+wg2qRnjjL2vBe$ooyihXV*~CeJ^~aSLts_;ne{ zd&vuB_xUw^zhA}yzj9sj%a62|{mPB0cyfg?Q>eoYzcSqPbN#kod*Qp~*RtDwHT{>o z@A>r>tM2=GE`VRw1HTqNWZXx7je1U7^n2mgXvC!Y)%m4g1z+)+CQi!`NgJmwc#J^$ zIK4(pjyT2Uj8hYAgCizRS#rhcK5FNSmF$gXsgxmm#2} z%mIze8_*3n@&^=OAfSo3fno&%YE~$q`^Xy`V2-+g{`w%Gi)jC0Ky6C|bO>il29&2A z%e&B5*MK(SS+{_4eG^cLApvC_70}G&fL2TnDED0YnjcUf+`!4j0To>vPzS8p7?68Y zKwbXib#FlZ&jeJyOuTkBi`Sp6<5jY4ykdICtNxOBwc8P|A?UgHI;sfIwz)|f=Cou8g|LlWpIf5Swi}FEU%b8A*A9H zL#jDBq?uDfGNy*OraPoxrib*;jF4`vqo4I59oZ1lAAf|Db#q7!F?LHxTegPOXHQ76 zCqlZM64K&_A}NFVV&#~R<%K4#S9M1gF(~6IzKb4LbJj;gbPTX9agzHVO_-|yq+6Y)dlpAOGsK6 zR`#X5$IaDY)msymjq7;1HmpkP!Wx3{IEQ@e!}4JsGH(bgFFc#VT7+g>!+MMlj)Zj> zw=abGZZ9n334NgYQ*y*DjC~Q-6{Mzy)#_zfUDHLh9Ietv)D3wuM07r5M1?X%bO;xa zoH?SZSt8nk#B40b#!RG21FD)FrwzjmK0H8 zoJE;o5w%0X;SrU^A!HaC(dQU7np{wSY()K0X=r<>#@pB{W%ZQH6Bft4FbWE>sUYc%>ks@^z()nn*uY*aTVL^W|@R5d3>bu>AuGLxe`$1{8L|XHhN1!jP6QN?y*C0POF%%B z4KkIzmwoqXXmpZlD1e`(WizQxz}{qIZldhyZ>RF=HbNh@`O zFTQM4^=++39H-^$p;1{XZ6q1@jhSZXGT568$Z3W-H zr8Rm%m)>wkihTg~{)+LDVhn(+LGa@z@Z?kI`Wf{60#*%%Dqlj}FlhS~beGJpVX@p9 z4sVWt9#VHCw33`}poVlE4Ijv$G4Qp#7^`>_V9hFsSq-i=u=*$1D)ZLD!i~ypGi;Q7 zlD7pcze0i>kxSBaJM7p2$7Re;m?On^L7hF&M(n>qvP_oW_rh73v=6?Mxc%z$VOT0% zjzC|zDjb8NGFyVj;dS{>ik*PZWwgvX3BAsO`48A~9-=NlDLF1zq{W}m@FH}Ol9#|K zGvwpTFiL9v1ubRI|6I{t%Y>^sCM5P6RJg9S<+l7Q@7{n{|0u7U8ZW1$_ATXj8&*j7 zJ1{_Q$o~6qUZy^PMUwas?mq(KW7s77CI1PmeX3(kzIX=X#PD3blNA#40^XL7#Qzei z%4*prGyYS*3=#AbpD}{U@}q2#EK>vnWu&}rj-a{hk`a~&W=L~u1YP8W-W*npZl4YVt~ol!@Ro$x4c# zmKZ8%jtr6UQnO+NXJx7*f(yS+VYK@l`=VcER$qP zegylgMlhyY1RbhJknnm0Z`M%m;;$9KA&ILK!BFW|H-hE$A}C!yg53?2U!w>Eg5qu;w-i+X4d*$6Rf=@cBZ*o~2Z$&Uo)^v^F#oH0|=oZ2G?hz#SP^@0+h+ym92rT;}=>I>bBG`O70?(NU_Wcn-iSrSB zDLu^wR!17BU@=g$uz}G<4E!q}#2Hv0Z=hwOfv-~x9IRxZAk{!UIV&ez2C8}tG?XNt zf$Hf7GW-U{Ntfyd{&?NMmo*GLlY&|XmdgftD#hv;_(ZnXHQ=vj;ALY2eVQ65-^{>5 zx!K%6n-&JT$xRvG(!fWp3`D-6^;;WA>|kI|CjEMlZkQ6p!I85v#N$ZRPRZKP?8 zk?k^~gpnE2Jl04TIVol0G*<4$8;M9TvO)GrIMK+El13g%Mp+{@gmOlT%V7DfypfzF zBfBdYIVIyO8kr}t$wu0wD261Z8wtoQc_r`qjjRnANzr%Bw=#|N6>pZ20{Ky%W*h02 zV`N>($nP>FY-FND<{PPBU}TdlsAA+NdAF*O&*YwDS2waqzNo1@q+Tr}ZRLR2>lm3^ z*GRQyMw&^{=Bio7%E=Z+wzM*0Yj32a9FxDKMF%6ZI;wY_G^e|I_KxDq?H)$<^i+)A zM&kRb?$7l2b3GnxhBI66FaqUyOi&4BUyWl)IF@6CHtt6?d)PB;%2hL641mE%qlyzLS5R>iBuCJt%BqUJ(;3B)O=G zTg6O#8f_vy#zYlaDUVB-bS#=E8)srjqKT79CN8C#@TQrl>o$?%F;OVpL=(S>RY4QY zvP`^^F4-m$a!jPk6gih`qF$bf*3!G0i7mBFxa*kspswP{xCSON8=9CYml~P4BkdcT zDBMJ`o0`}rwOW|;waCOX8Q9vy>NdJIfS{|=bwbI8OWl61s` z?XrneQtOI|(N|5>xvBkpVB)ek9+~(_A|9Kl`NTx^XD0SY(HAB@k+%PtxG&ieW{O(P zd|1S+$nWJsZT$IV3&AgJ8 zZ<*OD-Y#bPb~W>t+?Rem%$$(nJF&J&D~~J%d{osVRM$bhF6JXTi9Btlwah(Zrr25a=)A`NX{M2^l5!W#biHJz z#$_|NZ<+b*wi*8&GgakBd2-jx&U@;!cpjOVAg3RjsrAInji+XO&&|w{WwQ8R<@2AJ zm+}dbJdhkiB#UH|{3kn2k<>LuGA=SwKafOXm&4Xb4!R?G-xJ9_$?`?AP&SA$J(8N4 zk!;P5q)<*Itz@a(%Z;Q%UL-O3kqni+1(D=djwHQmB$3r3saHLcH>Bw6k&Kd~H6p26 zGm?k~iY>VfBRSbPk{(SW`LSsvlbS~|PwKbQyf-3ww{;|o+eA{mZ6wcS_M4Hk?hr|! zVtK2}^AHAHI<)#G82{Pk5N&f$?vljbuc znK3JpsM(Q}mHKldS-nnct&haAA(AE1Yoq$IRXzGOk|DBWS0s0LN78#{1M4 zIWAoeM3QtTlJ0jS=_fZN{eC3h%Grl{?QtYtdF@Fg-DLUGNJ>9bFJ44)^JOG$UPZFc zV4;f9!dE5>kHu!O(9mjOv#c&+A+o52dc`aZC~jfDl!&oVPMjqy{3uUiEnFyN;Z+3- ztt(oXn{1(2iiOFQ^qj0rwXjvZ4hwyq7XFg^lH<}?Y3jDnS&m48S9!=JiAcB5O-lJK zq{(#oGoajp7TU>(3=7X>S*C@Jl9pwmPqxO$ZFwzh(R&;VS@{-f%366@V4+84)gs~A z7N*MiIu`2JwQ#wCg>4NjRBmKprxa>pVRuUl$7IMG7Am%}kS+@)rmclm?ex0r>S&>S zCktq9bx4U zsbjD*)@a3TvQiLfWuzRoSh*5qCB2Z9{)Mf?6}8ey78SD+U)-vnL9J{PO9?AA?N%np z={PI<yF zpEIqTk~UdZK9j-ORu)Rl94mXp5VCSC-^zmmD{s`bvRoe4v(mY~mG|U(+1EfhG*qsQ ztelgfO|1Mb4Vqe6B6pivY2RG&TU$9QiEXWXE#~%CTFLAVR*G~~UR|w3ysfpnSy?L| zzHeo#M1E+cuMFsGrDZ=WQT?sjdn?1`;73;S2UzueM(fM!VOE-dWySinl?3@p_7Arb z8eyfe^c2G+oIaWTE9doVN=UM3}-_N)5 zWPz0~-&t9@P`P|>#Vb>mS$Tc6m0zUC8Y_e3hWOT6nImgt+$Jj@ZBtHCV!Qe+$vaew z9Nej6Vy~4k$E@5G{|PJK%AGS-+MU&LAeM7h`pJyT>c>^hlVei$n)Xpr|5o2*{dFsj z8&)!9`9D@l-O@bSc-zWv627Z_xTk%&Z{>homVc$t11l+ytb8Y>p6FPR&!1U2@m$Bx z3)S#ad;6c(!A9>08-wJGWEpIHVze{|_FJ{A5+(yG_8=K{*+?E$| zD#k`;2^$~B+88cJ5tV`XzM8;;&K-hJ1`c}ec096q%1 zQX2KO>FbtFU$<;*mEcD<1`e=sT`CQ6D7s2{$nUF_#~K?uf3i{NXXPoIf3b0Eo%UjbVu^K+`XzUMv+?HdHjeGJQF6cb zP-e@~1M0&G8w=%v+&N_<|E!G$^5Gvg*2!-Yd(K8h>2%)44>I9`ju%-iwg0p+QI=h_ z@kE}+Mp4ZkMg4M7OqKm|EjJ2(UKF25s33|%vaU)Lm8(YKd_9U!Wk-!D0yU#pR4a<6 zEu;8Ia$7}VeM65Wr*#yLHc@;i{sqx|A~$}CCSzSRN7qMla6>dDH%3!rQ#3z`4q|S~ zv8~aR-4@M^U!xhhJ(?*yq8YwBn!$Ub*)KW2Mf1VlXg16D`=WVpAeuRcqp5r}nuW)r zxhIa}(d@hsP4PdYv0jd*sRXV>GvInO%Wp*UOn&<(nxeO&c|+oEN7L_qG~1-*!)QKz zqF&& zCiIWtynOY8p8rYDOZ55}){A+AUXv!fW0)n&4=Mgx#g~Hm;33?4I!7s9Ia0yCHDM459FD}8Xl_mIFD()%4 zr^ie1o1DK^g0zOhv5 z7fX@;vG@kWGD!ZE1p^i9Q^oo$mXV*wVi>Hk^23+0^cfP%MwvV`mej9f`9Sg~#L{|l zEZ<4hDY4{Di)ENJn;y%XFNm{15e~xARrdZBNnJuxj z+!3pvl~m8JSoZIZrSEUCwAdfZw{q-2EN33ZlKd!^gy*qL_&1jG(hxhpi#@{5e50Li zW;?4T(_-f%tDWuQvDtZ4)K2AMcE%RBQ#{&E8z~oK*Lz<(eI+;6&M>>3!%`>C&Php% zx3fx?mD9LXJGay9dar9I&uyoq*G?h7oxz!Q_RFv=J3r*wc`BRo>@*77XxY;dZXd#gTS>P^8#$ zWP+WMbM2gv?hEV;_}}RKNX_GR#>?;W?HM~arQ%sTe_XOt>9YFv zmwJ2KP8XSe$IktSb}GEE)881UQ+07Xmy9BDd@er}jblN49CzfK#5fkd7RNntl#b(Y zavZOv#PL_9IIP|{n#y*69HRqqoR*QnI4Whv@xF}9ilcI_o|9^!I9BGz@j@O|j-yGn zIA%%F>T#5>7e`Oo-XM;tt>d^XnH}P2-YJetlH4VZ_heevI6i(Sj@{zz6~|<`D2ct} zSSI0taeOU@zlfvdkT~W^gJD|xE9ED<1$28{=6nvF3QHMa45({DtD#P$Hhl*mx$r7Ej00@hp>H%EaqEemuA2S-E&} zD#YtErg)}QjAwIlJhqg0s>ot@JP+kfe>@)t<8{s`o^x_06wiRF@$8VL)#G_wOXF+D zL*sZ}HILVM#&}+~iRaxe@vN6^-QsD}E1rci=RM`qC!WSKTw3;1F7noZcuo(Br{c%) ztdNdhC|AiCs#wG0sW~DZLuE?-C@f?=Ti{kliX*_r3!VmGp{}@jvnJ$CZ z#Is*Eu8rr7&G9Ud@>}B>x-*_bvTB#s*d5R3;@_hl?2YG=bl4Zq+yn9aBmE9)++o!w zUmuBQ{;_y&%P+?j`$RkmC*x@(i_fZGa_3w;Qy<53Syq$4x3LM_l)k$c>YYI5`w4s@pM9X``XT|{XQZa`l z@N`%L-G?WzMhZqK{%FM?qvyvZuy1k#@l!N+x^8DD&`Dm-Nnq#P1d4x~z-#mLSZdBs zpy`4HwpU7|Xlf!pZz4_e5}7SKt0iKoo=9c!yq?Ga*;XTwy)_ewtCdJ^soyw}sj|39 zBC*X9`BwgrO3f4bN%C4HGE6G9No3tyiI}=1QoMU2&3h&?SE}^Vy1fcyi+N zL>`UMx+4>bnUKis8Hwb~)bn!^IlCy4l*NgBwltA<)@TiJ{*p+aUlZ9VCH5vVZ(ky} zr1}9pCzgX+OX3eD(n+SvHzyN0DX(49+`lwVR$NPD>)(kKx}M1Re-f$tFp?#w870HaL$fV8{srpVuMoCit zimZ_5;{T{3e@gq26iqq$*j!QYcfAKnK~go&evlJ z6eQETax!UElJ)&5S^ox-8Bimcd$p5!P&b*)4YW?iiA%%~nV#ySS%8pVg6nia&ZlzPWk&;42CCzoF@Idm@Qn)7dyeUkPxS- zp=y2#yK1BmT{DIAO;hOGDuu1GqFoAwyQk1n7Js0zpQbQSQbwjQV64`Yw8<$f{4Rxi zQevk&f@=7HhUaLgG-<23~yOKU1&~vi#VI_>VR2s#5Dl=sKKdHL5CzYDFQn@6(ZfoqFRNBk?GVy+@&WES6 z^g$~3W%~0}HvgB3DZ;@A^11AiqDBYJOb)iovBD0%DB@suQ3sjD9IQ=n@G8+kuaXXC zmUeKtjDx0S9i$}dxfBQIq@u&Yeu+(UFhn|~JFxp5B+DfEBjBK3&_T<52i+v8z=2;D z$Ul`Gw5j6Y&)N?Cdvvh0j)M*2uIu2#dJg`QOHCa-kRO^k*d*TO4*Iola8>SgaA4@@ zV597l{7w#rc6RVcc64`eT*kcPV2(uhaL}r!L!Y%fC_X^>3{;(RXeFi)D zz-zaL{n4gDp~MpZb2lL63tD&dSe+9l9>f!Lp+cUOVO>T?Rs^PYSpYCXX?mEbolaCxcd+s3Wg?c8(q{d4Jqh4w6rD=qd=>{iJMkn7yIXPO$ zNwvaGmKAf-wz!k|(N29f;?y-)PL9jLGEU;kIT$HBVC_Gr?sX>>YdV=IYim1sRmVxMx=wy-;G{!CC*L>H_{L6VHF5G+ zQ>U)KaME4Y%TI4OdD+@Y&o)l3v~@D3os$!9I_cQKNvj@C=Ja$@te2C+eVinG;N)vr z{*jX{GGKs{;gUMY$+gd&Je5^nIQdnAgPjce(#b#aRNflur2N-TewS0yVz`syBb2|a zlXt#RPe!Q@IWM=R!)WC`M!Ao5k}SjI?a5kyij%t2oLrsh#64Rv=P2evCuJ8Ye|cw# za$V}A{WA4d=B;pYeWjB{Yn_Z*@8sA9C)GEqUz_#Z7AG6GI@z$ziDA3e{>@3lGg@0p zo^|4sfBtl`@3Q(VQ~pv;l6Xa9t~xm+SESKRCvEPjkCJlVNv154I}en{Lnj}~g=gBw zf1P|KRsM6*Shh=4L>dESj69D_td;i)r}4Smmz<($ESAmUh)v^cLK-(^VWP%L z|FUV6t(b;SZpd@#nViPzlr$<-N+Vn5yVCeAJB>3kF(-`$5|^7sySy~^%Ox3FC5`G0 z(r7Nl8Y-rYlT(e-sMT0wWlxJVj2*0Mab43GCNm_mXBzK+ zn8ue9?yGUKMI!sB(N9Lor$TW_Alg3{%dsG_B<=qKsq)yZA^fWF=-w5X-v7F#`yNZt$);$mG>#cSpwU&^;p-aS=MFBkjelGJ|J#o;eqBn)+tEER{j=<$_{v+}oO z3|CGgTnv{7^369cW=YFYF5Z^YQf`ckrDI*xn&{%&$u3q&&ncQGwabgNtQSX1R+lD_k5G!z%St_RBeGxLR}9xQP5ob^fe6e^H&XYQ2kR z8(a+8ZVr`o>+>KtCz9RNNO6;#>ZYf|%^$MY=_bbIX0Y7xy2(s;vrsn3 zeZQM+VK>$SHy_EXT5gKgcC$xLNu4@w#?^HbQO`}^25xK(-85?CW~yE*@X^i|&d z-As}tl0U#r(;;rA4|NkY%uUCy+pY{Inqw7jqQ*>iGf+-XQ@>`o z87uBNZa$pr<}bPMz52V@tqa->-`zA2 z>s~hrGD4c}ck`B%IpD@4`wwdDQ8&Y+@-g*B?i^QMe=4twZrc9k=D|xhx&NvrS^b}S zfd@;3hp*&-!9%{$!}n$nw-1=vm3b>QoOE93IN0 zd3f99(Y3`M;;MUS_qvDu^1P-;=gK_%D9h`6c+|i{mxdn3H1=?!iH90ZJwxE(>{)2~amV1~c zrB`@(Yo+?NR(tldhZ(X+YW(8i#U>BWHfxWzdRQr&q|!F^ZoA^{@GwaV?ex%Omxo{F zpbXiq{oSKI{7uJ!oRx3)d-(f+hgJvG%flYV9q|xx)I*8m9$KI9@Vitw<>8hD&v;lM zBmVGk_?(_U?_ux-55N8Cq3uNv-Q|&lE_+xe>!jxu4@czoH4m}ZJ#3U4H$9}^*4mPD z-^1q*JlvI6Qu(2JDIY%au;H=xR0clru?NYO zms-(YEb(3*m)30=FWcm>R4eOcL^&_d<=rGNYb$v9t)iFWDP9hy>DKF|rO(T5x#ss0 z6Y%mz&`UzDZo^*Y=4(uWm;WkzsZmuit9kWa*Gu(!nqS|`)D~VYwDi)jm6x`%M25ei zeA;*!(^m6jdOI&EZ+dl2hT=+^H0b1|jck$AoxRNO;^jtHFRkD9Qog&FZtr+GB}006 z+1t}gUN0}j-u2SrJukcDtR(gE;{4c4pHIA8l=p{tDK*qfr(s@>$dALlbRFU4hmnds z+DrOaFW*YXiCz{>QZAFdoSW*U;&d+)<-ZxKah7@{Q|G9zxvJ}1-Cyd(y3DKVl-19b zUjF>iOTk(%!+ut+o4xcp>}Aan#W|`mXEo-Wm(qWEdGofH@9uc9-}Q3xp_k7esn3tS zWIa*+Pqimf<+<{dviRs4;p2pCGWsx?eS9cyTYN0H`Y2=b5s+Vt`sf$y<149R_v!18 zkL?l_?_;2}FX>}pDIamK`Pf_0M@)*3!Sb<7+LdwtyX`RI`DV_(q6M;Si0WcqY1 zx{otbKF7y6`M8S4SJj%;d~A~@)qU)E-AA7q%B7}aOH6IWmPHMG+-ayhoBJr+UUhU( z9rBM1?&_mRZy(Lx)qFYI$4Al!%D1l%=ckJInU9yB`xrAsbB6l#eMjq#(Cgo*9{Fdq z5C2#n^Ta&fN5hFePEPi5Zi@-bJ2uJhquuYK6y<1d-C*~cGSv?tqq zcz*NI_jez`L)wR`P0~qdmd^a<>9lE|&b$tKtz$ZkGYPZ;_8-8Se}TbdpZMT>pSTz>Y2`3+0je6zpvasQ0}s~Z#p0LOJ}GQ^iQXuY!mB% zbUu<{Qf^>6s|Ka>?BjI0f1-Ln)BG=#?~rtU8=6kDuatxQJwfKHU*D+*vP?`1RrB}i z=c07XOVV}DBb|k-(}`P?PM@{u{PJ@;)z+ocWK%lRHm76TlFrF(>6F=?&S;skFP-!I z(`j%(H62#HN7Gp@r;epF;<);CBAwxsc}U$%ARZL|Mhe}lLr5!GwG)KD8}3A z)VY(+dYSTA^*&L3Pqn8q?|C}cU!?QKOFj2rI{Wbxj_?yQ`l&A#lb?7QE{Dv1Do6V1 zUDVHKl2go2ZP_4(Xg}{u$pk-Xaz!4=+lhXbm-JJnl%Ilfei}(sd5x2ADy`JIcc8;HnJU`z_#{xf#D*FjkRSvb4LtQ_k>iK!m z*iY4_epX3r3qNgI`q?X;TKjcvub*H$z1GRkv(A3~-jkmtef->eU-3Th(`1mJX&?Kk z_^Imt#?PCh{2Y)^CivMgQFABxIV0t#_!%c>rt1E5Kg(wLDYaBdi(!pKtQ( zoR!wx;pgs7KZADr`T93M2Y**D_WF4sx%;)gY>~$Y{JeY6&%bAt?;n0*&Z}nGd(qFp zOMbRp_LKgX*1V!MuW5bx?r%Rguls3x!%wS!{JeMD&(C-KRJ!Zu)IC3CA1MAq_3){B z_{>j>=YBfNBB}er&-j<>+bchl|Mhe3KkYdIwwMA$Mg|yX2~f09faZk*{8=PGLUe%k zF#!%rjo1LA>;YcM@c00S5&~3C3^1#7fWBn{yj?cH@^S&nln?Mis#XXP;Rs-I1@wC- z0ipr{mShCDmlIUduFF|cD`C7YU zfTps(vto7$@J-hMvAqJc=^fzey8#}E{i6VF2L#wBrzLZs))=HUJ`ND~Nq~l51eiQn zwS666$TtD@jtY=BI>7cZ%57YLf%4)T_ z`;X?`4$$*XfP%XLTHgy0{UkuErvdiJy64I}BFJuIkfP=wpUMRJLmov2iL?aSDu<-1 zHOO#VkiNx({7@#y!?Ho%Di>sBQjiuEg3PKIq)2j*wSVsnF_)U;4@_2NR@L1I?8^;Irdx=4e6N7A${ZcR~ z$XvNLS#hW6wW&d3<$#=*M$;5?dJxNuAh|Pxd@(D?J()f`$i+G8*SG5R!l2GaD5e~d zR?CB&*{n6U1lhAyx$aUfyMuW51ogW)L4BU3{vJ@B7nT2ItszGw@rr7acdiEc@mi43 z^&mSQ1S#|=NP>JLM;`}y^Qro8$zY>31D7p>7sWHE8k0do*&>m#8I+Jka>t%Q`?w6; zi5YxYGJ`<53~UuLXjCzSt@5w5NzUM!M5ko1OHRv8Ddx=JHR&m}T^WpZXVBY|!B5@{ zl6@Ie%F*N842IUv&~?)pgc@exZIVI1rWtf^m7!~o6z46i*)@ZAdSzhgoxyC`H6eo{ zlQM{ymqD%hdVaBTU8Y=r$Y9`#3`{>~Q1_P%Hpu0588|m&uzRD{*`jr}W-xM>aypv9 z>SGyHIG(}WQ_BBz1})EIP~&_C=8GAeiOi(DHIrqwOd?8VQma%ZM_0nn~0OxuAJ} zW)i-Z$@H>WTr8JGGFN^$fSqvSY#r5e~ytg5XpEqVvb#oS1_GRHZ zki|?X`bQSc&t)>!#cZ7e%;tAbHqpLpzL0x) z*<^>aStNa`XY{~*vbjAqn~dq%d?)M0J|mmRS=rQ|oy{gWB0UylGynT+ZY;{C_2O*am8ccj z#I4Gv-Rf-i%O!cVA)EMv*}Qoun*(xL2A#&ukJeDKA-dKbvO{vN`%Z zTgO@sCp|gjW##Bv;vB{f)8nslm^>Va@l-U^RMNy<8Cg6?&mT{rbOg%-jK&EYaX3Tx|c_n`*}QjmPh3miYvd!e=qZR_m%Q9geYPP z@rnFw3GuHrL~mP&DMdq^FBak-nN&Q)AJHM|#e^sm8)CNNP@)tQq2k6sjGfNu3bC%Fud>Szj?5glN?;#GFPUiZu?gr-^Qx zh4@TnG!Jp9h32#jQM+A;v2TW;eTWquLOkvmqH8C`?HZzLw-BqO`#T|4_6Sj~XNZD6 zA%?xLaZ>!F5G@C&ei=GM>kier!$PbXq4^_2^!P@-8mnH73vpeljaN@5gm^CRO;dlT zhv+v~G3P7h0>zX<--TGPEX1y#v=2XPA7tn+ioH&;*M}IrDa7&3Azt4SqRx&G<93FK z*cD>P-Vl5Dg}8b!#1r}PP>5~P;Yf%^$JI|Mbs|KX{C+Y-i8CQupVfUC|3`?^=hTby zAv)a-@qxJSgb2$Dd3;wrxu+gV)2AV(KMN7{Jj52lL>j_evV!QJ6Z7!>kuavoP;95A&z2Zylyx+c57)n|5L5y%}bOT%rlL#`#)iq0Z{+B>u#TNDjpU69VdhQ@Q+$$oDYs{WSD2C!i+r^ z=H&S>H7}^XKb6C!Fso(SE%pAk^0}j2?yJ`i!up+pFh!n(Y4%jTlwkRM1|{W_o0^Za zMm~LN=5tY^>gLn9UOwBz)i9qA8s&3Y4mQaru30|AqcX12_yaI1U+wyrLSFhyb zzLt;udOoHy1=KBDz=?7Ne4kRl?Mel_nOeXb&I0D96)@0WK>02Obn9BcDLLP(faG@z zm?SlZ6fkON0k7o9lmZf`6);?W*i^v7%?13iwSc213MhH1fJ##1w8o#&cyV1X;DZ|l zd@h+c3;5(#0k@>c-2$53D`1D@KPX`6!ve<3tVacmc~ZbkIaQ^|l-J*V{xCxSB;L!FYPT|B44i3#Xa5}#q#DYmNQ459L3U06wg&E-CNSg7-uus zXZ>%i|NXZ$pzQzu9L)chp-E}!3Lck{@^Wg@|4x^a95{vo<)!+FuRu%{B`*%*4pvl> zmR6Pyqjweh5b-w*t1113?6swi_`9o=-c9;~ofD)ii=!Qwvp8y!mcs4x1I^pSsQA7w`0az3h8!AJct>lYt=Zs{Xa zDb@-1kr7L^d~OkY+E0tw)0V86zuAw-o1S^0%iL8=v6--4e0NqaTqd? zv4;ET_ff=$z|lVPo8qJ3sXlsxwX+!Oj*ogh@X?c(KKh9EuY9x~bzb{u`&%C!LD6?U zs`SlA-+T>f>Sxe}AcM9B8*~uQGZ=Iv#Gve%4cd&oSq!S1)u5x<3`z<$s0S{)4Qd%~ z(Ej2ET|}u81|2J9(6h1znJXF8sIo!rkY3%OA~*m?4TD-^5xUi640Nk!(Ce|ep zkDUxk=xop!%s|;L1`WiQuH5csP}c4S#o>DogBtguZ*PO4Qhx#@O}XE z4m2p&AcHy&HfSey4Kc_%)F2Ob3?nBPMi^8Sdogen_eUGlcZ@-A#xoZhP9WAv25GWE zgRx=?IpfGwgPgw;H$F`x_UQ)Y#%^3i=h+5D%`qtdJcHKGHz>yfgN9=YT#F1!Txw9} z6$ag1Y0&sp#J|>{yqLDmpwrmD-k=T}m=D=E8gve~(QvClz6T9DiJXUM3*SF!bK0QS z=ZX2IL6%zvdC?HVumEc@@oR&Y z{zEPw40?!|kJRR~K>;X^webDQ+F=k@;t4GO8k7+wztQHqLBanS)DPEj=m-19$Ealn zqfQ!)%II%YHIq>XFx+g^6g;pP<+2$Sik5bxYC4VTfDo5ak@y{-Q7+J^c9@9GxPsjw zMqNc@Mx*Yaa3-UsVSZ+#US}~XUsj{K;VVM38PyQ;up2|O8#OxAr~zR{-9rPnQRiWa zFzQ^SQIn%M4o{p>V-t+(lFaQiqaJyTy6ZJ6OS(~Wa~bs>cXAu`A)iqx`HdP>z^F!r zj5>>?B1XN#@S;Yo!{10LX4E*$M!(|3Si-3LaF^m7LQ5O97Z1x&gR({yLuJ$}XVhc- zUfw8M1*0}0tfEmPky^>9gkOxRgt};3l{iuMSK8rtHKRJ$FefQv>Ke7HiBZq-8B?1wcQbNqX;hO|MonmK)FJ$XCvA-~wKHlUoE?}CSJ1kX zQO7zPmAyObg_}K$dezgYF}}+qfTr#YSb3iYAd;IGivP)qmp-#+is(7VDvtts_bX}W30(}=DJD0+eQ_C zLJa7KEKk`FnDC7K^qhHKQV)Dat5-(leQi|#H|%k&Me~nFP5NZis?SClzZkW^?5hbD zUzN1_Y8jT>eD&DrtFi&UYKERJUu{IDtiDRdP8`kdtL<)I9gOtVeKd;pRZ@(vA`^VI zC*48mA3Yvrr*ZG3g09pkm9eFtA9cJx(vC*tqytNLAh)vzyd_48GM0lun& zYeRjta+t4fBFhM0?HcK;8#q6T@yGZoVw|rQ&mf0c#Ewt!&i2(@oIvm#Uu~J|t0oH> z7i|{#YU*NNy!3T*-WE86Ueh`|3MRZShsUZN6H1n3~-1Rs3yV z^|8D^6&*Z0pnf-Jii=Rej_ftTqpH`zon4h-c6tcSg^b)(n{j?*( zPsL*VR2eg3{gfrnPu0;m$xjneDcMhV)BN-bSG<1m&FQDb1yI6IB`W*rZ4Eyitmmg; z&HR+R4aeHj9>28n(}E6u`qar!DV_b)8ppc$>0Wm~o$KwV+sN6+PiN4)ub;kQLO(x6 z_4m^*qz?2`L3jrF>G#2YdV~T)m zy`TFh{dDPqpW0mVlg~Bk4D)qAjk)P3$1Okg#W8fg?WcFB`xmvx&pUpaf0s45=ciSV z{nY4A2DV+$KfU}AIx`pFO{(6H#$^NQ>b?`~?*D1U}xm16B z!r(N2ZNgfQzwY7B9R6yY%U}QE&)oj{oR{(Q`KxYzf5jB=SG~f-RKZ`ZDlrb~RrS}! z!NfM&Uu{rs3~|9Vmj1Xl(O-Qh5z`8P4_?L4FP3w0CauTWc$049dxA;UM3Y)1nbZxFl1-YA9VsT2N;T;`{=$?rlNR7t zk4cT-@|qNi)3||S=_XalVbX?NCVk9pQdAz|#pj|X{Zh;%XK|BO;2tuRFsT|YA%97e z_Lm|bj4NZ(EZi$gyck%{q(|sdp4(Vj!6d(mCT+uEJVlF2Catb)(kB%E#iRpxhl*8A z>V;J(@hdrD4L)OgHIvF#=OT`%| zu8F@V?45ZgZCzkez(Uqzkx7}Cm^5#xNpZ`mD;z6Ls<6hSC0kjSZPaqRNfWUW4={d* zNrs*D!+Ff#Z&KrfCiTE?hfF$ngu4G}QeW&r&tt6Tan>0JPO`6YAHSb6Y2+F9$64k) zXHwA%?2U`m;u33q*`&Q!sr_}@AngY0fkOi1!F<8 z-lAeLvsB6~2b$p$nwDlx9K&VoEMwN_vgA^Z7%H0iJvHlnC1R^=R-a$Y>h`Nyzg9Qv zRxPte);8+^&fqiZ);DWCeqv4ovobU^D+2S7y|G!ZnwZtEsaa{w%xZ|6_|n|0a_!7| z*VQbaZp4EANb61wdzw`f4>7WrS+3q@RqtcgZDj37UGcm>eFm7daiCeb2btAsuvxG1 z9jk|!RcxqPCvgoQ(0v#&4L8e+#dwbvBg{I5o+FtDUodTyS*=H#)dS8kW*wYh){=?L zgEMG2iM5_gO{S3NRI~QtB%WaN@0_1zRtMb0u<67z)2zX>%$k5TNSWA+yI?N-L#P7XWG%Cn2Lf^oN5B~Mb+E9p~q?F$4=BgLyhqb zlg^rzbb*>)G%FR|E>ZK#W|g>V)?avjjlF^5kI5I!o)h;A_SH+)@fE)p82Fm~|JJNO za0quX{~dM0aoGN$|G(@{+{X{h{zm)%nA2=gb&ExfF#v&9i^8x9myvF>D5KM&C=|sp zbPcd*C_dp>kVTGQi?SjQj-qo0iw5H#bPBPkWJZe?XSS$pR*S|XUv}m~T$n}e;0m{> z2CR`5Rl&n3i{hg#I)`~N7OloHRE)LAm_&P|;1ATwWzo{y7Hz^=)Xig&e_mq7Xq+uz zQHFvRMW8TFqEb!ibeI&FdbGFbDjp(x2aED{w5SxGBVQ+r!uwO>0Tzu# z{(%-b2QePb;5qsYw#YQvqUFdn)}sBGH_oCqUYPaXqVxZ-&p)z%KePW3@WrAA zXanO{i$;ATw(soEAGGnYs;R-M&Nyha>KvN*S#{dqs=+3!Cg2E)Ijl+yu*&VSDj8kz z0Q~~3+LF<#?U`tYXK0eys*YHJve~S>#%a~6>{dlYShY6Ns-37BWtBO`st~k5P#j~U z2mXk+>JaiJST!fns+EXHCPw^7v8ryWRW0H0ShWV#yjET(vT8h1a#*!27rErNDn5@@ z$M6(0^I26nzm?~QR+TDf)s#Y3Eh=o)=pt6V#fM^6u!2>ipo+|o;gzf!P?=gGdljoLV)idqUBHqWR&BzEnpQQh zWz}-LLa{nlO`K1=#nccrmas-ktx8*NRh|`A{kD=kR$0|&wN(|@Q2TXOP1<7BJna92 zwL{l!R(*&6PGZ|-Rj0jHMINx~S2RMogI1*I{d@!57g)* z<01HyRo5`p0 z7@NMv+H@k(CP%VOS&_H6O`UNA1xnad76Z%K)Vh*Q?#eb*L{BWiS-9%h6pCH-=vUvS zgLvP}rk`ls+@?N=Y-LkjY)0!g^h4QpHq}6Z_BKsMjt(}h=w#CmROxKfx2`r_?`BiM z?lyJBAo%pKsd;~!y2CxdrcZ-yG7hn+_fVTg!f%*OMNkQ8!)+>rcle1>BbaxzO}CIV z#-^57g_rP*We%J|i*YvXK*tF-&6q?Vm?zt`7pD+7)uvzZ5tXLdGP#5flFRbFodkaRP;wQd=BH&E+;t z!xF4rVbentSw$SEu$nnA30c?J6psdLS(|m_i}~wqx`)@uu#vH_20QV36ZP6`({N11 zku5g)ZY5W2!x1EGqh{!iUfbCpJ8b$JMR&5s7=@F&$Y(eCpyVFb1k=!LuT6`w5kvM- zE40~9-vc(KAG9gcA?k9(rotF^l(wp?Is zQTZY{U$QCUGJ6OmudwbIbk(MmYt#~RuXFx}P1EtuP1g68O*!un^F5nl@3a3rX`pO!j4bCF`Uw&tB0GYqpl>IyNU_O@o z$L}3p;a^1mpk6Tkq~^GT4YKR7!LBDpy9)Z+)eXP<+4Y;ruJ%|GXjg_zc6E*5Htyp! zZb$Mn%C4AbyPPq0)yGs6isgQsU9+$pKN1)((XK^Um||BhuU&g{*mV+lbJ{fxi}7!6 zyPoB->l13`vuhRd=eO%Bsui&70a_O1JText>nEBQwre%!6tU}a4ZG^pwCit-t7TWG z+ICs%*tG)x*0*awbGydkYb(2IceZOAiuSPcyvMFnDBs7f5`FF33ZMRVwHspB_K|i4 zOtb6TLc20AranvTDu*Gsj|J=OdV}xiu->i%NZ4RkKb%0^M!VWNbMO{F(C#0*cHuaRf3RyZ79h(Br7!fuI;4K3HW-QbDEhBmwr`AynRtSa==Pnsa0O-l;~bWw;t%S9#|DR7Mu%Es zH-7j!l-JLpQFw^z{thj}XQY}OJkE0{huNWFc!|Omhh`$q>QGL!#zHu44%NYK+1vqpSM_mpj20Anst{{hwU~nk?!yNK=J5&lg@d^9F9jYARP-Aq6bm(tX zj&kTc9wR>5p}H7`DKQT1z(W*?btpWJ*s%~@;vFiM;LtOC!u>?zOkqrzQXMLt=Fm4( z@i2$ip{3~#wa@9$zbK!J+j$&nl9%@R96FHSp`-#1jm5Nr4h0r+=zU>_Y(*Tp0^gzz z)kf}OjD^m{9omGiNG<8mN9-=;P|wm1y+Eci!r;*D5*W zQ`w3%w^aw65*Yf;tWrtn1Kvgx7PZ zY<-7LBfNn_Bd`&V8afoz*rEOC(S-BZ*p&5Y=1|k-#MhGCun!qpGZ)^qb11gGLl;o6 zgG1%86gN7Oe<#+iGdXu5|E{dv7zdA49GZx)@E=Q@I1G(r9Wf2pkYzmQa2#m-N1qvT|VW@81iOrd@_KApPEaHt-9XF9Y6hFK03n9UxCcRpjI>H>$R;~w%X zWGsxsf<@%C*rDH+IMi?{@hoFcEO#h)C3CKFsNHIZuH)buha%TGl!oy2>~Xj@u>bK2 z(Hk8ag5wC-#2&(Ln;puxg*tC_=+qy?w4In?+DYBfc^7rvO$>Xe^l^ zSbLB9;x%&KXV2g~Dm|el&{O7l#ys$O;ZPyudBt3>sl^-i$XkbUy>n>52mZc%WWRi( zKU#ivsM;5Y`hI0DT=|!LzEPJS{0_*ezYR`R^mS^o$*G%Wr&+Am-bf-$@aOyht=X9!AE@I5h7#om2MqPF2Sg9O>ZH;jYY$*4>>t zhFU$Hvh^a*-pt>Jy!tvdxW7~Gf#fuZe)x(BgPlqoN)3lQ)oX-P)kZNF@{e^Y*Eo)i zcPh&SC%->Vtw6v;r&4iwl2bJ%JM|2Ur#SUtDzQ&^hzmd$Xg@=T}hqx&qUZqFg! zxlYB-b1GuKQyUf#=OU-NZFb6M8+jadYR_@%e8Q;|yt_oKx11V!$EmYn0je1npt$-0 z%85+f0u+rQ*ouR2cc%@SBCJP%l5hnhdj{xtH0>3j73kbMKm!ooCqO9}24mj&5kKR^j+fujgq$XrVUR1v0S z0ZLmLpeERX1FHgb2BtO4y)HmU)(5E5<^bKrrtJY*zk~C;1N3NLfXW;Q(6Pe-x_%@; z>y8HK$*BPSb|FBIuTqO!0jhmJKzW`9sK)C6z4<_{Ujj7lzW~klacKo^8eKd_cFEy% zDJ#YXxKzgF(q?>yZ=g&0unY}?T$+NX*zkV{GBUFurFrGk}Qs``sdC91j9 zy}CCLGNAhzFIgE9w^*EOd<6U|@!KE4#U1~Ckai);hRF{ILxzq~5(_N}F z!zIrwms+4J)*y8r{qPUvC|mc|BZLwulCBn9d~a-e3X2WnoPK<&*NsQme8mp@Rq3Ir;sP@o1EW-cr(!d%4y zHN1GB!b=2d6r803wH~(8f%*-HQMzoP=9CLmL?vQDi7J8GitkwaYoKDP1!@)!;!UkU zjjkK0^xpzibwHrTj1APU(*w2q34OzZv?n4+H4=g}!xN;X7~&05&KyC?lQT#qs|2Yk zHdhVOztw|Orv^XKu~v|})d^CAx1p#It!fdZ_*S%S9i;4S zgOq>^=+G`mj}X>ANaHaZZMy}rr-SrtP>^nnVw}lAYB4QHuh#`>-ufW@xgkhz@N#RA ze%}_P_t>%{NC7*8R1L*;1?eHC>h}qxE-XGe=*%sIH0@cC8omzFOq{}mH{5?4q}xA<7r!W2 zAwIzxkJ&h32v%ofurB%rE6Fcd_mRy%SiMZa`UaOdSl3{%1S z9M2W32YG`vFdz5x2kQzF3Ir=(!C(!-^TLc*G+2Hmf)!kvG0FsMc-df;D;KP>XkR{9 zeJTX&3`SK9)}l(ms$Dr)m8%A8UG-pnLZuqPDpNODH|hneQ2k)-X%MW`hQT`8C|Esz z3s#=S!SXgG=9a-4(JEMrM+7TzOt2>7BmS95|5?GRkAI-q!77Q#Sb(f^g0&T$=TRek zL6P~~$48u78m#5(X}>X8-F9*e#$CZ`xF=Y1@D}Cv25Su-A?LneO+lXh!77D$2ZB}M zFz2!2NU)mz$=YG`iD0Fl3|5nG!CHu{nKGy}dLc*V3_O0zpjufnXtpPV!fI#GjOH11 z1wRjE(DOGLH1ksi{eibg@Cnf$wh(Q1hG?oQL~qb4Dn!fizDS5p7Yk8R=@6w=4AHD# zLsYwVh}xses1W@!K14aDhRCoqgvZ?>yv7%zUi(5c@<@m_<1@Nn2~ptf5WRR7qAbrt z)c8e+mSQK4!Sg0W9gAhu?`6~#)chx- zR)5Q=r`Ve*6W2mz(%dYWl%;MawQi6}VQn($afeJA**%lm56q->$1=%yHk15*WYP>n zX7!HD%=6yN`ZX%E7Gr~T|Z7_=bC^}{fZ6wLY1CBRAsOqr?I9$ zs45o>)p^t|6skk$QY2K>i-sz9@ldWq57nlUp~_JzR7Ei!_uyYTRAt_n2hge(VKV?-X~NWQN3@dPGVHQP}Ld8c?`ly6dD?;oWnwuGCWlI@edk|2-Rn_ z9Tlox*oBs(L)8siabrxVo?ynGTvr-pL9O{liO{yVk7 zLOe$Dv`{t2GW?BI)9H`U8Po{5W`?RGR$`>juqB*P)>dYlJWS++{Brgfo zw56e1f*i|2Rcbl$pZg-Vv%=XpR#oyEjye_lIic z0s0*b)j6~~#F`$aK4^F(RIQGMsyn`)2vyjHP*uZkxQr54LY4Iv`vK!|97Au1YA>?h z3DrDo#=5)Yf&2G~;Yp}=Jg3czQ2D$JRpcAy|HQaoLv`#2``{;egomkhRG3nt!xZWX zQwJQa7AEtcFy8wJ(~!wwdW(Q5Vah%?OgYgU{c#8x=Y=VGQJ7lb@ZvCemWJ{ELzqV3 z7{1}?#W1cd3eyVAjdbffBBR|(!xf~)xwSaKtpSN{?LbJfTPJW8^QyRY3ln~EYd+dk zb#r~1TP=QdYd88n@1 zVz;?f3OTmBRbdBh(QBt$tMCvxb`cj&?sluv9=Dp{B(C8n^6qtOI416MYc9g~yVV~T zu=OCZ9&&5cQMaCA=$~#~LgX>G4&mf+#zEi-@>3-%etVn0f~baPFNTch96 z<~{ZO$E`Qm`H4O9*{!T!*<1eMT#Fm7qX;#JE4w9J38-od*QT&=)lCT3?fl`g6%E%O zTrU}}$A~Q#u2tp3wGAni!}+`y?eU>jxO{4ds~ZZ{4Oe-TXc(@V?U|!fxGv&Dmv9Aj zV;q#|5zh6DjMp<l{|B z50~$Ta9KBoYYtXo(xz}d!12xDs<0(oQ*jHaTfkCGxd%Xyi=@_ABy&_~@8=?9~B6RCqgeG5zQ2eC`xvxa%0s38y z&{ed%Mw{yq>iaZ8YhOiZ=$i<&`VpaAhDa61Mf`4z)EeBv59IKTRDVSJMXHp4q~c7G zN-;<3HTqg2H5qnmq{`zzIBb#HggASo+Tk#s;crJIFPSk`K&0e~L#9GYraSwM9U(~RWwqc zu%cL`e2Yga2xIUF^-4tQJX|FsxyCqB&2bX{p=PN_O~R|vk-AhSQumOlY@`a*j#PJC ztP`mlb;$#*Mnv*BI#NGJMrz0?Vn&(Kk*bb<7%_(2rbNoJAW|i;aA72`2S;ixLKjDB z(Gv1o7pcGvk!pP^lJ~J9RsS^g#6_f^iRArVVm}+H7U+wW_ygZi{#>ML<03krkJO$E zk^DQ#8eNQ39UOz}61BR_TEKagb;5EuuSF^wnxWZ+&f+1g_al`V zw~_dO_Rk_UfQA$KJ9Gn-Wzy(nXLzz`kx{Bi)qh#0=rAC{hRAUQcVFcp0 zQ^);L%6uS7EsjTNI4+>Xi71`K-jh*!fiGxvih1!Trk;+{CrmpNrGT?hT7Y}#bB_Kf ze4h9*9WP0e97gpbl(jyeR9i`+u)ER9s^g)!i zKZ?@B$59G-%9x0MPQ0(8c;7Tijo*;tTXIDA|DtpP4HT_@aQZ~6E?VLQDjA|x5BZGI zx{Nix(fSNOzi17?1b^hc`+(8KSrZ) z7<(4Q=p=eBj#1Fk7_Oa;(VLYqirWyQp?}0^FS2frQKlU+ibh$S*+mY!V>ES7j9%`I zQLcT&hk^%VGz~+J#OMIJ9%T%~{Yi{?hwjIT3%5?j@HjF?<8cMir(-l3VP|4A3>h!S zs1yccE1o0kl^EXVi%}nJMc}m<-Nj4HyB(uz$ayD5mb)>!_%ufLXVm{W`M-!!A{t}I z>ll5)syEagtKY`(d?HrwP`OR4qT9yu*_K#s8yu^*s5CTI3BzKQ8!ho=M69ZfjMahB zvHBOa#>OgjT&xOU8;XpN)j#+?AyyqH#wzRNSXG!3t9@uNEmm_-d3vlG;t`6?jMXcY zpBKyD)mV*M6RV%FuZ>lX&5XB&w%7#M)>!?DcDMd8cL4fB;)Wxg7#rq^QC87bFewE~rH#HtA< zA=}MZJxA4BvATpRw_`N`p?}4y2O{poYAvpz>s@MhFIK1Ff1hz5#OiN+!_0@ogfp1` zC05sw>tD{n{4G{_(Hj#Kr{jn*#K~feQ%2Gzt>V!E% z8E;&i?rw-vxh-+pg&JGq^y6e4*BHg=4Sr(D={Qw8AE%wDcbPh%;*~hnhpxt{2eRKJ zC&b-mj>mC2h%*`ExjsK$`R>PS6}}_=LA*NS8lEHJVZ3rIEk<5_=z|_$8+6Xyxt?nmw4W*iPvRR{x@Dz5c7@uKjKwD3AzYBp9HS=PS9Cw zF(l|A+{Oge#3-CWX5R$W#Uk8ApkIQDp%a$k2F(5m%7-pkhO2Ox5>y!NF&}5)YfexB zbi^`Tfxjg|h0qska2qabf{LOO)}yg4L7nj#)g1{c=}geGkOX}~SjGfJW=)U>Q}8i7 zL1_^Q8W)+M8BqypmOx+3$ep0zJPE3V)p^M~UxFs!c98^SESjLM#S#=(JV80pwp4;v zp?>KEwZnTNZ*m5;y8|&U5v9gLBp;k==r?_m3xxFdus{G|1?46 z5%7%TZxR&!mbu?0DA#-X;vAlQPEf>`1P%B~ZvQ5zD!OCq&jh_j1)oIaFeIudhGV&Z zqVA!PIZ-xCqB3JwP@=wIO>m-iqgaMS%@0XbyNrqI1D{NZdWrDNi5i98SrhrZDebc* zs!n#=yA%04k*Mq8iK-Wos7^3PCMpD#u@skZF+EZC9Eob3Gf}a*hztD+FhANCOjLgu z3nl8e!ih>QlBm5E6ZH-2DinZ8xTDwQ8RIVMd@&# z=}e-w;4pffP1FcvI8Q7%i$5TAlJp*Jl9>k^aR!Z3lC%!HQ9LzCzG+EnirdKH zN#ecFBz=Lyo22|GgNe9@*BFtWq^&rVBS}SaCTSlmxsuckYjFv+awlmnhUHCCNd6?X zEs&%?(7a%h3Kn8KR4AOJyKojsQdfLM^Pv< zP_K$fDp{AB<1HH3OVR~AM9%t2s)!~Hs5fj4$)!<}Ry0nMwQZ7KqE5RcmFSeD!N}Q} zv2YS`U6Yid8}%5RqY5#nV zW8;D(9YE=Y)P7NtdM{4W>D`>)$9Zhr&v}$S!1;qoYIG<`?T;sE4H}+EQU_!`$(o$y z=Q-95e_`_ZB(=E88ll!T)*G)-{zj78-DEHR#~Q%$lXbxKBx(Z3xbgtn>H_turO7L*`_ygkRQV?ZPp9 zfH^i)63Yf7hN-g8UViXO=_^-R_{9POQ~0)3LT8rk|L z>&l>Hy+Y9;$*MLqStW)g>kHZpPv*Oel2v|mvYw4i*4PQjybqMD>ywhzY9iHWNpV296g>a;|XemKT+{yvR0i+)`8Q>I*Wue$$E^xFVpWz zvLdb~^Lh{C!*iE-@$)`w@*r8$A13S9N6B2{%yC3KNmf1VcuL;SlC>7^{w0=g#P&T| zHL>NtWR3cftZ6WtQdAsA%_+Kw{?-%?ccf?v{4%F#Je*llR39(1rf5dC6g>$`QG`21 z1Hx03KO#kC&=zxIQgj33VpB91b>mXhEKiDdAgmx`AfQl++*k%fkrZvms|qQKtC*r; zm58NsimG5j;}o67z$Pi0h>)f!>e4JlyPBtPZC8rc!8#yC`*9jKN2Msk=oEDxlcLbE zDN4lPIVswW%=1!o1rLyIeu{oyl%h7y|dD6m>%SHO9S_q7is_oAtRvd#roNnxN$4 z6czcKHdy&OMce*M(OXpdNiN{qDHQ0Fs&+{6O;yLhRIS5rL8oXI=EPLR*Gttf6lj>LiRjccRaf!0RjNw1PSqFG zXp<_nO;vT2?#g&r*DF;+deeVes)i$FcB(brfLN8%}Z4|rL^>EIONpPHs6Xz_cR zhRjS;^;v0ZhD@{5RCjKg`YcV;1WaF-rd}J;G#s9dXLqF^|5( zQrx4hc!#i39(BP$B$oE5XBiLQqu|l}@{C=@qjOa~s$I>a{53q|c=WWMN8=lKG_etL{N_quYKYRrxtj03lkQ4^l1t8Uh2_x^jqdp)C!M2 z!f&OAYgwtmdXMZ|JSuUFe)xzMC&&rUFH?(a9{s?o>mD_{;nB%E)c3we89sT`20an^ z*`p?3Ji7eVqc`6@di#SKVdYP9kXOMzUe)&Vs!2w#8fWtI*S9kV# z`Fo*3$X>4|MKeHJ+F2>@yhkot7e#wGq{No&$y4Z_~p4*U2qnKUU+pCAF=wSSDshI z_S&n*81IwLbMJKhg8lIGP3QB5=^7E3t{JErl&;3Oh|C$%H4?ep=_(C{r^|)GI2Mtv z+>z;;oS3e~sGpRscK8cXDe0Pm{yEY$0cCTht2Ry`Aa}Y3V0__p%}4Db>1u@=a2KOJ z63V8lW4Uzo!y|mehVsOVNfpxd1tlt_>olI=K;?9`uad5@zohGL%>6Z8LDkaL5L@9} zomg-mC2OQBwPw1Gz*IY3baPS>_3#MwMugIcF6Ya8m+ zHl6FR$saY^r)xM~qkM;SJ;%I`jMX_^g>W5XyQFI&N^~WM9_jktCtbb!rfcTFbafs? z{jdR7k!^6gQif7%bVJH8>NF!=Z(x|2uBPaOvnVo)_-8X70_LQv=iGE{LgsntT8ix$ zv^kgRzs{?L_#0W?CLbD*Z`mO{HlT>xQd+R^7DO!`4v+>zj9$WGFQy6PqU)d2(eZX1=iJ08;~jc=H;(VH;`BO) zMYVHUG(ML_TRyaCKdR@p==Z!9c?(!H5Elwsn6u5Iedt=)qS=^S&7!|ixrRlLpqduF zsb^6r&Z5TkEgFme5-eI}w`eQwpub_!QQQbxbs0A<_@CXej<2PCg?nYPHm&G`wC$&dV*DfJ`eavaGeJ2ac?> zXwC+Ue!)@9+-6bV9TxT5XVKn67JYu3+>nM5cP%=Y-m2mmtU8y;s{EO)nw!O{l{oo< zRe5q)HL-w|`E{(CRNSg#81k7_lToyURlQ1Dit!QG#;R+0gobU2G1#hw$T-xhKX4eIPqr$C z%~PxzIn}D4@jJH9u<9LF&17A8)2y05%c`rhsb{-YJ^!$3)()%EU$QCzkC5TARl{)Y zidEyTS`~lSsy?XlpH=m-3nlJbbrGMuvnmVy(qY^sh8 z$k&Y;@EDD{+casAO~)|gN1G4aQs>=hZUC ze47?8v*|j1UQUjvy27TBzt~i7rA>P`Qul8*ZNxqVH`%movrS)YAusH~p*=P=*lSZ0 z{Pc+Wo>Ip%>UhrndqGdi#H%&B;V;ZA8?U$ct6aP;qILOr-LJqhw5}Mh)fibdUYn}( zSR-CD;H??2MyM7SulYD;jn`E?Mn+q_K1M0jgbT@NiS8JL37Cg9c!0t6<5k!m&p8C~ za=YUB`8QsjJj62NHPsid$_?YS!ym6E!FW}fz*wRBnvo+xCC4OaH9D30gQcLAGfLIyyZ;ZD%IvU0Q-B%}!9Ixe3}<)UL+G?E0^`ow;@Ge2!$-a$GKJ z*N*abEv{@=x!QJBYGBtl__U#&@$I^UWyy9qQtX-GS=AD2=&+6)n%WZ->2;Qa=%?&G4X(1H7?pU1br{twFw=s*wqi6 zuiE9hXV*Z~x^I^o=^s$b6T1#z%qzS8#DLd!jYX|Db}fbVtzDk<4lTv$3=Xatbm;qx z4(-NG1T#692g;$@Sb;aNWOm5JuSm$^P#UUcbto0xFcl{XIdrrr>wW4_C*&yRP%-%5 zEAG%;Y%T53zep_O(9^OGwJ+z;I2?kfyhF$E2%lDEIo{z?HR9B8FvqV${jj1g;~;%K zhiamt#i1k|t50qT#6%hnz-Ol}+(UPVL*<M)1)ShXy`(Xb}#*bST#=hmO2<=ruy`7#A7jRJjaJ?ZQ2r$?nwloK79Z&{9ri z_}r;37>~nvj8JK(X5tnemvO3TS=PZkY{xs~EANyA{V@WgD>zlVqEj1DwUSeQw5sgX zPx!csQ)Li(uc}iIu)4ZaV`@0H4o7M_b+)!s=ju3>x2{uJEKYrfwn%Sdd&IvN@6>r@ zvO84~E*K7{N;%2X>(s<#r+!XxY8xsva>|A_?=>c76Q@#9qq$SR<0>k*a4H$svEnPI zP9dSKQ{y^1wE+jZI`t6QyE# zr>4zvY7w5Hz*?so?sTdvZX9$f*CBE_LM}LldnkAm$LJ?=pP;vxgEct+-bttWopS2L zKTf@d`@B=%U?A39aq2YgT&JHmoa%VjsR;<*cd9R1JaK9;EYI0TDDj3oQCKdyQ6Z~K zA+-6xr8k9LDp|y(cEwzpfIvl;y2Dn5*Kwh`OWA6;6s_gbP)w-j;@V@EGTU6Lit7n3 z<*~c8+vC!G6bibOfGPL`PeLvgPI9RmW}se*OEIj+CFE)1QXO1w=2DL4F3pa)v(eX&87BujLg^R=X*C?`U|$3 zECz=e4*LK@ZHw7UX_LY`CAhRO5w9#}W6Eda>l4OX=9tud}!{C%;<-i@4>- zHyDAHID)6hSJW*lnxhY<;WwNHAG)e6644z~@CWXoWd*lJp>bum2H-_aw@TJ>D_32& z>f(XTt-|qcb?~@##p_l(pIh!Ew>n{BGq*lSb!%M2txscaEok9Z=u5XUwsfm97PWV) zL`Sz)b#lwz#m%)cZtefpt@~*8om<~y&U@dx<>=|wv0iR9?CsVVoI>e7JjZcd#)`gf zJ;Y!Ai1UM6CsApTTbTyCb!jAd&7?Qjh9kHD|17tbEMOa?Tjoe~kSA+X=V6!avAcCI{rXLf>z=75{*JfPD|$x`%U5+{*Bj<*+|<^K&uFQ1k`+4_nh2 z%AVU$Rk-sR`UaN@7fOLlmPA84Q;6Hd&=j0R))of;{u*lC($EN`YiFnoZg)16r;DM}-3@MPWT-v*VbOcv z8q7y*Xf0m#G}NKD!S#oR>h>{|h`;fypP_914ekD)p;O2|$WRpw#u?Q9(NLGchL+>* z5JSy}85)31==BqiBMiO7x>1I@jyLqhWa`3sWSU~ADEyd(ZMcZ0Qw=5jZ1DM(p*^#x zZMMNYeDrA!ugx`NTWB!fo}uE44829GB?jkN8nWQsa{91>Wh)Jh!}wLKyV_8twT8mz zg`*n`ZT`*BWi;AkXb5(0rB}$X%}`;~Km%OcLF}D8#|d26Mc%u~2eWbDy*=#Ty@n3% zH}nwM4j5{Owg(OMz`#R>uAt#zL-#T0FGEXk53lj$h@q`V4fQ`}C~%xQ(c^@nX?TOY zCkXtd7{`;azS&9Lhk4E6s2AmN=ADO z!fdpBX=o_+y(W*$9yLG{II?*3Hit)MX^$GC8>W`^=&N!bD4^iR^6i;$XU~)Us1Z2N6GlFjz^X2d9>H&kvE>$xP_v2j|#aw z+&9OgkG&q|s`7B1yGJV;dbAnq{T@{cdh`v}VP43iXp%=Cggq*cW!Q%s_#)Y(?l^=B zDU5?QIEb6b+K9OLtg%P&h~O+u(|AIbz<>7i0kE*t0eB3~*)*jtP`8FOk!!ERIOHTOuYmdsd^XN@?5BJN$ zw;t_5{qH;)_M=A!hI%w)q=)aeJ(@AaqY2wQ+WH4|?C@y8evc*{C&v@SJmpczv-JL) zN4YN22MoE)zQdo_JnEO-tG&6r+EUW15}$kZOI5Fu| z6>)jxYvPr&saNG%d3CdkS5Gmwt5^BEc@^#9RjF^ide+OUjJ>_OgJ2)8Ui9^{V0D#Z%aacr^%nkUG?>6Zm+TS7}&| zOe4Me2>wxCKIio^7m-&x@i%@N<5jLHUKPeLeDX83qQx|7M}g^H{yn448ElI#GpRF; zZRWAgLUKd>MP8*_;?)}%OTGGXnOB{0c7<05S9-N*omV~Ado>ufHhc9i{9C!z&k-BHIpXMjdp-A2<%}^eQJD7=&@ivCFGb$iAEW5ZU8Z)x9jkX*lyCQ$?l?WV=+#>+zQjI2oy+tB*{^uj3l~x8DzBsDzh16wq`%j^ z>WBYO<+_(^Nxk|NU)}I(7QVd6wzs_6jZbdV!+T!!c+6{0ytl0J?@)HZg3YdCY(A4unrp6XF^<5ED8H<{ljMAT) zT94+%Ol2!>>H@+gOfA9#>@7*WQsfC&8FDXcYC(CE?_5m2V=?8eYwF8-rgmbT%j7cz z>i3%JghQxkni_?>@cT?HLyiWfI^a*NY-p;gpWK6{nkJfhga%2bQp2WB!If_{W0R9U<>L;(ih~6ufH@^@+(u1 zv8$!YXJw{>=!lV6iKBRkJgrUDL}LucZj@=me#GCX*w)lcRQ}r37IbMxACTu8azcjo zjEBV?Oa(fcnu={W(aF@Oo!K`yfplF>HN;d@?`EoKcT;PTzK5y&@Zlt!{Y;I+p#G*V zA@Bdl71e*F=fg}r!~Egwm!IepZlb~nQ=M@d14gnAR*s@iqfO1hIcN-zxP^^lO>G}< z@_QD2o=ESIG|AK+)Sb-!n?kRqa=cEbzL_R-f6*5dOXHZHWorCvQyQ(b@Icw9+681k#BV`#g|)NyoQ&HhnZiceknXdwG9h!9Moae#XK11Ew+`H1!iQ z9x~PMF!|%Rqr89d!EyHUN%A~xs@54(XV04Y{5;1U-eUa)-ZK|Do-b4X6^<#)ylU#m zzox9$O-;JN`{|~scNlq_W9JTeq0R%2@2B+gnW@@%3+Ho=?-%sx74JKI{hIe#4j=Q2 z`cx>VPfhVvE}w>f;*&kUPd{N!VW0AS=2NYbK0QaPQa+{s+^1L>pZ1mWsZM#H_ToeZ zpAsti^fyjb@~K%BpN8Ntc2@N=1xjc!ta1#!Qt^~DE>rxFY(b9 z^Kk>kOk!a?{z5(<^1`$R`WBVj<2UZ<0?g^ub!(MTxLajWH5`;4vyD6B{#d1X)si zvY{*H;Q|Ub@~II~Gr#7c zadSWM{kjWZ#4knty3yLN(rx_u2RG5FtzQSf_Vb;sUt2r*)vlXgvwQn>0pt4kH3wz; z`t@T!zee`=>*SAq*+%-6XOv&9&=spue6(NVu^So3__ZE;;2-PPl5u|ZAJ6vq8*gxY zvR_rF_|ewEqc*MEEcs<@9laSuKA z`*q}iUxN?&H36sa{7=7XAEr*cK>xq|I{UX@V~)^^<9@|q@(I7fC;e)Hv{Q`pk6(pO zlMD8o^XrR?{Eqjf+N zI}#Huz6)p#hW8BUU@so~1auy^@vvV&Rr?2Y1&`44hk#BD2x#EIfX0ps=r9J34`>_; zOrWlb0ev=!oK^?)63f>Fv<1$!0nJ($P{Z{B{c<#*yO?z>pp~e7JfQI>$n9i6IWGs) z0B@1&NjhQV64Xs>w-U=9 zRDv_8Tdttq8bK}e1a;CI)NC`T3mE4MY7WXa2p)O>E(8@s`inv3#S}cb#F&@q!}Xvt-3W5te^7f7xEa*aTR}CxP2Kl` zdWTi_gWN+YDDQ)y=09ZIM?npH&bH|FBBOSgy!VG`;6P1Pq3aMhc zkm@0VJsCoJgo7DF`Xp0G{j!EMG+#*9;m99SQh|`h;yQ{I45>+>knSU2;Sh8AhV)nQ zkj|scXCbvJ8PXw~E)~+pty$iYSe-)JglC;Y%JW@FB?pF-eOO2{#)q_GLP&XM6Kifr z-{U%tFAV9^wIQ{`noS{jHiy*lcOLhK)caIO70M=QXOkrT{#BAnwMtU%9!at-N>b|` zNg9Yw`;t`r?%3u=ObTn$mtk#h8P*@I!W!Q$tb=&gEvy{f z!`P}3oB(rSdT`Bb#`J{WhaHD$ze6ZNwoMmEZ3Z{(#;L) z!BXOG3hN&J-W*o9EnyADEA;(6tRCCK`gnU-Rd$3me-}CJW?g)^H>^zi!Ya2vEc=15 z>KzN~lapbU$Eveo{qI~@6EB9f21_q7&gHO1Jqc_2i?G};!|M1dth}$o3ScTmWlGlU z50Z5mzvf8RH!YKO7%y>RQL;ua;Smp(Cac}DWNk))mB|XPN@mWCWYt-ptaUiBBU!ec z$%^3ou4L8Tova0zxhGj;_a^J3eaU)uKUs+nlGQm|it>M)qPkdzj`>ow0QvH#D2i3c zULZx^q5Y>R>QEv@{*o!`TRKGpLMiIeHAUVLDOx)>MJxBDXa@%DBgVlLRlky=nQElw z=^CjgUe<1;EM_BF+BH&v&5gKUSgPi=PSvjVsT$ZhRgZe4s#VWa{fTdTr)nq`_es^@ z{;8VyLn_yarK;LU9x-i9s!EJaRhC^i|0W0$H=Xz+PW=O-|tCP;bW<~csW%IAEqkpQ7YH|q-tY^h};Hb=AoO}0h!7{w1q^e1kei}1Z-M6M^qK&_|Lh?^MsBBD!p`7)vwuOjM{ zA*$tQkuj>y_&8HkXER4tC`(j_a1P_MMpZpqR9lgfgXMT!II2*QsG|52*^5TyL?Wi+ zByxWmRZ+xBM0LDORMpBxwWLB+NtL2pGauF0&Zz2zqPmd8I^n2lH)C5U7S%8e>KWB3 z?CKR|4(q7aVK@5piK=klsG1^2zo?4fG|K)MRcjO+9920SLZ+cneSu-asRg!?QT0aU zQBlPs=jbT+`iZJ1c8rV4H$KXF{!yL5j+s%VON(;P&!~2y*Q}^U&yKP$qdGE&`sT6@ zj^gKeQ8ii?)dYB!N7WdguZSx1ny6}Sh;siM`n5Nz_Lz^ZcUZ4*Om#nt>4+t!^41u? zPsEhkGNv}IVw#7Pp)oDSX1qqWVKLb-98-{acua55;HQ{+;22hqAlAs3Zj6a(?AVy< zjEnKJY)oY*#JE3sO!v@aVoU>Y43Q(!p*_yemzxnbo8rvmPn_Z iowr7Q8kF?%^$)Ys_3ih0ueMwN|8^Pv{|5i}`2PTB9q~Z` literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/f655ca43d2607cea_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/f655ca43d2607cea_0 new file mode 100644 index 0000000000000000000000000000000000000000..207767ba685cee8d610dfaa69d9b052c3fc207aa GIT binary patch literal 18180 zcmY-1cX*TKAMf#Zo1{s~Y-u_`R-vUyvy<+mWe?dKMP(=mvP5J%5CLWHy@$vW5OAdTN8gs}_Tr@ps4Rnrl}gtQfedeE zwQOH?f3RBBn$-e1HN5^Bfoj>_nmO4yHLKV3R`+LC&&tUTR?G2aWLK|NC8JtRUzRse zCA+%6YK^Kj{07B16jylq|6={`Pqj<6|L<*r{_Br`E7CU-_Q(t)oE58zxFb`{@OyDM zQWCZV;g@W%z}YS*kUKa4dW+FUBd}M2MIMQ)S&6h+PZLb+Gma*d_~pga>lrCz!Nek8gyRvUro` zu?05C0m<76=3gLDj>%86(}!gXuTedJ&>8K`A*Y*QCYo(C`mvDQp^*0o~rS)<~>fDAocVLxtz6<^3 zrX2hSF3PkAutbs`!at9|@EA7BLCJptKR(rSO}=;r<0bMry#E6FiT@>3m9^3#GJ-zh zHAGNZzLx>U2u4Z`Qv}Urw~R1HFjJaaBIqEeBriIGdJX6$ZctpqddSXnQE()AK+5nSvXK}r|J>ZUnPieTd82n&|*;p+xACbJ{UpY|2Y%Ema`GK&qZ+Hw+KpHjNnV@YKmlSR3sJ5k<=<2 z$(SOM{42fUBiWD;Nz0^2zD|wgaHU8J(juuR=jD_$lB(`V8cMP^lJWjXI#iG3w;GXr zSu>JnQcydRl~U~WNIsPvbtCcDi{xeFNP0GnqIug&=NJ8@7xJVMlNAmWBNDfH! z#7MH`efdXTn-s}WxhhX2Fg=pW(r{KJ7p3u>NJ`I-q}jqqewV)ADCW13e7hu)+e;&P z_xngLtLvIc4j&JkB)S!X)G7a<=PnLlK`Cgu88|ai{V13BIJ{b}=FiE2F4b(3% zuvr#WG4O-*sA}MIxi8t(4J?r_YN-yXSKGi_a!72i8<RHCg=@tgI zwlZLCW1ys*kgL+7t%2F?G`sfN(^)h7K=I{H7Xy2{Dn@q$3BA?#=ej>g_XivJ=S$T# z!GLq3fsZB`crn?){Arq>teR=ib3rqa=1UDMmAlIfytCZE%asOduhKbKtr^MmA2crs z{G@rxt)C4vT5n*=1_P#z27caT;KR)ZZis8E&bjc5&aE8Tp;_+K`QN2;v|F|9F_5*_ zK;5INPqL32_*PRB=#85sE3z}I4XV&EJ3 z`>CEE&o$%1Mivw?vPx2l8o6D}$Y(J|e6dEV$ZC09!l>t(k+Shdh9ns|oowWCnh{UB zk-9D;scs{Md`6o1jjRb8X_jT=m2}89l9*#8O{U6)TqE`JjC8MNWNRHGuGfw9s;gKs zzJZa+ zMeL7^{2&pJjnsN#r1~=>d!^_LBcIA!{~7s5vLj3swV3$0h)K^E6KCX4X<5v~?BXU0 z$C$WQ$;9w96Nl|4TBVz)?=|t0eBd)NK>iX>z{DI`Aro>;)XUXvo{5N%iFlb-)kOKm z$|D<^n6NiBVQFQeuQ=W?kt<8(?wcl#zhz>|yCz=A>i0}+6Hf;dy*rw?Dt)?`I3>fo znwTz@ZYCOZH?di!_A*iGV-xLqn>Zo^`YL}v6XT>>e-lmR7qJXfZaMvlVox-2Od3ow zF=?_%KYvXm%95!j0^gX}C&j-t@wI&SqlxsNObnH*pH0k?cI!=a-e6+YMiXT=X^$-0 zto_?fEc?a8Q)#i&!~*$qm+tR2@y;F-YvtKq6Pc%c)=0TOOmw_#qUIG7cW#^b{Ei9#T@zL1dwFut#IE}$ z+>cC5l(Uab)P7>(=2H{i=O*UL(tlOQeXa1qd3tn zici`{@u#@oi{es;C{o^!!rD2Cmjkr_6RnleLlkeQ?hlLN>Q_-XhDR}7n$L=2=Ikh< z=R{Ff>d%W}?fNL5Z-~OYF^Xlwd6;6SzxA1Wi#PAW~Rx-*Ui+gYvxJ= zGus=QsocoSE-BQ+%$}BJDz-MWSYqEY)9P&nNerRUz$7UM!R^NThnEIM2Da-nqagH?e(I_*2$YY5aZRYj_Gg~K_Iq73m*Q%2sFZy%Z| z{YZ0tthve!@jp?{XJ)!SH?!u2`gv(4Q^vnCGbh5rZ}NJig>eQ8E~ABlC<`OysM*4` zXbZkV7Wx*p5MR_nds$M989oKF402ABnxS;S(qZf zmA3Fj84C-_T6iVZ%3D|?@1^(?$w-@=FTtsH2eSPhl4k%bE~ zw26g%(x9n@Wpb~Xg*MGCeEz0|<%U)Bz@(EKY4mai=&%2#r5xP{ON z3yr0#L{3(1GHHs1yHhRXO;i8VRj1UPXL>WPKLGU%CwQ_pqoU#RYvI-mb3 zHdeYvSQ#kiBrDR&rv@t{sOKxg>9- zsJ>JyiIuF3mg8wws@knYdaW#wVLmGd{8sV;$|J5^D@*HHao4xtj$R_xua^yp#bqNMax4If*1DUEtt^*zU` z?>SbsNwA-l0sYnc=T;_vVdc40{!(kdw$gQ^)=1Q7E4`)m7%R)={#Yw*$60AH-pX2e zHbK2ixAID=&9t&cBIa7@CTr(enYzGA&xKZsuCX#i_N}#&v(Cz{AFLGmN%>{V&sJ`) z*NitRmRR;`4s!QbEAQ;Ha$>)gk_UBeWR4s^r2bA>SuB_2?inlj=dCo5kAJhWUVfFh z3sx#h`-@h-lZlt~Jdm|g=XWcUWW^s=p2*Xw3*nz9a@A-YHKO@UcGiq0P%D}xwWDd;GMavp+bSB%8@ew!Z$@Kp9nHt$UlhZqa`WdH zGS&s)6#qR2%as_KO5j=y{r`$#<;@tL z$*+IMQ1o^TZ%F)|82bDZ!**%;Fow?_sop0s?3FH0W0+uw<$^4Uj%9G6SPn|v!m-RN z63gFmp=hkW*T>RccErTeH!hZ6#8N7jiG5?aC|`Z2<3H%Q#B7LVgP1nzF=?_Vmf5oM zh~l4Dd|CZxEKP64GDimA)4m6>6nPlSy;reJDN=$zq;#bcG?24ZOHi>|32JvMLAL=V z_*vEuE|_akm5Vn@@Z(=4h`3pT{&z|+4ElEh$z^>to|+CIf77 zv`vg-x!6m_@kyyT(#yrsM^2~4(b*BlI;oc)$9{ht@qsw*=fn}pjpJHg94GVR_`G=> z`=s-GC>~>@ zwUmps>Gh_K-jW+e$3`K)jlr2V z4$81B8{g&Hcq*IoY%~hnXj9e3GTBy5dtbM4pstOCdNw|i)(vd>eZaSg0S+1%U4?jIa2wa?N>HvV~NqrwXteGTz?Ybu`Sl2Ig{ zLGoSEcorqZb5}+s#k2Uec;(0AKo~xDOv3TNXDm(n~j0wbZRz?QnsgxPd zM>0Mup31p8Ce=dmtj>?;g*>VpPm^l#%$B0n<0)S+p02W^K|IsmjOU7EwvDHG`*!3?UGWsz9Z%T<@sv3jPiMI$Qx0pN z)IOfMYd`CdHTWW|$sHob_){4!pzj}my-kibfbGbK5(z}b zB{2E51lpBOV1@i#CPA;e6SytU$|aCfAwi#UBrvsN0$WlNu%;$ZMV7h}cqs4q6Zj;U zp!Zo4xFF|33G}a;z)o3SJ%PuywZ2XQG)~}E^8~%mmcYx_3H0cYzy{ggDS_7A5?CyA zKU6(E6KE{MrDY%0BJcH2;OxKzDt?l{DrxtHYL$$kiZwieS|buLj7cCcK7r5Vnhcwp zz){(=VcO`H{*6db}JqZjF z|6a{te*%}K?STa59ZKMD>2p}?j;c5L`d9)BPb6?hem<$#rxHj!oj@a5dS3IAyB89e z_BeqnvX(^V$0c%0dV3SuCP}_T+GZrOM`AM*nIZME61gnhauVs2m&kUh7t(E&L<(0; zB)VE60tx+swym69l$mW0=nMAN(^=E$yUNtmlAQCZwI zlISnnYbLS3Rub{Gljtt>8z(VMmNrQuu2~ZEJmq*Ci7*1wm8u|pEY zJ15b+YZCLMN;l>0u6R9?)T83bsX<9R8lk)+lZc&|#GRQ*btNfCbs#cPYa^cOA9Pd_= zGTlpZen)v`-z!h-^YXkchC<2ok4t8!{N+f-?n~xlIaMW@Ayt#9-z1r7GPhka8{bbR zs#7xMdnVIT#>ldP$vlz?Lz8L#bu#m0$mnGDjZellL2+hl&zxj3#IiJ*rm}QXGTyDp z43zmhlKJM>WbVnnYBlgv74dp(&350jZLr_2?w6skZ|iB77(%hDC7Ri*+Ce+A+@ zRiK?L8c>0HpH*P0lpR@tapNm+Ub@byK%dPOST1|ES0MHm#X4GnI%g{|Nh)2gp!Y#4 zP~*C8V=9svTan4{R;20&6&WqbeJip`o{PUnnJlZQs^RUTc=R0qRci%nDM-71xBvg++r3U^MWr7Z2G zwV$OjKvGAh(tn)tN&1vj7Jrkjdl zCudV>`gl*g`nM`! ze7h2*`c$If|17A)4C%G264g#s(sdz~czLZ74{ubW;Ll2oxKl~*uj`nsepm^EHH`-H zS4ne7BuVdHWIXlZ=x3f`Pb?tmy&(2l3+|v9ckMiqot^ERl(8S!nJY0}?6m4?*Js6ciuYGN1JtJ+`^-+#AUngQ z=U_WOe`zOeh@B;0+jZTOoi-!v{4~MNzZ30rpJXR?rk!E4)bngR;W>7m&b3o8-_E`T zc4{rLGiIsQ%DC_CG+AS(?piw&)~U`PH0Ph~%v^7$&<1_ISzm9_*ITu3haJmKI}LZ) z*(!w&Xs(CsbUAG2y!>?3uIrWTtT=AxwG(!H(q9Trsg~1r9!sG!cB)@gjd$$)a98uc zXD3%qKeF@ext-`2nu(l{nlJ5)ex-9OO(Pu4h;$Hba4;&`!SO;4sugyyqL_oXiaS^s z7AgJCiu*}>Tg4(e2NFw?F*($V3dkNhbfr-M5_2MIY2-pO@P zy0U`{H5^o|)?k54%#+!@NFZlZ|q=p69-qDI&^)2gU+%+et5&d z%Qqc#ZSCONTMov)?cmfq4%)SK(5j1rxm_I;>*nBSPX~#;9DFS+`#IPu{rfu@E@=ZD z+!*BGsjT_J!7maV>|o%R4*r(+hB_$!wS#?9e1wDb^1&$0V6^I%i*iTWj!~^+RqHqh z?@v*lsSfH+cW`}{1J@kwpX=bvVh3fHs80D{nQB_@pv?-+P!_Cm@YiYwOMY}PdV_-# z8y!^Nq`7R-v8@g^ZF8`3yMxFb%K589MHP;;+ zk!#ZEmV?&!H7`m1$3dnnk-HC6$3q7n%cW;JU;jGzN~-+lpt0Th9M0HK)qmR@1Qo_BpPPR%^-*o!ONO}B8I=6?X z6C9b&@lokql{ur+St&gxrjs^Zw=>eYB)w-Twp5;-P9yn6taH=pFJt7{BF$-eI;QW^ zS+Fvl<=>~XN&2kOK6xqy>(W^zJH@jhowv4WKHJkN@r!cF#69WEKa|cI>3TSwPvnkd z9M$=eI;YbacP5>F=hB(_PdXPLr0exxI}y(|PliV*Z;> z%zx>$!O7wXC-IR^-ZnZ}WO5Q0<)nD5la?iPJjqFRDJONr@S2knGE@$fb`mP%GTF(s3Qn9UPG(6`B`0muoE(vD4ku=(lL;;-X&Fv>WIC~DIr%W#sm}?W+{<;6 z6>{>elrC`cUS%ge<+cQ?I(bmbNzvDxG_UJqmzzgW8Gbi~{zP0M@sy@0o zIVhK}OsPG(EX(N5l%vr=xXljY-_ z)Sl#I{uC!`r0Z1elRJ_z-O1~-oJ{$~$%VyE>VKzqXWpdNoxk3XwNS+l{(vyD!MY<6;ZyZYMUq||9A?ayc~XPq3oth~3J zjKA$9;*OKScb%l)(>amH5_R86KiT?^6VC%DEgq@2$2xaUHGh+fAER8Pnq3^QxF`|r z;!EjV$i?cyF3J^gaXrq3E8fLyDPPh>r&2Edea%IUGA@pkb?NgL7pGEO)J%1elIEhT z-NkRR-{B(G>0+?l^|;9NxmYY4$un}XXN$QU5u~mBBGv) z-VIz>8@g!J$i+5U*v!ROEnQ5LCaqkwmlIOzO&25OmP~8y;?i3#p0{yPrJZ_f?_%Kl zE_QTsVgJyj>xEoQ{m8||Uea52_jNH@mPvkp7fpw_m@(8v^e`9gzH;gHfQug_dAMdX z!ln2BT+|w;c$2hdii-hqcDm*@)5SP(&2{ndJQr8x(zlxLQkOnM*6dcgShdPU+0`zp zuTi~gUA&MUKj=LCs9ra@2=8;zKrH)RB+3YBdeFstQs$5gw;VjIwZ~lylgcMF8@YQ@ zb^Wfo{&4ZuRTmFly2$-kJ;~btGz;9ABiwu?ha%nN8{B+ra&srj%{yi{A*-AEVvcr` zAj9QIAvcu^yD416P1B-oc1ZnLt(U|SZqj6i{1NA-vCYk-csJ)0+|*5U<0<8)&ueb3 zOSiIa)|JzmWH((axmla$rh?r~xpX)0JKehG)J=SKH*eQ)b5Newa_c=TH{Z+3`feUI zaMPioo3V}EoND5xW>Yr{-*R*FZ8wHCZeDNerlow*&aLZ9-DJP3I^}q0~Qn-PB)XK&@MMkcDwmS6837=zv_I+{DW@(JmjX;VfA~|&G=(( zB96N$anjA3r`+t5Drel>mf$%zi)6%aZjN5i@r!N-Uvl&7?{41uL-Ul-6*nv7<}EkA zJBlwk|F{|Sz|B4R_>r59k2Oyj@Wjpbr*7&!cXPw+(Psf3=E&-34^Iktc)zfRh~ge< z$9OO&cz9e|w`DwRm!ndxtcMZhJUo{k$sT^J;NjPb9*U=WIGnCqkB63C4}0W>-$QJ` z!y7>liMhHBdzhE6H3c62tL&j>RmH64(Q8K!)$3`0eGk)Gc(~NkL&H|8p|yvxZ+U3Y z-owHU9&UE@@aFp-%6InA=>rdEWJnhe`@4F`>*k?Y4-YLq^srmbOL9*Sj!!)F{M5rA z^3f0vrG|QFKg`21`F^;Ejw3vLH&U_3c<_z$FkjkD@~~vGYM$cZ!ZZ&RXLy(-|IJj* zv(>Xqo2xqKsm}TOdbtP73XiTg)qGZa`2Bki1wVQi_LGOS5h6#W}7u=e6d7 zhtgL)ymQCHH+MbQ?s+)<(8Hidn%iR!Sx?mSQ_WbaJXf7k7B3wmyquEF1}{dFmyhLr zvzL_?FJ-J=0`f~yFMZ;?d?i(EUj1G6vO}U1ybO>wCA};z^@KYI))xK3uskYS1S}DBROVjU_SN>Y-#ruPo zc`|gp7uN=zhmBsY%H%Cxe%q>ZvfYdOS1-Nyc?llTc{uLn>l0p{N|Uo*rl0fj_`H|! z1ux&pmzTWk``t_KAF5w&T=z2bA1{|5X#GPkpFi=k`>FE%>t%1OkJ{yZj7|3OpX^BS z5naj007*{svC84&ak`H$Tt3o#K3x~?b$xWH=i|KWZ|Ebov5&!Ww26hqM3;b%45D?Vyo^YNqXy`fqC z<>PZ{@VAf2w=}mqK3>1;V}ne6te&3u81_`Nmj%y#{Pn`e8!vV2KOYD26OQl`GWe-4 zW}}}387@amekw=#>0Z>&=aN&*PaWAPkuiQgl9Gvj(&d^wlJ}GRtSsrLOesGF<@_{~ z=<-@8qvUw9pK2BS^i20NSVB%e^<;~f+3!K|P+~=T45Fj66TzNV@_*ODg*b zR80D^EbHm# z{zr<}%TJSmex`ror{ZVodz7DdM*BG=pHB3%bCUK>_H$0kPxUii&P~(TGyJTW>8I3k z%A7`-0A1uEix}6>_zn~`~UDW;Ig0XSN!;{D(5xjyrKN^&7Xd5{pIJan|@mT?dQWgetx>^r_wz? zXYTtc`#|v@YKBiW!)Jb4Joi)gg`Wv8HLq8Gru^&Y!hbr~1lVc}5ET_*yg5M8LIIi= z4)A-C0EsaH+QbGpEH&c-jJ5@MCBqW}97zmNIVr&G(gAvx3GjZ|04vJ{C{sSb3#nQm zK!iPj(HYQn{sE!`0hVP1xSttdbx3gw0xYf^&^5RLlIsTOTrWUclYp+R4e(ow0QFi1 z7~3YG@4?F5F2II&6|X~pQ5^%sbqmnCdw}ab0@(Tmc&mSa1JY)oVtx`J{?h;rzX&j8 zuzLAAz>rY^_KyybHzvT2v8rW!fC2LTv;a@12k10Ieas4Qb#{PebJXX&04L@LsJy19UkN zpvT|ZcPBvCy8#OB1$gs*fS4x%T0IT0SJppQ-4Q|d7=jcv1^G-S%5U;0DoB($$Tm45 zRV_h=TZ8m29^|_+K^~S3@?NH>gvQL$B zaFBjqswb&7B&gqsg6xvQ!-7oxDu`udkcOjzY?a4jf`rGZZ`m{$SuYOicWT9y zW72A6kaJsj+f?gr)v_muXK#?d_6PNuiRODqeg2{PuPBEclca0vNj|t9z zLVpF>`5;K4M?n&0lpKE?!$Cs+^6{`EY339ZfPh?QxWCrujsQ$AVv^b25R3_yunXIs85>Yaf+NCl%{#qt) zXJ)b}E0Z%hnG9{3$$@5>gqmm4SXRlg4>L*nD3ebIWb*ogOvW$N{zaL@OM6+lER#pe zGl^a$m$dKqOu{!ZnNc>2Kgwm%xO^68t7TEHMizzZWsyHVi=h*;_-jTMA8yRzr%hQ@ z-IB$%16eo^Wid;N{+31a3t8-vD}QF;xS7QaDR(=I_wQtp`Y?;$6|&h>F*98$(WJNH?l!&GqZ`BolX5Y*=&|$(q&OL3%||g=8|mQ zT$)V}iC&dW{F-duUYpH9xh#)1W|MF@n|F?6b4aepfK&SVjN+clW~dzdJ)5M;<}r`Hb$aOc|X+qp>+m9hbvr6LQ!!F^7yvIlL|% zrRtO%hEL7mnY_0=hvh4BDD_C$>nx#E+ay@ zjA@_C$#-*E*DseB{d4IuAeZf9aBad6{^9a0`$3LC( zI5{Sd*T&^BO1@Z-$KHi`WG~YC#d!?=R%;|`bsqJ<&!g~9%6mSKbyxB@d^L|_*YZfZ zk*8TI-(PvGx|zo&$@)8w&u-;$M>gEaBjR2jMP;Qtx}QgffAV%=(JiAVjN%A?7v; zQLJ%@y-jr6EX3zBvw4WiEwra)h&peF823&H+JsouHpJt0Av(5K+>Rltb_%gZI)4yi zb(aw3x`rs|8DiK+S|`Q(g=pDd{malH$~#nfhlN--LiV#P$$iaGnm!FN<5`I4=OMNdCMq(_WpkJ^iD5b< zg*ho@O6%(~`daRm3zL}~rgnuerz(aiof>9Ir7(ShVK!%kab%8 zFz)tY=E(4O!yI`pOyv%W-%;^9DZcFL5~gssFiEmg3iSw+C=2AT55qi`fggqWrB|54 zGWg>#zxGxi(!EcZANq#*_|q_7$e_=3e{h(WUxu*`3FDQsQf`=flo4|Dt1wl*4%0wl zM}&D}q~ggbagI`rqr)VO4O3Aj%BXQ+j*k!Pc@w6QyfHD%yh&k-Pu3jew#=HMb1*H8 zaeA1#Gs0|?y)tm7>Yf$GKRZm5xnZWy3)52#Q9XTprT5a#s7FtskJpWl`La+tL;{kCR)N44Bl9sg*?55l^3Jxq}&VVXVF3?*1T zpMlBw(r`)`J-k+b(X<4&0pJ&VR>AXB&@2%$Z z)%JXz$n|UaxNhWQ`zs$~nF8vTE#OqS0=`Wx;7+9i-bpLq4Mzd<(hC^iFQ9yf0y=dp z;EY`CRzOOR0wzn%Aq9*cTEHtgHno7H=>-gz?=~0ka7zKdZ7bmTsRBx#DWHnOdXA z^M?`oUzSX`Gry>A{_mgqhHcwENv%0;-}Mr&wWz)0{gEezA3nDy>Cm4IOPB{WtXuN` M?bE+V|Ns8{A8tmFVE_OC literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/f9741c0887f69ce7_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/f9741c0887f69ce7_0 new file mode 100644 index 0000000000000000000000000000000000000000..c5ce375049808264c6fc599081fa93d9fd49309f GIT binary patch literal 37300 zcmXus1z46@*M{LmhY6AM-QC^Y-5sBa-8%oez4t%Ian2>e z`#ifq#TN{(-(`88_CJ5wh)6MYvT@vh8YvN<78zB%WMpb=iBhE^OQuGKhnI>gkq}oR zKB{;`@%ZS3=(wnuh>{V}B~wd9riDkBDpevaAv!)LyhLhbY*c)Lm0shVOV*jV7XGtd zU+Hh%_5YC;^jO=|QslTX%UT3(8V)+Bx5hL(5qOZ3F60)0ebIC%UIgqDsizjMCsRTR z5y)MVT2~Q)byX=}HIaI1he}HqX|KGii^Qlh>YrNFQwsy?(8A^-;Lx60bP$0|BS%*e zaP3L0d+B}Ey51DmR|Gcpr?3BtK+6HtZjcCU8cfB9h=AL0sy{*m+8D7TMPQ}M%n)ff zirQ+S{AjAJg@iFwN((K=QCDr>@ibBkKPOPT$vP&rWfM7X775-WvUw{V&@S30@=@L0 zF5?>5=o5rO^p$nm}iSo{K=C7Zk09x5ghWbbLv_Ux`5W*K|S)H;l4xL}1=qTCasR znbcbgFO9PwMBtt=QR5O80v;u)VJQoN*G6O+T?ci+a4V<#t%ez`%UcMnt3dfGS_mAk zMA@q7dZ~U!h87N2*FCCfA-#;*4fQOlhm9z%iLR^a-;_pa;jt0W+(KZcv8APjz|U6H zwzY-8y*3u&+g8WWo^op+chR%n%|a#*vXGZUEW~Ssp6Mwxd8+=rvYJLYwd>UtWi#DE zCe5Rp^DP9*E})uP=(5m4b}rJfE!LNpP%~}Ul@=1ZR_CbhueXr-8!RMtlZCX}tn0tU zLhfv{kP$m9q|F{(?|l~1{D6h*KdAFNtY_$`?)NbZseRl+4xA>tvlaq9|KAP$vD$Z& zLT~B)RFXP#$3k-5vydT1I~z-Z&9+p?&Qc)Uc&vreS!rB0OMyQ|S2s(6UG7xN(^8uoRdW zNi9lP3fw74LrPf+d^d`g(fg=%Mviip0{zwD@|F@=fqqrB6zH5z1*=;MEHhr$uoS3Q zlUi%xwVG6mdeycRu&qNC>gwFoZsWTaYSyENTF6qL4rt-B@k|Szjmb|7y^OS`mI5c# z2ct_fOM#&+D5JHdK$bR^QuQB8$<~QpjMa5iVdE)T3(Y5x`$S8D29xNF791y2D=mC5 z@=mc7xM)1l!dJs{hNVQ!q+(jAJjYV*8Tl4k3RGWA546y8Da~4@<62J3S6B+XSxL<{ zS_<6XM9sJB+o>!2=%E%iAEZS`Ed^qaQD5y^W597sfukoV`lO{mStCOWaToLqUDP$X zL9@PE3Ox8mmA~u!RC8mk7V`b3W`A_ds(`iCUp2E@3CzhxS+ZLR+|EJca#{(@GqO2Z z38XvIVJ(cxMYFX~!-ZOC;kuFE%}QXL@y^{!z`}!eYvHt!;%Ox?G&g`bOpS{Rx_Q?y`Pgen%b64+}jDQ+dO)##Y2<5B~R z_gaWAK`XQ{s5DK|LWMF^Ukm39*K$?@3(8Ykbt{4DM)n$30{M*zTDV@5_Sd!&aA-ui zwQ$9FqJ^4`X>JoMfox5wdKC`bX@*)vIs%G35u< z&uT5OC>yQUf^T+ulfzozUnh!iwiYOEY|wtmWvw6MsDPWbz)(-R?rkmb$e+T3tOd%4 zkYA{^K$Zxq7HKW8DVnOsSquC&TEy#plt%*jYhk)^H_=+4LK4;0c1WZBWvvB5%2C(y z)&h@=iIuDcVk^@eEj+41nObO6m9kc|7O0j^2eoicm8nTJw6BftTIf{ETKd$b&GoDW z`qU@S2G#;clw%`n>1}jtY%Or8DSd2VEpWFLRd229r0yE+{;?LgXau*l7UPd^VuwGgBqXAl2IFRxWvKH8Bv>UABRQ-%s zT8J1*KZjWhv>ZpaRa{^#(A3DXOwXNiUP~ET zIKPgHthW|exq+%~v=%tIiCi~Z3)I^}!CQ5mRn2X*QVW^eY1eLRfn0m&m=>-XCHGnj zjNV5-wBUD)x@cj?aVmVmS|HkpJ*j6`^*cqcwD8S%aoSp-^98!21@BAb@Yq`5hEe9J zo?|uc8I^l&EinBfJ=Q|NXWFU-i!W6AtF=Ih?{q>7*?&@hE!6*yK4>A{!sf5+_BI0D zvXO6g8~xa1BR7oyX`xmQ8=0HaMzT85)510a8UA!Wz($~U5LFDf5!i106JaCJ$9SQI zuqc|Rg*C>c1RH@0i8LumUse{$Pd6KZCf(_R7W(ugw_ZAbHNi;hZ6lCw9ManN)%hCN``HMDO{Pm)s5FJ9OtlfP znnoU4STUWVmf8rMGIB1r5g2K#-DV>Yw4H`&A#MlF(L$4*)Ml5B!1~>ke~*nol(A&5 zjlhb7wCa$Jz&E4j5gUO;#{Z7$IaS||QN!al0-KHRCu{^-pQOyQy3Z=@9A%u>{ZZcx zn@ctVO^p?obsWn53fbPY5vXe{xMd@d<2L=ir{_hbJ)kOD*kpJ;w2_vNY^2mpMF7-bNtwGfmdQ%`a5utBt_RZxsH+Mqs|N@{gW(mH8k2(n5c+ z{p+I^5-e$j7WNwdY2m0fmAA1Km}pC4XRCi{VJoi2MSEL;^C8qF)K=iV5f^SNu*}%4 z1*-@u9cwFaAfB=$*b3A(R%_vXA~jC36>u&>!?bX^C?yuN6^KYB+caB&3MHtH7P6P5 zvD(X}Y$dfcSyZwWSY{+v*6XS3RjF+?TY-(~G_{7Uz#^k!ZCimlb*N)qTY;7JsBU9h zfv6_7a>aP4?bnq4r-jhwbiakIfNv{uXk#nzs}H62({Zbf#@L~@0+)wT>TrF%dNP6n zGi(KB8a3wF3e28Mj`M5<3K$g^=zP@Xo%Caut$^KbTBU{dd+7WDJqOD55DnGBs$=x- zxUE2=6O`q&?zgIXh7M@qs?p+{t$=qXwRvYN(8GACg@_NdPz$#|k@pvUoC-7Yezg^7 zZLIrdE0FIyE&FLJuYcJ}z29`k(oUeb6^*dA6Zm2{*x3nGwx@ks*qn`Qv)c(&$U(hx z+6kOBayi=xco~7Y>;yI%UtR13?&qQ3h3o|C`p^PjJAoX2lvg{gF#XoT27fxBg|GnX z9%v`<#7GFX6IfuRhu8@;GcIYtBaB99!6JfMYavf01!-ZH@gT}hpmH>gim?;;Zmfy5 z6WC(}#p&Z!=XiRcg}f;=R10xMsI(Tg8NZ6!3A8OnDP`>hW*GO%*$GrEPme3v2^_3U z#j4l|95u33vlBR8i>_#4XdUvYXD1M0EYpH>eX8BSPT;t4tcjgK!KT!znVrC(mh@B$ zL9J<)792ZJOh-F`zMbeqH#>nU-Dz46JqOCBC*{_{s$LX4+D@R$7<#CMFNV`tJApTo zX#W&Dfiug=d8N)v4Kk)_;q)r%w#QE3yDGZRP6{8TSC8!kx;~+uPwfQ!pHYeyh8S~S z+6h#DMYCS(Iw*%XlwS)CjOCx~1oC~RW?%FSt4qdnEku5$H{W%Bs@)IT^wUnD;4g~R z!o=S+&%$2dj#19iUSNV1g;?7Q6t$(%TDWLOPaW+ABC=4=to8zK*{P`(R^%Y}oc018 zoamqy>~c|QS9^iU#!WYSfwS)9C ztTNtJw-;zsg9g;K7r1PA*0&cJY1lNf7pQH_YpnaIvNfT#E$sy?T2blNx~^)Q(XETU zzyZUyo4r7Hqjz_Efm%Jtv8TO2ZX-hr=X+6+-u43NMh7iy9!@nz*bCT?Bo8f&FwSP^ z{;K3rR875oz&8Ed#crk}+&(*b4k@M+aEgV@u zu8Zsini$I$>t3s`OQ^+Cdx6!|uUt=#&ax?AFLfb9WR|_wV@NM=2^NlT9 zn7EgE9kdrXYvej?FEH5fJz_7AVVpmz`=Umlrtw$o1zsDG*L2=$p^jfMH3VBhRf(`;VjDg+`0=En= z9|wW)#vCo&H|qF02z2ms5Rbw%R(sjsK~e+AGTcF6kuf~NLEuazB}F+1R53yl9RyZZ zpwNmA0^KUnV=XkPLVL7eS&jD9(lu5|b?AZ?-0IQmCJqAQ|DoGjDAy3@2C4*Gi<2mL(_9neB_FY43VLEwc^xQ~OtP$NfQ2Z03R ztrjf$k&6~$2T+<8HW^a~ISBkPiVblP_%)K+jdljh3APBndB(Y-$*X%C~(2pS=>>eSSkgUbQJj4I8w?{AgVO2DB~!Q zUWN1OyQj?>^1P6B6*gp*DJT~E_KEi6AnAI~`n z%)dy*E;|Vple0ii7doT``#dzcr?bF4W5il#fu39GkQSVF(Jn36?52BKsCJy@ zYGK_48hl&Fug)49{^u-^{+i}#VemUT^il7pvVEd=znul9Wy|%~LoMVhOqH~7GnIVO zatV}aPwo5U64+tv9Gpua&va_3g~*jOcSA0L{~10f^m^*wt8`Ke_nyT4lK4svkT>#OQUA6FNF#vZg<3jw*QUmh2MATR2nh3kIQCeTG-i%}uSMc{NKxkb4M zyicIyL>GalNp!V{i@<;ybV>{P8q)5jE&{gA=%yByw5CigH0Vx+d$>q+6gT?G0X z545nP5550a$EA`7(CC3K0+xfRffm*dq0U2H1ojxyhPep%kEE_zC^DJqPID1hYNSqg z5lEUz!?jR-7JZuQB2aW5jhpWxV6%{_Xrav_y1rWXL3yvC`rCEC)ug?2R}1;~Q>`N| z0*ef{W4b@;>~ZRT(nX-=Sz4%tE9dCeCl>+V&*bsLMPTwDx~GN8;`-MqEx20HVk=jH z);6?R3$b?8%idMsuo3FuD)2cw70cl&Fd--9baEA_XLvcg>gP^f^>e1wT?>gWG~Cry z;G$8^%~jyK;qC4!u*q2Cq8hH9O&!YT?HEdOEm_%3M?=j z2e}H|96~-rT?N(~vorMm>Y4Fyw2oWJcq*@jOOt8z0#|`+Mw=zB0=<{hzE!RQ4y&o@ z8dm|kZB$JQUAI&7T{<_l-mu@}DllyyJ=8+Q{j~jntAOP}ay+E-Qw@!kT6kzYIpQi1 zc9aetcNO?^nj9|ZI8}9Hj222?rAb;iWh}hqD)8FyxvlG|?mVKxk6i_-JfYlg_1vl! z#;ip#u9n!)NBPN@hz(8Ydb~k|~?v$y8F`l$6ubaSoBOsrfz(rrm z>*pr$q%hfsxe25jha=qt#zoOhEsTz)!m(}wU5trwZUV&;X|xv7l4(N`H-VqV=VERG z)zWCL7P6P1f)(5Z+8Ku{>3GzPy7X8Jv5l!lQ#XM}hHncuflkKEmTm(5{-NVq2y0K% zwD8dI?BFJ_#z^VoCNR>tI7rt~)f!5Rv`}d{rH#;et8vCLEi@cOE49#b5*=LXCXjU* zJzTA0QN7pE5iKmjmSE*RzD$A?^a7jE0f! z0{x&zZuWH-@aaeEwa{b`t*k5~JV&cY$F?>4FwE9iy1zIuA9_h&-X^OHDsbkF?PE3@te4F7V3eao$~E(?$BN zg^`zN@fCN0x5kdEdLGr;Yvgg=U7(7w^0uBY^~uP*>nTf^#g*(n5tedZdN+3DhIWL*SrMAz9x}9V|{+Q#}M6)2Lv14}sTJ zD6Xo9KtMYEuH_+6rZx?)>mhKp6?wJx5U}n*v0Xd_1{njodI)%Rr?y)7VzlbvA+X6v z?dc(4*^54DAlT!=ji*43cC70StLdLDo&sBqz#X0foe$9-E#x{)i_UloyfI3g^Ay-)*qzsX zPzwzA3!VZ^jagb4bDgehA@3vV{6z1o_89A*dkP%*A7y#rDKP03mH*@^FwOA#!+rPW$Eevq6G6%w$&NM&yp5}0BXepE={)nh98 ztdPJfC!fD!oqYtRHlx&kd<4cC-aUN;)*C;x5ZQ|!Xra+)TBU^!yXoa&AAy)7boiQ& zK<=M3U3>)|8PPd?1uDAG3@yZa(JOCXf!IP6;^Ql@z@J`ep-(WSg!u{_45yzFz5=Bp zX|WdON7G9!oQt6i@xB5-jm3%j_NrVmZ78CzS3ixYqP_whicwH;Ux8|A6k5_(e=YEp z-lgb$Szm#Vy^9LYmD^7;w1&POl(`~+eOQ~N-@uli^d3Gx$oZd3^K6PRwe zMf(XnNuaPqKY`RDbgY!0fKzF@m+mLfy*3@t!ukf3wT+)ZEn{U@KY_4+sgD-?MpN$z zega2~plN;r%a+o6Eo9q98HfD@t{8()`U&`)qMhgc1gtMm*DHPkrLWN>EquL6=@0w_ z<{4|A`w3imO9e9h1de{EJ$VZY*yW@9afJnP#8X8r%rMeZ3Jc6L+7&M>u(Li{Hz+KS zrw3Km{b>nVMDURa>$|7g_P!U7vJ>6aEZd?G6ce}PKI3nzbp zBu^Tyg=K}vF4AA1nlY%Fzrf2D6w}gQpz=So;$MG(k4DH+e}QFd=)D$Z?W3zl{RO;^ z(fCXL0$Z<=T=N&0b&GD_^B3^DPjjC73siVUlb-tv%r~C>&tD+;CC%2tq*rv~wZDG9 z8GkALh8}65{adP#sn=DFj4oQ3@_`m=Vf9D)poLjKXy1SS0@fA*e|6QuK;xJevReg6 zb?X2*Y+T72ATTH!9nT&h5SxRxc?1aj_N4Z?0|e&eqsRFJ1kwwTpKpLbdq29X1)l&q zs|A-J8mfh+5#$;fAmD3E)!vB;kP6XMt4M%AYs0%}fIy_NMEj~(fYd8a56T7zyf;>t z3lP|Cgp?1EZWRLLiSZ~sK;WaXwt9fTUL&kVfb^&tAkU2VjrH2fvI*_c!WpAT(*POP zEI>XRN7@7kTs6l36QIx436S}QQ`-Qk-7Y}C7MgPQ4iKo-hmLFE(!b<6FhC%~=sY+; zV8;;h9~vOAVkBi|1nBqa3Xn#lX#1o9`7=2{I!qzw*#QE>=g`@?x?d_~9(|i1AW(E6 zomvziP_2qr~kD=!u8Me{YQX+<4-!Gg)2s>UjYJRf75R*q+103HOn$k zz|o4vI0gz_&O&Kf0|nOPp!zuj1r|F|F6Th~dWS&$9!Ydn3+MBbn^&N~aAT5ppuo*S zRMsa@V0Hkl(L&2W>Y;`I8DYVJ0&gS8Jt0t_VIt)#7ASDHB>9vM6qsUcD;p^AyBxJI zA1JW35;d+ID6qT=xmVTetGU(aNqV3__3G3{3%iW1b@V#wS6ymXFHqoVeHz~&P~cj_ zKxxvLYPSs(nBR_av=0=x*qJ=K1`3Qc*7XV$*l+ai9Vn1t`1jSlP|pX_H!W-$M2EBx zJvdPM4hfW3#y4&AVN`Hrpuj2PhPGx#pyV7y`LsKYf5rp~h)pBX6dYz~FY3lumtpKdG*6ezHQ#%tl9RphZ+*H1NCL+7=y zXg$5y5Gb%>8;#u+C|7m|N{Kx*WuKlOwPHW*IS?qY`yg2!4iva|k}BT{6liSZz8xqK zXuNu$Yp%{brn_30{)Com!Sg9Kex}z_7mTM`sPdZXy$=*x6o@reXd&|>HTtCM zpt>3NzXuBR_(LPKQ2alts)fUbqeYNFA7i{0e%R8|EI|U>j80jD1O^%(w2+XUR%&6N z5#SOeaNC1kYhjruZPP-}0#v{!NFdyJsf8a#JKrFI&3;s4H9TzoTwQjaHRp|X%r+d z+8Ep{NMN#2v3Za{1LM3F+*;CbEzCA-+XV@9=|)4ekkXwhYGJ=&+f(0O^)N%o`gdu+Hc>IY_{NCUu;pFRS}T_c=iV!;NBdg9NG=hqT}@pL%Oy zobi20kifpxWV1F%V9`2Sy)j5&kI`e3&P@$BzG z3pM*1Byict`6Ec6)=xUFg^jL5prb!{e0{$`7F*aBrAdWi42Matf-X#VL#3j>mE#xao&5H#KbT-~- zAv%>lmJSxkUXE&%4;DCT+|t4qqf515ft~3TP+iBRiWmj!1q-;f(|u?kEN6{JS}5C* zE)EG6@EAtETJRZ8ZASzP+%{q|f(81Gq6{s3G{%ex7MN?)8ms%PS{XOB;5D9BPY4z$ zGldpT3l`X9w3{9*(9d|Qg_xOCZcebkw54=+S+GFG<#ch4&QCou=B(9opw<}q*98l- zSWj2AV7ZBMY2mDKR|}Ol)3hymUuC)(^_-|nkEq;hov)hshAiF&3k=Srpm)In$;KBg*uJM;TG;=A!afEI)cj0y zzv$knVc)2uO^CoYTk^9D5jbN{xg0|Th8S(Kga~ZNN?zGQ1fIE2h+BxjT%%y_5P{Zt z=uh4dfs*;@LV*y0@ji6TH$XR2wJ9v-NuK= z5P^d!A!1)NM0y#&%Y+DIFH0x1aKk89E<|8rd9tVwBGA1OIaCgjDpf+{fU&rGh`@+i zG(!v3YEx4!Tru+04G|b^yw<{udUU^jh`^6VRJ=)uz?r7hw^fM1;noz;DMX-CXPVw6 zMBrXmqq|o5_N1v=SY;IH9im^y7$WIIY1Xh10mtFgWJHL-ijlNc3*H&jW|W>2CF7~| zgb;zlQ^;|eUPtvYZq5u5@S05%v=A~sM7k{qktfFe<+={aZzWCBLhE(3etn2Qfeln* zQ;5Lm&Gb_X9k>Twv%H7D&!i6kUENiGh)@+oXJyhVZQPEkir5YL@xk3f}jagcF z=t5OpLj|U|(QWrof$|;{mM2u8M_ziSh4uw#i&v;XRc~rnI8

KNSiH74Qn8R>7hA zJzUAHM5sW6l5|!JKT1>avZ4Cis!-Wztg9F*@VOGTs2nOVzG|pks}?Gy(rI!1P=S{X z$f{AOK)J?LOACXV(21s@`h8PFCB7L|)WYR9)V`0-Rc+}@KK(-VIaZT@1P+7SoR6Lhb zUoDJO!&cFm)u95(YpARiO0K0b>p}%)8u`|T3N+t9g|_J#QAM`XY%Q!XO6|~nRX_LA z_kE!P#SYL0E$lT49}E>Jewaoc(ebLOMwX+Y0@aSuAuYI{poS;){YRZM7M=~&=k15e z|IShE^PvLeF4DwHp#m0{Dc99dfx6e|lopELpf_5GzC}y4FzOCnyc;S|{2mRyA1ZM2 z0o8vPD$vIGtcB#qv_=arUsJ@}P=SR;!iP|SfgkCe7JeJWKIyuu(?++?p#r}>aCQ!2z9n->X!@F~sKw!Tx>D)g| z9vWSSh6&^uMoou@30yKZW`qf}97StKhY7qKM-dak1Qr@iri2Nsm`WbgbbZy`8RRo7 zOkj%f-)vo9RcbD6)547Tx_%3E?H1CE)%tVFehvLv7pC9KRnN%=dayA}py)OlzCBDJ zV;{A@7$&gg68T)#aj0LnDebOaN9B7$4c~^z(#$Y%eMi?ng$WG&Ovk_Ixl(aosnR#y zPxZqn{v%9aqftP@1zK9rH7)G5B5Rv)fo?`CyKsSZ_LSctTp-Fgls#OahYO9+LUC8B zs)fUbqkFhOAEQz3aDioc$SrTUz-b?H_6rvnZ1f8b7dRY3E5pJC-i1@+h;V^3(bOv@ zTws4Jg~f&I_hJs0TSmczaDjpHnS_{r) zX|NVnRHDqv;R5SwP=Q9eAF5?zx~7F!#^9Fvc$KXKRqq%saKyOXIb6WID>-)8^;LoY zQs)6WKJ{xLjUO5=aBUbh84<3(zt_2rBF8cMc-6;vH7;BtCxpu)!)8*rK;l2$3FiobG6iY8cZ9%y#$n$G0ms7BM+@Hmv_3FG;7bq< z3W*T#kBHFki5?;Mjc z+E$?3S~y*qoU29%3^p!SixBXrPK#?q2-IstiyB7=G-*k}ts?|djIUa-YeT)YaNr+W z(Jn&3zYBHjs`FR(jnmzAT&i0S8m5J!J*l!54jT5oBLsRGoBBq`_kI!5rayffpzEnR z4x)bA!9(ffun2+bBj|sNBLu>h(tIsMEvG&!bWfGdDr&STLSWfua@!Ii(0Lo}*d8H} zwv(#ujS!f*j~w<#2wXo%`42}3j5DU6i4eGVmMWc#5cqnLid>EmSZCb05+N|^DqXy$ zd#N&R(tnTjysA=9X`2>KJf|El^h~J%Mx|GJKQ;9=S-p*ra+wjb%b5N}$ES*ZrQzQq z1il!He&|_IFMd*;Ul9Vs|D&@KDUf18$ySj96%9MB+9s8^&w6~nP$q(E+CjP|m3q@)$1 z&Owm^gN@{1osX(u?9MepIBuvuGL|qmNZ@6DTGrQedgkq-dnTieeO%8Y!^5 zELoP<`KqxM=x5bPfz))`qy?9nRIgT~z-gmt-AI9z^(eYQq`;=8^u1Z6z|a=7s&k~k z`!3X^tBy}q>q|5HMGE-*OYUPLrQz5}IcM~r94T;Q3Pn%V`>9(-!Re6#6OCIl^mVG> zELt-=QXtQ2YPv?puYA^1!X7;jYT#bVvOiLv*P?SfLhp`73iLfrBTq&OoIgcHPwW1x zk4ECzNP$(xel2`CM;*^c3jDdPYkG&A??nm>Hcmg(pI3bz(ZR=&0ufK>)>ECMD)^ix zYGLXB==F<8f%-40_Nz#NPH$;@W~4yjcXZ=@q(Fg>wCaXYx>GYsph7Jg-zZApT4O5J zMCYw`H6x1_IzBa~CAqYZ5~$aKo^^~8aP39)dq)YJF&g#NajIqg$gO{rK;=O+ZE%!8 zjgd5TOq9Usv6M6}O5pH#a-68^qWTycXG95nn@O!_MG4HELr>;L2~?j)V;AUtsw)er z#G)vH+)Jp*(kOw8#xpHgE~7ikb^TPKl{8rkD~w$0qXfK9QJd4c59+2-_H2~EgmWb4 zqXhb2qAHi81lnGqj<2Ew3caOvnNb2o-%;K7Q36h1srI)hffL5gA5j98Eu#NAZWS$% z-G=_v!erx)7CzgOtzERh0po%eQtc_jAzGk&PFkBkTHsRwYVH*+u)&*Z7K#>_>qFUm zqXm2mQ#=1?fjh?Tz-R%>VCtfUW8su7QXjAS8~b9T1#IG}yB2aLQ>~O}fn`PLP0?t9 zH6^K1g=m>tQ6F20O4W=O7+Z^eYhgqkI#)MZpiX_d-6&eXy9rIwLWyQHx_PvKTT5Ee zGg=_C7yZ)0=-xC(3pM*tOD)_m3iOK>Sk<3u4c7UoUPCBD3u!|sT?Kb66QTvy8ha*13w)SNR#Tz{_8MokP;@FS(8BX+RBO79S6R&<7cHDK z?rEXQOqxDR$EoaQQ{tRxfkAWWy%uK8qlfdO1==kn+huy5RmJ7BR|}Vn+UuePZtbJB z`*p7B!~yDcOxIQIKTcsMq6J=@rtq`T`n4o_X3x>Dhq|9C?J-r+!X?A=X|z6XO!vt6 z=UKGC#^;p$B3j_cN6PX!TEN2?qlL>~sNuJ0f$nxOf9OF-^=e4Pn(26(Q&dY`2lY>T>Z!HsKrY&O#%k@3P88Br z*HRrdT6T{Si0u_4iM?awe|=-*;P4n}GLeo=*7Z`^rc&!^F#@48X}A_{%_ECNF#=^4 z(+(|sG18aB=+_{}$bG|MsqUfLXI#|66T@z$&PTZzGqq52wVstVl(|;dS2bD}BYoD> z2raDGMAHd0#}Tny)gnd`)QaK&K#iRgSwBZ zk8xcK%?{C6Eul`*n_9YOkE9c9-?6s?ArZ(A5}$ zaHHsT9iy?}MvTDon^fyoj6kV-Wb;txrEb~A{#DRER$z?-S>%otD3gaS=ZzI;5KBwq zVg+2{W93EyJ=I=IjFlgiV`W%6ov9uxkX(bRYGJ)`sZ*?gXBWEBGgdzKik1F-Xq5Iy z|5*LI$5{C@JyyETjFsZEW95mOJ||Wl&5ISU1+h|Y5lvhiD`2sN+_cctShp%x;PYx~ zu_jgqu8kGP_2jNSqk=ZY>bZ)Q?weyJZcD6;+!`wx+hb+x&RA)(J66u`iIwvEV#WSo zto~!(x+W)LrN*gP>3v$)^H!{UzY{Bc?&>w~Q`HALZs$*cnO&?`=$YC&qKJy9r5iu&qf z3&+XbVsUaajl4?631qE6MJC1x44XtRX2l6~+D+T{#0jMCqo-%$1cJ}e94%zOLpAQk z2^=*Z|1VA;@FmUCg4Y{r^)^nx?-O+|6fdyHhk||M^|^iVaw?RZ!s7)78Sj(g1>#d^ zg%&!OpdBUS1^i1<>GJUc<0?>(O7Q~g+tQbI@dAT7P)7fFfeZgqu>tV{6^)Mr;{_52 z(<&|OHx`YG7kE2^VrIn)EH!p%!F4v-&W#tSIFI&f;gZpINxZ<~<@9nzyg=QR)KLqL z>&b0Xyg-A^bXE(GjL*B{1>Db5!wc~O=Zwc%=yQ$E-O$%5*IP793zLjX4|J@`^ATle zVbcft{xM$Q@(-F2lAyoFCdlG$dOwx%oXWgO5Sa3X zZhuV>nDv{UW=)jf?1>VWgPOV|3KVmr4EIF+TtuQQ4os9>L9{d~QD9jDy-7?I7?n)p znkEWdZAM#qB?|oPO>O%m3LG3q_7f5Xp3kGu1&IRljJ6x}?bW7@)OmZNK>9wKwLek7 z@c?;UN)%{ynXYSL=`DJFJ5gZuL+bf7QDEOQ3Vp8kS4ZAamJf*neU0fBNdosQX|8>e zK(k!5$|Xr4w<}%Fo20*1>W}l&C@mE9qSghI1XBHJXw4*n)3qq6c9MQSlq9KQ9IKNg z@VY5QHBS=w(1xy#OA^RCfyQWI&>}jqI7uLW2_-Gl>#M=b>4O$*H&DfmNdj57)7;xS zU$y0NlAM2%B$u9&=kp|i45Rf6otIkwlJ;mJ?iKy}I!WNIvFmM;fW6m4*KsIaYuZ8V)^v6C~po0TV&z>xBF9*HS!ql8} z$0=E$f-~iJNftP6WOqvz_}4hb<4E#!`+CUMCE7mY?q$pXug$t@*W;B_iRl}Hv? zY?LUKEHJt>{nSF1vQ({HvcMr@SOp!YI#ZF7E9p2@?aDO2O0qzXs&t}SvOtdNG(Zcp zYtW;b$pY1CQP~E`0uvgNG)fj&-it|7cJ!MMYVeC-W$V)>Ri>CVU#>v=c=}hqMxJn-m2{wnmR$xl)5vKUT7h05{;Uy zXGHxlI?YTL*glJTEJzk8x|oJ9(J`toMwX?zCu+$WI<{5c7gVufI&PJ` zi^lCu7Pz{PO72eCyexO z$pW*!ljDzMf&G&5m#t-rz#}`#?~x+V!jrCQA%8w>ion*v^lM0pfWuG<*TPN1Yj}!4h%rhF7e`R>ktqU|j1gMrQB-Giioi+Z znihh`=$efs_wgwLKE`A%$OKB#!WiT7#1w(FNmNA(btcn-DJcRur&2yGyfNlXOA&Z$ z*v`=R2W35z%Fjv>*lnE9{$I`X77|qyg>n4rf)AnuQ9(iFM5UQQNc0e#wUcNh3^K9Q zZWLu%VG=?YB~ZvNf)qteLrV5ilxSc@lb3L0f}n?}U}n5zW|U|-X--ULLTkCU2Y&n? z_Spya;%rfVM|IZn+*x{^GF*{!S9$9li2VDikSm@xsmaFgAT;0km}=3gjHM@pM_oN;dgrZ-m&W+RjAK_$o!;ox#C~H+A_fN zWKS&b2%m%XM^yGto-^Ce4v+F|$9T@a)ZjSZ5tbKKi8226AO5ec4K70Y3c{uomFgyl z)0yfsSHx$jo!be*Z>8-Zh|+BJg)83Xs71L1aml*L6}xt;+B||t$X8_r1mWMKDh?9F zz*)kY^8~L|?IFCoO~~-7qu-ZUGlGT9}15uD_P`}ooEM2(@4MfpV z73PY*VuMvB2DdEtMT43ugDLC1$6&G7;HuTwZXlvBRd0uZ_z+Y}!UiJQa(5Ysnr=14 z74bbPZOA~B4yy{T*!V+T7%>ndR^q6E$Q@GwuAp&M6*Ukyth(O@;#y4Aaz!{J(X+MW zZ*&%bqR#Kdoav|1<%=Y2^DRBJvab9AEb7nT!{s%a! BQ566H literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/fb2abdf29f069dcc_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/fb2abdf29f069dcc_0 new file mode 100644 index 0000000000000000000000000000000000000000..ac74842527adc55a83ac2c64133e8e71a4ce30c8 GIT binary patch literal 19084 zcmY-1cX-p~7x(dZo1{s~Y-u_`R-vUyvqxvrvSi5KC@MoikR>7;7Xk{%-g_em0)hkC z$W-eXunL)q0sL0?wL@2{5Q4fujJvT_31!H`A-YI(gi zLcUtLwE{J()iNl?frO&d{}=0j|F+*~@PBWU^k07zT$Fy%uv=yr;j~y)#7&uEhCfQe zq0+E92tVh5B~Rn!WEgU5Lg|;Gb7NT91j;srHnL7?G=uJv+8jbsN8W9vx$^O=F#m1k z=?)!xz%41!8*Kd)tG{9mfb2o=?T7H_Bk1%obo&(641sE&LE>CFg*+RlcoX5fH4wiRoZrFP?_sMf_yO+8*&p@X23WFD zb#8`@vQP52fca-gmLqaOnr(+2JK(sC-3fE0FN!=T& z@g}U2F1KKST$BBG;hapn2TLX8KHPl(hKI08_DjJd_~Ef$d-CZM7%$OJ;hksDU;NLZ zx~!Fs(NXjjuOW)6@~sRsMlniWHbv1wcF9O{6f>oTC5n!6LM};uY!vk+rbrZt@`X&1 zVnw5DIMI|{a zH>7QfVwa7ghP;qs<)ZjlvQwj|Bhi&KM~2D-Ia4``J!w%)vqy2>5k;d+#g`wXyEBT) z-YAY_N0F2hMP2z)&PcgjJ(kHbwLrC0k7B?4A!BPq(XM6`$uCFoW-YB#{B@!@B#Ey? zF-$twi(+N{D9Sd7Vs}H;*;qZ05wg9x*4Z+O{xb8;DE@4#`rAkGVF&eFE{gr_D5lGI zouYX5P83}`M{%x86lq-*tGjwXDT;}cqcBX-I_E@jdaml77ez~Xe|{7{Eztc%QEc5C zg?WDz{r=}v6q`>+;r>ngC;NVnqSU!4K9g>yXx7F=Q^_2SS1wBJqS1^g7R|rXJ29H| zNzt@QiRNwjv~)DzmW}4AjII#Pcd5~Qksi&#D$x{XL{neR$O&gO)!orFl2mUrfBT{t z?~kTq&1imqIhxOEMe{@o>qN6sO1u)yhqAq1H2(V0JZ}V1Xp08EBKP7?SEU5Re=4 zLVEfQ{17mZ9yIWFmVrLv$u>|Z-^$}01D$gX{1i6us|<}8m?SX;1{xF^*d&Xp8Tej$ zRyXjm+>xA`2A0aFwN;1IuVdhKIUu%I49u%%phj~8&82t?ty#v&$(9DTv^HREYoN3o zlS|UFoq^fy)w>Rw(?vadSMlX$R|9*xDMk+iNqw~LkM;NyJsx7@xQCLVmPPTAfJ#HEJ?zVwScMRN<+}LP5nmJ1dTM$Hu6F`<`_xNHIgAyNLC{wv*bc!Be$e&6C*{NDsD3)+vI@MX=$W|T$d;EUMnL5Uo*0{jc#8zlJbU; z9TMBt$N>4EospkA7`fL``QK4(opmeS-ZgSqoL!B)-_1y)_l#_k_j(!mL~co_w~lPAtv1r+TO+@$F=AV5q|JA#`FkTR zf6#Ms>qjH&HyA0k(a0`2Aun$-GHSDtr;@%)>yvf6ja1oVBq&+GsLo$ir#zOw_ZsPS z$jI-Kdc=tJqLEWl=dzJ8SB$)JUHf;>$VIU~F!H@bJv37Lk&&8DjO>x(&y0L1um5M{ zuH;0SC~h(FK{1nFS0+x$U(%|CiPs6M@AhewC76nfOA!`N2fy zk0ypm_Bs=@r2S7Ox~w;`YJ-V#8#PB3ZPNU0CcggJ#A9i>!^8slYo{LXGV$ha6Kmzk z9uu8^(Yp7mz5`m*K|L>~BPKe?(xWDlj+ux#ZQ?bV_nV0lXVjZ>8vloh#UDwJeuAc`>xhk0HJwhGDX|FowLUG5D&-5K|+D`ZZ&CRf@kH!)Q5LD~9T| zV~A>~*pk;MhLcTV=-M=fZ=1z1xkU^Mq(N)Vdo_lhuf?#eO$@KKiy_cHhGX)l4DJxa zU*di{hVva`NP8y+YnK?F4^;fYiY23mD&H_Y9v;J`&tq_mh+(?4m=(j!*)hb0v^pJI5rJ_hrK7`~S78`X=g>dVhD43)2U#c+Ff3~l#l{d;3*vQNE`Smm+4pFENu{V5YYGAkPcUbggP8QrFBhIroa02KCHbY-na% zBQsSSo7pKvnwr_&%FHnt`l^}AZOr&&iNwEdru7?oUUs!NQ?Y}YciuAdX(uz6C9|_? zl-M3-LOsn4de6+B56m>~qaO4%W9nz7w0zy)jB}Kk_rEmrr#zIn(PnN;FtcTnnSEa= z*D}SGDYEx#Gaqc!dZlo)nJPQY{BzMv?@MNWx@;!niq<8c$?R)pn*XCZu4@l(m?i+<0vuuaUREY!AHm?)lVHcQ(FtIWllQ_#oAl=rjv!JcT{g@ z3qQyQ?_1a^F&|jyBLn(aXw}z3Y(IPWD8H;7ZlT5J7A#*_NS4oK z{|F1=krtXrH;JCC+GNrc3%90P$e*V5Pgk8%Yo>*T^7ky&Hrs-Ku7!_e$2<$R1s2-N zR|_pXT4bT)VhhWcsFtrRcx37d3ooy=uui&uXJL?B6Ymce=E`?6ev^g%+fc;JZ3zh)szR{mq5%ni+xjW;bsZfg(jXix51I3O40Unz3WLiz&>i>1sX3rpmaCl*dT z)ob9H>VK|%{ZBct(j&^sAo)$Qqpf^surg9^NmrwlZ%tM@S*$E9VZ~a~N~1U{o8_q7 zlxK1(-bz*}D}xiPjF6-9sm;pnL@SMxtz3P{N}#Nj0p+axB`3>UsZ_yAmx`JzpQI|k zRH$ratjv=0@@ksuOSh6-#mZxqKtiBa@11ldi zwCekjmG+ITY?SDxs=JlOzG~%=B(||~y}k0iYvqho>}F-0Z0>Hw-or}Io>tCDS})b` zftBadxQ|ued#w82V`ZxZ`&$_}z{=lJWuTRzQeu#mT)8PxgRLY;*2h+A$QqgasgZ~kiK*j_88 z_iGPjjvPIpKAfhQ1S}gW9v3wx@MR9y6*Ve@m`YDd1>*F}MA&$};<0!T%j_*Y; zVy?@vt#Op!7RSt=;~2F)j;TB17_mE!A$#K3FS)PJ0+-_$@OK<5uf_31e)%Vk;y2=WRT6K;(f4i~+oaX~ zI6iuydLPBHN4h?aV}c=`v$8Zco*_lz*)R2q#xt*2Jpahq;_>>~5Kjl$9v4r)gm``y zOPP2k_KWA7eEyA&f3M>bw?3ZrV%nhRr0MQ>X3NS$ihoA&W%Xb2G`k+p92s(3^X|n{ z?0!7AU&J$|SSkLLvQRKrV+$_b=XQenO-~U^R75|muk-S9$o1+u38WQ-&n83fL z1X{-=uu#nA1lr3ADP>6@E;fPJr9=shk58bv474TCE;)haVlSP*;4%qhR!E?)oJ>!k ziz9*Wq<&@sd;JL{1`@cFn?N`(fy?;`94|=V;}!}0DrMhHU_*xlV%|#Nv@GhJz%6;B zPXbl?CQz(j0^R`$43a-&(LlxeNU=UnVALlGL=Vwe`R20(dJRorqf8l=K*kpd^p=8& z3A{EXfyGjNY6AJw6BsVdXC!ccb^?WS5*RZ#0n_{h8cUZ2TEp@LQdel*KPE6?QvzqD z+?E7d?MTq?GFs2B1orPvpwBM}wA`P-d^vU?f#2>YkoF*f~< zLW7OYCL3!d%WR{+#m07VTWvfjZlh`m8{dv?jZ}!Y>HVsWK9ZMUW4O)6VR1RM5B#8#gm;dVgvo-({n;$3_vqjUib!_RH{W8{g#Fcr2UpZ8VP9Xj|RJ z*Rr*S=DuQMUp*U1^=-T_Z5rD2`-YA6jr6#Q=E&-%HvVjB!`aG4z1FJlO&eWhW)B;+ zdfFH-&EK<;(%Z({vZ;@a3j=Mq2H9x$k&PCg*qA4=pV~P6nT^UrZLE@+BWzreKS$a0 zL5^a}k%=}&&9iYrx-7CW;42%OzqVmrZll8r8|EKuG?m^zD%X0&5z9s!Q#LD(G}vO} z$E`M^w<+JxHr|wF@~2$dVZ*c2#|E({NHR`m&#{s{C>ek zm5b`zCH3~EjgB(omW{jjZB%+@qn{yBr^pg{DxqSDd?MczPh?S2BDdtrlth-il*k>i zmrdkwTB3f}NaRwLL@b^}n#p#5B4YxHoR(3+M5<&Z^1h7EPNZs{j!BJhBC87$c_t64 zCepMiDA8Zvon!myAmnCFOhQl6X_z?Wy(R#lRC$>){BX3lKR&YNxhv&cUkc$ zk&Vw1F+We#`=}(|G9w1}68Ggze-eX(Nji^{#98?*oWy|YN$im2HIsN) zN8{@zL6an2v`Esqz9gQvNup=RB-YEe&PlZCp2QNF`=09Ql|&O6A+7qV7I}L>5~l|x zQF(9@tEBy>s#QY66l+8hwMQml7?VU`d=ekYWf?vr0+qE zJFKK*%|dqZkElgitEBjn zX%|Xnx5Q^9GehcUCv!o%=O)uPKbdV(Kdjqo$rP=gOl*y0D%Mk+#>r$iN!IzYWL~sN zrcUc*hQF4~@pqD`&^Z}nk7TmmPv%qkxVMh=Nv5kjly~|jvqq}-OD4L1GWVs-CyM!* zVh&B_@$h82j7a7?DIBTzV-$a^j*m}f-;`vMrfTjC-Ofp-gFK&`%+7hql$@W;OAGW^ zYA;Nt*`j2&S4p9GMhad}3eECUm?JxDq+qU@LRE3UoWcOvRx5?QwNpr}lR^(^&?JRv zvaD$e3C&ZOFTYEb7Abr$`K?nJE>+s3@YCBV7(1p=vP%jrx}`8rs&!Z19*Wm9MQc<% zIq^vf4@N5Qs1)KSrf_p+3c0g%d~OP7mZp%tEQODkr||A~${~(*DfId|g^f~bZwd?c zrEo)P9?&r{A5<<$I+Q{OnIT`EOyQ)wbU|}3X`HOOn!?tvQ7&x&=p5_L~kVvOXYcPlem zQu|fbx&F#L6@UNA{2^^eRpx8yv7s{8wpS*!qcYo1RHpQ^%1kAV3lc1uMuUVjrb$kP zH2z6VBdbyxuF7dTccI5J(3wWWlg2i08qa)b)bgjXQ04~HxF!ceX{^rCbFwfmjaR~Y zT%gAiC`_YA)ig4zrRnEWn!X0o7*H#XJ9X2zS1*mt4V9-!8oQdMQQ_4zy2{!%X;gnB zO`n&g(Yiw#&R%Ks6W1U;|6v+G$m-A1xG_pKf0@R=6Vmu>s_Kwh(=~Ty8l$DxtTg)1 zNn^Ws=B80>x#CIpZ_`+?S@Y$cooSTYmqr)y?oXrM$uy=&pWo9+JDuamAR9&y-Hd*mRsl(&;BHOQzF3E}eC}loX%jWTsoa$vZG8oC0C!ML17*w3x zbUb(_LCI+%{}P&&PjrBnMvIuqp4>2#X?ks2tmQH3&ntI+6w7F1z|^xj#8 z8Yimgx|%9Hzg&g;SF2F?R~1IytfKSxIwq^{SHWP-prQO7mqC6?2E%1Zr3}pe41KPb z!KY0#xYjX)P^SzUy_><(k21I?uEiR+B7-|JV{-<_cV@+KHCp}Ha((Rm;%62>ZB_Y$!Q0d^aWAocdlgaXXz)t<3omK^QI!kJy z9ltD+f2!JPQ_apFb?y3kw6pvbI~&AR&&~(+?Oc)z&FtKhZ<^cLB%T&_`nI%lMeek- z6W!j^mP->J^;)#r6~X8vTS$a>x1r2Ct7e~adAw`191r_oM3 zTcpT7_4RcZ>j&c z?c~YH2X>x3wG;bHJ&|Kl>$#oLFSNJPEXu)*Xa}(d2VcfII9kL(jiL@#lyLBRNe2t# z9QwS%p=+NU9G8RT93)n7FkB|2Iyha)LEXv@X4*AJIyoHlmA}N}ba2z>ASu_un|Th( zR&{XpWe1gOJD4Ot)OGOU6$jnxIrzSzgLaJ^eAQUvn>d)=)WM}@4qemWpo^@R?_YKB z{51#N+BmrUx`VNAI5_d9gZAwlwC?I)ZZ`)dx;r@B%RzE)2Vcm_{tmXtfB_ChNX8%s zS3hy^Sk`>%;AaUAaWLpJ2mi=pd3%_HieEVRRZdCE5e`a@RQ>Xky!)kkGFt19b8=JK zjZy7mRr@#xX);{inWFqt9n_od;L0oqt~rW1S2343D8E$o%e!Bz*5wY`u264f!72xT zuXeEX2M43qJ2Lt}ADVH_oii1OPSsGt=(B_W%DCu_{WXV#wbx(ENckqFnf1-W-*TLsf?LP-iWV^&h zWin94%F~!k78l9n2YIh(CZEV%$t|AAGTAKlgiOvPXL4PZq-d=4E1yaE%9(iOnmm4|&!ke7OmbwQGm~F(GWks=7BR`YNL?<+0!zUV{c?qrfnvpWXM~YOq2$1>v=gSiJdYTE;A*jTPE*+kjZBf>7#M7MPmA8 z(pN^w!@-%{7?DYER3=Bi%;b{H8J)>W={YfzjOn_ak;!@KGfT0h>g-G!%gDmeMNqLb38PA*q+;!JZgOH!&hX_w*TkZg50F*}`1a5>2cIq8|@#GdWs zy&R`LmvnMF&q;RJ$yZXg(8=3Xo%E6$60GjzUTr7EUvbi+o|B#On>>{Fn>zWanPN3} zQXm!EsNQZ`M|UUt<$~1h>E!TdPLhW?Nt4RMopk-&$r%Zaa58wLlM!-HzWmb3Y-u&x z$vbjdDvWiqe4LXylbp<-;$)3wQB)D)Tx|l5$OS|Y?#>Kxcxp=vpi$mpI`fSI= zi8L3r(p{uwxaekg@w@DGxQKVU7$UbkF0yvyp&;=)qsqQAVTDAbf8E8? zwl1o**V;O`81#;d?VVlN-*f4jCKprRcX6(_^ikdYTuhd)rC@-IWHOM`fgm*i4zGGvDQnc$|0&CR4lH)oRE z)Jt~bDdVQ^OKz@6_wsJOtDrHdZn{-*vo^y`CA*snnQq>3x^)e%o5Y%K-gw!~etBBk zt@B=PzLk{?+&pOLreh;FW1F}+(bP??W^NX~?&jJXZVYYRywc81EBUm&Ti4CH$$3k4 z%F!;$Jy5v^xpn@_t)KgD3WvE_CEGuD6Fb7qK$$Sg&FL@Q)E(_++E_Q|$El|A$~Q?l zCcAkgv!}SZG}X-=`EQzfGF{`O-3&KprSVKRd!^&m$IweyuDie`ayg4qnnwsRBEkr z^K6rwC!4iLTivXdO;Tl>dbeG1cet4>MRvMry35ValC(#A_lx#l=I?j&*8w-J52}BM z-HbotChDl0QperAcEZiCQtgzR8xs7@%_153yPLyjb^M&0A?Mxv@`sz(|8&zu9!U72 zn-y~Hx*Ok3<&fOFZa%r^=C-_$s`u3=`QU+@4G*QPRY=&9`<(gkl)=yiJl%>zUN_= zoRQRC9vp)`^!m`lpYr}t4`qgV=rG*F5&3q6hfX6sd^1Y1$9V9K^Dtl9Px7#IvTB~< z;p{XIm1lUEB>&A+&9k*;nKoB-&QqQ9b$_`B%L4&5zY%srFQLN_o6= zit=(oHW|DaOPuu zm%Qw)>?JF< zUS3jrtKL3d93Ls($6lU);$`em%^Bv^&j{rmspr4cdgPxmUi{;{ED+NKFO4R7IXT74 z*{NPCPxmrO&du};-$t{$|*ILd08t( zS9@vpt@6s>YrS~C_cBk0{p7{9Ui+}Y%O#n-*~{-+v?trVxPS4|=T|SmL)wRq@gkCpRZ zFMHyB)T!uWY^sm{WP6&A*eX5-N@|9WRSq8yGktvO@{!^5={kBJ=jCypkHWB?m(~#< za|?WwDD+{d?&EuTUc<-dFZ-xm&qvq#KF-MAMn2-3_!uIGoBBv@?qgvKA8p$DSkTT# z`%XTboqa^)k(j&q7$95U^|7>@^1rYAy_H|~_VMvSUmwGyu%C}cvP~=leDs$!gM2(0 z?4!$vs`X>d`_#u^88XzzFT;E^|J=u43w?MNt9A)|r8O`0Vfxxf+ciFxto4!josV8W z_*nO&j~YMuXu8SA^vyo3TYQ|{=A+zpA7f$n6|c9Sri1)UAMB^{M_Tune%>7I=YV`T(a(-anmgIg zZ&GoppYihBG~J)!XT?lEWtJ<)3e8=m-fZ;q$tJ(f^(f~KKeu=K8MNEa7r*#9_^W!c z*Uvr4+pqkxMIIjT)AOL8f6u7i-~Gg&)0$=PpMC~j@U!irAKxYAysVs8m0uSB<>&g} zeqO)kr}aO6-n;4N$6J1?-1c+oj-T@P6#u?@_*gxB;-}?PKlPsZnebfwdf{ivzkbgC zr@bb?7Gr>zm;mF=0g4w1(4uI7KZ*rNjtkH>KEOe#l@MUGEx-#Ikrd!ia)7ES0cMvC z(5GC0cghD?Ss_5ViUFQU^-2Mv>;a6l|Fg99Xf7@*Oo0j3PmTD}M{^veKyM+e9s6JYyT)iOT7K>2oBfXCAVbe^Gg z%nER6c7Wz{w9a_}j?E8Hb3uU8ivqM?9N@5Ak?19=@2dcnmIat7OQqB*t>IU#VQ+xb zQg?rVaR&l$Fu;dL0yI7vpzE;!J^#_Xn*qAr3Q%}Ez-xB`#61eo`f-3g^3zk*9TjA^ zAxLpkkdI`d{4Nh-g2b4EY?VV&-4bMkHAtV5LB1&$Zo0jRyJr)gT963-apgLC&-dlG;AV1gZH}kWp_3b*?4I(tbg1^$+q~ zMhyruOIi*L(n(H9`N2WH{!lrG1nK{o)+9BC2KBpFkeyO=c#x@|2eFI_(&)<|Tjb%G zAdzuew``mc)Ze!SF-!`wN%l+OJ-JDs^_K!Nst3_P8v^F%o#z-CZ%|h_qfALEzo;B?L{ctmP4e!QAm3gM68<~Lj(b6hJP493U&_&kLEe0<{+mN=w1jY4Lp&=P zqI!IYMzTd>5<--crE<#_qHSUbS4xNvN{0wk2w|-hqH*OATjgJAlNREt#HEMWC8y=O zlyHQ2NxDg0XNYmG5VNI+JH+>%5NX~JRdV$>FNCj}a#at}x<-h5wL%PQ5YlzTA;OJ9 zc$$Xj+bl$v*1DAnZ-%J)mU6tUdOC%8w|j_wV(t+lLFUMES@)jm?j2&Mbm|i#tAB{R z0U_FtSDh0>6q_8P^OO+o=^x!A)*$9sIyRW<)JiN6ym&C7l+s^hvkx(mnoM_ zmzK-bs}-vM8}({sh=Hp@d@f7ZD973m#ven}TNh%3?2(HY;LF++B53~@{{H-#{5 z(Yj^dR;_!R;>byP>*o-orTX>|Eu^!I+7)7&71k`GN@r20OcqC9%HoZzEEZ*F zaVj^9%QCE47W{ff;=DP0DtGd8$cf~zRC?9SVcp9)WYo%`cD)?N)X$-B!yHz1&Ea7;jqj1e zh!1l(^id8~KhB|n-1{VlydgP!En8&4$Q*7?%ONx)hsCm9Y%_C+nXU12a@ZtCr0b#_ z7Jik(wWT?{wk(I961ysg#5Fm*u{MYOazP$!$RX)q4sRaH;ecF}fhTnTl;ZxD!!Vg3 zNB+nm<$~&yHFtA(axaIYPjmEjo6AXeF8SHHx-L1Fal`fa^IWEk&ZY6#T&9l8<)aC? z?3|cOXi_e(NGGX2C6^IXb9o|fFVAK9id@QklZ#h|$hFnE_}1hyUta9VrRJ}C?y%-v z(Y&j<)VYz%q=&hjd6dhH7r9(6nuoJ^9@!=G=#Y>{)xbRC$-wlR5F#^rH!P9E-gdCZZntMgd%Z63XT z%%j=nJZ5akBX(;Z6^`Wb&e1$h%HrShxPB&&<$vbU?{XfSuW0_&Ja*j9qsZMn2FcW@ ze9lGZGux8STcz^(Iw7CZwtRg(>9$-xBc)=6d^%Umr+P*{LtEzSePh0^g~_L}?0Pky z>mBk5yq(Y8F8LfElg~@z^7&FeU69Y7h56(x()cC$4Eai9BxZF!4Zh8%=#R>KCZF#v z=5z2;K1VL+lX5j*y;Q!x^I3H*pN*3JPd*=A&*!GBznM?e?R<*MN_lW6pN@C)dGaKm zs?QWx*2#a*^Xd6Q^+ks%W(@P8{AdpIuO&eZ_2` zm<_|UZWLy2<1i(fgxS+nx6Q+REHhh#xzJK`T7{|mMwoGLhM{ekRqet&Y#*jm2gU6a zrh4ZvYoyD&VODnyQ=wa!!d_v9zprspvVWLX1GIh_HdJ|sDev$w-;LD#QDM4%sa}m! zuf~V@TWU;DPbP+WD(_8Ke`kd0J5MneD&``^lp>46ELss}*Z10oAGHrMY@K5Nq}c1j zjM)_C_~tM#Zwd3tjxghQhKbr0X6W89d-sL8axlyz`SwtlZPM;Yn8wG|PbqUEOs4#L zGEAx8!n}4y_hrKGVNRb_FV2POa5GGAaoq|NkyY~Wwt8|$J(OmT!_0URCiZEVEkuZk zj&Q*op*u zp$vLI!q2@U9F!p+MEIqT)*(ImM)>f`UON#Q%c~P3%$pRUT{Zql)B5#HVrVfjw=cW;C$C$#R95zfhzQ_6Qb!WU5e0Zaf8&d3cAiqXt973Ah9ju@K6LcLLgv8_R z%Zfcd9z`=Xcjne~-|qhFe|-PGtp&;Og(TzYGV69h?B!>ZHy(iP_F!>_-xzX|{T%9S@f zT3vqq!&jc#b~=A{|KnG`=cj-3Lr2@I9kO%gey%eyG4mS zmxJq<&(72L{W4Z`m@T~T27b5;K6&mW+-o0m)BOA_ON*nc-0$3b^|3R!ng#gl(d?R+ z8%a6&WCwleZN|~xeG5D*IM3q13XUe%bH@dP_>X@6vCJrnU7FiZ{wpR=ZU#>2-pq{L zI4^EGuj|~rH|(4~`JY_BX*+dbIS*<_PY2)hAo`}aU$p|$xL-Z`OqB2xFms0bi7hj*8JW^C<=vedF(IZ)9 z!n->9X7t}6XGP#8LE@bmv3K?<`lj%jYjYJNDGckp#YwEZ$qrXIBs@vy__9$}#@oPHX_Xya8T)X7@+yD_f#*M+<*6IQ-1^BM^q)F!ILk__qZ*Jb)xtjTD^2LdM zdIS&siO%U?m_O5b@Cp4ExCT-{u-H`$<~lVpPX57n9(?)!i?84Ow#?a-aLi-~Zj8>YP3KbJxLVN+%w z(`z-v)s6SLN59vpj{f{oU>uDvIs5nBxfGU9UcL7pUxsXR^lvU1=SRq;z&`q>tMC)7 zqem_!#=UR6ngmvK|9x-Cz&D*dckHt-e&_v$nlbqdu|0Cyt4O!&D<40WMJcyeI zkI~@X%a5JG3kGiB9Q`=^x39Ko;(YNhjlaB{T88s~-Tc7OwX>u;H}C!YBUxaTRetpR zBRj{0)OGX?S3L;zd*5{34D!;qje8%xbh!MN?6Yrv&2^(Z^NqrP@_kpXTzdD7KNQ|_ z21ziEoy2qWPaXY|^;lBoX^}bBN8bJW$dzxDzIbCk@7$Ta=C@|Axtcq58vMoQf3I`I zccLeM@aW3TQRmKYcYf=)J6GWa&))EXc6Y zly>E6nODwnb>+&NJLw;N{<)96w$qoit2a*i>K|2?`sx>xFaGU6|KTgwJM;UmccfST z+w)E&s?g?dmsMPqn$JKf#1L9o=chW zzWl0bSkW8)^8U`*e?5E5c49Dc-b_CB4Og=?j*tHADXMeyBY*PmkN@=YgFkxbJx3pX z&(Y;9&Aun;yzZy2Jo$Sc{AWkkeaEn!yg2^d`(O9&<4achzHd2x>;e1S*q=i3`F4gP z5ah-a=M@xCu!s={@B3Hp`)nsYe$AEF@%LSYVq*N&uU&mQEYjm=?|Qb0z)tg{(Y0gZerLIJ$Z5R-uJ%u#zSwvuTxCk`OvLT9bc-^*ZtYm?#~@R zg0m!p6UO7O`{AocZ+_?v_djv-UGF)G%I4(e@ppg2|Mat$V(;FogMa_YD1dZ((nSV~ z)0TC*(PVk<=UlJHucc}-n6;~cV0pbg>F^pBZl-y3+_`%E4G&yBft>Wk-~V!O1kdIa zj)x$F8gr7%O+}AoEgqdRq`NhC7B}N28QJPx>VA95a^N@z6ug)KN)9f<3+O5nq@s|#=UeStWFiN7%avUL+<*nEcxq-j`{wQ zNd{B3jhDEe_cD5GyBWP+PNLS|o>IvS-Rjiouu)Jwk( z-S2W;U+d1?hTXBta|*L9vgbF-$$M|WwQGOn=r%uMPY3NTTf_@xldbzfx;_*7nS?vR z;M6wx-qc|xti_WgQ~%1*m!Cb_Z%4*R4x)0m9<<4>Jr_sKIhmCc5%uS0uSz-Io`>WT zU9d$D6$op#Gz!r(YfTuRiR9@h^k{^q3By}Ry)z}FHFdCv=$y~$@pgHZPm#em?+1OC zm`!C=T7~=;*=WQ>#vCKkRAS#}_gSk*Z9C3dTtKC0!0Jr-Mn@q65IMV!Oh+C zxI6Z?a{wWPFp0F>HMxaV8`XK#j{2k1C0&hrPI77^W3kneWxV6hC^MwR+TSM0zP1^a z(J{>#TWzslFXmgkJYBELB{i3%d~!zfjws^>JrHs2d{?Z*33{qXvCcY+9oH7v2tAXB z6V~1d#(LQI&&+|ZubgIFZN^PI=yQW~Iaai7VvwgBxFGMoadHUuwzzbiU}=`c$UD`g zw=Ny~#uF$Bu^RuK>NaR_kh=r4uAfif42GT2mbWZi_dqsU;mR!XRm<# zR{{A8i2pLwhBO5k{}f7cQW(~u$iD)-kN)qMdjNogBdkXaH@k}O^~RV#P`g&KZA4-^ z3s*@i5)Fe84A);Q7NgnNn~pFiHeG+t52#9Ls1dz6KtCI*mjJc-0(=25XHf)$Yz3Gb zpm6@^bI7al;mL#l{f$>QB}boHo&N`L6tY2;$HnL0(K#AFc0iGimdDT6FQdmtzwPLI zum3e%{B*bT;LXS2;U$2{ENR%Q$xdKn9)$=8S?*Aq|JIAQOm|L(DmO)^ z>TJ2zhiy1!s>mQo7ah&g9+@;$%sWmpVmWR+G6}a#V`DLFwsD(=boc0|RsibK+)?2# z09!e{gloiwbK~BB{)m22y`{hUc?YFUmnLnRwhaRCo{ho9G)S7jU6ZyP0>cb|crNNX z#L10&znu_XsmSsHyFB^cs|T2P>rI^(EBFAKyUCo*Y0n9JUWUXOwJ>a3rB7pbF=6u^ zE_Uf2DzV&tYe887H0`P!PcC+7%5W)S)7GH!>ssX;%j0>A-b(FczO?qmawhK?izo-l zIK-5h$SwQ?*tijl^*Cwa$^}3A(mg+b z(U@a87G@GSW0@5Avx(3Y$q*Dl+6=)Eta0@CRfodNTmRyo=U%$!#rM^wA$EnOK~|>} zv$jRulxrt-HR@dGoo*8BbhL2XQ(Qb(Up5XyW%_zw5qjL!RtBEN_LL>ZjWe_pTO3dZ zwnqjd)rnBeuBLr=>lW3zM{oB^KX+?+axl(+5Osg}mFqZykPJ)R%~Ei_e(9bL1C9vB zdZtZ0Kd3!&;I=M3S?vSC8Fo{(F?Y;pj4bv&Rhx{!Zj&7vE8D@4>08qsH6#Mc!r6LZ zoP7ADdu}@jVqh-n;5bPbU>C~(hjT23bWnnJ9F`*C(H4!l2KEVf_b-Qbmp)3b=R zS%Dhc+sT&PtrgkXEyR%awEfhR7j&cPzOo#q18S-`o`U$EVCeI$5F;laed(SLp*H1G z4o%n)Zzu#A3SL7S7K<3TZ5ys*S_I|T7VYx?`+Xg`{qlXchxt4)C-XJFU1~g=*Wz9v z{dvPq37YTE<4KjK+hIHllbQqDJR?i{oXwZzWHp^{02LY24Dp-A%5n#C89A|-8pOVu z_?u~WD;dq!t(WRNoGA;Yq>;Uao;>@~J=Z7(r!n~WcRRpeF3j>?c)>2_;>HH2=%uo8 zLw{Fuqg9UTMxdZubcXWSrkm&yH%IHaFW1u?E#^@W;V8}xU8|R#-1zW|58NgQhXLC% z7Em!3OIaw6yEcoV3~N!SX;3bS5{AiOHhS{9(`$!kYykWMwsFT4gz zkviBj;?Ui*;i@Oh>t;$7$Dev&{*~7nFLmg!lxbcyYYgP*Viaxd<;p5U=5*CO*QY5f(`pXwgZC2-BWskh%6EyZtBQPQiBw&>nW zjGK89$8AE(A!Fy0tm0OU=dC@C~DQBqH!Ma<@PQ4$c)BZ@{>-AWQpxH3Auo?6LN(a^W z!X5-p;|#@EECG!Xh8hq=He)*$f|0ai<6t5i;)Y})10U>R@pe}A;#HYs#&{kTUPiOK zI1c5W!i_@C$q=)`lTc+F?O>0%q@y{qM+kl;bp2YNuEcFuU&MO8+f$RhjWdHV^krg& zSKXb)GCij|Eyo=1H|n13t!F3tOZPkiKo-HimXko-ypm*Z8Fi(TIy^`>jYS1ku)f!7txZY59GgZ%jWPd@mC$8SSWV6^Q*y{1fy zq#OsM4AcOsmmvwLg|tbr42jVwP1y&lBwDj7yUR_})8~pZ&ohY^gHi1(B;hEeBKiy9 ze&jQn)-F=4BS1H`iXt9K(w~$>+l~Z0+je(3=)2<;K`IsTf6*=AE)kI&3q9H7$ z)pTNnG?&kdpjZsaVcMVX1_G;n^p79DO#^9-69iOT+GSmXMI8#UF&1M?11NEdp-hKx z2-E}y{9p^{&hgMHC~bH?T+QkrKC`FU>8f#Xc39dLVhOZBD`cfbgM){x1Ckx^D_U_T z?Id4RG_m9-eTm!qj6+0iEGwQaVO>=txPH^`mVzro6PFKMKw%@rWiCAAz^T*pov*z1 zZb$o-*S_K*&$Ruun)MgxY+|wH(oK3CF>sQkulG%Kv&-pxhX^yq;l|sXl~P`r7ns`) zly0=ybf@F~{N%%sEKQ)PSrfM~(sFGIp-C3U42Q)i6h|PxIy7sbE;Rl&P9BURQ!>t`>nxCck>Q7|B8bglBzwcH#i|w z>{Ozt@qjM|AzcO|dq7Jgwr;1U-X6s7uyAky)!qMp<{Y z45o;h1O?@14c3b;Dh*1a2t(fao4(K&LkAHziQo@ioauRL_5A1Fe4Di_7l5n95DpG`1b~@|87_*! z49F!c5}^&lM4?x*Y~&(?oN*125gBQskz;E04o}6_-;c~K#;wKBvMX1t3zBPq*awsJ z5VJs%{+M&OSa*l4+1&~qTP0EF%?u#IszNnA={r>-xGb}N5HT!l z+i5yV)i%_!QO*(Y$xRl|tC}qKbje$-Gf`)}6U;%D-Sg;gLqX%n{>|*8* zVw6ZymGFA!47OUIt@8!RjRFQ;D|PAi@r;{DoP4mxGMvusK-UFc&?e&@8mQG)no2Z| zHqgdS{E+}>{bOP!p^;eMqQP&iLE09i4bfEMSo-+H&B{p`2CVv}3= zB-_%G>;z1IO+@BmH)FxQVKBl=f(SOoC7qYGU=WneUf%;HnPRD?u)-o(ZDuO={AZrN zO_1;#K?%emahEj-i?yN0F;L)Q0i_}+bkR16Qzk}T;E;yYhv4dE)7|!WzB3dTGjiT0 zbP`z+xgdAEdfmu1 zIa=&$H{7MNC=}d^N5-Un;UB+&-?_`t{s#VvEuQI`8+U>SR7`C~(ri-=oyPALp*d_s zh0U;d&b9FQD!fKl(?oX(b-ScAeq>^5v6bXybm1Qq7{aw|)}{f+15!0z)&`SUFfDa0 zfMtM17~FJ7%%TqdA)T%fXKX5ct%SPa4r)sxtt~a~;fl;w$dJ-V-&rez)7U%s2frUE zC7Ov*Hx26`&E}-J+t!3NZ>ohp63j~35JPXJWQOEWqUcWgLvCLbO_X3$yW+xwe_VwE zh}^Bb!1?F?ro!BE(3CCZZRhQP9J z`Enq761Oso?(_-X+fF$f!4V9J0HvJ4D+0SrQ)apwkm zx?Ho|&XiBBffHl#W`zwRTE=!u~!GP>E8eF1OI19O#UXCcQK zxHngBQ%j5-h%ve9%Y-p$ehuHRn4t<<>BY{dE)LYBb3Hx*bHVZhme`U zOmo<^ON~znVcuJe+krlyHhzet{b+6XS4QAA!*u4a)k#{{ZSC~j{!T*H88oI~nv0MD zXGq{<}) zxf6IXPV8w(sEd(@)x&k;?=!V0oQ-y*GhC~DDK3^5RmLaAeN?xNX_Gqmco-+tcINGP zMND>^YPyLA$Sn8KDrH2$Ku{i^(>a0m$z3a2j;@cWMTjk`gfXL}*h}uXfx12JPY!VP*0Qp?RIl#Eh1zwh zG0UX(bh%DlW80?4sO%1~h2{}Z;ipuPk5^&f`RcaHoM_iyi$ZLE<+WE?ltu1*;qkj2 z&wb(XuR2M>d4w{VJG}u)4^)&k#tha~Li80FH4I6NQ7e`!HK)o{(ZwbuP|P zT~5)=l!uh7N0fy1#d+N0=ego6X4T|G|MGp;X_RE44gDIRr2ZRF@(h>kXEQqxw#a~A z`+M8q(3N1I+ImFsYiEy6NP3t6IYsyCx!uyv1e02Jj4L*~9sm=$JXob9pxQXl{3C?x zFbIM$kZEn!uvvg>n0fqbTTQ$DvWq*`!je#{w~X1=Z@uIH{PBPIap6NQK_DjO;*#0N)^~W(0 zuSmAZxiG=Ay}n|XQp_E&{38flf1Eh}KOeSXrUlUg!)+2r8NlVEDeZl>;onJWFO%w`;d%38+!+ zp(<7_#Raz*8*5~VdnlewOC0RFGucU_iG@t~!rD;R+|*JE><~APfLN0yh&vw_?sl{v z7rvTI_@%I!ZIzuAE?v^=p+-?}+r>a&qLKvK%Hf7AyYhiMi-QK*C&U&Nt}$oIl3MLY zV|9CxOdviGD8Dp@LRu$Hld&x5hz$%%4FfiTlZN9!$45ByCtx%YXudYJWsn`&bJm%v z%V<;VZMMs1XPE8R&6uA~k;Fcq^$(=;t<kurd1V&rcs=2!f>WyV(QIzse-Hq=;s-T3gSe0Ec1c zeuVC0(jM;6G2Nf(c7|+sWh;Zqra#%OWO^BdoHEphp(fZsyYk2Hj6Mhq8U<5)0|h(} z6s(H^e+Uf?jUhB`AeaqZ4~eok>5@RdUQhxSk!NFp3sgRm$Jo4t2E4m*qBPp?@%YRW zRAojtGpp~)7YrJ=$Yz2r57F&hN9KO0sc5KgdQ;oNwRVJ-I=RHk039u@9ZxXZ$pjyQ z-v|9gNhP_JKl?N9x&}f6oVXh(f%C7%C4?;&Lqr@-ETb_tgG`MRVkEV?q)4kpq?*Xc z6#64&G&Y$blanjg6xGJH>Uk-%gPd6%0_PF{)L(MnY8fCyrg76ojW7P&u|u#XjMo7U zxVVKFCgGseL;s-s1@MwywZqm6j%*e%*J;XixXmZ$UNQ2C%$Y>^JmlLbau!_)iVTEK zx}3{g8snv{*tC}k6=|t`_+Ng!>}{)Jyh{y+akX)mZ#N?XFRHPySs+7m+vSQvlC6`? zm+!j@q7CY6n*=m%FORSsq3E$R$@_ViYIn$r2z%JtFQY~1n(LiVZ^SBX8hn%{J{B0p zzPF*Vo-ztCp$?riQVxN06@|}!{E4^!085ZC@U;+xpm7_xc!r`8oCeYbN)2ha27;TP zfQc8;XGE@AoiRqTXcI+?oHEZ*QS019W%VAx5M+qyBnoh_3e2iqnA*XIP5#62bVW62={T@dm zJ}U+mwq75sa{Rm9YY62S*zx~%-&+`)!dS|*q59sZGAIG46*y>{0iumTUI3zL+|%U> zPgj_Uthz-Igag*x^O&Im2)EAE(^l5qa8Fv$`W)QEVLW!KV6&AI5d{bbB%km%O6c^2 zcuTBlV!8{p<+5JR5N5^~g2qL{umPAe9CSkq9pxwbS6+J=NY3N`YO8SMj#Q^|^p!#sCMe@!em;U?sk`~5mG#$)q&m?P50Uyk85aTFAnm<Fn3nEo(&K+4H`y(IXDqfqaMThqj@%1 z44nPA9L?FH4O5p6B&%OC>NBg-q zzmiLC1x6z%Mb(?ZP$Ec-WZ_msQ-!I}FG+Jh;Q`hHH>3y?VV1!Zt2ge3iOY{FCyvBb z=s*7hyS>Rm0d@@&1Hu*bBQOUCPQW1%(y)MIBaVOn+3TofGY&=^X}|EL*WY$@YsOj2 z=@4{yr#%DB*lIL9CANB?OvFG*im3LxYk$k}7i~^Hn@{*I&b!PYc0nD9@0a{m!^GKk zSLkz}GYC3#oo+f>1y*CO!m(2`LavD>^f~)kZ+S9@xPf;=fspae-PI)RtLDGbW*v4% zf!d2g&CflF4yI!=t6MWs=En0NE++^~E zqhZtv-m?p^4Bl&=&nRU;^|;*96?{E&Y;kz+@2C`saTVz!f6bJ7EabX&)?<+1Wc6VnRl>b^?qgCQlKo|g#> zguou&EVlIsqXSvn&ApY>4T^|i^0*Pu_1=|>vC(c}T%UAdNef}ea}0%UqML+`67E{8 z)_+dD#F7vBKL*;GpLy5aj`nBX_0_b?2c>tCnwt&gC^AIc;MiHh9Ga3gsP=tl)9&oKBpf$&U;U~1f zH0e-~1y64L6UZi(waLckqj=pTk=Y~!8u?W1R#MvIA%A#r=$zZdMj6hO>48|gHTK9J zXUsONEK%0nk%v{kHzM|iuHmkpZg77x?$txAh&Q{0*EgFgnA=M=4{T;b?|X|Jg2n#v zyB*KjKmLj>o*4-@&Jnqf6%^mTvM>#x=`1aG)8$tMHD=~7{)XoVp5 zM9i_{QN;N8#rOvL8<6*~pb90xH82!7HRySPS44n5qA11%+(rO9i;@>)Ng(30L}~01 z%uhF5yoNfk>2Hv2F0$P+%@AgEx;DHT)mM;0WTW>d_ATe#YlO<5^BWoCQmC9Vt39TRTT*%@rR!(OJO!8Ko1>p>EX*5C~ z|KwSWkRY~VOczSB8)7uF?Q?;f!{;hBQ4%jIm$R(02 zP$uy}CeM`t%;$uQ+}fM$XP7dcD_u#FB}uCU-wSslMsi+T#+!WB7KoA2KJ5J5A%DwlY9c0`g7(^C00w@#FvH zTi*&|0S8(@%rcnc^Pl+zNILVg)j&^A?RAr%NyWTnv2;{dAQ)II&1yeaVeGI&y{$2U z3=J496y;*5Ypyj{*8?rrLWu>nGzi#RB&7quil}c|n_@v0dt$#v(SZu{t-_iyQJwj= z-aYBQbkAFW(;`sd2MGM@D>u(@I|*%+k(K9=OlF`(1{GFe}w$vu(@{-?_njb8f zu{D9QZbQTN>~J8)8!>6=ynhisAY#T)pd@GXnYWa5wQVy=oFo-BoQ~s=QqRZhi|}c3lTWuM%Le#hx0VTW zIWlTvAnm)uVWsc3V%qoYos#+`o4{}n=Oat2*+Sa^RATk`p+9;4=4YNZUU~#B)ImY< znWyh|w4ZtUt7%2TccjmflR4~h6be?*8=;ifbg&&-&JNGjMrLSHN8&k52a;AE1L2HU zGz;K;8!NTaI|R^&Kr4V!2xiidS`lb;SSU77e}EXkFpM++$ho))k|gWXfbN%~}+cIZnC=dLqfs zN<#5GUY+!Xa2sv|I`6Xiet;pGzO$I2X>ek9I-UFm?!0sjhgl@{HHLn#7TV0@o;p#f zk%w}q2g(L+PY6NJ&CF6{unFjWYB>vFv|EE}Qgk@kA9K29X>wG5IZ7Zbp)jKiZr5JCj=a~>H~t|AWIkQtVy#eZMS0~O{X%VR}*{A zMYyP#imD-995bnc8q4Vh3trYmV~d|PUb;pC&?fHOUf%6^?)I{yyv!BcqPy!9o!jP0 zni)X}8g*C%aM9j$Ld!{@jlJct$M|R&_0w@&FB4CS!X&a?8N@BIFOOhG{21`^28kQ? z@r{3S{3Ggj0?z}Z44h#>5^dlB^a;}e=RxgH|IE8?7r~k8A!_M}4yH=kIK~7N~ck_!&yP7 zy_UeYEG^Po!XHS~emtK1!5blZCQ>c(5+ZuN@kKJt0(5Lt= z*@rxWMOJ78b)K=M4|C~mzQU=3?20i?Z`|iU*8Aea9n83MTu0YY)C5hZb^MVjtPz^j z@$G4cIR2~ezIGUpTF1Zn{fAUr${9!&*E?^K`p8>-jEx0Ew3 z)e9DuTQ9k;YVXqFAQW1oD9d1(&&);LPjU>ThMrC=dg@SbD1Dz6Efe!vG!^C^Q*6Yt zp7al;=MjovU|9S0rP*78pqD)w1+QOCTD)E$BdE|y*4QOg$pc`{f%PTZJR}CzkYCdX zS5T#8srE_=kpVG${_mxiZ38`iE_w@zlP2t#GlX&c7Z1!V04b;e9kL4v7PWzG0-e?i zUwZwAnAs^kDhKYVy8;E$q$WpUMAf>v4(ro!ihJS$9Vzp9BfQ~rZ~m^Do+tw*rPjm! zg4&=umsoC!#@y7XaDQ5q$A9np{3w*ln4Sf6u>#Vu7%M?5irH`{P~o#*di~ce*V`*t z3mPFxv<767PV2C)tp$iRga+e>1D186)5KTXm|B4=$aUxsa}x%X1S78s2dncFkiLHi z*bo$fK_?3OMNs7d>&iG3=#NaqMxhm^2>U?NJDC0HpRjIw#?qMLM!Bl&xl}964y!Gy zSkTsdnU4C&bO{v7ei{qHjyb3)g1MiyG%ofwNMO^2HDN~jj8)mB51Vn6Mx~2+U1Hrt z>1Tl>rTft$aD>&I@vNQBdFkpP*1JXmOHSVTzW3biXut10e_d(5bCjq(nQ;m;idj(> zgK}2#J(1D1tzA)4P=RuDh^invM=D>&mK7RFkwqrN zz?iYwK+=(6wwnzm9=XbPtCbb3=wZCbOM3A94@b{{b2tD;;0_KHiUI3P9RK1wXHZ_i zw-CT5w!s({=;txkf+BOfzq9bXWFtpvS1VyUAGoMOX_%canp5+yb1^pf6*8e<2Qp6oR?)r#%jZud(zWVE4a?YiV@v7SR;#q#UL2#dvo ze_UmuxZJI|f%C8GZ*HOKLbG;-w5VcZKJqzi+#iqi39BqNU2O)Mg%KjHB9J-&M?k3q zjFgjsw{5JY5*8MRKmP}ByatN`FtK`{_Y4W09!Wxtb_|3Cfw+78?w>?35R{mf3Hk{T zdwv3dNIt<53yBrvblzrqg2&r1L~D8}YKYLd4qs0~k6(|ME9PR40yAc<1JKn4jNuG7 zl~gU%;dJWnQheYol1&3-S~m!L;NS9zgaNU=Wo&O3KG+E2do z6;O6-yxv>XvTBo6SW~vdr##WC$OWI{6K0_%2+rrw2QE`7&9yPn-{r6euw*LEH`$O! zkmrE_0?i2E4p6WH_ij53VVj_d!}5>C{}%PR^j`KVU~R~!54mtFA2Kk?a*HBHF_mC z5zzxUPd9?kWu-b<`${u~p?;cAx|lpW@I{y5t}4gb>Q46lyB%%z{;!%uR}FU8(>7C5 zcC*nk(-2tMM!K*ZV$IgcG$KuP2i>pI=d)1|$f2<#fy4+##Xyq%dH?zNzd%4WK^QpH z4F(2R$N&1ij(hxHogF3>AfP~j53nfb_`d6xF#~6J{ zgPm)({IpMvr!mUIRuFWNr6+?zVKsO@dp|&P7(F1U1A#(;?;Ll3dIgITjO&2>-2@m$ zFqDmhAcHav%o*%iRArmZ8>Zi1pP%A9>*}g5MvWJ?wN?d)x#}e__@OY)GMXhkd!8o&6&vUX0TJ<)m*!% zm;Hj=_nc*JYate-y0imudYgpRJWwZM4E)AnrNkys#I^J!~#*_{j=6-N#SJ#SsFcB<2i+S3iz`1*wye9iK+wDlq&>E#{kCxOTm z2`VlEVy~!XrusciR8+-{VTaA`j`vJ52aq|XrHdfP8RJ<{7R;#6F7O%EFWDYM(n(mdssprBlA6zSx{ zUw9mWxgewn6Ieuuieu)98>R*0aE5Vg5}}TNRd@oY3>fWUq4%rMnw zHZmHm34O!}dS;bNbfq`e0*wY6r1CB_Y2dZ!*TAOFy^3)bV4jMLGmj1Jl~yi7w4)O4X}~+GMg=I=lUHF*cT1I+7;ZJ!y1*vh29^l=I@kuLT-enk;opb@ z_zTi0qz~MH@c{@L0j|Nk;y?hL^E|$CMT=GC-YH;8A%c4u1j2yuK|(VR;HDrWahbwa zG3*yW)MT^PTh*qj5JZ^IDFGBV%e_mx8+kT$%{@jY0j&*^nX%Y02p7=+bb;Aj!5t(@ z44GP+FFf8M!9VVfKVB`3XKP|@&YIy?=p)=L9QO&6r(|MY4z@_edK164rl233m&`C< zSQVxYV`;iHw|-=IVRisW{X0Po4{iao2%I+Ij#~`uQLq%8qK<$6^_PLjJAT{0c!Y)m zY@09KUfv!>T1on_L!7YMfXV3o!W_)BZhk5d)ZF9v@rGTYdJ~U|i^)~qAJQ#b4fu%x=N$(kImJD%QK{l)Lj<1U`KB(=yVz-ErCF7dfwq@V0 zmx^iDM!nK6w7!^$!@@i)`2zBQ?%xJMC!|#P0@`O6G)J&)kD(yIBAAQG)sRu0xz?9( zV;{R)mcrJ(Aw%K(Fekl~uIO{2*oGwAcJ~J+@s?cLn@D3sI=3c60SS~SNJJny{BdSe z5!)j}$6li|F-@AaGS0hZr1gWnfp%Bhg_Ojb&pZv@arbij++Ua5&W)36fA+Bv8o+uF zj`$;SWw>fqp-MS3IMOA?`)Zenql}hAjoky!A5}<1eIj8#q$RtGFu+KNmq-qwqzf>2Z zdYjch1a>vwS((+5sjc7uiEui&2hnI_Q$}HgL3sq`{Upv0DsBpeIk70v0R` zv80vN3R}|JCKR1)Cr@|WfFV<5zdzAmeBcobHanoV{jTr5+tGg4_r8)*Zy6I?D@u?8 zC=+^^ks(88>!P=>Jk5#M%Blw&D(Es7t(Zd>_*C`+$zEsf4v~t%u;ePxp?&bXz88V! zjV53p5n2@jIS$`{8DXsB&pj?uIEw&YN8pwW7zU7op$$o1i6lbtaBt8+Is&(fXY8b!He1*YCE%V6AYDPF8G~6|F76Y!T}`>E z(fK0FCpBEAg|SAJZndm-D{W8L;-tY(LKsJ*cYbknx1;^V(O2z}lgzjnqw`pdc(o35 zVdDw&OyJYCz|QRMT%VBLa2gSKy-kPXeT|xlvz&rMVK6D$Esr1mu@8bEA8vxekmm7^ zMVDQ}IX?X#zY~Pc4ge*C23aSCK(%pU`obsQd3(?^R*5{DEq8GjC~BVP_iJ*T zC($&E?Jj7lK`C{9+7GzX3+{c}z!H_V>Ve|7z)=)KYtSa~z{{?Y5xyRqrh2%iNn>@D za5B`x1tk|;;Z=-_?N^`z6E0Q;;MRYj3j6v761VCq6;K#`GcaU#v({qWMUrh811%(F z>C>`lWGkb$?DmAA0^3N-H9ZAA{|HMIxbXpIKi~gvMVLkquqVNwqzypBVGZI~|H&}} z`|$<Rkh#Qq|0MoW22CUK)+&XUhq5!V0D;$%kcoqP{q z^}xQHP^ACA_Pz(Yk@~)KMo4Gvu2*=4cUjCXjLo{cUe>>Gtx+-f3VGN`kE$9ph;ho<58M)NkS->f8_~BuU;B-1S)Td*`To9tKc8mTo^>`|YTIY8C%kK!-Aoh!V8CsW{#63$Hem2rpdn?3<%Yz7ffV0jk?; z7%qSj(IIPYo!f$PArpi`Ub7wl?@a(*bO@JCKo|aNCti=};(yzSE{BGQE>k|m*lkXJ zY-|(ta{5zm3hnaWoaFx*xXb_buxs+xZ903975=4Zd$aqz-D_+hff ztq00ow2c~Q*+HzNw}+Fu zb2d~b3vS@dm;uUzeDQ_b zRc+PjU8+_4d_S3sGOdMvglSZ~}2^G%7SgZRe6r*&JSbSI!h#nYw*Ras%2h zFR!f>eCo0rtrKc6h}v*R8NNm@YwzX@^*Cac?r=O+5S4z=<4Xh=`foYB08`yIyl;)u zL)f?S2*G$<1b~pg(`fW0rJ7EAgs5|6*|xlFP3v zUb@CY)!oY}YGZx2U5E$0jZ8GFy6sYUr52>qvyEsgqnn@+p@X`CwOUqK67$#%{&-L9 zR~w$$jmB(*KLv#*X@0QEvZZb0+b;O9H| z?QIXb0I>9S5|xJ{vzwh zt*OC;V|}yGuFSGdrvuFo7!Wvc4!~w0x5A?7444Qm0VTcYTSPOf-RaN+Kv|K_E>u$d zLZ{nfy|E1`(2itQ^YL6TlvZl9Atv1vGD+k*7B-O)a#=?qv)~t&=~^t^ZaQ*eCFsrC z-J&blb^@+|USk&O1^c>~^dXNM6UvpKeeTh$yW@yxevvkKeptmiUb zjYShpnzhY3ytClBG-vB@;J9@RPUx)s28UI z{}re^v>Oo*#%D(tFOX=;ZX|S_x_w6Ly}g@(!h$Qf9-ZYY;drNYLt3c@TdSNDEIY&T ze78|g=6dU>Tur*;D`>uhxsi6mdvw}@v|e`E4E5Nh#1J6l=rGOZfVWY zuJsuJ4lJV$)ESF99le$oTxkOckZpRnN*>MpY}QfSS|?Dzu+0TT0~r)g0dxge2|i@@ z-GEW!c`t$=E|0*W3t|%@p;*kWYW-HT9xen{mb9u6Qa5UgjZl)7Z^*?ROJ&4omy3Z& zp}QF-3`f#jG!^Es66r>|QI9g55{oej)UDWBYmW6^g%weXE;^Sbq;HaJU0R8)xV`e4 z5}*|!v)QgW?r^!i-nS}z*fuEhOJtx5Y>PW0p$uP6`#)w`#{j!Xpwk9J3LyRQJUyO z$pQKVHdRT6-%zApAt$y&j$X0ujQA^ou=9q_TAPlfb2mitv*m)AS?Ney^&pG=j(wrx z6AI#@jcIW5sx#4RIN4QKSPEuqE6h@e4_DoerBK7;lGRvV5SEi#L#A!rR6=Q$Ynw~N z`^J?q{K;#h0l)T#mtUAy>s&Gn_$WG`uh+BA@R|?}IyqaejI>v(9)f*tOY=<7SrPj} z7HM_a#%1Ffxl_~n*;Z4woThI7;pKPR9RNbm`|VH?f{tDr>K+hDMTQ@so2b&nK7tE_ zwi?%~UA@h6ZX@hki-he_L8Mph@rI|9joX+m6Itx1v*nCbsK;DkbS~-Jh8J>eH=T+` zdTWJ_=&~(Dol?w$L(!S(t>%NuN-*xy}Kz2|x+R zh5)kZZAA;`ljRQDuSMRmCM+!%+hHFUjI|c(U3)z5>jiQR=lY6`k2e-_VLFlRgn|Gd zDR}61PGuLHiRSV>2!^6y$i}le(hSfwke)@OH?nfTqCvek3YYP~ceKS9HH6 zf#$Xt-&u{+lihf{e}gL&cW?NMefLIMtp!>LjRq@lUuf^9Cnqe>d0T8D4jfS}TJW^! zUMm>xz=vz4J=1qZ;9P)7yx1ZfCV$~wF_pvwp%0%C+lLX$>J8RJ4b7M9n7(X3QX z2W{QiiqPa{YbYme(Xe@gH*Cz>qI7xzWfN|_Jmv%=i2Xdh8g5jQ?m#b}YKYyq$on%( zViCBjS`Cfx;e0#M;@8VuQFgjI9GB)p*`g2^3Jt{kHh0gzf*AOk$A5y0arHF^6Zhqp zYF=Q?<^`8M(q2OwD+53_K|&R2)lf)L+s1TfkmEAQR!k z<6>w;+c5w(^gFw~G~SCwK#>Xq7dobbvD}8Os^|L)QnY}Mkd9E!E&D6pERM(U*3a0z!Iqb3NkwaA1>5XPQTFmT>(`hTa^)wwy zB4`dag23Z@m)`vSq`J7gwj=`cjAL9G4bA-PJgUxOybI+VGSAK~^_5(tOve|hG5AD3 z!_!@#nz-)X_ZlvoARNTMf~NaA;)?(ADu>3@2gz5dHFg}mmIJ;yt1v1TVp9QNaHqcrG8vJHJ!HzNnpB@eX4Z)u0cDp!-4+Xu@dU#^F z4M=uzT}SrMiY>`%0HQ=;$Thc28eOh=nREvGJVrgkZ!s?nTI80TZ;>-CGkjFJMH*4$ z)gqk~TBTbIl>~NuO=xY_DP%CRH27J&Yhw{-TX>_{fCMktSRwIbO9H-*cvIZIu)EQ9GYU37h4j(fsppi>1M8F8QwwA!w*Sp#z;VQk~5_?u6$DC;Gl4}}4;2~%JyoV`G30DZ1dRX?>CRbzsKYczG&W(^ItSu zzi2iC2CQ_+?rDv%3)MZ>Qc;y*l}@uNV$oMMcJ4=p;Y8yCv#dUAAnelLnocB?rilI` zhDvmprp!>Gi4W~Rde%Bz-nbBYIZ193%D5Vz+cwUFkTcRgsx44w8wYEQh8Pl+Wz_ooiJjYD zUh0vSukJV6oyE`ZGG@b;U*9R+VL5_r1QrS^skNH!+bl*q9hl!amhJEyKQK^Ra^65$ z4V1nC>5_q(QH0O#I)aJdRVtu>2W4{M=&hE4LJmbzNFye^V4POum#jw;jD(Ry-H0L# zo-z#O&Zi7Uv|cDAkvN?ao-&+u@5ei)lv+7(WT(;Ro&SJ^$XfWrM0IeBWlPTAV%c|# z1vg^%mj3&dGpc-xCCwtriNC5a8ygHqWh`N81Ip-d`l@erQ+_=GW_S?<_%Oh0K= zaf9+#%gp4`@!-gIjK`gy2Q=NN{WuTHnk)ey+rEi&_5F#VT zqFSvi%2c?16SjaMES-XO04ZI^mxyw63cuOtIOkH?zFA+XRhnD(PMb$Q-C=#G7TG#sg+|<#* z!=|Cg51Ux)?wOl~`4J?rRgO`qEdGBFTkdRh@UmejcfD*Ne5Hq{XWCF%2eQ}@J!(m| ze%d;C)HIZjJZdt!=+cL;p4kur-X*7lJocNx8ApZ`liz1iJ6;()JP~_V>od` zRB_nUM9}awt8<^#XF(YO_(Q8@HlHDP9A ze_ZE4HN{aDpaXg}PrIqIgd(VDmVs31r zA0IsF9m>R$-pK|Ik*7^KqP}i6QYp(-DKqBDdb4xx-2Uz7t=c5ndw0z=g?o1$f>vj! zG|VbxsBCd@uR@k?n}mjX)MWV~0M!DcDo%~LTlNgj8ivw7YhbTAIIT)Muev2W9>mSH zn8BI(q1H?kH~e>!w3gngKapx!_a^UM2V?d-oHF}&^(koA2geF`|EGK`~J&{@OP#w zo?0>I#n!w+S{(U_BfBS@mkthIKa?vDUeE4G&&a~xO~axE`(7W0XIj~)i-QMNhjPyY ztL%LXSWRCt$DTIIiuK89BU1}}!!$T&7)tTnrsHBSU31j>3=8A({;Q2~#d6=(W~Ii@ zeZd_6)YXH}RE9F~nF`@3oxXggD#XSQg*gq*HMT!L{}t0)cEtv1xv^3Dv3=i-4dHLCM*vYE^RS3fiZ@qTv^;jX`wz@SaKJW( zGRHQIK3nO1yKsno!hC=VtC))gJ~DlH`w9OWZPE;9nSD~V{*@;E`P5h*UU<#&t;{G> zWBP*!w4vPffHn%p*HwDdg~f2)h~<)<`+GRVpt~(U`S)|Lj3P&!O~z*tu{nqn_N9Nhj?g8oz<8=G{(cKMdca?w#UpuqwknBT5xR9I{F z(v^p2l%Wf;?~CSRI`a**c^Q;I=?U%B=plsGe&bW8j4r3;{H0g?PI+Iv7yq?Ww~xMy zICojQPs$|g7FoJr2)v@yPW9 z9IgZWy6C45fVRywOWS6x>Sg3*=CI6JKJo5xP`S<0?j4sBD(N$WmuT{967oBbHxWY`nU^L+*hY0W;kQROT6+t+ z(c@?SdK?ZZjEpl+5I>)9)Z9G2QCfU+#?cP(){LV9h%0~Te53O}Fn#q6e53Y##INW^ z|1Ic759oBGItldI9pC#j`STe^ANpl8juyyG#?fOs<0u|XCzF0l($UFtZ=Z8i=gXe@ zg-AyUeqX}!LHu?0%}GZc-tDBLmbr`H{Tk(H@zWN<_bay1U$Kq;if#0l%{J<_qec4d zv5mfTq}chFiP6_tkDCVI>k^|s*|Hrs?MMB~;l~bc48Qrym(P6uf04HlM=pAuL0Z;B zO=W%?b16r@^2#fuVVrpSQo?WQA17LG&1FiG`_Enajn9(ARqhxuzIBV_yGAz%a$}FW z|Gux0-<>9oNLLf?I|=GTFOYvRPV6w=xW_;G#3{o(*-9SA9d__}Cq5s?rwO0rfBNf( d10OkUFn|2C;clIK^{qY%|9tBGhqUP5|8LA$?(qNs literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000188.ldb b/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000188.ldb new file mode 100644 index 0000000000000000000000000000000000000000..2e17bc8165f40e47cb58a7f3129b3a662be213cc GIT binary patch literal 23545 zcmbTedyFjkbslzCONPsk94)n*ETadO83`dB?P%-$SW8!1T~%G()m>dxUDfqy*&Nlg zyBe+#0TE{#J}_MgQxzh zfAKf|-fzD4_2-`cwMXy$@G~F!fggL%6aU7Ce(>qP{)IpM(r2Ie!H@idzx7=|@V*Z{ z@uBBF_}~6F|JiHreeQ*S`nSI8Js*F-@w{jl=`TEZ@UP$h3m<&ux%Uq*!Jq%l4{bmE z3r{`w%=>@jQ%%p>DN|Neug-k&}Fy&rq+|9a1R7eaIN>L|QvYp-a$piRo+!`6GAc;EY9 zcs+XJlh-RuqU8O#n@Q3dJ1&iR(40nrP_@)4CV?0kgkZRZX__l-eNb0el>6~O|vM1F%&^F$P3r-vLAj0xqMa9G+k6*zjW=t_X+dG z((BqI_F@>tUYEDmFI;zZ-uzEL`rwK6_m_1tMY}qGwSVxz7kl)@f9p>_@pB((qB<$! z@{98aAAafk;mg}Hi;6GK9=w;nd{#$&nf?9Wd+>hdqwpELgJsu#@n_-FPhJ1?3)exO zL`A!VZ|)i?J(R4G2F(KOPM>d1Xv@6!H$ECBbriI_I{C5krT_Z79=!P8KlP(cRTfQT zj#UKzEGWY#e(iHjP*zcM{nAfd!|z2B!b?SWUXsJ_Rb9qO9$o+07p|KY3~~L^|MvOs zT7Lf77p{x42%h+JuRrwTEtwjeimHZYyOunqYo^OQl8n)nR!U?sQu!>3iWSRo>y=N$ zZJB$fJf8BYOzHU(|EZH4in5Lj_|0p(8eSsy@+NxWz5n!C3yc#d;=lS_gwlRYlOauq z9zkJPh{4lS ziG*~p?2dhJa8YoW%>w!)PMfVA42`WR0}~MKvRJ2>t_iH&%oM%FzvW8S8&AFmf8otH zo_yS?-*^&?D}H`_<8?khZ;G-_qhXpG$Z5xThmw(vv)?Ua<}mQZp~W=&R8U%9IBs&_ zcKGTTu9y(_lC_l=6TEfFUwPxnPhm6``B8xR1kMCL1upC(G(|E5MUWvwFa+y8@%#rP z3iBWSvnOA9if?e?&iJNv7^ah%tMtW*JC7yMJOyO4;zr>%7`*_7k26*KE+MvO7v;a7j@h#o42e37Y+Ny z`#ypr2+6S2<4gq4`!}9^z`XhS?*c2mJQasy(jUlWJjL|J84^B{=cO_FXJ)lV%t11C zn-v&rb4GLhw3L}epq?q2NT>j3d(*rA%o|TWiV(!ZVl={WlJLMFfd{S@1q>OX1RX^z zMZ#AHG!}c<7vRf>)17i-?+=krT56ULC6aZ=GhOP0qmo#JcmqFgR0v8dF@kTgTH^S; z(iFKhnNDH@t6J<9wy;@6{j?Htzeh+DM_kO_Ef=v^E|0?!pCz(1KTE#6SI2AXk3NvR z0YCBM{RS-ZmfyVWj(F$ew3e|U%Tw#{v^kMyS68C5DWvpaH>d~2q{p3g)NQ$3QmP&u zbmVy8J!^a7bL9H7Z#?;{Xh_9WL=z!gF%<3<3VuR+0gHHe7s}am^0*yYm7r&fZNBNs@+9Y4TJ+q-D2h1LY;Ct2N8Roh zwC|}EavV)3h?h#6MY&LV#L#Vydv$&iz3~+Hwy{k$-DFxC83OeB6K_2EG{xXF_Abow z)9`|GEXKV(PSLi$kJID1=T=UQT3(`~Csadc*nVDE8Mj6I?NRB~8f~^&lHn-M$#Ec+ z*DrkL_3wT}5D^2mWdfYR1C|O<9FId5Lm4)pP~W3s5+yvJ!9w)<-@bYJ@-Oz}WR2&I z6=ao6?lZ~VAHzc?(0ISMl={@DX<-kC)DLc&Mg>A)Y@lADliRZK^RS*X@w#uf0c9n`~c z@+N9_Dh1K%QaYd|O~}V>ktw34%GdjEyzf~YCvY5j2a~-01`%8tjbSEO5>8E+Jw=(b zE~_r=TYI(Q%#1h^R^Q_Lql;yBw5a(6$;!C*wZ7fOxU1a96e@yjMYC{!0s@O;KMs+I zj){<9|~YjgWNfdwUQ#jWZMzumnTK80x__3Yjnp5R9aw5C;>5aC1l&g73v1!7QvgDRmDyZL#?GEy{G+ch^kj>bSru6Av`@#M1vOC#7jISJgGx5Dg0ukS39945>2 zozPjyl4o?ao)Fy_2+Bl}?xG3uh2~?D>LN!Yh%nao7~Y?Eis~-wtG{sl>90Kh2rdOi zhcV=6$`42?iZIGUJqE!Ul7KWw`xMKN7>&|Yc(F>c8=ZD;??=hn>iV{>#F>z+`lC(~ zkxuHu(Tu`QxuxmdeUOd#<8JO`Vw59J9USnLSEZ|6R%ZrtUKJU)fBSjdd(26L#k)I z+gOeuc)Tq->c&fHuHH6DW6GplF1F_-&+b0^^=BT@EZk9ofMiR@Z0xaUL?I!@VvO%0 z5L+3_kBEpseGBb=4nFhByH=4qYmcG>dcA#Osl z%b7##(PrAzW=9kDY_kx#;mAZpHsy+butaQb>LDtmWRANEnK5on5ec1*w&5Dva2r=>p6_WQZIUTm*F1Hsa#32+=dz{nsDDTF3j9P=U;qfi`y_!`lyhsIt&hd6n0 z5QU}!{mrOj3bu8cA&bSrn?C9HLyGS!I%0oV`3GZa#sv1P%ezC<| zfPwbB%%^q1Qru!t_OrUhY<*=_EJUk7Y7YgC*~QrmoQV9yAABr%<8j^r&);&83s4KS zevcD;$EqSlt(UWAnbK{t3YWCFV*5$;kJ5HL%e+J>BeI$$Awndzg&`}?tBuY!zZp~+ z9MUZtF&;wuxE~{IOnYDik`7ST^S#(dV+@B1gA6X#kQXyFW8^~)_1K*+A4c_1!H;Aw z+L}#v&v4N9U2L%#X-XC8O@uRrsai#+5ID+{Zv+qcV}jPq76DKSzu z8$KFOVrwS`FA*)mAJS;Q;1@y~A;P}kk8+GN(!uCn{qhe!VuK(C%o;F6ghLzwXy#*H zjAAUo#za6OwCDLK6i7jc+((dGZX_zAB7HQA{9S*>OJO<=EB}OXu8;;{7Yltua$|CD z5()7eq*$!E_=L^Rh|8WGbRD!rUym9<1gArHRf{$6o3@~TS){LI;)y_z>aqiwn zkk`Na&BvVS_3wVm7B9<&E$1@WTk`aNZ#Ijy*d*OaWsK9wm<`2lkX%GkLj=>!F)~!vFTO|zY>U|q8@QT}roN{pxJ5{$~Vp;r*-)+`sG%>o9sERa> zj!?U96r0D6^WEt6%W@ZO>hQE**cQ1_(!tRiNSxPu0Ie8JKy~v6AA8)H{@`P8+2kR< zsZO-0Ly?Uo) z=DCm4bEyb?!#Oi#OJ?f~16%)qErgpQHj~UHLRP5~DKPWIn9E5C01Cj@%>c?ydCJAs79s?`` zEW+S^L}CGT@elFFMWVH@FLo{DjdaEZ6+qO~8)l6(pMohFVJ5QBLKh4^u za1c4iZ|1K;()FR9iD(}ofe;8VkH&(~58-0~Xv8BzsD3FAu2A4%*lS=A`j)%%*c;nr zxwEg_1j{JL^1XvCGg`q>-y9Iumv8DRJX~M>?vKCzGOds(mehMjsfX3O4oTIcLa+lt z5I$fLiuJDk@eeal(XdcL&}=~XA%1^XoEdLr^u{xE1>K+81&@z+iSN|aZOU;Tc^k|q zv{dhG`Bwbr-+29HoFdssST=2d_3Rd3(>f9Dx@K#+YYmMvBdgDsa*oOO>mWnav!b8e z!8-&rVKqfR<`?gH7SIvE!FR~H{kK5bCFfESTsh}dVg@$bpKJ(ZD?ZN2Q*>An(DfU%b=6PYI^j?lJWRr`g&+|oqQZG+r7;CJC&5uXDu71y_z7R@gR1K2A@=m3g;nx+{aBO~(aUw_~u9uc4+bB|QHq9M=xOvsB+ zZ3)9%9k5<@$Ky~L5`ViolacHivsN(e`z&)L)(g}MJ#{Q2d@bh%b`2F|H5)fJ>^?6R2R}O?sk2#gdDpD?15vmuRmk=ER@!QOe(0!vJdlUX>h7T##^O-% zh5*Va8juJDR7nJ80^E+`K&SaEL3vQr-~mNk+yvo{`-3x}h`T+sJ>o7hM7YTbaJ)6U zms&JXFzvA64uy7~XLi2CD%(&Qo8!_|(_n4X>LxzSBu}Abk{*q?YlMtmA){8#u)@yk zz3Qqwsnd&InknYJn?N~^zWF)zap#rKsoyqe5o$GXUgCPJqnt=#IsmzZj7g)M3+C0hB4OvP44iP%Ee z=F)6i>yfE-n+x~+5gH{~C_~=?l=R;LB`Vwh*Z!vQXl5Q_M_TE3s9R^3=GX!li$%U#uX<}70ZNZ}9@h|w<5P1~V|SU`r=Yef6aU2T(N8l7 zg^=%XZ(jM%y?MBr9}hcAI{OD(T?fF74PGF+o1U+cXvvNpy#FU@OLvu{&KK<*j{-9g z(Ll0ub~;XntN-x%|K#)huf_y{_*9Hj5wss^oDCv`qT&!zEkb#4Alnc)N=3xgr^Bn? z4nG5C0VH2_F+Hce-0;_B9gdqe7vw@Dkad=N{a#9sC5Gq7{{Hf;LadI@{?guu1KL{y zgp=ts9a(m%)QvaTJGk^MLRiPWLb-F3T+=nuO0#6N1f~j&PkiNhAOjv#=)v>1*Lsfa zG{IrlZS!mlNEPt!$~*EAhb~x@@t|iQFOCvF6eOuLjFuZ87IASpHcA z-hZ69`k$W(p^pW(1@{1mpbX%7V9#jyTN(+kzJ@=bzxez3BV*}+#XXl=0jQPJhP7JX zl()lBt(nvV2SejpKW&>+s9#_Sb_f)EF zLOMSzy>N44jJ%x9q!Wd*v@~BgZ76Q00hJG}GoOuqvSA#9TTlrd^OCeeOB8bfW1DP_ ze&TcLvkXCy6#h7S!1K46VFY`Jn(RjqH#Y&y+8cl*Ac<`&{GFE5aR*j`9y?L-}4{0zXe_*b!W^qIdU|i zuQRr8da5^fhh}vos%Vqp+jKT%S!B*dNHTDBN_(qtWsbL@9@2-3@5sPdz~9c+wsh*6 z^||yICf=>*vuVE~@TObydlQlU)0}G>Q3P(pM?Q_i0pS`sLz$5QU%p>I*;o zDV89i*Bc-RLE|BC@eD;HI1Qu=q#DwTJp}i^039!4!3bRE+%jWjG|bS|n5?Pn+?y!` zcd`sfJO)diw)^PdUM`Nur}o*^Y{NRw(qp#;e&JZgo5Vy#c_SZUN&>@{+-!-UpqWtuiyjm<}U}2JJT-*-wr3I_0hCkHk>tw_Hrxd95$!V z6z?1;Rb9`vYowB8&N%Hedae!7(yW4o#F5C66_NmR-HTPO{_*^2go-@u>c9WM4>2Ky zv6LS|_Wgjtpah^+;GjbWh&Bd!4Tz?-WGNk9I+%|*^Cn5sCF>6}%rgLl2e-z}q*!q} zkO7oF7dMHR1FPzo=0q9MfLK60634xsMiQT&2$v?*bGozb-qsLCn>GB7%XoPNm?JOe zX@IWkYwH{DdkRR-tN-BqIIITG`?tZhmZVkzn+xX@Tte0zyPiAJ*y|9vg^j(Y=&dI- zGla%ZnvBj0UD|B5=7`h+RJZeOyStCDpq)Z6z=*&g#dw5a30~snzf|}aUHgPI3IngW^;czZDXcquQzWz`4N_Y_)lT) zkcwY<8#>9_!kTj&093at&8|51v9kOjOd|yxpSJ#}XAOjR&6F2P*J1$j!TuL1!faD}5HvO#XNPHmj_z)j}(@^8%l+9c% z*B8kt%*o5ed6q>{0%za+@((`lOke)Nw_?e|#2b0N=_C!B5=r3|X50~DmzMmZCH-MD z16T{(kj`&-t%5F=w4SF$JX>{9o(WEReDzc3!Dk@>$DWS?;R*^8=z{|%5RnM!1;DWp zSO4S_A3=kVi7?`c-EV#Exkr%|Xk1{cGRW<2BoD3FZYAFkCo9o6LZTN<)*t8Y@x;yU z%bZ%a|TVa zueWe-;Jcw%_MP-3Z}0z#dpDi05<|+;-LXE1bfT`ws-OHqS6s{Wl0D91qQCG7qhAoB zbL0k@GI!hn{5_;T;9fuCArW*m$*b>qW&kQJU?QN@JeI^zXlHp?MAMOvg0KyZi7Vx) z--2p*chI!E!&qoirY#$q;5hauS37fg)cgXKGUe7um4vCRWUbDsMC=!)V#sf-yEG7`I~hB+7~ZF2FvR##Cp;as)QD1AvuTpd_C?rKpe$k(3% zHW~rZ5rxDU@Xa(sU?Br^GStFI9D&tX!oxz=2l)gII<1S6B)=oHv%>lt$sN0?&*|X6 zD*K&Kc0gAz4ANT4lyY;|7SIp^dmOYpv@(oNl-+rIaKw4iWDHa1Baga6tTbzHIzhX> zm`LNzfj(os*(6V_XQ)A%5~JIvKzN8bGPpLpDve*GuDeQ`2p$;_$wHdSaN zI0orj(l{QXoO>8+!7*i4HRhVmGs!}C(2e4D=604kSgk^>hb$AgIG=;df?*Wl$IzpR za1TXT=FR}8d$>N366a}qRuQRS8!2+PkXFRtSvx$o$~}JEtfgMYntXpQX4Zb+ zCEL(8>Lg_L^dOlaSbQ`5rN^CD!e4sJ7B8=OEtYnJfEabH&vOIuQ$Oug#&Q>$v~XMv z!AEXQ&WfcM&8f7~cMUH{0v3h&Dr1iLeftLL8<6*~AO$7BH82!7HK=)kS44n5q9`T? z+(rO9i<0+bNh07{p^xDT`lov?cOeh#7klJX3+%itD}-6yxZdrqQ@neaMhge(Od`He zr@g?7%#@xL@w^)m7usB{zO`y%x5#E(%Hk8& zs@esUd>m&%I0IZ7jnG%Wa+@P0h^-huhLjw|A<94wick*-1CY=Hr^av_C&n~u+Tfb8 z8^^1E@UcH*BMXAGk-|io;xH9wu1%mn$KS_RX)|b;zTWC{QB*{6*YU?gdKNH}J4|i9 zueH&ubEP-s^t@nu9x?J2NE>`96=|(q*~zu_^=E(>_>)u3MMjeCLbPp~tt=TdrVQ56 z-l3bKol?Rd% zP<8^C2lXb3U;V?6eH_FB5tM*f;4xQszy4bgbhfw7(kgF4cdT#4W;?N1x#~L*44Agx z4O;`+4rlam@-`5m0i&gY(#X~>4z`B7+||2OWI-Yg^7#oV=>)JMdh~;RW0K843@(Z; z4d`z*fyQKgbquZf_56(|e+W1&0tJ46z~6kls`G8>=4I|IqNBbF>KcNH1_ESIVKrW@ z;Jej{+UH!|&i3u@n3&8u*g#u%q(Sm8FNJ(B6cb%9?ynChmoXG52^t5Uk%fX6ikuh( zY5pZ25yS00N zea70Kl_#HN6MT7g6~ebyUhgf%VJ^#^bv_B@;t-zo^4PKkH23gX7VLVq*_{C@u~z;) z|LdzSed$H-jc4JFx+o~V^y1^r^raWS9acpAOdeTsv*l)Cqhk%d=Uc_4lam}oXS_B> zg`out$+yrQC?;hMgfrgJEP(e@uJ^ihxj?@PS^<mLb8GU1H=G^VWbB@ zF2;S3Bn4jtbT`hayVKUa|f zEZKoJp`gr(N;8oJa;CL}emKmG&4N!)=_#S>Ia?1)4B1)dfRTNV6XvSA`F#*`K8-^! z5_^ZH-`j;Ynj#q+gIXO>4n2Uffg1=uk>bj41qR!I-ltcp1X{a2s3wJoQ;uuS+8NkZ z%zK@vt>R*l9|iR@NusfjcmUj?UvZ`Xl1Vclt@1oj^@FMe3KpOafO&iEw^y%sXgADE z$D7@N4tno;%EVe6p@CyHl*>7wNRMXuZH0sxq2KH2b#X<-Q3^QDSpb6JAWAo^HkOr2 zhtrxbOI1OvZWC^~3>S1?H+IMz$9$@x)=Ig@l5gtiG4pSDZ#+!`&?eq|WIyh_^2mOm zf0HYCNYC98-G;s+YF^TUE*;eWF)FDWS}Bs<`e4fvb41&0QLgjeE)HUr7Fif8Aa2Qz z$_jeK-w(XJN8(<1^}^r2`pd>o0?z}j44h#>6z$;v^a(!#=Rw0S{`yZmYLZ*yfEaBg zM3^DccLh1Fkeyo!fwb7`bWUV0#X(I3wOAGXgI4(tMSg$u<{XV!o6aq3^`rY};!?mi-M^bDmok}@! z>hXAYVE218JyNqdxqvu=WkKpCeO*gEYAM@BYFi)V4|mk_Dw<*VGc-XY)xz^TG(H zx{z)x?YO6;Iewy|b!*(Su$*gib0a*L@-pQouW8%Ft~KB67e$SM)bL;trew(0NLfSK zOiVu8Wh%ctFwI_Q`_1B#dY+{S2AZ|+F3djUd8?IZ6ujQqOn7f1E6C7#HHIzKDNA6^ zf%PS)Iwh8YJacJ;Yp6B|jL;ENWJ$=c{>AdC&_l0Y$$p5$NuQxXHt${i%kS0#04b;k z6>c0hr&>B&`^QN886X@8Td_(3qymA>7M{P%wO z2Y;%kH~Nw(DOVm$YL8l65yT~$bE?&YYtm3-!@ z^b=ou?p@3E1|6F~BSZuV6d|0=K{C<2X66!eRr$^+Jwi73z?`ACRDDNGUJg`|(L@Qc43JUV!`r{Z4g zbm3O)b>@uq0o9mvu(iw8qEKz1PzE*U`7?7-QzYACHPN^r?U5v;n_$DNER8kTVqxcJ zYDbmkwr{a{p)aZ=63by_CK2y!nL}{4xI^h&#ClJYz><@1{`@B&cc!2J zQkbamvz!$aA!)UCCJBtSyZUncsd<)evk~bf2CrA^-b`E$l8`Q*n6Ahxw^*;m&wl0k zA4Ne04(trbZNiv}G4jg$MUAFt%!8amk^$&&pxH$+H1kEcEBtNZ--=6ePE2F7@3m#M zkBfpmt-B&CSRLeV1Tml4n6SMk=dogY&qPRD)QH+nM^AL9_>VA5<0HtozOHNZ<4Ncf;HO@i<)?Jn!EoO`9A_Ogd0*%BTUdbEG>e znBAe7m<41(EIo~_mZF8o)md9^4y03^9VbW}TF%Y7rI)Y%rR-&JjtJlg%*jzG2COr2 z_1izLL3#n-LI9tH9^(a|pU2n$lFXyUIl$|d%_4Df9A4cnV^pVhSXi6mjej@Y7=hSo zNxM8p_x$2vgZcUS+^$Qg58V@O(`RAFgh^)=!;UR?&1ndy!DdrtC;P#9PCBN$g}REJ zx#kMXg^Pbcxd+0McU9j!L`!oQoEy>Xa&Nmja@cyYURxVhH}~_M2AYKxB03pJ9e^XC zj3q`Y#qw|(16xmi0bjg96a8`q{(FBvg7N2{}6Q5EcaD@ztOG6$Ar8i68i& zp8&Dv7XXOV8>|SBTt{xUQ)Lx+eo9lcr)^<}@M9d!`b~P6xog{D?&l~lPn#lut}$SY zNZxm1XBx7q9?vDdJeb8^@-e&a8uy^ftA^aI&bhyklA#4X66(~AelNxP-5-DRF=zVS zAAbv!JzTp(K-t|?IB8FX;;ftzQb(Gz8s9LcQ6TuNhC0wL#j@V5iN(2wIRKmKxTDXe zGX!}R2q4gm0PX+^c{E)I#~9spDlLlB?!VPNZ`6UYWlkfIs_1&ZM9 zsVMjns6#JNo4^)s4HvsrT6afJxB7jL!dZ}7hYuaY*bB74&0~q%1U=2dG<1d??I>eL zNC4;Qkw0=(Yi!)3KB~~vFYC=5Q?v_T^c0D(SC#W-^^1=?Q}v7AHi>0;>{;6FRZ@wo zm0j(Se04(RFdPzSZlPwRZ=9j})fcmBl_W~)ok<`ul2x-5mE(5tYW^P~pqd~&9P$PO zjjOBw`yawL9NvsoxxNPRKu(O-aFovF8*PdD@UhaH7XtOLVzdjY!Si;B|dh7vKtgVVWjE^ z!#h~cnL$c#Dr|_BINKf+P$)RdSF2wHXb!Ch1dZULP~baP^IvmdP=bjgkiYu?!w7~7 zaS&us-i0}XIg75Hs_n=u7Vg~*K4W9cu=qM`x!c37IxnIkADBahm$9r|{No`@pc`FP zVCJzX*PUx|wi^~PL^{+5f?}$sViQs)rCZpOMN2-yb3L(Ca4UyFtraV7e*TjmhYAlS z=Ri5ZV2@LR!}GU`!P`#C#^q+-EeM=E%(f8+P_GqxPt?ak@il=vYhJdS@8YoO?L|Wl zQe@ZRF2$1463+lmACWMe2kJzOfnPX`l!OF|#34;mAZYYF-1i6^6u)Qyb>4+PqX084 zjOf77vvTt1>{$VhiX-KvbZ~p;Y((Q~y4hpn(YhCdyX;IWr$YuLy>e!cMItawfeL0q z47%Z0#!=b{x}nE8OtFRY^}rMwHz$wTrfB`V6~YVi3;^VhKJd5$bA)eQn3u(AChwU# z<+r}LaJX%*=M}DQ77UTPr$qzm5os{(6}Uc?9}` z5F&hF5#d%`F&}-w51<{+Fi}V%)Yb3tAH^vTT6-AjUpiO~ejdqezRme|CyT{iSu5b` zmbG=dVUwaEt~QH1YmV{G{Y1%}T{8ednrP$TW0sW_e$#qFnK1b1)e;Q%<{n zGe2$h3FPaGF}Ak!Qb*7B?5rQLjagboyIl!=vj2O3`XeL;Gwv+@4&mcF`serH&DB5u z-mmd2mIMZrnDoFtG}ENTO#+App^FTvs8Lu@ad^p^IulS&Xi} zuIGNXTO@;r&YhDf7Ww{5FM@YGKHa|Zt#td~h3lvP#qX@p1jc)CyYHC|11JiC8oV+*&3Dl{b&Et55EAs5CMbWFqVdatV(@~ zqWr5rc;@PVd=3aRm|`Re3eXA2IpfzrCLvf}c()%n-DuWF+b{*=u9%%fVZ_(m9kcar zYkPAF6O1qJqlfMaS&eWO=#uIwiFT&AgE?*DY|1OplNVzH0~Vgp(z@edHoe=YLR6g< z^~^09vebv++Is!FpT%IZ18Uo!`nkuQ>8F0~t%&;2+l0HO1u1~Oq2-E98M<;CY3L5S zD0g*7f(aGWu7x1yP!m^`Ln4N56`v8YS;{Tffe!7{KlO766mK*E^N3KY5Xe>fi%%g; zaP{Tq1qx>o!0QO?VZbne91Qi^Kl4JBX^14vg;QDd-xtA(LZ=Erv5qg%78H$A*frstyiytBKr zvm5AM*o^pf3hik0&EH-TLp*0pi^|Vub%m!c9KHZe>b(EwXt``sUZw3IxjP&Cax=X0Q_XS3PhlIyz2)G80>ps5C>)ZNV@;co7^ z_tOYNR69ok#czY7D2Dc+O_~8O>mn=MUHiUqSzR&)b3NV2R%%j8!!?JFiLt=}6&Qa% zGQi>#sKVY|L*ilIl{^ZqZw8v|aWw^OY!=m?@z6%p?IW%DUgda_J(qY{hiN3+rB%@L zudqUgod;O>>f-M_1>K0(mjp~oFen)U)QDJUzk-sLff;!ZAR7&B8c=n@8Vc|r*ir!- zNMKO)?b|vo>r5`|I`04S2Y%p>-unbRfM}?!O@_~pW<9QKWla|OsAG{mt5^Xx1>EL^ zMh#It#MwQ^nEH^;n*lS3hOB!Qt5%G=T|3%_J9aa5Pm-O1>4~tQU~$FFkv67cpF`ji zT1JtP6Bqw6>t8OI4s`BdPWFEN%UfG#{vSJF9=mMkk6#S)|K;EQ$d5iCF3V-!S|fA) z(q~?JYmv;y!C2k@&s8!Xf7>b>SpKF{UkGDP4q#s=|qeeOY4_D>Q2 z7%#*Db5RKK|MtSa|GQ7Vr>h@_C}D!=f%+{jT$!!nGd~f>fy7EHLQAqaq%iut2Jz6` zoUiFfo{1R37fDj34o#=Qu=FE@7FcRam+H^{4n)7tg)lM?BAJK;?QKAU>V<-KQVheV z0Za%nA%+H^ov$ama+(gauAPmO?C^SX`8!Wq$fvBWJS+SFH;%Rop zFQ#u9@ZqKOfE_B2FH!sNXxMpKPGBn#cRroQw9GV(jwNEJqqM@-mjY; z#0!yOW1TO}_c69oXi|pl72y5JUjYCOVld!78K98@=$+6oEJRU&8lb@ib5vj=0u&zj zW!TWW*PbGo9>T2LX^~N*S=Oh+O>fIQbJ|KqO<}3H%Xvh*IZ5sIe%vrVgD$|$jaW@A za8^zplPSYvkt&X|($i2Jpa7-JspxaLGNuz-3Z?C;r-@AKKBkQO>;O9%V65wL4g=5o z@01`f8&rPepNnH+h>z^H`edjb{_ zAg;HlZ0wM%S?JJ8iJw@htkvH7L~=a1fJQ*rMORGSYqEMNZJH(NReKo5#8XA=8y**&jLCi2z49Y0jp8^odXQAIm z14Rz={&0Ul+yTR>80~#?W_hW?x7y(#-n4r3ru6&s!Q3*P592YKkKW+SjdmB@Sj&{S zcam;SFQvAi7U}5ERx>Q&#-Pi|qhL*ShfnP$0*U{LuhAK2pHqdWlu$Tf+LZ72DsiN? z7fInqaS&TD3=B=bOF!90rQ&VIv0V2#x}-NF&kxI{V+DF2o+U5Hm3H7x0|E8ZnU0GL;O zKbzabJpm}rwNO&T5Ihk%X{So^!g9IvR-i~hTNgi!M?V3Pc|zzZG-lR*mF|{1iYeT3 zhLrL4eh~9noTM1$og@u!yF3pAAza4WggBbzw%E7+yeGGm0E@GhXjvH!kZ+8Uq}FtM!0u2p$Tb%Q5GTNrN`q__u z`m5jf2*Y8)!DWsPq#iJ-i-Mj37*gomQy2_I_;8D$G=Xs$@>|ooO<>-Mq&pWeDNYav zlTY;7kWp{&=9@_~f^BM7OHzc1q|2p=VzZ|ZMVgPUeNISpAra}4hGa-=N5|sJ-8}Av zPMH>10A2mfRIut8Sq7bYs1sBn>|%li2+-w#RZQ=S1$?*;&M;P;M7SHP`o0(0kYBco zYQSWR9cSi=IPB0!J}pcUSs7=6hs7c`jr3;iZ<8J3%21dIg6q0e5@4Y`7$wPkd6=GA(T<>{6bWa^IFPt=`O=d%_lPyPti z2EyD|Xz>EE(B(q*4rV9Wbc>8FFOH_*JLcIvaRSWcxeQjUq1jW+U|fr3M++B;lPXM% zEGqN+@Cu|8?59Fd{2i>)zl|Hss~nbRHMF{yLRy3_3ymGt1|W>^pbs6F2qK(i+Nt^R#Y&k+?KxAE6-{Ky;09Sb7BdD1arGFgZto{np3 zHd@Ll8RR75wraAcky)3+fV*h*t2R0W;l3cqa~NuoVC-W#wokz2-G|pdVF}<{mHf-$ zGOS$OlUYm6nK?JNViKG8E{vyouxc$%K^>aW_I8->iQ{&auJO%QK_p6$hIHC>(>E7( zv9NIn{-a3`0Tvw$fWjOz#USwiLVzfYVvq#Eq#evRUxvDWHS0=c9$HI6-xaXoA@a*& zCy4P3kLFE|7fW_=E2sROK7H@kp8<2QE|98PFq?@|w%hh67B&N1}no;P+>0 zA0Cfn;+TdsE%h+WZG+xmY*D_4%>Rfjo9k$-Hk(i@C+*cNaocuyDjMa}CY%>7CL3P= z7aQW^u)hztBA@9%?hc(@V6KDa1i_t|j(T z)DWy^^KX$(bAiyyrPeVIrZL9mINA}?!W%>ml#AG4;^COj?A)uiG3@xDn7KCJjbYC} z^PnTEdprahp*OzU*)L4Rp>EPv!Qwg=8p7h`Ncagx%$`YAJ@p zs9>;MOk-O#{P`l3_!hsaSWXB=!f1Btx8Pb`vYvcFXPr`lv)_SROt7(J7UAp$-VOE_ z%H?g$#t;}5VSa~8h@!Gl|!Wd(wPA4|!jrXB~cB*YC<% zP+~CJerQVuZAurL@qEE*t{5;ZO%2L`DFq~p*X!YG8V*b%<}z3@Yu z^OQm5yg3L>r93q&+&B^-tF0M8iALJ&-uB*RrVW|eNU0*3@E|2Mlj;83m&`8&OMv5* zbDjT@jUoO8r+o7;y_nG6Zx?;Kr1pHILc4o|%8(qHY!*Dn7cjgStu zNdP!XB6m_a`ZMQPlh4m1ox=<7zD4vdY0@|H``#}Qf8{N2zfHW%oIcE3eNZ5t<*m{# zOM9Gn{PWYVUL1V;>(}29(v4Si|I2Xd=WJ`TkUxib@{lBM9^NOP<=amW$)^YDQ)<|= eAKx9QA3c6VzW(DQ(n~K~xAp({^o#dm^~vA+`8q8C literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000189.log b/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000189.log new file mode 100644 index 0000000000000000000000000000000000000000..a985c594f586f84e0623077790fb76c301fa66ab GIT binary patch literal 76349 zcmeHQO^+i2e^P1t_X4AiHvehIbCmd+I{JfVs}Q8BfBvsG@?s_kmMTCTnLqxb%FH&&Vt#EURF8 z>z$oWXTRIsCLZs1fA~-T`fvaI?XQ3HlZ~I6S5vS1(c|lW{11QggPs5Ui|F@WY_JCe z3=E(B&S(99|J4uXU;4y=@-zBjeI5;aifez5$NX0t-;`w38H)Z$_@(U|9z^10X`)rE z`YJdWmA0#mcCGx~mpaN9rR`F)S*cY#ull<4s#-34rI)2>qQXe&3qCgAKjC2%iI821 zNO0XBG9LPDPuz(>O~xXOU$V2aPU+poAJWem$S8gz#l3mVzyHTi@Sry`h=n$PFKz$) zo5!alA8GzEj`7K=UaeNHn}1vBhq)E~_#zqigvQfWylT18HXkDCWqzpIZr2;Na`R)m~?Yyo=u^A9NP>8*31!w!VjJd6dNps$iJ z)>HH5UiS>j!%;m0(%w6 zJNcmho%&zn3c&5G=IfspiT;_u1?X@@ME#*u?(DC1_AB{k-vks3w%LY8aQb(-?!o-B zw=xJ27`fBG#_5Lvs8%xoFE~G*iAtZxpI!1;%l?S%DnwmlXMoqhAKIsqk3SuE?IX75 zJrNJ#{If$X#EsKHt81W|hxjaW#OF7lb7W`-S^^hx6!3_h>SQv?xITvMd0-(PXov2- zjAud{RRuZC&x)fSi~uMDYz06Bzn5CwY_V=ECPN;wU2s1J*eBGFlYt@Zig0g@I{4h& zOF+lKXGx#!O5qDV=3(e0uqOLi_8OES=zN*aezJ2Oi(7WUgZ?7?_4?y|cu+!}nE;J^ zB_>HPkml7+52dWO;h!M^QV*pPAoLJiQFbOq5od3BKj3#x20&o_TR`y<_7>251Ur}g zArIK83PnGhIw^dJ6za&DEO`BoE>U_D=%9?9NG;iAGM>QGaWeQI8Bl?7dK0`d-g`kr zkAd+8@5zAe2keaZ@JC-dIed^DU_}>zUbqV$9Uj0ny@6-y6w(K$hRa?(*E#ZN)4a#; zq@P9!V&v|@huni&u1)ahG!4oajEkz03`OMJ(^c|hWv`a6h-la7N})m{Mta`Y?h1U+ z703+`Dzr&PkSsycrNupcIZ}7dH~N4|p|VFN%u?T|LX+006pAI-BBkR%I)m_GLdXr( zDzsySdWl%GBMtY|iQof7(5h7^)^6`T6?0eomb0B$i)mI9fec?Ht`AdYZwkHX$f8HG zs8#c*({G{AIsF~3qZnnKyNL*8ILMe}hkub`(N>kDOH=%F+);KM4peZ%x=7lKn^C4- z)Fgx4`G0S*ZmUX$0~UYU8)coLMpZJZhY%I;2(`nHh#P;{37|;ErrxUN>;4?`d!qV7 zsGrk-FGXbT@E1}(l?qj^n;!m3&fz~%LJy4YNrIVEJ#&v@l|Z;zCregR^s70h_moR^ zB*I7pPU);(D^YKG?c9T3rPIW0u61M_JM??&9Q>BoqWA}U@M*Pkt$GrbDsM$Nb0>ct z>?^Gn#X#?OO?p13M)y(%Tq8NGMZnp$=4fv-(bSVlmBy0Y?M~2bhZoJC)zt~rD=jh! zkcuEDBgS@6sJoB!ur|p_nfRGvU59^xCZ$TNLa85%e~#Tf<^#p9l&|F=5wp!R{MFrn zv^#Va&!^HV=SzS#zcvlFn?zqFB92hB9-&FqiC}dRG@DdfKD`7vIRJKm62-oZ`ih-w zvGXnFZ$S=vl1a}yUG#okgql&ZUG?B9zgq53kq}11402*YYGI$4;U;d^BKMPu%!Fyq z4$rAiU|*$z0E<1HjAuKr0H7W&B>LicvZ#L?`USWLpief;SoCQdz&cZ)9|TB5GGCx3 z0x?;H>S-qiJE&m=Q*6XQ#RFChbUDPX2!${Eu`t>nGX)-Xj`{uW5)``x9+mjA=+luf z62OwP3l0KKXQD8NeL?K=Pd*(9qX-BomxR5Z&A2=FtMhNrI%EJ~&%H?|FVreN7KPdX z;EW>%mKomJo%=%PzSYjvIXU#hP8bhWI7Px&Mv>F_b6L^8au*zcKhkj>l7WCdb*{3v-Va8HU#(rl9%k6oo*(azn`$Cc?F=ZHjD5 zC6J@^-=a5u%ue_X&y<%q39Mjt+g`IwsUIr=dN>NZGW~d%&UBSvh+&Y`{_Y~!d5T4f zeQI8#O*LN}rgUcx<%S^z;M!D#F@1cN9h22sN<5lD5`D*bKGj2j-{ADTB}n0?IX5(a zMKPvQ$`BIhs^lgRD1KYye4G#pc|wh5{vDthH_Q24&s1{9vt6kU{376EN^SlPpd*0p zLPs^3sbi}Aow5)OFEOwVZ&SNa13OwPwWKFd${vYm+EAOyZc`N3pXR}=n`hw6mDF!Y*^*Je*Js^Lb z=rG$|GxfzD5lOFmlLJ?(ZJ3X@kWzpY1j(K2wQs->W zoy~f)QqC6vef|%5&y=_cwufy)Ds=F#p?=CWvbNUV0NU3yJ9t9OVMVRKoXtS`XR7?& z`7c1WVJ5U$TJ$W>bCE{7wDHBru{+e)o`^&*O&0LXP`^dxbAjp6b|kUkC7cSHtDsu5 zS*579%lC-DlFg@B(WUy?snFhX(ZeN3Q8y8KVG|h8Cwtp1`gFbpkuKJ+u>)|C18A&tw>lvewrLpr8P#l)DuGZGPc<$`Qu;B!eW1r&*@W z!Cw%5s>ja4PZwNWabHCNzh|dnJaHFb%^A=}15xh3l>kk+q0bkMzHcRloU8k2#5YgX zEJ*+4Y{43lK(lGGBhNabRuXi%x!Daf9kK3Mq07#hg0(iH)|zzLPl|sI|9L4DM(iD8 zIi&MJd-K3%g~~UBJ=Nx7v8RKuQ|#8&v#HTU>K4;Jo$gsj_cX}0JSqM;^R3R)inm+r z<(W;3f$t58w?{kE9(?M@y zWEL}HL-uUyRMC3ZpiE_e(`!(r=RRA1R7IO#nhFTxl70ln;9vgsum9_R|LnJ(+a>=| zFDZvjCKCfz5VTExSPt_RJCbJEp~H@qE0h^)*4w#pS(Rpn_WdbRW2gL{2O}4btsNNG zTeE~LG*wHN<%;=tH*N->>6cIqJS+7x!s1*S13Y~}$qks+*WGeOY zG$4n6A^cIJNQJ`J@0tI3ffnG9y$;jZ>Z$7SmVz)e5RB5({H{ZmN) zRLNBssSI*DWcIM|ZpQX?EV6#TgT4s#&4!r{|E%t@33)mbX$yk({iTLTmy0ige7Q=F z0J4XkMxK3vKCm%+g>neC6Y!zWdrt4HQ4v(GlKDrg`{{CsYd$qj|0%z7$ghVy)sSS7 zr=#8DV93XkeUXfocCI;>r;y8otP90ATkz?u@6OaPokwstCE~4-bVhd`$gfZd+Gv+a z!ruy@xEY>6RkSCpMnu)BSYR`x=X`_d)nOrg^=byGgZB zzK>=4Y3Yi`q^Dmj_5Dw{nRM7&1Tza)4QJxKsO|;qj_H@8Lr23srG{S zHz?I(OHOFl-|YH=`)Mj2^k691u9AI`<=mVcY6a!cq@n;T2RaJqUSrPWCxpU6pbCGi5NK=A!Psqt0i0c` zTQzWnS8Fvzf`X&0!DU(jN;{%Qn92n7uVhb1z0?o3lzMmd&jXHqMcu{0C`kS0SK!i0 z$kttPlYZBbK=uN-3iN^+2-Eqf3`}|h=x|_HC!u0HTB}=!{<;nEbO(kR%T%Gg(Q^*_ zo2sCl&_`?P?Z?uM_xNDwrtlHzpfUllU`5?KW&BQ@GF11BXu9I# z><$vw1zd=TXg0`&gcg4~3;$(L4onw3dpivTdK;I#Al$0O1|&BeaXAKn0CJUo&PGTy zU7+aP7wE-4(9PPl%U6e@)tCDCGKiqk?xv=GLmm#JG| z$E4@b5FA~=fxHdbULtQXkRTS>{Jfi%{?PK(t~YAgj+aGR+6=6x0%9u(+8!JVp)s1~ zXGdIw*=ykD)o)k5qO>%ri|oz@ni$2*+<^!xx-)J@B@F!3|stZ zGrWVzprOQEARhI&#&{YhfYmQRJ*Owq3V^o0T^ZZ~f5gNhT3Q$8R#m;%^FcDWOnE*Q zdpaF_U{+Plfc~zEoaSFA46c;xR36fTPgeu&1OlKV5o{9j<775-nrC&*gVRrTX4plA zwCX?NXo>6&C6s>F<3v!sm<4bPnU}Kw*bzz9gIefmrN84#cE&M-WAjUu<=@;k>>@cx zuTHjMTkvVc(;WuNbmO^A*z5IUKl8Ui+LiR=|Oc{X^U{3HIH5eV45zA|^r~FNeJ*{{!ZEuWGW9KRWxxA?L9r#7Trwp$JpANJRr`UPK4!2I1 zynTm#LF~yoLyLXR#H-^dzC*L)1s^!2Gq+=_jGSpS$ojSv`PWSk*Yv1tmX!ca>>Oj4 zU?>q}sRWgSNso_YCZp&?P$;3;s!-gT6+w;$dRSz)i`+_fvZn*T0QmKGm0TuxxN9hV zS_54{^PpUoT_q8wI-4D(59-En9OhjYwa@DiQ*3;8ib0@$Isw#aq4_!;NP!G_trY0E zYiAS<`4mjgM5zqD>}0S4+g9^h6)LxAWkCC(*y}6Vk@_mhgkMeos|lb=wezL|$myTx z3^CV@z2%s)n%(8-WI)K^_xmqDZT#^k^0^6P823z(pH>vKKEhxd#SV#F^1DEy z$JE&dAh2$!TZ>$BXJtY2Lf5FSz2Y)-YN`Dp_&4(J0_~ojBJ&&I62w_h8cq$vI^wtQ(67)?Wx@A%|IlZh6$wf##Tvi?iZ<)46X7zla=pYtg6uB8<5m zCT8FG0q9X4#u+oPH0Z~{|4fO0iyXFU;in0T3)x32FDN32L5jqouVMv6R!}`S{B3Hw zgGHZK{#R-Y(`(j_+>61$fxia$?d-&Xi)4&US82PHf}ax*u#+T^*tB*kb$>VzQJ76i zI^AD@9jbY4()Y9ypq0-P!wZv|Ne?*m3!q=GG+PuSvEMa*4_$)7jzg?C_1P=!XL(W6 zw6w^~bth0%&gl`4hM`ukw8+`27J6Fm9|&yMgyls`=^!!X5E1^g#7;XYynmJT<3gF&g%SaewYhQ62~4jxM_GW(XD6bea!^gyi?Xfo)8-(j>ByF}Ulj2+6z zl&LIwLQVojB+xEX%&3(BO##9A521zFE+%U%uUv5G7eb$`4zlRe)j_rr^mvOM_mtLH zzN1XvZGO9%Yq$a4!n9TGgm!r1?dJf(xbH^0=60apS2->Q<+B~$n-Im+imAq8OSbgwYr zGs^@y?Ng*qv=02KSj^&|qkZ1W;6|hN=giDn%1}WL{(|t=s1U%yPir5*t|M&xLY1^T z`)leRvP?GxKWF>(YaN*m)UJ^JQe%ue`UQ`^+0y&$z?l^NGR;50@ZO*U6<#NTUz0g_ zq&|)5arhU(ADb>3l%fll-r+fJN4)s zjNNvM3vdk<4m{A}@&Aa|&He(_QrHyQN5SyrgRA~oY5SX!j5g&#{Dsm>kAeyK!Qu+cLk@5W#9-@9Zgl`xLj%*== zlfw4Ioe0!q3=a7vJ3H%?-hKB(2QomJ;c+a+QEB_<-;{#1_h`E`e^UGgzXzr#8HafL z`O`=f^v*xj8y+OW{Pfb(J^AFvzIg>^f7i-&^KUEtUSEYiMx)qoKKJ7{na9H~HUq@x zZ}PHqXMXwfz$hIX#klmg?|$*_<#!*nqmnRA{kSKe^C6`~e9X=a?gt>AB)vfPOG}@! zUVrApE&tGSpRJDOf%!+u`~(1>f1;)D^yddD)``I9d-6!#n8(=0V9p!BfbN^W{Z0^| z)o(mOP6xsqA*;Dv;z97;m%w)4KO8H39b?YSOE&}T95&y1dWiN=6n4cibKU$JAAi{u z10>?=Ll>Z|dKjc`yoh6}P~iW0WO*AuCypKf@~R=I)M@-463sBZl9eE)i9 bn|OyG{qWmA|GWSA_Se7p$&dg0e?IwtGX<*D literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000190.ldb b/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000190.ldb new file mode 100644 index 0000000000000000000000000000000000000000..2f8769e88e68d914298fa968bdc1797bfb4699dc GIT binary patch literal 25884 zcma&O3$!E&c^=l6ojJ^CXYbA~yD)+k>|T%nGk3S%kC8NNz4~3Go7T8HeMxx3EzD2+@ZclOj@?_BE~ot-`K zy`8fo?AqB`=XF*C*Su3_5FoY6hWE{KJ>{>=b=Z< zN7+665(?MznmCX7Ec7LV<4Km_vb^LPk=KH?zRBBYEk3D5Ou2IG1Q%~-kI6jS%beBAp z!Zir&Q!7o}z^ihj1OuGhde4b-^z+x9f-6rXJ*F{+Ca{|)xl?3mQh;gSa}pFq<>V)~ zKGJlqfJu&i;#!&q?PdS*Gq|Q%8YJa&V&~dZHTu*;Qpe%md?k&X|9jB6{DW_UM^}ZD z2Z@`05BZ;)&~CP?Y)SzS^0=6RbFJlCprug}bOYtMcH#{qCbHk<%RAMn9&X zl}!fTQdC)%=A~nw+_po z!HsKY=c#?W=rCJ&+YS6~7ku>GNw`-(=BD}iS(X+@*SO!geC@F_xVQ!Q@6qhKmm5hr z`Ai3W@$JUZfBqJDR&buhffXE0Zsd*&_V6G5%43;P6uUIHpZI4?p4+_IfIu$+gMM^6QBddni$OHmoBolB|t@r$odOdcsJGjy!^?C6oKGT~hv zeJ}bik+UN3k|6QUjMzK-taM9w)%CfGkrak?-r^)y-eiX>9FmQR zed3ByR>s@GSZS3VT^;*yeex=R2SFe_mF1}$#N7IcpYWeNZ#c_JtE7C=$TALG5-xLK z84wj8`=76rPV#Vm<;uB{aQ}Vh<}Z_-E4gEEKlh*doe%v`XEW) zab0+vb7ol9)$jhBAGlH!Dfi`%{q5iV#m?CizjOn9ru0+$)-T-m8(p{rj+Hy*nQ0X8 z={leNp@&}k58p#Q+PM_&evx}ymIt*_I%nX|4?KJ&Nt2I#@VXTn!TGK8PA9nhKV7dO ztZu&FJ^H;)b@WG<0^?|W$=SdE?xnDN;@ahZbOn;n(Z9T8oF5^V0{iHV*Wfo;M~_@e zjLUDhmIPMx!2NH@z&D*dckHvT{qO^iKH>$nlbk*9z$52@4GHC;<40WMJcyfzj?v)q zmB-HD1p_y5j((2)8`s)2alZCv#-CkDEyMYLZ~g4i^|PcpH!pwXku0#vDnEMek)2~g zCOi7BYaT@UmR_m)?Ez4}`azK~9Wg zC-EHZvq!&bJ(iStT4av(v3Gw7x%%DG*KW?|ox8JF{nqSN*K(&$gFpVt?{$v&PV~f2 z99_LN>fHV9&Tsv8=Ni1=+3WwwwXgh>&UGkaY4yaN$8rY(x+u>c{)bntIi-_7`RiA& zm3ieHS68pTxs(2juRQz7S9ki-^4iUlzWOh!OMUfg$=CkIAARuZjn4dm8y)H8KbLR7 z8~w@u()jI8diV49|HL0W{D!MX<0pReT2>Xl@${vty!@KaKH51$ANXIe*FWF-+I@3PNK3oxpn+kzw3Ye2bW^+^0mRg|4bA>rakE*gT-mfI^Afp zI`?y~*W=exH5trWeIQs~Z%;b>5(_ueJUZ@NJN~W*ubn_X`r4PS!*e<1;ZI)wlV^^g zyqx56Q_*928IMjG(%l+6i<@zijBK?vAr6h$_WQKCDTEsF!oC_gLfYjhZl`XB9%HhF zb;buljv1@%c<3Q#>L{gq1D9SmmDCktd&6(fmMf&c4^JtPn(}Jm)blJ~*)9f<3+MtHmiEnjC<)u&`%Yy7%avUL+<*nEcxq-j`{wINd{B3 zjaRsz_cD5GyBWP+O`_J{o>IvS-D=e7uu)JgVI;Sw(B71(LoV@SmdrqGHwWB-yh&>&&yKE6Jlufqo2kH7u=w}k{1cOuC zHs}?z2{r+IF0^xPVI0fZ=NvLP1>ick|kfNNnrd1UGljcGMr8uIOsibCOdV8H?>QS;ag4j50%7to?10>}#7*84X)H zW2-Ip>&1MFm#6D>xuWKhluyoR-VtTopa&wpJl_?%I6+SpDb`qLvE$kT8=+_NaKhR< z!B`Lb{+T)OHQi~()n?qZgFZJ%S7T+lO$_pM1J~o-H%|^>-WHc`5G>8I73>Iq3kUT|Hj^(c#aRe(J4%{J}rH^ulu;?sNa<(%H+%{T1l^ z0=K^ex*pyPL1$&2pZ^Cy6pC$?$HiBEpmQ{S>;NB~Wgb6QzXTf}{r;mLx$ze` z@pIkIL$@A-hnIjNlh5&;%k<&9L#2rRmtXH(Wgds`E-FI#x%b1jKMs*_@)C?39MTq& z8Yr0~1sYk{xze3%(UQ6RvB&KTbiT}kA53q3_*I>!F2DT;UIMrafH3ehfR#so?~?$0 z0B{~)=1W)^Ug`pTz~3){8|MTrGxP)H;W?wbpL*3JH%~6A@?U%5w&~8vQ01oRRGqEX z+OQ4BOcfa<>7t`q+9Q*Oih0LLMl8pTM<(HxX>2Tp%{Fe+knSG+q7HB_%^el~0+^M< zOSnc{I5#i^y z{y{=`xfaU@)bhmpt{nj4?eFQlP{9XSx|__|oc5fs=VeHoQ47PiRr)k`7ZWz$;bNEW zp%TmOw-yu>z|pSC@#JEMrVN)NHf;?mzphozu{@r)=&jUF<|}JotY-3_v50bzj6+PB ziR`N2Wu?TyXWSR>y8><7-)X<{nfva(_#Z#a7w`MmpL&(_spiEO1a~({(lT`RZC6FM zOUCe0W~lDWYTz>7UP!zWo2|A9HLDYS9eCUlANlr(v2i09YjM)Tl?#6Q#ru97`as8Y zEX;%^&@w6TXA_|*k|8L9v>AdSSmWqT*BlBnZ~xQ#o_+DY7v5i+hS(KW23eg_%-R+; zQ?8xVT~g;l?{t%3r=x}Ap5o%U`jT-ND$~~ciqPWjQaA84wx=vPZk(Z=*y4aPust#u zsZNA0?P}V0w{B6bd-Qg%^mDhCCkNyF2T}J2-@Jh%2+6S2y(|Ui>lg3qFyM$_tf$+= z^Ml$W2X5=q6MY{D&aj)Rjk#k+V`Q=KsmsX->^9kq!s zyzh>KAO_~54vv$A0d}zra5%?eNCzco$6+ZF9&OQ>Yha&-hwr!N^66^hIVP!1qj;Yp zQRVOGR3Y>!i8+X|7rMn1^3_OkUVLGY4RE}h&E#RZV5%N#X<2{SUx|~EQ@0~AHfw}j z;K&+VEeCy9N(cUafb+qy*WLBZ;bsa@RgJ|Kt9S-2Tb^cZT^qF(>mizFjSOHm}9KK>G8B zof0(PpU0CbO}E2%7A7?Zws~5X_Borc%85RmZvYe-(+u&Og>Jb6xs04xObudRP5jNY zyOoS)>((oE9?p~nQ_{%ZLQkG~@xJR6gVPv%{CgeXFBfKcAG}}}b8%yXQ}jyNxS_wR zxsjfunh_}I7M-Cyw&^BX#Ldxq?#uNwM~itBL^z6bL)Yr1CpSOx!h?4R!ePL+jD<6} z#ZnfEX>cz6i3bb!csKjl!6bnk#9t?8LZyGue`a2G7)(fw}Qlt*{ zj5u`nY^e8ydEHE@;`p-<&cFF;O}aR45#Svb<^ap( zGKS-tI74Hsi`x!KxGv_P2>ogB6Yq3?)}-t0VBw0!d}{UP5r;))PE7s>N2V6Y1kLtL(a5jYixeB78!t zOMK(6v1sM=b0I*Y)UC}~T`paGEng%S%7MZ~vk*NNfw`{f+K5BDgiTNsh2ysA7~nIG ziD8!eX-F)Q8`Tv#T?fU)0D#KbKY;L8PUHjVb4xnfGmQ2J12p-c{$16HtI?v$$hICrf%z_Vb4&jTnUJ( zu|&D0$aTN4;{MFUdeb%HtCoYYK=2A?x00vpL4N#WCm;Iio9;kRV6^Q*y{1fyq#OsM z4Afu{oFNIQg|tbr42jVwP1y&lB+EuGyQ@vp)8>jY&ohY^gHi1(B;hEeBKiwpedIHm zUS6bFM}THZk0d8X^xX3Bk&%U?Wt2xMvl}H5HxMej9I6^Cvf?62#EL|^gFK66%!s5# z)*ig%?$=*;ucQ6?>t0T-w~<{-l~Z0+je(3=)2<;K`IsR}ot*CQYNF|)Xb3AwpH7UB z=JI(F6pJA_O#AcQKwy_2|HfN)S(a?16JEKfE%Y6%5(^aKur?A zD82$Iy>W1MSlSk13A8{fWVMV22M<{XBs<`BT5%@rBwtiC zvEnCviQD^(Lqu&XE1o7{U3E!t{ife71y_b9E+4pn!bXbATzCkHU^q?R{pPFhb+q4n z^~)aeblYF6S$~1fCKg+++@!}511CxPTHi!ByPVE!WP-L%aJzyIkpB!xay{HJ5E@N z>+j_apO@H58EF{{*~;pbUP5E5WVf(%hkWLXZw+3&mv_MVmmTDgRP9;4!3m*arxHbt z2YfLI=`tAE16mrfbvrfv-n`ijg&rk0$cPVYga~pCLq>*?tJP}pQc`7bD7LJ_7zl0R zri-vHZGaI-+Co{wG+YyPF&vr=(mGgU*yquR8G13y2+qx+*G#<(KGLdR=4`NRwrkQd zvA&nDbL-$DTeROVICZIav0bp(YvrOpg$#kuHdCl(+q9V=NU-z$fMXY8ly&u0Fh$fP zC@4Q`uwHagX;2bH81n8nUURRb{>E!wc9Gj0qD6KVRhx29lWtrpDJ41bWFk1tRw`G4 zD)fjF5xmgZ^o70{I*7PQ1b^t_OwUuR=f3>rJFI2709-AGaB#>Y0L)Cxa8ZmUSeLL! zgf`XYn8@ZjBh z9PJAazHE!9hw5q=55e9&L#a25qCb|3pxRCub-PvheX{I_JU>}UR&J(+h+$#dPSa7U zw&5}x))TP_UGj1Yr^1&Lba5}dGO%r%wIT`QJK&`gYRHAXTfi`v` zuLR8RE*qmBq)TU#+uKclrI8ak-0MmKh4W+skQF9#(BgdYt@k?GFTV9%EYJ(9MX{55L~@%y4(KFcZT9(M$X%WP9iHJ z7lfg2MjFc-3sJeKyK8HnAP%)qVQxEUP4w{vHePNP{1`3z=vGy{+$!?9$qMtbkarm`m0Q&%%98DdK(cQ6av*vV zr<+ChIVid&bTbZZB0!iD7G}_xWt%p9wE&G6gbgh)Wk3j728KNk2BFWmbAvrytyyko z%BR-AiLrR2V}pp6anxMw5!M`@=B@3W9DnAWFFZ}lFm(&^4I}6K5x)yIJ;%j&v*~7? z3ckxD`<+8^xbE-qI$POmHG^7SCjG%TUw9g)NY)VtMQLF*JIBYgLO9E+m}~3t40R(l%6Ermj)^y8D?+9_S=p}l zhG)@)RwQ*3AH3rcKt})vzfH}p{{oa9YA)4-kkhv*regeNyMjbE65N>FI^KwA+u>m1 zh;}+G{oYzD1l^9%L~?i!Qpa*yWPU4NAP^V93>$YG!zEb+fU1cifP!4abuEZ|#zrg} zG7HTBj6H;mv)Ib6gO>Fu+w?`|j3%sVZpFHXpWEk&yR(c?8lPb^n6w;1W(L#DVb?B~ zd`bxO-eTMiv;np8LnQ4-YrC%-f!hqznZH&iXXJpQdTX#7Kuc{r_dwI`g7cBC_0t9&UgRu@&qC&qnLvyEw!I{0`PC)9T4?RZ5@cAILt zi3Z3l_t7e4M8QB%9-q@Wf%eH=E1|}o`%*~&8HLB<9mio4@tUF-Kr2HdW1Byl*eE= zl5eK#sX!`pzwYrcAv|POXvfjJpP1h3c=i+1Z<)j-&|nrUg*+I`19v|vsM3cCM7!U$ zc`sGQ%3Lbi#K~ldhDo~IYWtmt}WK z1_eYqbQJeOXK=oL1wcz}wW67EmryqGDxSzhxhhtOAnJS(vSqd)cD|hAi%eIPbhd&a zSs(Y|<>OV#_Vz>Czpx1y!*VIh#w~_|m@z2UVqsJU@*XJ640Kl*X;UUe0?T%=iSKN? zbE=y13OhL8%tpN!kGtr8JxUleN{YSYjvJ`kt4sCjUR<~LsrGh-IH`_(ty>v;C7Z~B&# zB%DVmleyCyp!7gRX=BV_T}6&9&Ce^B-7;a5gx+E~^_x2Jvq&DA=}Ib?(T)YJ4HdlP zBoyu%goB}o;~vHdW{19M$9$%}jYn zxmrX?SYMpSJ${}m&SF+gPP9L{{|1ecEVQBD29(r)2}+*klKpIE2f`K^@N0i>8yu<& z2D)62D1Pni(FsWp6CkJPUOl&4+L>Td%Z_oyX4eB?B3B2ilmt{82bzC`a2*Cg5C$@> z%^Effa1Aq$|Izd@3K|~5G|cCJNxj1_JXcr7bVkA;v=HQ3nlW8rF&jjZ*APP$+J<#d z3CMJFU=(l1YcAZtEZpX(qAZx{TwjJU)(6I-ACJbPT5B4B(hVNFIb>pYTliCVJ&0FZ zE7!6G{>-n_*Flwskl!Y5p8dSOLr+FR?RW!xSB~Bi^D`BkZ}|m^`;m4DTc?$<|24T zHkP|PbFkXjd$iW}kWSid>$B`Y&I@C|T0+p52%-5KnOb)j2YNF%jz|+vHrB z;Mrc&*_9M?2Q2>x0@oiWj{l$6*f7(AXo2B2iK7hQd0@|I_$iIp$6v=g^yfa0-%$rT zSln1sBLKC-uwb>)Tny*?eKux70~`!>a|MR)TU$B663nw?Hg&spYnFf-)gG#1)k<7& zi?OjrR=9`a*|fyLt~-;RG)u9N313(n>YAHcN`W2X<`D)bS%SFxDdAp6`zhgD$%J1C zo7q;`N#V*Ry&h^5^|oCM1STp;psgHk$g;W*+*uqn&^{rysBn!rQ&yC|AC1-RMKXc- zK%o4B3KY^hX_|~>K}T$0P-+;k37j+>2Rc5&p+60yiD2n3r?w1&BYVy|Q*{+>ioMNt z+3XCn{kj?R(G*=z2&{){-s>^y>vBU=evX7Pvs=BYBL?OK8Bm8z)Mm{T`3cJV8}vbThO1 zu6)6uaf@swXz~!<&NXE2hf5U=wM}noTllgap`}KyurfeLD{IFS%yu%thv4@?e^F9N zZspH>^j+6MXn+&<0wr+%mAHhk#bStv!--`y#%7SIaYBrwR+AJ-Uqq^jj7*_FQbuEw z88SJkyQZi%u2s)VnH}Veeh8dP08oF`eVb)~9+}2X8#TW6r(=g;O&G5O9B^?9F-*ci zsfYhg`ODxXy=sT87aZ9vV6M}Y>u{S-&b?yf6PYuK@Oj9$QRFPT5)>H-opd#qxirR0 zTd`>`6DrbD`|wkKyy|VMV!TTYhH;nUF5hlO1YT5QVY5Jn=C;cfg(O=in?Je#8i+Qi zZ*LM%v%NIJa)hGC(j@QaU8>z7IuZ7;wO>Yy&^6aPq27p9+BEnmO?)gcjD2rIV?AXQ zVnQ7{X`~zi=Nby1{rJ=G_;HpXVc=^a2tngEaPbU9BRCDD3zQnta18`EKMfNvqR)t2 zrJpfPrWVY;%CX^W%61K2Cb+GpLg7(aay#ER-ue(Yh7hiH>)A@xc6{hpbKn>J)SUzi zR2oi(o=f$>u%JY0of5e6RlJ{&3pZU*gJnEHhSP`Ny&L|l*I|$03vu`7t$Q8q&s*P0 zC)=^V(AKQY7hZXY$}Wd>=^Z8L9yOhg`S}>hhC@!>ZX&un+rvOJv-&-bM0{2ZENs0# zSmpS4yVnuQF|gzR{rS-%$Zn!5cXnhWD;xHaNRj`@vL_`6?0m&!)jS@ONA>I;enwajw zf#gCF(CM+j8n_gKI2hx?cL4Pdj>6TT#K`*CFfEt;YR#MVY1hGU$si)UQ3g?e ze%{-O=>!AT0gMtml@lx!Il)FSX=U3bsn+OXHB{GiU=urQLu5AZ&9pg1NMpM+?QUaI zIUAdUcJ4AYdop?Pz8fq7`JckRO(}l%73d@?6Rpc}08rOef=<|;=(Bs%FYr|_Fl4k3 zC{86SE)MhDCH*zA+Ju{sTkZGj#2Amw=U|RV8-F&2*Thkh!7&>c5(}6ljJA&d8{sBv z0&K&8NI`J?P=~p*()DZ*#S2D}!$UnmTG1ZH_Z*DFmPkc+ryF%g&e_RM7^C_ z3xQ0OdA6IIeHl|{Bc7;XhNtXMDvKS970uxsTTG-HYgyO`*r76M1&AcF+6SY@fEz$5 zm>J!x6NdAzXohdg2ui1!-l(#_u^rr=%ef`X;u<830CR96qDDQ2^+)q;uoyV|aXFf^ zMIT5ERI(@i-GP#aVH|4%X@=sYVUn%|B?d@nngqH6$O3{kO_RiI7o}bL;3N59#hK!! zCKpJwYf;D0BqPiUu}=@sU}2}bGlJ06u00JdM!(8T&l1u?0XA{%MqRn-)NBU5iV{J0 z;u4dZ&ngn%6S3>L9&j2{*KZ?!J&Toou(f0I5IB#pC@;&8zwG4s+>3y_0WIr$9H>^ zg#zpvCI*Bn=tp1<4xE5PBBWsf$3`4~>6sg-Wit*&94&wO>#w`xXx5CgR?{Kq@J@RM znz7YrcuH)wK$(bvk`z(xch~-w<1gBrd^Vr(U7UBBLF|G$65p@*?Gh7b+g+i}ea;~0 z&~>`$NDr*W)Wfk;GeW);P3Uv>v)<}t4siqTh5{ku-FvG^+E>hfrOi6*jsmq8g-bv8 zBs!Rm$*gY8M3L9p+6XqV%OaV5lThnEA?ZH1A5x1Yw+H?nN*{2qHw?sqi6(jc@N4!! zrCE#vl$ybk7z*Po19NEFF;URCp)PSOU-@O|hL_%KcJ4LFtQXA&1x;`q>kqT#V&Kor z1nougnI6gkd&Z5BL-1%>1F$q+VR{c=l?;`%*0SAIl0iqZ=2VLo9j`W-JmF{=N8 zEbYeAk>j*Dm-T0qGN5`~ZfOd>o;kKSJoyN)(FjP6D8$8pZ>AXnvl*b1p%+G62du^t z24=G+$R}tJYaNs%@i{Tu$*ei)fk3*gW7_gqd9xJL3h3&-N@{~4C7+&`2@Hh59^Ndr zwFsjFdAXZ=y3`Gdh+*=$5zzJCm5Z^_Zed)XbYWWyVaIa}g>IsogpCsJTCCQ7Nxj69 z5Bom@+M18P>t09u(RY0-a3X!cbgAw|V zI+54aV$O#;mQSJALk0l^&L<#PFpMHh7iKgLZlDMY(>>r?NkD6k0mDydfoamAAPb({ z{Kt?@ENhdE&qwjPM#a zflYsdY;%$AmT87CqtmrOGKe43>z zzU|iAjVMS=8}4KY#QVq^#$2T`*K%Unk9aO*@fItmvjZl18_t4o2DmgDp^tyzEJjEW zTQQ~!CE0Oplz|%Lpau{Ipr!>*jo~J`i_Nrlg3r`t(;WZSTYm^v3J7wABny;DJdnwA zWdQRz;Uc&8Ci@wtjOR*Ml4MC*R)X(^I}sx}uPx(EK5L9Tmg~hZ-1XU7K-72y(gw2^ zO7yH8t%4Kn8?OOk;QznWfJX0jw6xK(DCWbSN@Ma~^H<9$bf5Ngh;1C%tZkxV*x_`h zIqnE#mk1rM7egW~r;gR4s{8T3_E&w#oG|V*jf2|C07(hRI|0mtgcHS&|JS#^4a5Qt zw1AjpFvsT~{bfix^D}**rKk3~$-m+Lasw)r-ELLWHCNYzWxfn07Sz%pU~iF>4gf2nzG-cW1zGHg{Tf9FD$KVEYsN%%=G$8Lr2FE1 zZvjq=K!G11@b9eLJk9MSv{6P@o=Cq}X&84_jh+In!7Wn~?K$9funur0w z9p)9s%Fium2BcMn0Rn$el|aJ+)B!MW&;QEkg$k|q{6aVQQxHRM)`r}&8b{2)u?lL< z>7Y(``1mYC?1+HX5s=m^(ui`M5OAE{2L!`GmM+*?lV(%eZpT8JPGv-^Cia|*a8WT8 zb%}Iw%%loxET$HgWgP>R!jQcUB$cC9dE$-Cd{X+%|P-W&|Z@ z)L{|8MSIf;EhoWp?5&19#z)JjpN`{tm3UGVCXwyRAa03$c?2`!$AFhNNZhcGZ~o)s zpHhDqcpeyK;0z0rXafhJPnZrk4{Cqzqwl&?1ZS#;sHG!1m@3id3E7O0JL<2xYd3qx+>6m8rihokrOXX9c15S_0p) zv`B9We;`r&@p$t4Z-D5b5Rlo@-}G?8KE-#*KI9QB zvO*)M^NcNhm`ita9j6MiE5xTiUb^Mz@c1X3QoPlIPF4!?OKsQmhouP4}+HIcnPPLi8p?Y0>OF83Gy zYU@&n42a=#e=EIW8|d+~(OXEIG-0`%A&lccesE?1NI?zgkX=Zys10lr=(L{y`s+T- z%ueZ1IdD&19TZ5DnjD1@Rcq!ttWU!!?uiR@q|E1y@cJ*m`MotgQ3gy(t%v&swLvv5 zvD_4mxv5d%{ERN;WJ-<-FGb4+bdWL8X-!w z24s>>>#(k^1&B3-2IGeVmUW@i#Pw}V>EH@-9s0xEgaIYN$a>*mb$$ZU_YVUbf+8^J zL_xm@sytv_8HWP>k%`zSw89i&A4qx!vp@Iq)*a7S8B^RS^~#=0wZiPM+M4HeFZ~W~9wnl}-Av8AmOtbTO|>teYtPEO4ZB zKUxHipwAi4+G(7Z>IbpjbrM)|^6rnm=Uzwqqwo2PO7p{`MD59pQ;i-Bw@GXDv1(S0r?w2 zbomt~&M(M$Eb21jsL9&g@u|ty-;}UbS?m+CD|1m8Q+Q)|@s@>@?+X6DoU@AMY{1?3 z(R-n_vc#)U%;JFV*PlIzf07u~74HSw2>r5Q~$~$LJUck2yz$doB z7#8T~G1h`2bEm(v@VsOrM{0Fln9c_-s!&VJ&KJ$8dETC?mQ>DyaKc&trWWwGflXP{XaA(9?})B!jGN*!RNoD95e zW3801usHm=-+#k(SQLPX)%(4tN$B)Q5^A(#Ah5$syT|YT1q1^@iD{Xjp8&DvrvZrM z6D+ZiSV2zbZKfr7ybVLNrdQ$;5gOOw>q+SG>+wowF7_xeW7awVU0uK!&Tvyn)j}Ok zr~WR*2i_vt^h|7(SH;>>hNFU9j&`xx?*;o3^hl_l7s`bc>of1Xdyk|2%sXEOWw*!c zy+y66HqpbHvL!y{iC#r6_#B@w3pGJ-K8HSVl}c&8925Or4toGArs8~)4S5844hSI7 zi~#Nc1uJmxw!;v%3A$PeZkz%gA8r6ZB{2jsSrfLlpr^SL?Pp@o$stjo2wuWItk3{; zXav*3T8U@s8atEA^^$JSl#3aK-X~`jzONW&)khP2;iveDpj+M!ZGFF_b-9U%9>96J z5qvHy)ydjdnkfwR(|pp!tq^{rn-afSLyTFCM`kpqd~I9O?!GgRA3z zet*Y3{`+T#Nd*WfP~ZbB$~nIO#udy!pZ{dI5k)U1PW}({1jKkjl{8JW6bky_x$FY~&0+L_pbi8I1-^6K{d+nrN-(Yi@^=$p7{O3B4uTBI zI520hXHk`HHgA}Ie|>(6^Q^0>nvmNicjlcY8( z<7%yOtF@iDkm*np2#PjqlZj1j<*L7GHM(aa0#_3Q8P{T1(;BhTQ%oW_dREo z+shCOQccn$ z+?4t{H;5xzLxk&XzX0_}Z@-9Bam_V7X!xhhZZ}Kwlv{yG+Gnd zh!M2RDp#nkHP!-+1{C+Hg(NCMkWEh93(Siv11S}q5!OqxLG*v6DCi|#Jn7Ak&5*uer-)bKR7R$VZN{`OdZD3 zbY*V+$nL`I0Fe3*gBl*(0%j37ZNja$7}%p=DL6$Pf9Z8sfXF+3`#*hzh5~Gx&)-?y z8AZ#I^kIiMVV46Yqx%bUFk5!>Q-Pr79>vSp&Ga)U! z1;a-2c3Drl+qu$$e7)be+MFIJ=x)XD6d#)`QcW%ABe4!PzxMq%NDS89S^V3ikH6GE zU&4#yKY0Du1r`e|6~2{K zTlaphQ6;0@2}*Gntnml*G>T_TP$S`L@&9(ew!LW1M^;|Oe(ELIzq&Cy=H`S|a=<0kMz1Z;!D zS{eqjs_7MqGLOIbn&aPl9S~-)#Yhqqpc9aDy3d15LevcVeA7&-W|8|Vbs?(f3BQ%Z z1|M_h%-lH3SCg$BU_x?{J(RT=5dyPWUB1{96sTd4Pt^ys}hu-@m2sCdr0sDy1 zsu0L=_<<`3V;z6_O(KP}2;g-DZpnaQ067@y`QLfR9pqH%!$dtGs8y6H;~I~ZeK7K- zXKAsXn`@s)A`}nz1`VVmaI1L6PO53Mh22mB?#Tes6;zrrn8oGdK7qT{l$#ozFS2}6 z!)00+YgFl0t7@k&_jD~z8vG=LaWs1OS4Q_b+Fu!c%N{w&jEgZkkHv^r>o6BKo-oe@ zK3xm!% zr~ktbgV5Olpk&Y>>!c89y<#_B5JWT=G; zN-ns!1P?E>;Fu9BwX1eP;uS+jW%+D2%=t7_z%rYq9Pk$u^9E7Lu~^Y1uR~ z-RP~lJz=Q8HqvTMPeIQ=!V(2;e1O@{_5W)TrV#|}NiZmB1JH0-gE-cHVa&jOya9lX zh9M1TI^l*C4Dmc5cSv&bc)N*0*zmL_y{?i)ABbJs<0{3FlY*bVHJriYbBEr{LBUyxyBE43xz0fBEO1jEsDdh{b1{!`Hw6r7OzvPyXQ((JsGXZvSs^m;d*&K7e65 zPK-3H=3&p>aQvK2_`=N1biDRghe9dl203%&{X!e97Re$aG@BqQdPZ*Mv?(f}f@G9I zbPSVECc|{tn&^QI(*YXa02l^-S3ZcTkcLZ3=%gfw#B|&x{$N=4&?P{}M&vxkn|8na zaXw53(CGj%AN}Fy|LDm(c+tqhO+RQ58(nb2qZ!`$?vZ@lv+TJUATcf62`i3fc$J%t zuX6TOKB8tmY+H8h$<1!k_UNMQ4QlWJR{geArGX{u%VH_jZkH5T3HF5WXEVja(d$={ z^bzLc8G@*5A7~U-9Km!5qGtf4?nj>zD&P3qzkbcTdBA;II_#ofN@B16oZfSzDyBPo+M?ut+(oHFtK?*Tyhw^x;>D3PY+t&(!pD~P<(!@y z>S2x`>3RZyP_M44OIqwqlaEzqJ|kzVg6=g=b*Sg#(w6-F;S6&_WG|?buPW=98jX2Y z2i>B(#=8ZCSq$2!0GTPkY=uXdh~rRIU;u`k6&8_!1BC9vh~CwkO6+DKvUJsO$6cIa zUv2Kr3tbW_OSShLmCEx>BFwu=Jz8A}s>C&X1FOuAr-_TZp{HMxc1OoDmv8m)nMdE<})w1dS9CP-E>(+-~2;>HYzyAAwZ}890B>-$Un^MErsVrj$ zC9f0Rnstt`G&eCO`4*<~0mfmNtOId$7%GH3UtY|1;?vG*FOBHU)o2&^KEu!mKVU)7 zz|p{FV7B5TbOt5@8^h9z+#I70jx;cf>~7$h zhuAVO>lj|i2#!rJtYI&n5t(M5544kPCBde+gq6+=a0SH58a8OZZo2}PVX3JTf@$hvTmJC5awED#j=-DgJ zuZtBGV{dY~6vjCtHGXoDq((cO!~wq!Yt;*~@p=~|ECx@*hIK*38=vXKc8YZtj(O(6 zqxv@CV|!s@^sk`q5F8W_Po$9I1&Jo$FwkYX`i$tZy;q@d!AcwTF51d^eSB;dJL$L# zQz>9%-EFGUa4s7-R}D^|BYcN)!{pFCGNeRww#&nyB`PQAk&R+V)(pY$)Sk@XE1u<= zY3`4^deRmR-&zy+mln!)%5JXL3H$7S|Kc~#uZKc}$5V<8S*b=)4Dv8_g*_QgSM)h+ zJpc!0h=DSi%FvhNNt&Ml0`w1jxOEZc_icLpaGhWSMr|HL4fJ510(1qe1QC;c4j8p4 z5+HuCd>kSLaYZDo*Y@(%9uK9w=+CF8T|C&|XOn7R5cy+Ar>6n*+1a|UESjrKC@W^D zj^z+nB2k%Dsd{0dY2FCF74o>EH1zQvlQbS!!OghHs^$VRrHA>wytr_uh1+f z2rn}}Jhv!s1%ptFt%TV+g_W<5zH(+QZUDxXMi!;LghVIUN$MIFneI;(f4=Aet&bJO zc5z(vm+zo6gQ|fZ0-GyPDxxT$K8U**Ee0=$!z1zxYoZ9t0dfM@t;CA%i}bQ^lJkJR ztV>4eZTm9wxL%zJ#dIDk?p?4*ta+V2_(3LZO%1nVyhtXbSB3eK8C@#IU$Sy4+1cEi z4kCHS(bGZ2v-w_g<9KGAs+=I3@u)Zk+4T|;Uc54%z4CN5(AWO#Yfs+Vm!Tm8A4Rxs zS=x-eidBgTNhiSAYg`UcpOa?fNz68BV;f`joD6N<%IoaZ+Q&ow#lL#}dq4Zy+W><{ zkS5V+T@$?|d=F4kG2sVu6E02MM`&RXt6@J(^&SG}US?N{OsR1~EGfO>Yg;G1##1J( zX$MxiC^c3_a;dv*qS!fe#8_1>t3{o#}v%4^HEDNClYwPug6Z zULx1#Q;%E*We8>yKna+J0NM0PYT;W(P$PbwMD!}2&emsH3?=P2EE`I9#Y^9*n9ZDw z^lIqH#K^7(5&$F%o;W*ue{vWdX74}@g<*({{EjpOx(3Fx2zp~G2Nn(d-Y_r&fkrWi z4#uG`{#)0#j1X?qqI#*6Mx*QPV|Ji(_q}z?-JAQYe}ptDZPC6E!nKo&hlERNLmeE^ zle*xK#N{Z-7iZuvoqARE2FUNN1S&T$6w3REb&2A|rDdj?4q8E%$I5ksg*XL{6+zOk zco1i02FTWdpRU!Amobgusf}Ty(g-)R=G03DhEW!59KgSz5pW9Y90`VuZjzlYpj-bs^~CY$d678kiE<+->7S zc$dLWdL&TuN{{dFNR=>$uuX8CJ?4=YC#_2?pEg&3;` zAX}WmMY`h`R->$$tu;ywdSZk&}fu>d6U&YVEty$A@3 zQ4H%45_!l$cj529+ntKB61o~Qo97@wM1GOa2Xfq}Bju3Mxh4)D>#1}U!W;Dl;q$}C_ zKmOxC#FYYKAH}@d?enNNmU=z4bZUDwH4ZK9SmThHm(plmB;iyzSavG!BqC~r!_I8? zzKBF6y$<<2KCK*QrgSII-=M9BcNw|N&Kl$+DS|mJLg7dN5DZRX9uccA{_YpPfCK1y z5|4AU3N~rA=o2WaMvMfn&_IX(m0@}m@InrY#FV5t_vEgd_b*a)fka3h2hOaw6>MyF z&CXu>b0Uc_Cs@;c=Wz7Z(Foq=da_UJaN^~zIP1G3+#;-iL%8d@ zpjm{78Rany8F1a04weWaM2!$fc+OtK-}}jIHBG=g3q964A}OhRC_QvzW*s*(!#HZdBM_=RC4%{Z zT0qLAIqfP8;ZrBzaeK)na(-?eL#{2rnZ(xIU6L|)9F5zOiKGKSxGRh8$rEQuR^&a_ zVE2Q0kb|hOPTj;n#p&Ao};%i1hwlOCB)*@I@@Ndg+hk08T8c>f>&^@hIr z6uR)oKGNg&A9%t~ImI{sEWZ2hvnT)ltG|EuJGbAx`P0`vpy+( Z_H(~{@3z77mwqjN`H-~Q(( zzxns?KKblB_wxU~i~k?|?8{l2E|boK2XB()QOL)EikC-$THHIB@MJbtJf8G;%D*~z z>&T=#6Tw_eoX!;w6LIJ)W0k5vg%9UW$8Xe|-iL>}Y9gGDQ}7^8}^_BhU51-)Lu4I^s zSpV#FK7afE!pN)GT=_X}#&_%Wn(Nov&3bBUDU8ki?M z<`W)DagEmnDvQ#1r9a-ouf6&4<{hV5IOVbAc-`hgFJ&TAgF%#qVd06MNP<`{Q>h}S zW1g@0k#8@flLezM@vgtH4ZiRCmC>upOv#=oC!OCK${jPAUd18}z#aLu;+nWZ0! zNaLNbZWd%QsKG*Bh0N<-og(wx#$A_${9(+aBlej6GLsQJm11W{lcSR(i+e@f3tslU z6E(PN2fg3aAB!YQSpSF(j@VGd+**1SHg}Kf#|Y-OAl>-T^B3h|3pm?rfAQM6*GFm)AL%qwBu0O&Qs&WBGmyU>30WEx44tmmAa%2#}@UMF*%@!ZOc zT%Cq)v&&G0h%oOwy?E_5W$HQXCE*Jj^4B5^)~h)?Rcl0#7V}D`?t1NGDs(ZJ)07TQ z86*2=sF4I~VGTX6)KrRIn(Z3pN4qaIzcgUJTfvQ~Mxp5PG#eu=0_54Yh3n*Yn^d}M z5zN?ySZ3o;26vuZe4nhk4D*PQ#{9A3@Sq||c35Qx^r4E=Y??>$cRN({{RZhmHQXg! zKGLKzL>j8LP26o-xQQ~Z>-%-mb>?uFM2Q1k)C$=PRB?CxriGk_+;10HdXs|YgyPcm zEp~$P)c&@!>iH#3M8fWbMDiu44XA3;F?Kv+L3ch!~ zQK12^l>=TU!xT1@oUo@^nrz#;SKFbQ z(Q7dgcfMET9>W2Y!ChA5dct3UT|^YBD+_lOPYUbyT2#_MdZMknEOZ%9vXBkbj4u{^ z!bUS0y+&Jq8+x~m{C3-^jzU!3=hmyXyhe>`UA(v`ro%O$)!}(FzxXH(lX6NkW7%Q2(Gln{HdU#e2W&)OeFZiyZHgyl5b13z4#}xR!GZ zcNH$zaFacM12(=6{MlNK#-=I!2`Usth6?-1#r4vgpAEg(a@*h)lZc={Q#Mvn1*ATSy zvN5WN#fZhG`s8qh2A%548PMt2{DLF$OaMHz{*YO0bBe{h40Cdz#b8c1Ena48j>a6s z6>^SZmBqYTXD+WNQvTCmPBS?~&ybs=o)`v2&uOi^%*xwTYtA4}D-?Ttxms@|H$5M51VBZaOqdyKw+f|0iEyvVkO_EuVSC$2{2MFw!1TMV_F zDhqd2`}SMSnomg+FY+-tI!+u&sF?Fczj_5y$u)PwRU`OaXpvPd9=N2sqVSb7C#b!2*pm8YDIKZSsemKGN93d zU5_?(J(~-(SvTaF7BXTcU}=@3)#@=?IohDqi$*z0FLhy;GQgG?b~Y0V8*d6}s%wp% zHue@7%xGhG>BNa$axKI_$5e+i0=A!uLi}!lr#2X20TLa#=fKlx6Q)L?WgMwkM&O#E zR;L%MzSiJN44!Ik7?Po*cR182gU(AXu@5T3aC(5!!FEB+8a!d}n%&#wOhX4V?1JYz z7)(GjP!oj>0hvX?J1zgltXOJh#%9LZ^>RI84K zU7BAox?zpHTJTtReGFp|xssV{q$^>1^ab(DP+^5sfmH15F2Uyj+$ROo25?$wr{foO zv&X1V6R^|LboUgy04Onx*#$uJ_|33%7fn1&G+HyS+F82A9b( z$hZ)4Qj8QWwUkgxlL}Z2=5z(-B!t>ab4%WtyVb|D#6lB`*Cva*`8J)BIwN#mNiMHr zPhRr`#@@SGmb(SLT^+S|jWO03H7Grd0iHH=b{6xo-qR(a{F-OuV&GyS-wV0dL}X6z zxmjaeGU#67_V2mE4ysKvNvD>=4~?T&yBpq zd5+er1(vx=OxKN8A^x^eVwE8;Wc~CGsoc>AzujX4du zOLhMZaxyT?+H{^7zg5wr?l0B0+c+Rp) zH3y30T&SLNj(ACwXh;Q}3ay<(^kN~e3VDla#~H|JBG0@0dbKOg*h3Z9(n=-7Yjw|~ zj66Rj%A*yc*g%iTIu+u`$E`4B&n%ridk&{s);*t!QVi5|s^6bvI8ziMp(w_L7VN!s z6@X2u;&QM{$XlQB$ANW-$n=H-s2|1ht4wIgEoWzlRf_)7V!ju1 zx7lh_?lSL7lx!%*`t5}M3QJrH!xXkF@sX|sFsIsY2J@1pKH~6{v!^1O=)J?+Uef~q zG2q)SRVg=3I6CEI{TRipM`Cw&$f913I*#IQP!y93DoQ9uCqFAlhOh%b&qEjN-FEn? z4nHs_m7oT5I@Q-%5Y*)yjkr1f+Fhe#VK0Gw&$7#ZHV^*w*H1q+=h_CQwj7Zay*#lu8=IAHeS9Lm~8 zT}x&+2Z?pnL^vI%4p~aG?RkS<56v|_WR)zTMpp4N(;~+DvLwN&A48lEzu#lFz=Z(^mxXr?OdOLU7XzaPU-8b#KH|-iXw^Vos0N>ov z&NIQrc5t?l!2R92BpkPsX22dM1~4!#w)yyz5Ce~Vu|!OYo7d+9bQ~UrA0E1v;`NOs z;qk=0^nNIlR6lduhYu2aDHhexuzwzW4KwzI%k}W;$^Ow_T>9G&F240okC|`Y#Wv|om3gSG6w&|iAAb4HMf9=y%YUN5widLt zw|9<=Py-0E*)&k(F(Qx8JvW|4o<`6JDNRrUDMmWTB#9CQU-$|-UCm1E6LdIEN2+}c z$w_p5^`s~yg|NVN#jAZyo>sS`zNGkIyAYwPebp^3F1O3+Y}(bnv&rFbR@YZclL9XZ z;vktoi68coyd=>)F-%J|DTXHql8+D_bc*JL$ppxusU_UhSk>-YXQ#<5azH%m`- zpr??kl2cZO<&w0Be#2Pp`_lC4B2x6NnjkEy$?0}Gno$h#=3VZI(c$EvoS9kdh{*~ug;@YN>b@++vhzFMTCc^wtiodcb1)wA`=EDCsX*6i`L zxIN-5in*$Nl}PZ!)9`X)H_L}vlBbCQnUj<`RK?{v)C`MmcKe<~pWhu^N1CWP)G@@; zuuZV3Q!Jl+H1nhXUW0kvUYH$mQ?qCd(L;(P7a@k|suks-M#c4q8pNHtn};-0^Jsl% zM3BKCh<-t4b0@npi=MlSI7N8a1G5c{im*fy9;0AWd19xSq@$#=h^e@?h#^hB@&ccd zhqO>DsFm2su_^X{A<8FtDz1N$hcu-Y;4I-w-2F7n*iKHeU?{AhE)WLS;I*#QLk<3n zarf;F-T*05@G-;~%W+^(ilR|*MbTt;wW*0m^ARV$AK$%zdWj)2DYD@>5fI=&6Uw4a z#g#>!5%$!TT0oh7rjAZ9LXx7B6R@8|w@A~BvV^I)yo4Fu&erD80~~Ab!Kcj35?VjV z#yL_V`b2p$?pxPmZij!$TsktvCNs3S_;qF4tim;Iu38K&>gyq^lVqlXQ&eBDt_<9>toQ{VSNGJwt;h4%3q|#j$AP=GRLU?Qd~Y zTVm6eR4q{lvD&5agBY$Ysqd%b5=rbP!yK7XR|bOz`%%O>{-Oa^cHHbG2H5Zf$q{`5 zPlx%mvWlv>vkGr+6<1N_6;nOY%Ze;9Bqt_C&R1NZ9K%$6`xu5ahsp|R1Lky4r_4_e zk`&7kogC3mQZS6LiczcLfl-Sz^G0p#oXHBC$dJ5p0?WnG6XK=<#L2v>Gk1_FHe%Uo z#OS!9*Q&Uq*CKAw3Wma5EYm}*!vD~K39@gCg?zUBO%pO`8{CYvE3X+;h_4yISq@>$ z#)7(G0m4oayfh*zTCIu)TCG@RL|n{Ex>7hU7VOCK{VnD&8y8YaMS+S36$O-Yqotw% z9<48QK+H+9Ue56VIx(Ochmehg!CPku0gbh)aQ5CnAQN7pg3jIYf z(vfj(s~IL^B+-@>>9qeahIssL3({@5R*XMWs5DqqY;Ul@zjB5YjeR<%XuR#DC?z3U z2V|OO`Ka$Dow9(cIK6;E#Cg1=b|Lnn!Ak`BsK7DA2>2?^#C?wK>Vq&izkpJOM*9MD z%uqqJPlyoOS&Pl6CnehdvOz($D$b(X)Wf{kysoBK2v5Mv`#3Ui(xl9wDo)QpfOLi4 z+|l_l;);E&G4~3z7+svv%Unj8##CIL#;}%V>YLTIb4XKcT36FYvP2KfOEjmXbSkc< zbP&hI`x>N)*|r%WPNei~GO0#c82n-mMZBQ}bMQVhh1HD;6blYMM)MivfkwsE2O7Q0 z>kTd0u+9HkKHlBZR%mZ!y9T0*BP z>AV*Jw!z6O&``Z{O*g4rWE@k zX>m3g!8y41sE-d|EiV5xebN&;Danl43gmqS@f-%)LaIGvyjf5sRx=z zk0rt8Wnxz*Ln`+)Dz4qrP^d9@kNN5j8)~%nlW>MC{&#vMiK+N*62rW$ViIO!lr4@n zJ~<)qY4A8!l9XF{Dz4qigQWP-+W8>%(I!V1&9VE4Zb1eDLn-ST71!1^)NR~8%LqC% zF(OP(;Okp4I_*o_6key|G_S+FEn>n1FXeT09W*yN!2-ePr{yF5UR%eSNYs^c`rcR6)#*eoUz&?g$V2zwV zOC9|2Vx>T2)TiXD)F!Ds{tm=l@tZ|g(6fpi5P3@Ep(Dgw8x zh^MMLzv=ahN^GvHlE-k61i& zn7K#hqon1uO_3^8G)ff=F@^>EtEQQM+4Ka_CXo!BcM7tMkdorQ4TX?n1DXP3P!dVY z`8s70RpDBMKp*ht7=uZY z!y$boeuu3IgR!~A4Mke)^UU+Lj$tw)NE|su^wEh) zl_bF67OD+>vH{}6^TkF;kvv|+IDp0qQ&OC4=o2zroLBCi zzo^lN^eGsaOt6m#jqO`r>CK8?V;uu&F&Fi_ep z@L`fm#zU? z7yIrT%6?3RYd=O=x7Du1jupSV>>z>yFDHra2^uP(sxLK2Z|hZh4ujLc&|8{4p~EI* zB=fJ7d59Kc0&d@D?PvK2BlzD~!Ca2sKTBhD#PVjNf@xLEe#&asiouf(Vfd<{4q|Zt z2r!+1X!N0fR+Af%*A`HHv(rm0#~>yjF?oUhifo+diNSVCQ>1@iBzF_m7Ey>2&F;|I zte1Zl?q3L@p~h51iE*n#odv zSs*o|q!`CvNFgNt$rpU(HJ^(c__rUAO=HZAt{&PO5-jCemP?Sn<>Jpp`fOcrsy6tL zIa2)uu`?n=RT&i_*h}!OWPwLll3UoG-Va~eL}B6D{jrTrH62h4Wgu@QY5%F_fh!x=PqoB4QC5AiH5u?b>l z24Z;|M@~dYO4*00xV8_Y7Al|`DB7+cCDZur4M?AVZAF>FRGgjyXKJGM^}~+d#A|}w z1esuoXXSVxk;wh@v)LYyBeYZp6tTd8wWaYJ)|wvJBNjG3&MLA_#T8kn_p~~we|^lp zh&44byx9R0N-_ifAPP~=cZ14}$LCQkwbBAcc4v#RlaI3R%0?hlNq;h!>xyf0kIXSD zS#DTk_w_byYdsizl<1fFh?Ep9*LF81ixr_v#aW?@`h(N3^LOxyT~J?kg83>jn~Li( z8y+tUO%6juo`YTnaBNOUCTS@2B7QoiGGiE=Ue`c|cZY8E+W1OlTIcSRqi~io(Jqo< zR`&fT-SX(h?eaVHiBH&{!7` zWnLiKL{W(4p6vBG6pWu)a^lB>knaxJ%mZXJLar>Aw($`$11E8yMa9hnE!4gf_Eknx zwfW4MQZOf(qr=LHCsq97#FG@Z2AiX)X;{?vlT*s^b`>{|w^Nrc06|#QIp_64BprYh zeW+5!+M!B)i>F1*YlQ-5*VIN;%o3;`+%hDDDpXXpC7hz>|Wl?~_3_o3mmlgVt znsV*pEZD^X9eBn8T|HFgz*hy>MTx>+KBc@KRdMC@DAF9Ww!$IL>8v9xmtqC{R2N1| zfjTbm>bx?GsTiDvekOJJ2t=yF%}5viN3qfj%o-3R-~?X;brWY+T_l>k+G!Q6AE!Wiq z$RtF#F`AY9F|%@4qvG^kkOlBJn}@Nd;Dxl=Is)M*Nmz~@@jUc@uF9iQL3kzxseKqW zId}(~5d0NCQ0{9~oQ2k$D};HV5=rPPvi+MFWH%i74kB6h$ME;3%70X3`OQc!yE?m! zQfGf`UuIZSeGn2m(U#)bh5#F2&*UVT~zfKvTJ)yVao|A}4+Fj9N&; zAX`g+e-rQr(v1Jz+j!<3MD&k2a}VpnG#Z*{hr{ZsEFFSkaDbh_hri*Y&*U!pEHr1K zh4WN3?7+{8%HR1uHp2S9^H%OWP})<^JPGq$E2?XY@-#GDfHo%lKe+h09TKl^h+XzS zbI%-};7Q8=PDk$9L6t~dwE~6PYqAoZ2@n*|-9bppU%a5u1{H6CcHnk0|J`eQ`&H&c zz2)s!@!m6fP$rb_Gb(O&pTSz3A#WWdxE~jF1O<>%SWs}Fy(S7WMaKQRPT>vXiIVca zs#kV?O~v5Ouj!p$S7=YMeL1#-mH$s(A0QKf!85s^aT3}J(Eg$ZCXsIZ?=Qug8kKi0 z=3?tR7xAB7qE@lmRZyJj+v3s$nTFD8QV@J;6ZDs$W*U24g*f&)9OA?=P+6WULq_nQ z?J@QU&&xjlj@(rBZAeueS8EqzVzH(3hgM>Y1WM%p!SlJa_O1PB=E>5q8&q@$)3}yk__T8 z8hrZSXvZa0pI3OxzWnbfyjhW1riyl(n*S4xx1`GIc00Xp$EON!MRx#NJdWn9%v$hp z6lB&>2%XtpRj$7KEObCX->rB5UUM_C>H2RqUd;aGqPOzO)U=T;i9Bu}i8_B`UueS{ zzk@c6x?%1-|guq`}*v8SGny{=Q$Y zHGkTHCmUVA(&QHAkmy03$SS{2fVKyXYA9H{z?-0#nd>cALG5dGjn892&`dzst$5T~ zmx!tZdgxu}GP!FopGTZSnUC|_*)kU7aj0)WK)I)nA=-Kn zm7oy{axz>^@IYkoc>H(tk3^G=1UmQ)JzRa`E}*L$5_-`8!g9I$r4MF&Sy>;UHet*Qm`-4rcGJgY!e z0w)btsP({<@Mfa|ea_FY{bhsE3%4uA^Yej+CQJYIJI1BwHc=iPo z=v`3nf#lDKpgZ(uDbl&C+mBY{PMm$UJG5eeSI=QJ@Q^6MJr0QeIrkmjhr0wVq2#dWzfR`;xATJgQ};mQey!O zp!WjZ6ptq~jhTn~vn}Om%)1ln3Su-ZW#TNfDp^qBq5HZ}X@&p{`@Gqx+})sJ>)j2; zR#&qlbaz9xE0tf$>@V}Se=444`{7`BB=6H~Mx5l>KOZh{Ey4e5g`S7gMr&@OH5Rm{ zelJ8u8VU|jW`@cS)ehBE`~K~P9t&S<`QuvaquV@|H_M-S!uFR{y?<4Exn?UeTXu2} z^nBq$Nf0hdNZFe=)f`-i;2`Q3U2;I=jZk2ba)Ph+l^jFZw*Oo7BVg;COr!q5S!B}# zEEqwnx9{1SS78nde1ydRM=iQ(@F@gge6Jx0>p!;@Nujey^>7)ghnCd2vcMRE&F;mm z+loFw+HHMXJ^zRd1jm1cxPR}KLb&UF1a2?%{tW4AMh1V1=$o7COWyIh5Ujqs(DKGk4fHXS^e_p|g+?nPFb>dBw#`xDa=4ls9L@&I*jBVm-^oYt zuDVi(%hTZSG*~_?K}57wKboGb`YyVqAXqayo4uxmX8+E#&;9|@j6e4uT;buv!99B;jbn;c&|?Q1oBrAmq^nvM<9{S)u6fls7s6ZMBMS&Vc3aCI)C_q}cK!Cbv9}Khw2qX_iQ4|Ug zRQ_dUvXjB;2W<`>riwr`j&g-Rf0wvhYr3r>Ts|qUxo$kc7@R08`OuCYnhla;dbN z$R$#-LN1>u4&(}nd~qNVFAo&+#hq%0wBSYc4XNvIe^e`f{VyWw8TB$_UsYctcUJUSAMr3TXR zOmg_U9I)FRzeC|W)mNlNKiS^*ciTuR3Y`)M~Xun;k26D(SX~!@!%?oArgSPqo(0 z9X8@MK;2JOPz|-9+Ujk%YAUblianNoNqRp_BMqx`U}@;@#z?u6*6$BVL;#d_NIvmr zk)G2stp@NfuVGZVDy+&Xfqxme5-JLtgsXsdmsL^6I;w=!2^G_@h?IH61(ok2+RMg)&ocvAhB-T`9z6kczc1mhFq_xglM|bm}FBX|0&SLIJeWuuLMk&P{wpJ7Sox`Vmh51(#*g>G8#>!bJ2JznM=4)Czp;Vom?jB zWTMG@st_y3EvB&_8vy7S+BuAgD(a@EU1{ga!Epg&6-dYz2$K9F_uq z`j8Y90KMffiTJZ{>m5U*MI4i#$V22P!Cl5bqNW3P8m^3XGpvMEMTEySLMIU(gTHvY zUHc9Bb+}yXpF_ONNcr-9$Z}b?V;e|+H%7{pw0?g`A_AbaL-L6~i}alNWy~wuBz{xq zR~RnNL9=P(;d2mHKuAX80B0q)qXED?Lb=trNE1}P*}RAw8I(1k=XL@maeGQ2G_C8* z12m_z^~T2H|IHdV%xSf5TIbrx-f5@qcJeWIZ+y2x0u?ld%6f?5%J7udd(z z+A}r~D+;+It6*Ov^Z7`0oq~5sVh$+MEBGy5=D92X1+7&{k{;2;P zSt}YMq@JUIf~bO!;%7RGjl}nVdaCcI78~jPE!cpOjno?Fs`Ud+x4qD;pKR6!_rylk zy-nsd zz>lo|3k#(xpZ9heOZ z)t!AWgUjPyOD|`-V7JER{k43d*l3dcoQpK_3++lQQgX}rg<3nZ7>zKX(X3u{4-{)v zx8BZGOM^}$A5Au$R&=%)n>#T&@jybeyMw3C zA31&gRBUM=m3IqqD(S_7PKHp15QJTZ-3|9L;AU6I>-^Xr zbHn4OQ{w;m`+xEpB~G7NsChxe_md~|K*#!5EHtsVNg?rWSh3QmOwT#r3c0od?$`3C z0`P@2oiG9<{2Rbt%BU*9#R%}q)%)uL(zoGX1eQf^r(oWyx`;FfP*M$U7wc(T<=`q| zMRjy(#LFh!E##d=x)@mA6If{{)CUM@1GD$)cCfA-TosgG!#|dF4!?uQJ%JqWsdsg` z^JrfQX_9IZuB2K*3z#m7m7)x~)kWBObr>br;U;1JE>bkqH0tE~@Qyl)b{xA)tvR%k zdqf2}*_SD_o3z7Tl-htLyEF)RT3x{U(?)x_K8_;I1vRFQBV-nN7ZH98%vKgXNCRF( zNCK@JLHm!O+~a6{73F17nuFfFr^XRmMT@5pGmf55qs|4Cbr>a$BP@@vm4S;C%m7-$ zovef$ghkYvLu!7NLDViR-yWnMviqCanKY(svWe_(3+3lf;syBGbIu%ovAvo@ zAa}sf(`fw>{d*F>OZXl|^xy<)ub}_zQwnWgMt`Q%8I0IT^n$bIEMlAZjjLg#C(ltp zImhvD7U@qR-vr{%1D4<-yLt+va001MAq`o!7)Cv&Tf>%_HX2w*4JF-s2kGXJyNa=7 zA04D?B6V4ZxEt_Dc7B1Rxk;VK9z%aOMs_?&>-UEwA^=MLo29{%dhT)$=3ZziF}dyLYW7(~P$0y(*@7z7xp=3eZpyx3!u9tTG0*YLUgEAI%1 z+aVBWA#Cp;dQp@c(&Y|<5%t&m$Eb4@c8x7JC$U>6lnJTdMcc@vQz%o_Y_5xbgw%In zU$-OaZzsROHrOaEjXz$#Q>T(UrDuN1uQ+DQ`1O}3^*PK8!|%-cy?%z@%}BYD&hHON zL;&ReM1oxM-L%yC6@+o#t-yNCs@DUz%s&QmU&^u*FmL|+Pqnb`H!Zwk!>{^a5LaMI zS^Jgt3D+`%C>}-JXfXkc|XN`6dAR&5Qm4nO^9_OdWJNSih{5Gx;(FLiquy} zU2)jo#?BtbzY_A+b*?JP8%0^Bgt!(4Q2aj(Apmttl3F}QF&YI7hcLrN5OWAN4SyQ{ zQVk(izQ! zxNeP6(4)Q&6e7j&xojA%YXv~ReybJ4Ej8+bhA}KDX zP|~QR5*w+$N-=yK<(Kho*qXTJU+xF*w_f;~z(~3nsR8uY;61gFj7AcVUOBd0d)PaU zBM%O!=frg;jz03xwP1tX!j7CEavYR{?< ze#NAlvG5ZMO=wTt(i6Az#4V4qxJA~9hsAbry&{Jo?Fd@0R%Jo4u*Zh?*lD1U_X}*?CJRpTpG)eKM%rY#oa2{~8 z)U*h{SSHOU+|sNeAuaK<*MFjg#5D`Qu<3SKA+*4K)_>VTDa%u=4)U*l`;b77HN;r= zat(}nokq`(+MLv`9EYyrA~XRhE?I^y-lP^I#{pdks%D|XHv$br>gP>Du#kh!9`6M6 z-UYQ7sm(Zs{3VFhYA7l3i0Kdd$4#gYfe(uslKOY!>)y|((Qpb$&o=k54mf(24D@miFhSox=;` z7sHG0h0!B(t+DwJqGQpi>4A1LHe8+_E;#YZp}C92Ng~kR_p=>^D}IeO@iWh#@9ewU zQ~G}_l>YBkxbh3=n5@DQ{XPfW>~^qO;mQp6N|roN=uXhvG? zh0=vcJe5f}k=bfHT&*wSqGqFcA=0RaEBSgU>@Lq&oBA^UfmRjw822QH_rzi&XQPhe zM8mOY+(~5+@RkHdoeqJqSf{{FDWe@zcC0AXp-d;rrL4}7oA#I)pI_o9pZRyqXir)Akxh5am;S2w z?~$_l6x@oQKLLz(kY>u-H9Kk=Qa^>))2Uk(0lUTPS7e_eV4K=?jL8zAZ!!!@6o>!=@-~!u?D;WOR>X%p38ZBDeA&dyb#xOoBA@m z)<{8zd1B67PNZPNyi3K4q7-1H0|gySVV)4-)kg|VSUO+!p`e30H5_*eH8Q$RK10IV z_%I!HkoXo?2_;~w5!sH`KJD#2vPW+H-V?r9T_@y`?L&k*e#m$a)$ljZ_I(27X~-6{u%tMS0^TphQL&W5$3iin zTsp6il!Wn99CBZY@+2C8S{n!cGt|oQ7_1QMjDN-JQ5-Sozw;h*=s z^U&2pYTM28OEXB%H&D;O(%djWty-wHP2k>T5spV@GzTrrS~z2&=)YgFet-Ka$m_s< z+4qdNo{^-OzzP|HT>>}28y^1l$-SEx($e_jSq6p-f0(l9V97GAaRx`m%wxN4!^i;;ep z)ffv|n6@x$;b&IRy=tMd>}kJ+`z%abn6m{1!6Q-+t+bKb-!@iTviDn0Om=as2^92*T$k zE}4g*PiUS~I1l$I+%=GrZ^7+NABSJkkAd8r#UVx>VW;rRcPI1EDD>w^dGd@y7$omX zQZz)-5wCyNacttxm+|C#2l;sUmjb2*h{kypn6<6XW1f95?c>{o1>~q94_|ELb7TxL zp}chO&l|g4-;`#l_((h-lekkWc{C#P{B=?(W9lsV2rJBCq7N>mllp7&{ZnK7 z>%~^}_hHu`)UTlM$8Ft|e%x7X@#v`t^~4-&FMIctMINlO$Y#VG_P~x*;`g5E<4fO^ zc+mS}*e=z4l8J%XCe(Zq(3FYAGbyh$NbBir2&A5lKhR091qP|l{17KiR8`rHzVHC5 zACN|N0fDlbTtOWBzQRNvBlk-rNVo;@OZ@v*ZRR@`9<|)VjD?b(e>#cgnlF5t3BLX7 zZ{KAk(BB2Sd8d0Sn^T|R3&(uU;cXYvG*l;`Xw@7|Z9Jk{Q((D!N>O0BTS`8S z(y8_*UEPC!=`V%8^N%|5k2&$d6FzD}B@C)#7^NmY9Yf(Zh1mRi5)@nW85G9zHR|BU zm6$(@5_yw_>CNL!{96?)pK2vk-Jybq`KnX^;on3w`HTV=+lc8csHhq9Ct(fx`=S3@ zCwvy<7NN5rGTyT)e``lyKgQ%qS(WcsJ>h9C&#+w4DJ!|(6}{iCz#`}2=wqW$`uZiH ze?`A+SR~{xb`Mj#FjZvuL9q zIB-yZ@3@j*b&X4w@$rvWP&m_Z=r^mK_>ah2gk8g0zMr~w&~zB9Fb|`6(8NQrIc(T< z-+>mlbIEZQTRLxP@kovbbPXJ4@lV^WKLVq0L2{TQQ678oh?B>iyv@Z|;x`_hk>QYh zL%Q4+{QQHaJaXjA#9!991$~d8@caEv5BvD(Vb>otu0i4VJKjO%28BPU`g&{zkQheB UIScn2ust>-77IEQ*$kWUf4l~j&Hw-a literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Sessions/Session_13425116297819620 b/Covance_UCO3001/browser_profile/Default/Sessions/Session_13425116297819620 new file mode 100644 index 0000000000000000000000000000000000000000..94d4dbf84443694d4d50d23dc925765ed9fdbd8a GIT binary patch literal 81884 zcmeI5Uu+!5eaBa_OjC&xGmah8{ga&hM^W2Q+~eP4P*x{OqAA&uPmvU#QZ&5d-H}I& zf6gRDo#mupgQ8%I1h|K$AW#J0OHn-}DA5K1AA*7@@}Qyy$`on9plHE|6d=+(@SzV3 zP(=NHcfKQ@mOPOdqlQj`?zu(t-JZp8~(_rwPUY|GW-S8&7&*N;!OM4?8-`KvF^&e&oe)vcq z2Mz7pF*aQ5H*AmC3l(VNVehl{1pEit(rfcFc#AYLPm|Z|HQ;a5YezgAycWbVjkj#@ zI&j5@YXf}c;F5()G`J%MUs;4uDg0KiA0ftYcL$ynLkR7#XK*jWk0La>b-+$r1Fq0_ zA8h^b*%v&OG2?G-4YJdwdG1#~|F58+Sbz4OyA=%mp`?ES#l@T+z3iHv$sWU^`tF&ECS`m#>2W*vfCoW>xXdUAq<8g3c~&)HlPYD4~Jf?J%MxPqdpan zTu{(DP&oQfgiIlA39hmb#ZY)Ug5ug1_-jUS?8Coy6s=bLZNC?(PZPT+SM^(OI)jo>UN z`!KHC9BF^~Fc~hN?JI(`Z^zhht>3UcVlPynjfcI@+7s~4oFB!zFkiDOVjgY?T>6po zOr_KkxTO(qKggr3GFov@4*&Y$LiZ-vD}~>RoZE-%tcF+yOjXo@TyJuI7SChOZ-I{{ zoMrKkabX3-q zs{{UUL8hos5I%|P=a3~P5#4cQn?Y{?uRMXQGUi3RM8FBS48b2;a|* zEh8zz25OMofN+5cUIy+-`L`^{ey1#)vS4@`nD7tHj2xuRE)|$?_-xoehvV)GzY3nO zKX;!Uefh{pdU9|eJux^saxQ!B!23bWZ7yNF=-}%H+P7ou^R3^oJz_6Zpnd*laQ#Ib z6@+KS0<+fzvMDH985F7*iYAMBHYn08hAk*^S>$0BNM5H~8h~B~<^z>RT7M5mg_La^8XXuMIXRY_ zxG^?zb!@2fwWe$;0i0e7*df9NS?8r zwFXrstHUVnY)459r(*(X&Z?VLV-}^+^b^@Y<^XTQVuBDYZ-Ing4G@lqs_hm-M*!&!B98KSt z$Tu}+bN%TXLlcdY(MCFqjt$<*oy-gk=0+xZ2eY02XgbOLE~wRbp&M`k-OH?_7M8yQ85xbw!vbD3+I*AuS~U2V&sz5Z^`*qNSm*T`T` zM`C31>b3r4OETYdezN)88#miJ-pfW?-fC|3Z^q7d483*zd|M)OY%G@@9Lr@UdT)#k zb_TEiTJtFgFZ>U+yx{`htSr%)Zv-=Z4dRLttTSw103Y$6xzTp$MD8aTMo8uv!VZz#qHJ+$pp3)L!rP z4*AqLrNp2wi0k$26PD4JeOfeE?=^+2bwi1Y;bB3Z3rWaz33wvVKe3y}Hl6JVu;D+7 z@4evdvn(X4AB4t+_!!Q| zaqo5bYeJXz5+vG}+TE?#<-dEu(kMOVK{d(}`XYe9B~bAd@F?{OY6PayuM@m3SK+J&?zBIV8@ zrG}86XW`n7FxYw{>x`-I8g z_rRf=|3me}rcpJGv*!`So5)`4RoDFri3qORX8v#CIrTVLt=I9K&xf(u*wSX_60YrL z$H#VX<|s2@EUii+!UQNY@^;T99KR>K(z@}*HN-+k1(0Jr3OKX^oBoClmCS4 zC_N4xrBC7K3QOM8XtbR|gD-;WJ%Z*K6~!Ysqw@IMAHxtkj-$A57OYnK+D_9V^9#(H z$a9`9qQgcL?o`!Ll*1esV@HfVDb9(;)pe>|r^p1+egB%IEG?5_OPIN@W&;3h0vm3{Hx7>`x?wwL5;{74w z#!fnwGJ|*vDrh)__eVHhQA&p6$=~1rjwlYA@OAq;Z5Hxo{&_$3S4^`a{)WS|&+~aR z41Z@nzuZput&9!V`U~45_Cf`+eqw{%-nXXKc?oXJchfk^%}Tii=QjV*ne|eFF9Gw~ z>J^w!*8kf0*m7xwu_5to;6R8-{S8cq23Nx;o0 zNjNKkJy*`M;Y^t}{Ow12nBfyDTR6NywG3zMa8?4R*Kw9jJ5q;p7C5+4DSRpBx;#m%SsQpNqG zl?Tp9V+o)FupN1v`Lz$JU}oxYFps%37WksdvL9){IcJ=74Z$`P>fK?y0R~2QQ8?+pL)Pt5Ey!wqz zm9JJQYiTtw{AF((sVSh_>&B(`|G4zSs$0H`cFG)%qxhL`gKW;y*y_sCHfKt>wplg5 zmAYk>bv;a2-D1b8do)%Zf5!MriSwdyb?O$UZgJ|C{j6@Wa^g{SyC|>NL$L9vB(GMi zKoMOx+;zj56~gsh0&b5}H=Omj>vmw~vzse<-&abHW4A*CzHAx(^ia)@LH0msrBt__ z%+RFJ#*>@`+S%6CKbX1kW}lyE`C>jj^7h$lH;1#m_#FAo_FGp@y>;zE;_91M^B3}C z$$?#(Fp4O7{8FZfgQc(lR@<7k$}fgVGtVkbh7Dk4P!eAeSLLr(N@&aDvQLRN ztg>JOr?B)p4i7v? zKW`WchhC_&sD5}83Wi(348XT=?E?H?h1*r!aRJ8|X7UZ}v-yMJbhE7w%SY83vd=$? zUw0?90+q>B_)zUkB@w@x&fr(#8C7Hbfda|Q@i!_te!tDxeCES9Gn+qJv351;G%CrD7Y=|;N`SGrLtPQ^8q(i{|^O1#f2?<_K_=XvOBwT(0A1DD2$(d)U9 zMmy{LWH5XD3f(&WrW1qN6Zyf`cWyOZD7N@bSCbbCv10V*xwf<8U_dE+w%(*nF~#&(ZR}kKSpbXGh|tE@9d!EVmqn}2TU7d zO{9$-**djA!X4R!-18w$$-X3-P`7TmxQ^`hK7^~(kqx_Z=GeBDqc~_jVo$+8SCUHN zpt)noZmzR3s>vn$B~@#Ma2l` zfN_Qn*V5uV$!54bY6ZzpUeCX`+43h=abj6M`$RP^Y9a63Q#EH$ZLr3rHN5;u`SJ+k z>EXgqZelE*xjr~D(3l?`&M|{|Ux!|38plzbQyp4upL`_%%*;#I&Mxn6E}AWbziBnnZ>FZ!{qgEK2uYALL0A#I6(;qi}>0jXuR4+s#UXD&Z*H_ zOW9RswkqPT@#-3{AI7IfuJLLLrIp9K+j!l7YB|@~EpIUH{%GJ18@oSvy5{?+DXMMk zK8wtJxvY^F!HD|(%{5mRfZxka7hHKlJ3rO#$H%dq>lYX_|W8^`-mac8B%ZJg8GG4PhfRk1eoyM&*ghd&?3epik^tP-2= ziR_F#@Zco_whH%gmBwZs9u>Wmm{dPeR`N4XN=u^*GoQwCT|TOdDPOsQ9_R0IHXr3> ztfI815}7J!Dx9fU<662@sF_)S`~;S6=EGc`F)Z$^!jDY3%630u#V3>-iiq8ig$%Rr z=U;!Igtn5|lK1>gUCk`=4I9~yS}cDZE%s>~M-iznE?_NY=a0eWkWihDxV6Rs-W~;Th>`5^% zhC4mC5`#h927^I}n)5$D7^;*z)~)~R3}7h_^l zEQr(Mj5seYiYwxpSdZDg!TXCnVp1%MC6Tj%Y39Wxaa9bBIQDCGegtu2(cmmD znsEG;OdH(kk6Cl4)%k8ek7-S_-Eb+#`Hozonv>hFqdMf$!{PhwoPbKr6N+Do04_Y- z4~Flrl#cHCF8y8pbLG#;A18lZ{qyA1zfMhoMi7i`_at!sDvl>nP2sf1_a@Le?eR9J zUOVkErNg$nN$gJTMtAeUVtMss5UEZ6*zTOYRBrzOjuCsI0<9RVb}Y|nj~`xptnoc6 zkpA=Onk6W_s7R*uZ5%rq-)qD!V-vZt20QwP&Dt&pQ<}#;DgwGORhN5faY}u|eWQTm z-nWsBZ{wgMc^0GsfX3!1OPga#xJKRDG(DA>_yJ={h|?lnsfbvS!t-09@x8FZGpzWW zlOofEzO^Fxd+->fC*JqbjPEr<;ZmO7;juxp^H}*<>^R~aPG_6mVfSs12iBO6Y2pZ* zd5n^V=C*+w4^%por}KW5=!|Ma@vQ{=9@R>8Zqv@uKaRlhGY~FY%dOST> z%6Nf$CEk0w_yErfi}z`{&xSZJd);YspZ!}_YXnZ=?Bv9|w(gdA=dL&ZfJB?oIISI* zJ+ATBxR?<0;*@B|X=i1h7Z=54aaFA4Oi`GK=!-pKN-T&Ro2Ho&=fnkZNn91J{HW6p ze_V`<2{A8Di6wDXoEI0xWpPcc0oS4EGT;lb34z8Dvi zVnLh|OX6*DL0lA9MDGO?ew`Q*V`4%~iAAv_&Wdy59dTJ)6>GU14@^Y##kiOh3*wYG zBhHBn;-a`B2K&|{{JIx|$9TuZxR?-AVo@xKv*NtCC@zbuVyy&tMD)cTF(nqnDRD-e z6BooKaa9cF3GzKSUl8WF7#9;_UYrt3;;c9?E{e*1v*Mh% zATEikqW7C7{Cd$B<6=V0i&J7rye%$>i{i4lCf0GQ8kmR}6BA-eEQr(MtT-p$5tqeP z(fe%^e!b|6aWN?t#3`{P-WC_cMR7&+K5fFU6C+|wOo%D5D3-)oaZbD=E{m&TE!(9q z5z!apVp1%KQ{s#`CoYJK;)-b7$90k5G2U@8E+)j3SQJa*tT-<&ip%1vSbNk9Ohoj> z9x){r#3^w`oD&zsC2>{sUN+&^iO0pbm=N>glvomH#d&d2To%{Fx>xibqA&J{DX}0< zi?iaKxF9Zxt76dR$0H(a`@_VnB6JA7&i%GE{PKmSPytpVX zi}>y!F!iD@#>JFa6iec)xF9ZxtD^T=#Z!!l2{9#3i8JDyxF9ZzYhvATg)7Fzq*xHA z#947(Toji@?|1b6qA$k9lvor?;;gtJE{Ut6$M4}_B4SKTh$(SOoDt{51#wwi6YKcN zGs6|*Vp1%KQ{t>RFD{D9Vz8|h!mFoV1;!WSVoEHEC2>|<5SPSN5k1(zM8uew5L4om zI3v!93*xf4Cf1!$xMEyPiUn~>oE7KAMR8fg{Pe)oi@q2aQ({ppiL>H@xFoKM!6Y+; z9Pv%~F)<;g#3^w`oD&zsWpPcci<=A zbK-)yB0^7L!V~L^_1?H+9(KOUew}~!am4K@9Q+Wb9Sq067H%|QciIo(*l+Xi?9UvI zZ>9IB+kM`4!*%ar(zX2e*-n0QzsJr#Z`tj9?0ygTd+ddLbot8VE0?df z-uZa9<+*E@xOT~2lslKNT)uMosqohM)LzIHm#C5HF5IS)jzKOb?pz={&MY4*Zy|>57+-$z^Vhfk z$K4S}?U8$7Y<^Of41pM;T zM7Mm3S#PSbZ0RW^OI6FKL=V(_4tZcdtd7N3C^zi-zKx?o_SoKTJP%l{i_fZN#Tl(F z##~&s?J=$V&T*TuePr7n|E<;pyY03;#;>(*tkAYDVSB`0s6Z>!?0wd5g;qa4^5fRW zIjqQ(!8zAo;x@)+4;Zeu#Fd`FhH z8P4t2IpIy(?Fxt~wqsz5Vo40gFAqOHj{W*cux+AMYKpQv(1hQM_Wd|?U8%`z--As~ z{#5);Xzp)<8n?~<+V{8D!uE*0P=WUO)iy!*TAG_CZU^LeE97z(@|x@Y@iTEs^9)=m z!?}q)>kzKs#~s63an673!4-yqw6(8VwKT7pS-el0ThU~typ`tG&Lo#KKaA6|6|!mV z#Iembl3ii7xwWOe>2cg&@jIcm*5kTDHuDwNlXUwlrh`QnBHkq0N@Gwk3W4B4tRZCgr9%EDYAH@Uwe_XcH)mkVuhwNAC_mP@qOfX=_|51zO56}X< zgX1WowE)&LelRwhTiWbi!nGP4)AUqkY$Gwk76nXr+uK^Uu3*Aqxkv7)5R0-eistUE z8{=Pt$Ka>k)y8;uX=^qO9*tO@NBXwm9p{wJ5$0u>xR@04;*>Ze-WKP@MbR!>ZmY?9 z5)&JAIxX zyv6q4gL071-03_zJ1*e%Cv^KW_9H)SH($H_=gQxcD1Tfx$5ceNK1;y*q;_+h_Q|s& zeYRO$r{=Sz-4$p`?k01%ZcZEt@eB@%3!2*o_r@reWnUF*ZFfivSF?He^KtCg<~Dn| zjQal6K23KENzjwm%!K)y(*~Z+zeZGd|c6+E4ql z{at8$z)E7fFPo)Rc+5Sdg#MmQ&qt<+a{IFlLJK^Eae`aW1!p0P`Y~cK<_+U)9KXu1 z^LRpa5*=B3&m}r{W^2K3!?`hS(B@O4AA=gk%+<+4v!8=o8oy-@N?4A~a)g1iXE=|C zb8fg>TkD37wryy0hEE^z}qgnaFLw$ghZ<=&)+i#k5aNBR1 zba2~mnsjj6Z<=&)+i#k5aNBR1bcnp7@*%qIH%)rD?Ke$2xa~JhI=JmOO***kH%&UY z?Ke$2l&jNrLwy!j%aw=ECzjjycl9~t(QcQ=hs{^JwQP!A{>W|rpJ|iqblEId{@nJ9{HoT;UnhT^ z{M~-L%GE!v{$XFv)xU20XRfV%9V=aodc_U>GCRMlk{->qzg+vvwZB~Z)3v`JulDzD zZ)>?#Jz=jute$SSsA5+izC0I#${Co6H`2xquh5 R=YtkM#O3?UeqB)P{{cCpyxaf) literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Sessions/Tabs_13425116005578150 b/Covance_UCO3001/browser_profile/Default/Sessions/Tabs_13425116005578150 new file mode 100644 index 0000000000000000000000000000000000000000..eb14b468475aa66fff96359af61ce06a1375ca2c GIT binary patch literal 490794 zcmeFae~=tUcHddUC0E!V-tE;7@5r%UHC7}HSsG5w?;gstC;%h~5FpSb2%;f-7u_?{ zgBf6cG-d{11LP`NvaIF#*Y(-Aj&WSrZmoSbd=YZA?rhzhtgzdTy$I-TeeQ^hiqOYJP{3vk7?`tTJ+kte{D4Q>JQ#}>kY*-PXxiM%4^vVX?y+XvE20Rv7?hC zC!RYxJ~Day#MH=acw%g1V(j?X`1DL}Vs`4-x0F%gOTpv6DA8`8uituX=zF@1PyU>e zOY<8ywx5|_Ev;X3na=3=No@xei^O40%_Mk$cwPLowl|4;-0?fG*%!C`{`lXT`Kh1z zotHly{I~F)&u3NA7kcdH6X|_f+^#R@0SA;Qto9b9AC_w8j4P+<$dpoi%eH$^^LuC;{Y&5Z?;olSKHY1BkDIJtePZa2h6=9{ z)~uJew<}xEjE+{fDo-zL+$^mxl*P5tKcZvjgNi!C^v@%;pUpFVFgp7jR?(BJ=0==hhl4d`DUsL#CeKB>(Nk}=(h znIzVEjwn8_xOLW(u46URrKApYQTH^W{Nvi2(zc|}y!%Y(h%dJ%L-spLvxNB3jve5UoS^mGQ*6p)e(l2~!=nd(eC0q2}RQ5-7 z{FH_q8?fBS~CxRbU z{xd4DSp=qvl^{7QIivI|&OZH$t~0Fdpw7wIzG%T$qo=>;x{g_I@up?!3-{RX!O#j$ zkl4Um*nc~rmOJEYCg{~MYcspP&?nZVCd>CtrMmihpK7`Kc8wfSjg@uw4RJlVpzqaS zPB#5`a6+<^*Yov~OyBp65bp=Z@%ZCY>YUeacYZxepA zDs5mi%hGIE>k@28EbCKx;CbZrjN*aa2HLVVQ+Ml5%#BcHU^kbVskBQOVW81ky3mc2&%L~h;)z$L)mGa!;t?Jl`)zcf5qi3!?J6@QWoIHOu|LWeR`N zD~C4Aiz}Puh3(5XHdp4{?LRefR6U&jB|I@oQSPnE#`;$I^7gGtdCqR^(AIWoyF9mb ztCYKt+nmlXkDWMqHh28|)PbWpKzBGC5_^srDsMNbGCAXASrH#t2 z9MiYYVMAH$J~<-QH1|qbwYeQ!*50DJ=+H?UQwOoB{Vkn)P5H*^%aXsUkIA~C?>Qa0CCAm6&RGpkD`!Pd@{D9XD_I3~31*F)53b6k@T!i# z6r5E2qRPFZ{4WI0(d8@zuju)&$q_WJGvDi~mzC27on=?DImx%xfoYX>T`95KY);pF zQCB#ltG=L|>nfw&RYCD{D$Q+`$5md$DZmY!ZtrOv4o(<=Y6du}IH zFS+2j?t4ndUeaA(6mRM-tRyy1S>f|uoFTaa9<11pV{EG}crbsbrBcW>6>n#yPG!tOCtK666FE#<-0qCuv_ zSEPvMXnWB4`MOh4f1X+T8YXm|I9Pl?!J95VZ!(_s2L{mc+jV_8>e_!d6VZ$DGck)> zSCuy*3Y))u$MsiRuul4&1P7Ujv6TDY{(gMp z26OLPIqd%8)#rI#Gd7gtySJ;`a*C}iTWc6pk2a$<N5Y#`Da~n zU7J_mgvC92#4PN&Dighv2*LEU%Yv>^y-EA#nRd93)hdYTwg0+zJB`B zv8@X$8!vuH*7&2Yxjt@Vk~Zs>dRpIoRI}TADq0LjJt(nm7|UQ*|A%}3!VP0RSR;KW z!6xwoDpP;x6YG+b>TMns_k1)^y&ngp8PBo#JEy_qlGOiseJ;yLS<-Maqv2>w2GF{U zofl;?T~#OWs*I<3bq^(HZZ60~ID>!mYs~-oc=Tc;YC;B4yee&`(~>hE%*?Q*E;C+inJf0knFr8J z6Pp;BOW#b6CG|f^z09lkds3VE<;+)ShF!eUZRSczF_Ukmiun$$pPJIQx%bV#Xr`4d z9oXwhv6;ND(<_TlUtbt2TsZ&y z+0(1HZ@+fw!qn2G{PEM5bI)$BES^5TetNom=GOG$%#9nmRPYbK_t@&g76i(FW!??T zp8dn}KY3#4H#I!iuxz76(h1q`3*0KLRaVQ}o27+oE9+NAmp9hR!54MTc~#MxW}xQj z$ZB41^Ogn8a_l9QD?0vRy^?fKvMlss1YzGeW+p|}z7+19*!@ZKO8s3}B>lsBCF#8u z0tR`cw)*O6J5fucYAhRW*n4o+k`62Bt4pSv_8Qj*c~$D;p0z)0L8q^O8Q4ABoYFdW zn_1f16809e&6~|HF{w23K3ex|`!=7o#T=V`+Om$#FzrPp8xRI{|7L#L`mN1jb2`sv z>o)6+-=wfk-mYXmfcQNQ^Pk$B+I$B#|Ft(%Ex)=Wuc~hS_Wkyy)_1jj=eHl)g@5BW zzV6cfny!!AIp29=s7@DdhW?y3KkC@bs;`Pi6J2;5-5Q;ko}COwwdk&Du5#+^liSA1|RSD!(~%`-61_A4XqjGGE?(a_wQ3 zweNgUbAh@gTpz^iEN9~rQAqh~(!#AO&SA*&xHsDCPm7Vc&p zf_u6>+K1m@9LwFJvVFlLU4s5~}+=E@HMOzm#@Gy*E9xlTg ztiuM}g>Be@J(xKZUndJgcoG(21-=OzunAjm4|ZYj$71=zFoY4z!(~{5b$AE1U>kN| z4`vQ?A20{=um~&gP1t}~3~ zyRZ#AunP~2#PYK+gePGUR$vY8z$R?LJ=ld>QgCEdW-J^hA@H!Sb;TIhj(BLw&6V}OVNc4%)%VZ!y>H0I&8ouybC+93lCs{ zW?={;Sb!B+gFCPZTd)o9K{+1c`+$dG1oN;6tFR6ma2K{=2X^6s>G(QX7{ZgV2rIA# zcVH8?UYzEX=_?EW#Sxflb(g9oU1J2)QtV1z3SK*nqpR4LeXTYPm2BLm0s#tin2Mz!uzt zU8uEp7qT!1^RNhOa0fPF3wB@+W{x8lMz8=Yum&4&7q(#s>g@s-hG7UJScFwrhYi?* zd$0@jI-Cnxn1gv(gf+MWo3I5tum>|IkP9PNfE8GS4Y&*2umkm$g$u(lgb^&lDy+i> zY{5O)g?g>kg)Gd$JS@T*+<{Hlf*sg{nN!Gx5iGz8ticA{g>Be@dY#sVVHm;)7GV|E zVFR|{9_&KBf8s(G=3pKcVGZuUCTzhD?7_?#_EL4$7=|!{ zMOcM(*nlm#2fI)&c)O5=Ihcn_X>cl;rHiSbh%XVG-8g4s5~}?7$w(6k>T<7{LOpz#448UD$>l zsJG-?7=|H?U=dbf9X4PK?!hk9Pc>Y~!W_)QBCNq3*n}E8yK*aYCb1)B!um*Qv6SiOn_F(3l$b}IszzVFv z2Hb^h*nxV-(uH9d!Uz^&71m(`w%{J@!k|bwVGibD5!T=iY{C}oz#hz$0vEC{f(2NC zHQ0c=unjv9oDDlR9?!8|O&8r*?R*n%C{gPBF-!Uz^% z1=e5#?!q?gKrQ;XFbqQ&!6K}}I&8oe+=E@HMGhCTFbDIn2y1W$Hem~PU=L=lAQwik z04uNt8*mr4VF$W5?Idz|IhGs32o_-#)?ov-;2!KkE%CUJg*ljqMOcG7unAkR1A8!Y z6}d2i1z3SK*nqpR4LeXT+qp0dLm0s#tin2Mz!uztU8n^`7qT!1^RNhOa0fPF3wB@+ zX4a4kBUpeHSc46?3)`>*^`fB*!!U#qEW#?R!v<`@J=leMCC`N{%)vY?!W!IxP1u4R z*n^o0a$y7uumWqa0e4{=cA(yrcVQTYFoH!`g>~3~Ew~4}P)o@!WMK~GVG-8g4s5~} z?7$w(Y#|p$umCHt1{-h}wqXZq8Q6tk7{Uk^VHMV41GeBE>_Yvt)rBm~!8|O&8r*?R z*n%C{gPEJig%K>k3ar5f+=Xq}f%@U73&Svk5iG(gtiuLu!9Cc8dfm{4EX=_?EW#Sx zflb(g9oU1JTgZhGEWiq^!3NxgZPBe@!MC`77{UlH!y4RyP1u6>VDR(EgPAz`_Unx{ zJcimnsjqo`L1p`tHv9GFjF>F{0i{_;rd#}RZ6EYa+oaq-Xx9s^aum}0i0i>Wzt1W< zq-`ut-go`@^ON;y@%^;7^m%-+H{X->o<5Jb9jEOoZCBQnrTP(f=)Pa@{d}q)seYvT zG5C*jr}~lVN2(vGekAP&i|=P%lg^{wX?N_m-qL$~KF>Utu$Sv$wKhx{SI+xae z+Wu1gOZ%U+|4qlAbo@>2kEH#S+F$Sfo?2>uruKI_|48Rw>HIUDf2aP3)c=ySpZfj5 z);@eZ^*^QlCu<9-|1I^urT(|n|CajSQvX}(e@p#uN&7MNzoq`Scl(`e>VHiAkE#DL z^*^Tm$JGCr`X5vOW72-~{>Ef_>VHiAkE#DL^}nY6=hXk4`kzz(bLxLi{m-fYIrTp$ z=LxC*IrTrM{^!Aer!w`wr~dcU|DO8aQ~!JFe^34IssBA`Kd1h8(~1Y%MY{fwu0N#f z59#_ty8e)^Kcwpq>H0&u{*bOer0Wmq`a^R5l&(Ld>ksMrL%RNu{{6p)`%%*Mr*!=( zU4Kf~pVIZGbp7dJe)e?z;o;+Ey8e)^Kcwpq>H0&u{_ydvKYT^qviWwl^w-~4-Cuy; z4o2KxaWA_LdypS!JnqgP_&e|KkkZ|uaBS5@h@vz-rlZkJu^C5-KspjTAE+j*sMIg zu(9?)`SZ&Aq_#2l|HaSi|Bav3{(_$EtnOh#+ek1e&gy$4DCw{M+v?9qu%uiQ+QxKb zLFraMQ%dpW_T};NOFB9u88bS6R@WNQ8D+&y)}+o|l4O&=;65WdW~ErtXHxs)F87#Z z^aqGecjs-nOZ}a{_Pw=l|JtbAzpHO+3l_fd8(&|w^d#M};4=mB+h?ALtSMMA|Kkfk zQM2q{{lQyry`gyKi6D4YvP|3|ZLc3amYbeEc64&&#B)c-M<$P-m>QW4PmGOBj2#~v zpPtE0%uXHqmNF`QDR}%%iFW&Z{nlec-_vD$^5>LXn%}sw{mlGoY5khZbVkQdYCEV{ zB$`2G!9Orh|KRF6_GxWzTBg2mr*GeOn|*Q1?~niEpZ-^qzw`2^gBHB!^I4Vjg&zC) zM0#Hqx0@{ASC#7S)BQ&jH-hcp8SSmA39aitr?`J#2N0B`DW+XAH zXbazdu1WdRk}w`Dy1cQX=ajO9BHEdz@;N7O$;r3lIbCf^-(_8ITHCB^8~zs6oZ@GZ zXmhP^T>X|;9?NU(!-7wLi{RsSOs)IBKyfT;;RlZm{d--)k}dkM*8PT#SG8H|u81FX z>;6B-|BY+izYT|JyiUB(hff<6_pQo~+kcz1 zEd5)P_9gRYy`TZ?mt$FcJg5wos1;hvx4~#q?QlV@J=TFmnv>d*Y+2PD|%oXvYW+ z46!5FFqdWM{J&6{4lI&hO|VY<9`w@s#JZ&9qqU~(>PbyKU zu$XoB`=(;nB36Ris)0r2SaR)TO?z9avy!&5_HXKYQzn~_ zXJ?f=tL-(NW9KLHdCPv#%)n$=NSm$aR8 zT4ptomDb(TcV7D&x`PeZ7FU(Wg0%r$u#&9*PA>}E2UAu_IybFW+)n zM{XVStoCefU`ELOA)ur*Gka#-5U?bvv&x%u@7PT?jE~kfddH>T5%J~liOG1@9~eO2`uur5o>zWT zBx}Al?KQhUZpt%nH+i#Crkx_qyQXa_wWzdloiVTUl0FkknU?Ael5g_}Q&zKSV!Or^ zDppxjkO@gLTgN8(wrA4Eq&jh#OpRvTQE$cDZ4R<^KGS;bs#hM%=g;vm|2}Urp7jR?&|m*ihqQ4GH#Xlj_g2mgH0HLN zlJ3}$7Q3rVQ$lSvCn+nJ&8Vkzo((=Wo3^>SFSjpGUgb4Sx4FZT&N7WN*O|>aN|Iq( zZF3QmXTzusjyBAhym^<$nBiz36=nY5(lmgV(%P-c>pLkoGse{+FG$dad+v ztKOl1PPc|D_eV7GzR>|axNQ)qJ^lqJpNn}urXZb!_qU{{}U*RWEUO}(Jw3+f#DgEhtX ztBZF2KfmtoxwLkk;=<;x4p^1zqZ zuaxH&Z&k-mte)Pe96fXG+3~`}zPrbZW z)+HC`&W}$`A6nm#hh*;Ri!Yox{lfD4*xBoa)93QHCr_5IEnPTw?)t^e?emvzOirHK zICK5_v1jKmoO%A@=Go=^h1*lBw}0-~E3aHzojSR3<f-uzmT)=E|JA{ii05 zs)y4*TVv^)DJey{w<;U!Tjk5!w<_g1yRk!C+okRD+}5p9?m}*JI=?)2;^f)f@$*v` zUOIL0!p)P_t?iYi?bEC0!uN?@VhX4+;V7T0!BX+$BS?m#;N}#;Iwj9^d!$n*0YjTP?uoV$ob%^Tnex1_)Eb_#V@MdE6V>u@El#vLhy>7 z|C$^@<2v)bu6kKHZO~bEC7YA{aoxwX%DS$U*ljkaYrd!}oY7TZP|kIg(eA3C_&Js4 zw#so*Qm&~i7nE{N$1bWawk7S7YT3$tO480K{kqEath&Yviaqagot4DA;4-S?D^y`;OoDBjdv zSV?T2vZU|Ry0dd?DS6ek`K+($j9aRiqe`7ttxl?zFR7Nys+`q1S9Hcq@Uon2=C`&w zu+mt`;xfiu*O5hc_hv1wseINh>>fkqGbdEsQpyhuU4u*szr6mS^YeA5qW(Oy^fgTA zI&t{@vixlbw(I(G)V2R^CSqK=`!g|%TUV7gAqtzneaH1zTd+?0odgG&h_RIW-&Q^g zzI;XPn|XG>#m3I+{{Cu1t-+kK_j@X9_3_h=U9`8rCd8vAd4fU9Inp*JsT` z60bB4totGHk9MLx2xN7%A%{4 z!K=?Uqc!8!YBIj3oMhST*3W#+Jhs`iy;Nd`^1LL*Gi|%N8Nyb+{*cUx~F1fDFt8c>M9z9|f_T2GH<>#Njyt?%4%;wm+ z_0uojyjpto!u(?C?Dd7~$5*bel`mgEed*ZNg_VsLKO}4XQP*4_w=qeZbxS?1?>?&8 z?L8GOhNB*oST~GiFsuK=y?^0`u^z0EzLQ{+_yLuvKlF)p$;ocaJSy(_XrOvO4oEYe zWAk@TgUKazAkXV_Sw_l|hLaf$M`JR8)@AIxD3j@`I)YbaJk6_nC^>U;K_=314Sm<$ zuyN| z_k#Hjt)H6Gx4HMtzi6hFEw@eU?AT21_imUOvuqo0?mp;Rb19?S8`sL~quw2L#JQDT zv9!5x{OOg&r>`%J6)v2A{_N@1+qYl4bYW`gQvUeq%eiMaR~AnnUq3xvK67h&apuMi z>&XA%_a1X^vD*G!ZFp&d@?V*E!?I`pu>4P+82U{O4>l~@XpwY6_PuPJd;xcPW33!~ zQRkdjRjp|TYMzd)=Jhsju|KI|ivU-2{KI-B>7Ha+=*0-azH!WMHOu|pIkEeb=9T)p zut@rc^-9uvEd&hmNNx4i({`ekM%7q0+_3lHtR)>*(pQ&EH@Br)~)n=JCvy5k%wwM#Y18Q%Y+B>H2 zzqL86y(t~91^YKC;x|++ZBYY)4L;^SwK=u<4s8BAFX`qpQFr83)ve#Y-@eqkwbt+a z_CvdH|HA~ort9N&&Uc;|s?&v=p+Be1k2;CpizK^n|0{`i{)R&5o73UlyY+{?dm039 zsGU}|9n|?1@lj_&8M^i?EI^5Mqnf?uVd3v3y80gJw%%;P^DyxmjE}ze0>m#WqpQyW zGoeT8>iY+REjjyQ%f=i~qd0PtZxbeG6uzA$)Av2oU~M?k{h8HbU4w-?F`V^ayB*?P zcp&jylGk5WzEImI{cY9v`&Oyl=SSZKKicofzOS-nwY^*L?d4IsU|Z~pUxQhc-D_R2 zIsMFSX%@KcTNfO^NN={X<+q=uSjTNIvYAzFd6MlVuR=emZNk~mmeU-SCc$2XvyM5I zZwnsQ#ZNnH+bnRi#w~xmgtDmo=FII6))jmheWA&GdH2cp{kyUM^xdJ}cVo-i{6in* zPuuKgjVEMp+uEj0phw=(d2a>Z{}oLLv>jBwmiVaMax^3X3VHY@v^48k4>W8~YtV^q z`DDW-2gL-d#M>~=_1@j`uPdXg&yTHJ9+f)u*LSi@k5_*ChtMsRIobTZS|-!?-Hm^m zA0=e+7>1-=OzunF(N4(!6K!8}}s zHCTrYxC`5`1A8zN|I$3j!VsQ>MOcAv!Uk-@7TkkfC`-wOVHm;)=HW7|!8*JHTd)l~ zum>~P%UPI%d02!M_$F+?CcFzfunT3q#rFY27{LOpz#6Q>JFo@Y@E(+<=t2f&VGibD z5msRxHeeIpg&o+12e3f1FoY2-zzVFv9oU2|*oOC@91rn*z{4* zyYRqte4Q)|;YnD86WgTo}OutiT#&V?+@!8|O&8r*?R*n%C{gP9Y^g%K>k3ar5f+=Xq} zfqKirg<%-N2o_-#)?ov-;2!Kkz1HeN7Up0c7GVwUz$R?L4(!3qDdfTk7GMR|U<2;L zHtayXPV2%j3}FO|unOz20b6hncA?%saUlzHFb|8c26tc+wqOVLVCD>RVFU}X0&B1V zcVQcLpx%seVHk!mf<;(`b=ZI{xCgsXZ{@g5%)=tA!5!FyE!crQn0XnwFoFeG zfi>8GyRZ#AQ0_h#hG7UJScFwrhYi?*d$0?&nD0Us=3pKcVGZuUCTzhD?7_?h_ELo=E5)xVFZh?3hS@|TW}9{p>r}ya`s{@KL_)$2y1W$Hem~PU=L;r zvAisdU;$QO4L0B|Y{L%JTXHT8!w^QW2&=FT8?XiUU>EAA8ZKmE4(4GI*5D3o!WQhn z9?bkn2qRd8Ral1&*n)eo3-uQu;`@g=n1@AJgFCPZ zTd)IrF!N31!Uz^%1=e5#?!q?gK)qw>!Y~YB1dFf=>#zY^a1VB2P^6qN2lKE9Yj6iP zVGDL(4`xb%3t1S!0<6FqY`|UEh8?KYAQy&V2qRd8Ral1&*n)eo3$To{HSj9?K~VI4ML3+}-#)PkZ5 zS(t-)ScEmW1Dmh~JFo{cYsiHWEWiq^!3NxgZP_WYg z=Ry|dU>+7>4er1uY{3rf!Au3YFoFeGfi>8GyRZ#AP;bh+FbqQ&!6K}}I&8oe+=E@H zrDPYfFbDIn2y1W$Hem~PU=L=tkP9PNfE8GS4Y&*2umiOW?7}b%VFZh?3hS@|TW}9{ zp?=!xLKfy=9u{E@?!YE&!4B-f%uVFN2o_)k)?fqf!Zz$c{czNUVHm;)7GV|EVFR|{ z9_&KBZs_Gjf*o9#j!Uz^&71m(` zw%{J@!r*nv33D(Hi?9ZFU=y}r2lim*4dlWI7GMR|U<2;LHtfLQTiibkVFZ_94er1u zY{7dl_<7{POdNgt^+p>WLv5eb*Sx-xEW13h8~s_28f1XB8dNHWnxEyMFxn$@;YTe%f35JU-Z)@5y>kpGVw|({`1%E9=Tq z{fIks-!J%nKGly@KT`b|{KvUd{YdpA)sIv^lJ|X}_EHyJ^3h z_Pc4n8~2~ddhqkO{ia*K{ft*(e7O&OzMPJOamDsOxAb}3|8o+_cD&#AnzpO7U0Dqz z+fToq+427Pe)KMFS5|B9zuwaE;}5poKFl*u|J(A9=f5pa>p$*u()O3OKl_i{uLbrW zzg8a@-~Ia4pmF;1>c<|_X8#|8h5gzGss5$@<8Nwzr1n?R zeoXDpcYjYfwZGH(M>_vX=b!2PJM}-L{+HDMl(e7v*W;{x_;~7nOZ{)D|1I@DrvBH| z|C;(=Q~zt~e@*?bssA6NpHu&H>VHn! zkKW&$Oi%sKssB0kKd1iZ)c>6NpHu&H>VHoC&#C`8^*^Wn=j1#g^*^Wn=hXi^`0qrg z{`b`Xp8DTY|9k3xPyO$y|2_4;C++9d|883GV7o}yAJX-Qbp0V+e@NFK()EXQ{UKd{ zNY@|I^@nu*Azgn+&Y#lthjjfRU4KZ|AJV^n`EWlH1T;{`CIVpT45* z)NISGpd74fThRX$KH~n0a@lpXgY3}pxEp@p?<~KUo$8N=1I{0`PVixu^9#DZ{eS9X z`d{CzEQ9WIf^z0Wv%h?~Eq*_AkKEsX=bo4AQ+^+bgQ2!rTB9D@_6|r9i5Sk8J$0?YmMlPvf?IdQs*v7vdLd?pAj9i zQY`5+sr_-6drUI=gZ1MVwGFt}(XG;2WwpG$Sz5TZvVMi=*676a>|{7v+1%LPSlCz{ zU0PY)E^m&+nYTtutE=bTd0XyMf9J1#Z|&Q^HtP28>f73ag>U@E*HT$ZMtiGjLhJhD@b~ZQ0D_V<#k5O? z9Jly>f-i^9n~Z1ufdTa8@aOq>UinQCO-Yu5MK$@dIOSB$lycE2%7Qy?in6GZn;Ok( zKj(6qa+Y*_M&ILaKi8yuQ$tg#aeWpfV?^766nEUoH(nI$qUgt-B(A)UEq+`G0e*y9kGAyiUB( zhff<6_pQo~+kcz1Ed5)P_9gRYy`TZ?mt$FcJg%hg_%R*GX@AP? zg_1TSxi(17YHz|_XYB2kZTFz&_s}-_|4dzYs5ba?uMIwKvVQf6p*tEXyhd2F?jP+I zHg1;I7s@uWkNy!IJ0Db>O}3@)%^(}(9k+FhtBQ?idsh2fdR*o`FDcJr@UQj!I@%8E z{5|neRi~x%Ewp0<2Zq=YY?#Y3be2$=d9OmGR}-ugzX!dvKCv#zH#z@kt!cY@Qj^?P zeQar97}ck$y-M)39`8nQQ}@2^I=DE#rsGLDUS2Z&XC(iJwY~LYzvr&c*IQrQ_}b^! zOE*`pl(ttk)=w>-dhB&q)S@z2msKF+U3d?=QAqn4Zp?QX5ph2-7KvA39VW}SELowp z&jx=eI1)S+WP@XR`YUc&%sTshQ!#51E5U6w>P6*Pa_wYIdt0irlD4w;Z|ZwfDJwd< zuDIEFStoZ+MoaR#R_9h{XO%mv?KPca=O^=d%YM+zz+_lRo@a42Pgl08zLUqj+(DkN zL2?JBf6(jwah3H;+RiyGvzo|C>u%{gul)_(!G>##tIA`++U=0G&>{*J-%s%M;PWQq zS$|*v{rx{|=Fr!_JW$_x$$L`UlG@9x?yRH^cTsmVqE69FhPVs0nS)vOIUThw(>iPG zs;%R;jyiPRtj#`rxqW%OeCv9rl`oz*dcbTRJUHV>!Pi_4(dy-s{T#uQ-8)AFLxF9-O#W6yKlN~+;`VLZs&X>w*2dTmjAE( z@4x&PKSay_zk0ak?~@;98~uJ;{=+Z*(owVge;nSknz3N5yD#+E_Z?i{p?B;i8^%X# z8@=Pw?}+$v_{3y9>kkZ|Z+-qeAI~elDbkb_#VmPKAG5NpdC#liTa%yEcbsO{kXbe( zqRjv-)y^}O%BjIm4OFCQDZ`@jOu948g0d<0jHH-+o8X)Jy^i~olL$S%@Teg+U${tcb7T-_s8shUN<5_=T0R8nJbx5Dr8I`=%+T7dA)EDUZznMs&mmCz~tSFlY>wHvhnL%B#Gl>6U9=p9!6BE-!PZ znP$Cn4sLmDCS!Aao5@%o5YK&VSTjF?>ek=tzJ|2V{mWl{TPyFX9DYcCtrMmihpK7`Kc8wfSjg@uw4RJlVpzqaSPB#5`a6+<^*Yov~ zOyBp6R^5TQ zY6%;gE4Rx>7FJiv>)V%C7U#l^(%95yxHWcdVSMeS6KAiFZRZXxY%G>9FD%OgUtYgb zo*Tb7dt&|kRyBXTR5^8e`ozZNmD?{?F03DY^~T~$<5O2(IC|;ii&IMz*N<-`PQAQV z)+HC`&W}$`A6nm#hh*;f)#;ntr;pv9oVs!R#>)#Y=TDyFHI}}al2Vj=tFp1aRldA^t5Tk`8#}bMUD__sU3zVG>e^~Jvwk*Tom{zi;^d86 z&%HRYbn(Th!iDhE>|}N9()`OWovoa#PAr|iu(@X-Lt6_Q zlBjKcW$~%;u)J1USrxUMp@od{AJ+3pcDKi67aa{=3}Oe+d1o2fbl$9`e<$bCJ#7bd zUPpY?F1KazS{(Mh<9O}>wzi611gu(bzJ*Q zbh-Dt)Th;j+Q{mMqx%jZbBNhG!m^ZaRO)R0cS~7S+NkWxF@5_SHk8HglOvL3u9UKB zb33@Ky+w7=p}KHe6q{1MQ1B~)nH+NEuxnk`-m=bF)yHIA z(f6FrxTr4UgyQEVr7G9KapkG#*_~D=aY9$IE8f=At!Q{y*K>YVC0^83Y$k9uctI(b zf|ELKUC4y4dtB$d`&BQils4!rE2rJdc_(XHXRRwGcAL#f&Q+D*rt+PZgXy+9xG7!v zxVD#dCoij{r*)rW`o11Kr@J|+c6r^k!%fLMtCUlUU)9~csIzaYp5~QmUf$!n@=0+; zCBLqG=X7tC;CbEmZRKCr*)J%^A)R5J?uw%=M_<;p?WxS^sJDZk(mfw#z>J5@cXtEE zd1Be-F0}i#CGX3UcuR46Cf0K7i5+tDjM!N=r?S4LCpV?%ys9TYqw~(H4yvk`6+Ocf zx}zJC@SN^;LQmqNdm;rrvrzS5GpwrW>XPct)dNjzC@XPBD zIzL}`D(cTOOJBo;t`i4~-w&TW)4}?`AJ;Z;T%+)VhIpHM+gxB)GzXNeMBJado7HZ% zy{#MAJU(8n`__sp`rQ@#pargx^->7Stl%& z(IaM=%)NAVx_o7J<@o%O`U|9CATy*nTc?JCFtWH+>-U?hnZyhzGu4W z+MHTUx;FRWtj&G$%$Y~^gyhsJ>{TE0beMb6ObYXa#7hun;Kas-9gp{H`N2FF<_tAw zrL6!CUduDThRLwyhIwba*t8^m_s=E}X26*760abdC&XTXvSkbNq1c;;_L&VdyuBUF zj9IpgHy$5!Nw}2J?Tu^Y^-({KKjNn2uUOh#IR5m?;?vh(Svvkwe*XC@i<>7dT{<^@ zZfR@v<%?@qpL_o5t1E@I)rI->Gx9pD*@b8Rmv8?$zr1l*ab~x{PyF?N>xN~|{$cr_ zJTdf}8Xjyd!$ymw^QP}5&E$)V%NuLu;EOuvyllTUb=)>X%m%MWfz8Idrf%Kli@}HX zD#ty^vM|Vjn&p0v{J+PJ+iX69Mbba4S2^CxfjVd=ztvYy+lg8lRb$z3Gu)5Bftn60 z|Gyqqyjk+@v)@>^9`^0c8GkGp&-w!c=&%2x{xD5+~Ujny5#ky~kYVYOQYu^4XRFh+KV3WTnsdi0U zbn9ck2&(XDvR@84->D!_~?5(Zhui3U40Ii2|Zd@-#-v+ z$$e|Khc($y`>_Ko`4(2P-hBNf)Av2oU`;L3{h8I`9btF0Z{co?paZ+`K;pS1ufME( zp|(%@TYm5NZ9KbAGmq>I#1Hb8-@A9gkM=v9@2gx{ZSNL*dwJ9@cvc;vy(wq!vQ4PF zvlsAfjWK?k&Q>XH&t4NUOWoEF?Zt%nrGI;~&ejg z^Pj#u)cbC1Sz8zPQT`;zehzj*_O`7F*#vsz9i8`9@cmzrN^3i)d@b=&yX9y|0u=J_ zO=xM>vmR*JUJyK==$215TyjuMuu8lQ<6Q6EE&sYQy88Usy5&(d(Ej>PcIokoS^p4f zKio<-f3KFw^nG{ZpXO!mtX}3;|5Oky+|4=!_n>?5O3ECJ(+|T4=3x<5VI4ML6W)a# z*o6na7R%4V5Js>7E3gK4U=y}r8{UJ#PsZ{y@Gy*E9u{F0)?owg!Zz%{E<9j;l0p`S z@FXn43ar5$*n};(2fI*%diIP@D6OjHtfJ2%pB%EU=HSC5mw-vumPL!F6_WA41S9H zfFX=v0ajoQ*5Mu4f^B#Y2KLsyLI!4G4(4GIR$(1BU=!Yj9oU5jY|5dKg&~Y!0ajoQ z?!YE&!8W`H1M8R+GVm~rU>+7>71m(`?!q?gz%D#65??0^LwFJvVFlLU4s5~}+=E@H z-`lv5frnuP^Kco~U>!E#E^NaN?7>X@3*8_KLwFJvVFkVk8?Xsma1VB&w|IuJd_ow( zJY0q~Sci9D3$|eg_Fx8kISX?z4~wt@--Hd=gm+;FcA=~~7lvU7BUpeHSc7$V2ex1v z-h;9gtFbDIn2&=FT8?XuQ!Vc`h1C#M}vM_`ZEWiq^!5!FyE!c+lpe*6|KHy;( z!8|O&Dy+i>+=Xq}fn9iDn)`quJPC`i0&8#wHem~PU=LlsP`va7=|H?U=dbf9X4PK?!hk9yBaQJVGibD5!T=iY{C}oz#hz;LN1J8 z0ajoQHsCI7!w%HjBQ6ZX5Js>FtFR6mum$&E7wR=f7qT!1^RNhOa0fPF3wB@+X3iiN zMz8=Yum&4&7q(#s>fIO@hG7UJScFwrhYi?*d$0@jMve~e zkP9PNfE8GS4Y&*2umklbkqg5xgb^&lDy+i>Y{5O)g?fw0g)Gd$JS@T*+<{Hlf*sg{ znU|3ZBUpeHSc46?3)`>*Be@`XPV|!!U#qEW#?R!v<`@J=ldok#fQu z%)=tA!5!FyE!crQm?;G=WMKpgumWqa0e4{=cA(aQTo{HSj9?K~VI4ML3+}-#)XGv^ zPMCvvScEmW1Dmh~JFo{ci^zo$EWiq^!3NxgZPv)U=23lE^NaNbZ^>8+J@u#W zS06(=Ng;h6aXt9@Ozp(DK9cPsZCCGXCy!b`={WdcJ?^KU598C){)&1?`>O}rk)`;0 zN&Bl0r+(7@>cM(U`>S{A*`w%P+OE=eWi^nrqx$>rv|a7Lem-curS?_or~WAPF>P0A zyZR)wt6>$w`bhhm*!E}Nt_AiV)>R)Ef8NXg^Lfd5Ok4WjJ;yIv?RWf6>pyLOss5$? zPul;c<4-#NruIi_f2Hp{6NpC9IDP5sZ#{rrGmKJ`DR z{^!*HocfE|D5`tQ~z^3U-I+D)c>CP-&6m4>VF^f_qo&c zhjjfRU4KZ|AJX-Qbp0V+e|YdccW*~0=N0MtL%RNuu0MQy>knU1XJvESE&cWPRreR* zw}TP)SKP~P0-V%WKMx*vM<3L4e|(Ug?2m^7&L7lIeAwmug064>pZb{o*LN$+p!=Ml zoH^0vf4dKdy3F zjzyL9elR=wqP79|I=WR_tE`r{H%klGR@Sc&-5Q;ko}COwE1MhJ8w(q&qf0BR+vUxX zIP=zMX?69yJ8#QfXz%l<{=&C^ZPe}G)wi_;3mc{1`g4|^q#gT4@R@?}m(M&ASyQlL z`ta2sy!F-_ie#P$f>$NW#2wQ1`q5*#>DgmPCr3^^cXWJY^7x6Vk=gLX*vQ1#@v-sg zncT$e)Uj{HQoa;C{$ERU9Erbw>#?El=`ud~b4o4EZ`{~^W`4D_e$C}MqvI#F9aJn5 zZ9ui)ADE|qaCIH~w6-@bQ(w5#w{N@6zPRQ0$A@3~rK7*|@~49zhxdFwtCGIZV?Uor z@5|zLljZxWQr&&3nQR0%g6-fL?X9XouIoRixPM;<5R{}Trd=}RxW)Gqd^vpHWIXE+ z44^NEKhMYW%5REj%|54QZz_?~x2eLsN*OCfjCQCuGsT@j5lz`lIZd78t1n3MxN6mo%u9ho?T_nY&)Nqyr}$YU+uSRk`?Fqo zEU!Q3tpUOEsC9owt=ng{q+j^d&>K<|OSY)B+PGjw9aMDx&jh3TRJB(Lp4L;|P`#LbEU0$k_?nI< zTZ(Uy$@HI*{2$i#){p(3zTXaSeR1P!pIpyHr>}xX*+<#v3OcSS7PoY}>q-x6sKGU@s*Y@KfaYCu4DWOtL zPsf$d^sg*EDLIBpn;$6Oa?R^Aq4P_+)`-qA%^KI9U31dOw>&m<+Tb`ZPU?z_%44!; z^qI7}^|$KA8rKH;hX1~Mb>rCQ{^hT}t(A9mpRSFHS4&@Z>0UW~T!(_8$A^9w6|_hB z)7l29;OfSemGvW=lZdx=bjor5&Wp~pK-Tqjc`-V@tw+;)zJ;9>WUiYS9G0W zZ3lHu#`Z-E{_%VId#>x4^%iehroM2G{T>Xh-~@>c4io>U3ANlIy_uj_$E@{seW6dR zOHG#Vn@V-{^*+^d_3autq8cmf>>J{Ga6#Xz!Cdf^8o&w3PF~N~OEP`m>ihWnQQz(n zug>|tI38*dA{uFa;d3p;KryPF=K)K1vcNpX_RIdbdMGPRx3 zr?y|e-?`rrp-V!d{=KKSdq=wb+?hLf?!9woe)F5(%v`vrV62X_Xb`!VM2OcIQ=?^r zm`2zzDkdvFefGZX{lsv;6elU1&ni8ON;`~rY#TZ`SEj0y`{*J)M7ewEj154 zJd>ZxjD)WYkLNEI%dyd9Ve-u2_~Nzf+En3k{`hMv>GR=%>!*)jotPS!?OPgM^qqQb zA%jb%M=pj329M+yp(2coULRa7ojI}AKd>^oav^mgcII5~nWeG0iL*<`rnwu^ZP9@i_=fkJxk1S`>+2u^CbZuohJ7OOH<-X&PaQM%j zR*R@b2x1oti}_;aTIp6HGr|WuQYi z{IWYa++Xg!I&*^9H6bLrKaE7|qAG1sYRrSEuT%l9CkAc z$!rcprv}}b%(vtH_{Hrg^rGX=loLWB3pp2!W|YSswWU8oZ{!}f!#J-AKB>rUP_Dvl ziaR31xVtU?kNsND3HA-XASPJv;mSU)%fBspu@0aK;X0;#`b6%oNPWfh6lPG-yyj?E z8(KsaV{c*}m9GcYG-E2=3gVaGUqz+uxgUe)W}P*}Ifj&S*v}w0OU^ayr6HnSq@KhX z1BmBB3+qMCB!zSrobwRf=bR;kl+d0ZG55i1UBliy&dK2))0)HI5u9-af?*u~i%6vm zJ$4jv3V3&CAhgDD6<%=-Z?}NvA&>X`8lEAItFR|<-8qertIhoRvq2r$de)o$I)RRm3~voWLEh+rEO(73Tt;tc*$U1nJog&n=W+IF z#5jU8D0H)iDUHYA=N{4$>TxEf5a*?hQ8?8WiYrtZw=rQz!u(z^ve-w8_& z-`EixVUMC@La#bE@#Y5bo^yEPLpbjo@}P`-$>JT3m4{zd%c_VSWGZ*>5 z9#$E7brpGV0q^b{t~7xV#yn%1{aK`2gzqA@%eX=sIe!x=Qf(S^UdQ!#H@q|N9zEu9 zJZ+wy2Ac)kYZmA78C}F%M(kM=lG)RA*(S{2q*)`|-k!kcO%=80Q8nnm=BnaaRl)PV zc&Y>C-$${vZP)Z1{`{~_JWW^Z3(&~b3wFb|+jpndPThXS9H)XoWrO{9HvLJI8Y%=- zLfWOzUO^h^G7kF%-PofF;;AS+pJAR6jr|o~iAv0Xxu0Hh?hNjs)dg+&i`|yR`dpoM{_0%=Cx>anpSo<`Uo@3NZM$TU!%*+jEM`u#g;VTo_ zv2r+ea{6la)akS5&K8ztGvni9*KeekdT&iFJ|ivWJ8@4JA%Z;dy4OVGsVXN?go_a7 zH1j1PuF}rC+1bmn3>Wb~*H7KK)mdJhPS*O&FFLtDiy7JRvMd4OGv8*fn5bmkf zwIpkT{neX2QS*M#h&+zrhDwLm2#uh*U_+ciLpcm#K8oB*p~2h zz!o=e$8qk8_e9f%VZT!^(pnCp^2fx4SQe|I|NiEYmW%EE&WE5lzU+jcI#GF~;W~sI z&lm-UN}#7)rV%=ex3P@Io5!uX5km9NxJATc9SY&Sx%kU;NAT|a*QHv|JUfTjA#68s z4$t?;vtw_zq3|DP8g%|}`dJ023YGEKf83_qZp^P;y6wWB_Ilrgd;JKuY2*P_Ihu%P zQ1WS;qFO|=F>4r&#dPm9b>>MeAra&S$J%J=pm~xi1uY@o5Cjz*Pr2Z6Z;wL-v|P{_ zN@Haj@!O9D(yqZY`f<*TQC`?BnZ-UWAslz)_#>~}3yDv&=qy4xY(X0eS0C};u!H99 zzM~p5&rOEUy(S40(oE-dOSEs|% zv&GznD+|}hPF;U38(+w!X7XoYby(nqhko}*%@`o}?_yK$*7?L2|IjqcmaWb5Z@$#= z>u4T0mcgpxH{P@i)%u4o=NA_;&Nt(ni^!A(2yXTeL(U}>RqA**i~yO#@vkA_Cbq-a z-vU|f>1=hhwAHGLV^3m04e5E0{reN6?9E5Tgu=@{R^`7Znw!F(4!a}z@9$9tRF3)W z*OM={8OWn=dv$EdBQpG%G=~!XkRmX6)h3g|E=Jcx}0}L4JS89%w^b ze)kjqE%N2QJh1U&NbghFyb<3B7&ao8V_d`d=S|g!7~#z@j(1T!)0|CFPNOz^y z*EW4NDiq&LwbzLH4ANo)L-9Y1RN1I_(?l4?F|IxwPa*Cs{_+S%yCFC1t($SL$Cahb zzK<-Ye$0+g--X|bCOfUej)hr2&-w9}I;s-kRP;x%*;dCl+r}@#?HrQ_XQ1GG8XX=k z)+o@x7dJp%gfpaDxHE?R`)Ws>Nc^?cJ!u8oiaLQ1tqbPV5vXE)M`o@&MBW*o~W5%C*fmR{!P(~^=J+JR}shiF7w?Kqaa%m}NiY47=!#J>E*8X!xGvVkhPWx-6P@q!((e?Hicv8pCd9H>6>H*# zxG6TpZSfFg5?n}h#R)MX7Q~9UF4o0{xFv3ju(27}DIOK0VoaPDD`Hiwi5udk*c5lf z&LiG+LZT~9hzYSE-WF?OU2KS3;@hVpY5&HpES_Dej1!NA(lV#(fMvYhv#Y5fRbwZ*mPKXJyAXdb6u`V{mEpc1KWK-ih#iL?WjEVDNMXZW7aYNh`o8pex z>CMx3LZT~9hzYSE-WF?OU2KS3;IkI5v$@Iu_11X_e5xi-uo6qVnmFI39&3z z#hO?b?}|-vTRhb7T_+^EVpNQa1+gNoi*>OfZi@FrXu{reh)2b!7!wm>S*(gRaYNh` zo8q>3Xi(1~y5fYG5DQ{OTo>zNLu`sWV&{<37o%caEQl4cCT@tEVpFvJ*Dm#AT`?*q z#IjfwYhpv(61PS4GmHy~5iuqv#EQ5s*2RX{6nDhVSCy_972{$-tcW#nL);XbqVw0i z^twb>jEV`dELO#u*bukGZPEE&-KQ84V`4(Ai0fiqY=}*9N9<(33@#)_#kg1yD`HLD z5I4o9=zO1-UYF>KQ86Kw#j02n8{(F@En+m(xR4kTV`4(Ai0fiqY=}*9N9>F$T`?-g z#e!H7YvP8uDKk?ftDkj9TSQTqxL);R#Ma)1jE+j_8n3xbN;<{KD z8)8%35j)3~t{4^LVnM8kHE~1S6q_REPZ-xFx?)sJh-I-V*2IRmC2otDt6^M7jEFHY zAy&k7u`V{mrnn<^PAXk7D#pcvSP^UDhPWvqsF)DTVpXh(4RK4{7BS7y zxR4kTV`4(Ai0fiqY=}*9N9;VSbj7F`7YkxVtce@qrq~oQH^#Uw(G{a&LM)3_u_iXe zEpc1K%nai~VnmFI39%xsi*>OfHpLyWb6V+&Q86wS#EMuGH^fb`DPn$vab2P-M#Y3! z7OP@SY=~Rpwuo6w#)ZU)7!wm>MO+u_Vnb|-J7VVrr7K3oxL6P?Volr-H^rt1bDwct zqANzlgjg1OfHpLyW^Rm(vqheevh!wFWZit&= zQ^fRg;r2;)b{>Hbv+Az4W?7SB#1Yu`E`_n%EGx#BC8P=e_3_BVtTUh!t^N ztcwk?Dej1!pHsSGRE&!Su_D&Q4RKR!idYC>T$kvIQ86Kw#j02n8{(F@EjkI^rx+1q zVnVEl>tbDOh)r=v>`Xewg~X^B7YkxVtce@qrq~oQ4rE-H=!#J>A(q9eSQ8uKmbfiq zT*qsF)DTVpXh( z4RK4{7BR?STu6+FF)<-l#C5SQHpHg5BX-UyT`?-g#e!H7YvP8uDKIkI5o_XxxG6S8 zOtv$wOLWDkm=MciRji2(aZB75?M%~9&PzWc#>9kJ5!c1K*btlIj@Y@N=NF@5Tr7wc zu_kVan_^SMykYP8MOTc939&3z#hTaMO+u_Vnb|- zJ7Q;1>55S?E*8X!SQ9tIO|dCr7}&Tj(G{a&LM)3_u_iXeEpc1KQa0m4VnmFI39%xs zi*>OfHpLyWb5-ezQ86wS#EMuGH^fb`DPrclab2P-M#Y3!7OP@SY=~Rpwuo8t#)ZU) z7!wm>MO+u_Vnb|-J7VW8r7K3oxL6P?Volr-H^ruiC78x_iLMwG6JlAciZ!tzZi(BX z^LgE;7!hM)Lad1EVqI*AO>sx;d_(DqQ86wS#EMuGH^fb`DLOx>=NDZuD$a`)ab2v7 z4e_4n{E*TUJ3a6Hc?)bFU2HGvG_Mci-o6PNCoK(u{`)_KFgkxY{qM&1w9~x&>Aush z=Q4BPg6Ht^!M?xu!`p$a*9$&y{@C;V`APpl%3JV0o^INuKi`A*@!&f6XPrMm{qO`t zYdH(*`R=?&e|e+-Ao&xNtDsyl2mIxywVv^Kt3N1L59UW}{s#`4Gsfz2%4@HeUjH^=$GdkXL*2 zF_2de*0U$6cR{%d$`y0KuSd1Y@1R^AJb#`x-va$Auv0&e`WTd}pj^EO<*ExeK^e(! zV)L_aHynNhH2BeVfBX9=`_~7NhwsA1k3`b>&u`Zb1^FM8zo7mF@+XkLLHiT5zk&V{ z=wE^U8R*|Z|HI#Z2>KrnpQjr1zk>c}(EkqX4}tw9us;R%x4{1B*PjCWt1(OOu}cT` z=fM6P*q;OYb6|fC?9YMyIj}zm_UFL<9N3=&`?J6Q6xg2w`}4!T6A{?o1N(bme-G^M zf&D$OzX$gB!2a&n9|QY)V1M6FE(GHb!T3Wk{t%2m1mh3E_(L%M5R5+r;}603Loogj zj6eAMkHPpuF#ZsXKeYc&cQF1EjK2iqFTwarF#ZyZzwBpc4ealM{e8c35!l}Y`+H!2 z5A5%O{XMY12ln^C{vO!h1N(bme-G^Mf&Ja~Xiv`BvZZ zU-wzx=ZA59{+@a-e)XOA;=i7~&pzE}1Z4Yf@0iTr9kjOU|SgmkY0?78my1e++Ryg>4vjoW?i(hwyGQc-n4f0AVR? z-A+H4a+26f;#cJd%+Vq2xrmuG=kz)egr*Q?@7vywO@9`#2M~W4G1Ew~+v&rZ5ri`R zKAb&(y~cMRTF84^DpJM}Miu?BB&-mIb=SN-F>~Iz2U*3NZ;_li62BnxQ{sR{yRw8?Ca0(ysP84aTy!@ z0R$&!7FSBI&g7E$8z$0O9G}2;7``aT0UbK~!Yu8JtK!&uu-#^)7I&v*pS$%IKjYiu z|Ls>lHT~}{yvO+s@t%#xENO8&+K>6dTcVg<|NVU&q2@VJOctFLr{uhfy&MW;9zRa8 z`&@^Vke{rWyriq+^dH38`>=8S{*XP;hW0+}dDb68d{)FH?x+_9z83|bRg9I62G>DT zDP~kTlcqATa?aowt6mD{^xx3h8wt z)(p}c#C{qZt17Ey*pvi zU%u3_h5Eu^dRcN?t9)v4HJMLkDBgO$6UQz(1=BDU@pst?IWfZ$o+$@kH@1`5FXD$x zSaOnxlXkup>9bBA#`%XpUW3l&qNROXRUF%|b~Jbr+@=TTP=|H^*7cC&N9s4jrgo&o zs>1L1*pR=AznRzKT9P%P{`+HTHu;2lQ9^zcQ9F9@uZ+Ed^9tVWqO*!;&toqm{{oKt z)3ML%5C06(|0~$u{IJho_yEm&8;R7fweWRh}G6^#HzxRnkGg_p&u=)b>toa179zw;sInDep|a!%mwXN_zK86{>JK9-2A zvxXc^FeHH9k;AdKm=6&X^hL-2Pa&M-pyK`Ls!NI4Cr`7UhIMvr0n zZYO)0RsZAB8|zl$--Tb|%Q-jtPfSZ-CBF6ZoZoz@Yg~;rQ3^uAA5nV}A?eW6;^`v$W4z#j*Xw`#p1( zH}NAlLSgT=O`rW@3VQZ-dzEURxgNzeuS&s9Q64dZn+?GXVh-XT`^gz|?eHFP z{kXD}+4p;Y8UBg=MEF_t=a}36z*d_QNN?`PKk8Oqw-fCQ`G+rT*Kt& zGZpo%4M7nNLmvtfi=d1B!oHfBt#Y<1S^C2d+$6l)>lsAxeDB3(MZq2H)7|ypG{tSv z_NeT8@n3%)@my>#y5|2VQR#m!`ca%w3Z72$f4B&KG6UsTabF>94|BG>JgEp~zl$Z5 z8`+?~OmRxnXWFDn6Xc+|j%SSY zG-DblGf2g|<}iGW&8yIG$}0>$kOj|57BbP*55MtHv24Y$CC};Y==co877ZtqI?vNq zN;~;D^zED}pv%a9XZ{qQ|e+Y&vzC8RLe-`SSg9`*Y}_COoj>py8rNXz^nS{$nVX|#ZB z^-^eiXvbkYMZ1k>!Ds743qEZ*Y$?MyXV$cW472xb?jE6`!bor*=jLP|&DQ1)Y(%W*8#qj6B|K z33dV4`Jk9%H-p^`J8z;Nq29a(8tP|^*ra&$x)mSd!xPT*>pzyvXCP7Kflm;s93h**plb8bVg`ee-h>Y zfm?aV#ErMAGjh=T;p6}1T;lINtR=HqWyy0ik>n@Pf1~wDmL(o}Ruf5nQe)~SP5jYB z5*z#h1ijr8NxIJe&Ep(P`KWl$-Yc`D#qDT6<_m9$Vs`y??(20T3GKq3gyJxuH@(BN zAbT>z3-jaz%_&q8Dbu`pSu~kM&;qxgNHPeCMD>%#7b>0IkU<<|&)SPIb7|ZQsOwAdey*o80XL|%yj8&Nwc)t za23aRTelgh#Wl3QDOyt}y~b*+lKmV1!GC0G#D6Cm;ea^SL~U76{JXvy;q%_VPkVpt z7@54m^X@mg_?Ar`>F`X%t@p)ycd^m&J`dt-{@b{If5;waLwo)GI&3XvW=}rGkRCf! z>@vA1{rxCQY@1ovsNIH5O<}!YyH1^92>aa#=XemiQ*7}`7hyAP(`PJp2m5e7yMo;~ zhpBt%bE*K-XB^JKq!E)HHtG>Hn=);7#ApU zA8mCEQQEaQMY|v3zrRNf`nRi=x%)YC48kjeD!l^coy+)}L-+V)6o7GD)qg#kFaGey z9pSO*u)6XYT|ME0)%WXXZVwgj6snk4$*p~cgSc!MXN}^|>c~cuM?G5$Z8>ZlISA~H zL-_MOhJ2$q@oYU53`2-dTMxSy>>haO^L$ovHn*NI7&Loc9ClfFjila!2NuQ0t&2SK zr?ww10&LZ{N>=d1TDCRa-H;huD6Ho1~3^{n>xFko>x zyOueY%4IY8(zR@Q#9d7G4lKLH-W#d#!uj!YOTDGYkG>nenRIqJlPXlwpS?0Zv2tr{s&Dqn)Ij{QJ2~86?!7v5 z;rzM6M7eMF%;n|T8^zg+vzK$})tf8X{NU?DM~bOMq=+q_O}`v=GYiRV4#ezu%!|)_ zJKm39+>SyoI_^w4-c;I)Ml<5XNNP)e1cTc>Y=?1P6MRyU+km*H+Z1<1hH-aW{vZ3b zo)hdFd_hcb%m$7V09v^&|F-BI^~90gC;e3}g6o*_>C=REMd~XMq5IFZ;?!bJOP@#O z>p?Zmm`b-|M#y@gSN0;*#-LW|O+-D0D$7Z!8RTZkxrV(oM6?SLPK&_+;1M0^Z#j z2(59P%PX$o?H15H^4!E^TF?~*fyrN_ za=e$%=pr7c^Uj)(%$|B=RRDkeva7ZBP9y)ksh0MF9O3=+nsaAx53Md}%U|raobT!%{r<+jJ+>eDOPtJzbh&z?J5 zSeng@kB?oykzVS(HMRJRw3sJd_496a_pq_L?mUIMVtaUv4kX01MD8=sI;D1eu_I;F zm7f+X3b*QsWnJN1iPY*^k~P8p>dl_0c|Z3Xtb?ukq0-^04I^kS*bryXP!2u6xo287hab478?17|n-5kw1*@DqX%z!Lg)M?o!A0A&bkICWm4c>Fsw^DPqypkiYv<4d z_c&BQ%LR?0G*+e&zx|?e+BKL4hZ{KAp2M)5f8tp}xPYB&S$XANs4uj%*x4_%p>S0# z{|%e@$KIWLgKYEg*fwsjNy3EmlooGf@;$a2f6R2pFEMPy4Zo62zp`{`cJzE~=G0tz zdHm|t>G1SyF?Zq0!u7FJ*I&!V7jmhY{8?BX7I@vE-~Caun4J4}v8i|KeBz6LXqsiq z)@E4~71=DaweTBnT2?i@V^&Qa`}ZeC*_)4w3FSkuYARSf%c^0UX}ieP_CNg1wvFcx zr=NA@X{XTp(|z98dwB1cIkUgB_i2y%{ULjx4efL7H}2IUU)uIEy%AqdR}33L?yZpG zmqsZ5Il9ayfn=|heOzyXKaJY#^|A@zhX?F^+xv;(e%ZXRQK9(ex-0fdxg>xlZ#x3b zJ}}eg_eL1TF)q&6@n*}U%n^=uLupy$iaBY)r8K@u!XJSs-Tm^d$1#Hv^mH^fb`Dej1!N4)EVL|2>;6JkNUE!M=k z*bukGZPEE_Uiw|4D@MhbI4@Sjs(43ih?`N&)S7!wm>LA)*2#JYG_Y>L~W z^WAz5(G{a&Tr7wcu`1pX8{(#TPjvYGBDhX5Bu2!Tm=MciRji41@vhhux5Yy=-@t`L zSB#2ru^?8&b+Ils#7*&@=uj}hb&5yDs2CFyVp*(;HE~1S6r199ECB38wkxFK$eO>sx;^gj6LghW@I5EEiSye-zm zy4Vo6#BI@PJYCX!Trn!f#CfqIR>eDFL);Xb;*QuUeK{mX#F&^63*v3DCf3EfVpH4} zq174JCAwl%jEe=aB38vaVnf^%?}^YTz4tAK#E2LZ6JlAciZ!t=-W8kTws@%DyG}@S z#i$q;3t~lF7wcj}+!XJL(1g9`5RZycF(xL&vRD;s;)b{>HpOl6ke2*}L|2>;6JkNE zi0fiqY=}*9N9-I@K8aB=E*8X!SQ9tIO|dDW=V4rz=!#J>A(q9eSQ8uKmbfjVFJfFs zjEFHYAy&k7u`V{mrnn<^zN&P^s2CRuVnwWp8{($e6rI2BrPn38VpL3sWw9#O#D=&f zZi~+M>ORGY7!wm>MO+u_Vnb|-J7OpMWpE)eD#pcvSP^UDhPWvjEV`d zELO#u*bukGZ4uvmG%h4Y#F&^6E8@CX7aL+z+z~sYN>_}Eaj_s)#G1GvZi-D2lgW(h z5?wJWCd9H>6>DNc+!D7%OrbL_Bu2!Tm=G)Cx>y$*VpH4^J4cnS7!~7UL9B>1aYNh` znXC&E;hubxFdFsD_t=v#>IkI z5o_XxxG6S8%%3o>OLWDkm=MciRji2(aZB75F;~O5kQfnTVnVEl>tbDOh)r=v?3`4( zVpNQa1+gO5#0_y%Y>JpYVqBN#icv8kmc^=A6C2`|xGiFuqj4cIBF4moSP|F7y4Vn# z;*QvPR_TgSF)kLwidYjj#7(g&Vs4CaU7{;S#e`TEt71)Th+E>eh#5J?g~W&$6BA-Z zTo>zNLu`sWV&}Bd6{BKYEQl4cCT@tEVpGISBICM5SB#1Yu`E`_n%EGx#BC9?n2ZaF z5iuqv#EQ5s*2RX{6nDhV3rbgvigB?ZR>YdPA#RFI5fgBY>k?ftDkj9TSQTqxL);R# zMSKF)xR4kTV`4(Ai0fiqY=}*9N9??;bj7F`7YkxVtce@qrq~oQz1+Ai(G{a&LM)3_ zu_iXeEpb~kMn_}Eaj_s)#G1Gv zZi-FO`F=0GF3}aEVnQs7Rk0>E#4T}K#L9W^`NfDB6BA-ZTo>zNLu`sWV&~_St{4^L zVnM8kHE~1S6q_Oz0vOjNx?)sJh-I-V*2IRmC2osOLiZ^~#F&^6E8@CX7aL+z+z~sI zj&UI|D#pcvSP^UDhPWvYdPA#RFI5ld@~>k?ftDkj9TSQTqxL);R#MGWy6 z7ZM|4OiYLsab2v74Y4Wih@ID!t{4^LVnM8kHE~1S6q_PuNgLNCx?)sJh-I-V*2IRm zC2osYmSbEqsF)DT zVpXh(4RK4{7BS=8xR4kTV`4(Ai0fiqY=}*9N9-&pT`?-g#e!H7YvP8uDKsx;EGk_wD#pcvSP^UDhPWv< zMGONQ*Co1QR7{9vu`1TYhPWkei&)BLTu6+FF)<-l#C5SQHpHg5BX+JTT`?-g#e!H7 zYvP8uDKsx;yrp!- zs2CRuVnwWp8{($e6tM);xGvEZqhdlVi&e2EHpDG)TXa6J`xGN$OiYLsab2v74Y4Wi zh@EdJT`?-g#e!H7YvP8uDK|Ze%z=B>>Gpcb9ys0LIUfAf zN$@_r0%Xg@`{C`t7L=<8^M&Q)AaX3I=TG+|2+z7c2Ja(yAFRnixq48ZSveonkDz`8 z^`rgIbq4h#s2@T72>OD`q#tfMFsk2pnnJbkD&h*^go0CcVK@A>@R-(sn!0-@?rgf z{VA|Nu`C4kx4`}u*xv&CTVQ_+>~DenEwI1&^~b>e7TDh&wk|WUKL+;4!2TH69|QYi zV1EqkkAeNsuRmIQqdz>bKL+;4!2TH6UjzGdV1Ewm&w>3pus;X(=fM6P*q{CVguwnB z*q;OYbNlZi2KM*B{vO!h1N(bme-G^Mf&D$Ozx(y)!2Zr!vA0|V;}603Loogjj6Ve9 z55f3DF#ZsXKLq0s!T3Wk{t%2m`1?=6_(L%M5R5+r;}602|Ms_|1mjP^_){?c6pTLw z<4?i((|&gLVEkeKb~6}%2*w|R@rPjiAsBynd&VC=2C+=rP7z;!&zUd4mz-|%759u0 z*zN2J>_qms+vfas?c}q*&ky7J{5|zv{OUXJrQLJ(={_SM?H~5O>ECtR z$9DH0+_UN0P`^K95454pk5AzEcVL?@l?ugIdwR;n!YjGtOlont@JecNVbA@?5cgBq zhH=MfeA9mj?>2*{?REwbmcrKU^n)oUiM=F#Rer!69m1ZAm`QU^uMsXKPPXor*Ck$-|Z=K24$^Jf|T)?56HZ;$_PpZR~||L($joIeon*?7#77Pq7Qm@m8~irMww-^USZ zo)g7n(OGdy&a2qVp+M&G;}pBkbw~;M$%@HKx;jq(L7cr08`tj-*#m88@57#F{V~L6 zMI1m;52Mfzq392yVz46iqwo)zN-=|DtTMy+=OVNlRU(5hR=_a!San%J)A!%2Km9>e z(=`4K;f!HZsnaIDt>~^lcB3>7TW)gAI&e!n%n%EBG{4MZFt4;&w(`|Zi4s~b;U^5p|(-~5gIV>g=UiPsn z|2@&B){?9V^1oUZZIe$Zk|pFv5e-8R{*|#;a9+X7U36CQ?0M{E%3P_`^Sg z^#2OBH^1#K&Gq%?&2L`(++~ZO9 zAi@aC;Et%Mu;E}o19@v7)re@8*LJd$S@ng%SH5JGm%H#=G4$Dyzh%U@71!3!bENtI zbc^Qy$KUr~|H3oW{A>Gb{x*0&-RP~>{QvmKAO8R~|34A$F=yylx?9|i_N{rgNf@QN8!<8np-RVI^DzFhf1GSv8`wC|ctyjM z*H}>%qJGb2g$)<`0ABeIn=7$_W22JBRcMYH#GZS)BFd&>y3SDgAKQ}!TOoj zk9?fFj!#0{qP|A`E$htT(Wqbe`v8tZGf@NEVVtu8GF>_=G%T%f zs^S=HYRd=yuA&ig!wv-xl1`u!n$pbhQypH!QhMHOJDnPwobGO#J?Ll~d5elRl6(H~Cwi{CV3T-Nn6FZSD^*S54KlRnYpGy&doF_;Xc3 z*6dGXYo{>g7U#10W6PP+%5whla&F}1@VN7>h<_G0KZD0(RV+CE4*6Mx&!M{JosZ!< zUDyueoKEh8bT%6;?K4+#Y`+gP?>igo^ z&z`ipQ~R4i8D*7XrSmMyc38%1LD>opnySe?>Y1$iX@sS4Hm%O>hkd9`x`;)MlN~Wu za*7PkzD8>@+tvvF4Is^Kq)7W61;H%NVCRjM|3TsTBz2L6^fUkZ;Ud6ReM_G6mG^br zd7sw`v-+@_SP@{VeCya+&th_=G#~CsXJ(Ttxl+$+Zw~_&m$Pe`W2sy=lP_J%rbpbx zWbeSTTkO4&3NM@=KeyCdiX2HTrZd-4^B8=}AqwszLLH$wt7BtGrXD_ zEM6K)UAVG%W+Fd*WwCU*Je?aIz3D&o+Cm1GOpja)4-6j3FTyxDQa&GE>mBSLJeist z$S+Q>USC~JUAmbW9K97jae8uicy_k`Twi=CHyA&e>zi7=K7V?7X7b|Y{>W6kmDtP2cEmjX%YDZo;qafsi!DY1gdldYu$V7qu9a>TG9!GjBgIm(lo?qa zI(L3DvN(A4botWY>%FfX&!=V=dvnL9lPi7m)5X%c!qU)<>tm(dP%JxCjGwuZDxN)` zT|0TQaQf!x;Pvq%#nd8F#Fo#dUk+)}l zUaUR6=RG1Yg6o*_=@YrTBJ~xB(AMV2vxU<3Nn0?7(B@Gcdr-C6GBYHHupa1@z4&Wm zuqpE_hsRJsX+_K+H%rbn?4=>1U6UHSrOVha;@lgE7sl|wd5G?F&JsdOsM1Fex@fL- z4SVxQKZk!zYYu-$j1GGRq0aY$N4vr<|@t{#5FEKY@~4P3Q|1d zOdySEvtL5PQO17G8O6VwkG$$N+$9^Gd2?qYu&2|KG>Ci6BgC^9k08bK2w%f<3_?^5 z!ls@=i5f6*rg2Z#vGL9>;ffTFqpB3{ zrA%D|x_usDYsjgSh<_S+ zJBlk@N15W?@Xow@^q5E7w0U}V+ZJ%eEYjsOx`;>n>#PaM?5RiXR0%t?WUt--^QMa0 z^VnFSnZR{C_h94o;;9ale;>uxwq4V6_*JVI!as$LY6CmMlq@WjY{aQJP?=zl!5g|} z&wy$`H{JjT=BVGZ+0WoD^Q^u-@4=?uXJS$nV8@%OQt=qV)tEk2391#IvOxPUCBgtg zsXEZ=%xkej-|DDB1a0|?+m`cPB|g)=Z;$P8*Y}uk%T{%*_oa@{ped)(gso>4n=RHp zO{M1;HItEB6XkLyJege{%r7kF;*r?v>Ddc|1Cxc)nKP%SW8vVh|`G!_vw9Ir!A%t9HU z7?^~xFQExJg9c+7$8!kh@b`H%Bw26*0^=lNy;u#JKi_QAV)>2M#CVDpRXl4TV!x83 z9&7^GUu55L27bg!i^b$}Y$b{r{(x{^LmVI+adrZG>ak-~hT1ns1G|C&}|x11DY%heu!UbzQf&JKWpn4h|#WGd8f--6t>{-Y;;! zn7#YP-1kC*`=sgi?H4$_PhjuBeu4X*-g2Rr2Tr0_j48P3v)P4gX{5BglHnlcqi5@! zfsiUWUVoL=efG21|GMS8@gejau^mP_1@K9mhB)Ov+`PzU#yala=9nAY{}kCaO~Y5k z9ffytK`Wf)QTZ#Pcl6P{*G<$HQ}*zL`!x;idak=Y73ND1ggZ@!Y2;83swZvN)De5o zw_r|oG~R?DNX(ZG@fA?1{C>!Np1Te_elYLu$UB@2aU-g z@Pl2QqX!3zdGM?6|3rNEC)ER|QoBM#PvnFWwf{#kzP`yeIC6 zof_^xDn`T!F(H=4+v2)d7w?MxCZ0{Oi|s|94QH(c{`6OO*ed z!IpETP)Dt$F@!Dw;_FQM+{u!rr z1uy5hgrc}7_HOQ7KyJ~#vy8jr+hQBL?2Av^n!TU1h>^nma31L?lhfXuWQN^{^$M-|)EoVJU;4gDKi8JW@_2=uQUU4QeMd<}R zsb@Lo)4p}j`*vTy-Fs{o{!Wvd_Bq~ZUH<(Bqz|$Vk+xxW**P5S4GD90371>gp<~*3 z8H?)^8OGVfv?R0B&yGAT!R-g6X*cGyMw$#5w;SYgD9@VA?z}gx%riBxt554R*Ew>I zGHuZ8@b~YTe-iYYZU6rH_M0i&{_jTU&VF-we)`U;F@M;(Jl4;1G9T8`%wf9_E9ySS>Mu?J)8o3O=d% z;E=ivU83zqAXzi`eOvPD_hmNtXX0IjH+|fZKZZ#ct*)chgMEKs?Z7`OCWp)RyZYCAclW5wU7S2Y7Za^HtStX+ z(VE9L%ly(?P3eMyT}AMiIe;E z=a)V152v56;7PmJ|1-`_VQcNa_M=;3yRT#Dp0G2+jtV$B9*|U4-6at8_Z$3 zxBJsC-~V%;p5aW_9}w@^dqpW}bvyFJeBrHexNj?+txR993qUz$$Vm*Gh`>n;v_5z< z*l6eAWCL~)xHyz^=2+R;;B(y#=h@L(LOaRup8T?vo#T?6K*2Flc56I~inrL4>3g5O zU=^qJnG5b{iQ%*hiU&@o;JqDe$y?#~e)-F`kIr|f;Tgw<+sb48jDrQBKdb&Zy>wat z%3yl;E8TDP0??oTSKX#`-x2Ldoa-yaoa{u$uIaz`c!%H_#i_uq%I$}fp=J}Q@j@8$Xa=xn9WPHJ{0Z`xRXI7rVP&vXCW z%h$;QP|mDl^T4(Kta#qaYE}YPJF5|Ly%xVj;C(NE>%#_2b>mtst_hpj^PX(AW<$mA z7I0AqD;KLBP4-sfWCO@BHd0KVizQg$sB3bjAMcHSQ7)`LV5;52>IaI5^AG>y)IYQh zQmZ!i+yDMIOx3hi(E53f7J#w}vSxo8Te~XwPFn!_6<@VnS3RryXscsL23}?h-J_~y zumIG{C)>JtzP-9EkJHffv>#C0uY=jrM6|7r95v%VwwKgC*}-Jx^QP8v8m+e;+xwyp z*JJbJgsj4h&uYy0?N@Jjt1rCPm@Oy833Xd<0cbCLo)BRdlG#sg;VBt#f zR`(=zk>`Kziw_q8w(48*94!E)2w?w@)x?T`y)$~B-2%{wo2kC#((sMU*jhY3I(=bs zw)gzt<#2lW(yi{9g|+UBsj*TlTbjI?x$0Xxy3Yd8wfNvzc4c^V?R4+O_`syQGCvi* zveJ8F>_%!J-#?j*4HqWIUUN?uZpJ3h%?-p0H{JZcWJpaG?{%?3qZp+#v^BM z+$yXsXXXdbEzQ4PS}mS0mh%JSQ^#*y&kgq7O3vk$hLa~Vv!nCn(uLvksm$x6qpy{x zr+d$x#X{6~_5#rV{d>P=Iu1?IKNe7y&EJj%e4{S_oxl=5t}v$!dl+`_45m`8VGTzd zR`qF2c$qZ9;ylE|We5*WN4kWGTvXW?5U(3n@|0Ol$fblO#O7kmtC+fJ*OKhF?DSv@ zKzSE~NIQ#3PQ%bH*RZ;z7uSnJSWQB-tw5Yl;hwHwkIP@ju(3OmhlrbmxQyYf0`|r* zb9Q<{&QILI)GH@=W}whR2<^)G;H#hOg;=DR#wwbUz`P?VLabBMD|&bOGVdk zuNmaQpjqxak15h6+~(%~}R*AP05f4xZkEYjtI*rIu>obomTeV+^#fQHz9J;Yh{`7q)<%>qz% zxM@~OBG=gq@Jv*kD&uw3*^^*Dfl34QeJUILiW12VyVvP%{{cWM37lR}qm=j285*M4 zD`5IuV9G1;dR&A`qZ!xZc;9BF^1$!Ga>`DtqY4qUn7Z?RbA5pP^xQeO{>_fy0-rU(5d9qnHhYs=k=+wTbjFi>gN1hS^)aAPyRT@nzwoZ=>PJWZ%NT||9hhC_1T4=mT%_*&?!{tDa?zW zF$2^&GzwE_5L`4Ab7IpT0D(@KLJ31Jh%J@!{QUzCHM{0z9)+%TL? z67AF+KY1PtK#yn6pFAGxy;3-nDdjJo=sTUgkSY!>#dAxyuC6YO^~So(;n(5=S-$^& z@w-240oJjsB*jhzq%cR|X7l0;HrR-|9bgO$gQ&?Os6?@W) zsg(t+2QBtwmR2&$w^~<#4)?hO1HGCOX*_m*Bt7AQmLvUkfhdpk_q84wYVi!To-@#T zq^~uBzSipuw5Ha_+rbn|7STs9$UKgh%w-8&YQfKRXmE>oOGPk*~+;5 zb&hYmz9-K?Ld&ED>(jK9?YyWd7gxVeHYkOp<%@N++{;5$n-v0<^hqgP? z?s*1~7wyimx#P|C^p{UtPW|DJyKu3I0{2(3ZK>c*pj^?-ixsgd-VqyOQ)GFhvonva zisGt%L`AEj6y!gu1&8exE|zuNE?}(5zaegkb^)Uu_v?CxFFYLdvh%)tvhUl{|K91R zYW<`$BPkD=b_RWVuLg6GSn(~pe!J&t7yh)*`->=l7f@zfXM%E;ruSnUkGJ@-^_<69 z0NHxp<1T`1J@;`ILhhdTWQ!qp&wtznk-KL;&Z5ZOvktm2a`%jbFOJ+j=Sdex?xw(w z(BmwU+&wc`D9KL@dd@H3o|hc3>9VWFCd}3K>ECrPUe|5EfyI_S!5+CC!^3M&w+ z;F5k0Cvr}zm+J1~K3?1VZ3BL?(Hml92;PN#H4asUZ`A$|%iz(8xnJCGj>OUb*lJ`D*o6e-C^SN8*BR|NG!`NP=Zsi@R!yDqZ zh}$&X%6sZo{%dt7|IKsiR(>b0YsyN{tuzAf>%Cif1j>HibnWdIo4BAU4GV1^!+y6g zY-him!;-jbF0r!N(%&2e-B2&Tf^Mjn54N1p%0)G+-LJs~-B2zq3c8`R=<`cG?Y_yg z+i42Aq271yyzlhv=1b5GrQ|uN+<8$Jd_KGz$|u_2+4k2S_4`BiKpWb8deUws7dCP{ zZwQ@4&RgY-RO(J#EyYzKobbVsKu$Vg7}tq-tD-nbg}-9okGlTwpT}m`lQUL1=E#pC zaCFa0pGzd!mGwH3Jjzi<&QbN&R&koT_Y)~-d+ei{Ze`Ffdaz%_;_+v_pEWBZxqla% zU0``MRWset``u0X8BYr=e-5LSY~I;>`KSNKzy0lJxWMusAZes}-)VuR4aSh(+rGeZ z<)7ZY#WBBC@t(a|W=V_N(SFPq-V(*^+DdFo?APl8Oa3GP7c+A4Bd3;AcyQSy2mJXV zDXv3d<>sPGT9i0v&6_~L`D3iuv@|{J<5J$&p!vJw6iXBjoQl9H^qi)^nQ2Uwqn{Kb zT)4(%WSn}y=?N5Lyf3?0k}roPe7`dHbDxa;mbKL|o;}Bg+sb48jDrQ1Kd)hadg-*l zlEL)uccr&_f#om#>F=7-{mWvPO0VlH#Yg3@_`>-dt?sQY-7lU6*Z=%6WDYH~T*J>< zlx)7d1(x1d1K6ywNu~9c^D1doWm#q!rA?N4ubtnwHrQ}m8?2vcX@Mn+K1&dL zgsqm#men&a^a9KOQq|;FMDs9smbj{gWkLSCzUt!h?s=Wm6iwc=vD5_%EK7yrt35rw z`K5dE(N;UoU!#y`BfyE!o(4+|lGToticJsoOg2(n<X1`hgp`7r{nj$kNP z3o(q9l7_nWU-0pM;DFVa-}v(;r&3pC+s!J@Hk&#p|8X4#7kqL}1kE_?8gumx_gmeQ z)J2~E{=ay*2(VS(lILiFB}Kqnxxn&9Id<|?W*NVx+3WU|mh$=0Tc@%oliBHF>dMJ$ z7q5n|O_i=*9$LG0e(cc;EYDsorv|UAtmWg^R|nH$Cl*iipIRBXbYi*hT;$TlyxVtT z`J{XC%Hr7K^5wJr6E~OBnbeiY%JKP`;p-<{cjlQbuuR6*GE>FVv*pQf=Je|;V=I>~ zo}Qkbzq!~qId>`l`l*@lmF1P<)w%Ph&lCqPpShWvnK+d#mm;~>d*jPRtZ;Zo|H9@^ z{x_vHc8h;X3>H{EY^mc2mfw}J?C>PkOmHHt_sf~I@%BN}Tf(?p9+TE?;b<0d`1^_c zwZ;_IO`OE~iHlfk5eBCa_bOIm3}Ge3HB9LndnOAk&mzsT(Q~+jat(J9$5O#n2&*)% z!0*AIfM7d?V*^+ic>;IehsA&q>|aD&J^{l{V(%jEcM<1sg7#&s4e7_qkDJ)%=p&yc zf;5h!ap1=+uH!5&G@E$=7g%!9=o;>M3h&@FM0go%S*R(V#wwQ;Jl~3WcK*oOG@j-r zp0^J%<`9}kj8k|fE=T2WlN6D+b9hsyv4*CI{JRX^#2D-ha)$4kOD-eu^LK6HID^YJ zg9Vlg$Pueru-T#unZND-SQX?jqCCw4OMcs&Hfi<)Je{3gW3Fpq6Hfz^XOrggOE&iG zOYl1iR3%s!sNJ(`Z|~pUR}A+>LjV_V@*{!loZBDd=JmX(RNmJitRaBC6!sYStDoND zO`hS|yjydEDg;$ttIj{qk0k_c`Qx|cd{_VC|NM)6du(5Q_5U;BmaXbq$4ec54t1L9 z8nx;wHv5Ww9bo;!X883|Y9U^@D1Cqv3{{qXmw?Xs2SNnb~ zY4qZ&arF}EKZvvG+PHpy$R21zd;P;W{xnSnMKcF0X=C-i-NjK4Z%EYpMN7}N%jUrw z^I((0@dtj1%NzdWdG`M8eZ_EJY%;t!RGRqFNpF2W*G_pxESj;{B(ag8O_%1TA*Anp zT9S6*UWCw;^*k0#p6s7Wjn58b^Jnu5L%Bl!>g=sc!xxu_CeE&0Sz1^wWG-Jhcl_l1 zIA6h~FZcXoJBo4_e%4hw8@`_i9C=?y1hXV50=XvWGPYI`*fKeK-vyJUOtFN;lEsxA zmPnd4kVE)IP5f$Rayi}IdJyRz!S?9cqnw$-58QFeGd0@~DlM1P@RypnJh2F^F9%=I z`2*zl7B&{IP4G#@owYH?I*<_DZIS!TLOUC6VeU7LxXX)ijZzhSw7=@sR5;V2Yf0Al z{l)Q@5o+=uPxm|)CvuS!^U+(BxSNkXD8hDe;SiQ1GEVCo=!Sp)GtFb{saCdn`JeBt zp515+y|~3rH9NK$GS*pyClqcM)!mlACf3DzO5q(tt z&;UQyL;3VpUBBIPwF`gR=WUm6yYP3~^*)Jri60?`(nmYe3e?6B8h9>`KLNe_`UCV zb8ww17*#9&Bzc5+Ym;^;dY`9m!mR$&ANtFE)u+hzDHCqT{H&knXa?6Es81{kyv_Xh zyMN{OFZDPd|FbvWd;|VY=vA*lUznxM-71bz zSGmndE$&XsK6mRae#W=Qe`xg8x&H^I>K_*G*?7#77Pq5)t7x?xdSKUoe_yXNxO!3K z*>~Wq6@I{*RgGW$V)dZ0i|Y+pd1#PgMd8#>4taBK7tixn74H3c<`{C56_GzCNP`(w zY0g~XXTSLkLT}CrN8-GS$SX0-Glj8&^W&zTv5ghJRgYx}->=Mlw)mU>1xvkk_8c2- zE06Uv9!mF@)$g#UX$BXA8MNP(-s%}#i-X^5N_Ro*QmJ-*rJL3Yx{5E{3*G(u)|T#f z&I~S=c8Y(NN`4iDO%O+vy|G`Kg}u_s8HU_rZJ=dBBbGtA_2;jx4J^+ba^d_i zZ^j~PgEyk=eTSPhkTbP7C547(nx#3eOrtbS&TP^S_Ja|(Bma2c+F-+NZLofp4$a_V z(Ps&w&~ELCzf)##EvcF;i{@eQEOAu}%YyuN$_Szu=dV5f*Ga9*WeH<1E^-8|2h&K90+D+K}8S(E;7aGF=Hshpiqk`>(UYmZZ0W>AdT42^@7Bu6smtZ5^V!I$!hHV5R5*A1QtJB9 zxk9*{nd}=b%}vd|b|XG{@>$K`N=+_h`>*%S&CO>=$F7%Vlc&q2#iixhGww<=Xy_M&g6QBC(f+C!)I`P@YDa&bR0e;CRp#`?5FW9 zgHPo114bjTw3RRnTfivKEr^T>{JV-_Th1sy0nspvPo-bPHflzNN|@(#4Fj>)FhgkE z*yQ--g)+{YLkfMc)6HT)cM8L{&*BsL94MZG$c|%3nDdOLA+A!mlau({XRN&^aJT%? z$t5#Td<)NV5@%e-9Zg}zQ5N@g3imaSJH3IBFw#4Yajg_)Y4MA_1%#B52a`x`7`ZTq zIDFn4xFWyudj!wSZhY2|pP0OcEAU5mM@&QF>A^4K?BnLch~xTO#=RDtS8$#Eem07q zP#jm<_B$3uT<03n=ZEk4PVAh!2M4@UxT_^xy&w1Ahr6A_U1X6TWAK-7=Sk!}E$NGh zwG96mi1`(S#_@j3<}UeMe6MUMI5aze^KT;N3}T!>{!X9~I1A>`6r8}FoH2XD2tR{& z5X|6uJ7;jQPe8SR9d&-k*jpILjx#lS&b;y#2C}iI{n-1x9B)cE6%S4vXEX0tjbf0E zG+VJV&c%f6GkCMXIOogjhp-pH`C3#_I6<5W273;y9sDI8Uf-L)_4a)tKWNJzzb$9G z__fQk`}WxW`Ol?HxMi!lrcdNkU1RH7#b(vD{bz8cW;3PB;hPuFj$Me{aBn3?FD>++ zSUP^?+S<^`_)PNLKzI1Hq4e36iJ6pUa6PRS^EflO-s(@}e`ow7^R(RmRnhkPBI^BF z#^tv|;(T3nkLnfDCTiXZ8iU6%*0j#xVujD(?8^`VH=zQYMKf~&BH#up{w;`+Q8c6r zsQ4$)*c`{S;A?0?hR|rnAqbLaTxmHEqcNpW;dd%05S}tk2&Xx4(3j2J+uNY|MWO92 zTGHsnymp!CaP;rG7th9f7&rGcGrqXs&-;3!*PmoRl&Y3zl;T*4HzSL^NbYfk5yvyU zg@*j;Q?9*jKQhAJEPJQkig>0WiQt1wgZnlLsjY~Xk`_HVt>mx1Rp<7>J9 z)VZOt#s8nZH-V2VyX$+^i5-uPF%z@6ZNR9%fGD{v`4vDT6%wtIX=JD0J`c=X7*yUl# z-EC66!HZ(+Q$e%x<8=fNJs>>S3!?X2JL zG4;(^_V^-58b!NP;3G3*l|%D_#13O@9$!v&hwX6-XFKP4v{JZ)gvVQ4{f5L&T5K3D zoJMeGF-H^UQHHjF_HoF^nFW)8WAMxzk3Ep|*doI=)B+pdNqc<#*7e~ZDrO`6^54D@ zuvKOww6b2+JifkH>=RrAg3;ssKl#(g=<)S^YFe${-Mq(_RTuM#x!)dN&;Ey>_%L!~ zvxm3sVG9^3s_yvulE;@r6p#w*mdhc8>Wpj!APtB}LKKIHsFFb=Y-hMox&(muw_r(& zMnp2i6QhC+&Bel?T6MV?Ft$58A3ih0#vnK04TdZP3OiFh&uHFTd_G2au`&1V#=cJ( z@^GGAWA%nSR^}Xee0{%{J1DYwk1whz7Q55^_W1h4FTE9v?mzPIydTvik1xK^_Ex^V zTXfIn@+h*wc*L26)uE8{8IMTi&MJ+HnL0=i)@rxr0+KoU8%PO$jW~`(wNG{sTvL$N zodp^tGUFX=BLvwp*pW<=_T8Ed)T2(u!G-H>Wb=|y*zlL`^cTejt2b=0GHrQ}FNQuN z430NSd3g{e;wSZtH}$)q_FfUBT{i0`gZ6o@>lm+ijgtztn|}XQ4<9L*+yieKU;bl{ zCU-mxUPjlLrwn*^cfX63%WWqD+IK7F|6kxGc(+|UKd$!R*5Lf$1mOoQ zfgKzed?9Kshk&?%IG0QOyFfwgE}$N0iEYQ;Biuf!JN&vpT9k62HCMX`e{4D+8|dd8 zEkR@m5rhZAi2EmmOvB5X4$y8d{Gh9T_>E8BMZsGto5$C?{%|~~Hx#ro*LaUFP!P;M zOCDeUJA{_FvapprzFa>v3eY7nSJZ$k+)kfP{jlgx_E$oB2>U?@bP)xhH0X|I8!8K8 zBf>dzDycIZZRJYrDAD0Q#0y}GVUQHZotE9~_=a56@k?+%`BoIJ2}mo=tT0<{MM-=8n3##r{-oYAM&2 zc*s4zzT?M}-+);BogS7vzRZ8sZR!5JfZLk8r8oc8FkmB!R(ix5h)&OjmyZ)lMd>Kr`dp>rc-C(3w1>%=uSORgS@@g^~=jNy(BNFHXUi! zdy<|&iWLUkH*55h3`(+)WW>D|Cq@Ehr`3bes8@zc+tv9Pwr*jw8 zrzwquDV>+oRf&?vm&W*m%h^S=FM=@qJmNGC+$gI|e~chc9b7wmcyFO(a{NE6faCh3 zBnAX;7i~-)FwF5T!o&&cNFvk`8G`JBpzbu%Fe&(O+LQ-8~8;qbAMUWpXK?_fXrs**Fut}#EG=`4i@r8P*USGzA1VTixeV`;lio{Cd zNPtrlVPHh!MAAfh#708YdR3%S3T2b?-y$^ykw-|N5FXmcC7C)r!bo+&-Lc1@1?DQQ zg)r5hh{soYWoo%=AUB&FTI!phyfRTS+t$$ATwS}A-E1G~su=0n%ID|uwd>&Ne|hHd zpERpWp_0q$i%pr{uhb50M*I!Z7Rk*(7@#Xrfg|giOd&BdFjg$S>bKX%r+8)#OXW8QmqdDn(FnGIM3xsyNG(t{2?@a5Q z0kegCjw=XG?%3m;ydSOfcQQFk%Tqb-#Gc7@lRY^{`_& zooGzhrw?p=C++d|@89>|i?UBQ8!iU*W+SvRvzX8E^#fv`7{Ull>FRg?@iBUQ{h*pw zt9Li=@nzM;d}8jm$5-N?{>P7?+D>|S+a8uKDcJ7#{gTI*Gq%@BLP3gg3GA_nfha8a z>f{d0@W>sg%AD#9L%a)+#N1B&37%Qui7~Ez#+Z*k3tnO5Wx%NtHCdBtF|mVY82OQP zu>K+IAkEM!2#Tke3)0-5kIR4mov-;FlRfy%<`-l2hCEj09C>`*@Nx%5Ht+F8HN|41 z`+j?Tebw84DHz=!@bJ7J)g_NFzR>nozP(#?&*t)|(aOkUbV798$j39wk%;YNK#&Nm z$=IS@mJ-}YkjGIpLvo_pXEcK`sDvF3fKAx1!3LaCz%iZzQs;7fk?#v~iT(j%#vN>A z^ODT>#l~nw#n%rk@Uns~$v&c)vZqp7Ll?;bHJHdKdHb zGFbBXQm1IM;p$4e%jI?;0vcK!)&&HP&$(H$A|gZr^l(-c5YdG@LW1D^@Ylj43tJ9I z3gLi&MH3-hM_82wixAl#AZT!YPPs<5Sb zb~tiEMcs-O@Oy4$3#J0Mb|Tc!MH!HA8EVP7ObgD%GkS?7jK82X=Q-0a6dOL&QCaQ{ zAL^(vJSP+$DvZvaXaw$iJRV=K{@LDBfT6xYMuPYFVhXsQ9$!6+mveP4wgcsjm3tj!Z>sZT-+}b4%|;(|FbB=2A~~_TC;}P3yH+rsA93tF4`}=J-NyXYEu= zeP8WRu4^^6)->Bcw>~}4-#j~%YwXU9Os`cBcQ3UMj7_c1EhakF=Q;+D%i}8@-la^J|1QMhU-Gcz@wKIb@4_ehDm(-hMGQKmN&*;1K>52jEO{tC^W*v-%;M?NcHL0H1 z&{w8M7gfKgR@PM_xeIy0>eN3uT^Cau)4EG3$Jc}O_~N^u8-~R5&78TMKtV`6iY6yW z5}(Kz``AH3U@KU2<3!ZxwhEH&x^1}mkyt^9Yf*Lw4f3riA&)I zI}gii67@-Xe3fYV!D%_)>hbQf-!&Ctp~UuD=Fb9&&0rzB<~_b(*Y@Y}b>;HR=G1(D zYuEf(dupz~eypQzv1z7ZsCPbBy-+ch9-O}1HkOUm=EhgN$JbH0n1d*5?zhL+n`*u% zU{T)eVL5oB%{;vfK1h!*7G0hZ*_{%}=ofM65*!n;Oo=%5Yl;{XiNr}9MMQ%LP_K?d zEEY6LjEQj=)Wm^%@tD{F^yoQ}l$C&l~L&hez9$;b~QEIHP;`%G(UN@OHxt~ z_g($TSkWod>WfX8-s6iYv*htbCq{dGz2i4N8BC8~;9<$*%k@_nt!%mq*OxrLTz{23 zzFa@pI4OC29nC|@`Z0`eQT3d66pyH=cBASaw);J%{yEDYUyikbeZnOK8y`6vkf~vJ zsBsH>u%s326vhG0bt^wQudKb;DO~e$w8!BdS)ca#=h!uuFa?R-4ExTw;GFL9EptYL z`dv1@llJ)f*xMd?qnO0`$a6gbTV*yvD>I9EkFOsR`-BM%t}oI5{GT18$Ja;Iv|7Ep zd5VF=Hp8AUY{tP@{2o(3XtIxLjhQ zC&kO;zI=k+t?!NcV7_1zv#UiL6}8NG{ndKoNve5q5k z*>H8G-Q{vS5CILX4(|fuR?&vn!=s;=dBPpB+K`loeW&~)xDiK7$Og_KF3KO396X)9 zhds|W+Tmmg@{#I?AWcXMoS`E}*lIv^YPlzFBA`7SDO@H#WpJ#*32Qn)yS?y(t{Un8 z^}8r|OJ(!;`kTLaC8#$Pv@+Ltk1tRV%>ICWQ79N_@1Dsdb8DH@<;>E>$E!QazDVcy z2Cs^dIU{Xzxy+gDp<7;3saK_0X{1wSU#90duiph-^C}|eu5gh~Qx8{3L^e|k zZ4qcht59~tL+(TkW?;<2aIEma$K&z!nbh7>fT6xYzM1#0l%;efqu5!Jql8Tkg{8sXr>81H(DtC20aWS?sSyh*bWvdpatCt5m`d6!RjUl(K zi*2KmiRFpS{E{*-J04*j<24o`73qP zHLdPf27B4rpHDspyyIW)PgNyU2w(hCPx!!c5ezECN-9j>Pr7GUGlG?m7 z*qiB?TD;sjpP#Ji7+)P}Pc3ykmQQiD<$*r zad>?7X!@F$#}}dj5sP#3CS%zs_>y6f`86FM6p_bwsaa>?-9oOaHTf~6bY@TBvDPOe z^kq$bdHs6z#N@_`soh1joRHU8R%cf0J;wsiH4>Oq$#ZI5rPJo|)u(q&=(+IFYt&OW z=vk-L^WExm-e^!qU~<}2gEQ}(-Z!l)>Q&#QcdAoQU@*O+H;n5neCsw<8q|3i8Stlq zmOIr(URPJCW?Wx&Brx+YsZ{d#dXOGp;3!&RxPGTXf^6e$1&Jp7DIoza`W9U+vLXZmFD%@UUCa=63~U}Vkt7CJa%5S&zK}d=AL8Vs zR8(FNF5;pb33CL7oL|H}VY=k%h7xgn zVaemm^;gt%6|OINe7XKAd3?EkFmhJ%_$ql|!OoO&d^x-*cOdew;Y~3c-_qpN^hzfE z^z_Q|9_$XDUMzi$^o>Cs2M^K!!A@ZYaH@D#@nH|k8xASR?9NNfIl+hL_qd)IiJhxp zrpU|ytAxZ(q7)4Fuxl>w7w2Gjz=7VW`Eg#s5a6^4$z3+SllJ)f(d)lllzpmvTUAhR zHbN`&fxO4pzYzPx5Js`^P2V$r{%`(JW!ZcGK* zX|Ap4Xm75rsBP`2t7wXKR8`bewN_QvH#F8X)wO(BCu);V%)eCA!M^|FJ-)2En7_gO z_W0_Zp8vO~w);H1ZO==W6l`XdjECwAP6>9y1M9u24c=1&YekYhw&RHfa$<$U zI){XV+1%OekWi3!K&+_tL1v8jF6RO*V0{DiK}1|U9io%h2s<1{L0G(Am>fXF{jTcx zk1BreFEQ$EGrt(CH{`K0=V^5Rutv9?N|iUbQBCoFDe1Z{O^&Df;_&}e^M$HKs3ZO!`XN_TI5y=p3z92<~*t~%R0 zxiMCMTn4wAbW{J@z~*XAL!!37DKoq|Q`H`Cte$SpwB=KM9do&f^{Szfbf$k@roNHM zD^-IXYh!C0uvp;H4nML?YrLiq90*a`fd+P2DiNpZe7x+p)X4X0r_$1%{Da0 zVtzrP-xB=G2WBtKGR(XK(zGpUmgtZd%bMn*OVYYENgG!o^VPgeUu4@q4ue}p^H8IV zL0SE(q`_N~k!VrRGc0o$i3M2heO7;m^gOMqU(r*x>Ph0kvkgfT*sm5kbnbwz!zi&X z1Ja7Lftcmi)#jAmC#g3c(0qqEuR6HbqPK^oi$r(i8wd{@cW1OtuJ9^T;?(#%DVh*eBu_|Xs_>ll6*eSC7F zwW0X@&mc8ExBF>uE79_U({eu4 zJOAh(zr{GXTPmCO_;^ zay4F`O)S<;uU)-5v0NX|Z_bYmE~N%q7iMewd)w>hIvQf$;C56l<{$>Q=k?Bc{VwP| z(t_s&*^I$9XpB7XTg(m9+$e*K_2-oWfroCj<4R(=a>9VJVsw#V)tkmoJgh(kKFl(y0D)OMRMj_CGz|^32R^3X|9StR=oD!6 z#iqayzx7=Ht!@hBk&mvVs;X4lhg4!Rlc>lgv$={)GAnn|tlCC^tRE|N29AJeO{#Pr=M;W{ zipVS7yM*7v`a4{IzYS=QdU6x?1Bv_kw1-BPUi9S~9^UluRS$1_XsiX14s7KfHhLKM z@Hr15#cbC+e96Ob|IF!}n0{|l!1gm`k88ZQXr$wMxTyWCzF9^kVlU>EI1WW~xh5h; z!*Xz(uf{hn7g6Ngtj=Rxl(gBkPcnR1b77n?$jtHptq zEqvdTdS2_#VR`733!_O0$b5Cb?jQADQT0dtK2hyP)jw?adrV{J=qVIVpI_5q4RH7} zIjI>|*fB}4XfDGPsnn6`oyQZ56TVC&EhNa!N%c^gy@Kpu-HF$RdeN%O&Fl^+S3mOBR-a8tAPJ!7`@qljLofU#|XzA9$pg1bX9<&jf6l*$}MEHEVA@ zm-g%zRN?54SbyKxuP;*P!ggKIb3Y<@QtVf`XQ$rg*{;v?@Vc*mIRtO|^7)65{i;7h z?3YRZ=RMmL^RUyyIS=z5Uia{24`1={mWQuJR3#eDO=3LP7lXDob&Jn4`1{! zOpfPhL%$OHMQ?7;onNi}_vp9Hev!1Jko_VQI4LGIt7*7g<_acegq2|B*89fxl-Mr5 z+V*z~kM9!O<@(3|TL0XuEYcQi)_*4v?7SbpCj>t9T6h`N3g0kYkgU_KHiNekbwu$w zRt%pfST1TvAnS}S(J4hZPO=h=CdB-~Sm7S-7(B9K<79zm3|$;YIUg+?*$oJz#-P)1 z0&G__Ps4|K;klVdi?Lnr{nRJEfO=!Qtjsk9Y!{O0k=d^5x--jmeTiqc-gRc#E-Zm( zN9*;7XOBv3*Tb##`k>||j3(P`7dGvkY*$=UZcZAoa(S#|G;O2t!lRJQ$eWQbgW-B3 zYlqd&mDn!V-zU|-QSC<6AN6}arq?NHyJQVgKfGT*(ngUf9b+Hsf01Jb!?9Zu1U(ZP zDtuDFK4&mwX+I2tuwbxAc&~)<&f3S-9K9H6qA(_s@f{Bqm^oNI{9a(YxFr{zHHIjeofq+x0Eq`ZEDLW^9+0xu$^aI+kd?+NLwh zcD>)TTaTYvwu|VE65CbMcAYL`aR>B&{`ch)M zPKqswYB#F>sBBPFyHWK=ywg_z#S}Uhlg0aF$7d8mCh?E5|Lzw-X-V2{E ze7A57#yshKzNRACE*LAky_{hZ9T$w63t6Il$IKBq2y=$6jVHlT8TSLUZY(WZd;DzI z9y|^G^ZTFvsdpA*yZ-F|`HG<4*e)w`jZczb!AeKgcGcG0H@53nWW;+-zYBVeR|QYX z$avlx4QoBSRp;T^OOinR$k}1L0#Qd}<592mdeXyZJ$%l?w1?L`e96Nb9^UluH4oqL zu*{5w9zN;evmS!1*}L>BWV`BiuwC7n>|wb2 z1ao4#)?{uhv0FB-!sCqcQGD*A+KsAz*zWh3`se6cE;SOd+4r!+;c~ehh=A75hxO5d zJ#woG;vA2Oko4om-ne)w*e8}S#+XOsG`>@q3NhvpJxw&XJ-0niT+fSE4F4?_w?P*M z+vHk6407xl4)V0mG4@LDjpNSD(Y|M>ie)9=K9!|7t ztlp5v%ABJl2_Mtwwo|F{T41Uv9$g%1xNqXf{q}jB{wo8&2G%7!JbONmm{-n@I8rjc zpN)`{-Nttu+zYk9ZJI&X71%)#j?)OIHH(&v@671iVqKVOQ7(xk(YfM|M=Uuzp(cnC zMCXzZ-DzZ#!ZKTc17HH$%csgT_Kes*P%ix|)lBWT`HveK%g>hoHRQB4YvMc}O zTc4udI58`8O#$1b$36NZ)}39S#|_VJ<9?%~CM!=N z+lBsjUX$*ere5NFcbebB)4XY|!u6Do!iJQ59@T-`PO5*S+Ks9|>h~xY zHUSDF=lO`C9c?fQDcB+sqM)=w<>dSzG1il(6DA4DLVy_N^)TL9`=oJk`e;;O=!cz0 zr3+=j$PNR>UEDIA+zCTG{**9yERsW3(PL-3_TXvgp|_MRJzb3L8oK>&19r^VE-Q1* z@>|c%DZ&?R*RgPhb@xx(^>*PKk-Zmq55bc*zW-g%Zhe!7*Syy7r4W3@mmifwK;fq0 zuwx4kztfOly^Jv{3pmyXpGS_tZo%>pfI@0C zSR+jQXu}9i;fgT5v-Yv_xr}yPN4N@UThOGz&cSA(+XA`(7mWYh-37d``hiL|9)jLb}RKGzZtM$#%@`eYYNyclwwC##MRut5R?1OZhgeFS>JVL z*)3d%&yJR>#BQAp=uM% zo7Nq7|3-bcsQROR&l0=kzGqwj?G|ZD5ZEvjVlafE!qLjHLoQVc>=vm_2n?CjnXEcP zqF;=HXrnOwg~x@pPbO8e)WKxoWM!Hxr#+)BTID`4S{!vLR0t{|qy(=_jEu+5ZtcO# z&_mz(V}BSc#%}%8L_<(-?3R_e#-|TPyTz1qbapE`*UJ-X|6xua{3D*ty6NHBOCLB591!DJ$%8#7d^b;;Y|-;_3*ZbW~_hI8|}+IZ1gZ3Qj+%d*F1d5 z!|?Por)P}mR|+lRYi*P74(;PczpdTEj8MpK^@_oomRXV1$(Mq7UYDMnx?z!UhlA3uwO~B zLzn?cN>4}%t1hrm6stgxXD&Sd#nsQScVxUHF4!&RgJz3V!59^3ADx!-h$rnA+BBCq z7*8$|vEVU=Pkj9euwT)n35&+E>6j}qU1DTp zc`jNd2AQMi(0C#o@Hvi#4c*$g?I9Q#JdUhV+JmRz+kI8_yK9QEUBf?}3)nGZyR6JL z?QcEztoP}{73s*2Sabgt&HA)_re4?Yf}WeiDolH9_E`b%8XGg;2ayt+K?Y$41ScQCX=&E3+aB_!{L1*NQhxknqk?7bZ*c>!k_-diC z!l#RD3ot) z9zN^gZ99)HDcJ7#ePg%^4(-?t53IAASOpt7(hEVlAOKc;tnx@1#Hip93Gxsr0-`v% z2Gpw$5DKKFg>ZivBD(X4J3(P=i=ZH&1kjKiLqr@s7*XXuWsXF(jbAKwlqnhFe^t0uM^V#&%(<|$f zsp+KPa^=#>?0o8(Oft8YNnOq?U3|Q{qwI@xey@5E{|2|lEczJ77Px4;UX^A8hT+R} zpY!^GB^WXfizPPNZFI*9M!lLXV+nA!v3ETZV9AJwFZ%i$A$ZG|%jxQZ%~#*834isk z(~+RR!~zvtdpByS@uj;x@{HIgR%2KbOi3g}gLP4>xK_(ue*f&$zSqco)7J;D^oW0> zMnNiK1!cc0@NgK93dUz7Roc~a12ID@ov6oL=_bC0Cvg2IiVcu-vA`s&Buf5~Qr zTPlMOY~OVL+k)953_14wZ$0<2G!sk#3TTAZ$49_;8}t;#h%F};#VUY(wsTv|$| zW|J3Vi-U>GMB{4bV*TdGN@jJoVtuT;wQ+Um(r~7}dZGRDQfn+;v3e;tG#k3~>T*)I zOk5nUuB(3{wW9gyVt4m^Y$@HmvAVjsu(BABH_TkBy*yYocx9!gIX|+R-MHMB9&Vk= zWY@36lgZ(+>b0p$9TPLvJ$(&z-97QTCo;*zd?q=aySkQ{zZks!<2B8i;q*T=52{9I zXVWXGZ1QSuGo8H1i#?$g%yY?$)%n!WSZ*j?J+M%pSX&xRUAa8glo_m_jx}XkTVsv& zHPiXV)aGz?esnC|J+Qt|-`?FfHovmf+R)U~+PU>ac6voE>X({NJYF43E>F%c38phE zGxJNyFVXi2Pq(dFGPqd|pH5C2)>JziNM~L8``fbc-PZ4du6teZuv6|$KaO7Y@Q#fu zwae}szP$S0j|5Y0#>3|j^R(qd@I_yK!$Wu0y)`%Zy9DDiH05qjsZR$+fNgTLz2y0d z&}>cD%?U{>g?=s{yIat_QvMofWb6zGm|HOW86hb0ZBo6NE4!+_gr?}2rf`tAPUppx zRJ2O+FJynYY*15of7z;Pa+-3UQ0+=^udCW~0q9FXTeJF0JBzvkN8JgXy{aX77ByjP zYWaGeU{znTLQgg(V@GRnd`P|~!#V>0zMy5RFYDP_)k<9Ft?F1#%iYi3D@e>OHRLI$S1)^+whD7E@}WLvPL$+@rGz1n$;eT<{59 z!|HVyd6-V=d&uOxo(*-lBe;(T_jCl){mtu6X)W(vocOwPT-%(-`)1YtRkgRNGH-5Q z>IXqWbPRqWRdVhz%IaUE^9=xoH_3p z(|H-4JrmRE=Z2EN&wjzm*9T?0?qOpcnEzN9E0V4SZ?~J} zGRB^;_8R?zbhCgp(NL_Y=nNHz1xWD7&@Q;0Oo@&99xhirvk|$1c7F$JAHjeuLSO)+ z9u|VwDs%tEn+2y|mia+!L0CXHK)XB-h7q2yaD#;?(el$v%lTGc`m;|LW!EZS`an=` z(AYMvse1Fdr$owO*Z9QO^|N6e;#4Z1fitTofXZpuF zV*Tr@6U!CjZTab%maVzA>6K&RV!lw%1pBeBVay~7OX4zcv+i7>d{|cYeIn^E>j#Ry zBzRaB#iTkl6Kt=XvpvV6*zu2F`sIK{`Gkii^_i=#!ErAQnrp7LR?uuv6`n$oK7((f z_dbYJ2&3Uxg^TL9CXvyUe&nrLSC37KP%?!yiTK2{Kc;_OA|x|nHpWzr39gIqPKXRt zl#Q3QiM&i}LTC}`m{WW{i2bg1~P#P z8B)NQs1{iut2WxJXeF`JEs?g4m=PjOkZWD~U!+v$*oZES#B~rLvbXRfn3(&LzOGjJ zOtv>rWR71hm(G5$(rJixh>L*$S(#f|Or|PL#Cj$Wl}4z$7^{AIKJoO}Rwi+|<#JbF z}^hxqEYQF6EKKxi`F@wT?zOxyyVPSHw?le!1GaH;d(Rexd}Mk`%Qf#Ta%-mfQRn zvVY#t?}GMU7G&CGGgLQd{d`@=blNU=MkGD9Mi0{-QU|rX>6P2R=UJ)$>0wOLJ6mT6 zKIhA?c<9c$w^IBiof!0Sgv7a|VN^^ZzO4X7+3egA$r`b#eH2>QsbkuQq#?yu=q&b} z$~>zhO*)Urb>xsrNuEfnyL&v`pVqJ8`h&7gyf>PL7xiO%#P`2_m%y5(`na#3^Uzo- zW1(L4^|w6?@JiQ}dlo3>As!xV&v|Gp)eFA-qKC#(h2L*Z*T(ca?ZLLSyrj19^GAI* z&MUD#+w*d`-;UZpQT-lOe_Z#2B?Tp7`ms^o-X0GBfCABe*LaTWWgz`%UZyoeqT@hG z?{a%!^GEZ7uMi6(xm0TCWmtF#f($djajf^ul=M5BeHUvVp8%Ky$hgZG!u{MLPH1c_ z-v?$m?v8W#jOt-JaNT1jW}elzu%?44>bU7D&;AGRneHk^?z7+dBLN#=q;C$x$NzvQNx~|3ZC-* zJtv|FeK0KJPPt}MEc`jK+~NK>seX!TH>&=q-zBQusQQQPevj!}mb5I}S{B$VOi+Yx zI^Bv}rwMZulmoU1&4_cq#6cQA2+jxMvxUZ_W*0uh)z7eUq)>y+s@Ff)epA3ap>M&6 zMk})on(kt3*H?e>zY5qfW4o-( zHOV)fdrosAY!}?Z0l2|Pw(B^xEKi9Q>uZXlDqQhCsQLSw;_-+l4#E8yy9J-lrX>n9T{-tjx8a--rR8u?vXA$9xa(2^i zrKQgJJ3vRnK`x(PBll8&&_X-LIrAaRbe`8ytW!!V^M@`G^P*bQo^QLqrHT9%mdv zbirUmRtLlzG#dyd#A$`cr?n5Kg@Z2|8R!0spyLwEyLE*yd{N`_Mz}zA^dw|QMPGw+ z@JTGG7|qkrL!bCZfLIuo3Lxi$cIFsu~y($UZKsHNpMxoY6F8TS^P0_XVHS$=QKb40>3Sl- zwj+N^SvS=kyQJ2r{*S6Z>UW81H>&<&yWeB#ilxG?t;cZU`Q3zF$w(14Kc z999SeF(zXeCxWms`{GyPd?a_Ta2{7bV<;wP2aFv06&4b#(6tzh-JLKYV+(`%qCM_} zsTd2Gvz@U94$l{6wN8?!(PNiQfAMeRi?LnP{kH>l%-Aj~b4`J^1?9|+?K3d)gMqT9vdd41Q_yJPQR$U^9|2r~R0IC2b46vfVEw7RdF78T?M0!Rd2F z+k!E}D#EnvoKkT> zbqT+m`zy=@8W2=*lenVi6AWSkiY76NTem<2d)`pRg0Zsz@4#mN49rvBQJ929Z9nYVmKM(nw0ih(__iF}UDf4K+}3whM1~VH zfc7u-J*9Ksso(BQg^#^GHMu@NJDHnbNp&TFjkw9SC={4+xS!QFM!}XMpqIHXEH>&=q_j^pwThg{{Ygz{)u`&uLrS ziYeq-!Bocm_&X!W6NXu>ljLc@%O_u~`1)dO*E^p3+W|Xf+7>HwO@X!rH;n^ugOP04 z!>nz2-m_F6eyFr92WPEH+7*HJ?BCMQTv~tr&42CrLT!tc zIq$-o&V89!U<)uhGG|iLq^!5awJirp=>2I)xJb7b^oXws9@drhS@nD2))^|>@mD;V z|Com_`14*2oqyezZ-?qb#a+Yc!RJ&#&3Jr%EBl*f3VVL%zL6WN4VTO9Km@e=+jUls z>wN5_E^3dJ7EpxZbmkIUJFj<8o(Y19fK@NZlt^SDygE^RhP{HCXe|5Dkehqv96 z?s8(kDG2-Pl`1___AQQ#qp|EOEC#3j=}SjUEe^&&bi8gw1x zA~xUIJ2;;uPN2`MkOq3gBY@&42*|uf&@L_*B<>AJgczQ>prszi{pkbPK8}7Q55)I*t@D<^~1Zje>n1 z$&N4le_s@g?nMvJdwLcN(X}Ui*~nu-b31m!)8@&Brk_4f?eP1@)jN<{ywhbDpXSSyVwhBA99q?nWV5m)kXU*9WmHI!W_EM|JS~~C^lHVVS|+!Am8{G&pj`$l%dZ^Vpta@ z^(|P4vGO3?;wSZtH$A#wBRMR(+|={1z3RZ-WUv$iX4((`C66Y{9tJO?bH@E~gK1y3 zfE?c}RDZ`79xjbK8uX3qTnAbHCESj&7UBAR+r7>mWU01iMOe9*sb72BUFoOrfD2}1rp&i7*WsG8NF3=7gF3w1BYzTcWbRwDvfpWA?OQ5GS z$=3&@2d_VbNJtMP2XX}GM?NYLpEyhB7Es5yuvZO;&|dgKSN(8*`!5+mx}~xSd>?<~ z`vTN76tpte__caLK`{FR`bDAO!?sp$I)s)cyxs8lX3)^FoDL}1?uC|Lr*nh;Iv`qZ zFDzMFtC#LB=g%IS;lSb1om6a?UO+g9j$~$XIvYZtUBVcU*71o@Mg&2`GpH{bo9Jv! zAUcWnSuW3c^SFR&$I~*kFvTz#z{5h%5jdGhpyS*N!O@}-T}K=S7rFAMCik8K4D}6i zjbE#mDS#ORG_fh*B-iSlm>3>k+sb9r?PD#M2i6v6+A_;a{i|)gvDDR(?wWz=-rCN= ziI$GBe0Z7PB5U<_#1gr+h3b{jj@6!?#@19~VYD$*l^D2Ev%a)7xtQ)4Os#L$c3rBi z+03oAUS5y&woPRl5_6+E^0@M{n!U zU`@JtVYq*AB{esg>WarRxy6nCt(APk)=+=r^yFB_+(6yzL%vq;N1yssAUOPU4@oA- zR$8mK_*%UaT3l~fOY5y^Nj-A1rnUa=m=@T(to2*hls9%p%j}Ugb}3l@w@qf)nBx4d zD!#8`>rfGc4c`2|f}D_U2!LrVen=wG9v zitxQ!P+g;*4!&tXE7jI$vA`w0$E2P+t+NMp*18scs8!xsR`spXKJB&Y?bg+LuikA+ z?+nK?r?%j=s`MMynG<@4OfW5;mbH50n%=whOe1=eD!l_dTZ*f>tTW&iM&{&5HI)0S3dNJalDuSE0OmJj(g|NFEv+Oxy?$**J zI~-27upWd~fvQ$gcUddSTa~uGjT5cCGkYy;pnUHMKR(>z(<_ zo2&h)iG|70iN^K(TwQ9sqhh4JF1JxJIF_ntU!BVOwR(^G<_A&M-0!t|Kk(Pfz8TH^ zQy!Ys*XX4`gX6w@!$Uq7+r6YhbfUpGIiOTnxK{7gV8MD!R5cmu-Z5zS4Jn0}Ft z36YaY5zGlq0_!?5rwJn^CZa=A#E2M(I^B6g`-37NDZzGK2cg}$R_}u*Xr}bBDLM>M zdePT0I$ay(?d|mGc#leAu!^AH#d`q>5fdePTj#upLm?yvnb8?5Aw&=t2on-45-z&k zaKFaYY3Q1fGErj@_kordr5EN+C-Gv0L^3Ao1ltQ_4RYt&MURZ?3u2>$S9dp1V~*bu z*Xper=~`W^ZkbwZxLgx!su-E5s_ChlxYW~^8*FNdO%69?^383%UG3cXZC~*>icXnU zUu??!Z;zgPUH!t8i8EtDxss}wlSe~EGM}E$1Q7wx zWao3qi;vf}JYHShI#Csi#i}Z*t7>BPO{#dxDyw2eDyyrDRTew5s_2pe%k#O5xy)J;Gta%Vm-GbdQIv}#c8j~GG<~sn z+-BMHa&FG+2Wq7S(SNep5I1O3$8{aURB?@y3bycyCoh>|ROhgJ4V#;`Z~wpF6_AF1 zFF&I|! zl1z}UCiOHdW|%5_MnrtW&g9#-c?leu zlbk}m8W}hT=QK8Qs#()03FDvPVYq(Z_9Y)zRj&E@eL|}9f^643eA&aB9=__~Z4Uz@ ziOzr2vut73F7E4J^IECf9+vq;gy%hc(!+2_y(KQZ=8wPV;SCROd3f8yJ03pj?Wa$A z*yv%WhtGMK_wbsBFM3GwMz&iXhWi&19MkW#hkzRk7k>Vzal?6hB4(t#{)VqRZO*p1 zX?##)ap!zl9_a9%E-Sv)_EV}aJikU|bbg%QtM^{ioII)hQT?5ker-}LfB2gEf@}JO zqtn4WzogopU|z=wH6?l)zOJd@x^7*^T2BIldMP*JeWJ!=Bso^y-XhJx@|Kmx7+o>Tf2fTh!jV?z;1C%=C6O z&%~Xe*5#tLT$xipvR+vDs_mZR`y_Q`X(wnBF3r+H} z+V0o;KIr>LeaEQ!hi%@p_juSu{$d8{{VWd4`e68=U=YSb1P>6R1L5#6Ji}L`0Y;w; zcZ!=A-XYFW5ziGCj*U(UfiW3=k&pvcpvV6NGqdw=p*1)}T1T0{9;yIL;w0rnML1&UhUvSK1zqla-1Z2{oCFJJS})MKys z@@pR6_Arpi)ZTe7J~w*U>0#LEI7|mI=KtO z{bk3)^_2M(hZV1XPS;NBS17)+0J4d%#TP%`DcXROcEyC4kfa!VgkA)^6$wL2D($=i zmdLJfA~j+YA~NDKjw$$8?iRh6bL_h2pxvy>mnA|WK(Q!uxPMNn-=f-$sz2&?deGv_ zgT8-Mzed#`wZEg(R}o<%Wb&uz~W*Ymz#KZGBmwNbVs;<%V_Qn%1Pc1}bj zbJbywFi^xH6jVf!yX7O#ZBMm*I7BP^Fc=PE3w3g zOH%24<%INmdsNfBUJ_Y+0+7#{xvNr}31sV^6 zNO5!EKAi8?Y$XndxSX26j%=@p+*fSOeeG9&XAt&m=Xvu?nbjNeSef$_0QwVNKDWz! z04UW|6}!{@4gmd%UwwBly30K@OI$28ig9*gLp0rM3xBPX9o?tTIVk-8h7AxoCy?UG z<9tYQ@j>{-`3s*>Ml0hN41p{X$_WPG5Cl5%fW(tCu5g-yoc z`h6Sd&qx3$1cBgA7EW+37`SM=+yJP_;VBL6KuSU!AXp^%;5v?TUbr9Q`c4ozh!j`A zJK~y+3ZH;bNE?cNvJ6@Kj@;qSjSn7fiWsh zz?F6@QaFyHX-?A@u}tCf%k9DlXgE+zz$_pUciXk|4ISYsiNJuKIzKAbRdMOTKs4tB z>nI~sa9Rk8b1i}?Zm)2X#N*g=huddLVB#e;7Hyw(A2{1Fu2I|zw^<(rvO8JgIwbSK$!wi@q#8c1)O96XfiuJvfN&GrK7$2(#(8p zyt;d}VPm+vYBE3B(Z3ZRo*r5lOLx_^k4(2eF};#VUY(wsTv|$|W|Kt%Kr`t?Z+lxq zO>A^DogS`jzcO>FwKh>TGQG4>-!-LtTR8?ZQdnmQBw6-;z z%cho&D*&{AYooezu4!g$zQ1a6HIW*x?b%$dof@xeUuYd(x;#11mTX_FuNi1tZKz9S zx<+Sa27A|5Q?aUiU(ZTzdg&n#0R4q)zYquxzvyAu7LaEiV2pYAhKH{9-cv3%j9`3* zIHB#B`lmI);1uH=7t;mY(2DBUblsegv{K0G9FW#@eop0eA#UZ}GjPV4S1?{uPO-RM z;pBs3@>T660IE;QpTvX}odxc_NRI6ECH=^r^+qj}@ z+ttb?O%C&FcU=43YO6u<9K+f}PnOq@J8a1jXjs<{DH>!s>CZ4+hjLN%h;J`iRiow&1%Gxs%bi8&!)l>KR-tCKnS7h*OK1n-C$WE+U9$K?{zqnrvy4!F4tMYd8Q4QKIEX2mn1{TFzH`s{gs7 z5?lOjUmMgLEM(Vw04VGl)bqN2#;z3)0If?`4COmp$3~_)mdARVV~th4>+92rm6nQy z=ArED$X05iD>0ays2-g50iZ{H^V1vv`eQARd<&ZUANSCtJ`4Ob_#gv7>om<*h%n|w zZdyfZMug%Wn&8JoAeuETprh**%d#F!8!Pf2t`Hm0tShqej~x-IB22VP)5oADh6znR zgF16(0O*4zXyK{QNQ=SGH4=k$0$G$i07!?Zom?_XNDLZZ>L3beX3^S`lZ-G>u0lD5 z4mobrPb2`eWxXqz8C}YZ zEsmv!)@x^%mbQAAXIIyo`!+L8tBJ{$?uPN@Y+ZsWv+5VVspynx^~I*li|;ts_>QtN zrc4~k{~$DF7C7xzX45OF>`F#ytJe~nl{LXi@{`lK`StnSW<@5MUdiOLm5G(K0~+W0=%s9x5O_FfW1FUe*o zZO~8|5`_uj8YdNOd9QH0=HX2bIR#C`E8au$;(Om0OxYju@JU!yZFqGS!f{`|;h{Tv zZ>jPPv9iIK(EA;qXC;P5kOrx8XOC8>CzG1utw)hYS9A`6H%`vX>Z+t90mAGEg^dc$ z#18`F5ISQQtZAW`+egA)mUe{1*2S+uDHe64Ch|x_#1WpZcxxDSiywhkjye+cK6s5p zU1PoDd_BYC)5dAIe&2SHV_FdIb&W$d#v_|~9vh1i^Z4!uL@s;8I$(O7KHGI4$zq$ zc?twPd<@V-awpn27xE+cT$O+H$;zIZe(qO_`AGcy^?w$KmF6R1Wv=uDWs=CpiDY6RwX_)|`B8sd(C;|J%1=t%yQv@TA^IIwtbEzC z!>@SwhKFi45G&28=8_jDJ3V~X&tKyqnD%80=%XDr4TBw97>(bf`vzmBBvxvoViJoI z>Ts(nF1q2VQT)j16Dyw(vyV9sRv+P>U?jXk2DG;%A$~h^jvF@N@nYmNT>r3%p@A2P zUNIbK_yRf|ZPz_~$wLb?eASoV@Gy|UbpCl{F>Nsq!~HYIG5tznD7~~z>p$1T&`;{! z@yRPxa3Nw^8GZTAa($@Ww4=UF>MMTy6&?7MdVt262GM8N3*=09EZ8UvWL}`}IS7Ajv0rtMN+28brypPdZv!MIfO) z#F-`u9>mPx98J~{+?c0!i5n$;c_+Wj@c8B*Y6~Lf*uSNpk-XpkhJPH0Cnknine%+$ z-KQjmzf{*V9T#s7Ycfp#u(+=KC-8@U}f{h#SA- z>*Jw%JKdlmu_5Qlh9=ovcSCy)I}$FJ+kpsZ&u`aRIj-|TZhVvYL8L70k4s(8 zZ3ruq4@dSBYVMkcQUGAM+Pt`QXIx?3t?cR~5 zr!(HsIojNs?(dlx@96E{T1}@$;tNBIiTSBSswvx)ZLXbLotT;&%nyyWj<1aL%yxFx zj$|i>@;&QK8~OL>neHuGqXW*$FL6pj2l~=P*_-GR{VoXHkyYogqO^rd-1Jy_ z=k%eN{m1Hs2?8|7#a{Nony1`bN+bV!|NV~pKngr#PmDuB3-qA|M2ri z^*iT*8V?K0{#AO`zpURtFstB;P_9vlPY8?G;G2x!0-0Lewl`~i`T}!{vEl{u{w{oq z>ouXKZn;SG|Ij!WNKPOw3^LS=P#~x&)DvrfV~+6w#wvhr9%?re**;7>tTcYXP)4X} zQYDyj?&ny2Lf2`HIxG?R1LNWamB+%+bRy1L@sZi)h0SzpU31l9Z)@{t>y_cf*~C~~ zZgRDzdMGhB)H}7*-B}S#6@PE}&aWAzX3j7+_f6kE9Ml{9`gd*KrRYEU=5rqxd4Mc4 zJA6RDLbAL=+djFRUP|UNlhcdysoBc8mE~mF7wG(9bqqOdaeXh>M43@}T9YlgR%dnm z)55{m^}C?`*8~qs9&P%&qjuP0Jh0z*)pGy74IlfSe*k%G^zb=fpASLPjNMJO<=ZM~ zHmC_tH}{G}j0%a#7W5N2Wea<$QbdR_;-u~vzF*YzRw65(FD>sAyZVdqMW6MnN6Yow z&^Tl=4fiX4YkcdoPF8IEH2U|A39?b%&u0B*=Z4GWb|3=U{fkZi1@p_U?-N&hO#k@Y zV$wx)!Td^|5|(IjDTNSinDoi<%8GUbi$Eq^Bq*X5rdb^K?78iEtbG;>b%tIR3dP)u zj>Y9hLCkUj9MPss_OwsN1_%XCG%Qw%2v*NnvZe!d!9nLzy6>;ve(m*QQ}|p+uqYUzD8j=sI2UHP49U> z)u)dz)f;D9?&soh5A|39RWoDb#n4oL#~U9X^;5mUCw=(^4{3+3pxK}t9wL8LwLyPI zNJ593>I(@0zNbj(=Dq47$-CiVuUYt95d!Y&2On;?Rn8(njf z&%@o;zT}e!?y>@51Z+Df0X>bvNSCKj-6dgUekIkF=0!5rMVFbVVe!fhxI#h&WG}d;1gpbggppuI=_dKa6u{*8#|_35MPo10`%6Nrs&H5YwWYLvY(cr;KNzml2Gbr*ZiUb#RNVDB(T)dw6Jc$M@;eI;3uEZQ z_4~GtoRQ4i2@P{J@eV>}+}bUUk;O&bp<;v3i#@dP=rSM~5EdY%a6iWNonXY#XOJEX zO}$I?%bm#W4O$az%N}g9^U#T@ranMa>@$*{Sx0$IFcr9RE=h7G(y&9%5guMP7Q*%WMqh8-w04+Qc*mH3XUf~#>7$~> zjC2JgVpo3|IwI#f2^W-v>mzOjRV3)REv;faa}qKxbEpwr6bf1m0_DT~Ztde~f!77R zCp6h5-UOj(A6Gc`kdBF(p$?fDuGXPD6Anpr3%A4IBG-T0&+k1280s73nh(GATwa0B zOaaUopovWZCz*MBac!lqBQe@lJ9s%&J3W+~T1j1QYoBSUNp@tHYEoTIomaaTT9*g6 z@{RY-yq)Muq_5OWb~lXN~E?+mkc%Tcfe@_SL!G`j*YnzSa4B_k6N>XkdP#A=a|C zv=|#`A6@UsC17E%|?W~MT13DBXKt#ci z;sh2Hg-|0m#38+TOmPkMy6Tdid_m8DSyyeT{)vDz5|;ppBy-)>fK1No*;vBCWypJ6 z?KFFW>BweYPh$Djcdtg{&T(y9czjmvUsZdXx{f!8Y!ell8O5x zc1Oo@z#2FS0F}FI6_$fKj-a*zzmW-eIx=tjuTBT(Ufvnki$!zOJWmBe6;Wy*K!En$O2 zw~Bj=lRBLrJ*2=bC|s?tiku3&EnF#W4qnxTak>IS^#AI8pd9`D`aj>gpDxVtYsP1fSX|8GOt=($99KW*GJ)4^8 z%C3NTfB!Fk#k5&bZmDdNh1D0EGJPg(rc9h^K36lzF+}ejm))#ka=J2UKfm@v!Ib@B z4@;S}TYP#kOA>@a2wA0Csd^mTJ`$CAx|B)VNR7cTN!qufw3JC(?91b2+hoI(` zDl)Ad<~^KV$#aeV4v`8G4>udcF*JA_36F!g#td3VA`uY6$ky!=+L1k*fNVrI1T*J0 zOAU1dTO%AIIO6=~GF8QP`2~Eg%0J-ZcYV$86%`+U?ROi3dh>a(GS@7>PRV*c1a9% z_*z=f$@PP=kM|PGaNgkD(t=K<1)Zj(g26e0%--7zUZK@56xd1&I>F8($nIPStWOMh zX+fv`&N~l>80zNIVt-8>vt!|MxgCgr)=$O!Pxm8MBDi7aBXWaiBo}$vAi)l?k7O~p zoj4bBvTV6XP5eno8slO__7W?J-Ng2X&{`j~KclNG<_Qa-b3nn3ipUZ~Pv^*P325+A z-7Qv@(yg)>W94dtl(jtLto~;1>22+edKF9KKlc=zZ~b#IS+5! zd2~s^cE|6>L-hrx1iOaEhM#9QW)h_lF^f2$ISeLd%zVj-3PUZ0;tB;7xQr7Sv5Y{x z1W-7I`zx+qL@h-G8lftI8L#!;u#;#=Fs2ro9~ z-uoX{W(XfwL5b?uM)ac+X z)}<$1G8r}b=VFkdr>=dl3BMX}jHCGL;5-VY=E+c$>-zjc1r2+}Q;&He1-U;BK3nudZ_<{BR} z2?~PQXDMd#3qxp$!#UfH5HxfwrvnPMd!c11X3}+*p@DUsm2K=&#)X4Wmt{HJ*l|0* z+;$?MwNp%H-A~M<%M?wx1HlL&IUFJj4mc`^CoAX(?W4{m{D%`o-{LY5ah*N4Jx^TE z3%aAJA}*8M15i!4N|L35+IX=#KUvylnjtd*lL=`}377!&$%qi!@%D$oMH=|o@7{X~ zFw{55HQ)c%b1%#6#1z1c0h$;UKFOHLO#k4Of%!ywEiqX)v{tvVHJhxendwT_EwtxS z$*GEgt(B3E=~#E?V%NQ6CR1aZO}VA1+K#%--k#jz-1<^iKHlG$-&(I-Xq~*2=-HTG zi6>)gSNay_2ZlHLG9&eCi|tE&85HtBp|L?cG7qR#?51#|?wUIBp5ZdZRZ}@t5^xgpsXDwzjqsYNQ#TOD`M}*>< z{=$C@X^%L%Ek)Kj*Y+6&OyD!Ipt!r7ycnH-#emLW4Wo`=0_j$K-J;HWLM0cjaaDVB zYH>;blDdl4_7^jmQh>*%Ca9dQWCHEby*CxkLA>9h+FVzCmpt;~dV@y6E!EWO=~{KS zOL~hQJw2)Physl1ZLTP;a6vT#GRJRdpB19&RllhBSyFjJ*QIs8zJL#E&^r()a(ZGW z$Mp1<)F%sy>KxP4qMjJhw`*2kGzRZfuV>HeeTEelGo`a)dfTL;9~<>16MCx_osVDX zl-lXhzeSxts+Rh7d_gdwy-9teQT4*0&K}h{@R_WiRsB%KOrAb3stcN6juK-@bTI4y zNflg-C9(lLJ|rGN+<7~Jp{Tv#OyU8Mcvxs zNPX{mBE1x^^)Z%5ee;7TYn~U+$*N7DXj<^F${LgE)J(9wQXsym*}GET;?185Sd=9X z-|*)>;-x=>Px|r;9{OhQsjNXK8hjH?^#@Vb6fUfYBA`p;AughNRR}*L!a|CHtWdm0 zFex&-D5BCT0t&$x68c{i5kZrVIsvi@dF|EpuoX*csWud2`Jf3}cq%lh${n;n;yv%Trn zs@|&Mk%nBRx@BghWhz!P*S5ShJ;be__}X~UDbVVRO@aUI(Q~isyD|k5Gnvphu}2Oi z7_Q8wS5n!POl3B=me}-*AT7@4D&|w`$y9D7vst;4s+gNhB`T8n^n7MArxgsI$I(3}5jFx3xxc*oa2`gV8R;FG@mf`{(t zy`|Atg)hO_i6gktDnRnv46PHz@`^bjHc@Lkd$KaPz9NwAQo0hu zPF@o|8D>~H*CjE3MlI6#aaIEmCJ6&D3&&2s?e`hjn?f1<6 zwu#DYzisaSjhy?6)4cEX?o849yF0x8{?2r{6mjOdchB$t?#17TZ{Ox6YBU2GjhJ4I zjOAc-T+|53h-KKF0mew7kx(n|+g{{jPs=qwzfVYYUXbmYhcA10)5BLiyzOCN^w9Z_ zdKSzS^p*xA?(11_lEUx8<~_XT;fo&L@bH$0;r@jL$MiexE36qy7JhykC*gX^d?IF~!^Cn%wHsA` z)cfIf@j;En?OBld^571;ZNjgobzQICdr@=pr1nSkcUp`&YoPCRd}SUkyvMxGb2_|o zX@sB~7%x(y7UAof3a%r27ZJ{^E4?O6XPFP~w(}Zhb-UN$;zZrM9n?A3UB&8>>v~3F zuU!jd1Y6wojCFUPv0GQLI0sIza20Fn&F~v-_ui1sz>14|EZ0C|GokZcT&R1V!^VWV zs}Jgk>#pMakT#Wdz&rI9oe#O^*uwa8QsX?T-KhGb;?;w8!hO*9kLuT``lI%DRJ&32 z$92EGMflUFB`#)Q-j7o>f;ZU_Nqp;^4iT_x0^SP0p>v!e*y0|VIt*(H+cghOJ@$$(zvkg>4+EJ@ z=b!iDbEAir;5zKYam^n$CypDwe9OaoiQ{2BnA5#u`jy08b%HiOo!o`t{<7oYddhr) z!;05Gr)#J6D-?HY%S=2hm!k#(CF!#|#ZZta3t?=h_ytbd6%%4sQ2!#*A>ge@0L2Yu z=M`0&J?si6*deYVA|o!N++>Z3b=8EgBRwHsA` z)bI45#g_+t|EPYAsy}LfN3|POe_Z$5TYS<0kJxP7+u?Az+zv!Qd#}TaLqt#!*@8DL zPV+df;GBYT8bQYy9T0*LV-Q#HkwrkkorUAL%GB?|-?*Ol{ra(#5l&^aisK8;GPupb zHxLnnD-7Zgp0$`pCWAIzqz(2_;!Cm4p4*;k199kK=dbykU-{2onlC11e5(0>2I7Z_ K8CK?+|9=20&pFco literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Sessions/Tabs_13425116298054337 b/Covance_UCO3001/browser_profile/Default/Sessions/Tabs_13425116298054337 new file mode 100644 index 0000000000000000000000000000000000000000..193195408664c108cdcc104c2abdd8092818a5c1 GIT binary patch literal 496945 zcmeFae~cVScHfyjJG0CEq1{^j+Lp0i6<0enZKS}hA-Cf1*Ca1`m6-tIJ4gBL!fFYv|!**$Xu;~M2lyJ7LPd4nbu?J9h^0|P+0S(xv zE8uJ#eefS8z&O{!vgW=o@)KlDlFjMi%xXuzjAqs+BQo-3WMsUE7ca7k7tUR{@TnjO zz7>2nFMQ_gbK#Kqj5Z&>_Wk$Xdq=#I+TK2XB0D{M;`rpq{L9D3M1N+cl-=F8>IpzO`wwYilCo6g`VroBM40t!uyX8>2qkgLB^7Cs;z;^=5?tNKEza;vyeDvRr*Kc-`+)B>@=>Zd?VV5X!WF|n7k3mndIswZ_(v3xl=B0M!8hC{#M;s+J@@fLNCrFWgwx5s^!{)8abxUtE{tc ziW|X2eXa#_!SiZ9^O7CEp0Ag9`hnH=*$<<>y<=XTa|3l^yZ-taFXw61eMX91(iW+fDfFyb?3C2o2Hv7JQ~X8M`i!;_rI)1Qk-|^wcu~)& ztWRHVU!I)G8x8C>jF+`7I%y+1e@yXcU|&|6sk>cgR!8jWGwvEzin80wDt+R8cW+Jc z!|I|5_*a*o+y!{m_q20veqpHkg=iGE%bJ?_F2Je$3v0#2Qf1S|@#gl*_~=r3 zxp;GJd-T@Ws3lZ3SMQXMmDX0v8{1b_m*z5+;@H$?W^3$vX?*>)`ExhMwzEe{m8J5P z(n@h{t-NuyJhybaHa5R@x>7xU=K4$H`H9KN3)gaQo_=j%^3w9^+N&?mE*48~oLxUL z{!;wZE9+%la%t|u_|)`~jfzZ!xoc-%J#+fim5s4;H}a>?=k81{l&>#eJb(VirOoXN zmv2r^o~oR=apS~Gixs5 zx!Zq!;<$P^{fn6*N>T2uYGq@qd}aG~wLE7xc4TY2xLuyxx?Rj(%x+HSR>tNR&Sg(t zn7a7dsY@4cE!4KQSC_X>ubt22#+N6rpS*qJ`1$GltD8r* zN)<`ewz0bO{CK9kUR+%htD6;7O8F=CeB#~hN!dlmgR?;{Q4P?$>Q@@cS@hdatkm!_P$V0^EgB>H~wyM;}qS ztghqQXROP8*rmSUW(p67qsTfkYp5c1v)ROolzdd`U6ztt%9_$fWj~GS)8{a&ay7W4 zJjbM(YuYcXHn)Q-+FMc=opI8})QN0re@o|HSH5v|Z?CEAJ{R0j%C^-0h*B%=T358U zBKd3jGg(*lIj1AHWyOu@oVDPza#r;u&q&rwl9gANFsZ)_!8O^pZ|eAK!GhwKRPI&f ze>HfSE~gZ{q36FIoX}Y>ec)BED5niNE3Ra7l0UBdm{wUgloHvHbGqhPUEz$b`l@nn zsEl@3dBxAGG5b=UOy3(E0^{;n%FCAnrW9FerL>Sxulw4J45r{JiSuI0I%hY(Cj0 zj`BpZ&33l?-O_cgNZxJ5?V0!|c0@;PMzQTuw{+Y(@{8IwRa-fg!k*iL>LnYT)O}Cs z*lW7$OX4l1TS;u5vaHY3y0i0YDLK{kvg+o#&bY0bIj+=c)#{{b`Lb%stjbxPb5&=| z1g{5gsWelr4y-g*vZ#y^H*{pl-Mv|h>nfkM3%kdR@@*=2)Kbci=#d}7;zQb3rFoyz z_UKIDZKsp|JTnc3v}IiCAKo0>%4^s4|u+IW^RN1RYk4A+S$XN%36K&v~9M#sg^RTlx6J|o$kKi zzRKbVOH&LLhWr{tt~6sOvq+7C)FY+^_fxJ zIH^9y45f_nSnlJ>J*zWK_BVAMf88Hed+^sktg`%+wteju9kURBJ~^eC30IP~nNP;< zdO~+NqEDL#+T6`NBo;FhaZ0sh#$r)~Z?026wqc!8!YBIW~tYq2j*5q4_Sv}fpy5z28N6ZAbnYLZs3}GwZ zU`TAzPqs~J&+6abec`d5ht5Ab>e4+2ryalgnW2WvKXd+Bm)y|i)i-8wj~+7%d+y}r z@++@gSzCT-W^?TP#_6-St`*FQ3@DxLP^;FT5yZY0Yl$sc17C^`XSNVJwAN{h#jt zYd4JbVV(4y7+b^-sZ4`mK&(rStG9Vn-1E^u^`+rytm3^GxKiDd?$uUR&Nhoglae??Y!3X+On-wC80Zgx=gK5U)XR?!?QtqH{Ca zJ{SCmCP2>zY1O$+f@}dMt=c!EWL3||(rl8nq|{|Sk4-%%JMPWqw4SQv-EvRMCZ#s~ zrJdY4J-hgIO;4=O&Pi5U+grM#ogdFPY0$HGGM|(@QfqZ|YLPKmOh`YmZwHDF3xZH!OP&4$J@ixuJie;lYMwQ*e4}I_H9_YF)#oc{eHfkn!Ct8kS_rVU>&JPdwg&2H zJ621hYAh8u>>a!tN`{pmk^d$cRt`FhJ$bnBt^ZN_Zqpx$$J746KJ>%o;}&!V`j>sX zXPZ-6$8I`hZ%d50Za8{tVp3`5eYEb`_H90Ei#ay?v}GNeVJ_*@1_WPjUmoB6oB6q{ zzRTvYS)FIIb({4@Z&Fw%Zypfy0YvX{nE%w~)aE;|`R}5nTYhy%UbI`k{jhzhRbTt} ze)q9m__u!Rn=ak2>H4^x^Q+GdHR!_4(4W)hM;)744OH=HtP78#TcZ=xvy+)oEjnyh zN)@v%%<1stZapoFK0Xf$f_K!t*XZi2AEB#H(Y2>xKGxOSYaSNqf5L855=BK{Q4`(m(lh~pGkaJi{I{3%~@^Wqs=6q+y(cJ=@O3(zMlQT z!T9eeG3^iRL*HJWwhOk!uIM$GCE2~!1)I~)*3iuYw|(n^&4xBx-R$Ra{aKFaMK-gl zEsrm^FHcV8{f4#)XG7a7Z|0~p3HB-)U=M{erW| zw}LN9_Pp$ETidj0eoamUZHJYwEe?wo{NwQSkENkwk6UL6humoo)>Gak zZmHI@9%|a2)}UkE@L)4hf!J%BlS;t(Zap7LvSCu2d|`*H2{U9FoZc+fHl~FP1u6>U>Ek_ zp|3~s(=Y==n1@wZhdZzZ+pq)g!{BEk`6+l5hA;;Uum&5j33p)!c3}@5vOY;64Kr{7 z7GM?D;SOxUHr#_fC?A^(DR>lyFb7v)9X4PS?!pf2!ahtLiLR4|8MpuounOOWP1u5M zxCeVM_!E)*VVHp-%)u2{hYffawqXZ$VIQWBavv}YbFcub@Lkx1EqD)hVGjm>lKX%e z7{WZP!a8igyRZ#A@IDO8v!{@PX_$pMSb#OyfKAwf_h1+H;31oGD5PNqhA;whA!_*A&VF>fE3hS^5cVP#1p`X7F zGmp){5Eft!HeeIB;U4Tk&1hUm!z|3f0<6Ow*n(}?g?*TM5xFpgd02&Y*o3>V1G_Nz z`AFU{%)k&9U=2246Sm_NR)6x~0}!W=BXI^2OR*oIx$hbfzvDWqWt^RNo*unBiz z2X>)*IZ5({?Ik6J3=Clb)?foRVH@tj9@J{63u%~zIaq*oxC2|T4ZE-pQz3F;2=lNC z>#zxTVFz}hUet177-nDy3$O+ounF665B8wefn7+$EX=_Itiv7Hf^FD^eV96lTo}SU ztin2M!d=*bT_|6q3&Su2Ls)<{*nmyghI_CF^*WpjX_$pMSb%l716!~SyRZ*a^T>rE z%)=_I!zSE?9oU6>%ff|Wn1LZIz#448CTzn!*n@hl)rB<7!W=BXI^2OR*oIx$hpAJ@ zg(1wtDy+jM+=U(3g?gRVg<+V1AuPZeY``XL!#&u8djG_QG|a*rEWkS4fi2jEUD$`I zGsuM@%)=_I!zSE?9oU6>GscBsn1LZIz#448CTzn!*n@gA!-X`=!W=BXI^2OR*oIx$ zhpF?(g(1wtDy+jM+=U(3g?c~2g<+V1AuPZeY``XL!#&u8dcoU;G|a*rEWkS4fi2jE zUD$`I*O3cDn1@wZhfTN(JFpAo?sH)nW?%>lum&5j3EOZF_MjH?T}Z<$%)tVz!yVXy zZPfE3hS^5cVP#1Ven@odBZRRLs)<{*nmyghI_CF^$QTu z{lhHG!2+zq9oT|x*oA$V`ZjW52=lNC>#zxTVFz}h-m!FH7-nDy3$O+ounF665B6YC zpqwxZbFcvGa0j+v8+KtIriy_JX&Ayhtin2M!d=*bU8vO{7lvU5hOhu@umPK}4fkLV zYSk(#C(ObeEWkS4fi2jEUD$`ICFH^o=3y1qVH57c4(viL`nWI*Gcbe&Sc47Ngl)J7 zdr*rUE~H@==3oKV;SOxUHtfPaOkG7T3}GHtVI4N%F6_WAbZ^>8ahfHl~F zP1uHeum`oo<3bu{VGb5x9qzyuY{M?>!_+n8!Vu#zxTVFz}hmVsRu zh8Y;b0<6IXY{E9&gFUFPwz`mpS(t+bScf~X1>3L-`!ID2xiExzScP@iguAcfE3hS^5cVP#1 zVelR9A7)?(S706Pz!q%7`!M)L`mz5PrxX21^dr%aL_gy8gT)UruSw=n z@3%V+T5n0eoAkR$znk>CNxvKQpYeL|^SFbiTfT#gSDEN?ANzbc83&_^9ei%d^LY4k z67hC?(Ds_NtE6374aD2epq|M%F9-G;XZ9nY zwMX>J`;Yh2lP^flGurI;$SoXHKa=Z6I+xUc(*6?tOZuOr|4qi9Wc*F+kGTDm*k4b6 zPc5-O6Z<=ve+xc!*;-xB}ZlfEaL_#YGhW8!~I{EvzMG4Vep{>Q}s7`Gq2zcHSk_#YGh zW8!~I{I7}sIq^Ry{^!L1ocNy;|8wGhPW;dDc|ziUPW;b_|9Su4sZ9LuiT^$EzbF3p z#Q&c7-xL3P;(w3Z&x!xtwBpfrk*q%?>krBLL$dymtUn~{56SvNvi^{)KP2l9$@)XG z{t%x(CF>8#`a`n*kgPu>zyJ4mKT5Lxl&n7`>rcu0Q?mY)tUo=@&z`J5Jbv6v)*q7f zhh+UBS${~@AAUIN4_{TcY`&c>{rdZw`vv&zV8s23d)al^`}u*!qwf5X-+BKaKaoG4 z+2{QI#>tPnoL|)S?f+9B)BpNzW!djOCn#rDH2;S$x5XcZ-m!=K@89!seQG?O_6PQ% zuaBSB@vmrG+1{>hy*N5r+p4~>R$MGqHmfg`D(jDwKc~Fk&^G4&zxYM{zwxu$FX`FN z>K-PvjRce8tUgDAqJH(?R)0oDaDuDm&eO5>gbGQ%;@}CU28;V zlodBwlR9@8u156sg)xQ32>THCvpX&~Gk*tgx* zK-}{C_cA;f1Z!$l;0F_QBA(6Mn5Sf$*9?z zBF-w+)MHZdtV_%4m?@>H%((U!r5dx^Cbc)CE%V^H#^p~-!g#Rc@pZL_Xz_*+zSik?NR&9%RE?K@t1EU&c>3qJilf{)uVweByV zI2N_={bz>$qb^~|7JXdnen-b^+N^a~#UFI*{y)b5oon5{3x{dFnOG}6O1vIRxBD0j z@z(HzZQZ?NzO`Gc8w|c2K5f6aZ&h~O{@bJ#>EF7vFP=Z`1?|H@IhMu8bJ{m;D5<4R zt94p?x1nZ4tWU=OG+Pix?ts-e9*G(9@P9E+eQz6W$m%r;M2V}__)dX z_2-7}YN+rUVa ztzH+EXDRr%dVXDPhjsp*__V6i*7+7X5rRWQ>y|e+b zE-C(Kt!cY@Qj^?PeQar97}Z}*d)43tJ-SM8OZUE^y)yB29goZLO(mZGbCUm~+TQz# zKXBLQc5>%rw8XD#b#8TbPPxB?5qXZ*OAyWh&wescFq|ESmdQ!4A1wViibW;KzP*4@@;PWu(zLB+MjHRZ8j?RH38 z#v%$9KS=QP;Pb}gX@6iJ`ul&}%weE^d8EE`lJ^a5W!FKQZC_T|&15h`WL$sNMVql; z-Kv=mk=<{GidpnC;<$2{L1VdmxqW%Oe9LJaxpmC5+OxTV86gjcfTGgO?3r;xz_O&y zDsR@6%Zw=-492Z)y=d1(TYKHFFSV-rpZ?nyf6*H+_Z0Wt(0~6w-gMo#@2-8^&iPhk z`Txj(ty4GP!QN$xvlN6&e;`Bt_5Fnp8g3nbj*tNu4NhsZT34bZt}SPT*toq z*T3&H;_txF`gw(Xj8)?IV3g|-#d%OpU%sp|y1LQ*{!mSxp~&PJESKF%h8wYR9whks z_j%*-v_G&9{q>)ANE_F1WAj~eZ)M#;V{WS{>5dI)k-N$?C8N#eBxU8Y8TFLTv%$w^ z(>7Q4<@V*tsl2A?Hg{OoS*CI3IX4Uv<hhDj0I&L?jE^prmy0*ownuM`jaouwbM;R7SZQswys>>{b!jeBDUMBT zX12zzm&Vs$n?HABY&(0TR9PxtDXqu@U*5P{o?E(I8=GG{U8x>FbN!|9{KVwsg=@Jt zPrtS>c}YI|S6`l8ESBClyMAK)rTD2=*2}u&(%gmdsp%sd6?sVJuAP1L%;{HGHpb4~ z$e%u+yEC~^zP^0%{P`P~Hn%TazBxI0s&eMWjT0{|UOe;4rOk6Ixr=wE*6#emi8tQ3 zzBaW`xq4)?ytKMmE^S}Axw$&$ZvXj-H5W=cv??yYKNW2<~+`*yWFXE%0a zYrD8zp4+-z%wEiHPUlv}<`>RoPhOb1_}ZyU7jG@pwzgN7w@HOrYmtUG3n_azndgk@FN>i(wN4828Nz}Hny7c^bro3KUT@$sOp-L(Lq@GW_yFDqp z=y-58h#Wu{oMmLwd9#-Oq56!Lw!=E_uK2WFZrl1*g%0dPOS9b`@&6ot_v>#-0R9WE+6S@>blPb zHm|v`t4lCzLB{Iy^~@k=WAs`9@YyiAu<3f|E3Uza0jTxWjJRj(+g4LU2XWOI@~uKSo)SvQmt zxy|Nu&9l0~8C~^N<=jvi?XL2QpI2$_s2mHDa$RM)sFd?Mc1d-yEoqlk%U14Fl6FSv zH&m{d)HPmI>=l>moFwKHzoYA}>GKzq;|={?S8Pgh&0shpY396Ibu78Mw_$QswPxPv z$PRv9b#$BoGa5FZ>;{bTM6%6YX!mPN-d7~=w&M0o{1ZFk<{6Q*Y)<>P_4KkTbylUA zR{2-lb6ZfoWP_8s?WrD-bvfD0Z*6s8rLmGlWsJC?BTMe?&01Vn`K(>oJ!X{8oKR6q zDL*oF?Pp5(<@HCMpKm)A_2-$TuVF&hiNYV2Jvf<8JRqL65AYoSRZ$j;DUac)F z+Dyo1HYe30C-rHoF~&*tF=i-bl*e)(SMFJzX|lhm>-g*bu-b#a{$Z8nr?l;Bx9FIK z`18pr%}h93XEL9R-F39?YJG3CK5HJ5Xhq6aVaJ`ZSX5q{$C;65D@W$Znb5Ysd|OSj z6)1DE+e((1gO(PVh~|kg!*E*C%vg+!QOjwsRoHydyhhV*9RDcyX(p(Z!g{i(99D*C zo!HivZSHC1u-8B$Lpi#8ySgo>EV)|QfA!gBv}W8|O-A>Wl`Nax`kAkp$2Oa`mrBe~ zUX;XWrfpX@L)gkU7!sTGlWmjQv-eOM=bC&m`> zLn_l?7!d1{*bA6?~Xd=+)8g)+FWM*h1I1OZj{FI7cabW?)2K7J8xaSIJJB^ zck=X=>`R-gOQ%n6oSrV9xjnr!bMvNkiAM{^!pP z{SyrjHZ0p{5qClkylfnQ0e7XcUJkybb1tZ=)-?k)Pe)qwdYiY{Ppa4=z*QapxL!%R zFIg7)5rWLXIA*t+=6>(a@BWN=rT#uFkp6MKlJr3f0sDERwg&2HJ621hYAh8u>^(Yb zNrsi=)g{x-ZRyuXc~$C%J!^m5g3dtyvTyfnb4u&jZDwgN0@+)mHgAsBS8WZ|W|=m# zjAog(m=nDNYHym_JEu0Ep4?ZynV+_PYjaq8Q#x7;_HR-|Z>U<@k_H4De9V7pb87P) z*!*`<(#>b0?#QdETfhCVeW`V8?ce*|$9CcViwS;B*T?OgUwv+H>cqY; z67RzOwyLZ)Gzi{NJFRIutn;hl)6RrabnR)FhZ5^XHG9p&!as<0 z^?lN9z1f22QQ~zN9sS@1h(D){u0Hpf2|Zm`KR6I<$=MfKHs*jD#gQ9-n=n43@a-&~ ze&Cq~Yr~=L&#V^f8Z6w6;H(GR?Go?7L$T))zy6ByWwd?L-&XywZQpdYcNZ)d#wvLr=Phk%>uW5>w=>f>CINQ{PwjJ>$vSjHnXZN zPrSY4ROoMLn{YO?jHy zw)nK&ayTRb3OV>Lv^48k4>fI1YtXT7d7}`rvN)HL*lFD0b)r3Cd)dC|hXv_o(ox(BbM)Zr-oC=6i^ z7GMoFU=z0BJ=ldkc*yRZ*aN4XD}g*jM&RroG! z!WO&-yRZj?KgoT-3=Cl&R$(1B;9b~;9e5uG_U#dc6imY`%)tVz!3J!?7Q6?$um=y> zltUp6GcbgCScP@C16!~SJMcbqi`$Z)vJOh&C=6i^7GMoFU=!}b4(!4nJTwx?Ps0pc zfCX5Eb+`jtunqTM4{Ax>g%msrLzsgrunrrr33p)!c3~f;qHmf9X_$cvumG#@UD$*z z*oJ$s2W2U_Fbp#=ggLkZ>#zau!Zz%{F6_e;_Hr6#VGb5x6}}6bum$hIF6=>BZ_$0g z3=Cl&R$(1B;9b~;9e5wgQgk5&(=ZEjumEeY0h_P|@4+tY!9!S}X_$c_%)=_I!yVXy zZP=dZ)eV>2*>1z3X(*o1Ak2YXO68W++q3v;jl>u?9QU>kN}AEsVJ zE(~EFR$(1B;V$gJE)0G?k~a)9FoXqIgALe(ZMX+}P%jom_Ybo$2Me$ccVG*)VHfsc z%I0MXX&Ayhtin2M!d=*bUFcp;lDuJiNl76CLs)<{*nmyghI_CF^^IE>(l85iumJ0D z2ex1vc3~f;Lgc~_=3y1qVH57c4(vj`sO7>i%)k&9U=2246Sm_M%)yO4%in1cma zhdZzZ+pr7!Fm)2SFobzng>~43yRZYhP;VEwFbp#=gaufG4cLTjxCeVsufw^JhFO?{ z1z3kWum#(&3;QrNk6akSJgmYxY{FgGfnBJ#EL<3d85qI>tic9s!ZzH4J*d}OT}Z<$ z%)tVz!yVXyZPtic9s!ZzH4J*c;G zTu8$#%)tVz!yVXyZPV1G`Y}J{N{z28OTzYp?;EunqTM z4{9;rg*42<94x>(+<`6FhF#c)sf);kAAq}%I2Me$ccVG*)VHfsc>dzn-hA4Kg_}$EWkS4fi2jEUD$`IZzC6mFb}J+4x4Znc3>Ck9ZMI6 zVFre<0Bf)To3IV{U=Icb$_cYD2Me$ccVG*)VHfscsu;MCh9S(uDy+jM+=U(3g<1`A zVHjp$2n(LM{wp9#&x;HsLPpz%JCH zj|;;v14CGVHQ0bn*oJ$s2eruILK(+<`6FhF#c)sVZ_|2=lNC z>#zxTVFz}h-jsJ?7-nDy3$O+ounF665B8vzl3hr{EX=_Itiv7Hf^FD^eVE!pE(~EF zR$(1B;V$gJF4Qux3&Su2Ls)<{*nmyghI_CF_0?7v(l85iumJ0D2ex1vc3~f;ZXp+j zFb}J+4x4Znc3>Cki=!?K!wd{z0oGsxHenm?!5-A>hAyOG7Up09*5M9p!8Yu|K1|(4 zE(~EFR$(1B;V$gJF4UKbT^NQL7{UUq!3J!?Hr#_f7`#n6VHW0K0oLITY{53{!ahvB zgIpNGJgmYxY{FgGfn6AUhx>;a7{V1;hdZzZ+weXNei3;v6-6Js-e|*PM%yR#HLowK zY@gC*-`<=NdhpNhbBYdW8;g<;TtEK& zczs&@Anh%A9v|(^_jtW0&m(HbNxMqgm33u_encI*?-zVOpXf)TABleK|Kr?=ekA&l z=trU-ar?pI2btF-^QiaR9S5zqq~A^Y-K5`5`rV}8jrz}cJ@|RtLDMbYLB^|0bh(dx zzMPDMQN<2Ex8!*|{5gquJ3eT8P1;q`uB-;)?PpNW?D$~(AbOXyE335+UvJ6y@kiTk zALf}S|84mX=f5pa>ObmplJ=LhKl_i{uLt%Yzt$cZ-~Ia4e&h5P)Q>%*&Hg_G3kS6i z68%f`&uqn{|4I6vr2k3!-(>tr#^1#LNbIk;{g~LFPkv80vA>h~M>79P=AX&@JMljx z{+Go66t|xS*W;{x_;})fOZ;z%|1I%9CjQsN|C;z;6aQ=Ce@*Oc*z;^=5?tNOxPaj{g{tiDjHtUprzobrA{+nD?R z;urP*#?NZMq-Q&;dzjER5=@G-`Wy+0`qgcF_9MZva!qI((~*+Wt$wDI;>+#JO=YZu&kTkcYS?{9u@ z{a1ct)a~EXr?mwO-}$z zcvG@W+!1YWA3u?uo;`7Va%BGHkxwCG{v+_W;kx~g9Kj=pEn*)`vd#Xm&2du<2mIwMKmQ@ z4wls9%i@$%HB-tZrzj4ZsA3WE%d{aYHs&W05Bx6Kd zNs2q}Y4H`Ik_cWYeIPzUEA=tsOA(si&&d`@jDm(yjLE}Ywg2= zPk)c#<91A~`$th6i(2^pGeiGTm#}1uKCX4YqvJJg*1D_W54v?(NhRz}?v*=Zb z^jeG!;`gDKHXzm|`6lNdtu<{|Pim6es*f!V45Rw1X|Ec*pvPMYZt31PTn87$*L6HD z$IFYS|D5FisJ8ch;t$;Q`FQV3m9Kwcqj+oeYH@qDvT4aLpIOFOx9GFsx-wK}&tJEz=fZExuuJ3pS! zTlV|S3`~ZF_<0sr^K@ma=`()Z%iYiOwV&Mm(m(3;{*=o4Wo_r3mRU`trFFOUnbUqn zcTjO{aZPzFSi2q4ma&L}#SapEJ@~xwc-kM>hyMN_H**;1UmmINoaB8&+p^lrtnRF+ z4tGg+G@?$?OopfnwV8ui_E{aZF4H<|>#D8ewvIaEx>=ij_;UO5c=^`#PAgwDZ^%l5 z$yrjGbkl>(XNZO_PSqRYE|{`+MoIh-gvpE zxbKF3?LU0mb>qIf_HjGsTao4eV*{4|ul;Yo{NH?xmj91G-tza!kF$;bur2@L*Z%x* zv;2Pw-nW{uV6A%~^x5|v+`yst?Zz9%57st%-=*Id@#XM|@p#%F*oVIL`SW}{r~IZ! zQ&JSOiSBxLX);aUW=l`Nt9;*&-`TKOQJU(uDWcmMu zTDQ+?Nx$@|p?9QrmTb`{sqByG_$duJHfY%(wi;Yjd99O;8$v-~bLBR(h24)ZTWDLM z6gm+eF?oE8|EGWamz_rZGZ>-?`53Fj@5MAF7JcLi+fd=^M)&(eHF<_2lgGDgE0>i$ zL;YC%Ai-;h&l``Y{egYxum7||n$3O9`DLyr8`ezMW?b7hO)sa;8S4Y0xsMHN<|k0y z`ddBFkoNh1^Xm_^@}A1!hqP}_&wd|ftl$KR4ZMZ@FJfxBL%vpwULDgmvl|ElVqI#yeBV~8tFI5KmTM1c zBob4$&O#o*GoM8z%!O-KaBc*@|*}ytL`?SmZV~llG|`= zN@vsT9YiHZxme z*GuE;ug#ykF}9sOQmQPKuas8gfiG`dEzgZ#nw{UcuvN>QELKmQo}RBUwU8=t!N>ha49XQ!4YZk(*dPQ9{T)+LwbE{so2AK9qLLo#>r+VrjM(>cW{D$Iot#pSybM#N1 z+%C^uers*&`dVgY<6N#bxq4}S;pXj^&rU2~Iy;rWm^n2&SsS~&`1)(-stdJ=<&4YIQOg-x$SD7$o=?2HJt@2B zcyKm|96%SGWn|NNvzGpYoJ;q$9oBhW@oBr2ugn7P(K3Ns_rz%Bs!n;EMK^)J131h1;Uol=5X{kB(_gq9nQN!E5Te z&jmM>vaQbKh%1L(>x%YPbk3UoOx9I>&gqOx>N4gPzaS|!xeiV$PgT$Ev^t4-UB#|= zM^Cq^;bBA1`AwC0NmsF%z_s92rCbgcblkd-30?Q3&Ux}xuc(wZ=&UHG-OB|hYg%V* zC?#^6%}LHRmEe~0otA^?jykw0UHPQ8*L5eatE8uOpJV#G5xlIsSx~#Y;o9M* zDaEhp?#}A$JF2HerJ9%bq^`UmuBzlWl<&Omts1zQR#4>rT9sje=o4qn%@ zJEtoxD8+J~cEkR%_u|Myec_8r$K z{C-2c&An|dFe{n^%2pyC&fU#wH{0IU4Qw7Ctzy{x-G+W!e=vi#%CgP%|_jZHs7pcmdfZcvrOh*yEa|EI=gyuv2=d?(!%P?wej3b=P$3m z^6Hs$XR0@r%k%RuU%S3^W9;_X%Ex5IJndT5vo_t+X6oAi2+}_$wMb&uD--qXFQC>we}nIK36FE%ZS-u<%)gc&eqyhJOA z<_WP^plsQ~d?@zjq5aJU8r~iRGheA-?<;&;C&o6JSy?$x^+RLw8dvi6vzE)b?I3usax?OnYfBu!f zCiG~MT%dpWR?z|azNi+W9;!0(`9DGUVT#)Uz zu8!Mgi0R-BDX`gi*VV1td@=agUgfwiSr+zlpr*OsWB>1olQx?VVS)6I>s5{qa-i-v zliwPsr|noRjjFL!+zj^z;6P1=mH%H4E8Z-5^6WR#t;cQlyDmuqWW_9{iRLTszcHY6Br)@pNH^ITYtC3W2PvbYTk`@aNkgNk+E zCe_}{v)8=+Tc{?-=D;R@NmA{aw#GG~GwdDIWqsNaTkV$B>~Gbrdwtlx)T-~xo29?} zxGua>{B75@`?WA1w{w2=xuFJKxEcC$+We>!d(S@Jh5NV5-~aBp&NrvSle_iDy|Wht z?`RA$r|DsxUloT%3%<#C`g&^U*yGm9QmRV}X_$wWX1%#Bk6U;-*46h(w{Zy8G-Z8}?}v^{%G$SieRKeQJUqL=>d%{p6W zoY1j&d&#NL-_T}GNn4hf)Ti0)W@FpyJ+@~SxV>s^7PwjJ)}gDcFuqK?oj``k!5XN+z;|ALH2d9dD+{xCS()nk@t1p zTfy)Anp9fbVdZO!PunerLlU5ngYQC1v!3-()AoYkl~}jD&~(W`A;uc<4vcbraJT%M z%INCzht@5Rs(}vHcf3oFR?G&6Q2XLmy!m^zjHe&C8~-#fbEow(xB92NXyIPkA-E6S zgI7}OaFl)&hA;;Uum&5j30v?U?7|*A^z}%78fIV!^RNo*a0j+v8+PD*82n5mKLwA% z5awV3)?foR;V$gJF6_ZW)+Z^XVFoV10<6M1+<`6FhI_CFwbpd>1xh3*LiW*n`2Js}!R(=ZEjumEeY z0h_P|@4+tY!9zCXP)NfJ3}GHtVIA(k7Hq=~yblBGm=sd*C=6i^7GMoFU=!}b4(!4n zJTwwrCk-=j0Ty5t*5M9p!8Y83J*e;7xR8QJVF+_@1=e8$HsLPpz%J~=RP+tqAPqBc z0Ty5tz6+bM1>0~B_Mo?ThOvAyFoZd{0_(5=@4`0hz%J~=6!vl&W?>E%U=_X#o3I7% z!7l7US#>T9!wd{z9#&x;HsD>@h8=hx%2te?H%!AU%)tVz!3J!?7Q6?$um=xKM%PKh z3=Cl&R$(3Pz!q%74!jR#2}kzBySjIU!_-CO!Vutic9s!ZzH4J*Zc>T}Z<$%)tVz!yVXyZPumJ0D2ex1vc3~f;mXHfWn1@wZhfTN( zJFpA2=;OjL%)k&9U=2246Sm_IJZxR8cfn1cmahdZzZ+pr7!Fm)BVFobzng>~43 zyRZYh(7kCVk;5yI+zbq10oGsxHenm?!5-8Sj|*v-g*jM&b+`jtunoJg4^!8W3qzQP zRal2jxC=Y53-z*{3&Su2Ls)<{*nmyghI_CFwV>!i8fIY*7GNFjz!q%7F6_h9I&xtM z^RNo*unBiz2X>)eG<0DYW?%>lum&5j3EOZF_Ml$Lb0H10Fb4~;4tHP+wqY0cVXBH; z7{WZP!a8iiUD$zLs5j(Y7={@b!UC+p25iDM+=D%+rDPY(+<`6FhF#c) zsawc}A28OTzYp?;EunqTM4+d{jPMC!`Sb%l716!~S zyRZ*a?;sb3Fb}J+4x4Znc3>9<-{JmY28M72*5M9p!8W`PgI`1*OhwTLuQ%H8n9=r0 zea-8OD%+>D*-J|^V!Zr^lx88GZt-Weebm>y;&T6}T`yymqmbN3R1g07eNNFKZDUdL zf$PVgAFoe~AEdn{&*P)Lb{VhtT zv@5HDc>5XDGdn&QPukV{>tnEf2J2}s{h<1ov6B>%=MmL|ug}CzjOruaE|PZj{&w=T z^^=T)kJjTs`uR+BTGC%p4@rOZXgjhLUoT02_3_kC(qBDVk4b;^em#2{y-V6v(ypuq z;&#+v|DCj}gV)bTt+&L!O8nG62z^Z2Rno3L3GHfFg|I%-eiPe%_U(FL|6yJ2k@4q) z{6AlijAyhZ|J`%+qSZmi@1*{d_Lt~i(*Gp=Z!-QQ<8NYrB=%QgeKGXIFrACmdk zliyQK=AX&@JMljx{+Go6l=z?IhJ3_-x!*ca;(ts0Z;Agc@xLYhx5WRJ_}>!$TjGC9 z{BMc>E%Co4{x_RNJ$#=v@joX1$0z+xK;nN*{I7}sHSxbD{@29+YIZ~1eoFkWRx6Lz zOX7b{{LhL1Iq^Ry{^!L1ocNy;|8wGhPW;b_|2gqL$LCLp|26TyCjQs`f2TI_KPUd@ z#Q&W5pA-Lc;(vaepEdD6JNNS=e)+`zocNy;|8wGhPW;b_|2gqLC;sQe|D5=r6aRDK ze@^_*(R|6z8x#L~;(t&4?}`6?zu)Ih)*q7fhh+UBS${~@ACmQlWc}gM_uRc59iLYu z>krBLL$dzx!&`s&syZv1+ivOC-`CtPz;6d5?pNH)ZUP+FS3eIPcSj%9bANn4JJ}!4 z>~sEp{lv#z&M)fv_W!Am>3@BZ^kzi6R1x4)@^}otbxuY}M%P42joii3>m0D7oFSjp`m%pssQ_4T9oJ*285=`jK ztWr(>gwCGQ-mJK+R7;!E@g>D(wLh+MS&k)@^kFbN`jWPN?saslxL#c=Z*LY$*H<^L z65Se|n4X=?j8-=*+m%vfZFG5cZM(cV5@p^REv~IyaOZ8g3+;X3)L;3P-xziK_w;FP z!9u0@+keT@TWclPBk=MrJefV{lc@ibS8k{mjt!bQz!g zd8HN?D>t`aTwE(|Tz7fS==g%R!-|EX4X76U1M~C`uAyU}*7mMt8VGj>_HDN{5V!pP z`0#6g{`l{`{^{VS;C-LZs$?Ma+0Vt&2eP=`c=^7jRCk|hCY9i3upPXpy)`w+4gKd7 z5AW*`g5osAv`c0D-oT6tDZ*y;a{x5pvvAq7A_x1^vN3DBUt=ng{q+j~f&^uBTOSY)B z+(DHuRc;kGN@eTbMt@AlPN@alQc1VeCRT&1D(|*h$YziZa*o?dSyMjKm^K=*`w=vv zEm;;i5rRVlE!lM!#Q*6Z|7E8U{|vg$LFeQ-?pY;%Z$OTTjzu4N!q$Ra-ROR|gR1WT z#b8u_HSJY{7xa`Xsu$Cbl4>W4uj_ccrT7*ZPyac||50u4{lp*W^Fes;OO>yGVWW6! z^=ff@wX$()>D18MuBcv)mCF(`oMQ2V1b=;>Hy%&>1N+cl|8Ya&K%05w{&SLNnmDa` z%Bb~EsA3Ql{*|RCMaPWN7Wb8Jxfb;|q4SHn)`-qA z%^KI9U31dOw>&m<+Tge-PU?zF%44!;^fzgB>u=SKHLeW|4F3c7>c+9p|C?Wbpq2M@ zpRSFH*NR_p>0UW~T!(_8XNP_t6|_hBv)cAk!L`cO)s17Du5!)x~j(cRlAP1!#XEr`=SN^_&xnSH+0N;i+3&4K)BC-A7-rJ z1c?of68{%5wcH`S6{ArZ*sL!=v zE_hxIU|zE0*YoufPd~8wKKo(Rw|C5|b8etcY}a4kC+`;@Ebp_*yrMf@*B!?5r@f$k z=;b`Ey4!$Sl8Qx2Zo{o9Wkw2S>bR@{(e{c;i3Ve{Xl+1TQrfH((-hxgzTCb%IhEJC zlakIim0p(8&MKb`yk+g%Aa3&Qd{c58Zllg%+U-So%pkC96yJCE))YUiE}DS9(R*?i z;8ow#&iVDv4&D8%)KR0bUDnjZcL7f22d5dMmEz6qmGRM~@^bO!+V<$Ju~AE?Y_8rZ zA1ke`mN&MqtS-%ED#fv>&CJ%=_0stIYxC!BjBRI+lqyT*E2S0L;pL61<+<@ov-2Al zwraVP#p{OsoVxvQscT$??6=g#Kh zxtZycD+|-Bmv3A>U#-4UymM`1{MD5so8_g|&2nk`%FWHyId}WdPaIbdr++rn8t7`3 zqTE~6%Engt|6}i6pyNu?`@W0S&Mx;Uto6dK*1OHo3`Ok@293t6F&4xoL4W{B5Y5-H zIV&x@(cJ)=1R71C0XDg_Qp+cacx>%S=j7-Zwvts#v0_@*CRjz05Jyp3@>-_kbq?Z4 zHsZ)mAA5Zc<>(}E^f2~B(&YcI`WMl>=qADEaAt3j7r$F|>(;%uZau#G>Z{wAiq{L- zAwJlFrDCd>9lCgJuJ6iRcp!f&Uh2(V7#&-_J~GiWePN<6aXvgg*jwtpICbXqslr&P zXZpnX#px?c(`Tp8&t+DwE$8z6Zwwq*N-rQqZ24T~5uFAh9+E{y#gm4{GK7CE@PLuko87WMmqS@|fM;cl{72{}P7L~6H)ii4= z-7?}A;a@?e?YbL-=jOZ{h;s-j&0#-_+$?&Ru$Ms-9Y*RYoY9APVMt-!7@4Gz?!0#z zP4_A9Dng3r&kvaU;I%GcZx-jw;UCkQ!QUaAaRCj(DEw!UN(pl8Fya*O?oOc58pTz3 z#T$6L1#}O2yyw^P3>jR7BZ14_afDp-#&DcXNDr<%jC1aP)l0Zbb~>|&$!9rh((1=q zd4yOQatP^M#vQC6-U;sr?tsJgWrQw!XYeFvaHl8moZa|))f>UnjG77Ez zIQ*CKbQ3uH2J&eNp;Rsmmin{YC8nj^xtKvFQ!Fr!R(ShyX$Fa5S*Yq6z z{BT`7RaYDfP|4K|cEYzacBj-%*?!6#r+`6WgX4F0{V9|h3Ir5FTBXlXK?dnE4#x$Z z*rNzyMHHUTFsnr4c!gJ@5YuPwr`w!6g?ngpL0|rS_vL(7fB*N^n~vCi{Ka1};f{^s z+E2Z|t@3^=uCdpxU~|RVC#iHDqGU33`f`7EW-vEAm7a`T7|V^6BJrb>7jwsspFDN4 zaCJI6Iy!RsO6F?!^@)WiB*lCJ_jDFbkZoRft7xpKauh{)35_|`d?_?n8SlLu?qOqf z-F^&l#f|W4Y@?W#$bIHnyTpz!x227^@-t#t;Z8hpTvPZy+*6}#NY(`Vt2alY=KY`( zc^JhFg$~;Z4WYYWN1R1RIf%x57`c^3mr2244E_;xBN22&M-g@r{$uDoPojf4iQK&LK7A`d9aQAIq3l26?f#UiSWS;MF- zrhBJ}GmokXi6SpJ*G5eT)sqw{s0p!C5EO8%aKYntk5dKITu>QGWn~8OTh9ejufa5W zan6(xUN|h7#y&M6oOk5>Bd^?z7N2U-X@qjxf;tqgKH|SY58c~cM=@rWn-rhBRT3to ztGI9_o9}YN_(NtmevV;7;mE7G%&S+=O%I=rPaT`dERJ5hI2oCoUYa{|VgB;SvCFUL z67zHEsr*T39p-uAf#3NFGY821+t@U^^*;UOKQP_0V`I1c8!xo|8oMlLQCL;{%A1C% zTL1Lr?81E3`*xgj7MU`ShMObAkarG6l``HH(}2w2_&1Pn9ov5FZ-T7$bgnu&x@uLy zu}4v$hV;CL{`AN&NAoc;sqm7I75VRo=BDtc&FzT(`+JZAm2-a0M)FGy`Be1fQWpx# zf*IlNNB?~U-Ad4{u!!!p8@qpZ;VbkFURUm1kl!D22U^gT-)7B!L;G^KJ#g{k zNbelHy7soJm;rgXsf6Rr=UNC&GkAyYa4$P?rco%wLro7R65+hSr0*W_m6`-?@cuC zB{lVh$7t%EWE)ajoM>p1nI)VaryKD#_1g;PJRP0mLHWxrKkeZMHuZlM@l1X~_G&f~ zdbFm#u_IW5`j)Z>i)AEg#H4Rp6G?v6O>@^6Xz z^d8)M@n3%y@xs`i_mRZIO8k6I6lauy#~Vr9zX^UcYrL=HzCzgU=UjPt)FyZk4Pw7( z?%4Eku8<8TC1W;`oTcO*&4ehaGmM4_GzUoG9~;aR&fBffjpL?Y!bYVerzLvvmvTF0 zY?}9Qj}ka70V#n~Ql~7=hMM=mkO5quT?9>r8XcR0C(#x%&DY-ih5I(kt~qw(Ie-3h zZQDO*C2LBvPt!1vMxmpSw>c-oVPoe#jrWrG^`FIn0NZ}VtAURyfydgA0Gv}W+?1bT zY+3hJx#xMue9iJ$)dYJ;(;#Wk@eZish8@B3`}?czZ(CdS32SQ0B@Ra_T0#Jad8?qiz- z7ZStbn3xm`Vp&`j*TkB*DQ=0-u^HDc9u#9@T$~llVnwWq>*9u37q`Xs1NJ&0F)WUW zNwFZ_6szKzSQ9tJEz$dan|_BF7Gq*uoE6JrMZ6`}#0{}7Zj0>)^&DbUjEhOJAl?+K z;+l9{tczQs_XBzkF)YT!gjf*EVnw_q*2E3*j_6Ud2iGo!#Hbh-lVVA%h*fb-ye-zn zEpZ=*9B?5qEXKrySP;wNs<6F0=VxGlCzUJi*-F)k*>f_PJ` zifiI+u`X_jkm`)<5W`|jOo#=sELOx@Volr-?}(5N?fVu(VpNQaNwFkW#HzR^-WKcP zmbkCiUMD1m#h9273u0MZ71zX?xFOyVAqm^(5D$tmF)k*>l2{R|;<~sY*2OJxU%#G1 z42xr8QY?sNaaCLsYhqp87TX7uz8Dh|VnHm6RdHS15bL5FzjkOG8x~_?QY?uTu`1TY zO>s-aIK#M*7!~7UQY?$B;+j|!>*BW9{+iMiV`4%qh-I-Vu8SLDUG)BnO|L@?i!m`N zmc)u!6>H+AxFvc&sQVP7Vq8p$WpPzp6Ki5!+!ot8E`tk+F)<+)#Ijfw*ToI7E_y#? z)9Vn!VoXemC9xt_#hSP&Zi$!;H7+DZ#kiOh%i^lICf3BdxGlEFl&%;P6JkLui&b%5 z+z{&`jLD4a5W`|jOo}D3B38wkxG8Rlm^F(xL& zf>;)-;<~sY)*iRVOA%?}6m=sH5MXZW7aZ}t9VXI+WNQ{bcF)5bCRdG$M ziFI*XY#&#;VoXek1+gqv#dUE*tc$Q7F|I=li!m`Nmc)u!6>H+AxFy2O(YTNp72{%3 zEQ_n+nphL-;XDz1wgVqJuNgmE2WSd58Du_RW+s#p^@ z#Vrw5OvZ)8s2CTMVp&`j*TkAw7q`XsGfG#Ci3zbFmc^>LE^df*5$ZnUI>fLT6O&>| ztcX>yCT@ybA|~^V3yD!NE+)mYxGJuRHL)&ki|yx?t{4*&VnHm6RdHS15bGk$%Z=+0 z!(vQKiY2ikR>hjQDQ<~I$%vFg7i{`bF)k*>vbZX)i8Zk+n_ftai3zbFmc^>L zE^df*5jJ$jb%M3`_J7ZRglTuh2(aaCLsYhqp87TZ6kbj6sM z5DQ{itcvU6hFBN9AGYarh+#1%CdHCi5vyWN+!VJ&tem&cFGj_pSSd58Du_RW+s#p^@#VyfG>ORG&7#EXbSzHy@ z#F|(ax5f69XIw~(i3zbFmc^>LE^df*5%WOCb%M9eGM`xK*M zTuh2(aaCLsYhqp87TYsQSB!}Xu^^Vks<K`e_^ab4UH>mrQpjO!4? zVoXemC9xt_#hSP&Zi&v)G&E<^kBV_IDVD`maZRj=b#Ys4pV#w?F)<+)#Ijfw*ToI7 zF2ZiuKED_iV`5S)i50Ob*2GP5ON2?DaUn4(#>J#q7FWeJu_o5VZLz(ebj6sM5DQ{i ztcvU6hFBM2A#YrV7#3qs-aRI+g)F)GHzq*xYL#Wk@e*2QhHeM#wx zF)<+)#Ijfw*ToI7E@B$kxDGKa#>Avp5-Va=tcjcAmWZWn#)ZVF7#EXbSzHy@#F|(a zx5f4qr7On7gjf*EVpUuhH^jOK%X#BE#IP6>lVVA%h*hyBZi-tXtmcgiiBT~wCdIP2 zDz1q&u`X_l?bnsA7!wm>K`e_^ab4UH>mrt58rLC)#h92BOJYT=iZyXl+!DPn=sv}$ z7#EXbSzHy@#F|(ax5f51m97{Q6JkLui&b%5+z{)c_eDLw7#3sVtXLLT#Wk@e-VwbY zReEB(_1?8xVD}it_Pm;TeH8chZP;kEGywYVe;>l={NeP!7u(~SdHK_Qr(G}1%z+D@ z!{&o~e;8`+N<5=h#@Xtg7)gkrUI&c$gBl%5ie)jE( z$B%#pKf3Pke;=g(`Y`hFJ=pk>NIL)dt@@!L|AX=u)W4wp3EJPF{|WlvK>i5iuR#6` zsRrY(VEh@3zXSb4pnnPUPl5g|&_DX+r$GN|)Y7~3(t-Xt&_4(I z=Rp4)=$`}qbD)0?^v{9*InX}``sYCZ>>ob``sYCZe82BR1p4r@--r@--|cwOjhln{hhY98n12Z7A6orBLoojm%)bQlFTwoF zJ8k~ulMr(#+brSh?{nr0@I|lFe8oI#1fW)OV8n_?yS^v$AUVk$54Skq$y@&GKI!}X zD6Y@nQ}4#FzVlxE*K_yTqx+14?El?;)4$`k4(;sUyXVq%p?-hJ9cV$9AD_nY@4+@( zEEbkt>*^{k6<(c7O{EtW3$LaZ=6BtH9C2U5Hi$dU;G6yfc(++RZKv0Vur#(#uNO>v zDeR^2tMYy3=m7S@h?z3ybbC>RrV-}u+ue^#e;Tp-5PuLcGf1)1>%o~(gfjgeoZW}L zL2w$O4C}-3419ywkKn!-BZE8LacoB~U~BQLT}!F?!d$kvm`Y#Cgwqq>4mwj>D*i~yVz+XFLkBn=FXb)mdu4VKRo`WpZIE**}sjyEDLlCso(zV4EK}A ze#HAg0{HmE3o#Z2-sa^$`@=6Y`lr76)?07F-~NKV0g5_;HGz=h~-) z{A9)CCBr&S|6ZKC4;R<(54i&^=ZNf`5B_ElgO#UM`aL+-jq1c|IBinxGgs>|=`$r({uGX}RmCsAQaMZ@9|CxGW!ZF8nPy=jSn$?(aqEc2ODhFJEZe zM15f}y)3znRX)A2lFFyEY~H#)fn#UAg6Wu+@ORM*d2z!co@oxgPHac9zl0w$VaZ7$ zPR9FAq|Z9JALs7_c?~+3i;nJXRdB3X?Wpl2xD5+$Uz>IS*7cCukMwUuOzp^s6@}mO zu_k{9e>1PaH6&|7{rAVxZ1M^9qKN!hLhb0nzY_Ke-m7@G3*HKzJ&(Pt{PQ^OPscs4 zKl~M>|Cg}6^<95quCG6Defz?TAI_&%axwO0I`Y~*irj{`$La24u@i&hB1w6rm zDT{N6L&tL4hAm7F9Q`|P>yY!ucLL3x%LfW!8}TVKYqw1)PgRZX5v;u zdvrHl7oYddR=yuk7REM>me{t!(`Z@Qwo>%z$J@ zyKjH`(`cdl5ig2ZVUubaSL#C;(`PR-pi~Fo??jwIg!FbT0cG-LqD3tXcDZ$DHMP z+hUkEEXPN6&HH!%*!$xYe!fRcDj!Ndx@P~5%O|DPkgN&u-{0pEYVrxiw^{Q}F^GZz zJ3!amvw2@?$fu$&m%30H7Lbcsr0u_+%NKum&<%XV3%UWT8DN=xP`AV8oAJWf=;+^z zbLGy(_4`BaKnuF^+pM{6XkT`f`#92Lb3KiELvcBbCNhHkPBfNT_*`>MA-NMzGl*DO z9i2v4uZbVU5jOVWmg#d`%!Zz$-EO7YW3I>Mnpb7R&89qR8g6z3Q;6A*e;g-g&9x)D zn(K#cOPPJY`xlYF*{liw%K!Z()3m!L-1&LVPrcAqQ4`Lwz!0`QHsNmAeea+g=YJgA z{hRe>a=hogiRQheroQkPO?|uC;Em+)RYGKk^%-jB^S1-GzIciY0N zi(8@_QMvcxzy2)Zg|R*FlK+F6O8;}wkK&9{@OYB{{hQ!NQ&4^#_Z7l+Kj+HJqc*`D zcd>+Wqj1xSe4rG~#<&;FZUjfHt|Wq(R9~h+O4TVGp*+k6cA#Yw%;uD;&x}cxD#(6w z9jlDAk}(yOS)^jGIS3zP^D0!F@(TU;WWkea3z_K3N8h|}v+SBO4(dDfQ%|khkYd0bNA)H8$Q>m&#jmj#=|G?}yj9aQTye>wZ0%%PL2n(=ZreZF|@b z^m!bN98?eW1HoV<&`Dv4_pPpzay`-gdqOq_&7JF+-BG_k&*(tsI^P@hE2(lo-U&6-Bq?03=gxTKBl=waJZX5T;C_`-kDtO+0Z zkALT<8SVxn&d+li1|t}gJknsKuXiAFcZLvYyi*1vulkz$cj{oI4+V_^RWKNNHq#Kn zVC3PfB{&4&;DgN^hZ!7hIJ=2ngj%}>D(a_9v&rVs4lk@71Dn`xl<`(gFq=^hFQyRB zs_I!E=wlPiNr7qXagx?H@tm|}BW)XQ-W&B*Pi8RUZwuMP{x@f8_idJ4bL_}-8U`a& ztv`zJf6uMl$8h6W4Mz5QKYaYZm`VPZ_v^`ARypz<8IpVw<2P!bq*>yTCuKZru_}ksXFO3T4R;$U;oShiK!9)vuGLz#BnNW$AaSD_SFcV_wIeV z`{TgK~~#1{&;08=ln|M1JV^zjC)$-o|sf znT^Y-?=j)7Rysekx9z=cf2JzPSLq)UHeOxE5~Z?sqMT1YJyXCqyi>~v~*uGqEG-Nk@~ z#oUeTq4ZoXn=f9<0tw@7cS*)Occ)N55K;gIUVV{eEjgmv5CIvo~y$PzEdyFXK~5Q(Ah{| z|AG7hY)yxTFZZt$PaL_?+qXQtd?tM+e&SU3iK`+{Wni;=(d2r&!jm4=` z1O3CZWBs{{S7#;*g=483m-CV1vj-NlncQMFUA(lsm>V*W|8mb^v~c)Oll_Kv5Fv=Y zR9MI_WiJ)47qUZqumelQR53er@!DM9mAUXh{#3lwo4YVNwtRhLqG$TTL|@{3czm$8 z)O~U4%;{5wu~N_UiSvuoSC*#FPM@F4tXx~p<@?_lIIxsnK#JJ%xy;LvaCSbGn*(7T z54-s6cjNu|o7-W?MTfl!&zjPnHIfkxBPlKYArx+Ruq0fnno759X2`lAS9T-R#h_Ga4N(uF%F-w`i`*=Fm#~*X6CFkqPK`ky;)NlP zcEh%f2H*4EX*AuZysHQ)qA@vu&;@g?OW2#mIdk~Ov}W*k2xnYC!!Qc}S)@{e5#})B z6!7j&pwSw|xxC^Hyxju2hdkc%>v)C?uELSPW$!pbE_!1)&L*S>*B!<=_rK~TV^hX_ z;GGTO%1o;tXXO!M4UmVB&SiwH;3-bPRQCoN%066q7~2^<$r;?~2|Q;v{$BM)@HAs6 zmsd?WTts@O5Hb$`Wjx&k&c1*-hqf$21bPa`4M|=ELeRZMS)UgK8VcrcJ|ZJ}*~LT|#=-;paPXZ|r~> zXIOpT5bpIF-drEv^Bmsz0M0vwJSZVwa(IWMc%o&bFoLJ0ozMmIMiO{uVdMixSS94u zMdZO5yt`Al(ilP*^MvX4r;+Xwd}pzp#}zWj`D;j#2GafB8@L|thIeM~(K3(Y8T0g9 z`7@6ki2(lkh-__s$z4fLewjY1-S4_BL zqqz1{?{BNXK#NKf_PP~pu2}mdm99gSOomQh?$6E)=7y)zlaUK!xsg&NesuC;?%45@ zr%o2GPG?6)M=oEpfsnIngYl8jNnfHSK=DHbw_?}0)!73-b`Cye(u*%7{R&n4ZY*Ca7F50H1gX&3&6jX&$WZ{G+1rTf2 z&Z!6PajJlt3o1jYtjr*O>qX_%YcLH?H_+Ig)3CHZv6>JrVCPy^Ub!3M3pFjy`h_|a zuBzp~L1TYx@7zwZ&BEjQxZNrV6Vg>&xRT9xxncYvGaNt1u%U3|)m-M)tLLVNPsgW@ z&14owFJ7FCOinM&ow+c7dF0sT*K>*ax%5>2B(x6myzap7{DfId&i&iiG`jUZ{pCL} z-Lhk2w=6?NcFXK7{K}h#RSoZ$Ra1xl^vEzr^D!~0dxdSceo~zlsS3~>Ka+GOjd}*#2F%7w0 zA;m9^u=(fgGP?wlqgIY_t${z4+8p(=3*d(b+@ z2AX4FrqAzf5+C*Mz(8gSfdc=VzA7 zP?1eI1^sWORZ}Crrv9C3s2Hr8dbZz72n-b;&QNg>4I)hsr%ltxxk5IWl#JN~bC!~O zG!vqvZl!W-4#4jWu)$2B$=t2bbxkmplAM<4#b3(pl(FrX378h;cgo^ZxCegG#;O$g zZ2^W1n5LLU3t_f~cO4apPogbkg0H>#3-@i7U32WnbN>A2+O~hrD!iy4dK5#&y?$Zp zL57N7|5*$OuhA9rG#-7>V%9Dc(8g72{&Ve&*;y2O_dN-&UGqyIPF(PZ z?^$8=K7AG^1j!yEX#%9X9WwClh~~v3sGS7>?w}YG<6=@Qi50Obu8FtBy0|6od(oyJ z62oFlOo#=sEUt=cVolr-?}*;_+4S4RgJMjKi%GF0R>Z2fE^df*aZB7su@EjKhQ%>4 zDHg=CxGJuRHE~ni5;56jT)TKsjEQk^RxFDZu_~^M8)9AD7TXWl>x9IxI3^~=f_PJ` zifdv`+!VJ&@B3}~9b#CFiE(jOEQ=NKmRJ)v#JadGwjb1Uh*2>vCdGnyQ>=<>;%%`m zZi(Ix=sCo&7!wm>K`e_E@s?NZ2fE^df*aa(M+AAIyeVptp#lVU-< zDOSZbu_kVcTcVSAIwbjo#h4fuXT`Eu5pRh#aYL+&+hV)q<&YQ^<6=@Qh&RQmxF+5f z>*AIOsm{0#F)YT!gjf*EVnw_q*2E3*jtGg;zHc!kM#Z?86iZ@7tcq*mZLuzHiTir( zbwXlTjEM=cAeO~daZRj=8{!=ilCXUa@t_zJ<6=@Qi50Obu8SLDUEC7)X~|DW42xr8 zQY?sNaaCLsYhqp87TX7uPhw0=hy}4MR>gI3L#&G!c^KCrhQ*ke6iZ@7tco>pQ`{0U z7BMa)M#Z?86wBhOxF*)by0|U2zovA>n3xa?Vp*(;>*9u37rnn?)9Vn!VoXemC9xt_ z#hSP&Zi(Ix>ORG&7#EXbSzHy@#F|(ax5ajj%iuy{OiYLcu`E`_b#X(ii{1~}^g6__ z7!#9XNvw!fu_kVcTOz*sXk18)ig7V1mc> z7?T;-A%?}6m=sH5MXZW7aZ}t9VM1qINQ{bcF)5bCRdG$MiFI*XY#&y-VoXek1+gqv z#dUE*tc$QCFs?%ki!m`Nmc)u!6>H+AxFx~@!MKnZ72{%3EQ_n+nphL-;_bRE&#Bu`I5N zYhq2Ti`!!RNu?{s#DrK7%VJer7dOPZ2-_IrI>fLT6O&>|tcX>yCT@ybA}n%@3yD!N zE+)mYxGJuRHL)&ki|vz2SB!}Xu^^Vks< zlVVA%h*hyBZi-u?Q8FUs&;^@*RE&#Bu`I5NYhq2Ti`!y*!loAzV`4%qh-I-Vu8SLD zU4#vtaUEh?}u%A9b#CFiAk{}R>Z1U6F0>z5i95I^NUe2E+)mYxGJuRHL)&ki|wCR zx?)UBhy}4MR>gI3L#&Hf2w+@?7#3qs-~lDbbZD#pd6SQb~sHL)hv z#ci=YVpxocNwFkW#Hv^mH^nUxlN`o{ z#Hbh-lVVw171zX?SQod&_8Fxs#>9kJ5X)j!To*UQx`?GU#&w8cF(xL(l2{R|Volr> zw?s_w7#9+wVq8p$WpPzp6Ki5!+!os}D_t=rCd7hR7OUdAxFOa>SVX zDz1wgVqL^EuyGw?Sd58Du_RW+s#p^@#Vrv_*^CQ`Q86wi#j?06u8B3VE^dqMD@s?4 zi3zbFmc^>LE^df*5sU7O>kz|YOiYR;u_9K*nz$)$iCCp!Tu6+HaWN^D#Z_@ltci7T zTWr6sbj6sM5DQ{itcvU6hFBM|1k<<*9u37rig)`Ngmp6KBP;xGJuRHSvz<{ixCt+pYJm zc_X{WFt+FQG_zwqXm()xG(`a@+1 zd{94v`VrKR)<4%7)Q_Nk1ob1RAAb3P{=JL`f^pQna>ritEogUxb~k8ugLXG)cWwLW z&j+Wk+iN)E?WMm8+si%i@p8})+Kg>{Z^8T6`Mig}9PhQf2IVR!SIhx_`Dv_YJl^Qv zOT7!q6?5(3^X*~#j}Bdf-^Au;->!I5-hx-!^*)`xvekR}Fw%JsHh#yMZm;DbxW0YI zLH-BjFQ|V(`xCUkLH`r;868f&3ZB-@*7J7=H!h&tUu==pO?8i(h_f z)IYL(IDepj3iMAb3xWPE(7y%xw?O|E=-&eUTcCdn^lyIoG0?vS`nUV7%MA37f&MYj zKL+~8K>rx%9|Qekpnvqsk51p{4-fQ@f&MYjKL+~OK>r-*p9B4KpnneZ&w>6q&_4(I zXa6`M&_4(I=Rp75`n!mM{yosY2m1Fw{~qYy1O0oTe-HHUe)&1jzq3~CE*HW4Loojk z%s&M455fFHF#izDKLqm+!Tduo{}9YS1oIF6@l!DW5X?UW^AExNL-75-=6aN1{wbJ$ z3g(}J`KMt1DVTq1re_c4ADZ`@!Tduo{}9YS1oIEU{KMNb|L{pP%hc^G;p^{n<_qve zuhV?RJ!=~5R(ha_ZO(Un=lwx?B6mF8;`~O1eH)pPdfKBFM@ zAMU>C-*H=qcJ}YxbLqNJzdz&-w4lq6PviLaV4E!#3rnwcb(NM1ug;~W(hG})SJMmg zyY4@ZxG!NF#2shwP5%MB+bo{8)9XW68e6B=3#Ppk_EPv&`95=W0DED?Oqp}Ky(mJ{ z2y^%C?#HD+jo5vNKZuwaq}b{8;LIpOnSKw>?!(?7IE_$-_2GC1zCr9qa9@m(!JY0n zj-xJMYw@gIOR4$7T(-EFN?*z4XXIV#>ggZs4R;k57m5q%g}JWj+*~oc*l8m#b*1L! z&YJU<%!M{TJpQGh_-dEgzm2~v3v>&q-~Q_i_mjtd#QQ)3`1HgJF%|{h=IQ^u{ckh+ zr@r~tTW`YO{(|SdjA5d?eaGc;s+z=jh1cNN4ZxXkX`Gc(l8-r+c_N(mxRG z8SFdqMMQ-AnD^cgk~aJL^V{!f`x-9efMrv@k8uq!n*5GG+cl`f&xPE`g9cV#! zAMQNok0U-SVjqfn1ciP8MZX^vgB7tCg@3?QiYXjpl^MjpFhV;~C9()(1&m;iRhJbs zbN9Xa)9*($&EVev&KNY6I%DFyiq7iE^m~(zDh|DL-+WKoAG74D&^IgHZ{m1~aS*)#KJC)|sl+!; z>Hf6Xq0$@nmEwc)mwn;pxf=fXOT*JG-CKuTX=kZxbnZS}SS!CPRXon0>6u0Sn@8>Q z#}B!LTCg!4MsfZ)_E{UkraPEMX=M4!st&L`+Abn$N^r`Q>3)O_;9m;mnH@2V-ceTO!nbuccXuE~3!qo^C>&D(Ly|9wXr?c$YyFP(qXT5@v$(HbU(F=KT z!y;~S4!%xoN3p+z*TqINg*X}S8+d%1ag+K1~K7)Jx7`91M%a{`()Vk~V8^`_v zo?yY0#W}>GW4Ud^7N!S|{=GPt4=%3XA94p;&^>>%kwZiKvMayiNbe_trTPGKa{GJQ7gY<&B16^cb{sM_ zp+V*~xyPd%K|~Oi#T`*lVaLI72J+TDs%fHGUR$-L%&IT-zxs1dc)1O~Ylc2I^w&%? z?wV`o=Q)!6Uu=;4|LBMQhrjy-CI9bhF8RCQX0p+2^^WB*~w_^foKq&sy>y z9{m$jx{r#1t+3KR+4}J_r2M) zHn?zC8=RkM{rI=Fy@@V|MW5~F{d%kK!0~ZNTa?!*zva9cJR0Q-{}{mYs3xjm+mCbB zL8eRR8VyI+I8|_rHS#7SHMpAgH$=a*?;86NRg+QCJPgiBs55XZ$bVZ@vMw3ty?dYT z{-QWy@&?cQwo3bLR@!g8FFs0Gch39Vi*xz!;`;p|cc2B`^&eH5n?@DjpqXkQTN&6D z^&pJZf=BEinH>%#umSj4g*eRaK?sNH5mXR&-|l|mxL@1Ju`;ux>IbKh0(HV^T#M;b z+e;adLuy`uT_A_ptj?7B29b6IM+aCgT+(}z=Ei^X#lPb^q}#X`C(ZrA`HHEUt_nIo zv$yTNZGWaJ$eR6GY^?;wxrLcr{?KB!xV)G@zc@Gaa%9x|PQ*Wno1entu__ik|A71? z!e>xj^WGj_#Q&IM%FM-Z5u+-nJNK8I(h^o*P__`>N%t;;s4U zs$+;5(BK-9HKG3d`#eHTem!KhoV%MNhmd1goV^U@z4Q1x=M7;v8}UYww*PuAU;N>F z9<0CjVXE)*r$2kt>Q3oz3T2d4ij~f4mff_B?LpZK_M587J<6G^`Wb|!aW=Kit*3n` zO@;XR{nb%&qt|?ETpge>-#qW zuIfAToUeSK?bZiuFU;!0YT}vzQ{@}y*18r_%f;D9S0+21TAnL*t#o%WU|}(LBYP-4 zm&@jhmvWh*@ItD)Z!x^oeI*^4KRtTtYIiYuAia>uUP{km@+q62$qvn=E~F-VQpLn_ z=FG^->FBk{O1gjP+(7!wg@qGi`N<0l#q*`fx#8h!{!=f_XK~5Q(Ah{||AG7hl!HU1 z(~%q9{k{E1)8l>lg~^r6D=X=9*RuV?*CR)cj}Hz`PxqecNnD-lPaK`=nOM0zdwg+f z{OtMO=tN>E8(CRAu$ax{7PIN%rRBxkka_%N703&*bw_g@}8u#{dvirDhG%*&B*c0QGx12L0_IlSz5hrJ2U>ORjJ$%vXPN=ttTz3Lt6R&ib(eAFhl#)1L2A#RHdPTAw^W_0|;F(*SdtgS)@OQe@trze}{|=djX-7Xg(;-CU8F)?~FHs`#FvCuOZD9 zoY{|SoI|sb#<2@X@q{;qG$ze{5gkVf`*Yqf{#|?ERWIQ#+3C!hI~#&NotmV6+-n{o zR%1Mb6i*}k2A-oIO;ta1>S>gyJ`-mW_jDN>@9Z3|$i{IPTE7Uiu*VULG7KBHUgSg% zp6M#?tsguJ_MoKl>{-NIMDsU}>z_x=D8dtXO6u2EaO40s4pwr8X_NQtCUeL&PQ+L_ z_+_MbSRJPAHt(+iw{dLR)RgmidCf~m?>hW^C+>|Mz!9e>9>P5h;Au|dexo?6-@AzW zFX8F?y*H3Yuj4M5bJQ_+<0%j0eXuO`;9e(9I;W8ORitqR&pv{5=dd5g(+uEf0`Kzz z&R#;@K8>&&$f=`&g?x}<`Fkzo}R7#H0Ro+Jt0x z)uUFTgtIK!t@rnA8{oto<$HGfS-fSQ)wAn8xb%BWOo{>=cr#TB9s{@< z)2ApwvBC-q)c>+Y=tC$)2Wp*pEe_}#9Yu(sFModfa=xqNE1gY8Z2LPtW5OL9#kKAi z+Fn6dPNfNZ&k8nItbLM7*C9$KL)XVjrEFw8x7eSbUzkfo<8Nf9&-C|=7m6oN9G^_g zomrYaeIqwJ)_HXN2}v;zqpbNwbm_OSv5Ho~M-@@rs1C^(x6bxS4#|4%_^V_8+=wV$ zq8s%^HTrW*$iF7Kv>K8%LH;I#qfhfr(8xcGvW9|&6%~fi6^)^DDWTFw(BZHP>__)9 zkK=RbETZT*-atb!4Pk)Iz&INFBD#u`i02eU99MGIgIxf}iyS*n!B5*JDy61DYqLQ`6T1Wor2c%3qm;4>*5ZSPh#b8#eQS-<333jG<64T!6!AD>p7P%BDgwx=G0RPcn7fCICZwyl za3!1Xazm^`W~g+IVMF1_tGUdpN5Ye-p6H2zVty)qqHkqkDYY1%?aL(kv(d=X>B;l? zXe3_9TwLL$Kk^4Z(zMBR;mw-Nf7{+xN4~JhM9b-AP(|G>`)o(M%(!l0v1_TgoVhMD z$}72IXD+{jvF*a*^{$0{=WHsU>CBc2xkY0KacC)rq2J4WM_!IZhTrH8hr`{Sk?x*w z{~!Whae>|8CV`Piv%qFCyPL*rdZGR%X@+~61r9a|?Cxt8*!1*<3%%TT6r*C8;AT$d z=5xiN;^K0alb8>-);WPjs_5DADz*C@XL0;>-Fx#R7&&6wk8}#)qjn7mw*PRmBD)#q zxO81*HOJ)iZ4dT&WsWu?-YdIeGCt+t2gl_3dyTo*G-;c$*EA_@ z@8v$(K<_Ok8_m7OrRo6bZi=_Wnz$j}5lw%D`0Wze{Gwf4;j{pxyCZt+6yQ3st)3D~alTV{Fm7XI@F8_qk9^Qc|p^xZOQI`v1q z+P&wnRd@Gy3P-1K#vDRM%-@qH#D-FH=RY@c_uRAQol^fwP4)fmlKqFfBJFxtkS?t` zZ3@(eUDz8n#4EA4ru{10S?UFOuK%o^oa6hU_Lf!;WBAM5PT>qX zfBkv4)GJydvnf4;C$*Y$KJBx6-naYut=?m+@ON6f>7L`AHso(MA-$J%h|~>p$j<3t zJ0(o(5-zuJQ^(ZtG8We-GK|*5)FgAz&w)HO!L28xsW+xsBUJ{B+X-?xl+`A4IB(6$ ztg3-SeQKw<&XG3C)IoE=-@D8HBp5fl@%_^sH?wW~e`=vy&1`vo=GKZ)e>htn=jS=u z54R;TB&C{zlH#vn+oPJJuXiBQ_3&zrUT6v;J%j!Cs5z*o*cC`Ug+DMH-3fde>VuP5 zEir~|Kk^|4KC1d)pN0(`q8mmaSu^>4Q|;I9Np0}Y#M=t5`?xKC97Y$7uC397eSdde zMg;Rt(fvO;^#NC2vf4iz^#PkW3PIFs(%`MN`oIm~9~{#S;2#u|(`C)B{%#-c9+bL^ z#uIdL(W%2q^4}DldTd?(P4SLs#$-sRL&N8&I41gyK5i=98GWqDe_MReaNJ)HW^wH> zwqUr6On_5!a+m)6a>xDQ^z#)w>hSu1!MSN{jlR%4&IKbm<7ma1^9Sm{q!kuA<)EqW(h|J+Km76pM+CB7Qo8!(qY|>qV zpEj2qK=DIe{``4b`PM4kR^gBPp5E@^%iDeZR{7d0{BiTURl2RhpVam4KYT&~Z{b|I zcZdD{kUP+V?ztXyIK)W>J3GnsS84Ro9PBuAd>Yy?jH_6*9a&tG{W6A8wf8{EVjspf79H4yEGPH-GFaPjCU~0VK^U zIj2v*xL{7pz1^RF`Qe}c>=Z3se?+|F?iHn^(QV5U_k}mc;l8VMt}?w_7l3lkkVXtN zM4-_EwGY;Ujd~6m8*qrg#i6vBV`XQD&viGnv!k|zdXm9i`Q<7*=Ot-C!8uV5Yph1a zF7{;l_OlnP;?zEK!5uX*G`nE)KywP-+uoME6@K@Ze!-2=`3^NbGvQeyGz=u+Ag>6Zpr35W_#bPjE;Wjzi(O_T)3+Z&d;>80F*_a zC5RfDMvYa&s*A3Nu_=7k3qb#_s>v^i=3($G2~`Wng8a9A)y3!C^*SlpnY?MC`Qaoz zM?6pcb1(0b1)#L7WB0(d{;YU*Wi=}StDTbwxn7H3BCy{J;QFvWQ{A{$i)+HBcD*N8 zt=UoWy9Hd-!OF#IN0q&kIN1R*jGYwI=VA#~ILex|^y9tpFUp0J2TZlQU;RK4@&4X_ zn*MvPLu!=fzV@fTZmOoMg3ix#v;dS@O*Oa)8OoXH9EqMr+q& z+b`;HJvKj1$STbEtj3Jrdi91~ePMfJ_MB`^DBIcvpxyA?Md?d4Y?t16c{Eg1D>5*bQR~)~Vz35vz+GGLfjYR)QZh3I!#_{g6iN5jh z^6W(9!gBYOkt^xGeD8QFK3EtZc|Cl*a4kN5YNjtyxRywybBTfDbLSR|1LL_TwE#47 zWi)#7%JssH#q4bVsjIVZ6jzo`FO~9rqZ5a(T%POixt^MtyE>RUnw=h=EfvoUo=#`q z7#@DTG&$LQ>LeDTzOxsA{+~bi4Kr}4i~hNQl63xVF5p{z0q7W(_;H0fb=ZT@duL%v zbpvZS640to!r*1xG#01PJe)`4L35;YFyx}hK96{v(2}RkazZX8EFv}+V_t;mrdvzW zY}x7F7J%|D`jK`HMoxo}E^lCUNjI*SKw~wIrfnI``2_Ci0`|E4bp#uSBY8A&<7h79 zIIDoY5ty!pac%+k7Ki^77QOZ%75e#{G?q%BIXn)X{5g{k1BjKA`RVhs05pQ<8%2|S z668|R8@Sgj@}S==_nn1_bP>6(NTm5`trwE0Q!{sa=xqW-UO&A>Ri7TSAXLW~PI zFO9Cse!Jk_1)y(thvr6&u8H=ON-vJU!`SHP-*L~Mj`wl97=Ar~##o%3Vc0qQ$%Eg}cyJGB=IFh7NtM$hK*@f7T9C5mpX=Ompgs_X@9>=S+7v-cUKLc*N z8-}w>qMn-bCr@Jm=;7??qle?&7YZk`#r)YLJ;!rr(n|wZ6LVLuUtF0V>5g}nBCjX< za(w^);&=XL(~R zTg}iAOC@dk3Uxfbu z7B;3=1*w;$b5+{WRp|~^6mB=gn#d^BM6Am~a`V%#rrBiw@8UsNbJEeO zvyln;*F<~t!HT@CHkAoH?~}8v+*z2(r8|u|+G)lPJ2}eF5%ELWTzF#_z%IcaGmDV| zm)UVCY^$Z2RATW*XZU*<_u5kK9PwLOx+7F~H9v=qP^%+7EsqSeIKsPYo*HH2=0|89 z+UiKF=jlUUv^vM-jfYHtSb-cqD9`@VpyxTsx_wDF^ z@AOl&epJgywuekRi!r^e!CWM^^vtf`>bY8lKkoDXBFf(xl-Wj0P+Do)ALDqq#gC2W zJj?>f#`7L_5oF`J53>+*=e$Q-47qdu!!C&2IrCu_Medxn*M*TgXY74($7X)9nT^E3|Lm8| zu+rH`I6u#s|7hE+hL4nlK7joERvbPaSkBuI-)6Fz$^6`P^N}Cq$9`zc9>3@c58_ii6n9)Pf)H$!{(#U?Ij%0NS#$F$#d zOxw9H=ddL1s7qYi?C9?ff?=r5uV5Hz^TCx9YPl$8wfZ%M4!MZqwX8hw7Lr`0!k zb_PwsFw}nM&VHw7CtreLC|jPrwmZ+ug3tR8L-|C_o$G(yQNKUr4z!@lr$-%Da$zIq z^9C?Tq}?hlQYkxewG>x{(BOkJfiyZ{7}tr|RZ%oj;jh^DqORZn=dn5Tq{S-d9QjcM z&hFXtxkQpfSv!#AQO+{bM%AvZqM5q=i4^ob?orLKG8h-#J1%1J_-6O#%*sga-^S(^ zSRPDQ%`o)ta8rK9(*nzbn5|^@&e6+1{dfQNYfo^2`Lsrb%7;+5`c>tx%iQ$taOkvY`Rat%MNDA|44 z1(x=!0qoY;rBZuKyGm+RS(aHwsgva|YjTAb*Mz08^Zq z)sFUSY~TACi`Os)?9{*Gf^&_JYcHb{ptsbi1(>K_@ld3uu+;D z`&XYc;jRigKhMzuOIAVF?9XCrRR!N^3oL)tS1oC6PPgWxtBxUNK!bZwwG0+m+RSp* zz-68DyRu6^?N#2c1(vMrlrp(GfpeW)9brFl%Ie5tT(dw^Q+|wqt0Nf7)j|worKF;+ z^%s2X4;--i@*98FIF+(0`)*co_Suv<`H$-`xZsm(BB;jU(3q=lxZmg=r7rUP5B~Z6 zn*dk!9eIuxSh5LtmJ2Mel;TH^Wf$>ln%&`^;?;b9`1-Nj(Nu17DShGSrLz|!mnMoA z&kx+Vbb92$3oK7wET#J|EZ@i{F0b@wMvg2T={>gGckaky&#CCSv-xn(k;S9ovlkXd z78cK+>>azdn8~IuM3)cGP7Pi@5)My2u?3c?_>Jtu((&oicqDuLjpdQ$b7zlFPR?Fi z=oz0mmw)5fROG_q^3uhb)5lLN^_@R)ZEkApSgurz&b`r{SX{yihj;WZZ2qnPv3P^S z;-40S1(x?)>NteucO@)4Jc>0FG^Dk^oJk#T4@| zQLLXhi?tRJZ~}2JVkO1^R#IGoN#Dp5Szvh*X_kzf!zGkAa3={Y6&mXNnIcvHu*hGq%*cOJZkIoK)W4Bs`ETt?yN@7g4A2A6FH3oPf6 zBTlqnw?!8+e_Q`?BFKJ3d7K57{I)rD(i{g^nVmypu4`czPX&|JNptxnJ9~~L_#Fj` z608f9?m4t~_wVj2j{Bk_fQvWzkw6a4-4Al}de)T6ejUOo0ys+Hh=ITQX%}zu46E~Q z%n6DR6nULE|1>|A5cK5_-z%%FeDvZQXQMNv>njsW=O&Jg^n|CDGBa+0 zF>FR*-jJ2d}$b??`aN-w^e zuwEkldvPvZ7uW9(xdSceuD>70AE(P;)6B_A>R9c!yEyA%r$p^9T3X#My9Ybx!7hdK z5Bw6Bo&Mx`?*83<#c^NkGHe_QP5kJjUEj~OQ&x#ZH5R)hb`sR-Qr$Fw^zEl5sTb}> z2vu26W5MLn-ih?+bYCuiGCw~sSIA$SzJ6}-?Bc-K$>j@I=NAjv^A}DXJ~}(fS8(nZ zy8eNiMY#<>>nfcKZ`K43eV{E0D@itiToZI2TVoU0U>x0a!DKPJRK#M*rR6y+ku+-{ z2k?uU_|?qRVy3h4Aksa6?ZMWgv`pa#?r8E%$u@*a%Oy4Zr6w*h zsL6jk-P2f{$VE=fN4qF-Cm*{|gx%u80W3#koW?iM34il5&13AUR<3&apYK^)HyTAR zZn0h6j_Zbub{64Dg}X&{H|4L2Yhq2@6z^IYtA4eM?&lYb>Idn&pI=Doxcm8qiaXC{ z-(AJ@Ec{_?&->3EJnKbv?5gt2^)FUlJYz(1;=koYd@bhOYtYf)kn;vfP zYxllz<-$es`$O(P3%Y!MRI4*C7^1*J0f%3RplCx=5<92HSv3ki{8~0eAN!GhenEn^ zV;qfhtjr$6-M71+IPRC?6a^)keo!IL=>ZB%cHYm9@OzPiRN_;aPZhuYjyEUQDS}b7 z;!l!CnYS)!k4^8>luek`fAXV$(NuhjZXGk>ZqCp7d5$c&J`3@QMS-`OAARpH-~4Kq z_o;8b_12s4w?nRa9Zf!4eTqO|ID919KX~MDZ|CU9;Yeri@MvG>V0g5s7F^vZ@*F$RYK0&0 zW>w=?zgRt}?BaSuRvs#(SW#&D$tiEzcJVyBs&MzuGslsetcd(EK`P8BO4D+MpZ(@H z2(8TuXX0!{EWvO@0o#Vn?<#B$-L+S3+ zxWk<$3oZsTsM(dCwFTEg{|}ndT@X7|s>8n0O>G5T*%xj@cm6)x(*4e{;9_ZK^UqSr zuY#}(;*7GL`=wggmR4FAa*wrv8X1n-d5oP{7UkBTzpgg0Jafv0_F>jyk+s3jDBJIF zvj);qizX>lJX0;rd1Wf4sd8qQwznUQxEcKiO>2V-ceTO!Svq9F#iGv=#74VuB>qmZ z;JT`6vM8E|!LuY(EgTE-JChMaG0tCm{I8Qzm&qH**v&@Cfd$vYS#Z&wit-j^J8P|F zS0&hLN4qU6A=>#ARy)d!l;^m#ofVcw$gNE}Xc9tWU@GtI*Unf4Ih(^yj^{IdT6Eb? zh}Dd0J637V5Lxq&jE8cuPesItS@)|SjF8haf^Bh@l zu?n)EdpB8dE&HnFs_NOAkFGj~m;nv$LDe#_;If(Jnk$!e&hN@D{Zux*eHL8o@z|?z z2xx8jDIHpwkP<2TR%*D}OVUo-{v0)bz=jjC_6Mw6|11-GV5Y`tUJeu4U~rgcb?NNk z*|)Mm;6fx0{wSd`F72vmO3I&vdNLMVAJ5#s32;^4k?%|vTxnsT?(n(v<$+U$NGUtsGgzFNn120A zV*KcnvfxUOU(NMi?wOgH%?*!SE>5S8mx>El7pG5zms5!wrJloy@tz}@Xe!c|yEZ*_ zJ42#p$@9KXC!!g(`Dp$B@p zX-w!&VA}Rcd?KF{#S>_<6POaFozWzkt2FN9DE{^sZSN7>Eq`?Ks+lOhj%PWFGtT3V zCSY-t!+jmYea+%duOK9X^bTWQD-A0xezCWJkP`A>9H|W=7iJKL&wB+|{^;(I=}4>`{4&lyY(9)Qs=p=NYr%UJ*J<{%QT&ABsM2=du~@=&E+Kt> z_@3{?+1%Yb;hn}^UB%UVasNHI+Zo(N4*4+xe-U?{Lf%u8zJOSZ@Si|4zl_iX-fzj= zC7+A$l^q4AX8UmdHN>1kj3db3F?0ea!8vpVM{p-6%-$fvPv9K{7F=(q1sBHz6bm>| z=XZ?l!axq3DbdsN$}S9KXHWgH{kCN`hU4t!{i0DEZ6noI9E@`@A;%2X8jLny zb{xV{1nspbqR>E`0tQD8tR4I%9$w$tZ@qn=$PfDRhwsbTFMi|vbkh;rKmYl(33qH1 z*Yt^eifim$E7+X4*4%sfyy{}YLi%~Es!y`mfSMK$_!Ovvx1#QD1D9yBVXPSm^; zbOsNjtZB61VujD*?DJ>>u0aGiiEic$nt&^)_}9^l45K5RN5wya&gL-8f-j*989=9* zKtqs1=St0a1f3}x6@I634B=_hh0x4_lfLZc-rf$)-xRvhq9c`F%NbsDaE-GYmvoKB=@+&i1QhCp&@_zlxuHW&x~+1%h9P_ z5zkbqaI&Anr^3lk^4$41dPd_XU%xgpIDKMbWqO+L|F{0b-)P!oy6|RArYyeLWCj*rwi4ZJXva9} zcNSk`S3hH#$8j;R__F!cs=4xq2Nqv8zXFRdn-8u#d(ijn*u7D|A6R_ZeDl{Umydf5 zXFQ6>6m}lP!tLFDy%&);?`DfHE|R9A-74@oX6CFMH7^{oQ!sWGUv}(HvB&;!wl$uo zR*EJe{_++_zH!9P&tg;HqR|M=S)8GXwJ4*ufa%j9pT;bl60icEn~vvvAU}_dZrBwy zGspL|Ex!I;{=MAR_(VKIN5IJ`Dio4wJ{tw z(He|nAy#2KRnL2L)?0jiEaA<{+{dF6zvU_q;y9n>k)v`uD@_$M z!`KCJw%Y#Y0!QZ5->@s8T_X)gTBXmggU~dEqjft2O(inRJ8K)4AiFQv@nf1y-~MI; z!>LZDfeX)fC7Tb~sy4iD`&84~;KE&PaDJvGi!T;^mM}`Zt(2D!qeT1~?y>g&v-d9W zk!5#%r#i9Yu`y;a4>tykdhD6cfJdX!TXJak=-GO!^i~U&9!XVtt5m8gNhNtqhJ1FD z&I@|Ok{up_N%mtHUPisWz~0~Yp7U>&uIj4Q zdUUJhy4|J!J?Gwg?!D)p|M|cFN52bd?^QwCWwUNFXrJf0j`51uIH_Q}>Gxmr@Ueo) zJ@BUSv8qWps^sdKoNve7TOa{`cK__q$lR+;$?MeYax%{{>!xciXk|<7y9X z4bBfv5Pr}S*ujCp7oz5J2#5=abGgL73lzle0_uU5*mmqa!tJBF!>5=4d&L3kjHxPL;(G`y_o0PXg}54!4~z4__8D0oX{^Z0ttA58@HhJse+ z8t?H13WC{Z$>ZyPgwPUK7PgYdm+OZ{0lFmSiW-oG+v(G(9~Rxo{z^y>VLu3gE}{UG z2HnwYLuEm1L^x+oC3S|Qtz3y6B|6-PcmYhYoCCe2RZtk(x+7c?VB~~LxLv^mjJaE?!yd z%r;!!xSStZUTwS5ymdJls~TwB+>EbgR-4CX^Nk~u$_kcACKfWuncUU&%)${CQoqvF z5?|e(TUu}E=-X_XPc5`HW>ZydBMY_p!Qtuj@ciY`w!z`S+2yr~Y@(w#-a679zt0ebXRn&Lla7C;4gI? z9$)Q&9}@Yf8s)*XsFsKH6z#g#gpABQ>7aginhoe_I&~JlP*-Gv?$i@C$lGf}zr0M- z%kqM1(~)MqC%MVshz4~2rvAlsj2KhQ)?~pV=hviK#%t|#d3;^bCx_0)vUPpFmN;LTHN zy;-F?ox7wyO=%=d>%5$4dkZC# zNuF(7!mXk+q#VUBkZCQeXC5}}UB5M&nwb*GVrNx=^d4KvSIxWPie@|r|_ zlHS`TT7LhuoNx6T|M%|~W!HYL<+p=+gN5vx_xOTcJDA5;!&Xm6P3>^5wPLn=t0^!@7J{U~c5w8z(Pe(ZY#7Uj1*EC)}t znWvY*hw1UvAX3>QQb6z*>3~{=^0;$vX`09g<=0j26Ul5Av0Ty7yvRS!!=0*6i=2`q zb3o)crusFJtwE7pNUBS0gAw$i2=c=vXyK{QG#v&XHR<$%#?VnbzEBU<>&v*1K!^yo z50pemkyuF_32{`TTso zb^|>9&zGM3X|uW%D!Ht_*p%r#zL+vg9$$1~bdIlg|L8vprpGVwu;lUO`YUR>3fGrB zzFdEmJic5%7&$9>e3d+~P_|oOZ+PCYadOal&O3@n+Y`F}EPH%mG$)-825*;ZfzWQ3 zM#!n>ooSsjV78FYaRtH29ebRU_oJ2mP9|q*xoRq7mRI(OP5_ z!?O&w9(D|;6O9S`^ns1d=-}nD|QTFL(!^NQ9Y=l;37V|m2s>D7qgb|q1)nD-^ z$LR4@t)|uL-OYP^S#>d=mR2)}&fY z?4TJ&eqbEH=6yw8z)iz4I4?(fvUW&-+nb^7!Hl?QG>cyG8eGE{__mj66msM8}PMJhL2$ z*hvNiiNKnSE!t%%!F>dI97QuEC#ro$GZ=$P*x>-!g#8+9z$pbB<0&9@F2@)7z95(A zA0TGj!A3SO$$VdIj8;^9Q&DWNdcy`Q)0X%6V(2r%&g*CT>2SE}{U{M1w8z&o9!)Ad z3|>a>VxC?GOCDe96m2$KU1@K*+zv!QL#xBOfWYxNH%nGTgh+rM&Z+_;x^PEG5WFA$ zT6kn(%K=Ft91yT*B82M*tFmAbBKrdb4bIOg*T^;t+Cj*$)^K-6cu?x$5RE+tvM8Le zR}Ii^Km4Gp-ujDwbQcA0scar!@1B_t>J0_0%r)NQ3ls#i&yvSiEQFSrzt~D1U#=e> zHJ$ol(H-6nM^31yTd@Lu&#i31RN&T5gc`ai0}?JnEjgEI!MS)wFR_I27nJ5aXZnR= z!-qO5%e~=49W{pMgu+9G(b*G?zt#W%s_wh+)%EuJ2Nt~UOn8s+&(Zqy*9s;=-8O=7(6bI zuXKESZenA4c(As1F*8)(+Iu-Mo}X=)o$QMb%ueU4>rx91qg|=^)W~LIta+(nseU6i zo1ECL>&{ij24*skxX0HoyuR`Mh{eC?Vaelbe~+&o`Sy&;q>GnNrzVI2`S~=drc2XB zT2n%&e21o0imR?e#@-50`*vHR{ut%2;pR*l9;nK9A z5+jLA;RZVo%WD$#NqT&hX!-rqa=z7*-DSUPD#SvG?e)x`2NIjXLUzr2e8H|A%;W3I z=UvF`gcr8EqTS#%gmDtKQ@5s9enbC~F?H z$JbkGekfp3-s)jFc%scby$n7~k1rNoo)y`h7Rl%rap@8q7qLurGDUb8I=L5%4W>+1ek|Wezj8#9oka)JQv9@t^bgh1-YPh>0+m;=UEiNpzP1mla=DOzlfyd?KOHMNWm<%?K92S{+#~DLKK~rM<`SkLv72Gv85f+> zJ-%hmXi&e$#&^;lU!Qo#V{aCdI3IhyCt$10MrdVbG4JtJEA|N!8eCtZ|Ajw4Mvt#L zHLX_fZrJZO)v|NLD)^>I|&zvAI-dsuH(wBjAVQ}X!Q@%VCTF{Buz4X5P7 z@Qn`(u_n$31)CU(HKY+TGoTPd%0YQn8!6W~6hvZj>+H}fCD%SO4~R~R7u0Cn9keAQ zGA@^x=t=Q1bs!&?CqLWwKMZ;J%;pzk^@coF<{Wu^)qA;vBAfU4qMBl{(fy!3zCQN5 zw}R3A{T`n8qq^kr#TVMy%6E2)?nSW&ah;764q=k+t?!K38y^#dMFUhyz^8NG{ndKoNv ze5q5k*>H8Gz2$N{5CILX4(|fuR?&vn!=s;=dBPpB+K`loeW&~)xDiK7$Og_KF3KO3 z96X)9hds{@+Tmmg@{#I?AWcXMoS`E}*lIv^YPlzFBA`7SDO@H#WpJ#*32Qn)yZ!Kk zt{Un8wYw;IOJ(!;`WwG+C8#$Pv@+Ltk1tRV%>JN$Q79N_?=EGMx%EtHG_!p1$?A@> zFV*?I!K-3q&Pdx_E^{V(=$4mN>Q!k@8tGKoSLu1q>vuudJkGu#n{}f>d*|yq#>{h# zlM1%me&2YjLaM|ov#ti)4~Nha^B3EV5WMBf<#a&7=Bw}4grBdps-x=~>lf=NE8BOZ zjPU)iR&~UM0U-;Hb5?sUm!*qo#<>$+xI=g7A1Dfigw{eWL1gsd(GH%VD_o@0)WcO0 zkDwG}ZkULR>85r|094kEV@pycFCbj<*V5o19Z{|I|m;yi_(8Q*Iy(;|G zsrB4^b!8$sJGH)?tK6unq+&I*u${a#v%HW@<*qIyF2+`;s_HVaY}L|C^~zvJ|5{b9 zG32&&v2AQBu`;>UzrHn+nI9h>X&YWiwXC(bZPoNPuQU!#UCoU5uO$|$TT=(f@zqnc zaHVdhCN|&GHZe6joL;XQ%*Cgg>t<_v^Xr?bww`oD-{NRfzNvR;X+5^EbS2T5ZL1y` zpKNN%R9)VfJT8x~zFcB*X|%DeAv4q8-5OgMTv|xAbx%*t_ofr|OHG&S7L$o9Rq?jf z)Yg^3-b}~z(rD*GeyXZtVr`^7wcPQDdwl(;is^rXSo}*KmOQ@p^S!z#qwJU_fP{Ro zCS~C5moLBH9>1d4zYP0GZW$2yKa!whY*{`Fle@Kq6 zl+44&;qld@>1#nAUx)@oEY8cDjAf(XONK?}*L8eQL>}LzW}St13%RP+<;RrLnLUBW zTAz&2qni5i`t|CG$&D3LyGv?0A+NEl&aBpZjt8D=BrvIx=hTKur_JN5Pw$%0bK#-a zsHbkwv(BjJyVd8s(V&jNtG-F^RHvT6V0uMw7}r_&)@`XYsPi&1 z;7I>v(HwY#!PUDM z5qNsc^h9xxw->e|%o@c-Z&3uGDRxo6NFqoFXrd9@oy34i-?1oQ8heQSFcOIC?jOpn z!VPY=M9Ytmuk(ayIp6BX-~3EbiS65N+z#pu7P4#J;|q2TuKK!u#;%2xCYNSb6UmEH zwF3>=nalH=sg>@9)v>YqTsk>2HZ(OczMSpundlxGZpo|w0<_HWqzleLnbjj5XC*tw7mS0OHs;@MSY}BQ$Yz(b;4c292P1}tF zP1VD-R~It1(^a|6Y+{=4|HD1+`7^V++)^2lmCfplO_|=~iz&0@@#VTJYE{R7o&TX= zdi*I5OCDdYzoMqAaDB<+%k@{u|6yiMP>$AB_wtdrC_j!U2}QAI0wT64)jjVkMjzK0H;kz?y>Qmw8z&^UjL<{>{I1C zs)Bm65n7oKYZ8m7pS)TJiKksOP3UEW|fSG>I+T@cEbbfeX0%KQv+*Nl3T9qL)u%`07^+U zxML+X#0bOv<)!f5cgpr0Rue9l+kpsZ&tcbDIj-|T6jWEv(_}_S0IE3yyEC@qi3M_E zg~K|BgoD}K+3b)|kas|=sP;i-jQB3+0xe*D1NA{fTs$43lh+7497jP|yk3|bK*WQt z>i9hszxS6I^|qN`jMW?RSef%Qx|=k*?Nq9~!HsH)4@ybbb$Mzc)fbPCZ!ULCPbFJg zTJl%wdNZk|f%I~sV{X0v@<`K4Mdw0uMPJBPcXcHx8(-q$aCKe%Q>oR|O!8u;uCX`U zTQ#)Yw$w7bv6yL{oNFCQx3;WaX>E!pI)=vj>pB((mTGG@)>gZF^BYyuspR;8>~q!G z-l@&;`r|UV)ufyH*9W%NY8n!?{Y{zSt=X#fcw_ZUbEYky>g$-#O>R^TjifXE8#48c zOkJrO>{uUP-<%lDH*B=^Z`C~F2Dk5j^Gkn%S?LEnEE(MPH@J04pN76H6$IqRr8nEu z9Ex$FCUn_Fv~FW4oK6stXZN%UM%aHi!Mv+)+B9Qh0IqAGJTP4|2Pb88O=kD zG6rS!tC9w9Sw^BIJ*aNa4Yko9m|05(w})wPBbJt9^yjp0W_e5_;mVf69I ziPnbV^Fu3e801}|eYeD>6Azp>E`k90NZ}gr=YgMqm*MG>s;`55-`yUh!L3Bg@1K_Q zq2B$+fB$X9!QE2Xw8y{uL*E_L8~pe`{qwt=-nqA)`!iYEVAtU3uj{wJ!R>11@_6;! z{FSTm`fOsUZf5=J)yb9mcz$bPd~i86(7HHR+uz$>Ki|<1^9Hx0axwQ~aC<@ToY(Jy z-Xkq|UXaZgY=g$g^S;I0FwKoJxLAK)Ef9FeL~AlnCqpAUCWo{=dZvshMwQ>FgpwU;h?R;aqFX&o^Nq;=&L9lsPD!J2eWJr zCWlza;P$WyTDafr`x<=M0wm+{CB~?|W(mtdTQ<+3XE}6|$WRh9AlV;U6+9MpyaFELCZ>B8l zQC^`MR=xtI$yA)t-*RzvNu8h5-cYc&F67Lq=BqTm&+B(V?LN-FAe*6sK^+P3SnCW%G2DGP5!rx2;)7?1_U-I=gLhzO^mluu)wSO*nik&~<=li%01^utLD>mJs zF~UmhyzzIYJ0`=OKCKM;YF$0IrKu2mFhK}0?UN6NeymWxvSE0#$9@gLC`Uh=5d)$+oupda=*QY%+vh*132v-)Nkm59AqP~tcg&E=Yi z7!51IalRVgxLib$bF(^+aZ#?X8q;6ey(laU-xs{$oAvALa{cg0;rj4-X6UNdxoqL% zQQw{O@Mq%L^70Qys&^hwFi!X~k+hH?J15mcY4!`UgLNlf8|p=?E;q9?z`@GV zDuHz924KuM8`cl$oh(^c25O+UHU!I#U#)hk9{U!%glygWv*F& z`?<7dzn}_7f5iF+#(sUNIv2LXYTxZ?Y~#Q9rlZ)9fj-{p}4IdPZnYV_m8c_% z&#_|oJi&5NLjqZ6bcs$W!f}$7U^F4-55@}jaL3@06&oiDG-K%EILi5G;mB@47&Qi+ zh7(}BqInuV%!|*@K3>L^8hP!2&Y}tB2nUY!~;$M+UW|6>MYS7Mf7JVx*e)TDHe-v>Hlek0dLV2emu05gQy&*{DJ z`NDS#*I>+(&gW}7lI?=A!rRLkCed-hsJW0O+IP$xk%KU2=-PM^9F=iDK7RLbF}CZ^|F^FR>W%HPGS~Pd2^Oq$WNlY%%>!e*epyDm*Y&%g*LY3v zq>PN`z0t7Nvs-l@p1mXq#E+aEwkr^IG&UahTCb-)e9pt?JxqIe&BK>Hyy4+Z4`282 zO%Kb=Sm@!?9zN$`*w-uX>#utVSzt4=F|YlYekCI#y|U9U_>{dzze2XFZWr6tt;rsS zt4}Z|rfXg1#uB?_<0?GPC?Cb=E~?$A`bX`4PpE&6uH{lA5u1GvI~*>T+kpsZ{d`y- zE!ZQssvyqsmMP-v#k*BeU?wJ!{pQ3pay1M+cfAA&6*r&1I>J93ReX=sw z_#_D*@=-!ihVT0EAFrjEV@i_nmwmiAcVqKO60G_(BuQv_dHPofM{f1-wtLb&UhQ{$ zy*bm{X<-;1SZ6g!f|Ev&N;Vj}%kU+SGY$TvnxW9G~ z(Mdf729T~CcT1GdP8E$5!##mGN4juFl-8gj1~PJ?;7#E9-{3Pb!i$Z$@yu^NWyr&c zc8%2=@>rR3lqBKnHM;Fos=OAMYKlh}M;acOIP#!<9%uf_z^{UJ2@lVn&m-oQvm=g_ zjPGY7lI5uQaQ(T@*3G z33_3;Gc><0buNMtdjyt{_KF4CxHq28nB&jw4EZv+r<3Gqz^|>p*i>Ph*e#X4wyEsO zKlqMks5ef`%3M>xcIk1C{)lyF*XME5vs?Ky%XT5Pm)Ne7@%?le-=EXG^i}%pXo1Pf zQ^7z@>W}(8OKg|>o^b)R zyR1!s!pM0(VrWMjj6w>wh=eF8tx!2RKS+%AT%0}{6&U(q z=TYfGSunE0fN>YMOec535RX443?7T*kX7{9*{*$f8hYq$Wy{YNW4nfK|BHYfGq%gh zT(k1_bMuPuMcZ{OoMGLA({{a6_(o*!1>QsOq>b-?$Fp1C>ftr7HGDY)U-jk3glS&ZFE{lsquY?!fIR_2-lb_=E0kri<@4=%*yL9<&Q^K91l zpILSb7vi&{CsNb{1Zn^In7eKp3ni2#y422jBVW@Dla_o>xl>)m(Y7+uOrgSE& z&XDLAqafNSOn>2VVeOMil`M5ISvXmlCd+BhXp2_44~!N^T?!R~N(d>zD-$E*v9nwI z@G|t!_x;O1iWOtGerB>Es5f@Y%3R~q2cz9$$~ii_6`kwlDYgG7rw{%K&t~29@a&}z zCSBv%VYf`HRgT(LTcd|@57QpL=;2Eq-th3Ihp%~f+e0(fKkkk8sXx>JTUH0yZcT^W+zn=Ytt5wt+`({rQ^{%mNwilq;3+QojAYbC=4>9-bC8y73KqV-HN zK>}f>xbQT8Qe?WM^`f_T*yeD*Q!cSxK^FyotbeQ~s$4i;>A#1SJ{S!b=}z#Ya#}Am zP~?$=Eg~Wqwu|g?ut;dVoX;2QEn;xQbja2Ap7vgGy%TH~?)i9wVUUDHW7%}fm6$Fu zGO|1utrCOGQFLfL5f1nqN5h70?cB}~3=AGeRw?bn)9~%SuKFu#im_e8|0Wl(W5#w_ znQPkLe(pK%(}gS2ksq<?5x?Jh^ z=CNaIk8>nymsaT!!v{7`GN9L*n$$<ffk#qw0_P zJ&#A*WwZZYXyeb0gv;f2AOhNZA2zWH`Qp%3!A{}i4kLrk$Qcjun<667u}iQyXteOv zLSuzb7ugnIfb6;LdE$Cr*eG&1I0twl4QU_fm@|xztb6L1Gt81`uP{5IVQLpn@_A_)y0xr^y)D>^}C?cpA$SRgY-&p!<|1jc6I}X%8q~b=id5R zQapUl!`pTqT~e^!@%zSb6&%{N8y;9^HL(gda-!})Cb*_qXi zsnkqTaHVp2b#5VbDU-~tXHuh?<%>^Nca(jp&hJ$Z;@{xbm_;As*a8=A*Q?T8z%YE3 z?sHy0umnTqVX?$UyN&Kx!KhcWWh?>CHvXQ+0xTKv@Fib=BLr{xayeaHu=(n{HQ}%R zO*#_vmsp@;Ywt!aHNJeeM=ptdVl{?!!IVToG*}n4ifgspzP9!$y0(Z!x^NVqY!-XpL--V7Zh#`#rwrYuCIRb1D9=9 zxTP}q!1k@@zcZLE!jNM>`u20LNHf6{z;FOfYzhca{@H?+rYcvb)^qdKm5Jo+l$PkO z+^DLgVl}g{oxC)&ypT-gt}Y}l##X1Q>N2rx)zVD$%3w$TT2-#`shQP8^6Jd|)besN zHJ7{?TN+GcCL7l}m+H4hRx@jJ6&vH-t&M9#mxnX;)r;+;%dN3^#oFcE&|K)!t1C&} zGI4RZx~~4I)T-vEi{0G|vE_90=GxlU;_6a7-Y|Q)c66|6@XBgUbADtkyE)pI9&Vk^ zWH+wFlgZ)n>hA4jiwc*n+- z+GY1mUtW9P$AT$0wQb>7hI8-kKZyU4ro$nsRrh)Mo=Dzz#XuS@L{U zXtu8F=7pq{LO+*}-7RQdDSr(#GIj<8%q^IGNeGI3n^bS+%C2fJp(#41DIDaj(|Iu^ z6|Iu|3)x>O8`RX@U$&;2oTi+oRJ$77>#Fu#0Qz#!)|~#*&XTUcQFl^juW3o1B~2Jx zTE3nqSksrR(36eJ*wGpsACj-hu#UjLFKXH9Q9WC$T8ZntH66=ox%;_$-1VxS5~4F7 zJlRFH2P;&st5T{-={b3_?!dqjQ~PO+u1&SRrsrDJ8B4lbT+`L8?pLcP7}UECmR-@2 z8l9Qfv#+T~Hg%*=*ADCXruD>Gy~h<@hs)%!-l$sNVp=V9=*^jedvrE|z}?!53qGZ5 zSiKG-57Q}q51Cxhv!M=m1oz3{o{nI;zj@s$t>wLo6JK|ZYn$_U->llds`j>2=FRPk zJ*6YIJo-gFVP5AB>B;Hiw8{hO4g3xmL1Q|0MQ=Q=sXe3KaNY{+w+7z_#t_LbudhhX zfBHPHtH#w*w_4f=+G^K+pXxB;ZRvL9@1zmK$xW=kpfGrf9}gZYbXi)+!w8WBq-Z;j~eU1{Kvvrk#sG1yS*%z zG4_PD*XSRln+2?ihGIoUXQ)6dK!QhxcERmrN^I2kaJk}{jmQ)%+LT&b97%g@xbY|ppNtR52=^CfyF*pCejV|A@!?Lm;5lMeVKTz~# z!NamBCe^8#V0-nP?Ku|3j(_sai&iN~Vw|5ucd$$MvsEgk)CC#<orXA+|=qg{QC zYm*&SD>Wna6DwEiwtM31t=Zw8x`ouhWc_GeOCNV0`}9=NDbwnUO_@Hxmnl;-jQF&j zM`p?_ly3vMZZ)Iq!0U;v%9{G7+E`^Snax#5xb}nr;IY=uuI}X z?qGd(B2LJ_P-uHEz~!7`@kljLR8eA(}P^oh=528I80XDeXC%*<$IuK90o zJ9k@bBJ37ZVy}M2As&|9T3MLMtWGbiil5y2YPEN77R%-QLc3)+80kZG6AP~D*Q^K~85X?xrmk@VOaJxqH@9n|usS8o5FXQh7M!9AI%HCLM)8rQmLVrVc{hRGRy$SvEDON((i2cU95e40$>s#<1S+e_j8Llp|P=i zADH2|JI>*=s)y;ob&r{tc~;-TnhvI@4k2s6D%j1pK*Y0Y2-YMKHjIuo=AR%jXNVZ8~lgDmYnx!b9$4 zA{**7SWz_Y#|kiv3D;p*mm(Wp@vOkB9^Ufs4G-^l_?XwK;1L0cHJ)v(|(z5JmSzxa)K@q;` zbSrM1Cd^S#4%i|zBhLL22Wk8uI3I}578;Y9J@^n;Kf}tALJc;nUjJPCO#$TUB{_qc}64(W5ESITe%=p8=FmK2Cbj3>)2tmEGE@|!K^b} zz0<>2^bOf=hT!YIY*M{D>)x!@%R2G+wJi6~T0Lkji+!K{r9tb(z0kh19SN7q?LY*y z`yV#=ibxA0I-Io}B`Y>=mrv2TbveZ@QW}#FnlEB9kiu~JVzOY8vgfwviR*cpa_|i2 zALrrq&7^`gojVcd!Bj*Y_In~ih%zDdwp(M{IesP7iiV{%eZSJ(f$*8`ec!LP1(8zh z-_p->k!4r^=-Ydker%etGUxe#tLHS$fH^R(-9PfTKg#LH6mZq7rq$}*%?Dgrb+O== z2OV(rvtRoEeAyo;;OgIcc-tPW8H*xqsH`L2FB1RtFu$ zC*>A{Q=4h2-t^_iJd5Q;@Rj%4Tx(EHV19*Dj&79ac9>CIwf z|J85!>3|(D1&o!sra;@mOn78%%RU*co>Kewc1s`k#`3(>6cv$jHVFKBi*KB?Zvrv?eBGrFb*AoG@ z6Zuohx~cBiBeh2Le^mWZze`lRQT317{hm-CmwZ!pd{aopg}IlwJG3ZRkWBA_2849y zutFG!F&V=+5rmD|7rzqcBe{2l^SJsMLoqo!VC2xRu#jMduEk*N?t}>$TNun2?Qthe z#aO_c?Tj^Wc)l>Jb&@=d9=mMj%YGwYjP07~za6k+#&%hmYYMb2C})nWZ4uk`C~I5Z zQSA&_U*O@{)3!L)s-$gU@Jo~DStv*Xn~{up?Z@;hX#PM}rUfGvci>)_u3R1!SUJb$Ic` zyIYq9w!_8fvCKd$cp{hA1=m>?Yzwmh$4y@ujbHeSvq4B5`?vHnm)4(q>;L>hp|-`! zoOj_Z=e|lTumu<$nKP+rQr6qz+LrrC=>2I)xJb7b^oXwu9@drhIrV$t))^|>@mD>W z|AdDx`tx22oqyezZ-?qb#XZC6;pbFA&3Jr%D+ilq3VVL{zL6WN4VTO9Km@e=+jUls z>wN5_E^3dJ7EpxZbmkIUJFj<8o(Y19fK@NZlt^SDygE^R7jTb~{NOJ!Rg-gZyA z$BF%puP+7fIz%K9DM;YFJsr{^RJ&vvBz(d~frlvmqi)F(mrMg;9UBJLi|D*)&~=cD z*nDU2;Cz-ifj+ZB8t4s=0E(j^AoChQySQMGw1Yb|-3`R$^D)AUjk)*#=1af8sJBfa z7QtrqhCEj0pn`YXHM;Fos{ZsZoclxFf@+Gz?(~9=qXfR7<7vUelD}8DLBV#TV4p{_ ztN^uHEpod9tDDr_WP6{QhzE4rGb(#$r3<@+15S z+aL-lmnG0;0|Xn$*N4xvQzMbTkL$P!l~ny6_QKkS93^xnDQr-6(Y{MZ3^tH3#|3-2 zj1lB0blfn{f}Ic?#7bB=Ts8cPj?o|e)$cBf4OVa1U}Xl#xBSI(FNiB;=rfWS)`dxZ z3l?ImydQ4yQ+mdm9$m1J92Q+}>Ur2+bKq_=Sc(BN?T7!eN0Su~gO|}c6aKitv@csg zj&ByKziSH*mqr~8`bKuH`&s@a+>Wsp;ravHz0TdwVxPNSX;;DSZ3q zuMbEMUVjLYkRC`5d{iJlahA?4ppJ22uNn}c{qTdX`e*&^zi0&MmdYmZee%s8 z2~g8e(8^rn*XjiY!R!y}7lne4+FHHo5L%k>cEjVFK|{xKI-p>?7g~Ok&JFtOKGAY# zVad{3y>xdufA-l72M&+!q+-ML0>U|TBr}uK*%12d62^eEj!%R#A_yX$L4DEKL}zOP z(Mi0|a(T|1#|2b7o|dVFDTc`a9u|6zz{x}c9p_#MjuwsRI^r<6$dx}cwf_`gsBe&K z{93(C0n8YniA@0~xmNGw6#`5;mQo3U>wXs#(b-A`? zE4SV{x)JMbo6a^Q=Ev%$tEPu*CXZ{a-gtd?W~8>NHI`_Zi)Y)mV{0Qb%~ko1-qxYP znsoExaR1$k2eZ|tm=*&}Q0auXAkPE4K4gotGu(U>RY3I+H2L@ZK(BLz1y_j z8IEUOZNY0*={Kx1C-n}QU|KvaYxTx8y?5)GM)W3CdIxy67A^h}*Bi9ytz+t)5q*zl z9nI_Qdv(r``k+RA(X752))yR9Kc@7q^h}qojH|tzdTUe1wskD8zS!1P{pweEOcr6B zSKrnJ>n~?jS6Zvr%_sJ^+;$?Mu?`n>{3vVnV#GmJ1UGM);K=R@VRt!Z*>l9)t))wL zIGk)@JqWGF4L5ovAEI)c;tFPi7EnaFRe_xM2&ytnTCT1^cXq+m?k}qZqp>dBU?EDh z{0M9Ho-i%vTfO$Vcu|S%w|}rVs5e;1uKBfkVb`Fp*Yz`Yt@v8KS9{_$wKdHfo%zwN zwf@xP;?&q=<3@hIE;Z3nG16X_+pHKIPgS(9O=taDy+?iX`%%_B=(T!3_}9w54bA;C z9-7qG=%qh{6TW=ILp~SVy`(~PqQN)0PpPnQt=_A_g7uiFYD7FXMBwuxnp+|<{URNc zA}3QKn3I|WHgsfO6Glo*M2Dt`5it;Ty7Q*?2Sq?qg6+BvLc4pd-iJ-lOzC4&bQq%a zqOW6gx;Dx?+v(Hs9+kvk6+yp?_W}|kCQ9_S&Uq1sLP!iUqcc`Qh#)QyCL~xSTy(qP zevPZs&^04vqQ)Zb11&E~FU*@x;>8GwWK7fvwin168YE%+|!pEY-);44L4-+&27D1?cDesU-Q?CPMKC; zY|8wvkDq%({lb)qGh;&I${zV3i^nZ3%dV=*R%Eb}8#obeyzF0hN ztLz0iH|O;OwbFvq8x{hJ0xW-8ZTX@BjmrXIMbJ)Fx%}v{P|F7=}NW=Gd zc*oa2{!Vw?;M2bRqKEG2y-CAs!k1v|MUaN0E~>W_^kjwphI_IykUT1ctS(OshSj_z z6QrvtJq?Q)rphjfNU%0Yvg~5nlS26x{bfSh$s&OUoQZ=7bzGd9{29;eITLO9!Or9k z2R-wkZMvYhgFGka9PIAShvOh^VnRMxo6bYzAZ?OA;9za?Z4P!OU$EGjeET*pfg^L0 zQ>a%X1LxqJ#zsyx>l!6t{4+cZ*B{uv+EzH`*ef{fRD|Oq$GM|X>yoXPF7!Iko#D&-V@s~Wj;o&V0Z+m#h!^ge-^l1+p zJ?!-Gc@Og*Ui0uJ4@ut0cFV(X|3ZRe`knR=aAV=Z&mT2zIFC=njFi{k@O7un*%mjA z4{0p!o-fM-9p1BL#n;+?M)if~*QkunkMn!=-bo}pNL{G!lH5FXft?O8;s$5#Bbzyp1CGNKS8fJBSzJ48L8C>qu9{lYM zYFuqXN5a=u-@TTMWjNqKjrM;^W;45Eo6g@*yJR?XEu@1U3g4&h?iJns4t;`f73=EF z@Yy@PH>5N00Yodu*J9z?Oz3>rb9D{%>;Ez+S|}wci)Yf-md1E zxD(X6T(p)ebLvOd3kzSh({p^Eq|VFenoj+tx6!z=h4JI8;1w~sOr=A5)0A|fNnTdl zgL>bGegCNM7*+qM&71ZfkDAC|%piS`#bH?=3?CE>!gz?_0YY>j93F;e_-Zu3=#$}2 zar44E#5pSBxx&J+(J3J?Cc`fha=;4o_@7{AcK$8228T%NC==L26@W>cq@1V-NXWT& zaoCdFZ1Vld%FWDeU;Ve|UoYm%^UimFZ=n7#Umh!SP4b=Ro|j09ngdSpllmP{%@M?G z-oKioR+@t9nx^_)Y7X=idn(aWgezl>JC!G)KIj#H*s0$I^}}<5hgBau=Ea8d9-0`T zW}W)L&tD(&YJ>0h@RqNCBLwgGa{TSIu(O@p*$wu>{Q#tlvj{U`l~|pJ@X8z0PzA^7h{Stc$y>n8?=XVcbJo066c<*E}@!*sH$$ zx`($t3}iC3cixN7jUIM-7!BZos|7@h~3D>)tW_O5(0ML7SgW?!s_? z+3|2aWj@7W#p{2kYiIN;6kk~Y*~Hi4iy!Y6ZNN#pVp2>W}Mw`-@K+;1QdRdpjI1m)n5|Xzz7caR{RV0te1DPF%qqW=8)I zhoIMpLtv?M%t!RW6$UX1#~i$8QB2u$+w;WrydTgH;fH8#laCa6GVOs@Zde!5V`Q(cgpr0Rue9l+kpsZ$Y3rqTc{tq!8Il|_I+uEc1?LON6`(O`8$inF_R*-|4TnAj`xe?1?g+9s1``Du4}wT> zbKpLl@78Q34u`m$n!t{1uZY}NY|MS**MDCS_H5^Q^Guo58}eA0^ArHu>E&~~%m;u{ zO;xcwJ?H??ulbd)2u63ghh~Y3g+?*XPHc##`)%Q`b+V)T^f?EG-`}tSBIg8BTzQ-i zDK0(;zc_#4Gs1E-!&w#>a)GkQv?` z1xE-sCEOZ6Q|@FVn{OP24WIth%SExl>J1yLOk3aL0zeu1j36{Lg&M1ZV7^lw0D8fr z$rBz1FQa#v@MvK$?aQ}9=n^XK`J8ZeLEl7ZelXG_@uc*rk}@4qUQv3F@UXDSI9z{V z1N|8Z0EHkB+{wZT&IJP(ZI>GWH90(`p&dv`hyw(RBp+PIan1|(V_e?}A_tM;3V26c zvr*v_5DIBS(NC5kYu}MO+_~|=!)+X2JN9eKG%oCu1!%V)e(1Jkf9r3K{8BM)F8P^% z9H6G5pq07C2Y`ZtVD<;~i$cLiEdcb%5L&+E@$5zj8akGH1uxygb}zIn1%SGKGBj|d zy^0i$qiCAf^hGRF`22FaFajD56caEDNW|TC?R-N=xJn{0pr_7{igi_7dN2^pIl(&0 z2o;_B(uw4=N;DuMV(Jr7UBU!q5F z+a)x$a61exa{cdoeE%uHP~RZe_yAC*093r7iA@0~833Bh&WxzS)=(20 z8%w8$Yum5PUT&>TRE^9mZ`Svv+osYJRq^ChYwi5P_U!OrwkcJW815cQZ7#2G59hL} z<>Lwf?cd(4?woI$9bf3Lnp#VwCTe@O)@r9G>e?4uhnGjE2HKMCOZ7DaZEFp6sZ7_{ z?CfCg`dTVhmGA3W&CM)7;sKyPf9>Z3!QmG?4BG{kpE37m`*AS)BvYy3Wt3ydlJ`yn6=DI138KOUfx0w=0}{ za7@0cy@XsKW8$!!0X?JrtgcwWrzFS4fhApWLS?smlJ zkb`O>_!^6P^I^TqsQO?)y^>VFEvb(P-E9lLE0H@HeY-KWIIEt)rEE=gke+Z=1G>fP9wNvyV1EH)2i z=SH?ulU<3yYJbD0MLKg^4Pbdx&K!ln$%~3p9UXh0BD`2`3e!nyvR+f zNX>{)yh9WGxClhErUi6#y<%B5f@xz_-oq7Q1DbV3R{pUgB2|Qmc4_(;)Wk5U$!Ab! z?hXKb*aR&+6&h(V`1wX+uudS0k_Q0k5Vey_MhS^Q<4YYx0nIF0TXK>S2Fg_^r_dos zuN4ZRK=p(pgsnD;qKTL)b+O5o{S5w*5jM7%GC$=hUf|cZ_W^xM~3%RX|OftQi$z>}Ot265>iU-YB zCfC-JnXSSI(59MLU0s!Ti3|$nA4#FQuHZY;6TDORNTHGX_Hd(dtBeGGwq95(OEQnr`%~0B) zp)w>26T&r4D%kQ~;daf#n;vosnuu4uhvdcgy+4?;KkVVtu&CPb>MVp4zI?+&cl6#; z<(pzPSuGk%ovPJYDhDFzOaR0~xZDsVCHk6Qra z%f9@ohp&5R0gPt%JMZm(;r^M|Gsg5g?VgyXS`9yc)OY7RSnI=jMlv7Lc2aDY!(jAB z*}L6W`^%c|c6)Zh z?CiegegYtO-|PN@APcX(pFqf+>kbzTxpV#f21M>$c|SpsJ69bvFmmULg9k_MTyxj} z$(Kg9mA4AjE?hHg)hR4N&93ALU=<5=**5h z1p*#E2IwKV6K$Le`4N1+%0K#KWzWn!|I5XEB!2Gt4+dhT`AArqYyOvao+H-_;v<~U z+tr_i8n=R>a;C+{r`A)MB=T`0nHWedZv{zy)E^i0I}Wk(Qxf-X>PLHseuot+U-9hl zs~*1Tp_&cEN^`2Y?8V7W51;e%*F*@Wec1x~XopS1VAmE#KWbuV;6g{;2mmErEdhizj@6;+uUJI~p#R+kpsZ{d!n&1Gizs0M-k1LI!4kJPZ*B zh#z3j#jm)9CWx6q93XNAFGegtReQ!)T+jOf{SY5W@=4xmyb`enQF85*j+RytNN5jn zrb&VaF*7(vlXV0)=IK4+Mu}hE%`Y=NzU{}_f`~cxZ|P?w?+?ED?+4zO=ojt0#! zB}4X@Mwm_-G%0W$PS8#p5!F7^4BkojDxrm7qF}-z`hh75Z3hzyj?T1?z9gw9!K@8o zW%A+3K|+nb;oIhZ#bkK8!>+M4Gwt4yrl&LB z(K*)Kn(ptJoapH7-(E|nM&gS@ONoW)M5-yY45>TB8Hb$}e$RLI?WNMA=*D68$a++>ur1u%fhuO5F5Vbf*BDn6e&+ z|Iqd)zx1ou*E{n@Rb(j;faAgDH(r9B?{x4Y?!m zwax08oNeQx{53n(W{3Wc>AY6muU~bO@&{!}5L|B7RF~3y;zz7>XP(rtyy`Y|<)-$+*lDvsxc+`c%IEc= znEfaG2fO9rZ4XTs^0*%#78n{3DxG7q@bmt7-oxu2hM#X<*TnQY?IK;ZfB*3FNA)}B zff|nr%l>tG)-Tp?AedF~MJU&(#3zKsYw%6RZ-GoLZrh)=K7E0?#aQuzd4CT+#r2v{ zQ@30s`hRGg3nV8H7X}$>Mko-}6zYjJz%j@80Am$EHxIR&jcgw#9#$H^U??NhG^r9y zIrnp{KB4QhMje(2{DE=tg34oIXgU#Rt@y}X^Ws*zwXV5pskgOxto6$9(p+M^E;qGS zQ$3WJAL^Z6?(VDzri#D2a_3i#QZr{5oBNjU9uDdae&jt{cPaW$zV+NEMIIo_%nl#a zuaGS7(zZ{nq?ePq%+$=%LTavZesv{T_C-2>SRF$STU_7EHBn|%p3!7WuGKjm|Fm%M z4gD@?|8>E`l1H2V?x-EM7!T|>UbWo6Z^I{k=zoViHhTEHug`~|X~yoR+VX7`G#k`} zr<;34B1VP8WDELCVSc^V*`W&CmI$jMFgv7ELqcmy5N52Qo8T2-hTa!VpI5hOI1*B!j_e} z<~!bc?z*4C(NbL0?|@TyHki?~-tjh_SIjF4c1x@dHKh>v? zFx4ApTkhxL2@myH0aY_&E^xaBFVy>Uii6eoQ3NTOcLJW78id`?LD(kruMX5k|ojOddCmGBLszJB}H1G^+IIB^gn&PX`k%8Z9Pq zGJ3e^J~U)Z;pnrNp5f0Oz7WDOtt(wP1xW)6x8s@%Y4hptEdRCrre&Ls4RTG@xpU75 zUEr*lb;k8O(zIMTyRe)~W-4sbR(Srfo4?BxZ6TEh!KaA28Ff(M-s2 z>tFt<`|h#=VFYZuUjlj>g^?~#p}I@L$iix>E79e>_n+7IE$O&+IL4ANq5*M$t&s9@ zdbnJEk2a1<32QaMCPi~_h;q41St0^!jp>R=Y6Der2@!F`f@(pfoS!JPEIM$|Ee(Mc zh~PsgA*N=84BAH=A*l_1tuE0G!HAA7x&%6Cu}NAd%44s3Xkp~#Uw+@Gi&4G*@tNd* zq27cME7SD_!U$G}!w4h6`UsDpFftID>K|2MWM`3rk}v{4RW5@MTovmz;%8Vc#y6(F z2sy{0e<}$hxpekJm6f5@Ved}uHjl+MpL{?+rbtx&h|Fa9ayh=x4lzYy|-)Y&VV}o2%AdFzFJ`D4}>rqaDFmll6;q|vZ{JHz?GVcJ?>n$UE z!KdH#70Gvh{Ma&Y_jz9ko{-Hu09iHc@x#u%{cOX>zTyShQYt;X9XzQ1h`%V@?)XAH zR9|=w`(d0ryAD8ZO)&J%7${-mNHXNihnN=K9D>^pI%PZyEe|k;NNDhW3KM(>X$>_A z#!9jk!}hsgD6U0KLUP+=m`eN$N$l^|Lz}+q%)_@~gclogzwousOf%|jGY256 zH#X49oF@mMevNKBl`5Zkn`(;1?)0EDZ-4lmKM;)WOCFy0qqoqq$g`S*#fztEbe}#0 ze;B)sVxzQUgge(W>^8Wjp-zNidr)z_UZJ9lSg0#l6xBX$!3ki7cZ*tp zUzP%x?DJro;~3xwNQP(5bMOm14K%xOxJF^aZ~ab1QEae!!v-reethO_hCULc<(Qyn~P#w|0wTWN}edd6Cm3<`8KlQTQ}0s! zawl?ogVsdbvIm>&Jal5JsSgkpI|4>mJZWa(CG3+0L})+!&~3~9@hAV|T@<{fvKjSm zf8xVIy`i9$xyEPS1_ie0W(bpR{tsSNn-ZAFinextd`lx6zBV7TB z*wbHzj>x%A!UZMa`iNUW6$v`-NUIpnoP>2XLTl;ug;B^7-2~Bp1 zH$iCH#}$q}q+_CHs6%Fkt99tkghNu@!tF4)$o1d(bNf#LhWZA%=A&;vmsg-OQvfpt zXkt^qNoL+&T3_w!NQ`yW4vwa3XNHo~tEthp_Su%2WJh+nCe_u{d9{17b!Bin-+1rL z+lj73`by1IchlIwa$`qx$JlILb;rh)@$C52Qd`69;+3uSrH1jLe8*(%{7}zgZ%zMD zU+i*y+vWV?_UQU{-*IK$o|;|Q9*a%1ug&+?w``5|tu5rc7n03G0}GQ4v6l7arPx6G z*hWt-IX9D-Ox4zHCKB;v+wkOU_w4vuXYKScXWqtzk-SP5^j&WVLP6MUC>yjX;ku5& z>|Nueg6*a!C9ipS$4HCLVfRg6{_0zk??o(rpNAGKYpZe^oX3o*?WTvWv`2cr`<(WC zXD##glBWJuWmxXe6f&k%nYHq?9~CJ;fj6Y-fmjL%Lz{g3XB9Jmjif^g*JbUcbbgb3 z@UJR+H94Ni`n@gh`+Md4z8bhwl7W0xcfBZ+I62trOJpHgwLoo@rd?E$K;_G#6F3rFUCWX*`Gy=ungZ5d}kv6IfIf zLXF%IhxFz##WmFHs>^!vMLqwhuG&`pQvqotE&&or=DMo^nOxAbv4n%mkoTn8Y4!xu zkY9d8cVCMsxmOa(cV$;CdVC!WyPSkqJV>d9Ml z-I$(tO-J+UCvt3&0(C%plY0A@&LF${lJ*94-I)5TM|Vrg1sK9H8GP+JIb*^j##P^@ zFEXjSb?Y~-c8Ri>4xWZ5bI<7DY0bQC*t{3od}Bw#<#Ia^0c{>&KEoF;l1};St$n*L zu6j6h)Ygc`5M*afgrCQu67mdjc4{bsRbdlQY9l}+AY*q#@FoX#RQt{)6Zc2#j*jJk zHE>>tH{EvPqG z$bR`u+OS_x!|VFlur8iSJJDTnb-ZSxXMS;hal0zDvE9(p*tN9SJ2X%+Ha#}5l1a|4 zcQq`oB^P5p0Pv`9ews6Bzk2PZfaUmvhbF}}dTGw!gfHLlkk7>?Zg3}dH^K!y9wrd)%MnzVUT5`#6CDc`NPgbfzmD(*2( z>U4hekOH@$aJ9ZFaw_bW^Q1>kjP}k)awYcx+G6MY!e88JXy3&KIDIk^0=R}Y1ns+J zBFMjua;oM;g0tolQ*F8CwT_L(!LF9+d}^Shy0f*Vxu&hRcDr>ner3ITE;ZYgT?O&} z-WPw(j9F1`sce#k)fbyGeI{+DOq^*xUo*)uMDHD!-K=49x-x0Mu>NDgl>Jc;OPRD= ze0niU5`;nsS*2R3dK}z25|w$nlu6r2jlnQUICw^Lel`*Q~tj+`K{q5g##jl`;eF z&J1`#eR7(_%6nzfzAfW5+h6nIgLj7e@z^-W8reS9f*L|PsRLC4M=U?L)d#x@UWhtuiU+<+qqFtM!2@)bN}e}SK}Ev@8NAbk1i?L?)d$9sJ`Ho zVAqh?kn`*YOrkL&U=i;#hrR@inIkzNVd$jLTA`f+k?|lSkP(QB0NSQ-f5p{{=%ffg zBTfZ>HkTcp8gfB1IpM_4ghhKK4`k0R_U-)CIO;T7d~4en;l;+>`~Jh~tRWBQ+BH^h z$YW*BQNZM&*V9mB^8u4oQ!I9;2OTi^g*BfEM)$isJnu(uEHsKs0h4^O=*_S>YP1rn zi*kV&srq0%y1XzrxVWX^(VM!Qfz+WnbsAc5h~Qz!X>{Zki_()TnRJ@`a{=1rrp;s5&MwW8Qy^@a^rrY#>Z$)Bp&pzN`N;UD<*`0^KdG^;AM2pggq z4A8`=@JR+tX8H%O3@jwl>xrqlq4m1W?YU%C&1_e)Zm~U=N={b{Y_E=V%*47om%8p9 zFqs&F zUus|O+nh=__0_~0jw@hteDU)5;^_G1?99ku^L*p*W_@3NX?S9KG`5hOY|Kp7w2WkP z)0caCmiopv`!kE1iT~BA+)87-t_hE=)I#C&RW1^Mqz`43N9qPj_|~F{e}M+(jGx{+X}05e(kf0 zmcU_RQ9*Y(xiC8CiUFO$0!AId1k$bGx+R_Wlu9mEa%e@i-lOfB{6_@ZD! zdsF&GW9o%Lojs;=;4@h~tNM`&m^^(hR2MYC93{Y#&|ugBGAg(LOJoChd`LWkxN~&^ zL(zG|%j5LUQbt^b%)qr#ECfm_0x-#q#1$;%M}`GjMPfi6a1sfQRWKL?R3e9b8kKOXCj-hYf#VY`Wd@c zJiszG+tnA}xSE{J_YY-fYKD@nOOvhZsj;EztBbX@6?N-NBlW!-iS%;3)(2P~_08`` zS@VK;PL^x}Mbmm4)r(_~+o%4i6Ds;w6CUT~4bh~_KhzWs{OzlXO(P?@hDFjw>4GJgB zutexPC6*%(=yqM4KT@Ylo5#ITMnRm=4!^CS9~kQM{BkZ;?_TjQsHx1YE+tcynPg%i zlbp$2%I2nW$r0)<#;TuPNIZLWB-Xy(w_UN3-0HZzlI=~eRrOX4k2K^m)h)9lEz_}@ z`L>nqnIUfd)HlY9PJvcmYzq9ZkDq%(-<2tlfXRf$i9K>CyKrSTy_(9dW-7C}^~9E6 z0cmL=SFw=VNTzbDnXSszRK@&MDp8Tlrx!9)IW1psDZ7wMUVO5y<;m*m*2$_^ELK%f zT~!mSZ&JlGR#_D*QdwPHtg_gdRYlJ%dZYRxZN_SfRW=o=tg0(kS@iOP8$DUqCYg9< zHIwLFSXszj%w^V-7$xuRN!ug7H&<4!35-~9qz;xj%1C;6;R`j@>j!G31rIybPcWZr zoA>Z#52<7K8a6a-LvQ^r!Bju&;T>Q9_&eQkgHQYNiype8_m)Oq6TSpvFJh{XUN$PN z9!Y6Br(Y@qsQ}4uE3`-yYb)l2*o3U@?#asF`ieldOX*4sJ9$m?q?cjYT$jQ8l3Jz( z(!e~aiN(S)cRZ|c;dfbM;aK5Ocl){SoQdbr!OmpbI_Q}PZ4;H*LEAj|8#&(@18&S-HX2w-@eUD)My4W8Zo^Z87sl)xTq155zDYQ{fm)8 zBcWD4u)W9!o|bEVe!r0Fydc{(4`1={riZV2c-zCk=%Mo;_biwx=q(3E+}E?(DBEq* zCP5Umo%ir*4;wv-S<;T;bj_m=*rJ#6%_)5GUI%zJpv!sQ1I|;zJsXJF_73<^6l> zwh6zU)pfmk?y>%9@E!{~&*|{Wr4fQ|V7y3)T7<7_D!7i+ zU4%EYsPwupoi#qV+wN?m=1iVv! z(fN>gjxCHoCpFHa+Ks9|DqcNo58Q`+|EPYAsy}LfN3|POe_Z$5UxYt>TH;~`=7V@d zBY2YpHFw(=di-OwBl0;Sr4w3K@?O;iCg>ao|FQKyG{z_951z zN^ovsXq?$&H5--?BmEx6Wi-?{S>ox!{tW6A`{V&@Rg#-czCT&HnYn!R3%+u`m~T$S z_ClckFy9<2b4~J{=bo2HikbsX@ss);P|Xo6nsfhZj#_C7s%x6+cd0qhQ|zfkPZ6$+ zHSScNg!-UY5oMkFT~I$fCwN%(foXWpd-1`<2sP`}2Odej(W?#qCl7D=`Zq%GjxWc3 z;4ba33Eg&WVRHVWP6)oK$bT_S@!`}5JIlH~2=xK_W`tO#GbX8M^??cS_de4E_HPCvd~Wp6vRj9pIIj8Q z=EQNsmv4D^FL6AK2lKjjOuv%2t4`47r<1!d++TJ)Tu+%#a9HvB-|5;J{R+k1+A5j(~YLR53mZdT<{Jr@F0O79WwpOfmhsCJ|3kNTY+w)pa}?;q8#QT0dd z@2Ga8>W}Mw`-@K+;1QdRdpjI1m)n5|Xzz7cafk>iB3tl=#c3YL6`WI0P9x|zqXR+^ zVhrL6KC%cXxU+B^SDE@f_#4;ren3CgF~X^gR&jj6Sq8T`_y!_kaD_n}!m}3B$W+j# zi?qQ$N^mLG*>gKnZ6FRk>ijjI^J{ejt9Bm|I+T@b`9?gpU!GbCn^q>sl;&=p55`}C`7Vrm;>B8>^QB?>P+0}SSG3ZKv8U;{jFcw zH2mQsdJ9dN)f@g;nR7I{N4<#tJKyC-_jkPQ+;urtPz^_RUB5!fy&!6#^3u#|B6+dC zWp-g^y>~hmuN{*&!g%|Y&6UJep;T|f_DJ)uD0d=_FTtyZPVQPP~BjzWn*(=B2iO6I^2E6bCRP{#g5?cob1WU(`d_Q;hOJ2@-ZfrMFQu(5n^Sk%ny?giWeSd%NcSAv%m^yR1 zz*jjP@;jm2qz}tY3ON#tbgIIoM73@|9%awMUyF59SWjhMCWcFH#NluCVKC2M73X|S z4!$+@-bc=ndRS+@EtlzOxes42+coe~FM5D$G$M`mPbyC_$T_rxJjI@j?FsspFdMYZ(VD zA~`~(+)#Knl(#~@5%RcwRb5liw%?`A5w(#Nw?D1lIgd}HSLrXU-n8<5@Atae`jWQG z4popRbNX^_>wihV>w1p5z9(cxpE`5H2g8_v=qGtbQh+R`lnienL5m!UGm|fSUU2eFTQ<+J{>E z1$$Zck2^AD^-Z;BFZ>3pOK;s+ADL*KER4*QCst0kifiMi#+uD?rP->jPgc*@CbYWU zt@jxb4=+}48>RkD`_K$h{*PZ;lw1By<-bjee*aLGCFCH>P>DCRCCPHa){}3})mD}l zRvUBkHq2-zdU*C6E8; zdeRf0WeVBwLm7{n3(tG^*P}(qo<>d~CGHK%ZEw4En=Nrrd*ypt6h zKb^^iIwB?6c(lXue$Ec0foNX>(aXEp>pf({)NZ&_L|0I+T1!%YYc-X%aa({K3 z8l!E9e5n&%e~S0&&K}tb>T!27g4v85oN-EP=k(&CYeP6L-!(}H3q_yR^TD+M4WxTM z+mtvSh5g4NKN8-9y_fj@Rh?JRw%;X*v~@Ak`jzL@aPC`@=nTP+-_b30OxDkKFuDIg zg*iKrlG}6j3c;Sowx!G9i-}i;lMWE+!P!R+^O|fpVX={j43JEB=YfNU|AyNJ z=z(AW9^j=6?G_w3Gk5q!U4CIT*4gA*H0E>Lo*pQ87FbB7AOHJxM_4vEww!B<+3X2@ zE^yX-Vpp~G1v;W7t4@Zh3jiapcX6LfuO_u_O*0QMaKEN`iM&N4F=sW-r^r z-KHN7f7*$XSyx%kH3?ya5!)>R-H*b^kAXtn8wewsMmBzZJWPO?)%zXjxVFq~17So1 zVize%`8Yk^&poA%ekox^Gzfu&zyv;C5)q61EaQ`o)-m15uL+Ii#k-s`8`Z}hM3g~5 zv36T~N^18pZKL}0`YY_eeike)t5}IxGajoAl(ypT3MGWnV&~zHh)W13qX@QEwX~J8A_^I{LJoQwFgyCn|EZkWL8^wrx!?vF%KZj%{aRPi)(o*vZ7Uor!Huob8$4?)mmR@9tmlZl9A@ zo^$KgARy=C7TP+E%T#-E8M7*rf@7ktqL1?HU%Z>i0+My0{bni=Z{wk zk#P!h5$TZ;xVWg$RP3Np8E}beZ6gU8>j&`Sv{WT_xg@9)H#k!(v(3tMmC0M&Ot6a* z%h*F1?KsZnXeeByoIHTDVc}8nYbO;eNt{^hSx~fwMA}lpSh{PG3+Xd+s>fbjtBfDi zxXfO1KS|?a{_68OK=sd|wlN*jY#Q$Cm{pi?YM?JI`>UE&$~m@WzM8o5LC-gV8a-&V z1t^?hw4Noh8*7yY8N0SWPp|z_?{hrtQg?p(Pf{^bq8_@w@V)dkg)xY3pv`A zdwOp4R?K`<39YFihSY0iUz-;;c-mQa_nSr8%N({De=i_Q^xFdi@ADHJMCt#Ry-nX( z$nSywkpm_tJTQ9=oJ?(;nVJ4R|G%vLZ=9bCf>_?Rv!<4NQ8E0(UZwJcwDbcknNmbFGXPG8A94NPo$?!+>?(cirp6|zQD$T-lR*rp|iDf1ruv>Q2Y#bkQwJMt1<5M0_bz~bQ!wtO%&kQCcUu-F-oN@@eRY)t@YD=iCT-Fa z&MCVzL{Em6Tm@Oqc*mxdEG5lRYJ^?m{5Ci{BdXU z73Dxg!LvLm=eXC81ciuPw^VP5i}#) z#_a^=^t^>glY#7WN9VKR%eBr<&xzi5#!?@`=4}0$6P|wIE$ctO^0!WPeZow{a0Urd z={8+7McsdLHr@eF$@Q1myRefvRzq(l*S!gRwmKG^w_N+y#xH3+Q*;=QNwt5grd%IY zA3SOIR&MS%fALgAPYz7`Y6wzOmAi@3E=9WAgM2SaK>s4vwXL=Mb(t38>r{0U`WAq2 z3q>HN>wMq{4^*89Eof{?)h4b}R*vLyWoE7+5wo34B(52KJO(K7?|&UQl(9P|8^eygi!&WCuouGEbSr z;Nx!ms&RK_jpt2!x9Lan*UHUy2gCxdhQK9+CE|$6e8lNrdniE?lP-Q`W41#d@oBAb`U z(7F^v@J04(QcJ(pK1Cg$iGh{lzt)xnT+|&dVAW}a1_8kXfdK{9mjCqN|GmQeuYL>) zWYIwEfA2?U^0-w$3yS!kkdL6*u9ORksi2Y7B#~y@7tlT;!Ei?0=$Gp)cNUIv(lRX^ zTLkia-mvdsHy_uVO}*4OHjQWuNaR@lW3IDhGPQr^$LB*KEsE((DluU=LFz>xpKAR= z)U~~WUFVI3=-?nLe_ps}8S9Huvo7${w9_`76cx{@b*4URsrMw($h19I_SXL}b6|jA z9}axU4bA!bS@Uzeeso9ch?tP(dm-fK++oxge@bOby4pa!n7CN3%(!seZbWqE!=heo zJeuECqzyMR96WBb6L8L9U*NGP)|?fr%@szgcvka^>$;;5Vwx&Ht1hmjs2nqPc+yuO z6TL#Ev!@1}=QOpw9I_MY_V<=gM#dV*=}XBQKYvxPb35%Y@Xs^ovFJ>*tQ+76JTIFG z{vX4Ro1AiXi5>)GfB_T)2Z;EeEzQ}&)YQe9`QHoc-`D1*+6D@0gKe4Wh({xz`F)oE{eIo^NA-0k~%`97a&-}NJxNKmlr!`ABld@}Wq{pao7 za_Lc6uE6WjN57sxr{CRh!)JHz=co9&*-Mt!%k9(0^U1-<-r1k7gS%C8-?xkB$G06H zs~@@D<+$#iAKq^lj&I2{l&bzpEqHa5bx7_H-A!hySs6r_Z1Zt zyQ2)=2HhKPZN0xgd3oQpe7+riR{1&rjqCIBXg?fV)3J9n-6j4Rj(lZ6?8p1Dn7Ntt zeh)P0z3H1T-fhiCVeGWxr~BL22hTU}`{v)7b@ImN{9hHBl0W&|-35Pv`}z3Z?L6J= zEKk>b-rT?LJU!i&&X$f}EfZxrI{bRSZh5~s_(i<<`_C2gl5x!y&`uI>f?M961O|$N zbi^O6Ja;jlA5S|E^G~l0TvvWRH@=_tPb6s!e08@^d!uf!xT)1VvZ={q7z^Lp5fE8v;&{0ui}NBpAG2e@hiD~u zYmQI@+P}JM)c429$0zxF_6JQ*XYF;Abx) z#7DMu7=WXT=gwXaGjP?2kYuHLJGLcqiyFo#ksN|0=dzU-y8lr>4J7U=7}mvwCVNDX zi~BjuZrGATpNOtOoPbUT+HYO&O<)HjlfbdBC8EO_;KVG4LTw1fe3b7}5SW;2xbBD- zojN>k6F)Q$$+yhpo9hrEAHyB+>b{X3bmRFC9Eh%TA_hq$Q@d|um z`j3rB?GJT8H8)T&VEwU&6R1S68~Q3;dewF{yJDtO6`E| z!(NYka_Xa?^_XktMtvef)gUf&!*E;mr_=KpkkTR_7Mzlmenal$uF1M_5a#P&wWLpK zyetLCONns)J~yufb4=p;cAU~d7lFI(9R9rx$c(yEAVw@HU5p^XZD;x`+r+!sR?y3k zXVQ>8)!UodF~5VP@dB))Mip?+RjKFCWH-X}T6-RZTSq}6+#Et`bJRf2;odh-Rs_?E zP(7lBM`(k5PEEj2`nh)cAgeL@LP7T>ds}Y-{N*4kgRnycBjr3ZwSm#(>L_dBq6>yk z?TXoQAV#{>x~(K1n>`q6yse>{igX}u@sRErj1Y<3V4IYk2E1(ksV=!+(?JGc6k8pH zBc;GYlrCn-=7h*}u_M!}6s!6|C2clB4~1A-1Jlj_0X6>t!%2`vdewLv!#Qf ztnqJlU^);ve;8i#63|M(y{I(MAyT{y@F}rL{~&qU2fUOO1?pm3rd3^77_sy z>&l&M(^95ne1j#Or8W&tLPR7sgHLS?=A40C9>k_PQ|%vC3Vld{v9d6k>X;5s-uVhi z7>Ek6lX@DorfPBiq1Ct$LpaR2w>F3mb%@9@6eypaNfngk7Cl)(5r3RmFE$1>oOVly zYgw-)QWZ&qAcuj&Dhjc*Zk@F+NI-cxuWcJ>o#0jhuZ_e-AW&fUFJanVBS@$<1Q{#@*e(ArpcA`)3SL$CW|#!pcX6OEO(9V9fAJoGm3W6B zg3}N|zT6(%2nDB5{bDj>aTu8d$&l$YYl3QV%a3=OV@KsS+Y>8Iib3Z@NOvF-U0s+$ zGttupY?EY?Hq?DYoTXd%L+&h$?{k&x2O}pXpmRo%2#(`@XhWY#7vpV+LqRDlum_f8 z)oLkAP;exa{9>FdUlSU%s!%fCO^)XVRNG~da@o|#Mjq+J| z9CnHS0Z)aF5V}d#xCx*@!=p_gE7$r9yye7wj0}stCJZvzlcIe3b-b=JK*~i9)e%u` zXtpV@_d5%-PUp#_+H|KVw`+o#z&1^pQ|cyU5^uhBC?3y9&t)gj*hXSvCgi~l-fu+D zqKLrQR5K>A^EfeqY%CN7y^CB>>Vg5H!*|Panqr!ilN{;|#2|ljp_tH^QZP?iF9|eG zIfQDwf(f#v4+=gp%%mY$6Pv#kh4hR3Dat!CPDY4?lQc2>RC(&Gy<7wgwgqoAFlL^W zIY*G9$eU6dBMEg`c(+NR&q3%(J7%PqPWmhB6@Qf#g*yZ!ko_nBtL}UMg%^QtxPOL3 zUi7;Lj^mXGd0SB|#FvKxAPSNJumO(`6-R6;%BzH5frzcQ0jL+iOx3chZ6ETov?$Wm zl!u9tMxCXl6c0ue9Wns~nUFL!u$<|+#RrV8r8FKFBXU|w*&3>>XS1!8>YJ#DJqbyp z8j8ZeWg^-hF`khmw=CtFo~%Ai96(FVT#7o;NBNa94JW%n96N~uU97ZPmei%UQbu7z zLxjbNKT)Ei$dTQCZiJHfP|j*Gj*7Ip%fyjTPt_`InClfUjk*K=R}u1&D5IdLJ}(vF z+DK(xPL>EjVkpkkFfUur3grV?B3U1_Oau(RL|m?E5JLYyl%cLuQVhid=SopMecg&l zTrA7+z^4nwp~C%-B!P4a8O269m8!yWE%6iaT(Og6 z#5u+T-X$!c?ZxvV`E(<~@ndBmGaIAOHf5kZpORiZk71%#IK<2Wc$`?UTQzZv6q&_6 zg^`R=VW@`mJh7|*c(E1{@&g=tWH^#yY#+2@4Ni`s6?eHfA{AcQaM#%&Sya_|9B?n8 zH#!a#3SpIo!a^zF$c@v&tJ?z5hRz}0J=`ka={uf!iebuOS+~J8A=W}9(8$GyniPN0 z$S~`Y$S~V*Hy=p0iMRm>%0XH$ji3{oq9=|ifiBYScQAJ!1LS%sC+W8eCF!rA`1c*c zjRrUtK>@ING}(CoAUkn=m{iFkxQGN zueW4MQ4!den92P?KC>Nm;M|4&MG<5RHbE5m7m$v!UhUv{h`h~;{bLdp3kpYQZ}30m zsg_Os7(cE9R4DpFQTNT;`qbJV#8iV^vA+OYiF}}2O+rV{d|-aOoMOCgvA#(JFqCM~ z4Etf&CVNi~fsG7Ud#IOmakjN)u*eB6GLfS9Gx$48U;h@WOMFz|-WD+K?$uTRa5w(} zGcOSg8;GiT;oHn{cu1c~Rq5|1?ooF8KVFLEN+~8v7nI(QlKRvODK6_R7}kfXmO(%% zK_jF9D{A1^A~Q^WOdmA9_>xwULfEdF?5^88;0pnqb|DgQr*RpCsG?qU zFGUdz^`ryAS2)jjl2+la%3)uI*Q0Q3*tG-BfQiX7G^PT!x!B`#Yl;Z0V(49}W$U#+ zE#?O?sjRuJLhMaz%k6Dtp`PbL*$fq1IIq>Ix|)SoNcg{X8UN;8Wk7k6$L0YVXu`Oc zN>ZP@ybzS=Y@<{kgCCO#g&&g>L!(Txx3R^s=r+NweWcgK$7)1)$G--a$FLR{6<&0@ zBwlnjI6_p=+@Qq&Tr<)e3T~Bg5GY@b4|s@0*#5co{|Q6L^T61L0#-MFU>)ec;UHpc zN90_Lcw@rdm$omrA$b{SWk@e-jS}D~QpDP=m)A%W)av(!%Grd;CS+kSO>S&s>#BQ6+@4H{-%D+1!R_q@PE!7kel*q~`&Xdj$m zgSZ(`N6?i)glg_(g$CW)@?q0bgvWAh%v4xx8YW=lB@u+XoDjf~v;uKs4WdUXZK?gS z53Dz>QEp&VK^PH5W*55b_D4!SB^z5NPPuX_x)Qkra>U8#cp7@jA11bYY*64bAoLsj z#CWtz6AM*isXqj0nN&Gj&FHpRtGHqoLKQVM{RR#B$)RZdzHSlz2Nf|c_RrWNa!)b% z0HA{h+KoQx6>iv#;&w~X1`~$rcCz=;wd$yt*&Yr-#^_m+LS?gMR#Q^mL7{xoN#^xlK0h{X59peX zz}L|=1)V4@7MWRo)G?Dd7TJr6L1ov7?}W*S3J-IhQAg3#$t{=d^f|dziqQ=KHPfgL zlQ>p-MTEWEvacbMzce_5aV4*j`ujz#EG)BJL#~&1-k=2=wMO#eG8!&no)|cz>2_wKobKVK>sb_c36%a-Rgbqd2MS7z2C6Bmqn6Wj{_pOOvFgqwi%DkD5tjZ(%8W zMh11c)a^ia#UVzMM}l0cF^J+Gz*iofSKa!decpD23K77s=Y^v!EsB8nSdRaUR*(FK z1}6wBVi=@TfHahd7p&*_(F7AiIH26pOS4%UfOC}~>RSO)jiEj>gyym z$?z*!kM*@Fe3kW!1Af%)4h6$JRZ!HB$^_F_N)8qgzf|8OqsRMEG`znkxab{2`ygck z{AHI{8MYCNV?tJEJ4F{6i-E19x`12)6?S+Fn~s8;QM>}jFbjx6ZqDkHZEZFwiy}8k z#rWPbg_~Q6lQdJFt0F{+y`jXh^ZJX3A!=*Q1swJUdOsg|?Al=U2yw=yN}Q-u4BRLe z1XlFf*8ZQI!1AdQf6fELR_3!T-ilnVtuK- z^T4WZ6GZi=7`HDJ0iN%@chfZ5Q;!57~m3&q2t1-Bz!ic>;If2~^Y8;kHrTBGwc!182ZEb(^^4`Zlv0M?}Vk2=YZAjaC zNJUK#23a=YHSv@6T_ajev(Df=hm<-s#bEC~FV(^N zNafaKn10BV9@=9JUmNOZ*~V+l6dvEGqaSFV9>KZ~a^@q&-=lIopgPaS&$Lo_V=Inb>);H&Q1bIpOB667);dVp zP+v^8`vX+tX9qR z1zAQQ;rJfaL`LqgHdRGw{-SqP`|S~31-VfkJ;C&QcYM&LDcNiCqPYN*DCY){Q+o}_ z$bbynKZmIdqqFxkiID8O$n-TiMT;Oz&t@Bw$xAbER+7PDD=1~?#HekU$MQfnYh#B!Lw6rTRmZeV zRL4p}%)ABQxmy7qZwM)M8G1Op&G)1ve+LY)X?d{7b_Kn<@~6qEY8p05n`z;ac0BwC zi%LXk6ou?~R+Vx4qV10htBAxv-#+AQ$i;a=e!865kb3f=Cx>g6nZ&*y%f~>OSV6Gi zkSO6W3{Ow?4!_~Y&Xuub8qYm}1<4?bpRkMkX5a;yvLXTs@4IhE`&!;NCn*}7R*POM z6b)XQpRJ*gp?<2ij{{ixQ==~pPIIs7tJGK!WfAaAqSdn3cvVE^D`rASb!{KeLQ-jb zDbx&nDU|SeBZ@DetEU@cs0*wqfvvSmKfl>lPa64TiP2#5E<`;vr0q}?>}N7YEW4Ip zqWabHMa~`;zcn-(Q2RA1y*gyqkILj~_85&5>n3D%5FWLGr4)lny$SO~)_FK3dewVF z7@1)A#691P>4=8Al)$Nt64MLVj-@Fp{#fqNU~^ zg>I?Im1#=rCFeJ-2(8Vl@204mxu-Z?BrDI#)XbRNCs+DXB(A6ud#4fc50u#Jb`C%7+oaeDJ<<8TIQ>8I7Se|;${ z$n<5iuB}|!r4?LOS-QuX&Q4E7E2o+J#Q}L5*(|b?Lt{S{+!B*)TueJr-pu?yKCIXT zvMPBMpF-7GjpQI7`k&4p(`gAWDje`zsEI0zHNi8tNs8 z;sOYShY;yCn-8*nBTWxIEyN8oWkwXQfl(zDmC5x2`S$GL#)47nvc`~7Jzox?HMCX1-K{e);hHrmGJPchZ<=j?_VHC-EE0G39`L~V3L*53;v zN76B^@5SmeqhPW+MS1l6CasI%5;Vlkl zm;v7ns6Zn6g^uM*kung(WdkF5{NZ=P7(|;koRKCO8QieEeP%SEqLglhD_!gvk-{Gt zbln$(+a}G5fo+XjU>uQ>C?At@QYd=vMP%G$(WY3oDl2|%2b#p&6|HWWI!0Msrdh?q z#cw1%TYs8XU}`D`n#)GkYj`H_>UFlRT)Yqm=}}t)q-?#@@(T6KdZT*__8>)mQsr6RgpDdjbzF^E;Tfr|xbEVJcNv&)#B*>AQtgg{q zDKCGLW8E0w1jl16QSIV=QyAlu9GkV_EU0?-VpxjflIF0`#Ha+lVodky_f1u*PHIVf9p5q6$hh?kRc3 zm`(vAGRzFaw5R2z6uyBWEv(QO!HP*U-P^n>8K>&B$=&JO6n64A-R#LBkdD0&j2mt% z5HHR1YT7TEj;#G7465qlKX~qJs5R<|Y>>=HaQQ0Fs+w7;A}4I4 z2iPXfWJc2K>Bho)R3#`hvWQ(yLbAl7*Cli2RIs*tt7)SO+?dJ*u(y+o0?gPKSrK&OR6H!97?KWBFCK1*G#@i9r5V= zol#02MG_?Nm;7*R>#T3zAF;0CE(-_WN=vIE626zv){0;8{82qGCL1(AlV_wlnfG>+ zk<$WLHcS6(8G(8i`saFU?4)nXebY(bER}ti6ve`ZbOv%ai|jXUR3hQRdeEkfW-hp# zTe!>*e&VTHrXN?J`Gk7j32<72@fB3c;AObvI;%$7yBhou9bw@OAWGu)xFa7E-IM3> zrN~fStEJmGsEN!jaN9>`lhB%+e9V7a)pM5oKpK z`@QzOivtspI+K8LUXm!q30s3vI|m}3_qS4=k8}^%Yspg-sH_+-`J~)zJ(~Yvv53bo zYor&%8rLEj#s$^tA=0&)kN@R>l=h4vc9|w!niU1+>5U`-V`L1Ewp~7+$ih7 zul=oNegbh$hF^>(fyF}FA|ge{rSO4#W~vP9#A3OWkUtZA6mz?Gil#af^4npjG4f%J z&!zO`iYnY32V}F9)ERZbS%tP*(PmN7h5)2YfLR8ZFpbxsD|@~F@{)0zhmhz~FYlxF zLXorJ0WH!R)gl?q1y%k562l-UA}iC5Kh);dS9cwPnLK#i!ojSqLcF55^h3NNmfiMr z4zfeT`?AVP*)1N&;x~p`jtS$2-Bze?l_yjh=8gH~P_%E`cttK)cJ)*57<&o96+gMY zF}!+&&jn*?f+3SC%ct&F^yeTpUSGAszWrE$m28Eg{Y42(a8g8ThtfV#s?EcgRNZqO zG(g`HJySC!O27e$j)P z;9f$OQiit?26wZ3l2N^ncEE`L{4cg$`oLg|7V-n2d``AkIBJnMZODB$>y)i1Q9vN% zp#^{1!4gAMC10AH?)4ljvKf4bvP4lJ;-y;8`FyXNiebhsnOggy559@;A4V-iDW-dcjM1EGa(lo8skFshS36|nyjClZ#e_w4}DB51PN9gxI zxt#`r^6s2YTGYEmfDz1A-gx`+jilyNL}3UQ=Z(b=&OwXbzm#zq$O7GAL}{hqHS?@` zsVTHJ)^L?A$L`BxejGL*>m2!xp`;y)MGiD|Tm7_F4M0o8+6K+uMrWvU=KqeyJdh`s zdz!}P!>F>{mV5gZ=85+ye%WbSEqAR+HDMNvZyPzw-f-}2;~ryeRcc?sO)g#FfUw4A z0vk%@7qE$pEEk<`u#Uoak@SFf`9l-EQ%vg=MGbM7z65W4fei)LM|ukt?o5S{78?By zX_$6!zFuSq4+k}H=E3Xj?AjH{$gyt>B2byrhjamUyV~`XbZ$7m&QFET3!!CPv;meu zpO`tW51K%#ubFc1f4bX;JatbCT-}tQ^ha0`Gk#sGR+ReA8HT`N46Cw6Up0Pi#A|xd zFQcgnCq4pjh7-3mMfa*G#>5oV#%R*ZEqb&;8bl5t%0iQbkNpiB>2qmG#*P6Ek7%oq zPm^y8mH0;wv8WLk0O6-ajGF@Dbib@XsR#yp5W=DFf5L&&|;+iz2_tQXPr zpIkuxt_PHni|rVDg6HwFM1%?LfGeL2)jbSOI7#l1f=*MG^aX_0!GR#ljq-q1NzEjp z7LfTAQExMZJ7t>HXe=T*=kP2Qnm$yZ2KKme)z=8E_`^Zv(~ax!l`jjO*-Dc{*CG?^ z7Rk-s*No!~$Jv=F>jq-OViAe*RD*vx;z3`9bbPz=~Q#yZbt zbVwMoK^euY;Uq7J+S~0WoAL~ZD&8JrtAZg6CGcRq66cJD*an;IU>f4e?6^ARvY@s)dbOBRJqxe1;cM2LTNMJUP7msfLCM3&JwuQ_%8m`yKa#5 z#BDqZnE~o-0liEncq!YX_iUBF^Ru>5%w(_wApyeEH8lVg45)1%^6!s1G8qAIe|tRJ zajSSrcc1qChBo;n8is(dYtnD@@?AIBwQG=z-FsBmr5n*I)TQi*jJNwQ@nvyyWJ;G* zu$M8ZS&G3lEViT}YP4?7Eqg!WYDldMb@HyJQaFK)AWHxAlI2F%k?TSc6qm92c z44Yn}>qhch9BCpX;cGqJ&VX4k9?y|oQRCO4qzcM826x7S1G~A~OAyssTrAi6_Ja>I z>2}c2ka2TGqaU%7WbSeZ=}qI#h0olskzQ??`|Z2{RN*dvNO%etP+0o3>6|F^vnQGB zG&H`D{{9qjGLb=VoHDaHGUH3C%}bwc>RS{m41 z!h)DP!=yrZXo3b%uME0HfRnYIpz@iFR2b9Y%aTXsJdkgLq5|n;Co77*uPt;jIa5zi z1TB!f@YjR~J(+(aD=L>_Dw2u$0q- zr&v$3%@Px`GDdn>0nd?v>G4Q(5^w>98|#~7jUlYt44E#)ew z0bB+{De{A4gY!g-G!~91Ou8=j8YZI?`~Z^6HYwYkzS{e)Xlg8D%p!z%AzI< zE*-98Z$)0CD6(OmqAfuL7d+n^u%b{mO~=Jp2q@NzaU}y5?6_Oha1l*NXFY1X7m9xK zyF_RGndNG@z$+tO*U{^Z#Hhd!9B$hjwJA6TaoZq_{-0cn0V~5a!JUsi_N=D?d#2Y! zvH%Q=x>&3`y2woGyOu#JhfXyqT-d*G2p}BT>v2L*5QwE%Hn0nVjxDRe46|u;_76;y zS@=Hk0I56*kag2)D{%5?m&Cr|Sd*eAVz~0QpuH@?VXa70 z4B;fgkVnV^Y5Y=&MVolR_qbRgQ-7=MY|#`=3YDKCfB2Jxw&JZW%2~% z@U-ACgja_0YK7tj>)2Kun!ivQvB;4r+iwcWHa9Lj>WuX9qu_wcV-;z9E~7uth3$2r|yH*U|A5!t_UaFBPuNZAU&&jkbqi_xd%s>d{1CwN9rYoqjy4%jM#WyC&QN^m5C&4v9kOJ!tCto3!3Rv-`;^DFQ};+ z;b)+8I^Gbkvx-(IO)fs2nrlLMS^Mi z!c)QOdc!f=3WFlGuSIjo{@BD!fLZL>Hp)bnz$gRY(X^jTn<((g2r1vUQN&RYhg59R z$^L3+OY%tT^xEe%ULO&$f#VNke$w%oqDc$$tyxMUHRAC)JmXpzi)ge?MDk~4N5*=PM)rJp7^xC z@5L%A{!V@Nd*Yn-^Yi*Jb^0^>2|Q%}Uyq=h)D7Wg0dH?Ue+Bu!odst5ch5yf&%RI! z%g4a-GidPpFw`6FAa1niI+3M1-o+8S?H)vvZKqJerQW39mW~>3=6575#mF*Vg^`_& ziv9zomI$w>lXb(b@3OaKlQGWI-S{5A_FG4rPi{Of-}kP@6;*3Al5QOFuNsWm{&Z1? z{F&d&{k*@XCetQ`a3ZlRB`BbG(Sa2F{qPj!=y zTZOdO=E;?JEx)B$t}p11pHz5$E7OTB3%Wh<->!}2ZzaEIIFQ2o#o6d4;Uws2cjxKn?bOn!}U1+V>KZ zdG(b}v8B6YSgc<8cE#j4mEqMYuUl$AATDRuc<%M1B~kaNjarYPVZLUx+FR!FJ1psB z6qo5s${ST}+aF5$@pHh3{w8=a!P>#9UxM*sgh?)pdWJbS=F^sIqEFDpvV7Oa^TwO0 zYvfzXpXN~}-_2CN$=}P;FK=Xw_hIhj@l*T1-ygpxVc<)9os8;nvvp?LFjL(Aa+jLi zq?g9`s}$Ipw|zF6`s0QyYcw$$oRNU0 zj47Mv0yaj>VV|8qt1ljtK+AymL{{VMW6X5^{h@eEy)N_BTJtbR_h)+t_@b5=#GWPk z-2h7i6%|?9kBEnK!#Aqw1j9fovq2U^^aisu!)Qw>#vd>$%Pp&uD)=dF)LdeWO$m+x z;Q%%j6`hI3v5EK>;{li<`M_x`_6~*XA2QdJx4_*BdMp{kB?M>b$k2gZNkSb$Tp@@ajtXzD4AMmU%@@;VD-O*rn*!12sD z&unx_AVQjPQl~18P|0W5bS8#RqWJRN5WtjwY9%hoF^?{en6ZW-QE)QQWj5V0!9a<- zkz`Jin+Bs6&#>{%46jb4HQJ-dmD$aHIcVd9##4#Rbt7pqRQ_F+!wVmrH-lx|;8_4e zCXr`Kl~yjZNNE&0)~yjNVa^`8kT6-Ytwv7&87ugK5IJ^Ojz`Y$PyEqj#o1r!>?p@_ zLL?mIb29S)MwQ4|SD;)=vpYFtL)1VKov6vfI$tO@Fh=%X|1pTdbAUL>X^v)t6l18N z1T>+A?rfR&BlMUKHbRI-ii z8nFdBDG6DdsS`M|Em@RNMfHU_+??5@5DC{K9Y_qAp;cK(Vtto~ zGx<1uNUtbN1kJgUab+!$w;Cf>M>`T`ULOYrjhs>*iz!%$H3rRwys$;d`b1e_dOzJe z76PVRGA&=WGG`e0yHF8D8H=S7%eSC?%DuokX!|cxy3i0mI%px}Wy)tmYc8yXg~WhA z7dTYuvKe8}TrnPy7zUmo;>l0j&*(R)Z5~=KhnTjmmBr7rKSa`{$$T$p*|TCdMT^jc z63wSY$Iyf_4fL*7j+@?03heqBl~F>_M-r45-iKr=k4tBd6+t5>8elqOR_UpX=KzPc ztVZI-*EE+HX5mGHzF0_jWiRP{f_R>sdWp*Pq z9m0kYzv9@&5SkAOD_)@fhO2pAa!S!S_(~O+ioeDHq!CmsreuEW-q^a9;GB&%IN`jy)am{rzA1nSD6sWZO zl|*Voeg}JdEUl*03JXFEqFK(3NR*jSJPPcf3BxFrm_ZGdN>kJjhaXpl*R`(f5YC;teFtlJ0Ho$p!BT)8*B8T{Q>rw{0-B@_E%b_YiUJCnC;2a=dx05oP-2;OKVgIH ztokA(ra{lFyYpz0T9wgHi6s9T=?f_z3@n^Y23vr9OG>aI7p0+ip-dmif<2lN2939b zRwmN@OnQQU9|mM(AV%?4Tt12Ie5bW-&7!L+T1M&@`CoG$EB#3{;`zrh<39_Ic`RfC z3+5A)O26#QS<3GPIO-~S-J`mxqN;OveZ?&iqlLq?Qwz>-7blkqgxhLF8)+3X94m_6 z>w|!ES49c6X+zN0D=Ne7Bwf>l9dH-ZqEUM)NfufnQ3Ag7z@q~*2otBiz#3+0LaEH5 z5H5K2D;^wXS2>)CE-=Re3G9A?nVyMIUvV|4z?wZ&0@i*i??_-CpOy3c9Zn6BjR`1- z?z#_x=bs?V`uv>qLK?N!x~Ed&R8*iJP7<<#-{^Xo#ROg}FSoy7yQ$uN17#F zptL)5O5AxbBCWKWss2fW9koq^`6PCBnrriTIzYVwA75*y0y!^gnFLG&VYVnLO`4>% ze22IRC9lokW;_ftISup#H>Q3&&XqQE-T{P)jsO) z&lAg6W*u{+qq*n}ZPmxN^%@PXlTsSQzs}Da*7unl8dR@%o@KKHONR?uQW-tWme<9i zSX+4a&YA0drj;Jg6@Hx#W3L)zj8Fmh`*>Q$*-k><2U|^kSw7tO{U2|4k$o1GH3Baz zLt*}386EpSMyIJ9yUU5-zc2 zn3`gMNMVD{A~ksb?&z71eahsJSpRNS_mNol$XByJ$EIvw|$1K^9}h;PN@Yv-aSG-^G*6ASNtK zZ67+%;}BQFK6K&Ft;?gO2247idERSsRKmjde_GvuSXGA0KeU zBH@tEZf$=y4JNn<_^Q5nCfFK(lBfS1T|mZiMi<)R=1tW&(r?2)+M?L9czflLTLf3lojGW(4o}r=lMX1L{A4WzoIV|T0v!6Wc)S^PXuss7q3YuK& z3gOe*C!20Sd>Eze1Og+u9)wSp8!J5oJFXk6H3WJSAED(oi=_76Lr1Y?%1W-Tbi;*y zJIYsFoi*Kw8SR2EBJ7li@{)LBYRGdO@B`E~Y|-mk+afI0+z4Wf!-i=(w}7i-;T*FQ zub5zUZbrSRN~GSEU6c_646 z7^?btq+UMlfFHAsX$os6baQJ9qtjP38H116!wqBWMy`G^%w?u^6CCti6R_KeD6y$|3~Qh?SL* zqk?ZPtSD}ZY&aQNUFE?*DTgmm#t2opwH@^PMqs~3Y}*v7o{csQC@si~1&{v^(*8QE z=|B7*M`=mfCN)af=w_sZ)M$j!-2>?s5$PP=sUY1TAP6X^ASf-}ARr(T(u#`kdkx>8 z^F7!3e$F4~I)A8>YutP8zVAoe_qNxP^y?zx7D!&l&FPRRrP6QJEY;&vSKqaW6X-X@ zfLp2cjcw!}B(6Ml6Eu5Hs7W3f#cj54V&VFA>-G~nU=MlyR6eln~7P3@| zY&$*E|Fr#6ne$e4M%+U~Q99ZJNh@TBTbAL^l0aUaWDS`kEn(B2wpHKWul{{n_5EvZ zMY6}1yuE7Zn_Y>$rvprr1=$mteYy|Dh&yv6jGr&a&@;7oEx(*^l7n=7QU2yImNHI} zMzZm=E}vtXa(grPyTbHK;mXI`5{Q83ln?YBcnPYiLbgfrZ*Hys?@YJyN!|G6UmP5l zwj2N7W>?Yc&#?wu`ZC;kx$#G3FVt&0_`?O4o?Yxd!_Ve>N$eWRaeK@6Q_N-e=@xey zmzPCeH(dpH!$|qij!cY8Nz2}z+`B#9TIZ&?bp!cZbGPB@ayvwiK~;)&fh1$cIDpw z{e61+SGnuA$)S04bI`9}e?JP+a+1jfoy`SYZsw%iE({5}JpA*uQt-2m%A32vfmgD< zSNpRmZ-aO1gD+QwfByPA8+v)UXnj{E^pZdK{Le?7+i$O4iv%96pTyo?`TJ$)WcFw1 z71ijgt~^&>e{0C7{B&C`DERWn#n8{UL_>l)!oI(2b82%ARU8_0dE%*a`|4;{xMJ&h!kGBS(X;oTt}c(hEyj-3D(!_9 z2qs&}$%K-s^jy6;zW^-r81Lt++CM)(rO1U|odsO=B~ZQ%CG);I2w+|Df5nQPTLvw> zeai}3YG=*e^&r0bA;CAopm@4WfxAie4Y2~cOp+MhPwl~(dPIEnTc&QEV(s%~%$S$T z#3bllwdMQJ)3zv%7ar;TctF^X6G?x}B!8r;$>D_D zd*^e?`w7u3+E$~Vx-vDdRx7`9hPnmRru|Wsdm#76`RXv`YFwiE@9F)&lX91_8Ag96 zpHURP*%K1fA^#o|d;4=}=+)Nr>{mJKsIyX_9NBI}w2NLog@gKLn zorW?hqJ$}u$rSNgXrhTHS?K4D&}YNND63kF#>LazDfh!3AnN{dg-0Yty3;GAtpzi; z7JZ}h5F`ErBl%Q-ZkYqGM{YCAU{0;}UoC*3GRdtyHf?uoe~-t!z6W&B#le!hfxw)5 zpw^Cfz#357A0GN`3cXBL?H|p}kb8$c_*MZ(hQ~-oZQ4YSTeuA#zDtYs^J_9anqThS zza{URYgWfj{92nJiSiEnJ0hH=#|Dfddv{4Pe^Xj^6!W$XJls)?>L}&?>1V8&%Vhbe zh&Kg&Unf_o)9$pKd2LtgBgOmp{o~0?JCkncpF8@v`Cnp^33TsEnbP0Jlw|1w5lcj> z6RSkdihS?)@JetOGy6UXdM15q<$>zMoLvGMVNkq zd8INIV*6w_ODkgE&oZ_>V#7%3zts&~Al$5>sZYFV$$+CpBc%D($osHA>d%XV3HM;t z>*N0H5E=i0Sbm`Mur+FaJnP1*V>SODQFnTIjqcaX-@mKTB37WjKdN^h!t!*oLHeW6 zWWN6Woi-g+X?@(rIFH}OntmKv;3Tbf*FOT$q2IMI9rxaRDj*Sli2hpm-G$^uDKDkp zX4>8!i7&>uZq(q#pCGCOSKwsT&e?Z>=bnxFO2=t5mG}GJ^!TU&j$6r-kZnkTx&yL+ zwgKRbtXs)@OaIH$cllA4QhCP(c=7|~Y3gBHD65%*FYEnNo~_CL6?itc zmg(RbgBYn>-w)qtt^sMZ^T;^xy{|aTG~ZGA+N@`9dl2995u5bm9>#U*T9N5J1D%vV z8PvWUO>Y-b_w`to?(Q&td6lYC5rQwy^O3DjmA7L!kW2k1)2?687 z2v6dFWpX#4wEVwH@AF-&-SR{~rJrMUB+o5R{Pv!~1CFNMp@KLC{Q#NWQ9%!FUF)5P z4yu3jut{BiSN1zy1M?daS>*Co^B1F1pNN_SkNHyS+h`NxfGs=T`gc6Pv?FZJe64+^ z^S|wtQO<1#_iMdFU14ywioNz_1#W^f+vQ!)o&_RDqfg!sb$Bhs*VCE&>00T|Oz9|+ zHz+4`QbBM3%vT*i;kYHMO1$rpOzw;)=P`jPQA$zP1#EHz=0CVmlybiqNY}}`_=n5m z|M#;>mzvDHF{9tBy81}a)z3!OW6a2pqp5qOKs}7cufZU!UF1x9th505xI81}SPRnp8)MguAZrZPX++i7w}f@KL=!owcPbO?xm0 z6Kz(+k!h|G-Co@$K_}IL*XT`CK6dc-k9FIYsG~tF!w>4oM^IcTMMwBF?C-FZK?QVW zld#ef5O<`qq>~K};c*)|BQ|dN+!knUUpYt_tn(Z76NkkkrP&Dzb2lS<}zv%RtBYIG_b~02dph<}M z?+wb+=UMFe?8>P}W(oqJ@y9owEcLAKkQNTM4rBV|f9t&BcTXJ8THKJn*FoZ|YW)3M zL$;9gt7Ca%=7G^dq1b@FT%VuBvzd>LDzE&!<|0h@3w=;A?Sh*-$pOmcICDq| z=MN*n>iu#pf*cX$;jL|@H;mQ@KV_~c*6}{gb9eYM`K|_15-#T2M%dw!!7JOyb6d3W zrg;>R5i!ne(&Ic{iaOn=JJua*U5QRa+0X3pT?>L91ldxF`EEtv@E>NzH20$Wr@0kk zusAF0BIk%4#1I+%zj9*{qF5I}&SM0N!~;W{{q@m}6Y~Qe@@Tqz7KA*G7Eu;a+8RN# zBXG^6CqA59a&{+gh%eknIFy(udWvni9nO<@gJv}~St!{_8<4MJ#U zl@i)!Eb;D3R`Meb?+Ri5J`Qi(#=K$;thO{>B$foyjhwf8U2vHa(ncJOnU8%)_u-k z8{2*@7U*iXFjNMhEi_dOGkE9ys>MM6hm}t4yL+qU_dIZWg1@vPkQrsfh`Uwz$FRbi z%NsN_wNSqT*F2DScsbwFyGJ?X&IqnwAc-GBCLEEfcQc`2DCv%+YsHI1O9ru>Tb?gMLmNz>TM1{wqTGMBILRkirrW$w^0Y+wa?hvdhyDM^$6y z?Lqkb{H-m}bGj$Ovan~4iJi1Uayz`2XZLRiCf6zcHpOe58H7Bn&~ku$ew=8OSWNB5 zQ+S`NAbtxO@jcpA>4 zLOU~N24{&83^Q)(hO_vK+g@0%k3$IU#4`zco%-m^M95s6&WJHE6GtUaH678+Dh;0S~y;o_~Dw!QCTRdH@o;3=}#9FrpSYiJQ%dSXz- zUdXS@vXX*JlBwOO!duE94uE5>2vM?t%9hu^n@`>|1PR>c{}9iF<~4r?phjM^!Azu} zfIO<-M!o28wKpVD$w3y$O9ORb8+%khu+W|G!lRf+ptu@HLk2DzibLtzf4pF~Q~Cf8 zkGFC5ZEhPoHEHcyU zBhP!?^%@f~F54s?{K)O6(-w5=&UzIm)yn^ZE5-5#{rqm$*ZoHr#=0GOkj{FKXxc;c z9-gT$Nz~$?O&s|kbsCTovB~)Xc?@|l%SRekfZB{vi9fN5(%g@NuZ`}qE#0)LBdlqZrjyMJ}uOS55t zsxzQUIv zhWbRx`aALuILdkT?(Zmk9gQ;f&{LG%0$A-KN9S(x_gDXmgHosPMpwSBo&-q;c%vaa zGwdN%3a0C$1`u#*)=|NC#v-Wk?VWoTyS2Zu_MKK#ph4;f4so?H-ouMOA ziMR6Jiy5@q3xzJ_xJs`Rx86EKB2Bl$PG!^UsA!g6qFsIs@-WBx>*~ybKEF6^D%K`+ z&lFX5vjK%1KCCAnU$G)cx-G+pD}F~liztPdC!(*bi(uRWWaU)KU|-%PJAd9wm_qdL zoIu3rVjit5)=BxC&bF`K-WZkyGBJ85{mO9v!}T)rD&w4hPNbTU>Bi^RZT2+h?WVLtyGNt8kmKN8XDn!(#qz>3d`FoAH%0G*mbKwocyu1b@C zB1O^?NlQynXJspB#j7+NosLIepU7KuN8Y=;Gz@5;Y*DIR^?k$rjZjb7eO z>xPGCTL4PN5vlYns9y`^(0{w0B~leHNq`SArB-zB8dX^e*i#y5nF0*JHs;h5~q zrcblR-(T&UU@>Udl;N%5J0g9>76B9}1QH*79uqT+F&Yb2`8uNB>61ZTAi??gGxj#N zjdZxr{y&G0nXR%Z&_{93UC~~ZIMo&$2hfg#s{`hbp1Kl1e#>;JHHW>kty-Ah>1xD; zXK1zO^2)ErCF+meXn2>N1ITnPTpI`d52J7_D;Z{~7zGIN(*5}dOqCgW3UA#?R{z6^ z{u=rAUQ=FB6Kli=v0jKx20jh1UF0zFJd1pb{xhL;ib0Ad+(>ruew#E3NYqK@M`imiGig=|l&L`T&v1?d3i8GiY5yIwPBiTXo=q|xfn**Mp}U|e3gv7IS{ zC7-Nkh`mrc3hiY0GAl{P0!0F*_3_TLXmym5h7x;s2U1e`7IdH59SocSx#HovNkV~$ zx1eB;2pLmMvb~!^hm+Brw##bP)Q>u0-Y(JZ0czF5BHF8Y!Ijh8J6V<<1pr=<-bWs# zd?X>}pdxy2M?`~c%+LJy0_(M4;bjUv^xOQurn*EzrxY)yRd5SO?DJuWQ_T09;YNI5frEzU1%NZ$im?7ZIA;YEH1j7SZMVR?ocyH8(^6IH-zT6lMu8`R9`W z!%-sSelLO`zW4LBkKv&Zg8*g3yM`Rw7_SVnj!&3D1LD+TS4S_8=OB);`6i13^LbAF zj1gssVsOMK7;-~(>p7!X?68xH-pnob&B!?+H?W=3rBferU~L^#+A`;b`0^*{TZ#62 zAg*B~3alG$%BwjXla67iryC*~Bh91GI4=83M|6aA<}#hI6`uEMapNL>V(uJ0w+i+? ziTOgU@x;Oza0tCbn!VASoO4AM@(r<0eRfJonAdf;yrl!G#fd?|8GP07Ndy->qcqvPJ*|iD@5_0=Grd@AI5NKJO$SmXRwYCoxuby zwf&g+4jy?pH1-mGN@!;{uFo6QCQ@{xdxIhCxNCW#Ebz;~I z^aAY~Zs?R`9FS-N2yUjq5|$LmTsDDmx&rzXoMsDjt4h}~;Nfv>GX{WGbx>@PF!h?| z;PolB`ptqcfeFa8lVm7tk_y}$k5?vQUr!!IB-7_y$sOOvM@>=+9XF2QrL6mvDl2u~LGtSst8#6tw@hT=a+ z-1W-O%##7l*8TJn#^H$6z@H_*PV!nZO^g)D zPrYw0lA4gBZb6&EkYjmZ9?PV{#_a~;k~0$;vm?=TJ6SDg)VBuIiwL&>3H6tE1)yvg z9(+vS9PJ`nc{II@6864Pxe9RK0a_u~Eu28E(aprJR1opF8Z8Ek#Hl}w%o~KfC@x!7 z;ZBcAGKxH6DqVh*xb@=B0l% zT<^5Z2BP9(2ejT8+XR$*m_>)Uqy?j0Ce6RFlSP7AJ=bBGolw}YiX#6B9ec&HVIFW= z5j$~mG2;e`ntM(a1cQ7eo(QbiMUO5jH+2K6t!rWv1&9shJf_9%GW_?IK$39{oE)!5sKkY$DQ!C?(`fBq+YZ1d=of2QC{BLVxR~T~RYy6^1JfB+ z_9X!L@%UX@!|HRaF0sUT!Zy~}3JT&PD8lX#In^IA(ri}h~ERYqwNhfh) z3AWD7ZUNJPj1isk?o!2^|BO^qG3CY_tV+=yhpqDwcJ2oRh&0%=Qt=^{gz?r%KcTra zeYd0KR8Vj2Tk^xR+OXUF3~oN_1_za1qESqygnqP<)pi)w(C|E9 zfS=RL@c21K7*T+5m{94?V=~x8$Y2vugH1%WDAyQiD4{_(h8#TQNhb`|2&2HsB}c&7 zB5_!u5Tp^&W^{j869kH`Gl8-Z5B$$UvW`5Dgbkla9({N{^FRZmG-KY>WMCsAh=Hs1 z<7)t;FY9bE;k9#^oTUKhsS zI)7rr9%(D3^!JY?c20U3aw-AIaIkUC38~hGmWU}4Bt6sN!4<~=SseC{!Azt&@`YX@ zh$T*wNXTivj$h9ySztq=%;NCHe}aT=L^};rGuU4Pt`;%XKW6*@;devOh=_fmg#219 z5P(_;DB;UDcEgntfRRFJJWDgu>%E)2JKd{oBXPMV1&3?2W$;?kGtwU^IpWQ@q@3I2 zQZPfM0DS{RyL^_Z){c2|+&_kglryX(2hzy{#B5N+mrn)i4a6j`Ag!M$-)AGIk?y~q zd#<|xJNE#6tM$(29D`fL_BN+uom48K?oqm4vFca#2Rx@)s?jt>juH0}ne2{A>e0zY zi4!<>obH?hiB5zg&LRw2)Mg#F;zfuA&ro30r(mY0r}v2H1xB4CydrkdjX^-) z$Ht=#>0J!AYo(}PMba8m)ZG?1Vz@O3$|z=2R0Ws@$1-Q2s6`uwAF1Z7M)J)t(o5+^ zCd(6&=kx}RfHNhw{5PCR6d6Xc1KmpIbkg;)@1Fw!vIzsS*+6eXK{&5;j{|7)cij_PJ1B1lfyQu0#V56o z5T^|nMjtdR4xPs4_}WtzIgInk25)!+D{j$y5f+bpr>~tO4F#vj;ho*4k!dN4-x_f# z0VXEoy4~NTj3LMB8msSZJ4PC4CXwvR2&-vlz>FBs5me=^?mioYTr1l)#0DRy;UBuz zbR;@8=>~|t5xw0{?q26uGBPcml`H2(EBz;HsT6r6XaHhv*AVNDVNP>zNNz6Hj9{B-Qt z_ARpCCT=X3H>3MRz^}zFO`(fSRwG6V99T|;t$Q}tYi^~Mu;e0d@GF8j9C@#9IMBAv zxCKJM8jPZAEwX#P#OHbo1_n_3KU=Ukpm3KVD=XOb;s?A}s^~1+z5P#y1;oqUnv3dq zQ(A|sHO;+lTybN-V!kl(gBXCV zHtN@1_TxXsk|?`S^cneV#p+wHDdsJ>>6A|KN+xUP+W!uf;&!AhIl4g zr6p#o1=uW*)&o6@ijI+d`A=YCV&Ln*uA%|JnUsivTbM;2_SUP$IaI0QzoxCDsEb^G z`Oyrz&hFR1dh*?+1@Y=j3+_9D&$+L&Nx)D^)}RL`mWZ+(3Jv-S3ij0DrbssjEW}8Y z_9OmFt43rwfU)yU%r(a9#99C{m>mPiKtnyUCB_l-7nX?tUequ&{r92>^%IgNzr%R$nEhCn1>pT#>SvVaud=cqz#=y=5QY*_sem8qu%_Q9FNKns*= ze7$1%so@-nBr2Yth)EX$VwY=N$Nq8;CYqtZj?7YEBY+&go6-;aq zT*fW0f%X2iIu;F%-6)BY2omaiT{FRgcq&f=g~2XF&Nqj_)PaUrMO%+aPqnBFU{k^} zgaN=1sr2&uXz>68CotcqjF=MMf`L>DRX2HOnwY%$7N7%C$SEi!)*ht;(C8Q)FE%;ss#hnAO%uZ8FU$#qsd(B5E`w z-{NQ{se~^@e;cVL4v%s1Q7L=Y7ffltR`B0YIh4IY8gagM?6a*)qy*_T6zXAYaQW@m zlcN!%DAvBqqYwdO4}R4qVkHJD=2}mya_BuzS{HGOg7r+YhcrKdebDhDjIYAv!3t-~ z6ISq)V-!WQ-^+tz(=TvTthz3~jMV1bUg_MqYxGx5!2+-Ehk#%>OgEYNs!$~YO$A-V z6lm|T?cRE0p==^3X!slPAf)CXC;p3{-TznUf=*mcjHQ9*KDoKSeS>8JAA$ zP2GUXIk$_#pOy9`g|qa8T1KM)ljwr-VCthcuFQ@yiPoIcde<3p`v|HsG$S z%ZtKyO4ts(lc$_lCgW63jjD*O-OOF71m}Fc4ZO?3h#7Ii4ZV=W=hbzhIkn*UMj52M~ zXWE%#gTDMKV)`r7dR!dp>XZle%`=rzD-GWhj*bNIRZLs;#aPHJI}$pNQ6Zrvn-WQ;%|8IRPq zI>1xI+{8^MyN3`-i1Ja0xvSI-V>xz=???z0&EKA1ekG?`4RE}^T`-|t{08KCzAH7z zwjm47K~}Wes+}-IteWV_S-_v9)jEe1iN^hzjaPBPCS~J@2{h|u4Bt}l3}@{sNUP5F zd2fhzih`!!5H5(&17+{s6bxtO%)B!hpL(ccs`X5JXX^CUo4TY%NW3*YX)TyFC%tf` z^n)C~6_Ow(OoN|peSFHW*G|l?W(VQ=y9%Mq$5jGzj1R~>D`}Gl>zmJZMR40y@6usA z*!o~Um#SKCt}=`CajYQlmJ0)szK6LLgEYQuCFF5kQFEt-6Rdn&nBjyPjJz(jI-R95 zdJ;t)o~gz)H~7I714HoFz}P+a=btpdCMa~-T%k2EP*f4-<4`f>bcvei#vh@6KeOt_ zhv#_^YfQwapq1~8{#C}X3 zTp+G%gWsz+d(J^<80f|=waX%ERYt{-RbsV0JN^l!Ad!0K^4^uTA%`gTS)$My9xo*E ziwL-KlI();j~1L_$@Pgju=~ywIOl_au7xV;3ZAN4lI1JgWb&jj zb^ZXgc=%0rIj^$1rk@~ARUWY))tdISRgN*0k1GeWSJiaUDgJd*c(CSNm+H>;WFZZ& zUYdEs87y$B-~wrucLlf9y3JQH{LPvY*rP7|jQ&_9xel2xW%6w>WN+5tRsM0)x&f|; zex{H@_5kTr0UR?;cA;s97}Fntjeyj8u2wKfUk&fM)x|c=piais4YrM4Ay0E(5>hP+ z4lw3*xZBL^-T#^L(a@mj;7^Wx}>B6 zR}d(ZlKx&?Nj6lG@1myicHV>81sZNVogr3^;#2@*=pIA}P5U_SLHek;1IQeDXXeTo z1mH?=tuz@-W4I=jxB8wi&5J|>^}WebW>eNAzjGfbSno8k1?-^d#b#_3Ee_c?aUdXc zolrqr$xN?z5~#YxSw4a=hGPg-Eg-Ll|6>!)y$K3mprP-i-vCOIK4;Izp;|(Ezz5HQ zJU+ZwH-BWFpgWQ{dck83Bqi=TDa11+$?a_ZVBv#{1=80-tfxw9>iZY3sQiDm=fcKh z>?$01fuQ<8P~*KvAQ!Q9J#19v65@lheqHxEZn(x4TlC-deMSt`OWO3P`Qh!dZ21vF zWuI?`SpWlK;CB@Fv6V~|iszoNS8+5eaW=907}jTpBphaVOWH>jz6A#8d*N(fI%wr2 zh8rQ;L-s?4SQ(r}E~ui-l>q}oF1^+ECN<)^-sjX3ClqTIIti;W#;4q*06;@b&aJVB z;CIAG-ofcYIKf}`Hpm>AswC##J@WMz2^!P_=k!_~({Px*>=k&D!fmIqM@R5%@;HEG z_pIuf`R*A{T(A*$)5G(1J7iHlw7|iDD@0l19~`xCS!)0=O2Sa53hgWNdx|;W&A2-e zU=dYxZ!b8m1fh34vjDu~DwG+LEtwvn`%I=dwwEz&00oWXs!covSwr&-UG|vXn5YoA zsNdpui03o|J7lIoU??_Y&u@|Iv$C)~x|!*)?Nf}KmxV6K$OUXu(I4-<&CM0Q4~o_?Py`A9=w4I8`_0&W;tG4oCtv){JqZq2!2A=WZp^sCVwxDLG2FYfQ0quY+Zg{uwTB zB%7k%cjDHMfGLLqEZ`5Y0M|NX&d}^!y~7zV355(WllOeJpH!wpQkqV~1>0*3;JQt# z&*o`Av5%+h77j2%d@i1}3|o`c&j1ptxSftBx^Jx7@dl)OBIRWh+1c`9A_8y$Aa*ki zoRH-1a0|*NRszzaHN@UXmYM5(R-qyZlZnftsTmmy42SdB6*_ZM`IfB$G^WABr;^FA z1sp#IOsqKE!f1u3s$Jy^1&h=ZLw$O4oehD<$ayD#q6oc^d61I>8|<8{Ats$!I%uU z8dwddMYO#Go7?6rN8ADWpD~=}{7fk&2c=pP>+04f7xj!XdUNl=)(^p)LB4FoDjep6)U*)L)4qJmIWU{++P2=sRVh@*cdU5vfGo`eKTsD?FWa*exLUjW>t@MaCc?fTHBTUyLmn{!`5y36< zu~9*p!ThFRar#pfhdPYy;tOj2eijcPeZ~-)he!BA#i{KEKQPT3X%a40k;^o{K?1yD(H6}mmSXjDKF!m6FjNc}P1y}lz|>QPM} z5Ir^|3y5wJLcM5)#gq?2Je)_c&^4|z7oN=)EJAI{n;f>yC;9&#Tf?O?9deM2R>_5f zqE;~)F?S%!eznO+Oa?ql>d#X73o-+dSagqt<{SX3oolGd->3EE&lwef0a!A>Z)}>- zLBsRek4E_}$rfhtKRMjpL(nwHWpHjQE5+<2k|8bbVhBeO^s3Hb;X|dradYjURg_6$H>=j(}J>q z2Pqk3-ZwEMFz{CZ=L|MXL?j=2ETMJ zEPdW&tUB@R#`E(}-D)P!zv9*gTT=^(AdA~ERGow|r~WEs;LR8)z&XkU5g=D^Yz_(u zXf7+DxzM2dYmAD zQh@Xpc72nAErZmXvx^UkZ9wO;SzW+IbYqzv(%4@4yeVHa(7|AVI<#iRgv5D=!02a^`a##eVs zvwV3QOPcC<3ajlPwUYGWq|X?Hx({N5UA?@2g=;)J8;%$KmXLuoPSZYxt2UL&;2fpq z6Sa;3TrK$IjVD$KpUT<%1;K8v<4*&%z4vnC3(!6vlCkN*`r>%B%3-fyMQ7Qqx6FdY z$!tk~H=h{aPX6qA&TaYn74huxw2FRp(Zh3}ED(?IC^J5O6bnxcQda@+$vkO`D00*~ zpD{@qZFMBTJVaa!eh@Mr$PmRZwp?5RLVz%Z-WiPn$PFt77p>VJz`CA(8lp(ac^B3k zv7+>JD5*5tr0M=N7dRs!3YE_gD2xPjYarTCEQ5zdF{>Yp#qJhysgrVHGkr0}iGHOe z;=d9{ufuQ`#0Jm8VZbES7o)Tg(w{U|L0!SewSEZUf=qiW$sb(H`F4_~JZ%+G>r0f1 z1zsQ$dLvL1BM%0R^~Eo-7bO5ogO?!<`6?)aUi4ji*lhy+-tuQkCzyM+8}3oCn-0<_ z^c=!MnZ*IXO9*pUu4WR?-_Gi(Pk_=+#yc!J9zH%;CJ;jPvKOglw$5;oZrdmsg4soV zsckdOQq1j6lC;e0K9c$Pn4~16_607L7b)S7@5oJo%@uO~MpT*s9vq@(TKCZq(aEez zSU}19!K-WcNQ1CTmxn{Am2O(}wB%JYdxe=Y3E-Bq;mRbITYYS6o#&C915^DLL+r&$ z+KPZP^kwx{-)8p&2sjE$z~o85;1H_Tas&LM&H@sM%!@A5Q1ndpu^aJ0e#;#OtB9T3 z>2R_20P{{mea$AYhuAW^qeuaJ>oaUe0)nreOLrMBU00@Si4b%g2) z_bJ)9Yqk-B93-lI{{HSz%K%8_3aee~i{12b2diN)Xuof?fxlE!!a^-ZWg9720o=Wu65ctQDMfovr6lzcx)iD@E4Uz;bnO^(cj)(okF1b-<=$VTeVE1~&=^3FO+;*1+k%_r? z*3!_?ldS~6COOzQN%yi;AW*Z!_rBwqpVtgfYqglF;mR;+GrVFM%I;qu`;`& z_Le+AMlSDi;&QL%E!C@F$cIm4n9F=g`ew=aDC$32OmAck$-*IeNx*p`Q4&!;1q2w{3_C7)O)za{Q}Tj-8JhDQhGG$t)L)y2=^8 zPbk6t0zvv8er7A(e^|W&&f+in<63iN?6N?XQ^Aj-2rbi?hY<9)0@tCV-={MpVA(dd zdSCQ?qJ=P?#Kv`@**O=7F#KUH{+94^xwFyO_UAgmpl>m1fZZf=f(fw_9 zPI*YvqZ`$FO;%hZsrSVcn^fk73~+Mnm~>}`-&UDKQYZue;fFcm%>}j!jbli0*6XWq zcx*VrG@r+8=@K-axy{j$I+)NFOV>xx=(i|Td;eBEPSG$aUR78g4r!l$QA8UGIH@9`SAQ>M z2iWSDA}9jqrl2i}m*OS?W|j&!Ip2H)A|DrQflJp~Hc3ZDR9*kfBGf>n2oJ{R>Kny_ z!^8jmD$x$iUoO^61S&+u5-*m5n&y7%f<}4G{j?z&@@mcLj#Ty+yeKQMNN#v z6(=@FKJ3=u5_3}OVak`t?F5bDj`un21V#jcrV1dJ78Hn-$H#=7_JN~3S3DO<26qov z(~14=a1HJ+&Ma2D1s?KRf}Bx4T`llf-jVr6IPB#p-!j&F6nVer01S+=$DO6o+!i@>&9eI^OhZ!0SRDDq!7|_y9@L^i38jt&R``tckEHMD2RG#k)h2 z+>fbFRHO1P+o+e7Q&HTZd?Ub{wSCi?503YMFhvlBRBMia zb=>841RP(}1Wpte9Kl~ftQw>&XP2!72%y^g&Y2iYpR@{(-Q5Y!6F~lmh7aiS)c2=K zscwH8P8{>#tw?-J-tq7eaCn{#JDFJ9^wmK}*FJd9i>-ey=F^IO@kpsG=VU7+`r;vn^n;3a5F{OH-1?sjGU7 zF=PVkC<41I5XC;+s#jAtMXMDUEiu!Gl=I9UPsKG#(Sb@NXFhDutQpv6sq;kdm+R3w z8*3IdY&XUr&aSwnXBh{)`Aj{_#~E_HD1Qdv$e!3Y^Sbhg)E?jA%_X!by3zjd&+Jk` zCh~<2+gT;VChsQYrehFe29@bFf7OaN+9p^NzO{7MQ~tYhar-Iw^RVd2*+oTHRd#qvV zvYSSWOo?9$kUMY8lLpwTT~jHlcO@mt{4;+@_qnaS=|L@GrfyJd=WyfGqiC;qs}@GI zpksv7PpV^yTKXh$t1HQ!`Xw*g2w%Kd`;;so_|hw=p{?TP?+wQ(+RjJ6jC&5h4#owp z{*9ju#;1R+u06}bpgmhC@zg(4((>X<%;cZKee;C{YUSeRpTa8D*R7$7n};;+;LQuyk}(TQFV*jw{*)HL-^EVUupdmhgJJEVV<-L zy|Is!?ys3kL|s7~ec+(+h|HIZMCN7L+$v`ab(hz2znUE$qF`bVGRhjN{uCU2+WwV# z61|aURTicyxQrJXzWpqYHr@K>@7{+O0V_Ai<~|E%sl3}ENFq;Khg7yHNKity{&JVn zAz~;3KXX;+z9(8n#OQy`)J=SA?1CP9!g2XVH*pzT(2-v2$17SF$&h{8gNMP&MK8O1 zuL8&ByS~J-Ka#h!sw4WdhHOfoBAlKtN&($=)fozrP*3_2A9ovd=SYyH@VvV6>AAbs zVYaLz<7+6Auv)b%*fNw?K*CN!VP|X91R}StIv5vPkz*~U?YS-(&QY*D8#(%&N$%-6 z?t_8YZ7v!ow9|gJWI^0#kQb)UyIf@=``)4pNoy%ssO5y=eWABUve1{Q{we7Xr7LA= z`@7x0VqX9kPFDNLWUm8zixi$r5N$Sjz00EuTnJgxY3WV6675HP;Na_PMDc{Abo6cP z+8^7+2)Jzq+oKZ|aLpf23><$${v@KZ5#ZnoLueCfLEAz?j{_RfT`x3%+xJq1JY-2w z?~sCe@9dU5s89=PxHsJAXSvO3PzN3N@_igMtCD%86`h`-nK|7uoJ=|h!gyV0)^4}H z82bD$8)uu_()82ZTg_vKeaGFja-0f_d0kI4yug?p32ly?F!xldu)k`*HdQyQa+?XK zmpNo#bs?)fQXAV*h*2~l0@FoDre5tUm;G%;^Lqf0RvJvi5Q^o!g34U(=hPlP-;QUB| zHAzV@LJep2Wb2DN;j}p$5%Y7JxZ=o!_ZqnG8rQ*N>{FvK+(MUEmW99f=cPZ7cOWN;uZ%5R%z;?x!>@ovyoGV%Qv&*?L zLK85tW{UKLD0W=>;_eMt)7;0l+wz}bgE~$*e)lExB%XZ_gZ|VovMYRfYxC1D7btEm zb#~g!1%Y5g@3*Wc!}5f2V~svgb%T%}-q4w3WD#d7#^GrwJvbDzq&nWN2a8-`OQXO4 zwej9^8SI~nIlc47bd(yj;36K4GQ z$6xG>;NwxTWfHVfrGH90iF|*jyp1UdB~hKWUoha%n;!P%94R^w+ zsm0l|HakKaiQ=%W(I`BbIKG9^)8pET1#@1JN*^9A zn8-`hhZi2V0Fj;XL*u6UGyll$+@t?y`up?D)$-pDLATh%?BpO$=)u1NU4FA^edN#X zxOXz0egyhlD*ff2CZjl)!Ce+TRF^}Un9-Mhfwx)?VI!q zp87H3MFP){N+|pA^eFdsK5GL6Q!9k*+~C*Kfi8sM>HVZ|e2eY;PcoAkMt?A{+OxOuN2ix<@+}SrdpHKg2zfj;Ln73D#KoNF8nZM2*CjAX)*>o z8!HnhNX!3_#c+xI)uwS}65A@GuatP9^r^5(ha|t6`^(d6lB_cEjD^Rys{e3^aR5r8 zAYRrW>#4TSmG&xkaM2jy%8>TEsP;nTgH<{pHhHe3gio3C2idhfOPF&j@~bMf9OQ8; zA7Acr?tH_$)hb=*pU~$#D0xTLfoG8^>cB#L14fygsrJMR4 zz0PeseNG&>OG_{CL*^Lf{kg-CmR4VW832syRF4$u)p)Ai^cf^tJK64I6ze^|Dpvb* z&yX9(E(~u;{vIJfUpR`Jb$7S#y$JL~NtI}~cjy7^k}bu5&AVoJ%vDCX>K|9?1p^FXNE?{D0`3)4iDrD;YpmSl^R3`QC2SVBl8Webrlva1*+h9Udd z*M!KvRQ7CH%a$zJLbhaouHnA#&*$^~KELPtJik9G@0pzUxvq0w=e*8&pKB(4UM2{L zPf*gWqewoQRsP}uRk~w36@)f!{q=Ip8)RLUHEY51+i$hFGpQJeOvl#*Y1ilwv^bga zH`!V3H5tFFz7EK$rFl!0q@A_H%mwf*p7?5owRvE9bE5hLnX-74ft@jy@nl!koKVv} z!=yU0@!)nZX3j4;`vvRW_%uO%f=5@J>d1*mRr&AvHpXwVShHbY@#jlBmcM%X#ecUgZK=CPy^+-mbc-~?h>6J#2#|e0*%QkUG-CrSCd>Qb-!bkPi2;88R zvBJ!&8tn@izH;(U%4v|X1J6ROgL_c*C;We`qne-+9hRY7U7=K@%*U~9k{vLXJxDeM zkD>hn_-}5wZ(3ka1bBPy#>YL9=k4*g!QL>{hpj6%t$DSI)Al0v(Z`cl#K-;T+UJ#< zdd=ChGf(y)Cbo`RIV|ptX5Qa2jms|`$l0HE*x%ZywSD`YYcEFAXX;7p?Oi3u*0>tW zo|n(lgC#~+6YO4ZL*!y|*T94X-E6 z{BJW({HQ-!U^3dW+CpubGA{Pk>aBXeiM^`{KVI!Pbs*mT2k3geY$T>-IDXC0T(#(o z?}=x;@m|*fMV)&}tETydg3;M^KyBwnN%b}rKIOfJy-)i+xl1V2@PeDANHx0!Cqt3;Snf?O{&z&0{6Ry6!6w z*?XrGlbTzWgA;HL*%T{1kD1Ms7X}bd8BldBIj;sD8D;yn$#xKJvv?`%SRae4d51n% zq+q9~IX3}2;u%3vaTfNihRm#(>b&9XbBBk2y%y%r0qME#UCwyt{J+8m)KtK z@2f^14r6R)P)Cx(#lvF9-K)cV-VA>!3z%O2AbsRAf5Ql<)>=Qgdht#_?G5cVLnORU zfAL$WDgOOx&vQxDtWR+l1A?e@U&g=Z$&|Skw@MpF*>HnvamTssiRW0;TXPTNXc?c6Ps~3X zEByLW-2c*4_G(w2?8FD1#&g2`xQmrHW*F~*&uRZ|`}qA$swfX0!wx*~-$CHNx8?*b zRW^1obAzk*3|K4+QjB$%B{3QN-Dk0UEBj~^V;doSHEYX zcKEg9ENS$Exr1%TJx42ZX61*&Yn+I=i>=As_vMXWeb_rVq^?Dj67#g6g%y^m*1{Aw z6sGYK^E2!TeM16!0;W4^%L2ptVuOnr;bq02T{rGEoeZbA zaOHZedM{!RTDQrFD;TlUJWBxCa4??xZovr1hBOe`N@C))AT3%O7xxyFJM8qX!czJA zbtD-SNd}4Xt-#XW4@jdDVa#gRT!YbG!Y%Y?6o*sU_qTJcyXmN8d8Lp`f4-0M;i8Kz8Hnm=MHiM;=pp9G_58 z&^FA{Hh6l@3ArgII;r`NPxAOuGc!K-*fw_f&b`k*Si0`Barwj-x?t(L2vx?hTN+li zHexSmT8Yl=f5}#)z(u>StZN{{(6*-UVYqSUBUDcX7{fM+5Q=BrH-oM}D@pZ5J?oaF z1KgvKVQh)WbnfA~J(!UXPPZ=5?N2o;f$6whBw(wQ4KIc-304+=hCS#?z7+obSfv2^ z#^c&w-!+i9x~^mqM>$$P&iK-*nML`VPR3^@q%&P)kam+Wmrj?yVl9Bg z9+GKe`6(BkNZP)|Yj|s{I(WG;LHyQ=4A1 z=c4x|y#VVizWj^zFkLpy9!RE)UL1-+ay`IUNZ8Plb zPdx_&Qpg8S5md8R;bHLFa zxq#H+5$PJd5?S*|nVy9-#GeOAAKDaA=MS!^YN9rQGRuz0-O=AUAt0q)*$^F{;fTl- zw(%Nw;KtZ(>3d!j`=u26fY+UaI$B)Ln{Kdy+Y4=Yc4|(K zPsceuT4lLBl%|vvW;F9&JG!2K)2rEmKUNZR>|aFnOi?#o+GT!cS^&yChAj21ai}o% z1}q8fN!^DUBOymOR~$(){*z_G;r+43dMvv}o{3#JFPg&r4GT%DHjk z2Ad_GmWHRo0+d<^Ng58TRz#{JP|(-)Uc=8>f^fBEys-Qpn7zPlj;i`K7CZ)@xjZW_b6la*n41ow@|7TMHqgiXy^6pB% z)h4;1^_{oRZ6$^KY5G^SNm9Zd?(KN*%#B?KTHEVSjL@XyZN2fedjhMv zzG%J0PQvoNn+9UTZD=5=yk+?=uU9pWW`$WrpcY5t6bWtz3zG>(^Qn_B)~vv6=wJ|< zJ|Rl7uQvicR(xqQI<*7J%pi46SBjeTHK%e{&GSa0WLPCdEYL=h{HxLp?JSc>j^;Sb z|52pfi`B^2lv%cq*|vbi(aJYd>u1}+Kh#Y`nw8kfzZEg79r(YIrWv>z8BCFt>%*v` ze!QNFid8cZv@_{>Vi{!f;ka0aPfy|yZ91^9fh83(Q2xs<(ySPfx0G~MPo30#g{FdN z&i0DIGKX^-5|uTtcS)3@aE$Sl|J-AZyMegsKKx_>eTpN(ud3!XcXON+^`i)e$r2}y zW*{Cc-#eM%uhjzsU5X-K92$qxFOiM&CjbwM1vilC9?ptGllQWNK-IA(4kwjSj`Siu(Rr%E}540VaP6DKbFEgUh=`Ze)OkONA_+^=&$Sjz~+?ddwNC4XAtoL|P zv9b?hN*Q46FN7HwgelgM$n z7Z!w;%7=$>*{dAlm}Ui5@VDRmAAnfOGr>XC*FE)n0T0KecVd{XZ}*XwtM zfg`K`7C-#C4BDs3^cLglhu8mrh=%jP)IfEx$D!oFL9-&r(R?SEe8HzF>Zf*sW5(dl zB_)z^#m}QaVZBQodn^E!CEgVZ)U50Q;;Ss=)I2CCQaP&Z!ioB~J@^Jb6kMN|UsW_R3`L_H~?>H$xGYg}a2gfP82z@?X z-}LsBFIqNVpv&KQ9{qVO`}e!o7%|2?;!N4E&Z=K;q*qJAj&pf`Vy-2Z*6WfwwKjUn zq;ABu6ft_?&!9m<_EexEIlARxqGc20!cGOD^@uZw30AUqW_3;@{8;^Vl*kV2_Ig8`t<0`vYB{u~XQyiRZ{lz+*uDBn}QL6W>s zV2aAPnSb!}JQ-4LQ5EA?6_qPbj%8*vdjt^4#d`Ug#Xzt~N3?;U?$FJ5;5glUS^5d3 z{A}5F#epL>&#y9Ijt$8^xdCyJKcS{>ltKzK!X?OcF(hj`zka{i?|dxKF59fTJ3XTVITQ9b%@@b@yss6zh6AxOQ48HtR6LJaxhFfK7T=Zf>4 zV!w7j;xCbYMg_t7hhYf-QnuQ-QSQm-G6LGH?AYIk4ypT_8vsB3DZhO#AXy|i;>c~HZGOLi}w*H0^a8;llz*KrRqRShxfnV#O$9l!^l$9C#O~)Cj$HOAe_Xs-QJ%T~`_2C9{@w)tR_C`pM2@M$wPxz+ z;)^v2sX^w~pVVA#Qsg)1Xvphefu0b+6w>)YQ=dnen+@)!KCKZ+QtvxIq?7V0I=B|D z23=(?Q3vEs{Hk^Ms-R9=T(SC!QOc{-;&yK-7nFfO1hldb^%5tNTZ0it%U?x}#UfLT zUccwmp=_XI(8*I2Xh2S+z2fpw5qE$zRAHg3N=3*YNFWCzUWOnD^}Y|f`n zzW8l5r<;csM7ic#@Fg4dKM6MX_2@8HObIeCQLEH0q*Q|1va5=>%A$Tu-9C^(7TPO< zzX0?E%85Z6P9pG+A`XN$LC6>Ku@z9^Ff4w=CgCd5Ks_t&+VS6Hp-xIEiSkju%}YW} zkgkPaah`|5Q(lP<4u6 z)3&c6BRR=ekx?agV;d;e<7uB^I2vry-IC0y1Cjj#VdjyJx^3!h2a6@kEjNDqDiuTC zl^rFWHn81b6UeWNkT1TZW~&!c#iV}u^gd^cSK*Qlq_uW!>pKh52+5rDFy$oqX`9;f z`AP-by^B*$Uhgss_iR;OpJ~0zZi|J*UVg)v_tuEC*Y*o^gKr*P7d`9+A117q=7{x{ zqf?*WS8N{&-fs>=(v>WV7(;tkWLO?nDkue+YcBAiqRQDDsx)>%O~QJxt1a8=W=QVb$5O%O*JIcskx|6WG8}m`3iH~o0^4D&IKjKta~(GemfPo`T#hKXN_#f6~;C|RG@DwF1G!>tzqIg5!;PV0_P7Uj5LuIT%1tS0k3{e zdm>@G!J!WQH0WhLr+XhYrLFVxmdk#6R6yk!HKiLVYfM?w#m|^>Rs%mWoWe`@?M7$j z9>W!L1vpYRR2|R1E|R=GT0ys{rd%Tp!|p!Fui`2H6QwhCRq!^C2 zGle#}>I><*$Q@vOO^*#!9wc)D&Et=xo1nr!5;ujeW@vu}R=$11lkESif(wV{H%3+i zYzT@*9^l}&`OA#64NMkJVy?oye96c4-}{;SuGBt4;t_bHfo=CTK&@0r2}8 z4*eb&z7RvcI9NJnUqgT6=HHsOnfq4M_uSg3S!j{?vN#aCcKINv<%(GoUkgXCb?h0uRt%NL$ij{&~%s zcVMgP3t?O?q~VFrk0(B_W8S>H)b!-r%7=rl@vcVio59{xqn2AMm`#s@3ZEvndGo-E z#?!&RFuXMJ(Uyj7aL)xDVEyygMs7-s;>f!R{3x2{JUQ4!_3f7ZvP}VQzX;qOT%m)_ zC+57LXmps<=Wf5j(bgJ|>?w5m%H6%eg2Q=;W`$n8pk&2qo4f6>ccgA9a(SKSrRGE# z%X$;f{JY}q4ci8E#S;Umou8=M%7*PH6JPEiQ|x~K{&_}BGwPm?y93Pig>nF-#Tpm& zJfq)^{X`M`7WU8XK$?2B(F;8o>c>YLzpvQUS}xVogn1_0q#-Z)8SUZa^K1dCq(Pq- z)Xep;aF*R*h~>aDqN=fvKSqf=Qx)Rk^i2hpoy8lDGei;2--R$XV8h{fjKqv4Y?f6G z7NdFv_LUABZUhm4%pp`((01pAQ3R?OXp7>rsbldB?AR2oO=;yI6`1u1$FE@Z_)zU( zSUw!WV~7uIyjvBiDr9pN-g^z7#{GMJp+PIp7>m@x!*$>U(E7zX;27wC*_zD`Jy}sq0jjywyswYT^rxP^GKJ z!mAar@S`oN@F4*dM4bwwRGp^EmzA%|WT6X}>6r;q&5fr%QM&rh08-(?d9@D+ z6DCl7R>(E1xH(es)$A&UDiIb0*U5ZrzaR}vIrnQJ2}{QioTf+uH$eg0NBIf^vv(Z} zO4HmNQJ04>rpLql;#mHRS-y;CLkbYfHfzzUS<$B0!v$%<9q30!FOCk6LK&0I#;ZNh zeyU74Zwb%Y`8!4ZG5!-w;S@}2bgAiAeD-rhX!IhH}~4v z6$HFY_BUMb9Z5<9p8^ljhN<`~9|?!*Yr~HLdjxo|pZHTD06|yRM^g%L2B)p(CexUX zJLi~)QmKIXqHs7<2mDi+D@IA?j7m4l_Eyx8=nhI3{`G`@=?>i^;JGh8-W%7D_%x(Lqh(9J+^B5rtMyf zatG1kXIXUq;F%=XPPl{2{Bm8)WGKJfVxUKGW)~$u;A10b3&pAMVzb2)L4j4nP;81S zT>hc)-`KGDFu51ukxB$Ze3z2$!K<0#0x-)jXODupt#hYUP z8~%)P6m|?fd{~=!JpsHuX7OogK^3RBd@q9nFLgp0WqUU5c4W>4tTJ=c_H8OPGMox8 zi;jaG`mD}~abw9tLBIT>io2+$Vxe%{NzXh*Va8z#*|Jg@q(_A6yL%T-4xb@}tG-io zLKMOu2jnks?y8{(2VM&T)nALzg9qc^)<0W4@#?(*q48M*k-QpXvFLXuQu$=~Jto{W zJ;b>1wNjD03Jq%TNT+=Gg9t@9m;)n#Ik2(I;m zE-Jttu=49KuVR!sZ16O=H_Jw?CMh!-E9mvd1WF~CHG59x57!W~L7+r{I!lCK{w+jd z{Y|`xrcX}QIH42JsPHsC8r@y!xLlnsM>A1UFM9R4hcJ0B$5(5ov3L19&mB_ zL&WANT`;je;@48*{v@!0?$5Q3`O5TMtmN`8X~Mhdr6J@&#_o3_n$M;T8Sjn+a8T zn8f|kfBEUGhQy(t4vDIN*w0COXR;=o4${$L41jef9K@v{)#g==aEdwUL@IB3$>W&r zKLuq37Ip}Beu_ZO5ClvD`k%mbPa!~6;7AaSy+qJofeG`Md{`kI4R@aZw>f$H;=Kf2- zBbiM^C@lr21b9w-Oi?|^oHH+{11FA@*KwT$fjoO+kb`j~9*Vt~b!Ol89fWZgdVR$I zpZu9lw19C3TbzKam}CFU>&r!;#rD?f-{9x)lN?#{Wwoy_+1HN!@ji&J@qGvJ^=jLq z*U(1YZN%R>qAWQccvOR1slXk%h_yCryHb+y7yI(v`zUqzQNhy31WdU0e{#UW%I(wM zh1-25?Qhw)}DA!+Au2cIk;S|m;q*9df z0P#Lw2_9aQWM2EAwT3XJ8A`M`oR85&tX8v*3uECNug`G$4d5p_OpZR7V2qV>JFTUyUFXt0i1U$O~Q*Dx)6{pkfSA+%Gf+3R4bOs zv=N8g@28>D_U4%l0vWB+UGds0U_ivtXRJvWB%U)vuC@qDNm;%Jd0D%brB4}x>wnJ6 zM*J$%g-f0FNwOf{;KA^>Dw>n1?HA#y&E?wRIESZOwhMNfM^D=R8BCi>Y0S|~sg~Jo zHiDI=diQ0xRBSB#@evEVSK(tK{rTicFpu+foNZ@D#aSs~#{m-5Vi9uU+x~T(>e(4ZY0YcjL|iz+3Xbg2L6-<*S%;QxA520irn^{>~#A(_PY#d5}zZ zbViOl?Re4b5q06pCRKE?$6DI?0WXjc)PwtaJd~W+WISo|<*4*M)FClg*9`9h`xe|P zw;%^%R9Ab8e0VyGFyMaVY|Y+6k_k?0RFn+x{xsj0Wa$tv`Tjk@ml*goo=nR#=c!^Y z-T1ci9z>}-5-L<#GBT2hNp*#^;ZlFeZ+q}0fck(X8)H3=teoL_w|AvkVQ*o7uL=C^ z16pPKtEE1>+uuqEMy&+|H271eNf!=A#Z^55x?{{?+^_$l&jye!u%v&;xdKSt78)RR zuSaFtKDe(4e{mfT;}(EJBuy3JfEygJDEjNL zN#~bo%VQ{UL8tgkPF8|Ehx0L?+0(jD&4tqAHJ-+?^i+=sENS+5IpAU!&k#74N)??d zO5vneYSoj@`)HTUZNSDQ-wgx#Fo+WyU^a4_H?s}Em;Uzs$``iT=dC@Z1QWOI=hxaz za4O%5?%NB&!3l}&xwCxs-*Xklz6Z3@Uy_}Iwmf%}{|V|mj{&{I+Jf-I(Bl!F{!&4- zdtGWu1?<$4#}ehs=^n);@YF!=NT7!d%FBIiq>*Z=qJGYO03`20z2IbG{qNaYy|V(4 z<6J=&ipykzpkf|C6+WiT0i)EvJa$`V1_AQxsKDhLop1nl2yFROCZPOKtl~OG_f)%D zkr*LhbltkOQn0tu&I}GIxb_f%%IZ*)P*R02-pB+gWABpaT@Bdm*Qz9B^D#_!T72=Y zzhl+h>Y35WVf(M5@bI;2+ewv35@)ZbH41VsTUdRKr7@0Yf%i_K1_dercitv}RBSet@3<&}6{scd7k&U33 zbM9E^j}$dCce%gJ0qilrbx1Y8j4!+0w{_s!`6O1lX_08-#S@l(7s%B zk$-xYZEi>(l*av>Y)zd$i2amWjKtj#E>KW5Tu8cDmULur91O-HD5nQ%KfEErb#Nm> zfKK5~2V%zGx#zCJ znxH`M^elU#DJWk$HbLFJH|96j57uCct-I{qvA`+&?t!3no36X$MEPX#{s@Qi%$WV! z!21M1I{h4{s14Nf4vNYPxYzK7g4EvB1kY7mtx*gN&(x}X3=S+kdYOL0tB zyJcDsso&e-9a7P{VsH^Dr)3 z=}r)!<52x3B=@PymrEIpu@6j70cPrixQ?qL;0!k_%2=6>Ada6of^d#_h~QrTT{8M1 zK_R#X%=op%!>kuI^5BUWJ~gXm6agI609AJ>A)d{6(QW6~t|B0~(VM?mkXe9%l5YTq zln&oPya$SRuRKw1f!JP!kDZu48k$%Xw{mmlcS8uL&p3$WUszYjW$_d!i$yjB$t|M? z8#8B)T-bwqsDL`jbn^<_(`VtjO zHt5y0=RcaD2&hlI5}->oJgY5z!>@ngTu>VKJFUg2A^^1Vp1(53R@C-EnZM`4x6S)z z34}P{ZuiThozHyZzrrPsQT9~bimm|Fx_SE*ZQvpzumu@nrK2}Uz#D})_k0A z)EEaq=uCWb`YOW8-n5YM^^qQzdH=Sn>cBR8kouI04diER(mv=J;H=u<%?tc|ZfV4zT zX#w#EThVd1k>uKdJUqL6KblCEMFN}W| z-6x{q59af~M}VV};bBuXK7!?s$faw)^B=fnQN~0$6!b%kPe&cJL#)}6pyc2iwl>|n znrh=<%0N(UPS6TBYOU!9d+?y#<$*Tz()XD|%$;;SdUzL5RQWWWQE0HK{5NjRw)jug z5hl$Wwaq;|_V{Qu$)oReqgV%P48}ZEB9ENP8DD%lLh|Vy{Vn2l{I_&%=oD%jWdH;B zLL7v~Lk~+d*|QTmO)JEAnfG#->mpjOC-(}Jqp z%t?XYne1LM@PyCNneNgY=AYk>oODA{vauUu+Z>;fOUh@@XEnOrhG#iHsF|Zas*xLp z87JLp6$=P!yl#^!TksoA)tX9)ia?)9Q*2|X=d6tr;?ZSt9sY5Sle9)>vrU=B)_H*R z=_dqo|J-^Rs|%OSH^Nd7eWYx7x!!>0Z9e=w(g=HQiXD{Wrr0ahUJGn&vB!`~XVb0*)SR}zA$MwA}3mG9pqT9Sli9ey+5uU-swE9{6 zWZ1;s<1WYA2|(X3EdJic!h=Cqn|A|}`B2cB14%$N@k-DoSttU@6;$92H*(*O+{00B zs=kN}w)n8OUz6eve8?I?ZU}Q$i%$qhuU z(sMVRN)_L4!=Y!AMpEKfgt6O3%H-BK??#LToM0DbiWLcdoD}Hc7vNdgbMZ2kQEKyY z%PQ!YjYSLt!UTMeOKb*9?g*(b()K+{vIq=QZL6U>)c#tj$B*K7CVHWjnem|)8-q8n z2V1gNg8@!SM(cs{V`ZneS2PaV5ML!*z(zl6b)@fY*>6t6NKBQ14B*HQGJs^HA{_Kg zUohvGkUN$w`DTgZh0qiFKjn)@{6RM>#%cKKf3{Edvd>>DwQ7C`+s(;Zbj^LW5`h>4 zjVucU=yI?v2Fuy;@mKCAvjo$$jX8sOIvr80Wd{vLkUQe^pin8I(U@Rr^5P!QatXOV z;qEo?l$D?Q>5v;O@WQ9WwCX3n5_%R%`Xl~|Q*ptXVZ-*LzQhr3q^5kR&G_4xuSge&Q8oz zHokA^ihy^|EzGCN)X+Yk;JRAZ-u$I(x4;2)6S8+yS&I;9=0QwT`XSU}ojLCPkxiJ9 z)UhWON7k21-%?vbDF`lzq{ga>YY}|M_XzOpg9U7M5ou{ZiEarM5xNAZv4gg(1;fTa z?}yR&w@w+{fk&C}Ih`#z`|ArqoB*0UjogQoGr^C+3Dcv6yMSdxZ_=F~)8oYYrgs>%V6(P;c0xg58gnH=4 zaM_*aLPxPIdju-wu^#q3e}&w^_BbNQd#^!&<5eZ}heNaz{W2ooEUjk2@ng^-USbbW`!4Jy~`bMo@jYd zd4Uqd?2ey1Ir*+wUCd_7i*2ojT}-Ro?o9$L1 zO?JuR;W^>OTY*s~cDUkU*wkgH8;^wm;H~5h(=)3}Ov^1R{RT<2*J&<4!!5j+p8NGc zv{X6>t&f9D>U>kwy0fO%)RN6J4Y5!07aNI0cxt9vx8ZQMu#tVq?Vj2G$Z@Rz7C3mS zMp!%M#>AxBeQkKbGcf5}L-Hpz-O07lSx(gAkS8H`txVZbAzUH>L`};Zbf z%4P^_qA_mR{SRiH8@lh59blI7gd+joe>HP_rC3*qW0LN$b(kM`V4#oP!f!v994vD?=C;k3O*UhLRy15CGU;^7C$QH~ z`4jCaf!H2VG$j@sz{Xw)+GyfbB+^VU5h$31TKvbscmo0}f|MOmik^4`;hBWDWR<>g zVJICHQaJFws`!os)dU*PV3Ru9zSGzzQt+?6STk3lMVXyn&dfN={YTkuSJCfR;UI1& zS_HCVHE`beo16_`Pp%p6E!?dAW^cW>&X986t1UyDjb3Q(VM>if&$ms*^xTWfqH&Qg zL$|`;c?-@N+IggXY2jqr7YTFa^M=nm>~ALR?+z?&P1o+FZoI1f*_-R|XZaEf;pfAu z2;TcT_!zT=kVJ(g@x0NNMTYcOsN^v7w2zkfYrR5XCIR(BQ>}2WPN?BzIvAHof8~Qi z{XnL_l0hB3_b$>rR2M%IS3w?3LcP;l@H%x(s{f;}-1N&JYP@b+ubCoRC9_ERJPNaDTQ3=n=t|lH$^%kdPogUJZ3(e&> zJR-wMzBmtc{|}M!iaF+$Gt;?4D|k zS!Z84g(l(G6e{#rl@s#6%*N;Q_^T>8PF=c`-XrR07Y2U;oaO>G0sPN@f>UN{m1;u1 zIK+*9*My3I20$v*GOUP&zP*|6-*6;h@hSh(oLuy%_?^GS-{hY|oNV`b zu2#8aV8Il~DSTG>D|YD_zRT6+k<9YuSA+I_Z<0X>k!Q{Zbfb*(^yv*kj$O4b90x!D zp(o~tcAGcENm+YFa0=V2AH3t_(0$3&s}HMV?OFZqYhjlb>-=4{k5s*z7oTV@Z)U$YpqGYpMQKD4Wrq5%H6)|Q;7ul zjAL67^PKpnD?LqvL#q;+ULLZ)UfrDtxVaMGGfiJBIA?O+t22Y&dfqYxbcXLmiPi{Z znn%em^}5;rNv@&JdRX)EI4%Nnhzpm*A^JiiA0a4(c~!R zL7H{c1RQj!HtC7z>?KSD1i7A2kPfD2Av2@Bf;j6`nhL)9C8OztdB^>&Ql4=f6K?vk zCOZk~m-FL+s7IzGc|W+bRB%*xO(W4~U3ac&DrB5Mgr$Ou_{Un2kYbV99ldy`ddYA%4rxYZBDO?CytY1^Pj?pEv zc67cy5)7g;P8J3IyUwAyV7wbbmTa%iIEh4bRcC90V-}3g@|bTC=ro)K6=Lo|=)|js zDPyu3Bst5d(?G1vkqvknjoM8sI{z}WpIuiXbXAtGP=0ty|6q7ZX8sDd>P?m5iDbo& z7ay`@((S~M>AwOcTjxr`WkZ*jKJ$Ootx*;$*Fk2DzW07&MZf!}FLmIxI_GpQOTjaE zS|J<@K3OsNlYME;ko4*BG$FnXnrE54_=Jv_^ix6bS@H0|aeTloBA-mZHmlxN{-k$@ zF+M)_$S#(STebVhO2mdBp?CDp;M#LZ*a6LmZyu3ar-D1Ke{zZU$vOSDayDUZ;E~!c zRquOk@ljq%6*#w*iI2g>gy{rz?PH2?5cQ*A!E$KCETf8Xc9_jwjh^v_wX8lVx5|5G z2)?|X$3-0=v<}Dl*Fhfad&6ysA>?mOX}K@!BVrh?hh)R-Ttef8(q6+~w$#W+%P;BI z+W%P&rewI}Z6S8ZXln5ZW(aXd`q22gI|7W^H_M0T7*$}5*#=n1LvB@xQ?$YGbImv` zU3DFd}wMu8SgGpvQTFCs|Tf&e$Xai`NMw-vFg7mi7I>3D5A9tp$t z-G3KtLLK-UkTD@fcNRDndJUAiM)vR7e+=ym-~AHNWf<-WIc^~k%o+wZYR$hp(c%O5 zH9|=^JlN}H!I|XbkgFHe#YW^?M#4l(&u_pl9;;c6{6L?zDlW5V9irNe*DgN8Er1~; zf4Is=jYWU|RJtkp?z}3MIqWC44anC(J!U^HT6&=Slb0*7V>OLrI_4|S7|7yDDEwe} zGG;i!)K%!Q%nt55b?^6+3Wh95Sw1j=^+86dN`Ys*mwknN3LTjfVFd8HE3OJkfI5PU(@*0cN#Cegckv1*!R|)wxo|- z#iz@!@$fOHMElQVLagY$GKwJ#4$)x+<2Ofnu!Lf*lRM>C!a+}fAR>4FMsm|b*M_c1 zr+KHoG1s41`#+8d%8{OL0lyX*-UY$0-5iDv;uG49Q`Nc$1qf+P7y{;fqD8Q60GPqi z2i6v1ERP2?sbF}8l6)T<%K-S%jv%=0X)J^pytzgNFHfx?x37g;u2~K%6ZGwF?wmQX zzwJ(Gw{g7m2yotPp1Jd2#wR>Yg&m8`H?>DFnd!f)FHwZ>oUH80RWm=UjG&B8K5)Dl zO?bBJc~yz;&sB@g6X4bfBsHpP3hZLmXk)dkgb5Z}$-fUhJ|b83Q$H2(5D#9OfmAPEV>}!W$?8L*z&w9@QN}|hD!=0Sp+298CaF)q z1BYH(OtQ?c`$^@lZ$2Z*jfHS@D$)ATcZmNbEj7sO%MOnW)U0eK}H=xKCxGtCVZrZ)= zXTO^XQOo<)UQ;3Ie5cFaNf-vwbHNV|H6#F;X5)iKZz9ro6zZ(b@|(KoB2Gm=)Vr8| z<)w!nVm9})WJeYu?*$w?=rB9hNwl7lO25LT4|r!mBE02V)Q~bnmv>_28$!qO%_C!b z1YWhAl5iK7(VGlfa?@z^OD)Pe|PBZ58UAvc5tk@ z76sO7M(G9k7#*yWj8r9{%2#e?^je`4v{A)=JPB+fTqf0O-8rv*!6U!AukZ&%cF{o` zb3QZMlw`l=2PgHbv2lZQ<2HKp$b+Aa_km?~)N~wlFMC9sFR@qGdz)IET`f}*H`qw`E`r0vUKzy7rD4EGM?Pa<8Du(oT+%d22js)vfU3}uvqG_in4b8H{_$A2w z6rLp(c2V@6((a^GfgYbL00@32P1BY<#;hZd`s`r>s5fcR&*ZPa3!)NKGrKQ&nyJf> zgPE1bf&`Aq>yX}j?2ujEy`2_C;D0G=+jDSC&(46WoLID#Bd}m}xt4&Ay3R^kWHe0m1TrsoPbq#9pdW!Qeqq}gnG`Hx6u-qSZQHgl`6Q@KNm zp`(#~Uf-P?x$n9d%C3hcG`DV`z88~>nMBmAs|3f^g-$IbQ?xw8QsVX=50|{7Y&gr+ zMB8`$S#&=8I;B^-XrCvuU{BiTfwaomey&F-~ zt`n;~!Z;O~D)sDaiuw9_Qu>P@T?vHm^N|(|S#Pze)JVlD4`*-^BCZ|}v#?LY(6h|# z$-yZ^MHRa|7LxEQWs_*@BTwE?{lFc!c%@8Vjk5DpL_IkZuVe7$#pL*xc;5?955I($8*y-cKOu-eQ@gF7Se<~BDtri?*5o`(H?=JomLDs1D~jn6#^zPsNeXRiM&h9Z@aI=3>@Hsui3RCAA+ zM)+|UzvQ&*Ki6`6X9LiF&qH$RBGbz2OLS;S!dX-qOYhY@)Vk9Yp9-Cu(Y!_yv(`0B zOZ$4fMd+3m`q(Ril)9KGEhnp_VfRJaPXnm;5S*ottSa-VuI^iikyfMPn3Dpf1z7*3EzhL?-6S7c~qd>^iy<5L5m?p0|nzhD_PmWQDphP zX17i`UoC+m?euB$E7}s<;VoL_>}tJViC#JskrE`dur3EJID|n`>3YQE&cd9G`K*+c zIUGy{f;wf-4-!+IA*Cnf@xPppD-wC``*UQ$c>?s@84?p(4DEL@Cmn5ln#uHTnmklh z=SY4`t-tdI#QZeL>XbgBsNMEQgO-C>*PsBCZxh-N?6i>0ol`V76pvZm$f&09I(D5F zqT>0N<~p}NaO>RqM{!>&H+^-#ZaS#@5Gs1~mvT82H_gSoIl_TM`}xl`rvrvO*aM5+ zdc*52aP!tF8a`@TPN<$Q-I)>?^IVuQhxai>N}kC)s?^b%%XC3g-Q1Qn3ePVUr=(9m zGbsL&qggvgAD4IbT*cSDcY2i7-=E10QMz~syYW!qi#)P?IWHyzkFaZp^$Do|sIPI~ zkww1Dc-aJwE5(^bxk>qG^+w;{x~Px^x*G;(YVHE!siV*h4$Y$cqNZi}>8DCwWHcn0 zPYgwV0Uo{7A|;w3szyrwVg#_L%A&|9g*bnf?+ql&yWl*E%w_ch+>xSwhva)t@qjb~ zR=y&L2piG`C)F7BEy~xI1bfe`krH%Ah9dO=iSG?3_gtDTj zhJakHJsnLF!DII z`n(-njPAT_f~T?$L3XwB7e7BPpigT|BYL`|w?bxiIO zDTpdy6ys-xGj7J2)w?`vRMoAE_Z6b3p5(BcO;4}ejc`Bie2n5Zjv|fD2pbUfF!W5> zH*jFZYKkqTj^Y$kF+&Q4JB#ov0E}fN-Twb`jErOxvX88gLS^I-am*u|%yegj?2uK8gN$P( z;n=cg_NYj*S7awUBRl(dy^rqu^Z7nLzwh_={rz)4+^XySeqY!1TF=+>^?H?(`Nz3P z#N;BdTIe2VImX_HA;J>CfV z=ea-?va{X?BYF@7w2?&(@UAY+!v}lxo z-pa!~%kb;J>(eMN#5elm{Rp8=J!AU}#?d6RryBP0ehQ6jS-U9_i6UL`Jggqr!-Kn1 zF;~+N%5D+Y84IpK)wYR)iQPoW$va3lz+SLC^IgzaIQXHKUPMNX?Sq5JR_d6+MW+T- ztaKK-eq`jc?fDCzmn4=6ti-F|7$)(3S(0=7vSf;SJq($XAm87=ZS@RU_bn7F3{Auo zU+3*E24!b69Yvz%f8S7)*V3yTF#`?Lk|yqsk6`n&s+p8x%}$ai7N00!9|mpxB(o zI>q;~*Xv$NQnz#Kfhc~2{=hrm>k8H%tt{W9m|0g`PiMc0f?iSuYnzuA10;G7l(6$e zUgHlqe5S&ogi}h8)~LiG06Bd2>M;9U$LwsMrBRU5eH9Q#4-@;AM#%iuaZtmN_=*!L zjrDCGZ-6LZ_uuQ1ZeHX;xtYfz{>0=U@CPu$Y0yvTY>ZofRegmS*GfXBe^UE{a{4dr z_I}#WSBuTm>3C3i);-MD{yk@Ba)UkdnMkBxa3_Wsfw!|E1}gFYz4EE{`HB9WOqfP{ ztj0lg?TKSL0VNgBG<9~!Qqo>Uh+KnOm;D8EVps%c08MQCD7%yWLyFYAsxda<)>(Jv z20B@%$RExJ#Xtq=?3@aP=dfL#duO@Bf<#IJX%G=@qQUGJ9+)c!MQ6|;y{k4@SmMElvz+W z94A+y-Gm^85TpBUE1t1~;dk^V6Gy6R%H{Of-IuNcSf~ORkduL~T3Rf27^FW6**GVL zl5;6u<+c6jSR&fy+v(j}ryjajTT=C#Z)g3z$lm)#_T(YTe_A;}RtdCnP>0c*eSh7$ zSgbu>^`h0=FS)9T*C%yOHRof!uJ#~o z!9mW?Xz91zdlhgPd;r8F;%LdzPMkpZjNVnqz(Kf;Y!1^O0BSbDXZQ{b{MW|z0e0o; z!N;zv2Q0qQ1hb^S_og*jlbaZLdVX~@41+!%?ti6>QvBjsGr9@kLcS7(xK0^hSqK37 zbD6QyWf9=gB!3Hn-dT*`eS(jDI@5v|bM3wRe%P{=Hvu$mJDG34BG73xdYT2-x|c(f zy3h%n)1^&kHlEXbj;Im`y*F^T*LUmq1^~$*n}@s7e?fSeXY|*9Ax=r4#Q{$bc;Sx& z2{PC&M!%`=gkXbr>R8{s0FDr`t^FxH=G$C=v+j_*Ro(r!xBU;%`v-hW{$bDC;liM&vef9s4F;pTDk7!qSSBD47@~k>CEBojrm9Ag~x^*^1{(Wd)rPuTcdu*^L{7Wwa0r! zC)O{d?sjYKc9cHyrGVoP*sXkQ=k5(XL2C z!lG;`Oo0463n$%P9K4JZeliYfl$p-F}bFw#&y(?gk~1CP=}TSnKo@yt9(c6iQ>}_#F$s@2pZ=bNDN<< z%o;&Vdw~Ort1S>fja~qfv;TbhDT=$_@&U67iAnm>t zHdhG&4wZEmABQE#aUehcfFsj_;q(=97%_Rcjmbq!B-pnFia2B7%3w@Ux$qe^3|M;y zz9UqRkG$wb4FIB5=RCwkr1PMI`@^x6Jb3wQCzl`Ravqx%D`VbSSL?dHy(48&Esh9= zQ%uhews7gv1e3=Zqq#6T1H?#`|!l>+Mp^ zE86bc+`6atAXgQXF#=E|W#kqO>cAgxXlHbrK!+A&?#?@P!1#yTP$`24D8roIf2vOd z*rNpjKt%2Z2>*f&EyhzWN0>2DEU-jA@x*=sv@dh0J4Y z82>avK6Gn0FDm6J5*9RgIby07CsQq$@B;r^r8cR2R1rbpk+Y(0IN{1;bglZ~^MmxIwS&v{==g21)AC=EfxK8&83;3+GNG~~nRH-F96aeI_1D#$V^GDWkXUyH^ zgrh3ZdmvahjL5K944qCks3%<0gwX4jSdeoKQ7Oe%VNk;W{+_)~d35)gZDx{zgN38k zAM{s}G~6sQgDHUnE%kkkWbX$32B@}(%5W8bTgC1HWn599P$BPRe}@zZcj~n1vMb## zLjXMC&e;1OAD4{ARv06Wy&$x-ujxpMG&hQ7fIP}d#VH$bEi4J>003WaM>x4q8)(P> zGV1!cGp|2f8=`{nAgO101=~Qn_{O21IS z^vbrbxeQIbTXoPHMj=OvEi|7Bw>p!1x2xc8so?6>t|yK!t$0Lvoi(rYhYGYAI2A#M zoe4_vFx=M3)x1ClrtHAzqB5wTMd7q8*_UFFK=+3;$y~q}c_$%2YCToWD;hs}D6P|8 zz~7QY%p`#3U!6!)2D$s*guADEPuhr1p9L9wQ`ERhsj8E#>EGuI<4dWZOmgt4JYa#o zfD5N52A$FHjM-10Sfv5F*t{5VULw+pLpBtEj(PyV9v5Q4Vl$Nc$W_`4NQLe~nke3w z;Yy@c8lx^o3U{>maQ#ImN+e>F5QDcQq){2pK|H^xCuhHU{aE@X6&F&Fj~1!iu8x6| zxng(}ozDI)B_k#RX9X)Hr`$Ltl=#AmhAAheO zc_oR(gX-BP!>^KFi|(Mhsq291QaJlsgk2y_MnDDFi*+l@MSB-bn8m^9Q`zV34WYU` zoO?F}Nw~PUQji#r5Wi z525IJ<-P@={(w4i61s+zH*&xP0+e>E*+!_6ds+wDG{E&{ob#DRRy3Q$S+s);Oa z@rVLgKeF8riM@8p^I(iomhYNzw!@*oKzEQBp6U*&qXg7g#J?W!#V=Y7+ObrOnB*lr z+!x4!-LR=fVt|tMnl2Y04Ws~Qc>shl6MFsY-A@ez4q`st8tB!-;it43oiWl`&PFMG zGJ$^xO*#)zJe(1mB^mj@)AnBo5Z>ajE+1t24s!K>ld zTx_DSPbYkEVKZU5X_0~AN@O$fXKz|S_K*rsi4})5YO-4S+WI2@szWC*19Ug)H-9@k zSJT4)Qjm=b&=SUVk~AnCq?*$iP!Y$4%&YncB$yauwWWYbzAl8xh`J|SIR?yEYJ168 z8ZZMA2+x{|;cq#hQ`p|Sm`}==Dy3)cI&=nJ!i3T9k^ut-v;$z*(0(y%0t~Ret2#9O z{Wv#i`l<6W^7B28wwURLVUU}X1B#*Jeh$zqQsA{gsht3z8nv#ss{nq@sNP|m9j z-2u5*p(%#-jkv}Z4K|QXYLRh-^p3K8i1!%G9b6MvBuBh)4@)G-6LH{PJ+!~zFDvIC z4j>o72k0>dP9otQ4r4`qKay2ouOG1Cr_gLKd(4%O!9=eYWzy*sVZ>DI`;=pw%kOf4 zYv@E6=G3wYC&yV{9gIXycA3z3z~G^(Zkz%sIpTVo>I#N-Z6~D%&eatX7;hREE=T@qF)e(JE@jAsaY8y(y$EN3OAK zyOD%qnjEBj{d>f%#*;gvtdD92|L7Z0Ax7nY(>JX6+0>7prPnU=E*Lqef9}qOLr2l# zAXUVOGrzQ5%DjdwCA~)$lYM)O=3;%He9{=BX2O>+8HhRMjZ%ob7L;x5UnAWTjrM=4 zatFoQ;uHAT&z8Czm>K6E=K#~m2xR~Gmh<5ZbUMJrmiSwGB?F&S?2Z0ttc}fJV*2r& z@*u8D(-8TW{ITxJmhzpm>JDROINB2m@Jcz&G|m7U$xW;c{A&qu&!}d?*?c%1V zNsk*nw2vedW}c~_BNxaT>=x%s@+j0h3;CrWr|*2qIJ?kj;2?h6vU-;DfNXPK2c*Iw zTiK=pzQ7M$Z_xjb+T;<52BKgp}BeFL!_H&O+c zD3k#;43`7H!;`wM`X@QZ9A|vBJ{W$lrC$Cb@}HF-*&rdG0dxrRunR=-h{}Q7ETk_1 zs}XGn_=3a70tuRP&R@XhpGt8C6LuLmp?}OfyO%djzcVl% zz=Z?Oj@k4G2k;?^d2K#s$^4gxczhu@J3s?LfY=8hxBp*s+kF-2R9h4f?<-=SF7d5$ z2SRQKFD>g$o#v@khEMm0?2o;M!P0!IdlNz)-!yx4A&M+uCH~vmUi(})q)FO@unm*?;zz3Z2=!5k2(fa!2I6H$I&`y6J$V~h-NIL~NoTk^c#{%Fn z`nMHNp9SK9z8`EDozC(DRece( zljLcoCk{Tf(+>Q*t#7fCYvatE3N*Aar$+>GChZY?`9^{~sJwP;kZ02p0?4*ecpcw`nXO-sws8q3d zPXe%`P+BRp+dPTKUH<`r)zb-n>{%Eb72My{sNa9VUbp}REkvr^KaK8cy`*1U+3;fi zf-#|x9-pvsiNHu9j*|z-czJU9e{<*nISOJALR30HvvW{|h=s!jD+Q6;m%buPl5E#J zRaS@wHp_$t#X>WMR7ADCIa>fb!1Cf>A1+B`?pWR}VKYV5v1JvP4O9xJq#SmYX1ym3 z(6u3d_9oMJ0AkebbU}=|-1^nP#%hDGSHSaO%Bu(VY{?_HexARA5yj}ItN`b%xc2oU zNW4-;P;sH()&o*<1*7zf2TTmOD3t?^Oo4tC4|qg4-#o8AhSBr(N4orBNGmvf0^bL#o6DuhGfdX|dN2YH9GM>654 zNfS&D%EydY&~_uMgppP%D?;uyqZ3>tnm{XzcqiZS#&^5XT+a#Anr9)7tK z`q+~I6Y0v_8ZjlRi%GsLfbkz8kIkS+6ljYXQLUFdb;}1$_djW`*oVzHx4*%|sJ*Sv zj2A|Ra7Y8d!*-1c{z*Fh%)sV*of|92K87(CQ2$6VKrJ8J+^hzCo{>-|rdUA2wH0}u zG*m8>^LSqoM8M}bLxH3Ds%NQtBpB{f;qeK_NqQ{Mb<4NJyxb{;#IU{KbnmObm`Vla zUtO?AU=*PJFII%xh#_hMjFw%K?^{zFAeEImR4{;*PG3>Ni{$>bkVCY+^>8R!0iZU! zkZH_dox$M)ncQQ`FLq9q8#?-5k*P6~Ou_Hsz{IBR4ger}Mgag(1ChJ%zgao|0v-&HUN*GJ)jlHFIoRlsNf=+yZ!VC}+tfXWc@D0UY@3tonHBi#0 ze*CDr_fqAlQwv~L*+*vBHjlI9Fwnhm=+%#k2=401*SN|2vfr^Xvm}xKshqEvf4{%>X-ajG)3=D^x6(n$Ak zfWHPzA-Ig9E#tgSrv&$m>521gDvdYSmU<)!+ z#baE1lJUmqr!Nm^hCVrm(s|T=JYKW{$JeKEfzRiy`&WI^scX$j5CyL#sbPJr>KXt_ zvZ@XOCN#;2lS2dny#~hm$8`vpQ@ zx>yoZPkQE(o5uih$O`*X<#aI?lA%A|ym**AC+K~@Ye_Q|m$FpYm0!vUU$+IrMMO>3% zZ{KN-wr~Zr{Cs5dOSfR}9D{ z)q+19Ya`QY=kDl3nGyy@V3K;|l@PsDzz_$(Ilqfm-UaaEmX)HAL_cu*13x~okQxqP ze5d^{oGtK^2oliXjD`Q@;{)u=1@1ZiHWu&&w=ZLpH!0F^4sjCiJ*D8?Yz8?vC=!&38IOJ=4s5&bn)a={#^x74pAm5Z$E{vDkQ6RfH7=4ecVV7#%Sqr!vR4l{(6VF)LpG$-C20{^n)KTner$sK2p^;| z;4H@$t~OUbymM1>NofT1(+Bp`CO>jpy3R*9y)&X7!dnuNDDGH196`mFm1kG6t#e22(kTFXF-Ro2AxV-=d zFhCRBvlL0ev)Wz8jJ?(Apa@VJe8-jm((W0+((wT-eOeSYjDTp!uxHEqE#<2I{{eXa zS4$Rrd@16&>$$Z;Ogn(nzY@Ta1K))-^$^aRX3M{SY>g~wI{KC$&r_w!pvi6A-y?%O zGAy3=k?cM5IL>@k&|&{O90L~WvbFRy6i@3N*n`E z8boFuG0Jx+nT`!dOpELbh5-vnsqTBw{E&Z5mC@lUVa~lfSgb8Q9vMK9?KB5(OV1tz zJPFve`*ohL7+a-*8b;!ilkp+U6j!h3RAw}RG*JZpG;1pkfzsj~LuWLpiGWEo6hvQm zc`jTea?cHP#Ae;6#~W~IK(hj_g&q%_>?~E9zf9hItODJuJEZtTs+mL;askU^x&GBp zemz*Z8Qor-f|VmCtD>{hF6TqlPhjz0nmw#x;YQ-S!1ylrhVm6JyonG1vv6Tjx*e4R zyx&c^u)@jixj42=?kj}=(2UobT8D_Ea7@U*Rfj0IfPxG$j3P3Me@hnGzCI&EaRp`G zlgQUYzQp1a?{p_$;FMbC4+D_~pnn+?sjz5G3A|bvCa()%Ce`K8V)WY$;fv%;LktqH zWvl#ofC7FnIqsK=fba8xn5T2qXvq)dvHcBSe{}F=|bP z+w!9T14UoXk&*}@L_`K(at;fvbOh8GofYRq7-+}a!xappVnlIhl~d*BK(CDm_Y&BvML#<9{ptCe+ ziY=!ma<}bq)MggLo^v!LLWFhd57Ha6&YA~O5vh$6lBwDB(8Zrv4x3e6YX}q~v(o34 zB{`rIuI0#E`4z}<@ErB4xt0<t+3G9W(NhisEo_RcFXx2)V-DQ65!k9+q)TA|KE;SL}$2_V34WKjl0mzS^WI>)=H zzI=8eTV>c7We%EC`JyHtA3k|Iz`QO%rO_Pcg`3@$1!lL=4QF3&lHbrudBzHdhIor8dgc)F0UNB31W zj^|JIidKs#%Zr-mj)f_7=E|dQeiR6JLNC?{2lGPdpFwOkaNoU{T?5a$S>AqD=q{P9 zLT;sw=}aF2-I%>9gWy9%3tDI&ML8zR4 z4;;wCaG+QCkREM_^7K-c)>OCc1LKrOz@tkZS3J zFDbd_UkAh?@17=ZeK_*cjQ*`)_*F@FMK@&W=Mh@jFFPCMnu`rTT6wkkKbVFehh6vv zaH0JNA&&>Uz;10^{UX07lk*FVim6!)#FN$1L~Sz zylyX0=>1gBOBM=}#85p4RKoh`2{}ld6W70mi23U)5INv9O)RmBGhjNEAOSt|=_nTu zckV-Hd%6yktpFjA#I@X49{!;6=-)n{2eoNrJ* zPW@NH=kHn$QC{;OH~%exdrUC~j`(&JIO5wdKtH&#f3Up

jmES)DSVgO5rdS1>%I z^dd0&?FGpX^HngnLHbts<0l{a^IwzyJ?V3ru#%{eoi+x+(m#3bj;NVpZK0Esm?Zmf zZYht9O3TLtg?C~zY^PXHUhS+Tk4~Dck=5Z5NL(&EB1KyLb!8ff*_)SmY<-`_z^PT{IggDe4=J1F0Ct-Kvf>6S6;vn=hUTfjWs0J>N4%( zEzr}3;Ec^hVNZ7jOmv7P98|CXbklK1xw3kk2;L`u{1+V>G?Uf;Jmd5e`{P)87J#?=OWpIy_=-|UJK|d&c{7Xu ztorSihaI%4^VmnVa-__A4UDHXZ$K{szFK8013C&hWj8)Ptb33M_n;Akxnt1$s-U^r z<|E6O@1qU7uiaa3vfpEso#5@;m7d+KjwEN(01YcPtGNSrNL_4`G}#5^1v|3hsViqu z>uqMUgBH0DWc<=nH|FE&W*(djHi^Up!SPmQl(9$tmSRZkTJ}fYTS0FNQylyZWKJDxCe!SOdO{MXwxPG$>?g53ytBU@F7qc#r(g{A+xYuILtd5Z;`KC>|Xx^b_NMlgsIvg9Fh>2(X2v2WbQp%B;h(BMlKiA7@ zA^z%F(~?5cbRt<-rF)@4z095d4-?FB%}e<5`4auKT@qGabL+`-_hrmk*92{Y1~1#o z{`LvS94Ya-)^$s}zDw zBLl7A>mIK^*<1(@ChU*{4Z{l?CKibC?rIzC8xO^RRzS+|xw@yypSRRN<8iM{8AknU zc$e)B_D3-`iz&Zs8mFy`w#y5DJlhP(^pjif)9k;QxV!sJHQenNxzCg0 zt$yn^+XIq&n|(1r`X29e4amq&{N zpR$-8_$$MWS%%kKebwkUT@=S}CeWePL8m6s`#=_X^goa7Ex7im0y`r`>e;qq{^8&% z&?n^*yl7wwG%WS_m*Iv^$0~%nP$Rs;lt&|;wBLE=)d`{lU*5oHvi5F{IbX} zP~RIV*H64VE6Sq%YrWrHO$;~I0}a(x!jGxd!rU?Mt%0bke(Dz4S5n7}AxF5B;k4Ru z$_yf&yKghdzJ*wwtgQ6QRf1z!gHK5uc*;pZjS~x~RiuC+NU~ax=&wV-4Mn9NmCS(d zroS8acHYG=YqBp?#R6@T;GC$G4!Yx3dS;zpftyr*3;h+u<)(?-8mGivs0*@Go1E;v z*sKyzRLqVlcp(aXUTtuwGb_`6FSPMp$?lj2c8Xi|O&XRwA2ncpAx}hOZ$D$%#l3h0 zcySL*A-laF&j=ETcGM-`tp;T>D`(yt3kE4!7wixw-N!Ps4{)u2+}iq`@+su5t!jsh z>!?W~Cre(ye@RBgpOr$!sY$iP+>>DjT@$6gZZUQTNxX)8j+M@n6(0Y1+5GBNsY2=X zuLoR)XP24o{cycXOnIKg{l?#cgLx9MnBWcBnr=d)}YSf4jB79z%ydirq-6O#mI&Tks|s+oprM z>t1=)cs^HBz+AlVtGTzATv6{*y^ogPg(rY+WX##FW6T_`V<5vC-30a?4cm207z$Uu z(nb!f1923p&GW~(^!HA7mtQN~*f4^WgkIiGw>Cq5xXF`hZNaEUlwsio?wx z)KUKQuNn4a^6FjY9raY;Q}o%2rl|T=y`O6zJcfDPWt;t!)t#Y#GCk*t4zNWwwYDX4FVc<<>Ww=O`AoFdg0WJYYaa;F}CP#Gz9c&XdFX|bJOk0NSsi!x2*3a0$QTKplFx^zG@p%NQ`?fDQCgO*{ zFK@k8P42Q8qk`kVVpIlY58|!~3KTw)N((L&NshAHM=2*8lP5pT8sSTJFB)c_bEPwK z!n_t9yzsp*?DR$CQ2UlpK!~?0q2$8H27j}J#LK|RXl;}w2q6*MvQSOd=>7;sAMvv@ z2)u}1dOBiw>pfHF{6N0dV~v-`bl=WrP%?e(*}3&XDW*1>=K11gyLfrp*ZF}s&%*Av zLe;j)`KI}U+wTvUx%Jq^G|aNXv=JspZB8Z37n-Gw70n34EZ(xkH;iec<+snUD*Y=3hSk5nW};{=LVOSBc!PGFNPBY<+E5hT3)2c; zfmi+gJSsc;cL6OTfRHTrN5e}h_O2Irq&;;Tk3gmU1rfeDJh-Q4*}eXGzHjXE$9Jfg z-a1TJReGp2(vZQY*drr$d^$hUG|l8e*lBK9+DQ!?agfAYZPYZg24{QW>^Vo`QhU7Rji9 z8Y-fw z{A2-Rrvys~bjKHDg5&v-MdF3U3DKPRKLP%&qr~)l{F&6kZ`O*^vZK{9)d( zXJQaQx{4`DcF+x}lG)1gqG|GpFQRHA1TDFLr)C$ZW z??C}g1LO*o=@~%SgnFKSXA<>1bs@)!=cDlD`#F8qk93%Eel!0H3|J=^uucK*NF)W+ z!?;N4Hn;YR4wN!M-)I5W^1Ei)m-G=y8tX53u*&dT?G+$?q5Z3Rzt#xnmXR71?iGlr z7AB?BfS>wPB=~=0WG>ya;t$l)->oqmlhs_&aX$iPY+(=2@zmMF(n44w_et!GUx4I|CbkS|7d+Gb&0T zoG32Gq#RZ8>;|ZS?uOPJm>q(UUO49UgX}diEig+$9RtF>I<;|E%`h%7_omN2Felpa$y&GnQxhy! zk`36`)bR2r>`tpNv7#}eN2crNKRvZ1MbP~I#E_^{ZqU%vdS=bD$GVz4?Dj!J_@`Pt zU*BFY`z`yK0F9nN}H!XRedrleq`~jSC>lq?4wdWIh8os%C&kGkeX71av!9rJx6~!Hd=GtMGsnk9U~w z^TP|8Q4Fjvi4Ovqnj7A#!hPbsvd*Ke5<$Ow#orVdg)85m+oj;e*L<3C`2M6P6FA%l z3N>hbzpHXenf&oJSn$@|f#E6+d#_LSqHOUA&Iu6jTF9*|(}J$FLm5VGt~#%s-=5-j(a7OE)nG zdjo8@Fv2hM@!g`ZJ{9cmKH$@^ZFzoqMm(@tdwB|vsK|w0$C2^Rx?h(Dgb}NM)%}*= zR3UHxFAuvh@Uv`O#b*bT;zQI+u^GsD5Q~E2m-+epc?dV@0Q~3AyX`4|`6LOVBuD)V z?%r!&N^Ep*I(z+D$r*BQFl<&l-)NXtG2fx{_T#FYnMKyMadCCMXp4mW!klfl!uvGh z8Jo4~&AmoV`;z+DW<=vJV^cog8%s(r6gZR?m!}jL>X!MabFLSTX1}rvBXR9$9E`Y@IQN;1@C8*q!hE!Trr|Z8?d9@|^aY?r(as>l`b;;sof%KMpgzZI z{lm)>7`q2%o$y~r`+6H?CxzIZ!43j5)^mI#`kka(y$Yj}BO2UZI2#COIja|VqVndq zhF_+%(M?nVp$eqS!lgC8ML};a`WO*KNc`6ivw09qy?A#6SPyr&&e_I=3amRE&)w>{ zIZ!WUt?a2|V*E#=+$Z7)vz9+UwdE;xR5Cp`5(Nac z^K8yfaW>~ObQieEa{JBCbKZPIvA)%1yJtXci*oSVEFr%{U(^~*;$!5ZJ1}42zkQyX z(YF&fnUi*#`RXRy&w83u00(=hr`I~oezGHx|8{;M^6Tj4{h93@ zX_TdS9kF-SD_tPXfE+sq#N zUJv#+)Kra07hQL)`}F7-b3n=1wkowXZ^ z2IVW>`XDw-pM5%VDb#JIv(z9cm$RhCKyx%p`z3WA<%m{1zZ4lt{~GIL3cg}K+beay zL1_7v9INdZRw8=ZyaRVScxvZF9n=ylpRr^B;=s`4>9_1l-iPyqqrl%4I{6RKvAD4ZrwMlCk zzBRIJhfeIA&>C5m$>^NGIdh#8;J5u9=({7!U?XJYS7cD=-qOcC9o1?HH=uiFD1gn$xjF<{ zvofbUOBdK)#wmj1adlC;HV2&j1x}$*-_$roCA2mhm~5Wm&C#8CzgNqMfju=2!2_nI zyG=w;k$4>yohX0ME^bJc0#P4x>0q0P+SioM$Hyo9(_t??|E}GDh|J z78gp$95?tIyx^btx6lM-x4`DERod-nB zoHqxe;zmp0AmXenCaR#}lTZ2Ti4(9`1eo_+2lUx*87TUSB+I<%&6^fvVcB2&-# zTH%@Tmr}lu?LfqHlAlLHxVAjQpodBdqEsTG{%rabAEsW-f?9XE`J@W_+lmr7WwpjL z|1oGQ`}4fx;;k-;32U+5cWVwEbliH`wIyM7$;$*hde3UL?v-C+bG=qL1)F()7Nvjk z&AUX>rML9D>ot|+uA^MeDf8Q#Pw)43`Zo?C^ADCVc4e2cYN`2zLKht_#SYz_)~{iq zrU~d94+i4ZKhBrxZg?sD4A{zArzGcVcy4YjA&8#GLHC^&9Ac!Co+UuDu2+e5)Y>g4 z$Nk~umue=>llK_+e^2rJwI69=cp>cK$j&&$v|>X-88-Jq`L}G`v!)yd0HFByn%k4N zsq<3T&*ih#u<&R)8j9uNfy?i4@9kq3qb7~g_wU=7S(9)c%|igN12v zk=LZjLGI}xubv5pW-3d=VYp%MxPymoYCJSpeSzARR0oPpZ+~$6q6}~Vp)f*7rf$mv znF`1kq!jFliNd4rZy32o!$G=|=K!B+P~mC4#@!Qi_F%~zoRA}&O2phuo!esXhrPqK zK4rd~xWR+lAGW`8-7LK%|B*GWMIlLJ#|phOsPO*YS77DQg%le}&$X}h3O$Wee8qSv z^m5Vs?=Ok>O{K2&CJ;8r_p9#2zpf~})7EBtp2EN$L`4_%hNKU(-m8fkfp~pd)Gnp; zCcb8&fMe*C>NQ^ep!T;tZx>f1aJn5<@W*aGXN4>gHQ(m z8vb+iBBPf!N1_lQ=}=U+jydY2Mf$5~kODUp{{Rz$G*vb(d$3>thagT^@E_nUyR+Y@8cj%8Fekc5CS!P1C8|J&lm5nU~ODm zDb=|VCX+2rM5v~vr%SJHb2kTp@$G|RMONb2DZ2*@bY;w#CZ`tFt{-G^7xJ@uF@x#7 z4MP!;jZb!3_ZusV=vuCARit!4BVd*o>rXZ(Pu5c^%{GtefuSz!P}|e&>{rI#MZOyv zl^gvT&OT!5FIlg^O#ouJ@2WDueT=dQ{>|JM@!&P1GDoMV!EpRtDH^=W?#AXF7oi-D zrEh*#Yvi$KDa+qCPX$Q)3C_IVUw(Ag5cTszLs*^gasW-<`<+}-qhZPsQ%CK0jM&0s zw``zIfabR^!esZGh!U1C&k^No(3RArxf@V8uou@PNt8%#Qsr5Q84RCEM-SE`Z7fpw z=H^32ifh8_EZn@DczkO0*1Vk@&(v3e*8h6hWp165&d=^PFQqc-Z)|#KN%yhub+ z;|5z&(ku4oN-tDZJR#^7a1_FK+xB>0q4z-8(#-BCz2dBSLX4qE}<+RiO4c#yuL zOz#1WWku{+-pGzycH&{gcH8D+B{kRh3kGRhtP2WrDDr-OPOKQwk_?cR7s^u&Gw><% z4KHR66Ek;9D_ondn66Zy&dV#P=mu$p$~d8?1{9kxz1ox=5A`Fj1B;&rLVek17h{$u z-h{U#tNzRl0!Z6*e0noKP}yvK1&NI7Qd(R+1cNj=z{5L3@u8Cc85L^i@QMN?xx^Nb zHS9cj+Ufg+(ZcPKv#YR*n z`e*HBE)GU&>#6c1H(^h&Y{kmg({?|sO^acJp7xLf`rq0W8={T7VBC5+u-HNYDq(uq zMAk=E*`?wZwqgDAvRAc*1?D+qjEfjnHbl^;UoAoh ztpgqe0*M%z128f^Q?}9PLjEUknY?$_u$2^qDg&e1Pu4HZaKR|NcYw(vDvc9+XrV20 zkU32eP)8wz``2CNkOhG@){GCdSNao|0DDDr>QopTK=w-J6Sp8$c~k%b?d2U(Wbbn( zX;fN)QD^P!z>fR(Jo-y#3J{k?37eCb%-1Qrw_0a|7<`W{hv$f2n+pR-2I4kk^t;Ia&T6Ojo2)DKCK?KaLxo% zj=O<}nPBM!1&&vYRG(QYarX!)jtN4BzmJ{#@An2ifu}IED?Qu;IAv1F_JbNG*UCT= zlT(?!pwI{j>W=2FJ{Dj80hU1ygrNA~qy+z5p8v&`ULtk%l>CbJol;7&malJdWTz4! z)zLZ-?4eqJPmSbwqfce6DD(h(*5^wPh}bftUgZ=qfs}}^=0L>RqmG`Uj%_I|KU-^6 zEbyekIt|ittrB`1^7VTx8Ed49gv@SfcF9LqBe{bSSCbYhz~xM%P2!{Glk5d|9sCFs zUN5>Ul7ud4p@Rpe$XoLQIL@nL)C&f@`x`N=qm>VSik>*iCz&1vT#>JTlRy5OoxbA9 zjii(C1+!a$df2SQ0$zsvxCm*HyxEgqb@`3kyCEN1;Z7sR--Dg)+t#}DIv9n&g;4Wv zQpQo9oKvE;w_|%k5D{9UX_!B8v4qs-c{#t?A!B~l?Ox`Ztv>ebGlbwsPGKA;rhaqvb&go{p}eKf-BJWisqXMCeRdGwnxiO{WJb$aiPze$`4F<{l_4 z<++`=ToBB5{;O6!vJ}SkYc!9`F|H} zG;}Z7{scDLS`k!ywS5X4@_R{hv;0~L*b(jt-X1(om^cZXO7{)8nTz6;iy4s2sKl#n?Xb;3s9&da{f^+ZFovSTvr2!b%X|A80mx``60YfckgslGNr(Pt9Ocg- zc4}k|Ih;m*?_)%KwgTAtB0n=w`wt$3g6lYe>DuMdIs@U#=AftSJ1ZK}STMvHus)sv z1al$-jzNP=GssFJ4?N&eYB>Dz&)jaA6K<}zdLMQiuGE4K$MyRWBBseSime4p50=?M z@gbNKy&(GJX4~E)j|Y@Q1dBlpy{P=9$9NO|qy(*4a_I9Aj9d}x`aAB+&*xky$tO@u_dWD3^drvzjrHVr@0$z1#@Bz)^Vw%c``yST zA)M2ed_pv69KifQnLQ*)N0DPQ{Lt?E%{xLsQx1J|usShyS(i}n@A{gme!%bRoS+(R z&#V;s^*b&M{lzJg<~9sR+mD3)dLZ5Gu@P@iSCD!ys7U@|4}mXsKk81x=xga`$=VdJL!V3e#mFErJ>soa9shF4Jvx}~YT&b&-vV9d=$Fae$} zeX~~r?bhb{^&OWvFSNcV*6Z36XbyPdeK#<*IW|)n&_>SWCcjq*{GoS`YtCY+2uhJz8Sgm+^A`;Zj~=-NG5~jW+TegErxFi%4Tz=&iC~#^Jy(p z+jjrtA=W$D?CiQB&#@7OLHJ85uI=4)_uk3YeYgE?;f14rkHF~vA?>Zhs&2OS@l8of zr?fOkC`ihtrCUHcL_oR`q@_zjLAqN?N?ICGLK+05yQKR!d+YN&=Y6mDe9yVA-#@U4 zJ$q)&s=3!apG9N;HuoiiAHLM%n6!B&Z?jku{xI!cd&2kShmvxn*im!=0EC>)k(>`T z>DaJ|6)w}o1Aioy!gtT8FShnmD6QlZS_N%(AIpI@yM)S1mc)Q6v{)*$X%hqMC)=SQ zsBLBmq!Tt(Qb`qyA)NE1hPeEx86|_br%Z8)A#=T;9O2QM(>2-;m1*+DCE1b{fJtK} zAE7y!JnHaTbg6>g56Fb+*T_l(p3F&kc%OK&_2R|PhmS-jW|=QF-}yyAGg16tgwX>Gi;ihXWP1aA}50~z$eV2`=`ZF6j|hP6O=_YQKV(< z>BDq|D$~Xg>+Y|xVik4qfr5RYg;kon%(C;~RsCXjF?$^$=k*gW5?DRMT^Asb4V&ef zPn}vs>6eN-9%2)vUv@qS%`qpm#Je?&Bl%q^S@OOyisf?NkQ&?tH(vz8EvI9~`9kYE z($g+d8w~XwEiudV37ajg9?*uq-Y}o#1XCq{oWBndBMqISz%0E7b@ee&j}m%ZSOmGh z?0xTGYErf}I*gj6I`+u6jC)01svx}SDV7tUuMf(RNot8T7^&K1h-Eo} zH@m+z3A#lpefGQ4OmK$d(Ehj}!95lebQ&EacnKP>f_~2dt&7Cqb7Gm-`Zx|?tRL0= zMMF);`_gpp%l!c>#bPqS2AV;kNH!*hrzuVfiTxF_KwN}Tj);B}AahbR*o$F7>kkF;FL!V^ zhDUZQUwOMMXB-=>67CN`=S#qn`cV=Ey3a;4fbO#ijSi>>EOY9@yv@-Hju&gr%5a(* z>^zI6< zT6Fms`i(>KT^0})g=CL%kKJHACQCf!fn!uP&v@_&nJ+upv_ZKt6?}wH=-aJ`AtiB! zRVBo1Kbc#AC&h~cjp0-OtAGf+8sHuM-7Nl0{jsE)P1%lT7?WsIN4vByU5v)A&F{bt zNLz3zS-^efv)Id+K4w^5IA6wy2RGD9R3u3f^e6!w&fl>;ln4Rtk^l6cd@zjI{L&uu z^NV`E1D=C%1Fv7B}iphL3j(PbnCL zOsnGlgk2LD&J{BvEF|j;E(C%TscYto=yeEMq@&ixVE3{iTN>N=X2 zpuyCuI#NV<=!F0}FG{Bnx}uQO0$4!#66h8Bjt*vm-mjT7uA`59+|Gxf)AY3XoODw6 zA1p&%;?rd0vZg;m350t4KqE5H(st*yM`-?Sgtv42J}d=ShEx=EKzplw90yiRr3xO@ zoeipirz^B$;`TKHimvR>AwAAXpT={{gx{IaF~S*0PrkJaq5qAOL8kBnu3LAc@{I2r>R{$Xiw#yaBiebYR zHEzg1tYA(+`dY3_5Y~^OaQtCtJGSU|2lTFcrHt5L039ny1zprmBkRL9E(HNv3PNKa zO3a&tiz_j6c zZ;Oli37moLBIVfQ;PdGztjT4Xc^I+^=X~8zJ0L#ypNI=_smb0#@^;CIxicIG}qq1?vWfF>~QmGG6^{glQn3+aKRoRQx)v6>eAr% zy&gLD7>sOQ3{Is6NnHNtSwjd)v9*{>|0ckD1;0BQ3_KxTB?1o5%+pzH|7B`kDqV%_ zqg-IlTvHZRguNDkm`fcl1bxtXX&pC_f6;d%M-%&A^?F43QB1sK997$<7$0a(T|e~N z0~-ec7JQfkQ*)NqFOTzSe=_?6hxFzSrBE**+|aArRwZE3y?0+e-wYIahTA(Bxudj! zicR1)0s1U|kLr(BeE)}xD-DS8N{)k(-l>k+=tnP}eOE%Pv8JlUC<1iZ%NN`9&uiM0 z?k`Jo5|ynU0aR?Y+Pkkyt<}RI8dGXbM^eg5m(8%n?5;{yfg!VqhYXv`72%80xlsJh zFjdd1ag2*q{D6b=O|ksrDC)Axp9L?&6_FA9@X>gjUjY1-)vAUG*Wyc|KI<%Q0jQkr zp=>y%ZoE9pe)ZJc5a3y$n4!To_ZMpRcV$aM;cJj+ctzp;De7pirbz)*+f#sUJ|+H< zcNu8bBQ@>3X)^@UHw%>eK7fLEt!+C@R89LPxC)kV6`@#b{tfS>vVsES?<{QT6C6Q| zRvG3l;MVc8)$GPYjOoUw4A2r?j#fnoLmNp_mIQbS@_nSf-A4c`6lt7Q4~8LeqlLDb zu&P_NFZO>%Vo+zw##v6nRlEg9iEll`wKhhw+bm1UKcJ8zvusL^;;ij{xs0K~HVe{C z9oVTI6b}E3BYSmEbcyIl@&FN<%2|6+nUM~}Pp8FK6HJ%w&CA>6h(nFBqHqzwt3?0R zL~E(efB+iaAR}sce;%~TvcN2Ey6$GvhRfgup0X(57U1_N2DMmi3_A+LF{n?*nG#k1 zvA8)VA|g(+q08h4d21KYA}&F#nNgFV1OqH+9-#P&@|4l5NZG&z3eema2+2hM0o?<+ zvB(h`P* zPVaGErWH_=oxjgCe81_Ibv>dYk)g)sHNA0WR12czu^-yo=r>^7dA4d2gi}S{fP&#j zw<6+`ksuh#{2zDboq@}TqjYe{$OuSXJJ4WCQn`*y-Q@%oe(dwFApcEmD8H|^%7L}| z7Wvol&fF&b*z_rb7B&peyN(6$)?{eZZ#WOU0B~;V8h~>LLrVeW@w3w5d%+rqTXY)U za}NMI+^*ydujvtZRd;8I7}y)g(%Aig5AX*Zh1pRKQO{rSFdLjrk_!{7%DSMP&=4;u zW*<@FP-G2^R45`Mu+Dvbtp_k4=u8s~$z)SWUPMQeJdi_txu^-S;2N&~0(49R^#L^J zO>Qb$6&rom7TYzff>*BC02~LS0wgI@!a1A|tefSGl=kxmu5dF8+@jr0$NX0jRx6gVG(F(%g zF8CyA5vu{*4o+%Ik-BhP7~uB*J%U?cnhcwxL4q(7K;$m+eV;WUm^gX^%vpiHzi=qR2W#z1fw5hIePB}irjAi7o7*3QSbTx%l7=YBjT<( zmJ4yW#c+hHuw zX#);02;TXtrx+8s%tAvBnSV6i^nCPNSQb{i;^_gya3dcfH}Wy=i9uQ|aOJYgq~eWt4(@Ut!jld+#d@LjYk22F~mF$&J6X zG8+MWkAF7TCA5sKnf`B$aSpM?lY~23INKm1b|occ}T&qXRY)fGA985|V;E>gh>yY2CS?$c3NbjWML z-A{3l4HHFeN-1z}rO<273x1*xr->PCRHF~|FZ-mw0+_`L;N1E@0o6iqoALhN}&bv)wz7igMRK%y-r&FVUkbPO0eJH7hujqXjka_+>Y<{hi z!Y=UitAGobedG&gENQr1ATusP`e^&TJdXVn>=0-0E7+{*nfccQ%y+*}aofR{Td*_r zK$MIl>8W%EW2jes%LeYz?&%iv;s|hD0T0+_n+iPh8g^O8TR;B?r?~!tl`R5{hiV9n z@WdL%L%l!&Jk%GZlrc*n33Z(k)BPVpw^M`Wg$*eI#;*|kBm@rZm8WhOaNL2y`LtC1 zHg$&5q#-J}mbtbExNfOA-^4&tysQ)pP9RSJ2!9{_vb;nQuo4oq=rUu~>AA>5Iz(uw z|2Kd=8~^OTZN8|GqDj`xyO`45CDIC5#(wa~oWHe2h*MhYaS7 zzNAv64DiRqtXOrxQ}?@rKiV-^UvWpL+@|;dFZpO zzgW4j^UlA3BqaL)B#Bc5(B=yOFatn-q5Ytkg2Y{D?kOY zOXu1=d&WuY-T1Rn4RHxPn{j@Z7jTvD_sU;4)+w@57|tjwd|LMPr#2#w1Q$wXet}zd zen~kZluWbZP(|$Zo+aiA5AN3Svcm#ylcR5|LY3ulpA#{KGD^Gf?ri}kU~L{#g@^B8 z+fJ8dWzx!97+>~Dlo|e}X$0PRBXPM%D0M;ECaRk1+%NI{zVJbCtp?6HxFUS`hqd;b z5Jfcs^3St($aLX6v(k->AOR=$hbNzo>fGqCd}OF`fi?@!i~39$GvoZ;Zbb^*3nvgM zkU`J>+zU3cXNxHe@6TnRy3TAAClf;1pMD!u>6nsjiS8l`+Zjim-8gr+U)Og{ z-||I_A=KzTr=%6p!`e?VM@`WRK~}MUWuU^2FN0`~$~id@Yq*g!;xT)fx_GLPoeRG- z{n#|-=c;+nS1FVkL}a+)ot^Y*IoJ0I4XcQD-__#ISLxk);DFRq64im@<-4^Q39&Jsc9>d(jlq z$dW=P1@6yI9i8f#+MmB{c&dh~1O=UCj8VI{$T=NEIbuaO2R^UoFReRIV2k0?L~}Bz zsBZ3q;=9KykV5J+RZyiP9aU$IaUNWP%V`k?9nn~!Hc@aogB-HXtFPF8#EWVb$N9Xo zwo&~+_R56atDc&=mRDV8S12HN8*2cO7*~)i@dkw{;6{1!Q)w5rgxKkmwrjfvdD`OF zj4I45*f}R6z7mZjNn@WKEHV#ggmmN$Ec-_)5AG(cYm2bXsXmJi7;R)19b?G4G&Z<- zDj{XtQ>*7ou^KeuGeM>hvIWWIPo5wn?7w9_?CT&kfQc}V-s!thAtuWI#Q0=DT`7QS zt($Bb`na#->Z7vrigRdKtaSp~_>{2WR*AfeER|g$2MhloL(1^`a0S(H-ARrLqT;Iq z?G-o5aM_cl1-dwSVxdU%LaO?X`i`dB?~{WJrg7p43e30kV{e<>C+85~;$cidQN&mK zayTHBo##p}Quclrk(Igf9*v%rQ+nsqgcp9ojcWH)>@!f9A&Uu?jghx6S0kIm%?tP^ zEjwiCg|Oe1Z*?Qarrv7sWs{$<-1GB|(TBWY80^9yGp526!gfW-F!)k7=AQ@oHPl7n zs}W*?fL~hu(qiyw0wObxE1@U~DkRHZ29mR4Ha@r}2Qfhpr?$kqkZ?s*0F ztF+?LIQ@)#w0BkU3p}=N^V}j=S@Ybw``kp|FgqTB@P*>tXp-oL`kh$~eV4N$kBy|_ zD=)2DCYz>D+KmROK0*-(4Uc@L=JeUG+1tAxyn1wy{;pfOFX0M$eY7j)Sx|GNIBI(W zrB>eA#4fdXH*odQbKAS&j`vzpa5##s{MZb}G*6#T~Bn$ykB(aOof%*@$| z6aI~t!`;R@<^8ndlnidrZtaUXv0P7G8PaK$APxV;4&457&wJsYHBoRGdh@N9XKEj3 z$MD`@A&O7RR5kAi97696{&?jvUGjm1n8~=xW_su4x0;EEA@AmoD{MGd+|0*o-sW7p zu9s!svzp#zuYkH-UvIAPhWRimN8}PqO)%PAuqe9S>z4Irs@ab_u;{LFHY4i11I>-z z&yL$NS>b$;|7~jjMYX*7Vz92Rq(x_UM~G%Imr&QvnoY< zg}O-Un^&``C_~R5(^9p$BsQCi*;o-&?NHaMZb3^df7tB=Qfu3BU%fmuO!)T9^+T>A zX@@HQhwn~dTOlHw?RJ8S-8f+~=cmyaiw6AMp6D+Tq2e!n#u#c@8$fVF2svbaZvl!BYm5>ILBsME_(*2My|oSDbJTj94gaJ@{qB_1}bSu zZgYC1u+Q>d)8R1O=HtW3Bs}@ld2XUak0nBV*7Uxe88dk!3SIe{U+LrPJRVp5ZQV?> z`QZn*6tTxOtX#Z!rU*%-0~J%vBD<;F)Ledu{r z=j^z&#^RFoR_!)U6)xZ(lfceE%}G{UQB4 zHJRU|x&SfGR9rq~$J{pjF?X4wPCUi+S4%oeg{l_>Mf{wUWs{8#1_if~1r9qQqgK2` z8|1WFfwqxv^2H4!RrCXQA_fC7ydH>S6P??>=6JF;i>6U+W|=^R*vo@F{6OO0k_jG+}b_)5L7>*d0gvXXfA)a@ZH6jwRwg6v^FRq3ZYINk*BoGz9LZ&BlVPn%-d@9Xpsv0 z5znF7$M4Ii_((ihLuRi#NU;fc6u7&vLIv={@iQ&_cifmP{D*ClZQY5IxVYa8l=iPB z;VPJxF?P7rUu_M)#&69)SAVQZ5X-{j7eqyVUO6dFAcHl?C7FPSZ_1-E$kj>ufPO`W zUG8-j`j=hwq@RbGg2qO|1q}MBL%g(!S1xqX6@~?Gy z*CkxqTHWp0b~hqQ(LZmM5xk7JauG)#v>2;U`maZ_>;HSCQ%ZGnXGOH6lY#VR^ z4I8QaR|2|zbAD>L4PRG8@Eo^`^!RI|>S#M%i>zrIPlTfvMM#(1j!MV)Hb;Zh~H#{}GAASf(F`0f%TaS5$jDpd17hin#5D8 z0V1!>$WDpCS1;(G5Y+#t1kVzni7P%SFm8CRUj`F50Ij?(v#Ks4gbc24T` z$w$Q3#zVBWWZh`%)8VcyZzmO?jU6%7rgWGu7p8Mor-0YhwOPzqx0GQ-V%{;zujXVQ+kIX zo$yJ8LLhB3DkU)}RNo>o#MF6jloe|t1$8=+p;CoTTaw{4-KLFacxvG%sS7vJ!1N*g zPX`Rvv^M7WvQKK$VFA6%g7f|&QsuiO_cQ#C=zcDKHZ)A`UDbWJz=bQk$To@eO=;fA z^TO18YcS*c$n1^ki=I|IYmy>lDvg&utN3J^^^F0Q*M_Wjo_x`$>v(pD!|NhJ*MP~M zX`}CvL-0ni>s5{Uuo)VeWi?%DC<`!Bbq`>m4>R@2{Xf1H|7bAGjO`ShNiKN$&6 z4v+EJrWb}R%8TiDOY20sy-vhZ88{DRkjQo>uv=eUgv$4tR;Ljdw2jE^rL*_iRE8iB zzfu*vW3<;(s8xqXwW2)2hrNJQ4yvok^Sr;wCebDme3 zmE?P9@vXH)!A1Ojafb{oyY0C@m|sp~)R3KC*$JqI5h0eh>p`;0P%;{YkVW-5Aa3`# zHV7fRP6(outKThIASY_ANR*TupTVP6d@me`yK*5vsv*dw?TCJfgbsmXEQoFT_)i#( z>{GNPSH-ap`y1lKXlw!vt1n&hCH6CM3(at`T(_n2-?aYh@%1AJe5*4xSDtmCbUReb zVb@W?JdGk%R@qz)JBl4IRj%xvT!`B=cYZ-v;`Q%O%CM8h4Lf~{E~(N{7D+?6zYF^j=PsJmWfz(_ zUJI|kO2=*l_`N6WSD(SJe0cnC?nFgH1y3>IPt4p$*aZF*pGLw)p89`y#j7nKA$bub z+!<4M|7BQ8-NQ+-#NDYVk80K6d7OJWOtyO+_tNUx1$Vd?5LQw47l)SCGmXfXUQ_!+ zY4XJ{9$x;^Wb#Z-x%HKd(frOZqq!g1HK)Lwwjs|L_7cxFO5Dd*_nD=Uu!todDWo`p zms524z3K`|ag+*5Hu-e<#6>-!Ot$+Slw%IjcsTr=i7AZA+yddQ+3u*By1gXE^zRGY zWLKVB={?ka*`1qoZ>@ghNS7CzMgOA}>zHxuQ#>BAB20lmEpb(6)=nfIm9q<_A-3gq zZ0AF)7n4s?zlJ&O<+!VOsUAW7Cw>0Ua4_F8uL0 z@yToAifwGY={70x@tlc{V?!SfyRMoi4jLt@(wG#}c6F6=-+ZpjTr;+Er%b-y8&uJ# zXj*Pe5mb6>?GROjaL)ljh{a4`!M^XI(v$lUW7R5Y0?nJ!N>MV#^4RLGk++lb=s#m7 zZ8_@M7rvgya@cE`imiN6z1+*Y;n-o|x~wREfUhAO7qM5XQ)si?d+4pM5|s8JA^hI;@ijoue^XP=?9B1s2P(nBAfHdDWL(e*^G~_i$~lu+xOB!5YsfypsTTb z!W+MozxbzX5L3Plb*@;CDlxq|X!Yjb zYpo{o?Knc-_CvZ~R&F6FTBp3AjjpY?`gVLwoLvVmq;LQuUh&*TGwRyk)8Ypz<|BRhs10@!?8Ao_NzW45O2v%j5;DC15<}w%$VeG2#wrT z%uQNl1ZC!qST@I693IaO%mc}FQ7h0W_nv0s5Z1*KP0IC z`KB~(E)#oGo188+m~beupeQdzCRRqb@UPw={9pNtf~~sE*&PUkVCvtx4t}`nNY!IuYct71WASFtHGwJo2lA^ z8iIQ}@{5bENSHK+SBqsA4cSml@D#|+;E#(7-Lv~c8}rYv_K)WeCilS&fURJX?#If> zo59iJZkxfQllybU`HMb{*8?~1N2}-iC;6Pkqbmhrdwb5Vmu4T&&VMZ}t*`WLT%WIZ zAB~Sn9K|Vbc3*5N9+gF>E2lM!l$Jtm4V``5zV9A&F`bOp;&cz-8HlWOX#1Qydw%rz z*nH;N;xQqN`ciL3->&F9z4?c?*OXL4OE0>c&(-NgZ5i}O$!?1#t#?CH!^~w9w#O@H zpMzfu2kqzk=d}$*yDee!N8g4FqepMfM{iIYc&2Y`-|yJjQH?8aDkoDH_b?6cdS2u+ z|$aWS)j^0pN@7dkDQ~P;i+2hsO_VME6KGgFY z6splea>Ut04W3k!(ByONa(O=5J-vZ8u21=>R3w%1Mx(JYDI!|gpk)g25L#OdO+UVV zrEzdN?Q!LK6%fvHw~xLT~7yuPthiosu?)7U)u<)oZ^NjxgUxO18yx8<;2zGT|sv@l5OUY!n?Dh ziV~sXsf`7`c5BxVyW-yBa!+G>IP=w2@j)GSh zM#D|ZETSckf*Xs%W-1D91{-szp&n8$6KR`MLKLA1TTzcyuV_DBYz#g!Kl8>?58S?O zvVX-q7EY>LF=NbL8Esl2^yY}#l`ZJ;ucb4uN-u)uPqTV0-bZ!U2L(y_Z_f)oS~Pux zh&VTyFQtoTjjK=db-Y~lP7In*(u>aayEm`b*NfwzMSMq!chAWr0}MC`6;(A}XYny_ z1ZNql@SsUOAjFm!5(tydT)P+6mAQr}6{m7|TZ&VBh#~A*=PEtxv(C9}8O=*A!rrh1 z=2#-b3>nQ=p>$98alj8P;zK7y&_a8=_hnu3s4G@3otIR<0y0as2TEC-ukuUDh$}1Y z(s%>5?^yARY-3`#(0hwu`WPId#5-+By>Q2DI;8LKR8q%**c?*QlcAd@sI95Y-f?2p zsB>2)|GY3RnRb7y#~)uNv+oM>i};kLx4RNeYyT9Xa&*p#^38`)^X?1vsTh}Udx0f; zggil8AD=tpPIe5K&ks;O-H?iLQ8ez^;R#`<=YE!}BJmF6$ursP9>!ns71G4&Ef@(2ptz z(JfYgFvi=SiI3?JF#*OUgOB@(K)wkK%5CC?PftA77J|L$Y*MJi@Qz2$nogO_>X{gN z{KOTcKK1RAw6(CesI`mWl;4C-Dmj=(l$ospZ4}-`iGZ*v0W>`j%6WLWpW>lvqHo%< zLodT#5{Sp3k)H@7>$b5|ljqE>RD z9b(!cVs(390xr8$?G33=mq@&ZIGT!bV(F3*%MP_vId;qVi9h?nTycRAuPtla(Y1)$ zF}9<0jZ&$Tnp9EBa>%Txzes|a#v5#Iy|DUmZ&iu?D66A>MI&msQ^~(W{I<}3tl)M> z_=bjwY<9rzRdK5@3DPn$SXkIKC|EuIr zl1~{?pH+H0qm~Nvs_0%P{331A`7kf9s`Sk^BOnKoul9DxmAKCOi#@J*(Pak8T5tao zI;ju`8*yi@;j~BL8yHend1q!*ZBm>OCgYIKfvooS+FoZBE&>D<1#Gg;!8dxJ>MfF= zhtNhEpf!$|P@04+;Hp2qZzmkMaiN*V z6Az#BhX->Wij#&~qYj18edOoS|0%-RcKXY)Hh{jp+`B`IBT%JckC zoU%M~FUX)^c>30YD%R!-Zhp!GcFmJ^=1SF+`vY0q>|DXyOvhIb?sUG$=cx-lK2nE2l%gXBOkOMwMrFD32pTEe z3NglV{f_xb_qop8Jk$6?Bhp}RETa_MuSq-&me{1~kAo`0Uy*i46uJ#^Y%zCuJBAf% z-|3>iA4X94rN$_a-}beQos8Zs+6a^CDQi-|PJPhT=${UsmnyzZb)G50!)RAe0gv*5dk@1@? zK2pa>jG_q%SqJyY2BkA5ZusM6T=fsPxI?XRnbh9ed=?H_w0-&@Na>!wB%uum_jvq2mSpJxLkwyyFX%zuYEIj)Wb;cptNrA z=9{)XngO0BVJg7ys)bi? zBbPRdN6-cGzb%TW`PfQP&vaXSElnFUaUy`o+32=j>YCew?V4XBSNJsK8#W8-VM~Ph zdJT+U=H)x-AYo2=LK`x-`=pAE!+LXg!batWRU`WB2v_S|>p5JXlh~O11(J3)h;I;8 z_siQc5YuFoL`voQm;1?8JA!rd#(pY-ebvcdCv@(Venu zj`uU?nM5v7j4KiMmnm1FECwM8aD|zcrV{@obhF<+pV4dhAS@6*lSQs{NOuQ}rCy^? zz;HiYy@t~DnGnWW&-49e*=1!5apZjMCZ254uTY`d_9*MeF<>uL6HQn~k~`IW z)hU$mL=1j>t0_*;OX$P6+q87{AOyqn6kBpH#NkVgRhHy)2hz-ZH^&qS%Ee}igW8dy zp0o#1Q?6Bx`HpR#EZc-$2&PJ^U5-g-RFX(u@tflsMU|0lq)2EwJ;0-o7Ta0eF_qb0 zxVRAPs7tmPcjH9iavjpPqevB}Z{;_e=2fL@=Z}DpN>oHugkyB`Z%hw;5$IYl6X+_x zj&g{yV`4MkO{~0^$lcHUjO;a6#3(;c1Z}5SM8lb@ms=pjl!OSWi3p7j`;~Ic-ml`Jv=K^?w#keM>A>& z5&Aq-y}e%u=@7bD4oXAu-**`!w~~grMCc=vKHe5uBjF;J@8ixp;)`(F5_&4o%0JeR zC^o1Z_d?43lj4;`a@XJ{Sox%z7vB@G^2lvzj1Xkf{H+E?xo70Tco0+OF>Y5pBMRQV z48vA!J>Krbu{o}O?!9NrkVS1FOytj8vpB}X+LV&*q#lo6J6wH=rF=-F`_g@Mg8P=L zF;2LDkMchGkTEJJLt<#F@_xqcxjX8QUBkx1?Clg@N}sFxsM&DG52p!~wwPeiwW!6& zJ&~S%xhq&2zQg9ytj>_rM3W#X<`ZmE4LoB5j45!%TL6kT{9Exv-~;IkueoiJ7FR!qZ{{Hw|Byyi}jrrIepN$NvlySYp>~P5MH0jJx_gZP$ythH}-% z5mzZ=b6Yq%It{id{|Ia%Ph77tlpj+IE;GHx4SAwNG3>-HqlonNFM{JKs$KHXqeac>U>(86jy_OQV1HCL;fR9h$nHV!0hT(X7tmLx%wmk~ym-z>&u z9$qyy8+UwMh@qPQdo+)8+QQY5p;;3f>d;r1SqmEJhA*TdxV5d0&scS~W%`*{s;V9d zb@n;zs}+8+5DHHbeL#MgqGkT2(?gqe-oP+;!!UJpiQ zZT9$;5~V=b&jo=lRT7+EScmQRIC4|dRuU!RLrqf_7ji-DV{ObwOi;XbgiFAMeOa>@ zBpQ3+59>d? z5iD<0VI#t`wlD`=aqf4B7*`PmU^t-F9J9EM%-s`GSK_<&0W!W0UplR_DAKyEWNKJ9LNA9R|R_k27SrYir;_Wx$iF?Lk!1{#D#ymzHxYo?{rh6!a9^#H~ zW$;XXeCxd9zq(A?U|~}GO#(R9WuV`;4GVD*jIh9}IW{&;v z08)%TKeA*W73|XZU&lzZNU#VBHGStuYWIw`R4?nf?|o1<!aL%Nz+MB829MNS3wLpIV?UL1h_5WaSjww zoR>%gIM+#jWN}a(3Jne*HN?AaZFwne?v6(~={14~uh>aCT>1X0qJ=I9CZB44#`4tYT5Jr!iFNBg&4tE8&7IKjv;2mO_ZuD^7iZLv-kg6;6#f_@a*d#Tr zuIJ0ss40}m{oD6A+m)b@c7+nsb^&Wvg}K@Vjj}rdJ$yuwYkRZ&AT(v>-tC^4 z<}g@$8}<<26bq+koykF8u39Qn*~h3l$f5tEd*MHkz205N*Sm5Ner5uGC?4j|vZxn% zQ1FaW9QTu$gHK?_2V}ua%rz@z67guDm7CbSj~n<&3rjC@SXxZ@LjxDhHJ1)8GZ{nR z{&8p;$hQBPVY62SM+is}fCL2^`G^sWfIWy+cw4EknM8cnaRMf{?fPDTa6yaJ!jf`P zvgrO)zrUz`gegZF1zBrdKsevV$^u9Yo4D)TpZkdZF<+q9Us>lgmg?M9*cBEF!XIA= zb}d++@qk$|zcqy=)vE5~V1Hp2qULMIDp=?KTmIgS+$js6!g+>-7T^&W_`vuc9%7OK z?puc6Pr5h|Bi!iHfIwNE&omz5mO z_r+mfl!t6>Rl^sJOX;7{z(g{%Cp5M^HIKPxM#@YnG%=Gg%7`Bl32>y9q~x+r`;#qV z2|2*BHV_5=S*9h{?dT*Fn5_jXMNd=1CU^U8>n!Oj*>u?COl!u4HpaO%trV4ZS8-9e zZnY2c5dnt)R5;IUc(V)U^D%(2v9wvj+}?7XJ55p|88$3C_~Q+PJ&B`%FKDu9<=3tCIIs+cLKR@;a(Ej`AEUz+#g$rbcET0m)%xO>oqKF6!q|cwE}wu zp?8LSM0%kKM52vOJvpJkS&j$YFKq07M~#1cN}c<;bc0+D8W$CCD&XMo76Vsts{#5u zUT_%5aS`}6fB}s`?$rK)h_(yY#E4YBI*MDfm{grLx$9pP*5qGI0PGEFRCiOF`bC|!Ie=6L-TL2thK=t!EH;z$akA|-lMMq8CA(u608Zbqp%YOr0JJ;># z4_+!=L{#s0?Iz*=9fWG6p=VihZnytP?sr}V6iTIJZhkC`)YN{T!n9(H!ZaF@RDw1A zPpF_YZ5p+OZz<&BJF=!G=mQPQ88NE=ZV3%4CUt zyE_36Drb=T=?kOHr>oO$LqHxvmFpN`W=sJ~a}ht6YE)%y-?9FbH|A?2z&v;yxK(^{V zQwI-At^D)W-zs$4e`iW%5mEoFU8|daM>{Av3^-A+^f?XR@ce;I1zP;yPAaAeI9hNb z3Ps<0bTxa`v)8~x4&qbh2VNq*oLetAd)ON&tc!zs!9uS&=A!U-wk2n1wk=QIv1zdxR# z4mAj{6kdn}5z4#m@}&d4OMDysNVVy3Bq(zz_c zl7cKIqZHG}zes-SZuB%;*Al@qjbKB|>iW2J)9UkFbedo4AmILE$UyC&f~Tx8bl^B0 z&gWnb9ORH>>7nx9dSY3^k!GwwNd~e$A(*0^A4Ssvo9j+2;)R_vi^G{z|2d-q8vup@ zFaVgMfN3Iw9G6ZXrgRj7kFF0N6EIZr5tqq8y$>mb?ngA;ZFOf_u*4cmf^Ep}gQ}kJ zQvuKJ`0X~X-=|*JuzZd*?-NwuX?~|ej5{TeE}HL~)&H7ZX)XQ6&S1$O_bsb$-0xmc znih@0jwXMdR>fL?I7Zn_k}+KNu@>FS21wI|y`Fw}XjjTNUS_E8GhJd{>y|vaIJCGi zJh`vj*;icux`oQnyWz^+^>V=AU;t-yHy>1qc3Tb^2cVbZ`@Nf5hGo#QSwpCIvzNPI zy{^|(3gwA+$=s9Z+VqyHo64s?kAzBi96VYF|Dy7_btI+r&pVZ=?I_R$Jzv zsW*KWKG*rREh56#i|hFp7posj+Y<8KR-uoeK3+}^`_3oBSF6+cc2v!?KI_-X)YMea zIT5#;-NiXhP&u5P^IpR_zg#zI(%I$^ne)DMyjGk4maV=x-%Smjo$}%UO5$V(0dZ zhU~cATg$2N?h8YaG!7%y>g#mH!bzp-vBHTJA8l(sBB9jMZa%2b<=)QaO=-~0nZ${? z(|Pv>PI3D>^~aktpVi$t@6!qW`Qf5|s$HK~Zr9x_-*6fh&o39QrqeQR&fRY|hqvYi zltiz$=jW;OZx$MCGoENIZf+-Be4M*E8Q-aNwNFof1buaNecinZo$)yzdGf=>dT#cS z&*k#tU~i?K~&ebJib<>n2IVmvh}` zSD$X=_jaSrsds!Dug-=KZahwp&aW5ed;}GXuAWb)rV!}ciCkW9Uk&RAyYQXaJ)9mc z0OG8tn}H69_y}KJZIw4(eYiOokETxZ5v26-c0D;z=i9xZx(=8xPe7_Ko}eDQ5}+vG zxptZN-H|&&b@qw6>m0yAF&H@q`wLaMu5gB~t&ivlcrtsb9{9fMF6y?`7JuB1Fq1wT zFL?VLuO8a{v8r)x(H{JfU;LyDQ~gDK^SR@4y$>1AdXTQ*v-*jd7OY_F`s{?;WSnks zrEVWz@h0v2r(btUEWQ5Gr}KQgvHabB7T)4k27Iv;8N}?Z_4xA63OG4K6k_^ zjfZ>ncH1_t5i{E>y!6*Su>$)X12XNOUWb7%-Wj30!!PUC5|djuuUVTAqdkv$##v_e zN2}91#<^2s<*@=WubI#&wdVbO!ZYnZ-w=r>yA&L*(mJo*$W={C++p-0LYfwB=j~^3 zcD?cdM$JAwZj*vv(Q@~>h+XLd^c z)71qJ(-&EH%4nVWrM=75PB#zl1%ZE8^A1wkfEtTvahGFzPFSVLFPUQ~Uj8%&bK^A* zIDW+O;I%Cm;k)zkarqfu8|@7o_<)*q@ByipQN_RDXomeQ3Z6}9Ogbs9w>?KpIt$N! zKrj##{pH|&zIoF&?6mNIro@Es=;mk3<=JNZyK91^H3qPx62i03DobF%0bKI)0o!VH zt!p_%<0s?)y13X2l6y`BP#N*gtZ;BNhvXuR6%I?ZPx>UeZ= zEK;Vdb3r_K0t;s$M#8CM*TRbQ`+j%~a_I7PQ;HK^KkQk*6Ka+4?{_!}OT{(4lCZj^ zHAyQ(mbu94N-u|?tS#@}7Qctg@^hV`dhlJ)`vLqmg8s+uNot`?!Yc0m@xLUCXF@W% z;`a#q(f3{x4D4$#6(~msIR_JB^XB?8l`sfDjZKn9PV-OFw?RtKGEFTEuxZ~pOd9ar z%gIZ^AxxvtiY%UyeA>Y>&yqs$v#?7moeFvE$L^pRhVr}0o#1yf3470Et%^{DQJ!E5 z%Zj^KcDN)dZz#X3&kMBhq2p`{{e?CldzrC6PRr}^47}ekor+|9@3pPEdnKVOv}&vK zHIuxF`n{hl1-d_F@!R4UDu-X;E5G}a7s#xv3_v-yiqqNG{vFt<0)H{HarNVz(RG z_s;ab=k8mymsvGtEa?o+9b5P3=$y*nVflj#3~B`f)v~|p7(5m&(0tn;TJH1a*&FqQ z%3XSEMP9$=xKYZDzTDr$-_n1av1zF!^++{k^N`JLu9e2nZ0jT3ce5qiJMX9+al5@w zuR60oHf}JoR7{ca77cA_YknlF5VN84LuUI{)#zn0??*K(s$4WJB9_FQUemezgRa(W z|JD4J?3ItL_RZ+Lwq2=My}_e6X(vthtR#nC5ozj~zCf>TS@edv=9!yAs$JoigVviz zEQ#Kwt!b`N=p1t4R(xSVrgu*KJq?S3YkiHoC=a~{dOC>WF7<`UR&DdF9?8CpX7 zvG-p_>@icfuya)~YVpz-HdY_7aMEy#Ej(=-aor+6)oV?gdcx<>h+EpRdG4BxY8nLk zd2RVdIdk8Yv18X{-o0~R&bT+8k@|{5H3(d79i5*z(>!uz=~CNEa`%ooTkLo-`Z?d; z^ZY=_>$%0jJFTK?!mGDu7+RWn#ld;TgU#G-Cmt&u>y%^8)Q{=y7xW}L6@{0cqwH31 zElcO<#SI&CwKOdl`*`CoqoUq8wg2qlRlTeHR)d%QkGzh0FOAG#ZeQ~;vn&fI7mCUZ zf=^xj(AkG8xt!0j+h4zVBG0?>#m3z)a%JMuwsZUjs+@)PV}qOb4#qq^klkExF<Maxe3F z7EeMUE35DNhs^7Q7{KoB^A^pH`8mO$N;zxj_%9FjTh-rtbzA6oQ;w>Yir!GNWt9r{ zm=z2xGRbKg`~@1*n-X0o=ozdx)=v#SEqmHcqtses=tP;92E(ALvHg-9bDm1Gzuhn5 z^+!JBv?j)eK8H#$i;v9f54~10OYgC-Li8_d^$xjH?$(X=Eb^T1KDol^(9!CK8ER)a zzCUNEm4MJ^Mn{%M+O*u6?`#pbH^4!V>iHS z)f6l8rCAr%Ov5=YoWu6IcdcSVyrUV`;fY%y0@_Cd4j&0f@6h{V6|+I#Jo7^0Bj!c5 z-9JJ|EJk+2<3ulygWMOJ7WkVTAe!iIG@2-iQomf?BT{z>99Npnwe;)_T~5+^RAcGc zejv9Q%0{zu!NORXO&v;X+y zeuy! z@7J=jPYKJP1^7^`yGkGlZ{(u$pF%M!l`bs~v!35z{R`W)c=xhPw>nDzmr(jU-gw!& zX*LJ1OV-PC_@(VYe2MN^mt1||+OjY0G1u((G^;-wa-u|a-v2hMd3UYe z${+RgU6i|C-WoUVG7iwl_F~R_n{)J`68n)7E@p#nc;={k(C-Ha&qXTXO{33QG{js| znhUSTe2Hv;{d=BtH-~?F8ERC#JE7*}HJ|O`q>?Z{_A|RoB~#sv28Y~p@!8!a`cOFT zlxLYWvD1rxf9Rjyq^D&Y5U1bY{%Wg+jDbS49_iu{TCxvEX<0(HQjmNT7dBVz6@T>R zIK8+k85QdEY5|h;B<85!kuElBu2McXtVLR1%1NBTpFZ>8o%70&#|PIRvO!KPFv3n?&V%n%ZKA!Xm<7P22lukQcUSK4reA8@qT5n>lE22_5Fy-2s}uG+AnQM$aTR|j@$UYZ z=Q!vWU^1mdV6sg?M<=(4O<3W`^<x$Yg%lIXyF3ndbb63A+)?Fj=LaH>i761L7a5DbYe@V(E8y@kE-xJwDf+g zS+|;Jwg%#wUk}U6mBTwho1^b&8TZRw{o=JXJkj_>!QJ}~%D6-MQR+d^Z6224vgVP> zrS>6m%&ZLqWf7cr*Y^ylmwOe%m(FhUAXU}7Eu&8_0!1Hg)>GMh)o13fx1>1H0{MqR zLFYd33h2JHbSW+iN=6gGgzFvz6XqeqvlAQ-zkLiJ@a~h5GuLs?ec^*jjSPkS#VY#K zBiLODzw?NTMOBz4dSb*4eOYG=k6Q)LmW9P&1hR%Z3~n&tmW64-L)SOm8Nno{ols^`|%;g84Z zt9ZrT&H|yO=cUmyxIRHIENS%E#`ZPy3g($cjNi5bPJNW6W;V}UFGwKXpnG>2h@Bo= zLCyOiw};AHPC9kjbhHo{x9+Za%|l5-SPZqLoOt!Ud-V39mDiOF)~1sct>ABcpM%Z4 z2a-O9c~pg=I6;;GJd&2TuK9M@^FQ0dmoqFXUY}r)=b$}wfK&4Nta~nf4|%>v)Df%s z?tZ89I1e=R;`&R}WeiM4R>t}rU3m6$7mGS+MpEAG;n!Qz^RG9}`tHhIOIV)WbF9zj zXkw5ifu?-jU2+v`$^p~?_W9PE*yTW@@DJbuF(e{mNiz|8**7TB*z0`Wu?E97X*a_{ zX*Z+(Js|5D^1qsSt;h0KAa4i4UC%<2w3bh5estW zl&eKQdz1L`m~fy&$Aw~>SR(STGPIoUxxHs)vt0Q4*IUhgFkj7-0lbRdpcC`$mS=hm z^u5<5E4Rs2=J03WttoCtXkQH-o*wZ_w&rX-!1?@egHCv6#@0hF(JudUX`Fr$BP6fD zC(b~j78($`$Ax0Ltq& zDCkm8^qECNCJKAiEiA)aX@z~aIgnlM{;*Ouai4nYyoV`GgBx_rRkzbZ+C?kQy@ZLy znRa%;$lH>ezWhxewhTdJH3&Ig^UEw&wHlxNO=bCljdFy5!NkFHh@~qAccVxA^11Qh zUu6QV2#G*cf#NQ&cK_YBEQ{M9ZQMcHq#D+~9a@>~)duxowM!{fyeBVD&?#;V&Eb2H z0*jQ@H1w{@TvqIoHX^s|R>`R<;BDJz_-`$i?#0VnHI-oeX z#=liEM=eOw->s z>TR2!ed{FD*MNECPk5IP=PjB-UAKFt|LK4KY+>22oQxyI^SYL>H6K|CRlglC_I;hA z%@J++t);Z$f!ZJW`PkCVV292~0!7hP>r711Ls`V512s25#Ei^_88CXs1X)BvwZnE@*5Hmsz02Xz^9A>b83Tbbq< z476BrZeNmI`Mj0*_TAD0hHPC}?P zd}SK6KV5mYhO;eoC9JpcZ$bb zFR%7sn3*nk zAjnDNgwXr;cg@ZH_SV*B5l|_;qATaUT*7UjM3I-diN3jdr}N%0_M#-@9u(fZB89NA zk(CKo)M9o}UeB;Dv_6tH43e=rcG1~$us+42P_F*4bX4pw1#Xg2SYS|mWq9_hFJi3D z)1l5ggZl*<#N2lPL{}ANS@@#{=^2{U3!VHKI$3lpp)_eZPyWa+7@sCc`BVk?R1&;> zSmwFE*$L66r^BS~3QY2-7(G(KMQ<<+&y-iY{mMJ%)hL=Sl*`6bSSXFa|N^CHE&#(VR+~q z#uXLVXpOdw&1wa!BxHKit%3jAy3t@8fbPjs1iFzc@vbncwuU@5e0*=w);8|v=W_63 zVyA`$00JxHf<{4e>iW`&nH`>>Oy}O_T#|b-1B4vsdWc-`v4HwtYwQ~gWo#DcAma; zpMTN$eIpl}Z^+y|ab9mF*Jqd2cQ$>IOc;cD`=r zFdFJH+Ht#A+|8Pk$)KrcnD2M+y0kwhr1Fw;ei&x-w4E)_NOXFr#O1V?s3HV^8QEW= zuW<5*1Ycd^)2H85|E@51Ki@~-db9;^cQf$O)w6C>PqhnZ*ZhM6x(Q!)Yx8#q{{5i; zY9}qR^9pUZ*xQNSC3jGZWv)dnre+ebT~{Sm#u~hnq39VFI_{HpFjDxxH9F)DppVI( zPqBz99Jd2+`~|>Y!>v!_j;@PYc2mYlgIhB3Yi9$<5TiIH$n#ssGfeD=S_zqv4aj%E z1QU8~d7R#3B|2j{N^)UHEs_L7AhhU6XzePHYTGlY8%#!C45+WWt(MNqrdsKmTVENt z#evTl9-Ww%JQPuqx@pvqihuM$syQ{nOqgIic&*NIM5E0zyXKX9RF{Hl`DY-JV7{4c`ghQ)NTPi!!KI(Q(T3#SIMSFBhse#a@9oPs(jK?$RY@zYEqd zKVEP_&H<5x`{b^;174TpeIXT`>kSV#=n}u!cbiwmXo5#G7*hj?dyEf5y2e`e;(e<; zWlVIXt)yfWp=J|}rtFNZkMG?XJnOKtKkN~B&-G?;%Evppn#&R|M4ha7tJr#S!u$D7e-r#ha&p?|=V|H= zk-x=$aK09G@`IQD1zf;L_tKZk+Z4l%3$0A4xgw(L$Ur zw%E?f{Z!D`68hw|!M>O|M;pi{1slodqq8-F4xPD%`}5YgL->i(fQ)^ki|*ZZXBHL) z6LMD^V)pJOzgj)Cka8&XVagArNVig#8fM(Spz*a!-AIvM@Sr78olRc)pO~MrU8f4~ z4l67-r?eHnAGSHw^59NFi}udgm0A-YFNd%TR}3kT4CgY}#8Gbc1yzPypMjOFUi$es zdDjPm&nnB~MNXDQr#9}4WNcAjKi`0(Yq!hlcudC3R*@H^Qzq@)wgqf6o`@^BKsY=6 zMmgK4@W*`IlLmn-Ia`b?$)G8GpnP*YF_G*u@?m}_rGEZV#~Xt5QG>CzN^4BVXfb)YJJ{Ec$Jv+GH39;K42&iufLdsBHNUD;t@!dvc0J99Q6 zWE;QGB?MR6QLS1$gQ1=EDR0wi|F&c2{r09^!L6L%9O@W?OK9+y%X9Y3F1J0RmqB1c zq%~@(mwO#1hHDHD&SDyzwWz($cs7_xU3lm79JdroKra!+I&sh$B9%!+ zyQ_s!9N6~u2PRqvwIp4~?B2(9@?X_svGCyK@vGsau`6oaplzpO7n-EH7*7m$Q0?1p z5cF=3&Mp)EQp+8Z&vFeA>^fynI=nJvU)QzK*$y{0knRjKhdK<4pV0z_RpwrmK!DO3 zA|&$}4;cTl_;l>0cqZ(>in$@cqPQW`fbs;&9a_QWtLW+H7XE}lXVW7!12Vn#5e+`Q zmRu!HJHrh!3l(Ay{YnBMv=1jzp46Co(0^HD&=}sgE|+KD(NLF-7N_SWuE-!ff9mhG z*PSjuE4QS6yXf=vCKaz=+(_z?yto~Ysg`?(;tu45vz|XGxXT2WVi9EsHK8-N?lkw^ zZ-RhfBY8rK=X?%@LgRdr#E zVm>O%h?7H5mae}1kf^S~G{sh^O|(B`8P^w)TrtZe%q1HdZcRc__ znFzb_;D?|ngQIK_;QU+j$h&fIUz;}hyFa4cX*MLig3JyEh7CgJHKESiKhzgw`ngAV zc?aiF&%5~Hwb*yC0;z1SF8hJ`zS*OrOC@Q=8-~C8Ga80A4W7Q9{0N^YXs_Vo9_XCB~#A|D=9 zAI7nC1_qiREN0QjQ@(yvofFLyy$?Q&Pl_8Qe%_O5JtLjtCfcV-cKe3f@19|;pW`2v zc6B^qX@TrqYrj~>d4w(U4Y*=?f?1|gz~(F3XZc=jp5%_uo35k>W`69h&MGInk0*C% zw?k<3p0%i`16cUsV{49vRddZdMXy=89)2kghdc8E{z9teKuZ@Tma;NqZqv#j$7;la zs4$wvbDE(r5XcQ+apr|Ms_-JN!%GOQ9Aa_+tsDTYNJ^CI*0)v7;uVKqk|-b2DK_Pz zh2`WIQIYO&|I*5ZJew>&wyZ(4umP66!j|=8%kE2; zjbmv&1$Cc~`zi{{-Ey&Oj$poQqR8n^9ye?7Y$I6;kfJKi?~4S(|JPayrO0O%<<0;U z+i{oIdHjBi3dk50eB%%QK5FMIyz&$6&WKLx5{D1Fr#p5L?<#H$CBU$9 zId6XAwFcWex$FbwA|fGHMF9i$d<@um0PMVoU8g^-bco5dNP}SICN7;p*rNOR>$x2A zeXUlTb9_o!dUML>W{>w-rFhluY-!(K4Iy>HSEbvmT|W;hG#mOtohK@M<5RFXDg#NgxV%#vma&G4gTG`mi!P0mFy_v3^LY)*DwaVfCAls@rj*Y^U9Pa z>fxS2QSKXZTc~5}!L<9s#oEp!`B_XU(DANbPRg-JD+1~qjBzZ-J#AOdon}s6F;2CP z)qtw3B8L#NloXRwx~;a^`i3B6&_PtUU;QmP&#?VieqBZ(a9K{`(hG$3U#Lf2o0>Vm zfu8Qy85#lXgAgo_Q7ly5i11vBY&VVM!;t~$u_PmKgW6~e78P30`Yx>oAW*Nn2gk;{ zQ91f!oa+Fb>#)o+7vtP_80Y4PHc=@L({l_zBht;mNEci9Pq+|38Dpf2l`%RfkZ#A| z;eZiYREv-pRKnS!<;@5b{!faB?KHXOt%v{zV;F~k0R7nKA#53Wrb{;%9Spr(I3DA0 ztxlHJo|PhgDLx zO`+C_m)Jz|cO(?k=}<_h2Fn1Cc{0Tf0;MzAV&HTRrX9aZfPM~FwpiZ~0`&|4<0ozl zCRmO*a!bu*D}lVaN!2x{C_slhXMj#{zQY}CM+Poa@>>(@O z7HIT|9)EV68Xl$Iuf9RBU{`xzAbjS(5YDq;mtK`4*$4ve#9V zd6Hbklog8|$FgM_(6B>D5E+DcOY3SvD&|@6YlG_0MAl5N>Kf0x;seEafTU{WkO|8w%rh7iRvajd3KzPA2UQ6GIY*mI{gu} z>l3wOvju`5lODF4MBs^r*UnmtlGFK(W@L6(*tkqc6b}G-(R}}#kLTpZlsUPN>K!_9`hoeH&mZuTBltO>BD+iick|;`v|g(Q)rYh_ti@!?EQR1E{prptRgb^1wd1b>lh*>?25e zD|j-)F^krMa-^TKAG&1E%OrUM;+>yD~j{z#1%!lX1^hj+!E}MKa zpMHYE?G36a`VxbX0e@HL*UAH7i_CXOLx7RPp7AP zU9Dlk2?X%|FYG&K$2d=XK5ceU6q0yNI!D3TS7wuoVPp7D-|6V^zT_J~*7KJZ!fTjb z_d|O9Q*%Y4sex|qU{HO8s2znI-Wek=0&lrXL!zj+9Fej3Sd z&7wTciLzCDwqopWSmo}DFD1>WgPH_EbO8cqtqRk|%oXzN*D1YcIqKSe2cd_wJga|OZpsrCBm0U{BD z^zU;N_kHtr1dm8Uu7Km`;^*wc;~&#xg7;B?M_za$jnUKbuc_5qtXp{M6Gva#hDI{; zcYWsgopEMms3bySqAd_yuf0tOpGT6vEQ0FlCTY*4v>kJ?wMNLbeJTzi*Fl=Zk$6G--E@W~Oc8(8ai0+y=GwK3eL-LBa{9w6;VNGe`R`sM5=IrQMI``bhN^P2F^ zRWFE5C7?I1`s|?C^oXblOzy}|gii-AO8{!oD5txaa`nfd&c8bmPEBR7mi>g-=nG;a zaf%h2Ysu~tF9ksgU3?jyeN?>P&3Q^e6#*!Q?82CXFN7+UVU*uyB;>c0q8>ay5=e69 zigK%%`9sSbUm;Ns|Px1R)OEA4z(I;YTC4Eoph3#KI-uB zl`Oz1C!IHj=K*M|2GX9RNvaWEOGF)!h>8q1{%Rhge=qp3AbQzKo2PXz}xOeU<6ufx5KiV7tV;b902Gbxg!nr@_rT}JUAzD z1y84B`8g;kJWy|^X7MtT?|O>=6I4;>)VSY{?PcfEWrJWKx^ZMmx?IBBHLckP2SKyn zX@;kE=3l-11Bv&|aHSdLkVlJk+Gfe6<_B|}z!+#AK@(@s;NmA$V_%oRjCp(5n^v^# zA_0b}-d;PmBs6Y)m`5~xTK}8|a%txUiOFCfftzZj{l=)oXNOo;DpzR#^259HqZYzD zR5o)SYwby^a+90Hk3To_ z1HJ~T!#Ggt@>0D0=<`N+C;DY`M(r$zs%C}){0j-#OFMeTcO7(4ajRB8!{I;odu@7u z+d7qenT& z@o?n3asz|gTB;3_s0Em9mS><`_f>UG35?e zkV&(=A(($naU8H~tq4`xF>cTP_KNc(F(H}cDv}-;UT35ao544Q`3hGAMbd(b>o>XA#dNoVNDd9UxN7_#%^Gr72Rw?(}D!oo$;J&3|pWtT&l; z%_UR}59Ms`OO8fH-7Eg4nY^px4h|n5I~F0kP3q&&VXqa)pi!2GVG{V*Sp+lcCbf3i ze(1$Uayox_>kHmqO^5xVy!m}k8(|7HI@kdE;S3AePVkr!q}Omhc+4{h^Q_f!F#&;M zbQ%o4L+Ye86UWIUNb84mDE}6`A=yIPh4icwCY-Mzz(FtqVA?mpqa)bEDVq%dpJWj- z_``#S50!f1+w|Ed*kMF$*HK7|lTJ5j{X`~|RNxBVG#bpe`yL7b-M8F^I$}^BbE3H7 zIPG9YdLB$gJ)}OHhk3LzoDoPT5zbbQ`D@yHKBn;e&2J;YI6yzboDRQ$>tFF~gZ#r&-bB1g>wt;bH*q8%s$h=)^Di1}k_8<0^~SGNb*t z6VecAl#Bk%eBW-P28;Hl8(34FkSk^=WR}LNyEhhxRUFHzFIP}s8Ldmi)5DO8QPBrZU)~bGOyHT7KGNY zXaKidmFbYIMRD^5k6L8=FptF8^`xSLv_h4+zoL{*H(1Xz*?zRY_W+<|aH}nI1KH?- z@CKoxg@cV`Dsg$GPz+TqQhS`tayT@u;#3rMk{htUwIUsqcd^7KgRiHSZIql>y2Du{ zgEUSHzMUV~cK82SXPucKUDv*6z);1EqCc(@ni(V*)+jY*l%w%4j7ehjj*9oR)YA?L zV^S{0yabsLPp7wk<5Ul%eQqx`J%4Zp9&f|u7z7iRjabr-r;RTmIdrbz+0^jwxke6< z&I$wb(nk$To}o7YWHH&fa-3vBHClML4$j+)a9l*#!{+?xNn1muUH70J*UmOtK1Rj7 z{Azxm!ad)5_F>q2+Z4Rb!Fb79cL$NJC41!9C)NQr=Wz{7nOd2+zY$lnIyYpT=u_tH zuY>ed)PP~}BkFOT;!r0?t~%ye4Mgqi;HWNo>Yrfe0_4|fqU}by?Xoz|R{QDeQh=nu zX-HB+U5Xr=Mai#CvHmqW0Cf+OoV0kMz7$*+4-EwClw4q>GrK}>f{)JDjbWk&?ZFy! z6lwwZZVdP?i=@7}j|AUb`iSyAOygNfyn5< z;m;(+DpCC3B5EP!CX-Gb{e2(O_h`QX(j6glXw(oW(t?f9FA+n(l;;2=)3O}K%^9%F zsGPG(1GpQeHe_M{=c*tCK4?`Dt{eJtoD|7SbR4i$S$urKI2sVANAdmapn;Cg`_rRw zE6jCHnMt(Fw(7~+O=9^fk?O)ZBJwA=VQ5FgUN6C*`fwV5)004*3(p^9k!;49Nr0LT zS)>qvTh&Ty~DA!|ui>AYp_(70U%JSJDs{#6(HHG4XLvaO<$QR+tVu`~qmnb7e z_d_yG1K#Wd7&{pteHLsji1Shx5P$&|wa=&~zbzgBzZCap@Hx`YT<4e~Tp8Jo^rVx1 zp8TX|`xH`vpwYiz8a)rkTt7!Fo1#uqmIHKbb-kfAD&@IxhWwt_rd#9%ad*eT2Q>}Y za;4ga*SOY(cbSB0xg!6<=>X+|`I4H$2x5e)#D+LU?RSe}$%W*?~N?a++~q$|kdRk{M!I$oVOl zSzBSb6QG5{fZ-@XaRGvH5b5~iv!@qIVH|bB=N3j4-0v(=1%XY!JQGn)veq~}?L}B8 zm{DTWlFsXXDbup~O6=Q@-Xr)gq0~(A4z-BZHpP4Llk##JlhP8oaF;bse#73@R zIt%Og&uoSv4LMZBxs#q+Xikp*f*)LwtTo62Z|9pa+$A&GI!#~rK|sg@S8trrZ^oz6U_IU7&TUi4HXlHVf^T_nR?|I~wK>5{Vyj@7EU zQCZNA<%8{EfX-Pl0_OWTQd%czMhAMo8}DI*T(4hRWhbSAo^74xHmQ03)zcM2Hsc`h zz;zUg!n(K!pClMQ{T-c4A}1uWx z@!TMnSKro198}NKMkgViU^ucd!!hd)*Wsu&8eNdG6WJ!P*#7XaFmz*eH-gn2oMscS zMJvd`Y@-NPl-N+A5%PgNI+1it6H{N;8TAomqlu?{$y14ewAK4Yz4u9<8|r=n>fUh* ze)zuJkcs69+-H4 z2<{_iYy`k^jDNeK1TWhwh$~&#Ya3Lb;n~2hF0OwvHwH&v%wp0S#hlUhsq-k5xdMh~ z4p%UfzZbo~-g=N%YsFSyQ`cO*cjB3$tWxPauF zh6h8dG~r9@w@<+(@zu-fZ~-XF*OHyu#S zqcEW{#IDaWGB8(_hg{XMDfOJ3wWbk$<%NvxeRDspk^G?e;P>RmY00L~zy0>fKDYCI z{jXu8<8rg*uD^d}WTDLJ3C#-Q4DxJLR5X=uz8K+aoNFkq=&V1=8*5uQ6g+bY9 zV%wkId|{~5Xwjp5KII*4Y|=2LfMz+8I0dmWjgNf+Pm-4%-nGN^%qtdmf}A;n*}>(v zac%Ze?pzH0YoVc$*LrL5NygnT*n`@!AS-zdJKc*bxT@ajO7}gKA7f9O5tum%F&c*$ zRZAq9EZraCyXc7!-paZ$%?Yaolr;NPQh2d2VZ~&x>i7}X#{yg92*T#bx>B92RFZJL zz-oi|id7<2Kt87{c3G+Sg&_A!hwEo{?1`oVoHVPaQ%NDgj9zYmZP*2Z@5;WqhQx&= z!83u&1bLw_V==9gJBN}t&R=)zJt~K)mXa~c|B+V6R9&hEDzPxdKBxz=t05G`wLT}Y zdq&{C2~qVE7ORWIWy#Bt3~7}+3v4UdEL+i;DTSpxC=u5>U8s?~oeNR0h9t^ZLFCO_ zk%|(#hT~B8l|U{nCw9@cUK8VVXoDzRRj<2*XVv{iNV?+l`-c`zan&YSQ}48Udh60h zBq~n)LA$S4#FPCEP963S^;kR3uN#;QcF&@SWesnvH8k8>>099|R@ukE%@~`aVlsFEO}#qw4EK^%F9y%ZYoNvh9-#*O>2MP*sR?3UG_R zwz2ZzawbuDa@a<-HFW-#iA!YYgQzBQDoJs4RnxNuc~Ws6Hy@|w1SujLRpqWD8S+26 zKv4}Itu?n}eP2m39v-{lHvY|Iir|gkP;uFcVV#~93j_U!lvPj1 zLI(}&2qoU)?RzQI(Ta|go%uM{^$yv=qwL3D7?EV#wCYvO&tmqp3hkP51nnno2)0;c z^U1_I25}6=HH+ZMHr0boM(95ZP-G1kABF3-0-%{x@ zH&&5u4T?7$Uc_7i1;~?UXY^E-sdD6$g<2O)xz3WBWL9MaLMop;rA&fYbM%pHz@^dSH1R>POeSA?~PZ9 z@ObUqVqDi5tYP;Yu4~&MLMWpHcrS(Gs#3X(*Vd06ztR-K#OKVI0+Tfe=rRH5-Vj|r zmGV+tel4SKIhEA4n9#x*A9w{O$60Qie(LRFj%P)vh zbIJ%j3OgE-#8d=_gzQ$qz-pxrV)!(CiXKoS_fE{*{Ff{~1l!Q`O&g$H?My)g%c$h5 zHDFa|&QkQmzoI8D5z6p4NLh%WqPmzRd^Y}7I9A1uErviajPMQxvASackA}zqPo(#xKl$qom>LI zWDI>Qr8|;9E-u0y^^C4O9^WckYi{E%9{T!vY|?nr?TYDT*C%IAGrg`P3NWKm zb$3bZ?FG77GngkPs%br%S4dj3>PA*slz57P8F4Os9q^!sv?_61B1Pm0GS8-CGE)*U z+ULDOBDp5%QZ08Cr+q1u(xeb$jPZEpKCidLxVwV$16;$Ob}%8RR~xoWK-nCe1<22E zv1bv>CpszSsidW4V|!YZp?FhbvEn@w#WhDXITzlR^*quk|F^HiWAQR#{|Jf+G^#Zn?FO}{viZo7a_e;!HEUoIjS z=hvx@=juPVSjZyguy&R&eT(*g>(MJo9lO#mOTNDX{_NjYw)I&fv%HG)voA*;iUUj3^$7ZdSQ=P?4ME>r{sO$nJ}8 zpk;mprMHp&Fd3?eDrxcAoJ%wpiZnsYLJvKk!}Rai%Agz4rdqnQ11};4gHzhWYy~Mh zR67hZcuSXr*~P8!dxxYY!a^33mZ%<(uC&?LXM1O)6{sz0(r}#r7ZwSXyIAtoLJ-g7 zkJpfR{(HakaNMH57lA;NLLWM$_&MZ6&ofmD*Aj^tsL_97SEqp>St@m6H;c%W1C%m$ z)V_k)aYf($av0zcCCyU%|Ff6^X8j%sal*=|H^l*m=%|+6HDX%%^*W;wLqE2W#vG#p zgnnr(ThRB8l@H!^Xs#}cQVJD|6%S8*HZ6#9>`|+y?=irGfV^|jRXluR0jhIdp~&vL zK&z&yuVW@h&n4+drG7Og^*x8-5A66-N&WmhM}LVx<#44%hsei3+UH?#Dru2HdXoRw z>ij67*F2ao+F|(M0c?4o9$8Goa|s9belIJ?r-K`Z)lM-tPVL0aVUPF9#dt6PtN=Wg zds1(ARSpQ}^g%+lkr&T*NV~KF1?NjP zBR&s;4-A~aarq~;hsL~GrLyTG8{g8+y#-kB2NFgL`nNsheZUZCVMHH>PD)IBNzA(+ zNWG@DXW57LQfz2=5u*S>_Xs~o_b0wEI|&jF&jfD}Z^yES`PYp)Wtd9G>zrdco_|Xm zZX!>t5?MT`zXm^YN)}X4lA!VHjn0wB!sb?f=08sVHV`IEdr1pSn2{{nL6~1`fHi{Y zR|z`T#x%u-M#*9{`%tw)2hMdSoT?C-&`6F(b=+$dF94Gd6QXxY2)%~+sW2H;uwUIz zrJH>06WXc1A(pc*Gftg(6^Mdxd2COlk!17MP-mE6At8&uftHJA8RhOy;0Wts^&Irb zfJOf+ekUgQV`A?O(0{DC7@+t_B)pxp*ggyum<0~_lz(4~Y8Ye~LKfkG2ayfA=L&I}-qbgDgG3 zgKv}KHdL#yo$ajuD`}-VeE#(wp`F<93&FhPI-?l_F(69MsrQ(K<4PqQpT2ZAqL|E* zgUnIOCL@hVN*exkJxzTMCjJ6`#lU){m?{=!&MhuNBvmyk2e|sj$e6f_KIkDaJ`rF% z5vKa*ND9g{7#E(O8Nb?0{Za}#KX5FsL5)i|kA)q5U@2cJ+3K zc&eRLNRD-)@ExpVxC@8$N%*;`UG$h&Ao(SMrr$Y)pus_4fe$0{NoPMZRep^CQ0tJD zIK+RE?2#}f%<-?a#fp<%bfZb(J1&h+Vi`5}vS}yw_92DX;abk-B5{jn;mrUdzC%?i zeN~r_806Gi8of^yQ!*#MaVGu<85j?s8fy=5Nq?c$*8f1OKSs)s&j6ATtd+nJ!o7)( zJ>oaD{EC$zfspc(f|dDrmgMaN!rWrtsa?1uH28z|x=luACrd@z_}a}PhIfO{TjDhq zVd_$($P_#aQvsQJfbv+TpLKgn$Jk8?^GtPM>a4CYuj%uXxOnLlf=m-zofo84UANFU zG5pPr)yl247`nPVKgwz-aQJdVjU+`VGMMVrS3(v-pc)KMe?PcjzJ4qkog#GS!q@{d z2>3hb_#^zend(^ESW5zp5VqI#MS&fbZa>^<2NgGmsggD((H4~N;&qm^3*VF+Gac`xP|=9iWFZ98I1TKp?+P7sa=b%e?oAY;XF?UFR)6TXlznJV1Ac#-Q9qKu$qY5Qbd z!x#)X*o;Zl%@NKWSPoUdr09;yeNQmvEdZk+1J0o~BhW^FG1Fx>#8~_f7wo)WNY{># z9?8((y`A{Ix22???5%?Qh`*vWw3ZetA}91-j|30&D4=PnB(R)Kh`PX@6yj+UjSM5n zOVNN)xWgoWP!L556mh3Uf>;t^1!*cvS^c~y>YcN`&1i*(M8a7-b^c8k2}asB;Xm=P zT3Sm@b^?)3)^GwU!_OAKoVAa-CCa6CHyytp`w&Z zUpPI3+JKFuiv-)#Mh-`lY(Vs*AsDkfB$9tkW6*IlKiI%Wi$7jQ#PN@^YLzYi=#e&M zh1MB@8H7p6x&Hwe8ePaZnBa*xG`{;&$^0_Zo^$==R77%G5!NN%`z&QIIU1E=D50blZARGF_i{c zPbbA*2-@2~j!GRhsilz|T`K(Vj0`S;X#sExKi8c3ePx&k6~zB{N??8;=*6$GLlj3V zA`Zb*wvEA_0CWz3BpBQwGl*MD9O3_j6p=9a)EP{@*Pu?!(Tj}-=TLHJ;1%cyWF1N* z@Z;EQq-RtBzU7_s(Xsw;IWh$!Zi?fd3qc+SD=E8ilF$bz_%CnPsA%#jP-p5ctv9w9QvW(P@ul_9%tSPrjc+HMxOvR`M8u$$zNr3 zYfMwsi|XrCP=`&Tz?yrQx3_Q$*_z*L2oOtpR{(SDbP=Ho2RJP3dq(W-R95G61)FrV zE)X8F7#;?K!2Q_w$x;Zhu4HSjW3KV*57K%~xL)Rz-e-yWUt26nUj6FCKpotc3Ors9J%w~?_bahF@o;k@5zoF9wpUiC?5 zt+Ek)vxg(xP>pLN`dp+9*rZ)EOGN1Y3)vt@a=e_1`}Lz3YRX8Fs;4ppP9T9BAIvvR z>1*%%3O6lS{9tI1h)p4UCtJ6o!Po*5pkmu;qeIF~3Z`1j)e+yh3D$w`mfzYXLU&8( zf(%N`85O4&wCX<^V$AX*A=Ek`H}eQy^}kkgLCiv!k$nnw`QHZz+ixMoa-?evF{@JZ znbZhIT-sR}k40yt!6z*O`;#5SLI$Q(y8rS0sh3nE-{tFiM9%1{QEXdP-yRy45bH0k zw4GrhQ~Ab+?fjJ*>x_oLXOZR&g8%m=<^FwjrR~qoQg7^Xz<;$HMi+SR8F4bawKNvJ zYln+9*8lLKwl2(=lB6u?s*qkhP<=O~(lNw(8(3TIPl|1(?d+9RV}a}GI&riZhP>&U zhmO!B>&d`f+B_T9gQG;+s1&?T#X#DS#SeE>K4PoA6iELZqzE4OwS(Rk%acz30M-rO zQEc@9)B4lPgd*=lc3%iZ*xX@>02llRp@K+s{Q?>dVaR%pGHux9R96XH6+r(wYU_w96Lb)j$Twc@|f?^C+2L#yo~9~%+q4*O45gE zWbYONR6kTK6}pnW-|2b^ql!MKX^Tr``30$G{#b@*Lc_BxtRJ+eEI2{|&wK>w10~FU zk=pxzk-T&|Jc6JH#_M5z0NkGz!Tl$41f_u&JG~{7q#mo(Q={1Elic{;Q!8%jO%<2q ze{U3MRiTJS!YZw}4oC-yPU08FzgZwsz(+#`vJs`UR>tlUsU7(1?lcBnx;kN2<}6ap zWDlq|NmaMTYi}A!3nME!li#7?U^4K1()Con) z5z@1Cvs;WD|8Y?aHx!X9TUZ%`@CP$&t~36+S17P}iG~5V+e)Rwy+WVu&UWE@Fhg{* z9Pne7yaYR;O~OZ;GgQQhz4>i_S>O`lm+zy%D7tR_W5kO}VPqU?|4wkScmfiKFy}i5mUHc zz%&8o!;kXc{zKq{q6KFV`S%jy6jSsMsVt;i$8Z~q8+QJidBsS!fL)7F3=^KnjGQ!- z+NU`Ce35ia#$gb=8}ry{29UR$Km z{SZY30@9--(Rar7;RNRy89VWDoVC& z!z7g=DMDqdq(~7ZA~QuOLW&R>`($e{7&FYw?|R)cgLC5Jj5oazWyVnZoE=G&Jb-P z!4V!uZ2!WIV=ROyMksL;n<;yM=O-zz{g;~!^FCB4@KmUTAELwIv8LESLGgdP6UG-{ zGC>OA7JXy~7eV}2#((0L#SADa9O6YTeC29H*kWQ?6IB^}^g70nU@^so?V~aARHXtP z3L%K6s&d0FqBH1?+*H#~@5Ad9ls)m#c!X5d$hbTG^h}iS0!X67dHy(C44>n$Y&Vw^ zeycGkcs0)6A(v2zD1J{)V&xll5X1N2EPR!pznp&INme$19B&O@00=uE&Y^(P!8PBo zyc5bnTAG3@2Q?i+FW6R~u;JYA%|m=GUa6T^SdpQyak`0i9*B%@5rqS;Y4f)?TFLoxsm>lS8-i3(bN#*iQ5j? z)`=Lfl4ol1}F8-}-Lwdp|DE;?Uk=7Es zsba`D^?!ZTP&lqPRpDdoVxHy2_Fgx96phaL96(CNZ;oJ>OknpNx=C}A@Nd$3fh`S_ z^Oa{PRZ~>>UG>)2rX=`d410hn zNPI3%j>S3(Xc36?mMB9n%NwLk2CiuhgbXTyDGKXOJ3J`zp6eN4KQd?L8 zQBYx@28)6qEIaU)ATQ(&(EX7*O`(Q>^3({_mgQ`Cef4CpT_hGD6BQ4^a4&mMqtZYv zfl!e^lKKpxOoc$ehwT$YZwxwQ8`bmxV9X5&Vt&FD0Q9IX%BYm<^A+H|GFLl5ubgXX z3J#G8m#UDG^}8aVIiXT);|RP4`2(h-m|vyT?T^V%-4anAVBOe1_ulnVVLGRp%%O5d zSkws4XiH;Z-OgPBcx4=LfrzVFfDBW0#}=^6#Vvj#-UDpN_oHy zh-<3nETmKx*&r8zo(x!$AnX+2hvgLSVY~vEP{uS>t}IGq`~FJY5hn+66AKtT|6|Pc zZG7>38tzbMhlv!b2m=cnkh27rL&O*<%m5h)u@(#KJa-@v-&>;P01KfwZGcWBwaS*0}S{q!0FlC2;<=I`Ys zR5A_`G+hm6vAe`1Ijl3r*}+JR{hM;YFPtE3*G+xpaGkGh>ZLA8!PQy;Pb+V;y*Ya zvwdVZE0_X@<3pmZOvhcSAh3t?Q#D7~?wmpIzQJy;4HQ`qV&n$tySh{O$tnj+R-B2V z1D|`JAXuW(B9b|BBOXvpH9OWt(F&P=ZeXhB7$+^;ibp=FKRB;XWL)!TB>$>bdyKL_ zLMoo>qk>7`j(bGdepP2Xqz!xU>tsek%1=|HlD}mT5A@5fNGMhs>aftyW52rg9G?_7 zV*W;(sr33LKB;CSogTQPQ|b!)jmYTRy72JcatL%WaWxoEPSkvI_T~a&V{E|!__zf} z0B^)2zI+WL_PUl<;PUm?LO}Bu?&Z4csB}JxKE`_3u1`!%cVU5z15;AC zH6oO^qC{}!B^YW*eO1~(3?x-E$FBwH)Qt2C>KE(vjEBW~L=Dx`Xi0Q~{XjU(M~HeS z_(7$bNb-)&$-~|}PanFgt#Sz}lusMgj#fP%-TD1WTB?OFgF*1k5zVi0jAt~#;@$dpVhLMB{^ zX|A8hHZ1PiQ3rosO=UJtM&?0u5(sLJBMPG?DX1Lh*+%d_u9cXd;;jm%T0_{D`|xhT zh#1?796bC~bR#lieyDaX{;fn}7vb2iH@*CCRKHrb52E@#y}SwfKvPi}z4W#^P985r z7J%=%u}chAjwwIf^>U4Ok0;@BgLA>M6e=fP7k~n3_yofExMNp2CUo$1 zJ`5|5s}tzhPr{{-dioko1f!z-&B=G${R`LKN~M83I6-s*p8G$r%AbZ2v@pOnV9}UY zr%f5#LW$R15Kj@JrCCQn43-xgGa=y(N5Bj?>~oKpN88{V_ZV~5VB~AMdmQw-0RB-Y z5FB%n49^t;jmm6Tf29I&$jFqZc7ihx{4uO}ibIw!e9!TF!!lHTsFqbB)oXr7UM^P- z-%&=nZ|_dh)PD7`g5q>`0_^;kYkN_u#Ax{MT&D*Z5`+FKfbWy!vOW6dPS`;6RS0#F zL1lR+yPNSMlDed9UX}HcHg|v3u9YRs%Zh#YoLLqWX*I5n3QRsGMe{3La6kMfPWWgd1blGZLchQE?TWoe zqyNlH|K%~u7GQ6O-3{EtB+akn$QB3O4Uhvtp=t>Eq(!6G!I4-&aU2ZE zloy^u+bN`zod&L42lrBNc!8|r*TsncYjwH8Bj3rveQJy#Jy|71%NGb==xQs^ib|iaZT}omX%( z1krFZpfYj4O`jWp5gu33O**oH;k+L0lrAxImJdSeLBVZo`{3vJj(G55fKBvCGc$4F z5Z$)1AN*OE{IL7aY6ywL<7buo#0MQBNo3=RK?1SC6KSK54CF%pn@N%^N1Pz$Sv*#EpWj#ZEDPw|r90c0B9MWQF%!u8n zJSro3fCO6wSquJ-wQFA|(-#TzF6JuVac~a!T@)QUcp|3@i1LvlXgV>Wg7yr$%5dUu z$b}{0&HCCtN|Bk$QqN)6Q&0fr?I2h=>*gS9%%o-#Zw3O#2z_6Orh#iVhH6J%adp;b zxV7g!gJ_q5%;Xz_KwQ{Oz_~U!BfFb%K9Wz34!~ZLdp&~E%<2?kbFZZKjB)2chsoW2 zq^DSm$u(qeLHJbqFNGIbLjFVHjbzT>I0CFVmr3k%!}wc__Og&Nov@WewWlHg1!5Lg z&9>$wAazlpEEP-_#qZpF^LWelzxVHgK+A?aLJ}5|;xxUujLz2oy_*m<81m;L@yT>v zM*P=}+ubitK?F5QU&!|a$o1}@(HbGwu{6P>wUcVV3o$@@_#eS$kvR00@GKQP1>J0kb&~A} zIAC@Nq(b=1%`c(N<-aVK2*vsfc+EMHx4kr^yi#9-&TKTFqk_3WxQbW&bO7rLL##w@ z>;|c-97$EFY+;P>IL4P9K&eMT80}@Q#)Y)1obF}@I;|m7;73g!pM^|Pga{~wC#1$d zSs8TpT4~w|Lpka37T-ZaNOxp2#Jr#Ns7m!9vHC7VrqQlJ-OYdOrjg@ZE-ZnB!x9{v zlTQnR+88qndQn!z^Q>Y)hF+M}KahcRQTVBquw|U#G|~4(Z7@TzXPm-prMd%814ZB< z-IKo+amRTr5nMCUzpC7Tmzd)#C5NpPH7=2m(p7?VVb}MFRL_-|53Y)8P0fDL7~NP; z-5-#ZcMf0U8-zZwau1EXB^b_v<6V=@DIU@Ormd0iC%WUHQ!Es|l4VjKw z`@Dcr^r@_QA~}4>CX0aQ>3p++Lrf2%qr-^)0$w)&oA~Q3@=Kt86vINa0xa+Ns8XYT zppDdDWOhSc>KlydKR`l)&52jx@d7+Nepj5o`2?c>2f;`sjv&=;(DCNOACV6UU6enW zXJG9AP3Za)WNge)#;ge~@7|y$LHMb1h%_Db0nuj&huQc6dLtXZMRX{FC=ToCJo18M zvYug`HjoU=1!!_@Tm>Dmy!=+X--vCk0-onD3ym(@m;0#Ts$!RLV;znk>o7O~o>z1l z`EZjTM~)B)+*ki#gS zA@5DBXqthAR6^yqRE?+VWp_wb-(o>a#jUix1iKUHT|Q|7oLZz$G;;qSA%YxT_X6G z%MPXCIf$Hqz64M_Nr?aAZld4Z)HlQ>?!#CnS{I>X6E-~pQDC=OjoW8Agm~dzBSE4r zQEgHDU>D{z@5R{<;(TdzDZ(&6)MLFMGB=pdV+%(>`*D%%e=R3^9n|jLx%}`IHsbxb zpSlthXGhynmFd38Q#e}%eI;XYx!5D|MObt$z`ibX!|Xrt%lRaN*zXap`h&z@OoUKE zfp1Kr3j~VyZzLJmHiC{H^u2;&)XP-vpgN)=bNS;g8^op|VHx}ZZ#a2_X(t^lrK;d~ zm2;iBiSGfWVY`ak9fjppzV&^g4a#UG0?^254-Zof6ci8K*)}%wJcfKaJ%giP`*VZJ zc?&xU;(V>R5DS99(}gQmR>mL9%s<;DaWZLeZj0FbRXw+CtbhA#e{tcn75Sxo>VTia zWzA=wcZ0;*{8Mu61WKO!vY$_(&ghKAuq8PQ%PEPV(+DrX)n7kA6lbx7|3V#Op1Tm0 z1Be5O0JD4dz>)e=20rBf@j}jJYr0%5X-*jD2c6#V^8bE2!-DT`2w-9#V&&2u{8RIP z-Xn2VOF@rf3{BmJ!9f20;3I={p!hRudT2J6DZ8|mmXPj;EM2dmsh1{+!=D24e>3w} zrS9F|(uMuZg~H`sErll>`ZL<8qV9NrKBv_YJq>4=@pWZiAHK=$%NZ3yd$NpgZxwtg zvnJHQO)H&*1L;0ZgHr%NV!Z|4X{#c`4D9;bYU>VT{&=p#y^=K4I(ipH%MAq0QdsLY z>KnAyxF_Df5uUarkkag;@Xx_m9|P*|1RmR7zbpWLMg?ZZDC-prx&lTkYA(h5@zTe2rICUn zWh`Nvc7{en6yDd`rkwZK2n>%20ZD|OPYf3hDsm>?UFLio3#lXG8;Qo?jz3#U=7c)p zeI3Th_y6+HoI@;`AQ%mGt}mk*78xEo60fFti}%!A=|LT>F%(E8WEi@I7Gk3yKIzD) z#@xRzj7MECd@p~7G^HFJ_tT7#Q+jg|YYArbdE3;#Q%peV=z(z;>UC-aw7ftG4`C_^ zdZ%ZwfBxmWK(hmZ69jN0g+#7-xq=rs2lx3 z5J`IQv%_|VuQ&cHUgz7CB zAz}R{g#G6eyghQz*&KDE{feV>bBN}`Eh>NEMcXB?=hVdy)&Gw(jWPs+n z#0rSSe{ham|M=!7$huPPjO2>L^{C26Cm?H46b0Q;pAd&xWdG9)_i^ZRNdi6k<7 zg;X8gNY!@WEz_a29Im$utrFN)j||Ww@#rS%$xV2$R6l*()j}i@o)5HB!2Bu&@d=iG zgCHE+B4C<$x#%SUj*noi`2cK|F;p?cVr6_a|8sTw=>Z;WU5GM75D+(428thwAT?EHRwJ{32a_qdy7;~OBJn;ui=0l*C)--pGiu(?>kVzwTA>_9? z9419uj_t%5_$ftXw-7i(v=GAZXl5MI)197Nl%L~B@L??NbrgvlWm5qEFG#lKU{u&I zTy>2kTVrJ(g-_6Hxd_ml~qD8miVf#%$k`BoEzAvi4l zCpchNF(MFzID=-V22u~3Hfg8Kp^Wg4%vb%jZmJ(>mjmDHS6&W+$i~S+k?j|bYa2lu z2Ot~I3ImE7|GIaPfj=)JOrAld=GsNEAeL$tH+(1jq_DZ1THy@q>fvWZw z>`P5!Wi+kD%LN_O<*}#{fO|QLYudHun15_KG4VQzFeDMLZG;DW(*D`GW?{K124uiN z@mLX?92`MYd*anJQ%*9?&M!`LcXT;hGgg$%8SD{8n*e&k4GS?Fo(S^<2jyJYnMVL3 zl#{zkcW`#XoQct=@V(NZnE{Sc3p)6c6geHM7>Lrb{>^B2RiAbo#HO`O&!-fbV|y~= zG?XPzytZ|XGQ_ygv530}`x3a@@&Rnl+@~FQ%rz+Xi3XI*#H=9NH+qS?OVsO7A_Cf# zg0}A1zC=tK*GfMYrS=fw;-tWjF~V-}evO40#DmX)W>R$ikRZ!3>w$P~G>SC?++kv& zxC(@Ry?`tZumtvGviH{4!(OmSV2d$y(HxCh(&8Xmt~IvBD5=+XbDEEOvL#T~3@k^q z{l1tRP8s|BaK zzwOvuFZC4AsxF&-s)CH`55_jf74+*&AmRJ@6bf9afDM=vQ0^~6K`QJ&Fy&6pm=^63< z=S3+B`=L(yh@nMcKM++Qkkbblkeu!HJT&Y+V7U$AC}YG1OHyd>FN&%z;;$$Gf^M`3 zkknym>=TqUp)-VahyS3khzseN;Kau6_mc$imv2PJGV*=&1~}PVH})Urbd{iRGHQ2eW_UReo)f^^D`hfm}U)|K}<$KLEvOB$O-!_W)KKf#V#*n=iHBhxdkv$U&6-*yfq| zh>g1Y)JZt+=R@BaSdjrU(mD~3nQ85>OE5 z4fzSxMZc(`$df@8<(*1+UdT_K)VLDO5Yg%meRgvFImXBNowSxS0Kw67Q)rj>#ppQ^ zbT+Huh9z<~Sj0)a;lfKKL4x{)wlFe0y~jGDw5*VccpMEU)mRSweSaPU1wa5>;%}6q zZrmOlGK{GKM=(^P@w5e60yrJGE5`sp1TQ~g*`^lkUamcgL)YLR5wh+<+ zonExsf6(H5)rJ4zQ{D1;E4haum~2{fV{U`6*=R9xj439fejAz<4V)`KB5T7InOkMy)~chmf4O9&wzY zPuD1P*^j{P4jFrDlwo$L{CTB8A?poP(s)c*;a^S?Q5{U}FK@|rV}@~LL|+kFg{q)m zHRE&)6$GA#oN!te;S&vwfPiJ^CLAf-dfvPpWE26ksQL>feeQsOBB3YfeY{-0Ku@NA zA7*nL%Q}$fFUoyzCBh*U2}F4f!tqOjQ2~y0)8#i#Viv`F*gMydg%IN-y}rsUuzqEGT5IexOb{_u{R_jhaSXxoNn-wn2lW!z@A0HOY%z zHa?DDNN*QmHCULTmydZl-2Ly#L9l2x+#?2=j4_hEoWEtb30w117C1Q&DvtGUXMjA% z8#r`1DPRBk7-Iu9V+$hnv2=|^6zL>a-ipBuAaf!r48VcwOMz-W9>Msb#pQ?zAKzws zdHg-!aKW9a^w&dDJT#CKe+=vD570f)$A!%admqX(@asW&rmH0U1@@GJehk$dx-|64 zo20Sa&%+{`e@UFlN+AjhBZ+SoxbEbNemZRqwTit`T&9Ap^D zg(1evkxvn!(2#eSrB%tGL0YY*Yx!D#BF8}nTunxkclgE`7Mj}dXDNvw9$fhTE?W2E zyn<@jgn%}6!N<28)t~%JF^eQb98|aPGOi~y!}q(Gl!W zG8Ie@+|tlO3fi)(YY;wvzd*2r#=;6i_+4G%k?zf9h=R>NHz4O&xCUXFH-Kg4;^xu% z@bZF~nhQ&j8vb}CCI^jg9Rz~zagQsPsLTZ#oi(o=-`&5FaH7`m5s@AoT z;vxjz{qC}f^*1~SSicz-t!6)E8@1uppX0Oi2m`4_9=;d-o6w}A$WG=}NM}E1d0Z!# zSKQ&Fp(4B$Dz&0XC;`|hM5BU^+hW1h$^p}&6O7T5IKsx3@en(NpvGVNCbB7Wg?aR< z9!X5-eNf{h?1}5Aqh%QjF@(o|8az<_@n@b#fvKz7uN=``<28icUyAWqPw;p}2%us$ zhKFQ?Bjb+r)3ML#h~DcDV&TubLA~PRt9gKbO0ZX3A8sXOw~gS71aAIG8PiY3D|H|Q z_mTn;_iDmvKH<?_P^S(LW?*c}Q$�qwZ-gPDM4^0$5*Ia0noa=iwjRV8_gC`v9X5c@lWIRgxWlE ziq8&Ul?|wOe?;}MzT)wtnfvWq%PhihXMkfvOlk;#*s+vK(n)9;g|+#Ae^Qk8|L)O% z;MXpXmfB2Y`0F-Ha-Pc=teuW4%26P2bV2NC3rZW9n<9=s^WiDUZapKr;5BQ(if}nm zabN4epTo_%-}E<$vm2#Oj)7WHNz{r9}5L zM%F0~A})JIqptft;E~f{3k?3Z>+Ca^~Rfc;H)`n1;A5M zOSFlErWsB|yUwPh&n=ncY{rQt3;uphn5(HU%d}nNReDC?TCSUx5bfG9NMT%p+y?cfRf=F z6x48L@xF#>%&Z@b(aSY0yFB-I4<_JkaPJFt9o; z9c1hzDskPvh~V-?b$t`HB!|OJT&SUm4KjfsbdS{~AsHuCGN4)im=IJcg8wQB;LItw_u1+33#5Q7;(+0>sgElM$ASxgl z?syMt%dCe~1ZvIV^`jqv##vw`1Ngd&mW&sUYoViUJlLQWizq1+ufW*as%yLm9cjS> z9Mn-+U1QGb(hc_Un2s}B&g6a|scP*Ff-GH{$J&Lysz`-Z0)s8x0R;p^9>cU!RLcW1 zngF~i(Y3N0$&kuNhWN`83IQs?vr_a52KEZbEwp$pQ36-vTuT_Epi0H2EwGR>FNY7+ zJJ`0hJs^_VR!C#Wu5cn;mEFzBK7iGs3X_?UflFH0$N<|9WAPwgpyH0om+3KW5FQ3* zGI7Q3@d#+xy$&XiO$bIj59>I*88cV%;Y}mFabh`{hZlHZGxo2r`5$;{67F8nE)~Jp za)4bN3CZ$^Mm(fq#N>j;#~o+H&xZegEfeFBn^oI;YL$C4_?MFY3cN4@iaXF@Jn)vb zEHB4#=Qtrc0OKGq9L8;!9X1lV7blgPmJFE;IvmxG3}3^DQfNwCjf*bYrH1++A?c%% zIfk?pVMin!A?Q@T;~T;0Ak3cp*PF)10nu2JqfF`?-kh$dk3%Mim+H}+y2)Ix2Z9? zZaTn5h)%IrVT?u|64m#FIO)Oe%J?zx^J)LJHo7)%XYe1I|8@Tb>%dK6m63021n*nL z<0$X{FDUmevfY4MLqI2w>D)w-WYr=f78649(Olkfh(10#XW}0IOoNc2Mj$M4!Dp&7 z_&Y4eA4C! zLC++|8ta*yyI7u)U6{gwIn*%5N>rTf`(ZlHYn=v~D(18_#ED=IMQB%^6a1VJv>o|6 zCT}~YI>UAxYd#u31H9b;KBgglMFCX8NaQnT4OpgMz$PFz6>51I!qXPMPzr1D~&FknpWrSPmWwU$s9bL!x*dM#h#3PJjDE` zo*o|c2>!`jFf1c6k|I>H6@CwuEgnf_APJ{>sx9sxy*wsXVs(DpAWbp|si9-t9R1hd z0I`!kk-hzelQ};N8z{n8_(A_bEprntLoIXIl$Y@$fG-O{Jvg=wf6nhhCY8U$MFfWl zhGU`|PbuJX5wMM*EGOQksgbp@kyd;@vX@~{AOf?_W|2ZXm(aWv=OZrM3FXWx5H}_g z2yJR*^uGxI1W&aq*!T;s%=Zmx6Y+#_!bWNc=r!1wfMGe2d%lAbIX=G6I6olQYOdI` z)@MNI8_)@}iSqi8_SdI|SPUElJQlZ3v;$T)e0DB7zB{NkO#4nYn68pqNV=-@U?u% z6DEBRvYlb}6D;z9JN$nNz@C-*A1GbWOo&JqWVsli0}sL#!B8z_G}b!}8+RO+tMyae z`4ki8kO5QqsUj@6U{4wApQmrAf)l0MX^Pz%X1^8;qPS@BMa{3?xDL3Js zhdKWyytUsV$vwf&3T0$9f%6L0lf$Eb3}hK^2ObX{r7NMIoR1JXaTuGDhJV;nx)3OIb)M`|?~r91N~_#Bvj_Zc8e;ip!-?;Dj7ETxzL z^ZO%=X2)ycm=K{qQjx)PycmQ`!Yz0(7GHu3%Fvim__h5LJs(5ybQW|aNq7&_v8jLjI!%XNqVw>;+D=Z6Q#eYeQ` z8k;Ml{@w7z>o0hr(+A$Pa_2@56|yT_v*yymcv^F*FSQzwCh z8eqmy;&@}igzu;PVZ62$$AMgh`9V&00SG!r#B4Xc^u_Y!^y->YLQHX_k_LkOtuQk9 zXcH*-KxV+~C6x36fYSmpgQ(QYrv(rV9%@vE1#1JEG|sTI4-vX8(B6zDy@8OB2JR@Z zc0^4f%7^U26Lk0#48p}Be|*~f!9EG^WWHWJA&#_?QPdtMiT>{938($y`3fgqMCF-a zc+R(R!hVcS;5uc;W8FP%-~W8R$Y)#1&;swEfjRsG$cSp>>KVgdg}xDj$Jh(`5SvkA zD)(q|**>X+uQ)E@hP(vTpp%=l@5? z55GBO;vT>f(SKjWvE~_mNfJhii?7_(0P~+oaWo0RBJ`6COZY%S1*9 z))Y(Dc!GvN}L*$z;0`OnhJTV2FQw`&cu0>c0Nu*C>@p^D#RG`e(>0{HOkb`_qi(_1Ke_*LW*zNV zWa;rw{YMP;;`m-Tl!i?}84r8>iDDB*)r4O~$8bWtGLXt-p^QGh7yfRfLMGJRNL}ae z1$20sl=J22hv!VZnOxj(SsYk&xy-A}LA>vJXJ94vb4D3yT1)q}!oMgJJwR_Yp>rO* zoW9}6qeVk-D4&el54l(Gy48QnZmhmrBUZ9GmL zwRxr&Ge#FA`^lYVw+8J~*U%)2sJ4nDl=_EJWD<_&xEgBz3YrcpOki3Jvl z7n{sj!=xSN4Hy7+=Wfa(h?N{Dq`^#7fFBjYq;p zwmZqthWQK5Jq7627{W!c#zbKdOpBPl{Ad1bnOBZF3&*vVzgv|4#Vjlza##)bM_wua zBgl>o?wYubzN+c<;cxJv1?Fb?MviQI3)8JMcWjm_*FSeKnv_^c8#QVhwHZ#Wo&;_} z_A;7wD)^ASA$xgL&&m&MhZ ztl`M=I0CcBUDJo&lS&#Xk0Ww^;y5i&$~EzW`4mkb+HWN~j>8^yxl0)B9VD;^!G1PE za!=*ZG|M<6Z4^$HB*%$9TEd}ma<`HE37p^MaqxHL$8ngMQY2^vN7nlskp6mcwT0Yx;0tsxk$qL7*3vYmP>11aJmebjq92eq5OXr-Os%M-nm@Y6wKtN!*z|RJ?;hR$g1m@2Y5Lg7iSzD&lqSj_wWHSyY;d9>;? z4S`4Q`CnUoAQAsf>sFXn%M-UkWveysMjGkoS{Eyis`gUF&koRp_16U}&s`sJ=0*3t zJ8~T%^|ylJ!xD7a!JmiKBg2*$O;d~N#IIjPBBWQTNOt*tscAgEKOrb2({=uRQbXU# z_npaM)%{wXhN=w}uIUdC9xEtrS|#$uUsHs7b6d)yKP=p?f(>r9`vdQH*s znCCJSa9nkI&%T1k4#w~1Jn$Au!&_dG>|E0KIcEN~KE+$)TDI_muHe9=>fgH_8zu*v zIJ&G@@yqFI?#~|CR59ImGooW|KP?qf4-~z!!SYk^S8csl^XJg1E&lQM3}w0Jgpu;v@D+-?;-Mh)o1<<{F6RRwN;T{U%LLN#tsizQ=PecJv<-1(O49GBkb1F zkjmpzSB9!KR4q_1vhSZwQz*R@_U_U{txMZ}$(${m;WFi0F#G)79a^}vM@QH69-~#> z5!*Wb)*VTOSJBg%9hz`R|MM7kJYJo3V!D99VMzgjx!hyydeZictsM62W^{nNO-s*8 zD$OA-__b}0xBmLtQ0qmvrszgAD>_-%>B)>b=$J%e@ff#_wZDOu3v-K z+8@((E?9ki;uQ7pfZyAl0j>MY%nTi*r^Amvbl5;|87)6|CEKfKNAZ{CVxj%d<{QeH zOx~S-Q(HdB{C$is^{dx~M|q}~7M1JB-kGz=q7Ki=P4?Kede!O~Lw3$nGB552gH=8CSc`=fs?K(<&D@xA5X) z#pAOBW7RjA(y_@Onc!iN_9Qwb4@>5Uz51WGBbadY9f*G+(^)I zyEqQ_uKI_0j9&hG$(sdA;=Q@DrCOy0k_YonDw=J#4;b>AHn`~c$J!eUh$6j%`zFQ3 zFOxV?kzhK@^KnFhSs>M=V#v?FET;>PDQPiR;~WfkVg-uD>3P+de{Vk-L2 zX5-3yhE}NRJIgZDDB;veXHQzK7N!@OcH3<%w5``D4A5v;60MTbbHgR^-naX%4&=R8 zSGF(Bzni!D)772KB~oI|6~C7z+^}>%wKl7D*X7>^m4%h|p&Cn+{p887b{+05`S4_G z){nH(-b&CFYD5EXLmmu=y|hYJ2~{5!~ocN7t7m&RnUK&=IzJvABV#_<<>okF#pO+?MXmSo>RKqj*jCj*H15iTgzU ziQW}rsjw2aUifR;Zk5PQb$4yI;zQ@YDplV5pj0vJm}U8_*GqMto%cK*SzY|H>H77% z^K7;f^cFooHQCPg_4&4*J4Vmp=bpAdHCA|d_Yfsf@$e#iR-(lEvS%|bXIyNU_N@Mb zm}QB`%b6!ueLbJ)LaW?xZ}4)q&Kl(vmqT7P1Zg~#kUn5zE1|ViszZf3Pbxf1L7_IY z@w~Wncx_e0izqMZnYZ#w&Qh$tdU~%|Vrs0X7x5t8_{+1@?^EVAznwqp*t5&2r$nqG zv-|SbU&(oJaHizYlQl1AR=-h-V!wEnci?iy$i+OpB_A&v)*V@+DE~Qm#ndAwuAE!R zIlbhwmw`}?4q?i=@86d%WGk+FcO%9A(>a};M(59;DyTPDxZPkM!nkgEq$bVn&9}ij5}`xK13QOKs(xHpbO)DFtf|)b z-sjwaqD5cG-O!=aoJkga?{6O?th&&eS*BpF#F_kWY00z6_R*wi0s`_Y1q5bu(~^s; zr-Q8vmXOSTIyNiMA!v561J+Vc5ob)>eIz_YN4Dp=-f8{p0H4j*rWnU8RCz4yoy}nt z>g~Lq{pHKo4LXtgR>#(CB{5#8-}M+i6=u*flXmfin*2}6BKdPmUtVer`ZC(JJl*TD z!HnC|SJM{*W>bg>U<;%W=l7Ys_LCR zx~(DhwiUKn%m z$A_z;J65cVU;bIz&vWUHe3)MHTDBJ_a+o9^*Gb<=ou+MGE&M}t?ZVa9cBkD*O!Pc) z$b8rICevcVq=HG0Z%K3Jz23UT$iV%?yJUmHQOgboG zbiTth4rTw08U^kAOZTUhh=qIWsPB}Td3Wln*$>u5yy&R*-mOq)bTon;u~TNz2JN+K zLV6{W1l|_@bl#oRTIU*_s9Q@)xbfradDYWX%sLZ;l^@%*9h?!e@UWNM5{7$r7fGvThGrIik4$q{#o2`Yp1N3~M=??D+sT8Ia+jXD zUln-P_TkFIcb-nWC;vR{-ns)LH$wNsHmTAtsy%U#&@KEVdUVy?M+;+ZK58%T5?}Rw z?bpRo126I}yi|O|S$>ls^rBc=7ngZu*e#}Xb4X>0--(~@>4P&PdMt>xA-mqLFIjr; z#GJJzn@a0*6Pj3?ODvnt2C z3y$h}hMZ`THI>nr(|77H^ta9DZ}&%`~-pk!h04UZuZ(t@wl5dcrNTVSUP|sz6syO%gB?e{ znYNm$+tt5R)ew2+yD8RehuxM~y?A1aN*EzyrHG?)<9)s3+r@tL%n}kRTIP}9FpW)o zaQX4~wN1&6k^<&M4fO0X%SKh>)@>uxx|n|Rr==+MoG*O2Oh~@_y{za?<=0&i z+A^z#k1o@>vhI^Tu4?Jmq{dYzmm1`ys2@`*vee>C`nOnFafN*9%RB*rn^pn>@Gn$} zyPQ1cY|-&lNO&U`25P{9N*_s@9spqzP&+A<)iw9CUd7t=~Zvw}DbF^)^mP)R)sr z<^1kD@p8j(U0XX%(D8L$30d9im5R?+-2SNesg#Wx znn%CACok4=Gb|_#AFK&zBAHe@9xyFhci8etlhqPWznPAdwpVH~nz05;%GZV`*>}Bo z%}J0^G^js*_uhb{s@>dz=izN%+?oV@UG^9(DK>Pu!?9bmCtRoW;N$xyq&F+lN}isM zdeM?g6H6M}C2{1?4PbH!>eo4Em z^vnAFblqVg?bu?OjO>!v&pz1Bw)|GINh5cb=9|bjYmc7JnU`_@S;gdAjGEwzjz+EC zckPxh6jdG&Q)R_WYOlx47Il*jyM3)Mah}o7OzS0!K1 z=~kIWuS=Ir$0_cb>#ln;G5Pz$?IvVtNrT_%OT7I|-J~OYUOxZ6Y=9kq?xvE|>>-nN zgPtqOL$B;wJkrF&`zo;wh`WL?bG*$Aht%X<@T zcZJp@P2WPAqGfCJ524=O=)>)Gs|^{k*QN>?*WAqNsPy-k6`~-vFD)(m`pl(e!Uc*? zVz15)oiuCR#rRzO=L04_azj%OcI{!?#LbgebXQ&Ae`iCZ=?eV>r>73dIWM#|O!^u& zEG0KOk#9VVY*Q9#F5fhw_dQl&@8@UJpC+a*o~3y6(#aPq2d=nLMM4H}N3P!PeU=gP zkI=fn>WE!!_uZ99A0ID2XSU_Ld;AQKsVX|10_znD^ek;p&Fs^iMe1~-KHO^g&8Vq& zXa()4`qi>I%chBjof-J&%v05137cDyiHB^ifHCuJr*_~+M=y~p<+ygSKO)uPdAV+uau{j?RiS?wDYf`83Ex_jkhkAvsU6!t#c z9QaeG{ZRPxq`AXHh0nK~QZJdm-F4mD`_0u0$z_w*F1!3uLjHn_vG6+krt}$^Hsl}) zH-Y_qTZidu>sde4w-y)LWC3%GDd?WU=qv{8n0%Itafr>=g|<+Rd+WAc-u?=G!RQobXuBVBRVwf5N(uf3)L+2Vy$CGHX) zk~@mC`&ykdSEu1>h&v`94)D+1@ZSGgMz#8~oxQl(>5<1QYL=+p%UrD)^y99hWb%XC z8JSs=KNWQyd)0EGJAF?1Nt@BxuO&)mC>10$S5+0jgfZMGoy5_uI4Jk4=&4s7DGpgEHg|sg%<5eO?czyA0Qsa|S7y@BLF7o_(*&H~7WwscJtr zz}TG>99Y#fOsD1a%%-Nq9Wm;TJ8{~%q&zUSI_SkJIawbWbpxF`pXDD1l=gNunxqRz zMf}V^=@O@LO^@P@|o<(2j ztD~Lyq7@;%thZOn12tnxOH_1*YOP(e&CV_;k&R$#}ZAX#L%IH+7%Ffvz6c>f2(=e=gm(>0_Og@D2L7-^=(3kNC4pob{ zRQRP{T=PtOqnL*AOIuUJ8$nN^svms8AAX@>aYoUJr3pa8aYX*EFkwQIpb3gF?z4upEGrqM2Nw!h1s)y zGtW6XmOmMEeP#N#&U!!2BIQYST|xUV*ZJ~gI#M(0-`AYp8FD;md#P4Up-}H)(+e#U zyHDK--LbsU&!~}-Uz$cqQ4kS!{wkzsIQdfUvbNt-m);Z_jMy;Qp}X#Yu&=tsvLjD# z?;Uy~Ta$8P^D&P#WlM5vr{&5i(gNCCom`nsz10_5-s>-&R?h5kO}F|?nS0tj_s2$m z`%>{Oa!Ll~gxG4x=skw`H?f-QBYuT>w5^>KINy19WLwV*08Z3lksFPc7Rcp6N^%xZBB?`QGcQuWtXS5-c8YIy~;t zsYelqrUvd~tt7mwyv9RULNzL`mzmj=8l0rflvgnQDNWrXRCi9`^wDW2JnFQvAn~W9Om#2gZ{E+{V zDKLNiGYf@AjSr2~3d(vqJG`_;db*}LSJ_D)8Pv&h94b6%fRbja}7rKY?|M}C{B z>dvsEcB@vNk-j+Z94Wr4*=+mktlaazuG^luR=+ddeRb}M&G+3uJxzFI@!{8SPppBY z)(ge`-M3y`$#9=sqQ!jmTuZBYecO}ki!x>wZ#unKD&Upk*V>bNHx3?@aF6e4^^j(4 zuN8?P^+s7=NO~%{>&2t?hiOTY34M|6VJQ`58uvDT-k5Z0?={IgYtwEjDrnpcD;m6N z9Gv}I=$m+BnXXSH?Usd)&JC z;r?I6;-Y?2RWgUqbSi#dGIdtQF*CtuCa$0pVubf+Z z?YqFDcH^C`omyYM#w$kY7RF88jM=3PVQWAB-GJmq1p0mZMhE-mk(rq*qxghUUBWt zmDp4F7O;@;%X52LqTo)>pX<89)d*~+!|^t>)a?LO5xTYSMOty`6T zC$zc-u6}#yD_(S3^;*G>B9h}~?b_YRc5#fE_NNy&7R}0U>pHyRTH#K|Ya&A5rQ0iX zrG74}f4HaYit$1*>AH$baYEq<0vYv=j2E)O)XCrRsa+JcCh^sK%J4y|TS~6}6Z|pM z*ucR?_Tlt;LoxrNHP37R8D4XFw!N~%y!ly5(@e}#53Z?rB$L_l{kXKit(r|&pM0NP z7=L53_yVmYgZpB=xaB_EoGVsboMM)jD-qaJ;COh;CXGT4Cwli(KIjahqH+0^Yx||)&7x~UT;}g44q=N zy9Fz%B$@N4ew>@smtc)II&&vX_R&}qy}MRnJifvGKg-W z7^Fqdad+P@cXQ8w@I2>-d7U55=Y6iZ=DNP~J?Hw!)J#F+?nb~w_#EFR7{$^wnDAVd z&RQ*IV?7DB^!no@`y^Z%ox3d4A0o6f{}A40aF#E+ zWmgKDUl7O|wX0fH9k)Myvgy<5g)olQvhF9zNCO2mR>&ZWVQ*-w*ng6_j$gkJ%CI|V zx?7dpv|!6P6b1NfpW}@dV;=-(KUY(&Q@*X9JvAktCVeL7hM^T^K9<(zJxCP(L212pD-8M#)R}xs~E(gBV3>= zHDwdLw5Kpu8pX4)>Eb{*vkPBAIbV#@u8~^xIG9;@l22|&mWeLrOL~3MkvE|MViHwH zHyiD)#=suktv5oz^xKa|EeN1WRJ>NN*K81&Eln9~4L86si@{YPcl16jBsc}J>zEJ} zrJKLs&$sTf0^Y?ufa%|m8|%8yUH585s8kyQPCgtTXg+@by#Pad3_pfbpF#f+V{i(i z7il(zT39DgchWYuDxvqo!Z{K5KDf(MwNgb|`3afw>&E4g*NQP0mkE)gmX4aTMu)z= zm3C~+dUYwBRUz0(W!Y0ntAyw=DaPaNen$|?=8zaaoXY%GDcf&;0(vuPd@anq=yjFk zmw=MA<#AM{_|*Bro<^Va+Ly7pPeQJe5}a*}qOtnR!E4RDTCp44%R~b<6As6f8dp=U zyhW&g20q|p3DW=kWlr_P)r$FBR?Ta54#UDjn9J_NuaSj=gG-jWe=IPBHxtKJgOk9O z+K?e3dL>=Ahc8P@Uj&sw6HJHlwIRjr=M zt5cRTNoA+Hr$Vysdr+fcbuE4$s99Iy<5A99i(!}s<}#Oi4sTPM>Irxqx1@1fUH;RL z(?RIxQgMjB?c?C#&#v6^o9o$%Bjdi@Y%0BvdDzdA^rS9b614+u>ouEiG)$+X2Zkk% z*B5`xesA`Wo!Yoo69+%(tDn-+Z!oQPKL0_?M5N6~L43fu?JNuNFJj825L4(;STauU za-a3|HKAmw%wr3loAS>MMd18znxt)dl)v93@cJyX9(|wc&QHQ~ucg{W4@Bvhl-v3; zb#cVkyVPz#l z27fq5?0mM+juO}$AO`MW9orzebv*4~NevF18qr8~!L`M0vuAU0ccZNN>Y~Hc_5$Cx zoB66vu{#V_ZW6y{&};hXXoe%zmR1R<%9Sl*1Y+X$(E*Q zv3KihYg(0HblX$4WUDsoZs(}YE0qY@Z%G~&_d`QkE7tQ;WuE-#oI{3hkIfAWZnguD zG6U@uoh*u6XzOEU`R;8y5ntv;ylu~k3xLv#x(jBn4Bmaz-@hpor71V$*{%NR(92ru z4w0G|{1{0hIrCK}Q(v9aoI(m$qeT=po;@k@O?7wMxO40g?QXYEJyE3N%xdNgi%m2A zvejbkzHJe%uZ1VsKfGg4M<~(bXlHuGirF?brlnYZ&S+#w=ox!8O9BJRvY;EP)l~yn z6rC`ienWboS8$CKUBz{-Bg;J>3NG+SFT1$sLgGj7qTRThaQT?M2gD__AEsU$+3YXS zkcawnuVJEJ(nGbQba5Ih*62Y{g_9ecfcc7}U-X#wW2itKX6j`cS*u#G;zPh;R$wMu zvtx!%DZZ_7Ni;H1hDlq}uP%SyY8eDRdy?|!>dZN2z<4CGHe-SimWRzE5vm4?4 zZj1X)Ny}x?*-mr&eC2n|UEq(j!ZZ&qt7}oATsF8i6?j0c7d@}tvdf@Rjo;dROOpPG z61XRM!Uz~hJB-mIaL280^L=EN#KvjS7@w^i7@pweZ~B(VuS4)TR+o>r59;{lB{Sdi zXm!@P;B1@3&jln!6GQY)$IJ!b-KZxpOJV~ZqH^_fF%R_f4?5}M7YN^<7zvfqP)QVn zfJ^?jkF@N5uTD9RGdqcU@%Wj%RZR(OsE~|}vbo3C;#0x|F_AoJv5JguTe+)UAs$?` zi1ItvZlfja3SA+QaSf#x)s0KJX^XA96Q>rJ;f;*z=8pWA3iEQ~_>>*-rLFCKx5aA| zKDnM?e#uZD`yWY@+k^NSbyK-!AC~N?-cvbTEx9*GcOOkUnNG&8fhq$ud)WCFM=joh z^|e^>kiN;7(X*DJph3ADAzk&CkJy7jm%5Q(+oC{Eg}>-7lh0&T``+ z{A0IduMgdSx3e`LWTnheP2i-4x)!pz#XQAvAdrMY98;#iG;QAK({G z3ro{K&n3g6)Y+j`G(EOF_ncZVjifA#n_k#+YSc5}soa#?c5hBz?+rF~+sstKjz#h| zA+wf*eu@veiJ6}5I$XRQ=zz>10$!PaJ88;Ac#CL&0=z^60|6hX#eOCz8 z^_`YuZR1)NJVZeB`FeBE)e8Avq(O{uXU!Mcc){6jo{Pm?T-_^Y!F4=E@!0ql@6qZa3B1zN3@H=?_#bEom3V$AhM%GXomBe7^R)TJi zn%^?g$gKI>tfAxtpSXWD$U;6eDdqZMGWl7eYzl4oF`04ib?EtaPISX-H z&U#m(nk8)AH5H71Edgc@J(M469F^?sGF*6KRk=<8sek3PMw_9|_m?j_wm-if%lp1}>~+U8LVz(ZwayUAe*MI} zFehVT{~3}K3Ef=gsdVq2frCgvExa{E>|%T&G}1_1RMUJF5}mhlc=n2auK}aamD=eW z_h`k@52q&Xw@%fG%F~EE?7z7CLvfnL$oc19z{f`oELR;A-q(b1Z4YFz>5g&Ntx2^Au7DXjEr`Hu{1?DU`d8;rfn|VU)!$}P z=xraHL|}EcVff`jJE)fZGdq1h-(a|Jumd#QA0A}C-%REvzXP6Jk`pBXm!1b2@bGWy zXMji5ArS5pbW(QzlU%rm#iX7DIyMKevF=BAaLfa)xW7!T&VGL0lXazt4(@}(d(I1{l-*x` zZt@NycaR=nk_7+6ko!r=0pwnv1Au_|pMV4B54n_l^nD;Tmii?nAB2+=e&0GC=z*o= sG#K=+jU>7J_dorA%JF*tkpHy>FgKwEs(F8jI||wXYU!{cuv~%u3ng>k5C8xG literal 0 HcmV?d00001 diff --git a/IWRS/Drugs/output/2026-06-05 77242113UCO3001 CZ IWRS overview v1.xlsx b/IWRS/Drugs/output/2026-06-05 77242113UCO3001 CZ IWRS overview v1.xlsx new file mode 100644 index 0000000000000000000000000000000000000000..b5d15d8624cff87b6ba25fafbee1be0f5540f92b GIT binary patch literal 36163 zcmaHTWmH`2vMuiJ5Zv8^26xxsPS9Y%AxLm{cX#(7!QI_0xV!6X*!SFX&d$E?N7Kz< zb$wN}s^*+k-2-_kP%tzgARs89l+Qg{qJ1*rae&`O01qU<J!|5>?pOuSC|A%b)AY$_RM3Hm) zElU>WK6w6Fk_X%u>Goj;;aN5fXmt5#Sd$hN*i}zoD}OWa`K+FFVl)@v z(lqjisripK;L?npdYh`i*Mg}fo(8)Jm3FqF#uD&dk%%Rn367NO$NT3-I_xa&qzg3C z71_x47eDnA1}aLLACE!5O6iodq|5%=Zpbbc*8U||&i7Q_IcrwK@;dzU#n=tm;=|oF z!=l`OCn!lPl>`X_2q={T2nZFBAZH5(ds8DzqrZMKy`|__L(^`N1I^>KV%*u}#uB!d z&8xl^)y~XusW!>?SeC#KSuM=MB<_3n{XSAVN zt#wTt29nu>+NBj0Uo(p=EU_tgwWBXiq%wATEAJhmvN39FCWHkbRD|dFco15^deC?Z<6#wBp;2sO!Byp27 zg$~6G&&`#lHtOhh(|w!~I=E=hYKgPHdG5?nKQtL)gA2B<(45|xc4g6)D*#=aV>bR} z{${Z}D!({PNp9-aeeE#CG!-UHQ*P?3)5=tMP;c3|Gkoj0TtHWOP;be&{h=8-#dG=B z+=t-@}*)gg*c^s(Zey?jWZ=#;%is$Qu=7C%m*EDyo z(XX+dW+lJ{$IU5YF;8}TTNwp0b25UXHZ8Q!=Z_?s`T-PH+^Du(xF&*bV>dTZd1TCE zr}r?2vY$){RN^bO$HunOLv2Z#S8mkYZ{)?SN8 zA@f8hZa%jx=On1111Dguu@--%?U{9sYdf}tN{&**=^-PI`a+Yp z_>wxse-_I?`XCt$AZ%#TJgalz;yDH>kIgO>PHyds1JA`CLd}c18F>S>_#PB_a>)*?Ttmwt@l)$2bRiE;xoh5hP?VO(U?qhkU zjaNKblMU=7?j{{mA)2eAR+`<9?r!Y}EQ?Tst<*t%Y-=4khvZe&u#GJK5FEG3r)a!-r%b$$k2l(mTO@gm zN(n+gaRggIEt}Goxj51jqZ(nR6eF#>?)Q6~aW*&?z#82XRV{btCng?uI}|E&PCv!t z^#xvJ6P;xFCysRq1-N|IO*Dz?m1jk>v?wK|6>ZS_Id@Krw*EzrE)&wHLILDL@v|P2 zW-lmBWVV}hsK}npZi1HX=0x=7Qod20RRxt3wk5G5XQx>rs!7S(PXS}h`nirL= z<~+6NvSTmmW&Ig&$g&u)DB^~(nE8^~m)J_JyEGErpE=q@Sn5#{uv#{E`o763{X}uB zM+9MRZ00O-HDWT!zgVM#gQnFCR7cs6(LSEpO-U_xC3bvBaO%*zc(xf3L)_-x)xFXd zD)+cq*?h2y;TD%pb?HF{wif{*iNl4!z+~Q%KZ%ZnKm{I&9S}YP@&1yJ`y=rI_SXem zBNh5+884@&2(6F5tj;7E3R-X_95@lC?dIuejJZ?j+ykwbrLQvcml@1Kp`Z>P7F(ft zWwOiiMRHibr48kgW}H@XJ*h5Nt28=_*Cm~4o?1*E(aW5qb^MwDyA;=-og$^LYP0zF z%xj!BOI)j|<24gKS!@te9 zG!1Wh1J8;Z1+K%CRL_>PB@6Ru`Q;S8va>t<_i;!Y@P8A?96kKAC=3t~w+s*v)?WnT zWNrJ^&eX`r-j3n@>77N&QZ?QVaIV8l+#0$~{r=F@}na<5W%Y>#Tw_NDym%~B|$ z3l;5Cucip14ZvXLVW;=C2 z^-!<9Xjuk3JSGGb>uk$B8a{KZSRD|zou;V_6~T2mHw_M5Z*7#mt^_=6l)75QZ#Uh^ zLoV&kP*=2RV+KPcDtV2a;NYfU-y`y;CvkI zp1vb}S{N%p{rGb0v~B&+Uhma3($LeQ@uI%UF1H(FkFt!3cz;>lSguoT0Hrb==A=s3 z@a*Z6kXAMxvwq^TRE(Xf30`9R>(TSY0jfH}2NyT@IFb;-+(y3MM;P~NJ<~D(?OPy3 zK)YzF31Pf(AuR(8qX!3Mh1`dZl_vzxu6sgD z#+6!5M&G8Uk9CJ;D;j^gv_9)LmyhPlaI4*x?60glOK`s^SPhYz^3?#j?G6Xj_qe~d z(4H{8f**T2JTu+heRNg@F0bJE0%~P#+R)JB?vmiN4SDx6_yD0ALbskc5&mk~ipM3h zv~|Kldy5_aObLT+^pXJ8C12~V$gjT2dAQnmn59c^k8AGE_RKuGJ8%AkOm1k1-2AQk zH&%sN61$UwLg~;oNi6R0Ozw}mel4%xI_m;@GrX0>PC+l)dQPL~`g*8l;25>RIYK2p zYW<^wIJ+O|uE(?%Xt$Hxe#OFR3kcA=V>pSH!!GMb@w}b<-aj2 z$&>wLL9=nZ;^lr2i~r>x|7>Aw1X*n!P*%Id5^l zY+kcKtDQ^&X&>z~(yqkf-C>TQ7jSxo#;&~*)b}ZJ>z{FKhAM7!Bk8pF4{i`_YNlNcNN_%Z1 z>1$Bq=?^=h>A%}RX1k+tyTgoN46VNrg--S}GhnyFL`pM0>1nrN;iCd$$q8bVbO3Xh zg-axx9fpU5B|z$(0%IW_s!m z?H6!|swla7X167vEL(bEg8kaTSVdP8I6GfK#!|lg5YI)*{jIg%(I}V=nSiwG&+-VP za*;~oGHR4NiM+#^!2WisuNXxaeyWr()|Qt3+L^%c(Ffki9`WWGM%yBluAle|=7|$c zJnVj_P9Qbi8ev{W`@loO$%JYcixQ|7#yQJg7>USOjc6o{<$d`{3F@lRiJeUFXETDbqO2CZEFjzwJd5YXFkRxTdhK9s`FIbWH;~1W?97P(En5i?`cI zERV{%O<4O^Gz@C~k24bbN!T*J`zJ_Xlwj6s@euKOkhG{~-umhbW*5ww;t3*Y9wI|z zkLbs)7Ri9@%kYa%GY`&@cI?0cMf}H?50YilJfCmGB?S+YrVK&tETf_rQiuv(FEfK*z2nsv znMOfvq8qn~*Iw9)&`%T0Byr_nFQ$JTLxwf}89x(HY!KQ7DUUohWp_D7fQX~y+4Nr zed5Vnak2PYdb6tLEPBfWMWA@#x zP{xC=#P65Uc0$=$da0to&LP)+wFt82nSK>RtYS8eJ%B(#Sy>~Uw|b1yB)+-97*v9DoG z&!;K6XvSo(F>#QXo@%3h&Bw@wZk_Q7B*lQDn6kh%ZAx4`W)Z18Crkh${)MW|A^OJ0 zUBlYGS-a2lANz-k?EJb}YIc&6q9nx6yXce7gQGf0iX&k+BTx*R$*%4M%Xc@io^6((p9&cYufw%&3Mu9y* z&^O6x^FSTFYd_*5+G?52!E;zvWAV787fC7&^>DQ(eE*tc28YVrcK9^IL zXWgeRH%8x6wjv-NRaAca_nA=|M4$E5tb#uu`-j0~e%kojuRG<_CeegZA&XL8ewlvB z&U_TLF~S3NuGMl>7F-ZKY9QOXW}U-$ntm-#UO)H5)V!q->!g1zUOC)}>5)RY zh$}*o7gEU2*yYvN>SHHS=$>$n3XT*y+B%49KTWNvvTL6bT2%Tb6(VSz%skjWre<`I zhnBoTt{v#}0bwZtl|rb&CQ^ns9Bh`&o-5CE6heqv{-FNx4L(%!M;V8QA^{)Mv7QF# z6dR*5kR$xOzX@weL`G7$!i3#N%PzL;)V*ivh60ThDVDifo(1#VB&)?FYbifgRM{bH z0_8a?m*1W+)$32J$Q7hi5e)Qa4X}2e1G@+eAtaJzgZqOS@S7W#JG@dCs$DG|M^7HN zXL98fjTOAs{bPI!q1A|AxQs|di>|jX5WjNd`bO&dZ??9DJX-XVx1}RgKa~cPLkvB& zJz3lobQddS*FVInxk%Q(#D+Ihc0{<2hv+&d`^gEAqd>bC6|}uPq1Kckj-gz{q_?1b zjp`r0b>eaAn=SA7?Y?dcq~nva#YG9|_Cj($!|P z^)=DI`s+sTj}i1;oUYQv%AiHYlA|yAO?t2SU0MfE>Ar)sQ(YlXTQ5Ya0=2Q6DpfsV z-w-g_xfymz9_`O;O=DW0Lq6lT7%}60q{HSUs(}LK#Om+i$A`FJ8gKD0JgA`zR5d_- zp?IcknjM?ZNaaJVki*7~6!D})h4`8KK$1k|S{Nww{5w}J0Ozx4C3TLu9@ZXAOe4s+ ztGf9-S7Z-<{TE;^`9<65`XV~4{tkY6pywW=jCuTg8UoOfucp3};E6Shm|0FG@ciN4$_&_ExePc0m~qlumTHn)R+gu^7{tT^-Y;VH*;|LD(`zhIoB~+cM0& zzvDp`f%Ei9Zt8S7;FXY}W2x zUnICKJwi-S7p(q1e!E8=8Z^B@dm1zrL|wH0?wxf2is_4hRHRmd}}9Hhj{8 zw#`cxF_e+_lV|a=ScRy0%zb4kTt3;jXxrJ8h$8ot=Bx5Qe}KxQjp7NZm?L(dSWnq^ z_$z{X7Js6_^LY{9g!lD%nSR=`(X?2;f!q^59#c5%ebJ+Y6ltU!6jJbTDn+CP_W!9d z6k`tZ$OuZ6C?KCDjjasy#Jd?GP}&UtRf7YLru3I4 zoI}p6cUC8izpZ?1NcJbR?VLgvA)+oAMu#T9P@)pe0e%_QiJr-A$|3>Y3>?y{BHIYK zOg?ai-@#kVmW`zk+tHHI52be2{=)|Z>{dre`~#N(2*oUzA}*AJVhWf3on_`fil(@( zRtJB4$n<+QZWlI*6iCiU-ny6a+qyLYLf|4DxOT$pB!8r$UW)jSl*q2dT?FLIHn(=n z!7lS3dAPGo-5W-p7C=D1DiWA=5@ZT|CzW_TIRRomlv6PCMBC1!{GUVZ9?G})80|Ei z&h|ZlJ~lhCPy%I=qXQ`?b$Xp~M^%8bRL_^?ii|0%fQ^^;`##7w`%r`apqyFxP>cff zFSi9n@!h;V_4@~}nMx7#4Ab}^wt=TJd4Eu&ast6GkWe9EIou#dqJyA)CI(WVc9H)K z@~=CA)}ac+zlV5K@cSz`kbT==(t#FJAx0+oHi(7z=PHQy3a6n+RI%gEeb+8%iL6jQfhqdo zEc3Pqe5C=q&a&V8>7W!KAM2B?g|?kV*~UF3ena}DnW~iKe`vsy0 zXgC)u(_XO2*vqCLT7vG!%qpGFgFLraF*v^hLa?nuY(VzYi5daN`Kks`r5Aw>h%RjV zx(1N3JZ!tPIj|%}E_Xi?0w)m_*dCV`9Tgl3N$-DR5y`*n(lsSewy6a?&ug30dJPp@>7U^)Ozm3`RYMx)fH24fjO^Ojn@1# z{_E?}lJ(%{wt*W*=W8GP5JDH2%~;_lCb0mDspZ|==vvpvAj=8TB9EK0C%X|Jbh%*A zi#YzaI)F=Xv}jBhgd@^3;Ne~r633b|O2kMQL>J89au@i?O=u)Sk|6jO zlK-bX2^CuJUrhIpzbgZ8iMM;W<3fg47pT*04H>Sj)V4IvWauPgh+w-07`K^W<1d>m z@)GPmCkq=Jd>UgV8FNFBOn1BY2(yEh@I%$Mk-^FId5-CMSjmk+ z9NM+6t;NBl0{=#JOi_JclFVVi^c2w-hbC(C-Rvk}{!keyqd6X%TG1Dxl)SqN89I--YY}Qx-(o19g~P`M%%uyNrY?g((-T9fLUKk?JI$F z5{Ptm{6KDogtC*(>{Lh38Y^5EONx472rTUjX&q?^^N2&IwwB(tDiOk#E2FJ~SKN#= zw(m^u|}d>(XEYjZ=Zf5uE5$ZJBW4cP3K;GmVlcP zTs60^myhhWJu&ls5ED&V?b)cPI3UvG95F$CvCtIm@<`WZp|_uiJd35f7ivP_Ci%I| zC`p8DxuLWZBQdyS$0w6FQuFVY^@)x zXTcpGX20ctCNihJCA5t&^Q|3MNCt`>wUIQzr!t*P$kb$tj6_0Aq^W(wq z>Y{*={9kMz6b$j(hm4x<@8&H+Od#;6UFR)!ENisYf8)k<9l|RK{Q#t@hBHZ7_ zY&uRlbo}@c*wK|Q66RM4;u$uhdhP~)a1>(goBZ0sOEvwFDjA37G~+nd zR`~pO`pP;466_Q&Bm1@MAF@hdZeCQV?3xO>_H?Rg+d%&t+$c69eGf>1fCyZG|F2Ix zSl_^{EKS{RNj%=~6{hRdlB6o9YrC*&#U=%*YED|XO?n)~vZPjCXrg#~4v|UGL!lYje}Ke*Ha@GRJ<&5MovJa-6SY`Eqj*Ftl(#v+;1_ z=E9>+$NPG*(KgKI$&%hy_A}w>_I@K`DUDCAzVE`Uv1R^cdvk$-p#@X(^sr~E;$-LI z$)k3_)y1y*uEnF_XUj6j0|WWx)b;&J_G-U}%eh&j4nsx#tNYZhE5P}w-IeNkJ$dt!R6FeHsg> zY0+F)hj|JBd97@3Km$Vr@6Z>ppn@WR>FfeoViHCKkE$p1pbSKW@t#(U{Deljh&&nK zeO1}622&m2eN@>#J9z{C@G|JKm_HnW`FJ*SW66;2;?_7aacGIReGbkpR`IiL>zoYm z+<5Gk)Q7o(+j`LI5ZjjkcyThz-t6M`JM1BjJ%ZsEr|U6`=D=o%b-0fE(%}YQ>%+@L z3BkN1zOMW0W9+4S_|FWz)v>ut_6pS@KJt<>kIjbXu4h^Yg1eCxTaRC9WzE;-m%3x@ z4u|Y3_pav;Gp?Jp&yOWj0mTg`#S0r27w5m^Z%4JAsx23Yqel=HWq=5R8yl&GwDes&N-dv5U+t(|4NJzhN;Lr2S^Tqx+ycT!NStn~mLwc*Zl5O1(maHpwr~Re-;~v38VjWB4Is&DX zS3~p5(-9C&g3}z&mdA+mPh;XNsm=4wUYHc=tUZmeU4)lPW3Req!?$ZvU5}H;4p%EF zj0jJA*Cov>jna98WO0}-kHv^5#_X86AxmSILsPoen4Y?06*}oJbR#NkG5WHCJ!t4X zC%{3$s8@+u+1(1%SA_}_nb|$OTvvN-H1(MHYy;M7WJ|E{0@au$>tdzekI8#3RkoNP zP`f2C!~rj?4A3ozsr(MU>$hO~j)x!$<|%GRA8;t2sKjO2rhH1(*X11|a0+R=#lCx# zkzILttx?mG=6w<3%JOqYi3WW|ZFse?L-EMiN~s~FJ3d2LqKyqX)cgia^?Bs8o5un2 zGkf0+q;-^v1C--`bB+= zc}pdot%)2&&fP4o-HC`)F+&U&rz)nPb5N$;6Tv=Wf+7r;IO+uDJ}Re%V(G>uFvV6) z3yH?1SEB7KH0yIxTzYv5D^I7E-*`L04aJSYV{$y%uRHUrxbqE)8DdlN?AbxQ8&_fn zSABew1QF`nD?Pm-Q;cD`SIw|^`w@QoFC5R*pXrNQNO{EDnm-#otdK{(03vu;c`3gN zq4-Vt3^4uxFfQ5lZ{sg#D7xmC98V;!dxi*}r3juEBu@j0d28AhEvzgTyWgF%NS=bs z_f?B*B^+=)oJt1Inq~aY9u@DLLg;=wJvMhTq=BL0r~0Bcv~fS3A=vrp&S>@Q7T`~K z8kXR7wk_qm8Aaf`cb>~mpUZl7bK}+2H;05t22hC%o(-pRD=Nz#N+ZH8< zmKuWd(caS46N617{XGiBmN&a5#WR|3^}BG>jA;$<+PPVVaJ9K79$-$pq`?^_T*VsT z@G8LJ9?k!7c;nYnKCboE9!t1Wet5&V$JX}{CLYgc{{xv7^1_V(yFz>6r>y9Bn>1QX zqh3C(?ksJi;WB!mM0I8(i7F@Mi-x5mWh?sl?D${KAscEU%=n6O}&(jKNb z%mjolo_b9n4>g(Cy}4 zaa*7;68p-K4T&Tn)n^DoscZk`4vbIjAawJvn&JgNdh;}`ncAc+177o$DDXZOPo5!! zbYJL(eWt4&wiyb^iyJz1L&m%`?Mj)mHK{X6xOZ1!5g9hHXKEj}!bw+D0_wEW z#MST5Z0ibC+_}2;5bUArN>zwkKQ_o)e&U1KlKU#ZADrBs0;Qk?sCZ+8S4MN;iqi5? zxm_eyV^uYPSHD@BJLy^CV?W9F(0`P|iLYIj>ZAWvp{MG`)4cI0G+uiYjLT}EnmvBI z73QC)T?HugNG!-t#;=2;D1*cxobd`YfsVqqNtBbnJO|$)fc8bMI zt1BMi#gLir{n6KtFgo3Hm&7maA$J-&!r?epSExOjH-dqSfoUFYD=K_k>hy!Yg~&|V zK{%JhwC{CAE;XHqssA^8_-{K8+Q*uOt6IGI`lQeDM|jFjIr*C+_JA673E~V*ZvGu| z?^?yxmfrSB^T~rvm+o|@O^41?SBsv0r(~o}BYXG8jpMwYhvTN0&W${DeS@Xv(xAoX z(iVhdcvP-!l!2n>!u6Z$b3(W2B=>la>49r0nn^MKcigZUJricVbU$rZ-Hw_&*Yq9& zXAIq;n*JEzGg@-SAd0nGmz!1YR;x?AH|XnBUbnh+Q39@^`ztQdA?jfZ*uUY`s%j-& zYr5q*WPQ(EHJ$BQq~(A#^;);fO)Gn=)#iscJA!A+$Gi;A!;OEH)962yQ%B>S>u3)F z2d3^&V}C~uyjeA4=r%ecCuZMvMRz__LL2p4p7$C*c<5ZQE=|ufc%nZ}w?mbu(RN?j z)@JlUhi3kK!mH8^EANy1mVZ#yH=zdaNDfN=Z9eZ7oix0H;@gu~_jw&@_$O?npiQHw zsB<9FZ@4jD!edY|UT?)<_fyOBhkph;wkca(l^jH{wxu4}?w8EPDMnfL)9Q5#+_!A}h5zsXe@LF6E=5bSva1!oNNIFzpEH%&_+ zy1pPWj&#$zXJ#gW@Qk3ru_|TeC2b7=nUdGQXWW4r7uw4~pm>o=L%e5Ypnc`+k{om= z<*mPv8P~f1=r8xo^%M}EHMBdSt6H}hT%Pq5X(Yd-J8ecl;T3$3O_q%hsm^hS1>h{^ z<wE0EqQkg8l%22YxSha5?AF#ZkMNTIZNlmd+I7nEvk#f_aA% z<|yH$pETd0GLqS;IXISSq5B=UL925^2gv`{`|g>90N)nS;JzqjlBI0L0xxX!2w(*3 zUh!|U8F`Rb7@-8&OCP>50gHrl;$QZr|7|bpPkTR-L3pOo;N+DUVa&Y`WClCCQM1Sk z?enBT)O};$kwj5c95o+KKQ7|0!X}g&{F4X}(Q4&03;evjFknO{1ObFX3Z-}-9A!qN zIY`tf9nrk`Ah*Xe0UfLR!S^C2mld(OTD{5 zt-yw_&Xe|b`Corbk@7=13EyxCY#6xe527TX|(a9rs zr-cZ!_R+f>RNPo&FA#g~P z1I|dBb$&rQNMf-t4kW&Cp>yaA`F))^Qb!@RxxWO39eXK!%F_04xjuG<`74 zecFtmvojM!#!k=H=U<$dF$ON2e81FIN62Ou%&SlhdZqtEZXlv3N)+}HhMCG zbYF?Z;MHSj<8J}_^VXH>oT$^aD0(}47 zG>yz&I{Q!ef=~`5Vr>W&1nGi^1H#2)NfGF1Rstaz{hA;d_uu$kaM$XtD9e!1@BQBT zQ2o=rWh9&Sq52J!?<>jJBi`og0Xx$xC5km9J$? zX^ve#+G$6`ZAj0I_qNqn>}+lI4beP zT$;t@9IuL9rf@0cy_Fade}3@T_>?&x+slMV$(HAZoa$sElDv0DJ_q2cL`YE!$(+L~ z#nd94Mfnj>xLaSi+e#?{>h*Ma#9Lv|WmKx)_%8TA4vxou*C;=cqfz5IIg&v4akkc! z03tkc#`xiw!3L`~;$K+v*6#-60e`l;IPin8>o^4te}*{pgBpt1_qJRe>YU&5`;w_( zJ5WJy3XPm}bmasUwXYWOt>cOF-T!R(2(((c+yZxEPw~{~n<~=qdbe|L{#93a>a@A0 zD61jNzlNk`OK2PqgB`3#eE<}Sbk8IHDT$*%9)qst_x)3<@gew$RoyYj9FO-Uh^la*_xc$K<|_SV z^JUGz4)d+?HzJ)?!N$uAl^Oj!4!P@}Ii{uC+*KxSLD~=EUJN3xZd5pDdEy}q1634m zR5#VqFBf0HTG95;$o^7wEAWTjV=0I4gd?c7^ACh0E&wIsDoBX~l_f3(HJ|{PJMvN@ z?k-@4QV!=;)SwZNRn*>R#qs6i1MmC}?<1O05LjU0Hv~&jYQ%u!_`ew0CtVf|*+lGKS(3O5!fX8qmu3sqeBeT>(;DS&=m95)k z!xZ-oFSrZs%R8!0BvjtHsQ|)M?c+x^9{;EJ#xYh2{IhY?I$(NSRVeY*vebrP1{5}B zylCYjeI@&Fa1Ygp-s_#)EfAvi`*+6%tr3P3PrS|H7^-~z>!KONj)Prmi# z*4#=tSDRG|QQL+R{%x`4y+g$MaD_8<_8DW_S$NiyVB;aP#@yR&`&jFhFfsd(w#Ne0 zL+@S+lxe^NgpLTLTne7KwTB86cNf)S1f$%P%>XPVc=cAm&=XD#CE=}05WE7XpO>;v z@jDzMGL!Da1Hd+383{qA_DX@_Ds|9%6Zd_&w;$Fd`}=mn5PTQy zkh8#fJ=K72mlQILqk!@9OF03xwm?ijDUs=04@^)p9e~~?_)0>%@f14@#(@bWv0nZE?qO#Jb zU~_MCLpMH|EyOVCj|<-U-#HTAd)1WB%e>n42rR5Yz(4|-MA7aaL`~^>paG8<8X~U3 zr(hC*nQY37?J?6a4_?*M@4WwOhWOnK6>&TolalbCB-aNMOgXD0e9n*DlS4^dxXNqA z97li;7FV9Rk3aFgx`A4h%M2{V=N8y3u&)9vGRURI@2Ir@wh#dn*><-pH3fEIs<6~{ zpxnOq!H7vM2UNF|SfRZlXHfXy#M_AOEkq58)0*tbnW9TyzRSSS>b}TZbNDh8a9FYw zA{W1`4j-`mJ_YCt{{zJcd+m|B3R7Ssr3r`Z^*53TQ%L!UYprKarg5*>HNT^JBLLMy zm(TNg-?X-PBs1rqI|*Ke%#T6%WfD(BP8zkMqj=dLlNhWWf#SkX=TPx9-Y8vKJgs@f zBv%%6p}XFC5f%IkU_nLr;Xc=*jeg}ZA5XLp^Kd3tN2^~GZ~Vj9HBWPSo8-56b5p~c zyH45Q-+pneHVqF)(%_+sl~Ng$@+ra*i=?3DF{TP1T&M}B$)$4C+`6%poAN>M%->H- zgaJ&fhSdCn8zgVMc!Mxr4V3eTD9@l|Oc0J}Bn91xHf6%(bf{g5+!cvRZ89;W4??he z%dR8X7tbG#3~g!J0P(83O3T1x1=swBmjbUtE6&YER=hBAsy5ZEGU%bWREmV<1y+W%Se~HZ0hc;F*>-rn{O}amv@?uA{p&nLj_(cN=<4 zA8sH=fYsrGDVF~u{AA;&n6tC=mFJGG>SfKL-BL_;89ldvai#x%AfzzxEU9ZHId*%p zF!ZdNH=JG=f$KMFPrU4f%sz}SD-b+yU@q-;cL`~#hW91^>l=ecF=}`HIr?U2ensKY zj)Ak6$|)Gwk+%LoH|$wm;jF0;ZdM zf`o1V$9%42x2Ws~5`th*{rSv@S_F1!#O=m+S>*p=JGFL~kGUV*r(%^D3r?&Bf&XbG#>zBQRgpk9K z`--`c5~U>`tdc3&^~6Gbi6~};e~7l2&|Hy6A?877Jytl3%!Ys3St3?sgB=cl(>Odc z$RFQ>{n@zWF1d_G8D?!kDO1dErUy1BgLQ6!%Lk7kdN;OkLo2NTgnd=QAqSn|@F2cQIr2B<#AsZ^sH?rpae=0LfjG?JW3ENN=KgUvZAZY*$U2+Hb#%?!ewa_A>1UWV4hcjC^1@J9Yu>{bn)2Iahj8Ptk>h&FoSt$m043MG3 z(PRM(E!B*n#QqPmJW1LCW@x1NTJ_JME+~4m18mUZgi(ypg>Rz`Ij~c+ToM?T)L)V@ zN}aw1Tgu>XE5iS0NaFm4X(UcfGE-W%>^jx*YnM zd~ra)Brv{Y-B~0q`(hl0tl|*f9^m^&!8vw-H$CLP{-{E6e*??|93hWIwMU3TVNkF1=HJXu}JT_!X*4ap7F z&`sIYad7i#>#Vt@Rg_yy7{&&^wG~y)Kd@Z^Of2P0j_|?{6eEpT@lbrg8sI!f_z4#> zE*y49TF^6`f%aWkKq4->tDLo8{;pk0zo=2QY%Bv%fYo8(ZqHr79(O3?iudXDh53tv zhk0X(kTw6DHlB7&+=lW@4q`5{D5q&|+#^p*>4E6&qzMcb^;DPq0+5iA29{(x1CT$n ze)51Es+Z)hV%okQxTwhrhsoio-SvF=4GK#Gjsu#wSYQjWFC&0^!UGbDGE|KZ^| zVuCqx1XoM#-n)xj)KgOm3;be68e9Mu1H)mWSuynC3++cRQAS9IG2ir2%aJL7)gD{! zJC8YsF(+kiBfihn-*@tO+qFiHhMbT5cKeMlz@pp!VVqO9Fu4@1pcvnsFpN>sjYBu^ z8UJ@|&i8#5@a4Gu-{lrRnwjaA$;L2&oLtOs2R~o~VrU)j(0-5MzH{Z|at9WE$EdAU zUQdV7`%>ixlsw)Vj7>yl5`(C`P7^szPf@WLfjCL1LHG%HAUweuEY^~A1{Hs$G@`c= zC{(Imzg<4OIZg8t;eW6k#-)H8XhLyaUS9Ybr zlSgWg2uRRU%sQYDmAuX=D#%%eRv^!}aCL6e+xe5Rfmi)Tu?1!Tp&0&8C@dhCfR77J zVAAQQF6|fEr;IexWz&%Z3#6)9G1xb~CFep3k!?CdGvBcj8Gv{uqI%`wZ~cR9=kO;j znZT6OPuV#vw9gpj{NyTRBmXEs%+UQb%&mDuiXa=923S*8Z|)-VH;+C37*)o5lQYcu z2Y-(FV`$3S`2`1T0uNCw#~EU!&dOGy1bIQucA=7ZaQB8(0$Y;W^oQY2``PgfJBRn? zDec<{)+JM?5uggf<5t{X_sF>pT<$u1KqH=o>g9lSYtic{zgWjS{4I2!D_UTts5r7{l z_?gS!r0L;Ecy4A!fSz0=sB}b7Oc%Mw@_!f;2>I3Y+@w~zX1&U0tuxkEmT-T+?OK&w zijmPU@wEGEpoG1`dPf(d=Kf&l{`z>!_T0sA_t!FS?-z%c?Zb$+(ggODcpYh8y1B#c znP-AF`W=&y8I{WW(~N|n>rGv@^okd?a{7}1&&${U{(cmlBT~g0;Qy_t!Tz6L{`~m% z{iv|`CEGwQCpQigVo|kb`!C z3)&ziLYXBwP1d2aeOz9r2uOQiCf^~KBH|tXf)d`6ZXzrD19!))+fElujYDj|JVROD9jwF&D)D$dSA4C$7Oo<`dHG#I=p46BAK0~n zmdH!w?&n>z0kq}dJxs)J+!yqpP&$*1kVm^ukO#HWQZ7}974I1q(Ca}XN}2O~sMPWJ zhhsJ}j)%}ZtJ-SkA@khjYYKQ^Z8Sg%95SteMoNte|IKx2NvhR zg1x)Dx~jUW`Kp^cPG2;ydf_0MUpog*S_LyBNt{QtxSEZb*RdaI)nBwILLxQsIJz5187kBqHuJhY#OLi{IAwu}zDB?ARBw8B zy`|jHPW;1nT?gKGt~YMofSKnF`hOY)!`#vQUr$6EV*Q^+!S>rIlC&I_KcfV`hxXt9 z__UOi2QHbKS6iD$;+ZzSyC3cc`JhWjq{bJcqccR*i!*dBrN8vts(xm!65=j8Tz?dZ zf~4&tmj8@M|AfMj4XIkGOb zm?e784QIflN4$37oYb}!6HNGwRXdD5W81cM{hjBK!d1#RfFTAJo$NUeEr1KHkmLs_ zS!w$%rkA$sG%xc5CHX+@HNvjAHr3j27uBIg1Vy|7*t+po3}XjS=~za!D=su)0c150 z1~*q?biMfoZK?xD$_{u2&i(DV&?y%*6Ni{!7>z9nd%d(Uj2!!rckDOy!acFVl8O9- z9=ZxrX$B4o7nUb!by#L^_l$r$MrSm+QamCN&4Jem&Npa2z=)WA3n`(-P`3MwE)~F z?eIrVk?Brr9}WeTN$hzDvLpZ!#@zdp9|+*0kc~+wc~ar2IqMT4oh>>E#Xv;v;V#EP zBB-G|j^h1V*`p%qH2rNVVNu|fnqI~_*|P+}KWh;>9=edF*j9Dh^#$?J^fUC03gp8G$S}^)#}D|bAxB`hx+(0E=m2!+M_#4Lj+M!j zU%d6fHM^LHd1JLHkYDPOoW&dc((1oPrPG1xddm8JSm%M?a4jwwN4pjQ=P(VeLU7-MIf;Qn7&Geva7eJlP>TcV|C4BKuf) ztGD?`kM@(GWUM@XPSyx=YpiMR-q?hlqkn}V2+(~2+7onX{#bFW)dVwLjKPof&Rm4W zQ_>v8b)4hC;LYao7!>sh=bOEvmN+hCrANgV>v`|>jxY`%9hUBqPdvIxD$~@Sju|DC z;$fn>{k^7FhP6p}uSvM9`yxMtWBb+WnhVXHnDY!uln+Zv>Tm<42QH|(T8w2COHUe0 z(w#E>-tf?E|Ht`;Z%!(kOm-l`B$WnEh@(n}qWzBOFU1mxwvHf3>LE zbee-!@j|gkyTt&r*xqvmL2%cprM-}5))??bndi3pxbCyEh8m)hGRj=!oUuu6197iP zP?X7B^LBNCVjEU|C_xdYN-3|Yc-_)ifxJ>+my3D+a+ywA>4a;KElN;xt`g<7T(y$P zET+Z(ZhDY*zCsghlc%r;upKaWuCVud0&aW)kmeUs78q?h4(08<_89Q&G>g&V*u~CV z+6mnB0hkfDS5ocm@vZZx(I-HA|51l4Nqb>!0(5Shz!Sv&k27G{f0uhCsm11e#u(@j z54}ePYm_RUn+aofUYT*`l9>C}gh^tqPP~dz*Yf3++()~QT$Yt#*xrlMWXoF>%43*q z3C{p&eVb}1a6aYc*H0^xF1!IMizy7s?a`PT9J}ffW#;tv97kYhXF7BUEq%>u7x2A2n4%3ppB5)=6#5>2r9R+jC|kG^ zG&taYe>;(^#gY@dR%gx7VSovna3u*2RWC6;~BZ z{PF8m0q7@ROl=ZH^?!xhKraLWPrsK-*C>j6fZU!M#H2ebUi& z>b4z;v-X4XbA`}5}I*?QN- zQ?#s_E8df=w0d~>=x)5cJw*_6f{Q~VhpKV-Qq*r-`7&F+cIm5{-qqz%3C1@#Y&-XJ zx2SvL_YTH&pCL*mej-I-l<2hQ%#_zJp`@*T)kS{dd8{f)jjMeQj7UmwRv4=a-@X}p zqrN+I4Y%ByVZ6OB3?R71K6O zwV{+0?v@b*sW3L~6+@Z*Mfx5?ADxREMU)NV<7e(^Lz$uRvm*l_@Uv^NkYGhsMhv^q zN}^MiRMgDVXJ3}HzuDZ`#H5s9q1@5RGe2iKvoQ>4NU_K{f~&fj}-YYRb(4Rkwmv5-XQ-o@|wV5M(qWja2QMXe>x|Q-_9xJKap3^ zGZefxe~{ty$NcXx`dK{bN9kasjn$usR-$S<-Uj<^{aUrnE~WhRHs(s>3Cs1kJ-3b= z>W%2wwQ~XE6-^Q@W2c z`XEF%4n~Miy`t&D8+9+CkLAa-o$1qNXrqnar$`7qV~)Q6k;iqJG7QyJC z8qLd;C~RL-$JjnuezBRkHI@X5iL#xd%bBwyoe zlXg1dx5mwQzZW-DMvjXb=?P~On)RQ%J}|2utei-97?dpqo_Bk8>9kjss7goM^!1dz zShN!8hpaIww@5Y?_jdDR^aj2Es-wBq@LeK4RPxKH=q!OqptHq?aHgm-;-4W%6W=_9 zTNU3F2P++lQGw-NLw$7WS^{*eNePE-56tXLMg#Ll0N zF(Ie#oQdyMN_4HNmH7t^wmaYP3Bn3stEs;VJ^_6A`#4(HbiO$)vni!ZUx>qJXZJ#b zLY4iR6wOtxi*qm385UT_hfRF}x&?gI$t{0)D+}G^1lV*Q=xi;xFpY`VA7{%2T&L$7 z831)TGOA(6(VL=)MkPD+ff__al?L2r{Fy`ZTkOw#m*h&{J#6C#Z2F)xl`mFzAtv5q zt4$1EkZ2B7s$eqWyh9JXQG_3?!i6xinE9)FAhfovGt0BV`A1eIwTL>tzq|3Y)e2)} zjdg8uo4X|kF4*Ic|{Iq zxeeX&%Hb@6A0eg^}MkYTbrSQC*B zrHgtv4eI;G$4?KRUM5bC_MG9D$_zaI>TNoDeS~%k#pKwzsHWs-yM(1F<@%NYgofyU z(dwynV>LW+!5^jYY@F{5u$vGJc!r4B(%M6QtuQVYg_IhXx~FrmM%DW=uY(Y z_5Mop1z)G#5rEKEDLwc-pr1Apm)puq7NhcVC#6w+6TjGur;e*Z^|~|TcugogAuwNNEn498t7DlQ(>#`&FjgXyS|vl8&fk&8tZ;Dp zFL8C99yx7mBm3cEqi^5A`qoc;pcm4;tNmQ9JPQ-bWOelGC0s-5P`g#QvWCZd*Fx^s zN^rS9W@PLqsZ{I2t2m`L$oa{&iA9CGbl41{9z41szGl6&?MF(Mg1`x~=KNBq63kSj zT=kJHNiFh@GxGgg#@&maC>1+R3E2jKeZS*-ucOXSet*dweSLN9jqd?2jVOA}m2+8j zIU=%goKeaB<=VY08Q0zg*&FEn-;B^xfa5I4j)~gdKMgnI?tq#Jl?q}k-?J^CkJ)fW zyLrNyhSKoSw)oNfJ({@ynz8`e>WPIOi+zn}0K9{7M&2MI+d+U-pN)J> z@qiQYV)J=-Ju*PqdIhF4gT6+z0_c5mv#)g@49>c)*0Cq8$Rvnn9Vlb>t>ie1_+CTC zAOX(z!K9u*i?jwt2avYs{U(;?kw+>RhlF974Xnr$-pOCo!OUca_>4(zdm%d%Jly&2 zje~CTybvy~lJ%ZVMvi0Cq_Q9zGGzXL7AkW7 zweppx1CM4DsTX;N8@Vv)?f*bMpcMUK!?3S{!=&K2HIEp!9#lGC9>t@#d zd7W?nNch>WAnTHQ`PfeV`vxQU!s}_wHH>ald$E%^lwezQ-+}zX~hBGCHo5(Sz zmh-of!m+!OB`5DSFW%;+_4=_st;6GMDmD7B+*0E@uj|vJwT^F#ydKR>Yg!faXF+G% z`*+7BOK(oA+Scvw54}8Y4?#LAnH{Hh@3y~yntRjqx_JI}|I}0eyfU?;M6axJ_GDbA z#!!D&NR;`q>*acp(8p`Hu$x(W_dM2>iT%7_U%%wJ_P#gP7b%k9+Mw`Z?j8A6>&FWDe(FPz7bmQ2h0*v}T$%Ll0=-sSYpI$oag zJZhS?nJFtHYn7=Nl`GGg%IzKNkNemA=ib;G@75;70&iD&JGyC`9mOi@^)4WjYLMbO^zfF8-BA zsJJ1iJf2maC-l49lrEXUFdECR+j*r`TvG_ZZhiDL0jC%O2IP4NITq8&pinf7yHamO6f!oV$D5 z8$^F1tRT*Im}Pu}alamPxW134*%P;Jl8g}&!1Y6BrMQBhVn3O)rkJ0C7kfMDbAZ(p zYjcf$pSXEH(LS2~db(bC((>y~YpKCRt$OsjP;>(cH$HW5VYUMacr+i zCu#TQTjCB13nrP2q~&pIDVxOfEelwB_H?eAe9rwL7^c;rLp}WPK!zc6Nu7%ICge> zoBxaY6;cQ@kQfpHa~n>f06Z|xc+Q6eMLL|x= zQBIGzqVcqCBsFe#@XybpaY}qSI8nb)Dxt$0LB-Wuw%mn!V0-ckJyLSqIkJC=Wgr;M z>ydbI6~T}AleuImaA+rE6cFPY!ut<-2+n) z=ZY+*YT%b40$>`k%evDks2U5)Ez}KSz$4KpY#YKzjuCS-uG`v{ahOU9b0DQ50$8OS zvTztFc)75Xq$1%d zpq7A}fJ;jK{6Hll8G<|sSrF$;s36zxpTVn3GwhZH?DnMl;7wV~0`)whVnOc^N|GPF zq~z_ozu;B2MnXOfSAk&^^(a(Q%EvFV;YnzjMJ=ALEiz^*vw{UV5HLL7Iu+x<_>Zb3 z?UM6DR80yo5KDxv9UthUvx!&E)*s$$mw3H)NQG1@g*iN(%h9k%L~Pmk7Fk&R^o5ch zTD6EJtq;(#@eNk0ZbpkR(C|DFKz^TyFG_G*m zX3wH(e&5}LI|_VdxHiOa`@9=AVn?9UX1#Tp+&HWfVB56>qB9c*ABw6|BeivtUwiWq zI!zDkiH_VhWd6YQcOzx`8G-$gO>I-pkXVw-zCDi6$~<;PG*6+5E8(Hd1!pozgkkfI z)gR1^gxj@VW@mw(Q?{EcEl}uWB|+%ok*{D3@yVqlngP3UIiT&kLzjYmaBUtOufPAfJgew6f{T7XK?84F;k=+qp zBU$W=!_)kL$kIXp2f&n2nBq;qUlN{adqGVk`2Q+$&_%cGL z+>CZ7us?H1&_9-9^Xl1iWdbm$x&zeMvV7>Hs*>5WI|W958d6^f=vA?>boV}@z!;dB z66m#6M`u-MqhaY;%CZS9vgr8(rQaPZI~<0qtxAX`qI!K(Y;sc;Hw?f*g|Ba!(#g-LFNwwM*}v<|Yfz*TfXj?SFbm1V zR@vkGeLu8yF^nF}fKfwbkeL+FFF(c6@19GxRZcgp*}j0P=P1k8yU3F5ug_yJeSf9> z@md5^nA1?wTBVu90FV}IykMeFQ#?t|NkbUXyI*lG=}oF<{w6nEh+x$!QLfwLi&M^7iBKfOW_qKAwCSqYQsUqjMb zFhqbs*1C&G@7Wsn1Hj#?%OTQ=AP;?O*lD3%4Ng0rUst-TK{(UUA4MtB3EvFZnkyxM zb3YF!g!tb_78RBQ`mWTs`Xa&ki8$dv&4VCNf&a}x|Ip>Rca7;(LI~P_S(YYdM zXCBZHq)4665Y#pjeYuY7Msc3bKSZpHN)K(s+C54iB$;$-N*7C_C(d=D#*8o^meh5W zm4Og2cH)F1UNN5jvYOl$0W{88n1HdWN|EIi0_tS~JiR!CbD|G=4zkKC0?U>T!2vwI z7Q~Vk?BwBr24s>Q;xah5y#Z60{pU14jDu$80ijT^v4#DV;h!0;Cf1(`s4r@=QL(lh zetQStd;wL){2_q)jJq2shi(LIpd5%TwSR(3jGv8Yzsyqz_XLC}kfE^kWZ;`!IOMe+ zh@?xfx=0QY>!EsB%PNzN(m4(W4CMrRqxel*KWG`_MMMMq7x;N_VNw@PJ7XNypx@O! zKZ;BN^!m|7iqO&ZpiROrk$}TsEDRSq?c`Vc0r)uyRQxbJUZ5Nz0XRVXNHJMn1VE2D zlc&4Iu2Ft{IVvZ6Mzm}oaQSEjhx=gS zYQ<=vCr~LoanpcG(Yes744tSMJ->|vD8yL1iJ!fGqL2>1_=qR&5H}NjCoMX>LTOqi z%<&-&v5HOVI18uRc;(wp{Pehq6;`oe$1teHlsvSS9-W1%y|8lVM)K!;(_mIReTaGE z^-8j{+laXPlS$RENiGh2U8|H0paG55BM;E#r%x=?c?EgJgU{!@A~kob&R6XYvtV8{ zq|3APrf@KVSukI$M&DJ44s*ExTW=)%-TK|{)}#Nc^`*aCule0Nl?R4!@*uPjo+0v& z|7yO6?5r;mqYpX04(7`LC+K`ZG7$#ZypR>2u9Wq`PqwhfY@I!yI@25f3P1uY%a`HW z!QJ~POE1$6idae!-5(MT1Qu=JG1p#%cowKgFecz-QVx7nB4tC?K@%x8nLz`~bV$L! z2k-&quK^V8YR1QH)1}F?)K=i$-vQ$Gspf0ep@t@*rc`qcFF|%;@B?a=aR=?#1_jgR zS@Y8e@DK<3Q@r9cSdT;0a%sbPuyC!SO6U@{V_8C>=2_kJJ?9bfIV0-U;fEICsl|_+ zh!mIxmw$cZr7Fobo);h|*)sZgLTK&Uo-uFTI7NzhAlR}(ug!k4UmBdm51mc8UQu7# z7qn7(a+V)(1uH!z)>$=vos;k-Pmaa&x={`)TbeF%x<(snNEK?TDm028Xu9Sp@B)n8 z;?CTjWx&N*89>lEyy+v096Z+w1+$Cl)6&{<5TM6=)mtd+lfo%UmL277nzsqnN*!&ls7DZi|( zmho2lpMRUzAi~Y;%8|p=`v&yVb1X+dlZ&Twcu)kIT!}6RUp)U^7GYG0n-X#vb7H;` z#rk-bscA72VYh%*QbLLL#h~j*L^DQ5?AIY;MO1g7<0u(*50Z>8vqHe^RS|F5qTE|x zNz0^Par*htXhBauk+P!P7NmE{RYcosq21z7TTuk>Rwy4Di2Z3N;R6RVR;PO*+0G{} zmQK<%q;V*a)O|nDgv<#b*X}wkuoK9eO(-Nf0j1;;L2B0>1391lbeg%>{Mgnxll1RsJps5QxouLj! z(bTl6qh@s1qcA>WRaT<&EBLs}_#>L!xH~}e?Hq)L@jOrYXd`|IfyBLv6 z=tZJnalo_dxAo##z04ZsGUh#BdQ*v~3FYMf^w?PHFgw_S>|xw8s$wl70@uD- z##6Pa@Q{%mDODMb_;3v*7^^Z6UFX8%{EUaE9fz&ypvw4eBI45Dj-WwKZ z&?V6!5{Z4=$uPCcU3XkQFf0z$K@# z02nrqHTIf3gK3I$A=BeTz|#At@W0}0rl^c}x;xC(#FT4?25zDi3j0_vkPWRIMc^$4e0@6YH1D@0(31XLH{SlN!H3-U&w<5Gnxw) z;i*k7K{x#um%!POkjnMx!KLZRhtMh(4*X4vlmdRnZHajX&vu~l>i`JQb)eLM@JrUp z3SY>D*D{(%2*%LBN2X)E-`Iu0r3E1NlJz&X>Mtx7Rh8V>*wv~kwU2rTj3UyEBIu&Awt$lSn(74x zFU&ewMjzDZ^faQ$0-6wipCD&;&}Ky5l~ei_nK&j)`?=ly353zTYph|eF9-Zg{d5PS z(3D(P)x@oOR9G}LCp&-C^&IZ4ip~bZ!kXbCiGqrm^hExXBf z*@DpcH~TUqWu>UBZhodsaQd{79*N4n3yaF@%}-hIjNjH6{j)J!50k_isHAf&c0eVK zr!#y|1^R_DT@Igk{-sWAN!2l0OWSm%?<2c)!&Pm8^~xbLBxOpfBP}au%^u9IcMID) zXG=t9ZinT%Q(^d!Vfb+WOKp|@R$KIb37LD>EqJI_+tB{4?@s#(X4)YpISMR|=0oV) zmFlx0MsqaoM!A5~T#|J%o&rOZ(%>51D+Gg2FA&)zkaZ$ND9< z<#dEsIB3hMu#ffox2%ne*8-d$!gGA{B{I;wk8M~etrbvMsS=tb7tvBvC~Ez$ESEt>jlOcf3V?8#zu>dK z;RV0po&N>r2g14kh9>~ww6U6RPhW%u4RK}UyND9Lm#t4xElw5nonZshQgYhvsjM=Q zgr%vdp_sKW%SQj~X?h~ORu+PXIHM}&OGtF3n`T^1)2|6}+mF;3h}=^#g+1Om!dgk| zuy@8HUB>-P@fqtM6qv-60+N9d3(e1D5`}!r1V-+62{RRhOyJ{5J~aNZz}YTJSs2_D z7&*?jJe6k=ioeRk5af?=m)86xBGM%iD54q=4a{crX2KCdQT2wcaS8Q8o3>CzG_(R> znHzB){6ebSq!8$9nIvc*9p)X;1v8L*tCFR{bJ!W-c!`9`=(>AU0k|^4j2OGXWaCqA=fEC~9;!N&33!0i z4HK0}KuF|0WH&H^)sxc>%-|)an;yw}QSC08Y|b>w7|d*29Fc`ZFBBvWhqni28rgD} zYE*c7sDZ!n3M@eUkVzUaZZs)y4G^Zr17^roV#5B{2CzLmtf4tEGDcaZ!GIlDsz5&i zVbvuGJPL61$#`=SsDQpVGi85IpRvB?YitSe8JR)hZvX~w;%9j6bHwW>o2i6B*DEQsKnbb_|S4TI&r2tMJU<)sD4xe z9a&{ia%o<2!|LCWQ6*3-5&x@sA(Sy%72Quw+|;`(#~6tG7MDvGDqjACXPktBBuVEBaTK6rUR5E#Bq zM$)71;1sR2?QakYMI39=8#F2#yF+|(78c6hOC|jJ01R^m3o`Wt`Prp|=pql+GYB)$P^&LwgF5?g!v&rB(K?5l^=(b)xcAzv z?076ZbPR#=T+tSou<4@eLjm*7GW|e-Bsyb+vt<=v9N`jf#vz&1wc06d84%sUm;j(@ zBGFq08CVt3x)_W$d(O5dJ3h? z4yK@b^p+7~pq=$|e`rQl*UAl17%2}m5K!Y4j8S>~jed};eu(C@YrqqSGE1fRl2!B{ zqwxxU&TKCevd~pSVlS0jRwA?nq`90uS^Ru>oN#KHGiAmhnjJCwxmG?Owln7J(u4*n zl2#P$B2=|JY(&pn$dhj>`xI3u3}OX!lzW^X8JdrbSOIhNcdQ1?qZ)-w_?r~ovTpu!K z1u&8OD_C^<-2sokJ0QFc-D7mg`?~`rM5%c-R(RWTAaCHz0Apy1s)pS zlRU}1=i-4lgdEIl4_Re{krEFo%OSiVmxR)3dZ{4G=<_a1Tu0>NzRvm9e&~eMk%T%= zZfs#eOWa8AE<~Bi&;wxQ&ZtZyg0;c*0K34oNNjW9A0&ME}~C35s07st9(Czs{fUs zSkaf7KQ7XT1}=QcE$2^9nlE3UFIt+P+zhQ^rNZ~KNGa!M^pmIucs2spa!mjMz9y6& zI2TysejRJovZfs8Rci2G+M*$%;ZN%xUM_cEFJe{2YW{ex7f{}{)cGO8tQiU?`Tl8Mzmff?N-?6a( zXBY7={n)nx>IWLpE4(ETTMxw6|HfJZvARu7ue>4GV?9Uff!x$!8qBWvT97>5b??mO znr@%0cLS$Tv~k{ye!gWk*m%WWc9(Ty?}JngylfuL+c&1BE>{r{2a-LNuhqYsVO>~v zux(hkhXz1aOpyhC05wP=f=$jp4W&bEC>*c^VKy@M9B)*X%xVIkRNax~54+?55I|S~ z?=$6ukWyxWn2ZbLH3g8On?j|7a|ulD*KszUYA(&CgDpE|3MS*i*5ZaEHAo`y2^I=M ze-b$Ev_+{kQ-_@7~+drAY1J%M73&4A5EbMXy47^;IuP;NA z=O+dsd8V-&tR(wwgrm+q@fTUK69`r+{@~vckOFs2QqY)RM)I%NP z8V?g5LEVac4tIq)hy!hdTg~ub_M^BT39x**o3i-`!v`fZx}dtoqgvg*p;YiBesrQf zuL)ivcH2G`+qH|1Ag|;gMt(&}Z-wFSML~*YA4BaTh@m8!B#okE#~AcSO&(${B3;Cd zVXvg?t~;nG5~mHym;I*>jo$dpSiDTEE{b6H?bCG-OdtplX_q04zK!H;}9z`>tznN^_`mx zbZ8HEieK^R#Jl4f5%6pdGHHpC83WFgN#J*U;;O-v&;kyfeNluw%JMLG;&BEHzg}lY zKxtMV71uOo9^=wDMIbd5g3@mYChtvxhn)7I&If*AJ968(^`y#3*aqMaddFGNh-jl5 zMcS(Zgy4d@dq%&(5&q?AH8z&Hba1w=FjGFL3UGgDdMER> z^XfrjQQ=#n);VEo_-=f^Dy)EJ;zp8SbAA@bz(%ZIK@%}^{v6nT_J`Vi1*NAF<&sH> z&Mr^!p}FiBtghYf#|cdI$6;`f)7BiAGSQP)k5G0Tw~fK%1M3yaJR2%JS|HuJVOG<^ zk#UTUberorn(Hd`sOS>$YWbzl)7XO(v%F@`I*;kLz_Lu4xW;0K#aT{8yBv)nhFF=f z4d07r-||(f>X&iN{iE5I+EQ~guSC_me$`~5NeU)-R93M8*IAs%xQ|DygiGNKeaaeP z+WJcpW$q!Tgi}`^*xPq}5oN5}ch&<_1I|~-Nyl7l!bizJI&Xa4;lf?K2pMzHpH;iJ zLR*$-W`S+nXcICHX&z*$cT%tJ047B8`(BD zJVz(J-QN35N8{&`yJY}KsHs6`p=6n z;w-wJKv(2e6i7Ngf7D-Ok5+B4A_?mn?GD@6}`wL3<7byFQ^)#`A_dlMBecoIdUUY_>TtUTNjlTYMqp_%ba-o zlaNL$bv8K2vmYXSrrFBa4RpxlpbM0K_WFa1<<056)FpNtC#+6v#b=IO|L_? zaoWr?BkRbIg}U*gLC8LHH0EmQ`Do9czRtswoPf2s0Ua@b#?}VP4N^A!Y>H!I_Nkjy z$=478UB5M8l-)mS3b)WFv?rjZoTffoH={ZnU!Y#Q`A}f!IFZR^4jrOk_p52jRd>Vn zc5L-t=yck(Imz{=j_Y*6c&R2dxD-~<(kx*q!B4oBrFu$^a zH|Vj)NLz9+NU86wLVhJW8yI?c>(1kcj)0FvBA{&KC`Ksy0D=9{$@;nCOf#wWqRZ`Q z-8+dR7CNrBanO!y#8t?Z)&7Hn3JV?+8a(WQV|763puOvup@3mXYlvy%;B*zv9G4Kf z8OBYLO{ftg@>!e0XD2lNx#@xE;2dj`12LbnrkQW#0!qBOdi-{2(^XL0je)EnqHJZp z9Hy#nWaxU*I38dz9otVl^u=s;2Hh8(j+x30Oy7q!gmVcy{zYqB-f73(>5LzQc5;UT~wwRF^X>Ggv<~Jy5bRuKKN}Or(s! z)3(i@%C#>e`ehNPPJ>HiZz9cQ!3|g|qq?^=b*iPo;_)8Vsv6nAp72^KHiE3|=A3w6 zSvI1#(OEu~H`iUU&MP_&ZBb*~(22i>fB88b)Q}h>Ka*V_){*%?-}mQ`c-;q&gDjFfh#2nU54Bs7Q9L2ya*0kohXK5TY{ogw#c4F?YYA z>r{WD{A@6dEk#yCA}7mx-A6acK-Ez{yTTKMg^+9M4!;Qak_3j3E1Q)0F7E+l>Jf)H z!#1f7MP=-xk0EXX8;X9DJJ88n-kzUvz)=w3s1ioYDVr z&z3>bF#%pCqT7n3uj>IjN_04sXRLB2(_AoKDg`gAYSI~ilz`#0S5FL9XO9uw}zh2X0nyh;O2z=gslNkW$Ns?e@ zqbn?kM^NP)n+Mj0XQqyPtb2plEy-;VUJxJBQ_#^NtmT9>dPy#l}p z(&-B$wS)XBh%YW2jS}9q=u?j0F!)0z_`88hy#ky~4fL|d89BwKBZ`!Qef+ZY#Qmd; z*HD-L^u0s=`4A2Ev}D`pavwR2WDLLbScJMyZ?xi3n!4q2OD7$RtT7WvY8WwG562*N z;`$c9)`>c_wV;|9oeCP)NCZ9-^1f56Wef$o=Qw0Tq(bG>r%p1?MD7Eb&I0X2)Y#%6 z=KROln1oQZoOl!kn<~OaP%F1={bY5VS;o?_EwfoqDq-LJ7|~t zPNh}Haq#d@0qPHVO4Xa!6?FbTVbaVLPh@o#!Z@bhYr<)y+`uSlsO_Vi+amCUsHvp- zvHQtl_5rsQ)$kX@?2YvEap;26oEkFIIq5$Q-Mj7hGJg*L6fNB7AV%*bNG=-Bw(^F`!XcOpPnS0u zRR3{~xcY$Qsy^HKf@R>3Ypnb1Rhy}$3$-8(;-91w#a@mIES6zYRm0DpcX9Iw*x%4j zST!bsSK^}{f&a1(^B*tnvKNT2EWitH4QGa`k-Y3FH*U50b{YB7)%)cpXve>k^dh- z)%b6d{qM^B+kE@xBqF*22vD1)iku+U@Nq%v%9e`}jeLr$L8hrxccz`dv_N zn4EH6-n3lrUE}sAQ0D3~Q{@*>G?G21_aKUFiyG=2kv$LcO_LggBeMPtdvo(JW&|cE z8O)<3-s9opE|Hn!%_Zg%+|Abw1HKy&J(=(-<|s=-Civ#N-JRvBm9Pb5YQS@MKWo9E zODFdFuu)-VDH7FUWaaakQt;7!n^gCif69{dVfr>H;=}foRSsfx%g+V6eB>XaD&7AO zM!xM4#Nt6%cltgyHM*mdwj#5)b8W;Uxr5V-#r^WfjW1ixZgISzARtLFK!*ktj)tI( zwWE=>qmH7Rt&xM)Uv@s0Fe2RpKoRz)7_Jvz#iBy4TLaNJ^dkZc+ON{5)mC`ITJ^2s7W{GyJA+)mTd^6^K^87!xY zGp8zTB)GI#-&X*M)VFSk@HrNUD=_BM1CdbwFZ8N9TNF0<{2LN zZo0eHG^eu>f0lw@eCo^43_bLME-L{Fh5>>B6fF!$s#2e($bghsJn*M6;1>$;>pvep zz)1ks(AyZu+S}MVFzDIZ{w4cA(Sml{AFqLbM+<-1Z-qY_xx6`F+*xpR)M#CboZAJ`?;a%kO*H{$%;{%A>~fl^81*OKUw}fN#P$B$*=#)^7~wcKUw}PS^kHGTKZpEeitzR$?|7y z;Xf?>^8d>6yVCGamOtw>{$c4<`&X9VRU3b@{JDYh4~v!izp^m?-cI?G=Fi0NKQum| ztKWXp{F5gB3H>wX`v=PH_dg=QKY@S7Q2zia{QrN~{}WOD3I22C`Uiaa{WtjkSjYb4 i`P0e&!vh=iuP$F!0utyYKtRxdpLM`g+BNvEpZ*_=EiTOf literal 0 HcmV?d00001